<SEC-DOCUMENT>0000912282-11-000145.txt : 20110324
<SEC-HEADER>0000912282-11-000145.hdr.sgml : 20110324
<ACCEPTANCE-DATETIME>20110324171705
ACCESSION NUMBER:		0000912282-11-000145
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20101231
FILED AS OF DATE:		20110324
DATE AS OF CHANGE:		20110324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		11710205

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>oncolytics_20f-12312010.htm
<TEXT>
<html>
<head>
    <title>oncolytics_20f-12312010.htm</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;Washington, D.C. 20549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">FORM 20-F</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: wingdings">o</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="74%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OR</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: wingdings">x</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="74%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For fiscal year ended December 31, 2010</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OR</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: wingdings">o</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="74%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the transition period from ____ to ____</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OR</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: wingdings">o</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="74%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="90%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of event requiring this shell company report:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission file number: 0-31062</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><img src="oncolytics_logo.jpg" alt=""></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC. </font></div>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(Exact name of Registrant as specified in its charter)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Province of Alberta, Canada </font>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Jurisdiction of incorporation or organization)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite 210, 1167 Kensington Crescent, N.W. Calgary, Alberta, T2N 1X7 </font>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address of principal executive offices)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Doug Ball</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite 210, 1167 Kensington Crescent, N.W. Calgary, Alberta, T2N 1X7</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel: (403) 670-7377</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E-mail: info@oncolytics.ca </font>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Title of Each Class</font></font></font></td>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Name of each exchange on which registered</font></font></font></td>
</tr><tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Common Shares, no par value</font></td>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;NASDAQ Capital Market</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities registered pursuant to Section 12(g) of the Act:&#160; &#160;None</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: &#160;None</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate the number of outstanding shares of each of the Registrant&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: 67,958,302 <font style="DISPLAY: inline; FONT-WEIGHT: bold">common shares as at December 31, 2010</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font> </font>No <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">x</font></font></font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this report is an annual or transition report, indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font> </font>No <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">x</font></font></font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font> </font>No <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every&#160;&#160;Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;Yes <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">x</font> </font>No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.&#160;&#160;See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule 12b-2 of the Exchange Act.&#160;&#160;(Check one)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Large accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>&#160;&#160;&#160;&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font>&#160;&#160;&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Non-accelerated filer&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></font></td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;U.S. GAAP <font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#160;</font></font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;International Reporting Standards as issued&#160;&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Other&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></font></td>
</tr><tr>
<td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;by the International Accounting Standards Board&#160; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></td>
<td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 17 <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Item 18&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">x</font></font></font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this is an annual report, indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;Yes <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font> </font>No <font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">x</font></font></font><br>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FORM 20-F</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TABLE OF CONTENTS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101343"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 1. &#160;&#160;&#160;&#160; Identity of Directors, Senior Management and Advisers</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; 5</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101344"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 2.&#160; &#160;&#160;&#160; Offer Statistics and Expected Timetable</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; 5</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101345"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 3. &#160;&#160;&#160; &#160;Key Information</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; 5</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101346"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 4.&#160;&#160;&#160;&#160;&#160; Information on the Company</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;19</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101347"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 5.&#160; &#160;&#160;&#160; Operating and Financial Review and Prospects</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;29</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101348"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 6.&#160; &#160;&#160; &#160;Directors, Senior Management and Employees</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;30</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;I<a href="#_toc224101349"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">tem 7.&#160; &#160;&#160;&#160; Major Shareholders and Related Party Transactions</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;51</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">I<a href="#_toc224101350"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">tem 8.&#160;&#160; &#160;&#160;&#160; Financial Information</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;53</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101351"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 9.&#160;&#160;&#160;&#160;&#160; The Offer and Listing</font></a><a href="#_toc224101350"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">item 8. Financial Information</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;53</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101352"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 10.&#160;&#160;&#160; Additional information</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;55</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101353"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 11.&#160;&#160;&#160; Quantitative and Qualitative Disclosures About Market Risk</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;69</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101354"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">item 12.&#160;&#160;&#160; Description of Securities Other Than Equity Securities</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;70</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101355"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 13.&#160;&#160;&#160; Defaults, Dividend Arrearages and Delinquencies</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;70</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101356"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 14.&#160;&#160;&#160; Material Modifications to the Rights of Security Holders and Use of Proceeds</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;70</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<!--efplaceholder--><font color="blue" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Item 15.&#160;&#160;&#160;&#160; Controls and Procedures</font></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;71</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101358"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16A. &#160;Audit Committee Financial Expert</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;72</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101359"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16B.&#160;&#160; Code of Ethics</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;72</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101360"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16C.&#160;&#160;&#160;Principal Accountant Fees and Services</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;73</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101361"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16D.&#160; &#160;Exemptions from the Listing Standards for Audit Committees</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;74</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101362"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16E.&#160;&#160; Purchase of Equity Securities by the Issuer and Affilicated Purchases </font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;74</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101363"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16F.&#160;&#160; Change in Registrant's Certifying Accountants</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;74</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101364"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 16.G.&#160; Corporate Governance </font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;74</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101365"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 17.&#160;&#160;&#160;&#160;&#160; Financial Statements</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;74</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101366"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 18&#160;&#160;&#160;&#160;&#160;&#160; Financial Statements </font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;75</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<a href="#_toc224101367"><!--efplaceholder--><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 19.&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</font></a></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;76</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font color="blue" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Signatures<!--efplaceholder--></font></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;77</font></td>
</tr><tr>
<td width="77%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font color="blue" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial Statements</font></font></td>
<td width="23%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;F1 - F33</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain statements in this annual report and the documents attached as exhibits to this annual report constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Oncolytics Biotech Inc., or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts, and include, but are not limited to, estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to the efficacy of our technologies; the timing and results of clinical studies related to our technologies; future operations, products and services; the impact of regulatory initiatives on our operations; the size of and opportunities related to the markets for our technologies; general industry and macroeconomic growth rates; expectations related to possible joint and/or strategic ventures and statements regarding future performance. Forward-looking statements generally, but not always, are identified by the words &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221;, &#8220;potential&#8221;, &#8220;possible&#8221; and similar expressions, or that events or conditions &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could&#8221; or &#8220;should&#8221; occur.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The forward-looking statements in this annual report are subject to various risks and uncertainties, most of which are difficult to predict and generally beyond our control, including without limitation:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related all of our products, including REOLYSIN<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, being in the research and development stage and requiring further development and testing before they can be marketed commercially;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks inherent in pharmaceutical research and development;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to timing and possible delays in our clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our pharmaceutical products being subject to intense regulatory approval processes;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to the extremely competitive biotechnology industry and our competition with larger companies with greater resources;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our reliance on patents and proprietary rights to protect our technology;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to potential products liability claims;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our limited manufacturing experience and reliance on third parties to commercially manufacture our products, if and when developed;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our new products not being accepted by the medical community or consumers;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our technologies becoming obsolete;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our dependence on third party relationships for research and clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our lack of operating revenues and history of losses;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">uncertainty regarding our ability to obtain third-party reimbursement for the costs of our product;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our ability to obtain additional financing to fund future research and development of our products and to meet ongoing capital requirements;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to potential increases in the cost of director and officer liability insurance;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our dependence on key employees and collaborators;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to Barbados law;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to the effect of changes in the law on our corporate structure;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to expenses in foreign currencies and our exposure to foreign currency exchange rate fluctuations;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our status as a foreign private issuer;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to our compliance with the Sarbanes-Oxley Act of 2002, as amended;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risk related to&#160;&#160;possible &#8220;passive foreign investment company&#8221; status;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">risks related to fluctuations in interest rates;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and risks related to our common shares.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This list is not exhaustive of the factors that ma<font style="DISPLAY: inline; FONT-SIZE: 10pt">y</font> affect any of the Company&#8217;s forward-looking statements.&#160;&#160;Some of the important risks and uncertainties that could affect forward-looking statements are described further under the section heading &#8220;Item 3. Key Information &#8211; D. Risk Factors&#8221; below.&#160;&#160;If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, our actual results may vary materially from those expected, estimated or projected.&#160;&#160;Forward-looking statements in this document are not a prediction of future events or circumstances, and those future events or circumstances may not occur.&#160;&#160;Given these uncertainties, users of the information included herein, including investors and prospective investors are cautioned not to place undue reliance on such forward-looking statements.&#160;&#160;Investors should consult our quarterly and annual filings with Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to forward-looking statements.&#160;&#160;We do not assume responsibility for the accuracy and completeness of these statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Forward-looking statements are based on our beliefs, opinions and expectations at the time they are made, and we do not assume any obligation to update our forward-looking statements if those beliefs, opinions, or expectations, or other circumstances, should change, except as required by applicable law.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All references in this annual report on Form 20-F to the terms &#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221;, &#8220;the Company&#8221; and &#8220;Oncolytics&#8221; refer to Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CURRENCY AND EXCHANGE RATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Canadian Dollars Per U.S. Dollar</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets out the exchange rates for one United States dollar (&#8220;US$&#8221;) expressed in terms of one Canadian dollar (&#8220;Cdn$&#8221;) in effect at the end of the following periods, and the average exchange rates (based on the average of the exchange rates on the last day of each month in such periods) and the range of high and low exchange rates for such periods.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="12%" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="6" valign="top" width="67%" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canadian Dollars Per U.S. Dollars</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2005</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average for the period</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9710</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.8760</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9441</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9348</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.8820</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.8259</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td colspan="7" valign="top" width="80%" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the Month of</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">February</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">January</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">October</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">High for the period</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0016</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9940</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9789</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9722</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9639</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9430</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Low for the period</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0299</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0154</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0069</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0020</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0014</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.9789</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exchange rates are based on the Bank of Canada nominal noon exchange rates.<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>&#160;&#160;The nominal noon exchange rate on March 23, 2011 as reported by the Bank of Canada for the conversion of United States dollars into Canadian dollars was US$1.00 = Cdn$0.9821.&#160;&#160;Unless otherwise indicated, in this annual report on Form 20-F, all references herein are to Canadian Dollars.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART I</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 3. KEY INFORMATION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Selected Financial Data</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table of selected financial data has been derived from financial statements prepared in accordance with Canadian generally accepted accounting principles (&#8220;GAAP&#8221;) which have been reconciled with U.S. GAAP in accordance with Item 18 (see note 22 of the audited financial statements).&#160;&#160;The data is qualified by reference to, and should be read in conjunction with, the audited financial statements, and <a name="page_ca41401_1_2"><!--EFPlaceholder--></a>related notes thereto, prepared in accordance with Canadian GAAP (See Item 18, "Financial Statements"). All dollar amounts are expressed in Canadian dollars.&#160;&#160;For exchange rate data please see the section heading &#8220;Currency and Exchange Rates&#8221; above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="31%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenues</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss, Canadian GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,973,772</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,231,249</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,550,204</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,950,426</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,628,291</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss, U.S. GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,815,721</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,999,569</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,188,704</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,588,926</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,266,791</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic and diluted loss per share, Canadian GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2), (3)</font></font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.32</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.33</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.42</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.39</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.40</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic and diluted loss per share, U.S. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2), (3)</font></font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.40</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.30</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.42</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.39</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.39</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets, Canadian GAAP <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (3)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432,442</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593,391</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,987,195</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,297,567</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29,389,636</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets, U.S. GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (3)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432,442</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593,391</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,806,445</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,755,317</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,485,886</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity, Canadian GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,931,760</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,366,458</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,453,084</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,476,340</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,773,217</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity, U.S. GAAP<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,278,996</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,343,407</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,272,334</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,934,090</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,869,467</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="31%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash dividends declared per share<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="31%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average number of common shares outstanding</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">62,475,403</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49,370,175</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,369,515</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,428,825</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,346,266</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent to the acquisition of Oncolytics Biotech Inc. by SYNSORB in April 1999, we applied push down accounting. See note 2 to the audited financial statements for 2010.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Included in net loss and net loss per share is stock based compensation expense of $3,251,041 (2009 &#8211; $424,273; 2008 &#8211; $64,039; 2007 &#8211; $539,156; 2006 &#8211; $403,550).</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We issued 6,408,333 common shares for net cash proceeds of $27,288,132 (2009 &#8211; 17,524,211 common shares for net cash proceeds of $37,052,900 and 200,000 common shares for a $684,000 investment in British Canadian Biosciences Corp.; 2008 &#8211; 2,650,000 commons shares for net cash proceeds of $3,421,309; 2007 &#8211; 4,660,000 common shares for net cash proceeds of $12,114,394; 2006 &#8211; 284,000 common shares for cash proceeds of $241,400)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not declared or paid any dividends since incorporation.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Capitalization and Indebtedness</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reasons for the Offer and Use of Proceeds</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Risk Factors</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investment in shares of our common stock ("Common Shares") involves a degree of risk. These risks should be carefully considered before any investment decision is made. The following are some of the key risk factors generally associated with our business. However, the risks described below are not the only ones that we face. Additional risks not currently known to us, or that we currently deem immaterial, may also impair our business operations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">All of our potential products, including REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, are in the research and development stage and will require further development and testing before they can be marketed commercially.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prospects for companies in the biotechnology industry generally may be regarded as uncertain given the nature of the industry and, accordingly, investments in biotechnology companies should be regarded as speculative. We are currently in the research and development stage on one product, REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, for human application, the riskiest stage for a company in the biotechnology industry. It is not possible to predict, based upon studies in animals and early stage human clinical trials, whether REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> will prove to be safe and effective in humans. REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> will require additional research and development, including extensive additional clinical testing, before we will be able to obtain the approvals of the relevant regulatory authorities in applicable countries to market REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> commercially. There can be no assurance that the research and development programs we conducted will result in REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> or any other products becoming commercially viable products, and in the event that any product or products result from the research and development program, it is unlikely they will be commercially available for a number of years.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To achieve profitable operations we, alone or with others, must successfully develop, introduce and market our products. To obtain regulatory approvals for products being developed for human use, and to achieve commercial success, human clinical trials must demonstrate that the product is safe for human use and that the product shows efficacy. Unsatisfactory results obtained from a particular study relating to a program may cause us to abandon our commitment to that program or the product being tested. No assurances can be provided that any current or future animal or human test, if undertaken, will yield favourable results. If we are unable to establish that REOLYSIN&#174; is a safe, effective treatment for cancer, we may be required to abandon further development of the product and develop a new business strategy.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">There are inherent risks in pharmaceutical research and development.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pharmaceutical research and development is highly speculative and involves a high and significant degree of risk. The marketability of any product we develop will be affected by numerous factors beyond our control, including but not limited to:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the discovery of unexpected toxicities or lack of sufficient efficacy of products which make them unattractive or unsuitable for human use;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">preliminary results as seen in animal and/or limited human testing may not be substantiated in larger, controlled clinical trials;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">manufacturing costs or other production factors may make manufacturing of products ineffective, impractical and non-competitive;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">proprietary rights of third parties or competing products or technologies may preclude commercialization;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">requisite regulatory approvals for the commercial distribution of products may not be obtained; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">other factors may become apparent during the course of research, up-scaling or manufacturing which may result in the discontinuation of research and other critical projects.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products under development have never been manufactured on a commercial scale, and there can be no assurance that such products can be manufactured at a cost or in a quantity to render such products commercially viable. Production and utilization of our products may require the development of new manufacturing technologies and expertise. The impact on our business in the event that new manufacturing technologies and expertise are required to be developed is uncertain. There can be no assurance that we will successfully meet any of these technological challenges or others that may arise in the course of development.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Any failure or delay in clinical trials for our products, including REOLYSIN</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">, may cause us to incur additional costs or delay or prevent the commercialization of our products and could severely harm our business.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We must conduct extensive clinical trials to demonstrate the safety and efficacy of our products in humans. Clinical testing, in particular, is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome.&#160;&#160;A failure of one or more of our clinical trials can occur at any stage of testing. We may experience numerous unforeseen events during, or as a result of, the clinical trial process, which could delay or prevent us from receiving marketing approval or commercializing our product candidates, including the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 25px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our clinical trials may produce negative or inconclusive results, and we may decide, or regulatory authorities may require us, to conduct additional clinical trials or we may abandon projects that we expect to be promising;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1348">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The number of subjects required for our clinical trials may be larger than we anticipate, enrollment in our clinical trials may be slower than we anticipate, or participants may drop out of our clinical trials at a higher rate than we anticipate;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 25px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We might have to suspend or terminate our clinical trials if the participants are being exposed to unacceptable health risks;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 26px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1348">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Regulators or institutional review boards may require that we hold, suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or our clinical protocols;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 25px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Regulators may refuse to accept or consider data from clinical trials for various reasons, including noncompliance with regulatory requirements or our clinical protocols;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 25px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The cost of our clinical trials may be greater than we anticipate; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 26px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The supply or quality of our products or other materials necessary to conduct our clinical trials may be insufficient or inadequate.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Additionally, subject enrollment, which is a significant factor in the timing of clinical trials, is affected by a variety of factors, including the following:</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 22px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 25px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1350">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The size and nature of the subject population;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 21px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 26px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1350">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The proximity of subjects to clinical sites;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 21px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 26px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1350">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The eligibility criteria for the trial;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1350">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The design of the clinical trial;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 28px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Competing clinical trials; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 29px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clinicians&#8217; and subjects&#8217; perceptions as to the potential advantages of the medication being studied in relation to other available therapies, including any new medications that may be approved for the indications we are investigating.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Furthermore, we plan to rely on clinical trial sites to ensure the proper and timely conduct of our clinical trials, and while we have agreements governing their committed activities, we have limited influence over their actual performance. Any delays or unanticipated problems during clinical testing, such as enrollment in our clinical trials being slower than we anticipate or participants dropping out of our clinical trials at a higher rate than we anticipate, could increase our costs, slow down our product development and approval process and jeopardize our ability to commence product sales and generate revenues.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Pharmaceutical products are subject to intense regulatory approval processes.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The regulatory process for pharmaceuticals, which includes preclinical studies and clinical trials of each compound to establish its safety and efficacy, takes many years and requires the expenditure of substantial resources. Moreover, if regulatory approval of a drug is granted, such approval may entail limitations on the indicated uses for which it may be marketed. Failure to comply with applicable regulatory requirements can, among other things, result in suspension of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. Further, government policy may change, and additional government regulations may be established that could prevent or delay regulatory approvals for our products. In addition, a marketed drug and its manufacturer are subject to continual review. Later discovery of previously unknown problems with the product or manufacturer may result in restrictions on such product or manufacturer, including withdrawal of the product from the market.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The United States Food and Drug Administration (&#8220;FDA&#8221;) and similar regulatory authorities in other countries may deny approval of a new drug application if required regulatory criteria are not satisfied, or may require additional testing. Product approvals may be withdrawn if compliance with regulatory standards is not maintained or if problems occur after the product reaches the market. The FDA and similar regulatory authorities in other countries may require further testing and surveillance programs to monitor the pharmaceutical product that has been commercialized. Non-compliance with applicable requirements can result in fines and other judicially imposed sanctions, including product withdrawals, product seizures, injunction actions and criminal prosecutions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to our own pharmaceuticals, we may supply active pharmaceutical ingredients and advanced pharmaceutical intermediates for use in our customers&#8217; drug products. The final drug products in which the pharmaceutical ingredients and advanced pharmaceutical intermediates are used, however, are subject to regulation for safety and efficacy by the FDA and possibly other regulatory authorities in other jurisdictions.&#160;&#160;Such products must be approved by such agencies before they can be commercially marketed. The process of obtaining regulatory clearance for marketing is uncertain, costly and time consuming. We cannot predict how long the necessary regulatory approvals will take or whether our customers will ever obtain such approval for their products. To the extent that our customers do not obtain the necessary regulatory approvals for marketing new products, our product sales could be adversely affected.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The FDA and other governmental regulators have increased requirements for drug purity and have increased environmental burdens upon the pharmaceutical industry. Because pharmaceutical drug manufacturing is a highly regulated industry, requiring significant documentation and validation of manufacturing processes and quality control assurance prior to approval of the facility to manufacture a specific drug, there can be considerable transition time between the initiation of a contract to manufacture a product and the actual initiation of manufacture of that product. Any lag time in the initiation of a contract to manufacture product and the actual initiation of manufacture could cause us to lose profits or incur liabilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The pharmaceutical regulatory regime in Europe and other countries is generally similar to that of the United States. We could face similar risks in these other jurisdictions as the risks described above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our operations and products may be subject to other government manufacturing and testing regulations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securing regulatory approval for the marketing of therapeutics by the FDA in the United States and similar regulatory agencies in other countries is a long and expensive process, which can delay or prevent product development and marketing. Approval to market products may be for limited applications or may not be received at all.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The products we anticipate manufacturing will have to comply with the FDA&#8217;s current Good Manufacturing Practices (<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8220;</font>cGMP<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8221;</font>) and other FDA and local government guidelines and regulations, including other international regulatory requirements and guidelines. Additionally, certain of our customers may require the manufacturing facilities contracted by us to adhere to additional manufacturing standards, even if not required by the FDA. Compliance with cGMP regulations requires manufacturers to expend time, money and effort in production and to maintain precise records and quality control to ensure that the product meets applicable specifications and other requirements. The FDA and other regulatory bodies periodically inspect drug-manufacturing facilities to ensure </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">compliance with applicable cGMP requirements. If the </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">manufacturing facilities contracted by us fail to comply with the cGMP requirements, the facilities may become subject to possible FDA or other regulatory action and manufacturing at the facility could consequently be suspended. We may not be able to contract suitable alternative or back-up manufacturing facilities on terms acceptable to us or at all.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The FDA or other regulatory agencies may also require the submission of any lot of a particular product for inspection. If the lot product fails to meet the FDA requirements, then the FDA could take any of the following actions: (i) restrict the release of the product; (ii) suspend manufacturing of the specific lot of the product; (iii) order a recall of the lot of the product; or (iv) order a seizure of the lot of the product.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to regulation by governments in many jurisdictions.&#160;&#160;If we do not comply with healthcare, drug, manufacturing and environmental regulations, among others, our existing and future operations may be curtailed, and we could be subject to liability.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to the regulatory approval process, we may be subject to regulations under local, provincial, state, federal and foreign law, including, but not limited to, requirements regarding occupational health, safety, laboratory practices, environmental protection and hazardous substance control, and may be subject to other present and future local, provincial, state, federal and foreign regulations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The biotechnology industry is extremely competitive and we must successfully compete with larger companies with substantially greater resources.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Technological competition in the pharmaceutical industry is intense and we expect competition to increase. Other companies are conducting research on therapeutics involving the Ras pathway as well as other novel treatments or therapeutics for the treatment of cancer which may compete with our product. Many of these competitors are more established, benefit from greater name recognition and have substantially greater financial, technical and marketing resources than us. In addition, many of these competitors have significantly greater experience in undertaking research, preclinical studies and human clinical trials of new pharmaceutical products, obtaining regulatory approvals and manufacturing and marketing such products. In addition, there are several other companies and products with which we may compete from time to time, and which may have significantly better and larger resources than we do. Accordingly, our competitors may succeed in manufacturing and/or commercializing products more rapidly or effectively, which could have a material adverse effect on our business, financial condition or results of operations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We anticipate that we will face increased competition in the future as new products enter the market and advanced technologies become available. There can be no assurance that existing products or new products developed by our competitors will not be more effective, or be more effectively manufactured, marketed and sold, than any that may be developed or sold by us. Competitive products may render our products obsolete and uncompetitive prior to recovering research, development or commercialization expenses incurred with respect to any such products.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We rely on patents and proprietary rights to protect our technology.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our success will depend, in part, on our ability to obtain patents, maintain trade secret protection and operate without infringing the rights of third parties. We have received Granted Patents in countries throughout the world, including the United States, Canada, Europe, and Japan.&#160;&#160;We file our Applications for Patent in the United States and under the PCT, allowing us to subsequently file in other jurisdictions.&#160;&#160;See &#8220;Narrative Description&#8212;Patent and Patent Application Summary&#8221;.&#160;&#160;Our success will depend, in part, on our ability to obtain, enforce and maintain patent protection for our technology in Canada, the United States and other countries. We cannot be assured that patents will issue from any pending applications or that claims now or in the future, if any, allowed under issued patents will be sufficiently broad to protect our technology. In addition, no assurance can be given that any patents issued to, or licensed by us, will not be challenged, invalidated, infringed or circumvented, or that the rights granted there under will provide continuing competitive advantages to us.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The patent positions of pharmaceutical and biotechnology firms, including us, are generally uncertain and involve complex legal and factual questions. In addition, it is not known whether any of our current research endeavours will result in the issuance of patents in Canada, the United States, or elsewhere, or if any patents already issued will</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">provide significant proprietary protection or will be circumvented or invalidated. Since patent applications in the United States and Canada may be maintained in secrecy until at least 18 months after filing of the original priority application, and since publication of discoveries in the scientific or patent literature tends to lag behind actual discoveries by several months, we cannot be certain that we or any licensor were the first to create inventions claimed by pending patent applications or that we or the licensor were the first to file patent applications for such inventions. Loss of patent protection could lead to generic competition for these products, and others in the future, which would materially and adversely affect our financial prospects for these products.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Similarly, since patent applications filed before November 29, 2000 in the United States may be maintained in secrecy until the patents issue or foreign counterparts, if any, publish, we cannot be certain that we or any licensor were the first creator of inventions covered by pending patent applications or that we or such licensor were the first to file patent applications for such inventions. There is no assurance that our patents, if issued, would be held valid or enforceable by a court or that a competitor&#8217;s technology or product would be found to infringe such patents.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accordingly, we may not be able to obtain and enforce effective patents to protect our proprietary rights from use by competitors.&#160;&#160;If other such parties obtain patents for certain information relied on by us in conducting our business, then we may be required to stop using, or pay to use, certain intellectual property, and as such, our competitive position and profitability could suffer as a result.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, we may be required to obtain licenses under patents or other proprietary rights of third parties. No assurance can be given that any licenses required under such patents or proprietary rights will be available on terms acceptable to us. If we do not obtain such licenses, we could encounter delays in introducing one or more of our products to the market while we attempt to design around such patents, or we could find that the development, manufacture or sale of products requiring such licenses could be foreclosed. In addition, we could incur substantial costs in defending ourselves in suits brought against us on such patents or in suits in which our attempts to enforce our own patents against other parties.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our products may fail or cause harm, subjecting us to product liability claims.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Use of our product during current clinical trials may entail risk of product liability.&#160;&#160;We maintain clinical trial liability insurance; however, it is possible this coverage may not provide full protection against all risks.&#160;&#160;Given the scope and complexity of the clinical development process, the uncertainty of product liability litigation, and the shrinking capacity of insurance underwriters, it is not possible at this time to assess the adequacy of current clinical trial coverage, nor the ability to secure continuing coverage at the same level and at reasonable cost in the foreseeable future.&#160;&#160;While we carry, and intend to continue carrying amounts believed to be appropriate under the circumstances, it is not possible at this time to determine the adequacy of such coverage.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, the sale and commercial use of our product entails risk of product liability. We currently do not carry any product liability insurance for this purpose. There can be no assurance that we will be able to obtain appropriate levels of product liability insurance prior to any sale of our pharmaceutical products. An inability to obtain insurance on economically feasible terms or to otherwise protect against potential product liability claims could inhibit or prevent the commercialization of products developed by us. The obligation to pay any product liability claim or a recall of a product could have a material adverse effect on our business, financial condition and future prospects.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We have limited manufacturing experience and intend to rely on third parties to commercially manufacture our products, if and when developed.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To date, we have relied upon a contract manufacturer to manufacture small quantities of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>. The manufacturer may encounter difficulties in scaling up production, including production yields, quality control and quality assurance. Only a limited number of manufacturers can supply therapeutic viruses and failure by the manufacturer to deliver the required quantities of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on a timely basis at a commercially reasonable price may have a material adverse effect on us. We have completed a program for the development of a commercial process for manufacturing REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and have filed a number of patent applications related to the process. There can be no assurance that we will successfully obtain sufficient patent protection related to our manufacturing process.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">New products may not be accepted by the medical community or consumers.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our primary activity to date has been research and development and we have no experience in marketing or commercializing products. We will likely rely on third parties to market our products, assuming that they receive regulatory approvals. If we rely on third parties to market our products, the commercial success of such product will be subject to a number of risks that may be outside of our control, including:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">competition in relation to alternative treatments, including efficacy advantages and cost advantages;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">perceived ease of use;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the availability of coverage or reimbursement by third-party payors;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">uncertainties regarding marketing and distribution support;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">distribution or use restrictions imposed by regulatory authorities.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Moreover, there can be no assurance that physicians, patients or the medical community will accept our product, even if it proves to be safe and effective and is approved for marketing by Health Canada, the FDA and other regulatory authorities. A failure to successfully market our product would have a material adverse effect on our revenue.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our technologies may become obsolete.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The pharmaceutical industry is characterized by rapidly changing markets, technology, emerging industry standards and frequent introduction of new products. The introduction of new products embodying new technologies, including new manufacturing processes and the emergence of new industry standards may render our products obsolete, less competitive or less marketable. The process of developing our products is extremely complex and requires significant continuing development efforts and third party commitments. Our failure to develop new technologies and products and the obsolescence of existing technologies could adversely affect our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may be unable to anticipate changes in our potential customer requirements that could make our existing technology obsolete. Our success will depend, in part, on our ability to continue to enhance our existing technologies, develop new technology that addresses the increasing sophistication and varied needs of the market, and respond to technological advances and emerging industry standards and practices on a timely and cost-effective basis. The development of our proprietary technology entails significant technical and business risks. We may not be successful in using our new technologies or exploiting our niche markets effectively or adapting our businesses to evolving customer or medical requirements or preferences or emerging industry standards.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We are highly dependent on third-party relationships for research and clinical trials.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We rely upon third party relationships for assistance in the conduct of research efforts, pre-clinical development and clinical trials, and manufacturing. In addition, we expect to rely on third parties to seek regulatory approvals for and to market our product. Although we believe that our collaborative partners will have an economic motivation to commercialize our product included in any collaborative agreement, the amount and timing of resources diverted to these activities generally is expected to be controlled by the third party. Furthermore, if we cannot maintain these relationships, our business may suffer.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We have no operating revenues and a history of losses.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To date, we have not generated sufficient revenues to offset our research and development costs and, accordingly, have not generated positive cash flow or made an operating profit.&#160;&#160;As of December 31, 2010, we had an accumulated deficit of $138.8 million and we incurred net losses of $20.0 million, $16.2 million, and $17.6 million,&#160;&#160;for the years ended December 31, 2010, 2009, and 2008, respectively.&#160;&#160;We anticipate that we will continue to incur significant losses during 2011 and in the foreseeable future.&#160;&#160;We do not expect to reach profitability at least until after successful and profitable commercialization of one or more of our products.&#160;&#160;Even if one or more of our products are profitably commercialized, the initial losses incurred by us may never be recovered.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We may not be able to obtain third-party reimbursement for the cost of our product.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Government authorities and third party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and these third party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Uncertainty exists regarding the reimbursement status of newly-approved pharmaceutical products and reimbursement may not be available for REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.&#160;&#160;Any reimbursements granted may not be maintained or limits on reimbursements available from third-party payors may reduce the demand for, or negatively affect the price of, these products. If REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> does not qualify for reimbursement, if reimbursement levels diminish, or if reimbursement is denied, our sales and profitability would be adversely affected.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Third-Party Risk</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the normal course of our business, we have entered into contractual arrangements with third parties which subject us to the risk that such parties may default on their obligations. Oncolytics may be exposed to third party credit risk through our contractual arrangements with our current contract manufacturer, the institutions which operate our clinical trials, or our contract research organizations and other parties.&#160;&#160;In the event such entities fail to meet their contractual obligations to Oncolytics, such failures could have a material adverse effect on Oncolytics and our operations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We may need additional financing in the future to fund the research and development of our products and to meet our ongoing capital requirements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of December 31, 2010, we had cash and cash equivalents (including short-term investments) of $42.9 million and working capital of approximately $41.7 million.&#160;&#160;We anticipate that we will need additional financing in the future to fund research and development and to meet our ongoing capital requirements.&#160;&#160;The amount of future capital requirements will depend on many factors, including continued scientific progress in our drug discovery and development programs, progress in our pre-clinical and clinical evaluation of drug candidates, time and expense associated with filing, prosecuting and enforcing our patent claims and costs associated with obtaining regulatory approvals.&#160;&#160;In order to meet such capital requirements, we will consider contract fees, collaborative research and development arrangements, and additional public or private financings (including the incurrence of debt and the issuance of additional equity securities) to fund all or a part of particular programs as well as potential partnering or licensing opportunities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of the weakened global economic situation, Oncolytics, along with all other pharmaceutical research and development entities, may have restricted access to capital, bank debt and equity, and is likely to face increased borrowing costs. Although our business and asset base have not changed, the lending capacity of all financial institutions has diminished and risk premiums have increased. As future operations will be financed out of funds generated from financing activities, our ability to do so is dependent on, among other factors, the overall state of capital markets and investor appetite for investments in the pharmaceutical industry and our securities in particular.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Should we elect to satisfy our cash commitments through the issuance of securities, by way of either private placement or public offering or otherwise, there can be no assurance that our efforts to raise such funding will be successful, or achieved on terms favourable to us or our existing shareholders.&#160;&#160;If adequate funds are not available on terms favorable to us, we may have to reduce substantially or eliminate expenditures for research and development, testing, production and marketing of our proposed product, or obtain funds through arrangements with corporate partners that require us to relinquish rights to certain of our technologies or product.&#160;&#160;There can be no assurance that we will be able to raise additional capital if our current capital resources are exhausted.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The cost of director and officer liability insurance may increase substantially and may affect our ability to retain quality directors and officers.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We carry liability insurance on behalf of our directors and officers. Given a number of large director and officer liability insurance claims in the U.S. equity markets, director and officer liability insurance has become increasingly more expensive with increased restrictions. Consequently, there is no assurance that we will continue to be offered</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">this insurance or be able to obtain adequate coverage. The inability to acquire the appropriate insurance coverage may limit our ability to attract and maintain directors and officers as required to conduct our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We are dependent on our key employees and collaborators.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our ability to develop the product will depend, to a great extent, on our ability to attract and retain highly qualified scientific personnel and to develop and maintain relationships with leading research institutions. Competition for such personnel and relationships is intense. We are highly dependent on the principal members of our management staff as well as our advisors and collaborators, the loss of whose services might impede the achievement of development objectives. The persons working with us are affected by a number of influences outside of our control. The loss of key employees and/or key collaborators may affect the speed and success of product development.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Barbados law differs from the laws in effect in Canada and may afford less protection to holders of our securities.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain of our assets and intellectual property are held by our wholly-owned subsidiary, Oncolytics Barbados, which is organized under the laws of Barbados. It may not be possible to enforce court judgments obtained in Canada against Oncolytics Barbados in Barbados based on the civil liabilities provisions of applicable securities laws. In addition, there is some doubt as to whether the courts of Barbados would recognize or enforce judgments of Canadian courts obtained against us or our directors or officers based on the civil liabilities provisions of Canadian securities laws or hear actions against us or those persons based on such laws.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Changes in law could adversely affect our business and corporate structure.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There can be no assurances that changes will not occur in corporate, tax, property and other laws in Canada and/or Barbados (or the interpretation thereof by regulatory or tax authorities) which may materially and adversely affect our businesses and corporate structure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We incur some of our expenses in foreign currencies and therefore we are exposed to foreign currency exchange rate fluctuations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We incur some of our manufacturing, clinical, collaborative and consulting expenses in foreign currencies, primarily the U.S. dollar and the British pound (&#8220;GBP&#8221;).&#160;&#160;We are therefore exposed to foreign currency rate fluctuations.&#160;&#160;Also, as we expand to other foreign jurisdictions there may be an increase in our foreign exchange exposure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We earn interest income on our excess cash reserves and are exposed to changes in interest rates.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We invest our excess cash reserves in investment vehicles that provide a rate of return with little risk to principal. As interest rates change the amount of interest income we earn will be directly impacted.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">The Corporation may fail to achieve and maintain adequate internal control over financial reporting pursuant to the requirements of the Sarbanes-Oxley Act and equivalent Canadian legislation.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation documented and tested during its most recent fiscal year its internal control procedures in order to satisfy the requirements of Section&#160;404 of the Sarbanes-Oxley Act (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">SOX</font>&#8221;) and equivalent Canadian legislation. SOX requires an annual assessment by management of the effectiveness of the Corporation&#8217;s internal controls over financial reporting and an attestation report by the Corporation&#8217;s independent auditors addressing this assessment. The Corporation may fail to achieve and maintain the adequacy of its internal controls over financial reporting as such standards are modified, supplemented, or amended from time to time, and the Corporation may not be able to ensure that it can conclude, on an ongoing basis, that it has effective internal controls over financial reporting in accordance with Section&#160;404 of SOX. The Corporation&#8217;s failure to satisfy the requirements of Section&#160;404 of SOX on an ongoing, timely basis could result in the loss of investor confidence in the reliability of its financial statements, which in turn could harm the Corporation&#8217;s business and negatively impact the trading price of the common shares or the market value of its other securities. In addition, any failure to implement required new or </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">improved controls, or difficulties encountered in their implementation, could harm the Corporation&#8217;s operating results or cause it to fail to meet its reporting obligations. Future acquisitions of companies, if any, may provide the Corporation with challenges in implementing the required processes, procedures and controls in its acquired operations. No evaluation can provide complete assurance that the Corporation&#8217;s internal controls over financial reporting will detect or uncover all failures of persons within the Corporation to disclose material information otherwise required to be reported. The effectiveness of the Corporation&#8217;s processes, procedures and controls could also be limited by simple errors or faulty judgments. In addition, if the Corporation expands, the challenges involved in implementing appropriate internal controls over financial reporting will increase and will require that the Corporation continue to improve its internal controls over financial reporting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Because the Corporation is a Canadian corporation and the majority of its directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against the Corporation based solely upon the federal securities laws of the United States.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation is a Canadian corporation, with its principal place of business in Canada. A majority of the Corporation&#8217;s directors and officers and some or all of the experts named in the registration statement to which this prospectus supplement relates are residents of Canada and a significant portion of the Corporation&#8217;s assets and the assets of a majority of the Corporation&#8217;s directors and officers and the experts named in this prospectus supplement are located outside the United States. Consequently, it may be difficult for U.S. investors to effect service of process within the United States upon the Corporation or its directors or officers or such experts who are not residents of the United States, or to realize in the United States upon judgments of courts of the United States predicated upon civil liabilities under the U.S. Securities Act of 1933, as amended. Investors should not assume that Canadian courts (1)&#160;would enforce judgments of U.S. courts obtained in actions against the Corporation or such directors, officers or experts predicated upon the civil liability provisions of the U.S. federal securities laws or the securities or &#8220;blue sky&#8221; laws of any state within the United States or (2)&#160;would enforce, in original actions, liabilities against the Corporation or such directors, officers or experts predicated upon the U.S. federal securities laws or any such state securities or &#8220;blue sky&#8221; laws. In addition, the protections afforded by Canadian securities laws may not be available to investors in the United States.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">As a foreign private issuer, our shareholders may have less complete and timely data.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation is a &#8220;foreign private issuer&#8221; as defined in Rule&#160;3b-4 under the United States Securities Exchange Act of 1934, as amended (the &#8220;U.S. Exchange Act&#8221;). Equity securities of the Corporation are accordingly exempt from Sections&#160;14(a), 14(b), 14(c), 14(f) and 16 of the U.S. Exchange Act pursuant to Rule&#160;3a12-3 of the U.S. Exchange Act. Therefore, the Corporation is not required to file a Schedule&#160;14A proxy statement in relation to the annual meeting of shareholders. The submission of proxy and annual meeting of&#160;&#160;shareholder information on Form 6-K may result in shareholders having less complete and timely information in connection with shareholder actions. The exemption from Section&#160;16 rules regarding reports of beneficial ownership and purchases and sales of common shares by insiders and restrictions on insider trading in our securities may result in shareholders having less data and there being fewer restrictions on insiders&#8217; activities in our securities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is likely a "passive foreign investment company" which will likely have adverse U.S. federal income tax consequences for U.S. shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. holders of the Common Shares should be aware that the Company believes it was classified as a passive foreign investment company (&#8220;PFIC&#8221;) during the tax year ended December 31, 2010, and based on current business plans and financial expectations, the Company anticipates that it may qualify as a PFIC for subsequent taxable years.&#160;&#160;If the Company is a PFIC for any year during a U.S. shareholder&#8217;s holding period, then such U.S. shareholder generally will be required to treat any gain realized upon a disposition of Common Shares, or any so-called &#8220;excess distribution&#8221; received on its Common Shares, as ordinary income, and to pay an interest charge on a portion of such gain or distributions, unless the shareholder makes a timely and effective "qualified electing fund" election (&#8220;QEF Election&#8221;) or a "mark-to-market" election with respect to the Common Shares.&#160;&#160;A U.S. shareholder who makes a </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">QEF Election generally must report on a current basis its share of the Company's net capital gain and ordinary earnings for any year in which the Company is a PFIC, whether or not the Company distributes any amounts to its shareholders.&#160;&#160;For each taxable year that the Company qualifies as a PFIC, the Company will make available to each U.S. Holder that has made a QEF Election, upon written request, a "PFIC Annual Information Statement" as </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">described in Treasury Regulation Section 1.1295-1(g) (or any successor Treasury Regulation) and use commercially reasonable efforts to provide all additional information that such U.S. Holder is required to obtain in connection with maintaining such QEF Election with regard to the Company.&#160;&#160;A U.S. shareholder who makes the mark-to-market election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the taxpayer&#8217;s basis therein.&#160;&#160;This paragraph is qualified in its entirety by the discussion below under the heading &#8220;Certain United States Federal Income Tax Considerations.&#8221;&#160;&#160;Each U.S. shareholder should consult its own tax advisor regarding the PFIC rules and the U.S. federal income tax consequences of the acquisition, ownership, and disposition of Common Shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our share price may be highly volatile.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Market prices for securities of biotechnology companies generally are volatile. This increases the risk of securities litigation. Factors such as announcements (publicly made or at scientific conferences) of technological innovations, new commercial products, patents, the development of proprietary rights, results of clinical trials, regulatory actions, publications, quarterly financial results, our financial position, public concern over the safety of biotechnology, future sales of shares by us or our current shareholders and other factors could have a significant effect on the market price and volatility of the common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Potential dilution of present and prospective shareholdings.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In order to finance future operations and development efforts, the Company may raise funds through the issue of common shares or the issue of securities convertible into common shares. The Company cannot predict the size of future issues of common shares or the issue of securities convertible into common shares or the effect, if any, that future issues and sales of the Company&#8217;s common shares will have on the market price of its common shares. Any transaction involving the issue of previously authorized but unissued shares, or securities convertible into shares, would result in dilution, possibly substantial, to present and prospective holders of shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The Company does not intend to pay cash dividends in the foreseeable future.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company has not declared or paid any dividends since its incorporation. The Company intends to retain earnings, if any, to finance the growth and development of its business and does not intend to pay cash dividends on the common shares in the foreseeable future. Any return on an investment in the common shares will come from the appreciation, if any, in the value of the common shares. The payment of future cash dividends, if any, will be reviewed periodically by the board of directors and will depend upon, among other things, conditions then existing including earnings, financial condition and capital requirements, restrictions in financing agreements, business opportunities and conditions and other factors.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 4.&#160;&#160;INFORMATION ON THE COMPANY</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">History and Development of the Company</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech Inc. was formed under the <font style="DISPLAY: inline; FONT-STYLE: italic">Business Corporations Act</font> (Alberta) on April 2, 1998 as 779738 Alberta Ltd.&#160;&#160;On April 8, 1998, we changed our name to Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">&#160;</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our principal executive office is located at 210, 1167 Kensington Cres. NW, Calgary, Alberta, Canada, T2N 1X7, telephone (403) 670-7377. Our agent for service in the U.S. is CT Corporation, 111 Eighth Avenue, 13<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> Floor, New York, New York 10011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A description of our principal capital expenditures and divestitures and a description of acquisitions of material assets can be found in our MD&amp;A and in the notes to our financial statements included elsewhere in this annual report.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business Overview</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since our inception in April of 1998, Oncolytics Biotech Inc. has been a development stage company and we have focused our research and development efforts on the development of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, our potential cancer therapeutic.&#160;&#160;We have not been profitable since our inception and expect to continue to incur substantial losses as we continue research and development efforts.&#160;&#160;We do not expect to generate significant revenues until, if and when, our cancer product becomes commercially viable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our Business</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our potential product for human use, REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, is developed from the reovirus.&#160;&#160;This virus has been demonstrated to replicate specifically in tumour cells bearing an activated Ras pathway.&#160;&#160;Activating mutations of Ras occur in approximately 30% of all human tumours directly, but considering its central role in signal transduction, activation of the Ras pathway has been shown to play a role in approximately two-thirds of all tumours.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The functionality of the product is based upon the finding that tumours bearing an activated Ras pathway are deficient in their ability to activate the anti-viral response mediated by the host cellular protein, PKR.&#160;&#160;Since PKR is responsible for preventing reovirus replication, tumour cells lacking the activity of PKR are susceptible to reovirus infections.&#160;&#160;As normal cells do not possess Ras activations, these cells are able to thwart reovirus infections by the activity of PKR.&#160;&#160;In a tumour cell with an activated Ras pathway, reovirus is able to freely replicate and hence kill the host tumour cell.&#160;&#160;The result of this replication is progeny viruses that are then free to infect surrounding cancer cells.&#160;&#160;This cycle of infection, replication and cell death is believed to be repeated until there are no longer any tumour cells carrying an activated Ras pathway available.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following schematic illustrates the molecular basis of how the reovirus kills cancer cells.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><img src="reovirus.jpg" alt=""></div>

<div style="DISPLAY: block; MARGIN-LEFT: 45pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Scientific Background</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Ras protein is a key regulator of cell growth and differentiation.&#160;&#160;It transmits signals from the cell's surface, via growth factor receptors, to downstream elements, which are in turn relayed to the nucleus.&#160;&#160;This transmission of signals from the cell surface to the cell's nucleus is collectively referred to as "signal transduction."&#160;&#160;The transmission of these signals results in cell growth, division, and in some instances cellular differentiation.&#160;&#160;In normal cells, cell growth occurs only in the presence of factors stimulating the cells to grow.&#160;&#160;Mutations in Ras </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">itself, or any of the elements along the Ras pathway, often lead to activation of the pathway in the absence of the appropriate growth stimuli, leading to the uncontrolled growth of these cells and ultimately to the development of a cancerous state.&#160;&#160;In fact, approximately 30% of all cancers are known to be due to mutations in Ras itself.&#160;&#160;The frequency of these Ras mutations, as well as their etiology in a given tumour is, however, tissue specific.&#160;&#160;Activating mutations in Ras are found in many types of human malignancies but are highly represented in pancreatic (90%), sporadic colorectal (50%), lung carcinomas (40%), and myeloid leukemia (30%).&#160;&#160;Because Ras is a regulator of key mitogenic signals, aberrant function of upstream elements such as receptor tyrosine kinases (RTKs) can also result in Ras activation in the absence of mutations in Ras itself.&#160;&#160;Indeed, over-expression of these RTKs such as HER2/neu/ErbB2 or the epidermal growth factor receptor is common in breast cancer (25-30%), and over-expression of the platelet-derived growth factor receptor (&#8220;PDGFR&#8221;) is common in glioblastomas and gliomas, all of which are tumour types in which Ras mutations are relatively rare.&#160;&#160;Although activating mutations of Ras itself are thought to occur in only about 30% of all tumours, it is expected that approximately two-thirds of all tumours have activated Ras signaling pathways as a result of mutations in genes that lie upstream of Ras.&#160;&#160;With this in mind, Ras becomes a significant therapeutic target in oncology.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All available scientific evidence developed or reviewed by us to date supports the premise that the reovirus only actively infects and replicates in cells with an activated Ras pathway.&#160;&#160;This naturally occurring virus is believed to cause only mild infections of the respiratory and gastrointestinal tract and in general, reovirus infections in humans are asymptomatic and usually sub-clinical.&#160;&#160;Research has indicated this virus replicates in, and therefore kills, only cancer cells (i.e. cancer cells with an activated Ras pathway), but does not replicate in normal cells.&#160;&#160;It has been demonstrated that reovirus replication is restricted in "normal" cells due to the activation of the double stranded RNA-activated protein kinase (&#8220;PKR&#8221;).&#160;&#160;PKR is a crucial element in protecting cells from reovirus infection and is capable of blocking viral protein translation.&#160;&#160;Activated Ras (or an activated element of the Ras pathway) prevents PKR activation, and thus allows viral replication to ensue only in this subset of cancer cells.&#160;&#160;To prove that reovirus could be used as a potential cancer therapeutic, a number of animal models were developed.&#160;&#160;Experiments using this virus to treat mouse tumours, expanded animal models as well as human brain, breast, and prostate tumours implanted in immuno-compromised mice have yielded promising results.&#160;&#160;In animals where tumour regression was noted, a single injection of reovirus is often enough to cause complete tumour regression.&#160;&#160;More importantly, it was demonstrated that this treatment is effective in causing tumour regression in immune competent animals.&#160;&#160;We believe that the nature of this virus, combined with its selective replication makes it an attractive candidate as a cancer therapy.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also believe that this research may have broad utility in the treatment of tumours with an activated Ras pathway as well as a potential use as an adjuvant therapy following surgical tumour resection or as an adjuvant therapy to conventional chemotherapeutic or radiation therapies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The Potential Cancer Product</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cancer is a group of related diseases characterized by the aberrant or uncontrolled growth of cells and the spread of these cells to other sites in the body.&#160;&#160;These cancer cells eventually accumulate and form tumours that can disrupt and impinge on normal tissue and organ function.&#160;&#160;In many instances, cells from these tumours can break away from the original tumour and travel through the body to form new tumours through a process referred to as metastasis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our cancer product is a potential therapeutic for tumours possessing an activated Ras pathway.&#160;&#160;In tumour cells with this type of activation, the virus is cytotoxic but may have no effect on the surrounding normal tissue.&#160;&#160;Activating mutations of Ras are believed to account for approximately 30% of all human tumours directly.&#160;&#160;It is also possible to activate Ras through mutation of proteins that control its activity rather than through direct mutations of Ras itself.&#160;&#160;This suggests that approximately two thirds of tumours may respond to this treatment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Clinical Trial Program</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are directing a broad clinical trial program with the objective of developing REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> as a human cancer therapeutic. The clinical program includes clinical trials which we sponsor directly along with clinical trials that are being sponsored by the U.S. National Cancer Institute (&#8220;NCI&#8221;), the University of Leeds and the Cancer Therapy &amp; Research Center at the University of Texas Health Center in San Antonio (&#8220;CTRC&#8221;).&#160;&#160;Our clinical trial program has included human trials using REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> alone, and in combination with radiation and chemotherapy, and delivered via local administration and/or intravenous administration.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clinical Trial Chart</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following chart shows our clinical trials along with the status for each as at December 31, 2010:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial number</font></div>
</td>
<td valign="middle" width="18%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Delivery Method</font></div>
</td>
<td valign="middle" width="17%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial Program and Cancer Indication</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Location</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Status</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 022</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with FOLFIRI</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I colorectal cancer</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 021</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin (sponsored by the CTRC)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II squamous cell carcinoma lung cancer</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 020</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin (sponsored by the CTRC)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II metastatic melanoma</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 018</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase III squamous cell carcinoma of the head and neck</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States, U.K., Belgium, Canada</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 017</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with gemcitabine (sponsored by the CTRC)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II advanced pancreatic cancer</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 016</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II non-small cell lung with K-RAS or EGFR-activated tumours</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">22</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial number</font></div>
</td>
<td valign="middle" width="18%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Delivery Method</font></div>
</td>
<td valign="middle" width="17%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial Program and Cancer Indication</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Location</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Status</font></div>
</td>
</tr></table>
</div>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 015</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II head and neck</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 014</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II sarcoma</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 013</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration monotherapy (sponsored by University of Leeds)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Translational metastatic colorectal</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NCI Trial</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration monotherapy (NCI)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II melanoma</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NCI Trial</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous and intraperitoneal administration monotherapy (NCI)</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II ovarian</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 012</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with cyclophosphamide</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II pancreatic, lung, ovarian</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ongoing</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 011</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with paclitaxel and carboplatin</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II melanoma, lung, ovarian</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 010</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with docetaxel</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II bladder, prostate, lung,&#160;&#160;upper gastro-intestinal</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 009</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration in combination with gemcitabine</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II pancreatic, lung, ovarian</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">23</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial number</font></div>
</td>
<td valign="middle" width="18%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Delivery Method</font></div>
</td>
<td valign="middle" width="17%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial Program and Cancer Indication</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Location</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Status</font></div>
</td>
</tr></table>
</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 008</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Local therapy in combination with radiation</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase II various metastatic tumours, including head &amp; neck</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 007</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Infusion monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I/II recurrent malignant gliomas</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 006</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Local therapy in combination with radiation</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I various metastatic tumours</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 005</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I various metastatic tumours</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United Kingdom</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 004</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intravenous administration monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I various metastatic tumours</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 003</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Local monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I recurrent malignant gliomas</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 002</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Local monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">T2 prostate cancer</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="middle" width="10%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REO 001</font></div>
</td>
<td align="left" valign="middle" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Local monotherapy</font></div>
</td>
<td align="left" valign="middle" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase I trial for various subcutaneous tumours</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Complete</font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Patents and Trade Secrets</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The patent positions and proprietary rights of pharmaceutical and biotechnology firms, including us, are generally uncertain and involve complex legal and factual questions. We believe there will continue to be significant litigation in the industry regarding patent and other intellectual property rights.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currently, we have over 250 issued patents including 40 issued U.S. patents.&#160;&#160;We also have over 200 patent applications filed in the U.S., Canada, and other jurisdictions, but we cannot be certain whether any given patent application filed by us will result in the issuance of a patent or if any given patent issued to us will later be challenged and invalidated. Nor can we be certain whether any given patent that may be issued to us will provide any significant proprietary protection to our product and business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Litigation or other proceedings may also be necessary to enforce or defend our proprietary rights and patents. To determine who was first to make an invention claimed in a United States patent application or patent and thus be entitled to a patent, the United States Patent and Trademark Office, or USPTO, can declare an interference proceeding. In Europe, patents can be revoked through opposition or nullity proceedings. In the United States patents may be revoked or invalidated in court actions or in re-examination proceedings in the USPTO. Such litigation or proceedings could result in substantial cost or distraction to us, or result in an adverse decision as to our or our licensors&#8217; patent applications and patents.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our commercial success depends, in part, on not infringing the patents or proprietary rights of others and not breaching licenses granted that may be granted to us. Competitors may have filed patent applications and obtained patents and may in the future file patent applications and obtain patents relevant to our product and technologies.&#160;&#160;We are not aware of competing intellectual property relating to our REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> project.&#160;&#160;While we currently believe that we have the necessary freedom to operate in these areas, there can be no assurance that others will not </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">24</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">challenge our position in the future.&#160;&#160;Litigation to defend our position could be costly and time consuming. We also cannot be certain that we will be successful. We may be required to obtain a license from a prevailing party in order to continue the portion of our business that relates to the proceeding. We may also be required to obtain licenses to other third-party technologies necessary in order to market our products. Such licenses may not be available to us on acceptable terms or on any terms and we may have to discontinue that portion of our business. Any failure to license any technologies required to commercialize our technologies or products at reasonable cost may have a material adverse effect on our business, results of operations, financial condition, cash flow and future prospects. We are not currently involved in any litigation concerning our competitors&#8217; patent applications and patents. We may be involved in such litigation in the future.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also rely on unpatented trade secrets and improvements, unpatented know-how and continuing technological innovation to develop and maintain our competitive position. No assurance can be given that others will not</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">independently develop substantially equivalent proprietary information and techniques, or otherwise gain access to our trade secrets or disclose such technology, or that we can meaningfully protect our rights to our unpatented trade secrets.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We require our employees and consultants to execute confidentiality agreements upon the commencement of employment and consulting relationships with us. These agreements provide that all confidential information developed by or made known to an individual during the course of the employment or consulting relationship generally must be kept confidential. In the case of employees, the agreements provide that all inventions conceived by the individual, while employed by us, relating to our business are our exclusive property. While we have implemented reasonable business measurements to protect confidential information, these agreements may not provide meaningful protection for our trade secrets in the event of unauthorized use or disclosure of such information.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Business Strategy</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our business strategy is to develop and market REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in an effective and timely manner, and access additional technologies at a time and in a manner that we believe is best for our development.&#160;&#160;We intend to achieve our business strategy by focusing on these key areas:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Develop REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> by continuing to progress the product through our clinical trial program assessing the safety and efficacy in human subjects;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Establish collaborations with experts to assist us with scientific and clinical developments of this new potential pharmaceutical product;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Implement strategic alliances with selected pharmaceutical and biotechnology companies and selected laboratories, at a time and in a manner where such alliances may complement and expand our research and development efforts on the product and provide sales and marketing capabilities;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Utilize our broadening patent base and collaborator network as a mechanism to meet our strategic objectives; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Develop relationships with companies that could be instrumental in assisting us to access other innovative therapeutics.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our business strategy is based on attaining a number of commercial objectives, which, in turn, are supported by a number of product development goals.&#160;&#160;Our new product development presently being conducted is primarily of a research and development nature.&#160;&#160;In the context of this Annual Report, statements of our "belief" are based primarily upon our results derived to date from our research and development program with animals, and early stage human trials, and upon which we believe that we have a reasonable scientific basis to expect the particular results to occur.&#160;&#160;It is not possible to predict, based upon studies in animals, or early stage human trials, whether a new therapeutic will ultimately prove to be safe and effective in humans.&#160;&#160;There are no assurances that the particular result expected by us will occur.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">25</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At this time we do not intend to become a fully integrated pharmaceutical company with substantial in-house research and development, marketing and distribution or manufacturing capabilities.&#160;&#160;We are pursuing a strategy of establishing relationships with larger companies as strategic partners.&#160;&#160;We intend to partner or joint venture with larger pharmaceutical companies that have existing and relevant marketing capability for our products.&#160;&#160;It is anticipated that future clinical development into large international or pivotal trials would generally occur in conjunction with a strategic partner or partners, who would contribute expertise and financial assistance.&#160;&#160;In exchange for certain product rights and commitments to market our products, the strategic partners would be expected to share in gross proceeds from the sale of our product or products and potentially share in various market or manufacturing opportunities.&#160;&#160;The proceeds generated from partnering or joint venturing projects are expected to be distributed on the basis of relative risk taken and resources contributed by each party to the partnership or joint venture.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Regulatory Requirements</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The development of new pharmaceuticals is strongly influenced by a country's regulatory environment.&#160;&#160;The drug approval process in Canada is regulated by Health Canada.&#160;&#160;The primary regulatory body in the United States is the FDA and in the UK is the Medicines and Healthcare Products Regulatory Agency (the &#8220;MHRA&#8221;).&#160;&#160;Similar processes are conducted in other countries by equivalent regulatory bodies.&#160;&#160;Regulations in each jurisdiction require the licensing of manufacturing facilities and mandate strict research and product testing standards.&#160;&#160;Companies must establish the safety and efficacy of their products, comply with current Good Manufacturing Practices and submit marketing materials before being allowed to market pharmaceutical products.&#160;&#160;While we plan to pursue or support the pursuit of the approval of our product, success in acquiring regulatory approval for any product is not assured.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In order to market our pharmaceutical product in Canada, the United States, Europe and other jurisdictions, we must successfully meet the requirements of those jurisdictions. The requirements of the Appropriate Regulatory Authority will generally include the following stages as part of the regulatory process:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 24px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td width="1349">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Pre-Pharmacological Studies</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>- Pre-Pharmacological studies involve extensive testing on laboratory animals to determine if a potential therapeutic product has utility in an <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> disease model and has any adverse toxicology in a disease model.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Investigational New Drug Application</font> - An Investigational New Drug ("IND") Submission, or the equivalent, must be submitted to the appropriate regulatory authority prior to conducting Pharmacological Studies.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Pharmacological Studies</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>(or Phase I Clinical Trials) - Pharmacological studies are designed to assess the potential harmful or other side effects that an individual receiving the therapeutic compound may experience.&#160;&#160;These studies, usually short in duration, are often conducted with healthy volunteers or actual patients and use up to the maximum expected therapeutic dose.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Therapeutic Studies</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>(or Phase II and III Clinical Trials) - Therapeutic studies are designed primarily to determine the appropriate manner for administering a drug to produce a preventive action or a significant beneficial effect against a disease.&#160;&#160;These studies are conducted using actual patients with the condition that the therapeutic is designed to remedy.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior to initiating these studies, the organization sponsoring the program is required to satisfy a number of requirements via the submission of documentation to support the approval for a clinical trial.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">New Drug Submission</font> - After all three phases of a clinical trial have been completed, the results are submitted with the original IND Submission to the appropriate regulatory authority for marketing approval.&#160;&#160;Once marketing approval is granted, the product is approved for commercial sales.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Marketing Approvals</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The results of the preclinical and clinical testing, together with manufacturing and controls information, are submitted to regulatory agencies in order to obtain approval to commence commercial sales. In responding to such an application, regulatory agencies may grant marketing approval, request additional information or further research, or deny the application if they determine that the application does not satisfy their regulatory approval criteria. Approval for a pharmaceutical or biologic product may not be granted on a timely basis, if at all, or if granted may not cover all the clinical indications for which approval is sought, or may contain significant limitations in the form of warnings, precautions or contraindications with respect to conditions of use.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">26</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Satisfaction of pre-market approval requirements for new drugs and biologics typically takes several years, and the actual time required may vary substantially based upon the type, complexity and novelty of the product or targeted disease. Government regulation may delay or prevent marketing of potential products for a considerable period of time and impose costly procedures upon our activities. Success in early stage clinical trials or with prior versions of products does not assure success in later stage clinical trials. Data obtained from clinical activities are not always conclusive and may be susceptible to varying interpretations that could delay, limit or prevent regulatory approval.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Post-Marketing Regulations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Once approved, regulatory agencies may withdraw the product approval if compliance with pre- and/or post-marketing regulatory standards is not maintained or if problems occur after the product reaches the marketplace. In addition, they may require post-marketing studies, referred to as Phase 4 studies, to monitor the effect of an approved product, and may limit further marketing of the product based on the results of these post-market studies. The FDA and other foreign regulatory agencies have broad post-market regulatory and enforcement powers, including the ability to levy fines and penalties, suspend or delay issuance of approvals, seize or recall products, or withdraw approvals.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Manufacturing Regulations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use contract toll manufacturers to produce REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.&#160;&#160;Our toll manufacturers are subject to periodic inspection by the FDA, the United States Drug Enforcement Administration, or DEA, and other domestic and foreign authorities where applicable, and must comply with cGMP regulations. Manufacturers of biologics also must comply with general biological product standards. Failure to comply with the statutory and regulatory requirements subjects the manufacturer to possible legal or regulatory action, such as suspension of manufacturing, seizure of product, or mandatory or voluntary recall of a product.&#160;&#160;Adverse experiences with the product must be reported to the FDA and foreign agencies and could result in the imposition of market restrictions through labeling changes or in product removal. Product approvals may be withdrawn if compliance with regulatory requirements is not maintained or if problems concerning safety or efficacy of the product occur following approval.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Advertising and Promotion Regulations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With respect to both pre- and post-market product advertising and promotion, the FDA and similar foreign agencies impose a number of complex regulations on entities that advertise and promote pharmaceuticals and biologics, which include, among other things, standards and regulations relating to direct-to-consumer advertising, off-label promotion, industry sponsored scientific and educational activities, and promotional activities involving the Internet. These agencies have very broad enforcement authority and failure to abide by these regulations can result in penalties including the issuance of a warning letter directing the entity to correct deviations from requisite standards, a requirement that future advertising and promotional materials be pre-cleared by the FDA or relevant foreign agencies, and foreign, state and federal civil and criminal investigations and prosecutions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other Government Regulations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to various laws and regulations regarding laboratory practices, the experimental use of animals, and the use and disposal of hazardous or potentially hazardous substances in connection with our research. In each of these areas, as above, the government has broad regulatory and enforcement powers, including the ability to levy fines and civil penalties, suspend or delay issuance of approvals, seize or recall products, and withdraw approvals, any one or more of which could have a material adverse effect upon us.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">27</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Market and Competition</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">According to estimates for 2010 from the American Cancer Society, 1.53 million Americans are expected to be diagnosed with cancer in the year, and 569,000 Americans are forecast to die of cancer.&#160;&#160;In the United States cancer accounts for 23% of all deaths, second only to heart disease.&#160;&#160;In the United States, the relative lifetime risk of a male developing cancer is 1 in 2, while for women, this risk is 1 in 3.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The costs of this disease state are also significant.&#160;&#160;In the United States, the National Institute of Health estimated the 2008 cost for cancer treatment were $228.1 billion.&#160;&#160;Of this figure, $93.2 billion can be attributed to direct patient costs.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It has been estimated that approximately 30% of all tumours are a result of activating mutations of Ras itself.&#160;&#160;Since Ras can be activated by mechanisms other than direct mutations it is believed that the number of tumours with activated Ras (either through direct activating mutation or mutation or over-expression of elements upstream of Ras) is approximately two thirds.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We face substantial competition in the development of products for cancer and other diseases. This competition from other manufacturers of the same types of products and from manufacturers of different types of products designed for the same uses is expected to continue in both U.S. and international markets.&#160;&#160;Oncolytic virus therapies, our primary focus area, are rapidly evolving areas in the biotechnology industry and are expected to undergo many changes in the coming years as a result of technological advances. We are currently aware of a number of groups that are developing oncolytic virus therapies including early-stage and established biotechnology companies, pharmaceutical companies, academic institutions, government agencies and research institutions. We face competition from all of these groups in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relationships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies. It is possible that our competitors could achieve earlier market commercialization, could have superior patent protection, or could have safer, more effective or more cost-effective products. These factors could render our potential products less competitive, which could adversely affect our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Product Marketing Strategy</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The markets for the cancer product being developed by us may be large and could require substantial sales and marketing capability.&#160;&#160;Before or upon successful completion of the development of a cancer product, we intend to enter into one or more strategic partnerships or other collaborative arrangements with a pharmaceutical company or other company with marketing and distribution expertise to address this need.&#160;&#160;If necessary, we will establish arrangements with various partners for different geographical areas or specific applications at various times in the development process.&#160;&#160;Our management and consultants have relevant experience with the partnering process.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Seasonality of Business</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our results of operations have not been materially impacted by seasonality.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Organizational Structure</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 31, 2010, we had two wholly-owned subsidiaries; Oncolytics Biotech (Barbados) Inc. (&#8220;OBB&#8221;), a Barbados Company, and Valens Pharma Ltd.&#160;&#160;As well, Oncolytics Biotech (US) Inc., a Delaware corporation is a wholly owned subsidiary of OBB.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.&#160;&#160;&#160;&#160;&#160;&#160;Property, Plants and Equipment</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We currently lease our head office in Calgary, Alberta, Canada.&#160;&#160;We do not own or lease any other office space, manufacturing facilities or equipment and do not have any current plans to construct or acquire any facilities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 4A.&#160;&#160;UNRESOLVED STAFF COMMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following Management Discussion and Analysis (&#8220;MD&amp;A&#8221;) contains forward-looking statements, including our belief as to the potential of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, a therapeutic reovirus, as a cancer therapeutic and our expectations as to the success of our research and development and manufacturing programs in 2010 and beyond, future financial position, business strategy and plans for future operations, and statements that are not historical facts, involve known and unknown risks and uncertainties, which could cause our actual results to differ materially from those in the forward-looking statements.&#160;&#160;See <font style="DISPLAY: inline; FONT-STYLE: italic">&#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With respect to the forward-looking statements made within this MD&amp;A, we have made numerous assumptions regarding among other things: our ability to obtain financing to fund our development program, our ability to receive regulatory approval to commence enrollment in our clinical trial program, the final results of our co-therapy clinical trials, our ability to maintain our supply of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and future expense levels being within our current</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">expectations.&#160;&#160;Investors are cautioned against placing undue reliance on forward-looking statements.&#160;&#160;We do not undertake to update these forward-looking statements except as required by applicable law.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">A.&#160;&#160; O</font>peration Results </font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please see our 2010 Management Discussion and Analysis in Exhibit 15.1, which is incorporated herrein by reference.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.&#160;&#160; Liquidity and Capital Resources</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please see our 2010 Management Discussion and Analysis in Exhibit 15.1, which is incorporated herrein by reference.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.&#160;&#160; Research and Development, Patents, and Licenses, etc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please see the disclosure in Item 4.&#160;&#160;Information on the Company B. Business Overview for information on the Company&#8217;s research and development policies.&#160;&#160;Our research and development expenses were $12,191,809, $11,606,514, and $13,351,875 for 2010, 2009, and 2008, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.&#160;&#160; Trend Information</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It is important to note that historical patterns of expenditures cannot be taken as an indication of future expenditures.&#160;&#160;The amount and timing of expenditures and availability of capital resources vary substantially from period to period, depending on the level of research and development activity being undertaken at any one time and the availability of funding from investors and prospective commercial partners.&#160;&#160;Prior to 2009, our level of expenditures increased due to our expanded clinical trial program and our manufacturing activity.&#160;&#160;In 2009, our overall expenditures were reduced as we completed our Phase II clinical trial program and prepared for the commencement of our Phase III head and neck study that was ultimately approved in October 2009.&#160;&#160;Our expenditures in 2010 increased, as expected, as we commenced enrollment in our Phase III study and expanded our clinical program.&#160;&#160;We expect 2011 expenditures to continue to increase as we enroll patients in our Phase III head and neck trial, support our other clinical trials, and incur manufacturing costs to supply this clinical program.&#160;&#160;As well, we expect to incur additional costs associated with the validation and commercial scale up of our manufacturing process.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as disclosed elsewhere in our annual report, we know of no trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on our liquidity or capital resources or that would cause reported financial information not necessarily to be indicative of future operating results or financial conditions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">29</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E.&#160;&#160; Off-Balance Sheet Arrangements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, we have not entered into any off-balance sheet arrangements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F.&#160;&#160;&#160; Tabular Disclosure of Contractual Obligations</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have the following contractual obligations as at December 31, 2010:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%" style="BORDER-TOP: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contractual Obligations</font></div>
</td>
<td align="left" colspan="5" valign="top" width="55%" style="BORDER-TOP: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments Due by Period</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less than 1<br>
year</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2 -3 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4 &#8211; 5 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After 5 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alberta Heritage Foundation<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></div>
</td>
<td align="right" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital lease obligations</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td align="right" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating lease <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">478,709</font></div>
</td>
<td align="right" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65,674</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">275,012</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,023</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchase obligations</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,140,000</font></div>
</td>
<td align="right" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,140,000</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other long term obligations</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td align="right" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total contractual obligations</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,768,709</font></div>
</td>
<td align="right" valign="top" width="13%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,205,674</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">275,012</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,023</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Note:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;&#160;Our Alberta Heritage Foundation obligation requires repayments equal to the lesser of 5% of gross sales generated by the Company or $15,000 per annum (see notes of our audited 2010 consolidated financial statements).</font></div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our operating lease is comprised of our office lease and exclude our portion of operating costs.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect to fund our capital expenditure requirements and commitments with existing working capital.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">G. Safe Harbor</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We seek safe harbor for our forward-looking statements contained in Items 5.E and F.&#160;&#160;See &#8220;<font style="DISPLAY: inline; FONT-STYLE: italic">Cautionary Note Regarding Forward-Looking Statements&#8221;.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors and Senior Management</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth the names and municipalities of residence of all our directors and officers as at the date hereof, as well as the positions and offices held by such persons and their principal occupations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">30</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="16%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and Municipality of Residence</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Position with the Corporation</font></div>
</td>
<td valign="middle" width="36%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Principal Occupation</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director of the Company Since</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bradley G. Thompson </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ph.D<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer and Chairman of the Board</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Chairman of the Board, President and Chief Executive Officer of Oncolytics since April&#160;1999.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 21, 1999</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas A. Ball C.A.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer and Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer of the Corporation since May&#160;2000.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 21, 1999</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">William A. Cochrane, OC, M.D. <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2),(3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President of W.A. Cochrane &amp; Associates, Inc. (a consulting company) since 1989 and from April 2003 to December 2010, Chairman of Resverlogix Corp. (a public biopharmaceutical company) and is a Director of Immunovaccine Inc.&#160;&#160;Dr. Cochrane was formerly Chairman of QSV Biologics Ltd. (biologics contract manufacturer) from 2003 to 2009 and was a director of Sernova Corp. from 2005 to 2008, and a former chairman of University Technologies International Inc. (UTI) at the University of Calgary.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">October 31, 2002</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matthew C. Coffey Ph.D.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Operating Officer</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Operating Officer of the Corporation since December 2008.&#160;&#160;Since April 1999 to December 2008, Dr. Coffey held other senior management positions with the Corporation and is a co-founder of Oncolytics.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">George M. Gill, M.D.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Washington, D.C.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior Vice President, Clinical and Regulatory Affairs</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Gill has been a consultant in clinical research and regulatory affairs to the pharmaceutical and biotechnology industries since he retired from Ligand Pharmaceuticals in 1999. During his 38 years in the industry, he also served in senior executive positions with ICI Pharmaceuticals (now AstraZeneca), Bristol-Myers Squibb, and Hoffmann-La Roche. Dr. Gill holds a B.Sc. in chemistry from Dickinson College in Pennsylvania and an M.D. from the School of Medicine of the University of Pennsylvania in Philadelphia.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">31</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="16%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and Municipality of Residence</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Position with the Corporation</font></div>
</td>
<td valign="middle" width="36%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Principal Occupation</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director of the Company Since</font></div>
</td>
</tr></table>
</div>

<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Robert B. Schultz, F.C.A. <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (4)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Toronto, Ontario</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lead Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Former Chairman and Director of Rockwater Capital Corporation, formerly McCarvill Corporation (a financial services company) from 2001 to 2007.&#160;&#160;Mr.&#160;Schultz has held a variety of senior positions, and has participated on various industry-related boards and committees including Director and Chairman of the Investment Dealers Association of Canada.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30, 2000</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fred A. Stewart, Q.C.<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)(2)</font><font style="DISPLAY: inline; FONT-STYLE: italic">,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Former practising lawyer in Calgary; President of Fred Stewart &amp; Associates Inc., consultant in commercialization of technology. Mr Stewart has served in a number of positions of corporate &#160;governance, in both private and public organizations</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">August 27, 1999</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">J. Mark Lievonen, F.C.A.<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Markham, Ontario</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President of Sanofi Pasteur Limited, a vaccine development, manufacturing and marketing company, since October 1998.&#160; Mr.&#160;Lievonen&#160;serves on a number of industry and&#160;&#160;not-for-profit boards including&#160; BIOTECanada,&#160;the Ontario Institute for Cancer Research&#160;and&#160;York University, and is a past Chair of&#160; &#160;BIOTECanada&#160;and the&#160;Ontario Genomics Institute.&#160;&#160; He was named a Chevalier de l'Ordre National de Merite by the government of France in 2007.<font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 5, 2004</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">32</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="16%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and Municipality of Residence</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Position with the Corporation</font></div>
</td>
<td valign="middle" width="36%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Principal Occupation</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director of the Company Since</font></div>
</td>
</tr></table>
</div>

<table cellpadding="2" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Karl Mettinger, M.D., Ph.D</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Berkeley, CA</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Medical Officer</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Mettinger has been our CMO since 2005.&#160;&#160;Dr. Mettinger has been involved in clinical and regulatory affairs with various pharmaceutical companies since 1985. Prior to joining Oncolytics, he was Senior Vice President and Chief Medical Officer with SuperGen Inc. Prior to that, he was Executive Director, Clinical Research at IVAX/Baker Norton,&#160;the new drug subsidiary of IVAX Corporation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jim Dinning<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Chair of Western Financial Group since September 2004. Mr. Dinning was Executive Vice President of TransAlta Corporation (power generation and wholesale marketing company) from 1997 to 2004. Mr. Dinning is the Chair of Export Development Canada and Canada West Foundation and serves as a director of other public and private companies. He is the Chancellor of the University of Calgary.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 24, 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ger van Amersfoort,<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Oakville, Ont</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President and Chief Executive Officer of Novartis Canada, a pharmaceutical company, until his retirement in 2001.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 15, 2006</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed Levy, Ph.D,<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Lund, BC</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjunct professor at the W. Maurice Young Centre for Applied Ethics at the University of British Columbia since retiring from QLT Inc. in late 2002.</font></div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 17, 2006</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mary Ann Dillahunty, JD, MBA</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Half Moon Bay, CA</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vice President, Intellectual Property</font></div>
</td>
<td valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ms. Dillahunty has been our VP-Intellectual Property since 2007.&#160;&#160;Prior to joining Oncolytics, Ms. Dillahunty was a principal in the law firm of Fish &amp; Richardson, a leading intellectual property firm in the U.S.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">33</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Audit Committee.&#160;&#160;Mr. Stewart is the Chair of the Audit Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Compensation Committee.&#160;&#160;Mr. Stewart is the Chair of the Compensation Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Corporate Governance and Nominating Committee.&#160;&#160;Mr. Lievonen is the Chair of the Corporate Governance and Nominating Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As Lead Director, Mr. Schultz is an ex-officio member of the Compensation and Nominating Committees.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at the date hereof, the directors and senior officers as a group beneficially owned, directly or indirectly, 1,112,851 of our common shares, representing 1.6% of the issued and outstanding common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Certain of our directors are associated with other companies, which may give rise to conflicts of interest.&#160;&#160;In accordance with the</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">ABCA, directors who have a material interest in any person who is a party to a material contract or a proposed material contract with us are required, subject to certain exceptions, to disclose that interest and abstain from voting on any resolution to approve that contract.&#160;&#160;In addition, the directors are required to act honestly and in good faith with a view to the best interests of Oncolytics Biotech</font> Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None of our directors have been a director or officer of a company that went bankrupt in the last 10 years except for Dr. William Cochrane who was a director of QSV Biologics (&#8220;QSV&#8221;) a private company.&#160;&#160;QSV was a private contract manufacturing company that started in 2004.&#160;&#160;Its customers were other biotechnology companies in Canada and the USA.&#160;&#160;In 2008, as a result of the economic recession, these biotechnology companies were unable to raise capital and consequently were forced to discontinue clinical trials resulting in a loss of customers for QSV.&#160;&#160;QSV sought financing from private investors and governments but was unsuccessful.&#160;&#160;Consequently, QSV went bankrupt and had to terminate its employees and close the company in August 2009.&#160;&#160;Dr. Cochrane was a director from 2004 and chairman from 2006 to 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None of our directors or officers are related by blood, marriage or adoption to any other director or officer.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are not aware of any arrangement or understanding with major shareholders, customers, suppliers or others, pursuant to which any person referred to above was selected as a director or officer.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Executive Compensation</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth information concerning the total compensation paid in 2010 to each director.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">34</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name</font></div>
</div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fees &amp; </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Retainers Earned</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share-</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Based Awards</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Option-</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Based Awards<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-Equity Incentive Plan Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pension Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All Other Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;W. Cochrane</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mr.&#160;G. van Amersfoort</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27,250</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">126,250</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mr.&#160;J. Dinning</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mr.&#160;M. Lievonen</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,500</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">124,500</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;E. Levy</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,500</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">124,500</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mr.&#160;R. Schultz</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">264,000</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310,000</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mr.&#160;F. Stewart</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,250</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="middle" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">148,500</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">188,750</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Note:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options include grants from July and December 2010.&#160;&#160;The options granted in July, 2010 have an estimated grant date fair value of $1.32, and the options granted in December 2010 have an estimated grant date fair value of $3.30 per option using the following respective grant date assumptions: expected life of option, 3 years for both; volatility 61.7% and 74.9% respectively; risk free interest rate 1.55% and 1.95% respectively; dividend yield 0% for both.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">35</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Officers</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Summary Compensation Table</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth information concerning the total compensation paid to our officers in 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and principal position</font></div>
</div>
</td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year</font></div>
</div>
</td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Salary</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share-</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">based awards</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Option-</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">based awards<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
<td colspan="2" valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-equity incentive <br>
plan compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pension value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All other compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">($)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total <br>
compensation ($)</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;Bradley G.</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">444,996</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">709,500</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,163</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,712</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,355,371</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Thompson</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">444,996</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59,500</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">106,800</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,200</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">651,496</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">444,996</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,700</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">491,696</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas A. Ball</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">257,567</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">643,500</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,362</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,649</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">984,078</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">257,567</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,700</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34,654</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">373,921</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Officer</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">257,567</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,454</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">293,021</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Matt C.</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">326224</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">379,500</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88,080</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42,913</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">836,717</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Coffey</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">326,224</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,700</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38,520</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">446,444</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Operating Officer</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">326,224</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,573</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">365,797</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Karl</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">318,270</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">132,000</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,076</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38,686</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">519,032</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mettinger<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">333,101</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,700</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38,000</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,709</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">447,510</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Medical Officer</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">333,101</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,709</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">373,810</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mary Ann</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">153,665</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">82,500</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,467</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,066</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">274,698</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dillahunty <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">161,700</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,850</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,720</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,063</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">224,333</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VP Intellectual Property</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">242,550</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">None</font></div>
</td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,661</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">275,211</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 14.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The dollar amounts set forth under this column are related to RRSP contributions and amounts provided for health care benefits by the Corporation for the Named Executive Officers.&#160;&#160;For Named Executive Officers resident in Canada these benefits are provided in accordance the Corporation&#8217;s registered Health Benefit Plan.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 14.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. Employees are paid salaries and other compensation in U.S. Dollars.&#160;&#160;All amounts paid in U.S. Dollars for each U.S. Employee have been converted using the exchange rate of .9946 at December 31, 2010 and are indicated in Canadian Dollars.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 14.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The options granted in July, 2010 have an estimated grant date fair value of $1.32, and the options granted in December 2010 have an estimated grant date fair value of $3.30 per option using the following respective grant date assumptions: expected life of option, 3 years for both; volatility 61.7% and 74.9% respectively; risk free interest rate 1.55% and 1.95% respectively; dividend yield 0% for both.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">36</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Narrative Discussion</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation has entered into employment agreements with each of the following Executive Officers (each an "Employment Agreement").&#160;&#160;Pursuant to the terms of the Employment Agreements,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and principal position</font></div>
</div>
</td>
<td valign="bottom" width="23%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year</font></div>
</div>
</td>
<td valign="bottom" width="23%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Salary</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;Bradley G. Thompson</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">489,500</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas A. Ball</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">283,800</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matt C. Coffey</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">330,139</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Operating Officer</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Karl Mettinger</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">322,289<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Medical Officer</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mary Ann Dillahunty</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">156,354<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VP Intellectual Property</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt">Note 1:</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>U.S. Employees are paid in U.S. Dollars and are presented in U.S. dollars.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Further, each Officer is entitled to additional benefits and performance-based bonuses.&#160;&#160;As well, the Employment Agreements provide that each Officer is subject to certain confidentiality and non-competition restrictions during and following the course of their respective employment with the Corporation.&#160;&#160;Each Employment Agreement shall continue until terminated by either party in accordance with the notice provisions thereof.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no long term incentive, benefit or actuarial plans in place. The Company does not currently have a stock appreciation rights plan.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">37</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Termination of Employment or Change of Control</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table reflects amounts payable to the Officers, assuming that their employment was terminated on December 31, 2010 without cause or due to a change of control of the Corporation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="47%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name</font></div>
</div>
</td>
<td valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Termination without Cause <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</div>
</td>
<td valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change of Control <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Severance ($)</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Severance ($)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;Bradley G. Thompson</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,104,668</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,657,001</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas A. Ball, C.A.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">329,664</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">659,327</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;Matt C. Coffey</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Operating Officer</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">379,825</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">759,651</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.&#160;Karl Mettinger</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Medical Officer <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361,185</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">722,370</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mary Ann Dillahunty,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">J.D. M.B.A., VP Intellectual Property<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">175,524</font></div>
</td>
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">351,048</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 14.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010 all options granted to Officers had fully vested. As a result, all Officers shall be entitled to exercise all or any part of their Options, within the period ending on the earlier of the date of expiration of the Option and the ninetieth (90th) day after the date such Officer is terminated.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 14.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On a change of control of the Corporation, the Officers shall be entitled to exercise all or a part of their Options, whether vested or not, within the period ending on the earlier of the date of expiration of the Option and the ninetieth (90th) day after the date such Officer is terminated.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Board Practices</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our directors are elected by the shareholders at each Annual General Meeting and typically hold office until the next Annual General Meeting, at which time they may be re-elected or replaced.&#160;&#160;Casual vacancies on the board are filled by the remaining directors and the persons filling those vacancies hold office until the next Annual General Meeting, at which time they may be re-elected or replaced.&#160;&#160;The officers are appointed by the Board of Directors and hold office indefinitely at the pleasure of the Board of Directors.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">38</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name and Municipality of Residence</font></div>
</td>
<td valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Position with the Corporation</font></div>
</td>
<td valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director of the Corporation Since</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of Expiration of Current Term of Office</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bradley G. Thompson </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ph.D</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President, Chief Executive Officer and Chairman of the Board</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 21, 1999</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas A. Ball C.A.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer and Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 21, 1999</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">William A. Cochrane, OC, M.D. <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2),(3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">October 31, 2002</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Robert B. Schultz, F.C.A. <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (4)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Toronto, Ontario</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lead Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30, 2000</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fred A. Stewart, Q.C.<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)(2)</font><font style="DISPLAY: inline; FONT-STYLE: italic">,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">August 27, 1999</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">J. Mark Lievonen, F.C.A.<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Markham, Ontario</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 5, 2004</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jim Dinning<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 24, 2004</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ger van Amersfoort,<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Oakville, Ont</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 15, 2006</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed Levy, Ph.D,<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (3)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Lund, BC</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="20%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 17, 2006</font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date of 2011 Annual General Meeting of the Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Audit Committee.&#160;&#160;Mr. Stewart is the Chair of the Audit Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Compensation Committee.&#160;&#160;Mr. Stewart is the Chair of the Compensation Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These persons are members of the Corporate Governance and Nominating Committee.&#160;&#160;Mr. Lievonen is the Chair of the Corporate Governance and Nominating Committee.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As Lead Director, Mr. Schultz is an &#8220;ex officio&#8221; member of the Corporate Governance and Compensation Committees.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Directors&#8217; Contracts</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We receive a director&#8217;s consent from each of the independent directors upon their acceptance of their director&#8217;s position.&#160;&#160;We also enter into an Indemnity Agreement and Directors Confidentiality and Intellectual Property Assignment Agreement with each director.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company does not have any contracts with any of its directors which provide for benefits upon the termination of employment.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Compensation of Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each director who is not a salaried employee of the Corporation was entitled to a fee of $1,750 per Board and committee meeting attended.&#160;&#160;An annual retainer fee of $15,000 was paid for service during 2010 and the lead director, Mr. Schultz was entitled to an additional annual $10,000 retainer.&#160;&#160;Mr. Stewart, the chair of the audit committee, received an additional retainer of $6,000.&#160;&#160;We also grant to directors, from time to time, stock options in accordance with the Stock Option Plan and the reimbursement of any reasonable expenses incurred by them while acting in their directors' capacity.&#160;&#160;In the aggregate, a total of $222,500 in directors&#8217; fees was paid to the Board of Directors during the fiscal year ended December&#160;31, 2010.&#160;&#160;&#160;&#160;During the fiscal year ended December&#160;31, 2010, there were 305,000 options granted to these directors in accordance with the Compensation Committee recommendation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">39</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of the Compensation Committee recommendations, the board has determined that for 2011, the meeting fee for independent board members for each board and committee meeting attended, shall remain at $1,750, while the annual retainer for all independent board members shall increase to $25,000. In addition, the annual retainer for the lead director shall increase to $15,000, the annual retainer for the chairman of the audit committee shall increase to $12,000 and the annual retainer for the chairpersons of the Compensation Committee and the Governance and Nominating Committees shall be $6,000.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Compensation Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation has formed a compensation committee (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Compensation Committee</font>&#8221;) consisting of three outside directors: Mr. Stewart, Mr. van Amersfoort and Dr. Cochrane, none of whom are nor have been employees or officers of the Corporation or any of its affiliates.&#160;&#160;Mr. Stewart is presently the Chair of the Compensation Committee.&#160;&#160;Mr. Schultz, lead director, serves as an ex officio member of the Compensation Committee.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The objectives of the Corporation&#8217;s compensation arrangements are:&#160;&#160;(i) to attract and retain key personnel; (ii) to encourage commitment to the Corporation and its goals; (iii) to align executive interests with those of its shareholders; and (iv) to reward executives for performance in relation to overall corporate progress goals.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The key elements of the compensation program are the base salary, health benefits, payments allocated to employees to be directed by them to their personal retirement accounts, as well as bonuses and the granting of options, both based on corporate and personal performance. Performance goals are determined based on the strategic planning and budgeting process, which is conducted at least annually. The balance of performance during the year is assessed by the board of directors of Oncolytics (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Board</font>&#8221; or &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Board of Directors</font>&#8221;) and is normally the key determinant for the allocation of bonuses and options.&#160;&#160;The elements of the compensation plan are intended to reward performance, and the various elements are intended to provide a blend of short-term and long-term incentives to align the interests of management and the shareholders.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In arriving at its recommendations for compensation, the Compensation Committee considers the long-term interests of the Corporation as well as its current stage of development and the economic environment within which it operates. The market for biotechnology companies in the development phase has been extremely challenging, and was exacerbated by the deterioration of the capital markets late in 2008 and 2009.&#160;&#160;Based on these factors, the Compensation Committee recognized the need to strike a balance between compensation to retain employees and resources expended to maintain operations.&#160;&#160;In 2010, the Compensation Committee engaged Lane Caputo</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation Inc., executive compensation specialists (the &#8216;Specialist&#8221;), to assist in benchmarking its compensation practices, and provide recommendations to the committee with respect to compensation for directors and officers.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For 2010, the following guidelines were employed by the Board in granting bonuses and stock option grants to the Corporation&#8217;s executive and senior officers. For 2011, similar guidelines are expected to be applied.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Chief Executive Officer of the Corporation is eligible for a cash bonus of up to 30% of his base salary and the other senior officers are eligible for a cash bonus of up to 20% of their base salary. In addition, when available, the Chief Executive Officer of the Corporation is eligible for an option grant of up to 15% of base salary with such numbers of options calculated using the estimated grant date fair value, and the other officers are eligible for an option grant of up to 10% of salary based upon a similar calculation.&#160;&#160;The actual bonus provided and the number of options granted hereunder is based upon the overall performance of the Corporation as assessed by the committee and approved by the Board. In the event that the Corporation is operating in a challenging environment (as in 2008), these guidelines could result in the Board reducing the bonus awards and grants of stock options and in some circumstances result in no bonuses or stock options being granted to executive and senior officers. However, the guidelines referenced above can also be exceeded at the discretion of the Board. Upon completion of their review, the Compensation Committee then provided their specific recommendations to the Board with respect to compensation paid to the Corporation&#8217;s executive and senior officers.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">40</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Compensation Committee Mandate</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Mandate was reviewed, amended and approved by the Company&#8217;s board of directors on March 16, 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160; Policy Statement</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It is the policy of Oncolytics Biotech Inc. (the "Corporation") to establish and maintain a Compensation Committee (the "Committee"), composed entirely of independent directors, to assist the Board of Directors of the Corporation (the "Board") in carrying out its responsibility for the Corporation&#8217;s human resources and compensation policies and processes. The Committee will be provided with resources commensurate with the duties and responsibilities assigned to it by the Board, including administrative support. If determined necessary by the Committee, it will have the discretion to investigate and conduct reviews of any human resource or compensation matter including the standing authority to retain experts and, with approval of the Board, special counsel.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160; Composition of Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Committee shall consist of a minimum of two (2) directors, at least half of whom shall be resident Canadians. The Board shall appoint the members of the Committee and may seek the advice and assistance of the Corporate Governance and Nominating Committee in identifying qualified candidates. The Board shall appoint one member of the Committee to be the Chair of the Committee, or delegate such authority to appoint the Chair of the Committee to the Committee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Chair of the Committee shall be responsible for the leadership of the Committee, including preparing or approving the agenda, presiding over the meetings, and making committee assignments.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each director appointed to the Committee by the Board shall be an outside director who is unrelated. An outside, unrelated director is a director who meets the requirements of NASDAQ Rule 4200 and National Instrument 58-101 who is independent of management and is free from any interest, any business or other relationship which could, or could reasonably be perceived, to materially interfere with the director&#8217;s ability to act with a view to the best interests of the Corporation, other than interests and relationships arising from shareholding. In determining whether a director is independent of management, the Board shall make reference to the then current legislation, rules, policies and instruments of applicable regulatory authorities.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A director appointed by the Board to the Committee shall be a member of the Committee until replaced by the Board or until his or her resignation.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160; Meetings of the Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Committee shall convene a minimum of once each year at such times and places as may be designated by the Chair of the Committee and whenever a meeting is requested by the Board, a member of the Committee, or the Chief Executive Officer of the Corporation (the "CEO").</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice of each meeting of the Committee shall be given to each member of the Committee and the CEO, who shall each be entitled to attend each meeting of the Committee and shall attend whenever requested to do so by a member of the Committee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice of a meeting of the Committee shall:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 131px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 37px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c. i.</font></div>
</td>
<td width="1229">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">be in writing, including by electronic communication facilities;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">41</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c. ii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">state the nature of the business to be transacted at the meeting in reasonable detail;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.&#160;iii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to the extent practicable, be accompanied by copies of documentation to be considered at the meeting; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c. iv.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">be given at least two business days prior to the time stipulated for the meeting or such shorter period as the members of the Committee may permit.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A quorum for the transaction of business at a meeting of the Committee shall consist of a majority of the members of the Committee. However, it shall be the practice of the Committee to require review, and, if necessary, approval of certain important matters by all members of the Committee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A member or members of the Committee may participate in a meeting of the Committee by means of such telephonic, electronic or other communication facilities, as permits all persons participating in the meeting to communicate adequately with each other. A member participating in such a meeting by any such means is deemed to be present at the meeting.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the absence of the Chair of the Committee, the members of the Committee shall choose one of the members present to be Chair of the meeting. In addition, the members of the Committee shall choose one of the persons present to be the Secretary of the meeting.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Minutes shall be kept of all meetings of the Committee and shall be signed by the Chair and the Secretary of the meeting.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160; Duties and Responsibilities of the Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Committee shall, at the earliest opportunity after each meeting, report to the Board the results of its activities and any reviews undertaken and make recommendations to the Board as deemed appropriate.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Committee&#8217;s primary duties and responsibilities are to review and make recommendations to the Board in respect of:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 130px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 38px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.&#160; i.</font></div>
</td>
<td width="1229">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">human resource policies, practices and structures (to monitor consistency with the Corporation&#8217;s goals and near and long-term strategies, support of operational effectiveness and efficiency, and maximization of human resources potential);</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g. ii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">compensation policies and guidelines;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g. iii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">management incentive and perquisite plans and any non-standard remuneration plans;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g. iv.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">senior management, executive and officer appointments and their compensation;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.&#160;v.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">management succession plans, management training and development plans, termination policies and termination arrangements;</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 99pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g. vi.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Board compensation matters.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In carrying out its duties and responsibilities, the Committee shall:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">42</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 132px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.&#160;i.</font></div>
</td>
<td width="1229">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">annually assess and make a recommendation to the Board with regard to the competitiveness and appropriateness of the compensation package of the CEO, all other officers of the Corporation and such other key employees of the Corporation or any subsidiary of the Corporation as may be identified by the CEO and approved by the Committee (collectively, the "Designated Employees");</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 132px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. ii.</font></div>
</td>
<td width="1230">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">annually review the performance goals and criteria for the CEO and evaluate the performance of the CEO against such goals and criteria and recommend to the Board the amount of regular and incentive compensation to be paid to the CEO;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 131px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. iii.</font></div>
</td>
<td width="1231">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">annually, review and make a recommendation to the Board regarding the CEO&#8217;s performance evaluation of Designated Employees and his recommendations with respect to the amount of regular and incentive compensation to be paid to such Designated Employees;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 130px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. iv.</font></div>
</td>
<td width="1232">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review and make a recommendation to the Board regarding any employment contracts or arrangements with each of the Designated Employees, including any retiring allowance arrangements or any similar arrangements to take effect in the event of a termination of employment;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 129px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 34px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.&#160; v.</font></div>
</td>
<td width="1234">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">periodically, review the compensation philosophy statement of the Corporation and make recommendations for change to the Board as considered necessary;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 128px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. vi.</font></div>
</td>
<td width="1233">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">from time to time, review and make recommendations to the Board in respect of the design, benefit provisions, investment options and text of applicable pension, retirement and savings plans or related matters;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 128px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 34px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. vii.</font></div>
</td>
<td width="1235">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">annually, in conjunction with the Corporation&#8217;s general and administrative budget, review and make recommendations to the Board regarding compensation guidelines for the forthcoming budget period;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 127px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. viii.</font></div>
</td>
<td width="1235">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">when requested by the CEO, review and make recommendations to the Board regarding short term incentive or reward plans and, to the extent delegated by the Board, approve awards to eligible participants;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 126px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.&#160;ix.</font></div>
</td>
<td width="1236">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review and make recommendations to the Board regarding incentive stock option plans or any other long term incentive plans and to the extent delegated by the Board, approve grants to participants and the magnitude and terms of their participation;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 125px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.&#160; x.</font></div>
</td>
<td width="1236">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">as required, fulfill the obligations assigned to the Committee pursuant to any other employee benefit plans approved by the Board;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 126px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.&#160; xi.</font></div>
</td>
<td width="1236">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">annually, prepare or review the report on executive compensation required to be disclosed in the Corporation&#8217;s information circular or any other human resource or compensation matter required to be publicly disclosed by the Corporation;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 125px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. xii.</font></div>
</td>
<td width="1237">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">periodically, but at least every third year, review and make a recommendation to the Board regarding the compensation of the Board of Directors;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 125px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 34px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. xiii.</font></div>
</td>
<td width="1238">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">as required, retain independent advice in respect of human resources and compensation matters and, if deemed necessary by the Committee, meet separately with such advisors; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">43</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 124px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 35px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a. xiv.</font></div>
</td>
<td width="1238">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">assess, on an annual basis, the adequacy of this Mandate and the performance of the Committee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to the foregoing, the Committee shall undertake on behalf of the Board such other initiatives as may be necessary or desirable to assist the Board in discharging its responsibility to ensure that appropriate human resources development, performance evaluation, compensation and succession planning programs are in place and operating effectively.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Audit Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Corporation has formed an Audit Committee in accordance with Section 3(a)(58)(A) of the U.S. Securities and Exchange Commission of 1934, as amended, consisting of three independent directors pursuant to the Rule 5605(a)(2) of the NASDAQ Capital Market and Rule 10A-3 of the United States Securities Exchange Act of 1934, as amended: Mr. Fred Stewart, Mr. Jim Dinning and Mr. Robert Schultz, none of whom are nor have been employees or officers of the Company or any of its affiliates.&#160;&#160;Mr. Stewart is presently the Chair of the Audit Committee.&#160;&#160;Each Audit Committee member is financially literate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Mandate of the Audit Committee</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Mandate was reviewed and approved by the Company&#8217;s board of directors on March 16, 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Policy Statement</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It is the policy of Oncolytics Biotech Inc. (the "Corporation") to establish and maintain an Audit Committee, composed entirely of independent directors, to assist the Board of Directors (the "Board") in carrying out their oversight responsibility for the Corporation&#8217;s internal controls, financial reporting and risk management processes.&#160;&#160;The Audit Committee will be provided with resources commensurate with the duties and responsibilities assigned to it by the Board including administrative support.&#160;&#160;If determined necessary by the Audit Committee, it will have the discretion to institute investigations of improprieties, or suspected improprieties within the scope of its responsibilities, including the standing authority to retain special counsel or experts.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Composition of the Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall consist of a minimum of three (3) directors, at least half of whom shall be resident Canadians.&#160;&#160;The Board shall appoint the members of the Audit Committee and may seek the advice and assistance of the Corporate Governance and Nominating Committee in identifying qualified candidates.&#160;&#160;The Board shall appoint one member of the Audit Committee to be the Chair of the Audit Committee, or delegate such authority to appoint the Chair of the Audit Committee to the Audit Committee.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Chair of the Committee shall be responsible for leadership of the Committee, including preparing or approving the agenda, presiding over the meetings, and making committee assignments.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each director appointed to the Audit Committee by the Board shall be an outside director who is unrelated.&#160;&#160;An outside, unrelated director is a director who meets the requirements of NASDAQ Rule 5605(a)(2) and Multilaterial</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Instrument 52-110. A director appointed to the audit committee shall also meet the requirements of&#160;&#160;and Exchange Act Rule 10A-3(b)(1). Such director shall be independent of management and free from any interest, any business or other relationship which could, or could reasonably be perceived, to materially interfere with the director&#8217;s ability to act with a view to the best interests of the Corporation, other than interests and relationships arising from shareholding.&#160;&#160;In determining whether a director is independent of management, the Board shall make reference to the abovementioned rules and any applicable revisions thereto, and any additional relevant then current legislation, rules, policies and instruments of applicable regulatory authorities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each member of the Audit Committee shall be financially literate.&#160;&#160;In order to be financially literate, a director must be, at a minimum, able to read and understand basic financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation's financial statements.&#160;&#160;At least one member shall have accounting or related financial management expertise, meaning the ability to </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">44</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">analyze and interpret a full set of financial statements, including the notes attached thereto, in accordance with generally GAAP.&#160;&#160;In determining whether a member of the Audit Committee is financially literate or has accounting or related financial expertise, reference shall be made to the then current legislation, rules, policies and instruments of applicable regulatory authorities, which for further clarification, shall include but not be limited to the definition of &#8220;financial expert&#8221; as defined by the U.S. Securities and Exchange Commission rule.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A director appointed by the Board to the Audit Committee shall be a member of the Audit Committee until replaced by the Board or until his or her resignation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Meetings of the Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall convene a minimum of four times each year at such times and places as may be designated by the Chair of the Audit Committee and whenever a meeting is requested by the Board, a member of the Audit Committee, the auditors, or senior management of the Corporation.&#160;&#160;Scheduled meetings of the Audit Committee shall correspond with the review of the year-end and quarterly financial statements and management discussion and analysis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice of each meeting of the Audit Committee shall be given to each member of the Audit Committee and to the auditors, who shall be entitled to attend each meeting of the Audit Committee and shall attend whenever requested to do so by a member of the Audit Committee.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice of a meeting of the Audit Committee shall:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">be in writing, including by electronic communication facilities;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">state the nature of the business to be transacted at the meeting in reasonable detail;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to the extent practicable, be accompanied by copies of documentation to be considered at the meeting; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">be given at least two business days prior to the time stipulated for the meeting or such shorter period as the members of the Audit Committee may permit.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A quorum for the transaction of business at a meeting of the Audit Committee shall consist of a majority of the members of the Audit Committee.&#160;&#160;However, it shall be the practice of the Audit Committee to require review, and, if necessary, approval of certain important matters by all members of the Audit Committee.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A member or members of the Audit Committee may participate in a meeting of the Audit Committee by means of such telephonic, electronic or other communication facilities, as permits all persons participating in the meeting to communicate adequately with each other.&#160;&#160;A member participating in such a meeting by any such means is deemed to be present at the meeting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the absence of the Chair of the Audit Committee, the members of the Audit Committee shall choose one of the members present to be Chair of the meeting.&#160;&#160;In addition, the members of the Audit Committee shall choose one of the persons present to be the Secretary of the meeting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A member of the Board, senior management of the Corporation and other parties may attend meetings of the Audit Committee; however the Audit Committee (i) shall, at each meeting, meet with the external auditors independent of other individuals other than the Audit Committee and (ii) may meet separately with management.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">45</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Minutes shall be kept of all meetings of the Audit Committee and shall be signed by the Chair and the Secretary of the meeting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Duties and Responsibilities of the Committee</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee&#8217;s primary duties and responsibilities are to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">identify and monitor the management of the principal risks that could impact the financial reporting of the Corporation ;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">monitor the integrity of the Corporation&#8217;s financial reporting process and system of internal controls regarding financial reporting and accounting compliance;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">monitor the independence and performance of the Corporation&#8217;s external auditors. This will include receipt, review and evaluation, at least annually, of a formal written statement from the independent auditors confirming their independence, and qualifications, including their compliance with the requirements of the relevant oversight boards ;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">deal directly with the external auditors to pre-approve external audit plans, other services (if any) and fees;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">directly oversee the external audit process and results (in addition to items described in Section 4(d) below);</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">provide an avenue of communication among the external auditors, management and the Board;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">carry out a review designed to ensure that an effective "whistle blowing" procedure exists to permit stakeholders to express any concerns regarding accounting, internal controls, auditing matters or financial matters to an appropriately independent individual;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">h.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pre-approve any related party transactions to be entered into by the Company, and ensure appropriate disclosure thereof;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ensure financial disclosure incorporates inclusion of any material correcting adjustments required by the external auditors; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">j.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">require and ensure that the external auditors are directly responsible to the Audit Committee, to whom they report</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall have the authority to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inspect any and all of the books and records of the Corporation and its affiliates;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">discuss with the management of the Corporation and its affiliates, any affected party and the external auditors, such accounts, records and other matters as any member of the Audit Committee considers necessary and appropriate;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">engage independent counsel and other advisors as it determines necessary to carry out its duties; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to set and pay the compensation for any advisors employed by the Audit Committee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">46</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall, at the earliest opportunity after each meeting, report to the Board the results of its activities and any reviews undertaken and make recommendations to the Board as deemed appropriate.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review the audit plan with the Corporation&#8217;s external auditors and with management;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review with the independent auditors the matters required to be discussed relating to the conduct of the audit, including (a) the proposed scope of their examination, with emphasis on accounting and financial areas where the Committee, the independent auditors or management believes special attention should be directed; (b) the results of their audit, including their audit findings report and resulting letter, if any, of recommendations for management; (c) their evaluation of the adequacy and effectiveness of the Company&#8217;s internal controls over financial reporting; (d) significant areas of disagreement, if any, with management; (e) co-operation received from management in the conduct of the audit; (f) significant accounting, reporting, regulatory or industry developments affecting the Company; and (g) review any proposed changes in major accounting policies or principles proposed or contemplated by the independent auditors or management, the presentation and impact of material risks and uncertainties and key estimates and judgements of management that may be material to financial reporting;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review with management and with the external auditors material financial reporting issues arising during the most recent fiscal period and the resolution or proposed resolution of such issues;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review any problems experienced or concerns expressed by the external auditors in performing an audit, including any restrictions imposed by management or material accounting issues on which there was a disagreement with management;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review with senior management the process of identifying, monitoring and reporting the principal risks affecting financial reporting;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review audited annual financial statements (including management discussion and analysis) and related documents in conjunction with the report of the external auditors and obtain an explanation from management of all material variances between comparative reporting periods. Without restricting the generality of the foregoing, the committee will discuss with management and the independent auditors to the extent required, any issues and disclosure requirements regarding (a) the use of &#8220;pro forma&#8221; or &#8220;adjusted&#8221; non-GAAP information, as well as financial information and earnings guidance provided to analysts and rating agencies, (b) any off balance sheet arrangements, and (c) any going concern qualification.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">consider and review with management, the internal control memorandum or management letter containing the recommendations of the external auditors and management&#8217;s response, if any, including an evaluation of the adequacy and effectiveness of the internal financial controls of the Corporation and subsequent follow-up to any identified weaknesses;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">h.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review with financial management and the external auditors the quarterly unaudited financial statements and management discussion and analysis before release to the public;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">before release, review and if appropriate, recommend for approval by the Board, all public disclosure documents containing audited or unaudited financial information, including any prospectuses, annual reports, annual information forms, management discussion and analysis and press releases; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">47</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">j.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">oversee, any of the financial affairs of the Corporation or its affiliates, and, if deemed appropriate, make recommendations to the Board, external auditors or management.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">evaluate the independence and performance of the external auditors and annually recommend to the Board the appointment of the external auditor or the discharge of the external auditor when circumstances are warranted and monitor the audit partners&#8217; rotation as required by law.;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">consider the recommendations of management in respect of the appointment of the external auditors;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pre-approve all non-audit services to be provided to the Corporation or its subsidiary entities by its external auditors', or the external auditors of affiliates of the Corporation subject to the over-riding principle that the external auditors not being permitted to be retained by the Corporation to perform specifically listed categories of non-audit services as set forth by the Securities and Exchange Commission as well as internal audit outsourcing services, financial information systems work and expert services.&#160;&#160;Notwithstanding, the foregoing the pre-approval of non-audit services may be delegated to a member of the Audit Committee, with any decisions of the member with the delegated authority reporting to the Audit Committee at the next scheduled meeting;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">approve the engagement letter for non-audit services to be provided by the external auditors or affiliates, together with estimated fees, and considering the potential impact of such services on the independence of the external auditors;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">when there is to be a change of external auditors, review all issues and provide documentation related to the change, including the information to be included in the Notice of Change of Auditors and documentation required pursuant to the then current legislation, rules, policies and instruments of applicable regulatory authorities and the planned steps for an orderly transition period; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review all reportable events, including disagreements, unresolved issues and consultations, as defined by applicable securities policies, on a routine basis, whether or not there is to be a change of external auditors.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall enquire into and determine the appropriate resolution of any conflict of interest in respect of audit or financial matters, which are directed to the Audit Committee by any member of the Board, a shareholder of the Corporation, the external auditors, or senior management.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall periodically review with management the need for an internal audit function.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall review the Corporation&#8217;s accounting and reporting of costs, liabilities and contingencies.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall establish and maintain procedures for:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the receipt, retention and treatment of complaints received by the Corporation regarding accounting controls, or auditing matters; and</font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the confidential, anonymous submission by employees of the Corporation or concerns regarding questionable accounting or auditing matters.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">48</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall review and approve the Corporation's hiring policies regarding employees and former employees of the present and former external auditors.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall review with the Corporation's legal counsel, on no less than an annual basis, any legal matter that could have a material impact on the Corporation's financial statements, and any enquiries received from regulators, or government agencies.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee shall assess, on an annual basis, the adequacy of this Mandate and the performance of the Audit Committee.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets out the number of our employees at the end of each of the last three fiscal years by activity and geographic location.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Activity</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Geographic location</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canada</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States of America</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Share Ownership</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets out the share ownership and options held of our directors and officers as of March 16, 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="19%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common Shares</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of&#160;&#160;<br>
Ownership(1)</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options(2)</font></div>
</td>
<td valign="middle" width="8%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise <br>
Price</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expiry Date</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage <br>
of Outstanding (1)(3)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.75pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Officers</font></div>
</td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bradley Thompson</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">652,900</font></div>
</td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.15</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2010</font></div>
</td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.76</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 20, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 17, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 13, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">80,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">350,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">149,160</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">215,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,051,160</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.19%</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">48</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="19%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common Shares</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of&#160;&#160;<br>
Ownership(1)</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options(2)</font></div>
</td>
<td valign="middle" width="8%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise <br>
Price</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expiry Date</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage <br>
of Outstanding (1)(3)</font></div>
</td>
</tr></table>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matthew Coffey</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">288,550</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.15</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2010</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.76</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 20, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 17, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 13, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">53,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">180,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33,333</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">115,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">572,333</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.11%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Douglas Ball</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.15</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2010</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.76</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 20, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 17, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 13, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">180,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33,333</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">250,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.13</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">July 28, 2020</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">95,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">794,833</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.03%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mary Ann Dillahunty</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,201</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.28</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Feb 1, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,667</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2007</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131,667</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Karl Mettinger</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">200,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.18</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sept 23, 2015</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">270,000</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">George Gill</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Oct 18, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">87,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.85</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Oct 10, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,667</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">240,667</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">49</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="19%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common Shares</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of&#160;&#160;<br>
Ownership(1)</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options(2)</font></div>
</td>
<td valign="middle" width="8%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise <br>
Price</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expiry Date</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage <br>
of Outstanding (1)(3)</font></div>
</td>
</tr></table>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Directors</font></div>
</td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Robert Schultz</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.76</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 20, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 17, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 13, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.13</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">July 28, 2020</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">263,000</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fred Stewart</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.76</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 20, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 17, 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 13, 2012</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185,000</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jim Dinning</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.90</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mar 29, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">152,500</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mark Lievonen</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.38</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Apr 5, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">152,500</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">50</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="middle" width="19%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common Shares</font></div>
</td>
<td valign="middle" width="11%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of&#160;&#160;<br>
Ownership(1)</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options(2)</font></div>
</td>
<td valign="middle" width="8%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise <br>
Price</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expiry Date</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage <br>
of Outstanding (1)(3)</font></div>
</td>
</tr></table>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">William Cochrane</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54,700</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.33</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aug 5, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.50</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 11, 2013</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 28, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 9, 2014</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">116,500</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed Levy</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,300</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.10</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 16, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125,000</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ger van Amersfoort</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,200</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.60</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jun 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.25</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 15, 2016</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.22</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 12, 2017</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,500</font></div>
</td>
<td align="right" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 8, 2019</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></div>
</td>
<td align="right" valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72</font></div>
</td>
<td align="right" valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec 14, 2020</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125,000</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">**</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TOTAL:</font></div>
</td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,112,851</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,160,160</font></div>
</td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">** Less than 1% ownership</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based on 67,958,302 common shares issued and outstanding on December 31, 2010.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options exercisable to acquire common shares.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ownership percentage assumes aggregate beneficial ownership of common shares, common shares acquirable upon exercise of options and fully diluted share outstanding of 77,988,522.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 45pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Major Shareholders</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are not directly or indirectly owned or controlled by another corporation(s) or by any foreign government. To the knowledge of our directors and senior officers, at February 28, 2011, we have the following shareholder who beneficially owns, directly or indirectly, or exercises control or direction over, our common shares carrying more than 5% of the voting rights attached to all our outstanding common shares:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">51</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="27%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name of <br>
Shareholder</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Number of Common<br>
Shares </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Held</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of <br>
Outstanding</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acuity Investment Management Inc.</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,570,500</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.70</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Changes in ownership by major shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the best of the Company&#8217;s knowledge there have been no changes in the ownership of the Company&#8217;s shares other than disclosed herein.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Voting Rights</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no differences between the voting rights of Acuity Investment Management Inc. and all other common shareholders.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Shares Held in the United States</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table indicates, as of March 24, 2011, the total number of common shares issued and outstanding, the approximate total number of holders of record of common shares, the number of holders of record of common shares with U.S.&#160;addresses, the portion of the outstanding common shares held by U.S.&#160;holders of record, and the percentage of common shares held by U.S.&#160;holders of record. This table does not indicate beneficial ownership of common&#160;shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="27%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Number of Holders of Record</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Number of Common Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">issued and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number of U.S.&#160;Holders of Record<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number of Common Shares Held by U.S.&#160;Holders of Record</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage of Common Shares Held by U.S.&#160;Holders of Record</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">202</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71,207,318</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,063,614</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.52%</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Change of Control</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of March 24, 2010, there were no arrangements known to the Company which may, at a subsequent date, result in a change of control of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Control by Others</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the best of the Company&#8217;s knowledge, the Company is not directly or indirectly owned or controlled by another corporation, any foreign government, or any other natural or legal person, severally or jointly.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">52</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Related Party Transactions</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have entered into employment contracts with each of our officers (see Item 6).&#160;&#160;Since the beginning of the fiscal year ended December 31, 2010 up to March 23, 2011, we did not enter into any other related party transactions and we do not have any loans outstanding with any officer, director or major shareholder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interests of Experts and Council</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 8. FINANCIAL INFORMATION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consolidated Statements and Other Financial Statements</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial Statements</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements filed as part of this annual report are filed under Item 18.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Legal Proceedings</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The directors and the management of the Company do not know of any material, active or pending, legal proceedings against them; nor is the Company involved as a plaintiff in any material proceeding or pending litigation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The directors and the management of the Company know of no active or pending proceedings against anyone that might materially adversely affect an interest of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Dividend Policy</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;The Company has not paid any dividends on its common shares.&#160;&#160;The Company may pay dividends on its common shares in the future if it generates profits.&#160;&#160;Any decision to pay dividends on common shares in the future will be made by the board of directors on the basis of the earnings, financial requirements and other conditions existing at such time.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Significant Changes</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There have been no significant changes to our annual financial statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 9. THE OFFER AND LISTING</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Offering and Listing Details</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Common Shares are traded on the TSX and on the NASDAQ Capital Market under the symbol "ONC" and &#8220;ONCY&#8221;, respectively. The last reported sales price of our common shares on March 22, 2011 on the TSX was Cdn$5.65and on the NASDAQ Capital Market was US$5.75.&#160;&#160;The following table sets forth the high and low per share sales prices for our common shares on the NASDAQ and TSX for the periods indicated.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">53</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="4" valign="top" width="59%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common Shares</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="top" width="29%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NASDAQ</font></div>
</td>
<td colspan="2" valign="top" width="29%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TSX</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">High</font></div>
</td>
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Low</font></div>
</td>
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">High</font></div>
</td>
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Low</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.16</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.81</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.05</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.11</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.90</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.46</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.40</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.50</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.31</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.06</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.50</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.23</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.80</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.14</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.10</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.41</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.00</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.15</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.95</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.05</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 1</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.60</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.14</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.95</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.41</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 2</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.13</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.21</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.33</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.50</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 3</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.38</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.40</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.65</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.61</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 4</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.80</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.57</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.10</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.65</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 1</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.63</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.05</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.70</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.57</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 2</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.25</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.44</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.40</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.68</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 3</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.98</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.40</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.09</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.53</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Quarter 4</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.95</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.27</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.00</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.36</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.98</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.99</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.09</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.10</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">October</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.98</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.27</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.34</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.36</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.10</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.43</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.00</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.52</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.95</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.65</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.00</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.74</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">January</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.86</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.85</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.85</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.83</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">February</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.69</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.97</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.61</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.94</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March (1 &#8211; 22)</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.44</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.65</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.27</font></div>
</td>
<td valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.59</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Market Price Volatility of Common Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Market prices for the securities of biotechnology companies, including our securities, have historically been highly volatile, and the market has from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. Factors, such as fluctuations in our operating results, the aftermath of our public announcements, and general market conditions, can have an adverse effect on the market price of our common shares and other securities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plan of Distribution</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">54</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Markets</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our common shares, no par value, are traded on the NASDAQ Capital Market and the TSX under the symbol &#8220;ONCY" and &#8220;ONC&#8221;, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="page_ei41401_1_149"><!--EFPlaceholder--></a>D.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Selling Shareholders</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dilution</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Expenses of the Issue</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 10.&#160; ADDITIONAL INFORMATION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Share Capital</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Memorandum and Articles of Association</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Articles of Continuance</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are governed by our amended articles of incorporation (the "Articles") under the Business Corporations Act of Alberta (the &#8220;Act&#8221;) and by our by-laws (the&#160;"By-laws"). Our Alberta corporate access number is 207797382. Our Articles provide that there are no restrictions on the business we may carry on or on the powers we may exercise. Companies incorporated under the Act are not required to include specific objects or purposes in their articles or by-laws.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Directors</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to certain exceptions, including in respect of voting on any resolution to approve a contract that relates primarily to the director's remuneration, directors may not vote on resolutions to approve a material contract or material transaction if the director is a party to such contract or transaction. The directors are entitled to remuneration as shall from time to time be determined by the Board of Directors with no requirement for a quorum of independent directors. The directors have the ability under the Act to exercise our borrowing power, without authorization of the shareholders. The Act permits shareholders to restrict this authority through a company's articles or by-laws (or through a unanimous shareholder agreement), but no such restrictions are in place for us. Our Articles and By-laws do not require directors to hold shares for qualification.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">55</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Rights, Preferences and Dividends Attaching to Shares</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The holders of common shares have the right to receive dividends if and when declared. Each holder of common shares, as of the record date prior to a meeting, is entitled to attend and to cast one vote for each common share held as of such record date at such annual and/or special meeting, including with respect to the election or re-election of directors. Subject to the provisions of our By-laws, all directors may, if still qualified to serve as directors, stand for re-election. The numbers of our Board of Directors are not replaced at staggered intervals but are elected annually.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On a distribution of assets on a winding-up, dissolution or other return of capital (subject to certain exceptions) the holders of common shares shall have a right to receive their <font style="DISPLAY: inline; FONT-STYLE: italic">pro&#160;rata</font> share of such distribution. There are no sinking fund or redemption provisions in respect of the common shares. Our shareholders have no liability to further capital calls as all shares issued and outstanding are fully paid and non-assessable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No other classes of shares are currently permitted to be issued.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="page_ei41401_1_150"><!--EFPlaceholder--></a>Action Necessary to Change the Rights of Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The rights attaching to the different classes of shares may be varied by special resolution passed at a meeting of that class's shareholders.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Annual and Special Meetings of Shareholders</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the Act and our By-laws, we are required to mail a Notice of Meeting and Management Information Circular to registered shareholders not less than 21&#160;days and not more than 50 days prior to the date of the meeting. Such materials must be filed concurrently with the applicable securities regulatory authorities in Canada and the U.S.&#160;&#160;Subject to certain provisions of the By-laws, a quorum of two or more shareholders in person or represented by proxy holding or representing by proxy not less than five (5%) percent of the total number of issued and outstanding shares enjoying voting rights at such meeting is required to properly constitute a meeting of shareholders.&#160;&#160;Shareholders and their duly appointed proxies and corporate representatives are entitled to be admitted to our annual and/or special meetings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Limitations on the Rights to Own Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Articles do not contain any limitations on the rights to own shares. Except as described below, there are currently no limitations imposed by Canadian federal or provincial laws on the rights of non-resident or foreign owners of Canadian securities to hold or vote the securities held. There are also no such limitations imposed by the Articles and By-laws with respect to our common&#160;shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Disclosure of Share Ownership</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In general, under applicable securities regulation in Canada, a person or company who beneficially owns, directly or indirectly, voting securities of an issuer or who exercises control or direction over voting securities of an issuer or a combination of both, carrying more than 10% of the voting rights attached to all the issuer's outstanding voting securities is an insider and must, within 10&#160;days of becoming an insider, file&#160;a report in the required form effective the date on which the person became an insider. The report must </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">56</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">disclose any direct or indirect beneficial ownership of, or control or direction over, securities of the reporting issuer. Additionally, securities regulation in Canada provides for the filing of a report by an insider of a reporting issuer whose holdings change, which report must be filed within 10&#160;days from the day on which the change takes place.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The rules in the U.S. governing the ownership threshold above which shareholder ownership must be disclosed are more stringent than those discussed above. Section 13 of the Exchange Act imposes reporting requirements on persons who acquire beneficial ownership (as such term is defined in Rule 13d-3 under the Exchange Act) of more than 5% of a class of an equity security registered under Section 12 of the Exchange Act.&#160;&#160;In general, such persons must file, within 10&#160;days after such acquisition, a report of beneficial ownership with the SEC containing the information prescribed by the regulations under Section&#160;13 of the Exchange Act. This information is also required to be sent to the issuer of the securities and to each exchange where the securities are&#160;traded.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other Provisions of Articles and By-laws</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no provisions in the Articles or By-laws:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">delaying or prohibiting a change in control of our company that operate only with respect to a merger, acquisition or corporate restructuring;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of&#160;shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">requiring disclosure of share ownership; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">governing changes in capital, where such provisions are more stringent than those required by&#160;law.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="page_ei41401_1_151"><!--EFPlaceholder--></a>C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Material Contracts</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have employment contracts with each of our officers as summarized in Item 6B.&#160;&#160;Other than these employment contracts, we have not entered into any other contract other than in the ordinary course of business over the last two years.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><!--EFPlaceholder-->D.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exchange Controls</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Canada has no system of exchange controls. There are no Canadian restrictions on the repatriation of capital or earnings of a Canadian public company to non-resident investors. There are no laws in Canada or exchange restrictions affecting the remittance of dividends, profits, interest, royalties and other payments to non-resident holders of our securities, except as discussed below in Section&#160;E,&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Taxation</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">57</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Restrictions on Share Ownership by Non-Canadians</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no limitations under the laws of Canada or in our organizational documents on the right of foreigners to hold or vote securities of our company, except that the <font style="DISPLAY: inline; FONT-STYLE: italic">Investment Canada Act</font> (the "Investment Canada Act") may require review and approval by the Minister of Industry (Canada) of certain acquisitions of "control" of our Company by a "non-Canadian."</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Investment Canada Act</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the Investment Canada Act, transactions exceeding certain financial thresholds, and which involve the acquisition of control of a Canadian business by a non-Canadian, are subject to review and cannot be implemented unless the Minister of Industry and/or, in the case of a Canadian business engaged in cultural activities, the Minister of Canadian Heritage, are satisfied that the transaction is likely to be of "net benefit to Canada". If a transaction is subject to review (a&#160;"Reviewable Transaction"), an application for review must be filed with the Investment Review Division of Industry Canada and/or the Department of Canadian Heritage prior to the implementation of the Reviewable Transaction. The responsible Minister is then required to determine whether the Reviewable Transaction is likely to be of net benefit to Canada taking into account, among other things, certain factors specified in the Investment Canada Act and any written undertakings that may have been given by the applicant. The Investment Canada Act contemplates an initial review period of up to 45&#160;days after filing; however, if the responsible Minister has not completed the review by that date, the Minister may unilaterally extend the review period by up to 30&#160;days (or&#160;such longer period as may be agreed to by the applicant and the Minister) to permit completion of the review. Direct acquisitions of control of most Canadian businesses by or from World Trade Organization ("WTO") investors are reviewable under the Investment Canada Act only if, in the case of an acquisition of voting securities, the value of the worldwide assets of the Canadian business or, in the case of an acquisition of substantially all the assets of a Canadian business, the value of those assets exceed C$295 million for the year 2008 (this figure is adjusted annually to reflect inflation). Indirect acquisitions (e.g., an acquisition of a U.S. corporation with a Canadian subsidiary) of control of such businesses by or from WTO investors are not subject to review, regardless of the value of the Canadian businesses' assets. Significantly lower review thresholds apply where neither the investor nor the Canadian business is WTO investor controlled or where the Canadian business is engaged in uranium mining, certain cultural businesses, financial services or transportation services.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Even if the transaction is not reviewable because it does not meet or exceed the applicable financial threshold, the non-Canadian investor must still give notice to Industry Canada and, in the case of a Canadian business engaged in cultural activities, Canadian Heritage, of its acquisition of control of a Canadian business within 30&#160;days of its implementation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Competition Act</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The <font style="DISPLAY: inline; FONT-STYLE: italic">Competition Act</font> (Canada) (the&#160;"Competition Act") requires that a pre-merger notification filing be submitted to the Commissioner of Competition (the&#160;"Commissioner") in respect of proposed transactions that exceed certain financial and other thresholds. If a proposed transaction is subject to pre-merger notification, a pre-merger notification filing must be submitted to the Commissioner and a waiting period must expire or be waived by the Commissioner before the transaction may be completed. The parties to a proposed transaction may choose to submit either </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">59</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a short-form filing (in&#160;respect of which there is a 14-day statutory waiting period) or a long-form filing (in&#160;respect of which there is a 42-day statutory waiting period). However, where the parties <a name="page_ei41401_1_152"><!--EFPlaceholder--></a>choose to submit a short-form filing, the Commissioner may, within 14&#160;days, require that the parties submit a long-form filing, in which case the proposed transaction generally may not be completed until 42&#160;days after the long-form filing is submitted by the&#160;parties.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Commissioner may, upon request, issue an advance ruling certificate ("ARC") in respect of a proposed transaction where she is satisfied that she would not have sufficient grounds on which to apply to the Competition Tribunal for an order under the merger provisions of the Competition Act. If the Commissioner issues an ARC in respect of a proposed transaction, the transaction is exempt from the pre-merger notification provisions. In addition, if the transaction to which the ARC relates is substantially completed within one year after the ARC is issued, the Commissioner cannot seek an order of the Competition Tribunal under the merger provisions of the Competition Act in respect of the transaction solely on the basis of information that is the same or substantially the same as the information on the basis of which the ARC was&#160;issued.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the Commissioner is unwilling to issue an ARC, she may nevertheless issue a "no action" letter waiving notification and confirming that she is of the view that grounds do not then exist to initiate proceedings before the Competition Tribunal under the merger provisions of the Competition Act with respect to the proposed transaction, while preserving, during the three years following completion of the proposed transaction, her authority to initiate proceedings should circumstances change.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Regardless of whether pre-merger notification is required, the Commissioner may apply to the Competition Tribunal (a special purpose tribunal) for an order under the merger provisions of the Competition Act. If the Competition Tribunal finds that the transaction is or is likely to prevent or lessen competition substantially, it may order that the parties not proceed with the transaction or part of it or, in the event that the transaction has already been completed, order its dissolution or the disposition of some of the assets or shares involved. In addition, the Competition Tribunal may, with the consent of the person against whom the order is directed and the Commissioner, order that person to take any other action as is deemed necessary to remedy any substantial lessening or prevention of competition that the Competition Tribunal determines would or would likely result from the transaction.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Taxation</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following is a general summary of certain material U.S. federal income tax considerations applicable to a U.S. Holder (as defined below) arising from and relating to the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This summary is for general information purposes only and does not purport to be a complete analysis or listing of all potential U.S. federal income tax considerations that may apply to a U.S. Holder arising from and relating to the acquisition, ownership, and disposition of common shares.&#160;&#160;In addition, this summary does not take into account the individual facts and circumstances of any particular U.S. Holder that may affect the U.S. federal income tax consequences to such U.S. Holder,<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>including specific tax consequences to a U.S. Holder under an applicable tax treaty.&#160;&#160;Accordingly, this summary is not intended to be, and should not be construed as, legal or U.S. federal income tax advice with respect to any U.S. Holder.&#160;&#160;Each U.S. Holder should consult its own tax advisor regarding the U.S. federal, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local tax, and foreign tax consequences relating to the acquisition, ownership and disposition of common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">60</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No legal opinion from U.S. legal counsel or ruling from the Internal Revenue Service (the &#8220;IRS&#8221;) has been requested, or will be obtained, regarding the U.S. federal income tax consequences of the acquisition, ownership, and disposition of common shares.&#160;&#160;This summary is not binding on the IRS, and the IRS is not precluded from taking a position that is different from, and contrary to, the positions taken in this summary.&#160;&#160;In addition, because the authorities on which this summary is based are subject to various interpretations, the IRS and the U.S. courts could disagree with one or more of the positions taken in this summary.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scope of this Summary</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorities</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This summary is based on the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury Regulations (whether final, temporary, or proposed), published rulings of the IRS, published administrative positions of the IRS, the Convention Between Canada and the United States of America with Respect to Taxes on Income and on Capital,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">signed September 26, 1980, as amended (the &#8220;Canada-U.S. Tax Convention&#8221;), and U.S. court decisions that are applicable and, in each case, as in effect and available, as of the date of this document.&#160;&#160;Any of the authorities on which this summary is based could be changed in a material and adverse manner at any time, and any such change could be applied on a retroactive or prospective basis which could affect the U.S. federal income tax considerations described in this summary.&#160;&#160;This summary does not discuss the potential effects, whether adverse or beneficial, of any proposed legislation that, if enacted, could be applied on a retroactive or prospective basis.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">U.S. Holders</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For purposes of this summary, the term "U.S. Holder" means a beneficial owner of common shares that is for U.S. federal income tax purposes:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#9679;&#160;</font></td>
<td width="96%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">an individual who is a citizen or resident of the U.S.;</font></td>
</tr><tr>
<td width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#9679;&#160;&#160;&#160;</font></td>
<td width="96%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized under the laws of the U.S., any state thereof or the District of Columbia;</font></td>
</tr><tr>
<td width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#9679;&#160;&#160;</font></td>
<td width="96%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">an estate whose income is subject to U.S. federal income taxation regardless of its source; or</font></td>
</tr><tr>
<td width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td width="96%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">a trust that (1) is subject to the primary supervision of a court within the U.S. and the control of one or more U.S. persons for all substantial decisions or (2) has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Non-U.S. Holders</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For purposes of this summary, a &#8220;non-U.S. Holder&#8221; is a beneficial owner of common shares that is not a U.S. Holder.&#160;&#160;This summary does not address the U.S. federal income tax consequences to non-U.S. Holders arising from and relating to the acquisition, ownership, and disposition of common shares.&#160;&#160;Accordingly, a non-U.S. Holder should consult its own tax advisor regarding the U.S. federal, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local tax, and foreign tax consequences (including the potential application of and operation of any income tax treaties) relating to the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">U.S. Holders Subject to Special U.S. Federal Income Tax Rules Not Addressed</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This summary does not address the U.S. federal income tax considerations applicable to U.S. Holders that are subject to special provisions under the Code, including the following U.S. Holders:&#160;&#160;(a) U.S. Holders that are tax-exempt organizations, qualified retirement plans, individual retirement accounts, or other tax-deferred accounts; (b) U.S. Holders that are financial institutions, underwriters, insurance companies, real estate investment trusts, or regulated investment companies; (c) U.S. Holders that are dealers in securities or currencies or U.S. Holders that are traders in securities that elect to apply a mark-to-market accounting method; (d) U.S. Holders that have a &#8220;functional </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">61</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">currency&#8221; other than the U.S. dollar; (e) U.S. Holders that own common shares as part of a straddle, hedging transaction, conversion transaction, constructive sale, or other arrangement involving more than one position; (f) U.S. Holders that acquired common shares in connection with the exercise of employee stock options or otherwise as compensation for services; (g) U.S. Holders that hold common shares other than as a capital asset within the meaning of Section 1221 of the Code (generally, property held for investment purposes); (h) partnerships and other pass-through entities (and investors in such partnerships and entities); or (j) U.S. Holders that own or have owned&#160;&#160;(directly, indirectly, or by attribution) 10% or more of the total combined voting power of the outstanding shares of the Company.&#160;&#160;This summary also does not address the U.S. federal income tax considerations applicable to U.S. Holders who are (a) U.S. expatriates or former long-term residents of the U.S. subject to Section 877 of the Code, (b) persons that have been, are, or will be a resident or deemed to be a resident in Canada for purposes of the Tax Act; (c) persons that use or hold, will use or hold, or that are or will be deemed to use or hold common shares in connection with carrying on a business in Canada; (d) persons whose common shares constitute &#8220;taxable Canadian property&#8221; under the Tax Act; or (e) persons that have a permanent establishment in Canada for the purposes of the Canada-U.S. Tax Convention.&#160;&#160;U.S. Holders that are subject to special provisions under the Code, including U.S. Holders described immediately above, should consult their own tax advisor regarding the U.S. federal, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local tax, and foreign tax consequences relating to the acquisition, ownership and disposition of common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If an entity that is classified as a partnership for U.S. federal income tax purposes holds common shares, the U.S. federal income tax consequences to such partnership and the partners of such partnership generally will depend on the activities of the partnership and the status of such partners.&#160;&#160;Partners of entities that are classified as partnerships for U.S. federal income tax purposes should consult their own tax advisor regarding the U.S. federal income tax consequences arising from and relating to the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Tax Consequences Not Addressed</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This summary does not address the U.S. state and local, U.S. federal estate and gift, U.S. federal alternative minimum tax or foreign tax consequences to U.S. Holders of the acquisition, ownership, and disposition of common shares.&#160;&#160;Each U.S. Holder should consult its own tax advisor regarding the U.S. state and local, U.S. federal estate and gift, U.S. federal alternative minimum tax and foreign tax consequences of the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Passive Foreign Investment Company Rules</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the Company is considered a &#8220;passive foreign investment company&#8221; under the meaning of Section 1297 of the Code (a &#8220;PFIC&#8221;) at any time during a U.S. Holder&#8217;s holding period, the following sections will generally describe the U.S. federal income tax consequences to the U.S. Holder of the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PFIC Status of the Company</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company generally will be a PFIC if, for a tax year, (a) 75% or more of the gross income of the Company for such tax year is passive income or (b) 50% or more of the value of the Company&#8217;s assets either produce passive income (the &#8220;income test&#8221;) or are held for the production of passive income, based on the quarterly average of the fair market value of such assets (the &#8220;asset test&#8221;).&#160;&#160;&#8220;Gross income&#8221; generally means all sales revenues less the cost of goods sold, and &#8220;passive income&#8221; generally includes, for example, dividends, interest, certain rents and royalties, certain gains from the sale of stock and securities, and certain gains from commodities transactions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Active business gains arising from the sale of commodities generally are excluded from passive income if substantially all of a foreign corporation&#8217;s commodities are (a) stock in trade of such foreign corporation or other property of a kind which would properly be included in inventory of such foreign corporation, or property held by such foreign corporation primarily for sale to customers in the ordinary course of business, (b) property used in the trade or business of such foreign corporation that would be subject to the allowance for depreciation under Section 167 of the Code, or (c) supplies of a type regularly used or consumed by such foreign corporation in the ordinary course of its trade or business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">62</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For purposes of the PFIC income test and asset test described above, if the Company owns, directly or indirectly, 25% or more of the total value of the outstanding shares of another corporation, the Company will be treated as if it (a) held a proportionate share of the assets of such other corporation and (b) received directly a proportionate share of the income of such other corporation.&#160;&#160;In addition, for purposes of the PFIC income test and asset test described above, &#8220;passive income&#8221; does not include any interest, dividends, rents, or royalties that are received or accrued by the Company from a &#8220;related person&#8221; (as defined in Section 954(d)(3) of the Code), to the extent such items are properly allocable to the income of such related person that is not passive income.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, under certain attribution rules, if the Company is a PFIC, U.S. Holders will be deemed to own their proportionate share of any subsidiary of the Company which is also a PFIC (a &#8216;&#8216;Subsidiary PFIC&#8217;&#8217;), and will be subject to U.S. federal income tax on their proportionate share of (i) a distribution on the shares of a Subsidiary PFIC and (ii) a disposition or deemed disposition&#160;&#160;of shares of a Subsidiary PFIC, both as if such U.S. Holders directly held the shares of such Subsidiary PFIC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company believes that it qualified as a PFIC for the taxable year ended December 31, 2010, and based on current business plans and financial projections, the Company anticipates that it may qualify as a PFIC for subsequent taxable years.&#160;&#160;The determination of whether a corporation was, or will be, a PFIC for a tax year depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">interpretations.&#160;&#160;In addition, whether a corporation will be a PFIC for any tax year depends on the assets and income of such corporation over the course of each such tax year and, as a result, cannot be predicted with certainty as of the date of this document.&#160;&#160;Accordingly, there can be no assurance that the IRS will not challenge any determination made by the Company (or a Subsidiary PFIC) concerning its PFIC status.&#160;&#160;Each U.S. Holder should consult its own tax advisor regarding the PFIC status of the Company and each Subsidiary PFIC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Default PFIC Rules Under Section 1291 of the Code</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the Company is a PFIC, the U.S. federal income tax consequences to a U.S. Holder of the acquisition, ownership, and disposition of common shares will depend on whether such U.S. Holder makes an election to treat the Company and each Subsidiary PFIC, if any, as a &#8220;qualified electing fund&#8221; or &#8220;QEF&#8221; under Section 1295 of the Code (a &#8220;QEF Election&#8221;) or a mark-to-market election under Section 1296 of the Code (a &#8220;Mark-to-Market Election&#8221;).&#160;&#160;A U.S. Holder that does not make either a QEF Election or a Mark-to-Market Election will be referred to in this summary as a &#8220;Non-Electing U.S. Holder.&#8221;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A Non-Electing U.S. Holder will be subject to the rules of Section 1291 of the Code with respect to (a) any gain recognized on the sale or other taxable disposition of common shares and (b) any excess distribution received on the common shares.&#160;&#160;A distribution generally will be an &#8220;excess distribution&#8221; to the extent that such distribution (together with all other distributions received in the current tax year) exceeds 125% of the average distributions received during the three preceding tax years (or during a U.S. Holder&#8217;s holding period for the common shares, if shorter).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under Section 1291 of the Code, any gain recognized on the sale or other taxable disposition of common shares, and any &#8220;excess distribution&#8221; received on common shares, must be ratably allocated to each day in a Non-Electing U.S. Holder&#8217;s holding period for the respective common shares.&#160;&#160;The amount of any such gain or excess distribution allocated to the tax year of disposition or distribution of the excess distribution and to years before the entity became a PFIC, if any, would be taxed as ordinary income.&#160;&#160;The amounts allocated to any other tax year would be subject to U.S. federal income tax at the highest tax applicable to ordinary income in each such year, and an interest charge would be imposed on the tax liability for each such year, calculated as if such tax liability had been due in each such year.&#160;&#160;A Non-Electing U.S. Holder that is not a corporation must treat any such interest paid as &#8220;personal interest,&#8221; which is not deductible.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the Company is a PFIC for any tax year during which a Non-Electing U.S. Holder holds common shares, the Company will continue to be treated as a PFIC with respect to such Non-Electing U.S. Holder, regardless of whether the Company ceases to be a PFIC in one or more subsequent tax years.&#160;&#160;A Non-Electing U.S. Holder may terminate this deemed PFIC status by electing to recognize gain (which will be taxed under the rules of Section 1291 of the Code discussed above) as if such common shares were sold on the last day of the last tax year for which the Company was a PFIC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">63</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">QEF Election</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder that makes a timely and effective QEF Election for the first tax year in which its holding period of its common shares begins, generally, will not be subject to the rules of Section 1291 of the Code discussed above with respect to its common shares.&#160;&#160;However, a U.S. Holder that makes a QEF Election will be subject to U.S. federal income tax on such U.S. Holder&#8217;s pro rata share of (a) the net capital gain of the Company, which will be taxed as long-term capital gain to such U.S. Holder, and (b) and the ordinary earnings of the Company, which will be taxed as ordinary income to such U.S. Holder.&#160;&#160;Generally, &#8220;net capital gain&#8221; is the excess of (a) net long-term capital gain over (b) net short-term capital loss, and &#8220;ordinary earnings&#8221; are the excess of (a) &#8220;earnings and profits&#8221; over (b) net capital gain.&#160;&#160;A U.S. Holder that makes a QEF Election will be subject to U.S. federal income tax on such amounts for each tax year in which the Company is a PFIC, regardless of whether such amounts are actually distributed to such U.S. Holder by the Company.&#160;&#160;However, for any tax year in which the Company is a PFIC and has no net income or gain, U.S. Holders that have made a QEF Election would not have any income inclusions as a result of the QEF Election.&#160;&#160;If a U.S. Holder that made a QEF Election has an income inclusion, such a U.S. Holder may, subject to certain limitations, elect to defer payment of current U.S. federal income tax on such amounts, subject to an interest charge.&#160;&#160;If such U.S. Holder is not a corporation, any such interest paid will be treated as &#8220;personal interest,&#8221; which is not deductible.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder that makes a QEF Election generally (a) may receive a tax-free distribution from the Company to the extent that such distribution represents &#8220;earnings and profits&#8221; of the Company that were previously included in income by the U.S. Holder because of such QEF Election and (b) will adjust such U.S. Holder&#8217;s tax basis in the common shares to reflect the amount included in income or allowed as a tax-free distribution because of such QEF Election.&#160;&#160;In addition, a U.S. Holder that makes a QEF Election generally will recognize capital gain or loss on the sale or other taxable disposition of common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The procedure for making a QEF Election, and the U.S. federal income tax consequences of making a QEF Election, will depend on whether such QEF Election is timely.&#160;&#160;A QEF Election will be treated as &#8220;timely&#8221; if such QEF Election is made for the first year in the U.S. Holder&#8217;s holding period for the common shares in which the Company was a PFIC.&#160;&#160;A U.S. Holder may make a timely QEF Election by filing the appropriate QEF Election documents at the time such U.S. Holder files a U.S. federal income tax return for such year.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A QEF Election will apply to the tax year for which such QEF Election is made and to all subsequent tax years, unless such QEF Election is invalidated or terminated or the IRS consents to revocation of such QEF Election.&#160;&#160;If a U.S. Holder makes a QEF Election and, in a subsequent tax year, the Company ceases to be a PFIC, the QEF Election will remain in effect (although it will not be applicable) during those tax years in which the Company is not a PFIC.&#160;&#160;Accordingly, if the Company becomes a PFIC in another subsequent tax year, the QEF Election will be effective and the U.S. Holder will be subject to the QEF rules described above during any subsequent tax year in which the Company qualifies as a PFIC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">64</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For each taxable year that the Company qualifies as a PFIC, the Company will make available to each U.S. Holder that has made a QEF Election, upon written request, a "PFIC Annual Information Statement" as described in Treasury Regulation Section 1.1295-1(g) (or any successor Treasury Regulation) and use commercially reasonable efforts to provide all additional information that such U.S. Holder is required to obtain in connection with maintaining such QEF Election with regard to the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Mark-to-Market Election</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder may make a Mark-to-Market Election only if the common shares are marketable stock.&#160;&#160;The common shares generally will be &#8220;marketable stock&#8221; if the common shares are regularly traded on (a) a national securities exchange that is registered with the Securities and Exchange Commission, (b) the national market system established pursuant to section 11A of the Securities and Exchange Act of 1934, or (c) a foreign securities exchange that is regulated or supervised by a governmental authority of the country in which the market is located, provided that (i) such foreign exchange has trading volume, listing, financial disclosure, and meets other requirements and the laws of the country in which such foreign exchange is located, together with the rules of such foreign exchange, ensure that such requirements are actually enforced and (ii) the rules of such foreign exchange ensure active trading of listed stocks.&#160;&#160;If such stock is traded on such a qualified exchange or other market, such stock generally will be &#8220;regularly traded&#8221; for any calendar year during which such stock is traded, other than in de minimis quantities, on at least 15 days during each calendar quarter.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder that makes a Mark-to-Market Election with respect to its common shares generally will not be subject to the rules of Section 1291 of the Code discussed above with respect to such common shares.&#160;&#160;However, if a U.S. Holder does not make a Mark-to-Market Election beginning in the first tax year of such U.S. Holder&#8217;s holding period for the common shares or such U.S. Holder has not made a timely QEF Election, the rules of Section&#160;1291 of the Code discussed above will apply to certain dispositions of, and distributions on, the common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder that makes a Mark-to-Market Election will include in ordinary income, for each tax year in which the Company is a PFIC, an amount equal to the excess, if any, of (a) the fair market value of the common shares, as of the close of such tax year over (b) such U.S. Holder&#8217;s tax basis in such common shares.&#160;&#160;A U.S. Holder that makes a Mark-to-Market Election will be allowed a deduction in an amount equal to the excess, if any, of (i) such U.S. Holder&#8217;s adjusted tax basis in the common shares, over (ii) the fair market value of such common shares (but only to the extent of the net amount of previously included income as a result of the Mark-to-Market Election for prior tax years).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. Holder that makes a Mark-to-Market Election generally also will adjust such U.S. Holder&#8217;s tax basis in the common shares to reflect the amount included in gross income or allowed as a deduction because of such Mark-to-Market Election.&#160;&#160;In addition, upon a sale or other taxable disposition of common shares, a U.S. Holder that makes a Mark-to-Market Election will recognize ordinary income or ordinary loss (not to exceed the excess, if any, of (a) the amount included in ordinary income because of such Mark-to-Market Election for prior tax years over (b) the amount allowed as a deduction because of such Mark-to-Market Election for prior tax years).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">65</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A Mark-to-Market Election applies to the tax year in which such Mark-to-Market Election is made and to each subsequent tax year, unless the common shares cease to be &#8220;marketable stock&#8221; or the IRS consents to revocation of such election.&#160;&#160;Each U.S. Holder should consult its own tax advisor regarding the availability of, and procedure for making, a Mark-to-Market Election.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Although a U.S. Holder may be eligible to make a Mark-to-Market Election with respect to the common shares, no such election may be made with respect to the stock of any Subsidiary PFIC that a U.S. Holder is treated as owning, because such stock is not marketable.&#160;&#160;Hence, the Mark-to-Market Election will not be effective to eliminate the interest charge described above with respect to deemed dispositions of Subsidiary PFIC stock or distributions from a Subsidiary PFIC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other PFIC Rules</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under Section 1291(f) of the Code, the IRS has issued proposed Treasury Regulations that, subject to certain exceptions, would cause a U.S. Holder that had not made a timely QEF Election to recognize gain (but not loss) upon certain transfers of common shares that would otherwise be tax-deferred (e.g., gifts and exchanges pursuant to corporate reorganizations).&#160;&#160;However, the specific U.S. federal income tax consequences to a U.S. Holder may vary based on the manner in which common shares are transferred.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain additional adverse rules will apply with respect to a U.S. Holder if the Company is a PFIC, regardless of whether such U.S. Holder makes a QEF Election.&#160;&#160;For example under Section 1298(b)(6) of the Code, a U.S. Holder that uses common shares as security for a loan will, except as may be provided in Treasury Regulations, be treated as having made a taxable disposition of such common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Special rules also apply to the amount of foreign tax credit that a U.S. Holder may claim on a distribution from a PFIC.&#160;&#160;Subject to such special rules, foreign taxes paid with respect to any distribution in respect of stock in a PFIC are generally eligible for the foreign tax credit.&#160;&#160;The rules relating to distributions by a PFIC and their eligibility for the foreign tax credit are complicated, and a U.S. Holder should consult with their own tax advisor regarding the availability of the foreign tax credit with respect to distributions by a PFIC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, a U.S. Holder who acquires common shares from a decedent will not receive a &#8220;step up&#8221; in tax basis of such common shares to fair market value.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The PFIC rules are complex, and each U.S. Holder should consult its own tax advisor regarding the PFIC rules and how the PFIC rules may affect the U.S. federal income tax consequences of the acquisition, ownership, and disposition of common shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. Federal Income Tax Consequences of the Acquisition, Ownership, and Disposition of Common Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If either (a) the Company is not treated as a PFIC with respect to a U.S. Holder; (b) the Company is no longer a PFIC in the current taxable year and a U.S. Holder has recognized unrealized gain as of the last day of the taxable year in which the Company was a PFIC; or (c) a U.S. Holder has made a timely QEF Election and the Company is no longer a PFIC in the current taxable year, then a U.S. Holder generally will not be subject to the rules described above under the heading &#8220;Passive Foreign Investment Company Rules.&#8221;&#160;&#160;Instead, the U.S. Holder will have the tax consequences described below.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">66</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">General Taxation of Distributions</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to the PFIC rules discussed above, a U.S. Holder that receives a distribution, including a constructive distribution, with respect to a Common Share will be required to include the amount of such distribution in gross income as a dividend (without reduction for any Canadian income tax withheld from such distribution) to the extent of the current or accumulated &#8220;earnings and profits&#8221; of the Company, as computed for U.S. federal income tax purposes.&#160;&#160;A dividend generally will be taxed to a U.S. Holder at ordinary income tax rates.&#160;&#160;To the extent that a distribution exceeds the current and accumulated &#8220;earnings and profits&#8221; of the Company, such distribution will be treated first as a tax-free return of capital to the extent of a U.S. Holder's tax basis in the common shares and thereafter as gain from the sale or exchange of such common shares.&#160;&#160;(See &#8220; Sale or Other Taxable Disposition of common shares&#8221; below).&#160;&#160;However, the Company may not maintain the calculations of earnings and profits in accordance with U.S. federal income tax principles, and each U.S. Holder should therefore assume that any distribution by the Company with respect to the common shares will constitute ordinary dividend income.&#160;&#160;Dividends received on common shares generally will not be eligible for the &#8220;dividends received deduction&#8221;.&#160;&#160;In addition, the Company does not anticipate that its distributions will be eligible for the preferential tax rates applicable to long-term capital gains.&#160;&#160;The dividend rules are complex, and each U.S. Holder should consult its own tax advisor regarding the application of such rules.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Sale or Other Taxable Disposition of Common Shares</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to the PFIC rules discussed above, upon the sale or other taxable disposition of common shares, a U.S. Holder generally will recognize capital gain or loss in an amount equal to the difference between the amount of cash plus the fair market value of any property received and such U.S. Holder's tax basis in such common shares sold or otherwise disposed of.&#160;&#160;Subject to the PFIC rules discussed above, gain or loss recognized on such sale or other disposition generally will be long-term capital gain or loss if, at the time of the sale or other disposition, the common shares have been held for more than one year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Preferential tax rates apply to long-term capital gain of a U.S. Holder that is an individual, estate, or trust.&#160;&#160;There are currently no preferential tax rates for long-term capital gain of a U.S. Holder that is a corporation.&#160;&#160;Deductions for capital losses are subject to significant limitations under the Code.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Receipt of Foreign Currency</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The amount of any distribution paid to a U.S. Holder in foreign currency, or on the sale, exchange or other taxable disposition of common shares, generally will be equal to the U.S. dollar value of such foreign currency based on the exchange rate applicable on the date of receipt (regardless of whether such foreign currency is converted into U.S. dollars at that time).&#160;&#160;If the foreign currency received is not converted into U.S. dollars on the date of receipt, a U.S. Holder will have a basis in the foreign currency equal to its U.S. dollar value on the date of receipt.&#160;&#160;Any U.S. Holder who receives payment in foreign currency and engages in a subsequent conversion or other disposition of the foreign currency may have a foreign currency exchange gain or loss that would be treated as ordinary income or loss, and generally will be U.S. source income or loss for foreign tax credit purposes.&#160;&#160;Each U.S. Holder should consult its own U.S. tax advisor regarding the U.S. federal income tax consequences of receiving, owning, and disposing of foreign currency.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Foreign Tax Credit</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to the PFIC rules discussed above, a U.S. Holder who pays (whether directly or through withholding) Canadian income tax with respect to dividends paid on the common shares generally will be entitled, at the election of such U.S. Holder, to receive either a deduction or a credit for such Canadian income tax paid.&#160;&#160;Generally, a credit will reduce a U.S. Holder&#8217;s U.S. federal income tax liability on a dollar-for-dollar basis, whereas a deduction will reduce a U.S. Holder&#8217;s income subject to U.S. federal income tax.&#160;&#160;This election is made on a year-by-year basis and applies to all foreign taxes paid (whether directly or through withholding) by a U.S. Holder during a year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Complex limitations apply to the foreign tax credit, including the general limitation that the credit cannot exceed the proportionate share of a U.S. Holder&#8217;s U.S. federal income tax liability that such U.S. Holder&#8217;s &#8220;foreign source&#8221; taxable income bears to such U.S. Holder&#8217;s worldwide taxable income.&#160;&#160;In applying this limitation, a U.S. Holder&#8217;s </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">various items of income and deduction must be classified, under complex rules, as either &#8220;foreign source&#8221; or &#8220;U.S. </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">67</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">source.&#8221;&#160;&#160;Generally, dividends paid by a foreign corporation should be treated as foreign source for this purpose, and gains recognized on the sale of stock of a foreign corporation by a U.S. Holder should be treated as U.S. source for this purpose, except as otherwise provided in an applicable income tax treaty, and if an election is properly made under the Code.&#160;&#160;However, the amount of a distribution with respect to the Common Shares that is treated as a &#8220;dividend&#8221; may be lower for U.S. federal income tax purposes than it is for Canadian federal income tax purposes, resulting in a reduced foreign tax credit allowance to a U.S. Holder.&#160;&#160;In addition, this limitation is calculated separately with respect to specific categories of income.&#160;&#160;The foreign tax credit rules are complex, and each U.S. Holder should consult its own tax advisor regarding the foreign tax credit rules.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Backup Withholding and Information Reporting</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under U.S. federal income tax law and Treasury regulations, certain categories of U.S. Holders must file information returns with respect to their investment in, or involvement in, a foreign corporation.&#160;&#160;Penalties for failure to file certain of these information returns are substantial.&#160;&#160;U.S. Holders should consult with their own tax advisors regarding the requirements of filing information returns, and, if applicable mark-to-market and QEF elections.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Payments made within the U.S. or by a U.S. payor or U.S. middleman, of dividends on, and proceeds arising from the sale or other taxable disposition of, common shares will generally be subject to information reporting and backup withholding tax, at the rate of 28% (and increasing to 31% for payments made after December 31, 2012), if a U.S. Holder (a) fails to furnish such U.S.&#160;&#160;Holder&#8217;s correct U.S. taxpayer identification number (generally on Form W-9), (b) furnishes an incorrect U.S. taxpayer identification number, (c) is notified by the IRS that such U.S. Holder has previously failed to properly report items subject to backup withholding tax, or (d) fails to certify, under penalty of perjury, that such U.S. Holder has furnished its correct U.S. taxpayer identification number and that the IRS has not notified such U.S. Holder that it is subject to backup withholding tax.&#160;&#160;However, certain exempt persons, such as corporations, generally are excluded from these information reporting and backup withholding rules.&#160;&#160;Any amounts withheld under the U.S. backup withholding tax rules will be allowed as a credit against a U.S. Holder&#8217;s U.S. federal income tax liability, if any, or will be refunded, if such U.S. Holder furnishes required information to the IRS in a timely manner.&#160;&#160;Each U.S. Holder should consult its own tax advisor regarding the information reporting and backup withholding rules.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dividends and Paying Agents</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">G.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Statements by Experts</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">H.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Documents on Display</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to the informational requirements of the Exchange Act and file reports and other information with the SEC. You may read and copy any of our reports and other information at, and obtain copies upon payment of prescribed fees from, the Public Reference Room maintained by the SEC at 100&#160;F&#160;Street, N.E., Washington,&#160;D.C. 20549. In addition, the SEC maintains a Website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are required to file reports and other information with the securities commissions in Canada. You are invited to read and copy any reports, statements or other information, other than confidential filings, that we file with the provincial securities commissions. These filings are also electronically available from <a name="page_ei41401_1_157"><!--EFPlaceholder--></a>the Canadian System for Electronic Document Analysis and Retrieval ("SEDAR") (http://www.sedar.com), the Canadian equivalent of the SEC's electronic document gathering and retrieval system.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">68</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We "incorporate by reference" information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this Form&#160;20-F and&#160;more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this Form&#160;20-F.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements to shareholders.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We will provide without charge to each person, including any beneficial owner, to whom a copy of this annual report has been delivered, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this annual report (not&#160;including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: Oncolytics Biotech Inc., 210 &#8211; 1167 Kensington Crescent, NW, Calgary, Alberta, Canada, T2N 1X7, Attention:&#160;&#160;Doug Ball.&#160;&#160;Telephone (403) 670 - 7377. Facsimile (403)&#160;283-0858 EMAIL: info@oncolytics.ca.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsidiary Information</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not applicable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 11.&#160;&#160; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Foreign Currency Risk</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate primarily in Canada, the U.S., and the U.K.&#160;&#160;Therefore, we are exposed to foreign currency risk associated with our expenses outside of Canada.&#160;&#160;We do not use financial derivative instruments to manage this market risk.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Interest Rate Risk</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objective of our policy for the investment of temporary cash surpluses is the protection of principal, and, accordingly, we generally invest in investment-grade debt securities with varying maturities.&#160;&#160;As it is our intent and policy to hold these investments until maturity, we do not have a material exposure to interest rate risk.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not currently have any long-term debt, nor do we currently utilize interest rate swap contracts to hedge against interest rate&#160;risk.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">69</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not use financial instruments for trading purposes and are not parties to any leverage derivatives.&#160;&#160;We do not currently engage in hedging transactions.&#160;&#160;See &#8220;Currency and Exchange Rates&#8221; and Item 4 &#8211; &#8220;Information on the Company&#8221;.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 12.&#160;&#160; DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A. Debt Securities</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B. Warrants and Rights</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C. Other Securities</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Not Applicable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D. American Depository Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company&#8217;s common shares are not represented by American Depository Receipts.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART II</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 13.&#160; &#160;DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 14.&#160;&#160; MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Modification of Instruments Defining Rights of Security Holders.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Modification or Issuance of Other Class of Securities.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Withdrawal or Substitution of Security</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Change of Trustee or Paying Agent</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Use of Proceeds</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There has been no change to the information provided in our first annual report on Form 20-F.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">70</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 15.&#160;&#160;CONTROLS AND PROCEDURES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Evaluation of Disclosure Controls and Procedures</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It is the conclusion of our Chief Executive Officer and Chief Financial Officer that our Company's disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)), based on their evaluation of these controls and procedures as of the end of the period covered by this annual report, are effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms, and that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including its Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. As defined in Exchange Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with Canadian GAAP, including a reconciliation to U.S. GAAP, and includes those policies and procedures that (i) pertain to the</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with Canadian GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management, including the Company&#8217;s Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2010. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.&#160;&#160;Based on this assessment, management believes that, as of December 31, 2010, the Company&#8217;s internal control over financial reporting was effective based on those criteria.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is required to provide an auditor&#8217;s attestation report on internal control over financial reporting for the fiscal year ended December 31, 2010.&#160;&#160;&#160;In this report, the Company&#8217;s independent registered auditor, Ernst &amp; Young LLP, must state its opinion as to the effectiveness of the Company&#8217;s internal control over financial reporting for the fiscal year ended December 31, 2010.&#160;&#160;&#160;Ernst &amp; Young LLP has audited the Company&#8217;s financial statements included in this annual report on Form 20-F and has issued an attestation report on the Company&#8217;s internal control over financial reporting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">71</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attestation report of the register public accounting firms</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Auditor Attestation Report is included in the Ernst &amp; Young LLP Independent Auditor&#8217;s Report, included in the Company&#8217;s financial statements, beginning on page F-1 of this annual report on Form 20-F.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">D.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Changes in Internal Controls over Financial Reporting</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There were no changes in our internal controls over financial reporting that occurred during the period that is covered by this annual report that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16 .&#160; [RESERVED]</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16A.&#160; AUDIT COMMITTEE FINANCIAL EXPERT</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our board of directors has determined that each of the Audit Committee members, Fred Stewart, Robert Schultz and Jim Dinning, is a financial expert and each is independent pursuant to pursuant to the Rule 5605(a)(2) of the NASDAQ Capital Market and Rule 10A-3 of the Exchange Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="page_ek41401_1_159"><!--EFPlaceholder--></a>ITEM 16B.&#160; CODE OF ETHICS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Board of Directors has adopted a Code of Ethics for our CEO, CFO and Accounting Officer that applies to our CEO, CFO, and Controller.&#160;&#160;A copy of this Code of Ethics may be found on the Company&#8217;s website at http://www.oncolyticsbiotech.com.&#160;&#160;Requests for such copies should be directed to us at the following address: Oncolytics Biotech Inc., 210 &#8211; 1167 Kensington Crescent, NW, Calgary, Alberta, Canada, T2N 1X7, Attention:&#160;&#160;Doug Ball.&#160;&#160;Telephone (403) 670 - 7377. Facsimile (403)&#160;283-0858 EMAIL: info@oncolyticsbiotech.com.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">72</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16C.&#160; PRINCIPAL ACCOUNTANT FEES AND SERVICES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Audit Fees and Services</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the financial years ended December 31, 2010, 2009, and 2008, Ernst &amp; Young LLP received the following fees:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="4" valign="top" width="34%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
</tr><tr bgcolor="white">
<td colspan="2" valign="top" width="21%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Item</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td colspan="2" valign="top" width="21%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit fees</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">190,448</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">177,396</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140,961</font></div>
</td>
</tr><tr bgcolor="white">
<td colspan="2" valign="top" width="21%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit-related fees <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1),(3),</font></font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65,994</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">107,654</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">121,440</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td colspan="2" valign="top" width="21%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax fees <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,041</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,626</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,316</font></div>
</td>
</tr><tr bgcolor="white">
<td colspan="2" valign="top" width="21%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All other fees <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td align="right" valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,675</font></div>
</td>
<td align="right" valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,098</font></div>
</td>
<td align="right" valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112,352</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Includes review of interim financial statements, accounting consultations and subscription to on-line accounting services.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Comprised of tax return preparation, scientific research and development return and other tax consultation fees.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Includes fees associated with matters relating to a prospectus offering and base shelf prospectus filing (2009 -&#160;&#160;the prospectus offerings and a private company purchase; 2008 &#8211; the base shelf prospectus and prospectus offering).</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Includes fees associated with the adoption of International Financial Reporting Standards and&#160;&#160;the expansion of our corporate structure.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Audit Fees</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Audit fees were for professional services rendered by Ernst &amp; Young, LLP for the audit of our annual financial statements and services provided in connection with statutory and regulatory filings or engagements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Audit-Related Fees</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Audit-related fees were for assurance and related services reasonably related to the performance of the audit or review of the annual statements and are not reported under the heading Audit Fees above.&#160;&#160;These services consisted of accounting consultations, assistance with prospectus filings and assistance with preparations for compliance with section 404 of the <font style="DISPLAY: inline; FONT-STYLE: italic">Sarbanes-Oxley Act of 2002</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Tax Fees</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tax fees were for tax compliance and professional tax consultations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">All Other Fees</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other fees are for products and services other than those described under the headings Audit Fees, Audit-Related Fees and Tax Fees above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit Committee pre-approves all audit services to be provided to us by our independent auditors. The Audit Committee&#8217;s policy regarding the pre-approval of non-audit services to be provided to us by our independent auditors is that all such services shall be pre-approved by the Audit Committee or by the Chairman of the Audit Committee, who must report all such pre-approvals to the Audit Committee at their next meeting following the granting thereof. Non-audit services that are prohibited to be provided to us by our independent auditors may not be pre-approved. In addition, prior to the granting of any pre-approval, the Audit Committee or the Chairman, as the case may be, must be satisfied that the performance of the services in question will not compromise the independence of the independent auditors.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">73</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16E. PURCHASE OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company did not repurchase any common shares in the fiscal year ended December 31, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16F.&#160; CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 16G. CORPORATE GOVERNANCE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NASDAQ CORPORATE GOVERNANCE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our common shares are quoted for trading on the NASDAQ Capital Market.&#160;&#160;Section 5615(a)(3) of the NASDAQ Marketplace Rules permits NASDAQ to grant exemptions to a foreign private issuer for the provisions of the Rule 5600 series, Rule 5250 (d), and Rules 5210(c) and 5255 related to qualitative listing requirements.&#160;&#160;We are organized under the laws of the Province of Alberta and our common shares are listed for trading on The Toronto Stock Exchange.&#160;&#160;We comply with the laws of the Province of Alberta and rules and regulations of The Toronto Stock Exchange, including rules related to corporate governance practices.&#160;&#160;A description of the significant ways in which our governance practices differ from those followed by domestic companies pursuant to the NASDAQ Marketplace Rules is as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Shareholder Meeting Quorum Requirement</font>:&#160;&#160;The NASDAQ minimum quorum requirement for a shareholder meeting under Section 5620(c) of the NASDAQ Marketplace Rules is one-third of the outstanding shares of common stock.&#160;&#160;In addition, a company listed on NASDAQ is required to state our quorum requirement in our bylaws.&#160;&#160;Our quorum requirement is set forth in our corporate bylaws.&#160;&#160;A quorum for our shareholder meeting is two persons present and being, or representing by proxy, members holding not less than 5% of the issued shares entitled to be voted at such meeting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The foregoing is consistent with the laws, customs and practices in Canada and the rules of The Toronto Stock Exchange.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART III</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 17. FINANCIAL STATEMENTS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have elected to provide financial statements pursuant to Item 18.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">74</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 18 FINANCIAL STATEMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The financial statements appear on pages F-1 through F-33.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">75</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 19. EXHIBITS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following exhibits are filed as part of this annual report:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">EXHIBIT <br>
<font style="TEXT-DECORATION: underline">NUMBER</font></font></td>
<td valign="bottom" width="71%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="TEXT-DECORATION: underline">DESCRIPTION</font></font></td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Constating Documents</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1*</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Articles of Incorporation</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2*</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By-laws</font></div>
</td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Material Contracts</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.1**</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Services Agreement, dated October 16, 2002, between the Company and its Senior Vice President, Clinical and Regulatory Affairs, George Gill</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.2***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amending Agreement No. 1, dated January 6, 2005, to the Services Agreement between the Company and its Senior Vice President, Clinical and Regulatory Affairs, George Gill, dated October 16, 2001</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.3***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employment Agreement, dated January 12, 2007, between the Company and its Vice President, Intellectual Property, Mary Ann Dillahunty</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.4***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated May 29, 2007, between the Company and its Chief Scientific Officer, Matthew Coffey</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.5***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated May 29, 2007, between the Company and its Chief Medical Officer, Dr. Karl Mettinger</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated May 30, 2007, between the Company and its Chief Financial Officer, Douglas Ball</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.7***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated June 6, 2007, between the Company and its Chief Executive Officer, Bradley Thompson</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.8***</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amending Agreement No. 1, dated December 3, 2007, to the Employment Agreement between the Company and its Vice President, Intellectual Property, Mary Ann Dillahunty, dated January 12, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.9****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 1, dated March 7, 2008, to the Executive Employment Agreement between the Company and its Chief Financial Officer, Douglas Ball, dated May 30, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.10****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No.1, dated March 7, 2008, between the Company and its Chief Scientific Officer, Matthew Coffey, dated May 29, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.11****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 1, dated March 7, 2008, to the Executive Employment Agreement between the Company and its Chief Executive Officer, Bradley Thompson, dated June 6, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.12****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 1, dated March 20, 2008, to the Employment Agreement between the Company and its Vice President, Intellectual Property, Mary Ann Dillahunty, dated January 12, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.13****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 1, dated March 28, 2008, to the Executive Employment Agreement between the Company and its Chief Medical Officer, Dr. Karl Mettinger, dated May 29, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.14****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 2, dated March 31, 2008, to the Services Agreement between the Company and its Senior Vice President, Clinical and Regulatory Affairs, George Gill, dated October 16, 2001</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.15****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated January 26, 2009, between the Oncolytics Biotech (U.S.) Inc. and its Chief Medical Officer, Dr. Karl Mettinger</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.16****</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive Employment Agreement, dated January 22, 2009 between the Company and its Vice President, Intellectual Property, Mary Ann Dillahunty.</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.17</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 2, dated January 1, 2011, to the Executive Employment Agreement between the Company and its Chief Executive Officer, Bradley Thompson, dated June 6, 2007</font></div>
</td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Subsidiaries</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">List of subsidiaries</font></div>
</td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certifications</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.1</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certificate of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.2</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certificate of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.1</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certificate of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.2</font></div>
</td>
<td valign="middle" width="71%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certificate of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-WEIGHT: bold">Other Exhibits</font></font></td>
</tr><tr>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.1</font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Registrant's Management's Discussion and Analysis for the Year Ended December 31, 2010</font></td>
</tr><tr>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.2</font></td>
<td valign="middle" width="71%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent of Ernst &amp; Young LLP</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(*)&#160;&#160;Previously filed with the SEC on Form 20-F dated June 14, 2002</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(**)&#160;&#160;Previously filed with the SEC on Form 20-F dated June 27, 2003</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(***)&#160;&#160;Previously filed with the SEC on Form 20-F dated March 23, 2008</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(****) Previously filed with the SEC on Form 20-F dated March 6, 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">76</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<font style="FONT-WEIGHT: bold">SIGNATURE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date: March 24, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-STYLE: italic"><font style="TEXT-DECORATION: underline">/s/ Brad Thompson&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></font></font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;<font style="FONT-STYLE: italic; TEXT-DECORATION: underline">/s/ Doug Ball&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></font></font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Brad Thompson, Ph.D&#160;&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Doug Ball, CA</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer&#160;&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">77</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
<br>
&#160;

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Consolidated Financial Statements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">December 31, 2010 and 2009</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">STATEMENT OF MANAGEMENT&#8217;S RESPONSIBILITY</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management is responsible for the preparation and presentation of the consolidated financial statements, Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) and all other information in the Annual Report.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In management&#8217;s opinion, the accompanying consolidated financial statements have been properly prepared within reasonable limits of materiality and in accordance with the appropriately selected Canadian generally accepted accounting principles and policies consistently applied and summarized in the consolidated financial statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The MD&amp;A has been prepared in accordance with the requirements of securities regulators as applicable to Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements and information in the MD&amp;A generally include estimates that are necessary when transactions affecting the current accounting period cannot be finalized with certainty until future periods.&#160;&#160;Based on careful judgments by management, such estimates have been properly reflected in the accompanying consolidated financial statements and MD&amp;A.&#160;&#160;The MD&amp;A also includes information regarding the impact of current transactions and events, sources of liquidity and capital resources and risks and uncertainty.&#160;&#160;Actual results in the future may differ materially from our present assessment of this information because future events and circumstances may not occur as expected.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Systems of internal controls, including organizational and procedural controls and internal controls over financial reporting, assessed as reasonable and appropriate in the circumstances, are designed and maintained by management to provide reasonable assurance that assets are safeguarded from loss or unauthorized use and to produce reliable records for financial purposes.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We, as the Chief Executive Officer and Chief Financial Officer, will certify to our annual filings with the CSA and the SEC as required in Canada by National Instrument 52-109 (Certification of Disclosure in Issuers&#8217; Annual Interim Filings) and in the United States by the Sarbanes-Oxley Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The external auditors conducted an independent examination of corporate and accounting records in accordance with generally accepted auditing standards to express their opinion on the consolidated financial statements.&#160;&#160;Their examination included such tests and procedures as they considered necessary to provide reasonable assurance that the consolidated financial statements are presented fairly.&#160;&#160;The external auditors have full and free access to our Board of Directors and its Committees to discuss audit, financial reporting and related matters.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board of Directors is responsible for ensuring that management fulfills its responsibilities for financial reporting and internal control.&#160;&#160;The Board exercises this responsibility through the Audit Committee of the Board.&#160;&#160;This Committee meets with management and the external auditors to satisfy itself that management&#8217;s responsibilities are properly discharged and to review the consolidated financial statements and MD&amp;A before they are presented to the Board of Directors for approval.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">/s/ Brad Thompson&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;<font style="FONT-STYLE: italic">/s/ Doug Ball&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Brad Thompson, Ph.D&#160;&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Doug Ball, CA</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer&#160;&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-1</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INDEPENDENT AUDITORS&#8217; REPORT OF REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the Shareholders of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have audited the accompanying consolidated financial statements of Oncolytics Biotech Inc., which comprise the consolidated statements of financial position as at December 31, 2010 and 2009, and the consolidated statements of loss and comprehensive loss and cash flows for each of the years in the three-year period ended December 31, 2010 and for the cumulative period from inception on April 2, 1998, and a summary of significant accounting policies and other explanatory information.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management's responsibility for the consolidated financial statements</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with Canadian generally accepted accounting principles, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Auditors&#8217; responsibility</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with Canadian generally accepted auditing standards and the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditors&#8217; judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditors consider internal control relevant to the entity's preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe that the audit evidence we have obtained in our audits is sufficient and appropriate to provide a basis for our audit opinion.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Opinion</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Oncolytics Biotech Inc. as at December 31, 2010 and 2009, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2010 and the cumulative period from inception on April 2, 1998 in accordance with Canadian generally accepted accounting principles.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-2</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other matter</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Oncolytics Biotech Inc.&#8217;s internal control over financial reporting as of December 31, 2010, based on the criteria established in <font style="DISPLAY: inline; FONT-STYLE: italic">Internal Control &#8212; Integrated Framework</font> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 16, 2011 expressed an unqualified opinion on Oncolytics Biotech Inc.&#8217;s internal control over financial reporting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<img src="ernstyounglogo.jpg" alt=""></font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Canada<br>
March 16, 2011&#160;</font></td>
<td valign="top" width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Chartered Accountants</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-3</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Independent Auditors&#8217; Report on Internal Controls Under Standards of the Public Company Accounting Oversight Board (United States)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the Shareholders of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have audited Oncolytics Biotech Inc.&#8217;s internal control over financial reporting as of December 31, 2010, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Oncolytics Biotech Inc&#8217;s&#160;&#160;management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In our opinion, Oncolytics Biotech Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2010, based on the COSO criteria.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-4</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also have audited, in accordance with Canadian generally accepted auditing standards and the standards of the Public Company Accounting Oversight Board (United States), the consolidated statements of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">financial position of Oncolytics Biotech Inc. as at December 31, 2010 and 2009 and the consolidated statements of loss and comprehensive loss and cash flows for each of the years in the three-year period ended December 31, 2010, and for the cumulative period from inception on April 2, 1998, and our report dated March 16, 2011, expressed an unqualified opinion thereon.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<img src="ernstyounglogo.jpg" alt=""></font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Canada<br>
March 16, 2011&#160;</font></td>
<td valign="top" width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Chartered Accountants</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-5</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">As at December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Assets</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current assets</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,296,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,448,939</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short-term investments</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">284,988</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,787</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">278,934</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">507,408</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43,469,850</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34,701,071</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">226,911</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">208,320</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Asset held for sale</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">735,681</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">684,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total non-current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">962,592</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">892,320</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Total assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432,442</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593,391</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Liabilities And Shareholders&#8217; Equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current Liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable and accrued liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,500,682</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,226,933</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,500,682</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,226,933</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Commitments and contingencies</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="6" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">12, 13, 18 and 19</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share capital</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Authorized: unlimited</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Issued 67,958,302 (2009 &#8211; 61,549,969)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">155,227,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131,908,274</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,066,128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,511,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contributed surplus</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8, 11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,399,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,734,743</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deficit</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(138,761,772</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(118,788,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Total shareholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,931,760</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,366,458</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Total Liabilities And Equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432,442</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593,391</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">See accompanying notes</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="29%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">On behalf of the Board:</font></font></td>
<td width="68%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="29%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="68%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="29%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">/s/ Fred Stewart&#160;&#160;</font></font></td>
<td width="68%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">/s/ Jim Dinning</font></font></td>
</tr><tr>
<td width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="29%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="68%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="29%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Fred Stewart&#160;&#160;<br>
&#160;Dector&#160;&#160;&#160;</font></td>
<td width="68%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Jim Dinning<br>
&#160;Dector&#160;&#160;&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-6</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><br>
<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the periods ending December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cumulative from inception on April 2, 1998 to December 31, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Revenue</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Rights revenue</font></div>
</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310,000</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expenses</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7, 13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,191,809</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,606,514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,351,875</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">98,330,100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,190,403</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,782,507</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,311,575</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,809,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,251,041</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">424,273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,039</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,444,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign exchange loss (gain)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">346,686</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">179,716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(68,283</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,115,829</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization - intellectual property</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">180,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,615,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization - property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">63,156</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,930</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48,754</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">625,237</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,043,095</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,238,690</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,069,460</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">144,940,259</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Loss before the following</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,043,095</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,238,690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(18,069,460</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(144,630,259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">76,934</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">519,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,640,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gain on sale of BCY LifeSciences Inc.</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">299,403</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss on sale of Transition Therapeutics Inc.</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,156,685</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Loss before income taxes</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(19,966,161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(16,209,249</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(17,550,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(139,847,161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income taxes (recovery)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,611</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,085,389</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Net loss and comprehensive loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,973,772</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,231,249</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17,550,204</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(138,761,772</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="40%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Basic and diluted loss per common share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.32</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.33</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.42</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">See accompanying notes</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-7</font></font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the periods ending December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cumulative from inception on April 2, 1998 to December 31, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Cash Flows</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Activities</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss and comprehensive loss for the period</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,973,772</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,231,249</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17,550,204</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(138,761,772</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization - intellectual property</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">180,750</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361,500</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,615,000</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization - property and equipment</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">63,156</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,930</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48,754</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">625,237</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,251,041</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">424,273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,039</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,444,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other non-cash items</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">343,821</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">110,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,838,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net change in non-cash working capital</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,717,978</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(613,383</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,787,279</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,936,760</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash used in operating activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(18,033,732</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,063,879</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(15,288,632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(122,302,459</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investing Activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition of property and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(81,846</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,324</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(111,577</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(904,914</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchase of intellectual property</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(51,681</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(51,681</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchase of short-term investments</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,929,309</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,679,937</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(347,901</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(53,026,110</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Redemption of short-term investments</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,846,634</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48,998,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investment in BCY</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">464,602</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investment in Transition Therapeutics Inc.</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,532,343</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by (used in) investing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,062,836</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,157,373</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,540,522</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,987,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financing Activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from exercise of stock options and warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">528,211</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,210,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,039,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from private placements</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38,137,385</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from acquisition of private company</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,800,120</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,800,120</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from public offering</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,759,921</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,042,570</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,421,309</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">93,080,698</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by financing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27,288,132</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,052,900</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,462,909</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">164,057,692</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Increase in cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,191,564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,146,394</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">714,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,767,853</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents, beginning of period</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,448,939</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,429,895</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,715,096</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Impact of foreign exchange on cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(343,821</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(127,350</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(471,171</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Cash and cash equivalents, end of period</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,296,682</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,448,939</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,429,895</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,296,682</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">See accompanying notes</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-8</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 1: Incorporation and Nature of Operations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech Inc. (the &#8220;Company&#8221; or &#8220;Oncolytics&#8221;) was incorporated on April 2, 1998 under the Business Corporations Act (Alberta) as 779738 Alberta Ltd.&#160;&#160;On April 8, 1998, we changed our name to Oncolytics Biotech Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics.&#160;&#160;Our product being developed may represent a novel treatment for Ras mediated cancers which can be used as an alternative to existing cytotoxic or cytostatic therapies, as an adjuvant therapy to conventional chemotherapy, radiation therapy, or surgical resections, or to treat certain cellular proliferative disorders for which no current therapy exists.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 2: Basis of Financial Statement Presentation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 21, 1999, SYNSORB Biotech Inc. (&#8220;SYNSORB&#8221;) purchased all of our shares.&#160;&#160;In connection with this acquisition, the basis of accounting for our assets and liabilities was changed to reflect SYNSORB&#8217;s cost of acquiring its interest in such assets and liabilities (i.e. reflecting SYNSORB&#8217;s purchase cost in our consolidated financial statements).&#160;&#160;The amount by which SYNSORB&#8217;s purchase price exceeded the underlying net book value of our assets and liabilities at April 21, 1999 was $2,500,000.&#160;&#160;This amount was credited to contributed surplus and charged to intellectual property and was amortized to income based on the established amortization policies for such assets.&#160;&#160;Subsequent to April 21, 1999, SYNSORB&#8217;s ownership has been diluted through public offerings of our common shares, sales of our shares by SYNSORB and a distribution of SYNSORB&#8217;S ownership interest in the Company to their shareholders.&#160;&#160;As a result, SYNSORB no longer has any ownership in the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 3: Summary of Significant Accounting Policies</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These consolidated financial statements have been prepared in accordance with Canadian generally accepted accounting principles (&#8220;Canadian GAAP&#8221;).&#160;&#160;These policies are, in all material respects, in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) except as disclosed in note 23.&#160;&#160;The consolidated financial statements have, in management&#8217;s opinion, been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principles of consolidation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements include our accounts and the accounts of our incorporated subsidiaries.&#160;&#160;All intercompany transactions and balances have been eliminated.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Use of estimates</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements in conformity with Canadian GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods.&#160;&#160;Actual results could differ from those estimates and such differences could be significant.&#160;&#160;Significant estimates made by management affecting our consolidated financial statements include the inputs used to determine our stock based compensation expense for the year, the valuation of our investment in BCBC (reflected in the financial statements as an asset held for sale) and our assessment of our future income tax assets and related valuation allowance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-9</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Property and equipment</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Property and equipment are recorded at cost.&#160;&#160;Amortization is provided on bases and at rates designed to amortize the cost of the assets over their estimated useful lives.&#160;&#160;Amortization is recorded using the declining balance method at the following annual rates:</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="25%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office equipment and furniture</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20%</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="25%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Medical equipment</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20%</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="25%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Computer equipment</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30%</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="25%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Leasehold improvements</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Straight-line over the term of the lease</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual property</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual property costs initially related to the acquisition of our business by SYNSORB.&#160;&#160;These costs were amortized on a straight-line basis over a 10-year period (the expected useful life) commencing July 1, 1999 and are now fully amortized.&#160;&#160;Intellectual property acquired through our investment in BCBC is included in Asset Held for Sale on the balance sheet.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Foreign currency translation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transactions originating in foreign currencies are translated into the functional currency of the entity at the exchange rate in effect at the date of the transaction.&#160;&#160;Monetary assets and liabilities are translated at the year-end rate of exchange and non-monetary items are translated at historic exchange rates.&#160;&#160;Exchange gains and losses are included in net loss for the period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and development costs</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research costs are expensed as incurred.&#160;&#160;Development costs that meet specific criteria related to technical, market and financial feasibility will be capitalized.&#160;&#160;To date, all of the development costs have been expensed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investment tax credits</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investment tax credits relating to qualifying scientific research and experimental development expenditures that are recoverable in the current period are accounted for as a reduction in research and development expenditures. Investment tax credits not recoverable in the current period are accrued provided there is reasonable assurance that the credits a will be realized.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Loss per common share</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basic loss per common share is determined using the weighted average number of common shares outstanding during the period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use the treasury stock method to calculate diluted loss per common share.&#160;&#160;Under this method, diluted loss per common share is computed in a manner consistent with basic loss per common share except that the weighted average common shares outstanding are increased to include additional common shares from the assumed exercise of options and warrants, if dilutive.&#160;&#160;The number of additional common shares is calculated by assuming that any outstanding &#8220;in the money&#8221; options and warrants were exercised at the later of the beginning of the period or the date of issue and that the proceeds from such exercises were used to acquire shares of common stock at the average market price during the reporting period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-10</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock option plan</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have one stock option plan (the &#8220;Plan&#8221;) available to officers, directors, employees, consultants and suppliers with grants under the Plan approved from time to time by our Board of Directors (the &#8220;Board&#8221;).&#160;&#160;Under the Plan, the exercise price of each option equals the trading price of our stock on the date of grant in accordance with Toronto Stock Exchange guidelines.&#160;&#160;Vesting is provided for at the discretion of the Board and the expiration of options is to be no greater than 10 years from the date of grant.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock based compensation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Officers, directors and employees</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use the fair value based method of accounting for employee awards granted under the Plan.&#160;&#160;We calculate the fair value of each stock option grant using the Black Scholes Option Pricing Model and the fair value is recorded over the option&#8217;s vesting period on a straight-line basis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Non-employees</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock based compensation to non-employees is recorded at fair market value based on the fair value of the consideration received, or the fair value of the equity instruments granted, or liabilities incurred, whichever is more reliably measurable, on the earlier of the date at which a performance commitment is reached, performance is achieved, or the vesting date of the options.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial instruments</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial assets</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial assets are comprised of cash and cash equivalents, accounts receivable, short-term investments and long term investment.&#160;&#160;Financial assets are initially recorded at fair market value and are classified as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash and cash equivalents</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash and cash equivalents consist of cash on hand and interest bearing deposits with our bank and have been designated as held for trading.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Accounts receivable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accounts receivable have been designated as loans and receivables.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Short-term investments</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We determine the appropriate classification of our short-term investments at the time of purchase and re-evaluate such designation as of each balance sheet date.&#160;&#160;We classify our short-term investments as held-to-maturity as we have the positive intent and ability to hold the securities to maturity.&#160;&#160;Held-to-maturity securities are stated at original cost, adjusted for amortization of premiums and accretion of discounts to maturity computed under the effective interest rate method.&#160;&#160;Such amortization and interest on securities classified as held-to-maturity are included in interest income.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial liabilities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our financial liabilities are comprised of trade accounts payable and are non interest-bearing and recorded at fair market value.&#160;&#160;They are designated as Other Financial Liabilities and are subsequently measured at amortized cost using the effective interest rate method.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-11</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Transaction Costs</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transaction costs are expensed as incurred for financial instruments designated as held for trading.&#160;&#160;Transaction costs for financial assets classified as available for sale, loans and receivables, and financial liabilities classified as other than held for trading are recognized immediately in income.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Future income taxes</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We follow the liability method of accounting for income taxes.&#160;&#160;Under the liability method, future income taxes are recognized for the difference between financial statement carrying values and the respective income tax basis of assets and liabilities (temporary differences).&#160;&#160;Future income tax assets and liabilities are measured using substantively enacted income tax rates and laws expected to apply in the years in which temporary differences are expected to be recovered or settled.&#160;&#160;The effect on future income tax assets and liabilities of a change in tax rates is included in income in the period of the change.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Future Accounting Changes</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">International Financial Reporting Standards (&#8220;IFRS&#8221;)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Canadian Institute of Chartered Accountants&#8217; Accounting Standards Board announced that Canadian publicly accountable enterprises are required to adopt IFRS, as issued by the International Accounting Standards Board (IASB), effective January 1, 2011.&#160;&#160;We are prepared to adopt IFRS as at that date.&#160;&#160;Our transition process included the following phases:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scoping and diagnostic phase &#8212; This phase involved performing a high-level diagnostic assessment to identify key areas that were impacted by the transition to IFRS. This phase was finalized in 2008.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Impact analysis, evaluation and design phase &#8212;This phase involved specification of changes required to existing accounting policies, information systems and business processes, together with an analysis of policy alternatives allowed under IFRS.&#160;&#160;This phase was finalized in 2009.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Implementation and review phase &#8212; This phase included execution of changes to information systems and business processes, completing formal authorization processes to approve recommended accounting policy changes and training.&#160;&#160;At the end of the implementation and review phase we will be able to compile financial statements compliant with IFRS.&#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of completing these three phases we are now in the process of compiling financial statements in compliance with IFRS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial Statement Impact</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In preparing our opening balance sheet, we have adjusted amounts reported previously in our consolidated financial statements prepared in accordance with GAAP.&#160;&#160;The estimated impact on our balance sheet as at January 1, 2010 would be to reduce warrants in shareholders&#8217; equity by approximately $1 million and reflect a long term liability.&#160;&#160;In 2010, we anticipate a further charge to our Consolidated Statement of Loss of approximately $4.8 million related to the revaluation of warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-12</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 4: Cash Equivalents and Short Term Investments</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash Equivalents</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash equivalents consist of interest bearing deposits with our bank totaling $34,337,595 (December 31, 2009 - $15,518,939).&#160;&#160;The current annual interest rate earned on these deposits is 1.06% (December 31, 2009 &#8211; 0.30%).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Short-Term Investments</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Short-term investments which consist of guaranteed investment certificates are liquid investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value.&#160;&#160;The objectives for holding short-term investments are to invest our excess cash resources in investment vehicles that provide a better rate of return compared to our interest bearing bank account with limited risk to the principal invested.&#160;&#160;We intend to match the maturities of these short-term investments with the cash requirements of the Company&#8217;s activities and treat these as held-to-maturity short-term investments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Face</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Original Cost</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued Interest</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Carrying</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effective <br>
Interest Rate</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2010</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="16%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short-term investments</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></div>
</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></div>
</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.30%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="16%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short-term investments</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></div>
</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></div>
</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></div>
</td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.17%</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fair value is determined by using published market prices provided by our investment advisor.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-13</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 5: Property and Equipment</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="10" valign="bottom" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated <br>
Amortization</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Book <br>
Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Medical equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">107,471</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59,329</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,236</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,813</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,423</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office furniture</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">117,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">79,024</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Computer equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">339,074</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">213,744</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125,330</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Leasehold improvements</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">139,616</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">132,933</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,683</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">740,754</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">513,843</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">226,911</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="55%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="10" valign="bottom" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
</tr></table>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td valign="bottom" width="55%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated Amortization</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Book Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Medical equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100,816</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47,504</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">53,312</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,385</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27,006</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office furniture</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">111,076</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73,457</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37,619</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Computer equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">271,194</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185,905</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">85,289</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Leasehold improvements</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">139,616</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">116,895</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,721</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">659,087</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">450,767</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">208,320</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 6: Asset Held for Sale</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2009, we acquired all of the convertible preferred shares of British Canadian Biosciences Corp. (&#8220;BCBC&#8221;), a privately held biotechnology company specializing in the development of peptides for the treatment of a variety of conditions, including cancer.&#160;&#160;In February 2010, we completed the conversion of our preferred share holding in BCBC&#160;&#160;into common shares.&#160;&#160;As a result of this conversion we owned 10% of the issued common shares of BCBC.&#160;&#160;The common shares of BCBC do not have a quoted market price in an active market.&#160;&#160;BCBC&#8217;s only asset is intellectual property.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the fourth quarter of 2010, BCBC concluded that it was unable to obtain additional financing to support its business and subsequently suspended operations.&#160;&#160;In November 2010, in order to maintain our investment in BCBC, we purchased an additional 60% of the common shares of BCBC for $51,681 which included cash and the settlement of certain trade accounts payable.&#160;&#160;As the operations of BCBC had been suspended, its only remaining asset was intellectual property.&#160;&#160;&#160;&#160;In conjunction with this purchase, we assessed the cost of our investment against the estimated fair value of BCBC using a cash flow analysis and determined that the estimated fair value of our investment was in excess of our cost.&#160;&#160;At the end of 2010, we began the process to sell BCBC and as a result we are reflecting our investment in BCBC&#8217;s intellectual property as an asset held for sale.&#160;&#160;We have also reclassified the prior year&#8217;s balance to reflect our current accounting treatment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-14</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 7: Share Capital</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Authorized:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unlimited number of no par value common shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Issued</font>:</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 1998</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,145,300</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on exercise of stock options</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">76,922</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,222,222</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">81</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">July 29, 1999 share split <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(a)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">81</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to July 30, 1999 private placement (net of share issue costs of $45,000) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(b)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">855,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to August 24, 1999 private placement</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,399,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,049,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on initial public offering (net of share issue costs of $317,897)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (c)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,082,103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to exercise of share purchase warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 1999</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,669,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,002,182</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on exercise of stock options and warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">573,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">501,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to July 17, 2000 private placement <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(d)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">244,898</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,998,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on public offering (net of share issue costs of $998,900)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (e)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,101,100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2000</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,488,805</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,602,937</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on exercise of stock options and warrants</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,702,590</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,210,016</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2001</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,191,395</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,812,953</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on exercise of stock options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on acquisition of the interest in Transition Therapeutics Inc.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,913,889</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,689,028</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to December 11, 2002 private placement <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(f)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,896,714</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">550,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114,286</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(241,123</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2002</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,145,284</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,191,572</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">550,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114,286</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to February 10, 2003 private placement<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (g)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265,540</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to June 19, 2003 private placement <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(h)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,120,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,912,113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,272,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">543,287</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-15</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Issued</font>:</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr></table>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to August 21, 2003 private placement<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (i)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,363,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,801,778</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">813,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">349,176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to October 14, 2003 public offering<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (j)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,200,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,528,972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">720,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">617,428</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">149,615</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">174,378</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">593,194</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(174,378</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(41,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,730,195</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2003</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27,208,262</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,712,589</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,258,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,598,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to April 7, 2004 private placement<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(k)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,077,100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,924,050</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">646,260</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,028,631</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to November 23, 2004 public offering<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(l)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,504,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,693,120</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">864,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,521,672</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued pursuant to cancellation of contingent</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">payment <font style="DISPLAY: inline; FONT-STYLE: italic">[note 13]</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,459</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,907,175</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,178,546</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,907,175</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(798,096</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(6,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,827</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">197,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">778,951</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,796,758</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2004</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,915,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">66,640,498</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,855,340</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,347,630</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to December 29, 2005 private placement<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(m)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,200,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,176,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,920,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,908,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">771,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,417,271</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(771,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(329,984</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,219,288</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,496,514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">350,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">297,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,689,398</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2005</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,236,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">82,841,871</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,784,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,429,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">284,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">241,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(112,800</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(213,192</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2006</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36,520,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">83,083,271</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,672,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,216,740</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to February 22, 2007 public offering <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(n)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,600,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,362,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,300,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,438,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(752,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,308,480</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>

<div>&#160;</div>

<div>
<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-16</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div>&#160;</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Issued</font>:</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr></table>
</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,736,606</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2007</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,180,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">92,759,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,220,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,346,260</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to December 5, 2008 public offering<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(o)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,650,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,127,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,915,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">946,050</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,920,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,908,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(p)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">320,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(651,741</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2008</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43,830,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">95,234,924</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,535,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,425,110</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued on acquisition of private company <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(q)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,875,121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,113,275</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to May 13, 2009 public offering<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(r)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,450,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,623,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,795,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,442,100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to November 23, 2009 public offering<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(s)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,887,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,380,549</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,955,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,073,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of stock options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">281,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">318,541</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,030,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,360,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,030,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,429,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for investment in BCBC<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(t)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">200,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">684,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sale of intellectual property<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(u)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,790,715</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#59450;&#59450;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61,549,969</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131,908,274</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,255,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,511,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued for cash pursuant to November 8, 2010 bought deal financing<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(v)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,256,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,336,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,503,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,120,201</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">119,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">575,813</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(119,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(127,514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,300,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,438,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of stock options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,433</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">104,109</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,697,081</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">67,958,302</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">155,227,915</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,338,460</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,066,128</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to subsection 167(1)(f) of the Business Corporations Act (Alberta), the Articles of the Company were amended by subdividing the 2,222,222 issued and outstanding common shares of the Company into 6,750,000 common shares.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 1,500,000 common share purchase warrants were issued entitling the holders thereof to acquire one additional share at $0.75 per share until November&#160;8, 2001.&#160;&#160;At December 31, 2001, all of the warrants had been exercised.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-17</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the initial public offering, the agent was issued common share purchase warrants entitling it to acquire 400,000 common shares at $0.85 per share until May 8, 2001.&#160;&#160;At December 31, 2001, all of the warrants had been exercised.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 244,898 common shares were issued at an issue price of $12.25 per share net of issue costs of $1,355.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a special warrant offering, we sold 3,000,000 special warrants for $4.70 per warrant for net proceeds of $13,101,100.&#160;&#160;Each warrant entitled the holder to one common share upon exercise.&#160;&#160;At December 31, 2001, all of the warrants had been exercised.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 1,000,000 units were issued at an issue price of $2.00 per unit net of issue costs of $241,123.&#160;&#160;Each unit included one common share (ascribed value of $1.897) and one-half of one common share purchase warrant (ascribed value of $0.103) for a total of 500,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $3.00 per share until June 11, 2004.&#160;&#160;In addition, we issued 50,000 common share purchase warrants on the same terms to the brokerage firm assisting with the transaction.&#160;&#160;The ascribed value of these broker warrants was $11,000 ($0.22 per broker warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were based on the Black Scholes Option Pricing Model (&#8220;Black Scholes&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 140,000 units were issued at an issue price of $2.00 per unit net of issue costs of $37,369.&#160;&#160;Each unit included one common share (ascribed value of $1.897) and one-half of one common share purchase warrant (ascribed value of $0.103) for a total of 70,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $3.00 per share until August 10, 2004.&#160;&#160;In addition, we issued 7,000 common share purchase warrants on the same terms to the brokerage firm assisting with the transaction.&#160;&#160;The ascribed value of these broker warrants was $1,540 ($0.22 per broker warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 2,120,000 units were issued at an issue price of $3.00 per unit net of issue costs of $637,986.&#160;&#160;Each unit included one common share (ascribed value of $2.789) and one-half of one common share purchase warrant (ascribed value of $0.211) for a total of 1,060,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $4.00 per share until December 19, 2004.&#160;&#160;In addition, we issued 212,000 common share purchase warrants on the same terms to the brokerage firms assisting with the transaction.&#160;&#160;The ascribed value of these broker warrants was $95,400 ($0.45 per broker warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 1,363,900 common shares and 681,943 common share purchase warrants were issued for gross proceeds of $4,091,738.&#160;&#160;Each common share and whole common share purchase warrant have ascribed values of $2.787 and $0.425, respectively.&#160;&#160;Each common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $4.00 per share until February 21, 2005.&#160;&#160;Share issue costs related to this private placement were $367,839.&#160;&#160;In addition, we issued 131,590 common share purchase warrants on the same terms to the advisors assisting with the transaction.&#160;&#160;&#160;The ascribed value of these additional warrants was $59,216 ($0.45 per additional warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, 1,200,000 units were issued at an issue price of $5.00 per unit net of issue costs of $687,001.&#160;&#160;Each unit included one common share (ascribed value of $4.607) and one-half of one common share purchase warrant (ascribed value of $0.393) for a total of 600,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $6.25 per share until April 14, 2005.&#160;&#160;In addition, we issued 120,000 common share purchase warrants with an exercise price of $5.00 that expires on April 14, 2005 to the brokerage firms assisting with the transaction.&#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-18</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The ascribed value of these broker warrants was $146,400 ($1.19 per broker warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, the Company sold 1,077,100 units at an average price of $6.25 per unit for gross cash proceeds of $6,731,875.&#160;&#160;The units were comprised of 1,077,100 common shares and 538,550 common share purchase warrants and have ascribed values of $5.50 and $1.50, respectively.&#160;&#160;Each common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $7.75 per share until October 7, 2005.&#160;&#160;Share issue costs related to the private placement were $728,918.&#160;&#160;In addition, we issued 107,710 common share purchase warrants to our advisor entitling the holder to acquire one common share of the capital of the Company upon payment of $7.00 per share until October 7, 2005.&#160;&#160;The ascribed value of these additional warrants was $220,806 ($2.05 per additional warrant) and has been included in the share issue costs above.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, the Company sold 1,504,000 units at an issue price of $6.65 per unit for gross cash proceeds of $10,001,600.&#160;&#160;Each unit included one common share (ascribed value of $5.78) and one-half of one common share purchase warrant (ascribed value of $0.87) for a total of 752,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $8.00 per share until November 23, 2007.&#160;&#160;Share issue costs related to this public offering were $1,063,890.&#160;&#160;In addition, we issued 112,800 common share purchase warrants with an exercise price of $7.06 that expires on May 23, 2006 to the brokerage firm assisting with the transaction.&#160;&#160;The ascribed value of these broker warrants was $213,192 ($1.89 per broker warrant) and has been included in the share issue costs above.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 23px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)</font></div>
</td>
<td width="1374">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a private placement, 3,200,000 units were issued at an issue price of $5.15 per unit net of issue costs of $1,689,398.&#160;&#160;Each unit included one common share (ascribed value of $4.43) and one-half of one common share purchase warrant (ascribed value of $0.72) for a total of 1,600,000 warrants.&#160;&#160;Each whole common share purchase warrant entitled the holder to acquire one common share in the capital of the Company upon payment of $6.15 per share until December 29, 2008.&#160;&#160;In addition, we issued 320,000 common share purchase warrants with an exercise price of $5.65 expiring on December 29, 2008.&#160;&#160;The ascribed value of these broker warrants was $604,800 ($1.89 per broker warrant) and has been included in the issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, 4,600,000 units were issued at an issue price of $3.00 per unit for gross proceeds of $13,800,000.&#160;&#160;Each unit included one common share (ascribed value of $2.47) and one-half of one common share purchase warrant (ascribed value of $0.53) for a total of 2,300,000 warrants.&#160;&#160;The ascribed value was determined using the relative fair value method.&#160;&#160;Each whole common share purchase warrant entitles the holder to acquire one common share in the capital of the Company upon payment of $3.50 per share until February 22, 2010.&#160;&#160;Share issue costs for this offering were $1,736,606.&#160;&#160;The ascribed value of the warrants was determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(o)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, 2,650,000 units were issued at an issue price of $1.50 per unit for gross proceeds of $3,975,000.&#160;&#160;Each unit included one common share (ascribed value of $1.18) and one- common share purchase warrant (ascribed value of $0.32).&#160;&#160;The ascribed value was determined using the relative fair value method.&#160;&#160;Each common share purchase warrant entitles the holder to acquire one common share in the capital of the Company upon payment of $1.80 per share until December 5, 2011 subject to acceleration of the expiry date under certain circumstances.&#160;&#160;Share issue costs for this offering were $651,741.&#160;&#160;In addition, we issued 265,000 broker common share purchase warrants with an exercise price of $1.80 expiring on December 5, 2011 subject to acceleration of the expiry date under certain circumstances.&#160;&#160;The ascribed value of these broker warrants was $98,050 ($0.37 per broker warrant) and has been included in the share issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-19</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the terms of the warrant indenture and the broker warrant certificates, if the 10-day volume-weighted average trading price of our common shares (the &#8220;Common Shares&#8221;) on the Toronto Stock Exchange exceeded $2.50 per Common Share, then, at any date subsequent to this date, at our sole discretion and upon sending the holder written notice of such accelerated exercise date and issuing a news release announcing such accelerated exercise date, the expiry date of the warrant shall be the day that is 30 days following the later of (i) the date on which such notice is sent to the holder; and (ii) the date on which such announcement is made by news release. As of the close of business on September 18, 2009, the 10-day volume-weighted average trading price of the Common Shares exceeded $2.50 and we elected to accelerate the exercise date to October 23, 2009, the date of our news release.&#160;&#160;All of these warrants were exercised.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(p)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 18, 2008, we amended the terms of 320,000 previously issued broker warrants for cash consideration of $41,600.&#160;&#160;The amendments included adjusting the exercise price from $5.65 to $1.80 and extending the expiry date from December 29, 2008 to December 29, 2009, subject to acceleration of the expiry date in certain circumstances.&#160;&#160;All of these warrants were exercised in 2009.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(q)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 9, 2009, we completed our acquisition of an inactive private company pursuant to a plan of arrangement under the Business Corporations Act (Alberta).&#160;&#160;We issued 1,875,121 common shares in exchange for all of the issued and outstanding securities of the private company.&#160;&#160;The exchange ratio was at an agreed premium to the private company&#8217;s net cash per security at closing and was calculated using an ascribed value per common share of $1.69 (being the 20 day volume weighted average trading price of our common shares on the Toronto Stock Exchange up to and including March 2, 2009).&#160;&#160;We have treated this acquisition as a financing transaction for accounting purposes and we have allocated the net cash from the private company to the value of the common shares we issued net of related transaction costs.&#160;&#160;The private company had no other assets or liabilities.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(r)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, 3,450,000 units were issued at an issue price of $2.00 per unit for gross proceeds of $6,900,000.&#160;&#160;Each unit included one common share (ascribed value of $1.63) and one common share purchase warrant (ascribed value of $0.37).&#160;&#160;The ascribed value was determined using the relative fair value method.&#160;&#160;Each common share purchase warrant entitles the holder to acquire one common share in the capital of the Company upon payment of $2.40 per share until May 13, 2012 subject to acceleration of the expiry date under certain circumstances.&#160;&#160;Share issue costs for this offering were $952,854.&#160;&#160;In addition, we issued 345,000 broker common share purchase warrants with an exercise price of $2.40 expiring on May 13, 2012 subject to acceleration of the expiry date under certain circumstances.&#160;&#160;The ascribed value of these broker warrants was $165,600 ($0.48 per broker warrant) and has been included in the share issue costs.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.&#160;&#160;On October 2, 2009, the acceleration provisions under the warrant indenture were met allowing us to accelerate the expiry date of these warrants to November 2, 2009.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the terms of the warrant indenture and the broker warrant certificates, if the 10-day volume-weighted average trading price of our Common Shares on the Toronto Stock Exchange exceeded $3.35 per Common Share, then, at any date subsequent to this date, at our sole discretion and upon sending the holder written notice of such accelerated exercise date and issuing a news release announcing such accelerated exercise date, the expiry date of the warrant shall be the day that is 30 days following the later of (i) the date on which such notice is sent to the holder; and (ii) the date on which such announcement is made by news release. As of the close of business on October 2, 2009, the 10-day volume-weighted average trading price exceeded $3.35 and we elected to accelerate the exercise date to November 2, 2009.&#160;&#160;All of these warrants were exercised.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(s)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a public offering, 4,887,500 units were issued at an issue price of US$3.00 per unit for gross proceeds of US$14,662,500.&#160;&#160;Each unit included one common share (ascribed value of US$2.60) and 0.40 of one common share purchase warrant (ascribed value of US$0.40).&#160;&#160;The ascribed value was determined using the relative fair value method.&#160;&#160;Each common share purchase warrant entitles the holder to acquire one common share in the capital of the Company upon payment of US$3.50 per share until November 23, 2014 subject to <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">acceleration of the expiry date under certain circumstances.&#160;&#160;Share issue costs for this offering were $1,524,706.&#160;&#160;The ascribed value of the warrant was determined using Black Scholes.</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-20</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the terms of the warrant indenture, if the 10-day volume-weighted average trading price of our Common Shares on the Toronto Stock Exchange exceeded the dollar equivalent of US$6.50 per Common Share, then, at any date subsequent to this date, at our sole discretion and upon sending the holder written notice of such accelerated exercise date and issuing a news release announcing such accelerated exercise date, the expiry date of the warrant shall be the day that is 30 days following the later of (i) the date on which such notice is sent to the holder; and (ii) the date on which such announcement is made by news release. As of the close of business on December 23, 2010, the 10-day volume-weighted average trading price exceeded US$6.50 and we elected to accelerate the exercise date to January 24, 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(t)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On October 20, 2009 we made an investment in British Canadian Biosciences Corp. (&#8220;BCBC&#8221;), a privately held biotechnology company specializing in the development of peptides for the treatment of a variety of conditions, including cancer.&#160;&#160;We purchased all of the convertible preferred shares of BCBC in exchange for 200,000 common shares of Oncolytics.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(u)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On October 26, 2009, we received and cancelled 5,000 of our common shares in consideration for clinical trial data that we had obtained as part of our acquisition of Private Company in April 2009.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a bought deal financing, 6,256,000 units were issued at an issue price of $4.60 per unit for gross proceeds of $28,777,600.&#160;&#160;Each unit included one common share (ascribed value of $4.05) and 0.40 of one common share purchase warrant (ascribed value of $0.55).&#160;&#160;The ascribed value was determined using the relative fair value method.&#160;&#160;Each common share purchase warrant entitles the holder to acquire one common share in the capital of the Company upon payment of $6.15 per share until November 8, 2012.&#160;&#160;Share issue costs for this offering were $2,697,081 .&#160;&#160;In addition, we issued 375,360 common share purchase warrants with an exercise price of $4.60 that expires on November 8, 2012 to the brokerage firm assisting with the transaction.&#160;&#160;The ascribed value of these broker warrants was $679,402 ($1.81 per broker warrant) and has been included in the share issue costs above.&#160;&#160;The ascribed values of the warrants were determined using Black Scholes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes the weighted average assumptions used in the Black Scholes Option Pricing Model with respect to the valuation of warrants and broker warrants issued in those years:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
</td>
<td valign="top" width="5%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2005</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2004</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2003</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2002</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk-free interest rate</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.40%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.22%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.68%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.08%</font></div>
</td>
<td valign="top" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.82%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.82%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.01%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.41%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expected hold period to exercise</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.80</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.00</font></div>
</td>
<td valign="top" width="5%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.92</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.39</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.76</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.00</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Volatility in the price of the Company&#8217;s shares</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61.9%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61.43%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55.6%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">63%</font></div>
</td>
<td valign="top" width="5%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">66%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">72%</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">57%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividend yield</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="5%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-21</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes our outstanding warrants as at December 31, 2010:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise<br>
Price</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding, Beginning <br>
of the Year</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted During <br>
the Year</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised During <br>
the Year</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired During <br>
the Year</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding, <br>
End of Year</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average <br>
Remaining Contractual <br>
Life (years)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">US3.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,955,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(109,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,845,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,300,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,300,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.60</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">375,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">375,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,128,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(10,500</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,117,500</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.83</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,255,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,503,360</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(119,900</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,300,000</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,338,460</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.22</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 8: Stock Based Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock Option Plan</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have issued stock options to acquire common stock through our stock option plan of which the following are outstanding at December 31:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average Share Price</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average Share Price</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding, beginning of the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,936,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.72</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,885,993</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted during the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,183,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">332,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cancelled during the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(383,350</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(350</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised during the year</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(32,433</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.46</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(281,600</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.99</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding, end of the year</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,703,760</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.53</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,936,543</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.72</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options exercisable, end of the year</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,654,926</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.54</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,875,026</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.75</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes information about the stock options outstanding and exercisable at December 31, 2010:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Range of Exercise Prices</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number <br>
Outstanding</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average <br>
Remaining Contractual <br>
Life (years)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average <br>
Exercise Price</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number Exercisable</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average <br>
Exercise Price</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.45 - $2.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">788,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.09</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">767,426</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.09</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.70 - $3.60</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,407,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,392,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.00 - $5.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,224,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.86</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,212,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.86</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.72 - $9.76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,279,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,279,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.15 - $13.50</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.49</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.49</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,703,760</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.7</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.53</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,654,926</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.54</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-22</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">he outstanding options vest annually or after the completion of certain milestones.&#160;&#160;We have reserved 4,703,760 common shares for issuance relating to outstanding stock options.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As we are following the fair value based method of accounting for stock option awards, compensation expense related to options granted to employees and directors was $3,243,720 (2009 &#8211; $424,273 and 2008 &#8211; $64,039) and to consultants was $7,321 (nil for 2009 and 2008) with an offsetting credit to contributed surplus.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The estimated fair value of stock options issued during the year was determined using the Black Scholes Option Pricing Model using the following weighted average assumptions and fair value of options:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="39%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="39%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk-free interest rate</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.85%</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.21%</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.85%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expected hold period to exercise</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.0 years</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.0 years</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.0 years</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Volatility in the price of the Company&#8217;s shares</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71%</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">57%</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividend yield</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
<td valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="39%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average fair value of options</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$2.76</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$1.19</font></div>
</td>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$0.60</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use historical data to estimate the expected dividend yield and expected volatility of our stock in determining the fair value of the stock options. The risk-free interest rate is based on the Government of Canada marketable bond rate in effect at the time of grant and the expected life of the options represents the estimated length of time the options are expected to remain outstanding.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 9: Loss Per Common Share</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Loss per common share is calculated using the weighted average number of common shares outstanding for the year ended December 31, 2010 of 62,475,403 (2009 &#8211; 49,370,175; 2008 &#8211; 41,369,515).&#160;&#160;The effect of any potential exercise of our stock options and warrants outstanding during the year has been excluded from the calculation of diluted loss per common share, as it would be anti-dilutive.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 10: Deficit</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="96%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2008</font></div>
</td>
<td valign="top" width="14%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">102,556,751</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss and comprehensive loss for the year</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,231,249</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2009</font></div>
</td>
<td valign="top" width="14%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">118,788,000</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss and comprehensive loss for the year</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,973,772</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2010</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,761,772</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-23</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 11: Contributed Surplus</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes the change in contributed surplus as at and for the year ended December 31:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, beginning of the year</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,734,743</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,349,801</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,251,041</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">424,273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expired warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,438,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise of stock options</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(24,295</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(39,331</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, end of the year</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,399,489</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,734,743</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 12: Commitments</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are committed to payments totaling $1,140,000 during 2011 for activities related to our clinical trial program and collaborations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are committed to rental payments (excluding our portion of operating costs and rental taxes) under the terms of a lease for office premises which expires on May 31, 2016.&#160;&#160;Annual payments under the terms of this lease are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="94%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="top" width="12%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65,674</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div>
</td>
<td valign="top" width="12%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88,792</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div>
</td>
<td valign="top" width="12%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">91,332</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2014</font></div>
</td>
<td valign="top" width="12%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">94,888</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="81%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2015</font></div>
</td>
<td valign="top" width="12%" style="TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97,428</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2016</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,595</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="81%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">478,709</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under a clinical trial agreement entered into with the Alberta Cancer Board (&#8220;ACB&#8221;), we have agreed to repay the amount funded under the agreement together with a royalty, to a combined maximum amount of $400,000 plus an overhead repayment of $100,000, upon sales of a specified product.&#160;&#160;We agreed to repay the ACB in annual installments in an amount equal to the lesser of: (a) 5% of gross sales of a specified product; or (b) $100,000 per annum.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 13: Contingencies</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Assumption Agreement</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 1999, the Company entered into an agreement that assumed certain obligations (the &#8220;Assumption Agreement&#8221;) in connection with a Share Purchase Agreement (the &#8220;Agreement&#8221;) between SYNSORB and the former shareholders of the Company to make milestone payments and royalty payments.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-24</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of December 31, 2010, a milestone payment was still outstanding for $1.0 million, due within 90 days of the first receipt from an Appropriate Regulatory Authority, for marketing approval to sell REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> to the public or the approval of a new drug application for REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This milestone payment, when payable, will be accounted for as research and development expense and will not be deductible for income tax purposes.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to the milestone payment, payments may become due and payable in accordance with the Agreement upon realization of sales of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.&#160;&#160;In 2003, the Company completed amendments and revisions to the contingent obligations to its five founding shareholders with respect to these other contingent payments.&#160;&#160;The amendments and revisions reduced the amount and clarified the determination of potential obligations of the Company to these shareholders arising from the Agreement and Assumption Agreement entered into in 1999.&#160;&#160;Also, on September 23, 2004, the Company reached an agreement that further reduced its contingent payments to its founding shareholders through the cancellation of a portion of these contingent payments from one of its non-management founding shareholders.&#160;&#160;The consideration paid by the Company consisted of $250,000 cash and 21,459 common shares valued at $150,000 and has been recorded as research and development expense.&#160;&#160;The value of the common shares was based on the closing market price on September 23, 2004.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of the amendments and the cancellation agreement, if the Company receives royalty payments or other payments as a result of entering into partnerships or other arrangements for the development of the reovirus technology, the Company is obligated to pay to the founding shareholders 11.75% (formerly in 2003 &#8211; 14.25% and 2002 &#8211; 20%) of the royalty payments and other payments received.&#160;&#160;Alternatively, if the Company develops the reovirus treatment to the point where it may be marketed at a commercial level, the payments referred to in the foregoing sentence will be amended to a royalty payment of 2.35% (formerly in 2003 &#8211; 2.85% and 2002 &#8211; 4%) of Net Sales received by the Company for such products.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">BRI &#8220;Work in Kind&#8221; Contribution</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We entered into an engineering and process development agreement with the Biotechnology Research Institute of the National Research Council of Canada (&#8220;BRI&#8221;).&#160;&#160;The terms of this Agreement include a &#8220;work in kind&#8221; contribution from BRI.&#160;&#160;In exchange for this &#8220;work in kind&#8221; contribution, we agreed to provide a royalty, contingent upon receiving Sales Revenue, at the lesser of 0.5% of Sales Revenue or $20,000 per year.&#160;&#160;The total royalty under this Agreement is equal to two times the &#8220;work in kind&#8221; contribution.&#160;&#160;As of December 31, 2010, we estimate that the accumulated work in kind totals approximately $301,000.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-25</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 14: Income Taxes</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The recovery of income taxes recorded in the consolidated financial statements differs from the amount which would be obtained by applying the statutory income tax rate to the loss before income taxes as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss before income taxes</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,966,161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,209,249</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17,550,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statutory Canadian corporate tax rate</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anticipated tax recovery</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,590,525</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4,700,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,177,310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign jurisdiction tax rate difference</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,431,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,360,634</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">373,868</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee stock based compensation</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">910,291</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123,039</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,892</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in tax rate</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">124,696</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">151,038</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax return adjustment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(242,261</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,725,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(290,082</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other permanent differences</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(112,318</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42,929</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,456</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in valuation allowance</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,486,061</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(680,928</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,063,176</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Future income tax recovery</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current income taxes</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,611</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, we have non-capital losses for income tax purposes in Canada of approximately $31,626,000 which are available for application against future taxable income and expire in 2026 ($9,809,000), 2027 ($12,170,000), 2029 ($4,009,000), and 2030 ($5,638,000).&#160;&#160;As at December 31, 2010, we have non-refundable federal investment tax credits of approximately $4,104,000 (2009 &#8211; $3,730,000) which are available to reduce future taxes payable.&#160;&#160;We have unclaimed scientific research and experimental development expenditures available to reduce future years&#8217; taxable income of approximately $17,634,000 (2009 &#8211; $16,884,000) over an indefinite future period.&#160;&#160;We have not recorded the potential benefits of these tax pools in the consolidated financial statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The components of our future income tax asset are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> <br>
<font style="FONT-WEIGHT: bold">$</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> <br>
<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net operating losses carried forward</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,251,442</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,871,568</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Scientific research and experimental development</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,408,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,220,931</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investment tax credits</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,078,664</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,797,690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Undepreciated capital costs in excess of book value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;of property and equipment and intellectual property</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">307,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">290,724</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share issue costs</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">939,502</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">814,857</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Valuation allowance</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,986,251</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(14,995,770</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Future income tax asset</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-26</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 15: Capital Disclosures</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our objective when managing capital is to maintain adequate cash resources to support planned activities which include the clinical trial program, product manufacturing, administrative costs and intellectual property expansion and protection.&#160;&#160;We include shareholders&#8217; equity, cash and cash equivalents and short-term investments in the definition of capital.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="middle" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="middle" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,296,682</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,448,939</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="44%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short-term investments</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></div>
</td>
<td align="right" valign="middle" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity</font></div>
</td>
<td align="right" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,931,760</font></div>
</td>
<td align="right" valign="middle" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,366,458</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not have any debt other than trade accounts payable and we have potential contingent obligations relating to the completion of our research and development of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In managing our capital, we estimate our future cash requirements by preparing a budget and a multi-year plan annually for review and approval by our Board of Directors (the &#8220;Board&#8221;).&#160;&#160;The budget establishes the approved activities for the upcoming year and estimates the costs associated with these activities.&#160;&#160;The multi-year plan estimates future activity along with the potential cash requirements and is based on our assessment of our current clinical trial progress along with the expected results from the coming year&#8217;s activity.&#160;&#160;Budget to actual variances are prepared and reviewed by management and are presented quarterly to the Board.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Historically, funding for our plan is primarily managed through the issuance of additional common shares and common share purchase warrants that upon exercise are converted to common shares.&#160;&#160;Management regularly monitors the capital markets attempting to balance the timing of issuing additional equity with our progress through our clinical trial program, general market conditions, and the availability of capital.&#160;&#160;There are no assurances that funds will be made available to us when required.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On June 10, 2010, we renewed our existing short form base shelf prospectus (the &#8220;Base Shelf&#8221;) that qualifies for distribution up to $150,000,000 of common shares, subscription receipts, warrants, or units (the &#8220;Securities&#8221;).&#160;&#160;Under our Base Shelf, we may sell Securities to or through underwriters, dealers, placement agents or other intermediaries and also may sell Securities directly to purchasers or through agents, subject to obtaining any applicable exemption from registration requirements.&#160;&#160;The distribution of Securities may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at market prices prevailing at the time of sale, or at prices related to such prevailing market prices to be negotiated with purchasers and as set forth in an accompanying Prospectus Supplement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Renewing our Base Shelf provides us with additional flexibility when managing our cash resources as, under certain circumstances, it shortens the time period required to close a financing and is expected to increase the number of potential investors that may be prepared to invest in our company.&#160;&#160;Funds received from a Prospectus Supplement will be used in line with our Board approved budget and multi-year plan.&#160;&#160;The Base Shelf expires on July 10, 2012 and we have registered 9,759,360 units under this shelf.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are not subject to externally imposed capital requirements and there have been no changes in how we define or manage our capital in 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-27</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 16: Financial Instruments</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our financial instruments consist of cash and cash equivalents, short-term investments,&#160;&#160;accounts receivable, and accounts payable.&#160;&#160;As at December 31, 2010, there are no significant differences between the carrying values of these amounts and their estimated market values.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Credit risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Credit risk is the risk of financial loss if a counterparty to a financial instrument fails to meet its contractual obligations.&#160;&#160;We are exposed to credit risk on our cash and cash equivalents and short-term investments in the event of non-performance by counterparties, but we do not anticipate such non-performance.&#160;&#160;Our maximum exposure to credit risk at the end of the period is the carrying value of our cash and cash equivalents and short-term investments.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We mitigate our exposure to credit risk by maintaining our primary operating and investment bank accounts with Schedule I banks in Canada.&#160;&#160;For our foreign domiciled bank accounts, we use referrals or recommendations from our Canadian banks to open foreign bank accounts and these accounts are used solely for the purpose of settling accounts payable or payroll.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also mitigate our exposure to credit risk by restricting our portfolio to investment grade securities with short-term maturities and by monitoring the credit risk and credit standing of counterparties.&#160;&#160;Currently, 100% of our short-term investments are in guaranteed investment certificates.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Interest rate risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interest rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in market interest rates.&#160;&#160;We are exposed to interest rate risk through our cash and cash equivalents and our portfolio of short-term investments.&#160;&#160;We mitigate this risk through our investment policy that only allows investment of excess cash resources in investment grade vehicles while matching maturities with our operational requirements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fluctuations in market rates of interest do not have a significant impact on our results of operations due to the short term to maturity of the investments held.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Currency risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currency risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.&#160;&#160;We are exposed to currency risk from the purchase of goods and services primarily in the U.S. and the U.K. and to the extent cash is held in foreign currencies.&#160;&#160;The impact of a $0.01 increase in the value of the U.S. dollar against the Canadian dollar would have increased our net loss in 2010 by approximately $126,442.&#160;&#160;The impact of a $0.10 increase in the value of the British pound against the Canadian dollar would have increased our net loss in 2010 by approximately $128,859.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We mitigate our foreign exchange risk through the purchase of foreign currencies in sufficient amounts to settle our foreign accounts payable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Balances in foreign currencies at December 31, 2010 are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. dollars</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">British pounds</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#163;</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,933,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(561,907</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(64,441</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,371,827</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,693</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-28</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Liquidity risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity risk is the risk that we will encounter difficulty in meeting obligations associated with financial liabilities.&#160;&#160;We manage liquidity risk through the management of our capital structure as outlined in Note 15.&#160;&#160;Accounts payable are all due within the current operating period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 17: Additional Cash Flow Disclosures</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net Change In Non-Cash Working Capital</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">&#160; &#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">&#160; &#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">&#160; &#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cumulative from <br>
inception on <br>
April 2, 1998 to <br>
December 31, <br>
2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -4.15pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Change in:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(220,201</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(6,237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(284,988</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">228,474</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(327,740</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">80,632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(278,934</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable and accrued liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,726,251</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(307,178</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,712,884</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,500,682</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in non-cash working capital</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,717,978</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(613,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,787,279</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,936,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net change associated with investing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net change associated with operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,717,978</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(613,383</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,787,279</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,936,760</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Other Non-Cash Items</font><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -4.15pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -4.15pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cumulative from <br>
inception on <br>
April 2, 19</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">98 to <br>
December 31, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -4.15pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gain on disposal of clinical data</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(16,550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized foreign exchange loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">343,821</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">127,350</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">896,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Donation of medical equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">66,069</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss on sale of Transition Therapeutics Inc.</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,156,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gain on sale of BCY LifeSciences Inc.</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(299,403</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cancellation of contingent payment obligation settled in common shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">[note 7]</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Future income tax recovery</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,115,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">343,821</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">110,800</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,838,158</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 18: Alberta Heritage Loan</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We received a loan of $150,000 from the Alberta Heritage Foundation for Medical Research.&#160;&#160;Pursuant to the terms of the agreement, the Company is required to repay this amount in annual installments from the date of commencement of sales in an amount equal to the lesser of: (a) 5% of the gross sales generated by the Company; or (b) $15,000 per annum until the entire loan has been paid in full.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-29</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 19: Indemnification of Officers and Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our corporate by-laws require that, except to the extent expressly prohibited by law, we will indemnify our officers and directors against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment reasonably incurred in respect of any civil, criminal or administrative action or proceeding as it relates to their services to the Company.&#160;&#160;The by-laws provide no limit to the amount of the indemnification.&#160;&#160;We have purchased directors&#8217; and officers&#8217; insurance coverage to cover claims made against the directors and officers during the applicable policy periods.&#160;&#160;The amounts and types of coverage have varied from period to period as dictated by market conditions.&#160;&#160;We believe that we have adequate insurance coverage; however, there is no guarantee that all indemnification payments will be covered under our existing insurance policies.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There is no pending litigation or proceeding involving any of our officers or directors as to which indemnification is being sought, nor are we aware of any threatened litigation that may result in claims for indemnification.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 20: Economic Dependence</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are economically dependent on our toll manufacturers.&#160;&#160;We primarily use one toll manufacturer in the U.S. to produce the clinical grade REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> required for our clinical trial program.&#160;&#160;Any significant disruption of the services provided by our primary toll manufacturer has the potential to delay the progress of our clinical trial program.&#160;&#160;We have used another toll manufacturer in the U.K. that has also produced clinical grade REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> at a smaller scale.&#160;&#160;We have attempted to mitigate this risk by producing sufficient REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in advance of patient enrollment in a particular clinical trial.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 21: BCY Lifesciences</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On May 7, 2002, the shareholders of SYNSORB and the Company approved an arrangement whereby the Company would release from escrow 4,000,000 common shares held by SYNSORB. As consideration, SYNSORB provided the Company with 1,500,000 common shares of BCY LifeSciences Inc. (&#8220;BCY&#8221;) along with the rights to receive an additional 400,000 common shares of BCY upon the attainment of certain milestones by BCY at no cash cost to the Company.&#160;&#160;The Company received 200,000 of these 400,000 common shares on November 27, 2002.&#160;&#160;These 1,700,000 common shares in BCY were recorded as an investment at $170,000 based on the quoted market price of the BCY common shares at that time with an offsetting credit recorded to contributed surplus.&#160;&#160;On April 23, 2002, the Company acquired 694,445 common shares of BCY, a public company, for $0.18 per share, and warrants exercisable until April 23, 2004 to purchase up to 694,445 common shares in BCY at an exercise price of $0.27 per share for total consideration of $127,123 (including costs of $2,123).&#160;&#160;After these transactions, the Company held a total of 2,394,445 BCY shares which were all subsequently sold for net cash proceeds of $591,725, recording a gain on sale of investment of $299,403.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 22: Accounts Receivable</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Government grant receivable</font></div>
</td>
<td align="right" valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">244,000</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div>
</td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,988</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,787</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="42%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">284,988</font></div>
</td>
<td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 7.2pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,787</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-30</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 23: Reconciliation of Canadian GAAP to U.S. GAAP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our consolidated financial statements are prepared in accordance with Canadian GAAP which, in most respects, conforms to U.S. GAAP.&#160;&#160;Significant differences between Canadian and U.S. GAAP are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="40%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Years Ended December 31</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Cumulative from <br>
inception on <br>
April 2, 1998 to </font></font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> <br>
<font style="FONT-WEIGHT: bold">$</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> <br>
<font style="DISPLAY: inline; FONT-WEIGHT: bold">$</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> <br>
<font style="DISPLAY: inline; FONT-WEIGHT: bold">$</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss and comprehensive loss - Canadian GAAP</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,973,772</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,231,249</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,550,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,761,772</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in fair value of warrant liability</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,841,949</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,050,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,791,019</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization of intellectual property</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(180,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(361,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,615,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Future income tax recovery</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,115,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss and comprehensive loss &#8211; U.S. GAAP</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,815,721</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,999,569</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,188,704</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140,052,791</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="40%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic and diluted loss per common share &#8211; U.S. GAAP</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.40</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.42</font></td>
<td nowrap valign="top" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no differences between Canadian GAAP and U.S. GAAP in amounts reported as cash provided by (used in) operating, financing and investing activities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Balance sheet items in accordance with U.S. GAAP are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="24%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2010</font></div>
</td>
<td colspan="2" valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="24%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canadian <br>
GAAP</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">GAAP</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Canadian <br>
GAAP</font></div>
</td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">GAAP</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrant liability</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,652,764</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,023,051</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Future income taxes</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share capital</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">155,227,915</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">155,440,151</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131,908,274</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131,908,274</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,066,128</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,992,147</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,511,441</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,437,460</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contributed surplus</font></div>
</td>
<td valign="top" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,399,489</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,899,489</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,734,743</font></div>
</td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,234,743</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deficit</font></div>
</td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1), (3)</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,761,772</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">140,052,791</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5.05pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">118,788,000</font></div>
</td>
<td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">115,237,070</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;Push-Down&#8221; Accounting and In Process Research and Development</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual property of $2,500,000 recorded as a consequence of SYNSORB&#8217;s acquisition of the Company&#8217;s shares comprised intangible assets related to research and development activities.&#160;&#160;Under U.S. GAAP, this would not be capitalized on acquisition.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-31</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of removing the $2,500,000 from intellectual property in 1999 for U.S. GAAP purposes, the amortization of the intellectual property, the future income tax recovery, and contributed surplus amounts recorded for Canadian GAAP purposes have been reversed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Presentation of Stock Based Compensation Expense</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under U.S. GAAP, stock based compensation expense is to be presented within the appropriate category of expenses on the consolidated statements of loss.&#160;&#160;As a result, stock based compensation on the consolidated statement of loss would be reduced by $3,251,041 in 2010 (2009 &#8211; $424,273; 2008 &#8211; $64,039) and research and development and operating expenses would increase by$1,523,561 and $1,727,480, respectively (2009 &#8211; $211,263 and $213,010, respectively; 2008 &#8211; $64,039 and $nil, respectively).&#160;&#160;Cumulative from inception stock based compensation would be reduced by $8,444,158 and cumulative from inception research and development and operating expenses would increase by $4,469,948 and $3,974,210, respectively.&#160;&#160;There is no impact on the Company&#8217;s net loss.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Treatment of Warrants with a Foreign Currency Exercise Price</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under U.S. GAAP, the prescribed accounting treatment for warrants with an exercise price denominated in a foreign currency is to treat these warrants as a liability measured at fair value with changes in fair value accounted for through the consolidated statement of loss.&#160;&#160;The fair value of these warrants is determined using the Black Scholes Option Pricing Model.&#160;&#160;As a result of this prescribed accounting treatment, for U.S. GAAP, we have reclassified the warrants issued in our November 2009 unit offering from equity to liabilities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Additional Stock Based Payment Disclosure</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, the aggregate intrinsic value of the stock options outstanding and the stock options exercisable were $11,012,545 and $10,836,365, respectively.&#160;&#160;The total intrinsic value of the options exercised in 2010 was $35,769 (2009 &#8211; $519,245; 2008 &#8211; $nil).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A summary of our non-vested options as at December 31, 2010 and 2009 and the respective changes during the year ended are as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average Grant Date Fair Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average Grant Date Fair Value</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-vested options, beginning of the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61,167</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.92</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted during the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vested during the year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(26,508</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(77,183</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forfeited during the year</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(825</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.36</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(350</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.92</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-vested options, end of the year</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48,834</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.96</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61,167</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.92</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-32</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">ONCOLYTICS BIOTECH INC.<br>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">December 31, 2010<br>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, there was $nil (2009 &#8211; $2,206) of total unrecognized compensation costs related to non-vested stock options granted under our stock option plan.&#160;&#160;The total fair value of shares vested during the years ended December 31, 2010, 2009, and 2008 was $28,874,&#160;&#160;$101,617, and $93,572, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company issues shares from treasury to satisfy any exercise of stock options.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Additional Financial Instrument Disclosure</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial Liabilities</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial liabilities include the warrant liability which has been classified as held for trading and has been measured at the estimated fair value.&#160;&#160;These warrants have not been listed on an exchange and therefore do not trade on an active market.&#160;&#160;Changes in fair value are recorded as a gain or loss in the consolidated statement of loss.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Fair Value Measurement</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The accounting guidance for fair value measurements prioritizes the inputs used in measuring fair value into the following hierarchy:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 2 &#8211; Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 3 - Unobservable inputs in which little or no market activity exists, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fair value of our Warrant Liability is based on level 2 (significant observable inputs).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Accounting for Uncertainty in Income Taxes</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The tax years 2004 &#8211; 2009 remain open for audit examination by the respective Canadian taxing jurisdictions.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Note 24: Subsequent Event</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2011, we received proceeds of U.S.$6.4 million from the exercise of 1,823,100 warrants with an exercise of U.S.$3.50.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In February and March 2011, we received proceeds of $8.5 million from the exercise of 1,322,750 warrants with an exercise price of $6.15.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-33</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>2
<FILENAME>ex4_17.htm
<DESCRIPTION>AMENDMENT NO. 2, DATED JANUARY 1, 2011, TO THE EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND ITS CHIEF EXECUTIVE OFFICER, BRADLEY THOMPSON, DATED JUNE 6, 2007
<TEXT>
<html>
<head>
    <title>ex4_17.htm</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div>&#160;</div>

<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 4.17</font></div>

<div>&#160;</div>

<div>&#160;</div>

<div><img src="onco_p1.jpg" alt=""></div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div><img src="onco_p2.jpg" alt=""></div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>3
<FILENAME>ex8_1.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">EXHIBIT 8.0</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">LIST OF SUBSIDIARIES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name</font></div>
</td>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Jurisdiction</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech (Barbados) Inc.</font></div>
</td>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Barbados</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech (US) Inc.</font></div>
</td>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Delaware</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Valens Pharma Ltd.</font></div>
</td>
<td align="left" valign="top" width="39%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alberta</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ex12_1.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<br>
&#160;

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT 12.1</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CERTIFICATION</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I, Brad Thompson, certify that:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 20-F of Oncolytics Biotech Inc.;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 35pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="32%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date: March 24 , 2011</font></div>
</td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="59%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">/s/ Brad Thompson&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div>
</td>
</tr><tr>
<td valign="top" width="32%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="59%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Brad Thompson, PhD</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Executive Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principal Executive Officer</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ex12_2.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT 12.2</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CERTIFICATION</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I, Doug Ball, certify that:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 20-F of Oncolytics Biotech Inc.;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 40pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="32%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date: March 24, 2011</font></div>
</td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="61%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">/s/ Doug Ball</font></div>
</td>
</tr><tr>
<td valign="top" width="32%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></td>
<td valign="top" width="61%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Doug Ball, CA</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Financial Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principal Accounting and Financial Officer</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
<br>
&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ex13_1.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">EXHIBIT 13.1</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CERTIFICATION PURSUANT TO</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18 U.S.C. &#167;1350,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">AS ADOPTED PURSUANT TO</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with the annual report of Oncolytics Biotech Inc. (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date here of (the &#8220;Report&#8221;), I, Brad Thompson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>/s/ Brad Thompson</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>_________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Brad Thompson, PhD</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Chief Executive Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Principal Executive Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>March 24, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A signed original of this written statement required by Section 906 has been provided to Oncolytics Biotech Inc. and will be retained by Oncloytics Biotech Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>ex13_2.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT 13.2</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CERTIFICATION PURSUANT TO</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18 U.S.C. &#167;1350,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">AS ADOPTED PURSUANT TO</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with the annual report of Oncolytics Biotech Inc. (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date here of (the &#8220;Report&#8221;), I, Doug Ball, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>/s/ Doug Ball</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>__________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Doug Ball, CA</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Chief Financial Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>Principal Accounting and Financial Officer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>March 24, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A signed original of this written statement required by Section 906 has been provided to Oncolytics Biotech Inc. and will be retained by Oncolytics Biotech Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>8
<FILENAME>ex15_1.htm
<DESCRIPTION>THE REGISTRANT'S MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2010
<TEXT>
<html>
<head>
    <title>ex15_1.htm</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 15.1</font></div>

<div>&#160;</div>

<div><br>
&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><img src="oncolytics_logo.jpg" alt=""><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MANAGEMENT DISCUSSION &amp; ANALYSIS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2010</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Table of Contents</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#Forwardlookingstatements"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">FORWARD-LOOKING STATEMENTS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ReolysinDevelopmentUpdatefor2010"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">REOLYSIN</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">&#174;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline"> DEVELOPMENT UPDATE FOR 2010</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ClinicalTrialProgram"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Clinical Trial Program</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ClinicalTrialProgramExpansion"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-DECORATION: underline">Clinical Trial &#8211; Program Expansion</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ClinicalTrial2010Results"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-DECORATION: underline">Clinical Trial &#8211; 2010 Results</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#PreClinandCollaProgram"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Pre-Clinical and Collaborative Program</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#Publications"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-STYLE: italic; TEXT-DECORATION: underline">Publications</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#MfgandProcessDev"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Manufacturing and Process Development</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#IntellectualProperty"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Intellectual Property</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#FinancingActivity"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Financing Activity</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#BoughtDealFinancing"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-STYLE: italic; TEXT-DECORATION: underline">Bought Deal Financing</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#Warrants"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-STYLE: italic; TEXT-DECORATION: underline">Warrants</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#FinancialImpact"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Financial Impact</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#CashResources"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Cash Resources</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ReolysinDevfor2011"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">REOLYSIN</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">&#174;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline"> DEVELOPMENT FOR 2011</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#CriticalAcctgPolandEst"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#SelectedAnnualInfo"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">SELECTED ANNUAL INFORMATION</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#ResultsofOperations"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">RESULTS OF OPERATIONS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#SummaryofQuarterlyRes"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">SUMMARY OF QUARTERLY RESULTS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#FourthQuarter"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">FOURTH QUARTER</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#LiquidityandCapRes"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">LIQUIDITY AND CAPITAL RESOURCES</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#BDFinancing"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-STYLE: italic; TEXT-DECORATION: underline">Bought Deal Financing</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#Warrants"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-STYLE: italic; TEXT-DECORATION: underline">Warrants</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#OBSheetArrangements"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">OFF-BALANCE SHEET ARRANGEMENTS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#TransactionswithRelated"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">TRANSACTIONS WITH RELATED PARTIES</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#FinInstrumentsandOther"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">FINANCIAL INSTRUMENTS AND OTHER INSTRUMENTS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#RiskFactorsAffectingFuture"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">RISK FACTORS AFFECTING FUTURE PERFORMANCE</font></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#OtherMDARequirements"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">OTHER MD&amp;A REQUIREMENTS</font></a>&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a href="#DisclosureControls"><!--EFPlaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Disclosure Controls and Procedures</font></a>&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">March 16, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following information should be read in conjunction with our 2010 audited consolidated financial statements and notes thereto, which were prepared in accordance with Canadian generally accepted accounting principles (&#8220;GAAP&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Forwardlookingstatements">FORWARD-LOOKING STATEMENTS</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following discussion contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and under applicable Canadian provincial securities legislation.&#160;&#160;Forward-looking statements, including our belief as to the potential of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, a therapeutic reovirus, as a cancer therapeutic and our expectations as to the success of our research and development and manufacturing programs in 2011 and beyond, future financial position, business strategy and plans for future operations, and statements that are not historical facts, involve known and unknown risks and uncertainties, which could cause our actual results to differ materially from those in the forward-looking statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Such risks and uncertainties include, among others, the need for and availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>as a cancer treatment, the success and timely completion of clinical studies and trials, our ability to successfully commercialize REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, uncertainties related to the research, development and manufacturing of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, uncertainties related to competition, changes in technology, the regulatory process and general changes to the economic environment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With respect to the forward-looking statements made within this MD&amp;A, we have made numerous assumptions regarding among other things: our ability to obtain financing to fund our development program, our ability to receive regulatory approval to commence enrollment in our clinical trial program, the final results of our co-therapy clinical trials, our ability to maintain our supply of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and future expense levels being within our current expectations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investors should consult our quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements.&#160;&#160;Forward-looking statements are based on assumptions, projections, estimates and expectations of management at the time such forward-looking statements are made, and such assumptions, projections, estimates and/or expectations could change or prove to be incorrect or inaccurate.&#160;&#160;Investors are cautioned against placing undue reliance on forward-looking statements.&#160;&#160;We do not undertake to update these forward-looking statements except as required by applicable law.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="ReolysinDevelopmentUpdatefor2010">REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-FAMILY: Times New Roman">&#174;</font> DEVELOPMENT UPDATE FOR 2010</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oncolytics Biotech Inc. is a Development Stage Company</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since our inception in April of 1998, Oncolytics Biotech<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> Inc. has been a development stage company and we have focused our research and development efforts on the development of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, our potential cancer therapeutic.&#160;&#160;We have not been profitable since our inception and expect to continue to incur substantial losses as we continue research and development efforts.&#160;&#160;We do not expect to generate significant revenues until, if and when, our cancer product becomes commercially viable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our goal each year is to advance REOLYSIN through the various steps and stages of development required for potential pharmaceutical products.&#160;&#160;In order to achieve this goal, we believe that we have to actively manage the development of our clinical trial program, our pre-clinical and collaborative programs, our manufacturing process and REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>supply, and our intellectual property.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="ClinicalTrialProgram">Clinical Trial Program</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We began 2010 with eight clinical trials, either enrolling patients or approved to commence enrollment.&#160;&#160;We sponsor four of these eight clinical trials which include our randomized Phase III head and neck clinical trial associated with our Special Protocol Assessment agreement with the U.S. Food and Drug Administration (&#8220;FDA&#8221;).&#160;&#160;Of the four other clinical trials one was sponsored by the U.S. National Cancer Institute (&#8220;NCI&#8221;), two were sponsored by the Cancer Therapy &amp; Research Center at The University of Texas Health Center in San Antonio (&#8220;CTRC&#8221;) and one was sponsored by the University of Leeds (&#8220;Leeds&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, enrollment in our randomized Phase III head and neck trial commenced and we expanded into other jurisdictions including the U.K., Belgium, and Canada.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also expanded our clinical program in 2010, to include a Phase II squamous cell carcinoma of the lungs cancer study (sponsored by the CTRC), a Phase I colorectal cancer study (sponsored by Oncolytics), a Phase II pancreatic cancer clinical study (sponsored by the CTRC), a randomized Phase II ovarian cancer study (sponsored by the Gynecologic Oncology Group (&#8220;GOG&#8221;)), and a Phase I study in pediatric patients with relapsed or refractory solid tumours (sponsored by the NCI).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the year, we presented positive updated results from our U.K. Phase I/II clinical trial focused on the head and neck at the ASCO annual meeting and published final results of our U.K. Phase Ia/Ib radiotherapy clinical trial and our U.K. Phase I docetaxel combination clinical trial.&#160;&#160;We also completed patient enrollment in our U.S. Phase I/II recurrent malignant glioma clinical trial and our Phase II sarcoma clinical trial.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We exited 2010 with eleven clinical trials which includes two randomized studies (our randomized Phase III head and neck trial and our randomized Phase II ovarian cancer trial).&#160;&#160;Five of the eleven trials are funded by us and the remainder are sponsored by the NCI, CTRC, and Leeds.&#160;&#160;Our clinical trial program currently encompasses various cancer indications including head and neck, non-small cell lung, ovarian, pancreatic, colorectal, melanoma, and squamous cell carcinoma of the lung among others.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Clinical Trial &#8211; Randomized Phase III Head and Neck Pivotal Trial</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, we commenced enrollment in our randomized Phase III head and neck pivotal trial and throughout the year we expanded enrollment into other jurisdictions and sought out and initiated clinical sites within each jurisdiction.&#160;&#160;We obtained approval to conduct our randomized Phase III trial in the U.S., U.K. and Belgium.&#160;&#160;This is the same trial that we previously reached an agreement on with the FDA under the SPA process.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This trial is a randomized, two-arm, double-blind, multicentre, two-stage, adaptive Phase III trial that will assess the intravenous administration of REOLYSIN with the chemotherapy combination of paclitaxel and carboplatin versus the chemotherapy alone in patients with metastatic or recurrent squamous cell carcinoma of the head and neck, or squamous cell cancer of the nasopharynx, who have progressed on or after prior platinum-based chemotherapy. All patients will receive treatment every three weeks (21 day cycles) with paclitaxel and carboplatin and will also receive, on a blinded basis, either intravenous placebo or intravenous REOLYSIN.&#160;&#160;All dosing takes place in the first five days of each cycle with all patients receiving standard intravenous doses of paclitaxel and carboplatin on day one only, and on days one through five, either intravenous placebo or intravenous REOLYSIN at a dose of 3x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>.&#160;&#160;Patients may continue to receive the trial combination therapy for up to eight, 21-day cycles and, thereafter, blinded placebo or blinded REOLYSIN until the patient has progressive disease or meets other criteria for removal from the trial.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary endpoint for the trial is overall survival (OS); secondary endpoints include progression free survival (PFS), objective response rate (complete response (CR) + partial response (PR)) and duration of response, and safety and tolerability of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> when administered in combination with paclitaxel and carboplatin.&#160;&#160;The first stage of the trial is designed to enroll 80 patients. The second stage is adaptive, and is designed to enroll between 100 and 400 patients with the most probable statistical enrolment being 195 patients in this stage. This adaptive trial design allows frequent data evaluation to determine if the probability of reaching a statistically significant endpoint has been achieved.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The decision to pursue a Phase III trial in head and neck cancers was predicated on positive results seen in our Phase I and Phase II combination REOLYSIN and paclitaxel/carboplatin clinical trials, as well as significant preclinical work demonstrating synergy in combination with taxane or platinum-based drugs. Updated results from the U.K. Phase I/II trial reported in 2010 demonstrated an overall response rate (PR and CR) of 42% and a total clinical benefit rate (PR + CR + stable disease) of 74%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="ClinicalTrialProgramExpansion">Clinical Trial &#8211; Program Expansion</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.S. Randomized Phase II Combination REOLYSIN Paclitaxel Clinical Trial for Ovarian Cancer</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, the GOG received approval to commence a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H) and commenced enrollment. The study will be sponsored by the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the NCI, under our Clinical Trials Agreement.&#160;&#160;The Study Chair will be Dr. David E. Cohn of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This study is a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer. Patients will be randomized to receive either paclitaxel alone or paclitaxel plus REOLYSIN. Patients in both arms will receive treatment with paclitaxel, with the second arm also receiving intravenous REOLYSIN. Patients will receive standard doses of paclitaxel on days one, eight, and 15 every 28 days. In the second arm, patients will also receive, on days one through five of each 28-day cycle, intravenous REOLYSIN at a dose of 3x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objectives of this trial are to estimate the progression-free survival hazard ratio of the combination of weekly paclitaxel with REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> to weekly paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer and to determine the frequency and severity of adverse events associated with treatment with weekly paclitaxel alone and weekly paclitaxel with REOLYSIN as assessed by Common Terminology Criteria for Adverse Events (CTCAE). The secondary objectives are to estimate the progression-free survival and overall survival of patients treated with weekly paclitaxel alone and weekly paclitaxel with REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>; to estimate (and compare) the proportion of patients who respond to the regimen on each arm of the study (according to RECIST 1.1 with measurable patients and by CA-125 for those patients with detectable disease only); and to characterize and compare progression-free survival and overall survival in patients with measurable disease (RECIST 1.1 criteria) and patients with detectable (nonmeasurable) disease. The study is expected to enroll up to 150 patients.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.S. Phase II Pancreatic Cancer Clinical Trial</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, the CTRC started patient enrolment in a U.S. Phase II clinical trial using intravenous administration of REOLYSIN in combination with gemcitabine (Gemzar<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This trial is a single arm, open-label, Phase II study of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>given intravenously with gemcitabine every three weeks. Up to 33 patients are expected to be treated in this trial.&#160;&#160;Eligible patients include those with advanced or metastatic pancreatic cancer with measurable disease who have not received any prior chemotherapy or biotherapy.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objective of the Phase II trial is to determine the clinical benefit rate (complete response + partial response + stable disease) of intravenous multiple doses of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in combination with gemcitabine in patients with advanced or metastatic pancreatic cancer. The secondary objectives are to determine the progression-free survival, and to determine the safety and tolerability of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> when administered in combination with gemcitabine.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This trial is the third of five clinical trials with the CTRC under our broad preclinical and clinical collaboration contract.&#160;&#160;Our collaboration with CTRC will involve up to five, open-label, Phase 2 studies exploring the use of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in combination with chemotherapy for various cancer indications.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.S. Phase 1 Colorectal Cancer Clinical Trial</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, we initiated a U.S. Phase 1 study of REOLYSIN in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer.&#160;&#160;The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The trial is a Phase I dose escalation study with three dose levels and cohorts of three to six patients to determine a maximum tolerated dose and dose-limiting toxicities with the combination of REOLYSIN and FOLFIRI. FOLFIRI will be administered on the first day of a two week (14 day) cycle, while REOLYSIN will be administered on days one through five of a four week (28 day) cycle.&#160;&#160;Eligible patients include those with histologically confirmed cancer of the colon or rectum with Kras mutation and measurable disease.&#160;&#160;They must have progressed on or within 190 days after last dose of oxaliplatin regimen as front-line therapy in the metastatic setting or be intolerant to oxaliplatin.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The clinical rationale for conducting this study was based on positive efficacy results seen in a range of our prior preclinical and clinical work with REOLYSIN. This includes a National Cancer Institute screen of seven colorectal cancer cell lines (four with ras mutations), all of which were susceptible to REOLYSIN; preclinical research into the efficacy of REOLYSIN in combination with various chemotherapeutic agents in colorectal cancer cell lines; observation of CEA responses and stable disease in colorectal patients in a Phase I study of REOLYSIN as a monotherapy; and evidence of viral replication of reovirus in liver metastases in patients with metastatic colorectal cancer in a translational study with REOLYSIN as a monotherapy that is currently ongoing.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.S. Phase I Study in Pediatric Patients with Relapsed or Refractory Solid Tumors</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, we expanded our clinical program to include pediatric patients.&#160;&#160;We announced that the Children's Oncology Group (COG) intends to conduct a Phase I trial of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>in combination with cyclophosphamide in pediatric patients with relapsed or refractory solid tumors. The study will be conducted under our Clinical Trials Agreement with the NCI and in collaboration with the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, which is part of the National Institutes of Health.&#160;&#160;The study chair will be Dr. E. Anders Kolb of the Nemours/Alfred I. duPont Hospital for Children.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The study is an open label, multicentre, dose escalation Phase I study of REOLYSIN in patients aged three to 21 years with relapsed or refractory solid tumors.&#160;&#160;Patients will receive intravenous REOLYSIN on days one through five of each 28-day treatment cycle.&#160;&#160;Some patients will also receive oral cyclophosphamide on days one through 21.&#160;&#160;Treatments repeat every 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objectives of the trial include estimating maximum tolerated dose, and defining and describing the toxicities of REOLYSIN and REOLYSIN plus oral cyclophosphamide in this patient population. Secondary objectives include defining antitumor activity of REOLYSIN within the confines of a Phase I study, evaluating the development of neutralizing antibodies to REOLYSIN following intravenous administration of REOLYSIN alone and in combination with cyclophosphamide, and assessing the biologic activity of REOLYSIN. After completion of study treatment, patients are to be followed up periodically for up to one year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="ClinicalTrial2010Results">Clinical Trial &#8211; 2010 Results</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.K. Phase I/II REOLYSIN in Combination with Paclitaxel/Carboplatin</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, a poster was presented covering updated results of our Phase I/II U.K. clinical trial of REOLYSIN combined with paclitaxel/carboplatin for patients with advanced cancers at the ASCO 2010 Annual Meeting in Chicago, IL.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The poster entitled <font style="DISPLAY: inline; FONT-STYLE: italic">"Phase I/II Study of Oncolytic Reovirus Plus Carboplatin/Paclitaxel in Patients with Advanced Solid Cancers with Emphasis on Squamous Cell Carcinoma of the Head and Neck,"</font> (SCCHN) updated our previously disclosed interim data to include new overall survival data.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The researchers reported that 31 patients were enrolled (24 males; median age 59 years) with head and neck cancer (n=24), melanoma (n=4), peritoneal/endometrial cancer (n=2), or sarcoma (n=1). In the dose-escalation phase of the study, there were no dose-limiting toxicities. Grade 3/4 toxicities included anaemia, leucopenia, neutropenia, lymphopenia, thrombocytopenia, infection and hypotension. In the Phase II study, PR were noted in two of five patients with head and neck cancer. The Phase II study treated head and neck cancer patients at the maximum dose level (3 x 10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>) in order to further assess tumour response.&#160;&#160;In total, 19 patients with head and neck cancer received at least two cycles and were evaluable for response. Most were SCCHN patients refractory to previous platinum-based chemotherapy for recurrent/metastatic disease.&#160;&#160;Partial responses were seen in eight patients (42%) and stable disease (SD) in six (32%). One additional PR and one SD were observed among four patients with malignant melanoma.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The mean overall survival (OS) in 24 treated head and neck cancer patients is more than eight months, with four patients still alive at the time of the presentation.&#160;&#160;The mean OS of the patients experiencing PR and PR plus SD is statistically significantly greater than the mean survival of those patients experiencing progressive disease (PD) (hazard ratio 0.2, p=0.0249 and hazard ratio 0.27, p=0.04, respectively, with a 95% confidence interval).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The researchers concluded that intravenous administration of reovirus in combination with carboplatin/paclitaxel is a safe and well-tolerated combination with promising anticancer activity in SCCHN. Further evaluation of this combination in a randomized Phase III trial in SCCHN is underway.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.K. Phase Ia/Ib REOLYSIN in Combination with Radiotherapy Clinical Trial</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, a paper entitled "<font style="DISPLAY: inline; FONT-STYLE: italic">Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers,</font>" was published in the online version of the journal Clinical Cancer Research.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The paper covers final results from our Phase Ia/Ib U.K. clinical trial investigating the intratumoural delivery of REOLYSIN in combination with radiation to treat patients with advanced cancers.&#160;&#160;A total of 23 patients received a range of two to six intratumoural doses of REOLYSIN at escalating dosages up to a maximum of 1x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font> with a constant localized radiation dose of either 20 Gy or 36 Gy. The principal investigator for the study was Dr. Kevin Harrington from The Institute of Cancer Research and The Royal Marsden Hospital, London, U.K.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Of the seven evaluable patients in the low-dose (20Gy) radiation group, two patients had a partial response (&#8220;PR&#8221;) (esophageal adenocarcinoma and squamous cell carcinoma (SCC) of the skin) and five had stable disease (&#8220;SD&#8221;) including patients with malignant melanoma, pancreatic adenocarcinoma, SCC of the larynx and SCC of the skin (2). In the high-dose (36Gy) radiation group, five of seven evaluable patients had PR (malignant melanoma (2), lung adenocarcinoma, colorectal adenocarcinoma, and ovarian adenocarcinoma) and two had SD (malignant melanoma).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The primary objective of the trial was to determine the maximum tolerated dose (MTD), dose limiting toxicity (DLT), and safety profile of REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> when administered intratumourally to patients receiving radiation treatment. A secondary objective was to examine any evidence of anti-tumour activity. The treatment was well tolerated in all cohorts, with no DLTs, and no MTD was reached.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.K. Phase I REOLYSIN in Combination with Docetaxel Clinical Trial</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, a paper entitled <font style="DISPLAY: inline; FONT-STYLE: italic">"REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer,"</font> was published by Comins <font style="DISPLAY: inline; FONT-STYLE: italic">et al</font> in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The paper reported final results from a combination REOLYSIN and docetaxel trial, designed to evaluate the anti-tumour effects of systemic administration of REOLYSIN in combination with docetaxel (Taxotere<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>) in patients with advanced cancers.&#160;&#160;Patients received docetaxel on day one (75mg/m2) and escalating doses of reovirus up to 3 x 10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font> on days one through five, every three weeks.&#160;&#160;The principal investigator was Professor Hardev Pandha of the Royal Surrey County Hospital, U.K.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Twenty-five patients were enrolled, with 24 being exposed to treatment and 23 completing at least one cycle of therapy. Sixteen patients were suitable for response assessment. The combination was deemed to be safe and well tolerated and a maximum tolerated dose was not reached. Antitumour activity was seen with one complete response (in the liver of a breast cancer patient with no evidence of disease recurrence at the end of the study, following eight cycles of treatment) and three partial responses. A disease control rate (combined complete response, partial response and stable disease) of 88% was observed. The authors concluded that the combination of reovirus and docetaxel is safe, with evidence of objective disease response, and warrants further evaluation in a Phase II study at a recommended schedule of docetaxel (75mg/m<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">2</font>, three times weekly) and reovirus (3 x 10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">10</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>, days one to five, every three weeks).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Eligible patients included those who had been diagnosed with advanced or metastatic solid tumours including bladder, lung, prostate or upper gastro-intestinal cancers that were refractory (had not responded) to standard therapy or for which no curative standard therapy existed. The primary objective of the trial was to determine the MTD, DLT,&#160;&#160;recommended dose and dosing schedule and safety profile of REOLYSIN when administered in combination with docetaxel. Secondary objectives included the evaluation of immune response to the drug combination, the body's response to the drug combination compared to chemotherapy alone and any evidence of anti-tumour activity.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="PreClinandCollaProgram">Pre-Clinical and Collaborative Program</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="Publications">Publications</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, the following article was published:</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior Author</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Publication</font></div>
</td>
<td valign="top" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description/Conclusion</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">"Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice"</font></div>
</td>
<td align="left" valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Richard Vile</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Kevin Harrington</font></div>
</td>
<td align="left" valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 1, 2010 Journal of Clinical Investigation on</font></div>
</td>
<td valign="top" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The research demonstrated that combining VEGF165 inhibitors such as Avastin or Sunitinib with systemic delivery of REOLYSIN leads to substantial regression and cure of established tumors in immunocompetent mice. This approach led to direct tumor cell lysis (break down) and triggered innate immune&#8211;mediated attack on the tumor vasculature. It also resulted in long-term antitumor effects, even against tumors in which viral replication was poorly supported. The authors concluded that because this combinatorial approach targets the tumor endothelium, these data have direct, wide-ranging, and immediate clinical applicability across a broad range of tumor types using reagents that are already approved for use in patients.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="MfgandProcessDev">Manufacturing and Process Development</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, we completed the bulk production of two 100-litre cGMP production runs.&#160;&#160;As well, we finished the fill and packaging of the 100-litre cGMP production run that was completed at the end of 2009 along with the two production runs that occurred in 2010.&#160;&#160;Our process development activity in 2010 focused on process validation and formulation studies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="IntellectualProperty">Intellectual Property</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the end of 2010, we had been issued over 250 patents including 40 U.S. and 11 Canadian patents as well as issuances in other jurisdictions.&#160;&#160;We also have over 200 patent applications filed in the U.S., Canada and other jurisdictions.&#160;&#160;We have an extensive patent portfolio covering the oncolytic reovirus that we use in our clinical trial program including a composition of matter patent that expires in 2028.&#160;&#160;Our patent portfolio also includes methods for treating proliferative disorders using modified adenovirus, HSV, parapoxvirus and vaccinia virus.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="FinancingActivity">Financing Activity</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we received cash inflow from financing activities of $27.3 million as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="BoughtDealFinancing">Bought Deal Financing</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In November 2010, we closed a bought deal financing whereby we issued 6,256,000 units at an issue price of $4.60 per unit for net cash proceeds of $26.8 million.&#160;&#160;Each Unit consists of one common share and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant entitles the holder to acquire one common share at a price of $6.15 at any time until November 8, 2012.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="Warrants">Warrants</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In December 2010, and in conjunction with the terms of our warrant indenture, we accelerated the expiry date of our U.S.$3.50 warrants issued in November 2009 to January 24, 2010.&#160;&#160;As of the end of 2010, we had received U.S.$0.4 million with respect to the exercise of 119,900 warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent to December 31, 2010, we received U.S.$6.4 million from the exercise of 1,823,100 of our warrants with an exercise price of U.S.$3.50.&#160;&#160;As well, in February and March of 2011, we received proceeds of $8.2 million from the exercise of 1,322,750 warrants with an exercise price of $6.15.&#160;&#160;These warrants were issued in connection with the financing that closed on November 8, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Options</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we received cash proceeds of $0.1 million with respect to the exercise of 32,433 stock options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="FinancialImpact">Financial Impact</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimated at the beginning of 2010 that our cash requirements to fund our operations for the year would be approximately $24 million.&#160;&#160;We amended our estimate during the year to $21 million due to the timing of patient enrollment in our Phase III pivotal trial.&#160;&#160;Our cash usage for 2010 was $18,033,732 from operating activities and $81,846 for the acquisition of property and equipment.&#160;&#160;Our net loss for 2010 was $19,973,772.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="CashResources">Cash Resources</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We exited 2010 with cash resources (cash, cash equivalents and short-term investments) totaling $42,905,928&#160;&#160;(see <font style="DISPLAY: inline; FONT-STYLE: italic">&#8220;Liquidity and Capital Resources&#8221;)</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="ReolysinDevfor2011">REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-FAMILY: Times New Roman">&#174;</font> DEVELOPMENT FOR 2011</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our planned development activity for REOLYSIN in 2011 is made up of clinical, manufacturing, intellectual property and collaboration programs.&#160;&#160;Our 2011 clinical program includes the anticipated completion of stage 1 (approximately 80 patients) of our Phase III head and neck clinical trial and commencement of stage 2.&#160;&#160;As well, we expect to commence enrollment in our colorectal study and complete enrollment in our non-small cell lung, U.S. phase II head and neck cancer trials and support those clinical trials that are sponsored by CTRC, Leeds and the NCI.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our 2011 manufacturing program includes several 100-litre cGMP production runs along with the related fill, labeling, packaging and shipping of REOLYSIN to the various clinical sites.&#160;&#160;As well, we plan on performing smaller process development studies examining formulation, stability and additional scale up.&#160;&#160;Our intellectual property program includes filings for additional patents along with monitoring activities required to protect our patent portfolio.&#160;&#160;Finally, our 2011 collaboration program will finish the studies in place at the end of 2010 and contemplates the addition of future studies that may be required.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We estimate that the cash requirements to fund our operations for 2011 will be approximately $29,000,000 (see <font style="DISPLAY: inline; FONT-STYLE: italic">&#8220;Liquidity and Capital Resources&#8221;</font>).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="CriticalAcctgPolandEst">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In preparing our financial statements, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon the information available.&#160;&#160;These estimates and assumptions affect the reported amounts of assets at the date of the financial statements and the reported amounts of expenses during the periods presented.&#160;&#160;Significant estimates are used for, but not limited to, the treatment of our research and development expenditures, the assessment of realizable value of long-lived assets, the amortization period of intellectual property and the calculation of stock based compensation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The significant accounting policies which we believe are the most critical to aid in fully understanding and evaluating our reported financial results include the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and Development</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We account for our research and development activity in conjunction with the Canadian Institute of Chartered Accountants&#8217; (the &#8220;CICA&#8221;) Handbook Section 3064 <font style="DISPLAY: inline; FONT-STYLE: italic">&#8220;Goodwill and Intangible Assets&#8221; </font>(&#8220;Section 3064&#8221;) and expense all of our research and development costs as incurred.&#160;&#160;Under Section 3064, development costs should only be capitalized if all the criteria below are met:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The technical feasibility of completing the intangible asset so that it will be available for use or sale.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our intention to complete the intangible asset and use or sell it.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our ability to use or sell the intangible asset.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">How the intangible asset will generate probable future economic benefits.&#160;&#160;Among other things, we are able to demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our ability to measure reliably the expenditure attributable to the intangible asset during its development.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe that we do not meet all of the above criteria and for this reason, our research and development costs are expensed and not capitalized.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We will monitor our progress against these criteria and will capitalize our development costs once we can conclude we meet the above criteria.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Future Accounting Changes</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">International Financial Reporting Standards (&#8220;IFRS&#8221;)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Canadian Institute of Chartered Accountants&#8217; Accounting Standards Board announced that Canadian publicly accountable enterprises are required to adopt IFRS, as issued by the International Accounting Standards Board (IASB), effective January 1, 2011.&#160;&#160;We are prepared to adopt IFRS as at that date.&#160;&#160;Our transition process included the following phases:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scoping and diagnostic phase &#8212; This phase involved performing a high-level diagnostic assessment to identify key areas that were impacted by the transition to IFRS. This phase was finalized in 2008.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Impact analysis, evaluation and design phase &#8212;This phase involved specification of changes required to existing accounting policies, information systems and business processes, together with an analysis of policy alternatives allowed under IFRS.&#160;&#160;This phase was finalized in 2009.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Implementation and review phase &#8212; This phase included execution of changes to information systems and business processes, completing formal authorization processes to approve recommended accounting policy changes and training.&#160;&#160;At the end of the implementation and review phase we will be able to compile financial statements compliant with IFRS.&#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of completing these three phases we are now in the process of compiling financial statements in compliance with IFRS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Implementation and Review Phase</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we commenced the implementation and review phase of our IFRS transition plan.&#160;&#160;Throughout the year, we trained key accounting and finance personnel on the application of IFRS accounting policies and the potential impact on our consolidated financial statements.&#160;&#160;We prepared a draft opening balance sheet along with our accounting policies under IFRS and presented them to our Audit Committee for review.&#160;&#160;Our external auditor has also reviewed our opening balance sheet and our disclosures under IFRS, however all amounts are considered unaudited, as we have not yet prepared a full set of financial statements under IFRS.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IFRS 1 &#8220;<font style="DISPLAY: inline; FONT-STYLE: italic">First Time Adoption of International Financial Reporting Standards</font>&#8221;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, we will utilize the exemption relating to investments in subsidiaries, jointly controlled entities and associates and the exemption relating to cumulative translation differences.&#160;&#160;We do not expect there to be a significant impact on our financial statements as a result of using these exemptions.&#160;&#160;As well, based on the transactions we have incurred to date and our specific facts, we believe it will not be necessary to utilize the other exemptions made available by IFRS 1.&#160;&#160;As we move towards actual implementation and reporting under IFRS, we will continue to monitor our transactions and make use of any exemptions that are determined to benefit Oncolytics.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other GAAP to IFRS Differences</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Treatment of Warrants with an Exercise Price Denominated in a Foreign Currency</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There is a difference between GAAP and IFRS on the treatment of warrants with an exercise price denominated in a currency other than the entity&#8217;s functional currency.&#160;&#160;IFRS requires accounting for these warrants as a liability measured at fair value with changes in fair value recorded in the consolidated statement of loss.&#160;&#160;GAAP requires these warrants to be accounted for as an equity instrument.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Foreign Currency Translation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under IFRS, the assets and liabilities of our US subsidiary will be translated to Canadian dollars at the year-end exchange rate and the statements of income and cash flows are translated at period average rates.&#160;&#160;The translation differences that arise are taken directly to a currency translation account within equity.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Classification of expenses within the statement of loss and comprehensive loss</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under IFRS, we expect to choose to present our expenses based on the function of each expense rather than the nature of each expense.&#160;&#160;As a result, stock based compensation and amortization of capital assets will be re-classified between research and development and operating expenses.&#160;&#160;There will be no impact on our net loss or comprehensive loss.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial Statement Impact</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In preparing our opening balance sheet, we have adjusted amounts reported previously in our consolidated financial statements prepared in accordance with GAAP.&#160;&#160;The estimated impact on our balance sheet as at January 1, 2010 would be to reduce warrants in shareholders&#8217; equity by approximately $1 million and reflect a long term liability.&#160;&#160;In 2010, we anticipate a further charge to our Consolidated Statement of Loss of approximately $4.8 million related to the revaluation of warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Significant Estimates</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Stock Based Compensation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As required by the fair value based method for measuring stock based compensation under Canadian GAAP, we have chosen to use the Black Scholes Option Pricing Model (&#8220;Black Scholes&#8221; or the &#8220;Model&#8221;) to calculate the fair value of our options.&#160;&#160;Though there are other models available to calculate the option values (for example, the binomial model), Black Scholes is currently widely used and accepted by other publicly traded companies.&#160;&#160;Therefore, we have concluded that Black Scholes is the appropriate option pricing model to use for our stock options at this time.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Black Scholes uses inputs in its calculation of fair value that require us to make certain estimates and assumptions.&#160;&#160;For 2010, we used the following weighted average assumptions:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="42%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk-free interest rate</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.85%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expected hold period to exercise</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3 years</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="42%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Volatility in the price of the our shares</font></div>
</td>
<td valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="42%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividend yield</font></div>
</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Zero</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A change in these estimates and assumptions will impact the value calculated by the model.&#160;&#160;For instance, the volatility in the price of our shares is based on the quoted trading price.&#160;&#160;We assume that weekly trading prices best reflect our trading price volatility.&#160;&#160;However, an entity can choose between daily, weekly, or monthly trading prices in the volatility calculation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Model also uses an expected hold period to exercise in its calculation of fair value.&#160;&#160;When we are estimating the expected hold period to exercise we take into consideration past history, the current trading price and volatility of our common shares and have concluded that 3.0 years is an appropriate estimate.&#160;&#160;However, our options have a 10-year life and given the fluctuations in our stock price the expected hold period could be different.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consequently, in complying with GAAP and selecting what we believe are the most appropriate assumptions under the circumstances, we have recorded non-cash employee stock based compensation expense for the year of $3,251,041.&#160;&#160;However, given the above discussion, this expense could have been different and still be in accordance with GAAP.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Warrant Values</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since inception, we have raised cash through the issue of units and the exercise of warrants and options.&#160;&#160;Each issued unit has consisted of one common share and a portion of one common share purchase warrant with each whole warrant exercisable at a specified price for one additional common share for up to 60 months from the issue date.&#160;&#160;GAAP requires that when recording the issued units, a value should be ascribed to each component of the units based on the component&#8217;s fair value.&#160;&#160;The fair value of our common shares is established based on trading on stock exchanges in Canada and the U.S.&#160;&#160;However, as the warrants do not trade on an exchange, the Black Scholes Option Pricing Model has been used to determine the fair value of the warrants.&#160;&#160;In the event that the total calculated value of each individual component is greater than the price paid for the unit, the value of each component is reduced on a relative basis until the total is equal to the unit&#8217;s issue price.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For reasons discussed above under &#8220;Stock Based Compensation&#8221;, the model can produce a range of calculated values for our warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="SelectedAnnualInfo">SELECTED ANNUAL INFORMATION</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenue</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,973,772</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,231,249</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,550,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic and diluted loss per share<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2), (3)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (3)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432,442</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593,391</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,987,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash dividends declared per share<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(4)</font></font></div>
</td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notes:</font></div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent to the acquisition of Oncolytics Biotech Inc. by SYNSORB in April 1999, we applied push down accounting.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Included in net loss and loss per common share for 2010, 2009 and 2008 are stock based compensation expenses of $3,251,041, $424,273 and $64,039, respectively.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We issued 6,408,333 commons shares for net cash proceeds of $27,288,132 in 2010 (2009 &#8211; 17,524,211 common shares for net cash proceeds of $37,052,900; 2008 &#8211; 2,650,000 common shares for net cash proceeds of $3,421,309)</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not declared or paid any dividends since incorporation.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="ResultsofOperations">RESULTS OF OPERATIONS</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net loss for the year ended December 31, 2010 was $19,973,772 compared to $16,231,249 and $17,550,204 for 2009 and 2008, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Research and Development Expenses (&#8220;R&amp;D&#8221;)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,159,064</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,766,234</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,797,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacturing and related process development expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,528,115</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,720,251</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,062,951</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intellectual property expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,020,897</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">968,849</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,244,388</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research collaboration expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">303,929</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">509,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">687,679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Scientific Research and Development Refund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(531,506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(75,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other R&amp;D expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,711,310</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,641,580</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,635,605</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,191,809</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,606,514</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,351,875</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clinical Trial Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clinical trial expenses include those costs associated with our global clinical trial program that includes the U.S., U.K., Canada and Belgium as well as those incurred in the preparation of commencing other clinical trials.&#160;&#160;Included in clinical trial expenses are direct patient enrollment costs, contract research organization (&#8220;CRO&#8221;) expenses, clinical trial site selection and initiation costs, data management expenses and other costs associated with our clinical trial program.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Direct clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,630,202</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,691,553</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,797,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase III start up expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,528,862</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">74,681</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,159,064</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,766,234</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,797,085</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our clinical trial expenses in 2010 were $4,159,064 compared to $3,766,234 and $5,797,085 in 2009 and 2008, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we continued the start up stage of our Phase III head and neck pivotal trial incurring costs associated with regulatory filings and submissions in various jurisdictions along with site identification and initiation costs.&#160;&#160;We also commenced enrollment in our pivotal trial in 2010 and incurred direct clinical trial expenses relating to the five clinical trials that we are currently sponsoring.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2009, we commenced the year with twelve clinical trials (two sponsored by the NCI) and incurred costs associated with the completion of enrollment of six clinical trials throughout 2009.&#160;&#160;&#160;As well, we incurred grant costs in 2009 associated with our clinical trial research collaboration with the CTRC that were not incurred during 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We exited 2009 with a clinical trial program that included eight clinical trials, either underway or approved to commence, of which four were sponsored by Oncolytics and the remainder were being sponsored by the NCI (sponsoring one clinical trial), CTRC (sponsoring two clinical trials) and Leeds (sponsoring one clinical trial).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2008, our clinical trial program expanded from eight active clinical trials at the beginning of the year to 12 clinical trials by the end of 2008 of which two were sponsored by the NCI.&#160;&#160;Of the ten clinical trials being conducted by us, nine trials were actively enrolling patients throughout 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect our clinical trial expenses to increase in 2011 compared to 2010.&#160;&#160;We expect to complete enrollment in stage 1 of our Phase III pivotal trial and enter into stage 2.&#160;&#160;We also expect to complete enrollment in our Phase II NSCLC study, our U.S. Phase II head and neck cancer study, our U.K. Phase I combination with cyclophosphamide clinical study and our Phase I colorectal study.&#160;&#160;Finally, we will continue to support our clinical research collaboration with CTRC, our Clinical Agreement with the NCI and our clinical trial with Leeds.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Manufacturing &amp; Related Process Development Expenses (&#8220;M&amp;P&#8221;)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">M&amp;P expenses include product manufacturing expenses and process development.&#160;&#160;Product manufacturing expenses include third party direct manufacturing costs, quality control testing, fill, label and packaging costs.&#160;&#160;Process development expenses include costs associated with studies that examine components of our manufacturing process looking for improvements and costs associated with the creation and testing of our master and working viral and cell banks.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product manufacturing expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,694,324</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,367,631</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,774,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Process development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">833,791</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">352,620</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">288,204</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacturing and related process development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,528,115</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,720,251</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,062,951</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our M&amp;P expenses for 2010 were $4,528,115 compared to $3,720,251 and $3,062,951 for 2009 and 2008, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we incurred costs associated with two 100-litre cGMP production runs that commenced in 2010.&#160;&#160;As well, we incurred fill and packaging costs for these runs along with a 100-litre cGMP production run that was completed at the end of 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2009, we completed the production and fill of our first cGMP 100-litre production run and completed the bulk production of a second cGMP 100-litre production run towards the end of 2009.&#160;&#160;We also incurred costs associated with the fill, labeling, and packaging of the product from our 40-litre runs from 2008 for shipment to our clinical sites.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2008, we were producing REOLYSIN at the 40-litre scale and incurred costs associated with the completion of two 40-litre cGMP production runs.&#160;&#160;As well, we incurred costs associated with the fill, packaging, and shipping of these production runs.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our process development expenses in 2010 focused on optimization and validation studies anticipated to be required in support of product registration.&#160;&#160;During 2009, we focused on developing a lyophilization formulation plan which was completed in the second quarter of 2009 and we commenced validation studies.&#160;&#160;In 2008, we examined scale up to the 100-litre level, lyophilization and process validation studies.&#160;&#160;We completed our 100-litre scale up studies towards the end of 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect our M&amp;P expenses for 2011 to increase compared to 2010.&#160;&#160;We expect to complete several 100-litre cGMP production runs including fill and finish activities in 2011.&#160;&#160;We also expect to continue to perform a number of small scale process development studies focusing on formulation, process validation, and stability.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual Property Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual property expenses include legal and filing fees associated with our patent portfolio.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intellectual property expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,020,897</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">968,849</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,244,388</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our intellectual property expenses for 2010 were $1,020,897 compared to $968,849 and $1,244,388 for 2009 and 2008, respectively.&#160;&#160;The change in intellectual property expenditures reflects the timing of filing costs associated with our portfolio of patents and a change in the geographic focus of our worldwide patent filing strategy.&#160;&#160;At the end of 2010, we had been issued over 250 patents including 40 U.S. and 11 Canadian patents, as well as issuances in other jurisdictions.&#160;&#160;We also have over 200 patent applications filed in the U.S., Canada and other jurisdictions.&#160;&#160;We expect that our intellectual property expenses will remain consistent in 2011 compared to 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research Collaboration Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-clinical trial expenses include toxicology studies and are incurred by us in support of expanding our clinical trial program into other indications, drug combinations and jurisdictions.&#160;&#160;Research collaborations are intended to expand our intellectual property related to reovirus and identify potential licensing opportunities arising from our technology base.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research collaboration expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">303,929</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">509,600</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">687,679</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, research collaborations expenses were $303,929 compared to $509,600 and $687,679 in 2009 and 2008, respectively.&#160;&#160;Our research collaboration activity in 2010 continued to focus on the interaction of the immune system and the reovirus and the use of the reovirus as a co-therapy with existing chemotherapeutics and radiation.&#160;&#160;For 2010, we selectively entered into additional research collaborations.&#160;&#160;In 2009, we completed the collaborative agreements we had entered into in 2008 and we continued to be selective in the types of new collaborations we entered into throughout the year.&#160;&#160;Over the last three years we have seen a decline in these expenses as we have entered into fewer collaborative agreements each year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect that pre-clinical trial expenses and research collaborations in 2011 will remain consistent with 2010.&#160;&#160;We expect to complete our ongoing collaborative program carried over from 2010 and will continue to be selective in the types of new collaborations we enter into in 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scientific Research and Development Refund</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Scientific research and development refund</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(531,506</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(75,833</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we received scientific research and development refunds totaling $287,506 from the Alberta and Quebec governments.&#160;&#160;As well, we received a cash grant of approximately U.S.$244,000 under the U.S. Government&#8217;s Qualifying Therapeutic Discovery Project program (&#8220;QTDP&#8221;) for our oncology program.&#160;&#160;The QTDP was created by Congress in March 2010 as part of the Patient Protection and Affordable Care Act and provides a tax credit or grant equal to 50% of eligible costs and expenses for tax years 2009 and 2010. The Department of Treasury allocated these credits and grants among qualified applicants as the program was oversubscribed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other Research and Development Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other research and development expenses include compensation expenses for employees (excluding stock based compensation), consultant fees, travel and other miscellaneous R&amp;D expenses.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R&amp;D consulting fees</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">63,071</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">279,321</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">197,773</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R&amp;D salaries and benefits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,394,869</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,097,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,926,148</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other R&amp;D expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">253,370</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">264,758</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">511,684</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other research and development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,711,310</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,641,580</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,635,605</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010, our other research and development expenses were $2,711,310 compared to $2,641,580 and $2,635,605 for 2009 and 2008, respectively.&#160;&#160;In 2009, we incurred additional R&amp;D consulting costs relating to our Special Protocol Assessment and U.S. randomized Phase III filings that did not occur in 2010 or 2008.&#160;&#160;R&amp;D salaries and benefits in 2010 increased compared to 2009 and 2008 as our staff levels increased in order to support our clinical trial program.&#160;&#160;Our Other R&amp;D expenses continued to decrease in 2010 compared to 2009 and 2008 as there was less travel activity in 2010 associated with supporting our clinical trials as the number of trials we sponsor continues to decrease&#160;&#160;in the U.S. and the U.K. and there were fewer conferences, symposiums and meetings attended in 2010 and 2009 compared to 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2011, we expect that our Other R&amp;D expenses will remain consistent with 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Operating Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Public company related expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,806,048</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,326,431</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,099,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,384,355</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,456,076</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,211,992</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,190,403</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,782,507</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,311,575</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Public company related expenses include costs associated with investor relations and business development activities, legal and accounting fees, corporate insurance, and transfer agent and other fees relating to our U.S. and Canadian stock listings.&#160;&#160;In 2010, we incurred professional fees associated with the renewal of our base shelf prospectus and incurred additional costs associated with our AGM that were not incurred in 2009.&#160;&#160;As well, our investor relations, public relations, and business development activities increased in 2010 compared to 2009.&#160;&#160;In 2009, our investor relations, consulting, transfer agent and listing fees, and related travel costs decreased relative to 2008, as in 2008, we incurred professional fees associated with the expansion of our corporate structure that were not incurred in 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Office expenses include compensation costs (excluding stock based compensation), office rent, and other office related costs.&#160;&#160;In 2010, we incurred office expenses of $1,384,355 compared to $1,359,346 and $1,211,992 in 2009 and 2008, respectively.&#160;&#160;In 2010, our office expense activity remained consistent compared to 2009.&#160;&#160;In 2009, we began to incur additional expenses associated with supporting our expanded corporate structure that were not incurred in 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect our operating expenses to increase in 2011 compared to 2010 as we will increase our operating activities in support of our research and development programs.&#160;</font><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Stock Based Compensation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,251,041</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">424,273</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64,039</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-cash stock based compensation recorded for 2010 was $3,251,041 compared to $424,273 and $64,309 for 2009 and 2008, respectively.&#160;&#160;Stock based compensation in 2010 related to 1,183,000 options that were granted along with compensation expense relating to options that vested over the year.&#160;&#160;(2009 &#8211; 332,500 options; 2008 &#8211; 15,500 options).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commitments</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, we are committed to payments totaling $1,140,000 during 2010 for activities related to clinical trial activity and collaborations.&#160;&#160;All of these committed payments are considered to be part of our normal course of business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="SummaryofQuarterlyRes">SUMMARY OF QUARTERLY RESULTS</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following unaudited quarterly information is presented in thousands of dollars except for per share amounts:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-TOP: black 0.5pt solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec.</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sept.</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dec.</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sept.</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenue</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (3)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,472</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,009</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,352</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,141</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,245</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,694</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,335</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,958</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic and diluted loss per common share<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.11</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.07</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.07</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.07</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.09</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.05</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.09</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.09</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1), (4)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44,432</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,137</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26,569</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,159</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,593</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,240</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,755</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,802</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total cash<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2), (4)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42,906</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,708</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,885</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,823</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34,129</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,655</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,983</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,292</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total long-term debt</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash dividends declared<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(5)</font></font></div>
</td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent to the acquisition of Oncolytics Biotech Inc. by SYNSORB in April 1999, we applied push down accounting.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Included in total cash are cash and cash equivalents plus short-term investments.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Included in net loss and loss per common share between December 2010 and January 2009 are quarterly stock based compensation expenses of $2,850,938, $397,675, $1,399, $1,029, $396,110, $7,982, $8,544, and $11,637, respectively.</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We issued 6,408,333 commons shares for net cash proceeds of $27,288,132 in 2010 (2009 &#8211; 17,524,211 common shares for net cash proceeds of $37,052,900).</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not declared or paid any dividends since incorporation.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="FourthQuarter">FOURTH QUARTER</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Statement of loss for the three month period ended December 31, 2010 and 2009:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expenses</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,290,721</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,600,282</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,215,728</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,078,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,850,938</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">396,110</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign exchange (gain) loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">132,677</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">137,371</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization &#8211; property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,669</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,318</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,507,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,228,079</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest income</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(40,052</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,225</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income taxes</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,884</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,471,565</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,244,854</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fourth Quarter Review of Operations</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the three month period ended December 31, 2010, our net loss was $7,471,565 compared to $5,244,854 for the three month period ended December 31, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Research and Development Expenses (&#8220;R&amp;D&#8221;)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,164,960</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">805,188</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacturing and related process development expenses (&#8220;M&amp;P&#8221;)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">902,425</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,599,609</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intellectual property expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">343,764</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">201,854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research collaboration expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">146,315</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185,906</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Scientific Research and Development Refund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(244,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other R&amp;D expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">977,257</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">807,725</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,290,721</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,600,282</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clinical Trial Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Direct clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">788,679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">730,507</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase III start up expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">376,281</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">74,681</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Clinical trial expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,164,960</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">805,188</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the fourth quarter of 2010, our direct clinical trial expenses increased to $788,679 compared to $730,507 for the fourth quarter of 2009.&#160;&#160;In the fourth quarters of 2010 and 2009, we incurred direct patient expenses related to the four clinical trials that we are sponsoring.&#160;&#160;As well, we continued to incur start up costs in the fourth quarter of 2010 related to our randomized Phase III head and neck pivotal trial that commenced in the fourth quarter of 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Manufacturing &amp; Related Process Development Expenses (&#8220;M&amp;P&#8221;)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product manufacturing expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">681,012</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,553,558</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Process development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">221,413</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46,051</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacturing and related process development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">902,425</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,599,609</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the fourth quarter of 2010, our M&amp;P expenses were $902,425 compared to $1,599,609 for the fourth quarter of 2009. In the fourth quarter of 2010, we completed the fill, testing and packaging of our second cGMP 100-litre production run from earlier in 2010.&#160;&#160;As well, we incurred packaging and shipment activities required to supply our Phase III clinical sites with REOLYSIN that did not occur during the fourth quarter of 2009.&#160;&#160;During the fourth quarter of 2009, we completed our second cGMP 100-litre production run for the year and commenced the related fill process.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our process development activity in the fourth quarters of 2010 and 2009 focused on optimization and validation studies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual Property Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intellectual property expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">343,764</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">201,854</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our intellectual property expenses for the fourth quarter of 2010 were $343,764 compared to $201,854 for the fourth quarter of 2009.&#160;&#160;The change in intellectual property expenditures reflects the timing of filing costs associated with our expanded patent base.&#160;&#160;At the end of the third quarter of 2010, we had been issued over 250 patents including 40 U.S. and 11 Canadian patents, as well as issuances in other jurisdictions.&#160;&#160;We also have over 200 patent applications filed in the U.S., Canada and other jurisdictions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research Collaboration Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research collaboration expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">146,315</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185,906</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our research collaboration expenses were $146,315 in the fourth quarter of 2010 compared to $185,906 for the fourth quarter of 2009.&#160;&#160;During the fourth quarters of 2010 and 2009, our research collaboration activities continued to focus on the interaction of the immune system and the reovirus and the use of the reovirus as a co-therapy with existing chemotherapeutics and radiation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scientific Research and Development Refund</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Scientific research and development refund</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">244,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the fourth quarter of 2010, we received a cash grant of approximately U.S.$244,000 under the U.S. Government&#8217;s Qualifying Therapeutic Discovery Project program (&#8220;QTDP&#8221;) for our oncology program.&#160;&#160;The QTDP was created by Congress in March 2010 as part of the Patient Protection and Affordable Care Act and provides a tax credit or grant equal to 50% of eligible costs and expenses for tax years 2009 and 2010. The Department of Treasury allocated these credits and grants among qualified applicants as the program was oversubscribed.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other Research and Development Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R&amp;D consulting fees</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,437</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R&amp;D salaries and benefits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">913,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">711,774</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other R&amp;D expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,632</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77,514</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other research and development expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">977,257</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">807,725</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our other research and development expenses were $977,257 in the fourth quarter of 2010 compared to $807,725 in the fourth quarter of 2009.&#160;&#160;In the fourth quarter of 2010, our R&amp;D salaries and benefits increased compared to the fourth quarter of 2009 as our staff levels increased in order to support our clinical trial program.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Operating Expenses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Public company related expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">778,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">668,046</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">437,228</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">410,952</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,215,728</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,078,998</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our operating expenses in the fourth quarter of 2010 were $1,215,728 compared to $1,078,998 for the fourth quarter of 2009.&#160;&#160;In the fourth quarter of 2010, our public company related expenses increased as a result of additional investor and public relation activities compared to the fourth quarter of 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Stock Based Compensation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock based compensation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,850,938</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">396,110</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our non-cash stock based compensation expense recorded in the fourth quarter of 2010 was $2,850,938 compared to $396,110 for the fourth quarter of 2009.&#160;&#160;In the fourth quarter of 2010, 868,000 options were granted compared to 332,500 options in the fourth quarter of 2009.&#160;&#160;These options vested immediately.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="LiquidityandCapRes">LIQUIDITY AND CAPITAL RESOURCES</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2010 Financing Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we received cash inflow from financing activities of $27.3 million as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="BDFinancing">Bought Deal Financing</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In November 2010, we closed a bought deal financing whereby we issued 6,256,000 units at an issue price of $4.60 per unit for net cash proceeds of $26.8 million.&#160;&#160;Each Unit consists of one common share and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant entitles the holder to acquire one common share at a price of $6.15 at any time until November 8, 2012.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="Warrants2ndtime">Warrants</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In December 2010, and in conjunction with the terms of our warrant indenture with respect to our financing concluded in November 2009, we accelerated the expiry date of our U.S.$3.50 warrants to January 24, 2010.&#160;&#160;As of the end of 2010, we had received U.S.$0.4 million with respect to the exercise of 119,900 warrants.&#160;&#160;Subsequent to December 31, 2010, we received U.S.$6.4 million from the exercise of 1,823,100 of these warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Options</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we received cash proceeds of $0.1 million with respect to the exercise of 32,433 stock options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2009 Financing Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2009, we received cash inflow from financing activities of $37 million as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Acquisition of Inactive Private Company</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In April 2009, we completed the acquisition of an inactive private company.&#160;&#160;The cash available from the private company, at the time of closing, was $2.13 million and we issued 1,875,121 common shares in our capital based on a previously determined exchange ratio of $1.69.&#160;&#160;Net proceeds from this acquisition were $1.8 million.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Public Offerings</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In May 2009, we closed a public offering whereby we issued 3,450,000 units at $2.00 per unit for gross proceeds of $6.9 million.&#160;&#160;Each unit consisted of one common share and one common share purchase warrant. Each common share purchase warrant entitled the holder to purchase one common share at an exercise price of $2.40 per share for a three year period, subject to an acceleration of the expiry date in certain circumstances.&#160;&#160;Net cash proceeds from this public offering were $5.9 million.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In November 2009, we closed a public offering whereby we issued 4,887,500 units at US$3.00 per unit for gross proceeds of US$14,662,500.&#160;&#160;Each unit consisted of one common share and 0.40 of one common share purchase warrant.&#160;&#160;Each whole common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$3.50 per share for a five year period subject to an acceleration of the expiry date in certain circumstances.&#160;&#160;Net cash proceeds from this public offering were $13.9 million.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Exercise of Warrants</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">$1.80 Warrants</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On October 23, 2009, we announced that pursuant to the provision of written notification on September 23, 2009, of the accelerated expiry of our $1.80 warrants issued on December 5, 2008, and those warrants amended on December 18, 2008, we received total proceeds of $5,823,000 from the exercise of these warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">$2.40 Warrants</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On November 3, 2009, we announced that pursuant to the provision of written notification on October 2, 2009, of the accelerated expiry of our $2.40 warrants issued on May 13, 2009, we had received total proceeds of $9,108,000.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investment Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2009, we acquired all of the convertible preferred shares of British Canadian Biosciences Corp. (&#8220;BCBC&#8221;), a privately held biotechnology company specializing in the development of peptides for the treatment of a variety of conditions, including cancer.&#160;&#160;In February 2010, we completed the conversion of our preferred share holding in BCBC into common shares.&#160;&#160;As a result of this conversion we owned 10% of the issued common shares of BCBC.&#160;&#160;The common shares of BCBC do not have a quoted market price in an active market.&#160;&#160;BCBC&#8217;s only asset is intellectual property.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the fourth quarter of 2010, BCBC concluded that it was unable to obtain additional financing to support its business and subsequently suspended operations.&#160;&#160;In November 2010, in order to maintain our investment in BCBC, we purchased an additional 60% of the common shares of BCBC for $51,681 which included cash and the settlement of certain trade accounts payable.&#160;&#160;As the operations of BCBC had been suspended, its only remaining asset was intellectual property.&#160;&#160;In conjunction with this purchase, we assessed the cost of our investment against the estimated fair value of BCBC using a cash flow analysis and determined that the estimated fair value of our investment was in excess of our cost.&#160;&#160;At the end of 2010, we began the process to sell BCBC and as a result we are reflecting our investment in BCBC&#8217;s intellectual property as an asset held for sale.&#160;&#160;We have also reclassified the prior year&#8217;s balance to reflect our current accounting treatment.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010 and 2009, we had cash and cash equivalents, short-term investments and working capital positions as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39,296,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32,448,939</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short-term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,609,246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,679,937</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Working capital position</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,969,168</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,474,138</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The increase in our cash and cash equivalent and short term investment positions reflects the cash usage from our operating activities of $18,033,732 along with the cash provided by financing activities of $27,288,132 for the year ending December 31, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We desire to maintain adequate cash and short-term investment reserves to support our planned activities which include our clinical trial program, product manufacturing, administrative costs, and our intellectual property expansion and protection.&#160;&#160;To date, we have funded our operations through the issue of additional capital via public and private offerings and acquisition of a private company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of our financing activities in 2010, we raised over $27 million to be used to support our clinical trial, manufacturing, intellectual property and collaboration programs.&#160;&#160;We anticipate that the expected cash usage from our operations in 2011 will be $29 million.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Despite the anticipated increase in our cash requirements compared to 2010, we continue to manage our research and development plan with the objective of ensuring optimal use of our existing resources.&#160;&#160;Additional activities continue to be subject to adequate resources and we believe we will have sufficient cash resources to fund our presently planned operations into 2012.&#160;&#160;Factors that will affect our anticipated cash usage in 2011 and into 2012, and for which additional funding might be required include, but are not limited to, any expansion in our clinical trial program, the timing of patient enrollment in our approved clinical trials, the actual costs incurred to support each clinical trial, the number of treatments each patient will receive, the timing of R&amp;D activity with our clinical trial research collaborations, the number, timing and costs of manufacturing runs required to conclude the validation process, supply our clinical trial program and the level of collaborative activity undertaken.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During 2010, we were able to raise funds through a bought deal public offering and through the exercise of existing warrants and options.&#160;&#160;As well, we were able to raise funds in December 2009 through a public offering of units.&#160;&#160;We have no assurances that we will be able to raise funds through the sale of our common shares, consequently, we will continue to evaluate all types of financing arrangements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also want to be in a position to evaluate potential financings and be able to accept appropriate financings when available.&#160;&#160;As a result, we renewed our base shelf prospectus on June 10, 2010 which qualified for distribution up to $150,000,000 of common shares, subscription receipts, warrants, and/or units.&#160;&#160;Establishing our base shelf provides us with additional flexibility when seeking capital as, under certain circumstances, it shortens the time period to close a financing and is expected to increase the number of potential investors that may be prepared to invest in our company.&#160;&#160;We were able to take advantage of our renewed base shelf in 2010 with the bought deal financing along with the exercise of previously issued warrants raising approximately $27 million.&#160;&#160;Our renewed base shelf expires in July 2012.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contractual Obligations</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have the following contractual obligations as at December 31, 2010</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-TOP: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contractual Obligations</font></div>
</td>
<td align="left" valign="bottom" style="BORDER-TOP: black 0.5pt solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="18" valign="bottom" style="BORDER-TOP: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments Due by Period</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-TOP: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less than 1 year</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2 -3 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4 &#8211; 5 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After 5 years</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alberta Heritage Foundation<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital lease obligations</font></div>
</td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating lease <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">478,709</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65,674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">275,012</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchase obligations</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,140,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,140,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other long term obligations</font></div>
</td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nil</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total contractual obligations</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,768,709</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,205,674</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">275,012</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138,023</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Note:</font></div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Alberta Heritage Foundation obligation requires repayments upon the realization of sales (see notes of our audited 2010 consolidated financial statements).</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our operating lease is comprised of our office lease and exclude our portion of operating costs.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect to fund our capital expenditure requirements and commitments with existing working capital.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investing Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under our Investment Policy, we are permitted to invest in short-term instruments with a rating no less than R-1 (DBRS) with terms less than two years.&#160;&#160;Our portfolio consists of guarantee investment certificates.&#160;&#160;As of December 31, 2010, we had $3.6 million invested under this policy, currently earning interest at an effective rate of 0.30%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="OBSheetArrangements">OFF-BALANCE SHEET ARRANGEMENTS</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As at December 31, 2010, we had not entered into any off-balance sheet arrangements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="TransactionswithRelated">TRANSACTIONS WITH RELATED PARTIES</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2010 and 2009, we did not enter into any related party transactions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="FinInstrumentsandOther">FINANCIAL INSTRUMENTS AND OTHER INSTRUMENTS</a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our financial instruments consist of cash and cash equivalents, short-term investments, investment, accounts receivable, and accounts payable.&#160;&#160;As at December 31, 2010, there are no significant differences between the carrying values of these amounts and their estimated market values.&#160;&#160;These financial instruments expose us to the following risks:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Credit risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Credit risk is the risk of financial loss if a counter-party to a financial instrument fails to meet its contractual obligations.&#160;&#160;We are exposed to credit risk on our cash and cash equivalents and short-term investments in the event of non-performance by counterparties, but we do not anticipate such non-performance.&#160;&#160;Our maximum exposure to credit risk at the end of the period is the carrying value of our cash and cash equivalents and short-term investments.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We mitigate our exposure to credit risk by maintaining our primary operating and investment bank accounts with Schedule I banks in Canada.&#160;&#160;For our foreign domiciled bank accounts, we use referrals or recommendations from our Canadian banks to open foreign bank accounts and these accounts are used solely for the purpose of settling accounts payable or payroll.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also mitigate our exposure to credit risk by restricting our portfolio to investment grade securities with short-term maturities and by monitoring the credit risk and credit standing of counterparties.&#160;&#160;Currently, 100% of our short-term investments are in guaranteed investment certificates.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Interest rate risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interest rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in market interest rates.&#160;&#160;We are exposed to interest rate risk through our cash and cash equivalents and our portfolio of short-term investments.&#160;&#160;We mitigate this risk through our investment policy that only allows investment of excess cash resources in investment grade vehicles while matching maturities with our operational requirements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fluctuations in market rates of interest do not have a significant impact on our results of operations due to the short term to maturity of the investments held.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Currency risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currency risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.&#160;&#160;We are exposed to currency risk from the purchase of goods and services primarily in the U.S. and the U.K. and to the extent cash is held in foreign currencies.&#160;&#160;The impact of a $0.01 increase in the value of the U.S. dollar against the Canadian dollar would have increased our net loss in 2010 by approximately $126,442.&#160;&#160;The impact of a $0.10 increase in the value of the British pound against the Canadian dollar would have increased our net loss in 2010 by approximately $128,859.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We mitigate our foreign exchange risk through the purchase of foreign currencies in sufficient amounts to settle our foreign accounts payable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Balances in foreign currencies at December 31, 2010 are as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. dollars</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">British pounds</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#163;</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,933,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54,748</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(561,907</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(64,441</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,371,827</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9,693</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Liquidity risk</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity risk is the risk that we will encounter difficulty in meeting obligations associated with financial liabilities.&#160;&#160;We manage liquidity risk through the management of our capital structure as outlined in the notes to our audited financial statements.&#160;&#160;Accounts payable are all due within the current operating period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="RiskFactorsAffectingFuture">RISK FACTORS AFFECTING FUTURE PERFORMANCE</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">General Risk Factors</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prospects for biotechnology companies in the research and development stage should generally be regarded as speculative.&#160;&#160;It is not possible to predict, based upon studies in animals, or early studies in humans, whether a new therapeutic will ultimately prove to be safe and effective in humans, or whether necessary and sufficient data can be developed through the clinical trial process to support a successful product application and approval.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If a product is approved for sale, product manufacturing at a commercial scale and significant sales to end users at a commercially reasonable price may not be successful.&#160;&#160;There can be no assurance that we will generate adequate funds to continue development, or will ever achieve significant revenues or profitable operations.&#160;&#160;Many factors (e.g. competition, patent protection, appropriate regulatory approvals) can influence the revenue and product profitability potential.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In developing a pharmaceutical product, we rely upon our employees, contractors, consultants and collaborators and other third party relationships, including the ability to obtain appropriate product liability insurance.&#160;&#160;There can be no assurance that this reliance and these relationships will continue as required.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to developmental and operational considerations, market prices for securities of biotechnology companies generally are volatile, and may or may not move in a manner consistent with the progress we have made or are making.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Our product REOLYSIN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> is in the research and development stage and will require further development and testing before they can be marketed commercially.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prospects for companies in the biotechnology industry generally may be regarded as uncertain given the nature of the industry and, accordingly, investments in biotechnology companies should be regarded as speculative. We are currently in the research and development stage on one product, REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, for human application, the riskiest stage for a company in the biotechnology industry.&#160;&#160;It is not possible to predict, based upon studies in animals, or early studies in humans, whether REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> will prove to be safe and effective in humans.&#160;&#160;REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> will require additional research and development, including extensive clinical testing, before we will be able to obtain the approval of the United States Food and Drug Administration (the &#8220;FDA&#8221;) or from similar regulatory authorities in other countries to market REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> commercially.&#160;&#160;There can be no assurance that the research and development programs conducted by us will result in REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> or any other products becoming commercially viable products, and in the event that any product or products result from the research and development program, it is unlikely they will be commercially available for a number of years.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To achieve profitable operations, we, alone or with others, must successfully develop, introduce and market our products.&#160;&#160;To obtain regulatory approvals for products being developed for human use, and to achieve commercial success, human clinical trials must demonstrate that the product is safe for human use and that the product shows efficacy.&#160;&#160;Unsatisfactory results obtained from a particular study relating to a program may cause us to abandon our commitment to that program or the product being tested.&#160;&#160;No assurances can be provided that any current or future animal or human test, if undertaken, will yield favorable results.&#160;&#160;If we are unable to establish that REOLYSIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> is a safe, effective treatment for cancer, we may be required to abandon further development of the product and develop a new business strategy.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">There are inherent risks in pharmaceutical research and development</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pharmaceutical research and development is highly speculative and involves a high and significant degree of risk.&#160;&#160;The marketability of any product developed by us will be affected by numerous factors beyond our control, including:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the discovery of unexpected toxicities or lack of sufficient efficacy of products which make them unattractive or unsuitable for human use;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">preliminary results as seen in animal and/or limited human testing may not be substantiated in larger controlled clinical trials;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">manufacturing costs or other factors may make manufacturing of products impractical and non-competitive;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">proprietary rights of third parties or competing products or technologies may preclude commercialization;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">requisite regulatory approvals for the commercial distribution of products may not be obtained; and</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">other factors may become apparent during the course of research, up-scaling or manufacturing which may result in the discontinuation of research and other critical projects.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our product under development has never been manufactured on a commercial scale, and there can be no assurance that such products can be manufactured at a cost or in a quantity to render such products commercially viable.&#160;&#160;Production and utilization of our products may require the development of new manufacturing technologies and expertise. The impact on our business in the event that new manufacturing technologies and expertise are required to be developed is uncertain. There can be no assurance that we will successfully meet any of these technological challenges, or others that may arise in the course of development.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pharmaceutical products are subject to intense regulatory approval processes.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The regulatory process for pharmaceuticals, which includes preclinical studies and clinical trials of each compound to establish its safety and efficacy, takes many years and requires the expenditure of substantial resources.&#160;&#160;Moreover, if regulatory approval of a drug is granted, such approval may entail limitations on the indicated uses for which it may be marketed.&#160;&#160;Failure to comply with applicable regulatory requirements can, among other things, result in suspension of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.&#160;&#160;Further, government policy may change, and additional government regulations may be established that could prevent or delay regulatory approvals for our products.&#160;&#160;In addition, a marketed drug and its manufacturer are subject to continual review.&#160;&#160;Later discovery of previously unknown problems with the product or manufacturer may result in restrictions on such product or manufacturer, including withdrawal of the product from the market.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The FDA in the United States and other relevant regulatory authorities may deny approval of a new drug application (&#8220;NDA&#8221;) or its equivalent in the relevant jurisdiction if required regulatory criteria are not satisfied, or may require additional testing.&#160;&#160;Product approvals may be withdrawn if compliance with regulatory standards is not maintained or if problems occur after the product reaches the market.&#160;&#160;The FDA may require further testing and surveillance programs to monitor the pharmaceutical product that has been commercialized.&#160;&#160;Non-compliance with applicable requirements can result in fines and other judicially imposed sanctions, including product withdrawals, product seizures, injunction actions and criminal prosecutions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to our own pharmaceuticals, we may supply active pharmaceutical ingredients and advanced pharmaceutical intermediates for use in or with&#160;&#160;our customers&#8217; other drug products. The final drug products in which the pharmaceutical ingredients and advanced pharmaceutical intermediates are used, however, are subject to regulation for safety and efficacy by the FDA and other jurisdictions, as the case may be. Such products must be approved by such agencies before they can be commercially marketed. The process of obtaining regulatory clearance for marketing is uncertain, costly and time consuming.&#160;&#160;We cannot predict how long the necessary regulatory approvals will take or whether our customers will ever obtain such approval for their products. To the extent that our customers do not obtain the necessary regulatory approvals for marketing new products, our product sales could be adversely affected.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The FDA and other governmental regulators have increased requirements for drug purity and have increased environmental burdens upon the pharmaceutical industry. Because pharmaceutical drug manufacturing is a highly regulated industry, requiring significant documentation and validation of manufacturing processes and quality control assurance prior to approval of the facility to manufacture a specific drug, there can be considerable transition time between the initiation of a contract to manufacture a product and the actual initiation of manufacture of that product. Any lag time in the initiation of a contract to manufacture product and the actual initiation of manufacture could cause us to lose profits or incur liabilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The pharmaceutical regulatory regime in Europe and other countries is, by and large, generally similar to that of Canada and the United States.&#160;&#160;We could face similar risks in these other jurisdictions, as the risks described above.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our operations and products may be subject to other government manufacturing and testing regulations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securing regulatory approval for the marketing of therapeutics by the FDA in the United States and similar regulatory agencies in other countries is a long and expensive process, which can delay or prevent product development and marketing.&#160;&#160;Approval to market products may be for limited applications or may not be received at all.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The products anticipated to be manufactured by us will have to comply with the FDA&#8217;s current Good Manufacturing Practices (&#8220;cGMP&#8221;) and other FDA and local government guidelines and regulations, including other international regulatory requirements and guidelines.&#160;&#160;Additionally, certain of our customers may require the manufacturing facilities contracted by us to adhere to additional manufacturing standards, even if not required by the FDA. Compliance with cGMP regulations requires manufacturers to expend time, money and effort in production, and to maintain precise records and quality control to ensure that the product meets applicable specifications and other requirements. The FDA and other regulatory bodies periodically inspect drug-manufacturing facilities to ensure compliance with applicable cGMP requirements. If the manufacturing facilities contracted by us fail to comply with the cGMP requirements, the facilities may become subject to possible FDA or other regulatory action and manufacturing at the facility could consequently be suspended.&#160;&#160;We may not be able to contract suitable alternative or back-up manufacturing facilities on terms acceptable to us or at all.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The FDA or other regulatory agencies may also require the submission of any lot of a particular product for inspection. If the lot product fails to meet the FDA requirements, then the FDA could take any of the following actions: (i) restrict the release of the product; (ii) suspend manufacturing of the specific lot of the product; (iii) order a recall of the lot of the product; or (iv) order a seizure of the lot of the product.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to regulation by governments in many jurisdictions and, if we do not comply with healthcare, drug, manufacturing and environmental regulations, among others, our existing and future operations may be curtailed, and we could be subject to liability.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to the regulatory approval process, we may be subject to regulations under local, provincial, state, federal and foreign law, including requirements regarding occupational health, safety, laboratory practices, environmental protection and hazardous substance control, and may be subject to other present and future local, provincial, state, federal and foreign regulations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products may fail or cause harm, subjecting us to product liability claims, which are uninsured.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The sale and use of our products entail risk of product liability.&#160;&#160;We currently do not have any product liability insurance.&#160;&#160;There can be no assurance that we will be able to obtain appropriate levels of product liability insurance prior to any sale of our pharmaceutical products.&#160;&#160;An inability to obtain insurance on economically feasible terms or to otherwise protect against potential product liability claims could inhibit or prevent the commercialization of products developed by us.&#160;&#160;The obligation to pay any product liability claim or a recall of a product could have a material adverse effect on our business, financial condition and future prospects.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our technologies may become obsolete.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The pharmaceutical industry is characterized by rapidly changing markets, technology, emerging industry standards and frequent introduction of new products.&#160;&#160;The introduction of new products embodying new technologies, including new manufacturing processes, and the emergence of new industry standards may render our products obsolete, less competitive or less marketable.&#160;&#160;The process of developing our products is extremely complex and requires significant continuing development efforts and third party commitments.&#160;&#160;Our failure to develop new technologies and products and the obsolescence of existing technologies could adversely affect our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may be unable to anticipate changes in our potential customer requirements that could make our existing technology obsolete.&#160;&#160;Our success will depend, in part, on our ability to continue to enhance our existing technologies, develop new technology that addresses the increasing sophistication and varied needs of the market, and respond to technological advances and emerging industry standards and practices on a timely and cost-effective basis. The development of our proprietary technology entails significant technical and business risks.&#160;&#160;We may not be successful in using our new technologies or exploiting the respective niche markets effectively or adapting our businesses to evolving customer or medical requirements or preferences or emerging industry standards.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have no operating revenues and a history of losses.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To date, we have not generated sufficient revenues to offset our research and development costs and accordingly have not generated positive cash flow or made an operating profit.&#160;&#160;As of December 31, 2010, we had an accumulated deficit of $138.8 million and we incurred net losses of $20.0 million, $16.2 million, and $17.6 million, for the years ended December 31, 2010, 2009, and 2008, respectively.&#160;&#160;We anticipate that we will continue to incur significant losses during 2011 and in the foreseeable future.&#160;&#160;We do not expect to reach profitability at least until after successful and profitable commercialization of one or more of our products.&#160;&#160;Even if one or more of our products are profitably commercialized, the initial losses incurred by us may never be recovered.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may need additional financing in the future to fund the research and development of our products and to meet our ongoing capital requirements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We anticipate that we may need additional financing in the future to fund research and development and to meet our ongoing capital requirements.&#160;&#160;The amount of future capital requirements will depend on many factors, including continued scientific progress in our drug discovery and development programs, progress in our pre-clinical and clinical evaluation of drug candidates, time and expense associated with filing, prosecuting and enforcing our patent claims and costs associated with obtaining regulatory approvals.&#160;&#160;In order to meet such capital requirements, we will consider contract fees, collaborative research and development arrangements, and additional public or private financings (including the incurrence of debt and the issuance of additional equity securities) to fund all or a part of particular programs as well as potential partnering or licensing opportunities.&#160;&#160;There can be no assurance that additional funding will be available or, if available, that it will be available on acceptable terms.&#160;&#160;If adequate funds are not available on terms favorable to us, we may have to reduce substantially or eliminate expenditures for research and development, testing, production and marketing of our proposed product, or obtain funds through arrangements with corporate partners that require us to relinquish rights to certain of our technologies or product.&#160;&#160;There can be no assurance that we will be able to raise additional capital if our current capital resources are exhausted.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The cost of director and officer liability insurance may continue to increase substantially or may not be available to us and may affect our ability to retain quality directors and officers.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We carry liability insurance on behalf of our directors and officers. Given a number of large director and officer liability insurance claims in the U.S. equity markets, director and officer liability insurance had until recently become increasingly more expensive with increased restrictions. Consequently, there is no assurance that we will continue to be offered this insurance or be able to obtain adequate coverage. The inability to acquire the appropriate insurance coverage will limit our ability to attract and maintain directors and officers as required to conduct our business. </font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We incur some of our expenses in foreign currencies and therefore are exposed to foreign currency exchange rate fluctuations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We incur some of our manufacturing, clinical, collaborative and consulting expenses in foreign currencies, primarily the U.S. dollar and the British pound (&#8220;GBP&#8221;).&#160;&#160;We are therefore exposed to foreign currency rate fluctuations.&#160;&#160;Also, as we expand to other foreign jurisdictions there may be an increase in our foreign exchange exposure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We earn interest income on our excess cash reserves and are exposed to changes in interest rates.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We invest our excess cash reserves in investment vehicles that provide a rate of return with little risk to principle.&#160;&#160;As interest rates change the amount of interest income we earn will be directly impacted.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="OtherMDARequirements">OTHER MD&amp;A REQUIREMENTS</a></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have 71,207,318 common shares outstanding at March 16, 2011.&#160;&#160;If all of our warrants (2,170,110) and options (4,608,094) were exercised we would have 77,985,522 common shares outstanding.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our 2010 Annual Information Form on Form 20-F will be available on www.sedar.com.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><a name="DisclosureControls">Disclosure Controls and Procedures</a></font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Evaluation of Disclosure Controls and Procedures</font>:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our chief executive and financial officers reviewed and evaluated our disclosure controls and procedures.&#160;&#160;Based on that evaluation, they have concluded that our disclosure controls and procedures are effective in providing them with timely material information relating to the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</font>:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, and has designed such internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of financial statements for external purposes in accordance with Canadian generally accepted accounting principles (GAAP), including a reconciliation to U.S. GAAP.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our internal controls and procedures over financial reporting will prevent all error and all fraud.&#160;&#160;A control system can provide only reasonable, not absolute, assurance that the objectives of the control system are met.&#160;&#160;Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Oncolytics Biotech Inc. have been detected.&#160;&#160;These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.&#160;&#160;Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control.&#160;&#160;The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions.&#160;&#160;Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.&#160;&#160;Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management has evaluated the design and operation of our internal control over financial reporting as of December 31, 2010, and has concluded that such internal control over financial reporting is effective as of December 31, 2010. There are no material weaknesses that have been identified by management in this regard.&#160;&#160;This assessment was based on criteria for effective internal control over financial reporting described in Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Changes in Internal Controls over Financial Reporting</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There were no changes in our internal control over financial reporting that occurred during the last fiscal year that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.2
<SEQUENCE>9
<FILENAME>ex15_2.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG LLP
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!-- Licensed to: Dorsey & Whitney -->
    <!-- Document Created using EDGARizer 5.3.1.0 -->
    <!-- Copyright 1995 - 2011 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">EXHIBIT 15.2</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consent to the use of our reports dated March 16, 2011 with respect to the consolidated financial statements of Oncolytics Biotech Inc. (&#8220;Oncolytics&#8221;), and the effectiveness of internal control over financial reporting of Oncolytics, included in the Annual Report to Shareholders (Form 20-F) of Oncolytics for the year ended December&#160;31, 2010, as filed with the United States Securities and Exchange Commission.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also consent to the incorporation by reference in the Registration Statement on Form F-10 (No. 333-167250) and on the Registration Statement on Form S-8 (No. 333-171625), the related prospectuses of Oncolytics, of our reports dated March 16, 2011 with respect to the consolidated financial statements of Oncolytics, and the effectiveness of internal control over financial reporting of Oncolytics, included in the Annual Report to Shareholders (Form 20-F) of Oncolytics for the year ended December&#160;31, 2010, as filed with the United States Securities and Exchange Commission.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="18%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Calgary, Alberta</font></div>
</td>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 126pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;signed &#8220;Ernst &amp; Young LLP&#8221;</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 24, 2011</font></div>
</td>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chartered Accountants</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>oncolytics_logo.jpg
<TEXT>
begin 644 oncolytics_logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`&`!
M0`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****'H`5"\P!*`,6XP!C)!.,CG.>#CCMGI7,^.?&WA?X<^$=
M?\=>--=L?#?A/PMIEUK6O:WJ$FRVL=.LX7FFDVJKRW$T@416MI;)+=WER\-K
M:0S7$T<3?SP^)/VI?VM/^"GWQ0OOA'^R2^O_``3^`.D2>=XN^(]V9],U22UB
M@NT+>+=>TI)9;+^WH[J%=)^'>BW+7]U/"]WJMZMI97%SI_F8_-*&!=*BX5*^
M,Q/.L+@Z/*ZU=PCS2EJ^6G2CM.K/W8O:,W:+TITI3N[J,(VYIRTC&[LEYM]$
MM_(_7/XT_P#!0W]D/X"W]UHGCSXOZ'/XDLHO-NO#/A%+GQCKT*^<8/+FM/#\
M=XD=P)4E5[66=+F,PRB6)"A%?.__``^?_83_`.AK^(O_`(:KQC_\A5R/P5_X
M(L_LK^`+71K[XFOXI^,OBRUGTW4M4GUC4;GP]X/O-9BEM[J^">&=%EA>^T>^
MNH9A<6/B/4M=EO+:YFBU&XN3,&7[*_X=]?L1_P#1KGP8_P#")TK_`.-5YR_U
MGKMU8K*<%&5G&C66)Q%5*R?[R<53@I+9J*M?T1?^S*R?MIOJURQ5[KX=9-KU
MMVU3N-^#'[?'[)GQ[O;71/AW\8_#EQXFO;5;R#PIX@DF\+>)&A,ME;E$T_7H
MK'S;A+F^M[4VEO+-<M<%XDB8HV/L!95+;.=P'.<`^G0G/KGCC!K\8_C_`/\`
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M8Y_P"BBBF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!2,<#IG)Q2UP7Q0\8V_P\^'?CWQ[>N8['P3X
M)\4^++I]H;;%X>T:\U5V`*N"0MJ<*4<'H4(R#,Y1A"4Y.T8)R;TVBKO?3H'5
M+JVDK:ZMI+\6?A+_`,%`_B/XN_;5_:B\"?\`!/'X,ZJ?^$/T;7]/UOXZ:_8Z
M7(9=$UK1)Y;W4EGN[R:.RNM)\%:#=6NH"WCCV7GC6ZTVT#S&PP?VT^!WP.^'
M?[/OP^T#X<_#+0K/0]"TBPL8;F>&V@BU'Q%J=KI]K8W/B/7[B&.)M0US51:I
M<ZA=R`!YVD:-(D(2OQZ_X(E?#[6O$VD_'O\`:O\`B!!>ZKXV^+7C2?0+'Q?J
M,8CFUG3[.X.M>+[RQ$<*0"VOO%=U%I]T('6"VG\-)I]M:VD%HHF_>?`XQQMX
M';MBOG<CI/$J><UX)XG'RO2<E>6'P*:5"A3DUHIRC[6;5G-RUT1O6?+:C%OE
M@ES+I*;2<FTGKKHD_AM8.?4?EV_/]?TI:**^D,`.>V/Q&?ZBOGG]I+]FOX:_
MM/?#?6OA]\1]'L+M;K3]4A\.>(Y;"VO-:\%ZOJ-F;5->\/S7!3[/>0$1NT!E
M6WNDB2&Z#QYKZ&IKC<I&`0<<'GOZ5C6I4JU.5&K3C4I5/<G&235I.U[-=+WO
MNGJAI\LE)-QE?XEHUMU7Y=5H?SS_`/!)?]HCQK\+/B5XM_8!^-LMIH=[X*O/
M%`^&5IJ]MJ=MK$FN:7K%S=^(O"UE>7`6SN=*O+%KGQ1X6<V]E!>:=',VEO<)
M<VRR_P!#"MN[8Q7\^?\`P6#^'>F?!GXI_LV?MI^"DN_#WC'3/B7H/A[QIJM@
M88+/4_[`6'7=`U"[=;9Y/[9_L/3O$6BS7$K7'VG1H(8TM@UAYDO[\:'J=OK.
ME:=J]I*DUIJUA9:I:R1.)(7MK^UANH&AD4!9(S'*"L@^^#NX'`\3(Y5<//'9
M57FYRR^I3E0J/_EY@JT'[!:W_AJ#A)W;NK-Z&M6TN6JE936N_P`:2YMWIJ[I
M::>1K44@8'.#G'!X/7T_Q].]-,B#JZ_F.W'\^/K7T-U>U];VMUO:]O6VMNVI
MB/HI-R]<C'7/;KCKTX(Y&<BEHNEJW9;7\]-/Q7WH+I[._7Y/9A13=ZYQD$\\
M#D\=>!D\=Q2A@<X/3K['`.#Z'!!P><$'H11==]MP%HI`RD9!!'KGU&?Y4F],
M@;ER>@!!S[<=_;OVH"Z[CJ*3/U_(_P"''XTFY<[=PSUQGGKC^8(^HHNENP'4
M44F1D#/)R0.Y`QDCUQD9^M`"T449_P`X-`!130RGHP].M`93G!S@X.,D9],C
M(S2NG:S6JNM5JNZ[KS0#J*:'4G`()Z\<_J.*=3`**3/U_(C^8H9E4%F(`'4]
MJ`%HI"0.IQ]?Q_P-(74=6`^I]?\`]=)M)7;25KW;25N_H`ZBFAE.2#G'!QD]
M?I_G'/2E)`Y)`'J3@?F>.U#:6[2]78!:*3<,;LC;@G/;`Z_E4;SPQQ/.\L:0
MQH\DDSNJQ1QQJ6D>21B$1$4%F9B%5022`*=UW_K?\M0):*8LB,BR*ZLCJ&1P
M0592,AE(X96!!5AD,"""013@0P#*001D$="*`%HHHH`*^$?^"FVN:SX<_81_
M:0U70-3O-(U$^"]/THWMC((KC^SM>\6>'M"UJRWE7'V?5-&U*_TR\3;F2TNY
MXP5+[A]W5\A?M]>!%^)7[&O[1OA(W=[9-)\+]>\10RZ?9KJ%Y-=>"?(\:VFG
MPVC,GF#5+KP_#IDK(6FBBNWFMXY9HDC;CS!2>`QJA=R>$Q"C;1\WL9\K[[VV
MN_)ETVE4IM[*<&_123?X'!_\$P-!T;0?V$OV<QHVFVNFC6O!!\1:JMHAC6^U
MW6-5O[G5=5N`2Q>\U"X/G7,F0&D)*JHP!]\U^8?_``2&^*5A\2/V(_AKI4!L
M(M4^%<FK?#/6K"SN+FXFMI-%O&OM)NM0\^"%8+S6-#U/3]7:VMVN(((;R%5G
M+;HX_P!/*QR>5.>4Y;*DTZ?U'"J-MERT(1:>VJDFGYH*J:JU4_\`GY+[NGR"
MBBBO2("BBB@#\O?^"Q%I:W'[!OQ2FGMK>>6T\0_#&:TEF@AFEM)9/B%X>M7F
MLY)$9[2=[:XN+9YX&25[:XGMV8P3RQM]-?L/-)+^Q[^S#/++)-))\"OAH7EE
M=Y)'9O"VFN2[R,SL03@%F)`XR:^*_P#@M=\0])\)_L:ZCX/NX;BZUCXH>.?!
M^B:'#;21JUL?#6J0^,]2U"XB=6>XM4M]#BTU8K<_:/[0U6P<*UO'<%?OW]EC
MP;JGPZ_9N^!'@/6IK6?5O"'PD\!:%J<MDSO:27NG^&]/AG:V>0)(T(=-J,R`
MLO)'2O`I-3XAS!1=^3*\%"I9.T93Q&)DDWHE+EDI>DD]4;O_`':GH]:M5_)*
M$?6S=[=+W/QE_P""O>D?$/QK^T[^RE\*?A]X\\1^"M4^(WA_6_#MA/IGB?Q#
MH&D'6-1\0"'3Y]8CT&]MB\#3K!:RWI@N;BUAD:1(IE0PO]1_\$[_`-OR]^.%
MUJW[.GQ[CMO"G[3'PWFO]"N;2X4Z:OQ`MO#1N++59;6UO)8YE\::0=/NKWQ+
MI<,"Q2V136+%#$+^.S\7_P""BS)_P\4_X)WA@,#7+?'&>&\80AOYX/<\]:]3
M_P""CO["WB3QM<P_M:?LO2W_`(._:7^&:G7+N/PHL=IJ'Q#TW2+>9Q/8PPPF
M*[^(6G0I%!IDNH+-;^(-*BDT"_BG;[`J^2I8ZEF.<9AA:E;$PPF*I4\3E^K5
M?#1H0E*>'BDY+$T6I2IJG95HIT]9-(OW'3HQFHKFBVI]5)NR4M5>.RT>GR/,
MM0O-<TS_`(+?:9HD'BGQ:WA_6_AC%KEQX9G\1ZQ)X9@O4^'?V$M:>'OMHTB!
M)$TZ&Y8BR\PWDMS=$^;,6K]QM2U&TTJRO=4OIA;:?IUG<ZA?W+!REO9V4#W-
MS.RHK.RPP1O(556=@I"JQ(!_EP_8L_:&\1?M.?\`!3;X/?$[QGI,6C>-8_A)
MKG@_QA;PPSVL5SKWA3POJ.F3ZI]BN8H)M.N=4A%O>7^F-#&FG:C-=6<0\J&.
MOZ;O'GAA/&?@OQ?X.EE:"'Q9X5\1>&)KA&*-;Q>(-'O-)><,H9U,*W9D!568
M;=RJQ`!]#(<0\12S.M2E*K"6:8R5#VC;E&'LJ+A3DI7Y'&HK..Z6C>UHK149
M4XVBK4X*7+:S:O=^Z_/R\E8_$+P3\1?C7_P5E^(7Q2\.^%?B'XD^`'[&_P`.
M-;T_3+M_!`MM+^*_Q&U8*=2TFTU;7!?7-UH(>:VM]=N[>QBETN/2GT_3XWGU
M<7=W%],VO_!*/X<Z%>Q:UX+_`&C/VKO"7BK3YXKS1O$MK\7]5UB[TN_MW017
M@L->CU'1]1DCMQ):JFJ:?=P^7+DH6BB*_"/[`'QK\/?\$Z/'WQ0_9#_:HT^;
MX;W&N^/SJ7A+XMW&E72>`]>%OH.G6^GVMUXFEMTN[Z#5;4V\VE:HL5S8:7+<
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M'Q;TZRM=8\8WMMX=CL)M7L/!LMNS+X62VNG_`.$9.H3727-S=ZS(+I+>*#[%
M<_L]X.\8^%?B!X8T/QKX'\0:5XJ\)>)-.@U;0M?T6]AOM,U.PNHED@N;:YA9
MD8,K!9(VVS02J\,\<<T<D:_SO>/M'UK_`()[?\%-[C]I7XA69M_V>OC]K'CP
M7WC#P]!J6H6OART\8'2[O6/^$IB-I/)IUQ8>+!I6KSQ*^+^P-[+I3%K9;%^S
M.ZM2G1P#A.<<!4QM&GCZT*O*Z>%G.$4W5C)VBY\L)<LE>$G&]FQ44N:=_C4&
MX*4;^]>.\6MTKV5M'MM=?<L7_!(_X+);113?'']JV206\<$LI^./BF%YG,8B
MDE,<5R(4>=LRE(@(U+[8U5<`?./@3]IGXZ_L-?M>^!?V,/CE\0K#XQ?!7QA>
M:1%X#^*GC0QZ9XZ\,>'?$:W>F>$K#5M8-['8W<.A:G9V.D:O)K"E[A9&GTHA
MIX88_P!A+3]HG]G_`%'3[*_L?CC\(Y[:[MK:\M9#\1O"$)DM[F-)87:.?5XY
MXB\3JS)+%%+&25=4=2H_!?XVZ1IG_!03_@I_\-=,^%-IJ/C+X3?`M/#>G_$W
MXBZ'''8^&;8>"/$DWB37$T?Q9#:36^J2KKATW0])S)=_VG>_:TTM%TJWGU!>
M3,8T,']4J96U'%U<QP])4L-4<Y5L-.?[Y5*<:E5.E&FHRE-QO'O&XZ;<W+VN
ML.233:4;2MI:R5G?;5IZKH?TEW3EK*\(#*5MI_4'/DL>",$$'CLP([<$_BG_
M`,$7?$/B+Q!H7[54GB#Q%XA\0M9?&PVUDWB#7-5UQ[&W,6K$6UB^IW=T;.U`
M5?\`1[<QQ`@?+P,?M3<AA8WN[.3;W)&>N3')G`'0$].2<<'.`3^`G_!&[XH?
M#7P1IW[5VE>-/B#X+\(:E<?&B*_MK+Q3XFT?P[/=V4HUV$75HNL7MFMY%YUO
M-%*ULTOD.H681^9%YG9F%7V>;Y$YU%3A*.9*7/54(N3H48QO!R49W<FTFGRV
M=GKK,+.C6]V\N:GK9NRO+KLKO3S/Z"0,#&<^]?F9_P`%&?V-?%?[1?@Q?'/P
M6\8>+O!OQV\"::TVAVN@^,O$.@:/\0M$T^2?43X.U6QL=9T_28M5:\=Y?#NM
MW<:K;W<\UAJ+OIUXTEI]SZ-\:?@]XBU.TT70/BQ\,]<UC4)##8Z1HWCOPOJ>
MJ7LP5G\JSL++59[JZD"*S%((G;:K-C`)'I+)'(I)57QR,@'Y@"`1GC(!('ID
MCN:]2M"CC\-.C*7-3JKE=2E5:E!IIQG"=-WC)2U6O*[<LKIM&492IR4DE>+3
MM)73\I)IW3ZKJ?CQ^QO_`,%2O`'C;X<^+_#_`.TYJL'PM^-/P1T._E\?PZZL
M&F0>+X?#DEU9ZIJ'ARP:874WBNUN+18?$7A>*W6XBOKJ&?3?M-I)/]A\=^#5
MG\7/^"H/Q]T[]H?Q9<>-OA-^R#\)=3^Q_#'P1I/B'5_#^J?$[6;"ZM+F\NM?
MO-#N]/&J6,FI645UJLK":UL;40^&+)I9SJ]Z_CW_``5[_9\^%6F_M*?LH^,;
M'PXNFZS^T'\18_"7Q8^P3O;6?BBSTSQ+\/-%AU22UC`6T\0S:/XFO=.O-6MY
M$-Y!!I[3Q-<VS3S_`-$O@OP7X4^'GAC1/!7@?P]I7A7PGX;L5T[0]`T2SAL-
M,T^T1W=E@MH%1`\TSRW-U,P:>[NYY[NYDEN9Y97^>P5/,,;BJF`Q^(C*AD]>
MG[9T7*G4Q\ZM*&)P<Z[CRNFJ,'%U:<6J=6<N62E".O1-TX152FFI5E)VE9J"
MO:?*N[DG9M6MM9GD'[1?[.?AG]I3P58>!O%GBGQ_X3TZQU^U\0IJ7PZ\5:CX
M0UR:[M()X$MI]2TN6.9].=+AVELSE)'2-SR@S_/;_P`%0/V5M)_8V^'_`,-O
M%?PK^,/[0%WJ7B[Q5K&B:FGBGXO^,M5MQ::?HIU"!K=(]3M_+E,YVLS;LQY'
M&!7]3&%49QT(/?\`#^=?@9_P7T`'P7^!@S_S4+Q/W`X_X1;MD]\]<G)P*Z>(
ML-1_LW&XEPOB(4J;C64ZD9)J<(I\M.<+::6BK-7>KNB,/)JI3A?W?>NG&+5K
M=WZ=?7H?1'A?_@E1\'K[2?#&NW7QJ_:BEGN;'0=:N;=_C=XM:TN+EX;/4IXI
M8S=$FVN9]RSQ!P7A=HMP4YK]77MX[?3?LT`\J*WLVA@52Q\N.*W9(E5G9G/E
MJJ@%F9N`2Q;YJQ?!"J?!WA,G!SX8\/\`U_Y!-IU_^O6]=,!;7.>!Y$Y!S@!1
M$X'T/K[UZ]##4L/3;I04'*$9R<5+F;A#1^].>J;VLK]>ADY.3C=N6J6J7E_3
M]+[MG\[G_!##Q5XM\3>-?VIU\3>+?%?B=;*R^'36<?B3Q+KFOQ63S:W\01.U
MA%J]_>I9&80PK*;81F1(85?<(D"_K1^W#^U5I7['_P`"M8^*=QI'_"1^(KJ]
MM_"W@;P^TJ16FH^+]7M[Q]-FUEA<VUTOAW3EMI;K69=/\Z]$*1P1+";D7,'X
M]?\`!!8_\5O^U>>"38_#4C!SD#7?B*.OOCOUZ]*_2/\`X*F?LO\`C;]J3]F:
M\\/?#<)=>-/`OB"+QYIF@,7$WBFUTS2M3MM2\/Z85VK_`&[>V]RKZ,D\D=O/
M>1"U=TDN(I$^=RROBUPRZ^%<ZV,C#'NC*47*<IK$56K4Y_$J<4W"GM)Q4$M4
MCHJ*'UA)_"W3;:ZIQ5]=EKVTUOT2/EGX$_LO_'+]OCP+X&_:+_:P_:1\<Z9I
M/B;0#J_PO^&7P*U*\^&FBZ#X>UMYFFO_`!+-816UU>:]=M;Z>@6%G6*#3PEQ
M>WPN,1?8'PM_X)ZZ7\&_%6DZYX#_`&F/VH+#0H=3M=4\4^"=2^)/_"0:#XX>
MP5EL;/6Y]>T[4=6L["!7:.2WT.^TS[5"SPW+R*Y->9_L#?\`!0'X0?$[X8:#
M\,OB/J5I\&OC!\)_!/AC0_%WA;XB2Q>";*_MM)MH_#]MK'AR\\13V*74,RV-
MK+?:5<&'5M,EOHEFMWB?S%^S=7_:Y_9@T3Q5X+\#W_QW^&'_``E7Q#U9-$\&
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M:I<+H<5C:BW2SEN\R_TI>//'GA/X:>#/%/C_`,<:W8^'?"/@_1K_`%WQ!K6H
MSQP6NGZ=I\1DGE8R,F^5R%AMK:,M/>7<L-I:QRW,\4;_`)_>(+S_`()=?MF1
M7_C7Q/KW[.OQ.N89;3P_J7B75/$MEX5U^3^RH8;^SL9]0GU'POKMW!:P7T0B
MEWSVXA=K$S-'$]M'6;X?ZQ5P[^LX6/LX5>?`8VLZ>%Q4)))2FX2A-RBUIS^U
MII7O3;M(*;233B[-K]Y%7E&W175M=WU.5^#?["'@S1Y+'QO^SQ^W#^TB/AOK
M-UHVH7.D^$_BIX=\>>$_$UMH%_=0K9C7]5TWQ#>P64PBN=(G_LB_LUCABGAB
M>.969?U9CQL7`P,#``Q@=ACC^7TXK^2/]K7PE\/?V2_C'\//"?\`P3C^-_Q,
MN?B#\09[G6?$7P_^'OC6?QQX7LHI;N:W\,(A\-O/;ZPSRR7T;:!J4&JS:5H-
MI/JEQ>6XD6=_ZP/"G]MGPMX;/B8PGQ(=`T<^(3;HL<!UPZ?;G5S#&A94B.H?
M:#&BLRJN%!(&:>2UZ<JF,PL<*\/4PTJ2KNGC*N,PLJE2"DXT*M1I^YJI)0@D
M]+,=:"4824U)23:3BHSCM?FBM=>C;U^\WZ***^@,`K+UG1['7M+U+1=3A6YT
M[5]-OM*O[>15>.>RU"WDM;J%T=61EDAE=65U9&4D,I!-:E-;..!G(.>0#^OX
MU,MGI?576]TFKZ==.G78#^=;_@F_K[?L9_MI?'_]B3QU--I6B>,]:CU+X5:I
MXE6"POO$.H:69W\,M!(&CM;Z7QCX-NC(LEAYD5UJ7AX+:6UJ9;F&+^B@,QVG
M&`PSWR,C.#Z'_P#5VK\C_P#@J-^QWXD^+WA'0?VAO@;IVJVW[2/P4N++5M"O
M_#-[-;>(M;\)Z1<W>LRZ;I=K#%,-2\3Z-J+1:MX<C41W%P8[S1E>:WOQ;-V?
M_!/[_@HGX`_:H\/:3X"\6WY\(?'WPWI=CI6N>&?$5S96MW\0KW2-#M/[>\8>
M%H8+>S@`N]0AU*[O_"J(=8T*.&5IH);.%[L?.9;5CE.)J9+B)*G2]I.OE=24
ME&G5P]:7,\-S2LE5H5)3Y::DY2CRV25D]ZD75BJT-7:U6/5-63FUJ[-:[)7W
MMK;]0**C,L8.TL`W'RD$-STX(SCWQBG;U]?T/^%?277==/QV^^ZMZF`ZHV9E
M4G&<'T.2,@#`&22<\8I1(C$A6R1U`!)&>A(`SCWZ>]?D/_P4,_X*.>'?@?I^
MI?`OX)7-UX__`&B/&MIJ7AFQ3P1?V^H7/PLU[4&@T[2)=3@M;:_DO?%M[>7+
MPZ/X5M%.K0W,,=S?PV\4ENEYR8W'8;`8>6)Q-11IQ5XI-.=62LXTJ45>4YU'
M[J44W9WVU*A"522A!:O=_P`JZM]$EU;=EY['R#^V3XI\0?ML?\%(O@_^R'HM
M_(OPN^#OB33-8\5_V;!%=QS:U96-MXN\:ZG?WL,4JI]BT"VL?#6GP75PMM'<
M76H1>7;7UU(6_HQ@MX[=4CA1(HHHHX(HXU"K'%"H6.-1C`6-`%4`8"\5^8/_
M``3+_8DG_9@^&,GCGXC:=%)^T'\48);_`,?:F=3OM2N]*T6^U`ZQIOA6=[IQ
M"NKV\LJ7?BN:!)([W7%E)N+C[/'/)^HH&/R'\R?ZUYV383$1AB<=C8VQ>95_
MK%2FV[T*'LXQP]"]D[T::C!JR]Y-M<VI=64;J$'>-./*FKVD_M2OM[TE>WW:
M'F/BOX+_``H\=>*_"WCKQE\//"'B?QEX&E\_P9XGUS0K'4=<\+2BX%V)-"U&
MYCDN-.=;H"X#6SQGSAOZUZ;M.W:6)/\`>Y!ZYSD'/ZU_)W^VU^S+^W1XE_X*
M$_\`!0'XH?#SPUKEWIFJ_##]E;5?V)M7\11?M#^.HHOB1X4^&GB>Q\=7_P`!
M_#OPQ^-7PU^"7A/Q!H'CO2/#VH^-[3]HF?3?#VO7UOX>U&&RUC1IM:MM8_I*
M_98G^,<_[./P4/[0GAZ3PM\;8/AQX8L?B=HT_C#3?'MW%XNT[38;#5+[4/%F
MC:/H&D:MJFM26PUK5#IFE6]A9:CJ%UIUI+>06:7US[2IP3E)0C&4[.<HI1E)
MI<J<I*TFTDE=MNVES-MO?H:.C?LW_`7PY\0[OXMZ!\(/AWHWQ/O[S5=1O?'N
MF>%-)L_%5U?ZXK)K-W/K,%NEY)<:HCNM](TNZYWL92Q)S[5@9)ZYQVZ8KY;_
M`&X+'XV:C^QG^UI8?LVOKR?M"WW[-?QNM/@4WA:]L-.\2K\7[CX;>)(OAT?#
MVH:K/:Z;8ZW_`,)<VD?V5>7]S;V=M?>1-<3PQ1M(NM^QWI7C30?V2/V6M!^)
M,6NV_P`1=$_9Q^!^D^/K;Q1=7-[XF@\:Z=\-/#5EXJA\17EY/<W=WKL6NP7\
M>KW5U<W%S/J"W$L\\LK,[*%&E335.G"FI2<Y*G%04IR:<I-023E)I.4GJ^K8
M-M[MOUU/5/'WPP^'WQ4T&[\+?$KP9X8\>>&[X1K=Z)XKT/3M<TZ=8KF*\B5X
M+^"90L=S;P3J$V@20HQSBO&_"W[%7[(W@GQ!I?BOPC^S9\$_#OB71))9M(US
M2?ASX9L]2TV::WEM));2YCT\20NUO/-$2I!VR'!!YKFOV_\`PY^U+XK_`&.O
MCWH?[%GC2#P#^TQ=>![N7X8^('TW1]1U![ZRNK6^UC0/#3>(73P_HWC/Q7X<
MM]7\,>"?%&O+-HOA/Q9J^C^)=5MKBQTN>%_R6'@7]IN/Q#^RSJ/[(GP7_;T^
M"OQI\7?'#]GGQ)^VIXR_:)\=_#G6/A-XA^&_@N^U^V^.T'Q?L?\`A;'CC1-4
M^(WC;P?=WNK^'IOV?O!]AX4OM=\2>$-\WAJ[TB_T3PU$L-AIS]I/#T)U+I^T
ME1IRG=;>^XN6G373H";2LFTNR;7Z_?WZG]$&GZ;8:5:I8Z;9VNGV<6[R;2QM
MH+.UA#L780V]M''#&&=F=MJ`L[,S$DDUG:[X9T'Q/I5]H7B/2-+U[1-3MY[3
M4-)UG3[74M.O+2YB,,]M<6EW'+#)%+&2DBNIW*<`@`5M1AP&W=V)4=<*?NCD
MYR!C<.@;.T[<5^+O_!<3]DCQK^T1^Q;X_P#$GP#\%_$GQ/\`M5>"[OX36GPJ
MNOA;\3O'?@+Q98>$KKX]?#._^,$>FP>&O''A'1=5DE^%=OXT%VNI07^KS:8;
MVTT,-J<]I"VKA%QY7%..W+96MV2V7R%KO=W5M;N^FVNY]R/_`,$^_P!B.2X2
MY;]E;X%ETMY;;R_^%<^'1:M'/)%*[R6@LQ;O.&A`BN7C,\4;RQ)((Y9%;Z/\
M#_#SP-\,_#VG>$OAYX2\.^"O"VDQ"'3?#_AC2++1M*LH@\DGEP6=A#!"J^9-
M*XRI(>5R#\QKA/@5^SS\*/V;?#&I^"_@[X;O_"_AK5O$%SXFOK'4/&7CCQK/
M/K-W86&FS78U/Q[XD\4:M;QM9:780BPM;Z#3XWB>XCM%N)[B67VTG`SD#&"2
M>@`/S?IG!Z`]>*RAA<-3FZE/#T:=25TZD*4(3:=FTYQBI.]E?76R[#<I/>4G
MZMO\V(RJZLC`,K*596&596!!!'<$$@CN.*^4+O\`81_8RU"XFN]0_9=^!E[<
MW,\]U<3W7PV\,SRRW-U*\]S.[S6+L9)YG>65NKNS,Q).:_`C_@D!X5^+W@W]
MH;P7X?\`C=^R?\??"OB_3?#'Q*@U?XY_$/P?^U%-]N\7RWE[<SWGB/XC?$+]
MIGQC\*-7L-9M);VRTHZ-\(=,MYS-H\'ARVT2PMPJ_P!4XZ#/H*JI0H5G%UJ-
M*JX7<'4IQJ<C=DW#G3Y;I*_+:]E>]@4I*]I-7WLVKVVO;>Q\X^!_V/\`]EGX
M9^*--\;?#O\`9\^#_@GQAHPN_P"R/$_AGP#X=TC7-+-]:S6-VUCJ5G8Q7-LU
MQ:7$UO*T4BEX99(VRK$'Z,1-@QN)'N`/Y?\`ZSW)/-?C?^V#X?\`VI;C]LG0
M+CXA>'_CO\4?^";?B[X":GX$\0>`_P!EG6=&T/Q!X2^*&H>*=/E\8^,/VAM/
M76O#?Q<\6^!+WP4L5AX+?X$Z[/XAT**/QDNH>&-0U.\T&>;]*OV>#HD?P=\%
M:9X9^&?Q#^$'AGP[8W7A7PWX`^*DD4_C;2-`\+ZC>:#H]UJ=POB_QW=7-KK>
MGZ?!KFCW&K^)KW7YM'U&P?Q!!INLF^TRT=.C2I1<:5*G2B[WC3A&";>C;44M
M797>XFV]6[ONS=\??!GX4_%/4?"FK?$?X>>#_&^I^!=0?5O!M_XGT&PUB[\+
MZH]QI]V^H:'/>PROIUVUUI6F7#3VQ20S6%H^[="F/2P,8YSU_4@_TKY[_:WT
MOQ=KG[*O[3.A_#Z+7+CQ]K7[/?QITKP/;^&+FXL_$MQXOU#X<^([/PU#X>O+
M2:WNK37)=:GL8](N;:X@N(-0>WD@FBE577\5OCO\&_\`@KYXBT;_`()8Z'XR
M\3?"7XAZ'\-OVZ_V-O&'QWU7]G32/BU\*_B3=?#KP'X<\4O\2?%7Q<;Q%\3)
M_!E[\/);5)I_'_@BVTZXMM:\0WFB66CZ5.4M]/=QITXRE.,(QE/E<Y1BE*?+
M'ECSR5G/ECI'F;LK);(+OOMMY']%I&1CI7E_Q/\`@E\(_C58:;I?Q<^&_@SX
MD:;HUS/>Z58^,]`T_7[73KVY@^RW-U9P:A%-%;SSVW[B22-5=H\J6(XKU!6#
M`,I!!Z$=Z6G.$)IQG",XO>,XJ2?JFFF!7M;6&RMX;2VCC@M;:&*WMK>)%CAM
MX($$4,,2+PD<<2I&BCA50``"I)(ED1D;E6R"",@ALY!'&002",X(/2I*_,/_
M`(*L_#_]H#XD?!C]GW0_V<;#QUJ'C#3OVZ_V.?%7BV+P#KMSX>U"'X1^%?C'
MHNN?%6[UR_M]4TA)/"5KX-L]2E\1:?=W4EIJ5DILGM+R6:&WD?*NW;JULK+;
MI;2VSZ@?;WPR^`/P4^"]WKE]\)?A9X$^'%WXF%HOB*Y\&^&M-T";6UL)+N:R
M74I-/AA:[6TEO[V2W$VX1/=3LF/,?=ZYM/=L].P[9Z>G7J*4$,,@Y'^!P?R/
M!K\J?^"E_P`$_CI\=?&?["/A?X+^-_B_\+K;3?VE?%.O^//BK\(M1FMY_AM8
MZ=^SS\8)/`GBWQEHLMU%H/C'P?8?%8>!QJ7@WQ7:ZAX<\2F2/1]0MDCO/M$,
MQIPA'EA",(J[48144FW=M**5FWJVM^H/7=M[=7TV_+8^W?B1^RW^SG\8M:MO
M$?Q6^"'PN^(?B"SLO[.MM9\7>"M#UO48;$3S7*VJ75]:RR^4)[F>4`L2))I&
M!&XU<^'7[-?[/WPC-^?AC\%OA?X#;5)[2ZU%_"O@C0-'>\N+!2ME/-):62.T
MMH&/V>3<&B)RN"!7Y;_L2:)^W[)_P44^-_B']L'1=:M_#^@_L6?`3X96'BKP
M?JNIS_LV>/\`XH>'O'WC;4?%WCOX2Z/>36SZ)JOB_2]1TW6_%6A:SHXU[PGJ
M%Q/X777_`!!H>G:5?/\`MG(&*D+U^N/QS@]#@CU(P>,UE]4PO-S_`%>ASWYN
M?V4.;FTUYN6]]-[W^]E<TMN:5NUW_F4KW2K#4;62QU"TM;^RFV^?9WMM#=VE
MP$=9$$]O<)+%,$D1)$$BMMD19!\ZJ5^>/'?[&O[*?Q.UBX\0^/\`]GOX2>*?
M$%U;V=I<:[J?@C0WUB2UT\_Z';?VE%:1W:00)^Y6-)55H&>%PT<CJ?R\^(_A
M'XRZK^U;\?O#O[<_P;_:<^/W[-'B/XA>#O$W['VJ_LZ:Q/;?!SX=^%[?P%>6
MTWAWXL>'OA_\1/`'Q6M?BB?'>D:OIZZYJ.E^+?`-W;^,_"][J&K:#;&_ET7]
ML/!/B"Z\5^%-`\2WOA?Q/X)N]<TNSU*X\(>-(=(M_%GAN6Z@25]'\0P:!K'B
M'1(=6LBWDWB:7KFJV0E4^1?3IAS53#8>LK5J%&JEHE4I0J)+:UI1?302;6S:
M]&U^1P_PV_9\^"'P;2\C^$WPF^'GPX&H7HU&]/@WPCHF@M<WJVOV%;J1["TA
MD$XLB;7S$=&,#-'G:S`^PJH554=%``_`8KSCXL^/;WX9^!]3\8Z=\._B+\5K
MW3[O1;2W\"?"G3?#^K>.=9?6=:T_1FFTJR\4^)?"&@&UT>._?6M;N-2\1:=%
M9Z'IVI741N+B&*UF[^SG-S:6UPT%Q:M/;PS-;78C%U;-+&KM;W(AEGA%Q"S&
M*81331"16$<LB`.;ITJ5**A2ITZ4%>T:<(PCJ[O2*2WN]NK[L3;;NW=]WJ_O
M+-%%%6`4444`,=<@?,5.>".N3^H_`BOR2_;7_P""7'A#]H?Q-<?&7X0>*G^#
MGQXM8+>:+4=.MHK/PGXGU.P>XFM=1UA=&AM=7T;Q)-)/MN?%FG375Y-%!:Q7
M-I((Q<Q_KA1@>GO^/K7'C<#A\?1=#%4XU*3DI)?#*,XM.-2,U[T9Q:3@XM6:
M3U+A.5.7-%V?7LUV:ZKR9_.3H7[3/_!53]BS1]+\(?&KX!2?'[PAX?TV,67C
M"TFU;Q1K3V.Y8;2SO?B#X476;G5+G3U$*2G5O"USK!$H:]U*^),D>Q_P^:_:
M5'_-A7BC_P`#/B?_`/.EK^A[`'08HKS(Y1F%!*GA<]QE.A'2G3KT,/BIPCHE
M%5:BC)Q26B:=NYI[6F]94(MWOI*45NF]%>VJ^X_FY\5_&;_@K'^W'I5UX/\`
MAQ\&[G]G;X<Z['#?W/B0S:EX'U"YTV&YMY%TN;X@:_-9:V6N([RPGDT_0?#N
MC7^H6UM>PW%W]EEN-/?[[_85_P"":7@#]E4GX@^-M2@^)_QWURP1=<\37]G:
MW/A[PO>2W2ZA<CP3#J%F^J0ZB;L>7?>*+J[34M5@508+.-I4F_4L@'J`?K_G
MV%&!Z=.GM5X?(Z-/$QQF*Q.)S#%QNXUL3.*A2=DKT,-3C'#TI<MX\RIM\K:3
MU=YE5DX\L8Q@KWT6K[WEN_O5^HU%V`C).26Y]3R?S.3Z<\<4ZBBO<6B1D1>4
M.<,=K9)7MSP>^<$=0<_[.WC#U7:H4$D`8R>OZ4ZB@`IB)M+'))8Y/8?EZGJ2
M>2:?10`4PH&8,2?E((P2,8&.QY^AXZ\<T^B@`IK+NP02"N<$9XR,'C."<=,@
MX/(%.HH`11M`'7`QG@?H,"E(R"#@@C&",C\1W'M110!'Y>>KN?49(!'H`",8
M/((.?4M4@X`HHH`1AD$`X/'(ZC!S_GMZ@]*1%V+C);J23C))Y).,=3D_YS3J
M*`&.F_:<D%3D=Q^7J,9![&E9=PQG@]>,_I_C^5.HH`:BA%"@D@#`+$DGZD]:
M=110`4C#(QG'Z\=QCW&1^O:EHH`:JA%"@DXSR>O)R?U-(R;L?,5]<=QZ$'@]
M^H/7Z4^B@!B)LS@G!['IGC)'IGDX''/`&*?110!'Y8W,X)#$`9XX`[#V/4@]
M2!SCBECC$8(!)R<\]O8=3@=LDX'&>!3Z*`(WCW[?F9=N?NGJ",$,#D$=^F<@
M8."P9ZJ%`4=`,`<\`=N23CTYX'%+10`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
4`!1110`4444`%%%%`!1110!__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>reovirus.jpg
<TEXT>
begin 644 reovirus.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`:0"
MJ`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KY,^/
M7[=?[(W[,/C'1/AY\>?COX*^''CKQ'X9?QGHWA'5Y-4O/$-[X335)]$/B,:5
MHNG:G=P:,^L6UUID.H7,4-M/>VMS;P222V\RI]9U^&_Q4^-W@WX,_P#!<<:E
MXI\-?%?Q*NI?\$I]'TV#_A4?P/\`BU\==8TR7_AKCQ%>%=7T#X->"_'7B?1=
M.OHH@T>KW^D6^AO<VL=G<ZC#?SZ;;7<R=K;*[2U\_FBHJ[:LWHW9;O\`!_D?
MH!\*/^"A/[$WQO\`%.E>!OAA^TQ\*O$GC;7I[JVT#P=+XA3P_P"*_$$UDEK)
M=)X?\.^)H=&UC7/(6]M1(^E6=X@DF6+<90Z+]D5_/G^VE\7O!O\`P5<\`_\`
M#+O[$O@OQ_KWQ^^%?[0OP#\2>*?CS\3?@MXT^""?L&:AX.^)/@_XG3?$34;#
M]H+PM\.?'>O>-_$W@[POK/A[PUX&^&.AZWJ6L6>KRW'BV^\-Z#/IL^L_=G[1
M7[6_Q,L/VK?!7[%?[.VH_`_PO\4;CX+W/[2'Q3^(O[0L/B;5/!O@GX37'C&]
M^'/@^P\*>"/"WBKX?:K\0?&GC/QKI>NPS1Q>//#^E^"]#\/7&IZRU]<ZWH.G
M78I=]=DFMFV[66KV>^ME\F-PVW3=[J6\4K>\]%9.^EU?3K=7_2"BOS#^`/[9
M'Q67]LGQC^Q#^TI=_`CQ/XRN?@</VDO@Q\7OV>4\5:+X/\9_#?2_&0\`^-O#
M/CWP!XP\4>/M3^'GQ"\(Z]<:1JD"V/Q!\8^&_$OA?7(+RUU'3=5T[4=(C\^^
M"7[47[?7[:GPK\2?M+_LO^%_V6?AG\#M9U'Q9%^S7X:^.^D_%3QOX^_:"\,>
M$_$.K:!8_$#Q)XH\$>-_`&D?`?P[\1)M(EF\*Z?/X&^+6MZ5ITT.L:K;7EI-
M:0W9S+S;UT6^F_W77WZ"Y7W5K)WOIKMYWWTMI9WV/U]HK\9W_P""J6I>)?@%
M^P3^U[X)^'>B:1\`?V@?VCM/_9R_:CTCQ[K-K!XT^`'B#Q+K_BCX0V.MV7BC
M3=?A\,2Z)X-^/?AVW\/Z[=ZCH>H3>*O"6NZ+JEG9>#I;NYN-/^I_C7^U9XT\
M)?MP?L?_`+'7PP\,Z%XDOOC'X>^,GQ?^/&LZU9ZL\OPR^`WPQ\.QZ9HWB31;
MBVU;2+&37/&'Q?U[PCX'LXI(?$1L[:[OKR^T>U@:VU%!23VO]GH_M6L_37Y:
MAR273^;_`,EO?[K?BNY]A>%O'_@KQO?^-]+\(^)M(\1:A\-O%[^`/'EII5W'
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MJVE_N'[.6FUVU%)M7;:B_P#VY>GR/V6HKXH_;K_:;\8_LL?#?X4>*_`OA;PU
MXM\0?$W]J+]G#]GF*P\67^J:=H]A;?'7XG:-\/KK7I+G1XYKT3Z+'JWVZWC6
M">.1XL202K^[;PKXI?M@_'WQK^VSX^_8:_927]G7PGX]^$'P'\$_&SQOXH_:
M:3XD7EQXR?XB>(]1TS1O#_PD^'/@V]\%:EXJ\*^%-(T8W'Q&^+&G^+M:T+PS
MXF\7>%?!CZ!)K5OJ\:-R2];I6\WMY"46U?IKKVM:]_O1^IE%?.?[+'C_`./W
MQ&^$=CK'[3GP4L?@-\9]+U_Q'X8\6>#]"\7:9XX\&ZL=`U.6ST_QQX!\1V$\
MEY=>"O&-@+?5]$MO$5II7B;3DEFL-8TV&>W6:?Z,IK57[]]_F2]&UV[;!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!7Y8^'/@5\6;/_@M!\3OVDKKP7J$/P0UO_@G-\.O@[I7Q!:ZTLZ7
M>?$O1_V@_%/B[4O"<=FM^VLK?6GAR^M-5>XETU-/:&98X[Q[@-"OZG44FKV\
MG<:;5[=59^ET_P!#\L?VX/@M\9/`/QG^"7[>W[(/P[G\??&CX>:K9?"S]H[X
M2^'KS0M&U;]I+]E'Q7=;-9\/I<>(;[2M$N_B)\'?$O\`9?Q$^%FH7NJ:-=0-
M#XC\/W.LR^'M8O\`0-3\/_:Y_9?N?#W_``4"\/?MP^(OV0=)_;5^!_C?]E[2
M_P!GGXG_``^C\%^#/B7\6/@[XE\%>/O$GQ!\(_$KP!X#^)-V=,\2:'XELO$]
M]X1\8>'?"4^DZUIMWIVG:_;V^L2W^IQ2_M]12<4[^;3Z-)KK:W7JOFK/4I3:
MMY)I[IM/HVNW3_(_*;]ESP+X>\=?&_XFZMX=_P"":7PX_9*^`=I\(6\$>'/B
MIXJ^&OP]^$W[1GQ0\0^/+NRF\;>'--\(?#RUDUCP?\)[/0].M+?5YO$OB'2/
M$6L^*+32+BRT7['9&YLO$?V(?&WQT_8`_97T;]C#XA?L?_M)_%7QQ^S+IWBS
MP1\*_'?P@\(>'M=^&/[1_ABW\2>(M8^'VNZ/XL?Q<=/^&&HZEH&HZ+I_BW3_
M`(G2^'X]%UV'5I=/EU2S2UCE_4;1/VI_@%XB_:/\:_LC:1\1M/N/VC/A[X!T
M3XH^*_AA-I/B.PU2Q\`^(+BSM-,\2V.K:AHUKX:U^R-UJ.G6]_'X>UK5;S1I
MK^RCUBVL'N[<2?0-)16Z>JNKJW5JZLE;HO-=;@VU=.+L[-)M]M'=[W3]'?2V
MEOQJ\&?\$\_B7XI_X)-_$_\`9'^/NO>&M0_:&^.=O\=_C-XW\0Z3I>D:YX7\
M*?M%?&+XP^+OVB=!O=`T]M,TK2;J/X=?$?6O#YMKBQL;&RDU70)=1T+[#9R:
M>EMS7_!*OX??M3?%+XK_`+0/[>?[=/P/USX&?'[QUX4^%/[-WP_\`>)]3T75
MKSPO\+?A)X=MM0\=Z]H8TS3[0:-IWQ>^,>J:[XLO;:V,6GZA#HVAS65L]A:6
M%W<?MU7SS\#_`-J[]GK]I+Q%\9?"OP,^)^B_$C6?V??'C?#'XNIH-EK@T[PG
MX[CMY+F?P\NNW^E6>A>(;FT6&X@O[GPMJ6MV%A?VUUIE[=P:C;7%K&^57CKL
MK)7WMM?O:[^;N',^62MN[MVVNU?;92:2U[66Y^!'C+]D;]J:'_@G!_P7.^&>
MD?!GQ;<_%3]H/_@I#^TM\8O@#X133]+U/4?B5X$\8>,?@'JO@WQ=H-C-/=:=
M?:+J\'AS6+A(]4$<8BTN^BU*UC2*:.OTE_X*I_LY_%S]I+_@FUXS^&'PP\-O
MXG^+NA-\!OB7I?@6WFTW3;SQ=J/P<^)GP_\`B+XC\'Z5<2RV^E6FMZMI'AC6
M;+0(BR65SK1T_3@T$-T)X?U8HI<BUWU7+T[MWVWN_3R!U'>+LKQES+U2BM?+
MW$_FS\!/VW/C/\6OVV/#O['GAK]G7]DW]J)O#O@[_@H]^R/XS^.?B3XH_"34
M/A<WP^\*?"3XMVGB'Q6ZZ!XMNK/Q%XBM=#OM)CN=<\7>%M.U;P3I^GV#F#Q'
MJ"ZI9D]Q_P`%`XO@3KOQSUS1_P!N?_@G-XN^-?P*TKX>^`=0^!O[7'P!^&7C
MSXJ_%WPYXEEUS7F\:_#GQ!K7P8MM+^/7P@N=*UI-"USPC<^`]2O/#^L6FI7>
MI:EJUAJ,=S96/[AT4^7>[O>U[I6T\NS_`#\M`4[6LK)-O1M/6VM^^GW=+JY^
M4O\`P2F\&?M">#?!?[0D?Q,O/C9#\`-8^.^M:K^QEX4_:7U_6O$WQ^\'_`R;
M2K!9=.\<ZIXLN=4\<P:+=^*QJMYX`T3Q[KNK^,-%\)O96VK26FZ"UC_5JBBF
ME9)=B9/F;>U_Z^][M]7J%%%%,04444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?E[_P4;\%W7PEL?"O
M_!27X::1;R?%O]BG0/$.M_$:TLK+2TU3XN_L=WES8:W^T3\)K[4;N2S::[T'
MPMI%[\5_A=]LO?LVD?$;PI;V]ND%KXJUXW/>:M_P5._84\/^"1\2?$7QHU/P
MW\/O[+TS6I/&OB7X.?';P]X7M])UDVBZ5J%YK>M?#*QT^RMM0>_LHK62[G@$
ML]W;P+F:5$;\]/\`@L%\?_'_`,4?BE^S?_P3Y_9^^'_@_P",NH>-/VB_@1<?
MM-^%_''B--$^'5SH>IP^-?BK\+/@W\01#X:\3:CK'ASQ+:_!OQ5\=?C#X?T6
M&+5O^%'_``AO/#-W!+_PN3PRMU^A=I_P3C^"OCO3X[W]KK4O%7[:GCB_6XN_
M$5[\=];UO5?A%%JVIVUI%J4?P\_9JBUF3X(?#GP_:M;-;>&[>R\*:QXRTW29
M9;;7O'OBO5KS6=>U;.\G*7+;HG>[5UO:SW2LGYK6UM=-.6//>^MK-7Y=+733
MTW:VWNKK;Q']H;_@KM^R?9?"'0K;]D[]HCX$?M"?M'_'S5/!WPL_9J^%W@/X
MH^#/$&O:C\4OB[=6.@>!-1\>:#9ZO+K7@7POX=O]9M=;\8R^+-.TF]TZUT^Z
MT9[+^WI8M.;ZW_8G_8X^&?[$_P`%=.^&7@6RAOO%6NWL_C;XT?$J[C67Q5\8
M?C!XAQ?>./B)XKU-XH[F]O-;UJ:\FTZTD"6NBZ6UMI=A!#!`0_Y;_P#!0K]@
M^+X"_L;>-;?]GSQ/\2S^RW\,_"FFZ_XP_9=U+Q)XL^)5W\,K7X>ZKX;USP7^
MT#^REX]\7:MXE^)GPM\?_LW7/AZ'XBVOPCM=6\3_``A^*'A_0=4\#1>`_#6L
M:[+XANOT1_X)S?M;R_M>_LW^'_%/BN2PM?C9X`DM?AW\?-#L+>XLK.S^)&F:
M/IFHOXCT2UN['3)V\&_$CP_J>B_$7P/>KI]I;W?AGQ-8+'#%+;SP0B;YK22N
MEHTM-=[.[WLNSLGII=DDN2\+\O-9WWO96OHEIKM=*^[O9?>E%%%:&84444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110!Q'Q+\'7?Q#^'7CWP#I_C/Q=\.;[QMX.\2^$[/X
M@>`+ZTTOQUX'NO$.C7FDP>+O!FI7]CJ=CI_BGP[+=KJ^@7MWIU];6NJVEK/-
M:7$<;1/^;/A3_@FQ\;_#6A^#=)E_X*S?\%&M6N/",QO6OM0\0?LWZI)KM[+<
MVM[<IKL_B;]G?Q)K6N:2;FV,=GI7B+7=<6RT^>?3EN9;>23?^KM%)I/>_P![
M76_1C3:5EWOLGK\T?RU:1H(_8_\`^"FW['7P<^._CC4+O7M:_;/_`&C_`(@^
M!/C3X[L]+TS7_P!L:Q_:J_96\;:'X5\7^+M9TD:%X,U'XH_LY>/O"</[-6HZ
M)X>\-Z%!H?A'XC?`.'PYX=TBT\<QPZI_4K7X_?\`!:SX*_"'QS^R=8?&_P"(
MW@7PQ\0/%/[*_P`1?"/Q-^&WA'Q#I-A?S?$[4/%&L6'PS\1_`+2[R33=0UK2
M-9^.FB^+3X/\#ZUX6:S\2^$?C`GPM^)'AZZA\1>`]&FB^5O&'[0?_!7']FSP
MOH_A#]E?]D3XV_MD>$K2]33]$_X;!7X<>"_C-X,\,6]M<&WM/%'QB\*?M$^(
M;?XUW44HM;.W\1^(/"'ASQC-:@3>)=6\4ZJ+K6KR$^1M6T=FFKM[*.J]5OOW
MNW<T:]HHM-)ZQ:;26FMT_/F^]V6EC]FOVQ?%'AGP9^R;^TOXG\9:WI?AWPSI
M/P(^*TVKZSK.IVFCZ=9P3>"-;M8_/U*^(M+5KBXGAM;=Y0X>ZGAB2*61TC?^
M?S_@E1^S)X[_`&J_AIX6_:'\.?M%_M$_`_X<V7['?[.7[+GAKXE?")]+^&_B
MO]I3QU\)_!NL/XI^-OBW3_'_`(5\:2ZOIWP>\0^+9O@K\*KZYMFTOQ!8_#[5
MKZ[76/#<^D:=:^<_MVZM\=?VV/@?\-OAC^V3IW[0OP@TW]HCXI?`_P""UO\`
M":W^`GC7X(?LS?!+X@>.OB)HNFW'Q-^,'QLF\;Z]XC^,EUX>TBVUAOA-X4UN
MY\+?"Z_^)>L>#7\1^#;_`,1:=X=U+3OZF/A/\+?`OP0^&7@+X/\`PRT"S\+?
M#[X9^$]"\$^#M`L(DBM],T#P[I\&FZ?!\B)YUPT%NLM[>2`W%]>27%Y=/)<S
MRR,?')/5**371MR[]K6OWOUW0W^[A:]Y2;U5K)*S[7;;]%H]]&?GCX$_X)P?
M%SP7\9OA?\5-3_X*A?\`!0;XD:#\/M:.L:Q\*?'_`(W^%#^!/B%'$4>WT/Q7
MI_@GX4>"8;S0Y7\U=4@NK:]O[J!TCT[4M&DB\]_U/HKYD^*W[9/[-'P1\8CP
M'\4/BIIGA?Q);V7AO5-?B.B^*M8T?P'HOC#5;K1/"WB#XI^*?#^A:KX6^$GA
MK7]3L-0M]*\2?$W6?"6A7BZ;J=S#J#6NG7L\%I**[+S?^;\C.[E;2]E962V^
M2/INBOS$^./_``5.^"GP*\1?M.>'-<\,^*=>N_V6?B/^Q[\,O'/]ARV#/>:Y
M^V'KEII?A:2QBNS`L,/A#3[K^WM?CN)O.O+"/R]-62XGMDF^IF_;%_9@3XO3
M?`5OC9X&'Q:M_%MGX`N?"']HRF>V\>ZAX<_X2[3_``-<ZJ+<Z#;>,[[PYC5+
M/PK/JL>O74+)'!I\EQ(D+',GI=::?.[5OO3%RR2O9VWO\D_RDOO1]*T5\H^(
M/VUOV;],UOXK^!M#^*G@WQ9\5/A'X:\?Z]K_`,-=+UR"/7;J_P#AMX:_X2CQ
M5X8TZZFB.FWWB+1+![?_`(2'2=-N-0U/PT)9)-;L+,6=VL.#\"/^"@'[)7[0
M?A-_$W@?XX?#KS-)^#VB?'/QIINH^)K72QX*^&^J:<M[?^+]8U36DTG3I/"7
MAVX6ZTWQ!XLMIGT+2+VUDAU2[L962,EUW6NVO:W^:#E=KV=MOOV^\^S**^0K
MK]OW]BNSCUN6X_:<^#RQ>'9-/.L21^,=.G2TTW4[2#4+/Q.K0/(+KP,]A<Q7
MLOC^S^T>";6T+W-WK\$,4KIZKXJ_:,^`W@?QMH/PY\8?%_X>^&O&_B6RTS4=
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M44Q!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`5Y%^T!\5%^!OP)^,WQH.BW'B/\`X5-\+?'OQ'3P_;+J#3:Y+X+\+ZIX
MABT@/I6FZQJ%O'J,NGI:37MOI=^UA#+)>O:RQ0.M>NU^97_!1_XKZ[K/A_P3
M^PA\'[V-?V@OVXX/%7P[L;M]'&N6/PO^`=IIT=K^T!\:_$EM*R6<.G^&/!^K
M_P#"-^&(+IVFUCQ[XJ\.6EI;3P6^ISV2D[)O[O5Z)?-CBKM+[_1:M_)'@WA/
M7/V@?VZ_VY_@I<?%7]GO5?`/[$W[,GP?^&7[6?P\\7:G]GUCPQ\<_P!K/XJ?
M#;PQ-X'BM[W4M.MQJFB?LYZ/X]^)LNDQZ5:07-E\4M$\/^,=8DM+FQ\)6MO^
MUU?*/P`_8N^!7[-<WA[4/AO9?$*;7/#?@*#X<66K^-OC/\8?B&@\-HF@?:HK
M;P]XW\=:_P"$M'GU"?PSHUQ/+H&@:4(/LBVE@MI8$VAB_;M_:8NOV./V/_V@
M_P!I^Q\)P>.;_P""_P`.M6\8Z=X2N]4DT6SUS4;>2VLK"TO=3AM+Z:ULA>7L
M$UXT%K)/);12PPM%+(DT:BFDW+=ZOKTVT2V_X.[&_><5%=HI6M=]]WJWJ]?+
M9(ZK]K7P3\&/B-^S9\9?!/[0OB71?!7P<\0>!]5L_&_C?Q!KVG^%=/\`!%B%
M2:Q\:+XGU2XM+'PYJ7A/6(M.U_1=<GNK;^RM9T^PO8YHY848?BW_`,$W/^"Q
M_C3]H;3_`-DGX(^.?`_ASQK\1OB-^T?^TA^RGXC^-VB>/]-C\+>.M*_99^!6
MM?%EOC[X3T;2+/Q3_;B?$JSTK3--N["'6['0(M<N]1U?1M<N=&O=-MH/VK_9
M>^+$W[2O[*O[._QR\1>'=,T:X^/W[/OPD^+&N^$H)'U71M*F^*GPY\/^,-3\
M.PRWT*OJ6F6,FO3Z9')>0*]Y:Q!KB$&1TKX:_;M_8U\->$?!6B_M@_L<_L_?
M#'2?VR/V1=?D^-_PRM_`WP_T3PYKGQD\/Z7X;U;PO\6?@-K4WA'04UGQ$OQ5
M^#NM^,/"/A&T*3WVG>.+CPK<Z7<6*I=^>I<UU*+TZKJU=/\`*]MGJ[/4<6M8
M26K>CO\`#*UONO:^K5ELS]9Z_$C]OC]F+]M[]I/5/VKOA5X5M+S6OAM\9/@X
MGP__`&>M<T_]HV[^`_PA^&[>*/AKJOA3XH_\-'^%/A_X7N?BU\6M8N/%%P^O
M^#]/DM_B;\/=6T231O!E]I/PWL)OB%JWC+]7_@1\:?`G[1GP9^&/QV^&.I-J
MO@+XL>"]!\;^&;J:/R+V*PUVQBNSINK69)DT[7=&N'GTC7M*N-MWI.M6-_IM
MVD=U:S1KZQ5-*2WT>NG7_@"3<7MJNZU333\K/2WI='X]_'[]F7]ICQ/J/[:$
M7@CP%X6U>P\??M??L"_M7?"+6%\=^&--U/QIIOP6M?V:M`^+_@#4=/\`%GA3
M7]&\+^(_#%I^S9/K/AJ[\1:?JWACQ0GC[2[6.\T^\T_6!8\_\4/V5?VN_B_\
M:;._\11:L=%\#?MQ_!7XX>&]>;]H"/P!\`9?V=_AO\7_``Y\2[30]'^!7PV\
M%W.M?$GXWV6D>&X],\0W'QZL8[*Z\;ZQ=>*?#7Q7;0/"O@CPQI7[244G%/J_
MZ;?;S8^=Z:+2WX**[_W5Y:L_(;P]\*_VL_"GPJ\;_LG:?^S;X"U/PT?$7[4^
MH6/[1.J?$WPDWAO7O"WQ@N_BKXW\)WOA'P1%"GQ"T3XM:AK/Q%TGP9XFM/$N
MFZ;X0T4:=XKUJW\=^)=/ET:+5>*_:D_81^-WCSP'X5T+X;^'?`FIR>'/^"1_
M[9'[%5UH4GB&V\/6=S\4OC5I/[,6E>"M-TTW&DBP?PV\'PT\<R_;[T:?I]M-
M!I]I?MID&KF]MOVNHHY5:UW:R2\DK:;>6[N_,7.TT[+1WMK9O;6[_P"`?G!\
M<OV6?%/BKQ+^U6_@3P5X6@\-?$7_`()QVW[+OPQL;=]!TBSC\6V][\?EB\&P
MZ>?(CT+PS%IGC7P5;1RR16VA+!MME(32Y$A^*/B'^QO^T<EQ^UW\*-6\$?M"
M_$CX<?MC:I\$/$-MXF^`OQ0_9`\`Z%X)TSPG\`_A7\$_%WPX^*6O_'70M2^,
MO@]-.U7X:3>(M,\:?!#0_BS<IX?UG3KWP+IGP^\>V/B"Y\3?OM2$@`DD``$D
MDX``Y))/``'))Z4.*?=>GG?3\04VNB^=^G+Y_P!U'X4:I^P;^T=%\)_^"C6@
M^$;#1=%^)WQV_P""A'P3^/O[/'CS6-6\,>+M7L/`'P\U3]D"XA\=ZU/X@NKD
M2ZGX7G^$GCG6SX9\23_;]=FTXP-:W,GB")+K]"_V6/AOXW^'/Q3_`&Z;CQ3\
M-QX+\/\`Q2_:LMOBY\.?$5CK'A35-"\?^%=9_9U^`?@?4=9M+;2-9N/%.C:Y
M#XW^'GBU_%.F^,?#7AQAJE^+OP]=>)M)N1K#_8,^H6%JL3W-]9VZ3J6@>>YA
MB690%):)I'42*`Z$E"0`ZDG##-*X\1^'K2">ZNM>T6VMK:&2XN;FXU2QA@MX
M(4:2:>>:2=8XH8HU:2221E1$5F9@H)H44K>6U_G_`/)?D#DVK.WKU^RO_;5]
M[^6S17F6J_&OX-:%X7U3QQKGQ;^&6C>"]$;2UUKQ?JOCWPKIWA?2&UN+1Y]%
M75/$%YJL.DZ>VKP>(=`FTL7=W"=0BUS1Y+03)J=DT_,>"OVH?V9_B3K:>&?A
MU^T3\"_'WB22UN+U/#_@KXM^`/%6MO96@4W5VFDZ%X@O[]K6V#H;BX%N8H0Z
MF1U##+NMKJ_:XK/LSW2BOF*;]MG]C*WFEM[C]KC]F*">"1X9X)OCW\*HIH9H
MF*212QOXK5XY(W5D='4,C`JP!!%>CZ#\=_@?XIUC2_#OACXR_"GQ'X@UOPU!
MXTT70M!^(?A'5]8U?P=<F(6WBS2],T_6+B]O_#5P9X1!KMI!+I<IFB$=TQD3
M)==U]Z"S[/[CU:BLO^W-%_Z#&E_^#"T_^/4?VYHO_08TO_P86G_QZBZ[K^O^
M'7WB-2BJ$.JZ7<RK#;ZE83S/G9%#>6\LK[5+-MC21G;:JLQP#A02>`35^F`4
M5075M+>86Z:EI[3F3RA`MY;M,9=VWRQ&)"YDW?+L"[MW&,U8ANK:X:9(+B"=
M[=S'.D,T<C0R`L#',J,QC<%6!5PK95AC(.`">BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`9)(D,<DLK
M!(HD>21V.%1$4L[,>P5023V`K!\(>+?#7C[PGX8\=>#-:L/$G@_QIX=T7Q;X
M4\1:5,+G2]?\->(]-MM8T+6M-N``)[#5-+O+6^LY@`);>>-P`&K^:;]D7Q7X
M6UF^_8TU']G3QC\5_B#^U9XF_:-^/2_MKZ;XU^(_Q<\57>G?L[#0OVD['5-2
M^,.CWUYXF\/>#O`\'BK3/A5-^RB=5TGP_:>++ZS\-Z;X.U0Z9K'CS4*\L^/>
MLV,'[+G[-OPEUZZ\1?"[XX?"[_@E)\#+KX>Z%\0?CA^T1\'==\5_$K4O@_?Z
M;#IG[,/P.^"K:3XE^+G[0_@+6]%2Q\77%\=;O/!8O?#>@7_A&"QU+4M3,<_E
M_6G7RN[FGL];7>Z6R[M;-K3JG?5=.W]9M%?RR^+/BGK6EC]FOXP_'#XT_%#Q
M-\;_`/AE;_@G7J'C/]FW4_BI^T'^RY^T#<_%&2QB\1^-]<_9E\'6VE:1\%OV
MJO$WCOQ=XYTVQ^-?PZC\)^+=3T/4-!NOAQXG\1>#+K6-$TO0_5?CE\*/B!?:
M3^U3\>S\;/VBH_'T?_!5[]G#X/?"RW\$?&?XP^%=/^'OP1\<?&[]F'X,_$7P
M!I?@_0O&2>#=2TSQ%HOQ)^)NM-J<OA?[?HUUK5E=:=<VL_AZQND.?LO/Y6OO
MJO*WWV%R:I-VOW7G%=]O>O=VT6ES^D6BOY>_B#X^M/@Q\:OVI?V6?B%XI^,V
MB_`+1?VY?@%:_!#6?B)^U5\5?@Q\+/#&E^-OV-?"?Q,\7:5\7/VH-5G\8?%B
M3X6ZCX\TOQ/=>#O!6D^);"P\0_$.UG\'?\)/X>MYKR-OU#_X)$^*?&7B?]DO
M5X_&7C34O'__``BO[2'[3O@KP?XDU+7_`!MXL%Q\-_#/QJ\76'P^MM)\5?$E
M1\0/$WANS\*C38/#&N^,)KO7-2T!=.N+F]ND>*9FI7=K6T;^ZW3Y_AK;0'!J
M/-?33Y\RO^'5'Z@T4451`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`44R22.&.2661(HHD:2661E2..-%+/)([$*B(H+,S$*J@DD`$U\9
M^-O^"C/[!'P\5D\4_MD?LV6^I&?1[:V\,Z1\8O`WBGQKJ5SK^J6NBZ/;Z+X%
M\*ZSK7C+79[_`%*]M[>"'1M"OI-IEN'5+6WN)HDVENTO4:3>R;]%<^SZ*_/2
M7_@I1\'-9?2XOA/\&_VR_CG)JUAK]_:S?#S]C[X\:#H@'AZ:WM[BTD\8_&3P
M=\*?`_VV^N)I[?38(O$LHN)]/OXY9+=H4$LFD?M2_MB>+VUL^&/^";WQ*\-V
MUGXABTK0[OXU?M`_`3P"NM:+-/#CQ/=6?@7Q!\8=4TBSBLI7N+C318:CJR7,
M$EBEI*Q6=CF3V=_1-KONO(?++JK?XFH_FUW/T'HK\OO&WC7_`(*36'PRF\3>
M/?'7_!.S]D:ZELM.MI_$/C#5OBM\8=`T'Q!=ZH%6TFUC7M4_9^T":.[LHQ:6
M<;O/-<W=VSQA&MDBE^/?B/\`M)>%;F\M?!OB/_@O!X8F\6W'B37M>'A+]C3X
M)_`CQWX[31?"5JY\2^#9O"OA/1OVF_&MG!9)J$A2:]LX_$$\MA;+:O>W>E:L
M;E<R71KULOS:?Z#4&]FODI/M_+%KJ?NSXZ\;^%/AGX)\8?$?QWK=GX:\$>`?
M"^O^-/&'B+46=+#0?"_A?2KK6]>UB]:-))!:Z;I=C=7D_EQR2>5"PC1WPI_-
M/]@30K[X@R_%#_@IW\>+2R\'>+_VLM#\)-\&]%\4:AH9/P(_8IT.U@U#X,>"
M9=:=`FC:]\4[S5+SXY_%6RBU=K'_`(2CQCX=\,W5N+OP';SR_#>M^`/V7?C9
M?:WX)\:_#S_@M?\`M]>&+WP]HWA#7-#^(\7[0WP>^#?B?1?%>HGQ#IU_J.A^
M-M5_8U^'WBL:'?6!L+W4[_3-1&EPW%O-J:W%DNGZI;=;HO['_@;5M(CT3PO_
M`,$.]`U'PWIZQ_#G2;3]K7]I?X:W87P)X5BAM/"NHSZ0FN?M,RV6ERV\5OML
M;5+W5;-(YE9+R2-4GF[;6BLNB;>NFND6M+]'U]+-1233>KL_LK3>RYI)WOY7
MTMM<_7KQ=^V7^R)X!AUJ?QK^U'^SUX7'AS3;C5]<@UKXR?#VQO=-TZUL#JDU
MU<Z?-XA6^5!IX^UHJVS230,CPI()$W?CA_P6&_X*#?L>?%;_`()C?ME>!?A9
M\:]&^)GB/Q7\"Q-H4?@#0/&7B_1KJTUK7]"33[^;Q7H/AR^\*:?ITB,+B2^U
M+6[2UAM6CN994BF@:3Z$\&_L]?M?^$=/\$:5\$_^">G_``22_9AT6PN/["\4
M1W?Q)^(GQ8UBT\&O?63E?#.F>!_V0?@A92W-FD5UJ46D:MXS>SUJZ6PM)[WP
M\89-0/SU_P`%=_!/[>EC_P`$K_VSV^)_QP_8]A\"Z9\);Q-0\$?"?]D_XO:)
MKMUX1L=<\/\`V71M$\?^*?VP-=T/P[?20QK837<OPEURTMK-':PL8)YH'T\;
MDT^FC^R^W1N4=?DRJ:BIT]6WSQ^TNZZ)2_-=NY]0_LU?MW>`?#7[+?[/GAGX
M'?L=?MT>//"_AG]FWX7VGP_TWPO^S7XNT#P_>:-X9^'FD:=H/A?2/&?Q9U7P
M9H%Q*;#3;.STW6+W7Y=%U*.:UNH-?O8Y);A?H30_VJ?VL/%T>C7^@?\`!-OX
MV^'='U;1TU.2Y^+/QM_9B\$:OIUT[G;I5]X:\-?%+XBZQ;71A,;G[7#:M%+Y
MT-Q%"(XI9_$OA%^Q/^T-XY^%_P"S[K/Q._X*5_M8M;^'?AQ\,[H^$_@GX=_9
M^^!/A'75/A#PT-;L?$)T?X2^)O'&I:=JTM@K6B_\)U#J'A^*[U&/2=2BENS<
M)ZEJW_!,/X$^,=:L-;^*WQ4_;"^,9TG6[?Q!I.B?$']K_P"/;>$]/OX9`]S&
MGA/PCXT\)^'KO2]318K;4M%U+3K[2+BTB%JEE%#+<I.+F:6ZT7\J73RD[[_U
MM+Y+_?MS2_-PU[GR!^S_`*!_P4+_`&9;G]IV#0?@Q^R1\&_A5\3_`-H;Q1\9
M?@[\/_V@?VT=6&@?#7P_XUM-`N?B-8>%=(^&?[,6N/8Q>,_BW?\`B/XDZ[87
M7Q!_X1WPSKGQ%MO#GAK0W:WU+Q-XN]`N_P!HW]LE/&6JV7CK]NS_`((Y?`[P
M=>:3*VBV46C_`!+^+?Q!TC5E@L8'@N+OQ)^U7\`=`UJUCNVU.ZCU<>'=,-N$
MTZQN/#M]ONKH?2__``ZH_P""<4NF0Z/J7[&7P$\1V-N+@1#QCX'L/&MT$NKF
MWNYXFU'Q:=:U&2%[FSLYA!)=/"CVEKY:(+:`)[WHW[(W[*7AT:4-"_9F_9_T
MAM#%B-&ET_X._#RUGTPZ8(O[.DL;B+PZL]M+9&"%K::*1987B1T<.H:FHR22
M_#F>[=^B3?4.:/;7ORJ^EK?$Y=M>]]S\;O''[5FK7\FJ>!KC_@OS^S!X5\?^
M#)9M;\11_L]_LH_![Q+KLVB/86;P65[X7\7?%3]HMKJ&-M0M;@7/AZ&VOKBZ
MNK*R4AB]M<YWB7]J3X:V?A#1K_6/^"L__!3/XFVNL:WJ;6FM?LZ_L/\`PAO;
M9;73[J46UEJ+^#_^";OBF_MDAMY%L+^[.N0VVJ:C:W$T%CII1;*V_H!T3P3X
M,\-74E[X<\(^&-`O)H&M9KO1-`TK2KJ6U>2.9K:2XL;2"5X&EAAE:%G,9DBC
M<J6C4CIZ.5_S=OYW^+G^B\PYXVMR_A37_N._XG\_=K/X(^,@\`>++/XP?\%Y
M/BYH\&FZN]C:^'_"GQ+_`&:/#^MVL\"V,VH>*[SPA\)OV7QJMW'?01WFDP+K
M+7=K>VT\=I8Q:/=:C97N3+\/_#NL_%"R\/VW[$__``7%^)ZF^GU'2/'GB_\`
M;O\`BCX"\"V=L([GQ"/#-V/%'[?7@)4TC2GCET2S/B72+J]U>5H+2YU;69KI
M+B7^@B/6='EU>Z\/Q:MILFO66GV>KWFB1WUJ^KVFE:C<7MII^IW6FK*;V#3[
M^[TW4;6SO984MKJXL+V&"5Y+6=8]*CDONUO?9/M_-S=N_7R$YZ62:7JUO9].
M5?AV9^#'C3]G5O%5BO@[5O\`@EQ^W/X]\`:U;VUEXKT[QY_P5`@NX;JR6[C:
M>*7PM>?MZ^)M'\2+%%#%>11:KJ>G)<WT:1R-;A1>CD?A-^Q1\-_"/]LZ58_\
M$(]$TJRU2.*ZNK[XO_M._`SXPQ2RVW^C)8:7-XL^(OQ4U;1_/ANIIKBWT^#3
M-,O%@+7TDMS%9HW[[ZQXI\,>'K>ZN]?\1Z#H=I8W&CVE[=:QJ^GZ9;V=UXBU
M&#1_#]M=3WMQ!%;W&NZM=6VEZ/#,R2:GJ-Q!962SW,T<3;U'LX_U&'E_=\OZ
MTL<[MY/SE;I_>/P$\1?L;:3J^I7>GK_P0-_8?UOPYI?AV\'@V\\5_%CX"Q72
M>)F728[/2M3T>W^"?B*W\.>%ID2^&HZYHE_X@U6VBT[2Q;>%=1:[DCTWN/#/
M[%?B2TO=;\-1_P#!%W_@C[X>\/\`AMM,M_#VMW?Q5L;[3_%,%]9F\OI=*MK3
M_@G'J.O6*:/>.VG7:^)+'2IKFX_?::MY8XN*_<.BGR+^E'_Y$.=]O_)I^7][
MR_K2WXI1_L0^.Q]M\[_@E!_P12D\S5;>;3O+\2:Q%]ET1;BU:[T^]W?\$[9O
M[0U6>U2]AM]8@_LVTM;BXM;F70KR.TEM+[E9OV%?CBTTK6__``3!_P""%$5N
M9)#!%-9>+YYHX2Q,22SI^Q/;I-(B;5DE2W@61@76&($(O[KT4<B_I1_R!5&O
M^'GTM_>\OZTM^(&G?L&?%.6POY-7_P"";7_!$"QU.-H1IEGIW@SQ%JEA>(S?
MZ0U_J-S^RIH]QIS1+S"MOI>J"=OE=[<?-6=?_L(_&F.]NH],_P""9O\`P0OO
M-.2>1;*ZO]`\5Z=>W%L&(BENK"W_`&/-5@LYW3#26\6I7T<3$JMS,!O/[H44
MN1>?X?Y>7Y]V"J27_#RZ6_O>2/PTTO\`88^,<-_;2:U_P2X_X(9ZAI:LQN[/
M2_\`A*='OYT,;A%MM2N_V&-<M[5EE,;L\NE7@>-7B"(SK+'T^E_L1^,(K79K
M7_!)K_@BU?WOG7#?:-+\7:II%K]G:9VM8OL=W_P3BUN;SH8"D=Q/]NV7,RO/
M';6B.+>/]I**?(OZ4?\`(.=_EUGTM_>\OZTM^'$/_!.C3K756URS_P""/W_!
M':QUAY[FZ_M+3_BYXHL+Q)[P2BZDAGL_^";L#P&=9YDD6$QJ8Y'CV^6Q6N'\
M=_LH?%GPOJ]MI_A7_@AS_P`$SOB5I\VFPWDVN^'?VIM.T.RM+R2ZO(9-)EM/
M&W[$/AK59+J""WM[Q[BWL9M/>*_@BBNY+F&[A@_?^BER+^HQ\O[OD@YWV3^<
M_P#Y+^ON/YM-(_8_\76FIW&LZW_P;E?\$ZX'L[/5]5MKKP7^T3\#-6\5W?B&
MWL+J[T2WLU\0_LQ>"=-B;4=;6SMK[5;OQ-9OIEK/<ZG%'?W%M'8W,?B_]A3X
M4>--3&L7_P#P;W_\([?LLHNW^&G[5_[.OP?@U66:XENI+S7;'X3_`!M\%V.O
MZD9IYBNJ:W;7^HQI(\,=TL+&.OZ3Z*.1?U&'E_=\OZLK'M'T5O24_+^_Y?UH
M?SN3?!,?;?\`A'O$?_!-'_@J]X<NM/T277[&'X5_\%2?&.I^!X='@?1O#MKH
M=IK-C_P4,\'V$&N1FV%U;>#;;3G>UTU+S6K9F2\O1'R&F_#_`$OQAI,]E:_`
M7_@X;_9.T[PR+G4RWAK]K+Q_\0KKQNVH1YN(#::O^U%\?[Z.71$TY'M;?3K3
M0;B^DU9H8QK$D<4-E_2E11R+O_Y+'R[)/IT?Y)`IM?\`#R\M=6^WWZ]$?S:6
MNM^'?A7X)U/5+[]JK_@X=^$'A73M5CNK^Z^(7P$E^-FJ7][K(T_3(7M]=\??
ML?\`Q_\`$]AIT+VMI!!HMCJVCZ/;W=U=ZA%I375_J-[+7A_:H\/ZMX3O(/A]
M_P`%>?\`@H_\&Y?#VH65YJ_B_P#:L_X)V?#/6-"OM,U0WEJNEZ7/K/[`OPEN
M6U,ZF;!H[IO$U_;V=N#9'1Y)=2MKNS_I3HHY7:W-_P"E?I-?@/G6_+K_`-N/
MM_-!]NK^1_.3H7[=$_@S2-,?5O\`@N]^RW?6=EJF+S7?VGOV%;/P9JGB.XGE
M>\BT:SF\,?&K]FK0YM.@LK>6"1-"T"76(H6>:YUI)W@=.M^"_P#P4&_:D^(-
M^OB(?M__`/!"CXB^`-,O[[2]<L?!GB#XU?#WQ!/??V69[*"S\0^*?COXVLM.
M:VN+S3+^\,GA#6([RR6XTZ"6RN;A-1L_WOUOPWX=\300VOB/0-%\06UO*9[>
MWUO2K'58()RC1F:&*_@N(XI3&S(9$57V,R[MI(/`:[\`_@7XHLX]/\3?!;X3
M>(K"*Y2\BL==^'/@_5[.*[CCFACNH[;4-&N(4N4AN)XDG5!*L<\T:L%D<,E&
M2^TOOEY=Y2\PYX]8_A#R[1C_`%ZL_-2#]L+]O"ZA_M/X?>"?^"8?[25O?ZPG
MA_0/#?PC_;Y\6>&?$FIWUS>1PVMPNH^)OV?M?\-R3QQF.&Z\.V=Y<ZG)>7]L
MEE=7*P.+CT32?VIO^"DVEV.H7'Q"_P""6EO=7$2-<:?%\&?VUO@OXZBDMH(7
M>XBU'_A8WAOX+W\&I22!5L+31].UZ&Z4MYUW:3"."7Z%\9_\$_\`]AKXA?V-
M_P`)G^R#^S;KS>'=0_M70I;KX,^`(I])U,!`M_87%IH-O/;W2>7&8YHY!)&R
M*Z%64$>%Z[_P2`_X)\:Q9O;:=\#M2\"73SI-_;OPN^+WQK^&/B=%4L7M(?$G
M@;XB:'K,.GW&X"[T^*\2SNE2-)X76-`':??\5Y=X/SZK\;A>'\MMNC?W_O$O
MP.0L_P#@IA\6HY[%O$G_``2F_P""DWAW2)+JR@U;68/A_P#`SQ>NCP75Q#;S
M7_\`8/@KX]:_XMUBVLVE\V:+1/#]_?FV22<682.39H'_`(+%?L9^'?$;^%?C
M5)\=OV8-2@G:VO[_`/:8_9U^+WPA\&Z5,;2WOK2/5?B1KOA9_AQI[ZE;7=LU
MA'<>+$EFDFCMW2*Y815;G_X)8>!/#>@V?A[X#_M;?\%`/V;[&SF>40_#_P#:
MP\;_`!`L9OM$UU<:CYFC?M'0_''0X9]2FFMFN+VSTZUO8%T^WCT^XLDNM5&H
M[EA^Q+^TUHFG:?X9L?\`@IE^T9XO\$V,>R?0/C1\&/V0?BIJ6N;KR;4)4\1^
M*I?@+X;UO5[=+N5&LE>6&YL(;:TMHKQH;:%4%S]==NSMM?K'S_X(>X_+YR3T
MMY36NK\OS]L^%G[?W[#WQNCDD^$_[7'[.WCMH[^XTPV^@_%WP1/?/?6EC'J=
MS!#I\FLQ7UP8-/E2[E>"WDB2#>[.!%+L^C_#GCWP-XPFN;?PEXT\)^*;BRC2
M:\@\.>(]'UN:TAE8I'+<Q:9>73P1R.I1))5178%5)((K\LKC]BG]MVV\.W6C
M:S\;_P#@G5^T"TOB=M7T]/CI_P`$T+_2CH>F_89;6WM[:?X;_M7Z5HM]>61+
MA+JX\'P7MP=4U1_[3MK1+72Q\U6W_!/3XKZ?K.H:YX^_X)<_\$H?B)XHUGQN
MFKWGQ*_9X^-_QC_95\3RZ79F/[-K.K>'C^S/XTO[C6I;AKO5X]%MOBU<:397
M<EG8M=74VF1^)+H3EI==//?3MS>?J'+#=2^6E^G\W)?=G]!U%?SSVG[/OB_P
M;>>.KD_\$_\`_@IG\(=:\5^-[73;G5?V._\`@ISH'BWP+JGA[0(5M])\6Z9H
M_P`0?VN_A#<Z%I]Z)-89M#N?A'::A#:7,%Y*8=<U2ZL=+S?"?C7Q?X=;Q;JM
MA^TO_P`%WO@'=ZMXKM?"FG^%?CG^Q#HW[47AW0K32UCD75/#]_X;_91^/4\_
MAZ^\W4+,>(KKXG2ZQ?W-@;[43?:8=&GU(YNZM^';^9+O_2%R)[2[=+[V_E<O
MZ1_1517\^/@[]OW7[#Q#J9T[_@L)^P!KVA:CKVJ16_@?]L_]F7Q1^RU\5/"=
MCX8D73-7TJ"XU'X^_!2XU.^;5;@+?7NN?"6S1/L\,>F6[+]L8_8/PH_:F_;.
M\;):W'A3PO\`\$YOVI_"FOZGXEN/"?Q&_9X_;9\6^&EU/PSI,D=C9/-X"U/X
M#_%G3)]274K75X=;NM`^+VN6&FRVTEBT/GV#SWS4D^_RU[=F^_H#@U=Z:>J[
M?S)=S]3:*_/7Q+^VW\9_A[IRZE\0?^";7[;*V5K9VCZSJ/PI?]F/XXVT%_<7
M]EI;P:'X>^'O[1E]\3_$.GF]O#<07L7PXLK^+0X9=:UO1M#A@O8;.MJ/_!4_
M]COPMJ5GIGQ/USXW?`Y]2UV;PYINJ?'O]D[]J?X+^%;[4[9'DO!%XW^(GP<\
M/^"XK&QB1IK[5;KQ!;Z9:6^VYGNTMV$I.:/>WKI^=A<LGLK^GO?E<_1.BOD3
MX<?\%`?V%?C!?:;I/PN_;)_9>\>:YK"7\NF>'?#/QW^&6J>)KV+2UN)-0E@\
M-V_B9M=>.SAM+FYGD_L\)':0O=D_9@)3];03PW,,-S;317%O<11SV]Q!(DL,
M\,J"2*:&6,M'+%*C*\<B,R.C!E)!!JKI[.XFFMTUZDM%%%`@HHHH`****`"B
MBB@#SKX2_"CP%\#?AQX2^$OPOT1O#?@#P+I8T;POH3:GJ^LMIFFBXGNA;'5-
M>O\`4]8O<3W,S^=?W]U/AMIE*JH'?W-S;65M<7EY<06EI:02W-U=7,L<%M;6
MT$;2SW%Q/*R10P0Q(TDLLC+''&K.[!02)J\/_:<\*>(/'G[-G[0G@;PEISZQ
MXJ\9_`_XL>%/#.D1SVMK)JGB#Q%X"U_1]&TY+F^GM;*W>^U&\MK99[RYM[6%
MI1)<3PPJ\BK9:+9:+TZ#W>KW>_ZC+C]I7]FF.&_OKOX_?`Q(/#=WID&J7EQ\
M5/`*PZ#?Z]`ZZ/#?W$FO!-+N]9MII%TR.X>";48)7%J)HW8'J?%?QG^#W@.?
MPW;>./BO\-?!ESXQ,`\(V_BOQUX7\.S^*C=/#';#PW%J^J6<FN&XDN($@&F+
M=>:\\*Q[FE0-^26@?\$_=*LOBW^S!K^G_LP>%-$\`_"C_@E;\4_@3'I_B.S^
M'6N:UX)^-6LWW[/^F>"/!VK7<6LZ_)KWBZS\%:7\5]#NO&UEJGB+10EWXE1_
M%UPOB@3ZM^:W@C]C3]ICX??#GP1X-_:3^''[0&JW'C7_`()Q_L^?L_Z?;?#'
MX`_!7]KK5-(\6^!-%\1Z'\0_@#JWB#QK!KMM\$_$.J^)]<TWQIH7CS5/$^E_
M`'4W*:UXD^(GAG6_"KK<0Y26\?GKIMOIUO;?=/T5J$7;WNUUI?7LDWMN_N\W
M_4_XE^)?PIT#6])\'>,/'_P]T3Q)X@OK&TT+PKXE\5>&]-UO6]3E9KO3+;2=
M#U2_AO\`4KZ5[1KFQAL[6:X=K9IK=282R^4_%']KCX&?"SP-I'Q%O?&VB>*_
M">J?&[X4?`&XU;P-KWASQ'8:!X]^+GQ/\,_"K2HO$NH6^L1Z=H=CX<UWQ1:7
M_BY[V[CO-&TBTOI_L4]S'%:3?D;XM_X)QWWCWP#^UG!XO_9YU7X@_$+5/V=/
MV'_@9\(OB)\9[GX1:Y\5?&^G_!SP9HU]XSU&+Q!X7\5:KIGA'Q)8^*[R]C\8
M:EI]]X876O&.B7>H^')M8\.6_A?6;S8_:E_8=TW3OB%\:M-^&'[(>D^+/V>=
M9NO^"4/C;Q3\)/AOX/\`"&@Z)\1O^%$?M/\`[0FN_&Z>VT*ZU/P]X;\8:]X4
M^$L/PYF\1^%;J"35O&FBQ>%_#;2:BM[:V+MRE_+^=^O2WE^*[:BC'3WKZJ^R
MTO%/KI\6E_Y7?R_;O_A9?PX/AVV\7CX@>"3X3O;D65GXH_X2O0O^$=N[PK(X
MM+;6_M_]FSW)2&9A!%<O*5BD8)B-B+\?C?P7+X@3PG%XN\,2^*9(EN(_#4>O
MZ4_B!X'LAJ23)HRW9U%HGTXB_61;8HUD1=!C`1)7X?>!?V7[/XG_`!I\/3R?
MLH:MHW[%OC/]N"R^-WA/X1_$7X867@'0/`5[\,_V,OBOX/U;XN:_\&]9:VU/
MPSI7Q7^..M>&1X>\-^)_"6C3R:KX:B\4ZOX?L)?$6FR:A\O>-?A9\?\`XH?M
M`_LU>+K?]E"^^#?Q+^&'_!5#2?B5\1=*^%W[+'BW2(M/_9WC^(OBCP,WQ'\<
M_MI^(M:U;0_C5;^(/!NI^']=U#PK\''\*Z)H_A+Q[K&B^(_A]-X=^&E_K&@)
MS=E[M[OSUU6UUUOHM]'V8E!/2^MK[;>35[W5FGTO;7:_],EEXS\'ZCK,OAW3
M_%?AJ_\`$$$=W+-H5EKNEW6LPQ6%W)I]])+I<%U)>QQV5_#+97;O`%MKN*2V
MF*3(R"U;>)O#=[K>H>&;/Q!H=WXDTF"*YU7P_;:M83ZWIEM.D$D%QJ&E17#W
M]E!-'=6KQ2W-O''(ES`R,5FC+?@W\!/V.=7\#6G[`WQ-'[-,WA+XTZ/_`,%`
M/VS/&/Q;\=:7IE]HOC70/A'\4?$_[8VI:'=?$&[L[>XU3Q/X*\5Z;J7PC&GI
MXSU>:UTV1_"=RBOJ<L(7RK]@?]E3QEX4^)_[)4?CN]_:/\*?M.?`S4?B3=_M
M!:SIG[)/A;P1X$\0W.J:5XKT;X@#XJ_M8:YH%AI?[1?@#XPZL=`U+P2/!'C/
MXD>.;K5SX!^(5[X:\$WGA'Q/J_A1\[]V\;7MUV^'NEJN9Z>3^1RK7WMO+6]W
MTN]-%K_>7E?^E2BBBK("BBB@`HHHH`***Q?$/B3P[X1T>_\`$7BO7M%\,>']
M*MI[W5-<\0ZI8Z+H^FV=K#)<W-W?ZGJ4]M96=M;V\,MQ//<3QQ0PQ22R.L:,
MP`-JBO@;4_\`@I;^RA=7>IZ/\'_$WC;]JGQ-ID]A9RZ%^R1\+O'_`.T39C4-
M1NKJUM[#4/B%\.-!U?X0^%IXVL;V:^F\:_$3PS9:9;6S3ZE=VL<ML9]:3XN?
MMO\`C^1_^%<_LI^!?@KX=><;/%7[5/QLTB3QA;64,5K,][%\'?V=].^+FA:C
M'J,HOK.V@U;X_>#=1TJR>QUK4]/>_6]\)0+F3V=_37\5HBN5]=/5I?GJ]^A]
MQUEZSKFB^'-.N-7\0ZQI>@Z3:+ONM4UG4+32].MD_O7%[?306T*_[4DJCWK\
M9?B'\3[*^U1_"/Q\_P""L,,7C;2FOKWQ;^SY_P`$_?`'AN'XAJPL[J*;3[3P
MMX6LOVF?VIH=(T:QO[&^GOM-N]*O8[R'^V;^YL]/EM+#3N+\+?`?X&^+K_6M
M?\#?\$T?VL?VH-<U7Q#-XDT;XK?\%`O'$&B>";C5-)U*_CA-WH/[5WQ5\3?M
M`^"M$GN-)OM1\/Z?IO[*5Y!<ZIK&C:AJ.FZ5HNKMX@TQ<W9+3?75?**E^-MP
MY>[WVTLOODXK\S[S\;?\%-_V$O`\VOV$G[1W@CQUKWA@-_;GA+X+Q:[\>/&>
MGN@TMC%/X1^#.D>.O$*2F/6M,F2-M.#20W(EC#)'*R<E)^W3\8?&6H3Z1\"O
M^"=G[8OCB5-).IP^*?B[I7PV_9;\`>8YU&V@TZZNOC/X[TKXF)?+J-K9)?0:
M=\)]5FM]*U%=7M(M12W>UDG\/_"K]N7^P;/1/`=Q^Q/^QEX=O;O0[S4_#/PM
M^%GC#XZZ]HMC9WND1ZAH^C^);W4OV>/`<VJS^']/N]*M_$.H_"/4['3UO[:V
MMO#\Z:+#J.H[<W[#&K^.+?Q`GQZ_:^_:S^+/_"2SF2^T3PW\28?V>_!&GV;Z
M9I&G2:+HGAW]G_2OA]JD>C%M.O+D0Z]XG\1W\TNLW\NH:EJ%XEK>0KWGW^22
MWM_-=Z?X1^XM]?*[?;HN5=]I_P#!\U\3?$G_`(*&N=-O/B3X]_X)S_L1>&3&
M^J:Q/XC\7?$[]J'Q>EA?7V@)H6DJ_B&;]C3P9H5\&'B?0]8UM;GQOI=UJ8TF
M30K9T2Y63X^O_C-\`O'FF:+/XT_X*V_M:_M6SZ]K]C(G@']@?PIHNGZ#K-_.
MGB$67AW23^QK\$_$_P`</#WAZ\MQ):^3K'QZFN9+C3K.]U'Q&\ICG3].O`W_
M``3R_8A^'FH7>LZ#^S'\)M1\07L^GW-QXH\=>&XOBAXM\[2K[4M3TUH/%GQ,
MD\6^([46.HZQJ=];):ZI#'%=WDUPBB4JR_76DZ/I.@:;::/H6EZ=HND6$7DV
M&E:38VVFZ;90[F?R;2QLXH;6VBWN[^7#$B;F9L98DG*WO^;:Z=%RKIV#FBK6
M6WDE^?/KYW/PEL_AE^S'X[U+PSI6B_\`!'W]J3]J;6;+0[+6S\4?VVO#W@_6
M7B$S3>'Y+?QCXX_;N^-.I?%/7O$NG:5,LMEH\'A/Q)_96ESV]II$>EV^G2VV
MF?9&A^&_^"@5M-8:-\)O@G_P3V_9/\!S7>D227%QKOQ7^/?B>S\.VVFZG"NF
MZA\+OA_\//V5?!MEXELF.@6J0Z3\9O$GAW2(X=:L=/U;7[4:;J<OZ1T4U%+K
MZV25_N5_Q#G?:]MN9N5ODWR_A;4^!;3]FW]LSQ3J=[J7Q4_X*'^+-"M97T]M
M/\+?LN_LY?`[X1^&[-;:XU>2]%Y>?';3/VM/&VHR:A!=Z/`#;^,-)@M?[)GD
M%M.VI,;6+P[_`,$Y_A59Z,^F>/OCK^W/\9=0GCNX+SQ%X\_;F_:>\.7U]:WE
M[J-V]I<:#\%_B3\)O`:6R0Z@-,2.T\'VV_3;*RAN#/,EQ<7/W_13Y5Z^K;_-
MNWR)YGT=O1);>ECXY\,?\$\OV$?!_B:#QKH'['W[.%OXSM)[2ZL/&%]\'_`V
MM^*],N+&.6&TFTGQ)K>BZCK6DO!%/*B'3;VU^5R#G"X^K]%T#0?#=A#I?AW1
M-(T'3+=I7@T[1=-L]+L('GD::=H;2QA@MXVFE=Y962-3)([.Y+,2=>BA)+9)
M>BL#;>[;]7<****8@K^(/_@YF^.7[=_[(WB;Q[X)\,_$J]\8?L/?M_?#Z+PU
MJW@[QSI%AXDMOA7\1?!\&CV7B[0/AQKJ6FG:OX/M?$NB:9X=\46NDSZEK.ES
MZC=^+;^"P@N7ED7^WROR._X+;_L&2?\`!0/]@'XK?"[PGX2L?%'QP\$QVOQ0
M^`0FEM++4$^('AA]UWH6G:G=RVL-L_C7PG/X@\)B"\O;72IM1U/2KS47"Z=#
M+#%1.479M-:JWY?-71I2DHU(MI6ND[]-5K\FDS\K_P#@W:_:)_;P_P""B&J^
M,/VG_P!IGXOZU8_`3]G+0=%_9^^"_P`(/`&AZ=X&^&GC?Q]-X;AE\7^,?&D6
MFS-J_C#5O`O@ZX\+6=E9:]/?^'UU?QE%K.D6^F:MX==9OZP:^+_^">/[)?AO
M]AS]C']G[]F7P[:I%/\`#GP!I2>,KY5VR:]\2]>1O$7Q+\1RH-2UE(#KGC?5
M-<O[>R@U;4;+3+*6UTO3[N73[*U-?:%."Y8I-MNVK??_`(&WR%4DI3;BDH[1
M25M%UMY[OS9^7?\`P4A^('A#P?XT_8)\-?%#X[>+?@)\'_BC^U1XB\"?$C7/
M"OQ.\1_!Q/%UK>?LR_'N^\'^!?$/Q(\)Z_X7U_POHNN>/[+PNT=_I^OZ5<KK
M5KI"VE_I]^;/4;/\G=6^-OQWO]1^#/PJNOC"^B?L/6WQ,_;2E^'?[2'QY_:[
M^-O[.UM\:_#_`,-_$7@I/@KH'BS]J_P>4^+/BG3HM!\4?%3Q#\/KVV\3Z=I?
MQ=\*>`=-\27?BWQ?I?AN1=5_I2\??![P?\2?%OPE\8^)UOI[_P"#7BGQ+XN\
M+V$3V+:/J&I>*OAQXR^%VIV_B*RO+"\;4-/'AOQQK,UM;VT]A(FJ1V-Q+//;
M0SV5SV^I^%_#6M:)_P`(UK/AW0M6\.>5:V__``C^IZ1I]_HGD6+1-90_V5=6
M\MAY5FT$+6L?D;+=H8C"J&-"$XW;UMJNF]N5Z^6FWKW",E&VE^]^F]FEW5][
M_)6N?@1\%;3XN_M*>-_V5O@E\3?VP_'_`([^%'B+]B+]K3XK7'Q._9E^+OQ#
M^'^G?$.^\*_M'_";X>?`KQ1KWQ=T+3?AM\1/%&N^!_A]XSO&U'Q%IDO@K1OB
M3XL\/W7B'4M&U/PCJ-_HE_\`/9_:#^/_`,2/!?A>V^,7QVM?`.F^&?\`@G3\
M#OB[^S_XXUS]LW4OV/-/^+/QUO\`5OBAX7^)7Q?\3^)M!\(ZO;?$BZ^'IT?P
M!?>*?A[XQO\`Q5\.].M]3T+6O$WP^\2GXF::+#^I1(88]@CBCC$<?E1A$5=D
M60?+3:!MCRJG8N%R!QP*QM8\+^&?$,>G1>(/#NA:Y%H^H6^K:3%K&D:?J<>E
MZI:AA:ZEIR7MO.MCJ%L'<6]Y;"*XA#L(Y%#'*Y.S]=W?1+OTLVEY_,?.KWY5
MY+:VK;V2WV?EIZ?SA?&2X\;>&OB/^TY\9;#XXS:9^V%XC_8#_P""3_A&X\4_
M#?7+_3M(NH?BM^TY\0?!'Q7\;_#?X?:QI%UK]CX:OM3NH!H4L_AF>Z\-S>+6
M9=*MO$^LH#G?\%.?VC[7X!Z3^TK\-OA5\9OCUX5\;_L8_LC>`_&?@O5?'O[8
M4GPDT72_B;KMK\3?$7@'QMH\/B9?$/Q1_;;\=^+[K0M$\)>+O`'Q%O/%7PIN
MHK6/PS:+H7CC5IK^'^EU],TV2^35)-.L9-2CM'L(]1>TMVOH[&2X@NY+-+MH
MS<):275K:W+VZR"%KBV@F9#)#&RY.H>#?"&K:W8^)=5\*^&]3\1Z9;2V6FZ_
MJ&AZ9>ZWI]G.MRDUI8ZK<VLE]:6TR7EVDL$$\<4BW5RKH1/*&'!VMS?.W36^
M[:N[K6W1=DT*>UU>WG;912Z;6B__``)^=_YWI?BK\2(_&O[57Q5^'_Q6\5:)
M\=_B1;_\$/+*;09-7L(?#T`^.7QF^$'A'QQ<^%_#.KKJ4=KX6U[2_&VK^&KZ
M\@BBT>QN/%7BC3DMTO7-V_J\/[0WCFSU30?B;9_M6Z]X@_:3U;_@HCJG[/\`
MJG['=_XQ\%:/X.@^$$W[5FO_``.L_#LGPA/AZ]\=^';C3?V=;/2/CA:_$":Z
M:]U'55B\=RW5QX,UU=)F_=!_"OA>2:&XD\-Z#)<6UMI5E;SOH^GO-!9Z%J,&
MKZ):0RM;EXK;1]6MK;5-*@1EBT_4;>"]M$AN8HY5Q1\,OAL/'1^*`^'O@<?$
MPZ7)H9^(@\)Z"/'1T28VAET<^+OL']OG2Y386)DT_P#M#[(YLK0M"?LT.QN+
MT][\^][[[^H.:?V;;=G=)123NMM+^5S\1_V8/B)^U/?VG[(7QU^*7[0_Q5U'
M6/C3^WQ^U)\`O$7PL\36OPZ@^&/B;X%:3+^V!>_#&+0O#NB>"]%U;3=?T*U^
M$O@/Q#H_BZWUZYUZ\T_3]4TS6GO]$OS9V7[X5E)H6B116$$>CZ5'!I5[+J.E
MPII]HD6FZA,MXDU_81K"$L[V5-0OTENK<1SR+?7BO(1<S!]6JBK+=O;5[[)?
MI<F3OT2WVTW=UMVV"BBBF2%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`UD1\;D5L=-R@X^F0:^*/BG_`,$V/^"?GQJLM0L_
MB9^QA^S1XDEU,0"[UM?@[X'T3Q;M@U-=85;7QKX>T;2?%^GI-J(>>\2PUNV2
M_6XO+>^6XM;Z\AG^V:*32>Z3]1IM;-KT=OR/SFU/_@EY^SE;+;7'PK\:_M6_
ML^:S::KHVJP:O\%/VO\`]HS0[4CP_:75MH^D7/@?Q3\1/&/PNU'P[9R7$=V/
M#VI>!+S2+B:TBM[NTGTVYU.PU""7]B;]I+PU>:)=?"W_`(*;_M7Z?;:;-J]Y
MJNA_&3P;^S=\;M&\17MY9VUKIJ7UQ/\`!SP1XKL=)TQX9+F72=(\56"7L\H>
M.XL'-R]W^D%%+ECVMZ76VO2P^:75W_Q)2_-,_)/XL_LE_MM?$&YTVT^(7B'_
M`()P_M?^$M'\'W&DV.@?M,?L;:_H>I'Q%K&HV2:_>C6=*^)/Q1T;3M'U'1=,
ML7O].TSP;!%J^J1QQW%O9V5C9LGR7_PPOXK^'FH^-[G3_P#@ESX"\%P:EX@U
MG7['Q'_P3I_;_P#B?^S?J4D\7A@6=IX@LOA_:Q?L[^&[7Q'+.%T_1],CNY-(
MMA#'<7<(4""X_H@HHY%Y_.S[?S)OI_D-3:_X%X_^DN)_-G=:M\8/A;X6T"^C
M^*'_``7/_9KFT.X\"6>M:;X_^$GP;_;Q\+0:5<VIAN]";6?#7A#XV>,]=6WO
M$LKSQ5XZG\376MQ6YOH!<_O[@:9ZQX,_;V^)%EKJZ5H7_!2']@#XEB[AT2ZM
MO"?[7GPH^)/["OQ-FCU7Q#K>G;_#T.O>)(Y/$UE=QZ2=+TNYL?AM*4U1+BXN
MWF@EL+:Y_?2N;\3^#/!_C6P;2O&7A3PWXMTMRK/IOB?0M+UZP=E615+6>JVM
MW;L56:55)C)"RR`<.P*Y6MI/\?+S2Z=4'.NL;]]GV[QOT_FZ[GYW>%_VNOVT
MT\)>'?%?B/\`8-T?XKZ'JL5@]QXJ_9(_:L^$WQ7T2\%WXCETB[NO#ME\2+3X
M,SZM9:-IT4FI:C+!J<V987L+0SW`F%KJ2?\`!3[X->&M4.E_&3X(_MG_``"V
MZ*VN2:Q\2OV3?BYK'A6"V;5FT:SM+CQC\']%^*GA6WU34KF*>:RTR;6([O[)
M"+BZCM5N;$76AXB_X)+_`/!-[Q!(MS9?L??![X<ZC$;!K77/@3I%_P#LZ^)-
M/;3;R*_MFTKQ-\!=2^''B#26:ZABDNVTW4K4ZBL:PZ@;J`>74L'[!?BGP?>1
M77P6_;T_;N^&-MY>F17V@>*?BSX2_:@T+4UT[5-9U22::Y_:^^'?QY\::9=:
MF=7CTW47\.^,]%MY='TG2[*&T@EMOM3"4UUOZV;^ZT?Q;'>#Z6^]?C>?W\OR
M/8O@O^W/^QG^T4ND+\#_`-J7X#?$V_UXE=*\/^%OBCX0O?%MR_GWELD3^#6U
M6+Q7:SS26%XUO!=Z-!-<P0-<VZ2VQ25OJJOQF^*?["_[87CS0]'T3XGZQ_P3
M/_;?TJ"_\/QZ_8?M._L/:S\.O%>KV%G%?6VK^(;+XB>!/BI\2]!\/^-XM-N[
MC2/"]_HWP;M+30UU";4XP9+-K#5/E%_V,?BS\$K[7!X5_8$_:,^$&FZSH#7^
MN>+/^"7'_!63Q[>Z3:ZO/97]DQTK]GC]IO4_V9?AT[>!M-BN9?!/A[3_``;X
MET:TN]6TW2-'T"\A:Z;2#FDMX_@^W9*2^^5EW#E@]I??:W2^LG!_=%['](]%
M?SC6'[3'[1WPEGTO4]8_;&_;5^%OA_7]-\/:'9Z!_P`%&/\`@D[J7Q0\-^&?
M%'B'5K=[>'5OC=^QKIWP2\)V%]I.A:;+I]Y-XD\>:]H5M-<ZWXAUCQ#JBR61
MT3VKX+_\%-_VC?&B:;I?A_PM^P)^VQJ]O,R>+H_V-/VUM*^'OQ)T*.[76[_1
MC-\`?VG?#/AE;&?4;&VT^TM+;4/CFDMXUKJ^ON-.TZ:PL`<Z\U?;9WVZ)M]>
MJ0N26NVF[O9??*RZI:/<_<^BOS:U#_@IY\)/AY#;-^TO\#_VNOV4C)KDOAJ[
MU;XM_L[^,/%7P\T_68M0NK`&\^,OP!_X73\'+;0[B&PU'7K?Q1>^.[30(O"]
MC<>(-3OM-L5!/T?\)/VS/V2OCU<W%A\&?VE/@A\2]5LQ8_;]#\(?$OPEK'B#
M3I-1MEO+.WU/P_;:JVM:9>2V["0V5_86]Y%RDT$<BL@JZVNK]KZ_=N2XM:M.
MW?I]^Q]+4444Q!1110`4444`%%%%`!1110`4444`?('QE_;H_9V^"'C63X7>
M(=<\:>,/BS%_PC[2?"OX1?"OXE?%[QY!#XGN],M-&NM1TCX?>%M>AT2RNEU:
MUOEO->O-+MO[-6ZOEE:"TN&C\]T_]HO]LGXK0WLOP:_8HE^'6D.=FB>+OVP/
MBMI?PL>]1M.N;D7TWPR^%VA?&3Q]9PK=-IUNECKR>&M0FDDO8+J/2S:FX/TM
M\</!'QA\:^%K+2/@9\8]$^`GB>Y\5^'K[Q3X\O/A/I/Q7UF]\%::\LFM^'/#
M&EZ[XFT#P[H7B76E6SLK/QAXDTKQYIVAZ:-1BB\%WU_>6.I:1\F:?_P3-^%/
MB6;3=3_:6^,W[4'[8&MV&LZIXB\CXY_&SQ!IWPW.KZ[%>PZK#%\"?@Y%\*O@
MA-X=\G4]0L=*\-ZUX`URPTC29H=,@:2&TMV27S7TV[Z+_P"2;MKT70M<EM=^
MN[?R2Y5;UDW^GR!\9/V@KK3?$Z:1\=O^"LNA>&M:LHO$>O:M^RU_P3O^#/A+
MQ;\6-6L--_L*2R\*+JVH6'[3'QMNKO3;^ZTJVDUOP_X8^%EYXF7Q!/:-8:+;
M75J=.S_"OP2^%OC_`%:#Q%\./^"6?QF_:)U>UTRWTGP_\<?^"FGQ5U+6[53J
M>F7L\^N6^E_M3>-/CG\;-`LI[NWT^'69_"GP?TFYGL]0>WL-/2RM(M//[0_#
M/X+_``?^"^BVWASX0?"SX=_"[0;.`6MMH_P^\&>'O!^G0VX6%1"MKH&G6$.S
M;;P*5*G(@A!R(DV^F4N7N_U[?S.7X)`Y=K^>R3^44OQ;/SRL?@W^W]X\-MIW
MC?\`:4^$'[,?@:TT[3+6+PK^R)\)-/\`%?C83+,L^J):?%#]HO2_%/@[2;!(
MX4TO3X;/]GY[IK6ZO[_[78WW]G+I^KI7_!-W]G*\%[-\9[WXS_M67FJ:E+J>
MJQ_M4?''XE?&3P5J#-=7%[:Z>_P3U?7[3]G^QT;2[VY:^TG2-)^$^G:?87]O
MINH0P"^T;2+FQ^^**?*NJO;OK^>G3H+F>RT7EI][W?S;U..\#_#OX?\`PQT&
MR\*_#;P+X.^'OA?3(YXM-\-^!_#&B>$]!T^*YO+C4+F.RT?0;&PT^TCN+^[N
M[Z=(+>-9;RZN+F0---([=C115$A1110`4444`%%%%`!1110`444R22.&-Y97
M2**)&DDDD94CCC12SN[L0J(B@LS,0JJ"20!0`^OSY\>?M\:1J_C+7/A#^Q]\
M,]9_;(^+WAU+R'Q6O@#Q'H/AKX)_#34(M.%U:V?Q-^/6O._@G3M3>ZGL+6[\
M'^#3XX^(5F+F26?PC&MK<&/Y#_:%_:G\+?M'Z!\0M=\2_$ZY^'__``3,\->)
MM/\`@]JOC?X/W'CF\_:`_;K^.&H:T_AN7X#?L_3_``]V^,X_A<WB:6'PKK6H
M_"ZRU#QU\9=:TW6M!\,>)=!^%^F>-M1\0>M?"C]DSXG?'KPCI>C_`![\*#]C
M[]E'0HH=,^%/_!/O]G[Q+8^")I/"-K:6]G!+^U1\3/A/>6<>OWFI-!<7%O\`
M!+X.^(M(^%NC:-?II/Q!U[XOZE^\T6')OX>O7NN]]DM[-[]$UJ6HI:R^[IWM
MWD[.[2:M=7DF[+Y]\<?M%?%76-:\1>$/V@/^"B7A/X?^*/#UQ8>(-5_9V_X)
M;?`_5/CE\9M+\/7NFZK%I/A_QG\2?%GA#X^ZU8WUYXKL;R)[W3_A%\*WU&PT
M"QM?MEC'XDN81B6OPS\,'2?`'A/2_P!DC_@MA^T-]NUF<WOB[XR?MW_';X=6
MZ&QOY=0TK6?&NA^*?VW?A[X=CL7)%C;V#?#W3'-C:VXUO2I9[JYGN?W"^&7P
MD^%OP6\+6/@?X0_#KP5\,?!^F1+#8>&?`GAG1_"VBVT:R32@)I^C6EG;%C-<
M7$S2/&TCRSS2N[22R,WH='*]+O\`7MW;_!+]`Y^RMMMIM_A2?WMO;5V/Y\G^
M'>AZ59ZY:K^RI_P6Z_9SO?!GCRTU>RU7X1?MI_%3XS:7XD^S7@GN)M,\'W/[
M8OQ?\#ZYX2OKZ2'[?HLWP[NOMMA;"$6J:,;RVF['X6?M.^,?^$QTGP5\#?\`
M@I#X(^('B#7+NUUC1_V;O^"DOP)U7X'_`!MGTO6M'\/R+X-\._$?P_X>^!7B
M#4-8TO7+^W>/[1\%OBIK-G9^(SIVH7&J?V=IMY+^[E>9?%CX+?"/X[^$;_P'
M\9_AKX*^*'@[4XPEYX>\<>'-+\1::Q26*XAG@BU*VG-G>6US!!=6E]9M;WEG
M=0075K/#<0QR*<G9VTZ*S^^+2^]/I\SG3^)-[:WOVO\`$F^FEFNUSX]^'G[?
M-II'CWPS\#_VR?A7J_['WQK\6RW-AX*G\6>)-(\5_`#XO:KI^GZ;?7MA\'/C
MWI\>F:#K>LLE_(UKX(\;:/X"^(D\=C>O!X4N8[=Y3^A]?CE\;_V5O'_[.WPV
MU_0O`GA'Q7^W=^Q)>:8;;XI?L-_&+4T^*?Q8\!>"=%\,#2+2^_8Y\?>+`/%W
MBK4=(AL[6^N/@S\6O&/B?5]8:WDF^#GCOP7XJ>/PWXKX+]GG]I.X_9;T'X6^
M(K#XF>/_`-I'_@F#\5]5M?A]\+_CIXZTOQ#=_&K]B[Q^WBV[\%Z?\)OVCSK^
MA:+X_P!6^#/_``EFSX>:#\2OB'I!\=_!_P`0V>F^$OB]JFHZ#>Z=XRM!2:TE
M]_W+RNKNS:2M=<T4M1N*:O'RT[OLKMM2_NMOFUY6]C]RJ*0$$`@@@@$$'((/
M(((X((Z&EJS,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`*\#^*_[*O[,_QT74#\8_@#\'_B5<ZF(_MFJ>,?AYX6UO76DAMK:R@N(/
M$-YIDFN6=Y;6EG:6MM>V>H6]W;6]K;PP3QQPQJOOE%`7:V=C\Z-*_P""9_PB
M\!7NLW_P)^,W[6O[/G]L26\S:)\.?VC_`!]K?@FQEM=+U#3HAIWP_P#BU=?$
MOP99027.IWNNWD5IHL#7FO3MJ,LOF!`OS[\4?^":'Q@\;?V=-XF^)W[+'[5+
MV:P)J,_[8?[%_@+4OB%KJZ2?#K^'[EOC7\#=:^%WB?1]>T^ZT(7]QXAMO#EZ
M]]=?94N--DMH#"W[,T5/+':VG9-I?<G8OGE>][ONTF_OWZ;WOYG\V\?[*7[5
MOP0_LC7-._92_:'\"ZI)I\FG^(]7_P"";?\`P4KU3QYX5T:Q:?Q1JLVJ6?[/
M'[<EC\-_"^I7<%U<:-+-I>CW.NZCXAU01A);/3H9[&XRF_;,_:7_`&?K&/4O
M&W[7OQ\^'NC>#KG6-#UC0O\`@I-_P2N^+"^'M7MM-T_3;:PUJ3]IS]D'3]*^
M%YA@U'67@OO$<GBG5K7Q7XAL-'T_0K"ST_5([K7?Z7:*7)VDU^73LX]M>]Q^
MTO\`%%/SO=_-RYOPMY'XQ_"#_@HY^TAXT@N+K0?@9^R]^VIX?TW6)#K7B7_@
MG3^V[\*OB5XHT?PI//KZV&K:A\(/C5'\)9H]42W\-:@EUHEA\3M4O[S59XM,
MT.WU)-/UN_T[W*'_`(*M_LL>'--%Y\?])_:&_9"NEUN+0+FU_:H_9K^,OPOT
M&UO+B^.F6MR?BM#X3\0?`Z]TBYOHKN.'6M*^*&H:4UI87>L&[70Q#J<WT#\:
MOV'/V/?VBI&O/C5^S5\&_'VN"P_LRT\8:IX%T.U^(&DV0:^=(O#_`,1-)M=.
M\<^'&ADU/4I+>;0?$.G3V\NH7LL$L<EU.TG@NH_\$Z9_#=WJNJ_L]_ML?MS?
M`6[NO#NH:/IGAF^^-Z?M0?"NTO[JWU(6^I7_`,/?VRO#G[0/G6POM0%UJ.F^
M'O$/A22]M[:.RLM1TD!)XBTULT_77\/=Z=Y/5A[CW3CZ7\MW>7GM%6\]C[2^
M%_QP^"WQOT0>)?@Q\7?AC\7/#QN&L_[<^&?CSPMX[TA;Q;&QU-[-]1\+ZKJE
MHEW'INIZ;?R6KRK/'9ZA97+QK#=0._J-?@O\;_\`@FG\7_%6K:GXH\:_`G_@
MGG^V5JL=]I7B/3O'"_#_`,>?L"_M26NH:>+^&ZL=/^.?P4U;XER:KJHM--\&
M-H>M/=_#NUAOK+4([^VBL[71'LO+-1TW]IO]GC4-1O=%\4_\%??V<-`M+B/Q
MIJ%OXEM_@K_P58^`EOX?LGUFZU;P?9&YE^*/[4FBZ2FE^$]*M(Y(O&F@:E8Z
M3?H;.*V\4>*-2U]SF:WB_P"O_)5KI\3_``%R)_#+^O*WO/\`\`7ZG]'=%?@Q
MX*_X*/\`[05O>ZKX?\/_`!?_`."=?[7&L^%?$-OI&K^#C\0/B!^P#^T+<Z4T
M5JK3CX0_'U/B3H5QXH2+2_%-_/`_C#POX=U"X6RM;>XT*T@N[A/VB^$WBWQC
MXZ^'WA[Q3X_^&6L_!SQAJ::BNN?#?7O$/A7Q9J7ANYL-8U#3(E?Q)X*U/6/#
M&L6FJVEG;ZYI=[IE_)YFEZG9B\@L=06[L;:E)/;_`('WK3\12BX[_P!?)V:^
M:1Z+1113)"BBB@`HHHH`****`"BBB@`HKB?%WQ%\&^!-1\"Z5XLUJ/1KWXE>
M,(_`/@I)[6]EAUGQ?/H&O^)[;1!=VUM-:V5U=:-X8UNYM&U&:TANI+(VEO+)
M>3002^177[4GP8/CM/"%C\5/!S3Z,OQNC\6Z<;'7;Z^M[OX"V'@.]^)L5KK%
MHB:)8Q_#I?B%X<C\9/=&_,>H:K;:#:!-8L]6@LE=?I]]O\U]_F-)O9-^B_KL
MSZ3HKYE^#_[7WP'^.E_X-TOX?>)/$$VH?$7PIXS\>_#ZT\4?#SXA>`Y?''@'
MP%K'A'0_$'CKPJ/&WAC0%UKPA]O\=^%/['UZS:2P\06>L6^HZ)+?V"37$?!:
MW_P40_9$T7PUX"\:1_%*?Q+X.^(VB>)?%>A>*?`W@7XA^.]"T[P7X.\86W@#
MQ3X[\9:AX2\*ZQ%X$\#Z'XTNX/#=_P"+?&/]B:''JC/"MZXAG>,YH[W5O5>2
M_5?>@L[VL[]K._W'VO17C?QK^,7A[X._"75_BSJ>M^#=.T'39O!\46L>-=>U
MCP_X3E_X3+Q9X>\*Z0ESK7AWPMXVU:&;5;WQ#966AI9>&=3_`+0UF\TVPF-E
M:W<VHVGC>N?M^_LG^'?B?<?"+5?BB8/%>G?$W0?@MK]\G@[QU<>!O"GQ?\6K
M9'P=\,?%WQ)@\-2>`?#/CCQDVHV<7A/P]K/B.TO_`!!//';Z9%<3,L9&TMV@
MLWJDWOMY6O\`FOO/LBBBBF(****`"OS&_;T\7^)OC!XS^&W_``3U^&'B2?PM
MK'Q_\+>+OB'^TS\0=)U>UTW5O@S^QKX.EM-!\<:K:7)O+:_TKQ9\:O%>M:5\
M(?A_J%LIEM;2;XC>++=XD\!WMQ;_`*<U_-S\1_$/B+XI?#;]L3X@>!]:N8?B
ME_P4T_X*!Z%_P35^#OBK1=5\4:Q!X6_9R^`.L>)O@]XZO=#U'3+.QB\*6UCX
M2^&_[:GQPTW7M!N=1T==:\96&I#4M6U"2+2A,GTUUW]%T^;LOF7!7?W6\FWN
MUULKR[::Z'UQ^P]\,O#O[3GCS0?VPV@CT_\`9A^"=WK?PS_X)J?!G0HY-'^'
MOA/X=>&])U'X8^(/VD)-#MQ%;^(/%GQ1M/\`A(-'^'&KZJ;Q/#'PLNO-T>**
M_P#%>HW[_L=7R[\:?V@OV7_V"?@]\/\`5OC'XV\-?`WX-V7B#X=?`GP)=:E#
MJ7_"/Z7J.K0KH/@KPVLEG:Z@^F:3IND:1<7-]K&J/!I&@^'M%U'6-:U*TL+"
MXN5^GXY(YHXY8I$EBE19(I8V5XY(W4,DD;J2KHZD,K*2K*002"#1%):75]Y>
MK\NBTLEV5EL*5WK9V=U&_9=+]7K=^;N]Q]<3'\2OAS-\0[GX10^/_!,OQ7L_
M"47C^[^&$?BK0G^(=KX$GU7^P8/&MSX*6_/B2#PE-KG_`!)HO$DNF+HTFJ_\
M2Y+UKS]S7;5^.O[*OPL\$>+O^"N?_!3S]J&V\%75CXG\`^$?V7OV1=,\;G5O
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M7XK_`!G_`.":_P`6=:U/7O%G[->@^'/B1^S?XX\0W,,VM_%S]B_QYJVJZ1\.
M[J\EC=[C4_$7P$U[2[GX#^-M=OEM[OQ!)H7A7Q/<Q2WGB*[N9/U*K^87P1XO
M\9^`/AI_P3S^/7Q.\2VM]\=_^"<O[;/B[_@F'^U;XUUIO$$W]M_!CXIZ];_!
M32=:U2[N--M9?%E[XCM)_P!D[XN:3XVU8Z='++K.NZG;VT6K>(=1\,W']/5*
M#NONMWLUHGYIWCWTUU*FM;][I]N9.SMZJTO^W@HHHJR`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\N^
M(_P0^#/QATZ]TCXL?";X;?$O3=1LKG3KVR\>>"/#7BR"XL;RSGT^ZMI%US3;
M[]U/8W-Q:.JD9MYI8@0CL#YE\$OV-_V=OV;_`!AXG\9_`WP)=?#6Y\8:+;Z%
MKGA?PYXS\=1?#-[6UUK4-?@O-,^%%SXEN?AMH&M1:AJE^B:]H/A;3=873;E]
M'6]&E!;-?IZBE97O97[VU^\=W:UW;M?3[@HHHIB"BBB@`HHHH`****`"BBB@
M#YS_`&J_@YXF^-WP9UKPQ\/M:\.>%OBSX?UKPK\1_@UXO\5Z9?ZKH'A?XJ_#
MKQ%IWBSP=?ZS;:1=6.LC0M1O=-?PWXG?1[J+4G\*Z[KEO;)<F=K2?X%US_@F
MQ\1-4M/V0-4E^)_A'5/''P&^"O[<NC?%[6KW2=5TZW^+GQZ_;<\$::GCGX@:
M;]DBO'\.Z!=?%:Z\7^+KZUN;?4;ZTT?5;#3+&VN9;9MOW3^TE\6/&GPMU3]G
M&V\&65MJC_$W]H*T^'/B'2)8[/[7K&@R_!SXR^-UTO2+W4+JTLM)U2^\0>!]
M`@@U.[G2VMX6N$N&CAFDFC\>;_@HK\')_!_PM\8Z/X5^)?B.+XD_LG_$K]LJ
M[\-^'_#<6K>-/!'PC^%VD>$I]<LO$/A6ROIM6N_'FI>*_&FE>`?#O@WP_#JV
MHZQXGL/$J6S&R\.:A=++Y;Z]+?@TU^+5RUS)*WF]EU5G>_EMZZ:GEGBK]E[]
MI'X=_&G]C_\`:#^#&E?"[XH^)_@I^R3XR_9+^(?PZ\??%7Q1\+/"C)XLG^$'
MB'3OB-X5\4Z3\)?B9?7<>F^*?A8-,\0V-]X3M-3G\)ZI%J6DVE[K&G+H=W\:
M:?\`\$VOVL/@_P#LW_LX_"?X9Z+\,M?^+GP@_9T\>>#M)^/GP_\`VHOC1^SK
MX\^&OQW^*GCOQ/X_\7QC4?#WPVUO1_C!^S-9Z]KNBZCIGA'QAX.M/$5U?>$(
M+G5/#MZ=99=*^]/#7_!2/PWJ7P`U#]H#Q+\#_B+X;T/5+[X1:%\'M$TOQA\&
M/B!=?'WQE\<]>TWPA\.?`'PQUSP1\2-7\-3^.KSQ?J]AHGB#PYK^JZ+=^%H9
MFUG6##I-M>7-M;\;_P#!1WPA\+/"_P`0F^+'P?\`B)\-?BK\-_$'P%T#6?A5
MXIUSX:VMO=1_M,^,/$7@KX.^)[+XMQ^,Y/A#;^#-=UOP?XPT[6/$6L^,-)@\
M,ZOX5UC1]7@AO&TD:K-HOO\`#IILM.ZW]U-7UT;0TYV223LTO-VT2T:VYK.W
M\UFSV#XW?!#XH?%G]F/P+\*[SQ+X<UCXI:+XQ_9)\8^,?$^I:AK'AG0_$FI_
M`WX[?!SXL?$:]L;_`$#1+_5M(O/$UE\/_$2^&6M='A$&L:CI<5P^D6OGWMG\
M^S_L:?&>[^"_QW\#:GXA^$NK>.?BC_P4$\/_`+5?A[7VM]>TW0]*^&_AC]H_
MX1?$[P[INMVUOX>N=0NOB)HGPP^&4/@^1+-QINMZW!9NWBG1].OIY]-[S5/V
M\YM/\(_!18OV9OCK>?'7X]^*O&/ASP'^SFH^'T/BZ72/AU+;S>.OB;J/CN3Q
MF?A/:_"/0]&U'0-9M?'J>-9M/\0)XJ\*Z9H4%_J^M0V24Y?^"BO@BYMOAGX;
M\-_!_P"+_BOXZ_$OQ]\4OA*GP%TNU\&6WBCP/\3_`(*Z'IOB3XE>'/B#XJU?
MQ=IW@+0=+T70M8T;6].\5VOB+5-%\1:'KFA:KH\ES;ZI$$=XMWOT2UOUM;I>
M[NO/42YK:);M].FK?I[N^VC[:?H?17YM_#;_`(*3^$?'WBWX9Z=J_P``OCU\
M+OAU\4/$WQI^&&E?%[XF:5X'T/PKHGQN_9ZT'XE>)/B[\*_%&D6/C;5?%FCW
M/A;3O@Q\7K1/&$FB2>#]6UOX<^(M,TW59T_L^\ONL^#_`/P4"\`?%/Q]\*_!
M6L?#'XK_``GT[]HW3/$.O?LL^-OB-IWAFU\/?M!Z%X7\-2>-=4NO#%KH/B;7
M/$/A;49_`T-QX]T70O'VC>&=4U?P5;S:S!"D]O=:=!7,N^_JNWYW5N]]!.,E
MNOZUO]UG?M9W/OBBBBF2%?S0_L<^(;RXTO\`X-P?`[16L6G:_P#!W]K#X^:Q
M>01&"_U'Q[X>_9HD\)RW=X8W6SN$\0G]HOQYXB\174UH^K:AXD33]1&I1++K
M$.J_TO5_-/\`LX1K\-OAU_P13U[QMH,WA[6?V5/VOOVI_P#@G)X^U6`7FM2:
M=J$O@G]I+]G3P]%<WMI9Q:8GA[XF_%?X0?!N_EU@!=.M=?U'PUH^F:G?0WBO
MJ.<]X_U]NG?\+FD-I?U]BHOS:7S/Z"?C)\%OA/\`M"_#KQ%\)/C=\/O"_P`4
M/AKXL@@@\0>#?&&EP:MHNI+:W,5Y9S/;S#=!>6-Y!!>6%_:R07MC=PQ7-I<0
MSQI(/R@OO''[1/\`P36^('P._94^'FA:=^UC\!_C))\2K;X$2?%GXRVOPR^)
M7[-VC?#C19?'?B'PE\0_B;XCT+Q/9^._V?\`X=^`(+F3PGXLOM/U'XKZ#964
M?A34D\:QQ:!*G[75_*G_`,%8'\0_';_@LE_P3\_9T2T\0/\``JW\'6_PM_:5
MUR"QTJ\\*3:'^U1XD\4>+;3X.ZG<W)DNM/O/B[X=_9+O]#UL2VZP7OA:^&FV
M4TMUJ4]I*YZ)-:.Z2>FS:NM4UMWV:"FN9N+^&SDT[VNEHU9K6]ENK[7U/9_!
MW[2G_!9K]M37;_7/A!\*_@5X6_9(L5U?3+#XI?#'XOZQ\(/$'QQUFQUHV]ZW
MPF^)OQE^"/Q=\63_``NLH=.GT6Q^)MM^S=\-;CQPNHS^(_`?B&PMDL[G2_`O
M%7[3_P`9_P#@C'\=O^$_^(?[+'[6$G[*_P"TS\2M-'[1%_?>.-(_:^TX?%>\
M\)^'?!_ACXY_#KX]1>)]*^(5GXT\6'2_#/@+QS\&/C3X%\)VGB"U\,:5J?P8
MU?4IX+W1X_ZM=-TW3M&TZPT?1["RTK2=*LK73=+TO3;6"QT[3=.L8([6RL+"
MRM8XK:SLK.VBBM[6UMXHX+>"..&&-(T51Y%^T=\(O"_Q[^`OQ=^#?C.TCO/#
MOQ$^'_B;PU>A]1GT9[.>]TR<Z9J]IK5LR76B:CH>JQV6LZ9K=JZ76CZA86NI
M6[K-:H0<CM\3NMF[6OZ6O;ROL]6]!J<;ZPBHO1I7NU=:W3W35T[>5K:&[\'O
MC/\`"O\`:!^'GAWXK_!?QYX;^)'P\\56IN=%\4>%M2AU&PF:-O*O-/NUC(N=
M*UO2KI9-/US0=5@LM:T+5(+G2]8L++4+:XMH_GK6?^"B/[&&A_M3^%_V)[GX
M\^%[W]J#Q=QI?PHT#3_$WB;4K20Z%JOB5;7Q'KGAW0]4\*>$K]M"T>ZU0:;X
MHU[2-1%G/I=P]JL.M:0]]^"7_!-7X(^!?^"@WQ.\?>,/BP_Q4M?`EG^R)^S#
M8?M1?#[X6?';XQ_##X!_M-?ME^-CXYB^*/Q;^(G@[X;>/?#VG^.?%+?#WP#\
M.K/79M=FN-/\=6/B6#Q)XKTW6[S54:T_I%^%_P"RM^S#\$;^TU;X,_LY?`GX
M3:M8V%UI5GJWPV^$G@'P/JMMIM\ZR7UA#J7AK0-,ODM+V15EO;<3^5=R@27"
MR/\`-1&3DDU:SMK=NZZV73RN]]T3*,8MI\S=ME96;2:N];_)?Y'O5%%%60?S
M&?M):KJMOX9_X.$OAKJ=KHESI7A;XW_L<?'+PQJ<-O<MK%GXC^(GP)_9KLU>
M2XN)6MH+CPXWPC\.:EH-WI]I;7VGZK<:A=C4)S]A%C_3G7\O7QN>+Q5\$?\`
M@KGXX\$^%-5UKQ9^V%_P5!^!'[&_@'5=1N-6#^*;'X;I^R_^SQJ$WA^S274=
M+N](\`?$?2OCS<V$NGI8MK9TB^TK4=1M[FRM++3/ZA:B.\GO_P#MS:_!HTGM
M'Y+YJG33_'[@HHHJS,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`/*OB9\)=$^*&K_"'6-7U+5-/G^#GQ5LOBUH46FFT$6IZW8^"?'/@:/3=6
M^U6UP[:6^G>/=2NW%F]K=_;;.Q*W(@%Q#-\'?LS_`+&VLZ)<_MX^/]0_X6Y^
MS]XC_:R\>>,=)^&-K/XZ\)^(_B#\`_AC<V&M:W-J?@AO#_B#XD_#SPAJ7BK]
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M%_"G_@F)XJ^`VC:1XL^#WQ\\)>%/C[X9^*WQT^(OA75S\!$E_9L\)^$_VA-*
M\!Z;\0_@5X(_9WC^*L?B+P!\(M2U+X7>`/B%%8>$/CCIOB"V^*NC7_B8:W+X
M6\1:]X`O_5OA-_P3V@^&_P`5?A3\;-9^,VM^.OB1X6^*7[1GQL^*FJWW@S1=
M!TWXE_$?]HSX>>"_AQJ[>'-%T748[7X;>#?!>@^`_#UAX4\.R/XXUF?3;&%?
M$OBW7?$$VJ>)M3_1ZBA0BME^?EK;OHM?*VPG.3O=[W6RO9WNKVO;5Z=]=S\Y
M[;_@GGH5WH/P(T'QC\4]=\71?![]HC]M3X[Z[=2^&].T.?XCP_MIZ=^UAIOB
MSPKJ":+J-M;>&[KPS'^U)>2V?B31(?(U&3PDP@\-Z)'XAC3P_P`#^R!_P39M
M_P!EOX@?#O773]D_5_#WP:^'>I_#;X>^*?!'['7A7X>?M(Z]I3V]OH6@:G\3
M/CK'XVU]+[4]/\(P3Z=XG'@+P/X#M_'>N:E?:YJHLK-WT"?]5J*.6.FFVVK\
MO/79;AS2LU?1]-/-_+=[!1115$A7X*?&WX`:?_PT%^VA^Q-=ZK:>$-'_`."B
M'A?1/VR_V/M9U/1M,U'PMX>_;`^`T'AN#XWV-I:W]_+<S>*+;6O!WP!^/#VJ
M16%IK&G:O\0[W3DAO/#^O7E]^]=?(7[:O[+\W[4OPCLM"\+>*Y_AQ\:/ACXP
MT7XP?L]?%.T>_CG^'GQC\(6^H0:!J=\NEW-EJ%_X4U[3-5UGP9X\T*"ZA&O>
M"O$FNZ86$D\3I,E=:;K\>C7S5_G9]"HNSWM?KO9IW3Z[-*_E==3\Z?V6/VP_
M^"HW[?6C_$.W\-_LY?!G]@#0OAWXC\1_"?Q/\4?C-K6L?M%^.-0^*7A6X?P_
MXULO`'P.\/W_`,(1X>3PIK-M=7UKK/Q-\3ZAHFH0WVA#3-(\96(U:YC^6/VS
M/V0_VWOV/=$^+?[6'PZUKQ'_`,%$_$_C3QW^SG^T1\5+&3P-X&\!_&?PG\>?
MV38[*U^&/BSX<>`?AUX7MO"OB[]GWQ)X2TJV^%?Q4^&.DV5M\9?"GA;4+CXB
M>%OB!XPU^/Q'(WMW@'XZ>+/AIX]^(/[:7@GX:ZYX6N--\2^$OAM_P5V_8UTW
MPSXRU7Q?\-?B):6>@Z/I_P"V#\%?#WA;1_$&H>/M*L/"CVWB/7-0T71KY?BY
M\"+6'Q8FI0>,/!.HV1_=OX>_$+P/\6/`_A7XE?#3Q7H?CCP!XXT/3_$OA'Q=
MX:U"WU70O$&A:I`ES8:EIM_;.\4\$\3@\$212!X9DCFCDC6$E-:MW6J=_E=*
MR7DTU=.ZWU+<N1IJ,>5VTM?LVG)^\^C5G9JS2MH?GI^QI_P5[_87_;1^&G@[
MQKX2^-G@KX;>,?$FG7<FJ_!SXN>)M'\`_$70=8T543Q/I]GIOB6YTF/QGI.A
M73&&3Q9X.;5_#\B&-+FZL-32]TNR\9_:I_X*P_LL>)?!FO\`P2_90_:8_9X^
M)_Q>^(GAJ]TS4?B-IWQ4^'VL?`[]G#X?Z](/#7B7XZ_&'Q\_B6U\&7%GX'CU
M-+O0?A+I/B&[^)7Q*\0R:3H>B^'HM$GUWQ-H/@'QE_8WM?&O_!235?V9?@'\
M48O@G\%OB1\"M;_:M_:<\$:%X*^%'CV\\._$?5OB5I7@O0_$'P3L/B7X3\7V
M?P5\1_&A+'7;CXJ:UX;TN./7(_#=IJ]MIT7B#59=<M_T;_91_P""6G["W[&M
MK;7/P=^`7@VX\>)JS^(K_P",?Q`TNP^('QCU;Q+)=7-[+X@G\?\`B*SNM5TG
M4);FZEE,/A<:!ID;['@T^)D5@TYNZT5G9R^[97[7U[@_9Q?,N;O&.CM_B=DK
M)]KWZ]CX`_X-W_A#^SI\(/V:_P!H_2_V>_$]UK^DZG^U[\68IK3Q)?Z?-X^T
M?PGX.BT3P-\-7\5Z1$CZKX>B\6^$-`M?B-X?T_4;_4[6ZT?QM;ZYI-S!9ZQ]
MAM?Z!:_+;]O+]C3XH^)]6'[8O[".KZ-\+_\`@H!\//#4F@Z%J.H'3=.^'/[1
M?@F:XT^.\^$G[0]C+82CQ9HFG:?;SZC\/-7N+O3M5\(^)K;3UM-<TW2I[B6U
M^P?V3O&/[0?Q`_9W^%WB_P#:K^$^C?`[]H36-$O'^*'PN\/>(]+\6:'X7URS
MUO5-.MAI>NZ+K7B+3;JSUG1[33?$,5M;Z]J[:6-6_LJXU"ZNK&:5G'3W;;+1
MK9K]'Y?<^TS?,W.][O5-^\G;\5V?X+8^B*^4OVTOVC)_V8O@!XK\>>&]%'C'
MXMZ_-IOPU_9\^&\?V5[OXG?M`?$.Z7PQ\)?!,<5WJNB1#3-0\6W]A>>+-0;5
M+*/0?!FG^(O$,]Q'!I4AKU_XR?&?X6?L^?#;Q5\7OC1XY\/_``Z^'/@O2[C5
MO$/BCQ)?)9V5M!!$\D=I:1?/=ZMK.HR(+/1-`TFWOM;UW4YK;2M&T^^U&ZMK
M67\+_&OQ9^+%]X^\*?MU?'/P+=7'Q3\<WUW\(O\`@D)_P3P\3V`L?B$GBOQ_
M;Z?INK?'KXQ:7:O?7?AKQ;<>&FN/%WQ*U:[$&G_L\_`N#6+'6]6TWQ9JUS9S
MN4K:=7Y7LKI7]>RW;T0HQ;=[72?WM=/U;OHKOLG/\"_@%H]G^TU^PA_P3]\*
M7MGX[\$_\$M_AM>?M6_M:^.[*\U:UTW6?VP_C=HWBK1_A/IBKI^K22:;XEUS
M6_&7QU^/^I>"]9MH],L?"VL>!H=.F@TA7\/ZE_0O7Q+^P3^R3<?LC?!)]`\:
M>*(OB9^T!\4/%&N?%W]IGXRR0,E]\4/C/XSNGU#Q!J,#S10W-OX1\,PO:^#_
M`(?:(T5O!H?@[1-*M8[2"YDO6F^VJ(JRVM?IVT22^22OTO=A)W>]TNMK7;U;
MMYMNWE9=`HHHJB0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`^*?VH/V8_&WC[7O#'QV_9J\=:9\&
MOVI_A[]EM=*\4:I97-Q\//C'X&BNFN-0^"O[06C:1'_:?BKX>7WG7EWX;U6U
M\WQ1\,?$MR_BCP7+%+<ZWI>M_F#X%^(FI_#'XL^*%^&%QHW_``3V_;.^+FMZ
M'XF^)_[#W[4EQ+=_L/?M*^.HWFL_%_Q(_9Y^+'A+3HX='\?>,M,TK44D\=_"
M;4I-1URZTS2=?^-O[-7B+Q)-%J<7]"E><_%3X0_"WXX^#=3^'GQA^'WA'XF>
M"-80IJ/ACQIH6GZ_I$[;61)TM=0@F6VO(0[&VOK4PWMJY\RVGBD`82XW=T[?
MUWW3]-.Z9:E96:NOQM=.SZ-::)[=&M;_`,_WP%^/'QT_9W_X*1_M<?M%_P#!
M27X/^(OV9/!G[0WPP_9R^%WP(UCPOI^K_'/X.:'I/PNM_'VH^(-)\6_&_P"&
M?AZZT?P_>MXI\3ZI?6E[\1-"\!O?0^(-*M(;=)4^SQ_M1\/?VVOV.?BOI^D:
MG\-_VI_V>_&EIK\=Y+HW]@_%_P`!7MUJ,>GRW4-Z]MIZ:Z-0=;5[*[,Q^RC9
M';R2G]TN^OGMOV`_&OPQ6_;]D/\`;/\`VB/V>;!],U&UT?X9>,[O0OVH?@9H
MU]=SZGJ-O<Z?X*^.=KKGCSP_IMOJM[:L_A_P!\6O`VEC2+232--CTK[5]MM_
MG_XT?L:_MA>./!C:%J7P2_X(\_M':Q=R-X>UB?XN?L\?%CX2Z9J?@U)-1N8+
MH?V3J_[0.H66J-<_8'N?#=O-_9!N+[5;ZVUNV%O!87TKFC?2]W=]7KOJK7\O
M=5NQ3Y)/>VB6]E9)):-.VF_OO5-]3]"?B%^VE^R#\)].U+5/B1^U!\`_!MKH
M]M;7>HKKGQ9\#VM];VUY<16MI+_9?]MMJ<RW5Q-%%;B"TE:9W`C#<D?,.K?\
M%#O$GQ7%QH/["W[,'Q>_:7UZ26*UMOB7XXT+7?V=/V9=(,UOIEXVJ:I\6_B?
MH%EK/BJTM--U>RU2/3OA=X&\<7^K1-]EM)+=_/N+3YI\)?LD?MOZ!X<U)M2^
M%_\`P1=_9*_X1C2K:UT#XI?"[X`_$CXSZGX.\.Q:1JNGZWK%O9>-5_9XT?0[
M[PU8KIMWI4VK:UXBT/5+==2LM>L[*T59[CZ!_P"&+IOB##X#T/\`;._;\^-W
M[1MQX[L)-.T?X:>&?$G@W]E;X._$Z[LM._X3+6DTCX=?`&#POXT\>Z)'IFEW
M>K-H/C'XH?$FUM/"5L8M3N=2MQJ&H:@7FUM;IT6NEM6W_P"DL5H+K=_-]GHD
MDGU^VK==CX/UKQ'<^/OCQH1\6ZUI7_!5?_@H!X)O[/5/`GP0^$ENW@K_`()N
M_L"^,=.\.RW*>-?'E]J>M>*M+M/&6G3^(;]]/^)'Q-U?XD?M"ZX(](T[X5_#
M[X9R'[&GZF_LL?L<:O\`##Q;JO[1_P"T?\1)/V@OVRO'OAF'P]XN^)L^FVNE
M>!/A=X6FO7UF?X,?LW>#TM(9?`'PBTW4Y8_.N=3N-4\>_$*\T^T\2?$#Q!J%
M\MAINC_5OPO^$GPN^"?A#3/`'P?^'G@WX9>"M'@@M].\+^!O#FE>&=%MH[:W
MBM8F%CI-K:PRSBW@ACDNIUDN9A&IFFD89KT.J4;:MW?X7[]V]+7;TZ)"<V]%
MHK6\VNVEDEY)*_5MZA117CWQ3^.'@SX0>(_@9X7\5Q:W)J7[0?Q?'P3\!MI%
MC;WEM#XR/PP^)GQ:$NORSWMH^GZ+_P`(M\)_%$?VZVBU"X_M632K3[%Y-W-=
MVM?U]Y![#17YL:G_`,%/?A+-JFF^%OAS\'OVA/C)X]US]I#]I/\`9:T+P)\/
MO#/P]@UG4OB5^RI+<Q_%:^DU3QU\3_!?A+1_!44=I/<:'XEU[Q'I:W\2HEW9
M:=<SP6\FCIW_``4H^%WC/P5\$/$7P;^$'Q_^.7C+XZZ)\6/$.C?!SX>^%_!%
MC\1_!.E?`7Q1)\/_`(T7/Q+F^(?Q#\"_#[PHG@'XF1-\,C*?'=_;^-/'#P:9
M\-Y_&-I<0ZBT\T>_Y^7^:T\RN679_P!7^[9[]GV/T6HK\Z?&/_!2WX2^$X-1
MU&T^#G[4/B_1O`WP\\'_`!5^/6H^&_@U=6U]^S5X)\:66JZII]Y\8_!7B[6_
M"WQ'37=,T70]8\0Z_P""_AUX-^(7C/2?#FGMKDN@/I]]H\VI=5\6OV_OAO\`
M"#4-3O-7^$?[27B;X4^&]+^&>M>-/VA?!OPCN-1^"?A+2?BK);OH.IG7M5UG
M1?$_CG2]%TN_TG7?'6K?";P?\0]+\":9JMLGBF]TS5+;5--T]W7=?U^GGMH^
MS#EEIIOMT[?YKUNC[LHK\N;K_@HM#IOQC^-_PI\8^!_%?PQLO`/[;O[+_P"R
M!\+?'&O_``ZO_$>B?%KQ!\=/"7P[\7ZOHME:V?COP]=:3J,&G:SXFOK+QU?O
M;^%]#\(ZUX!\6P:!\0-6.H^!=1]2\#?\%%?@9\1OB)X*\%>%?"OQQN?"OQ$^
M)7Q%^"G@WXWZC\(_$6A_!C6_C/\`"J?Q1;^-/AI:^(=:-AXD_M*RD\%>*H=-
M\6OX17X8^(=1T#6M"T#QWJ7B+1]5TBR.9=UO;\;?G9?-=PY96O;I?Y6O?[OG
MH^Q]Z45^?'PU_P""F?[-/Q1^,/PL^#FAVWQATJ\_:!G\9Q?LV?$'Q1\'/'&A
M_"C]H>W^&_AOQ-XJ^(.H_#+QQ-ILEHFF^%M)\):O=+=^.K;P4OB[3WTCQ!\/
M5\7^%=?T/7M0_0>A-/9WZ"::W3777[OS37JFMT%%%%,04444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`45CZ7XBT'6[SQ!I^CZSI>J7WA/68_#OBBST^
M^MKNY\/:]-H>B^)HM&UJ""1Y--U23PYXC\/ZZEC=K%<MI.MZ5J`C-K?VTLEV
MZU"PL9+&&]OK.SFU.\_L_38KJYAMY-0O_LMU??8;%)71KN\^Q6-[>?9K<23?
M9;.ZN-GDV\KH`6Z***`"BBB@`HJM<7MG:-`EW=VUJ]T\L=LMQ/%"UQ)!;37D
MR0+(ZF5X;2VN+J58PS1VT$T[@11.RK:7=I?VMM?6-S;WME>0175I>6DT=S:W
M5M.BRP7%M<0L\,\$T3+)%-$[1R(RNC%2"0"Q13%DC9WC61&DCV^8BLI>/>"4
MWJ#N3>`2NX#<`2,@4^@#^<3_`(.)/C%^W%\(/V0_C/%\-O@#\#_CW^R/\3OA
MQ/\`#OXL7VN:-XNUKXE?`^;53,MQ\4-2T*VU6'0]8\/6UQ+I\_AKQ)96T,WP
MT\6:-I'B;6!<6\D,]G_.Q_P;W_'+]H#]H7_@K1^RYHGQQ^,OB3QYHW[-W['G
MC+PI\(=!\2:IHMW8>&?`4WPLT2QTWPMX=M?#MRVEC4(K'Q)93ZGJNHF[\:WN
ME^&K'2_&<T>HZ#'IVC?Z*FIZ9INMZ;J&C:SI]CJVD:M976FZKI6IVD%_INI:
M=?026U[8:A8W4<MM>65Y;2RV]U:W$4D%Q!(\4L;QNRG^>[]G/_@B9H'[%'_!
M7H?MF_LRZ;X>\/?LN_$?X._$WP]XF^%%E<?89/@S\1];3PF\*>#[._O)Y=1^
M'_C*XTW5-2M-+TY\^!]4FN=%L-/MO"#Z+;Z1C.$N>,DVUS1NNR3O?S7ET>VC
MTWA4C[.<&DI<LK2MNVDK>3:OM9-;ZK7^A^BBBMC`*^2?VM/V??&GQQMO@)XF
M^&7C#PSX.^)G[-_Q_P!$^/G@:3QOX?U/Q+X)\1:A;?#CXG_"37O"_BJQT/6M
M`UNVL=3\%?%SQ1-I^JZ5J!N=,\066C74MG?V275I+];44-7&G9W70_+W]FW_
M`()U:O\``3QSX%^(.N?&+2?B7XETG]H/]LK]HKQK?R_#&/PE!JOBS]L4Z?J'
MB*R\':<OC#Q,WA&V\,:U93I8W4VI:S=7WAW4K[1IO):9[M_-O@Y_P3+^(/[*
M$GP<\<_LW_%KP+J?QA^'7AG]IOX5>,-6^+_@GQ)<^#/B)\'_`-H3]IGQE^U/
MHNFOHWA3Q?;:IX:\7_"SQ_XD6RT?6=.U*XLO$NC:IXG@UZR:23PX^@?L714\
MD5T_%WZ=;_W5_3=WSR[_`"LK==-O[S^_R5OR:\1_L._M8R>#_C-X;T/]J7P!
MXAUO]K+X:^'?`7[27C3XC_!N[N+_`$O6K;PA??#GQ1X[^#>@>"O&/A70;&:_
M\`ZE#H6A>%/%D-]::9/X4\.:EJFO:Y<WFMFY^>OC5_P1NUOXA67C/P)H7CKX
M3ZU\.+KPO\(_"/P2U'XW^$?B-\5O&/[+O@[X/?#OX7^"-$\"?`G0-6^(_P#P
MK/P;'J5Y\-+W7[OXH:7X:L?B@M]\2_&S:EK&O_NEOOWJHH<(O=/MN_U?6[N]
MQJ<EL[?)=+6Z=++^FS\NOC%^P1XX^*_QDU?QD?B!X4T7P6O[=/[(O[<^@PC2
M=7O?%$WB']G_`.''@?X1^,_AMJ\'G6VDV^C:]X8^'VF>(/#'BJRO+J^AU[6+
M_2=5T"/3].M]2O\`5T']@/5M%^!'P"^"TOQ$LKZ+X3?M??%+]I'Q)JUO;>)O
M#TGB3PQ\5OB;^T-XYUGP3I%WX;\1Z7KFAZM9Z5\=FT.VUV+5A!-/HDEU<V+V
ME\^GC],**.6-[VU^?5I_FD+GEIKM:VBZ*R_`_G+_`&:-)^+?B/\`:*_X)A?`
MW2-/\4:G\%?V#]&^.#ZW)XB^`7Q@^%7CSP-!X9_9Y\7_`+.'P=M/C1XJ^(-F
MWPXU+Q=-X7^(4VCW'A[X4^)?%?\`PE>K22_$>QOW\$1V-S+_`$:44415KZWN
M[_<DOR02ES-:6LK?BV_Q;_K4****HD****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`_$#XN_%;XZ_$']JWP[^SEI?QS^(?PR\$^,/^"FWB?X2:GJWPZ;
MPUI?C"T^$7@;_@DMX._:>'PYT77=5\.ZS_96C^(?BQ-J6MZQJD-H_B6(:I<1
MZ1K6F""S%OY\(?%GC;Q%^POI?CWX[?%+Q)J7[.__``6!_:1^$&A^(]3\2>&(
M-<\;^'_`'[.?[7/B/P#X=^(4I\/P:=XA\07NE^'=&^&*:Q<VUOXCU3PYXM\0
MF._/B+Q';ZO:_OI_9VGF=;HV-F;I+E[U;G[+!YZWCV8TY[M9MGF"Y?3U6Q><
M,)6LP+4N8`$KCM<^%7PO\3VMO8^)?AOX"\0V-KXTL?B1:V>N>#_#VK6MM\1-
M,G6ZTWQ[;V]_IUQ##XTT^Z1+FQ\4QHNN6DZK-;WT<BAA/*[N\F[O;7173MOY
M/7?4M3M:RM96OI>]FF]NJ>U[:7W/P@_8X^/?[;'Q&\6?LM?'+QAXUT:QMOVC
M_%NJ:3\7/AG\2_VE_@\O@K3-*@M?%UQXA^&?P3^`>B^!K+Q_X8^-'P.US3$\
M+Z]H,_C35?$\LWA'Q99?%!;K5H9GTNW\._VFOVF_%^B?\$W==3]H#QC;W_\`
MP4:_:$^(^G>/[J?PM\,YX/A?\+OA-\._C[\0=#\"?"30I/!\VC>'[_Q-IWA3
MPQX?\:>+];B\3ZS?7.D)K^D'1[VYO(;G]@/A)X$_99^(%_HO[6GPF^%/PDG\
M5_%#0T\0Z9\<]+^%7AWP_P#$?Q;H/B"RA@CU.Y\877AS3?&UY9:WI4-KLEO[
MPIJ6E"S<>=9-;L?6W\/^`?`_ARVN+?PMX?T/P[X`@UCQ#I5IHGA>V$'AD?8M
M4FUF_P##NCZ+ITD]K?75G?ZNDZ:'9?VAJ(U&^MDCN9+^6*:5%Z>\^][O7X?.
MRO9][7NG>]VY*_PK56M;K9I+6^SL^EVMK6M^,W@/XE_M1_#NU\!_$[QI^U+X
MP^(WAX?\%(O$O[$NE^`-;\$?#2PTC5O@Y)^T3XF^"6CZMX]UC3?#%KXA\0_%
MRUN?#]AJD?CK1-3\*Z<]J$TM_"<DE[K5WJV=^SS^T1^V_P"-=?\`V1/C!J!\
M8:OX1_:`^*?[0/ASXV^%/'7BW]E#PM\*/"OACP'X=^+4WPK\%_!?PUH_B23X
MZ7_Q*U+7O#VE&:(+KOB?^R_#/C`_%?P=X>%K%?>&OVML?!W@"\TS3VL_!WA;
M^RW\1O\`$;3[=O#&FVT47C+5=0N?$4_C5+&>PA>T\77NKZE>ZS>:Z\$.NOJU
M]>7MU<?;I[B1O!/%7PO_`&-/V:=6\>?M?^(_A;\$/A/XFTS3M6U/X@_'BU^'
M7AO2/%JV7B*[TZVUV]UCQ1HNAGQ%>2Z_>1Z;%JTPDGN]6F6`7AN&I\LE;WG9
M+75^5W=WOL]'W$I)W]U-MNVG?9))K6[W\EHUH?C1:^/_`(O^/;'_`()Z_ME>
M*OVDKWQKJ'QX^%?[3?QQ/[/6JZ%\,;WP-\*O&-_^P[\2-=C\->!VT/0K#Q!>
M:%\&[V'5?AIXPLO%]WXDN/$/B'59]0\3RZ9K)DTV3Q[Q)_P4'_:2U/\`9#\(
M?%CX&_$?XA6OC;X%_P#!,K]FW]I/XM_#/X&_!+]EGP_\"/AA\1?B+\)/'WC'
M3]0^,GB7XY^+O#6M7/@#QKHL6BR>$_@]^SGH&M>+/#MCX*O+C3;?4M8U[0='
ML_Z)M(_9/_9=\/\`C[Q%\5=#_9R^!ND_$WQ<VO/XG^(.G_"GP-:^,]>?Q5%?
MP>*FU3Q)#H::O=GQ3%JFIKXF,MVW_"0_VC?-K'VUKNX:3G_%O[$?[&WCV[\/
MWWC;]E+]G3Q;<^%/!^C_``^\,MXC^#'P\UB+0/`?AU+Y/#O@S2+:_P##T]M8
M>%O#ZZGJ`T+0;:&/2]&-Y<-IMK:M*Q*Y9);ZMW>K7V8J_P!Z;MM9V5MT^>.G
MN[>2?5NVRNK.U[IWUVT/QQ^//QX^/7[-?[3W_!0OQ-\.?%7B3QOXB^)?QO\`
M^"9_P`\`^%UC^$5K/X!3XU6UUIFJZOX&M_B+=^$_!NI>,-/\.S:[I7@'1_B)
MXMT3P?XD\>:WH\OB;4;N.WN+2?\`2#]ACXD_M7^*/%/[1/@+]IOPEXGT32_`
M&N?#?4O@WXA^*&J_LR0?&WQ+X1\;>$KN?Q)!\3?`W[+7Q+^(?@3PLF@^-M`U
MNV\%ZL\?A^3Q7X8N[9S:WNIZ+K5Q']+:Q^R[^SGX@U+QSJNN_!'X8ZQ=?$[P
M+X;^&?Q%BU+P?HMYIOCCP%X-EEF\(>%_%6C3VCZ1KFE^%FF=/#L>HV-Q)HL'
MEVVG26UO%%$FA\#_`-G?X*?LW>&]7\)_!#X=Z#\/M&\1>)=5\9>)O[+%Y>:O
MXJ\6ZU(K:EXD\5^)-8N]2\1^*-;GBBM[*/4M?U74;NUTNRT_2+26#2].L;.W
M:C)/5Z7;W[MNS5M=^ZM;MH)R35K*]DKVU5E%;W_NO2SW[GM%%%?SO_MG?M3?
M\%0)/^"GO@+]BG]FN7P=\&?A;\8?AS#IO@KQSX\^&&C_`!'M=<\.Z?H]SXF_
M:!_:7\+^);;QCH%SX>\8?`=M0\&?#SP7\+?%-AJ^A^*_$6O2ZYK6AZGIVH:-
M+9N4E&S=W=I:=V*,7)M)I63;;VLM^Y^A'[>7_!4#]G'_`()VW/@.Q^.FC_%S
M7M1^(OA/XG^-_#^G?"CP)'XVO$\-?""#PS=>.=3U1)=;T6/3K72K3Q9I=[+<
MS2FTM]/BU+4M0N+'3]-NKJ/[Q\$^+M(\?^#/"/CSP^;EM!\;>&-`\7:(;V#[
M->'2/$FE6FLZ:;NVWR?9[DV=["9X/,D\J7?'O;;N/Y^>'?\`@D=^P9&E[JWQ
M>^!^B?M6?$C78[9_%OQ@_:VEG_:'^(WB3481<F74(M2^)+ZWI/@R*Y:Z=6T+
MX<Z-X/\`#4%M;Z98VNC0V>CZ7#:?%7[8/PW^+O\`P2/^"OBO]HK]A3Q\NC_L
MU^&M-\(>'/B]^SQ\=]6^)WQQ^'GP.\+7_B;P[X47X[?L]Z+J7C1/&MAJ'@>S
MU6[U#Q9\&[/QA9^$_&]DRW^FQ:5JNCPVNI*\E=R2Y>R>J\W>R?GVZ7&E&5HQ
MOS7MKHI7VMJVGV[^3=C]_P"BOA+_`()L?%3]J+XQ?L=_"?Q?^V3\,=<^%_[0
M4=C>Z!XSM]?T[2-`O?'BZ#=-I^E?%;_A$=*CLV\#GXAZ='!K]YX,U'1O#]YX
M=U6?4;&VT:VT9-)FN/NVJ3ND^ZN2U9M=NVH4444Q!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`%2YMY)IK"1)O*6TNWN)DS=#[1&UC>VHA
MQ;WEM"VV:YBN,7T&HVO[C<EFEZ+/4+&W110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!_.I#IECX)_X*3ZOX
MN\/:)\1/C?\`%/Q3^V3HMSJGA#XB_"GX]_"?X_\`P8^$'BGP,WPBUKX@_#'X
MV^%=4F^"_P`=/V#_``<-+G\5Q^$?%?A;2/!^DWNJ?V;KGBK4/CA=>"[#6.N_
M9P\<>-]>\+_\$Z/@%?0_&/6OC)\(?VZ/V@-0_::TJY\/?%O[+\._"/AOX<_M
MI7_A]OC)X]M='D\-:5H>L:AXT^#^I?#/3_%7B%=!^)<L_AM/"@US3K2:6S_:
M#4?V@?@-I'Q(T_X.:M\;?A%I?Q>U:9;?2OA7J/Q)\&V7Q(U.X>RM=22#3_`]
MSK47B>]F?3KZROUBMM+D=K*\M;H*8+B*1[MK\;_@O>_$FX^#-E\7OA?=_&"T
MLIM2NOA3:^/_``I<?$FVTZVB6>XU"X\"Q:L_BB&R@A99IKJ32U@BB99'D5""
M8Y4G?FZ_>[Q??XO=_P`DBW)V6CNHJSOT2:3VV5W;\6WJ?SN?\$[/AU\*?AQ;
M_P#!-KX=_!VQ^._@[]J+3=6^+Q_;@\#^*8OB3X9\7Z+\(]:^#WQHU7Q#8?'3
MPWXALM(L?#WP]TSX^:S\%;K]FJWU"PL;ZUTO7-&UGX?RWD'B+QEK.J^@7WC'
M]J?7/AE^UCX$.G_'OP3XE_X)?_L6_M5?#CPCX^MV\06.I?M"?&?Q9\.O%UO\
M`_B#X%UQ[N?6OB!=^%?@GX/\&^(8?$$V@W6JK\7O'NK#[=JUUI%EJNN?M!\:
M_P!KW]F_]GNZT;2OBK\7O`_ASQ'KWCOX7?#O3_"$GB319?&)U_XP>-_#O@+P
M=/=>&%OUUBRT)M6\3:?J&L:_=VD.EZ/X=AO]<O+E+&SD<^E#XJ^%;#1_'/B/
MQC=6_P`./#?@#Q3<^&-8\1^/=>\'Z-H,ODIHYM==BU6W\2ZA9Z9HVJ7&N6=C
MIT?B:70->DO/W=QH=M'<Z?+>BC96OMV7DK7UWND[Z7[#YG>[C>]K7W;O=V=E
M>ZDU;LT^B/Q^TN_UN%?^"@O[1/Q3O?VI?B9K'P5^'?P;\)?"GP1\/O$OQ`T3
M4_!_AWQ)^Q=\(/%?Q#UGX,3VDUMX?A\>>-/''C_Q)J7Q`\36]OKWB/PO)X2\
M/Z]-;6]Q8Z/%=_G]\1O&^K>`?@1^W^GPOA\.^._AE\0/V#?`^GVG@OX'_M(?
M&O\`:J^%,WQ#^)'Q<U7X%:EX^LOC-\0?"FDZ/XH^*$?@_7]+\2_$#1/!/@S0
MKC;HUAI?BJ_NKF[L_%*_TRV_QY^'E_\`%WP/\&-)O[O6_$GQ#^#/BSX\^%M<
MT6"'5/!-_P##SPAXG^''A2ZOT\4VES+8RW>KW_Q1\-W?AV"U%S#J^DPZMJ,-
MRD-D@N/2/#OBKPOXOM+N_P#"?B30/$]C8:IJ&AWU[X=UC3M:M++6M)G-KJNC
MW=SIMQ<PV^J:9<@V^H:?,Z7=E.##<PQ2`K1RW5N;OJM[N^M]>C6FUA<UK73^
MSUMHK>5M;;[Z]>N]1115D!1110`5^*WQ*_:'^`&D_P#!</\`9S^&VH>-O`WB
M#XE7/[(OQL^$[:,VLV,FK?"#XC>(?%/PN^+7A;1-2+K<1:1XO^,7PVT?7;G0
MO#KSZ7KNK>'?#R:BL-_87^E1S?M37P%\?O\`@FA^RM^TI\;+?]H3XF:'X[_X
M6CIOA+0O#^@:SX0^)?C'P39^'/$W@^Y\23^`/B[I6D>&M3T_3I/C!\/(/%_B
M?2_!?C75H-3?2-'UN^TMK"YM)%C12O;2U[IZW6B=^E_R*BTF[WLTUI;=[:.V
MWJC[]K\XO^"NGC_PYX!_X)L_MCQ:];7.JZG\2O@1\0O@=\/_``OI<%IJ'B3Q
ME\4_C=X;U'X8?#CPQX3T.XN(+KQ'XBO?%?B?3;JTT314O=?NK>RNYM&TZ_OK
M>*VD^"_VL_VR/^"B'_!-ZZ\.?#N[L_AE^VIX;\0_"#XN>+OAO\4/$'PX^,?@
M_P")\VO_``BT7X<V6B?#WXEVWP9\._$3P/XI^(?Q%U?Q/J-YHFJV.G?"30O$
M2:=K32_\(S/I]M:ZC]EQ_L"_\-66]EX]_P""B/BJV^/MW?Z5INJ^`_@7X2MO
M%GPR^!7P$U>\L)Q-XA\#V-GK.G?$;Q!\4[>WOOL]E\5/&^LP^*?"LB2GP5I7
M@JYENGFER<KQ2=]G?1*ZZM7_``O?TNU2CR\LI-.-[JVKE:U[)VMV=[6UWTO]
M7_L??'OX2?M*?LY_#'XK?!'Q==>./A_J&@Q^';37[_P[X@\*:D^M>"W;PGXH
MTW5?#_BBQT_6-+U?1?$6D:GI&KV=Q#(MOJ5E=0175TD8G?Z7KR3X#_`_X<?L
MV?!WX>?`GX1Z&/#OPZ^&/AJS\,>&=->=[N\>WMS)/>ZKK&HR@7&K^(O$&J7%
M]KWB76[LM?:YK^I:EJ]]))>7L\C>MU2O97WLK^O4AVN[7M?2^]NE_,****8@
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`*BGCDEAEBBGDM9)(V1+F%87E@9@0)8UN(IX&=#\RB:&6,D?
M,C#(J6B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/YJ3X%\1_
M%/QM_P`%$?@?X"^#/C7X\_$KQ[_P59^'/C#PO^UAH]]X/\,^!O@?<?#7X=_L
MI>//MNO_`!,LO'4_Q#\-:]^R%IFFW7@72?"NF:,NK^/=0N+?P9X3T^;3]3^)
M=CX,V-6^`O[1WB;]HOX#ZUH7P$\<?#'6/!7_``40N?BM\8='^%'P-^`GPL^`
M`^%,'Q!^(EG9_%[6?C#J.H^(_C7\8?'7Q(\`:EX:UCQA#X%\?0:+*^K76E^+
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MW]F_XC>+?`?B/0/V4/@%XV_9B\*:M^Q5^U%\-?A[X.D31_"-[X8G\<_M.?#K
MQ:N@>'=*L=>O=-^'%W\3/`UCXP\2?#_X>RWWAA?`FF:OIWA2_P!/^'<FCS:5
MH/OO[$_PP\$V7[1GQ)^*GP\\+_&OX;:6?A!X<^&>N>$;[]D"+]C[X(:[;:)X
MIN;CX=?VAH?C/P[I/Q)^*OQJ^%WABRU+PG_PLCPM</\`",^`O$-KI&GP1ZA%
M86UC^KE%'*KI]K?AM:UDON?R!S;33Z_YK>][[::Z:O<****H@****`"BBB@`
MK\^/VP/VQO&G[*WQ\_89\)7G@'0M2^`?[4'QLU3X!_$CXJ7NI:M%J_PW^(7B
M?PU<S?!+3K*QBM(M"6V\=>,K9M!GN]6U5YY$$T.G:=]KBB>Y_0>OS^_X*B?L
MQ^(?VMOV'?CE\*?`,PL/B_I^B6'Q/^!6M1(HU'1?C7\)=6LOB#\.;C2+PSVW
M]DZCJFO:!#X:76!(W]F6NNW5V\%W'&]K,I7L[;K5>=M;?/8<;75]GHV^E]+_
M`"W^1^@-%?(O[!/[4&C_`+9O[''[.W[3&DW-E-<_%3X8^'M7\66NGJ4MM$^(
MNGV_]A?$SPTD38>/_A&O'^E^(]#`95WI8),@\N1"?KJA.Z3757^\&FFT]&G9
MKLT>$^.?VC_A1\._C7\'/V?O$_B*ULOB;\=-*^(NN^!=$>_T6W>;1OA?I-CK
M'BG4[V&_U:RU$VL<.HVMO9G2]/U22:Y-PTT=M9V=Y=P9-U^U_P#LIV7A+6/'
MUU^TA\#X?!'A_P`67G@/6?%C?%#P:?#UAXUT\:>U_P"%9M676#9'7[%=5TY[
MS2HYGO+:.\@DFB1'W5\Y?MN_!OXA?$/XC?!+Q1X#^&3^/ETWX6_M?_"S5-7L
MKSPG8ZAX(U/XR?!JWTWP9J]Q)XDU32;C^P=6U_PT?"FI7.D37$NG7/B'3[K4
M;=-(-_=VWR5\/O@W^U)\`/V>/^"4?PHT[]GK5@_P7_9ITGP=\;_$'P;\-?LP
M^.OC9\)_C;8?#[X4:#=>!]!U[XP>++7P#X9\`?%:5_BSI_Q9^*?@&X\3ZA<:
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MG^(/[(OQ6\!_!_\`9@L],_9%^(_B[X\_#G]A+P]\$OM_A32OV8/C7\)]2U_P
MOK":Q:?L^?%;X;?&7Q-I_ASPOH,?B,V&LVGQF^&/BO1-672=1U[2(/$/V;2+
M547-*RO'=)]=-(Z;;MMI>G5Z#Y8W2YEYNZMN[6?RUT>_S/Z#->^)GPX\+>(=
M$\(^)_B!X(\.>*_$K6R>'/#&O>*]!TCQ#K[WEV=/M%T31=0O[?4M5:ZOU:RM
MEL;:<SW:FVB#3`I5/4/B=X6@UN/PQHM_IWB[Q1%JNC6.M^&/#GBCP1_PD/A?
M3=7U272&\3Z_I&N>*=$O(=#TR\@N([V.PBU'7KJ6WFL]#T/6-1C:S'XVV7PB
M^*-G\0_VE_\`AJC]@JX_:M\8?'OQS\`?'OPM\6^$K/X-1_"WP'I?ASX5?"31
M+'X0ZAXW\3^/XOB#\./#?P)^-/A+QGXOD\2:;X3U0ZKI?B";QQX;TCQ'XHU;
M5M#DI_`O]C+XK^`-#^(FMW_P,TO2O'GC_P#X+7_%?]HJ_P#$D#>"D\5ZG^S5
MJ'[3/B+QQX4\=ZIK&GW=QJ=[H<FAQ66H:?X8U2]@UNRL;Z*\&CPLJ035S-].
MOGHKK?3?6^^WXG+'^9;+^6UW9O[5[*[6J6JT[+]M+?Q_X$O/$UQX*M/&OA*Z
M\96EG-J%UX2M_$FC3^)K:PM[B2TGOKC08KUM5ALX+J&:VFN9+188[B*2%W62
M-E'FGPS_`&C?AO\`&:'P9JOPIGU7QWX/\;/\68+'Q]HEG;#PCIEY\'?&-KX$
M\1V.L76H7UCJD=QJ_B&:ZC\)OI^DZE::[IVEW^L)<V^EFPNK[^=G]@[P['^T
M'\*?V5=7\)?LU^*H/VC;W_@H[^TS^T=\8/VM;CX9KX9\%Q_#KP[^UI\>)?B9
MJ-W\;+))8_&5S\5O"#2?LW:?\'TU"[\2RZC'=:]XK\(:+\._#^A>-M3]F\)?
MLN?&2U^#+?#KX'_`7Q-\%OB'X#^!'_!;SX8^!C8^'#\,-"\/_&+XT?%;X>:A
M^S?K7A7Q?]DT;1Y-%\6^$Y-//@'X@0/'IITWPY>0":RN/#-U96$<[=K+31Z:
M[N&G:]I.Z\M]P<$FTWUMK;;5.32=]TK=MG>ZO_0_IWB+P_K`O#I&NZ-JHT_;
M]O.G:G97PL=_FE/MAMIY1;;Q!/M\[9N\F7&?+?%RTU+3K^2\BL-0LKV73[EK
M._BM+J"YDL;M!E[6\2&1VMKE!RT$P251U45_,)^T3\#!\4_AMJU]^P1^R9\>
M/V;/"VG?\$\OVJ/AA\?_``-:?LW>-?V>?'OC'Q?X]\.?!^U^"/PLT[0?%'@'
MPG/^T!\7O!NNZ1XWO]*\>^#?$OB3P9H"VGBN-_B%?_\`">:8NK?I1\&_@'XD
M^#/_``4<\-WWPN^%VH>`/V=-?_X)UC3/BAJ^D>%-'\->&O%G[1&@?'+PE_P@
MMSXYN=#0Z=KWQ<MO`&H?$B6_U%+[5M1_LR^N3JFI7-M-HDLEJ3;VTTU3OOUV
MV6SO:S$X)*_-K9NS5FK-;ZZ-WNM-=.Y^L%%%%40%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5\>?MM?M"_&7]E
MSX02_&?X3_LU:]^U)I?A*\N+WXF_#_P'XI&B_%+3_!,6EWTK>)?A[X;F\.:S
M;^/[[3-6CL%UOPVE_H^J1:#/?:OI*ZO<:>^FR?8='7K2>O6WF--)IM75]5JK
MKM=:H_S`/V=_^"I/[5OQN^*7A#]A/]FVYT;X%?LY?M8_\%&U^)UM\(_`VN^)
M='^('@GP9\6?B?X;U+6/@'IWQ1AG\-:/H/P8U6ZN[_56T;P7I^A:S=ZJWB*Q
MU/4+'PEK0\.:C_I_U_*Q^V-_P0PT+P%_P4Q_8M_X*%_L<^#)[#0#^V'\&M>_
M:@^#WAC3[5=$\+VUQXWL;W5/CGX1T^&6"33-#%ZB?\+'\/:99W5KITM^?&]K
M#IVC6_BB6T_JGK.G&4>92[Z/I;R[+RZ&M:4)<C@DDTV^_-U3?5JRU^?4****
MU,0HHHH`****`./\!_#[P'\+?#%GX)^&G@SPM\/_``=IU[KFI6'A7P9H.F>&
MO#UEJ'B?7M3\4^([ZUT;1[:ST^WN]>\3:UK'B#6+B*W274M:U34-3NWFO+RX
MFD["BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HKE?&7CKP1\.M$F\3?$'QEX5\">&[>01
M3^(/&7B'2/#&B02M%-.(IM5UN\L;".0P6]Q,$>X5C%!-(!LB<K\`^(O^"P?_
M``31\/7^LZ-#^U]\*O&7B'0HM>DU'PS\+[O5_BQXBB/AN18-4C&D?#?2?%%V
M&6[>*RM7D2.WOKR6*WLYIG;%)M+=I>K2&DWLF_1-_D?I117XK_\`#_W_`()Q
M?]#+^T-_XB'^TS_\["NW\)_\%T_^"7/B1H(-;_:<T_X3ZA=WEQ:V.F?'3P'\
M2_@O?7T5K:Q74FIVJ_$3PAH%N^CDRM:1:H]Q'9S:A!/I\<C7<?E%<\/YH_\`
M@2_S'R3_`))?^`O_`"/UQHKQ_P"$O[0GP'^/>EPZS\$OC-\+_BUITVEZ?K7G
M_#SQUX:\7-!I>JV]O=:?>7UOH>I7MSIT=S!=6[HM_#;2*9D1T20[*]@JB0HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^6/@]^UM\/\`XT_'3]H7
MX!^&O#GQ+TOQ-^SKJ/A?3O$NM^*_AE\0?"?A/7W\2Z/#J8?PUXC\3>%M'T;4
MC93R/;PQVU_.=?TX0^*/#;:MX7NH=5.S^UQH?[2OB/\`9T^*FC_L@^-/!?P_
M_:*O/#%VOPS\4>/O#W_"2^';+6TVR&%[*2\M[&SU*^MUFL](UK5K/7M&T;4I
M[;4=5\.:W9036,EGXE)^TQH?A?PI+\$?#O[/7C7XBWDVGP_%+5/B5KOC_P"$
M7A?4%M-!^SW&N^%++PCX3^,^NF:?68(8=/\`#?B+5[H:3H,_E/XNU2ZT]/[0
M3;OULM7I>][JRUO=;O1C2]-=%K:UK.[\K77_``VM'X[?M;?!#]F[5/"^B_%C
M5/B!9:GXRMM1N_#UMX(^!OQT^,'VN'2IK6"]^U3?!_X;^/+?2)DDO(!!;:S+
MI]S>H9);*&XBM[AXOG?_`(>O_L1_]#A\;?\`Q#/]M'_Z'VMK3/%?_!3Z^MM3
MFE^%/_!/[S;:[:TTY=,_:3_:$U.VN7MI9;;4HM3NF_9:L6TJ[L;J)K=K2"VU
M4F5)8YY+62(H=>VUW_@ID]K?/>?"W]A6"]C>X&F6]M\>_C_=VMW&L>;5KZ\E
M_9NLI=.>:7Y+B.WL=46VC_>1R7;?NJF[Z:+S@WVZW7GT_P"#24>N_E.*7W<K
M[ZZ]'Y''?\/7_P!B/_H</C;_`.(9_MH__0^U]._`/]IOX/\`[36E>(=:^#^I
M>-=4TWPOJ%II>L7'C'X0?&'X2NE]?6TEW!#I]M\7?`?@6ZUM5MXR]S/HD&HV
M]B9(([V6WDN;=)<3X:ZE^V1/XPL8?C#X+_9FTSP#)::A_:6I?#7XG?%/7/&%
MI?);[]*^PZ)XH^$GA[1=0M+BZ'D:@;CQ!IDUI;O]KMA>R1?8IOIFFKO=KTY6
MG^+?Z_@)\O1._?F37X17YA1115$A1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!117YP_\`!0/]
MO#5/V4;/X:?"GX(_#*3]H;]L?]H;6IO#?P#^`VGZG%8I=K9!9/$'Q'^(M]%-
M]M\+?"KP=:^9<:[XDDBAM99X_P"SX[ZS"WE]8)M)7?\`GOILM1I-M);O^M>R
M75]%J>\?M5?MD_`?]CGP?IOB;XQ>)KO^W?%=]_87PP^$_@S2[GQE\9_C-XNE
MDM[>S\&_"7X9Z/YOB3QIK]U=WMC;S?8;9-)T5+N+4/$>JZ-I*S7\7Q1-H/\`
MP4Z_;:MK+6KGQQ:_\$P/V?\`6)[N:R\$^']`\._%?]N?Q5X7E>_M[&X\<>*=
M<74O@W^SOK6I6Z:3K</AOP?IGQ9\2^'OM-WI.M>*H[^&6T@]P_9'_8-T3X->
M)]2_:1^/FO0?M"_MQ?$*V-S\0?V@/$^EV[/X+M=1L5BN/A+\`M(G-U%\*O@U
MX;$U[I>BZ#H3PZGKMM/=:GXNU+5]2U&X9/T-I*[U=TND;Z_-K6_DG;H[CNH_
M#9O^9K\D]/FU=^1^9GA7_@D-^PGIUW'K_P`3OA9JO[3_`(\.K#7[_P"(W[6/
MCCQ;^T'XKU/6U658M1EB^(6JZIX7TXVQGGELK'0?#>D:78W5Q=7MI8PWUY=W
M,_WQX.^%WPR^'<:P_#_X=>!/`T*I/&L7@[PCX?\`#,:QW4J3W,:IHNGV2A+B
M>..:=`-LTJ))(&=5(^<OVUOVS_!_[$W@CX4^+?%/@#XA_$_4_C3\?OAQ^S=\
M._!/PRM-"N_$VN?$GXHQ:_-X7LE'B/7/#^EP6MR?#E[:^=-J"G[;/8PE4BFE
MN(.:\7?M<_%WP</A+X2NOV+/CCXB^-'Q8U'Q:$\!>"M2\)>(?`OP_P##/A-R
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M72[B^TS4_$-G+HT6LWFB^%KS4(=;U>&WC.9:>?D^CMKIIKIKU]`Y9;VM;K==
MKZ:ZZ:Z7TU*_Q'_X),?\$]_B1KLWC!_V:O!OPV^(,NH6NK)\2_@/<Z[\`?B+
M!JEC/:7-E?Q^,/@]JO@S5Y9K6>PM)(H[R>YMB(?)D@DMY9XI?#;C]GG_`(*8
M?L@:A<^*OV9OVF;O]OCX3VZ"YU7]EW]M;4]$T#XS31PVL8NW^%'[7OA;P]:1
M/K]PNGZ?IN@^&OC!X%N?"\?VG6-6U[QG+J]^^I+^Q5%#BNGNOO'1_/H_1IKR
M#FEU?,NTM5\NJ]4T_,^#?V6O^"A'P=_:5\6:Y\'-9T'QS^SM^U%X.@GG\:_L
MM_'[2[+P;\6["SLV$5WXG\'6\.H7^A?%3X=R2_O--^(7PZU;Q!X=N[*:SN[F
M;3VO8(#]Y5\=_M?_`+$/P:_;)\->'H?&T6K>"?BM\.-9LO%?P2_:&^',MGH'
MQL^"?C'3+N*^M-9\!^,FL[FZ@TZ\FA2#Q+X4OQ=^&O$]@QAU/3FO+;3-0T_Y
M2_9)_:V^+GPO^/NL_P#!/']O?Q-I6H?'ZRMIO$7[,/[0R>'T\$^$_P!M7X0V
M]G;W%YJ6FZ;`&\.Z/\<?AQ--_8WQ1\":1>*\[+;^*-#TPZ'?07]Z7:=I==I;
M)^3[/MT?D]`:35XWT5W%ZM+NGI==U:Z7=)M?KC1115$A1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!113))(XHWEE=(HHD:2221E2..-%+.[NQ"HB*"S,Q"JH))`%`#Z*CAFBN
M(HKBWECG@GC2:&:%UEBFBE4/'+%(A9)(Y$971T8JZD,I((-24`%(1D$9(R",
M@D$9&,@CD'T(Y!YI:^6]0^#WQQNOVO\`P_\`'"U_:&US3_@!I?P6UCP#JG[-
M<&AZ8^@ZWX_O?$MIJUC\0[S5[F"YNQ?VFG1R6,=Q926%_;0V\>FH\^FZEJ*4
M?*_W??JU_GY!\[??]VB?^7F4OV?/V1O"_P"S3X#^)W@;X??$_P"-^JGXF>+O
MB/XXF\3?$7XE:Q\2=?\`"?B+XC^)_%?BV_U'PD/&8U?2;"ZL-9\67=Z]U=Z7
M?7/B:_L[35O&LWB35GO;Z[^7K?\`X)S_`!YMK:2U'_!6;_@H=,)+_3[\S7%Y
M^RS/<HVGQWT:6L<[_LT%TL+L7[/J%FI\F]DMK%Y@3:18]/\`CMX7_P""HNI?
M$[7[S]FOXQ?L/^$_@[+#HP\,:#\9O@;\;/&GQ$L[B/1;"/7VUOQ'X.^-O@[P
M]?17/B%=3NM)2R\/63VFDS65G=/=W<$UW/Y#_P`(3_P6[_Z.%_X)G?\`B,?[
M2?\`]$I4::)1EIHK.RM==I+3;?L_,M7O?GC=VO>[?1ZWB]KZ^C['MH_9(_:'
M6P%A_P`/)_VL"HUK4=:^U'P!^QL;\R:EJU_J[Z<;P_LP^:=%LWOVL-.TO/V6
MQTFUL-.@5;>SA4=#_P`,U?M&?])$/VC_`/PTW[%7_P!"]7SC_P`(3_P6[_Z.
M%_X)G?\`B,?[2?\`]$I7MOP0T3_@IMH_B6W'[1/Q#_8B\=>#Y]4TLWI^$WPP
M^-_P\\3:=HT1N1K*6`\4?$SQ_I6IZG=K):'3WN_[-M;(V\PG2\%TIMA?X9KU
MD_+^\_Z3\[CVO>#\DM>G]WS_``9]._"3P%XZ^'^CZGIWCSXX>._CKJ%[J8O;
M+7_'OAKX3^&=0T:S%K!`='LK7X2?#WX=:/<61GBEO3<:GIM_J?GW,L8OA:I!
M;Q>KT45:5M/S;?XO4@****`"BBB@`HHHH`****`"BBB@`HHHH`^;OC]\:]:^
M&GB/]GOX<^#-&MM8^('[0WQIT_X<Z#+J]E?W7ACPUX6\,^$_%7Q<^+/BSQ'-
MI][I\\!T[X6?#SQ7I7@V&.Z_XF?Q,UWP/IMY#_8ESK%W9?*7P9_;^UZ\\7^)
MO!'QL^$GQ!L]!L_VO/BA^S'X?_:4\*^%?"&D?L\OKD'Q&O/"OP=\+:V=1^,7
MB#XHVOB/Q5=WOASX:CQ-;^`I?`NJ_%.]L_#W]KZ+J6L6>F#Z*_:4^''Q#\1?
M$+]D3XI_#;3XM>O?@C^T3#JWCGPQ/J6G:4NK_"?XH_#'XB?!+QOJMI=ZA:S#
M^TOAY-\0]!^*B65M<6EWKFE>!M9\-VC37NMVL=?+?P[_`."=7C_P#=-\,4_:
M$TS4/V5G_:\U?]M*X\!0?"N/3_B]J?Q!/QZM/VE_"7P\U?XI7'C+5?#S_#KP
MY\9]-T?Q;?7VB_#K0/%WB#2]%L?!KZEIVEW&L7^IP^:[MWTT5K66][=;WM=I
M;+4M<MM;)_/75WV\K6NK7OKNB#X2_P#!4'PSXL^'GPT)^'_Q`_:`^-WQ#3XT
M^,(/AS^RM\/I-4N+'X'_``T^/WQ'^#.@_&G7K;XC^.="TOP?X9\3+X,LDT[2
M-9\;W/C#Q5XEEUO3?`_AG76T75K72?9M1_X*+_!.[L?!=W\*O!OQP_:%G\8?
M!>']H2?1O@A\,[GQ)X@\&_".[UG4_#>F>(_&6B>(-4\*ZA8:QK7B3P]XO\.Z
M#\/M*AUKXE:YK?@?QEIVE>#[NX\/7RI\X_!/_@F3XZ_8]M?A/XC_`&6OB[X$
MO_BEX$^"7C']G'Q=KOQO^'OB;5?#OCCX7ZU\<?B#\>_`MW;Z3X+^(6BR^&?%
M/PS\8_$OQ2CR6SW]G\0=*U.XT_4W\-O!H][H_H'@O]B;]H/]G--+UW]FKXZ?
M#W5_&^J?L^>#/@/\1;KXZ?#74KSP[K.K^!/B)\<OBMX;^,/A[3_A_P")M$OM
M(U.S\7_M"?$>WU#X;W-Y=Z%K6@WN@6R>*-&O?#<MYKZ7/977:]K/HMKO>]T[
MW\AM0N[/2^E]+Z];+16V_&VRV?@O_P`%%?!WCW]I;]H[]G_QFMAX?O?`7QN^
M%'PJ^!.DZ-H'CC4?B)\2--^(/[.7P]^.>L^(?%'@I=*N]=\+Z=X1?QA>6_B;
MQ#JVC^'_``YX.TR+38O&%WI.IW"BZ]P^%_[:GPQ^,'Q=\2?"CP/X+^-U_9>'
M/'/Q7^%K_&"X^$?BFU^".I_$WX&ZJ-!^*_@>R\>-"_V#4?"GB"'5O#\&M>)-
M*T#P=XOUWP[XBT?P'XF\4ZAI-Q;CY!\._P#!+:^\#?M"?$?]L+PO\8])U/\`
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MEZ%J%IX/\/'^U=8^(NAP6W*Z-_P41_9V\0?#SX?_`!0T31_VE]9\*?%2UUS5
MOA\="_8Q_:Y\1:]XF\+:%IWAW5Y?'%MX5\/?!35?$EEX%U72_%OAV^\-^+M6
MTO3]$\21ZD8-%N[V\L-4MK%O[5W[-_Q7^-/CSPCXE^&?BWPMX0MX?V9OVS?V
M>?$6LZO?^)+#Q1X:N_VC_#OPHG\#^/?`X\/Z?/'?ZCX0\:_"+1QJ]C?:MX<E
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MV9!X@\*>'--\:>)_$]SXR\'_``<^(&DZMX*^$GQ?\;>$[3P1^T%JLVB_!OQ3
MXD\:>$_`FL>$_".B^.]1MYXM-OO%&LZ1%:0Q/>ZN=.L1]I/S3^Q__P`$]_&'
M[-7PM\/?#[6OB%X2U^?1?V)O#?[*[3^']!UK3M/7Q!HWCSXQ>+[GQ19Q:GJ5
M]=+X>DM?B7IVG66E7$LNIV[Z/=RW%_="[B\GPOQC_P`$V_VCK+P)\!O`'P@\
M3?L_^$?&?P1_9A_9[^`G@G]K[1=3^,_PK_:-^'VM?![0-,T37-9O]&\`SWOA
M+]HOX::M<Z7%KWAOX(_%K7-$\!:=>7VNZ?XELO%.GZ[?AB\[)V5WTUT\MW?[
MEYVW':%VKO?1WLK::ZKUTW_7[GNOVVO!7@C7/CE8?%73?$UE;?#_`/:ETG]F
MGX<:;\,/AG\5OC/XW^(.KZG^S)\)OVB&:+P+\*O"/C?Q7+?6EAXS\9R7UQ9:
M(-&T[P[X274+^ZMY7F,G)>(O^"C7PIMOB;^Q)X#\$^&O&?CC2?VSOBO\:OA)
M;>(#X3^(/A?7_A-XC^"7P_\`%/BGQ'9^._AIK7@$>.='UFW\3>'H/"?B'1/%
MFF^"I/!6ESZYX]\27EMX:\*:J[><?%']B_\`:'O[WXDWO@CXG:#XKT/XJ_M>
MZI^T%X^^'NL_$+XG_L]VOC7X?W'[,_PY^"'AGX<:W\3?@?I&J>.+*+P3XL\`
M:;XVCL])MHM(\;6&E:1HGC`W0EU*:;R'X)_\$S?B[\(O%7[$'BI/%/P>>']E
MW]K#]L?XY^(_"^@3_$JUTN^\#?M8^`OB1X131?#&M^+G\;>)M7\5^!;SX@OJ
M-U=>++^*+QC]ADEN=8T:YNW9%>>UNJUMK\4;^5N5OST!*%KMN]GI?1^Z_+1J
M5NK3\];?64?_``4C_97T+X;?#[QIX@^*R>/W\5?"A/BYJ^I_`#X2?&_XPZ-H
MG@33[^^\/>(/B1XDT?X=>!_'/B7X8?#JV\5Z)XDT.#6?B?#X?6+4?#?B32)K
MB74_"_B&'3^M^*'_``4,_9&^#]VMKXT^)VJ/%%\+_!GQNUC6/!OPN^+GQ*\+
M^$O@Y\0=2UW2/"'Q1\>>+_AUX$\5>%O`7@76+WPSKH3Q%XRUC1-/M;33;C4K
MV6VTT+=M\2?L[_\`!/;]I+]B3PU9Z#^SEK_P&^)-MXN_9:^%7P.^)FD?'+6O
MB'HVF:-\0_AMXJ^.?C*Z^(/@F70?!_CB#7_!'B;6?C_XM>^^%FN:+X:,2Z?9
MNOC!SJ6H(N;H'_!)_P`=?#CX-?M[_"CX;?%KPNB_M3_L+_LY?LB?#C4==T6Z
MMAX5OO@A\$?BM\(=;UOQ=%I^GW=F-$\6Q_$."XLXO#VFS7FB645XD-M)=6]G
M)*[STT5^OD[7T=];O33;J%H7?O.UU9WW5TM?=TM=O7>VBMJ?N!1115F84444
M`<1\3/B+X.^$'PZ\=_%;XAZW:^&_`?PV\(>(O'7C+7[UMEKH_AGPKI-WK>MZ
MC,1EF6UTZRN)1'&&EE95BB1Y'53^6O\`P2V^#OB;X@IX_P#^"FGQ\TZZ/[0?
M[;5MIVO>!=%U=]0DE^!'[)<$KZA\#?@MHEE?EH-'NKC0KFW\<_$"XTD"T\1>
M+]=FOQ+)###4/_!;RUUKQ]^R/\.?V7=#OM4T6;]MS]KW]E[]D_5O$FE7$$,W
MAKPAXZ^(MMXO\=:M=12WFG2:CI[>"OA_K^EWNC6NH6<^LP:DVF&22WNKBVG_
M`%[T[3M/TC3['2=)L;/2]*TNSMM.TS3-.MH++3].T^R@2VL[&QL[9(K:TL[2
MVBCM[:VMXXX(((TBB1(T51.\O**3^;OK\DM/5E[0NMY-I]^6-OS;U_P]F7**
M**H@_.C_`(*%?![XD_%K5?V`K[X=^%+[Q3;?"#_@HO\``3XP_$9K"6R1_#/P
MV\/^#/B[X<UKQ7<07=U;S7=CI6K>+=`BO8M-CO+V"WO)-0:U%A97UU;>>_MO
M6OQ\O/VAO@_9ZKX<_:M\2_L1W_P[\2VWCB/]B_QS>^"/BAI'Q]@UM-0\*W_Q
M(G^'FO\`@[]H&_\`A5?>"K35-(L&^%'BVTTO3_&-U;'Q[HVIV=]HFI^'_P!6
M:*32=_-IOY6T]--?5E*5K:)VOOY]?)KH^A_-3^S'^SE\;M$_;@_;D^/WA']B
M7XT>'O`'QE_8`\#>%?A/X2_;7_:`USXFZI\;O&ECKVM)JG@;XQ>.?%WC_P#:
M-\0_#N]\06,-AX<7P-K/BKQ''X8\%6>G:MK&C:/-X@O-!T;4^$7P;^)_A'XD
M_L@0?L`?!?\`;V_8NL$^*VE:C^U)\$?C]XK\2^(?V+/!?[/T+R:S\7O".@>#
M/B/\0/B=X9TSX@:[K<4&G?!F[_9L;00;KQ!K&I>)+O1/#=N!I/\`2%14\B[O
M>_1-.Z>C2TVL^Z*]H]=%LE:[L[1Y;M7U=MK[?(****LS"OB']O[]D'3_`-L7
MX"WWA/2=5NO!?QM^'&KVOQ:_9G^+&D7EUIOB+X3_`!Y\'6]U<^!O%FE:A9W=
ME+':SW,LNA>(+2:9K._T#5=0BG@>18'B^WJ*32:L]F--IIK=.Y\0_P#!/']J
MZ?\`;&_99\"_%3Q%I8\,?%C1;C5_AC\??`LD,EI>^`OCK\.;UO#?Q)\-7>GW
M$-M=6$?]M6K:SH\-S;022^']7TFZ6/RKB-F^WJ_#[]D9;_X#_P#!9O\`X*5?
ML\27EQIW@O\`:1^$_P`!OV[?AGX3G74+NVFU9!/\$OCQXUTV\3S]/T^77/'5
MMX8L-8L-1GL[V\&F:*VA6$EAI6KW1_<&E%MK7=-I^;3M?Y[_`#'-)2TV:4EY
M<R3M\KV?F@HHHJB0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`*0D*"S$!0"220``!DDD\``<DG@"EIKJKJR.
MJNCJ5='`965@0RLI!#*P)!!!!!((Q0!R6L>-M#T_PY)XAT^_TK75N?#VJ^(O
M#EG9>(/#]H/%EKI>E2:N5T35=6U.PT1X)[58W_M6ZU*WT>S@GCOM0O[2P62Y
M2E_PLKX=2ZC-X;O?&G@ZU\1Q:"VOZIX3OO%/AMM>T[0A86NH7=_J>E0ZI<O'
MIEM87UK<76H#S=+^RW,-RMW):3PS2?ASKG_!/#]H6+P'^V)\-K+0]!E\$?"[
M]D/]M'X"_P#!.W0_#OB32--AU*?]KZ#QCXKDM+_3I;?2+/P)J'PXCC\"?!+P
MY=WEW!9P^&K"?4(]2:RN[HV_OUM^R]\2O"OPM_X*+:[:?L]^#_'_`,4/CL_P
M"TOPAX7\8/X6UG3/BQX0^%G[(W[.W@&WT+7[.3Q?H6F:EH_A#XE6/QEAT[PI
MXI\2>%+#7]23489]2MO#GB2WUF>.:7\O]);;:W:LGIHT[='?+'7WEY;+=Q6M
MWIHVWV::>S:^Y?&_[5WP%^&OPCTSXK:'XET?XA?#D?$[X.?!*QN/@UJ?A3QA
M96'BCXP?%SP1\#/"-D&T[7K31K33-$\5^.=$?Q!%%?"\TG0;:_GL=,O[NVM]
M-N?<_&'CSP-\/=,&M>/O&?A3P/HS/)&NK>+_`!%I'AK36DAMY;N6-;[6;RRM
MFDBM8)[F1!*62WAEF8".-V'\Z3?L@?MH>,OBA^V?XHU7X8>/YO#?Q'^+7_!&
MW6?AG_PF*?L\_#T:KH?[*7[5]AXW^-][H/@CX6?$WQ/H7A_0_AW\,M-TJ;3W
M\1WMMXN\2:1I-CHFF1Z]?Z?865?L+^T]\!V^,OQO_8;\1ZE\/;7QYX/^"?QV
M\:_$SQ+/?7&CBS\&WR_`;XH>&?!/BR;3M3U2PGU:2Q\:Z]HL%G!IEGK-W9WU
MS;:H^GI;V4E[:"E)IOEZI*Z>J;LWZ6UTV75[@XQ5O>3W;::>G+&27K=N-^Z>
MFECZ5T[XK?#/6KL:=H'Q`\%>(=6D\/MXKM]&T'Q5H.KZO>>&Q;VUVFN6>G66
MH375SI,UO>V,L.I1QFQD2]LW6XV7,+/^;O@7_@JG9>,?@)\./VM+S]D?]H3P
MI^RO\1Y_!-S!\:-:\4_LVRVOA7PIX_\`&&G>!M$\<^+O!.F_'2[\<V'AO3];
MU?3YO$_]GZ%JFK:%HS7FKMI=W;6$XKY4_94_X)]?&3X(^`/^">.D7/P>\/\`
MASQG\(OVY/\`@H!\4/COK6@ZGX*62S^'/Q?\%_MP>$OA=XGO=4L=3CN_$.E^
M*;#QG\`M-MM&TM=0UC2[%O#B:]H>E+X6U`:-YG\$?^"6_P`4?@+^QE^PEXH?
MX?\`Q*^(_P`=_P!FZY^&\_Q[_8^U?]H[QGXB^#_Q@TW3/'UC<:K>>'/!GB?X
MOV?P&L?B#\*IK;2OB[\)5N&T;P-<^(/"UOI6L6$%[?VM[IB;D[635TV_)^[;
M==+NZT;L[:Z#M!7UOJET5_B3MKL[*S>BNKZ:G[5?#W]LGX.?$;]JKX_?L<:7
M-KND_&?]GK1_`GB+Q!8>(+*PL-(\:>'_`!SX3\,^+9=7^'%[%JEU>>);7P/;
M>-/!NF?$(3:=ILWA?5/&'A..>*>T\1Z3>77F7B'_`(*+_!/PS^QYX5_;/O?"
MWQ5U3P5XZUO3O#'@GX9^%?#&E>)?C;XT\4:IXZU#P-;^&O!W@6P\1B'Q/KL;
MZ1K7BJYTO2-:N;R#P9H6MZZ8672[NWC\/\>?LG?&3Q+XV_:X^.?@KPYI'@[]
MH+P;^U;H'QU_8V\6ZQJVFWVF>-=#L/V,/V8/@]XZ\(>(CIUV+S1O!'Q@O/`'
MCKX7>*-*UN.RO=.N=.TGQI:P3)I'A[4YO$OV:?V,?VG;_0O^"?/AWX@Z;+\`
MM(_9(_9Y\4?$W6[>\N?!?Q3M]3_:U_:!N/%_@_Q?X+FT.W\07NA7-E\%_AWJ
MWCZ.T\4"TO;?4/\`A<NGVOAKQ"ZZ1XHM;P;G>UK[V:73F25^ETN9]G9/J%H6
MO?\`ENKZ_"W+9;.5E?5Q=[K37]M_"7BOPYX\\*>&?''@[6;#Q%X1\9^']&\5
M^%O$&ESI=:9KOASQ%IUMJ^B:QIUS&2EQ8ZGIEY:WMI.A*2V\\<BDAA70U\*?
M\$[?@O\`$S]F;]GA?V8/B')JFMZ+^SKXY\3_``N^"WQ$UK4+*\U3XG_`.WCT
MOQ5\+/$=_:65[=IHE[X5T7Q2_P`([_23'IELE_\`#2ZO]&T;2?#NH:/91?==
M6KM*ZL[:KL^I#LF[.ZOH^ZZ'R]^T'^VM^R;^RA>^']._:1_:`^&?P6OO%5C>
MZGX=M_B!XBMM!?6-/TZYM[*]N[+[0-LL%M=W5O;RON`66:-.2PKK/@[^U%^S
M3^T/:W-[\`_VA/@G\:[6RN);2]F^%'Q3\$?$%;&[@AT^YN+2]'A37-5:SN[>
M#5=+EN+:Y6*>!-1LFFC3[5#O]9\2^%_#7C/1+[PUXP\.Z%XK\.:F(%U+P_XE
MTFPUW1-06UNH+ZV6^TK5+>ZL+L6U[;6UY`+B"00W5O!<1[98HW7X/^.G_!*_
M]A?X[3Z5XAO_`("^$/AA\4O"T]QJ7@/XV_`>R3X)?%_P-XA>UM+6S\1:-XU^
M&P\.ZA?:AI<=A9C3K?Q'_;>F6R0F*.P$<LRNGS=+-=G=/[]==^BZ>HURV5^9
M/J]&ONT?XOOY'Z&45^/?['G[2'QE^"7[56O?\$P?VP_&,GQ,^(FF_"^+XR?L
MJ?M-:G!;:7J_[3OPBM=4OK#Q?I/CO38;^YLK'XT?"^_"VFKV^DK#'XJ\,:??
M>+1I.EV=E'>ZY^PE-.Z_!KL^J?\`6NZT8I*SMOHFGT:>S_S[.Z>J"BBBF(**
M**`/CS]JOQ/\7?`^C:SX^TSX\?"3]F_X'^`?A_JWBKQ=\1_&?@B\^(7B6?QU
M9:OI[>&]"N=#NM8T31H_AS>V4=QI_B/3-!>\^*'CB^UFS\.?#_5_`NNQ66M:
MCZ#^S-\2OB#\1/V=?@A\0?CMX4T_X6?&+QG\)/!?C/XF?#XK=Z0OA'Q1JOAV
MTU+Q'8#1M=N[G7-"M;*]:Z9M&UR[N]6\/(KZ1K-]=:AI]W<R<!^T1^R]XG^.
M/Q"^&'Q`TOXTW_A"#X3VNKWWAWX;Z]\//!WQ)^%>H>/[RZL;C0OBAX@\,Z\F
MGZG?^,_`T=D\7@B\M_$5C#X<GO[_`%33XH=8EAO[?+_:,^#_`,!)?AMJWC'X
MX^-_A1\(_BQKOPSB_9_7]LO5-$^%WP\^)WA^3X@6MWX0%AX%\?\`B^*:7PK>
M^*-8\3ZO#X9\)6>O7$"ZQXBDL],M[R]N<SSK=O6R75Z/;7?2VJV76[*T:2ZM
M]%JNB71N^[U?1)+6_P`Y_L;_`+:7Q1^-/QRNH_B'X@^%VH?`K]I_PO\`$7XK
M?L.+X+LX(?$L/P^^"OC>R\">+=/\<ZW%XNURV\2:KXS\-^(?A_\`&/PY/8Z9
M8)#I/B?Q%I@8)X<ELK#Y8U+]NCXHZ/;_`+0WB;PS^W'\*?B)^T9X'_:<_:,^
M&_PI_P""=2>"?A!KWC3Q3X;^'7[0/B[X4>`_AV/"O@W5]!_:%O/%_BCPCH%K
MXITGQ[-KFGZ!H@UC3?$WBO0]7\&Z/K$^K_IIXB_80^!,,_P&U/X-^#_!OP!\
M2?L__$OP+XU\+^)?AMX!\,:;K6J^$O#.G7OA?Q1\+-=U.WM;+5=0\)>/O`NK
M:IX<U@7FHW4D-\=(\2O#?ZIH=F#[3\`_@Q:_`CP1KG@RU\3ZKXN_M[XN_'CX
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M";]I32_$&E?$VRUNXB\1_`?X]?LXWUQHNM7&D7,7PS_:1T_P9IOQ/M;4QI-;
MQZQ>0>`?#3:1JTMO/-I$MK.UO&RW=PCIW:TW\_4<;77-MUMN?&/C']M?XO>%
MM$^-N@?'[X#:'X(.A?LPZ7^TIX!UCX&?M#ZUXH;Q+X7NO%?_``BGB/PCJ?B7
M6OA'\,/$?@+QUX9O+[PS=Q:CI?AKQ+X>UG3];N&LM7M[O3+FR;E;[]NKXN>!
M?B]\9/"'QF\"+8^&6_X*C?LW_L4_``^`?'&CSZNF@?%GX&?"?XERZ[\0XK[P
M)';+X9N]+\17/C66RM-1UKQ7<ZIXUO?AVMSX6LO!FE^--6^Y?B=^R5\)OBS_
M`&VGBAO$T2ZY\#KK]GV]CTG68;01_#Z]\1:1XF<V_GV%X\>MKJ6@V:Q:G(TL
M?V83Q-:.[^:G#>,OV%/A1X_^)VN_$GQ5K_CF^74_VDO@#^UUI7A6WU+2K'1?
M#7Q[_9_\`6'PLT?Q-IMS;Z,-7O-#\6>`?#G@O1/%'A76+[4=/%QX9_M;0Y-'
MO]7OY#+4NCZZ;=G>^GW%)PZK?UT^';7OS-^7W'C?PP_X*%:MXQ_:Q\/_`+,?
MBGP3\"-)OO&&I_%S3=,L?AS^UCX3^,7QD\`GX86=[K^E7/QP^$GAKP+8Z;\/
M8_B'X0@M?$&BPZ7\1?%T^B7%];Z'K"M>&::#Y+_93_X*>?$'_AEOX1?'_P#:
MKMM>UC5K_P""G_!1[XK>*-/^%R>"KC2_%EC^R[^UM\)?@QX-TFV\-3^!_#VK
M'QQ+:_$"T\&^#[G3_''@[PC+''K^N_$'2]=OO$/A_4_AU]N?`[_@G5X6^!^N
M_`ZZTSX]?'7Q)X._9GNO&I^!_P`-]9NOAO;^&=!TSQ_I.NZ3XCM/&6H:5\.[
M+Q;\1M5GB\1ZG*GBGQ#XB'B.:=H[K4[_`%+4)=2OM1YCPI_P2R^#6@_"F'X+
M:WX]^)GBWP'I'P\_:^^$_A.._P!0TC3/$'AGP%^U_P#%_P"&GQL\0V5OXATC
M2[2\N==^''C'X9:2?AWXB9(+G3[&Y,%_;WK6-A)"K5-[_*^F\.V^T]=]?.P_
MW>BZ:7>MW;FO;JKWB[;:;NUW1\>_\%'O$/P'OOB=X3_:*_9MUCPS\3_"OPO\
M+?&3X9_#CX/?%+PS\9-:^-7@CQ+\5/"OP8NM.\-2:MHOPL;1_'WA'X@>./!N
ME>*?#^IVDWALQ>*=%N/"WC?Q2)+^/3_JC]G_`./7C?XG>+_C!\,/BK\)K+X2
M?$WX.W7@6ZU73?#WQ$MOBGX,U_PK\2M!O-:\)ZYH7BT^%O`>KKJ$5SHWB/0_
M$F@ZOX+TO^RM2T=)]*U3Q%I&HV>IMX=9_P#!/?2/$-_JWBKXY?&_XC?'CXEW
MFC?";P;HGQ&\4:#\._#6M>$/AW\*_BQX+^,\G@[P_9^#O"NCZ=&/B!XX\#Z+
MJ'Q`UZ^AO=9UM;/2T2XMET:P"?7/A;X2:/X5^+7Q8^+UIJ>I7.L_%O1_AIHV
ML:7<"U&F:7!\,K3Q19Z7+IIBA2Z,NHIXJNWU#[5-,@:VM_LZQ`RAZ7-?7;L[
M7Z[VZWMMIZZB?)9V6MO.U_=VN^JYKWZ[=#Y*\;_M^Z=X&?Q5\1=1^%6JG]E3
MX??&RT_9T\?_`+0-YXNTC0[_`$'XFR_%;2O@CK&MV'PQUS3["[UOX.>"OBKJ
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M`!1110`4444`?BW_`,%G-7\,>"+'_@FC\6?&-[>Z9X9^&7_!5G]E34]?U>,Q
M+I&A:-X@TOXE^%;O7O$DLJJEKHNEW&KV4MU?/<VZVROE5NIW@M9OV2UJ;4[;
M1]6N-$LH=1UF#3;^;2-/N+A;6WO]3BM97L+*>Z8A;:&ZNEB@EN&(6%)&D)`6
MOC__`(*(_LIP_ML_L7?M`?LU)=P:7X@^(/@IYO`.MW#RPQ:!\3_"&I6'C7X9
M:U-<6Q6[M[.P\=>'M!DU-[1EGDTDW]LH=)WB>Y^P)^TY;_M=_LF?![XT71-I
MX\O_``W%X5^-'AFYMK33=8\#?'7P,Q\*?&#P9KNA6T\TGAZ_T;QUI>L_9=*O
M4M+S^Q+C2-0>RMH+^",2M)/S2:^6C_-??]]O6"?\K:?H[-/YZKY+N?DUIO[1
M'[7^K>$O"%G\)_VA_C?XP^*_Q!^'?AW3OVG;?QA\!?`<ME^R)\8_&G[2/[+?
MPR23X>Z&/A3I^CZ;JWA/P=\2/CA/IW@+QQJOQ-\/ZUX8\`V?Q+UD1V>@ZO>^
M,OU$_:<U_P")'P4^$GP/T+P]\8?'FD:;??&CX>^`OBW^T!JGAOP%XM^(7AGX
M8W>G^)[R_P#%-['<_#Z]^'-CJ&J^(=+\(^"M3\6:O\-M1TO2M+\1WNKW=E;Z
MJ%\0V7W/2$@`DD``$DDX``Y))/``'4T*+5_>;VMJ^GSZ]1.2T]U63OTU^:2^
M7XWU;_FH^#/QL^-/A+[9X=U#]J#XL?#/]GCQMXH_X*3_`!>\%_M4V'PT^%6M
M?$3X[_$_PA^TI=Z3X(\$ZCH/C/X`^+/AQI?A^/X>W6N^,_"UKX#\$^#]2^,.
MH:23X,A\/^&_#E[H/B+UGQW^W9^WC\(=/^$^N^-OAC=:SI%CH/P`_:]_:(_L
M?P!JPU#PI^RMXT\#^$?`'QQ^#_AS0]$\*^*-0UWXO_"_XU>(?$OQ#TS2([G2
M/%&H^"O!L&FWE^EEJ-T\?VS\3/\`@JO^R;X%^&7CKXE>'-?\4_$>+P'=?"*X
ME\/Z3X(\8>#+_P`<>"OB_P#'CP9^S]I/Q0^#^L?%#0?!/A3XS_"_2_&'C33I
MK_XA_"[7O%G@A[9].CA\1>=XC\.?VG]#Z?\`MG_LQZGXJ\6>#[;XL:3'J'@O
M3_'>IZQK&H:/XHTGP'>6_P`*C<K\5H/"?Q-U70K/X<>/-4^%3VES#\4-%\#>
M*O$6L?#JXA>W\9V&ASXC,I6LO:;6_3NVNC\[/7N7?6[IW[I_+7176C7EJFDE
MH?FCK?Q2_P""A5MX&^-_CSQ-\7=4\%^*_@-\"?A'^T#I_P`*O"/P;^&NJZ-X
MP\;?%OQ-\6O&VM_`GQQX@UWPQXIUCQ%X+^&/@S2/"7PD2Z^%M]\/_B#JE[I$
MOCG4?'DU]K;6+>`?M+_M7_M&2>.O^"A7P7L?C]XU\4W&H?`;]N3P_P#!GPM\
M!=(^%MYIWP-U7X<?`1/'/@>^^(F@CX;^%OVI?A;\2%DTCQ'H'AKXE7/Q$^)W
MP>^)_B?Q'ITO@8^#M:N/!^E6O[`Z5_P4%_9!U?7(O#L7Q@@T[5);_P`+6NWQ
M)X)^)'A&Q@T_QY<7%E\//&5[K'BKP?HVCV'PQ^)>JVSZ%\,?BS?7]O\`#+XD
M^));/PUX&\6Z_KVH6&G7/5V'[67[+=S\8_$WPEL_B7X7@^*FC7^H>&-:6?2=
M8TW3-2\3>%?#$OC;Q%\/]'^(UYHMKX'\8^/O`_@\3>*O&'PX\->*M;\:>!O#
M_F:QXF\/Z-8%IR-7VGY;WZO3?JM/E?NA7:>L.E]K6^'7;NO_`":RM<_);XI_
MM4_M4:=IO[:7Q(^"_P`>?''Q"\$?`V#]BKX6?#33U\$?`G0?!L&D_'KPE\)?
M$?Q/_:5U_P`;^)O@X+KQ=XK\/^%_B`/&.FZCH>L6_P`#O"BW?VWQ-\+]<T?1
M-7TJVY)OVY?C]H/P;\,Z/\0_VG+_`$J_\6_M*?&#PO\`#/XX^!;G]DC6=8\9
M_"[X>_`K1/B.GA;X@?'7QI\,O"/[&]CXMB^)?B7_`(1G0-1^$GP=\5ZU\3?`
MNAGP]X=\)Z=XVT+XC?$#PY^FOB/_`(*2_L9>'_`7B;Q=H_Q!C\8:%X;N/@M:
M7.E^%_"?B!9_$?ASX\>-=$^&O@#QCX`MM:TC1;'XI?#^XU;4I;"[\4?#>?Q9
MHL-QX=U_PM;SW/BW29/#9^Z9-`T"YL++39M#TB;3+!X)].T^;2[-[*QEMU=;
M:6TLY(##:2P)(ZPM%%')"'=4*[F!$KWM-O36SO:[?F^UK7Z>MQR223@EZI7T
MC'^[?^]Y\Q_.U\'OVT_V\_VG?A%X1^+.B_$-?@AXM\-/_P`$S?#'C'X7VGP"
MT?Q)H.L^*?VP?B;H'PT^-NM>,4\9PCQFVB^!?"_CK1OB9X7TGP/XA\!OX8UC
MP[=V/C#Q#XC\.W5_IUE^P'[(&N?&&XTOX[^`_C-X[U7XJ:M\'/VB/&'PY\'_
M`!.\1>#?"_@CQ7XX^'<_@[X??$/PO?>+--\":-X7\`ZEX@T$>/[[P5>>(_!/
MA#P?H6OQ>%K?4#X:TW5I=4$GURL42/)*D<:23%#-(J*KRF-=B&1P`SE$^5-Q
M.U?E&!Q61XE\2^'O!OA[7/%OBW7-)\,^%O#.DZAKWB+Q%KM_:Z5HNAZ+I5K+
M>ZGJVK:E>RPVEAI]A9PS7-W=W,L<%O!&\DCJBDBHQ:M>3;Z[V?RNTNFW9]V)
MR3T44ETLE?IUM=[/[_)'XR>'8+?Q[_P<,_$CQ-X?NY[C3_@'_P`$I_!/PL^(
M7DWLMBNF^._BG^TMJ?Q*\(:/<V!DB.NVE[X&LKS6VGCBN;#3+V.Q6XDAOVM5
M/[;5^/'_``29^'VJ^-9/VK?^"BOC;2-<T3QK_P`%"?B]9>+_``?HNO7AN+KP
M_P#LP?!RRU+X?_LU:<8X[J:R,NM>&)]<\=B_MK>QDN]'\8:#I]Q`\6BV<K?L
M/1':_P#,W)>CV_"UQ3W23ORI+YI>]\N:]O(****HD****`"BBB@`HHHH`***
M*`"BBB@`HHHH`**^,/"'[4_B;Q)\-OB/\6=)^#7C[XF:/;?M%?$;X*?"+P!\
M)]'TR7XC>)=*^%GC6[^#'B3Q-XJNOB%XK\$_#WP]I][\5/`WQ-U_3O$FL>,/
M#GA:S^%\G@B75+V'Q9>:AIC>;7_[:7B/Q3K'[*J^$?A]XI^&[?$3]MGQE^RW
M\:O`WQ3TSP;K/BOPR/!_[._Q_P#B+J-K!K7PO^(WCGP197*^+/`/@ZXLM?TK
MQ1XELKNR>ZT>6V@N+]WM%=:>?D^]NOJ5RO;]?*__``.U^I^C%%?EQ\(O^"BF
ML>+?@G^S_K\?[/7QI^/?Q;\6?L;_``!_:F^.VE?L[Z%\.K?PY\+['XR>`H?$
M=BH_X6]\7/AW-KM]XEU32?&[>#_`'@"]^(7CN;3/#,_VS2EDNM'DU?TWQ;_P
M4N_9-\#>`K[XE^*O&>K:+X.LOBU\"/@\NK7V@SV]O>:U^T5X3\"?$'X>>)8)
MI9DMK?P,GP\\>VOCKQ+XCU.?3U\/^'/#OBN:[M&O]+@L+XYE:][>NGX[:=>P
M<LNS?337[^VZW/OJBO@_QW_P4"^&7A;QA_PKKPE\./B_\7?B'<_'SQ=^SIHW
MA#P)8?#K1+CQ'X[^'_P?\+_&OQS=Z)XB^+7Q*^&/@N?0?#7A?Q5!H\TMUXFL
M]:U?QCI.N^'?#FAZS+IXN)_H/QG\7K[1/V=_%7QT\._#WQQJ^HZ/\)-;^)VD
M?##5M&MO"GQ"O;S3O"ESXDM?!VJ:#XOU;PU;:%XF::%=+O\`3-;UK2DL[X36
M\U_%L$I+IWL[V[?UKNMNZ%9Z>>WS/;:*_.GX!?M\K\4++]G7P;XA^#OQ*N?C
M3\2OV4/A3^U!\9=+\"Z5X-NO"WP/\._$31+MH;GQ5IM_\3;KQRHU[Q)HVM6O
M@GP7X5TCX@?$'5-.2(OI$]UIVO?V;WGA+]M[0M8\7W'@_P`<_`3]HGX)W-S\
M!/'7[2?@^\^*GAKX>P2^.OAA\,KOX?V'CZ32_"W@;XF^.?'_`(5\7>&+SXI>
M!;:_\!_$[PAX"\7O<:W]EMM(FO-.U6WL3F3MY_\``_S0<K[:[VZ_);OY=-=M
M3[:HK\X?A]_P4W^#?B_2[/Q!XS^%G[0?P*\,>(/V9?'7[7?@'Q#\8_`_AG3K
M+XC_``2^&-IH&I?$#5_"=IX'\=>/-9C\2>%]'\6>%M>NO`_B;3/#OBW4-`\0
M:=K6BZ1J6G?:KBVL>(/VZ/$.L_L_>,?BWX'^`OQ=^&.M:-JO[.L'AFV_:1\#
M6OA_P[XLT3X__$KPEX-L=;T*^\"^.?$5GK#Z'I.O7=YK>AIX@T[Q%X9U,Z-;
M^(](LDU.VCN3F7?S_7\OOZ#Y)7M;=I?>[+UU['Z+45\A>-/VS?`?@#XCZ-X'
M\3?#7X]Z?X6UCXI>$?@@?C?=?"K5=.^#FG?%KQ[J]CX=\%^$;K6-7N]-\7WV
MG>)?$VM>&O"ND_$SP_X)UKX.W/BOQ-I/A@?$1==CU;3]+\\^"?[:X^+VN>+M
M,U_P]=?!T^'OV[_BG^QUX1TWQAX0\4ZQJGQ8'PT^&7B#QM_:FC7-E<Z18^#+
MCQ`OAOQ%XDTWQ'JR^(/#+>&?#0T<6[Z]XKTNZTPNKVOKV_K^NVHN5VO;3<_0
M"BOCGP;^W;^S[XWUWX>Z7IM]X^TO1OC'X8\1>+_@KX]\4?"SX@>&/`'QAT;P
MAH6K>+?$\O@/Q%K6@6BW<EAX*TB;QUHXUBUT6/Q[X&F7Q?\`#67QGX?LM7O]
M,I?`']OO]GC]I3Q)X0\._#:?XFVR_$SP%K/Q.^#_`(B^('P<^)OPQ\+_`!D\
M"^&+[0].\5Z_\-=8\>^&-`37HO#5UXG\-R:A9SPZ?J5WI6NZ;XCT2SU;PU.=
M80YH]UKMJM=O\U]Z[ARR5[IZ;Z;?UV]>S/M.BBBF(****`"BBB@`HHHH`***
M*`"BBB@`HHHH`_#W_@N9I"_##X/?LT?\%!M'\^S\5?\`!.[]JSX1_&#6M1TD
M7P\2:Q\!?B'XJT7X3_'GX<Z1):W=M`EIXTT?Q'X:O]<AO5EAO]/\)G3&S%>S
MV]S^V>EZIIVN:9IVM:/?6FIZ1J]A9ZII6I6$\5U8ZCIVH6\=W8WUG=0,\-S:
M7=M-%<6\\+O%-#(DD;,C`GR']I3X)>'OVD_V>_C;^S]XK4?\(_\`&;X6^.?A
MMJ,P,*RV">+_``[J&BP:K:2W%CJ<%O?Z/=7<&JZ==2:=?K:7UG;W/V.Y,0A?
MX$_X(K_M'WWQR_88\`?#OQW!;:)\?_V.[N]_8W_:(\&B>W?4?#GQ)_9]$?@!
M;J]2+4=0:<^)/#VCZ1K-SJD1@TN]\0R^(K72(8[733##.T[?S*_SCH_FTU]Q
M>\%_=D[^2E:WXI_-H_6BBBBJ("BBB@`K\C?^"T_A&'Q]^R5\./!%S?ZCI=OX
MN_;9_8<\.3:EI'AZ^\6ZI81:Q^TU\.[%[O3O"^F2P:CXAO8%G,EMHUC-%=ZC
M,J6L$B22JP_7*OSD_P""F/\`R33]F'_M(W_P3N_]:V^%U3/X7\OS14/CC_BC
M^:/T;HHHJB0HHHH`*_.3]M?]LF[_`&'_`!EX3^)7Q&U"VG_9Y\7?"/XS:3'I
MKZ9:VVH0_M%_#GP^?B5\,?"&A:\&^T:QX@^.GA/3?'WA/P]X1N#$9_$?@S1D
MT,W%_K=[`?T;KB_'7PX^'_Q.TW2='^(O@OPQXXTK0?%?A?QUH>G^*M$T_7+3
M2/&?@G6;7Q#X1\4Z9#J-O<)8Z]X=UJRMM1TG4[81W=G<1YBE"/(KIIM.SL^C
M_KH]F--)ZJZZKR\NS/QA\0?M$?M9>'_'/Q8^%TU_\`O`7[1T7@O_`()&^`_%
MWQD\/?!JZUZVA\<?M1_$[XR^`OBQ=3:-JGC'1M8\7^$_`UUI>IW?P?\`#OB+
MQ!;IX:GUC6;G4#?_`-LW]F?)_P!M+]M3]KO]D[1/C#XA\)_'CQ3\;+C]A[X=
M_#=OC!I.A?L/Z3/X%^)'C'5/`?A7QCXHU#X]_&&\^)_@+PUX)U+Q#X=\2VOC
M#2/"7[/]OI1^'&E:EX=OM<_X3Z[UVR\"O^\6I_![X5ZUX@U/Q9JWP^\):CXG
MUK4?AWJ^KZ_=Z'83:MJ6I_"/5[[7_A??7M^\)N+FX\`ZWJ>HZKX3DED8Z)?W
M]Y<V/DRW$K/XE\7?V$OV1OCWXA\2^)_C%\"_!_Q"U'QI;Z5;^-;3Q"^LS^'/
M&;:%8VFF:'>^,/!\.JP>$O%.KZ+I^G:59Z1K>O:)J&L:9!HNA1V-]`NAZ3]C
MEQ=K)_.[[MWTZ[;I]2U*-]5V^S%[<J>_1VE:VU]#F_V3%>3XM?\`!0:\EN]2
MN&;]LC3+*&"[U74KNQLK.U_8]_9,N8K?3--N;N;3M)1[C4+NXNO[,M;0WT\W
MG7IN)4C9/@KP]^VC^V9?:7^QW^T5=>//V6[KX*_M8?MBS?L^:O\``:R^'OC)
M_'OPT\)WFM_$_P`/:=I7ACXO3_%331\0_C/X4N?A7J:?$O2+CX2:+INGZQ-X
MIM]+T*/2O`EQ=ZU^TGAOP1X4\(7_`(RU3PUH=GI&H?$+Q2OC;QI=6OF^9XA\
M5)X8\->#%UN^\R21?M8\+^#O#&BCR5BB^R:/:?N_-\V23\I[S_@F#J7BK]K7
MX;_';QEXC^#]AX%^$G[3/Q`_:CT'3?AUX"^(?A;X@^-/&'B6'XAMX0T;QBUS
M\5]2^%.D1^&-2^(]YK'C7Q9X5^&]OXF^,&M>'=.UKQ'+HVH:[XD>[&I:6[OK
M;>2:;[V5]`BXZ\W9)75[VC9I=KNUFM5;HKG'?LS?MS?MF?&OQI\+_'<WP6U;
M5?@/\7+_`.*5OK=C'\#=?^'^E_`KPSX<T+QCJO@#QL/C;XA^+.MVOQ?-UK7@
MZR\%^.-`/PV^&M]<ZKXZM-4\+6]C_P`(==^'_%'->'O^"A/[5WPN^"OA']H/
MX]6OP/\`B_HWQ,_X)E>,?VY=`^&OP-^'?C;X7:CX?\?>!M0^!<H^&]OXI\9?
M%OXM_P#"4Z%XET[]H30=);79=(T6_M-5\'W>JVND+;:XNBV7Z7>!_P!BO]G7
MX<^.7\>^$/!VKZ7?0ZQXI\1:%X8/CWQ]>?#7P7XA\=6&K:9XYUWP'\+KSQ+/
M\/O!>K>,K/7-7C\1WOASPYI\NH-J%Y*3')=7#2]O:_LS?`.S\,^%?!<7PJ\(
MOX1\$_!?7/V=O#'AN[L&O]%TOX(^)H/!UMK_`,-5TZ^EN+6[\,ZM;_#_`,&P
MWMK?1W4LL6@62&;:9Q,*,K?%KZO?37;K9NSNE?03E&_P^[IIULK];[[:Z-VU
MUW_.'P1^U5_P4(O]'^,]K;_!2/XH:Y;_`+)7_"\?@_XFO?V7_C!^SGX7TSXY
MQZQ<:?J7[/\`KFA?$KXLZUX@^*-T^F:AIGB?P=!H=W\-M7U"P\/:UX=\0ZUI
MVI:_I.NZ;D_%7]I3XN>*_P!C+X^?&L?$?2[#XP?L7^)?"G[0\_A[P=X$^*G[
M+_BZ\\#^`-(LO'/BKX9?'?X`_&SQ'XFUK1+;XC>`K?XD>']'L)_'OBCPOXRA
MNO#?BCPWJ.F>(-'MQ9_<G@_]A']G/P9X/\>^`K71/'GB+PM\1O!.E_#36].\
M=_&'XL>/&TOX>:#/J=UX=\%>"[SQ9XRU:]\!^'_#EYK&H7N@VG@^XT9])NYH
M[BSFBEM;5H>!\;_L`>`-3^&VL?"SP7K6M6NC?%?XO_"OQO\`M(^)_BGK_BOX
MX?$+XQ?#[X9:QIVN_P#"LM3\9?$[7O$>LG2-;'A[1_"/V?4+J]TG0_!FJ^+K
M;1M+MM2UDW@+2LM;Z.^O7I:Z6SL[MW[#3C?;JGK%:[7OKY.R22=]=]/OR"43
MP0SJ"JS11RA3C*B1`X!QQD`X..,U+2`!0%4`*```````,``#@`#@`<`4M69A
M1110`4444`%%%%`!7XD?M$^$/BE_P33^/WQ$_;M_9Z\#:A\2?V1_CE>Z9XB_
M;\_9Q\'6NHW?C#P7XUTN*;3[C]M#X):`EY-INH:_-X>.G:?\>O!6CZ;IE[XT
MTKPUIOBZ>36=<AEU7PU^V],DCCEC>*5$EBE1HY(Y%5XY(W4JZ.C`JZ.I*LK`
MJRD@@@TFK^36S[?\!]45%\KV335FGU7Z/JFMF<!\*/BO\.?CE\.?"'Q;^$GC
M#1/'OPY\>Z)9^(?"?BSP]>1WVE:QI5]&'BFAE0[HIHVWV]Y9W"17EC=Q3V=Y
M!!=02Q)TOBGPUHWC/PQXC\'^(K5K[P_XKT'5_#6NV2W%Q:->:-KNGW&EZG:K
M=6<L%W;-<65U/"+BUGAN(2XD@ECE57'Y:^*OV/OCC^Q_XR\4_&O_`()LQ>#K
MSP=XFGD\0?%+_@GUXVU!/!7P;^(OB6ZOK.X\0>.O@5X^A2Y@_9^^+NN6%J]O
M=07VB:U\)?%FIS&_\2:)H>IS7'B1?2_V=O\`@IY^S[\:O&UC\#_B/IGCS]DK
M]J6>(A_V:?VH?#S?#+Q]KDT,UQ97%Y\+-:OII/!/QH\.37]CJ"Z1KGPU\1:[
M+J%A:'4;K2],1_)1)]):/\'Z?Y;KM:S9R]8ZI:^<?5>7=:/?35+Y4T3_`((M
MZ'9?`#4/V=;WXP^"M-\):;X(^!'PT\!:_P##[]GFR\)^-;?PC\#/CM\*?CC9
MW_Q-\2>(OBGX^O/''CGQ;J'PET;1O$^L^!?^%.>$-9EU.]\2>(?A]X@UG2/"
M#^&NP\(_\$C?"_AW6?B#IUYKGPYU/PEKGA3]IG2?`OC*_P#`GC/7?C?X4UW]
MINS\7:9K^M/KWB?XIZSX"LY_#>E>//%&E_VEX0\"^%M>\8V%XEKK6IV,$VK1
M:K^R]%+DCVVVU?\`GY#]I/77=W>B5W9+MV1^>_C;]AFX\5ZS\>=3B^)*6T'Q
MB^#W[&?PMTZUG\+6[2^&I/V2?B3\4OB"-4N+NWU"&?5[?QO)\0X;,V<K1/X?
MDL+N>WGO([Q(8O'?`/\`P3,O/`OQ(U'4)/B!X?\`&'PYM?BO\?OCMX0D\<6W
MQ7\5?%'1?B/\>=+^*6G7J_;]9^+EY\,;.'PR?BWXB@L?&.C?#>R\;:GX<ME\
M+W]\(-;US4+C]:J*?*M--MM7WN)3DMG^79+\E9]^NI^5WBW_`()U:_J_AOX7
M1:-\3/#EOXM^%G[+/[.7P`TR_P!6\'ZA=:9J&N_L\?'3X1_'&R\03&T\0VM]
M9^'?%VH_"U-#UC1(C-?VT%[8ZA;:JTNFO;7OZGIOV+YFW?M7?LSLWX&[;NYV
MYSMSSC&>:=7RU^TM^VI^S%^R)X?77?CW\6_#G@ZYNFFAT+P?;-=>)?B1XNOX
M;-M0.E>#?AQX:M]6\:^*=3:S0W(M=&T2[,=M_I5PT-L&F5V4;O;17;>EEMOH
M#<I66^]DEWMV]#ZEK\'_`-HKQYX@_P""N/COQ!^Q9^S)KT]E^QA\./'J^'_V
M[_VF;.U>7P[\2+CPS/H^JS_LH_`?5TG^Q^,;W79Y9+7XR>+K(G1_"6CVUOIE
MO<ZA+X@LX]0VM8TW]M;_`(*J[=`UOP_XU_8)_P""=.M/8_\`"7Z%XF@U3PI^
MW3^U%H%K=/+J/@^>/1=;DT[]G7X)^.K1H;77KA;R\^*GB+P]!<:.D>F:+XNU
M%=)_87X5_"CX:?`[X?\`ACX4_![P)X7^&GPV\&6+:;X6\$^#-'LM!\.Z):2W
M,][<+9:;810P)->W]U=ZCJ-TZO=ZCJ5W=ZC?SW%[=7$\B^+351ZZ6YO)7Z=&
M^O334:M#71RZ=5'S?1M=MD]VWH=;H>B:1X9T71_#GA_3;/1M!\/Z7I^B:)I&
MG0):Z?I6D:5:0V&FZ;8VT06.WL[&R@AM;:"-0D4,21H`J@5J4451`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`?F1#^Q1XB\=_"1O@MXWOM#TK1/A;^V
MK\6/CWX1@\5>%M-^)WPR^-/@KQ_\2O'_`,:_#>D_$7X>MK_ARZU*P\*ZK\8[
MC1Q8W>MZ08OB1\*])\9"PU/PY)9Z5?;GPW_X)[Z9X,_X4]/J_P`1=)N)O@W^
MUSXK_:W\/:-\-_A!X,^#_@2+7/%_P'^(7P/U'P%IW@SPY=:A!IGA>"+XD:YX
MLM]1FU+5/$USJL=O!K&K:HSW=_<?HQ(76-VB19)`C&-&?RU=PI*(T@5RBLV`
M7"/M!+;6Q@_DIX=_;E^+NK_#'P'>_!;X+^`M7@M/V,]"_:Q\7ZI\?_VD_&NC
MW.C>'+W4O%6EKX3_`.$BT+X$?$?5/&&MI'X0U*^U#QAK(\/P(A@W:5=-+(T$
M-133>GS?2W3[NA:<G>WZ+?U[O_@'H/@W]@#Q;\%/#GAW0OV<_P!HB3X9W:?L
MI?`_]E3Q[KOB/X2:'X]U'Q5IG[/7A:_\&_#;XHZ%]E\4^#%\+?$K3]!U_P`2
MVEY/JI\:>&+Q;CP^C^&UA\-1Q:@[4/\`@ES\!-7\?Z)XBUK5_&GB'X?:9^R>
M/V6=1^#GB+6;K4?!7B(V/@35?@_X?^->I1P7-A]E^,FB_!#Q;\1?A"GB[1;7
M2[Z?P;\0_$=HDUJTL6WP7XT?MM_$CXC?"V7QM^QW./"_C/XD:)_P25\:>"/$
M_P`2==N+WP?)X`_;C_:(N?"4>EKX$O\`P?XDL_">LR^$Y+W2/%GB"WTV]U:\
MM->L=0M[:VU;P/H\-]]'>-?VNKOX=^"?C-XNT*P^&&A)X,_:PUKX)Z[XH_:>
M_:5C^%7PJ\/QP>`M&\1KXI_X2O4?!_BG4=+T[4]3N='\(^&_AAX3\.ZU>/KV
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M_:`_;*^%/QYL]-\>:CXHT#5+3]EZ#XT>`IM2^&WC&Y^$T5SKGAG6_$GPVOOB
M5X1N+BS^'NNZW;V7AOP]J+VFDW_B:ZM>H^$O[:'QB^*'@WX.>&/V;_V?[3QK
MXLN?V4_A=^T_\0!\??V@-5\.67AOP-\6->\:^&?A3X-L_B5HGPL^)>L_$'XE
M>.9?A=\2[]M5UOPSX<TS1-,\+6E]XIU!M5\10V$`G&^B>UEOLE%I);[271-:
M^;$U/K;1N3VT=VM7ZI_?Z'6_!'_@G_K7PQU?Q?XVUCXV:H_Q$\<?L0?!?]C'
M4M>\#:#+X3_L`?!&#XCV/A[XN^$+UM<O-4TCQ1J,/CV/4WTGSGAT/6M)BFTW
M5Y8701>#?![_`()5^(_!_C`>/-<\6?LW?#[7;[]E7XV?LJ>//^%`?LU1^&=>
M^,UI\:+7X?W>L?&;XM_$[Q%XZO\`QWXQ^)">,/AWI/BJ2'Q'<>(7DNK_`,4F
MX\47NI^+]9UBHA_P5L\1?%>TU[6_V3/V?/#7Q3\+>#/V&OAS^W?XLUOXH?'!
M_A5<GP;\07\<2P?"GPYI?A;X7?%VWU'XE:;;_#GQ;IVJ7FJ:UHGA/3/$=C'I
MTNJ7%I+_`&B/O7XP?M?_``\^%7[),?[75M"GC+P;KW@WX;>)?A]I>D:_H5LO
MCS4_C+?>%]$^%.@:7XGFNIO#\4?C'Q%XT\,Z9;:XEQ>Z>D&HC4+5-0C6*&X%
MR/;IKUZ6U_#Y];C?M$]=W96]UZV22:UL[6M>W<X6/]BA]-'[*^H>'OBB^F^)
MOV3_`-E/XL?LU>#-7O\`P/8:Y8:SJ7Q+\'_!3PI9_$76-`N]>BLY$\./\&K:
M_E\%S37ECKT?B&ZL)]9L%L([FZ^<?AS_`,$V_&F@^&/BGINH^*/@A\*HOB;=
M?`?4M3^%W[-7PX\6>`_@/+XR^"_Q5\(_$S4_BO%\/-;\;ZOH?A7QQ\0K?PV?
M"NMVW@31/#EI+;K;Z]XJU+QUKGD3Z9@_MR_MB_M<_#_]GG]ISP+X$^'OA'X,
M?M>^%_`WP%\5?!+Q%X:^*'AKXI_#GQ'I/QC^./A#X-ZM?67B3XG?";P=I^@>
M*/!VO:EJNDWFG?$CX91^$IX=3\->(;+7M0M)/$<'A3]>O"=AJVE^%O#6F:_J
M^HZ_KNG:!H]CK6NZO)HTVJZUJUII]O!J.JZG-X<\.^$/#TNH:A>1S7=Y+H7A
M/PQH\EQ-(^F>'M&LC#IUL)1;:L]DWNEJK=[WM'MMO>XFYI)W6_2S>C4U>W2\
MKKSNNA^1OCO_`()E^._B5\8X_&7C;Q]\,_%^GZ#^V?\`#?\`:Y\%?%CXA>&O
M&/Q*^/'A#P[\/OC3X3^+^F?LY_#-/%'B5O!WP.\&64'AZ3P!/XS^&\T=UXO\
M$0Z+I7B7P5]IT]M0D]RU']AW6?%FJZGHGCG7?">J_#.?]LSXF_M)/IEF/$=I
MKGB;P%\7_P!G?XJ_"#Q;\/=;DM)=/.AZS9ZW\4KV;3O$&AZO.+KP[I\4@72=
M9E40?I!13Y(]OQ_!^7^0N>6U^EO39:?)?Y=#\O?`G['WQ_31OV;OA/\`$;Q1
M\&(?A+^QSX?US2?A'XD\!6'B2U\=?$J]7]G7XC?LN^"+KQ[X,ET;1?`_PTL-
M#^'/Q/\`$.K^(=(\$ZKXLL]<\6VNCMH"^#?#]K-H]Q[Q\/OV7M8\%W/[$T]Q
MXLTV^'[*7P)\0?"#6EATVZA/B^^UKP'\,?!\>M:67N&_LRT@G\`W-Z]K=BXF
M>+48(EE#P2,_V513Y5^7X--?=9?=KU!R;_'HNM[_`'W?Z6"BBOAS]LG]N#PS
M^RL?A]\//"O@7Q#\?OVJ/CKJ5WX?_9Z_9D\!7VG6/B_XAZK90F74_$GB/7=3
M)TCX:_"/P?%MU#XA?%3Q,O\`87A32$GNO(U*ZB^PL-I*[T7]?U;J))MI+=_U
MN]$N[>BW9]QU\=_%W_@H+^Q-\"M9B\+_`!._:;^$>B>,I]2O-'@\`:5XIM?&
M?Q'FU>P%[]KTN+X=>"!XC\<2:A#)IU];&S30&N'O;2>QCC>\0P5\A:;^P!\?
M_P!K%-3\4?\`!2S]HKQCXA\)^,=)AC'[#O[,_C+Q?\%OV=/`5M-=6UZNB>,_
MB-X"U?PQ\8OC_K-D;*RENM7\1>)/#_A6'67U-M(\+S:='HT]IW/A_P",7_!(
MW]ACQ5X^^%?@O4?V4/V<_&/PZGT9_BEX?\"^"_#?A;7/#5_XIT/1]3T>Z^(&
MH^%?#HNHM7\1Z%::)?K?>([^34]8AM;2YN)[F6W#HKOLHJ^\GKYZ+\-?5(I1
M7G)]HK3?N[OR^&U^K':3_P`%;/V>_%UYXJM/AI\&_P!MOXJQ^%K+Q!J#:KX(
M_8T^.Y\/Z_;>&T#WW_"-^(O%'A3PSHNHW,VZ-;&RFOK.]NFD0+;KARG6?\/$
M+W_HP?\`X*-?^([:!_\`//KZ=\.?M4?LX^,/@CKW[2?A3XU?#KQ)\!_"VB^)
M/$'B;XJ:'XET_5/"'A[2?!T%Q<^*[C6]2LY9ETN7PW#:7+:Y97R07^F&"2.\
MMH9%*5V?Q3^,?PK^!_P[UKXM?%[Q_P"%OAS\-?#MM9W>M>-?%NK6VCZ!I\.H
MW5O9:=YU[=.B--J%[=VMI8VT0DN+RZN(;>WBDED1":[\RM9/1*UN^K>CU#2]
MN1WO:S;O?1-;+6_3S/SQTG_@L)^S,-2CTWXC_"G]M;X%D7NJ:;?:G\7_`-C#
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M;2Z77^]Y'Z645^4>J?LP_M<_L<Z?-XC_`&%/BWXH_:`^&VBVUY<3?L/?M;?$
M2^\7VT^G6=AIEKI/AO\`9S_:G\5G4/BC\*;ZRL])_L[1?#GQHU[XN_#%S?&&
M%?`<2RZL/JS]DS]L3X5_M>>%/$=_X,CUSPA\2/AGK,/@SX[?`[QYIT^@?%/X
M&_$9;;SK[P9XXT.YCC$@62.Z_L/Q5HDFI>$?%UE:RZCX;UG4+>*X%O2>MFK/
M\'YI]?S\A./5.Z[[->JZ>NJ[-GUA117RY^T;^VS^R9^R'/X1M?VF_C]\-O@E
M<>/8=;G\&P^/]>BT5_$D/AM]*CUZ32A(C_:4TI]<TA;PC'E'4+8'/F"FVEN[
M>HDFW9)M]EJSZCHK\Q/^'T?_``2F_P"C]/V<O_"[M?\`XS77Z'_P5L_X)?\`
MB&R-_8?\%`?V0[>`3R6YCUSX]_#CPQ>^9&J,S#3?$FOZ3J)@(D41W(M3;2L'
M6*5VCD"+FC_,OO7]=4/DG_++_P`!?^1^AE?D!^TY^R?^T1\$/VC]3_;X_P""
M>6D^$-?^)7CS2M#\,_M9?LN>*[^P\(>"_P!IKPQX96Z_X1_QQX?\4+;QQ^$O
MCYX3M9Y-,TKQ'JDDNE>)](:WTC72B6@-Y]%_\/3_`/@F9_TD(_8K_P#$G?@Q
M_P#-E1_P]/\`^"9G_20C]BO_`,2=^#'_`,V5)\K5N9+LTU=/R_+TNMAI36T7
MKHTXMIJZ=G\[/O>S6MC\R/VS_P#@N+X-^''[)WQ7\1>%KGQ/^QW^VS\-HX=;
M\,_L[?MC?![Q%I__``L34O">JZ!=^+?A]HFJ:=(G@_QY8^)?#>JW%EHOB'X>
M_$%;RVU&?3-721-.BG2X^6?V,O\`@[0_9(^+,=EX=_:_^'?B?]F/QA<7^FZ>
MGBCPX-0^*/PJNDOKH6DFI7MYIVG6GC'PS;V6Y+R^AN/#NM6]M:,YCU2[>!M_
MWK_P4N_;Z_8B^./["O[37P;^!G[9G[`WQ#^+7Q?^%^L?"#PEH_BO]KCX!^&M
M(TNW^*]S8>`/%?C*XU[6/&)M[(?#[P?K^N^/X[:W$FI:O<>%X-(TBWN]6O;&
MVE_)#]@+_@WG_P""4W@;3O"'Q:_:8_;6^$W[9&HWEKIFO:9X:\'?%;P3X)_9
M_FE,,4TB-+HWC"_\8_$;3+;4HW^Q:A/XD\*:+K5BOD:WX,F@GGM*S;J<R491
M:LKM[=M?-O\`EMTTV-8JER/GC-/FTMK+9;:)6U5N:^^CW/ZX_@C^T=\`OVE/
M#3>+_P!G_P",WPT^,GAR&'3)K[4OASXST'Q6ND'6;5K[3+?7K;2+VYO/#]_>
M6B23Q:;K=OI^H;(I=ULK12!?:*^/O@WJG[!?[._A&U\!?`?7OV4_@[X,M$58
MO#?PW\0_"KP=I3LLMS<&XNK70K^R6^O);J]O;NXOKW[1>W5Y>WEY<SRW-W<2
MR>M?\-'_`+/'_1>?@Q_X='P/_P#+RM4^[5_+^O-??YF#6NB=NE]^G;3JOO1Z
M!XM\;>#/`.E#7?'7BWPQX*T,W4-B-9\6Z]I7AS2C>W"R/;V8U'6+NSLS=3I#
M,T-OYWFRK%(R(P1B/QF_X*K_`+2/P[O?#_\`P3PL/A[\3?ACXOTCQ3_P5U_8
M)\+>.KS0?&^CZ['H6@6/C3Q+\1X;NXGT#Q!]CL'.K_#W3-\FO17FG?V>NH21
MVD=_%9:EI_WM\9Y_^"?G[1VAZ1X9_:"O_P!D/XX>&]`UC_A(-$\/?%K4O@]\
M0]#TO7/L-WIG]K6.D^++C5M/M]0%A?7=H+N.W$RPW$BAQD8^4]0_8,_X(@^+
M=2M]O[.__!/@WSK#%;V'A71_@WX=AFDM3<313+HWA*XTJRN+Z-9Y\WQLY+XP
MXC><PPQI',KM67+K;KYKR_X>Z+ARIIM2;3O9)-=+;OS_`"/UMGO+.UDLX;JZ
MMK:74+DV=A%//%#)?7BVMS>M:V:2.K7-R+*RO+LP0AY1:VES<%/*@E=+-?GQ
M\+_V!/\`@FQ\)?&WA3XK_"?]GS]GCP=XZ\)W?]M>#O&GANUT>'5-'N[JPN;'
M^T=(OTU"18WGTZ_NK=9XMP>VNI%4E)#GB/\`@J#_`,%!=4_X)Z?L]:%^U+X?
M\&>&/C-\./"GQ2\'^%/C7X1L_$3Z7XR@\%>.QJ.A:9K_`(#UFV.H:)!K^C^+
M7T.2;2?$NFOIVOZ3+?V$.JZ#>"'4HWS63;LK=G?3379=^VUGUL2E>2C%MMZ*
MZ4=>V[6OKN?I]17Y:_L0?\%E?^"?_P"WS816WP=^-6D^&/B,BC^T_@O\6IM,
M\!?%"PD\Z*W/V#3+K5+S0?&=H)KBU0ZK\/O$7BW2HI+NUM[J\M[R86P_4JFF
MFKIIKR$TXNTDT^S5F%%%?#W[4_[?'P@_9A\3>"/A+%H?CKXZ_M,?%662#X5?
MLP?`S2+'Q9\7/%L<#6XO?$>L0W^IZ-X7^&_P]T2*Y74?$?Q$^)'B+POX6TK1
M[;4[^&\U!]-NK56W;<$FW9*[_K[EY['W#17Y(WOPI_X*H?M765M<?%+XZ_#[
M_@G/\,==LM+N[SX2?LS:;I_QT_:=M;+4--8:SX6\6_M->/;&T^&'A+Q!97,J
MDZI\'_A+KB:==QO;:-XYUFUMX];U*>__`."+W['/CF2+4/V@O$7[5_[5'B-=
M(AT2Y\2_'W]L3]HO6;N^TZ+4-0U)[&?0?`WQ`\`^!X-)N+K4[PS>&].\)V/A
M8)-,EOH<`N;LW$W;VC_X$^7]&_O2'RQ6\OE%<WXW2?R;/T/\1_'KX&>#]:OO
M#GBWXT?"?PMXATQH4U+0?$?Q%\'Z)K6GO<6T-Y;K?:7J>L6M]:-/:7%O=0K/
M!&9;:>&=`T4J,U32?VB?V?M>U33M$T+XZ?!S6M:U>]MM-TG2-)^)W@G4=4U/
M4;V9+>SL-.T^SUN:[O;V[GDC@MK6VBEGGF=(HHW=E4_*FF?\$DO^"8>E7#7<
M7[`_[*6HW+M*\DWB/X*>!O%DDC2Q00GS&\4:1K&]4CMHE@5\K;'S'MA$\\[2
M7]4_X)1_\$R=7M?LD_[`'['MDHF@N$N=!_9Y^%WAC4XIK>02Q/!K'AOPSI6K
M6^'4%U@O8TE`V2JZ$J3WNT?O?^7K_2U?[OO/[H_YGW_17Y<ZE_P1N_8'36['
MQ1\._AW\2/@!XITJ1)M'U[]G#]HK]H/X&'1YU@N;:6\TOP_\//B9HG@ZSU*\
M@NI(M0U>+PV-6OXUCBN[Z:)`E<Q-^RS_`,%+_@#/I.H?LT?M]6O[2?A#04A@
M/P,_;]\`>&+^_P#$%K/K-Y<:D1^U3\#/"'ACXE:7J,.DW4,.BWGBCX=?$D0Z
MC9$WZW6D7-KI>D%Y+>/_`("[_FH_A<5HO:6O:2:_%.2^^Q^MM%?G5\)?^"BO
M@?5OBOHO[,_[3_PZ\8_L=?M3:[$Q\,_#?XHRV6M_#CXM?9]+@U2\U#X`?M`^
M&EG^&/Q2T^.&:1$T&ZO_``A\4;>:QU6WUCX;:3<:1J45M^BM--/;_@KR:>J?
MDQ--;KT[/T:T?R"BOFW]I3]K_P#9I_9`\+6?C#]H_P"+_A?X8:7JT\EIX?L-
M1&IZWXN\6WT*^9-I_@GP!X6T_7?'7C?4H8LS3:=X2\.:S?0P*\\ENL*.Z_*D
M7_!4GP3J5[HUUX:_8W_X*3>+/A]J^GIJ1^*^B?L1?%B'PI9075O+<Z24\*Z]
M;Z)\9?$4&M1'36L-4\%?"SQ1HD<>LV=SJ>IZ=:6.OW&C#DD[-J_];]OF-1D]
M4FUM>VE^U]K^1^GM%?*7[,O[;O[+_P"U]8:G-\!OBKI?B;7_``\B-XN^'6NZ
M;KO@+XM^"&DFFMD'C3X3^/-+\-_$+PU;W%Q;7$>G:GJGAV#1M;CA:\T+4=3T
M]X;N7ZMIIIZIW7="::=FFGV>C"BBB@04444`%%%%`!7A/Q__`&8?V>/VJ?""
M^`_VC?@Q\.OC-X5ADFN-/T[Q]X8TW79M"O;B-8IM3\,:K<0_VQX6UAHD6(:S
MX<O]+U5(P$2\5>*]VHH!-K5.S[H_*#5O^":?Q-^'6GO;?L7_`/!0S]KG]FJU
MCU"SDTWP'\0==T']K_X/:%H5H((QX5\->%/VBK'Q/XW\+Z+]DL[*PLH-!^)]
MC;Z3:PRO8V:W-_J<][6T'1?^"WW@\ZRVM^./^";'QMLK;P_$N@QMX0_:&^#&
MOZAKMK;EY7U-['6?B/H:_P!IS(+8&W&GV<$DQNQ#;0*+-/UHHJ>5=&U;HF[?
M=M^!7,^J4O5)O[]_Q/R(TSXS?\%L8M,2+6?V'/V'K_60LXEO],_;,^(&D:8[
MM)(;9DTB[_9_UNZC6&(PI.K:W*;F1))8WM5E6&'*T_Q-_P`%X/&NCZ_ITGPM
M_P"":WP.UR*/39-`\3:Y\0?CW\6=.N'^W*^IVTWAOP_H/AF;/V"*2"*:?6;5
M(YKN.X1;C[*]O+^QE%'*_P":7X>79+M^+'S+^2'W-_@Y-?@?D9H_[%/_``4/
M^)\%BG[4/_!4+QCH^FVUSI]U-X1_8P^"_@3]GY;W[+=W_P!OLM6^)?B?_A9?
MCV]L=7T^6RB<:$?!]SILL<CV4_VF.._D^COV;/\`@F]^QO\`LI>)F^(?PI^#
M^GW'Q@N(=6@U/XZ_$76->^*?QOUE=<DF?53J/Q1\?ZCK_BPB\AGDL9(K/4+.
MV&FLVG)`MI)+%)]RT4*$4[VN^[;;^]WM\A.4GI>RZI)13]4DD_F%%%%42%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!1U33X=7TS4=*N);N&WU.
MPN]/GFL+N>POHH;VWDMI9;.^M7CN;*[C25GM[NWDCGMY@DT+I(BL/DWP'^P[
M\"?AWX5/@K0;;QC<>'&_9=\-?L@FQUKQCJNJR'X/^&9?&4T"->W#?;I/%NJ-
MXXU9=;\5RW+ZC?K;:41Y+V1:;ZNUG^U_[(U7_A'_`.SO[>_LV^_L3^V!<MI/
M]K_99?[-_M063)>'3OMOD_;A:,MR;;S1`RR["/R$\1_M]>-O''[-_P`;/&.@
M>"OA5K^I_`S_`()]_'3XO?M+>#_%.AZMXH\*^'OVG?!>C^+?#$W[.VO:5:^*
M[6&/PUIWC?X7?&73/'&D7NIZWJ'B/PQIFC+I&M:?9:BFO:G+<>MO+2^FE_NO
MJ5%-NRTNTG]^GSOL?6&N_L#_``7N/A]KG@'P7=^*_ANES\-OV8/AOX-UGPOJ
M%B;KX9V_[&OB35/&/[.OB#P?8W^G7.FKK/@7Q1J,.J21:M;ZEI&M+I6FV-_I
MK6<=Q#<V/$'[%7A^ZU#2_&'@OXJ?$CX>?%32/BIXP^,=I\0M)B\$Z^'\9_$7
MP-H?PW\>R77@OQ;X3UOP7/8:YX2T46M@@T:+4?#=Y?W\^B:I;6E[?:?=^:67
M[2OQ8O/%_P"W]XFU;QS\'?AO\'OV2[RT^%_@F/QSX!\2PV,GCG4/V=?@1\<Y
MOB7\2/'NF?$:\N]:\'Z/JGQ1O?"EOX&\'^!O"NLW5BB,->U'5VL\?'WBS]JG
MXX^+/#/QR^$_C;Q1JFI-X3D_X)]?$SPE\0#\`_'_`.RGXJUK0OC5^VB_PW\9
M>&F\#>+OB!XOUO5?!W]F_#T6L&LRQZ"^IZ7XKU3P]K-GK5JB:IJ"?+V[I?*[
MZ.ZU3UMZE)2=M>JWUMS<JUNK/>.G9>1^@G@?]AGP3\.8/A.OAGXH?&"\O_A+
M^T7\6/VDM-U?QCK^@>+-0USQ3\=H?B`OQ=\/ZNEUX9M=.A\-^+KWXG^-M:C7
M2+#3M5T+6M<O+[1M2M!*T)R/^&"?"WA>W^&B?!+XR_&/X$7W@/X(^%/V:]<U
MGP7J'A#6=3^(WP2\$7.K7W@[P]XH3QKX2\1Z3:>*_!6H>)?&%_X)^(7A[2](
M\2>&[CQOXN6&6YMM62WM>O\`VI/B[\4_"?C3]FWX)?!J\\*^&?&_[2'Q#\8^
M%V^(_C;PMJ_C70/A_P"&/A[\+_%GQ/\`$FH6GA72]<\*Q:_XLUFW\-V^@>&;
M'5/$^E:9:2:A?:_=P:U;Z'-HM]\`ZY^WY^T[H5I\//@SJMCX1\0?&OQM^TM^
MUW\*-<^+GP3_`&=?BA\1_"WA;X2_LJQ)-=>--/\`V>M,^*_B;QYJ?Q!\77?B
M#P'X8&E1^/M5\,>&=7UG7M9NAK-MH6G>'?$0^1-Z;:7\_=25^_PZ[=WN)*3U
M7JUY:N]MNCTWOLC[=\"?\$[?V9OAE_PG-OX`\/Z[X5TCQ[^RMX#_`&.-2\/Z
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MOC;K^F?"_P"$FE:5:6_QNUSQ=^W=X5^(?Q+\`_LN?&SX^^';31OV(OVD++]F
MF?QCX3^`GPW\=7'BC2Y_BAXA\0^&O$,=KXH^*6I>'?AW!_:>E:IK?BF_O/"]
MOKIS1UTMT>B6_+IT[KR[,+2NG>[OT;;5KV>W:+\]-4?95_\`\$_]!\<:#\0H
MOC9\<?B]\8?'_P`0_"WPL\$W/Q-U>'X=>&-8\->%_@W\24^+?@RP\*^&/"?@
M;2_`UE<S>/436O%6I:AX;U6\\5""RL=4=K#3K"VM_P!`Z_&V_P#VR_VXM1^!
MWP:^(MS\%M.^`&I:WI7[0FG?%_Q)\4?V9?CY\4=#\,>+OAEXP\(^'_@_XAU'
MX5>!OB1X'^+'PI^$GQL\+2>/_B-?^+/$H\=W'PPT;1M(T;6K?6+ZY2^U+Z(T
M'XH:]_PUM^SEXI\-^)+'Q=\'?VQ?V7/$VK7C^%O'&H^,?AY:_$#X5CP/XX\!
M^,_AN^J2VUFOACQ?X!^(WCFPU#7/#GA[P_)XPBTSP+JGB*VFGTZQCL1-+9=M
M]];6;W;W5[^>N@-2MJ_YFNUUHU=:7M'3O9=T?H51115D!1110`5^/W[$7V[X
MD_\`!1K_`(*J?%;XGVMK%\4?A3X_^!_[+_PU\/WEQI.HW_P^_9PT?X5:;\6?
M"^HZ"T:-K&CZ9\<?%7Q$U[X@:['-,++5-1TG3;.-3-X9E2']@:_)K]KOX!_M
M`?!7]H&Y_P""C'[$WA;1/B1\14^%2_#C]J+]E>]N[GPU)^U5\/?"=^FL>!?$
M'@GQ/9F73])_:!^%5O-KVF>"[[Q-H>O6WBSPIJLW@2.XTIX]-6\F71[V=VM^
MZO9;VO?]+V*C]I7LY*R;TUNG9O9)VM=Z+JTKGZRU^"WP!_:,\4?!?]MO_@KI
MI>E?LK?M1_'6RN_VJ/@?JMKKOP/\!_#+5O#YOKK]CKX"6.I>'Y/$WCCQ[\-Y
MKC7]#M;#3-7U?1+G7-1L=)TKQ%H-]I5E8WNO:JVJ?I5^R]^W3^S?^UO;:AI_
MPO\`&ZZ?\2_#"QP?$7X%>/;*X\#?'+X7:R(]][H?CKX9^(%M/$6F7-BX9&U*
MTMK_`$"^C\J\TK5[^PN;:ZFZGX&_L^WGP8^)W[6/CYO&EMXETW]ISXVZ!\:[
M?0!X7ET6]\":CI?P.^$OP3U'0IM>/B;5H/%=EJ%K\(])\065VF@^&)],N-5U
M'3IX]5C2VNXT_><7%Z*]VK/1KS&O=YE);Q6CNK^]%^36B9^.'QE^#/Q/\'?\
M$\_^"Y7Q\^)?PM3X!R?M:?#3XZ_%30/@;/XETCQ7XB\(:?X?_9K_`.%?3>*_
M'>J>%]<\0^#;?Q[\39O#B>*_$FB^%=5U33M">6TTM]9U.:V+PR?"CXA^.?VN
M/VQ_V<Y/^"@_P4\1?L]_"+6/A5X>^+7_``3Y_9_\9:EX7\4>#/B?\5-,T&6Z
M\?ZU\>-1TZ:6`?'_`,`^'+W2/%GPL^#&L6%O8:)X9OM7\5*+_P`>^$=6M]!_
M:']J[X%)^U!^S)^T!^SC)XH;P2GQU^#WQ"^$[^,$T8>(G\+KX]\+ZGX:.O+H
M#:KH8UEM*&H_;1IAUG2A>F'[.=0M/,\].=_:B_9;\.?M/_!";X3:KXI\1>`O
M%&B3Z+XI^%/Q?\%S/8^-_A%\5_",32>"OB;X4D2Y@#ZAH5^S&^T:YNAIWB'0
M[O5?#>INVGZI<,$XNZMK9;.R4G>]G9?=:RO;1K0KG323T;;U5VXKEBDU>]]M
M=W9/5-W/BS]JWQI\3/!7_!3_`/8HO?A1\'YOC7XCOOV.?V[--U#PW#X]\,?#
MV/0]#D^)_P"Q/J,OB>^UGQ.LT$]LFI:5IWA^#3=/M+O4;B_UZUN3'#IECJE[
M:>/?`/QAX\_;V_;]\#?&CQS\'+3]D'QG_P`$\M.^*?P^^(7P>\6?$#PWXL_:
M)\<W?Q[\':!_PC`\1VW@O2+CPO%\`K:QMKSQ)X/U[3/''BC3O%OC*+4UT^#2
MY?#]]+>_?/AW]DGQ4O[57P4_:S^('Q@TOQCXZ^%_['_B?]F+Q/IVC?"71O!=
MIX^\3^-?&_PX\<^)OBJFKQ>)==\0Z!IMSJ/P^$6D_"Z^U+Q7HGALZW?WFB:[
M9W=WKK^(-_QS^R;8:S^UM\*/VP_`'C#_`(5U\1?"G@[7OA-\7K!-!N]=T;X[
M_!K5)&UC0_"'B*V@\4>'K;1_$G@'QBJ^)/`OCM[/7[S1X;_Q#H%SI&HZ9K*#
M3QQ;;>MG)-QNM;<JO>SV:O:^MO.Q-TE;2_*TI:[N]U;;5-QO;JGH?7U?BU\=
MX(?@'_P6D_89\;_#\W$5[^WG\'?VC/@=^T!X5L;V"UM?$%G^S-X(TWXL_";X
MIWFG2010ZEK'@PZQK_@>]U"YU*.^@\.:_IMEH]E?/%=0-]W_`+4G[;/P&_9(
MT:S?XC:[J?B'X@^(=EO\/O@;\--)G\>?''XG:K<2?9[/3/`WPUT1I=>U)9[D
MB.YUN[BL/#>CPB:]UO6=.L;>XN8_F#]C_P#9S^.?CK]I;Q]_P45_;!T3P_X,
M^*OCCX8Z-\'?V<_@%I%S=:Q=?LR_`%M7E\8:SI'C?Q`TJZ3K?QH^(WB";3-0
M^(D^AV<NE>&UT.V\.Z)K-[87%Y:6E2U:75-/TMKOYK2V^M[63".B;>S32O\`
M:>BLO1M2OLK;WL?JK7#^,?AC\-?B(^GO\0/A[X'\=/I*W*:4_C'PGH'B9],2
M],!O%T]M;T^^-DMV;6V-RML8Q.;:`RAS#'M[BOE+]K[]M;]G?]A?X9-\6_VD
M/%^J>$_"#3R6EG)HO@[Q=XTU/4;N$VYG@MM-\):-J\\0MX;E;NYNM0-E8V]G
M'<7,UTD5O,R-M)7;27=[>6_F2DVTE=MO2V]ST#_AFC]G'_HW_P""7_AJ?`G_
M`,H:/^&:/V<?^C?_`()?^&I\"?\`RAK^+']M[_@[L\8:O#K_`(._8&^"NE>$
M;0W\^G6'QK^.6_7O%,^GI'<1/K'AKX2Z4D?A?1)I9Q:7>CZCXN\8^+]]L9[;
M6?A_9SM')%^^O[#/_!5+]D31?V/OV<$^-W[76M^._C+K7PD\(>,_BSXE\:^#
M/B7JFOW/Q)\?Z;'XX\;Z:UQHGP^70X-'\/>)?$.I>'?#&EZ&/[$T7PQI6CZ-
MH^=-L+4U"J0;LFM%N[)=-%?5[?@C1TJD4FT]=DKM^KM>VRWU^X_52;]F#]FJ
MY18[C]GCX&SQK+;W"I-\)?`,J+/:SQW5K,JOX?91+;7,,-Q;R`;X9XHYHV61
M%8<?J'[#W[%>K&$ZK^R!^R[J9MS<F`ZA\`/A/>&`WMW-?WAA^T^$I/*-W?7-
MQ>W)3;Y]W/-<R[YI7=OGC4O^"P'_``3AT:SGU'6/VG-`TK3[6&>XN;[4O`_Q
M5L;.WM[:&2YN9Y[FZ\"10PPV]O#+<3RR.J10Q22R,L:,PS+?_@LW_P`$Q[IQ
M':_M9^#;F0W>F:>$M_"_Q+F<W^M6*:IH]D%C\$LQN]6TR2/4=,M@/.O[&1+N
MU26W99"^:GWA]\2>6ITC/[I>G^2/HG_A@?\`85_Z,L_9,_\`$<O@]_\`,=1_
MPP/^PK_T99^R9_XCE\'O_F.KYGT/_@MM_P`$GO$-W/96/[=WP%M9[:%II3X@
M\0WWA2#:LB1,D=WXHTO1[2>X#N,VL$\EUL#R^3Y<4CIU'_#X;_@EG_T?W^RU
M_P"'<\+?_)M%X=X?>OZZH.6IVG]TCW#_`(8'_85_Z,L_9,_\1R^#W_S'54M_
M^"?/[!EK/?7,/[%7[)ZS:E<175XS?L\_"657FAM+:QC:..7PD\5L@MK2!#%;
M)#$\BO.Z-<332R>-?\/AO^"6?_1_?[+7_AW/"W_R;1_P^&_X)9_]']_LM?\`
MAW/"W_R;1>'>'X?UU7WA:IVG]TC?\7_\$HO^":GCO6)M=\3?L-?LRW>ISZ*O
MA^66Q^$WA308#I27,EVL*V&@:?I>GQW`GE=CJ,=JFHLA$+79A1(UX+_ARK_P
M2C_Z,,_9X_\`"-7_`.2JWO\`A\-_P2S_`.C^_P!EK_P[GA;_`.3:]5\(_P#!
M1C]@7QY/=VWA+]LW]F369['3-$UFZCB^-?P^MS#IOB.WFNM%NB;W7K966^@M
MYI$1"TL00BXCB8JI/<?\C^[R_P"!^`_WJ_Y^+_P(\,_X<J_\$H_^C#/V>/\`
MPC5_^2J_-3_@K'_P1+^"7C#]D@?"+_@GI^P[\*=!^/'Q+^,7POMK?QGH!TCP
M7X<^&VA>'+O5M;U_X@>-KW6=<AMI]&M=!AU;P@L-AH?BK79O^$SGL=*T.X>^
MF9?W7_X;/_8\_P"CK_V:O_#Z_"[_`.:FC_AL_P#8\_Z.O_9J_P##Z_"[_P":
MFAQ@TU[JNK77+?Y?<ON!2J)IWD[.]FY-:=U<_F0_9._X-)?@-X=7P]XN_;8^
M-GB;XS^*H=+L$U7X<_"BSM_AK\-;2[LWLS!8-XACMCXO\0V-O9V[Z;<74$'A
M&XU%9IKQH[:=HO*_K'^%_P`,?!7P:\!>'/AE\.M+NM$\%^$[6XLM!TJ]UWQ#
MXFN;.VNK^[U*:.77/%6JZWX@U#=>7MS(CZEJEW)%&ZV\+QVT,,,?E\7[8?[(
M\\%U<P?M3?LY36UDD4E[<1?&_P"&<D%HD\R6\+W4J>)S';I-/(D$32L@DF=(
MT)=@I];\"_$7X??%#0SXF^&GCOP;\1/#8O;C33XA\"^)]$\6Z&-1M%B>ZL#J
MV@7VH6`O;9)X'N+7[1Y\*S1-)&HD0L1C"/PVO;>]V*<YR^-NW16LEZ+1;'F?
M[5OQK_X9L_9B_:&_:%&CMXA;X'_!3XG?%A-"29;=M8D\`>#-9\41Z8)W^2$7
MKZ8MN9&X02%NU?(7_!,/]EA/A5\&M-_:-^+DVG_$#]L7]K#1=&^,W[0GQCOM
M,L!K\VI>/-+TWQ#IWPN\.7<)N/["^&WPWTV;3?#'ASPQH]T-'QI`U%Q=W,RW
M1^Z?CC\(O"?[0'P8^+'P+\>1W<O@KXQ_#CQI\,/%B6%S/97Q\.^.O#NH^&M8
M-G=VTL-Q;72V&I3M;S12QO'*$96&*_-;_@G3^TGXF^'L]E_P38_:VU&;2?VL
M_P!G7PQ#X;\%>+M0T2\T'P=^U7\#O"4=CHO@CXQ?"[5[K?I^KZQ'X=DT33/B
M/X4^VMXDT+Q1!?W4]M=V4S7X;^)7VL[>4KK\6MOGWU%K%I7O>\E_=6S]$]_6
M+Z:?>7[7VJZIH7[)G[4.MZ)J5_H^M:-^SM\;-5TC5]*O+C3]4TK5-/\`AKXF
MN[#4M-O[22&[L;^QNX8KJSO+66*XMKB*.:&1)$5A^&<U]_P3<T?_`()\:%\1
MQ_P4(UKX??&72?V9O"OC>'XK>'/^"A?Q8\<_$W2/BS;>`-,UFUU2#X=2?&WQ
M1;>-O$%QXW,5M<_#Y?!&IMXEN9Y/#$.BM+>)`O[C?MA^&_B#XT_90_:2\%?"
MCPG;>.OB5XU^!WQ/\&>"/"-YXBTWPE:Z]XC\6>#M7\/:98S^)-84Z7H\;7&I
M+(UY?E+5!'MFEA1C*F!^SU^S)\,_A]\'?V9](\2?!?X6:=\1O@G\*/`GAW2]
M0@\$^#+K5?`?B:R\"Z+X=\5CPEK]EILSZ3+=S6=Q8WM_X?O88]3MD`:>XMW4
ME--RZ6Y>J\_7>W]((M*.M_BV32>W5:Z/^KGXY_M$_M1?$'X1Z_\`\&^WQ._:
M7^+NK_!>+Q?X;\:>)/VN)_$OB6Z^'7AC4O%8_8PTS7O$5A\2]#BN]-T>\ET_
MXC7ER=-\.ZG9W/V3Q/+;V>CV/]J/:Q-]`_L7^/?BK_P51\6^%_V[M9\<^+_A
M#^QCX`^('BV/]D;X!>`?&6J^&/&'Q5U7P/XGO?!6N_%W]K.Y\-ZO]FU&UEU?
MP[KNG^#?@-(9]`TC2]0N]1\4S^(YKC3KRY]*_;__`&;/&GQU_;7_`."37C*P
M^%:_$?X6?`SX[_&_QO\`%O4+_3M'U;P]X'AN?@Y+#\//$.L6.KR$-/#X_L-&
MN-`NK2TN[K3M>L;#48?LTUK#<Q]5<?!3XU_LJ_ML-\8/V??#%_\`$3]ES]L;
MQIIUO^U9\)++5[:VOO@5\:)M/_LO1OVJ/A=H%W/I>B2^%_'+PV>F_M-:1%--
MXGO[N'1OB7I2:O=:;K&D7"2=W>[2DE;K?EA9^B=[KYN]BKQY5;E4FGK=:>\W
M;R;6S;V5E\5SXF^'WQI^$GC']K[_`(*/^&?VK/\`@H;XU^!B_"S]J7P;\._@
MW\-;O]K6S_9_T+1O`VM?!3X8ZY:+X=T6ZUWP^=:?7O&^O>(;?S(WOG6]MH[6
M)(9)]L_T_P#\$OOB_P"//B/\5/V\_"^C?%OQI^T=^QY\.OBY\,;/]D?]HCQM
MJL_C67QU'KWPRMKGX\>$O"WQ931]-TCXJ>"/AE\5=/NM"T'Q'IM[XA>WEOM1
MT^7Q!J5C#I4QZ3]EC]DV";XR?\%3KOX__!#P[JW@K]HO]J6/4/"TGCKPUX=U
MZP^)?PBN_P!FWX0^"-215NH[Z:Y\,S:W8^,-$FTZ_6!#.-4(M1'=-+-U7_!/
M_P`+_&S]G?Q'\=?V)OB!X5\7:E\#O@'K>AZS^Q?\;]3@UG4=)\5_LV>.X+K4
M-"^">L^)M0U+7WO/''[,NL0WOPNBN=:U:PUSQ+\/+3P1K*>'H+>UN-5U1133
MBWWDV];];*5^EM?)I);@VG&2W:C#JK+2-VNO-?1J^SD^Y]<?M*?LS_!;]KCX
M0>*O@;\>O!6G^-_`'BRU,<]M<C[/JVA:K"&;2_%/A+6X0-1\,^+=!NBM]H?B
M#2IH+ZPND&UW@DG@F_-']@']K[5/A=X3_;)_94_:P^*D7C?XH?\`!,[6=2LM
M=^)NNZG8?\)[\7/V<F\!6_Q1^'/Q0\0:;+=Q#4/%%EX*O(_#/BO4[:417>L:
M98W.LO;:OJ\TMW^I7QT^/7P?_9H^&7B'XQ?'7Q]H'PV^''A=;4:MXF\0W#16
MZW6H7,=EIFF6%K!'/?ZMK.JWLT5GI>CZ7:WFI:A=2+#:6LKY`_'W]E;_`()_
M^!OVP]"_:L_:\_;G_9V\+#XA_MYZU/<_#OP-\5_`WACQ;\6/V9OV=-'\#+\-
MOA/X=LKSQOI7BNQ^'GQ+U+0HIOB9XBTSPQ%)I^B>+-?M5NWOK^PFM+*G\2Y;
M<UG>_P#+YV\[6^?F*-N67-I'2W^*ZO;_`+=O>WE?H>F_\$N?@1-\7-"TS_@J
M;^TIHWA_Q3^UE^U]X9TCXB>!;]XI]5TO]G+]FWQ/H[S_``:^#7PB_M=IV\,0
M7'P[U>V\0?$36-(@T[4O%GBOQ;XB35[C4H0]WJ'OGC[]N7Q;X#TG]HGXFWGP
M<\'M\!/V7?B;K'@7XI^-M0^-TNC_`!"DT;PSX4\)>)/$7B+P=\-)?A5<Z%XA
MU@S>+K/1_"O@J[^*&BZEXNOHH[:RO[;5-0T_29_)/^"2_P`:4T+X&>%_V`OC
M1>:;X._:\_8;\)>&/@;\0OAM>:A;B\\1_#[P;I7]C_!WXN>`I6BM$\7^`O'?
MPRTKP_J@U?1XKC^P]:35M`UT6FI6)$_US\,OV+O@?X`^)'Q>^+VJ>`/AMXT^
M)OQ5^-.I?&-?'^L_#+PJ?&OABYN/#/A/PQI.AZ?XKNX-3UV5-!M/"L<MAJ45
M]I[(U],D%E:K'F05[+E\^9];];I];WNK?<$OBES+HN5+:VG+:S5ER[/736S9
M\Z_\%)OV(;7X\^#;3]HWX*WDGPQ_;>_9ET[5OB)^SU\8?#=F/[8U+5/#MH=:
MD^%'CVSM;>63QU\-/'ATV/1-5\+:G%=I#+=)=Z6+>8W$=U]4_L9?M"Q?M7_L
MJ?`+]HU-#N_#$_Q?^&7AKQAJ?AR]39<:%KE[9K#X@TEE/)CT_7+?4+6!VP\E
MO%%(ZHS%1YC^W[^V)X5_9'^"6J7EO>2ZU\>/B='=?#C]FGX4>'_*O_'GQ.^,
MWB>TN=-\&Z3X=T407DKV.GZM+!JOB'7+NS.B:#H]E>7VJSQPHJ2=E^P;\!_$
MW[,7[&W[-WP%\;:I%K7CCX9_"?PMH/CC5+:6">SO/&TEG_:7B^2PEM[>UA?3
M5\27^IQZ:4A'^@I;AI)W#3R.WONW5>]ZJW+\[7^20G?D5_YK1[VM[WR3Y;=$
MV[;L^M:***H@****`"BBB@`HHHH`****`"BOQ3^'L<GQR_X+Q?M&^+%OM6G\
M+_L+_L._`_X+2Z#<ZUJ]OHUA\7_VE_%OC'XOKXKTKP\M['I5[=7GPIL%\.:I
MJQLIPPBL;2X;[5IFG26W[64D[WTV;7K;2^W>ZZ^HVK6]$WY75UZZ6"BBBF(*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*\$TS]EO]GC1=
M#^._AO1_A!X)TG0_VG=1\5:M^T!IVFZ2EC#\5]3\;Z"_ACQ9?>+FMGBEOKC7
MM"EFT^_D22$NEQ<RILN+F>:3WNBBR[!=]SP_Q!^S=\$O$_ASXU>%=6^'^E2:
M-^T1J,.L_&2*TGU+3KOQMKEIX/\`"O@+3]=O-2L+VWU&PUO2_"?@?PAI6E:K
MH]UI]]I@\.:5>64T%_:K='S?P?\`L-?LT^#M1\3Z_P#\(3K?C3Q=XUM?!-AX
MO\=_%;XC?$GXM>/?$FG?#;QA9^/OA_INK>,OB/XL\2^(;G3O!OB[3['6?#UC
M]O6UT^XM8DBB\@-$WUQ12LNR'=]W]_;;\E]Q\H_M=?!CQ;\:/`OAG3O!7AWX
M;^)]?\)>,[3Q=8Z=X\\:?%'X1:S#<6NC:SI=OJ/PU^/GP=&J^._@;XWL)]52
M:/QKI7@;X@"]T(:UX4E\/VJ^(/[>TGQCX+_\$]_`'AKX):=\/_BFLD_C*'XW
M_%G]H73?%'PC\=?%/P'KGPP\=?%[6O$MSK=E\-OBM8^*].^+QV^%?$U_X/\`
M%'BS4?$5AJ/Q(74/$6K:OH>B6&OQ^%M'_16BCE5[VZ6_+_)>07:5D[+?3^OZ
M^ZWS]X'_`&8/@]\/8_AG_8&D>(KJ^^$FL_$#Q'X/USQ3X]\<^-/$G_"0_%&W
MU&V\=ZYXD\2>+/$.LZWXQU37XM6OO/O/%5]J\UN\JO9-;M#`8^5U?]BO]GC4
M])T;3++PIKOA"\\-_$_XM?&'P[XK^'OQ`\??#[Q]H/CWX[^*O$/C3XP:CI/C
MWP=XET;Q=8Z7\0_$/B?5;OQ/X8AUA?#&I1?V;:3:0;71='BL?JNBBR[+[O3_
M`"7W+L%WW?W_`-=W]Y\C:E^Q'\#-1TKP-IT<WQ>T:[^'_A'Q?X$TCQ1X<^/_
M`,;O#_CC6/"OCS4#K'BK2O'/C?2?'MKXH^(2ZCK;/KL5UXVU37KW3-=D?6=)
MN;'46-S5[P/^RYX8\!?&'X<^-/#5OH7A[X;?`C]G"']G3X#?#/1-,,=KX(T/
M5M:\-7OBV_>^NFE<H=!^&_PQ\*^%[2U*RZ9IFE^)GO+R\/B'R;3ZKHHLNRZ;
M:;;;>B^Y!=]W_7]?GW"BBBF(****`"BBB@#XX_:(_8$_93_:@UO3_&OQ.^%U
MG;?%;0HD3PK\</A]JFL?#/XW>$)H;BTNK:Z\._%+P->Z'XLMGMI[&U9+2[U"
M]TR:)'L[NPN;&XN;:;YXMOV</^"F_P`%I+B7X*?M\>`/VB_"^G^&[31?#OPQ
M_;B^`&FR:[]JT\R2)JNI?M%?LX:O\,O$ESJVH0V]AI-WJGB/X2>-S%]KU;7[
MBPU>^^PZ?%^IU%+E7IYIVU\[;_.Y2D]MTMDTFEZ7V^5C\L?#/Q7_`."Q/A>2
M_M_B7^QS^Q'\5H_[<TF"QU;X,_MA?$SX</#H5U<6=IJ=Z/#WQ/\`V;_$BZQ<
M:8D]QJKB?Q-X7>6RLIK.TL;V_DM5N<*+]L#_`(*H78TFVM_^".RZ??WU]I-I
MJ%WXA_X*#_L[6OAO1;>[N8(=4U.ZU#P_X8\4>(;NQTB&2>[\O3?"5YJ5_#;^
M7;Z>MS*D%?K712Y7_-)?^`O\XL.9=81>W\Z_*26O7\#\M_$'Q#_X+)^)=1TN
MW\"?LO?\$^OA1806]])K=_\`$O\`:T^.?Q<&I3M-8+IT&CQ>!OV7?AG<:.\$
M1U&2Z^WP:S#?[K=4N=*:V9;_`%[G]F'_`(*`_%76=1?XW?\`!0BQ^'/P^U.#
M['/\,_V,OV>M`^$VL?9HYHR&'QP^,/B_X\_$*PGU""%5OKGP?8^#-6M)+B].
MCZQ8A[0V7Z8T4<M]VWY7LOPL'-;917RO^+N[^A\B?LS_`+"O[,?[)<FJZO\`
M"'X>D>/O$=M#:^+OC#X]U_7_`(F_&GQC!!)<316_B7XJ>/-1U[QE?:=%-=7$
MEKH4.JVOA_3Q*8M-TFSMTBA3Z[HHII)*R22\A-MN[;;[O5A5/4-/L-6LKK3=
M4L;/4M.O87MKVPU"VAO+*[MY!MD@NK6X22"XAD7AXI8W1QPRD5<HIB/Y^_V[
M/^#;O_@GE^V'I^N:]X!\'_\`#)WQEOWU+4+3XA_!?3+2'PK?:W?_`&R<3^-?
MA)/<67A37].?4KO[??Q^&KCP+XCO6A2"/Q5:0/(K_KQ^R%\*_&OP)_9<^`'P
M.^(5]X7U7Q7\%OA/X*^$5YK?@V;5I?#WB+3_`(9Z):>"?#OB:VAUNQL-2TN\
M\3>'-#TG7M:T"5;^#PWK>HZCH%CKWB6PTVV\0ZG]&45*C%-M*S>]NOR_KS*<
MY22BVVEM?6WSWMY=.ECPG]H+]H']G#]G;P5_PEG[37Q9^%'PE\#:G/<:1;:A
M\6?%/ASPYI>O7LEE.]SHFDVWB"ZA;Q#J4NG"ZDET;2K>_OI;%;F0VK6ZS,/Y
M,?V\/^#K3]GOP##J_@C_`()[?!.P^+7BX7,83XW_`!5\,2^#OAEI=_I-K%IF
MC:YX5\"1II_CWQK=V.G+)9Z9<>)9/AS%HT<%F(+;7=.:2Q']?'Q8^"_P?^/'
MA23P)\;OA9\._B_X*ENX]0;PI\3?!GAWQSX>7488+FUM]3ATCQ+IVI6,&IVU
MO>7<5KJ,$,=[:I<SBWGC\Q\_S<_MH_\`!JA^PU\=$OO$G[+^L^)/V2O&_P!A
MU*2'0=)GU'Q_\*-8U=XII[`WWA_Q3JUUXC\-6\M^ZQ7DGAOQ#_9UC8%5TWPU
M_HT=O+,_:6]RW_MWROIW_34NDZ2?[Q2\NL?FE[WYI]3]7OV)OBI^S)\2_P!G
M_P"#5EXU^,W[(?QD_:%7X0_"KQ-\<I_`_B#X+:G/#X_^(GA6P\3:A<+X<\/6
M^FW'AWP_JVJW^H+X*L;S0-)>70+>SBA@E>"60_>O_"J/A;_T37P!_P"$;X=_
M^5U?FS\(?^"57[*'C7]ECX*?#?\`;!_8F_9!USXO>#OAOX/\%?$#6_`?PM\'
M:?%J6N>!XH]+.N^&/&GA_P`,^$O&&F:/XKDTZ/Q1)HD5W9K9G6;C1=12^$$\
MMQS^H?\`!)BT^"-I/K7_``3C_:9^-_[%?B6PN+?4-&^&DOB[7?CE^RKJ9LC>
M7K>&]>^!?Q5U77X=$T+7M4NI7U34/`'B#PQJ^EP7VH2:-Y<BV$5HU=)>ZGIW
ML^G1JU].ZV1+Y6W:3CKU5X].J=[:=(NR2W9^HW_"J/A;_P!$U\`?^$;X=_\`
ME=6;J_P.^"GB#3Y])U[X/_"W6]+N3$;G3=7^'_A/4M/N#!*EQ`9[.]TB:VE,
M,\4<T1DC8QRQI(F'16'P)^SE^W#\7-`^+NF_LB_\%"OAYX4^"/[1OB2_NK#X
M'?$;X?W.NZG^SK^UEI^D>'X-9UF]^%GB#6[?[=X0\>Z3&+F;7OA1XSN8M;@1
MH&\.7_B*%G,7ZF52LUMY--:K;1K[OE9K2Q+NM_5:Z-=&G\OPMNCY]/[)7[*I
MC6(_LS?L^F)'>1(S\&?AP8TDE6-9'5/^$;VJ\BQ1*[`!G6*,,2$7#/\`AD;]
ME'_HV/\`9Z_\,M\-_P#YFJ^A:*++LON07?=_>SYZ_P"&1OV4?^C8_P!GK_PR
MWPW_`/F:K)U[]BG]CKQ1HNJ>'?$'[*?[.6JZ)K5E/IVJZ;=?!7X<M;7UC=(8
MKBVG5?#BL8I8V*.`RD@GD5]-T4679?<@N^[^]GP%KO\`P2I_X)I^)M6O==U[
M]@_]E'5-7U&1);V_NO@=\/VGN9(XHX$>1ET-5)6&*.,84?*@KZB^"OP#^"?[
M.'@P_#KX!?"GP#\'/`9U>_U\^$/AQX7TGPEX>;6]42VBU'5GTO1K6TM'U&]B
MLK.*YNVC,\L=K;QNY2&-5];HHLELDOD#;>[;]6_ZZ(*^=OVE/V4?@)^UQX)C
M\"_'CX?:7XQL=-DOKWPEX@1Y]'\<_#O7[ZQDL#XK^&WCC29+3Q/X%\4VT+JU
MMK?AW4K&Z#PP+.9X8_)/T313:3T:NNS$FUJG9]T?E%_PJ#_@I)^R:HA_9V^+
M/@W]NWX-6T]Q<0?!S]K_`,27WP[_`&B/"FEPO=W<6@>`/VJ/"/ASQ!H?Q!2[
MEO18V,/QR^&[:QI5II>FQ7/Q+OXI[IH+^@_\%*O&GA.Z@T#]JG_@GQ^W)^S_
M`.)9+>^N3J?@#X1WO[9'PLN4CU.^L]+M=.\?_LH?\++U?^T]3L[";4);#Q!X
M$\-G350BZF-I?>']0US]3J*GE:V;7D]5^.OXV_2N9/>*?FM'^&GSM?O<_*'0
M_P#@N!_P2[UJ?1X+K]J*R\'#6A$(;_XF_"KXX?"SP]I\\MI)>+:Z]XO^(?PT
M\->$-`N"L3VZ)K&O6:3W_EZ?;//>SV\$NGX[_P""VW_!)WX=:1;ZWX@_;P^`
M6H65SJ,.EQP^!/$EY\4=76YGMKNZ26X\/_#+3?%VOVFG+%93)-K%UIL.DV]R
M]I9W%]%>:A807/ZE,JL,,H8>C`$?D:9Y,7_/*/\`[X7_``HM+O&_^%_ES?J%
MX?RR\_?7_P`AI^)^4FD_\%I_V$?'6@ZEK/P,UK]H/]I>[T[1I];3PY^SW^Q_
M^U/\1M;OK<0RMIT<4UO\(K#P]IRZY=1C3=)U+Q!KVC:"]](JWNKV5LDUS%B:
ME^UQ_P`%(OV@SI.C_LG?\$_=8_9\\.^((V%W\??^"@OB[PEX)B\)10W^JV-]
M/9_LR_";Q=XU^+/B*^>TMK+4/#L7B76_`,%W=3/;ZU:Z?I36FK7WZ\@`````
M#@`#``]`!TI:+2ZR_P#`4E^;E_6UAWBMH_\`@4N;\E%?>FNZ/RW^$/\`P3$\
M+?\`"PM$_:!_;4^+7C#]N7]H[0[^SUWPSKGQ-M(-!^!OP?URSO5U"UF^`G[/
M&EW=YX+\"MI]S%:RV?B#7[CQIXTAO8)K^S\2:<M]/9)^I%%%-)+9>O=^K>K^
M9+;>[OV[+R2V2\D?(?[4/["W[-7[7J:)J/Q?\".GQ!\'H/\`A7WQI\!ZSJOP
M]^-WPXG2[COXI?!/Q2\)W.F>*](MUOHDNIM&DO[OP]J#^9'JFD7UO//#+\^:
M+^PG^U9X;T)_!FC?\%8?VP+GP>Z7=H)_%OPZ_9,\9?$Q-.U$,MZJ_%/6/@*V
MN_VM&LL_]CZS]C$VCO\`99+>WD:T4R?I_10TGKU[IM/\+#4I)6O=+9-*27HF
MG8^(/V<?V`/@9^SSXBD^)UY=>.OV@/VB+V&[M-8_:@_:2\21?%'X[7^FW#HL
M.AZ9XDN--TS1/`GAJPL8+/3;3PO\-?#?@SP\UO:+<7>F76IW6H7]Y]OT44))
M;";;U;N%%%%,04444`%%%%`!1110`445\4_\%%OVD[;]DK]BG]HCXX)?:E9^
M*=`^'>L:#\,(=#L[34_$&J_&+QRB^"OA+I.A:5>PW4&IZA>?$'7O#^ZW:QU%
M(;&.]O[C3KRTL[B!TW9-OHK_`'#2;:2W;27J]#XB_P"".-P_Q<\3?\%+_P!L
MK4(TO;C]H[_@H#\3_!_@3Q79M/)HOBOX!_LR:-H7P:^$-]H-V;6#3M7TRVFL
M/&T`US1KB^L+^Z-S%).FHV=_;0_MG7QQ_P`$]OV=+K]DK]B/]F']G?5(((/$
MWPS^$'A33?'8MM0N]5M[CXF:M:'Q+\4+^'4;ZXN9[R+4_B%K7B;44F$B6[+=
M#[%:V5F(+.#['I15HI/>UWZO5_B.;O)M;;+T2LOP2"BBBJ)"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M#X=_X*%_L=:/^VQ^S7XJ^&4%W%X8^+'AJXL_B3^SQ\4;:"!?$?PF^.?@MSJW
M@+QEX<U5_+NM(D;4H1HFNR6=S;F_\,ZMK&F77G6EW+"\'_!./]K*Y_;*_91\
M!_%7Q+86>@?%C0[S7_A9\>?!UK="XD\&?&[X9:K/X5^(.B7*BSL#;"YU.Q7Q
M!I\`M(X1I&M:<]I+=VCP7D_W37X4_#>[LO\`@G[_`,%=/B[\+_$]^-!_9Z_X
M*MVUM\;/@IJFHW\T/AS0?VT?AS9PZ+\9OAR'N5DM[;Q)\;/"NHZ%XWTRYOKZ
MQM]4U/P]HW@SPU97VKW!@$/22ET?NR_]M?WZ?]O%Q]Z+CU7O1[_WDOE[W_;K
M/W6HHHJR`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`*_#/XIO9_\%(?^"EO@/X'Z3?W^H_LK_P#!,?Q/X6^/
M/QIU31[JYMM$\??MM0WRWOP5^%<VHVDES8:S8_!K2+;4/'/C/2"^GW=IKVH6
M/A_5[>]T[4'2O;/VK?VR?B+\2/B!<_L/?\$[]4\-^,_VH=4,5K\:?C5Y+^)_
MA)^P_P"`KS[7!J?C/XCZGI\=QH&K_&RYCMY+7X8_`E]3B\4ZAJ=Q9^*O%.F:
M?X*LI+C4?L#]D']DSX8_L8?!30_@U\,TOM26&^U7Q-XY\>^(1:3^./BI\1O$
MU]-JWC'XC^/-5MH(#JWB;Q+J]S/<SS2!DLK06FEVFRRL;=%A^\[+9/WGW:VB
MO_;ONZNUKW5=_$U[JZJ_VO+2_+ZWTLF_J"BBBK("BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^
M4OVS/V//A7^W!\%+SX+?%2Z\4>'H[7Q-X8\?^`/B3\/=3MO#WQ1^$7Q,\%:D
MNJ>$_B1\,?%=Q8:E)X6\7Z/+]JL$U2UMC-/HFJZUH\C"TU2Y!^K:*32:L]4Q
MIM--.S3NGYGY)^$_VV?C?^R7;2>`/^"E7P^UBTTCPYYUAH'[<7P8\#^(/%WP
M&^)F@:9$\.G^)OBOX7\(66N^(_V?/B'K4%HU[X@\/:CIEWX`;5[B9/"GB)-.
M:TL8ONCX5?M:?LN_'*RTF_\`@]^T1\%?B5%KL=A)I4/@WXE^$-=U&Z_M19'T
MZ+^R;'5Y=4ANKQ89C;V=Q9PW<GE2@0YC<+]`RQ1SQR0S1I-#,CQ2Q2HLD<L<
MBE)(Y(W!5T=25=&!5E)!!!(KXS^*?_!.C]@_XV:P/$?Q0_9%_9_\5^*%"B+Q
M;/\`#+PQIOB^W*ZG+K#26OBS1K#3?$5I--J4]Q=7,]MJ<4UVUS=1W3S0W,\<
MBM);--?WM_O6_P`U?NV.\7NFO35?<_\`.W9(^SZ*^'_AI_P3:_8;^#OCKPY\
M3/AG^SGX)\(>._"-Z^H^&_$FFW/B1[[2;V2UN+)[BV6\UVZMB[6MU<0D302K
MME8A0V"/MJXMX+NWGM+F))[:YAEM[B&10T<T$R-'+%(IX9)(V9&4\%2135^J
M2]'?]$)VZ7?JK?JSXK_:X_X*+?L:_L.Z+<:G^T;\<?"?A#6(X89[+X?:9._B
MKXHZTEQ<:;;QG1OASX<74?%E\@&K65U)<#3([2+3VEOY;A+2WFF3XM_X)D?\
M%<#_`,%3_C9^T*/@G\*G\$?LN?L_6.@Z*GCOQW>I+\3?B9XW\9:AJS>'Y[+P
MKIM^EAX$\,6N@^&-;U*>+4'\4:IJ<E_I<$\GARYM;JSN/EW]LS_@V;_9)^._
MB/5/C#^S%\1?B7^QS^T'/?7FK6WBSPQJ^K_$#P#?7U]!:6MR-2\'>(M=M/$F
MC2?8[>ZM-*N_`WCSPO::/+J][?7>A^(%M]/T^V^-?^"/'_!!KQ!^SEXU_:]^
M"W[?WPGUSQ-'XPT;X?WGPD^.?P8^-7Q-\-?#/Q7X5TW4-5/C+2=-UOX>^,/A
M]XR\.>,DU2\\-N+3QIX7\/Z[<Z*/$,'A^[O]`EUMKG-NIS)-)1OO&[Z:)NUU
MKY*^QMRT?9R?,W-):/1J[2=HW2=E?[3[M;']C%%?DM;?\$1O^"?=FLJ6GA7]
MH>U2>XN+N9;;]M[]M.!9KN[E:>ZNI5B^/BB2XN9G>:XF<&2:5FDD9G8DV/\`
MARC^P+_T+W[1_P#XG)^VO_\`/_J[R_E7_@7I_=\W]WF96A_-+_P%?_)GZPT5
M^3W_``Y1_8%_Z%[]H_\`\3D_;7_^?_5WPY_P2#_9S\#RW`^'?QH_;K^'NG2Z
MVWB&#1/"G[<O[2,&FV.K-I5SH9O+5M3\=ZKJ33_V3>7EAYUYJ-W.;:ZFB,I1
M@`7E_*O_``+T_N^OW>86A_-+_P`!7_R9^JE%?G)_P[6\$?\`1V?_``4;_P#$
M\?VA/_FLH_X=K>"/^CL_^"C?_B>/[0G_`,UE%Y?RK[_^!_5GY7+1_F?_`(#Z
M?WO-_=YGZ-T5^0FL_P#!)'4+[7M2U?0O^"I'_!77P=I]_>V%];>%M(_:[T37
MM#T<Z?Y;16NG7'Q"^$GC7Q))93SH\]];:KX@U--0\Z2UO/.L%AM(M5?^"6WC
MQ9Y;@?\`!6+_`(*OF26*&%E;XV?L^-`$@>=T,5JW[+AMH96-Q()IX88Y[E%@
MCN))4M;982\OY?Q0^6/\_P#Y*_+^OEZ'ZS45^3W_``Z\\?\`_26'_@JS_P"'
MD_9U_P#H5Z/^'7GC_P#Z2P_\%6?_``\G[.O_`-"O1=_RO[U_GZ_T]#EC_.O_
M``%_U_PS\K_K#17Y/?\`#KSQ_P#])8?^"K/_`(>3]G7_`.A7K]&/@_\`#R]^
M%'PV\)_#S4?B3\2/B_>^%[":QN/B3\7=5T/6_B1XL>6^N[T7_BO5?#7ASPEH
M5Y?PI=+8PR:=X<TJ%;&TM8V@>5))Y6F^JM\U_7<326TK^5FOS^X])KS3XJ_&
M?X1_`SPKJ'CCXR_$SP+\+?".E6&H:G?>(/'GBC1_"^F1V6EQ)/?RQ7&KW=J+
MI[=)80T%J)[AY)[>&.)YKB&-_&OVO_@5\<_CY\,[KPG\`OVN?B)^R'XR:PUR
MU3QCX&\#?#'QW:ZL^J644-C_`&]8^./#5YXGL!HMW;BXT^]^'GC?P#JP2]U&
M.\O[YCIDFE_YL_\`P5K_`.">_P#P4G_95\7ZSX^_;1TWQA^U+H.HZU?75O\`
MMBCQ=\3_`(A^!KW3]9TF#PYX=\/>('N[ZP/PSUK1]0%OJ6FZ5XCL=.M=1UA;
M71]+O/%7ARRGMKN)S<%I%OSZ+[KO[[+S+I4XU'9S47_+9W?I>R_%M;V/].GX
M#_'3X;_M*_"KPM\;/A!JU_XA^&GC<:O<>#_$=]H.M^'%\2:3I.N:GH*>(=+T
M[Q#8:9JDOA[6I]+FU'PWJ\EE%:Z_H5QI^N::T^FZA:7$OK]?D?\`LZ?"[_@J
M#\.?@)\&_!_A;XP_\$]=0\(>"_@QX`\->"O#\G[+_P"T#X4O'TSP_P""]'TW
MPU8ZKX@TG]JG6='T_=96EM;ZE>Z+X"%G!(\EWIN@)!%%I;7_`+;_`,%S?^A:
M_P""3W_A;_M?_P#SOJ:D[*\97LMEIMZO\R7%7=I1M?2[_P`TN^OS/UAHK\FI
MKS_@NFT4JV_AW_@DU%.8W$,DWC+]L&>*.4J1&\L*>`[=YHT?:SQ)<0-(H*+-
M$2'7=\%:#_P6MU+2Y)_B+\5?^"6_@S6EO%AATOP5^S_^UE\3=+FT^.QL-^I2
M:]KO[2WPDN[:\NM3;4PNB+X;NX;"QBL"=?U*XN+@6SYO[LON_P""+E_O1^^_
M;HDWU_/J?J13)98X8Y)II$BAB1Y99976..*.-2SR2.Q"HB*"SNQ"JH))`!-?
ME%_PR#_P4S\7R:M:_$K_`(*RR^'_``UK.E>(K&?1/V>/V*O@U\-=?L)M:=(;
M-]+^('Q'\4_&W5["WT73FNX].FTW2],\30W\]KJ*^*?M.G*]U=M?^"1_P1\3
M1VT/[1_Q_P#VV/VQ;6SU;^V+;1?VBOVG?&4W@P3+#86\-I=_#?X/6_PA^&^J
MZ:EO92PW%AK'A+4+?5DU+4#K::G(]L]J7;VB_FTOR;_S\@M%;S3_`,*;_P#2
ME'\_^#[-\6/^"DO[(/PMUV#P'8?%&T^-'QBU.U>Y\._`O]G:RN?CE\7O$+I?
M66F^3;^$_AXNM-HT:WFH6BW.I>*[SP_H]C;R->WVHV]G%+.GS1?:'_P43_;Z
MM[_1?%B>)/\`@F)^S!?SQ1WMCX8\0^'O%?[=WQ5T0,B7>E'Q=X?OM6^'7[+V
MFWF;GS]0\.3_`!,^(,JVUDMAJNAV6H7H;]'/@O\`LX_`#]G+P]'X4^`?P7^&
M'P<\.QBX`TGX;^"?#WA"UD^UW/VRZ:X&B6%G)=/<W8%S/)<O,\TX$LC,X##V
MBBS?Q->D;K[W>[7R5^H[Q7PKYRLW\ELOG=]FCP+]FK]E_P"!7[(7PHT3X+_L
M]?#S0_AUX$T79<S6FE6X;5?$NO/965AJ'C#QKKTP?5O&'C76X=.LVUWQ7X@N
M[[6M4>WA%S=M%!!%%[[115)65ELM$0VWJW=]V%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!63KV@
MZ'XJT/6O#'B?1=)\2>&O$FDZCH/B'P]KVG6>L:'KVAZQ9S:?JVBZUI.H0W%A
MJFDZI87%Q8ZCIU];SV=[9SS6US#+#*Z,44`4_!_A'PSX`\)>%_`?@O1-/\->
M#O!/AW1/"/A/PYI,"VNE>'_#/AO3+71M!T33+9<K;Z?I6EV5K86<"G;%;01Q
MCA:Z*BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
0H`****`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ernstyounglogo.jpg
<TEXT>
begin 644 ernstyounglogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`"@`
MU@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[Y)[FWMH+F>><6UM:@F[NKK``5<<EB0`!D#=@#D``FOX_/^"B?
M_!8KXH_$?]O[2?\`@G_^S+\1/C+I_P"S1X?\"Z#KO[0'[1G_``3D^'$/[7'[
M37B/6?$:L\7PJ^'X\-0^,/#/P1F949;GQ>MCXS\<02")@MN76V;X;^)_[<6H
M?M7?\%3?VKOV0O\`@I;X7_::^+FF?#/XP:M\,/V"O^"87P"O%^%'PI_:HD3Q
MY\0ET'QM^T)XB;QEX+\+^+F7PAX?\*^+WN?'/CD>!)&\1>+@D1ALW\"S_P!#
M7P@^%/\`P5N^'W@.+PW^SI^S[_P24_8&^&%JC/X8^!<&A?''XS:QHNDXFWIX
MEUWX)M\!_!47BDB,YD\))XSMY"\;>:\C%@`>#?L`_LO_`+#_`(C_`&F/#'Q9
M\-?\$Y?^"G'@?XX_#73-;USPM^VG_P`%`-?^*R:]XBUD6LOA_6]"UA?B1^T'
MXO\`&,L]P-==43_A2\'@.18Y;D30M"3<?TI5_//J_P#P5/\`VH/V,_VN_@/^
MR7_P48^&G[*>IZ=^TO?ZIHG@+XP?L9_%+QM?:E\/VTN3PZD.K?&CX!?%*-?&
M/P_^&MP^NR22_%B+QU/X0\$6]K<7=VLMM#=R#XW_`."H'_!9#]J'XE_`O]IS
M7/\`@D-_PCEW\%OV7_`&IZ[^T1_P4*\4AHOAN-:CU^+PY-\)OV7$\1>&;KPS
M\4/B?'+(99?&<+W7@6*$+;VICGNO!E]<@']<%%?@UI?_``6.\.P_!/\`9;\(
M^#/A!\3OVB_^"AW[0?P.^&?Q`TS]B?P9J.@)\1?#0\1^']#>Y\?_`+0OB<+_
M`,(E\"/A@5EA\3MXN\8)$T5KXCCF3P5),[10?`GPP_X.*_CK?V/[6WP+\0_L
M-W'[0/[<O[,7COQ_8ZEX!_8OUGQ%XV_9]@^'7A7P_P#\)#K_`([^(7Q=\1Q"
M3PRO@CQ)'KO@RY,45P/'OC&."T^'<!EN#'&`?UP45_'U\0O^#J'X::3^PA\*
M_C-\,/AE8_$#]J'Q[H?@ZS^+UMIFD?%/5/V5OV3O&7Q`UF;1$?XS?%Z#PF\S
M!H;>W\2Q?"CP=)<^.YAB"9XT9;RX[;X6?\%;?$GQE_8C_:7\1?'7_@IA^SG^
MS1XD^#W[3&L_#;X;_MI_`SX4>'_B#HW[1WPZC\$>%_$0TCX-?LO_`!.\0^,?
M%_B3Q<?$/BJ3PH[0^$_&[/#X:=K2UEE:[>``_IP^.'QL^&O[./PG\>_&_P",
MWBG3_!GPM^&7AS4_%/C3Q'JBLXTW248D82,,[/([+!%$@=YIGBCPJAG7G?V:
MOCGH'[2WP0^%_P`>/"7AGQUX.\*?%/PU%XS\-:1\2/#$7A3Q\WA3Q"[OH&LZ
M]X>B9WT`^*[18?%D0)VO;30ODJPQ_`S\!O@+_P`%"O\`@MI^W1XX_8D_:]_:
MV_;AL/V$OAIX#TG]I6[/QE^&_@CX"_%3XC^$-=U<>'?A!XB_X5QX?\,7/A3P
MW>>-_$TOB'QC\/CXO3QO!;^`O##/:0F0H]O_`'0_LR?LO0_L[KJT%O\`M+_M
M1?'ZYFLM+T><_M%?%U?BA+I@"@K(NBP^&?"D6@3NN6RB`R0LQ*!04<`^QJ*_
MG2_X*K?\%3_^"DW[`'Q/NM2^$?\`P2]U#]IK]DC1O"VE^(->^.?AGQEXCU+4
M@ZJS>)1KNB>%_!_BV?X=0>%+F,I#<^,K5K6ZR)UD\H83X4_X)F?\%/O^"B7_
M``5A_:_UG]KGX7?LC^(O#G[)?PYT9_V=/!.DZC^U/HGAG]G[X?\`BSQ)-X:\
M3?&3Q]\8XE\&+XW^.?Q0?PK_`,*\7X?>#_!O@`>#/`*,%F"7?C23Q^`#^QBO
MQU_:S_X+3_LS_L<?%7QS\(_BI\'/VT-:U[P'I.GZOJWBCX:_LP^-?%?P^O=.
M;0U\0I+H/C^2:T\-:XB0N4DG:6VMXI7GB,[-`[C]BJ_GT_X.3?C]XO\`@=_P
M3>U3PSX7U7Q1X(T']I#XT?#7]G#XQ_&3PQH^LZK_`,*9^!/Q"%ZWQ?\`B!KP
MT`%B9/#&A7'@R.+:7NAXE^R6X\QP"`?:7_!,'_@HC8?\%./@GXF_:.\(_`CX
MD?!GX1'X@:IX.^$NM?%6^\//J_QAT/PTK0:WX[T+1O#CM_8%M#XH-WX:\N:Y
MOVDGT25XYB\3PQ_'_P"U5^V]^TO\</\`@HCX$_X)A_\`!.K7].\%Z_\`#.7P
MI\9/V^?VI[OPIH_CW1_@3\.F'_"0>'OA!H?A[7XU\(W'Q2^,D3018FCF2V@U
MZUV#,'CVX\$_F]^UE_P7J^#W[&?_``3]TC1/^"0?P*\??&[X1?!+PYX7^`?A
M']I7Q/\`#KQIX$_95^%4T,%GX7\.1C7?$OA?P3-\;/B<QE:[_P"$4\)@&25[
MGQWX^U"X2UFMKC\VO^"97[<'[5%IX,^)7P4_98/A7]CCQ]\/K;4_VO\`_@L'
M_P`%&?\`@H%X<AU+X@:E\0_$S2:Q+I&C?!MI[5E\)012CPUX!MKJ-I98D,\,
M/@34/&4$?C\`_P!#^BOXYK__`(./_P!LCX0?L$_#SXR_&S_@EC^T3;_'+QS<
M:-X1\*_%?4_`DGPT_9`^(/BOXC&>7X/>)/#ESXD\52?%=H_%WAP6\C>$$MF8
M`.MOX[D\Y&M?M/\`;-_X+X^`_P!CWPS\%OV:[2+X5?M%?\%4_B5_PK;X=Z[^
MSO\`!_Q5+=?!OP!\>?'']@^']>T7X@_$"19)O#GA[_A,==C%CX6N)G\<W!:-
MKO[-;XO*`/Z1J*_&#]H__@JE=?#^[\0?`3]D+X#^(_V^OVS_`(?>&H;[XK?#
M+X#:_I.G_`KX'ZO;Z-#=:Z?C'^T+XLGA\'_#4L([Z/P=X)D$_P`1-0C9?.\$
M0_.J_D#K7_!U/JWBG]C3PA^U'^S_`/L(?$KQT?`FN_#W1?VSO%7B[4QX4_9_
M^`&L^)/$GA_PY'X8\/?$)MX^)'BGQP94;P2ZR6T?@3^W_#-S\1$4S#3Y0#^Q
MVBOPR_:\_P""[O[&W[/FE0^#?@EXETS]MC]J/Q':%/!_[.O[-/BS0_'FJ-<O
MI4VNMK_Q`\=^&[JY\&?#KP?X=A$]SXR\32W,\UK;1B5K5DMIUM/SO_X(>?\`
M!6O_`(*?_P#!2O\`;0_:&\/_`!F^'W[-GA[]D[X0^'TM/%&L_#*TU[4_^$1\
M?^(C<2^`O!/@;XD1^+O&/A+X@>)UC_ML^.E:!X1%HGG0RVXDM+>X`/ZW:Y'2
MO%OA?Q'>:]8^'O$>@ZYJ?A+4/[$\3V>C:UH^HZIH.K%"[:)X@A@,KZ%<<#_1
MYUBG;:S*BE26\G_:?^/'@;]E_P#9]^-G[07Q%GM8/!WP6^&/BOXFZWE8G:_T
M[PUH[W,6CHC13G[1XJFC3PS9EHV5IYHBH4D,GXB?\&VTW@&?]@V\^/FL_%GX
M9>+_`(]?MP?M&?%[]HGXW_V)XST;6-8L?B/\1=?D&B>`==(E%U!XG\*>&]$C
MD_X1`PQM;RZY<,T*I+&P`/Z'+CQ#X?T_6M,T&\U?38=>UVVU.[T?19[M1JFI
MIH2J=:?1=&D)EECMXW62=X&<J)=SHZ*Q/E'QD_:1_9[_`&:]$TSQ%^T1\<OA
M%\"M#U74$TW1M>^+GQ#\%?#W1]4U)E"C2M!G\5^(K:)YP$Q);V[R,@([8V_A
M-\&OBSX%_:[_`.#B3]I+7KKXB^%7\)_\$Q/V6])_9_\`AQX4O?%&C6FHWWQE
M^-&OCQ5^T!\0_#FBL1*5\$^'O#C?!_X@NT<*6[)"4D4D"+`_X.>_BIH?@/\`
MX)Z>'_$G@K]GGP9\=/B;\4/B!HGPA^!7QKOO#'PN\=R_`SQ7\0YC.^O_``Z?
MQ+]H\3?\)AXS\+Z%XB\(^"I_`MO<LUS+!)<NT<<`<`_>[X*_M7_LR?M*6VJ7
M'[.?[07P5^/UOX?=(]</P4^+?@3XC?V$[E54:S/X6\47HM?,<JB&XV9<A<L6
M!)7\LOP'_P""#WQ3_;`\8^"OCU^UGX+E_P"":UI\/OV;_"/[/'AGX4_LH>.=
M!M/VB_BCJWA^?P_KNM?&[]J?XQ?"6WM?"_B3Q/XPE\U%\*P_:+NS>UL[S4'2
M:UBDN2@#W7_@FU_P1=\*>-OA_P#M:Z;_`,%?OV/O#/QL_:D\7?M1>,OB!J?[
M3/C75=&\6'XR^#_$L4,OA[7O@YXY\*^+O^$S^&WAA)H]<=?!./`LW@G^WX@8
M$<JUM^G6E?\`!$W]@[0X/[(T>W_:PTOPL!G_`(0NR_;]_;H_X1/UP?#_`/PT
M#CN<GI[U^N-%`'YG:/\`\$B/^":?A[X<>._A38?L:?!.3P?\3HM+B^(XUG06
M\4>+?'1\/Z\GBC0I?%'Q&\327?Q0\220^(U66$77C-E+`QK*$GD5O=OB)^P]
M^S)\3/V2_$?[#6L_"7P_X?\`V7O$GA+_`(06;X5^`8F\":)IFC?V^GB1$\-I
MX9EMV\.^5XABB\1PO:/N%T$GFBD<W*-]=T4`?$W[&_\`P3Z_9%_80^'5U\-O
MV6/@EX9^%>AZJJ_\)+JUDFHZEXY\8R1H?W_CCQ]XC:?QCXE9\!5^V7D@BVXA
M$:M)N[/]EO\`9`_9K_8S^'7_``K3]EKX*^#?@SX.O+D:EK-CX9LB-6\0ZS)'
MQK?B/Q#KPN?%/B;Q(%",+GQ9<W$B&1T5T0;6^IJ*`/FGXB?LK?L[?%OX.^,/
MV=?'_P`$OASK/P'^($)?Q1\,T\+:/IGA+4'?65\1H[:)X?DAB77?^$G6/Q4W
MB*W@$HO56Z+FX#SU\Y?LY?\`!(__`()J_LD:OI?B3]G[]C#X&^`/&.@H1H7C
MRZ\+GQY\0])=U#.^@_$+XCS>,?&4+HH5<PWJLW`#<"OTCHH`_*+X]_\`!*[X
M5?&C]I?6_P!K?0OVA?VQ?V9/B]XU^'WA?X8_$_4/V5?C,GPMTWXL^$O#FYO"
M\7C])_"OC-X[GPFDC):^)_!<G@EXH?DEN)&#LWV9^S]^S7\&?V5/A_-\//@E
MX,'AO1[S6)==\0ZUK.LZWXM\6^,_%]PJG6O''C_XA>*9?$_B[Q?XIF>U$ESX
MD\77<LTTFQ/.2%H0GTC10!\I?MG_`+.L7[6G[+OQF_9DD^(GB_X36GQN\&:G
M\/M0\?\`@,P+XJ\/Z/XA=#XA$<=U(MO)%XGLX[GPU=0LDGFV^N.J1.7(7RG_
M`()N_P#!/KX+?\$T/V9/#W[+OP+GUW5]!TGQ%KOC#Q+XP\5W&BKXL\8>+?$G
MD_VQXBU]O#\<-HDODZ%HGA<Q0Q1QQVWA^&%!+';^;-^@=%`!7Y@?M_\`[?FA
M_LR_\(9\`?AA\(=7_:Q_;+_:&M-;T[X(_LG:`-+B_P"$ATQE\K7_`!W\7/$E
MSGPM\./@3X29G'CSQGXK8P+$S+&9(XKJZ@^Q/VE?CAX8_9G^`'QN_:#\:6\]
MYX8^"/PJ^(/Q5UZTLE427>C_``^\/W7B*321Q@O,L9AC(X#%V(9`R-^*O_!,
M."U^!?[!WQ;_`."Q?[8FKGQ/^TE^U;\)M=_;+^./C*[>-I?!?P'T+P[)\1O@
MK\"/AP[;KCPY\.O!OPOB\/>1X4/FH_C?Q!=).6:.V"`'YO?LZ?LH?M1?M9_\
M%R_#]O\`MX?M#>%?VB=._8'^#/A#]HSQ_P#`?X9>%I?#O[*/[-?[17Q&69/V
M>_@+X`T"642>*/$O@[PKGXMGQSXS\(6WCB1/#'A>.>2=G+)_1I\3_P#@EK_P
M3^^,_P"T9HO[6WQ;_93^%GCK]H/1_P"Q?LGC_P`1:=JNHPW5QX>VG0-:UWPO
M+?3^$/$?B'PRT4:V?B7Q;X/NKJWC:*'ST1(?)^*?^#?+X2^-M,_8FU']L'XU
M6:1_M$?\%(/B_P",/VT?BI>S+@+H?Q&UJ9/@YH5JQ+!?#"_"X:!XN\#18C"1
M>+6Y5642?O10!\:?MJ?L.?L[_P#!07X)7?[/?[47@R]\8?#.]\3Z/XPM;/1M
M;USPIK/A_P`5>'EF30]<\/\`B#PY-!-!*(Y]<BE>;SPUMKTL,D*2.E?*/C__
M`((?_P#!,/QM^S-I?[(J_LN>%_"WP@T/Q7I?CRS'P[U/Q%X6^($WBOP]%-''
MX@UWXNPW<GC/Q%XBN!<3P74OBSQ5=/=02+%.YAMU"_KS10!\;>!_V*_V:_AI
M^RGXF_8X^"?@%/@?\"O$7P\\6_#Z]T/X47MWX2\266E_$7PN?#OB/7X?$1E?
MQ++\1Y;:8./&WBCS_&)N85D-Q/<0`#,^$W_!/[]D/X-?LH>&OV(/#/P/\#Z[
M^S!X=T=-&NOACX^\/Z'XZT?Q<HUE?$,NM^/(O$<4_P#PE/B2;Q03XME\17L4
MDINP9X%AEALVB^W*\3_:$^-/AG]GGX"_&CX^^,L+X9^"7PQ^(?Q0U\8)SHWP
M\\/Z]XGF1=N6WR1:"RH1R'96SF@#^4G_`(*T_L]?\$3OV//B%HLGP^_X);^$
MOVJ?VX+#X7>*_B+X9_93^`5KXX\)^`O#'PU\*0:]K6M_%;]H+X>_#&?_`(0O
M0_AK;332$R^+/!$__":1K/;Q0M%'+<PTO^"+G_!(OXC?%?\`8]T/]H_XF?MH
M_M`_`CX3?MH>*?%7[6%]^R!^Q)KNC?LP?"K0&^(\CQZ-HNO?$#PC%/XP?PS_
M`,(?X?\`#Z6G@SP%_P`(+'X(RMJLKLD\[]`WA_XB>$/^"7%W'?6^F>,/^"L_
M_!PY<MIU_=H)VU2S\*_M"^'-K`JC3W7A[X%_L;?LL^(6W1H;BW\`W3E4%N_B
M\*/ZJ_@'\'/#7[/_`,"?@Q\"?"6Q?#7P3^%_P^^%WA_:3@:)\._#VA>&+=B#
MR&:'049QQAR0`.@`/B+Q+_P2%_8%\4_LZ_$3]EV3X/:KIWPP^+^H^"[_`.*-
M[;_$;XHO\4/B2WP]\00^*/#O_"P?C!XA\7W7Q;\3I'XD0S%+SQC(9?.5$E2!
MY`9_AC_P1Z_X)D?!#XP>'_CS\*?V)O@1X$^*?A.XTN_\*>+]$\(.DOAK6=!,
MK)KOA_0Q+'X5\,^)%+'R_%5K;I>^<J,TQ.\/^G5%`'XH>(?^#?/_`()">++W
MQ?J7B[]CC0/$^O>./BKXP^+_`(G\6ZY\0/BP_BF_\6^/]9ED\0I_PD<?C5/$
MR^&Y'DDEC\'F1?`Y$TCM;-YDUP/JCXS_`/!-O]E?XR?#C]E3X+WG@_4O`_PG
M_8R^-WPT^/?P6^&_PSUF7PCX0L?%WP8\Y?`>A:]HH6X7Q%X8A76[C?9OL&Z1
M5:ZC>5A+^@]%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!\U_M;_L]Z
M/^U5^S)\?_V;=<UBX\/:;\>/@[\1/A9J.MV81Y-%3Q_X=N?#RZPB$$L87D,P
M7#%AYJ;>6K^,#XM?M(?M(Q_\$X/@Y_P;X?%;X6_%#X;_`+>GCCXL?!K]A6R\
M2S^`M;N/A9\4/V0/#WCZ)C^TG\&_'TI_X1KQ1X5L_AIX?T+P=XY#S&X6.>XG
MN(;=M\-H44`?W+_#OP'X<^%/P]\"_#3PA"EEX:^'O@OPEX#\,6H'_'AH?AG1
M8?#F@J5YRPM[:.)B.NTY!YKO***`"BBB@`KQCX\_!?P'^T=\%?BO\`OB79W>
MH_#[XT>`?&7PR\:V5A?/I6IMX4\4:')X=UZ/1945Y(6\N4%)!@1RNDA69=D4
MA10!^>7_``3_`/\`@DO\+/V'=1L/&^I?%SXP_M2_%?P_\+O#_P`!_AC\5_C]
MK&A:QJ?P<_9U\,(#X<^#WPBT'08+?PYX5\,*3;S>-;BU@ANO&=S9P3S/Y(-I
4+^NE%%`!1110`4444`%%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>onco_p1.jpg
<TEXT>
begin 644 onco_p1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`ST"
MJ`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HK\B/$/\`P6/_`&>/"W_!5CPY_P`$G==\
M.^)=/^+7BGPQ;:QIGQ(N-1T2'P`/$.H?#VX^)6D^"+H3SQ:A!XAUG0K;[-I,
M0#B_U>[TS3+:.2[U&WB,6D_\%D?@!=_\%0O%W_!+?7/"OB7PE\2_"W@/4O'$
M7Q-U_5=#MO`6MG3-$L?$=QH-E&9!J,&HC0Y]1U1IKSRK2*ST74)I)55%R`?K
MY17\WOP1_P"#E?\`9;_:&^$/[>/QP^&'P9^*^H>`?V$_#1\;>(+S6+W0='O_
M`(F^#IO%,_AS3M6\)Z>_VB;2;S4;=(-7CTK7S;RV\-R+2YGBN(G->Q?#G_@M
M=XO\8_`+XV_M-^,/^"<?[5GPA^"GP?\`V8_%/[4%CX[^(.I_#ZRT3XC>&?"\
MWARYE\,>$IK35KBX7Q)JGAC6=3\5:5'J-K;V]QIWAO4H&=+J6V1P#]X**_GD
M^!G_``<8?LP?M#^&/V)];^&WPK^(>H:U^V9^TCXC_9IMO"%UK7ABUUOX1>*/
M#$'AS4[[6_'2O,8[C2+KP_XA37-*33-USJ-M:2PP#S98JX&3_@Y/^&7_``GW
M[4>F:;^PY^UGXL^#O[&7QI\0?![]I'X_>`[/P9XT\%_#)=!\9^(/!S>-=9T[
M0]8N-2F\.W3^&M2UB)],DO\`.F0.\$US)Y"7`!_2S17X%_M%?\'"_P"R%^SU
M^U5^QO\`L[W6@^)?'7@7]M?X5?!SXQ_#3]HCPQJ5E'\/])\$?&/X@^-?`>DZ
MQK^D7UE'XA6RTT^$(]:N)+2&:YGM=4%K]BMKBR8W%#Q/_P`%_P#X.:7^UU^W
MO^R/X:^"?B;Q=K_[!W[*/[0'[3WB;QM:^.]$M/#?CUOV?_"6C^*-<^'VDQ1:
M'J5SHNH:L^LPZ7'KMQ)J<&FSPS2S:7<E1!0!_0'17\[7[,G_``7A^(G[4?PT
MC^//A'_@F1^TMX>_9UE^#OQ:^+47QX\1^-?`Z?#^YB^$GAGQ;JFJ:+:SZ?97
M>IRQZCXE\(W_`(1@U:2P@%M<^9J$FG2K`+.?Q;X&_P#!T+\"OCO^PM^T3^V%
MX>_9W\1Z3XQ_9S^,7P2^''B7]GO5?BEI(\1ZMX0^//COPMX"\%_%&P\61^"?
MLR:.=5UG7X[W2H_#MX]M=^%VLIM3B76].N@`?U'45_*]\=O^#BG]J+X$?M%?
M#G]FO7_^"-/QQNO''QT\47/AS]GD7'[1?@K1U^-<<=PL-GJWA7[1\,;G3[:R
MO8I8;EGU+5H(+.*0M=72)'(Z_J/\:?\`@I!\1_V>?^"7GB#_`(*)?&;]C_QE
M\.?&_@KPI+XJ\>?LH>*O'\5MXT\*0+X^G\%V]A>^.M,\!ZOIOVN\L6TOQ/;S
M7/ABQT\6.JQ6D]Y#.B27`!^K5%?S[_LZ?\'!/P,_:8_9^_8>^.'@/X5:C'J7
M[67[;.C?L/?$7X<W_C^SBUO]FSX@ZKX:\7^,%USQ+J,GA*&W\::1+X7\.Z/X
MATE=.M-`M]3TKQ3;"34]/U;1]:TFU\D\;?\`!P]XUU.P_:>^+?[*W_!-+XY?
MM4?L@?L?^*]?\*?'#]I[1/B[\/\`X?6FE/X*:*7Q[KGAGX4:_HFI_$#QCX=\
M(Z:TVM:GJVA6UQ;V6B6EYK.N-H>D6=Y?VP!_3'17C/[._P`>_AO^U'\#OA=^
MT-\(=3N]7^&OQ>\'Z3XU\(WNH6$NEZE_9FJP[C::GITQ=K/5--NDN--U*W26
MX@COK2X6UNKNV$5S+\)?\%.?VS/VUOV/]!\%^)?V2_V#M3_;'\/0^'?B'X^^
M.'B*#XG^%_A[8?"OP5\/D\-R>1#9:_<6E_XH\1^*;?7-4O\`2;'P\-7U*VLO
M">L2_P#"/:C&YFLP#]4Z*^,_^"??[9OA;_@H%^R/\'OVL_!_@_6_`.C?%C09
M=4_X0[Q!?6>JZCX?OK.]N-/U#3VU:PBMK?5+>&ZMI!:Z@MEI[W4)222PM7)B
M7[,H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`*J:A>+IUA?:@\%S=)8V=S>-;64)N+RX6VA>9H+2`,IGN90AC@A#*9)61-PW
M9JW10!_GY_%?_@FM_P`%@?B3X4^+'_!12S^%/A/1OVB]"_X*9:7^UQ\./@1'
MHNN0_M)ZG8:)XHT7X0Z%X5\-^*4\8#X?:;\+7\%W-K\0=2TZ_,>K2VWAM[>:
M_9$AM&^Q_'?_``1__:,_X*%?M\_MO_&SQSH'Q#_8]C^+_P`'_P!FC5_@[\>H
M;#1-8O/#?B'4OAUXL\'?M"_"FTLCK#7_`)UUX+^(NK^$-5O)K"")[BW273M2
MCE@:4?VBT4`?PD>&/^"/O[3WP.\*_P#!P3\#?@S^R_XMTKX9_''X+>$OAM^Q
M7I]M=^&#'\5=$\%WGAK3+1-*O6UN)?[8N+2R;4-5OO$[:3?ZOJ$M]J=TT]U/
M<RMT?[)W_!/CXZ>&_P!C/]O+X1:1_P`$\_V^?A!\>_B=_P`$N_C%\&++Q#\=
M_P!I'X;?$[X/?$OXGZA;>&+.S\#_``O\!Z?XDO;_`,&>*?%VK2MJ6D7^H:A;
M:'9>'?#E_I=Y-%<7%L[_`-RE%`'\&6A?\$2_VL_@=^U%_P`$;?VA/A?\%?%U
M[H%OXK^`WC#]M7P=#<>'Y+CX*?$OP%;:/X1U[QQ=S)XIL99;+6_"HLT\0KH<
MNK"3^P");6]LX1:7.S\//V:O^"J/P,\=?\%R_@1X%_X)Q?$#QYH__!3C]K[X
MNZG\+/CQXA\=?#30_A'X/^&_B;XF?&(6OCOQ18MXDO/%EU9:AX;\=6&OZ3':
M:0+J`1JM[:1S'RU_NTHH`_AW\:_\$!?C;J7[;O\`P3S_`&>=?\.^+_&/[)/P
M[_X)1>*?V6OC+^U+IKZ'+;?#WXPRWG[3GB_P[J'AW3+[7;368]5\->//$GP^
MU/PG''IEYIEO#<Z7;W$RQI<FWYO1/^")'[67[,G[:'_!0+3/AMX/^*_Q\^$?
MC_\`X(H_M2_`+P/^T#XNU'PW%J?QG_:;^*_@'34C\/36-UXIN+RQ\3>)O$*R
MV7FW,=OHPEM1)/J42$-7]UE%`'\&'_!+/]@[]J7]GKX$:A\'O&__``2X_:_\
M$_';5_V3/VL?A5XC^.WB7]HOPAJGP4O=?^)'@_XD+X5TW0?@S9>/+^PTVZU4
M:MX7\-PW'V"(1:N-0U:2>'[4TI\J^/'_``0,_;(N_P#@GA_P3Z^*OP4^%7BW
MP[^U[X4\`?#W]GG]LS]GJSN?!T=]\0?A)H7QA7XD>&==UNZN-7.B7FN?#C7]
M$\-7LC0:K+<7&C6.A36DZ77A6S@F_P!"2B@#^;#_`(*'?L6_M.?%O_@IK_P1
M%^.GPX^%&M>*_A;^S9XCED^.?BFPOM$BM_AQ;)9V!%WK=M?:G:7MQ;R.7BC;
M2+?4I#)#*#&JA6;]%/\`@LY\!?BI^T__`,$O_P!L3X!_!'PO-XT^*OQ,^&EC
MH7@OPM;W5E8S:SJD7C3PMJDEK'=ZA/:V4!6QT^[GWW$\28B*AMQ4'].Z*`/X
MM_%__!!?]HGP-^V?_P`$V?CQ\!;)=%^"^L>,/V<_B9^WO\(;?6-.MM-\(_'G
MX/>"-5\&:E\;=(BG9QJNIZ_X>\=^+[/5K32Y5,^NMJFJ7"W*ZK:K84OA1^S=
M_P`%>_\`@FS\*?VQ/^"<7[/O[$NA_M._#?\`:5\5_&35/A+^UK;_`!%T/PWX
M-\$6?QSTC4M#6\^)/AC5+ZVUI;CP;]M&H7MCIMK<I>-"(!/Y4V]/[5:*`/PZ
M_P"";WPD_;Z_8NO_`-E;]A/Q3\,?`/B/]CWX0_LC:5'XP_:'M/%$MQXM/[0E
MUJ&JZWK7@;3-#D*-<^%=-O=4?3].U=H8S-9VT,@2,,$7S_\`X+I^%?\`@IU\
M<_!'@_\`9?\`V)?@\GBGX#?%C2KN#]J3QYH7CS0?!OQ+E\)#5K:&Z^&/@:\U
MY);70V\5:.EVFL>)EMY[NWLYQ:Z?]GFD>YC_`*!:*`/SK_X):^!_&GPH_8^^
M'?P>\7?LN6O[(]I\)X&\#>$OA;;^.-.^(4TWAG2HH?LWB?4_$VG0PI?:OKUS
M+=7>I2W"M<RW322R-AE5?T4HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HK\R_'W_!8K_@G+\+_`!SJ?PV\=_M"W&@>-](UK5?#UWH$
MGP9^/U]<2:SHBR/JUEIMSI?PLOK#66L8HI9YYM'N[ZW6W1K@3&`&2OJ[X!?M
M6_`']J"#Q+/\#/B##XW_`.$.C\,R^*;9O#GB[PQJ&A)XQTZZU;PS_:.E^,=`
M\/:E`VKZ;9W%[;1FU,BP(&G6+S(@X!]#45\)2?\`!2_]BA/'WP6^&*?&.[NO
M&W[1?A/PSXZ^!^D6'PK^,NI0?$KPCXOT:#Q!HFN^&M:T_P"'ESH-S9-HMS#J
M.JF;4X)?#ELY;Q%'I3)(JV_AQ_P4C_8G^+OQFT_]G_X;_'/3?%?Q2UGQ-XT\
M%Z'I.G^#_B-'X>\0>+/AWH.L>*?&WAWP]\0KWP?:_#K7]7\.^'?#^MZQ?V.C
M^*[Z<6&EWL\*2K`^`#[BHKQOX]?M"?!?]E_X;:I\8/C_`/$/0?A;\,]%O]&T
MS5O&/B5[I-)L+[Q!J=OH^D0W#65K>3H+O4+J&$S>08+:,R75W)!:03SQ\K^T
M!^UO^SQ^R]H/A?7_`(W?$G3_``G'XYU.'1/`FB66D^(?%_C/QUK%Q$LT6F^#
M/`O@O2/$/C'Q/<B)TEG_`+'T.[BLHI$FOI;:%A)0!]'45^;LW_!7#_@G[9>!
M-%^(>J_':?2-&USQ]XE^%EOI%_\`"OXR'QU9?$;P;X3C\=^*_!VM?#NS^'UW
MXYT35_#_`(,EC\4:D-4T"UM(=";^U%NGLP9AV4W_``4U_8:C^$'A#X[V_P`>
M]*U?X9>._&M[\./"VK>'/!WQ(\3Z[J/CW3K2_P!0U#PA+X"\.^#=4^(&E^(+
M&PTR_O[O3-7\+V%U;V-L]Y+&ENR2L`?>%%?GOJ__``5-_8?T#1-/UW6?BCXQ
MTN+6?'2_#+0M'U']GW]H[3_%VO\`CYM"UGQ*/#&A>";[X2V_B_5[]-%\/ZS>
MSR6&B3V5H+"6&[NH)RD3Z5O_`,%,OV.9-6_9_P!$U#XC>(?#&H?M0_$G7OA#
M\$K?QQ\*_BKX"F\7_$708M`G/ADVWC+P9H=YH]WKD/B?1)O"\NM6UA:^)(;N
M2;2I[F*ROWM0#[VHKX1^,G_!2+]D[X#>//CK\-OB-XYU+3?%G[-WP3TO]H/X
MO6-CX;U74X?"_P`,=:NVLM*U:2[M8FM[B\OID?[-IL;_`&J6..1T4A&QX_'_
M`,%?OV68?"/Q%\?^(_!/[5O@#P1\*O!5]X^\:>*_B9^RK\9OAWH&GZ!8W=E8
ML+74_&'AG1[74]4NKO4+6"QTC3I+F_NGD)CAV*S``_4ZBOBKQY_P4"_9G\!>
M"O@5X^E\2^)/&.@?M+>%/&/C+X()\-?!'B?X@ZU\0M&\#?#2_P#BUKG_``C_
M`(>\,:??ZU?7Y\%Z==7MAI\%C)=7MTJV448E)Q\]?"W_`(+&_LH?&+XE67PG
M\#^"OVM+SQA+XY\+?#O6X+_]DGXY:9IW@;Q+XPNM/M]&A^(NJW?A)+/P%9>1
MJEIJU]?^*)--MK#0V?6;ETT^-IP`?JU1110`445X7X?_`&A_AYXE_:%^(O[,
MNFMKA^)GPO\`AYX#^)WBA;C3%B\/CPQ\1=2\1:5X=.GZL+IWN]0-UX8U/[=:
M&TA%K']G<32^<50`]THHKXW\2_MR_!#1/#.H>)M+NM?\20:+^UK\*?V,M>M+
M/1+_`$ZYTCXO_%;XR^!O@MI\4_\`;$%DEQHNC:[X\TW4]2U"R-RCZ=;SK"#<
M$(`#[(HHHH`**^.W_;B^!VI_'OXG_LN>!]0U?Q]\?OA5\'=9^,NO_#_0M/-M
M)-I&DZ[<>&%\/6>JZK)96L_B2]UZ&"QB@@2?3X%OK.:YU"/SEC/R+^SE_P`%
M%_BE^TC^T[\+OAWI'P<TWP-\-_$GP@\4>(_B-H?BO7->T_XM_#GXBZ-/H%RN
MA:]X9\2>"/"5[;165IJTNGSPK9R6VIW$0U72-4NM-:-Y`#]?J*Y/QKXST3P)
MX>U'Q!K=[8VR6EE?SV-G=ZA::?/K5]9V%S?Q:/IANY(Q<ZE>I:R1VUM"LLSM
MDK$P5J\:_9Y_:A^&W[0OP5^"'QHTJ^M?!UE\??#47B/P)X4\6:OI-CXFU%22
M+K3K&R:YC?5[ZQ^1[J/3([@Q1S0R2*BRID`^D:*QY/$7A^'3KW5Y=<T>+2=-
MEF@U'4Y-3LDTZPFMI!#<0WMZTXMK66"9EBFCGEC>*0A'"L0*EU?6M&T#2[S7
M->U;3-$T33K=KO4-8U>_M=-TNQM5QNN;S4+R6&TM;==R[IIYDC&1EN10!IT5
M\"?M/_\`!0CX4?LZ^+_V>_AMI-G:_%KXD?M*2^*=4^'WASPWXZ\#>']._P"%
M?^!=/L;[Q?\`$/4/%?B76+30DT2SFUC1-)T.VMYY[SQ3K&IFTT=94T[5)[/U
M_P#:C_:5B_98^`OB']H+Q%\*?B/\0/#'@;0M4\6_$70_AS!X<U+Q+X)\&>'O
M!^O>+_%'BV_M-<U[0+._TCPS;Z$;;5DTR]N=2/VN.XT^POA$\1`/IRBO$O!7
M[0_PA\9^'OAYK`\>^#M`U7XE>#O!WC30?!NO^+/#NG^+A8>-]"L=?T6UDT*?
M44U"2[EM-0B14AMW$TBMY!=<&NY/Q(^'8UNU\,GQ[X+'B.^O[[2K+P^?%.A_
MVW=ZIIC^7J6FVNE?;OM]Q?Z?)^[OK.*W>XM'^2>.-N*`.THKG%\8>$6CAF7Q
M3X<:*XUUO"]O*NMZ88Y_$R"4MX=A<716775$,Q;2$+:@HBE)MQY;8YO2/C'\
M(O$&J:SH>@_%3X<:WK7AVSGU#Q!I&D>./#&I:IH5A:F<75]K.GV6J37>F6=L
M;6Z$]S>PP0PFVG$CKY,FT`]'HKA]'^)WPV\0ZV?#6@?$+P/KGB-;7[:WA_1_
M%F@ZGK:V7E1S_:SI5E?SWXM?(FBF^T&W\KRI8Y-^QU)Z?3-8TC6HIY]&U33M
M6@M;RYTZZFTR^MK^*VU"R?RKRPGDM994AO+23]W<VLC+/`_R2HC<4`:-%?&'
M[5W[6GBC]F46]UH?[+_QQ^/NBV?@7Q?\1?&.O?"FV\+MIG@SPWX,-H^I0WK>
M(M=TB?5?$5[:7%Q?:/X=T>&[O]0MM.O3'MD6*.7YHUC_`(*X_";54\.7/P-^
M$'Q>_:"L;W]D_P`%?MG^-+GP-8Z'82_#CX*_$>_U*T\"MXCT[6]3M]1;QMXB
MM?#WBK68/!D%LNIPZ+H+:A(3#J%D9`#]9J*_/OQ%_P`%'_@?I/[17[)/[-FD
M:)\2O$7BO]KV&^U/P3XI@\`>+=+^'6B:!!\$_%'QST^_U#X@:IHEOX-UK4M4
M\,^&C:IX<\-Z]JFL:?=7\<FJ06B6\J'L;K]M[X?Q_MQ:%^PE:>$O'D_Q#U/X
M2>(/B_J'C"]\-:UHW@*ST30[S3[)=-T?7M2TN'3O%NIS3:C"+XZ#?3VNC%HH
M+Z?[9,MJH!]IT444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`'Y<_MC:=IH_;Q_X)*O+I]OMN_CA^U/;-(+"-XI[I_V,OC#
M>1PW4HCV!GALKNXB\TDN]LQ0%E)7XV^%'PD_:@^('_!1K_@IU<?L\_M8:7^S
M;H>C?$/]EN+Q;H5U^SWX0^,C>+(F^$^H3,]CJ/B+Q7X;?PM=)IZ36-M)!:ZK
M:1RS"]GL;HQ"W?\`H"N=,TV]N=.O;S3[&[O-(N)KO2;NYM()[G2[NXL[C3KB
MYTZ>6-Y;*XGT^\N[&::V>*26SNKBV=F@GE1H;/1=&T^^U/4[#2=,L=2UN2VE
MUG4+.PM;:^U>6SB-O:2:G=PQ)/?R6L#&&V>ZDE:"(F.(JA*T`?RI?#;Q?\-/
M#GBC_@W/LOB#XOTZQE\/?\$__'VF^,],.G(FO6^F_$O]CO1_#/AB]-W;6\FH
MZ7+XEU_PYK6@Z!I4#)'K&N(8H8I;S3K8#U+]B7XY6O[/_P`9?V5/V5/V8/VF
M_AM^WC^SSX[^*OC[POI'PXU[X72>#_VG/V,O!FE>"/B+XKUCQAXB\=Z(5T/7
M_!OA&>VL_AS./&O@_P`'^,=4D\<6&GV.NZS_`*3%=?T@MX`\"//IMT_@KPDU
MSHMIIUAH]PWAO1FGTFQTAY9-)LM-E-D9+"TTN2>=].MK5HH;)YI6MDB:1R7Z
M1X%\$>']7U'Q!H'@[PKH>O:O&L.K:WI'A[2--U?5(59&6+4=2LK."]O8U:.-
ME2YFE4,B$`%5(`/PK_X+">$OB3^V#\7?V?OV!?ACX)C\?:-JGA#XL_&[XY:+
MJ?C*7P%H-QX/N/!/B'X0>#+5]?\`L-U!=:YIGB+QQ>^,-,T8O"9Y]!LI9IH(
M"91\1_LS_M(7_@SXP_L7?'O]LJQU#0M1^!'[(G[0G_!.OQ?\2/&VGZKXH\"?
M!G]NKX!?%7PIX'\:^,_&-[H>G06'A?3/CYX4\%V7B/3/$FDV,%OJFC:_8:*]
M[&;2%T_K-_LW3OM_]J?8++^TS!]E.H_98/MYM0V\6WVOR_M'D;_F\GS/+W?-
MMSS5&;PSX;N;'4=,N/#^B3Z;K%U<7VKZ?-I5A+8ZI>W94W5YJ-H]NT%]=7)1
M#<7%S'++,54R.VT8`/Y.M2_:!_:1_:__`&J_V+/$?PJ3]EW0O'G@/]OG]KWX
M>_#KX^Z%\.OB#XM_9\^*>F6O_!-GQ`6\>^*-*7Q%X.\3>(Y3>ZQJWPSL;BV\
M7VD<6L:#I=A%=70L7TZ7YW^,^JZK\*M*^%=I\?\`XJ^*/V=?VM]%_P""J5O\
M5_VL/C#X8^%FF7WP\\(/XF^%/C3PSX#^*GP8\%^+?#WBOPU??!/6?#FG:)H4
M;>(8_$&L6LLVLOKU]!KZ0W$']H^G^$O"FDVFEV&E^&?#VFV.B327&BV6GZ+I
MMG::1<2[O-GTNVM[:.'3YI=[^9+:)"[[VW,=QR_5/"OAC7':36_#F@ZQ(ZQ(
MTFJ:/I^H.R0EVA1FN[>9BL322-$I)$9=R@!9L@'\A'[5'QN\,^)T_8>\0Z/_
M`,%C/$WQ7_X0+]M?4-0\4_M:Q?L^_L[:?J/[/]AK_P"SU\4K;2=*N/!N@_`W
M3?AQK%IXCNK&^6+4?%GA'7+V*9I(X;N`^2I^@?C%\+M&_;I_X8F^#NG?MCZU
M^VA=^-E_;LE\(?M<77PV^'7P\O/AK\2/`WPR^&OB?X9)'IOPB^'O@+0=/O/`
MWQ#T[PKXTT2^MK/2M3OM4\(V8O;[5K6WETV?^F,?#OX?BW>S'@;P<+1YH[E[
M4>&=%%N]Q$DD45P\`LO*::.*::..4J9$261%8*[`ZMAX8\-Z4MHFE^'M#TU+
M">XN;!+#2;"S6RN;N%K:ZN+1;>WC%M/<V[O!<2PA))H6:*1F1BI`/X=OVR/V
M=_V@_ADG_!0Z;]HS79_B1^TC\2_^"4GCWQM\3/$7A#2=2U#P9K'C#Q)\9[2!
M/"G@:>VT31[:#0O">AZ/I4>E:5%I=I<-+J&H.MG&%=Y/LK]H#XY:1\0?V0_V
MHO!^@?\`!8;QA^WMXDO_`(3:/=:+\$9_@+^S_P"`)K.?2?B/X#OKCQ19ZU\'
M_@CX"\3RW.BV\3LMK<:V]FZLTCVLLL:LO]9%[HNCZDTK:CI.F:@T]HVGSM>V
M%K=--8/)YKV4IGBD,EH\H$C6SDPM(-Y0MS6/:>`_`VG^=]@\&>%++[3%Y%Q]
MD\.Z1;?:(-ZR>3-Y-FGFQ;T1_+?<F]%;&5!`!_+_`.`?AI\1_P!F+_@JG_P3
M$_9)/A;Q#J?[.VE>-?VP/VE?V:_'D%A>3Z!X'\$?%S]DGXFV_P`0?V>]<OVC
MN#97OPM^*$]QJ'@F34M1D>_^'WC[PSHMM%`_A>=9?U6_8,L+ZT_;#_X*PW-U
M97=M;ZA^TS\*Y[">XMIH8;V&/X">#XGFM)9$5+F))5:-Y(6=%D4H2&!%?J5)
M86,T]G<RV5I+<:<96T^XDMX7GL&GA:VG-G*R&2U,UNS02F!D,D+-$^4)6G06
M5G;2W5Q;6EK;SWTBS7LT%O%%+>3(@B26ZDC17N)$C58U>5G944("%`%`'XX?
M\%`/V9/"'[3_`.T?I7A?XHV'Q"\0_#GP[^P_^T/XB3P9H'C[X@^$/!7BOQW;
M>+/!'_")IXDTCP%JV@MXJUOP]<*VO^&+37-1NK/3[ZU_M"RTN34H;:Z@_)+X
M4^`K[]G3P_\`\$VOV@]-\`?M#?%3XP_M:_\`!/#]K:+]JJRUSXH?'36+WXW^
M-_"WP9\`_%OP%X<^*^HWNLZS>>&9O#]PGQ#T/X<#3+?3-2\/Q:H=`T"PN!8Z
M7'I7]@>Q-XDV+Y@4H'VC>$)#%`V-VTL`2N<$@'&0*C6VMT6!4MX46U.;95BC
M5;<^6\68`%`B/E2/'F,+^[=T^ZQ!`/X0-*E^,_ACPK^VUX8_8(O8_!W@KQ;^
MP%\-O'>M^$_V/_"?[06AV?@GQ!>?M"^'[7X]R:5K7QF\6:UJ'C']HGPW\`KO
MXC6MMXH\*6G@S7IKJRTZS&E2:]86UU7JOQ!\$^"],\8?MV6'_!,#P/XQT+]G
M?4_A9^P_IWQ0N?#.A_&=;G6_AE9?%OQSJ/[2`\,:YX@U"R^(&KZG;:)>Z3'X
M^_X13Q#'XHETYO%5K9S+K-U<32?VSV]E9VI8VMI;6Q?=O-O!%"7W2/*VXQHI
M;=+(\C9SF1W<_,Q)FCBCA79%&D2;G?9&BHN^5VEE?:H`W22.\CMC+NS.Q+,2
M0#\0/^"1_P`.?AGX%\>?M66OP(^(7@[5/@=XCTOX*:Q)\%OAG\.?B[X)^#?P
MX^(]W;_$>U\3>)_`O_"U+^]CGUSXE:!:^'K?XFZ/I#3C3[OP7X4N[J6"/5;>
MSC_'[Q)^R3^S/X4U/]MCX(:9\"/$/PP^/?BS_@IE^SK/K/C/X8>#_'_AOXA7
MW[%7B+]O[]C_`,5:]XE^'GCRQBOG\,6>G:CKNE>(=*UGPGKC>([*X\)W.LI+
M:Z;X9O$L/[0Z*`/XZ?C7^S=XZ^!GC/\`;`^"OP;\!>)M-_8-\'_ME?LN>-/B
M?\+-8T_XB>,/AA:_"GQ3\&?$_P#PFK66B:5JMMX]U_X=O\2H/#.N>/M!\%^(
M7@N;XN_B&WO=,FN]/F_9O_@D+X8\#>%/!/[3EK\)/%NE:E\']9_:,OO$W@?X
M>^"/A9\1_A9\&_A'>ZA\/O`^G^./#?P5TKXF7-YJ;^!/%/C/1]7^)$MAX:DL
M_`VB>*?&/B&U\,Z/I<,]S%)^O=%`'\]VI?';X'^+/^"\&M>$-7T[QYJ&EZO^
MPM+^R3K4-]\+/&[?#3Q%\4;GXZ>+_&FO^%=;UR?PT?#&I(O@Y[9K76)M2.D2
M6^JWEBMQ-)=;$_5[X??L*?LC_"K6/!'B/X>?`SPAX3\2_#O4M1U;PGXFTM]9
M7Q+:7FJZ4-$O?[3\0S:K-K/B6T?2ECL8-.\37NL:=9PPP?8K6W>WA:/ZSHH`
M_FE_;Z\+>`9_^"C/Q(O/VY?@;XH_:1^!/C#]CG0/!W["GA1/@MXH^-GP[\,_
M'*\U3QL_Q<LHM"M]/U;PKX;^,VMO8>#KS3O&>I:;;ZB/"TV@V&E>([!]/OK4
M_BM\:_AO\5/%7[&?P4^"U[^RC-\//B3\&/\`@G!\+?$7P!\=77[&/BCX]_M`
M^./$OA;6?BCXH\3?#3P7\3U\8>'[3]DS3_A)K5YX:N_%7B*RT?5O&FKW.I"Y
M:35=`TY_#M__`*`=%`'\QWB#X9?%O6_VK/#7["<4.I6'PT_;4\1_`O\`X*,_
M&+4+1X[/2OAW9_"%_"6J?&[X6Q^&(1#;:'<_%SXQ^&/AU?I$IB2YTO\`X3.1
MEGU1(YD^V/\`@K)\,-;\9^*/V&O$OC+X>:I\8_V1/AI^T++K_P"T[\)=(\&S
M?$2#6M)N/!NLZ5\/_$/BOX?(TT/C?P9X4\77%G>ZEHUSI6MQV-\^F^(/[.D;
M21+%^FND_`3X::-\<_%_[1MII%X_Q9\;>!?#?PVUC7[S5]2O;:#P;X5O[[5=
M+T?1M(N;F33-$BDU+4;F^U*73;:WFU2Y\J6^>9H8MOLE`'\DWP(_8*^'7Q:_
M;H_9&^(OC#]BG0)OV6M0\:_\%/M8^&'@[XO_``)\-_V5\./A++?_`+.^K_`C
M2KSP;XB\,^5X"\,7OQ#N_C-X_P#@OX/O;2!/#,/BW7KO0+73I=2OT;]E_P#@
MJ_\`&JS\+_LG?'?]GK2/AM\9_B3\4OVHOV>/CC\'/A5I'PM^%_B?QQI<OC;X
MB?#[7O`7ARU\5>(='M)=&\'V,^M^(K$RZCKUW:6L5FEQ<M)LA:OU"HH`_B7_
M`&[_`(8_M+:=<_&OX*:K^S-<>$O$'AW]C_\`9BT#X)>-/A%^R!8?M`_$+]H/
MXF^`OA#ID&N>(O$'[2EYJMWI_P`#8O@AXVT6X\,>%M(T#3M+UF\BEF\2PZC?
MQZI9I![=?_L/:G?_`+!_[</QT'[.][/^VWIG[<"?%_X/?%F]\!6>J?'NQU#P
MQ\4/AGXETO4O`_BG6?#\GB.Q\+RSMXJ%UHVCR+H.HZ9K/BRWG%_%KNL7-]_7
MU10!_*TWA/XR^'/B-\.OV7)_@C\;[WQ7X(_X+8V/[6?B'Q[I_@/7;CX20_`3
MQSI_Q`ET+Q-%\0@@T:Y3[3K-O87^EQ2/<Z=<PR?;(8HC%))\,W'P^_:@^+GB
M'PMXEU/]E.^^!GQ<\,7O[=F@_&/X-?!+]C;1_@_\+_A%9^,_@[\9M"\%^&=+
M_:&T22YUC]HMOB-J\>F^+]0\1I=6WA[Q%XF\5OJ4?AS0KN&UM!_<710!_+AX
MX_9I\"_\$\?V#OV(OV^_@3\"?"OPS_:*_9IL/AQJ7QIT3P]X4TK0OB'\?]#^
M//A'3/A!\4O`'CO4IA8ZMXW\92Z]XD\.>+?"UOXNUF[%OXO\(:3%;".?[-Y7
MZ:?L3>-V_9VU?X&?L%^,M"\7>,OVA?&7P-\7_M9?'CQ_IPL)O"'@OQ+XT\=F
M;5M(\5W5[J*:W:ZIK?B?6]3T3P;8K8W9N-'\(7LKS106:9_03XN?!'X8_'72
MO"NA_%3PO:^+='\&?$#P?\3]!TR^EN5LK?QIX"U6/7/"FJW-O!+'%?#2=6A@
MOHK2\6:T>X@ADDA9HD*]%8?#CP)I?CSQ!\4-.\*:)9_$/Q7H6B>&/$GC&"QB
MCU_6O#WAN>^N=!T?4-0`\ZXT_2;C4]0FL;=SL@DO+AE&9&H`_,[_`(*I?$GX
M]IX#T/\`9W^#?PK_`&AM4\._'/2==T[XO?&OX#?"B?XKZ]X!^&UK):6?B?P3
MX7TR#5]+@T?XD?$O2+V\T#PYXHUK[3HOA2PFU/7WL=2OK.SM#\`^"-+\4?LI
M_$3X_P"O?#W]B3]INQ^!O[8'[`'[,/P0^`7@?P[\-[S6?&?PE^(7[-]I\?OA
MA;_!WXK:-;WETW@J;6O#?Q1\.>,=-\6:W?P>'9--L=1MY;TWUM+%'_3)10!_
M/9\:/#_Q;^$'Q8_X(M>&1\!_VF_B?HW[&$7B#4OCEXT^&WPSU/XD>&-/AUS]
MC/QI\&M.$6KZ5;/J&LZI:^/M?MM)33=+$<EAI3SZEJ<$EI%:SQ>C_M$:E\1M
M*_X+._LI?%G3?V7?C]X]^%7PY_9G^,'P>\3?&+PG\+M=USPIX8\9?%WQCX#O
M/#ZV.LVMS%;3:.-/TN_?Q;K+6UQ8Z%:VC?:)(92I;]S**`/"?A+\7/%OQ&\:
M?'+PGXD^"GQ%^%VG_"7X@6_A#PIXR\90:9'X:^-.A76B6>K+XX^'4UE?7-W<
M:#:W-Q-HMZ=3M;&>+4K61(DFB(DKW:BB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`**^6OB'^V[^R%\)/B7%\&_BA^TA\'
M_A_\49I=#A3P/XO\;:-H.O*_B58)-!,UKJ-S;BWCU2.ZMY;6:=XH6BE65I%C
MRPQ?BA^W_P#L3_!3Q?>>`?BS^U#\&/A]XTT^VLKR]\,^*?&^DZ7J]M::C`MU
M87,MI/,'$%Y;.L]O(,I+$RNA*D&@#Z_HKXEO/^"D?[!VGZC_`&1>_M6_!BVU
M0ZAJ>DKI\OBZS6[DU31)UM=8T^*#'F37FE7+I!J-M$KRV<SI'<+&S*#Z=9_M
M=_LQ7_PP\3_&FT^.?PXE^%'@K7['PKXN\>_\)'9Q^'/#7B34]7TC0-/T+7+Z
M5D73=4N]9U_1--@L[M8IY+O5+&()FXCR`?1E%>`_%O\`:G_9V^`^L67A_P",
M?Q@\$_#K6M1T6/Q%8Z;XGU5;"ZN]$FUVT\,0ZC!&R-YD$WB"_L](BVDO+?7$
M<*(Q/'E-O_P47_8ANO#=[XOB_:1^':^&=.\1Z)X0N]8GNM2M;2/Q-XCM=5O=
M"T1#=:;"\^H:I:Z'JTUI#`DID6QF&0VP,`?:E%?'.B?\%!OV+/$.GZ+JNE_M
M'_#5M.\1?%#PO\%M!O;[59](@U?XI^--)N-=\+>";!]7M+$7.LZSI-I<WMJD
M>Z`1P2+-/%(I2OH73OBM\.M6^)7B/X.Z=XNTB[^)_A'PUH?C'Q+X*BF?^W-(
M\+^)+F\L]"URZMVC5!I^IW=A>6]M-')(#-;RQN$88(!Z#1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'\9W_!1S3_B#XC_:N_X+B>&_#WC+]B'P;X)O/V7_`-G?3/'5
MS^TMX=\42_%S4=*\7?LU^(]&O-,^!'CK3]4BT#P+XJU&TM#I/AW5+WPGX^NX
M/$NJ0:F=$MSIEA!K73?LK6.K_$/]H?\`:J\2^"OBM^Q]^R?IFO?!O]A*XTKP
MO^VQ\!;/]I#XN^'K74OV;["^TW1],US5/CM\%K*+_A'K*:"P\2SZEH^N3ZOK
MULMY=6FDS-<6=?U/^*_V:OV<O'?C.+XC^./@!\$_&7Q#@DTR:'QYXK^%7@7Q
M%XSAET01+HTL7BC5]!O-<CDTA8(!ICI?!K`0Q"T,0C3&?XX_93_9=^)WB*[\
M7_$K]FWX!_$+Q9?QP17WBCQQ\'OAYXL\17L5M&(K:.[UO7_#NH:E<1V\0$<"
M37+K%&`D85>*`/S*_:)^'7P_E_X*._\`!(\2^%/AIK/]M6'[8FI:UJ>@>"M#
MT[P_XGU*?]G>?4;C7;?3,ZJHMM1U%5U:T6YU+59HF:"1M0NYHQ=/\&?M;?LT
MZ/X[_;M^*'_!-G3[!;7X<?MR?$KX??MY^-_#EKX?MM3\/6_PI^#G[/GQ*\$^
M-V%I>W#Z=#KVH_M4?#K]GJYTG%I=VFD3Z]::K<>'F33-.'B'^GT^"/!9O_"^
MJ'PCX8.I^![:[L_!6HG0-*-_X0L[^P&E7]KX7O#:?:/#]M>Z6!IMW!I,EI%<
MV`%G,CVX$=32>$O"DOBJV\=2^&?#TGC:RT&[\*V?C&31=-?Q5:>&-0O[35;_
M`,.6WB%K8ZO!H-[JFGV&I7>CQ7B:?<W]E:7DUN]Q;0R(`?Q>>)O&GC+]IGX#
M^(OVFM9\>^#_``!XQ^!/BW_@G+^Q7JGCWXAZ;9^+/"?PW^+'PA^)%D/VA_%O
MC+0KCQ%X3T[^R=-^*J1OJGA/46\+WFH0)%8WNKVD-S$D?T+^V%KGQ!N?AS^S
M5=:K_P`%'_V(OBYJUG_P4`_9O;1/C%\./V9_!O@[X9_`B5M'^(IEU7XN>"]/
M_:%\5Z=X_P!/U@K%+IMIJOB[P1'9)I.H)'=78NY&M?ZBK[X$?`_5/".M^`-2
M^#7PIU'P'XF\07_BWQ)X)OOAYX1N_"/B#Q5JMY_:.J>)M;\-W&CR:-JOB#4M
M0_TZ_P!9O[*XU*\O/])N+F2;YZX>V_8\_9'LO#VJ^$;/]EK]G*T\*:[J&F:M
MK?ABV^"'PS@\/:QJFBI>1Z/J6JZ+%X833=0U#28]0OX],O+NVFN;!+Z\2UDB
M6YF#@'\^/[0GP)TS]KV#]@WX"_&?]IO]G?\`:\MOBA^V)^TCX6M/C#^S'\'/
M!/P9L_A=>Q_\$U_VG=2\)Q0V=C\3?BY;OXZ\%>,X]*^)VEZ[_:D-U'=V'AIH
M=`DO=&TR74/(_AC\;]6\8>-O^"B-O^V?^T;\2/V/?BC^S3^Q[^SQ^SY^TY^U
MQ\,HU\%>(_"?C[PS\;=4F\-_$OX=:S=^'/$4=WH7Q5T6_P#"5_=30^?F'Q?K
MVAS:7H]]']OB_J6\&_L\_`#X=6^EV?P^^!OP>\"6FB>)9_&FC6O@WX9^"_#%
MOI'C&ZT23PS<^+-+@T31+&*P\2W/AR:;P_/KMHL6J3:)+)I4ETU@[6YU/$/P
M5^#?BX^,&\5_"7X9>)V^(=AI6E>/V\0^`_"NM'QQI>A7*7NB:;XP.I:5<GQ-
M8:/>11W>E6>M?;;?3[F-)[2.&5%<`'HEF5-G:E)VN4-M`4N7.7N%,2E9W.!E
MI1B1C@9+'BK--55151%5$10J(H"JJJ,*JJ``JJ``````,`8IU`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%<'\3_BA\._@KX`\4_%3XM>-/#GP[^'/@C2Y=:\6^
M-/%VJVFB>'?#^EQ/'$UYJ>IWTD5M;1---#;Q;W#37$T,$2O+*B,`=Y17P_\`
M!;_@I#^Q/^T'IWC;4/A1\??"'B.3X=>%]9\;^,=%N$U70?$^C>#_``_92ZAK
M'B>7PMX@T_3/$$^A6-K#*\VIVNG3V@=?*$IE(0^B^&?VR?V9O&7P_P#@C\4_
M"OQ=\+Z_X!_:+\6Z;X#^#GB32YY[NQ\9>,]4N-2LX?#%KY4#366MV]_H^K:;
MJ6G:G'9W.E:GIM[I^HQVUW;2PJ`?3=%?"NN_\%+OV'O#?Q:B^">K?M!>#X?'
M\GCK3OAC);01ZM>^'[/XAZK<1V=CX+U'QC9:=/X3T[Q)-?2Q:>=)O=9@NX]0
MFBL98TNI$B,=W_P4S_89L/BY??!"]_:&\%VGC_3/&EK\.-1@N/[3B\-V'CZ]
MDC@M/!UYXV>P'@^V\1W%W-#81Z3-K:7C:A+'8^4+MUB(!]W45XWX#_:`^$/Q
M-^)_QK^#7@;QMIGB#XE?LZZEX'TCXR^%;-+H7W@;4?B1X4C\;^"K;4WE@CMY
M'U[PO+'J]H;2:X46[`3&.3Y*\_UW]M7]E[PY\"+G]I?5OC#X6@^"MIX@B\(S
M>-(I;J[@'B^;Q:G@./P@FFVMM-J\OBMO&4B^&_\`A'8[!M7&KDV9M!*K``'U
M)17YDC_@L+_P3[;5'T,?&O43K,6GQ:K)I0^%_P`5#J":9/<36<.H/9_\(9YZ
MV4MU;SVT=R8Q"\\,L2N71E'HO@7_`(*9?L3_`!%T;XQ^(O#?QMTP:%^S_;33
M_&#5M=T#Q5X9L/`T\$MI`VDZO<>(=$TV,:^\U_910^'X#-K,[W=NL-DYF3<`
M?>-%?G%X3_X*Q?L,>*_!?Q3\>R?%77O!.A?!S1-!\2^-(/BK\*OBK\*/$#>'
M_%.M'PUX9UGPMX7^(?@WPYXB\;:=XA\3F'PQHMUX1TW68M2\1W5EHEJTNI7E
MM;2^^_LR_MB?`C]KK2/%&K?!77?$]ZW@O4[72/%6A>-_AUX_^%GBW0[R_LTO
M['^T/"/Q)\-^%_$<-M>VCB:TO#IIM;A0PBF9E8``^H**_.;QS_P5>_8;^&OQ
MS\8_L\^._BIKOA?Q_P##[QEX;^'WC?4-5^%GQ2M_AOX6\9>,-"\,^(_"V@:Y
M\6CX//PTTZ^U[2_%^@2:6ESXHC6[N;QK&)FO+6Z@AW?#'_!3;]C[Q9\=_C;^
MSE8>./&&F_$G]G71=6\2_&*3Q1\(/BQX2\">#?#FD_VNW]OW?Q/\2>#=,^'E
MWHNKQ:#K5SX9U/3_`!+=6?BBTTR]NM`FU""WDD4`^_**_,3X>_\`!87]@OXG
M:AK.D^&?B5XXM]6T_P`$>+_B%H.E>*/@7\;?!FI?$_PSX&\/ZWXJ\1R_!6Q\
M5>`-(N?C1J=KX=\/ZEJ]KH7PQC\4:UJ=DMM-IMA=+?6?GX?@W_@LW^P]X\\?
MZ7\,/#EY^T?-XVU;5/#.DQZ1J'[&W[5NC#3YO%^I?V3H%YKM[JWP?L['0-'O
M;P2*VMZS<66E6L-O=75U>0V]M/+&`?JO17YC_`[_`(*\_L3_`+1?BGPUX5^$
MVO\`QIUYO%VH:AIVA^*M0_9?_:-\-?#F=]*FO+?4+RY^)7B3X8Z5X&T_2K6;
M3[M)-7OM>M]-!A;_`$K!!.EX<_X*S?L5>+O%OAWPMX;\6_%+6+'Q;\5K+X)^
M&/B39?L\?'J;X)Z_\2M3ODTO3/#^E?&U?AW_`,*MO5U/4Y8-/T[5(/%;Z1?7
MMQ;VUM?22S1JP!^DU%?'&K?M\_LM:'\!?A'^TQJOQ"O+/X.?'/XA^!?A7\,_
M$LO@SQH+S7_'7Q)\83^`_!^BR^'!H!\1Z0=3\46T]A)>:QI=C8Z?'&U[J%Q;
M67[^NI_:O_:Y^$?[&'PYLOBO\;(/B*O@6[\16'A:XU?X>_"[Q[\4Y='U75XK
MA=%;7M,^'V@^(=4T?3M7U**VT&QU:^LXM-;7=3TK3I;J*6^B)`/IZBOA;P#_
M`,%%_P!F'XA_M*>.OV0],\0>+=#_`&A?AW\&]`^._B/X;^-?`7BOP7K4?@#7
M])T/63-;)XCTS3TGUS0[3Q+X?'B7P[N36-#EU>S6]M(U=W3S/7?^"L7[+>F_
M"K]GCXE>'-/^,?Q/US]J?P:?B!\%?@I\)?A3XE^(WQR\4>#X(Q)J'B&?X?>&
M(KZZT;1]*4A;_5-7N[/3TG(M8;J:Z(A(!^FM%>)_L^?'WP+^TM\,=,^*WP]M
M/&FF:%J&J>(-!NM%^(O@7Q5\-?&V@>(?"NLWGA_Q%H?B+P;XTTO1]?TF^TW5
MK"ZM]T]E]DOX%AU#3+F]TVZM;N;VR@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`*_'7_@M#;Z5!\'OV2/%OQ'TO5=7_`&9?AK_P4"_9T^(W
M[7T%MIEWK?AO3OV?_#&F_$69O%7Q)T:TAN6OOA?X%^,$_P`(_''CB2XMY[+2
M-'\.R>(+Z&6UTF6-OV*IDD:2H\4J))%(C1R1R*'21'!5T=&!5D92596!#`D$
M$&@#^8;_`(*,_'?]FW]KGXV?`#Q%^Q9\4OA?\?\`Q_\`"SX)_MHZW\>/B+\"
M/%VC?$'0_!7[/&N_LT>,].'A?XC^-_`YUOP_9S>)?B%+X4N/#?@O7M>L]6:[
MTO4=2ATL)`\M?$WB#PQ\1OV7_B1_P3H_9VT2'66^$?[6?[1/[-W[7W[,FOBW
M:73?`W[0'BCX3ZJ?VFOAC=ZSY=T;(^)_'5_H_P`=O"B:J]K9+<>)OB'9:>LJ
MZ:D5?V0^&_AO\._!NBW_`(;\(>`O!?A3P[JOVC^T]`\-^%M#T/1=2^U0FWNO
MM^E:78VMC>?:;=F@N/M$$GG0DQ2;D)6M_P#L+1/)TFW_`+&TKR-!:!]#@_LZ
MT\G1GMH#:VS:3'Y.S3FM[8FW@:S6$Q0$Q1E8SMH`_GI_8+_:J_8B^#/[!'@/
M]DWXT?%;X1?#7]J?1KS7?`7Q)_9O^+5]HEE\<-7_`&G-9\8:A>QZM#\&=02[
M\?>*9/%/CV\TSQ-X2\6Z3X7U&QU1+G2];TR^`6*2+Y$L?CG^RIX5_P""'7Q5
M_8(^(&N^')_V\-2^$OQ5^%WBC]D"^OC+^U#XO_;*\>:UXBO?#_B+0OAA?6=O
M\0/&$FK_`!%U'0?B+I/CO1-!OM#7PW'::L^NVUO9S3V_]8Z^%/"R>)I/&B>&
MM`3QC+HY\/2^+%T;3E\32:`;J&^.AR:\+8:J^CF]MK>\.F-=&R-U;PW!@\V*
M-U:WA'PFWB:/QHWACP\WC&'39-&B\6-HNFGQ-%I$TD<LVE1Z\;8ZHFFRRQ12
M26*W0M7DCC=HBR*0`?S"_L"?M9_`#]D;_@H;_P`%;M$_;9_:1^"/P-^*FOG_
M`()K6VIO\6OBQX"\&W_C?Q'X=_8<\*VOC;5=-MM9U73;O5[C3_$MW=PZSJ%M
M`;6**\T0&.V2[M6NO<O!7[*O@O4_^"U'B3P7;>*[C7_V7M-^"7A'_@J+X'^"
M<'D77P]A_:L^+7C7QW\";OXBVSK)+#J.B_V7X4U;XE:7HFUM)M_B%XCM/%=C
M'#<Z9`TO]%-?*OQP_;>_94_9N\13^$_C9\9_#7@3Q'9^%-.\=:EI%Y::_JMW
MH_@[6/%NG^!=)\2:Z/#^CZLFA:1J?BW5++0]/O-8>QCO+MIVMS)!97LUN`>?
MZ:#_`,/,O&1P<?\`#"GPU&>V?^%__%CC/K7\T/@GXY_";Q_-_P`%(K[P!\5_
MAM\7/`OPV_X+%_!S]K+QZGPK\8:'\2Y+C]FRVLO`9\0_%73M,\%7VHZEKGP_
M\,:O#8P^)_$4-KJGANSO--NX([L36,KM_5-??MK?LI:5\,]<^,6K_';P#HWP
MV\.>/==^%FK>)]:U*71X8_B1X:UAM!UKP/9Z?J=M:ZOJOBBSU93:+HVDZ?>W
MMV1Y]E%<VQ$Q[OX)?M%?`O\`:0\/7_BKX$_%7P7\4M#TC4&TC6KKPCK5MJ,^
M@ZLF_?I7B#30R:GH.IJ8I0UAK%G978:&93#NAD"@'Y)_MJ?M0_\`!*S]N#X&
M^+?!%Q^V9X)BM_!DGP]^)0_:*^"-MJWQ.\.?`C6_"WC[P;XG^'^M?$/XF>#O
M#?BGX9^#=,/C0^&[F]\)?%#Q#HUGJ4-KJ=U=6$8\.:I?Z-ZE_P`$N_VJOBK^
MT%XI_:)\&>,?B/\`"K]J;P'\)+WP%8_#S]MOX*>%K/P]X"^-2^(M!;5-<\'3
M76CZGJOAG5O%GPRN_+TWQ#-X7NGTVVFOHK:[6#5$N[>/]@:*`/XD?VP?%&F7
M/[4?_!8+X:Z+^UW/I?Q2U7]IS]G3Q5X._P"">UCX5TKQ;>_M<7'ACX`?L_ZO
M:>%)M,T72[OXH#2O$%_IT.FWM_X<O;+3]*^S+J>HW-O:6EU(/:_CY\2O"W[2
M'Q^_X+:?`/X+>*_"?B7XZ>)_V5?^">&D2?`WPUK\-UXMUVY_9YNOVB;O]I3X
M5:1I*&:XU/7?`VGZW9^%_$>B2%6@O-<TS3[Z:$WZ/7]6\/QA^'%Q\7KOX#0>
M)[.7XL6'@"+XH7O@]8[C[?;>!9]=C\-0:_+*81:BVFUJ5;*-%G:<N&8QA%W5
MT7BCQSX.\$OX<3Q=XET7PVWB[Q-I?@SPN-9O[>P_M[Q9K;2IH_AW2S<.@N]7
MU1X9(["QB+3W4B^7"CN0I`/P#_:3_:@_9N_;\U__`()R?"K]ASQ##\8_B9\*
M/V]/V8?C+XK_`.%9:9KTJ?LP?!_X03:KJ_QCB^+VO6^CII?PY&L>`[?5OA%_
MP@WBG5=$U/Q1J_B*/3+'3M3FTUK-ON7X3Z=?I_P5O_;`U5HYFTV;]D?]ENSC
MG%K<+;Q7<7B_XLRO`UXV;62>6)A*D$965(XW=PRD%?OKX>?%WX<?%AO&"_#S
MQ39>*#X`\7ZIX"\7FRM]0A71/%^BB(ZKH<[WUI:I/<V7G1":6R:YM=S;4G9@
MP'H]`'\;_P"P1<Z5X]_X)I^'/@3X'_X*"Z_%\<OB3\%/C3X8\`?L@W=QX8T>
MRFU[6KSXEZ1I_AC3+V/P^GBEHM4U-EOK:_CU21XKZ%K6.=;?ST7]@?V'OVZO
MV2](_9P_9L_968:U\//VA_"WP_\`A;\(]<_9+N_AE\19?B]\/_'%E;:?X:OK
MOQ#X%3P>NIZ1X-T?7K.\\4ZS\3KFWA^'VAZ#;7GBBZ\4PZ79/?CZ.^)O_!4W
M]C/X3>*?%7A#Q5\0M8FUCP5X_P#&OPS\3?V#X/\`$&N6FE^*_AIX&\.?$7XD
MV\EU8VCI+8_#[PMXKT2[\7ZE`);/1KFZ-C/(;I/*/WUX?U_1/%6A:/XF\-ZI
M8ZYX>\0:99:SHFLZ;<1W>GZII6I6\=W87]E<Q%HY[:ZMI8YH9$)#(X-`'\BO
MBG]D;XV'_@G#^Q7X^U?XP?M#ZU/#^V[^S%XLU+]G/4=!M[GPAX2BM?VP9;B]
M:WT32]%N/$.C:=I%I+-J\]]J.K7>G6]N\EQ<WLL#PSG]B/\`@M_KNFZ9^P5X
MITJZDN7U3Q'\3O@Q::'IMAIVI:KJ&IW&D?$SPWXCU-+6STNTO+EQ8:%I&IZI
M=2&-8X;2RGD=QMP?UYHH`_EP^/?P=\8_$+]K/_@HE^V;\"]#US5_BC^S/??L
MA?M!_`75]+T>_2/XR_#Z#]F4^%?VB?@EH-U<V]O#K=O\7OA!J/B;PM96,,RQ
MV/Q)L_`&K7DMI/H4<D?F?_!+:\OOV,_$W[+WQQ_:C\/_`!!\*?"/XH_\$R/@
M%\'_`(<^/+SX8_$/Q!X?^%GQ'\#>+_%6L^.?A_XQN?#^@:S_`,*\U7QG9W^F
MZQI\WB*RT9-:?2I-/2[FE@2"OZVZ*`/D;P'^V[\!OB9XR^#_`(+\%W/Q'U&Y
M^.^G?%75?AGKNH_![XH^%O#.M6/P;?2HO&5U>:KXM\*:$=!LYI-54>$M0UVV
MT_3?',5C?7?A&\UFQ6UN;KZYHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"OQH_9`^%'PR_:$^+__``5^D^-?A31?
M&OB#XB_M2R_L[_$'1/$%S::I?'X!_#GX.>`[;X5>"9_L,5LVF>%[W3O%GB3Q
MWH]C#-)=PZAXWU2ZN[P:N+B&S_9>OC_1?V5F\$_MD>,?VJ_AYXV;PUI7QG^'
M?A_P;^T#\+)-"LKO1_B!XF^'BZC!\,/B=I>KH\%_X?\`&&A:/K&H>%M?;%[8
M>)/#D.CPSVT-]I-O>4`?F/\`M"_!3]DO]EG_`(*#_L(ZWXZ\.>'O`'P(\3Q_
MM$7^EWOC34=6O?AE!^UIXBM?@YH7@76KYM?O;[P[H7CGQ%X7TG6[/3-7U'[$
M-7U1993<3ZW.LK_''[3_`(WT74?^"@W[0_B7]C3XCW_@/PFWPH_92^&'[07Q
M&_9]O7T#3KOXL>)_VE-&&G:/_P`)AX?=?#-YX]/PTFUJTU6ZBM]:U2U\.7OV
M&\>R-U:25_43\1/AK\/?BYX1U?P#\4?!/A?XA>"M>MY+76/"WC'0].\0:'?Q
M21R1$S:?J=O<6_G1I*_D7*(MS;.WFV\L4H5QS/@WX`_`[X=^"K7X<^`_A#\-
MO!W@.RN=+OK?PEX;\&>']'T(:CHJ6<>E:I+I]C80P7.KV*Z?9>3JURLNI!K6
M%VNF=`U`'\W'[0GQH^-/[-O[0W[6G[,&D?M)?&[1?V;=)_:)_P""2=SXA^)'
MC'XL^/?&'Q,^"'P@_:NU+XT>%OVBXM*^.7Q`\1>*?%7@_P`*ZG<?!G0M9L=:
M;4+3_A!KOQ;XDBT*ZTRSETI=,^CO$GCOX=K^WKX,_9UUG]L'XP:5^R!;_LM?
M%#Q]X<\1P_MF_$G29O%?QQL/B)+H7C33-0^.VD^.M-^(NNW/PZ\'W5HNF^"=
M7^(NJV&A"\@\0VVF)J"6-Y;?NWJWPO\`AMK]SXPN]=\`>#-;G^(.BZ)X;\>/
MK'AG1M3'C30/#;:P_A_1?%4=]9SQZ_IFC-XAUS^S;+54NK>S75;Y8$1;B13Q
M<G[,W[.,WA'1O`%Q\`O@O=^!?#M]?ZGH'@V]^&'@J]\+Z)J6JOYFIZAI.@W6
MB3:9IU[?N`;RZM+6&>XVH)7=44``_D1^#/Q._:[^)USHW[2>F?$SXAZ[^T#\
M)_\`@G!;?&>'7HG&A^)?V@_A)\$/V[/%MOI.D>*3H5KH^FZU_P`+E_9\\/:5
MJDVL/HLNF^)M6U.P\32:8XU#S4]\^/?C"Z_:[\'_``&_;Y^(GQ7^+/A[]G3X
MN?\`!6+]E*P^`OAF#XI_$+X:^"OA1^S?\++RZ^&&H?$CR?#OB70=.T35OBCX
M^@\<_$F'Q]<0V>MV^BZGX%N;/5-/;3]-M--_IL^+'P)\.?$#X8?$'P#X5&E_
M##7/''PIU;X-VGQ`\*>&/#Z>)O"7@K5].DTDZ;X?DEL1%!9Z19SR2Z%I4@;2
M--OX[2ZBLLVZ+47PX_9I^#7PV_9^^'_[,5AX&\/>(O@Y\.O!/ACP'H_A#QCH
MVF>*-(O-&\*6=I:Z8^KZ;K%I=V&HW9DLXKZ6>YMI&:^S<@B7#``_G#\/_M'?
M$"']J;1/A9XS_:'^)'A+]C3Q1_P4O_:*^&7B[XAV7Q-\;:%.;?PU\"/`^M?L
MQ_"Z?XZZ/XET[Q1X)\)>.O&>H:WK$UTOB6S@^(?B#2-*\,ZWJ.H6WB6]TS6>
MF_:8_:9TO]GWXHV_BWX7?M%^)?VN/V<=5U7X2^#[+P'X*_X*+_%OP;^TY\*O
M%FN?%?Q);:SK7@7PK.=;\-?M4:#X@U>Y@T<^%_%/B5M=T71/"%[X?74)O"XG
MLT_I&O/@S\']1\,ZMX*U#X4_#6^\&Z]=VNH:[X2O/`OA>Y\,ZU?V(M197NK:
M#/I;Z5J-W9BQLA:W-Y:336XL[40N@MXMF7:?L_?`:PU/PKK5C\$OA%9:QX%M
MDLO!.K6GPV\&VVI^#K..6XGCM/"M_#HJ77AZVCGN[J9(-(ELXEEN;B14#S2,
MP!Y7X?\`V/\`]ESP]/;>.U^%'A^'6(-*^-E]<Z]XE>ZU/5(3^TAJ^G^+_CQJ
MVK7>JWEV'UOXA:CI5@_BS69G>^EL=/@TJ.[BTFWCM%^9?^"-&IZOJ7_!/_X5
M)J%U<W>DZ1XI^+GA[P/-.QDB'PZT'XI^+=+\#0:=<MEKS2+;P];65OI=VTDQ
MFLHH2)I%`-?=WQY^%VH?&OX0^/OA/IWQ!\4?"Y_'WAZ]\,7GC?P7%I4GBG1]
M*U:,VFKC17UJRU"QM;R]TV2YL4O6M9)[,7+7-J4N(XW76^#_`,*/!'P*^%O@
M#X.?#?2(=!\"?#3PIHW@[PMI4(&VUTG1+.*SMS(P`\VZN/+:ZO)V&^XNYIYW
M^>1J`/1Z***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHKB?B/'\1I?`WB6/X1W?@JQ^)3Z:Z
M^#[SXC6&N:IX'M]7,D?ER>)-.\-:EI&O7>G"'SM\.F:G97+2&/$ZJ&!`.VHK
MP#P_K?Q@\)?`?Q+XC_:)MO`/B+XB>'M#\?ZUKUC\";/QE9>&-6T33)=:O?#M
MAX>M?%%YJ/BF'7;KPS#IMMJC?:IE'B![R32RMI]F`_B'U[]IC5=2\+?M1>._
M@CX_\%?"3PE\:/\`@D9^U=\8_$?PQ^#GQE^-OQ-\=?#GXF>!O''@F3X=7WQ7
M\6_%+6M1M--^+5I:^+]1T&\D\-:-I=]I0:2WT_48'L;*]A`/[]Z\CMOCC\.+
MOX\:U^S9!K4C_%SP_P#"/PQ\<=4\/?8YQ%!\./&'C+Q?X"T'6A?E?LKR7?B;
MP-XDL6LU<SQ+9+,ZB.:,G^6K_@I;X`U#_@GU\7-2T3]FCXD?'[PC\//C_P#L
M^:%K/[5.JZG\9_BKX_UY_"^A?M)_"3PI\2_C%%XG\2ZGXK\4Z'\0]5^''BCQ
M!I_B[Q_IVH66MSZ1#;I:ZEI<5BB/];_\$Y]!_8X\._\`!6S]H;2/V&M8TO7_
M`(.Z7_P3:_9FAUB^\/>-/%?CWP_;^.+_`/:%^/VI36UAKGBC6-<6W:Y\+3>&
MM1N]/T6[ATLZI<:G>R6JZW<ZW+(`?T=45\G^'],_;E3]HS6M0\5>-?V4I_V2
M6_M,>'?"7A_X9_%RU_:)AW6<2Z-)K/Q!U'XKW?PVN/+U#SI=3BL?AK;>=9F*
M"UE@G5KAOK"@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BO#_`-H?]I+X)?LH?#._^,7[07CRR^''PVTW6-`T
M"\\37^F:_K,2:UXIU2WT7P_IL6F^&=)UO6;JZU35;JWLK:.UTZ;,LJ^843+#
MY0M/^"N?_!.J]^'7C#XK0?M,^'E\%>`?%G@?P/XONKKP9\3[#7M%\4?$N6[@
M^'^F2^"K[P/;^-KD>,+G3]0M-`OK'P]<Z;J-Y87UG!>-<V=S%$`?H_17S-^S
MO^V1^S+^U=X;\4>+/@#\7?#WC[1?!%^^F^,F6UUSPQJGA6Z6T%^/^$B\/^,M
M)\.^(-&MI;(F[MK[4-+M[&ZMTDFMKF6.*1DX?P]_P4+_`&/_`!?^RIXB_;9\
M(?&;1?%'[,_A:3Q'#J_Q*T;3M=GMHY_"GB*3PMK-M!HLVF0>(;F\BUB,06UC
M#I37E]'-;SV=O-'<0EP#[1HKX9^%/_!23]C/XTZ-\6=5^'_QBM;V^^!OA+4/
M'?Q4\'^(/#'C'P/\0O"7@W3+>2YN_$UWX"\;Z!X=\576A(B+&=7T[2[S3DNY
MK:QEN8[VYAMW]'^(W[8W[/OPJ_9DLOVO_&/C8VWP%U/PUX%\6:9XNTS2-6UR
M?4M(^)-UH=CX--AHFD6EYJ]W>ZQ>>(M)M8M/AM'NTN;GR)(EF1D`!]/T5^<V
MG_\`!4[]DVZM;G5-6G^-7@C0++4/!FDWOBCXF?L[?&KX:>&;74?'VOZ9X7\.
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MMI\*/@+\:OB/=2^`Y?$VJ^#6US4++PQX%OK_`$46OBG1-3T#4K+5[6RU#2M5
MMOL.IVMI<S6\<H!^EK*K*RLH96!5E8`JRD8*L#D$$$@@C!'!KS*R^"?P9TVV
MU:RT[X1_#&PL]>MM8LM<M++P%X5M;;6;/Q#*DVOVFK00:3'%J-MKDT<<NL07
MB31:G+&DEZD[*I'ROXT_X*4?LK^!-1^'GAS5=:^(^H^._B7\,8/C+HWPQ\,_
M!GXI>)OB=H?PSN9!;6_BSQ]X%T;PK=^(/A[83W^[2X8_&5GHUW-JD4VGQ6[W
M,;QC#\3?\%4/V+_#OP^^"?Q,L_'_`(I\;^&_VA;KQM8?"NU^&OPM^)'Q`\5Z
M[J7PW2P;Q[IEUX)\,>&=0\6Z-J/A&34;:#7K/5=&M)].G\Q+A4"%J`/O74O"
MWAG6;F2\UCPYH6K7<VDW>@S76I:1I]]<RZ%?RQ3WVBR3W5O+*^DWL\$$UWIS
M,;.XEABDFA=XT(R/"?PV^'?@(L?`W@'P7X++Z?;:2Q\)^%M#\.EM*LKW4=2L
M],;^Q["SW:?::CJ^K7]M9'-M!>ZIJ-U%$D][<R2_)_\`P\=_8_D^`?A?]I*S
M^*4NI?#7QIXQN/AOX6CTWP?XSN_&^M?$NQU6YT/5?AS9_#M-!'C5O&VC:O8W
M]AJV@OHB7-C+87<DV+>,3-P6I_\`!5K]C_PYX=^)6O>--;^)_@&\^%$GP['B
MWP?XW^"_Q+\.^.GM/BQXU/P[^'^J>&O"]YX=%_XRTKQ%XT!\/6U_X5&KPP:D
M#:7AMYQY=`'Z0T5X'\$OVC/!'Q\@U>Y\&>'_`(GZ-;Z-%:S7$GQ$^&'C/X<-
M<B[DN8T33X/&&E:5<WLD;6LAN$AA)A1X7?Y9HR?FK7?^"G7[.7A_XAQ?".\\
M/?'V;XHWNC^*_$6C>`K/X"_$67Q!X@\/^"]:/A_7M<T1)-(AL;W28-2,,<%_
M]NBM[J*[LYH7:.YB+`'Z(T5\>^#_`-N;X">-?A-^T)\9],U#Q58^#OV7O$WB
M#P=\98M>\*ZAHWB#PQXC\+_#?P-\5M<TLZ%>%+V:YL/"/Q$\,S31D1.M_/=6
M#*LMI(3R?CO_`(*+?LY^"]:\#>$M._X67\3?'GCWX6>&OC9I_@#X1_#;Q'X_
M\6:)\+?%Z*?#GC#Q=:Z5`-.\,V6KS,UM86>IZG%JU[+#<2VFGSVD$ERH!]W4
M5^?U_P#\%._V.]-U_P#9S\.7?Q%OH+S]J/Q1XE\$?#&:?PUK%I:VWC/PCJEQ
MH6O>%/')O;>VNO`OB"RU^UET$Z7XCM;.Y;5S#9A-]S;F63XE_P#!2_\`94^%
M/Q!_:B^%_B;Q+XDG\9?L=?"[PW\7_CKINB^%[S4T\.>$?%=CX?U325L+E98H
M=7UIM+\5^'-3N-'M6^U6]CK.GSN,7,08`^_:*_-6R_X*Q_L?#1_'M]XLUSXA
M?#/Q#\/_``'X3^)EY\.?B3\-O$OA;XD^)_!'CWQMI'PS\#Z]X!\)RV]Q=>-;
M/Q5\2?$7AWP#I<F@RW83Q7K^C:5J)L)-0MW?KS_P4B_9XT?X=_$SXG_$G3/C
M%\%O#'PKM-`NM:7XN?"3Q7X4UC7I?%6IQZ'X;TOP+H\=OJ5[XUUO6]>GM=$L
M-&T&.[U)]1NH(WMXX2\Z`'WW17P;X9_X*-?L[:SXGNO`WB>/XE?"7QW_`,*J
M\8?&OP_X*^+WP_U3P-XA\<_#?P!I<>L^-==\#6]Y+<6OB*?POIT]M=:[HMM>
M)KFE0W5O/?Z=;P2>:)_@?_P4=_95_:(^$'P@^.'PN\9:MJ_@?XV_&*W^`O@\
M7OAV_P!*U^S^*-Q%X@G7PWXH\/WOEZAX<F6#PSJ4[2WT8C>W-G=0^;;7D$S`
M'W71110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!^''_``<)ZA/I
M7_!/K2[^V\4VG@>YM_VM_P!C<V_C&_T/P[XEL?#,S_M`^"XHM;O-!\67=AX;
MU6UTYW6ZN+/6+VULI8HW\R>,A6'\\G[;VO>/-!^)WQF-E^U)\*?VS_'7B?\`
M:(_X)1^+8?VH/A]\(=)^'_@CX<Z]X'_:1^*7A;PE\`?$7@;P/XQ\2?#[7Y?#
M)NKGX@-?Q:Y:>,M:LO%-[9ZU?7&F0:'%HW]W?C#P3X.^(.A7/A?QYX4\.>-/
M#5[);S7?A_Q5HNG>(-&N9K29+FTEGTS5;:ZLY9;:XC2>WD>$O#*BR1E6`-<Y
MIOP8^#VC:,?#NC_"?X::3X?.K66O'0M-\">%['1CKFFR";3M9.F6NE167]K6
M$H$MEJ/D?;+60!X)HV`-`'\P/Q`^,?Q._9K\$?\`!4P_M':[X0_X>;?''P=\
M./@9\*?"?PO\.VWPX^$'Q`\#?$RXB^"GP%\4?`C0?%/BGQ%J.J:KI?B3X@:U
MJWCA_&'C'4]6L-4TI+>[@MM)6VBF^7O%^K_$C]EKX$?\%6_V3/C5\!3^RCX)
M^,/[,?PI_:H^`GPNO?B?\._B7HNER_"FP^$OP`^.FH:;XB\#A;2.\\2Q>%?A
MSXSU'1+B2XN=-N+7Q#JY-M9ZG!;P?V>Z]X"\"^*M1TO5_%'@OPGXDU;0YH+C
M1-4U[PYH^L:CH\]K=Q7]M/I=[J%G<7.GS6U]!#>P26DL+PW<,5S&RS1HX3Q+
MX!\">,W23QAX*\)>*Y(]-U'1D?Q+X<T?7732-8^SG5M*1M4L[IETW5#:6IU&
MQ!%K>_9K?[3%+Y,>T`_ET_;/^)GPF_:G^)WP(\:?LA:_9_$>X_9W_8'_`&YA
M^UW\5/AHUO<>`=.^$?Q/_9CN?#_PZ^$_CSQ=9PBR\2^+-7^.FA>%?&WA;PA'
M=WMWX=M?!_B77[J/3UU"'^T///VL/VL?V8OB1_P0!^%/PC\"_M,?#:]^+'A+
MX-_L*W>JV&G^+/#OB;QI\/YO#/Q'^!MAK?B.\T75K41@^"KBX#W%OJNER6%L
MD*65ZEW9EWG_`*P_#OPR^&WA#1-0\->$_A[X'\+^'-669-5\/^'?">@Z)HFI
MI<QM%<+J&E:;86UA>+/$[QS+<V\@EC=D<,K$'BK?]FC]G&T2ZCM/V?\`X)6J
M7UL;*]2W^%/@2%+RS::&X:TNECT%1<6QN+:WG,$P>(S00RE-\2,H!^7/[.?@
MWX??M<>"OCY^SQ\5_P#@J1I?_!2[P'\2_A!>>'/$?PPO/AK^RQX5F\`:?J=U
M:V*^-K:X^`_P_P#!FIW5Q:7<UM!8CQ`]]8VNIBRO+=8;N%&;JO\`@A_\/],T
MC]BG2/B_?Z[K7C;XJ?'WQ;XC\6?%7Q_XGN[34->UW4/!VH3_``S\(Z&+JV+F
MV\/>"?!7A#1/#7AW2))6>PM;2::Y7^T;V_DE^IO@I\;_`-@=?%7C2P^"5[\&
M?!>O:#\7[S]F;6=<T/X?6WPOTGQ;\9M*:6YUGX0^!O'%[X6\,>'/B[XF\/7V
MGW%IXCT+X<Z[XP_X1O7]/N='UQ=/UNRFLHO=O@A\5?@G\2]/\?Z-\#[_`$NX
MTKX._%+QM\&O&^EZ-X5U;PEIWAGXF>"-2^S>,_#L%EJ6AZ';:@=/U*X)EUG0
MH[_0M3EE>XT_5+Y2\M`'X0V?QI\4_LH_M7_\%/?#7B+XY_L\_L[?M!_';XZ_
M"OXF_L[^-OVL-"\0:S\*?&GP'M/AQH'AHZ1H%AX/U+X6:QJFJ>'-:M-6T^]L
M;;QYJ]U;ZI>0ZA>)]GN(K8?"7P`_:6\<_M"_M8_L[?M2_'/]K*#_`()L?$/X
MW_\`!*GPWKOB[5_A5X'^#UMH/BC6H/VE->@/@[3?#?[5O@?XZ0:'ID4!MO$Z
M+8:38:])/,ZMXHU[2Y5\K^P'Q?\`#+X;_$&339?'WP^\$>-Y=&D>72)/%_A3
M0?$LFE2R,C/+IKZU87K6,CM'&SO:F)F9$))*KCX]_:'_`&A/V!/@E\1?"WPT
M_:)M/`VB^.M1\!7/BGPC:>(/@/XH\5V3^`=-\5:'X8U*72/%.E?#K7O#5O8Z
M-XD\3:$NLZ/#K45SHL&I0:WJ=A::5YFH(`?FK^SS^T;\"/V5/^"BW[='BS]I
M?XQV5GIG[57P;_8C^(_P$_:D^(%OIF@_#[XZ?#3X6_!F_P#A_P"*=+T#Q-H=
MAIO@+2O$>D_$>;Q-XNO/!>AV.BV^H6_C5]7T73[F&VOH].^,](T_XW_%C]J'
M]D?X@_LO^//!_P`&],^-_P"U/_P54^('[-_C;Q]\#]4\:^']-\":_P##/X1:
M=;^*D\$V_C;X;'4(O%NN:7J6O^$]5O\`4IM-MX-MY?>&?$=J\VGS_N9\1?VW
M_P#@FMI_B37_`("?$#QK\,-?UKX.ZQI^A:Y\.C\)O$?CS3?`&MG0SKVEZ<MA
MH_@+7M!TB\'AZ)M4L8[)T9=,A>XA(@B<K]Z>'X?!/B?1_!OBW0--T2_THZ-;
M:SX&U5-'@@>PT;Q%IMO<0W&BK<VD-WH\6IZ9+;">"*.SE>`I!=1`H8U`/Y6_
MV9?&/PZ_9.TS]D+QG^T%+KGAKQ=\&OVJ_P!K"]_X*,#Q#X#TJ]B\$_ME_M-:
M%JFHO\<I]3\&:59Z!IGP7\9ZN['X;>(="TB;0]*\(:EH%KJ.KVNJ:7?6X\-_
M;1_;=^-_[47P]_;+^#?Q#^,OP'\9?`OX'_$7_@F_XQ\+?M8_L@_"WQIX#N]$
MD\?_`+7NBW^KV3>)_B'\1_C9H6L:O\._"'A[2_$-S-I_AF;1K/4[Z[NM0MGL
M$LXM2_LJO?#/AO4EU1-1\/Z'?IKELEGK27NDV%TNL6D0Q':ZHL]O(-0MHQPD
M%V)HD'W5%?/?BWQ[^SQ\(/B)\"OV:M2\'Z%HVM?M*ZCXZTOX;>%M#\!Z4/"6
MH7?PC\"WOQ$\0#6TL[.'2]+33O#6DSS:2]S;2":[BAM+;RW*D`'SQ_P3M\3_
M``3UW1_B=;?!K_@H/\;_`-O2WM-=TZ;7]3^-?BKX8^+;_P"'E]/:R1QZ9H5Y
M\//@K\(38Z?J:0FXET^^36+:.:(RV0LS),)>`^)]MJG_``^A_94O(+2[;21^
MPW^T9:WUZFE7=S91W+?$KX=RVMO-JT<J6>FSR;'>**YCG>]56CA6,HTE?J3H
MOACPWX;6=/#OA[0]!2Y96N4T72;#2UN&0$(TZV-O`)60$A3(&*@D`@&M&2RL
M#=QZG+:6AOK>WEMXM0D@A-W!:RLLDT$=VR>=%;R,BO+$LBQNR*SJ2H(`/Y)O
MB5^R#XW^*_PS_P""^'Q6T[]JC]LCX.6>A_M>_M#6MI\$?@_XE^&VB?![XF1Z
M7^R3^S-J@USQ/X?\5_!GQGXQUR^\1OJ#>&-8NO#OC71K.\T;P]I5CI]M8ZC:
M7]_>>P_L5_&;P#^P/^U-\8?%'[8OB;4_AIX-_:6_9-_86\4_`_XS>./#-Y9>
M!=9TOP!\#](\*>)_A!:>)]-AU(67B/P-K<KS6^@ZR-.N]5L;RZU33[:7[-J/
MD?TW_P!FZ*+;4%^P:6+/5Y)+S55^RV@MM3FG@AMYKK4!Y?E7LDUM!!!)/<^:
MTD$,,3,8XT4?(?[6G[7'[-'[+5EX(TCX^6\MWIWBGPY\7_'FC:7I_A&T\66>
MB>"?V>/AGJ?Q.^)_CC5;&1EAT?P[X/\`!MH81J2PNUSK.LZ#X5TN.XUOQ'I&
MGWH!_-KI'[+.J_M7_M$^"].4:]\/O#/[3?B#_@I5\=OV=?'$&EZMI%Y\/[DZ
MM\%-0^!OQ4AM+W2[:;27N/B1\/A\2K*S%M&^NZ-J<K%I#K-V2O[3?[)_Q?\`
M@K\%OVP]%\?:Y/XG_:9^+G_!-/Q[\;OVBOB'X>BU>YT;Q%\?_B3^U/H/B'Q/
MI?AZUEDU<WG@SP/I,.A_#KP+X3CNK1)OAUX'\/65Q/:SO>7S_P!,G[+O[6/P
M0_:TM/$FI?#?3?$.@>*?AA+X:TSQ/X'^(_A*+P=\2/!=AX\\':)XX\(W-]X=
MFGO+S2=(\5>%M7LKJP_?Q-Y]GJ.D:A;6>JZ/?V-M]2W>D:3?F9K[3-.O6N;0
MV%PUW96UR;BQ,@F-G,9HG,MH9@)3;ONA,@#[-P!H`_GK^)?[`W@'3/@?XT_:
MK_X*8_M(_$SX^7%Y^SM\%_V>_#VO?!7X67'P2M/V;?AOK/QS^#_Q$T'QEX(\
M"^#->^)6I:MXY\$_&SP[\,/BCX@^)OC"Y\41:/I7PU@>[\-Q^$+37]%U+X+^
M+/Q+_:0^,^@>)HO!_P`7?%?_``5"_8]_8Q_:&_8Y_:ET[XPZ]\$O#/AOXDWV
ME^"_'VL6/C_X6Z+JOPP\%^&/"WQ]\3?#CPE>Z3\2_P"U+/X>6'B6^UG2KA[_
M`%%;QX6M_P"Q-H('@:V>&)[9HC`UNT:-`T)3RS"T1!C,13Y#&5*%/E(QQ533
M-)TK1+./3]&TS3](L(BS16.F65M86<3.=SF.VM(XH4+M\S%4!8\G)H`_FI_;
M5^,W@;_@H;\;/@9<?LE6FM_$#0/V7_A/^UA\3_C=\9-,\)>+M+TGP-9^*_V=
M/'/@S0?@C<ZIJ5EI=M>>*O'7B.\2+6_"5I%?:GI%QX<MCJL%M$X2;YS^%7[/
MWQ=^`?BS_@CSXD\">!O$-U\!/VL/'/[*GB[XZZ-::5?(/@[^U%\#_@KXTT:R
M\>:GI26]NFBZ5\;/A+?OH_BR^NH))(?&'P@T>[O)H;CQ1<--_7+;:;IUE'=1
M6=A96D5]=75[>QVUK!!'>7EZQ>]N[I(HT6XNKMR7NKB4/+<,2TKN3FK:JJ*J
M(JHB*%1%`5551A550`%50`````!@#%`#J***`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`*\9_:.USQMX8_9Y^/'B7X:Q"?XC>'O@S
M\4-<\`0-(8EF\;:3X(UR_P#"L32BUO3&)-=M[!#(+.[*`[A:W&/*?V:D(#`J
MP!4@@@@$$$8((/!!'!!X(H`_D8\:_#CX#Z)_P3'_`.#?+QIJOQ#U?X<?!GPM
MXY_94\4_$#XH:3\0)?`/A[PWK'Q:^%=_KWQ(\9>-O%-G=Q:+H/B#4?BAXBU]
M]3U37+Q9M+\5ZIJEM/.-4:=J\JTGP/9_"?\`9X_;]_;]^#_Q_P#COJ7B']G?
M_@JE\1M?^%UAX,^,VH:A\)?%/P__`.%[_#K1O%NG^)/#EA??\(O\3;#XA>&-
M4UEM5\3>)9==N[?[9;ZCH3PFQBAN?Z??V=?V-_`G[.G@SXH_!_1]5N?&GP`\
M:_$'Q+XY\!_!;QQI&EZYX7^#FF^-[N;7?%_PW\(O>)/]L^&UQXOO=7\1^&?#
M&I6;0^$$UB]T339I=(CL;>S^F[/P9X/T_1[GP]8>%?#EEH-Y'%%=Z)::)IMM
MI-U'#:V]E#'<:=#;):3I%9VEK:1K)"P2VMH(%`CB15`/YAO@-XV^)/C']MBV
M^(WQ4_;I\'?!?]HK3?VX?'/PW\0_LB^*OBEXXU+7/&?P.MAXGT+P?\//"7[.
M2:H-$CT[Q)X8?0/B#I'Q8LM!EBT_4+&\NM2UPV"SVR?T1_&S]E_X"?M&/X>E
M^-/PVT?QU<>%+7Q+8^'KR]N]9TR_TNQ\8Z2^A^)K&"_T'4]*O7LM7TUQ#<VD
MT\MNLT5M?0QQ7UI;7,/K4GA+PK+K\/BN7PUH$GBBWM'L+?Q))H^GOKT%C(XE
MDLXM7:W-_':O(!(\"7`B9P&*EN:Z&@#^."U^+OPR^`?_``4]_P""J'A[Q%_P
M5-TS_@G]8'XP?LY3:7X#\1>%?`?BV7XBZ5IO[//A*`ZA!J/C)'U&ULM!C"^'
MX1!)-*T$D<MW//=@ROZ=\=[+Q+XG\5>(/V@?"'[4G[1O]I:O_P`%/?V0?V8_
M#.K^"OC/XGTCX?WWP!_:?UCX=>`_B'_8G@2.:X\)0W/BCPUX_P!6\0>'=;?3
M;F^\*ZW/INJ>'9K`V$$0_JZNO#V@7L[W-YH>CW=S)CS+BZTRRGGDV@*N^66!
MY&PH"C<QP``.`*MC3M/"+&+&S$:RPSK&+:`(L]N5-O,JA-HE@*(89`-\11=C
M+M&`#^/_`,:^(O!WP)^+GQC_`&<OC/\`M9_'_P"&O[(?PE_X*%Z)X'F\7^)/
MVA?B+!XGT+P%XN_8R\"^/M4\-ZS\6;G4KWQH^@WWCC6I]2@CNM5(TZYFC739
MK')+^:?"WQI\6-8^(7[.>N_`WXB?$SXP?#K1OVNO^"M=O_P3X^)'Q,U36O&W
MB/Q;\#K'_@G]:W/AF^T'Q%XKE_X2OQGX=LOC!-\5-,\(:OXFG;4=4M=/MA;2
MR:3_`&8[?UT?$[]G[P!\6?&'PD\;>*4U)=4^#?C*_P#'/ANUTY]+BTS5M:U'
MP]=^&94\46U[I-_+J=E%IUVY@CMKG3[B.>.%C<O"AA;V.+3M/@6V2"QLX4L@
MXLUBMH8UM!*I206RH@$`D1F1Q$$#J2K9!(H`_D/\`VB_M)_$+P3^SW^P!^UQ
M\=?$MU\5OV`_%_B+]KGQ>WQD^*'C:#X$_M.>&+[PCXG^!?B_6-0\0:[JDGPP
M^*=U\7['Q)H7C#X4:1>:+8:MX*L-9T?6/"MQI%L\4M_QQ^UY^T3^U3\%9_VN
MM6TSXG?"+X277QV^#7['G[3OA"*\^*6DZ/\`#C1OAOIE_=?M-:U)IW@B6#Q1
MIG@^]^.NJZ1X!U[X@:!!I_B'2?"OA34[1]9LK6\U!(_ZU)=!T\6>J6NFQ1Z%
M-JMK<V\NI:-::?;7\,MQ%+&M[$TUG<VLMY;/*9[=KVUO+?S@#/;SQEXW\3_9
M=_9G^'?[)/[/_P`/?V;_`(;W7B?7/`_PZTW4[&SUCX@:K:^)?&?B:]UW7]5\
M4>(?$7C+6X--TJVUSQ'XA\0ZWJFL:SJ8TRT^VWUY-.T*LQR`?RQ:WX]T[P[X
M,TN#P'^UCX&^)W_!./QO^U9H^J?&C5]$\=?M8:A\)?@#IT'[,]YI&B_#N^^.
MTWB.X^+(^#^O_'#X;0^)]?.E>-K?1/"WB#Q%IW@[5[D6>KZIIZ?KY^P+^RQ^
MSW\??V5K2X^*GBOPE^V;H44_QS^#_@KXG37/Q4NK!?@5XO\`'^G:]??"O2M;
M\?:R?%'B7PY9RZ!H>BR^++B[NKCQ5HNBV=L^JWFEO/!-^RJ:/I$=I)81Z7IR
M6,I)ELDL;9;20EBQ,ELL0A<EB6.Y#EB3U-6[>VMK2)8+2W@M8$SLAMXHX8DS
MUVQQJJ+GOA10!^2&CPO;_P#!;?QG/X%%S-;:A^P5X83X^&49TZRO[+XJ7Y^#
MGV9H[DQIJMU93>+?-%Q;)=-I\1^SL]L)67]=:^=_@Q^S%\-O@AXV^-OQ,\/2
M^(_$?Q'_`&@?&Z^-/B-XY\::E9ZQXANHK"PATKPQX+TB>RTS2;72/`?@K3(6
ML_"_A^VM";;[3?7VHWNIZI>W5]+]$4`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445G6VKZ3>
M"9K35-.NEM]0ETF=K:]MIQ!JL#;)],F,4K"/4(7(26R?;<QL=KQ`\4`:-%87
MB7Q3X9\&:/=>(?&'B+0O"GA^R:W2\USQ+J^GZ%H]H]W<16EJMUJ>J7%K96[7
M-U-#;6ZRSH9KB6*&,-)(BG0T[4M.UBPM-4TF_LM4TS4+>*[L-1TZZ@O;"]M9
ME#PW-I>6TDMO<V\J$/%-#(\<BD,K$$&@"[17,P^-/!UQXFN?!5OXL\,S^,K*
MT34+SPE#KVER^)K2PD`,=[<Z"ETVJP6D@92ES+:)"P(*N01734`%%%8'BKQ7
MX6\"^'=9\8>-O$N@>#O"7AVPGU3Q!XH\5:SIWA[P[H6F6R[KG4=9UO5KFTTS
M3+"W7YI[R]NH+>)>9)%'-`&_14-M<VU[;6]Y9W$%W:7<$5S:W5M+'/;7-M/&
MLL%Q;SQ,\4T$T3K)%+&S1R1LKHQ4@G,UGQ'X>\.#2SXAU[1M"&N:S8>'-%.L
MZI8Z6-8\0ZJSII>@Z6;Z>`:AK.I/%(EAI=IYU]>-&ZV\$A1@`#9HHHH`****
M`"BN,U+XB^!=&\<>%_AIJGBS0K#X@>-M(\1:_P"$O!USJ$$?B'Q#HGA$Z8OB
M?5M+TPM]INM.T%]9TB/5+M$,%I+J=C%*ZR74*ONWFOZ'I]S-97NKZ;:WUOI5
MUKLUC->VZ7Z:+8NL=YJQLC)]J.G6TKI%/>+"8(Y72)I!(ZJ0#6HKC?AY\0_!
M/Q8\$>&/B3\-_$VE>,O`?C32+;7O"OBG1)_M6D:[H]XI:UU'3[C:GG6TZ@F-
M]JY`Z5V5`!17SI\5OVPOV2?@/XCA\'?'']J3]G/X->+KC3H-8M_"OQ6^-WPS
M^'?B.?2+J2:&VU2'0_%_B?1]3ETZYEM[B*"^2U:VFD@F2.5FB<+[9X5\6>%O
M'7AS1O&'@CQ+H'C'PEXBL(-4\/\`BGPKK.G>(?#FNZ9<KNMM1T;6](N;S3-4
ML+A?F@O+*ZGMY5YCD84`;]%%<+XZ^)O@#X91>%9O'_BO1_"<7CCQSX7^&GA&
M36+C[,OB#Q[XUOO[,\*>%=..UO.U?7K_`/T33[?Y?.F^7<O6@#NJ***`"BBB
M@`HHJ&YN;:RMKB\O+B"TM+2"6YNKJYEC@MK:V@C:6>XN)Y62*&"&)&DEED98
MXXU9W8*"0`345D:#X@T'Q5HVG>(O#&MZ1XD\/ZQ:QWNDZ[H.I6>L:-JEG+GR
MKO3M3T^:XLKZUDP?+N+:>6)\':YQ6O0`445YC??&7X9Z;\8?#OP"OO%=K;_%
M[Q9\/_$WQ3\/>"FLM5:\U+P#X.UWP[X9\2^(X]0CL'T6&WTK7/%GA[3Y;6YU
M*'49I-2CEM;.>WBN980#TZBO,M.^,WPLU?XM>)?@1IGCKP_>_&'P?X/T+X@>
M)_AY!=[O$NB>"_$U_>:7H'B2_LM@\K2]5U#3[VTLY]Y\R:VE7:-N3T'BWQYX
M-\!Q^'Y/&7B32?#B>*_%6@>!_#9U6[2V.M^+O%%\FF^'_#VFJWSW6IZM>R+;
MVEO&I9F)9BJ*S``ZVBBB@`HHHH`**_-*_P#^"O\`_P`$\].^(^N_":;XZZU<
M>/?#/CNZ^&>O:/I?P(_:+UJTTSQS8ZE%I-YX?N?$.C_"2_\`#0GMK^:&*:Z3
M6'T^..6.Z:[%HZSG]*T=9$21#E7574D$$JP#`D,`PR"."`1T(!H`=1110`45
MY]KWQ5^'GACQ_P"`_A9KWBO3-,^(7Q.@\377@+PI<&<ZIXFMO!VFC5_$\^GI
M'#)"(M&TUENKM[B:!0C*D9DE94*_#3XG^#?B[X;G\6^!+^]U+0K?Q)XK\)R7
M5_H>N>'ISK7@KQ%J7A7Q!"FG^(=.TO46MK?6=)O8+6_%I]BU*WCCO].GN;&X
M@N)`#T"BBO`?VF?VE?A?^R5\(]:^-?Q@N?$%OX*T/4="TB=/"OAS5/%WB*^U
M;Q+JMMHFAZ7HWAS1HI]4U?4=3U2[MK*SLK&":YN+B:.*&)Y'52`>_45\G_LO
M_MA>`?VL!XX/@?X<?M%?#_\`X0(^&AJG_"_?V?OB?\"O[6_X2G^W_L7_``B?
M_"R-`T/_`(2G[!_PCMW_`&[_`&-]J_L3[;HW]H^1_:]CYWUA0`445X1^S/\`
MM$_#[]J_X)^"/C[\+$U^/P)X_M]3NM!3Q/IL.D:X(M)UK4=!N_MVG6]]J,-N
MQOM+N3$$O)M\'E2$JSE%`/=Z***`"BBB@`HKRJT^-?PUO_C/K'[/MIXC2;XL
MZ!\/M-^*.L>%EL=05['P1J^N3>'=-UA]1>U73)!=ZM;SVR6L%Y+=H(VDEACC
M*LWJM`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M45'+-#"$,TL40DE2&,RR+&))I3MCB3>1OED;Y4C7+.>%!-24`%%%%`!7PS_P
M4I^"^I?'K]AW]HKP%X>=X/&=O\/]2\;?#^]CGO()+#Q]\.VC\;^$;Q!97-K)
M<-'K.A6J+:RR&VN#)Y<Z,K9'W-3)(XYHWBE1)8I4:.2.15>.2-U*NCHP*NCJ
M2K*P*LI(((-`'\<_@;]KS4/"WQAN?^"R>JZ_J-Q\'OV@_A!\7/V+M4L=4U*/
M3M,B\3?![]D/P9\?OAYJVEZ9'8*7U6Z^./[/G[5/@N;5[O5=5FEO_B+X3\.V
MD0F,03US]A;X>?M'?LS_`+9G@OX<?#;X>?#[XE_%2+_@FE\$?$_Q9'Q&\;:A
MX&;3_%OQ`^(GC_X@>-K[3]2@\(^*[^_U6X\=>(VTS489I=,!TRU,KSWSVEG9
MC]VM8_X)N?L7Z_\`L[^'OV4=9^".@:C\`_"_Q+@^+ND?#VYO-7?3(O'\/BS4
M?&SZY//]O%[=F\\0:QJL^HV=S<R6.H6NHWFG7=O+87$ENWT);_`SX5Z9\;-;
M_:0A\.PVOQ;UOX?:;\-=;\7F_O4^U>!]#U2[US3]+N+)[D:6J66H7EU<K>?9
MEN@KLC3^4`H`/XO/@1\&O#O[3GP__P""7WPQ\2_`3X/_`+0>HZG\>/\`@K_J
M?C3X0_$;6]0\*^!=1\<:+\;_`(MZI;W7B;Q7H]AJ6IZUJ/AW3GT9])UB72A<
M2Z9;:/I@M8[?3X&;Z6^/O[*_P4^'G[8?[,'P3^)'_!,KX:?%OP;X&_X)M?MI
M^.M#_8\^#_B_3M?\&^&?$T7[2/PHUZ?QUX1U?X@3^#'U+Q+>^']1\36\4-I"
MNN6FM^,IO[%0R6JWL/\`0CJ?_!,+]B;5-`\$^'/^%.PZ9IOPZ\9?$OQ_X);P
M_P")_%GA^_\`#WBKXPZG>:Q\2-4T_5-&UJRU",^*M1U"\N=1@-PUNQN)%2)$
M.T>B?#?]C3]E_P""_C?X8^,/!W@Z#2O'WP_\&?$/X;_#K6M9\5Z]K7B&'P;\
M0O$-KX[\>>'+>?7]8OKS6;/4-<TVSUJYBN#=M8BQ@:$V]O`JJ`?RQ^!O@9K'
MQ>\7_P#!+_P+I7PO_9J_;RTG4?V5/VP_&OA7X6?M)>-->UGX5?#KP3J'Q2\#
M#PSX(77_`!-X*^(FNW?C3X$Z#K=O\.--35]`CU#2Y;;4A:ZC82:?9M)]"_\`
M!2:R\.^`_P!F3]GC_@G;XD_9G\-_`.[^._Q#^)GQD\>?!K]@/2/&/CO3O!/A
M+X<Z?<:EH'C/PC8>!O#?PZU;2%U/XH:IX+EUB#3/#^DZ?;/#)'#,L1GF'[?_
M`!0_X)8_L(_%+5W\3^.?@O8C48=<\9^)XK[2/%?BSPG'INJ?$*.T3QO/8#P_
MKNE0:9:^)6LK:?5[.U$%E=72&[DA-P[2GU3X`?L)?LO_`+,?B.T\6_!KX<_\
M(YXCL/!=_P##VPU>_P#$?B;Q->V/A'5?$B>+=3TFSN/$NK:K);1ZAKT4%[=R
MPLD\XM[>"20P0QQJ`?A!X4\/>-_^"GOPI_X)J?M)W7P[^#/[4B?L_P#PV^-O
MP]_:)_X)]_M.ZCX;TK2M2^+%G=>&_A#K?QJN?`WC+PYXDT?5O&7PWUGPKX@T
M;31\1M%6/0[?QC'=>%[[1M3UW69=4_6/]DOXB?#:;]@7XCZS^QU\%[GX,+\+
M[/\`:#\,^&/@C;K%J6G>$?C'\/W\1QZCX5\)PQZAJ'A^Y\--XVMTCT"S\.3P
M>%1:SI::79V-LK6T73?$7_@EE^P#XZU+Q/XP\7_`;PQ8:]X@^)/C'XS>(_&.
MCZUK_@[6W\:^.;+0;?QSJ\WB#0=9TJ\M--\2GPKX?U37M(6YBT2]UC1[/6KF
MS;481<U]B?";X:_"[X'?##PI\._A5HFB>#_AEX3TF&T\-:;IDR?V5;:=<2&Y
M2X%]--*U[)?S7+74VHW-S//?SW!N)9YI)=[`'\G_`(H^`W[)OA;_`((:_`_]
MO/X2Z!X0UK]OG_A`_@!\;[+]I_2KG0+O]J7XG?MC^,O$/@[6?BKX%\5_%NYL
M;CQYXSU#5_''B#QEX5U?X;^(;_4=-M=.M8=%GTDV6FH&^Q-*_:J_X*&ZCX%_
M:/\`VE[K]H+P)I7@?]G3]NRY^!%A\`[CX'Z*^H>+_AS8>/\`X>:9K=CXT^(/
M_"0)JFBZ];V'C/4M$T.70_#EOYUKHNG^);N]N3XB%GHWZGZ%_P`$U?V`]"^.
M=]\;-#_9Z^&=K\6DUT^/)C;Q.^G:7XKU2\GO&\<VG@;[8WAO1_$FHZ@MU='Q
M):Z);7]S=K/*MTTJR$>]3_LL?`.X\,_$SP<_PXT1/#GQA^)UQ\9?B3ID(N((
MO%?Q,N[O0KVY\6ZDT4RR/J<]SX9T.25T=(V.GP`IM!!`/R"^'7[7/[8_Q$_9
MX_:%_P""@(^,7@G3O!7[/OQ`_:>8_L;Z9\+](NIO&7@?]F[3/B!IT/@"7XC:
MAKT?C"P^+?Q%O_#6G:YIE[#9PZ1I=U<VVG+H.IV$LDLGP#^V'^T[^U='^Q[J
M?A?XR_M`^!/VB?!'[>W_``3`^+_[2@M/#/P[T+P+:?!CQ;H_@7P#XL;1/AO>
MZ)>7FI^)/A+<0^)[K1],N?'=SJOBZ._BBN+W7)S<BPLOZ,Y?V`/V/A\<C^TD
M?@GX5MOBN-3U3Q#=Z]`^H6FDWOB'5]*ET;5O$VJ^%XKV/POJ&OWFDRRV=SK5
M]I,U\\#-OG)RU?(/C'X.?\$B_P!C&P/A37?AE\'/".A?M<ZOK/P*EL+:TB\1
MZ5KYO]+;6;SX86%I]MU!]!T?4D@A^P^#O#5M;PWFJRV,-KICW,L&0#YR'[4_
M[87A'XB>*OV"M+\668^-7Q@\6?LW?$3]COXG-H?A-1X9_9'^)7A4O\9!>Z)<
M:%)I?B#5?V<;_P"%'Q007FHZ9JNI:QI_B_P#!JTMQ<N=1N_CC]F;X>_$WX8?
M`']CC5_%?QHM?CKX*OO^"M2>%M.^%/Q-^"'P%\2Z=\./$^A?$;]H;Q,WCGPG
MX@U+P7JOBGPU\2X=2M+"/2O$^C:EI?BCP@L<9\+ZEHDESJ<E]^O'[/MG\$/V
MTOVK/@_^W5\*/B-X#\5_#CX`?LH7_P`(?AM\+K338[#XK?"/XC?'C6]`\4^.
MM1^)T(DGN]%>?X6>#?A[X6\+>$+][>XT"[F^(=Q/#=OJ\$EA]%O^Q+^PY\.?
M'^K_`!QOO@O\*_#7C+Q3\5/`GC>?Q5JT$-K:'XR-XBAT?P-XET>UOKE=(TSQ
MSJ_BSQ#;VEC?Z7:V^J:UK^KQH[75Y>`.`?E[\+OB1_P44^+?[%5Y^VSX"_;&
M\)7OQ=^-GPY\9ZA\./V3O%_P\^"7ACX6?#K7[CQU::+IVC>'/&NH7.E>-IOB
M#\.?#46I6NJ)X\\7^)?#NM^.[BPM;_0-)L(_L=Y]S?\`!-OXL_$?QI8?'CX;
M_&;XE?'CQS\6/A%XU\'6_BC1/VAOAO\`"+P+XW\$6/C?P)I?B'1;"SU?X(:-
MX<\!>-O#>M/%J>MZ)J]OH.GZK8V=Q'I^HO?JEKJ-UZRG_!-W]A5/$WCSQ=_P
MR_\`"9]:^)=OK%KXTDD\-PO9:O%XCU`:MXE/]E%_[,LI?$FJI#J6OSV%I:S:
MM?6UK<WKRRVT+)[9\"_V;/@3^S/H&L>&?@/\+_"GPQT;Q'JMOKWB.W\,V'V6
M7Q#K=KI&GZ#!J^N7DCS7FJ:C%HVE:=IJ75Y/-*EI9P0J51`*`/P`NOV[/C]J
M'[1G@+XP?"7]H_XR>-?V:/'_`.W=XI_9@NO`/Q#\+_LF^%_AS#9WH\6_#RX\
M->!?#EKX=T?]J.ZOOA?X[TB'Q/8^.-7U[6--\0V=J;36-&&E">ZE\U\`?MB_
M\%#?@%\!/V"?VP?BS^U3=?M4:7^TQX*^+=CXY^`W_"FOA-X&T#[;X(^!_P`3
M?BEX1\2>"M?\$Z#9>*;SQIJ][\.[;3=7M[GQ!!X0OWUR;^RM"TV."W=OW[7]
M@']BE?B.?B\O[,'P9'Q./BN'QV/&W_"$Z3_;\?C.">6YB\4PWGDY@UU9YIIC
MJ<*I=/)+(SR,7;-S4_`?[%_PW?X!?!K6/#_P-\(2_#*]67]G#X;ZDGAK3+CP
ME?'2M1\-J_PW\.7+I-9RMH^K:GHX_LVV(>SOKJUY25U(!^$_[&GBSXH_$[]O
M_P#X)G_'+XM?MBZ/^U)XA^._[#/[3GQ4_P"$=T'PY\+?"GA?X'7GQ!M/V>_%
M5S\/_!%EX)TW3_%^H^%D,EWIVDW/Q-N-<\7+;>$)7U#5&OI-21?LW]J7X?\`
MBK6?^"HWA76[3]IKXF?"/2)/^"?WQ"OK/PCX=LO@K_8/BP^'OCM\/(-?\#7%
MQX^^&'BK7[O2?'$.L:7::O'H&M:9XLTS47TV?P_X@TR*\.FW/WG\/OV0?V%/
MV=_B+I_CCX<?`W]G_P"$?Q1N+OQ'>:1K^A>'_"WA?Q9+=>-UCLO$S:7,OV:^
M*^(1#';7T-FODW1C$?EE@17K_P`6?V;_`(#?'?5?`VN_&/X3>!_B/K7PRU:3
M7/A_JOBO0K35-0\(:M-<Z;>37NA7<R>?8RRW>C:3=2B)Q')<:;8S.ADMH60`
M_EE_9$^+O[6G[#G[$'_!+WXK:5^T-XL^.7@?XX?L\?%CPK!^SEK_`,/?AQIG
M@WPQJ_@C]GWQW\9/A<O@JZ\+^'])\?7FI)JO@2ZT'7M0\1^.]:?6+?588K33
M++Y6L_TQ_8)\;_M>WGQX^&-SXQ_:3U;X[_`[XK?";QIXI\7K\1?B!^R;XCN9
MO'MROASQ)X*\7_`?P_\``C2-`\=^&?AWJ.C7&KVEQX7\;S^*H=%T]M-D:YL=
M1GE=_P!9]-_9M^`>CZ#\(?"^E_"'P#8^'/@%<-=?!71+?PYI\>F?#"X;1-0\
M-M-X,M!%Y.B.V@:MJ>CL;14SI]]=6QS%,ZGF/A+^QQ^RM\!O%^M^/O@S\`/A
M9\,O&GB*$6^M>)?!WA+2]%U:_MUC,0MY;JTA1TMQ$?+\B'RXB@"E-JJ``?C/
M\>_!/BKQC_P53_:Y_P"$2M?V(KG4-._9-_8G\UOVT?"O_"3:9;P7?BK]K;$_
M@/8DDMI<I/:PGQ-"HCCO;?\`L?S+B)K6(/\`+_[6_P`<_P!K[X;^,_VH/%7P
M6_:\D^'>C?LA_"'_`()VZYX)^&?P8\(_#Z__`&8?%WCOXZ^-_#/PF^)U[/X8
MU32-2U^]^&-VGB+5]6T#P=HGC70C;7L.FWLFL#4[-;M/Z.OBG^R9^RQ\6?$M
MQ\1OB_\``_X6>-?%,-AI4%WXP\8>&M*OM3CTSPT-3DTB&ZU6\CWBQT8:OJTE
MJDTOD6HO[QP%\UR>%\&_#+]@[QUX9\?:#X#\+_L[^*?"=QIO@_PI\2--\.)X
M0U32&TCX37L5YX(T?Q1%92RP)8>!K^PANM#BO=L&E7-JL\!1X]P`/PB_:O\`
MCU^U_P#LA:S^U[^SQI?[:WQ<\;?V-X*_8=^.7@GXZ?$_2?A)_P`)_P#"[4OC
M[^T)XQ^&?Q6T6R/AWP#X5\$WO@&:#P\-=T7P_K7AU]-\*V,G_"/V!32;42/Y
ME\3OBY\3V^-=Y^SG<_M%>*/VS?A5^SQ_P5F_X),>)?A7\:/&5UX-U7Q3;>-?
MBYK_`(PUKXH_`?4_%?P[\*^%?"&L+X"UGPKX=\3:5;6]A<ZMX;TCXHZ?H5[,
MNG66C6L'[9_M2?L\?LJ_\%"/@O\`$8^!/BA\&;.XUW4?@[;?$_XS:%8^&_B$
M+SP+\$?'8^).F^`/%D]GXFT)3X?=-1\0PV@O]86STD>(]0U%;.^#2VTOM&A7
MO_!/OX>_"O1/$'AV^_9H\*?!V/XK67B70M9TN\\#Z?X*'QFT99[W3]:L[^"5
M-./CS3X]!N+JTO!*=7AATIY8G$=KE0#\`O"'[0O[6OQGUK]FZ_T[]N/XKK\7
M?V]OBO\`M<?L]?$_X`^!IOAJOAO]CS2?AWX:^)$7P]\8>"/#EAX,M_'?A3Q;
M\'?$WAOPQ=>-?%?B'Q;>VGCZ#7)K"_M&FFT:U@[=O^"@O[7OQ[^%?B/QKX=\
M3>)OA;XF_8;_`&</^$+_`&QM&TDZ'H[3_MI^(_BU_P`*(\06MQ/JFF1:&EEX
M%\.^#/B)\8]$@OHO^$.LK;Q-X"\0:O:7.E&*WD_?KX(Z5^QQXT\7^+OB[^SY
M9?`KQ+XVDOKBR\:^/?AE'X3U/74U+68X+Z[M];UC0O-N8+S58XK>[N4GDCEO
ME2*:;S=H:N7_`&3/V-]`_9L^'?QE\)>)_$Z?&7Q)^T-\>/C)\??C%XH\0>&;
M'2M/\3^(?BYK\ET/#UOX:>]UQ+3PIX2\(VGA[P5HFF7VK:MC3M$$PD@CNA96
MH!^"_P`4?VDOVNOV;M#^(/ASPC^TWXS^)7P7^*7B;]CW1H_%_CCX\?L[?%;]
MHO\`9M\,_$/XC^+O!OQ\^)6C>-_`>CGP=H7@?Q1X<OO`M_X*\8_%83Z#\._$
M]EJSPZ7/H,@:OV3_`."=6O\`Q)N].^/WA3QM\69?BUX=\&?$[2X/AQ=>)/B_
MX"^-?Q1\,^&]<\&Z/K-WX<^)/C/X=9T.;4(]7FNK[0K>9GU%-#O+9KE@IB1/
MJ[PM^S!^SIX)T7Q9X=\(_!#X7^'="\=V$>E>,]*TKP7H5K8^*-+BCDBATS6X
M([()J.GPQRR+#97`>VB#L8XE)S79?#;X1_"_X.:+<^'/A3\/_"/P\T*\OY=4
MO-+\(:%I^A6=YJ4R)')?7<6GP0BZNVBBCB\^?S)!%&D:L$55`!_-'\.?VJ?V
MP_B3X[^,_P`2;SX\:_X2\<>#?VO_`-IWX0ZK\"_%/Q8^"'A'PCX>^`_P^A\=
M6/P\\'^%?@=(Z?$?4/BS+X?L/#GQ(C^(<T^IW/B1[J^FTZ\7PY;6.FVN)X)U
M_P#:1\*?LU?\$M_CYXV_;*_:=^,][^WWH6N?"CXX^`?'?BKPA%X+M[3XN?L<
M?$CQYX9UGP'IWAGP-HK>']6^&/B#X96ESIE_>_VYKWBZ?Q%K]SXMU[4+FXMY
M(/Z4=5_9O^`&N_$#_A:VL?!GX:ZE\2O):`^.KOP=H<WBAHVL[K3F+ZRUF;UY
M&T^]N[$S/*TQM+B6V\SR7*5U$?PF^&,6D>`O#\?@'PFFA_"VZL[[X<:2NAZ>
M-/\``]YIVD7WA^QN?#%KY'DZ/-::'J>HZ3;O9)$T6GWMS:J1#,ZD`_E$^'?Q
M2U;X9?#C_@G5\"/`G[5/Q<T?X!_$7X-^/_$OC_Q##^U-\/O!-];?'3P`/AQ'
MX3^!E[\:?$&EP0?";0=*\(7?B[XF-\-](G\.ZKXTFT^32[M-5\/C4]*N/=_V
M:]=_:V^/?QA3X.>+_P!MOXG^,/\`A1/[.OBCXIZ9J/[.'Q6\#ZB/CKKGPT^/
M\L'PK\+?%/QKI'A'4O#VJ:GJ_@Z;0/!WQ@E^'=IX;E\;W"WXNM;"7LU?N3I_
MP-_8?UVY^)_[.>F_"_\`9]U:[6]\/?$?XM_!^W\,^#[RXAU#Q*99O#'C+Q;X
M4%K));7.M#29SI.L7=K&]Y'93);S/''(M>^^#/A1\,?AS'8Q>`/A_P"#O!<>
MF:#;>%]/3POX=TK0UL_#MG)'+;:+;C3K6W\O3H9HHYEM1^Z,R+*RF0;J`/XY
M_#/[3W[;.E_LR:-^UY\/?VS;SQ5^TQXB^%?Q?\2_%CX#>,OVC8?B9=:SXRM/
MAU\3KB7X>^`_V,+/PGIL?P<\8?!KQ\\%Q;0^'K;1]VE^!'T[QA/XM_T.<?;G
M[!MC\-9O^"G/[*'B[P/^U_\`%']KOQ%XV_X)A?'7Q+\3/$7Q0^-S?%R_\-^.
M-=^*W[*.MZMI^F:);Q6VC?"NQN)]1D=?`.B:?HUEHXB6#^R+:2-Y)_W;^%&C
M_LC_`!!^(7Q<^(?PB\+?![7/B=X#\?Z[\$OC'XO\->%?#R^+-"^(7A[2M)UK
MQ!X'\4:M%IT>H)K%KH_C'2-0O[>:9FN+'7[>:5YHKL%M?X`Z%^R[JN@Q_$;]
MF_P[\)#H5]JOC.P7Q7\,]"\.V<,^L2Z]%9^.K*34=&M(9#=R>(?#T$&NVTC[
MFO\`2(%N$WVL6T`_!?\`X*D_%WXY>%/VMO'W@/X<?M$_&7X4Z9XB\-_\$^[>
MTMOAWX^GT2Y\)W7C/]L#3_`GB?Q'X6TJYTW4=&@N]=\/:G)I>OV^KVNL^&?$
MUO#;Z9XH\,:WI?G6LWS#_P`%$_A%??"7XE_%S]G;Q9^U7^V;XP^!7@KQ9_P3
M$_:[@\0>/?VIOBQ<>+OAEK7Q0_::^._P.^+$]O\`$S3]4MO$FA?#N+P]X(\.
M>.M*T5;RR\(?#7QGHEIXM\*Z;H%Y!<WDW]>&H>$_"NK7AU'5?#7A_4]0*V2&
M^U#1M.O+PIIMVNH:<IN;FVDG*Z??JM[9*7Q:W:K<P".8!QYA\9?'O[._PQLM
M,U+X]^)?A/X+T_XDZSH/PMTN]^)MWX8TJV\;ZWJ5S>S^&_`5O-XA,::]>7=W
M<:C/I/A[=<E[B>\EMK7S)9F8`_EZ\=_&+1M(T7]O6_@_;[_:6T3XD?LL^#O!
M=O\`\$T=!M_VK_BG<V7Q[TQOAMX?U/X5^*=:T>]\3ZQHO[8^N?&3XV:P_@#Q
M9/XTT;Q[->6+1Z?8PZ!*RW]O^XO_``4X^-[?!C]@WQ-XU\>:3\2M#U'Q-J7P
M=\':^?@O\7_$OP@UOP)KGC/QSX4M+_4;KX[^#%MO$GP_\!:#?-/9^,?'>BK:
MWG_"*/?Q0-;-J*O']YM\+/A@\V@W#_#CP&]QX62VC\,3MX0\/--X<2RE6>S3
M093IQ?2$M)U6:V73VMQ!*JR1!'`(ZO5M(TG7]-N]'UW2].UK2+^+R+_2M6LK
M;4=-O8=ROY-W8WD4UK<Q;U5O+FB=-RJV,@$`'\>O@_XS_%OXI6VF_`7P]^U3
M\5+#X7^)/^"G/[*'PYL_&?P!_;0_:'^+^OV7PV^,GP0LO$GCWP#X7_:C^*TU
MG\8/$/AV77K2:?[)J-[J5GX8UBYU>T\.:F8K>UEMOV[_`."8%[XKT3Q9_P`%
M!?@CJ_Q)^*WQ,\'?L^?MEZA\/OA=J/QG^)WC?XQ^/-&\&ZM\&OA/X]ET&_\`
MB)\1]<\1^,]>LK3Q%XLUJ73!K6M7SZ?93Q:?;.EK;0QK^F&F?#SP!HD%I:Z-
MX&\'Z1;6%[:ZE8V^F>&=%L(++4;%72RO[2&ULHH[>]LTDD2UNH52>W61UAD0
M,P/066DZ5ILVHW.G:9I]A<:O=_VAJT]E96UK-J=_Y$-M]MU&6".-[V[^S6\%
MO]IN6EF\B"&+?Y<:*H!_+7^QA\2'\*_%/]JWP[/_`,%(/`G[."WO_!1+XZ3Q
M_L_:_P#!OP%XK\0>(8+_`,1^%H1<V7BSQ!JMMK<">,RC:?8-!83QV$R&2T$[
M@I7D_A+XL?M4ZMXT\5>'(_BG\<_%?P&^'VB?M:ZI_P`$G_%_B[7_`!;8ZI^U
M1\3?"INT\-Q_&7Q+8ZV+'QW#\'+Y/%VF?LV6OCRWU&W^+_A_0]`\:WNG7=[;
MVL4G].OA'6?V;?B3\2/BKX/\+:)\/_$'Q(^#&O\`AVR^)\(\%:>-4\->(?%.
MDCQ-H(N]5N]'C6[O[W30NHK<65Y=20'9Y\D4Y5:]NC\.>'H;72;&'0=&BLM!
MDAET*TCTNQ2UT66W1HX)=)MU@$6G201LR0O9I"T:,RH54D$`_B/\*^,/V@/"
M_P"SE\?_`!O^S/\`M.WS^/O%7[*&A7W[1_A+P/\`M`?M?_M*_M(6_C>+]H[]
MG#3/C1\?-8T+XS^%_"FC?!+XO^"?@CXP^-&B)X6^%$F@:IJFKZUX8O\`0-(G
MM?!5A?6GWYXD\;?L7?L]_%C]ASQK^R/\</C;K'[.7@G]JB37?VD]?UOXV_M+
M_'#X;>&[?XC?LZ_%K3/">JZW?_%7Q1XWGTT^*?%)TZ?7=.TV:'2H]=2QOM2T
MJSU%89*_IOTWPKX7T:[U._T?PWH&E7VMRM/K-[INCZ=8W>KS.J*\VIW-K;Q3
M7\KK&BM)=/*[*B`DA1CF?$T?PJ^&W@3Q=XE\66G@7P7\./"FAZSXT\;ZMJ]C
MHFB^$]#\/^&M.NM:UWQ+XAGGA@TRTT[1=+M+S4M0U.]VQ6=I;SW,LJ1H[``_
MD`O/"_[-WQT\<_`;]H?]JR[^+VK_`+,VH?\`!17_`(*;:!#XTN?B;^U!\*7T
M'PA\57UWXD_!J]6R\#>.O#?B'PWX.O+2?34TW5HY=*\VS:RT*TL+;P[?+HL/
MUWK_`,6/BE^QW9Z9^W9X.7XG_$;X87_Q/_;X_8Q^(7@:&]\>^-!_9NH?M(_$
MGQ1^Q'\3O"OA_6;[5M1T6VTOQ[9WGPRU76DN+MKGPC\6?#$%XL^G>$]*N]+_
M`*6=*L_`GB[PWI6JZ/8^%O$7A/Q'9Z?XFT>\L[+2]1T/6;+5+"VN=,URR=(9
M;.\BOM->TEM+^/>)K0P&.1HME?-/AG]M?]CCQG\"Y?CWX9^+7@/6O@?!\3['
MX67/BVTMI9-%M?BC?_$C3OAQI_AR[L#8"ZMM;N?B)JFE:7;//9)OO+ZSU%)C
M:S179`/YB_VA_A#^TW\(KG7_`-GSX]_&'2_!U[X?_9"\)>,/@C^T)X_^.W[3
M/@J#PE^U!XFUWQ#XR^+'Q6^$L?P,\!^*_P#A._B%X*^*M]X=L[7PSXPUNVEU
M7P1H?A[PYI]H=#U'49I/US_X*^R^)M0_X)4>'=3UKQSJ=KXFB\3?LDZ]XG^*
MNB>%DFU#1[^T\>^!-2\1?$ZV\(WV@R6T1TB:.\\6#1=3\-_8K<6_V+4-&6W2
M6R'[9:AINB:M);V^JV&EZG+:L+RUAU"UM+R2W<,%%U;QW,<C0L'4`3QJI#*`
M&R.+-]I]AJEM)9:G8V>HV<N/-M+ZVAN[:3:<KYD%PDD3X/(W(<'D<T`?RO?$
M'QI%\=_!'P:\%^#/^"GOQS_;QTK6_P#@HC^P5X4^(-YH7A/PW^SYXB^$O@7Q
M9XP^(MGK]K9^)O@!\._@[KTVF?$6QM+A-9N]2O\`45TB/P9:O8S:4;Z\:^Q;
MC]G^^^#/B>+XC_#:7]H*P\6?!C_@MI^SY\"_A/%?_&+X_>*](\.?LM_$/XG>
M"?"'Q%\%6GASQ+XWUG2-6^&^I>%_&?B[4-3O=5LM1AMY2]_)J4=I:2PG^DWP
M%\2_V>O%WQ/^*OP9^'>K^`M5^)?P3M_AMKWQ6\)^';#3_M_@Q?B);^*;[X;7
MFLO:6B6T=YJUOX6\3W&EA)Y+NT2RN7D6V,Z>;[1=II-I$]S?)I]O"MPEV\]T
MEM$@NT_U5R9)0!]I7&(Y<^:#PC9H`_D=_9E\6?##Q;\6=0M_`/C?XI>*_P!O
M?0O^"PG[5]G!97'CSXXZ_8^&/V=]+_:.^)^D^+=)O-(\0:U??"?P]\+(_!<2
M6,^D:196-F=2BTKRX%U-(WKP[]F[2/A[H/@?]CW3O^"@-I\4M$_9)/\`P3^^
M(\?P(T>4?%;3?AX/VO+O]JKXDZAXPO?$6@_#IK/4KOXGK\+C\(I_A%/XE7['
M':WOBNX\,C^U99+RU_J!_86T?]ENP^#NJ_$+]F?6[O7/A_\`&/XY?M&?$W_A
M(_%EGJ6DZ[>?$+Q;\;O&R_%O3;*T\4Z3H7B&PTC3_B=IWB?3=,TV:Q2'[+:0
M364EY936MW/](:?\1/@_X@\>>*?@OI_B7P5JGQ`^&&E>!/$7BOX?QW.F3ZQX
M.TWQ\?$H^'^H7VCG+::/$"^#_$DFAD1)++%I5Q+"JQ[&<`_E1MM#_:E\`^!O
M"/[)=UJOQ'M==_X+3?!GP#X#T[Q;J1UCQ)XH^%/BOPS)_P`(C^U/XZ\3WWB2
MXOO$VA3W7[%QTOQ)837EUY]G\2C&(KNSUJ]>ZB35OV0I1'X\^*4VA_M!?\)[
M>_\`!9^;]G^QFF^(GQQ:-OV0_$WAWPCH/BGPKI6FS>)&2V^&WB[2;46OB[7=
M,2&'Q5'IT7]OZOJ(M`%_I]U7]GOX6^+/VD?!O[4.I2WFL?$WX8_#/Q3\*/"$
M+:M'<^'_``QH_C36].UKQ3J=IHRJRVOB;63H^F:9=ZJ9%F;2+&.Q5%C,I?HM
M*^-WP]\0_&;7?@5IUU<7WCGPMX%T?XE:@4M(Y]%BT#6=7N=#L9+;54EDC?4E
MO;>82VJHLD,++(7P^*`/Y2_&7P*^*?@3PA\4?V?-(\%W6C?\$]?A7_P5Y^.W
MAGQ%\-OB+I7QL\8_"GP_\`->_9/^#?B/X9^'I/"'AO5I_$_B+]F[_AH?QUXU
M\17FBZ-#JWA/3O'-S%=)#;6>G:A:KT_[*O['_@7]HKXV_LS_``@^.%AXV_:1
M_9DT3]DG]M^'3;?QAX6^.GP]^&%I/H'[57P5N?A-X#DTCQGJECK_`(A\,>!=
M)FU23X7V?CN[U1+NTTBR\4Z-9&ZT+3;_`$_^DOP]^VE^S1XH_:'^.G[*FC_$
M_3I?CQ^S=X0\*^//C%X&N]+UW39?"WA3QEX>TWQ7HFKQ:SJ&F6N@:]"-`UG1
MM1U6+P]JFJ7&@PZSI*ZW%82:C9I-H?LU?M??L\_M=?"6'XY?`7X@V_BWX7W'
MBSQ?X(M_$^HZ/K_@V*?Q)X$UZZ\->);*&Q\9Z7H&I2PV>L65Q;VVH1V;:?J<
M02\TVZN[.:*=P#^6_P#X)\?LW?`_X9?M+?LR?%S]L?X.76KZ_>?L[WWPX^`G
MQ'\9>`?B#XM\46/Q4^$O[:/Q5\#>`HY_$)TG4-=T/5;3X7WWA&VT/6?&-U;'
M5O!L-G>7E[=6=H)E_LEJD=2TX*'-_9!&1)5<W4`4QRMLCD#>9@I(_P`J.#M=
MOE4D\5XW\=OVAOAM^SQ\/?$7Q)\?:C<2Z'X5DT1=:L?#R6FK:_;1:]K=CX?L
MKH:/]LMKA[9+_4(?M#@ADA65T21HRA`/<:*H6.JZ9J?G_P!FZC8:A]FE:"Y^
MPWEO=_9YT)#PS^1))Y4JD$-')M=2""HK\\_V@?\`@JK^R#^R_P"(/B9X?^,]
M[\>_#B_!^SL]2^(?B?3/V2_VHO%_P_T#2[\:>+35C\1?"/PBUSP/J.E33ZI9
M6(U+2]>O+,:C*VG-,+V*6!`#]&Z*KV=W!?VEK?6KF2VO+>"[MW*/&7@N(EFB
M<I(JR(6C=24=5=2<,H((%B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`/YEO\`@N]^TG=I\3_@W^S=\/\`XN:Q\+?B9\$?A)\0?^"BFAW.@Q^*
MY7\5?%?X%>(_#&E_LZ?"35SX7L[N&73/B9K5W\2+?4M(UX/IMQ;Z987]Y:2P
M00K<?1FK?M_?M'?M/^./$@_8T\5?"'X>_"KX<_L-_#C]L#6?$OCSPU=_$C6O
M&VJ_&#PQXC\2>$O`5A%IFJZ3IVAV'AN#P[=VGBR_9I=4_M57TZ&VLI(+C;^K
MGA3]FCX9^#_CI\<_VB+!?$%]\2/V@O#_`,.?"?C>XUG66U#1[#PO\+=%U'1O
M"WA_PII36\<>A:6)-9US6]2A$ET]_KVMZGJ#R(LZ01_BK^TS_P`$>-3TU_AQ
MX(_8S\`?V7X?'P[^(/PX\:?%+Q!^V+\?_@KX@L/"GC#Q5KWB72?`'B[PA\';
M>UTWXW?"/PKJ7BG6=4T;X?\`B8V5M!`S^'#>-I-_>*P!'X6_X*+_`+9?BF3X
M\?$V#7?@U8?"C]EK]E']CG]J7XH^$+CP5J]]XT\8CXV?`7QG\0/$O@;PAJL.
MIV6G:#8ZWXI\-3/!KNJ'6+[2+"T%E:6<)D:XN/*X_P#@J5^WM\(/@C\4OCU\
M5_AMXK\;^$/%'P9^%OC/X8ZIJ/[-FL?#+PM\+?BS\9?CU\$_@EX*^&]G?GQ)
M-J?QDTR[@^.4/C*TE5--U?5-/^'NKV\5U"^JP!/VJ^`_[!?P,^"'A?Q?HJ:1
M/XNU'XI_`?X$?L__`!?N]>N9YM)\<^#?V?\`P!KOP[\(Q'1/,,.DF?1/%&OK
MJ)LYO-N7O(G,JRVT3CS/1?\`@E9^S!9:'XK\%>*M7^/7Q4^%_B'X;W7PCT/X
M3?%+X]?$7Q7X!^&O@"ZUGP-XD_LGX;6;:O9:WH&J6'B/X;^#=<T'QE>:]JWC
MGPQ?Z-;KX:\2Z19@6H`/S2G_`&R?^"GFEQK\*[O4#H&N?$#X_P#P+\!?#7]I
M#XU_LN/\*=!CT/XF6'Q#3QMX.L?AO)XGFC\4>+O"4WAO1]8T2Z6Y@BO+&6X;
M4C)%'+"UKX4_MF?\%(-$UKP'X_\`C#\4/@WXN^$'@?\`X*'?$K_@G[\6/#_A
MSX-7_A_Q'X_L?"7Q4\9>"-+^.$&J&\+>%-=U%4\-Z9IO@G1K670M0GL?M=IJ
M&IG7(-WZO>'?^"?/P>TC5-"USQ%\0?VC_BEK7AGQOX$\>^']0^+7[0'Q#\>I
MI&L?#JTUVT\.V]AI&K:H?#]M8R'Q#J-WKABTA=1\07HM+C5]1NS9VZIW-G^Q
M7\!]/\,ZMX3LM"U*WTC6?VH]8_;$OHA?PR%_CCKOQ!E^)NI:Z(IK*6S;39_%
MD\MZ^E36LT4BNQFDEN7>Y8`_#OPI_P`%*O\`@H#XYTC0OCOX-\`>/=:^$'Q+
M\-?M'WFJ:!>?LWW.G^#_`-GZV\,>!/B)KGP/\;VGQ-$_]J?$/39/%7A;PWX;
M^(VF:C9&[@E\0W%SHVG7"V36J\_\>?CM_P`%'-0_85\4:O\`%']H3X4:A;_M
M=?\`!)_]H3X_>&KGX??"-O!VJ?"7Q)\.O@3X+^)'BRSL+]M>O+_5IO&_@WQW
MJ&@6FIM=6LGA'Q#Y>NZ+&JVEK;K^PUY_P32_9FM[[Q1>3:U\:M.^'NN-\2]3
MO?@X?CK\0(?@-HFH?%+PWKGAWQEK6E_#.YUE_"^G,MEXBUS5-#LIX9_#_A'Q
M#>GQ+X;TG2M9M+&]M?8$_94_9M\3>%?AK\/+G1+#QAX2^"/P0\4_LYZ'X6O-
M>_MBP_X5+\2/`7A;P)XB\+>+;6&<OJB>(?!7A/1K(W%Z8IYK8W5Q"Q^UL]`'
ME'[(^J?%_P"%O[`OA;XA?%WXHM\=/$.F?`'PW\4_#NL7WA2Q\+:I#X;M?@;X
M4UZU\(Z\NA2W+>(M2M]>L-=FF\42`:OJUKJEL+U);ZV>:;\9/$'Q1_:;M_VB
M_P#@D!^UM^UM^T7\.G^'?CFW_;,^+-KX<T#X8V7@[1O@=9K^P;\=?%5^U[XC
M;47U'QKHNDZ)_9*SKXAA@N6OM&DNLQ?:3''_`$+?`']F+P#^SO\`"6X^"?AS
M7_B9X]\!S1K816?QG^(?B'XJWUAX<A\(>'_`MIX-TS4/%5Q=36'@ZS\.^&[*
M"'P];!+%[Z[UK5[E+C5=<U6\N_D3PA_P1Z_8N\)>(O!WB&33_C7XU7X=?\+1
ML?AYX8^)_P"T/\8_B3X#^'WA7XP?#37OA-XU\!>`O`GC+Q?J_A3P1X,O/!OB
M75;.#2O"NE:1<++_`&:;J^N[;0M#M=.`/P1_:]_;Y_:T^)7[&W[;?PH\2>+O
MB[IWAKQ=_P`$\;3]J_X,?&SQO\'_`(6_!#QMXB\/0^+[?PUKT7AGPU\-O'WC
M"]L/!7C*"XT_5O"^O^)%\(^/M)MY6\S3)8;B*8?HU^T7^U5^WAX`_:`U+]C3
MX1^*/BI\3?'GPT_9ETS]HK5/B[X#_9S^#?BB_P#'7B#QWXR\0>$/`?P^UKP9
MKWCOP+H6A>#M&G\-W#>)M<\,?;_$$C:EIKSRV,&^63[.\!_\$<OV)/`NE>.=
M$GT+XL_$C3/B)\!==_9E\16OQF^.7Q0^+@B^"&MN?L_@/P[)X\\1:U-X2TKP
MO"(;?P:OAB327\-+:6-SIS1ZA9V]Y'M:K_P2E_9=U3P]X1M]>\8_M47GC#P'
M9:QI%C\<V_;`_:(T;X\ZEX%UO6+;7]<^'7C'XQ:%\0M'\7>+_AS<W5FGE>&?
M$^H:E9:)`UPV@-I$\\MPP!^3?QO^.O[>/[9OPL_;\T#7O&L'[(6A?LC_`+%W
MPV3XF_!I/`/A;QIXC^(_QI^//[-%U\7/'6F>.-1U2^U.#PSX9\(:3KVG>&M)
MTWPMJ=U>)KEM<:PNJR)$D4OTQ^V]#XQ?_@@1\/;KP1X^\4_#K5M,_9\_88OY
M]:\%:79:MXGO--77?@;;7.BZ3!>@A;B_EN;=]MO^^OTMVT>3-IJ=T#]<>,/^
M"2O_``3^^,FKZ9XUB\&>+;/2+[X7:%\&_%ND_"C]H+XS>"?`GQH^&G@FQN]*
M\!>&OC'IW@+XAZ99_%>U^'Z7NI#PY=>*+G4;W?>7%KKMSK-C';V=O]H^+/V:
MO@IX\_9UO?V3_&G@BU\3?`+4OAC8?!W4O`.HZEK*07WP]TS0[3P[9:)+K-AJ
M-GXAAEM]+L;2.'5[/5;;6(+F".^@OXKU$G4`_`'XX^`?VSOA[^U-^V_XO\!_
MM<ZUH?CCX'_L%?#;XX:M\49_@]\/"GQBO/`OB;X\^+M&^&/B/0K2-=,T#PMI
MFGVM]IDLFBI:ZQ?0ZC;N+MDLYMV=+^WO_P`%!/VL?B9X^B_9J\(?&K2X?V??
MA?\`LC^)M.\+_!KP9^SOXD\!_$KXG?'7X&Z'\>/$VF_&[Q1\:?BOX#\5^'O!
MRZ?XS\->&=&TWX=:#JD]K:Z1KVM7>HS7NH6.GVW[6?#+]A3]F#X9Z?X]\+6E
MGXY\>^(OB?\`":Y^$OQ6\3?%SXY_%KXL?$OXA?#/43JUM/I_BOQ'XW\<ZSK;
MI(FM:G86FLZ=_9E]8VTRV&F7EI;VUO##SWB__@F-^Q=XRU7POK5S\,?$WA;4
MO"_PV\/?!Q[KX8?&KXY_"*?QG\)_"4,D/A;X>?%.?X7_`!(\(W'Q:\+>'C('
MTFP^)$WB=K55>U$QT^ZOK.Z`/FC_`(+7?$OXI>$O^":GB5?"5OK_`(.\5?&/
MX@?LS_!;QIK'AW6M4TF_^''ACXT?&7X?^#OB#/)XL\-VVHWN@03:5J^H^!?^
M$ET]9)K&Y\26]WI;3:B;"&;R;X%_#"?QC\?_`!M^QOJ_AKX2_L^?$O\`9$O?
MA3^T!I/CG]FKPN]UX`^)?@SXG>'?$W@<Z+XJ\)_$S4?%&M6OBN*UT;5-.U+6
M=2UG4K^ZM'TS4$<."LGZ_?&/X8_`;XB_"'5/@+\</#G@77?@[\2]*MOA7>>`
M/&LUE;Z#XGMKVU,>D^%],CN[JUN'UR)--2^\./HUQ%XBTS4-*MM9T*XM-3TR
MWO;?SG]G;X)?LJ_LW>'-:UKX'W6GVFE_%6\T75];^('BCXT>-?C'X@\>MHE@
M?#_AE+CXI_%GQ[X]\5Z]I&@Z?%-I7AK25\3W&C:)$]Y;Z/96AN+M9`#G_P!E
M+]BKP;^R?<V%UX6\6^(/$TMC^RQ^RW^RNQUJRTFS^U>'?V6=9^/NL>&O%L_]
MF009\0>)C\?=8L];@'_$OMK7PYHJ:=%%ON@W\]_[2/Q5_:C_`&MOV0?C1^V1
MX@^.>K>%?@YX%_X*-_`/X0>&_P!DC5OAOX6\.:.?#'P@_P""CW[/W@/2-:\0
M>/K^:#QEH?BZ\\2:=;>)&\0VNJ6%HGA^6?39(XK>]DNX_P"M>ROK+4K:.\TZ
M\M;^SEWB*ZLKB&ZMI3&[12".>!Y(GV2(\;[6.UU9&PRD#\ZOB%_P2,_X)T_%
M3XG>(?C#X[_9E\.ZUX\\4>+/#WC[6;R+QC\3M&\/S>/_``OKNB^(]'\?V?@3
M0?&^F>`](\>1ZIH%A]O\::/X:L/$VM:;-K.AZUJNH:)XC\0Z=J@!^2NE_MF_
MM<>+/CY\$W^#_P`3/CIJ?[/'[6_[17[1_P"SMX2^+?Q6\-_!FP\$Z1?VFD_%
M7_A%?$'PH\(>'[K4?'%]IGPM\7>#_P"P--U;Q//IR^*[?0[BYN[5H[I&K[2_
M8*_:T_:+_:T^+OP=\,:[XHT#1H?V9/@7\4M`_;L\*Z"VF7\VH?M6VGQI\6_L
M^^"_"E\MP1K?A^"W?X&?&CXEFR:VLII=.U+P1>SQ/I>NZ5+/])Z7_P`$R?\`
M@F[\$/B79?M.Q?!'P7X#\=^"_B+JOQ6T/XB^(OB/\0+?1/`/CKQC=ZO9ZQJG
MA:P\3^/9?!7@6P\2ZCXOU2.]\->']*T?POJFJ:O&\FC37XLWC]8_9(_95/[/
M7B']J7XE^(/$7A_Q9\2?VL_VB==^.?C'6/#'AFV\*Z)I6B0>%?"OP[^&O@K3
M[*TD9=2_X1OP/X,TV\USQ-=QQZIXI\9Z_P"*M?U!II-01Z`/B']J3XO?M)>-
MOVQ_CY\$_AQ^T`_[+_@;]FC]A_1?VA=+U.XT#P]J9^*'CWQEXI\=QKXEU%?$
M.GSS:C\+_AYI_P`.%\/^*K?1A(+74_$$IN;N*ZN+2WC^(_\`@FRGBO\`;,_X
M*#:W^UY\6-3UK1O$VM?L0?L1?&)OASK7A;PU?Z3H]]X^\,^,VO\`2O#L^NZ'
M)KOASPU=:O;GQGH4^CW-G?7,.IV;7-[?0)!*W[E_M+?L%_LB_MA:KX4U[]H[
MX(^'/B3KO@NTO-*T36KC4O$_AK5Y?#6HW,=YJG@CQ%J?@W7?#M[XR^'.KW<2
M76L_#?QA/KO@/6+@&;4_#MU([LWLO@_X&?"+X?\`C37/B%X(^'WAOPIXN\1^
M$/!?@#5M5T*R_LU)?!/PZMKNS\#>%K33+9X](TO1/#%I?7-MI.GZ5864%O;R
M+#L:.*%8P#\O?^"T'@;X=WWP<^`'CW5_"GA"X^(NB_MH_L@:1X4\87VCZ2WC
M#3["]^.'AT:II.BZY+!_;$5C<V4U[)>Z=:W/V9XGGGE@.'<?(7A#]L']I:X^
M"'[#^J:O\9-<N/%?C_\`X+2?'']G+QKJ"'3DN_%OP0\'Z'^V3)I/@>_CDLV>
M;1-,N?`O@.1YX$BNQ/HNF^==XE=)_P!D+S_@G_\`L>:G^TU=_MB:Q\#_``]K
MW[1-WJNA^(1X\\0ZQXM\06-AXK\->$-$\`Z!XVT3P%K7B&^^&_A[Q]I'@OPW
MH7AJQ\>Z%X0T[QE!I&F6UHNN;`V[.M_^"<O[#MK\:G_:)M_V:/AG%\:/^$SE
M^(EMX\73;S^T=*\<W>GWFEZKXKT"Q-\=&\.ZWXALKV5/%=_H.FZ=-XMF@TZ[
M\2MJMYI6ESV8!^`WPS_:A_;2^&OPD_8-_:\\2_M5?$OXPR?M#>,OVN?"/C/X
M(^)]$\(P?#^31?A1X1_:&\4^"8],71=$MM=?Q#:W_P`*]&M'U=[YYKZTO9[:
M6V8QPM7V+^P3XO\`V^/^%G_L_?%_XO>-_'^K?LW_`!R^"?B/Q_\`&#5?CO\`
M%'X+:AX9L=?U+P0GQ+\(>(O@1H?@VWTS5?#7AJ'SKR#4M)O;K4['2O!$,5]>
M3H]A-=U^QVE?LM_L\Z'H?PJ\-:5\(_!MEH'P/\0Z_P"*_A+I$>G%K'P'XB\4
MQ>(8/$6K:#!)*ZP76L0^*_$<5\9?.29-8O5*8EX^1OB'_P`$V/V%=&T+QEI/
M@#X=_"7]G#XF_&CP]\1_A;X0^(OAW3K#2_$_AT_&2:[U3XE:-\(-)NM;TJV\
M,ZCXUMIM8;6=(^'HT)]0M+F\2XMY].%Q:2`'V_J_BSX+_$CX-:QXQU+Q9\/_
M`!I\!?%7@?5-6U;QC;^)-%UKX:Z]\/+O3+B35=6/BC3[Z?0K_P`,3Z2+F2XU
M*WU"2Q>S$K^>8P37\IW[<WP[L?BU\#/VSOV\OA1\.8?V>_V1=`^`_P`'OV=_
MA=:?#W0/^$!MOVE?A#K?[3_PG\0?%[XZ>*O"OAS2-$U+3?AU8>`SXA\->$+F
M]L+2[N/`LGB/7_.?PYJ-G.?ZE--_9O\`@U9_LZVG[*=YX%T+5_@3%\+(_@UJ
M'P]OK)1X?UCX?-X?_P"$9O\`P_?V,#1JUCJFE--!>Q1NGF"XFPP+9KY@^$O_
M``24_P"":GP*\1ZEXK^$_P"Q;\!_!VNZSX4\2>!-:NK/P?#?6^M>"_&.G/I'
MBOPIK.F:Q-J.E:MX?\1Z5))INM:3J-E<V6HV$LMI=0RP2R1L`?S\_P#!5_P[
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M`;3]+T+4+N?2-*MIKE--LK7[5<F6AX2_X)]?L2>`_@]XF_9_\&_LN_!GPW\&
M?&WB;3/&7C;X>:3X+TRTT#QKXGT;6=-U_2=9\8Q1QBX\576G:EH^DFS&OW&H
M0V]CIMCI$<2Z1:PV*`'Q/_P2W\#>!OV:OV=)/VC?CW>?#GX"?%3_`(*"_&G3
MOB3?^&O$EYX:^%^G:?XA^)A&D?`;X"^%]+U1]!M+WQA;>"K+2M,TWPQI-H-<
M\0:Y+J(M=,N;I7)]P_X*<_&5OAQ\,/A!\/=%;XPM\0_V@OCSX&^%?PWLO@W\
M0-*^$>K:MXDF^VZXVE>(OBKK/A_Q39>!O"MQ8Z9<2ZGJ":!J=_>_9X]-L+66
M>Z"-]'?&?]EGP5\</B7^S%X_\57]W%IG[+GCS7OB9X2\"VUCI\GAK6_&E]X.
MO?!7AG5M8M[B.1(QX&L-7UF_\.Q6UNKVNKW5IJ$$UK-IMN6]`^-GP`^!_P"T
MEX*D^''[0'PD^'?QG\!2ZCI^KMX1^)GA'1/&6@#5=*N4N].U&/3==L[VWAO;
M29`8KF%$F\IY;=G:WGFBD`/Y?_V=_C_^U5^TMXN_8K^`?C?]I[XD^%[;Q'^W
M/_P4W_9L^(?C;X2?%#0?&&O>,_AI\#/AIJ/Q/\"Z8?BO;^$=+T[Q5>:#JOAC
M3]#T[Q]I?AG1+J\T;[;+'902ZA,`_P"&?[2_[6?P1;X$_'2U^-'QH_:.\8_%
M/X7?\%2M'\0?"?QGJ>G:QHWC>^_8KTO4M<^!=AX5T'3M'M(M(\;ZSJ%I'HFK
MZS9123^(9=3*W-LQ,2)_2/X(_9-_92^#">$M4^'OP(^#WPQM?A=XD^(GC[P5
M/X7\'>'O"FF^!/$WQ0TZXTOXC^)M!CT^ULM/T&]\3:'<7&BZK>6L=NJ>'W;1
M8#;Z0HM%P?$TW[%W[/Q^&VH^*-.^!7PVDT+2_C)X^^$^KWGA_P`+V-SH&D)H
M+^/?CMXN\$ZPFG27&B6=YX>7_A(OB%K&DW5I'JU@+>;5Y[M3;J0#^8+4/%O[
M>O@W]A6__:XTG]H;6;#0_P!H']EOP=X^\0^.)?VOK+XMZKXM\?\`C'Q/\+Y[
M'QY\%?A->?!+P-+\*X='_M[7](UWPMIVOW\'A?3KQM$UFVFU/3GF7V3]KKXG
M?M)?\$_M7_:2^'?PD_:6^.?Q+MOBK^PM\'OCQ_:/QB\7VGB+7_A)XW\5_M0:
M!\#?B]\;/`&OW6BQVMAH/A?P'XQL?$?B;PQ%;/8^&[K2_"]QIEF?[<G*_M]\
M#?V:O^"8/Q%U;XN_$_X#_L]_LD>)M9^(&JIHWQJU_P`,?"+X>37VOZM</8^-
M&L?&EE<>'4E$^M7-_IGB^]6\LH5\1ZA)8>([TZC?16][']?^*/@I\&O&]Y?:
MCXT^$GPR\7ZAJGP_U7X3:G?^*/`7A77[S4?A7KM_8:KK?PSOKK5M*NY[OX?Z
MQJFEZ9J6J^#+AY/#FH7^G6%Y=Z;-<6=O)&`?R+?%SQQ>_LB?M"?ME_#[]G/]
MJ'6_B7;>+-(_X)@_#+Q]\<OB5^T!HUWXH\!>&OC+\7/B1X3\76MW\:K3POXO
MLOADNOVR66D:1XJ\0Z#>V'@`>-?^$@9HM.TZ!U]P\=^(?VA_AO\`%OX#?LB?
M&7]H/7/@-^S=\>_CO#<>)/$OAO\`;4\._%7XF>#O#EI\'_$7B>W^'>M?&G5O
M`_P\U_P-I7Q%\0Z7I7B;PBL^D7%UJUCIVO0:9K3V["V']&_@C]CC]D3X9Z'X
ML\,?#C]E?]G#X?\`AKQ[X?MO"?CGP]X(^!WPQ\*:'XT\+64E]-9^&O%FDZ#X
M7L+#Q%X?M)M4U.6VT;6+>\TZ"34;YXK9&N[@R9=A^P[^Q5I7PTUKX+Z7^Q_^
MRYIOP=\2:S:>(_$7PGL/V?\`X3V?PTU_Q#8+LL=>UKP);^$H_"^J:S9(`EIJ
ME]I4]];*-L,Z#B@#\X_^"(MOX)L]+_X*<6/PY^*-[\:/!6G_`/!4KXJ:?H'Q
M-U+QUIOQ+U#Q7:6'[+'['MHUY>^.=)9K#Q%=6\\,MA/>PL6$EJT$Q,\4AK\<
M/V>M>TSX2?!3]CKQU\)?VJ_'4_[0_P`6/^"IL7P`US]FRS^,%C?^&-?^"?Q5
M_:;\8>$/B_I,GP8TY+G4]'M_#_P[N=5\9W'C_P"R+<^$;W3T\27-['$%BD_L
M)^&GP?\`A+\%]&U#PY\'?A=\.OA-X>U;58]=U70OAIX)\->!-&U/6X="T3PO
M%K.H:7X6TS2K&]U6+PSX9\-^'8]0N8)+M-"\/Z)I"S#3])L+>W\Z\`_L@?LE
M_"GX@WOQ:^%W[+O[.OPV^*NHVNIV6H?$SP#\$_AIX.^(-_9:W=1WNLVE[XS\
M.^&=.\1W5KJ]Y%%=ZG;SZE)%?W4<=Q=)+*BN`#\A?V+/B'\<?C5^UA\//V<M
M8\<^.+WPM_P38\,_%7PS^T7K>I7M[;ZI\2OC!XB\67^@?`*Q\8ZA!>/_`&W]
MJ^!7]D?$N[M=4A4:AJ6K_P!H*H\E=W.?\%?_`(;>*_VQ?C]X._93\!?"#7/B
M_K'PG_96^+_QVEAT7Q5X1\-OX&^)'Q?DU+X+_`;QD6\730VOVS3)M!^+6HZ3
M>V;1ZI8:EI-O>6%S;-;S25^R_P``?V9_!WP!U_X^>,-%OKK7O&/[1OQCU3XQ
M?$+Q+J5G:6VH7-_-H.A>%?#WAZ-[8&271?"?AOP]8Z=I`NI9IPTM]-NC2Y6W
MA]BTWX?^`]&\8^)_B'H_@GPCI7C_`,;:?H&D^,_'.F^&]&L?&/B[2O"B7T?A
M?3/$_B:ULHM:U_3_``W'J>I1Z!9ZK>W=MHZ:A?+IT=LMW.)`#^3?X<?'CXA_
MM_:UH5]XE^-GQ<\`Q>`?^".NM>-?'W@#X6_$N?0]*L?VL?A)\>_BE\//$FN:
M_J'A^1I-4UGPMKW@3R)88KV&VOW18=22[M8Q"\'B+XS?M+_LY>!],^+GP8^*
M7QK\>_$[]I7_`((W:9^U_P#$.R\3>*-3^(,-C\9K_4/A_)KOQ(\!>%;^RU'3
M_"T7@CPSXS\4ZO9>'O#VE)I[:=H5C;S6TTMJMR?ZO=*^$WPKT&_UC5=#^&?P
M_P!&U3Q#8W^EZ_J6E>#/#FG7^N:9JNJZAKFJ:=K%Y9Z;#<:G8ZEK>K:KK%_:
M7LD]O>:KJ>H:A<1R7=[<S2;.E^"?!FAMHCZ)X1\,:._AGP];^$?#;:7H&E:>
MWA_PG:1P16OAC1&M+2$Z5X>MHK6VCM]%L#;Z;#';P)';*L484`_C<^(?B#Q[
MX"^#'Q;D^&7[<?@;6/#'Q/\``O[,WQ=T_P``_!K]K'Q;\:OB]IGBC6OVD/A]
MH>I_'.+7]7NKC5?`W@[QWX8\8OX4U/P\BV?AS4M3L-/_`+(TA/L6LH/<OV@9
MK;]E_P"/O[3_`.R'>?M'?&/X:?L8ZW\7/^"9E_\`&/Q[XS^-'BB;7?ASX2_:
M7U?]H+PS\5;B+XT^(]2FUGX6^$_B#XH^&WPH\,ZSK<&K:3I'AA-<U6[M[W0X
MM3N;VW_J&T+X&_!3PM9:YIOAGX/_``M\.Z=XGOM.U/Q+8:%\/_">D67B'4M'
M(.D:AKEKI^D6\&K7VED`Z==W\=Q/8D`VTD1%=+K'@#P'XB'B!?$'@GPCK@\6
M:?I^D>*AK'AO1M3'B;2M)DN)M+TSQ`+VRG&LZ?ILMW=2Z?9:C]IMK.2YN'MX
MHVFD+`'\:F@:1\*]-\>_'_X;?LM?'GQSK?P8\7_\%;OV#_AA<?$GX>?';Q!X
MQUKQ-X/\1_L_?$^T\:^&X/C!::WJ]]XBTN[F%QI=\\>LZC%:SP-;P3V]_IL+
MVGMOP<\,:Q\+K3X8?'*W^-?[1<MY\$?^"U_[0G[$FDW6O?&7Q=XG\*V/[,FC
M?M2_$SP#X<\!>+_#WB._NM(\4I]DNK73+?Q!XAED\1+<O:"+5FBMK6R']5VG
M?"OX8:/!!:Z3\./`6EVUKJ.E:O:V^G>#_#UE!;:MH5M+9Z)JD$-MIT4<.HZ/
M:3S6NE7L:K<Z?;32P6DL,4CJ=JW\'>$;2%[>U\*^&[:WD\1W'C&2"WT/3(89
M/%UW?2:G=^*GBCM51O$=UJ4LNH7&N,IU.:^DDNY+IKAVD(!_'%^SKXN^*GQ4
M^(/A;7/'G[6GPI^&?[3=S\4/VP_!O[0WP>\2_M,_$"W_`&GO'_@G5O"WQ6\-
M6/P['[*%[J]I9^!5\#R:/X1^(_@+QAHOA72TTC3_``E;ZK:>(+O1O$-[<7?G
M7CWX<W?A_P#8+_9`\9>%?%_QU\<>,OVU_P#@EU^W]I?QKTKQC\6_B9\0$^(W
MB'PK^RQ9>._!5[9>%[S7[JPMO$NG>,-.MK;2)-#T^&YO]-NKC1;Z'44U&[6X
M_M=/@?P6?$MWXS/A#PN?&&H:*_AN_P#%AT#23XEO?#LDT%Q)H%WKOV3^U+G1
M7N+6VG?2YKI[%IK>"5H"\,;+?M_#GAZT.BFTT'1K4^&]/ETGPZ;?2[&$Z!I<
M\%I;3:;HIC@4Z7I\UM86-O+9V/D6TD%E:1/&8[>%4`/@_P#X)<3?LXS?L4_!
M8_LS>.O!OC_PG'X)\"Q>-M2\%?%F7XP6&D?%1/AMX)_X3'PYJ>N3>+/%[>'=
M>TH'3#J7@H7VGKH'VB`C1;#[83-_*-JW@?Q/^SU^Q;^RQXS\,6NHS_`7_@H!
M\8OV9/"7Q5L[*WGN]-^'7[6'[/O[7WA;X@?#7XB/9P,RZ;I/QR^#'@[Q=\,?
M%^IQV\5LOC3X??"J>_N'N-=F\W^Y_P`,>#O"/@JSO=/\&^%?#?A*PU'5+S7-
M0L?#&AZ9H-G?ZUJ`B%_K%[;:5:VD-UJE\((1>:A.CW=R(8A-,_EIC;MK.TL[
M>&SM+6VM;2W4);VMM!%!;P(N=J0P1*L42KDX5%4#)P*`/X^O#OQ'URX^-WAZ
M_P!0\=^-],_X*GQ_\%AM"\)^)/@KIWC?QK/XE3]A?5OB&]EK=Y/\(M5\0/X=
MNO@`G[.[ZCXNG^(6E^'6T+3?%`LQ'JT'B`Q6DG]47P2_:*^#'[1MG\2M0^"W
MCBU\<V?P?^,?Q!_9_P#B/-::5K^E#PQ\8/A7?VVF>/\`P7.OB#2=)DO[KP[?
M7=O;S:GI*7^A7K2!],U2]C5W7V5K:V>>.Z>W@:YA22.&X:*-IXDFV>:D<Q4R
M(DOEQ^8JL`_EIN!VKB4*JYV@#)+'``RQZDXZD]R>30!^"O[&/QY_9/'_``68
M_P""F7P_^&WQ?^`,OB7XE_";]@W2?"O@[P#XX^']SJ_C7QS\-=(_;,UKXPV>
ME:'X:U*2YUKQ+X#L[FRO?B.L5M/J'ADW^FGQ*;*;4+%9\K_@I-XS^!VE_P#!
M0#]G?PK^WIXVUSP/^P_JW[-7Q!N?![:MX@\<>"_A'XL_:D_X3FW8Z!XH\4>!
MM0TNYN_&5I\-].M[OP1X9U>^C@U*>ZOTT>WO=9GAM9/W]$<8;<(T#<_,$4-S
MUY`SSWYI656QN56P<C<`<'U&0<&@#^#>Z^,OPEN_V5?V7?@S+J>C_#G0/$/P
MO_X*0ZO\-/VAOB3-^T)-K%]J:_MB?&N[\,?#7X5?#SP+JND^)+KX]:A%_8'B
M2>?QE;S^._#6F*TT.F27,FI%/IO2(O@YHOQ-U_XP>)IEM_VR_P!J7_@DU^PO
M\3/V+O$/C/QMX]T?Q'\3/VF=!G_:.^&7C'PQX!M;K7]-TSXC?%"&+6_@GJM_
MX2@AN]3T*TU;1-8ET2P35M2U>?\`LL\N/CY$X)(^5>">I''!/?%+L0E244E/
MNG:,K_NG''X8H`_AGUW6];N_V<_C1XF_9X_:[\+^+O'$?[%_PS\)_M`_`#]E
MG2OVEKCX^:3X<\,_M)?`6?X_?$[XFZEXR\;>+S\,OCAX%^#/B+XS:+XDT:U3
MPUX_U<7D]_X=L+I?"+/#^TG_``3:U[]BSQ+^W;\<M8_87UZU\6?"*3]E7X56
M%SXKT:^^(NM^&-=US1?&-[HS3Z+XD\=F6RU^:WL+"TM=8O/"UW=V0U&.0:I(
M-5:?/[Z"-%)*H@+=2%`)SUR0.<^]"HB_=55XQ\J@<>G`'%`'\ROC?]B?QS^T
MK^W[_P`%-?%/PSU;2_!/Q+\(?M1?L>JOB74KRZLT\1_`#XB?L$_![X;_`!T\
M%SR::MS)<PZSH,.I7FD:=J5N;=?%GAO0]1'D"&&Z/QGX?^('A'X'_!7]GW]G
M7Q1X5^'OPV^$7C_]O_\`X*'>&9OC)\6/`GQ'\5>`/A1J/@?Q];Q>`/AS9>&_
M`%_IEK_PF7Q434KG1?!T'BR!K.XN](C@\-VU]K4P@C_LWP`20`">IQR<<#/K
M@4A1",%5(SG!48SZ].OOUH`_DF_X)K_"+2OVCOBC^S?X;^/%[\4_B)X'\'?!
M_P#;!U3P;;:C=_%?X9>&M<_X1C]MS6X/`&L>(O"VH:]X9\66(TC0!%)X.\+>
M+[;4-1\.:?,VAZC:6JV30KP?AG0?@!XB_P"";?Q>^#WQ0TKQYK__``5+;PO\
M<Y/CIX>\0:?\8)_B]/XK/QF\67>KWCW<MO%I]W\/!I-Y`OPPOO#US+X7_LB3
MP]'X7F-\B[?[%@`.@`Z]`!U.3^9Y/OS1M7.=JY]<#/Y]:`/QH_9Q^$-G^SU_
MP5%\9>`_A7X3U[P7\'?B%_P3S^$7Q!\7:4K^);WPG>?&?0OC?\2?#4NK?:=9
MN;VTM?&5UX6NXE\0A+A=6U6%+&\U03>1;R+O?MC^%?$/[8O[9G[.O[')TC5)
M_P!GCX/'3/VL?VH[Z?2]4B\->+M2\-:N8?@-\(+N_N[*#1M=@U3Q=:S>.]?T
MBRO=3"V/AJPM];T^.WO(]WZ]8&<XYZ9[X]*,#.<#/KW_`#H`\;\!_'+X?_$/
MXH?&WX.^$IM2N?%'[.^H^`?#_P`27?3'MM"TS7OB%X+M/B#H/A[3M2+^7?ZI
M:>#-4\/:YJ]K#"B:;9>)=!S)*]XR0^R5YM\/_A!\./A;J?Q+UKP'X7M=`U?X
MP_$&\^*?Q+U..\U._OO%OCR^T#P_X6FU[4+G5;Z^EB,7ASPIX=T6QTVQ:TT?
M3-.TFUMM-T^TC#A_2:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`_$?_@KW\&_!%]\//%'C[PQ\1/VD8/VU_B%X/G^%G[#?@+X/?'/XD^%9T_:
M`A@EUSP-X@\,?#CPUXHT7PFUAH&O:=9^+?BOXS\2Z;>:=HGP\T7Q#=:M>6^F
M^?;W/QK\5O#GQ7^)LG_!5?QU\4_CE\6=%^,_[!?[*/PDD^"6L^$/B#K7AG0O
M"/Q`\,_`'7OC%XJ\=Q>'/#MWH>@:[KWC/X@^&_[/UO4+VPDTG4M#F;2?[(^R
M,UL_['?'+_@GC\(/CO\`'S1OVE]8^(?[07@7XM^'?!L7@/0-;^%WQ<U;P?8Z
M)X>2_?4KB'2=(2RO[+3KK5;PH^MWEBEO/K4-O;6NI/<VMO#"G!?$#_@E5^SW
M\3M0.J>+O''Q^N;SQ%\-/!WPF^,;:=\6M7TJ/]H7P=X$O!?>';'XU0VELL?B
MR2&22\M+VXC6PGU+2;ZZTJ]EFLY/+H`_#I/B3\;/C5^QU^VK_P`%+]6^*?CG
MPM^TI\!OVUI/"OP>\-67Q,\3:-X>\%?"7X&7GPI\*6?PA3P59Z?'X2UJ?XT6
M^J^*_'<EEX@\(ZI)JT/Q0T2>YO[^^MH]<O,?X<?$;XY^(?VT/AE\;]1^(?Q8
MT+0_&?\`P5<TKP,O[84NM>,=1_9S\;?!74?`/B7P#J7[`4OP:O?%.G7WACQS
M<?&+4_#?PM\(>,;GP+=?#-/$NAZMX\T7Q]<ZU%;^$M<_?7QG_P`$N_V9?&_C
MWQ/XNOY?B;I7A3QWX_\`!?Q:^(/P3\.>/M1T3X*>._BG\/=.\&:/X4\>^)O`
MUI`(+S6[/2_`'A2TOEAN[>RU?^Q=/EU&UGDMP6TM._X)E?LO:5\7K3XM6EI\
M11;6'QI_X:,T_P"$$OQ#UV;X%:?\=459;?XI6/PRD8Z5:^*K/64C\46<\,R6
M=OXJ0:\EE]M:1W`.*_X*'ZQJ7C/X@?L1?LG1:@=-\)?M)_M`7=]\50(Y3_PD
M7PQ^!GAB?XEZIX%:5+2Y2.W\6>*(/!\.IQ22V'V[1++5+`WGDW,]I=^4^$?V
MS?VP?BKKO[6WQF^&&@?LV>'/V1OV-?CK\9/@3K7P_P#'.B?$?4_V@_B^G[,F
MGZE!\;?&OAWXA^'/'EGX"^%44OB>S?P_\,/!WB+X2^.;GQ#IVE7/BC7?$OA_
M3=;T2"OL7]L?]G_QA\8+'X*_$+X4G2!\:?V<?C+X;^*_P]M_$.N7GAOP_P"(
M;&6*Y\*?$/P;KFM6.DZ]<:?8^)/`>N:TMK<C1=4C@UVQT6>:TDBB9DY6]_X)
MR_L^7WQ;\<_%Z"[^*OAIOBOXWM/B;\6/A1X5^)VO:)\$_B/\0(O#-GX2U#Q-
MXR^'M@L&FZWJ.NZ'865EXF=Y(+?Q)]BMY]6MKB9-U`'XE?M.?\%"OVLO&W[&
M?Q`T']H'PA\$M*\#?MZ?\$N_VW?VAOV?-3^"$?C?2?&WP<U/X/?#GPIK=[\.
M_BGJ7B?QOXETKQY-=^#?B=INH6WQ&\$6/@6.#Q-IK:3'X(EL+R36=,;\$?VK
M/C#\`_B]^T3X1^#/AS3/%/Q&^.OQP_8[^'6E:WXO\)_$CXH>&_AMX<LOV.[+
MQAXO\;S_``P^%USIWCGXBWUG9:4MMI7@K0?$G@]M9U/4$N=1\4Z+I=EJ&HP?
MK?I?_!(7]C;3O#_BWPK<Z1\2O$'AWQ!\$OB9^SGX9T?Q+\3?$6M:?\(/@Q\7
MPB^/_`WP9M;E_)\`Z=KL<%E!+<6*3W\=KINFV278L[&W@3M]?_X)C?LKZ_9>
M-(7TKQYI&K^,_&GPO^(H\7^'?'VN:'XS\(^-_A!X#D^&O@GQ'X%\16+1WOAJ
M_MO!\]WI.I+;&2VUB*]NQJ%O.DS)0!\'^&?^"B?[=GC'XF_!;]CQ_AK\(?A+
M^U!\5OBC\>+"Q^,?QB^`W[1/A7X+>*/@+\"_!'@_QE<_%OX?_`'Q-X_\$?$Z
M^U;Q;>^,(_!5OX4U3XVPV?A_6M`UW5W\1:]HRV!O/F/XF>*OV]]0^./_``5Z
M\,?&;X@?LY>*_AY\._V#/V9_%?Q0^!'A_P"'?Q]UOPOX@MO&'PN_:H&M:5\&
M_$\'[2WPKUGX=ZYKGB#PBMGXK\2W6F7]]XJ\.'PT;$^#-7\)M=:_^O\`J?\`
MP3#_`&>-:^'V@>"=7\5_M`:GKWA7XB^)OBEX;^,M[\;_`!C/\<]#\6>,/#]K
MX4\1'2OB2T_]J6&AZEX:LK;1I_#5K#%H)MHS+_9_VR22Z>AK/_!*W]E[5_$=
MMXH34?C9H^J7'P3\._L_^-3H_P`9?%]O#\6/ASX2M/$EEX9M/BPMQ<W<OCC6
M-$A\6Z]]@US4IAJ$3W\K-(X9PP!\/^'/^"C/QK^'GP"\,?"GPE\-/A2?VB/&
MW_#&?@']C#X?QQ^-=4\+ZAX!^/GPQ\+:]'XP^)-MJ7Q!D\4ZYHWP;\/:/\1-
M1\77FB^-;&35D\+Z9I,VLV-]J-UKU;GP9_X*/?M:?'_X@Z#\1/A]\*X]9_9Q
MUS]IWQW^S^_PGLOV4?C_`*AX^M/ASX"^(7B3X5:[\<=8_:LN/'NF_`W3M4C\
M3>"]:UR^^%4_PT6/P_X:O[30K_QIJOBA#-7Z1:5^P;^S3I'QG^!7Q]M_!EY-
M\3?V</@M;_`3X4ZU=ZYJ-Q#H_@&TLXM/LQ?V+2BWUKQ!9Z>EQ86GB#4A/J%M
M::AJ<,+HM]/NY1?^"<G[.%K\<)/CKH?_``M'PIK%]X]U3XJ:[X`\)?%7QAX>
M^$'B?XF:W<B^UGQUXB^'.FW\.BZCXBU;45&IZI<XB@U#43)>WEM///</*`?B
M=_P3_P#^"@>M?L9?LL_!*T^/;>&K7]GCQ[^RY^T3\0_@;XO:+43XIU;]HWX%
M?&;XAZM\1_@SKMR^K72:C=^-?ACXD\&>*_AC9V&F65W?0>!?B?:JUQ-I,'VG
M[:_X*@^/_P!J&+_@A=\?OBM>^*]/^"W[1'_#-FG?$'QM=^'=%U.:Y\*W5_<Z
M3KFO>#?"D]EXKT6[\/Z[9V-VGA>'Q9-=ZP;%X+S4&T*ZNIXEM/2/CK_P2Z\%
M^.-`_P""?_[./@3PEX*'[)W[,G[1-]\?_B79^.=3U37/'E_-X5T'Q7>^"?"7
MACS;">#4]/\`&WCWQC=3_$2YU+4M.V^&M+&E06^HPZM<0P_I[\6_A1\/OCI\
M,O'?P<^*WAFP\9?#?XE>&-6\'^-/"^IJ[6.M^'];M7L]0L9S$\<L?F12%HYH
M9(YH)ECFB=)(U8`'\^'QXC_X*1?"?]I?XX>-O!7[5G[.VI?%#X+?L%:I\9?'
MGB#5_P!DOQ9;^#OB3X?\#^,/$7B72?AMX=^&\/[2>J7?@.754TF73]:\;R^/
M/%FJ2+<;M,T>P;RS;R-_P4^_;'_:8\:>+;+]F"U\._#BQ^"G[.'[*WQLU3PC
M:_LQ?%O]J"_^/WCO]H?X?W7Q7N_!,'C?PGXD\%:!\'/AOIOANWM?"&B^+KVT
MU[6;_P`87&M:E-<+IWAB]T:7]B_AE^PQ\!?A7HOB?1](M?&_B.X\9?#'5?@]
MXG\2>/O'OB/QMXLUCP!J\ES)<Z)=^(-<N[F^=8A=R16LP82P1A0K%][OP?B;
M_@F1^R#XDN/`5[#X&U_PAJ'P]^%6D?!#3-1^'WCOQ;X&O];^%?AX$>'O!OC*
MY\-ZK8/XMTS0$EOX]%;6OM-WID6K:K%9W,4=XZ``[SX^_`#1_P!MO]GKX>:3
MXOCUOX3^+K/Q/\#?VB/`NIK%:ZOXF^$'Q=^''B#P]\2/#<KPQ75E9:I<Z1J%
MK>>$_$5M'>6UMJVC:CK=E%<0I>+*G\_G[3'[&LWP7_;?_8__`&9/@Y^R?\+_
M`-NGX=Z)^S[^V!X^\*?`KX]_%RU^#'@GX>Z/XU^/GASQQ;P:1K5[\-_B_9ZJ
M?!.I>*=6T?PO!)X<LKJWT*>"T2\A%JQN/ZM-&T?3?#VCZ5H&C6D=AH^AZ;8Z
M/I5C$7:*RTW3+6*RL;2)I7DD:.VM8(H4,CNY5`7=FR3\;?M0_P#!/C]FK]K_
M`,:>!_B)\9-&\;-XU^'?AW7?"GA7Q)X$^)7C;X;ZM9>'_$E_8:GK.ES7W@O6
M-'N;RTO+W3+*=X;F62,-"N%ZT`?C#\5OV@?VX/V7O[&^`/P#^'O[,_[`NE_"
M?]@']HW]MWQI\!M/T&?]J_PE:ZQX"_:=TS1H?!W@OQ]I][^SY%I]I\1]#\8-
MKNJ:@?"DMOX0O-<U'3[+1=6NM-M-2?>^+/\`P4!_X*$_`CX4_''Q;XJ\=_`?
MXG^+_&__``3-UW_@H%^S_H'@/X&>*?`,?P<OO!U]X:'CGPAXAGU_XA_$>Q^*
MO@WPGX=\8:+XDNM8U#4/"/B74%M-6LDTW3[9[75(?UD\'?\`!-/]DOP5I6I:
M58>#O$^M'6?@O\0OV?M7U;QG\0O&?C7Q#J?PK^*'C#2O'/B_PW>Z]XHUC5-4
MEBO=?T32I;67[2&T^VL8;6T$<>_?B?M??L!^"_CG^S9\6_AE\,8-,\%?%37O
MV*?BI^QA\+/&VK3ZI<Z=X4^'/Q$\-V.C7/A[4+6VG#W.EWSZ)HL&HW@CEU&*
MVMV>V<,TB2@'XC?\%`_VC_VL=#\!_M>?L=?M'_$GX:?'S1M>_9G_`&<OVB?"
M7C_X8_")/A+<_#[6;W]J3X8:)KO@;Q9X>3XH_$=X?#]]!<6MUX,U'4]1O=;U
M%K6ZCGO)H[>6YG^B_$'_``4;_;`TKPG\9OVG/#>J?":7X'_LZ_\`!023]@^_
M_9AL_!;7/Q)\6^"-!\1^$?A5JGQ7N?BAK/C*P?3OBI?^+/%\OQ!\+>"]+\+W
M/A>\^&ND^%].:SU37M=U34H_TS^&W_!+O]C?X=?#KXC_``_M_A7#K$7QH/@R
M7XNZQKWB7Q=XFUSQBO@77=)\4^&M"?7_`!1KFL:_:>#]!\0:1!=:'X;CU+[)
M8V[/;9DWLY[76_\`@G=^R!XB^/=O^TEJWPATZY^)L6L:'XHN&&L:_#X.U7QK
MX9L-.TKP]X^USP!#J<?@W6?'6C:7I&DZ?8^*=2T:XU9+;3+$/<22VT4B@'Y0
MZQ_P5!_:>A\*S?LZ!/!MG^W-\&?'?[5&O?M-+I'A+^T_"/@G]G+]FKX:>*?B
M%X7^(]WIU[>BUM4^.>L>(?V??!7ARYL#<6TA\<^+;K3C:WGA:Y%OSGP>^-G_
M``52^+WB3]EOX6ZA^VI\'/#&L?MO_L*6'[5FD>.?#W[+/A[^V?@/XIL]/\':
MU'X1\$>'=;UOQ/X;\8:-X@L/%UA;>)/$'Q)FO9M+NK35)/"WA^8:C80>'_U$
M^&'[$,"_M4?MQ_M(_&NR\&>*I_VH-!\#_!;PUH^E6;J]G^SUX*\'R:._A[Q1
M>&VL[JYUKQ-KFL^(;K6/*N)X4TU-&M8+@?8QM^H/#7[-/P1\'ZS\&_$/ASP%
MI6EZW\`/AC)\&OA+J<#W7VKPE\,Y-+T31F\)6CM.1<::+#P[H\2K=K/(C6:2
MI()&=F`/YLOAQ_P4F_X*.?MJZ7X8M/@7K>K?"/Q/\+/V+OV=OCGX\C^%_P``
M/A9\7;+XV?&?XRZ5X_NKJW\13_%_Q[X:'PW^"$5Q\/?LD4'@B&3Q=8ZIKFII
M=^.A;:%9P:GK?'/]O/\`X*5:18?MI_&[3OC3X(^#6C_L.^!?V,OB)KO[-*?!
MOX>_$K3OB!KGQH^&OPRUCXI^`=<^,%QJ$>M:7X635=0\27GAC4?"EK_PD.DZ
MIK)FN/$FN:#I^G^'HOV\US_@F7^P]XBT/X>>'M0^`^B06/PM^'MO\)O!TNA>
M(/&7A74K3X96VHRZNO@/4M4\+>(M&O\`7O"KZI<7=^VCZW<7]FEU?7TT$<+W
MER9/1Y?V(?V3I_"7Q+\!R_`OP0W@_P",7A[P'X4^)WA_[-?+I_C/P[\,-)T[
M0O`&DZPBWRN]KX7TC2=.L=-$#PR"&TB,[S/N=@#\LO\`@FUX!_:,M/V[/^"E
M>N^+?VR_$WBOX>>'OVO=>TVY^!.M_"SX565CKZ^(/AEX)UOPOJ]CXJLM-MO&
MOA^+PEI%U;^'+&QT.[CT;7H=(EUC6;6[UF]O;JOB?_@LKXVU_P#:&_;$U3X>
M?#C0/C]XEU#_`()N?`G3_P!H'PW>?!+X,_$[XJ:+!^V)\1=8TK7_`(8^$O'F
MJ^`-#UO3O!Z:=\%O#7BC6[FX\7K9:/<:5XZLVBN$N0U[IG](,'[(_P"SE:_'
MJ^_:>M/A9HEG\>-3M;:SU3XB6=[KMIJ6J0V6GR:39G4]-M]6BT#4+BUTV62R
MM[R\TF>[AMV,<<ZC&.W\%?`[X3?#OQ'\6?%W@SP/HVB>)/CKXEMO&'Q=U>(7
M5W=>/O$=EH%EX6L]2U[^T+F[CF:U\-Z=8:';6T,<-G!I=I;V<5NL,2(`#^=[
MXY_M^?M'?%WX/?MC?M1_L\_MR^%?V?\`P7^S'^S#X`^(OPO^#%G\*/@QXRUC
MXU>+?%7[/'A[XVZCXP\5:M\6-!U/Q+I^@77B/Q!J?PH\->'?!EK8FW\1^!];
MU+4+[6'>3PY%4\>?MV_MX^&_"W[?W[1>G_'W3I_AY^R#X6_9YT_PQ\$;/X!?
M#O6+C7O%'Q\^&'@.+4O'?B?QW)>Z-J[^%/AOK_C27XDR^$K"'0YM2CT&_P!,
MU+QQ8^&[I;+3?J7]K7_@C7IOQW:^^''PJTS]DKX1_`;6?`NF?#B0:A^SUJ?B
M[XX>"O#-YK&KZCXU'PZ\?S^.+30],U&]CU_69?!MWK/AG5_^$)U6[34=+0-;
M6\<?ZR>$?V8O@-X)T;X@:#H?PS\-G3OBSH^@:%\4X=4M/[83XB:=X9\)V_@;
M2(?%T&I-<VNJB#PK;1:1('MTCGMPWG1NS%J`/YU?B%^W?_P4?_9G\`_$OQ=J
M^J?'/XN_#_Q)\,/@_IOA'XE_&CX1_L=:5XY^$OQ?\8_%/1?A]XH\4Z/X%_9\
M\0^&/"WB7X<2:#K5QXITB3QMJ.M:;X;U6#0]'\1>)-0M#J\]SH2_M9_\%,D\
M4?"CX*S?&+XC?#G1_C+^WY\`/@QX'^.OQP^$'['.N_&34?@Y\3_V5/VEO&OQ
M+\-W_@;X$:]>_#.SU+PQ\3/@]H^M>`O&%QX3\.71M=0LK?4)/'FF6OB#13^Y
M/PL_X)[?L6_!6#QQ:_#7]G?P#X>L_B3X6N/`_C:PG@U3Q!I^N^#+N^;4KGPI
M+8>)M2UFSL_#L^H$7LFCZ=!9V#74<,Y@\R"%H[_PW_8*_8\^$-AX:TSX;_`'
MP+X5M/!WQ'TSXN^&19P:E<7&C?$G1='\2^'M'\6VE[J&HWEZ-2TK0?&/B?1M
M.$EQ):V>F:U>V5O;QV[K&H!^(WPZ_:M_;R^'/QF\'67Q%_:Q_P"%P>$O`7_!
M4#3?^">7BKP+J7P6^&?A.7XE?#OQM\._%OC3PU\2_&GB31O!^D:KI?Q1\,7%
MGI41N?A^OAGPEXDLK1EU/PY#-<O<2?/7PP_;X_X*:?%#X+Z;^UUH>O?&?2=&
M^(>B?M!>(?'_`(0^(TO_``3W\+_L\_"OP?X8\*_%B]\$Z%\&_"VA>.==_:[N
MOBA\,]>L-!TG5X_'"7NK>-M0T35G\3^&+2VL;>TT_P#J!E_9@_9_GU5M;F^%
M/A.75G^,]M^T1)?R6<KSR?&VST&]\,6GQ(D9IR'\1VN@:A>:9;SN#!#;SL8[
M=9%21?+)O^">7[$D_P`0_$7Q6E_9H^%S>/O%<.O0Z_KO]B.HOW\4+J2>([[^
MR4N5T2UU?7$UC5%U36[+3;;5[T7]UY]\_FMD`_!WQ!XK_;<D^'GP1T_Q;^V?
M\7/C';_\%&?^":W[6OQ`\9^&M6\#?!SPO:?"KXG_``>^&?P:\6^"-1^`3>"O
MA"J>%O[3TCXA^+-!\4:=XK'CBY\1PQKXA%I>:S80ZGX?^MOV5?\`@G3\!OVP
M_P!B#]G'Q#\=OCE\7?VD9/$?[)'A3X:V^KZUXM^'D4O@KP)X_P!/^'WB+QW\
M//#]_P##OX9>`)X]-U2/PC9^!]2F\16NJ>))/![ZGH=SK=X][<:G<?L[_P`*
M'^#GG?#2X/PX\*M+\'/#WB+PG\+F;38V'@CPUXMT*R\,^)=$T%&)2UT[6_#^
MG6.D:A;E72XLK:*%N%YE^$?P.^$7P%T"\\*_!OX?>&OAQX;O]2EU>ZT3PM8+
MIVFR:A,BQO.EJC-'"!&B1Q00".W@C41P11H-M`'Y%?&KP#_PK#]OKXQ^%?@M
M\5M._9AB_:1_X)W^*/$WC;XDZ=H&F7^A?"#Q7\`O&6@^'O!7QAN?#<NK:!IM
MW>Z7X.\3ZKH]V;W5M#@N]'T>PAFOI%TRV-M^N7P(O%U#X+?"J]7XH6?QM6Z\
M`>%9A\8-.MK:RL/B=OT:T)\=6=I9:AJMI;6_B<YU>*"VU/4((DN@D=Y<*!*W
MPE\0_P#@F\_QMN?VS->^+_QEUJ_\7_M8^%M#^"^G:WX.T6U\.K\)_P!F[PWX
MF&NV_P`,O#B33WT]_J7BR*;41XY\27TYDU&]OP^G6NGVEG:VT?Z3^%O#6C^#
M?#/A[PCX>LX-/T+PQHNE^']'L;:**""TTS2+*&PLK>*&%(XHTBMX(T"QHJ#'
M"@<4`;U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%0/=6L=S#9O<P)=W$<TUO:O-&MS/#;&);B6&`L)98X&G@$TB*RQ&:(.5,
MB9GH`****`"BBH+JZM;&WFN[VY@L[2W0R3W-U-';V\$:_>DFFE9(XT'=W95'
M<T`3T4@(8!E(*D`@@@@@C(((X((Y!'!%+0`4454N[^QL!";Z]M+(7$Z6UN;N
MYAMA/<R<1V\)F=!+/(00D2;I'Q\JF@"W169K&MZ-X=TZXU?Q!J^F:%I-J81=
M:IK%_:Z9IUL;B>.V@%Q>WLL%M"9[B:*WA$DJ^9/+'$FZ1U4Z=`!13!)&7>(.
MAD149XPRET60N(V=`=RJYC<(2`&*.%)VG#Z`"BN/UGX@^!/#GB3PWX.U_P`9
M>&-%\6^,GNH_"?AG5-<TVQU[Q(]E#)<7:Z)I5S<QWVI&WABEDF^R02A%C<MC
M8V.PH`**IW.H6%F+@W5Y;6_V6SEU"Y$LT:/#80!C->2(6WK;1[6#S%?+4J06
MR,5G^&O$OA_QCH.E^*/"FLZ;XA\.ZW:I?:1K>D7<-]INI6<A8)<V=W`SPSQ,
MRLH=&(W*RG!!``-RBBB@`HHHH`****`"BN&\:?$WX??#F?PC:^._&&@>$[CQ
M]XILO!'@N'7-1@L)/$_B_4;:[N[#PYHRS,IO=6N[6QO)X+.'=+)%;3,HPAKJ
MKC5-,M+W3]-N]1L+74=6:X32K"XO+>&]U-[.W>[NTT^UDD6>\:UM8Y+FX6VC
MD,%NCS2A8U9@`7Z*X;X?_$WX??%;1K_Q#\-O&&@>-M#TOQ'XB\(:CJOAS48-
M3L;+Q1X2U2?1/$V@W$]NS)'J>AZO:W&G:E:L1):W<,D,@#*17<T`%%>)?%_]
MI/X`?L_/H2?&_P",?PZ^%#>)UOV\.CQ[XJTGPS_;2Z4;4:D=-.J7-N+O[";Z
MS%SY)8P_:8=^-ZYZ3X6?&/X4_'#PTWC+X/?$/PA\3/"BWUQIC>(O!6NZ?XAT
M<:C:;/M5D;_39I[<7-OYB>=#OWIO7<!D4`>DT45QWQ`^(7@?X4^#=?\`B'\2
M?%6B>"?`_A:S74/$?BKQ'?0Z9HFBV3W$-HMUJ-_<,L-M`US<00"21@IDE1<Y
M84`=C15>TN[:_M+6^LIX[JSO;>&[M+F%@\-Q;7,:S03Q..'CEB=)$8<,K`C@
MU8H`****`"BBN:T7QEX4\1ZOXIT#0?$6CZQK?@?4[/1O&&E:=?V]U?\`AG5M
M0TJSURQT[6[:)VETZ\N]'U"QU.W@N5CDELKNWN$4QRHQ`.EHKQKXH?M#_`SX
M*>)/A9X/^+?Q7\#?#KQ3\</%R^`OA#H'BWQ!8:-JGQ&\9L;0+X:\)6EW+'+K
M&KYOK(&TM5>0&Z@!`,J9]EH`****`"BBB@`HHK'\0^(-$\)Z!K?BGQ-JEEH?
MASPWI.HZ]K^M:E.EKIVD:-I%I-?ZGJ=_<R$1V]G865O/=7,[D)%#$\C$*I-`
M&Q17/>$?%GAGQ]X4\,>.O!>N:;XG\'>-/#VB^+/"?B71KJ.^T?Q#X9\1Z;;:
MQH.N:5>PEHKS3=6TN\M;^QNHF,=Q:W$4J$JX-=#0`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5R7C[QIHGPX\#^,
M?B#XENH;+P]X(\,:[XLUNZGGCMHH-+\/Z9=:K?.\\Q$46+>UD"LYQN('.<'K
M:\!_:B_9^T/]J?X#_$3]G_Q3XD\1>%?"OQ0T=/#GBG4_"D\=KKLOAZ6]MKC5
MM+L[N0-]D75[2"33;F=`9$M;F8(#N((!_+Y^Q?\`\%`OBIXS^$G_``5&\)>.
MOCYI_B[QE\3?V0O%/_!1/]G4Z)\4-*\4>(OA5X.\8^&_$W@OQS\-;=?"T][K
M'@RZ^$WC31/!NJ+I/V1=0TQ_B%87BV<4%WIUSJ/JG[*7[4/Q^\/>+O\`@F?^
MR-\8/B9XTU+X@V'QU\*^.+7Q+XHU3SO$GQ[_`&7_`(S_`+)?Q5^)G@2_\0ZC
M82OIOB6Z\!^-(K[P7XJECN+U?[5\-:'=,L!EC:3]G?V@O^":7P"^/MQ\&KB<
MZK\/9/@O\+?CQ\&-&E\#VNCV$VN?#G]H#X.#X/\`BKP]XA6:QDLM2@TZUL/#
M/BO1VN[&X-MXD\+:7(H2TEO[>ZVM8_X)U?`77/&_["7Q(U"3Q1+XW_X)]Z,?
M#WP>\1G4K<ZGK^BM\+KCX5/I_CVX:T:37;<Z1=3ZP%C:T*:_++?*0)9(F`/P
M-_9S\%_%#X3?\$COV>O^"G_@[]K/]I2+X_IX+^'GQ+^)FA>/_BMK_P`1?A;\
M7=-U3XD6V@>(?`%Y\.O$<MUINEQ:UI]RITR?P['#JEE?VT+VJSAG@?\`8[_@
MJ#X_\=_#'X)?LQ_M5^#M?UCPYH/P#_:R_9S^)7QKTO3+^YL$\3_`'QOJD_PL
M^*/AW6+9K=DOM*TFR^)&G>.;B"]-D+.X\%6NI-,YL7TZ^ROA-_P1M_9V^&OA
MCX*?#WQ!\6OVF?C+\(/@!%H3?#CX$_%3XC^'K[X)Z?J'AK47UK0-1U7P+X5\
M"^%/^$JFT/6Y)-5T>/QCJOB*.SNA`[_:&M8&3]&OC?\`!GP-^T)\&?B=\!OB
M/:7US\//BYX#\2_#CQA9Z/?RZ/J,OAGQ7I%SHNJPZ;J5L#-IMW]ANI1:7<*E
M[:4)(BDH!0!_,#X\_;S^.NG>#_\`@K$-/\5^+9-6_:<74O!G_!/ZTU)KJQGM
M_$'BCXG0_L/:18?"Z&S2UU^?6=$^(]_/X^N;?3;&^U?9;KKNE:;KEO`+>X[#
MX8_M`_M2_L\?M&_\%=/@5\*?V7/VB/VP?!?PJ7]G#P'I?Q#TGXX?!SPM:_"[
M3=#_`&%OAO"OVC3?C!\3_">JSZEJE]+JOC+6+GP5H\[7>J37ES>RSZC<6J#]
M=$_X)._LE)9_L/62V/C[9^P!J>HZK\$YSXKMS?:]<ZG<VFJSQ_%;4/[%^V>.
MK-/$UC:>,H;.2;3+=?%T$>N/')<J,>_^!/V-/@]\._BA^V#\7/#[^*CXK_;?
MO?!-_P#&H7VK6$^G)<>`?AA%\)-"_P"$0ABT>WN]&B/A.&,W<5_?:RCZIYE[
M;"U266W<`_DP^&GC?]H3XI?'W_@G1X>N?A9^U1^UWHGC;_@A3\._B;XK^"GP
MJ_:!\/\`P9U&Q^(NG_M"77AR_P#C'XA\=?$3XB^`O"/BS5+;0O'$_@;6=-TO
MQ!J7B=/[=T/5I[*73%M+ZUZS]K7Q#\,?@[\?_BMI'Q?^$7[?WA6/X;_\$]?A
M1J7P<\$_"/QI\1OB._[.?Q3\7>(OBGIA\0_'3XL>`O'D_P`)?"EI_;5[X>8_
M$;XB^-8O"7DZ;>,FM-%I<Z)^]GB#_@CM^S[?7OP#U?P/\9_VKO@IX@_9S_9R
MA_96\#>)O@S\6="\'>(M3^#T?B;3_%[Z)XPU67P%JUQKT]QK^D:1?RR`V5FD
MVFV\EM802O=27'TU\(OV&/A#\*/%/BOQK>Z]\1_C#XG\??!#PG^S[X_U7XX>
M(M*^(#^.OA[X0U+Q9J-G#XMMI?#NFV>MZEJ8\::SINOS7=LUAJNDFVL9=-2.
M.4S`'\[WQ7\#?M)?$+]H[]E_X8?M&?`_X[_MW?%;PG_P3/\`A;XC^*?AC]F[
M]I[P9\!-,TCXK7WB[2=-\9?$6]U3Q)\8OAMX=\;1W]XAT"75M%DU,ZG>,=9M
M8-.TZ]2V1?\`@J-\<-$^$?A#]A3]CK0/BI>?L/:G\,_@3\3?V\_'_@KXJ_M-
M>#;+XB:3JOPST2;P_P#`;X`Z]XSO_B#<6?Q>U#QY\9O$?B5;WP_X>\5:]!XF
MLOA9K$NE?VGI-A?7VE?KC'_P1F^!NC2^!I/A[^TA^VM\(T^&G@OQ!\,?`D/P
MP^-GA_PT/#GPLUWQ:GC.U^&=K<O\.+^_N_!OA758K:V\(V&IW=]>:-I%I9Z9
M]ON+>U@$?T_^S=^P5\)?V:_&OQH^).E^,_C%\6?B'\?/!WPG\`_$;QK\</&]
MKXX\1W_A3X-Z'XFT+PGI-AJ-EH'AY].AN8_%^OZEKYB5FU75[U;TF`6UM%$`
M?D'^U!'XH_:=^(/P9_:Z\5?`_P#:G_:V_8)^*_[-7PXUOPAX6_8T^*\FC>.?
M@5\0[\:OKOC#Q)XF^$^C^.?`OB/XI0^(K;4]$T.&Y\*:OK]_X=;PWK$9T>::
M6RCU#[TO/B?X4\0?\$;/B1\4/V+/BCXFUKPOIO[(/QJU+X0_$CXM)XTU/QUI
MP\$>&/&ECJ5OXN;6+SP_XT/CWP=J&@ZUX9:^U.]6\L?%6BPWUX^KVUO(M]G6
M'_!&;]GKPO9:'IWPQ^//[:_P:T[1K'5M&GT_X5?M(ZWX7T_7?#VJ:]?Z_#X?
MUFP?1-0LVLM#FU.^T_P_?:7!I>O:9I,YLTUEV2*9/O[P5^S1\%OAY^SW'^RU
MX0\&V^D_!%?!'B7X?2^$#>ZA?_;?#OC.+5U\7#4M5U*ZO-5U/4_$USK^MZEK
MNKW]Y<:CJ>JZK?:A=7$ES<2.0#^=^P\2_P#!0;5O&W_!*K7-"^,?P#3XPZ[_
M`,$_OVR_'T?B[7/AU\2M3\*3>!M.\/?L+ZS8Q>+?"EU\5+F[\5_%&ZUM]8M;
MSQ<FN:1H-M8:XUU9>%TN;2XCU/K8/^"O_P"T[\<-(^!'AOX.Z!I?PX\=W_[,
M?A#]HGXT:QH7['O[8O[:=E?>)O%/B_QGX0T'X6^&_"_[,W@CQ+=>`_#>MKX'
MU;6K_P"('CW5+.X1[O3]&\,Z;JL^G>(9[3]9?@!_P39^!?[/<_@6YT;QC\<?
MB-/\+O"GQ?\`A]\-)_B_\2I/'%QX%^''QJTOX0:1XH^'N@7)T?3+E/"FEVOP
M3\)/X7M+Z:^O=)N;WQ'/+?WKZLOV3,N_^"7G[-D'A[X-Z-X(U?XR_"76/@=X
M1?X<>$O'GPH^*&K>#?'>I?"^X\83>.;[X:>+=9MK:XM?$/A"]\17-S>&"XTV
M+5M/^UWAT75M+EO;N:8`@_:=_:T^,_PG_P""9&L?MB>'?AM#X5^.-M\"?A1\
M3;CX4?$72-<L%\&^+O'#>!V\3^#O&.BS?8O$FF7/@]_$>K:;K%G-`VM:9=Z5
M,LNF7M];-IMQ\.>._P!O7]J;]G7Q!\7_`(._M3_'C]F_P;XUUK]G+X>_M1?!
MKXN>"O@7\3M=\,^#=.\2_&*'X1>(_@Y<?"33O%/B[Q[\7O%LNM>(?`MM\-/[
M"FTKQ#XNU+6M0TX:+<3VFZW_`$/_`&XOV5=5^-__``3R^-G[(/PO@M]6U7Q1
M\#8/A5X$C^(/B75[V*[FT:TTFRT&;Q=XKOKFZUW4YMNDVUQJ^LWUY<:IJERL
MUS>7,US<RRMP&C?\$I_V7;KX7>,_`OQ"MOBC\0M=^)>A_"33O%7C_P`:_&+Q
MYXE^(_A\_!B6'5_A[I_PZ\=WFK#6_`VD>#_%9N_%.E:?X=FLK2Z\27=SK^K1
M:CJ=Q)<D`_,[P7_P5)_;A\6Z1\4/AEX8\-^#9?C+X8_:L_9`^#7P[\4?'_X#
M?$_]G5]9\(?M2:7)JIO?B7\%]:UFZ\:^'9_#B*\FFS6K:!?Z_I:VK2V&CW-R
M]U'\K_%K6OV^_!WAK_@MKKOQD_:-^%?Q;\,?!3X=_#V3XC^`H?A/XG\,Z'XU
M?4/A'J>H:#9_#N1?B3?W7POT:WDFCE\1Q6<FJWNO7T)N!?6>0B_T!?"[_@F)
M^RS\)]7UOQ'HUG\3/$WBGQ+\6_A3\</$/BOXC?%7QC\0O$^L_$?X+1RP^`=8
MO]<\4ZAJ.H26^EQ3/&^EK,FG/%LABMX(42-;OQ\_X)J_LR_M'>./'_CWQ_;_
M`!(L=1^+'@VQ\!_%71O!GQ*\2^$_"'Q*\.:5HVO:#I-KXW\*Z;<#1O$$NEZ=
MXDU-;*>]MG:.Y^PWCB2[TS3YK8`_+_Q9_P`%-_VM9?'7C^?X%_#CQMX[T#X0
M?M)^$_V>+7X$>%?V'/VP/B98^,_!_A]O!GA_XG?$'5?VL_`_P]UGX)>%M=M-
M5U[Q#KNF:')XBALO#?A30-'M/%2G6;^_NZ^@?V)OVVOVE?C)^U7JWPL_:)UJ
MS^!WB22^^.\$/[)OQ,_9R^(_PZ\2:AX1\!>*;:U\#_$7X$_M":GN^&GQYTQ]
M!N=.U'Q=;>%=;UZYBT36H=:.DZ"FGW$DGUYXL_X)H_LR>*_B=J_Q05OC%X/N
M?%6O^%/%OC[P-\-OCE\4/AQ\+?B1XO\`!^GZ1H^G^+/'?P_\&^)-'T'7/$6I
M:-X<\,Z1XIU/R;:;Q;I_AS1H?$?]I-;/)+U7P4_8"_9[^`?Q2?XM^"$^)NH^
M(;*Q\::7X,T?Q_\`%SX@_$;P=\+M.^(>K:;K'C*T^%WA;QGKVLZ;X*77+C2-
M/M)I]+1;JTT>&;0].N+/1[[4+*[`/A[]O7]OO]I']E_XR_%;X.^!/#/A;Q%X
MA^)'P,^%NK?L765UX?UN\?Q!\;_$7Q9MOAOXV\/^++O2X-3%]I^AZ/J4?CN'
M38;.WOI]'T74[:W,L\UNY^4/$W_!17QQ^TY\<?@AXD\$^!_"'BS]FT?M*_\`
M!/[P5\-+GQ-X>O;:^U+XH?&S]G[4OVD?B#=Z;XAO5LTT_6?#'@WXC_!K09+.
M^L;H^&=0U2^;4=-MK_S8&_>7XF_LO?!3XO\`Q>^`_P`=O'O@ZUUGXG_LUZOX
MKUSX1>)BY@N_#FH>,_#\OAG779HE#WL,VD7%S#!:W$C6]M+<SW$<8FD+UXKX
M7_X)L_L;^"_`^E?#KPO\([/1O"ND?M&>*_VJ[>RL]8UI)[GXU^--3U&_U[Q1
MJ5\;XW>I"XLM1_X1V&UO99EMO#NGZ5IT3J]A%<4`?S??MD?M;_M*_&']BG]O
M#X9_M8^,+31OB99?"G1?',O[&/C/]EWQQ\*/&/PXGT3]JSX0^$/"?Q*^%GQ:
MEU"+PI^TE^S_`*//?(/&/Q"\&:UKTNF:GJ7A#4+J[\,1ZO;Z/>?N]^R+\9_V
MJ-*_;$_:`_8\_:<^(?@3XSW7@CX0?#/X\^#_`(E^#O`4/PS>SLOB)XA\2>'=
M3\`W'A>TOM4MY],\/WN@B;0]:N]2O-:NK*<1:O<W5S&US)UMC_P29_89LM(^
M)6BR?"_Q)KEM\4O!NG?#37KKQG\6OBO\0-4T7X6Z9XOTGQ[!\+?`>J^//&7B
M2_\`A_\`#Z;QCH>F>(;[PSX1GTBQU'4;*RFOA/\`V=I@LOLW3O@I\-=)^,GB
M3X_:?X<CMOBOXO\``N@?#;Q%XI6]U!Y-2\'>%]6U'6]#TJ2PDNGTV'[#J.JW
MTRW-M:0W,HFV3RR*B!0#^<GXA_&7]K']E_\`;+_X+3?M-6'[04/B3X8?LY?#
MK]F7QO#\!]:\`Z!<:/KUMXI^'WQ'B\!Z%#XHO-2M;OP7I7A#5#)>^*];TF2R
MF\1V<TU]K,F_3H7'Z"?L@?M#_M5Z-^V-I_[)_P"TS\4_AY\>+7XO_L4V/[:G
MPZ\=>"O!>D>`-0\`/H_Q#\$?#/QW\,-3TK0;F\TWQ'X4N[[XA>'?$'P^\82W
M#:Q>0VGB?3=4>Z6PLKR;[+^(7["G[,/Q1^,EY\=_&7P]NKWX@:UX4A\%>,FT
M[QEXW\/^%?B1X;LK74['2;#XH>!?#_B'3/!OQ'_L*SUG5;71)_&6B:S/IMO>
MR06\BQ16R0V?V<OV'OV9/V4-8\2^(O@?\/+OP]XC\5Z%H?A'4_$/B'QS\0?B
M-KMKX'\+7NK:AX7\`>']6^(_BGQ7>^%?`?AVZUK49=)\'^&IM*T""26.:2PF
MN+>":,`_!7_@HIJ_[1?P%_:>_P""CG[9G@3XI^`KW4_V8/V'?`OCWX3>%?&G
MP0\#>-KGPGJ]]>^)+33)/#WB?Q!!>:GH3V.H-J6HZI/I0M9=>BO19:D\EO;Q
MBON[]N+]L?\`:5^$OQH^,'P]^"WBOP9IUOI'[&/@OXJ^`5\2>%=)\0:;IOQ7
M\1_M2?"[X2#5];EM[]=:U+P_)X9\:7<-SHSC3H02M[IEW+>H9+3]0/&?[-_P
M/^(D_P`5[CQO\.]%\3/\<OAP/A'\5X]5EU.>V\:?#E;35;)?"^I68OUM(+1;
M;6M3C6ZTZ"RU%6NC*MX)H8)(OFGX:?\`!+#]@GX0+K!^'_[/]AI%QX@\,Z/X
M+UO4K_Q]\5O$^LZKX/\`#GB#PMXJ\->%;[7/%?CK6]8N/#OAG7_!?AO4?#.B
MR7S:=X=>PE@T6VL;74M5@O0#\HC\-OVT]%_X*PS>"?BM^VQ)K_B+Q-_P2T\2
M?$77+SPA\%OAEH'@^_\`#_@+]J=-(\1_#;3_``OJ3ZU>Z)I]WIWQ(T9].\:R
MB;QG=W<%]&_B6XT_3H](M/F;]EG]L;]JG]A/]DS]E#QQJ?COPO\`&'X&>._V
M-/\`@HG\5_"OP*D\`:1X5O\`P3X@_9#T?7_BKX3M;?XBZ<]UXE\06WBBQBN?
M#NM1:L)BEQ=_VE9>4(8[0?TQ?&W]CS]G+]HGQEX$^(?Q<^'?_"0>.?AK8:SH
M_A#Q9I'B[QWX%UZST#Q#J&BZKK7AC5-1\`>)_"]SXH\):CJGAW1=2N/"?BE]
M:\.'4+".\72UN7FDE3PU^QQ^S/X/M_@E:>'?A/HEA:?LY:;\0]'^"]J^H^(K
MZV\$:7\5XTA^(=C;P:CK-W%K%OXHAC2*^3Q$FL"*,%++[*K,&`/Y[?$?[>?_
M``4O\!_`!/B[;^,/''B73];^!_PZ\:ZI\1OBS^RMX#^'OPO\&_$SQ)X^^'5B
MME\.;KPA?:C/\5?`'BK0O%6KV.DV*W]WX@N[.UL]9TCQ:DTR/)_0%X`NOBA\
M(/V=O%_BW]I7X]^'O&VOZ-HOB_QYJ/Q4@^'VC?#S0?"?A<:0^K:?:MX7M;J6
MUN;?PK!'*_GZC=/?ZLJK#>R-,<GR?P[_`,$M/V#O"EIKFG:%\!;:UTC7EMX9
M=`G^(GQ;U+PWH=C:>([+Q7;:/X(\.:IX]O="^'7A^'7--T^X3P[X!T_PUH0M
M+*UTG^S_`.R(([%?O"]TG3-1TF[T*_LK>]T>_P!.GTF]TZY036MWIEU;/9W-
ME<1R;A+;SVLCP2H^X21NRMG)H`_DA\3?\%,/V[/A5X6_:3_X1WQM\7-9L;[_
M`()N_%/]MW]G3QO^U/\`"K]FOPYKVH:Q\-_&GADZWXE\,>"/@KXJ\7ZO:?##
M4_"'B[3YO#?AGXRZ;X:\20,D#M:(DEZ;'Z"_:J^)W_!0W]G.Z_;,GB_;4U?Q
M"W[*G[//@#]K_1Q-\)_AQ8Z/X\\4:UK6N:?XL^#NIVD-C+J&D_!N"WT!4T*V
ML;N+QG;MJ)FO_%>JS0ES^J_A3_@DI_P3H\$:1XPT3PK^RQX%T>R\??#+QW\&
M/%LD&J^-9M4U?X4?$K4+#5/&/P_;7+KQ1<:W9^%M0O=+T]['2M/U"TM_#T-I
M#9^&UTFS7[.?JSQS^SG\$?B6WQ+;QY\.M"\4'XQ>!+/X9?$L:I]NE7Q;X#T]
M[^2S\,WZ)>1I#I\,NJ7TH-@MI</+/YDD[O%"T8!^`GBK]LS_`(*,?&S]HK]H
M/4?V=?"7Q;DT']F'XK_!GX3^&?AGH%E^R?X>^"OB>+7_`(7_``9^*7Q2\9_'
MSQ%\9?CQX)^.LMKXBLOB-J4'PVD^'?@&3PWIWAK2+"^T?6O$WBG4?$%CH7+0
M?M*_MS^&/@SXO_;[U_\`:NUW6OAM\%/^"E6F?`G5OV;+'X>>!X]`\5?`#Q+^
MU]X(_9M\1Z5J/B*?39O$^I>-["P\>-JO@S4(-4TG3])>PLEGM;NX@>>X_<[X
MG_L!?L:_&;QYX6^)_P`3?V>OA]XK\?>#[/P]IVD^)[NROK/4+O2_"2RKX7TC
MQ2-+O[&W\<Z-X=,SRZ+I'C6#Q!IFF7"PW5G:PW-O!+'Z=<?LS_`.Z^'>N_":
MX^%/@^;X;>)_'4/Q-\0>#'T[.AZMX_M_'6E_$V#Q7>6OF?O=8B\?Z)I/BM+G
M<,:Q86]QM^3:0#^=;XA>,OC+\4-=_8A_;`^*O[1?B;7?`?C;_@IY=>!=&_9>
MO?`GPTLM+^#^F>$?&WQO^$W@JUEMFCL_B!'\0+==`M+CQ^MQK\T6F7^HW,-Q
M8RC3+7[7^@G_``4(^'OB'Q[^WO\`\$K;;0OB]XU^$C)XK_:OMFU?P=_82W'V
MC_AG7Q!JR7+R:YIU_!YSVFCWVA&(J(Y-.U_4OD-RMK+#]E?\.[OV'#\59/CB
MW[+GP>D^+K^,C\0XOB%+X3M)?$UCXW>Z6]N?%&E:A*7?1]8U"[2.XU:[TH6;
MZQ+'$^J?:S&FWV3XV_LZ?`W]I'0]"\-?'7X8>$_BAHGA?Q%;^+?#ECXJT_[:
MNA>);6TN["'6M*F22&YL;\6%_?6$DUO-&9K*\NK2826]Q+&X!_+[\!/%_P"T
M=^S7\'?AE^T%\//VBO%Y\%^)/^"S&N_LW>(_V?)?"O@R\\!^+O!?QN_:[U;X
M<>,]7UC4WT=_%L_B[RM7U#6=!U"PU>TAL=2_LY!:RPV,2-[I^QU^UU_P4$^/
MNN_LC_M&V?A[]H6_^'_QH^,GBBV^/'AGQQK7[$7A?X`^$/AIK2^*M'TCPI\.
M=(T_]HK5_CQ:^-OAGK6C:':ZKI6O^!(_'.IZC;>+8M4TBRG$=C!_0#H_[,7[
M/N@>"]'^'6C_``A\#V/@CP]\3-(^,V@^&X]%@?3=%^*N@>,;3X@:-X^TN.7S
M'L/$^G^,;*WUZWU.VDBG6[61&+6T]Q!+PFA?L)?L;>%_C5+^T7X=_9H^#FB?
M&Z;6M2\3/\1M,\$Z19Z^OBK6;.;3M6\6PF&!+.W\6ZG87-U9W_BFWM(O$%W:
MW=Y!/J+QW=RLH!^6/_!4OP+XV^('_!1;_@EIH'@KP]\`]>U";0/VT9;>+]I7
MP9=_$+X427]K\)-'NX;+6O">G>(/#NH3W<]I#?7&D:I#>-'I6I6EO/+#/N6"
M7)^,GA']I;P[\3OV,/V;=%^-W@S]ER7XB_!__@H7\4OB<W["7@C1OAQX!\0:
MI\&M5_9?\1?"F.TT7Q3%XMN;.^TF/Q!>66OZBUX][K6GZKXCT:61=)UVYMQ^
MNO[27[%?[*'[8,'A:V_:>^`GPY^-T/@F;49_"2^/=#35F\/RZNEM'JC:9(9(
MI;<7Z6=H+I%<I*;:!F4M$A"?"7]BC]DSX#V^BVGP;_9]^&'PWM?#EI\0+'P_
M;>%/#5IIEOHEK\5CX5_X6-#I,,0\O3QXR'@CPHFNM:K$]Y%HEI$S"(S)*`?S
M7^$/VM?VR-%^!_A+XU>(/VIOB7XP\2?M5?\`!'S]L[]J;4-(U&+PYI?AGX4_
M%WX,?"G3KSP/KGPETG1M(LT\.M9ZC>3:K=B>2^:\U!4N9B2NVN2_;)^(_P`<
M/`GPH\?_``EU?]KCQM^U5X/_`&E/^";5Y\?OBEX8\=7?A'6KSX)_$#0/'/P+
M;0/$7A\>#K'3Y/!?A;XD)XRUO3M.T#6(!HUU)HLTF@E[B&?R_P"E?XW_`+$W
MP4^)W[.OC/X%>$_A_P##[P!<W'[-GQ=_9N^%'BG3_!VD/=_"/PK\5OA]J7@2
M\M_"SQVZ7ECI445W9WE_IUG<PKJ360-PSS2/*USX$_L,?LJ?`+X3?\*G\%?L
MZ?`/0]'\0>%?#?A_XH0^'O@[X!T33_BG<Z#`C_;O'-A9Z#%#XH1M5:[U.SMM
M?74(M/EN66S2%550`?S_`'Q%_:U_:%M/`?[;W[2-M\?_`(F_#7QA^P[^U+\`
MO@?\%_V9EU/0M!^'_P`4_AM/X<^#B/8ZSX-"7&M>/K[X^R?$?73X3\2(T6KV
M5YI&D6?A>V>;3M02\]!U_P#:P_:YT37/'O[`*_$_QH_[0GP1^,_[17QE\<_%
MF>X6R\4M^Q3X/^&VN_%'X/ZV;N_0IJL7BKQ3XG\)?#2&ZMXI9-2M?"GB)\6T
MUC-YG]#6K_L\?`#Q!\1?"_Q@U[X&?!W6_BWX'L;33/!?Q2U?X9>"M2^(OA#3
M;`72V.G^%_&]YHDWB;P_8V:WMZ+2TTG4[2"W%W="&-!<2[_(O!/[)&@:'^TW
M^T5^TQXRUNV\?Z]\<_!W@;X8:;X?U3PWI\.D>"OA;X/T[4(KKP8$GEU#^W8?
M$>L:KJ.J:W=7(M8+^.>.RGTTQP;Y`#\!_@9HO[7WQ)G_`."3>AZY_P`%%OVL
MX;3_`(*&_L6Z-\8/C-<6.K^"8=3\.^*/"O[.OPY^*%G)\-M1/A1I_";ZMJVH
M75GXHO8#->>(H;F\NKZ4WMW-,?)OAM^V3^V7^T,GPI^%&H_$+XP17_@K]AGP
MW\2M)\1>&OVBOAI^S3K?Q<\=ZW\4?C1X&\8_&'Q5XL\76S3?$+1/AIH?PW\%
MIK/AO2H;6QTS7]3US4->%K8^(-,N%_K1TSX4_"[17\`2Z-\-O`.DR?"C0#X4
M^%LFF>#O#M@_PU\+-I-MH#>&O`#VNG1-X.T!M"L[313HWATZ=IQTFUMM--M]
MC@BA7@?&/[*?[+OQ$\)^%_`7Q`_9M^`?CKP-X'O;O4O!7@SQC\'?AYXF\)^$
M-1O]WVZ_\+^'=;\.WVC^'[V]WO\`:[K2;.TGN-[>=(^XY`/Y=O'OC_\`;]\7
M?#/]O;X@^)/VO?B1X2^,?[$__!//]GWX]^%?#WP5^(WA[6/@Y=_%WPU\*?$G
MCGXC^+;R]T^Q33?'VE^-=+\*ZA#K%@UW)HES+J-U<65K->16Q;]&?^"=WA?P
M9IO_``4;_P""HWBFZ^-'Q"3Q%XE_:!^%OBKPE\,_$?Q>@NM!\8>&_B#^RU\*
MM<37[?P5'>SVGBS3O#M[+J7AOP9KFCS:EI.B:1H,.B:7?W,&D^97[.0?!#X+
M6VG^*M)MOA#\+[?2O'7A*W\`>-],@\`>%(M/\8^!+/2;G0;3P5XJLH])6V\0
M^$K70KV\T6W\-ZO'>:/!I-W<Z=%9+9SRPN3?`_X+7/Q!T'XMW'P@^%\_Q6\*
MZ"/"OACXFS>`/"<OQ!\.>&`LJ#PYH/C-]);Q'H^@A9YE&CZ?J5OIX6:4?9\2
M."`?R_?\%8+/XK?MF?M>?M$:'\$/V=_B]\>Y?^"=7[*^G:7\(_&?POUKX+Z'
MX<^&7[<?Q4\9>`OVA+K4?$NK_%OXG_#R]G;P[\,?@_\`"S29[CX9:;X[U[PT
MOBOQ1IVKZ5#J6IZ59%/VC/VOO"/[2GP,_:[_`&HM>_;-\>?L^>._A7^P)#\7
M/V.?A1X3^.%G\&]/UKXD>(/V6/$WC'Q1J]MX>:?3KGXQ:U!\8[>^^'5UI!75
M8K.7P^FA1Z98ZG+.K_U8Z-X1\*>'9/$,OA_PQX>T*7Q=K5SXD\5R:-HNFZ9)
MXG\17MG9Z?>:_P"(7LK:!M:UJ[T_3]/L;G5-2-S?3V=C9VTL[PVT*)^9G[5W
M_!-/6?VEKO5_"6@?M%O\#OV>_%G@'Q-\-?%WP5\!_`#X/75T_A3X@Z)JWAKX
MHVO@CXD:CIR>(/A_<_$/P_KNL:?KEYI5A=W"OJ5[=0.)9@$`/R(\8?%S]L:_
M\+_\%&?COX!_:!^,]QXG_9H_9M_8M\<?#SX9Z9J5O_PA>H^*?BM\"7F^(OCO
MQ#`FA:MJ<_\`8%C+J_C=XK>*XTJTU73$UV]TB_-@+9^#\=_$[]M#]G7X9?%[
MQC\*?CA\+=4\#_$[X(?".;5_AW#_`,%"M>_:<^*.C>(_$O[0?PA\!?$W]IW2
M_$.I?`;PAJ/P)^&6C?"+QSK5G\0O&]MI?B?PMX(\31^#];N;&!I9S-_6YX2\
M"^#O`>G6NE>#_#>D^'[.ST?0-`C^P6D:7<VD>%M-CT?P]97^HN'U'4TT?3(D
MLK&74KJ[GA@W*)29)"V1X5^$?PH\"/K,G@CX8_#SP;)XB%T/$#^%?!?AOP\^
MNB^N)[R]&LMI&FV9U,7EW=7-U=?;3/\`:+BXGGEWRRR,P!_+-KUA^TAH,OP*
M^!=]^U%IUA\*/BI_P4P_98\!Z/X9^!G[;NL_M,_&OX=?"_QU^S]\>9?B'X7\
M6?%VX^'/PU\1:+H'CK6-`LO$?A);K1KBXL9/]/T_47FL[:5.@^#U]\7/A/XO
M\)_&6Y_:4_:'\6Z-\$?^"MVO_L#Z#\/O&_Q)UG7/"NL?L^:_X>M#9:=XI2;3
M[^X\2^(;3Q'KEMJ">*]9@OM5,.F66F1WMA:&>X7^GCP[\(OA/X0L;73/"?PP
M^'GA?3;+7(?$]EI_AWP5X;T2QM/$EM;36=OXAM;33=,MH+?7(+2XGM8=6BC2
M_BMIYH$N%BD=6WCX+\'-')"?"?AHPRZ^/%<L1T+2S')XI4(%\2R1FUVOKX$<
M8&LL#J(")BY^5<`'\?7PH^)G[8WQ>^%7A/\`:#\5?%[X<?"CXR:Q\2/C]IWQ
M]LOB!^W3XM\*_$O5+$1?$C0+_P"!?A[]C'4O@GH$/P_^(7@W3M/\-R?#+PC;
M^.GU.U30-,UDW>H6^M333>J^+OA_XT\&>"?V5=&TWXL_M'_$L_\`!0'_`()G
M_MJ7OQP\._$+XE^)_&<VJ>./AU\#/A/\1O!6M^#=,C2!?#&NOKOB'5=$^RZ#
M:P)J6BZ@=->WFD;>W]3TWPS^&]QXHNO'$_P^\$3^-+ZUDLKWQ?-X4T&3Q1>6
M4NFKHTMI=:^]@VK7%K)HZKI4EO-=O$^FJMBR&U`BK8M_"?A:S?09+3PUX?M9
M/"MK=6/AB2WT;3H'\.65]%!;WUGH+Q6RMH]K>06MM#=6^GFWAN(K>".9'2*-
M5`/Q'_8`L/V8M#_9'_X)+7NE_M,Z]I/BF3X:?#Z#PSX&\-?$^Z\90_%7XFW_
M`.SWX/C^(WPN\1:)8R:_<S:?\/'0ZQ>>&BEA%X!NK8-J!TV+=&W[KU\XW7[*
M?P:N/CSX%_:)B\.1:=X[^'?AWQ[H/AJRTFRT+3?#,-U\3+_3[_QEXLNM-M=&
MCO+GQCK#:9;6USKIU-))K4RK<PSS2>>/HZ@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHJM=WMG80M<WUW;65NI`:>[GBMH5)!(#2S.B`D`D`L.`?2@"S132Z!#(741
MA=YD+#8$QNWEL[=NWYMV<8YSBJ\%[9715;:[M;AGMXKM1!<13%K6=I$@N5$;
ML3;S-%*L4PS'(T4@1F*,``6J***`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KQG]H[Q)KG@W]GGX\>
M+_#.H2Z3XD\*_!GXH>)/#^JP)#)-IFN:'X(US5-)U"&.YBFMY);*_M;>YC2>
M&6%WC"RQ2(60^S5P/Q7\"I\4?A;\2?AG+J;Z+%\1/`/C'P+)K$=H+]])3Q=X
M=U'P^^II8M<6BWKV"Z@;I;1KNU%R8A";B$/YB@'\S'P(_P""C7[0FI_L^?\`
M!.K1O'/QN\1ZO\=M(_;A^&WPO_:0U&[T'PUINH?'#X)_$[]CW]I+]H+X:ZGK
MFD6VD+:Z;8^/$\&>#6;6/#::4MEKOA_7;2.1X[2\MCUFL?%?_@H9??\`!.V]
M_P""OF@_M<:Y9Z['\/I?VEU_8\;P)X&O?@-'\&M+UAM8O/AHNJ'2X?'I\5R?
M#ZSE$_C7_A)6C37GGN(]&:W\N`?<M[_P1Q^&T_C_`/X)X?$NS^*.K:7XG_8;
MTC2O#?C=+#PQ<V6B?M1^'_#/PV\4_#KP/'\0M(TWQI8)HVN?#JV\=^/KGP'K
M[3^*9=$T[Q_XU\-7-IJ>D:](D&&__!(;QI=>%KW]F'5/VX/B;?\`_!-^]ULW
M;_L<)\,_!>F^*_\`A"7UN7Q)-\$G_:>TO4[/XA2?!:\U>9K6]\/CP_'XOF\+
M!?"T7CV"P,TDH!\2>._^"@G[3]Y\'OVU_A;\,?BYKUS\>?\`AKOX.^)/V:?&
MFH>#=/&J>'_V7_VL/A%X<_:8\!^&!I,.B7>E7%O\.=%L/B5\.'U?5C//);:'
M&E[?2WELM]=_IG^RY^T?\1_VB?VZ_BMHVF^.)Y?@9\"?V*_V7%UKPG:6^F2:
M/XG_`&A?VCK[Q9\3=9\72:A%9'48KWP?\,_"G@_1[;2!?06<$'CB\OVM;MK^
MUDL.^\6_\$UOA#XN_;R^&'[=%[K^MV^H_#'X-M\)+;X,QZ?IMU\--??3K3Q?
MI'@[Q=JMEJ`NUM]8\$:!\0?&VD:%_95G83F+7`;N_GM[*WLZZG_@G]^P9X._
M8`^&GCWX=^%/'_B[XG3_`!"^*.M?$S6O%OC>#3X==#7ND:'X:\/^&(_[-`@.
MA^#/"?AO0_#/A^,JKPZ5IMO&X+AW<`_+O]N7PO\`M9_#7]OK]@OX1>#/^"B_
M[37A'P#^W/\`%S]HCP]KGAG2=*^"JV?P[T[X;?!;4?B)X>TKP/+J7POU6_N8
M1JR1>?\`VS>W$\EA920FYW3,PN_!O]M/XH?LG_MS?M>_LM?&[QE^UU^V9H7P
MJ^%G[-^N_#BX\+?#7PCX_P#%,#^.%\7W7CC7_$MGX"T;P?9Z==W>I2:7:VL=
M]/$MMH>CP);64\LK7=U^LWQ^_9!T/X^_M#_L8_M`ZMXUU?P]>_L:^//BA\0/
M#_A;3M(TN\LO'&J_$OX9ZA\,GM=:U:\;[?I%EHFG:K?:C"FEH7U&\:WCNF2&
MW4-)\-_V0O#GPW_:^_:%_:^LO&WB?5/$G[0W@CX8>!]:\%W\=FOAGPY9?"Z+
M4(M+O-&EC_TR2YOSJ=U)=I<DQ1/+(8`/,?(!_+YX"_X*%?M,?$+Q1_P3X@^)
M/QK_`&YK[1OC)^QI^U)\1O$^B?LB_#GX>^)?BOXA^(7A?]I/PYX6\):SXMT'
M6?"=[I>F:)X9\%?;=,OYXX;98;Z/3[#<;G4II)O>_P!IS]KG0OA!\=O@=X=^
M,/[=O[>'[+7PEUW]@/QQ\6?"VI^)_"FAWGQON_C#>?%[Q9X:T>3XG^"]#^$G
MB_0+G5=/TM+6TTO0=2MO#^CWH33;:;6+::X$T7Z%:9_P1JO_`(<:Y^SMXS_9
MU_;3^+GP%^(7[.WP>^,'P3T3QGI/PL^"7Q%N?$/@_P",OQ%3XEZ__:>B?%/P
MEXM\.V=_8:Y;:>NG7=CI:S^381Q3R26MS?VEU]4>#?\`@GW8W/Q.TGXN_M*?
M&/6OVM?&:_LX:]^S/XRD^*?PP^$6A^'OB%X,U_QU?>-KFY\2>"O`?A/P]X*$
MP%_)H4NGV7AZ#3[W3EWWD4T[NQ`/Q?\`BW\=OVOK)_\`@F'X$_:[UW]N+P_X
MU^(O[$WQ"\5_M&^"/V'M)\+/\4-0^,NC:CX!LK/5/%FE_P!F:E:V$=CI>IWX
MUJ;1;VUMK76KRX2WA1?*\GG?C]\1]1M?VE/V1/A+J7C[_@L%=_!K7?V%_C/\
M63X1^%DNGQ_M73?$*W_:3\$Z)H^N?&O3+'3K.RB\/:#X9\2:]X<LG2W66V2Y
M\)6TLMQ*TD\GZ=-_P2<^)7A.[^#E_P#`[_@H;^T+\(]4_9\\._$7X:_![Q'?
M_#OX&?&CQ9X;^!WCS4]"U/3_`(.ZOKOQK\$^.!XMT3P`-`L='\&^)]=L9_&\
M/AZ&UTG6/$.K)8VDT7U3\%?V+/$W@'XZ?#W]I3XN_M)>/?VBOC5X)_9O^)?[
M->H^,_%G@7X7>`/^$N\,?$/XU^%/C';ZWJ7AWX4^&?"/A33-6\++X-T7P;IL
M>BZ%90:AI$+ZEJQNM:FN+N8`_,[X`>!?BA^WQ\6_C+\/+W]IS]L_X)?LY?L>
MZ/\`"[X2>#?#EEXTT3P+^T5X]^)7B?P78_$3Q)X\^._BM/"VI37FH6&E^(M+
M\/:?X>L[>SM8_LD]Q?":Z597^&?C;^TQX]T#XT?L]_LZ?MI?MM?'KP5X!^$O
MQA_;`^#7Q1^.OP!GUCPYXU^*,'P[\"?#+XG?"?Q+XQLOA;X(\8+!JUEX5^(U
MI8^,SI?A:#1K+5=,U%I_L,<9:OWB^.7_``3SUGQ?\>?$G[3?[,?[6/QI_8M^
M,_Q&\,Z#X0^,6J_#/PU\(OB;X+^+&D>%%EC\+:AXD^''QR\!_$#PMIOC#0+6
M5M-LO%_AJVT?5)=)S97HNB[SM@_"_P#X)4_"'X3^-OV9_B)H7Q-^*WB'QK^S
M_KOQL\5^*/%/CN\\->)M?^/WB[X_QH_Q%\5?%*^&@:='_;5]>060T]_#MKI-
MCINCZ9INAVUBMK:)(0#\B;OXQ?'OQ)^QK^Q3+\8OB=^V_P"(?A]\4OV]OV@_
M#GPS\:_`!_#OAO\`:X^-7[)&E?!/]HOQ?^S;KWB"WM6M=+O+O7$\.^%?$NMQ
MFWL]1O=`T^RGFLSJ!?S?W$_8&\+VGA3X*^))])N/VSYO[4\3ZI?)%^W)KFE:
MQ\4H)[33[:S1-*_LFYN[:P\*R&W62T@9EDDNFNKED(E!/A?BC_@E6MG=2M^S
MW^UC\9OV8M*\-?M!W7[2OP.\-^`/!GP3\5^&O@%X\\4_"KXA_"OXI>'?`&@?
M$GX>^*]&D^%WQ)L_B#>^)+WX>ZQI]YI/A7Q''J-SX,DT*VUZ_ME^[?V?OA/\
M5?A3X5UC0OB_^T[\2OVIM;U35%OK7Q=\2_`WP-\`ZCH5@=.M;.;0-+TSX#_"
M_P"%F@S:7)=PW&IK<:UIVKZW'/>RV_\`:[6<5M!$`?S8Z7^UG_P4;\9_![_@
MF5\0=7LM`\5^.?&O[=OQG\%Z5:Z;\4]5\)Q_%FWT#Q?^T5X33PS\4$T72-+T
M9/!/@G3O#]G]CM9-/U*75[3PII]V\!UBX%P/L?Q5_P`%B/BU\/AKWP%^)7PD
M^#OP\_;3\/?M$^*_@IJ&A^(/'_B6?X#V_A/PG\$?@_\`'Z3XN?\`"0:3HM]X
MXNM!UOP?\:?"&AZ/HMCHMSJ47B:]M1K4FDV=[;>9]9?#7_@E9X2^''C'X;:E
M_P`-)_'[Q=\,O@9^T-XL_:-^`OP3\36OP9_X1#X6>)O']Y\0M5\9^'+7Q1H?
MPHT;XG^*O"U_J_Q(URZTBU\6^-]6O=%@BMK<WNH3F>]EW?B[_P`$N_A?\2OB
MO\3?VA/#'Q?^-/P;_:(\;?&'PU\:_"7Q>^'=_P""+C4?AEXD\/?L_P#PX_9S
MO/#VE^$_&_@KQ;X%\9^`/&?@;X:Z2_CCPA\1_#OBJQU?4+J:>PDTB6STR:S`
M.^_8:_;*UC]K+]GOQA\4_$7@JP\(>,OAYXT^(O@+Q)I6C3ZW=^#M;U#P)<3K
M9^)?!FKZ[INEZEJ7A3Q18"TU/3;F:T$\,5RUM,S3P/7Y\_LY?\%9?VF/%^F?
ML'_%G]I']G[X)_"G]GK]O&6S\+>"?$GA+XLZWK_C+P?XXU'PIJWB?2;GQ-IV
ML:%IVC)X4U@Z)=Z;"L-X=5L;JYLOM32*\C+^M7P;^`NN?!GX6>,/!VL_&SXP
M_M"^*O%=QXCU[5_'7QEU#P.FM76L:YIWV=M*\/:!\-O`_P`._AYX'\*6LB+'
MH_AKPMX/TS3].C=WG:^NY+B\G_)7]@/_`((_-X=_9N_9'T_]L/XO?M*_$77?
M@7\*=;T+PM^S9X\\;?"]OA)\$O%OC/PYKG@SQ/>:'+\,/A=X'\2^.-2TOPUK
M.HZ1X4U'X@^+_&=IH=IJ5[+I]MOG@>U`/%XO^"\'CO0]._:*TW5?!?[/GQ7\
M9_"S]F'QK\>_`MS\#?%'Q2F^'.O>+OASX^\/^$?%?PHOO&WCOPEH6E>+9_[*
M\7>'/$6G^,_AE=^(O#PAGN8+UH%-G<7/LT7[1G_!47Q9^U9\--,UOX??LT_#
M_P`)^,/V4OB-\4;KX4-\6_&^LW.G_#U?'_P8LM2\9WFIZ-H=C]I^*'A^P\17
M^G:4EG''X>2$W,<=W%>7H=?4=*_X(3?LQ6?AC2O!VM_'?]L'QMX=\+?`[QE^
MS=X!TKQA\3_A]?Z9\./@OXN@^'=K%X,\$Z1I_P`(=*T;3!X:M_AGH4.D:_=:
M=J'BC6%N;UO'FM>,Y+7P^^A?=WQD_8XT'XLZY\'/$^C_`!I^.WP4\2_!OPCX
ME^'5GKGP=UOX=V%WX[^''C";P%=^(_`OQ"M_'WPS^(6FZGHM_>_#?PS>07^@
M6'AKQ/I$RZJNA^(-,M]:U."Y`/PH^"__``5B\3?"/]F[]F/X7?"_3/!4_B"V
M_8NU/]IGQ7K7[3?Q-^-'Q#UOQ`=2\4>)XO"7PU\)^+K'1_$'C;QMXKUZ\T^_
MMW\3>*GCT[3+1M*@M?[1M/)8?4G@S_@KI\2/BM^TWX6^$WAOP[\"O@OX8\9^
M#_V8/&'PU\*_M+ZS\1O`7Q2^/6A?M`?"KPG\5O$6L?"._P#^$?MO!%U<_#9?
M$5W\/[GPQ?WDNNZAXT\/>(+6YM;!+2)3]4VW_!)GX*^&_#_P@L_A5\9_VBO@
M?X[^#_@?7/AA;?&+X2ZM\%]`^('C[X:ZYKFM^(CX)^(^EZK\$->^%>M:9HNJ
M^(-0NO#&I:/\-/#_`(G\.W1BU'2M>MM50W[M\5?\$E?@KX^\8>"M4^(OQ\_;
M&^)OPQ\#>(_ACXVT_P#9Z^*?QXD^*'PFU'QQ\)-/TNU\(>*]5UGX@^%_$OQP
M^U+J6C:?XJU?0=)^,FE>"]6\7)<Z_=>&&N]1U+[6`=M_P42_:I\:?LT^&/A;
M8?#GXB?!/P#XY^*GBK6-"\/Q?%CPC\7?B7KOB:3PYI,7B*^T?X<?##X)Z%XA
M\:>+M7DL(;A-8N$L1IWAS3;A-7NY1LC1_@GX#?\`!5K]IK]M1OV;OAO^SI\)
MOAC\//C'\0_#7Q?^)/Q;U;XQGQQ_P@/A7P=\%OBK)\+KK1=&T"SMM.\=P>(?
M&^LV\ZI9:[:VNH>$X(YAJ5O)?0FWK]/_`-JW]A_X>_M9>*/@C\0-:^)7QR^#
M/Q-_9]U/QM=_#CXF?L_^/++P%XSL]'^)>DZ3H?Q$\(:C>:KX<\5:=?\`ACQC
MIN@Z)'J</]EP:O976DZ?J>@ZQH^J6D-ZGY=_M"_\$OK7X+>&O@/X<_9,_9\_
M:(^.VJ>"M>^+EYJGQ0T'_@H7XJ_9;^,FG:'\5/%5MXU\5>!?'WQ7T/4_#/CK
MXG_#KQKXCDN;W7H9]8U#Q?;3PR:JNIWNN7;7[@&9^S__`,%6OVQOVG_^&8K7
MX6_!+X"Z;)\7OV+X/VQ?BQKWC7QOXLT[1/AEX:C^,\?@K7=-T*RL-)O=4\5'
M3O#(F&FJWV.YN=2*7EYM@1H&Y/PC_P`%JOC!H.NZ?\5/B7\-K3QA^S)X^\(?
M%OQ>DWP^^!G[3WAOQ%^SOIOPX\!>)/'/A35?B?\`$;QS\-M.^%'C/PS\1#H)
M\+W&N>%-?6'0->U#0YK7^T],O;J:#]!_^"=/_!-SP]^QS\,OV7M1\6:_J/B#
MX]?"#]C#P_\`LI^-+K2M0CD^'FH:;+XKTSXE:_\`V=IU]I\FKWESH_C&WN=(
MT?Q!)J=BNKZ"9;K4M!BO+J!-.[?P;_P32^$/@_Q'K`E^+?[3'C+X):@OBFUT
MG]D?QW\6QXC_`&7?"NA^-?"GC+P?XD\(Z1X`D\.6VO:MX(NM,\<:K<Z5X-\;
M>,O%OAOPGJ5CX?NO!VF^'UT'3H80#YX_X)W_`+?7[0G[2GQ5G\&?&#P1IC>&
MO&GPDL?C)X2\2>#O@K^T7\-]'^&<US?VEO/\(O&GB7XS>`_"_A_QMXHBL-2L
M]1M==\'7TEA?"&_-M!+:QQSUP'_!1+_@IG\2_P!DO]H/_A!/A[XJ^%WBG3_"
M_@SX8^,O%/P9LOA;\7_B#\4)=(\5>-M4T3Q#K_B[QEX-TV7P%\(O"DFE6EM:
M^$M;\6WZB^\0/,E[;QV(ADE_0W]FG]B;P?\`LNZS>WOA3XT_M/?$#PW;:!:^
M$?A_\./C+\;M>^(?P]^$/A"R=#;>&_A[HE[:V=V]I;P066G6>I^.=4\;>)--
MT?3[+1M+URQTJ#[&WE7[07_!+3]F_P#:,^*OC/XM^*/%/[0O@G5_BEHW@?0/
MC)X7^$GQW\<_#KP!\9M+^&MY<WW@:W^)/A'1;S^S]9/A^>[FCCEL3I4FI6+'
M2];;4],+6;`'QYX5_P""E'QZ\2_MU:C\"_&.J?`G]G?PBGQT\/?#7X=?!CXX
M>&OBEHWQ3^/OPPU2QTH)\6OA1\68-,C^$6MZEXMN=6O+SX?^`K+5;W7+U_"N
MLZ/JUK;7D-X;+C?^"P/PH^-/[07[97_!.3X`^']9^$U_\'OB)I_[3.KZ]\-/
MBWI7C?6O`WBWQ=X%\*>$KFXO_'_A_P`+:YI%KXHTG3/"7B&ZC\&:=?+<1Z;X
MHN+W4+J-X)8C%^BMY_P3:^`VL?%/P7\3_%'C#]H+QG;_``Z^,MI\?_`OPO\`
M%_QR\;Z]\)/"OQ7TLZA<:'XAT;PC=W9FM-/\.ZOJ=UX@\/\`@]=6/@G2M9\F
M>U\.I;P16J_2OCS]G[X<?$?XO_!'XX>)[/5)_'O[/B?$>/X<7-KJL]IIEHOQ
M5T71M`\7C5=,C4P:M]HT[0M/2R^T$?8I5EEBRTK4`?AQX2_X*#?M!_$3]G?X
M,_&WQ5X-\!^%_P!DW]N>P^,/PK^`_@CPU;:M+\6?AAX5D^'GC3_A3'BGQMXA
MOKV;1+Z[\3:;X/O-0UW3+2RF&AG5=-M(I;MK6YD?\_OV<?VJO&?[*$?P2^*_
M@WP]IOC3QIJW_!#'_@E'\._"?AS7+Z71/"UYXY^+7[9GQ]^%_AC5_$)TJ`"#
M3-%O_&+7]Y]ALQ.MD+RWM%C^TL#_`$2>"/\`@EY^RI\/?$UUJ_AK3OB-#X0M
M]2^(NN^!_@K?_$OQ/JOP+^$/B+XK6=W:>.?$'P@^%^H7-QX?\`ZCJ9U/6KO3
M8](C&F^%;O7=:;PEI^A0ZA+!5.#_`()3?L8_\(_9^%=4\">(-?T'3OV8/@]^
MR/866K^--?\`,L/A3\!O'GB;XF?"R\T_4=-N=.U33?'GA7QOXJU#7K'QMI][
M:ZPEY;Z8Z.AL8B0#XD_X>:_M#?"3]JJ;]E;XX:?\)_$NJ_"_]IC]F+X:_%_Q
MEX#T_P`2Z7!>_"C]M;PIXLT+X%>*=+TJ_%\NBZQI7QTL/#/@OQ!%-=75OJ-E
MK,3P&R??/7CW@O\`X*]_M@?$C1;.T^'GP$\+^,/B;\0/$/[0'QG^#OP^LX-?
ML;CQ=^QEHGPHO/&G[.'BV.[U*VM"WBWXD:I;6YU6!DC)2\%EI$%PK07+?IY;
M_P#!*W]DUO@C\</@AXAM/BO\08?VC9O"UW\8_BU\4?C)X_\`B7\?/%VH^`]4
MTG6OA_J1^+OC?6-<\3Z+<_#[5-#TG4/`L6@3:78^$[^RAU'1+.SU`-=-Z;>_
M\$_?V6;WQC=^-F\!:C8:O=?L]>'_`-EV%M!\9^,/#,^C_![PM<PSZ!HWAO7_
M``WK>D^+_#.M:9#!'86_BO0/$FG>(QI^ZW;4FWLY`/SJ_9`_;&_;(_:>\,_$
MGP]X7^-'[/6K_M!Z-X0^&_C2\^!_Q`^!_P`6/@+\3_@D/%OC*)M<T_QKX'\>
M_9-3\7>%8_!T>HZ7X9\;^'TGTV[\36D#:E<Q)J=C`W[RU^:?A#_@D_\`LG^%
M[?QW=:M?_M$_$[QS\1]%\#>$O%'Q>^,7[4GQ[^)WQ>?P#\-/'%W\1O`WPZT3
MQYXJ\>WVJ>%?`N@^+]0U#5F\/>&/[(M];FOKG_A)'UG<I3]+*`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_%?]OK]KWXU>!OVO_@_^R7X
M)_:+^$G[$O@GX@?!/4/BJO[2WQA^%Y^)6F^+/B';_$-/!.D_`WPQ%KOBWP1X
M#TC4)[&6/Q-K]]K6N2:NNFW%@-'LMAO+F+VKQ+_P4%B^`G@S3?#7Q4T6\_:0
M^-_@'X*1_&K]H:\_9$\(ZEK?@#P?X&5-0G3QY866O:Y>ZK#H.MV>EZC>:!HL
M>JZYK=]!IE_);_:4C1W^=?\`@IS\5OV@K+X@/\/_`(:_#?2?C!\-;[X:S>&_
M%WPR^)__``38_:]_:D\(_P#"2>(C>SQ_$'P9\7/@#H=WX6ND.B:A#X<\4^`-
M6U33M1T^XT2.[L[D3:K*]G^.=A^R5\-_@H_PPG^%?P%^.?[2%];?L]67P(^(
M5G^U7_P2G_X*-Q>$]/U3PUXP\8^)?#?CCP1#X"\'6NL:%X5EN_'&MVNH?#2[
M3Q?)_P`(=!H>FZ?XJTG4[":WG`/Z*+'_`(*=_"[QIXW\6^$_@C\'_C]^T!H_
MPZF\#Z=\1OB#\*?`+:SX&\(Z_P#$'P7X;^(.A>')=8NKZS_MG6K7PEXN\-ZK
MXAM-$BOCX>CU6!-3,,FY1\1_LC?\%5/BK\>K/]A[Q%\:](N/@-%\:/C!^UAX
M4\46<OP\M4\'?$S0/@O\&_C;X^LK/3]>U+QGK6I_#QO`MG\.X?$'BC69I;T:
MSK.DMX>@L[73]7DN;+YK^`7CC]H_]CWQ;\3M*_9C^#W[0%_\!_CQ\4/A]\7/
M'?A'6O\`@F3^TMX6\;_"3Q;I_P`,OAQ\'OBBGP@@U+7M`\%:QX3\6Z9\&M/O
MO!OAWQ%.9/A^-1T]=OB/1IH+V_\`&?A_\&?BTNL?LZ_#[XB?LY?M;:_^SE^S
M/\1?VQ?'.C6VB_LE?$3P]\6/''P]_:N^!7QY^%6IZ'XAO;[QVWAJR\8^'[CX
MT:)<067AY8Y[BUT/6WB0WLL-G8`'[`7W_!:#]G/P]X*3XD^.OAQ\<OA_\/\`
MQ-\(?B-\;O@[XM\5^"5L-)^-O@;X96TFK:W-X$=;Z64:G?\`AG[+XLT33=;B
MTRXU/P]?6U_"-K$#Z<_9R_;N\%?M"_%KQ#\%I/A=\8?@]X[LOAGI?QK\(Z-\
M7_"L?A>_\?\`P@U3Q!_PBR>.-&L([V\N],BL]>ET^QU#1-?CT[6[,:KIL\MD
M(KC<O\W7Q'_93_:Z^.OP+\&_L\?&[P%\>O$/@;]F;]G_`.,GP*_91UKPW^Q[
MK>@^.=13XA?#ZT^%7@_Q5\>-4G^-^H>'YKWP3X!L+71[S3_`/ABSL_$%\'U?
M_B6O_HC_`*V:1X[\2:7^W#H7[6I_9>_;9GT;3_V/+W]F2[\&C]GK3X]3&LM\
M4?"'Q!M?%-MJI^)3VDVF2VNA:AIUQ82VMM=6]PUG/'-=1SSK:@'T)^V_^T+^
MT]\#?VAO^"?GAWP!#\*[#X"?M`_M@>#O@+\2]5O[S7-6^*NJGQ#\'_COX\DT
M+3/#MQX9B\*Z%X;5OAM8WLOBRW\7W7B1M0CM]+AT"'3[F]OJ_0[QIX_\"?#;
M1AXC^(GC7PEX!\/&\@T\:[XT\2:-X6T8W]TLKVUB-4UR]L+$WEPD$[P6PG\Z
M9896C1A&Y'X$?MW>./VO/VF?BA^R_P"(_@S\"OC+\-?`W[+GQD\&_M+:!IWQ
M._8T\7_$7Q9XP^,GASPU\7/AI<Z)K&H>%?VGOASH^D?#-OA]\5[K48(;+3[_
M`,4W'C+2H%DU.ST262,_<GQ&^/\`X"^-_@FQ\#?'7_@GI^UG\5M"BN-,U>^T
M/Q/^S-X<U/PQ/XCTZVEA76++0M9^)&KBS,3W5Z;!)KR^N;.WN6@:]N7WS2`'
MW3X*^/'P.^)6JOH7PY^,WPH\?ZY%;27LFC>"OB)X0\5:K'9Q$"6[?3M"UB_O
M$MHRRB2=H1$A8!G!(K\:_P#@H-_P4K^,G[-?[:WPI\)?#>3PU)^RW^SSI/P:
M\4_\%$-7O-#;Q'JN@^'_`-KKXPVOP8^"MM8RVGE:EX8O_!MMX?\`&GQ/U&XM
M'NUU319-.CO[+[%$3-[U\)?&'[-WP&UV]\3_``6_X):_M+?"[Q%J6G-I%_KG
M@?\`97\$>'=4NM,>:.X>PFO=.\;07#6KSPQ2O#OV,\:E@<5^<^O_`+)7PJ^,
M5[^V]XR_:6_96_;S^)WQ:_;&\9:_.OQ$T3X!CPG<_#CX6:5HNF^'O@C\.;'2
MT^,M]8Z]!\(K/2;;5M+N]154GUZ[U&Z6&(W,DL@!^D?QX_X*T^`/@%\2OB9X
M5U[]G;]H?Q/\-/@AX^^'WP[^-7QY\(>'-!U/X??#S6_B@^A6/@PW%G)KUOXI
MU]-2U_Q/X?T":+P]HVH3V5[JUM-=1QVF^9&:'_P5H\#S>"?CCJ/CK]GWXT_"
MOXN?!7QQ\+_`#_L^^-I_`-K\1/&FN_&O2;_6?A5%H%]:>*[CPE8_\)78Z/KD
MACU[7=-DT;^R+K^UQ:AHB_YO1_!'XH:_^R7\>/V<_B3X)_;8\6^-OCEXJ_9E
M\5:S\8;3]C2QTM5O?V>?$?PHUV>6]\$W/[1>J2W=[XRA^%\=K<W@\9+]AO=:
MGU1H;T6WV"YW_P!H'X(ZI\:?'7[4?Q)T[X+?MGZ%XG^.OCS]E'XE>!K+Q1^Q
MAX>\>^$/`7B?]E[1/%VB6UMXU\-7?QYTB/XG>&_&D'BZZ-[I5O>>![O2!;QF
MUU6YG*7$0!]H77_!9SX<V^@Z+9P?LY_''5_C9?\`[4WAC]DC5OV??#]S\.M=
M\<Z!\1?'7P-\6_'[P-K,NN:9XON/!&K>"_%'@SPG<16?B#1O$-[%:ZA<2)?Q
M6T6F:E);[D'_``5[\':SX*^&G_"%_LR_M!>-_P!H7XE?$/XK_#B#]E;0K7P6
M/B?X9U'X'M!'\4-:\3:Y=^)X/`6G^&?#DVHZ+9QZR/$DEKJNH:U8Z?IS3W1D
MC3\VO!GP\^,VGZ[\`O&7Q#_9<_:*@U[X5_MO>%/VE+CPW^S9_P`$_?`7PJ\$
MR>'_``+\$/C9\'[#2-1D\2_M8ZQXQOCKZ?$:QUV3Q3JOB'QWK>BRV]IX=T[P
M-::3<ZAJFC\QK7PY_:)\*>/K;X\?LT_`_P#X*)?"W]H?P_\`$O\`:B\<V7B/
M6_V,/V?/'G@/Q'\,_P!HB]\->+M>^$>M^`O$O[:G@N&YUC1=9\$:1=>'O&&F
M>-_"5UJ6L!;2YL)+.Y6S8`^D?V5_^"K?Q2\+_"GQL?B-\!_VCOVA/BSXE_:;
M_P""A&KZ'X%\/3^`F\1?##X6?`?X[:UI$'P_\2ZGK?B/1=!L3\._#EQ:>'[1
M;:^O;68Z/+;V]Y=.T+R_5O@/_@LM\*/$^K?"+4?&/P$^._PC^#GQ_P#A%\2/
MB_\`!3XX>/M.\*6WA7Q]I7PH^&FE?%?Q?I-MH&F>([_QAH]^OA"\U:^T.ZUG
M1;/3=?7PWJS:==2(;5I_ST_9U^#7[0WP;N-8US6OV.O^"B?Q+US4A^V]XG\1
MZI>?##_@GYX*O[[5?VR_B1=>,;N22Q3_`(*/6VE76L>#KJX9[K3?">GM8>(H
M;H7=A9^%+>";3+/8N?V4_C#XW^"?_!/GX1>*OV%_V^=0\*?L;?!#XL_"#Q!)
M$/\`@FOX;UCXKZ;\6_V<-7^`<NJVUKJ/_!3RXN/AK?:)_:X\5#3[^W\7R3R6
MXT69K4LVH*`?6&O_`/!=#X2>`_"?Q,\5_$;X&^//#T7@_P#9M\2?M5>"M)T+
MXB?!?QUK/Q)^%_ACQ'X<\/ZE8PV7A/QWJ3^"/'5J/%WAW4[OPEXX.BWUO9:B
M02TUI=I#Q?[6'_!77XR^"_@E^U)IG@C]E;XM?!+]I'X->!?A+\5O".A_%FY^
M%]U!K?PH^('QET;X9W'C8VL'BR\L+:XMKN2;2K[PKJDT'B"P;Q!H^HBT9(;L
MVWYZS?\`!/3]L/6/@;\</@)XA_9+^-T?A[XE?L\^)/@)X4\8^"?V7_\`@E!X
M&^)NEIK>M>$;ZS\8_$;QEIO_``5LN;KQWJ.GZ7X433[S2O"MO\,-+\07NI7.
ML:W%>7-MI\=I]K_M9_`GX[?M4_$3]H/QO?\`[#7[>W@NV^.'[*7AG]G"ST_3
M;[_@F)JFH>#M;\(?%W2OB]H7Q#34KW_@II'8ZY#!K.BZ?9W'A.XT2SCN;=)F
MDUL+*85`/J>#_@J;\0H_CIX<_9KG_8X\>W7Q@TOX;^!OBC\7_"2?%GX*VNO>
M%_"/Q1\6>-O"OP[O_`5A<^,(+?XPWFH6_@Q_$WBRR^']UJ<?A"RU)=%N[B?Q
M%9W.F+^R%?RI_$O]D[]O3]IK6_@)/^TM\#_VKO$ES\.-5\'R^(_&WA/X$?\`
M!)[P!XXTR+PCXXU+7M/?X0_$.P_X*@^,O'?PGTK5M#'A32O'FGW#_%)-2N=%
M\1Z[X/TSPQ?^+KBPM?ZJ(G:2**1XI+=Y(T=X)3$TL+,H9HI3!+-`9(R2CF&:
M6(LI,<LB8<@$E%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!14,%Q!
M=1+/;3PW$+%PLT$B31,4=HW"R1LR$HZLC@$E75E.""`Q+RTDNIK&.ZMGO;>*
M*:XLTGB:Z@AN"X@FFMU8RQ13&*012.BI(8W"%BC8`+-%%%`!15>[O+2P@:YO
MKJVL[97AB:XNYXK>!9+F:.VMXVEF9(P\]Q+%!"A;=+-+'$@9W538H`**KW5Y
M:6,)N+VZMK.W5D0SW4\5O"'E<1QH99F1`TDC*B*6R[L%4%B!5B@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`/AS]H7X^^,]/\`VE_V6OV2OA%K
M5AH'CSXN3^-?C'\3_$=_X8'BK_A%OV;O@S%I-MXP32K.>\LM/L?%7Q"\>^,/
M`'P_\/Z]J8U&P\.V6J>(]=;1]5U#3]+TZ\X[X;?M8_&KQO\`\%!OCM^Q]XP^
M%/AGX<_#WX=_L]^%OBUX#\>6'BU/%OC;QM=^)_'.I>$WU6ZL([6#0/"ND6=K
M9I+9:%?6.L:I-?%I[V^CM%%C-PW[1GD?`[_@I!^R/^T_XXUK2M*^#_Q-^$'Q
M-_8DU#6]:FM[.Q\$?&#QWXP\(_%;X/RSZI<XBTO3_BG+X'\5_#PRS2VMMJ7C
MA?AKX?,\FJ:SHUG<\)X6^$'[=^A?\%0_'O[4_B3X=?LX:?\`LV>*?A3I7P)O
M=9A^,/BM_B+I7P]\'Z[K?C>P\?R>&KGX>VVA?VW>ZG<VNEZAH$OB6.QL-/-Q
MJ*ZM*\(MW`/JC]B+]HOQI\9M*^.OPM^,D&E6?[0?[)GQS\0_`7XMOH]F=&TW
MQE;1Z#X=^(/PG^,.C>')I[FZ\/Z%\8/A%XV\&^,(=+>>YL]-UZ?Q)HVE7VH:
M=I5O>3?<%?EC_P`$Y)9_BY\3/V\/VU]*TVWTWX5?M6?M`>%M/^`]Y]CDM;_Q
M_P#";]FOX5^%_@':?&.>1FC%[H/Q4\:>%/&OB#X<ZA+907.J?"Q/!&L+<7FE
MZEI3Q_J=0`5Q?Q&M_B+=^!O$]M\)-7\%:#\2IM*G3P9K/Q&\.ZYXM\#:=K9*
M_9KGQ/X:\,^*/!6OZSI2#?Y]CI7BO0;N4E3'J$6TANTHH`_G]L?VJ?\`@JEJ
M/AK]N_7-0^)7[!UE;?L-^-?%'@WQ5!H7[+?[0-AK7CNRT#X'>!/C,VM>#M6\
M0_M=Z_I/AW4[J#QI-H-E%K_A/Q5I%K<Z3;ZS,NM6>HR:3:?0'[+'_!7+X$?$
M#X">#?&/QONOB?\`#+Q!H?[)W@?]H+XA?$'XE_!'Q[\-/AUX\LX/"'A^;XE^
M(?A)J>K:!9V?CBPTOQAJ,NF0V/A2VN3>7=]IUGX?@U%+NS,OJUA^Q/XQT_PE
M_P`%/O#\'B'0%F_;B\>^+_%_@>4MJ,L?AI/$W[.WP^^$/E^(C-O?S%\0>$K_
M`%-X]/+01Z=<V\<*HZLB_/GQQ_X)5^(OV@/V>?@;\`/$OC[1_#$'PX_8>\.?
MLVZYXPT*'5'U1_'_`(/F^$&N:!J]C%'<6,EQX+?Q-\+8FUBQ%W8:K>:/J%S:
MV]W:SRK-$`?<_P"SI^W!\*/VD?'/B7X8Z%X7^+OPV^(GASP+X6^*<7@OXU?#
M;7/AIXB\1?"_QI/-:>'O'_AS3=;7SK[09[Z$Z;J4,XM-:\/ZJ\6E^(-)TN_D
M6W/Y:?'S_@H_\2M"_;A_:S_9GO?V_/V&OV'?"GP#NO@C#X"MOVA?@;K'Q-\>
M_$JW^*OP7\*>/=<U.+4I/VJ/@GI-OI_AKQ#J%Y8V4-GX7OI76^6._P!0F\F"
M-?L3]AS]C#QG\"?BMKGQ8\??"?\`9_\``7B34/A!IWPVN]?^&?C?XZ?$GQAX
M@N6U_2O$.IV[:_\`&'Q=KJ^'_`MO?:4;JQ\-V-I-?3W]S;W5SJN+)X[KPWXD
M?L>?MO\`A+]M3]K;]H;X"^!_V&OB?X&_:8N/@=J$%E^TMI'CO4/%WA*[^$_P
M?\/_``VO+33Y/#D+6*:?JUYI=SJ.TNSE6@W88,*`/6O$G_!7+]FGX+ZWI/PZ
M^*5[\9/&<_ANX^'O@3XA?M%>`OV>_&U_\`I?B#XV\':?K?A20>(O#+>*].T>
MZ^*MW=6R^!?!NFZCXBUFXO\`7-)T>T-^LL-]/T/AW_@K=^S;KG@;X@>*K[P%
M^TOX2\5_##XK?#KX.>,O@?XN^`GC32?CYIOC#XNZ-<ZY\,%B^%2077B*^T[Q
MS965[_8-W913O</:7#RP0VZ>>>$\7_L`_%[QSX$^+MM>Z_\`##P[X\^(_P"U
M'^Q?^TCHATC3M6N?"7@K4?V=_&7P@\5>+=-TFQN/+N)+>1/`WB#3O"L$S>6U
MC>6,%^T9:5T\:_:P_98^/_@'X]_$[]H/X57O@/6_$_[0_P"U]_P3WO\`X8Z1
MXFTKQ3J>@>&KWX'^&_BGH&N7GQ&B\.3V.I1>'KZX\2VK)?:7?0FQBS-<N=HB
ME`.R^)W_``51@\9S_"C3/@%8^,OAKXW\'_\`!0_]F/\`9A_:J^%?Q[^%EYX5
M\>>&/AY\:[:]U.ZN?[+U2\VZ5:ZSX8GMO%/AKQKIEUJ-G)!H]];@<78A]=UG
M_@L%^R_X?CGOM7\(?M`V/AW4_!OQG\<_##Q;/\(=63PQ\==%^`.F7FN_$Z/X
M.:JUX(_%FIZ/X>TW4_$.GZ;,FF7.OZ)IU[J.B+?6\#-7S#<_\$JOCS\7?'GB
M#]HOX_?$+X36/[0'Q<_:Z_8G^-/Q2TKX6:)XBLOAQH/P<_8ML/%ECX0^'_A2
M36KR?Q#K/C'5F\=^,+B_\7ZY<J'74M)L5M$LM!MHI/4/@Q_P3O\`CS8^/_V6
M=!^.'C'X/:A^SW^POK_Q>U?X):/X*T'Q+<^-_BI_PLOP?XL^'>FK\77\5:AJ
M&A6%AX>\$>./$=E?Z5H5K,GB'59K:]N;B&TA-FX!]-_'W_@IQ^R]^SSX)\%?
M$+Q+?^.?%_A;X@_"_P`)_&+PI=_#7P5J?C"\U7P%X[\0>$O#/@W5+?2+5H-6
MENO$VJ^-_#\.CZ3%92:G>_:9%AM&FB:*O%8/^"R7P'77/B3X7U?X#?M>^'?$
M_P`#_$?AVR^/FA:O\%$%S\"O`7C?2](USX>_&7XGWFG^*+_2=#^'/Q`T759-
M5\*QVVHZAX[N[30/&!O/!-C+X-\3Q:5^;G[&W_!-KQY\9/V2?BS+:>,]3LM'
MNOVJ?!?A3]DB]^)>D:O;W>D?L-?L>?M0^(O$GPB\/VEI=M!K-IIGBC26U>'P
MGJ&HV-M/J/@W1OA]?36LEB;2=OU'^*G[`7C/XC?$G_@I9XR@\=>']*L/VX/@
M#^S!\&_"%O-IM]=7/@V_^!%C\;(=9UO7=D\*7UKK4WQ5LET^TLVBE@32+EYY
MG-U&D(!K?%O_`(*O_LX_!WXG^+_`FO\`AGXO:SX)^%GC/0?AW\;OV@?#/A;0
M;_X(_!+QOXCU+P]I&G^'_B#K5YXLT[Q=YEM?>*=#CU_4O"G@SQ/HOA2*[ENO
M%&I:/;65]-;Y5[_P5G^#6E_%Z7X8:K\#/VIM-\,P?'#7OV;IOCU<_"_1S\#5
M^-VE%QI/@&'Q1!XSFUV]U#Q@ZB'PYJ-AX7NM#2[DBL-?U30K^1;8_+OQ/_X)
M-?$4_%WXVZM\--._9*^(OPZ_:3^)'B7XE^+]7_:6^'7COQ?\0_AEK7B'3;,Z
MA:Z##X9\7Z+X8^(FB3ZM9H='TSQ=90OHD+*MQ<ZG:PI9U],>*?\`@G9XH\6>
M`/\`A$9/B5H>EW8_X*,VG[<(NO[`OKV$^']-\0C4H/`6T:C;.-7N[6&,MK6?
MLEM+*T?V"=8O,D`+G_!+[]OSXI?MT?#/5O$WQ/\`V:OB3\(-5T;QM\=-`;QI
M>^'-"T+X3:S;_#?X]>-_A?H'AG0))?BAXU\8WGCRQT#P[:GQXLVE6_AVV\5:
M5XH33;^WL'T2TNOGO]JC_@HO\;/A3_P4<^$_PJ\#VVB0_LA?"?QE\`/A7^VI
MKNL:*EQJL/C?]M63QIX/^`5[X6\0+9SQ:-H_@'QY;?"QOB!++J-O<&P^)ECY
M^E)I-M<Z]9?:W[%O[-?QS_97N?'_`,,-9\=_"_QA^SK<_$#XZ_%'X;KIOA?Q
M5I?Q>LO$/QV^.GBSXQWVC^,M9O?$NH^%M1T?PL?&&NZ5:7.E:+8WVJ&ZTZ6=
MH?[-G^W?`GQ%_P""$GPZ^/VA_M<>*_V@OB]XX\3?M#_M*^+_`!SXKT+X@^"O
M%/COP3X$^'ES!$B?`&5OAAI_BC^P?$]]\%[O2O"VMV5UJZRM>:WH4%U:&P"V
MX@`/HCXC_P#!83X->!/$WQ!M="_9Z_:R^+/PO^%7Q8TWX&?$+]H?X9_#GP;?
M?`_PU\6+WQ?X:\$7_@ZX\1>)_B1X5U^_N?#>O^*M-L_$NK:1X7U#P_I5PEUI
M[ZO)JL::?+3NO^"RWP&M'^-M[)\#?VI6\'?`?XR?$?\`9W\4_$6/X>^#W\#:
M[\=?`/Q('PNTSX5^"=5_X6*+GQ)XM^(GB&6SNO!UK!80VMAHVHZ=?>/KOP2]
MY#;M^0WQO^#_`,8?".D?$[_@G'\,_B;\4_B?J_Q5_:9^'GQ<\0^$(_V(OC;_
M`&5X9\??$'XM^`/C)\8/B?%^T;=Z*GPDM_V>DUX^+-8T2>'Q5+XGT[6A+X%_
MM9KF`@_JQKW_``28B\6_LP?'/X$>)/B=I=UXF^('[=GQ7_;C^'/B^#PS>C2/
M!_B;QI\6W^*/AGPIXCT&766?Q'IFGJ\GAWQ++#>61U6QNKF?3H]-N?(DB`/0
M(/\`@K?\';9_&/A'Q9\%/CYX%^/OAGXB?"/X8Z+^S1XC;X$W7Q0^(GB+XXZ5
MXCU[X=77@CQ1X6^./B/X%2^'M2T'P/\`$/6=6\0>(_C#X<TOPOI_P[\93>);
MC2CI2I<<Y>_\%C_A*$^'?AWPY^S3^U;XW^-7C[XU?$OX`77[._A70/@K<?%/
MP'\1OA=X6L/&^M0>-K[4_CCI?POM_#FK^$=3L/$'A;QAX?\`B/XA\,:[874'
MV;5%GFCA?Q;6_P#@D#XE\>>$]1D\9/\`LE^&_B'X;^*/PI^+WPQ/PQ^#7CO2
M_`FI^)_AEX3^+'@I-.^,UOXA^(VL^+_&GAN_T+XQ^+5L=+T?Q%H7]@W[6VH6
M$GG&99/8?A3_`,$T_&/A'XI?LU?%77/$/P$\*W_P-^+OQ<^)>O>&?@G\+?$?
MA'0/%MO\1_A[9^!-,LA<^(/%_B'69-8T6*SBFNM:UN]U*2]M8XK2**W"!Z`-
M_P"#?_!7OX._%7Q/\.M/\1?`S]HWX'^"?B[X"^+WC/X:?$[XN>'?A[9^&_$6
MI?L[:/>ZM^T!X,N]%\%_$CQIXU\.ZU\,9=)\0:/_`&MKOAJR\(>.]3\*>)+C
MX=>(_%.@+X<USQ+YVW_!;WX*:7\/O'?Q<\7?L^?M">%_AEH_P7\:?M`_"KQ$
MUY\!=<U'XZ_#/X=ZIX%T;Q?-X3\,Z'\:[W6/!_BVVF\?:3K>C>"_BC%X+UGQ
M!X/2XUO3T-_9ZKH6E]/IO_!*J&ZT7]E7PWXS^)EEK6A?`*S_`&W-#\6V=AX>
MNK%_&OA_]L"V^)MJ8M*FEU.=M$U'P?'X]M"UQ<?;X=1?3+AHX;;[1%Y/@GAG
M_@C+XI\*_`SXZ_L^:/XK_9ATSPWXZ_9O\<?`/X>?$K1OV<UTCXSV\_C+2-/\
M.2>*_B3XPL_$L::O+'H=DT>K6'A&V\-1>);V5;C6VNDC,3@'1?M!_P#!7GXC
M>$?A9^T'9^&/V/?CM\*?CKX-^#6A_'?X(Z'\6[SX(&T^*'PBU3QII'A+4?B!
M';Z5\6-0L]`N?#\UY+)JO@/Q)>V7BNWCN]'\^S@N;J\MM,_2GQC\4/B-K'[&
MWQ)^+>K^$_'O[-7Q"T_X2?$_Q:OA[6I_A/XW^('@5_"5AXCN])U1CX0\5?$;
MX3ZEJNMZ/H]EXDTRPMO%/B#3M/CUJTT[6)H]2LM0M;?YH_:@_P""<=U^TGX[
MU3QC=?$VT\*I=_L3^)OV5K*RL?#;7'V/Q)K/C#2_&6F^.<27XA;1M-U#1K&%
M_#HC$\]MYT8U!-R%?KN+X7?%'QG^RUXC^#7QD\9^$-7^)_C3X6>//AYXG\;^
M!O#.HZ!X1^U>+-)U[0-.U32/#.J:OJVHV\&F:3J.G"YMKC5YY+N\M+F9)84N
M$CB`/A+]GO\`X*.>,/B/XI^%7PK\)?L^_%SXVZ%:Z!^S_H_QC_:"N_&/[/O@
M77_#WB3XT_#7P;\0K7Q1<_`J[\<Z'XV\1^%/#.B?$#P5J/Q'\0^"]!%IHG]J
MZY_PCFB^(F\,7UO)Z5_P4!^.GQL^"/Q'_8PE^"/@3QQ\7]:\9_%CX@Z!JGP5
M\$>+O!O@B?XG6UK\*M?U>QTK5?$?Q#U[PWX*TO3M)OK--;>^US5H5A-D8K"&
M\U"XMK*Y^8[G_@CMJ.L^+OV6/$&K_%KP7I&H?LO:M^SMJ&B_%7X?_#"'P/\`
MM`>)-#^!EM;B_P#AUK?Q#T?5XK;4_`/C*YMA#>:;J^D:C+!I<B64AN/[/TYK
M;]2_BY\!X?BG\4?V<_B3+K\NDR?`#QQXH\9P:8EHDZ>(7\2^"-6\'-92S,ZM
M:+:IJAO1*BN7:(1$`-D`'YYZ!_P6&\'^+/`'PK/A[]GOXAG]HSXC_$[]H#X0
M:S^SEXC\;?#+PA/\+/&W[,'C+5O`WQD/Q`^+FO\`B&U^&\7AO0==T^QM=+US
MPW?>(GUVX\0:/:6>G+<_VG'IN;H?_!8W3?B+\1/"?PI^!?[(WQP^-WC;Q)^S
M99?M%ZO#X4\4?"C1O#/PZL[3XP?$+X-^.?"OQ#\<>,/%V@^$=*N?!>O_``U\
M02QZKHNK^(1XQ?R;#P?IFK3>9*F'JG_!&?PC/XUM_BK!XM\"^)/B#H?[37[8
MOQPT#3OBK\)?#?Q0^&U]X/\`VROB.OQ*\;>`?$W@[Q2MY%-J/A_78K2?P]XK
MTB;3[ZTDL;<>689;B.3ZH^"_[`VF?#'X\:C\<=1U_P`'[M=_8]T#]E'5_`'P
MZ^&WA_X:>`[:UTOXP?$SXKWWB+0/#WAY8M/TN*^D^(]QHYL%@:27[#_:5W<3
M7=W,2`?G_P#M%?\`!873?&_[-7[3%IX`^'7Q3^#<WQ`_8[_;H\8?LI?'<^,_
MAY)K6L>,?V??@[XOUS^WKGP9X2\6:G\0_A+=7/D6_C+X8:UXDTV%M8M=)N9K
MQ?#NIP6=C>=7\/O^"NOCGX7?#[X%:)^TM^Q[\;_AWJ?C_P#9K\/?%OP)X^\8
M?$GX0>*O^%I>'/!?AWP==?%/Q%XAM_`7BSQGJW@;Q3IWA[6W^(:Z!XHC:[UG
M3$O+*6]L?$,%YI=MU/AW_@C;H/@WX-_$W]GCPMXH^"NF_#7QC\"_V@O@GX=\
M8P_LP_"VP^/.AZ9\;?`WB;P3ILFH_%;2=/L=6U&'P3:>*K\13PK;:IK]A;V>
MFZM>20B8R][IO_!./7XKSPEX]_:?^+%]^T?H/[.7[.7Q4^"?PF^%G@SX=:+X
M-.K^"_''P\B\$^)$UP6MQ>7?B+QSJ?A/2(-#T&6TGTVU@U'4;FY2(3/`8@#[
M.^'/[6WASXK_`+4_Q2_9N\">%]3UO2/@[\%OA%\4?&_Q=BO#%X7L_$WQMN_$
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M_@&U@MK336M9[,7MW"\DUK<W$4@`L?\`P5]\:ZMXR\2^&/"O["7Q=UG3;#]K
M3XK_`+$_@OQ1J'Q7^#WA_3OB-\=?AU<ZA_9<6C6=YK4VHZ'X#\1Z19Q:S?>,
M?%<&C#0X[A]-TS2?%>K6LMD6>(?^"SOA?1OA?X+"?!&WL/VJ_%_QF_:)^`=U
M^SCXZ^.OP^^'WA'P?X]_95U,:;\:=6\3?M"ZS8S^%IOAWHDFH>$H]%\3^%/"
MGB?6M=U#Q]X0TR/PA:7,NO'0/I;3?^">.A6&OZ)KK?$;6YI-&_;Q\5?MR+;O
M86C1R:WXD\.KX<7P)'N)-OHMK;HMR;M-UU)=-*X*K)M'C.J_\$D?""^(M4^)
MOAKXC00_%^P_:7_:Z_:'\":_XS^'OA;Q_P"#["R_;$ET6]^(_P`+_%7@;Q#!
M/I?B#PS%JOAGPKJ6G:K&UGKUG>>&M,N+:[C9KM9P#R[PC_P6-^)?QT\1_#+X
M?_LI?L0:G\9OB+\0OV>-5^.^I:=XJ_:%\*?"?P9X`N/!_P`7O$OPA\=^#?$O
MC>Y\!>,&U46FJ^'X[_P1XD\%>'?%-MXXAOSYVF>&=/LY=7DQ]8_X*Q_&#]HK
MX,Z)=_LA?L8:Y\1]6\7_`+)7B;XX?&>X\7_M`>$O@^_[/+3'Q?X)N/!VF7EU
MX.\4CXC_`!$T+QOX2\6::VDH?`D5N?#S3ZO?:%>2R:?9_>_P?_8>A^'/[06D
M_M(:_P#$8^)?&]G^SQ/\`[[2="\">$_`/A&XM;_XCZO\1[W7K+0O#-I;VVGS
M17VJ?V9:6T>[?:0">]EGNY&DKYF^$_\`P24N?@1X=U'PW\'?VI?B!X+L_%OP
MK^)'PB^(<LO@CP1XD?Q/X?\`&OQ9^)_Q2T?5[*#6;62VT#Q'X8;XJ^(?#\%_
M91M'=V(@GEA%P@-`'R3X'_X+*/\`!GX'?`SPGIGPVT[XWR_##]C']F+XU_M&
M_$GXC_M`^'_A)XH5/BWX3N-3LO#WPR\*ZCX4^(%_\</BM!X8T27QWXFTJ+7O
M"7A:PTW7O#=K+X]FUG6DL8>1_P""D?\`P4\^.OQ8_9"_;VN_V.?@9J<GP.^!
MWA/3O"_B#]M"#X_:?\.O%GA?XEE_!OB6^C^''PCC\$ZAKWBS3?#MOK>FV%[X
MJM_'N@17%Y=74>DVFHQ6DKO]\?"S_@D=X.^!_P#9%S\+_C3KEEJK?L]_`SX#
M>.]4\;_"KX4?$N?QU<?L_>%5\#>"OB:Z^+=`NSX<\;7/A'.BZY)I$@L=2@MM
M):6`?V-8+'A_%#_@CYHWC?X7_M2_`CP?^TS\1OA?\#_VN_$B^,_BIX!T+P%\
M--4EA\578\/2>(;_`,+>(M1T9;_P_I_B*Z\-6%S>Z+:P_88#-?Q6@BCNFV@'
M9?\`!7[XC_$[X7_![]F'Q!\([+7=;\8WG[=?[..@VWA+0?%5GX*D\;VNJS^+
M4E\(ZIXDU&:+3M-T#5YXK5=:N+R.^C@L89;B+2]5NH;?3KKA_A/_`,%9?%EW
M^TU:_LE_M/\`[*Y_9S^*]I\5?!OPL\67F@_&RT^,_@+1;WXR_"+Q+\6?V?M9
MTGQ9:?#'P$WB&P^)0^'OQ*\#ZVDFDZ*?`?C'PUI=I<RZ[8>)8;_3ONK]L3]E
M6W_:U\"?#_PG_P`+&U_X6:S\,OC/X!^./A/Q;X=T70?$5S;>+/AV=6?1K:\T
M?Q);W.EWVF32ZM))=P2QAY/(C1756?/Y;_MJ?\$OO&_B']G#]I@>"=<\>_M$
M_M@_M<?%K]G>_P#$OQRN)?!?PWU?X9Z?\)+VV\+>"O%O@[2M.U+PWH?A+2/A
M!X-U3Q;JD-CX;>YUKQ%J6N:LT]M?RZB\2@'ZA?LO_M2W/[2WP<\:_'&V^'4_
M@SP7IWCGXIZ#\.!?>)3JVI_$/P5\.-<U/0-/^(%U"GAW3;/PS;^,KK2+R\TK
M2;*^\6PVVEM:73ZW<SS26EO^5^@_\%K?BO?_`+/7P)_:`\>_LA?#+X!^'_VL
MK'0[;]FR[^,/[9?A^#0-8UR;0-7\4^,M;^*>J>%?@OKMQ\//AGX0\/Z3)?6.
MO:=9>+_'/BB\N;+2[GX;>$TGGU.S_:SX6_!CPE\(O@=X+^`W@^V32O"'@CX>
M:;\/=*2TB6,I8V&C+I,M\(V+J;N\D,VH7#.7\V[GED<L78GXPTC_`()F_#KP
MW^SG^R%\#_#?Q#\5Z9XK_8CM8D^!WQEN-&\-:KXDL+U_#&J>$=7GU[PU?V4G
MA?6K#Q!H>JS6NL:-/:)97(AMR-OEX(!\B>`?^"M7[1WQM\5?#+X)?`C]E7X"
M?$/XU>-/$/[27@?Q7XWLOVPYKG]F/P?KOP`TWX0^(K#Q?X=\=:7\![[X@?$S
MP#XZ\*?&/0-2GM]+^'N@>,O`OB>PU?P!K^A7&J:;>ZK;>:^'O^"AWCWXM_'K
MX(_%]_"N@?"OQQ\*?V8_^"I_@CXQ_`OQ?\;V\+?"6?X]_LU?$#]D;3+"V\4?
M$^Z\!VIM/A]<2>)+O5O"_CGQ#X1O-2T'P]XIN=0G\"V&J6UY#J7TM\3_`-BS
M]J6Z_:D_9'\8^"_COXBAG\#^"_VGM+\??M`:=\*/@O:P>%H_B'X<^&%AX<\,
M6OPYDN+#2;:TUK4/!;7\<ND^'=:(UG[7J.HW=@&M@7^,O^")W[._COX86'PV
M\1?$'XG:C)<>`/VIO#7CKQI?W.CW_B_XB>./VKO&7P4\?>-?BEX@U&YL76'7
M]%\2?`_PZ=#TJRCCT;^QM0U#0[J"2Q2W5`#Y7^%'_!>JXOO#_P"T3X;\>_#G
MX)?&/XV?"`_!.T^&MI^Q_P#%OX@>*_A#\;O%'[0_Q!A^%OPT\$V?CCXM?!KX
M?ZGX.O(_&$\7_"0^*5T3Q?X:7P^[ZMH[ZC?Q0Z)>^V?%W]IW]K/X-_'/]F:_
M_:-\'^#?"_Q#/PI_;Q\32^!_@%^T'\2_$G[/WCO0/A/\#[3XI^#->\8^%/%7
MPU^'VH7GBH7VFW7A46&KV6L#PC<6FH^(_#_B&_A\11Z9I?K/B/\`X)#^!?B5
MK7Q9\8?&7X^_%GXB>//B9X(^#'A#1/%-K8>$?`R_">Y_9_\`'4/Q%^%WB7X;
M:)X5TJTTO1]5T/Q-;PW4\-Q'=6-]$)8)((XY<)[-XM_X)[V7Q3\7>'?'_P`:
M?CO\2/B7XP\+>&/CCX.T6]GTSPKX<TG3/#GQV^#=E\&_$NFZ9H6AZ=#:64=E
MI\%]XGM9-\TMQXDU>^N+ES;&*W0`^#/"?_!8_P",WP_^']W\3_VM_P!GCX8>
M%?"_C/\`82\2_MR_!/3_`($?%7Q?\0O%6JZ)X/\`&WP9^&UW\,/B3I_C'X:>
M!]&\->,O%?B_X[^!E\-7_AKQ!XL\+Z990ZZ/$.M01V=MJ%Y]6?LX?M>?MG:O
M^UMX9_9;_:X^"?[//PWU3QI^S/<_M&:-=?!/XH_$7X@ZAH21>,H?"LW@;Q?'
MXV^''@*RM]:TB2;RKZ]T*76M-OKJ&:6UGMH!''+H?$O_`()C?!+5_A;HWAZ_
MTGQ?\4;3X:?L(?$_]BGP[X";Q%I_ABX\9^"_&GB'X1>.5NV\3-:2+X>\;1>(
MO@EX330O$*1&ST>>[N;Z2VD:&+;\P_\`!/3]E_\`:YD_:Y7]JO\`:,T'XN?#
M[P]X._9=TO\`9W\+>#OC[\5/A]\5OB7J>I-XL/B34M5M;[X70GPOI?A[3X+>
MVLSJ%[J-[KOBV_=]9OK'2)6DMR`>3_M\:9K_`(?_`&QOBGX^_;3\%_\`!0/6
MOV-8?A_\-;G]G+XM_L9>./B3;?#[X`ZUX?L?$5Q\8O$?QE\&_`?QCI'CNPU1
MM7N?#VL:/XP\6^#_`!/H#:7IS:?#-)';RV<'UCX-_P""AMOH_P"Q5^W-\<OA
MK<0_&[PG^Q#H$*?"GQUXI\2:I?ZK\>_#5I^RK\&OC]HWBSQUK9LK:ZBUC6[C
MXF3Z3J5W9V43S1:?'?O;07=Q/!']6?&_]CWQW\8/%OC75M)_:[^/?PQ\%?$/
M1+;0/$_PP\)OX3NO"PLQI$N@ZO)X?N-8T2[U?P[=:_I<ICU&:PO<"ZCAOK9(
M;A&9_E?Q#_P1@^"I\$_%KX2_"[XT_'7X*_!7XX_#CP-\.?B5\*?`_B'2YO#>
MO67P\^&OA[X3:#J*S:YIFHWUC<W_`()\+Z1I7BN.TFC_`.$HCA=M0FW&)H@#
MX)T7]N_]J3]EK4_V^/VG[WX?_"/QE^RO\/?VD?V?O&WQM;7_`(E>.Y/C'H7@
M'X[>'OA%I'B%O@_X/TCX?S>$(8/A3:>*U\1OI_C'Q9;+XOMK?5H_[2\.BRM[
MS4_I.W_X*Y_$VP^)'[3=KXT\/_LN^"M!_9[\>_M">$6_9\\5?$_X@>'/VMM;
M\'_!B74++PE\:-(T;4O!+>%_%7@3XK(?#?C&TM]'TVQ3PUX-\1%[7Q'XQN]-
M::\^D?$'_!)/X1^*_$OBIO$'Q8^+=Y\*/B-XR^$'CKXI_!"WO]&L/!'Q(UGX
M(6'A:T\#VGB:[M=-77I]`,W@[1+C7]#CU!;/7889K"Z`M)W2M?Q1_P`$L/AS
M\3O%>@:K\</C+\7_`(V>$O`P^+/_``K;P9X\O="N9?!0^+^DZEH>M)#XPL]*
MMO$^LPZ'IFJ7-OX7@U2\EBTHQ6,VV>:Q@=0#X23_`(+/?'KP5X/^*3>./@7\
M/?B=XOC^'/PT\7_!7Q/\([3XS^!?A!>^/_B_\>O#GP+\.?!+XDZ_\9/">EZA
M;:[X<O\`XC_#CQ)>>-/#1ET_QCX=?QEJ.F^%O#+Z#%97/1?&SXE_\%;_``O^
MV1_P3[^&7B#QG^Q]H^N_$FP_:P:\TWX?7'[0&F_!OQW<>%?`/@/5K!_B)X/U
M/5[OQ%?1>"I=4!\,>3KIDO=3FU6_8:'#>0V\'W%XB_X)I>'_`(D_#KQC\*/C
M;^T?^T-\7O`>N^%;#PKX5T+7O$ND:/#\/'\/^*_!OC3P;XO\/S>']'L+FZ^(
M'@W7_`VB7&@>+-1FFN[>`WUNT+K>2-5_Q!_P3PG\67WPI\:^)OVI/CQK7QG^
M"NN^+]5^'OQ@N[CPM_;^BZ=X]T/0/#7B_P`/C1H]$30)M.UK1O#MC%<2261N
M4O&EU"*19VQ0!^<_P._;I_:)U[7[;]D_]D?X??!/2/C=XV_:G_X*-7<_B7X_
M>(_CEXP^%'AGX8_LU_M#:YX,%X+#3_$FI>,HM<\8SZAH6E:=H&C^*]-\'^#Y
M?MMUH'ABV\/0V7ANUWO`/_!4S]M/]J+5/AEX`_9M^%'[,_PV^)/B+]E/X[_'
M7XE2_'[5/B=XP\,>"?'G[+_[4"_LT_%3P5X:A^&=[H5YXUT7Q%XBCN&\'ZO=
M:IX6DTBQ3_A(-0?7R$\,W'W5#_P2W^"VA7ND^*_A]XZ^*/PT^*OA_P",/[1O
MQ?T/XK^$-:L+?Q98W'[4OC+4O&WQ6\&RB]TZ\T^^\'7VJ:A&^FZ;<VS/IT^G
MV%[%,;F$ENN^`?\`P36_9W_9PU[P-XB^'/\`PF,>H^!?V</B3^S1:S:UXAFU
M>?6O"WQ<^*^F?&KX@>*?$-S<QF?4O&WB+X@Z=)K5[K4CKOEU&_'D@2C:`>K_
M``?\82?ME_L;>&_$?B'^VOAS=?'_`."^IZ1XEG^'WB&]TG7O!^H^*M"U'PQX
M@U+P#XH5%U/2=0TJ^DO=1\(:VR#4]-EBTV]D7[9`PK\#?B?JOBS]@S_AXJ/@
M7\/_`(M_LMPZ/^S=9+\+O#WQ%^+K?%MOB=XC\=_';PO\)G_;"\+3Z;XJ\>:1
MX1O-#G\5!H?#.N>+H_B#KAGT:_\`$^C>"[UY[6V_H:T+]FWP;X8_9J;]E_P[
MKGC'0/!D?P_UOX>Z9XET/7I]*\=Z#9ZS;ZA%'KVA^([54GT[Q)H]SJ!U'1]2
MCC;[+?VUM*T,J(T;_'WQ$_X)>>#OBC\-/C[X3^(/QT^-GQ)\<?&OX*Z7\%].
M^)7Q"\0V.K:O\/\`2/#FMZ;XS\/7_AVPT[3=,T\72_$'0=`\8:V\T#OJ]_IH
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M%_B>RU3]F?\`9-NG^.$6M:EX@N[SXO?%K]IC3_#WBGX?^"1XQL8='L]$M/`?
M@_PQXT\0^+'N+.]?4=;\9MH\4MG;:;IKBY`,+]MK]N;Q5^QG\4?`Y\2>&O"V
MH?`[Q?\``7]HKQ?!JKB]7QS>_&OX-^&;7QIX6^'^DRGQ!::2;+QWHS7.DZ=;
MW6C"YN_$)M;>#7+;S!;2?D?\<O\`@JS\8/'_`.S?\/?"'C[X0?!+4OC'I$WQ
M1/[8/PX<^.HO#OPW\;?`_P#:Y^%'P#\.V7AEM"^*^F^)[/1_&EWXZL/B!X,U
M34=7U_\`X2/PW90WDMC86\]]:V7[Z?M6_L>?"3]L30_AAH/Q9'B*.V^$_P`7
M?!/QC\-W'AG6[K0[N?7/!.HIJ4&A:O);MY>I^$]?>*&T\3:%>12V>L:?&;.X
M0Q.X/@OQ$_X)7?LL_$;QW^T]\1=0TC7]'\2?M9WGP/U+XH2:!JSZ=9#4O@5-
MI,VAZEH6FQJ;#3-0\3CPYX5C\:7L-M]HU\>&-&DNI#-`\DH!^(G[62_MP:9^
MR9_P4?U#5_CK\&_'/A?0?^"E7[.5CH/@R/X1?&3P5XHBUC4OVX/V2KO0-/TG
MXJ:G^T/\0;+P7\.[.*_%GKGAW3_A!XL,UD^J3Z1K,-M=1V</[J_LC_M!_M#^
M*OCQ^T]^S+^U`OP7U+XA?`N'X4^+/#'C+X&^&O&'@KPQXM\`?%7P_J5];-JO
MA'QS\0OB7K6D:]H.NZ+JFDR7$'B>YL=7L4M-3%GH\]Q)ID%?XA?\$V?A-\1/
M%_Q;UR_^(WQET;P=\;?%OA?XB_$'X1Z%XNM[/X;:O\2/"/B7X>^*-(\;G2&T
MN6\AU1=2^&VA27$,.H1V=Q)/J-Q+"TUTS#ZO\+?`[P9X1^,_Q6^.NEG4V\:_
M&#0OA]X=\4BXNS)IB:=\-K36+/0!I]GM`MY6CUN[:\DW,9F$?"A<$`_F+_;>
M\0_M=3V?_!9""Y^-?PVU7P1X)_;A_8XT#X>>#W^&7Q%TC5O#=UXD^$'[(_BO
MP/9V?C)?CUK.G:5X6T[3/$-A:?$C2=-^'XN?'OC+_A*_'.BWG@2P\2VG@C0/
MMWXA?M[_`+97[->N?M(_L^?'/7?A5X^^+/AW6/V+HO@C\:_@U^S7\6=>L5M/
MVS/B'\1_!>IZ?K7[,OA;XE^/_'/CS4O@O%\*_&5_X8B\.^.='O\`XI2'PYH^
MI:;X:N;F[U:X^[OC-_P36^!WQP^(_P`4/'WBCQ3\5])T[XSS_#37/B=\.?"O
MC$:-\/\`QEX[^$A\/VO@;XA:SI"Z?/<S>*-*T'PIX<\--<17T%O<Z/HNG03P
M.]LCUZQ\6?V+?@M\9/%'Q/\`&GBB'Q/IWBKXJ^#O@=X1UCQ%X7\03Z%K>A3?
MLY_$/QM\4?A)XN\(ZA%%,^@>,O"_C#QUJ>H6^M0)(98[+3+:>"6"WDCF`/&/
M^"=OQW_:9^,6A_&C0?VD?"GB?SOA?X_T_0?AO\9?$G[-/Q4_9,D^.'@O6M#B
MUH:]_P`*9^+=[J6O:'J?A?49+CPSK%YIUZ=$U26WMKVSM+%YIH*_1RO`/@-^
MS[IOP&M?%R6_Q.^,WQ5U3QKJ]IK&L>(/C/X^N?'.KPOI]HUA966CE[/3['1M
M.AM2!):Z?90K=7`-U<M).Q:O?Z`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@#\MOVQ?V[?&_PB_:=^`'[)'P;\-:#-X]^)^@>)/BKX\\=_$;0_'$_@/P
M;\)?`_BGX?\`AW6%TRX\)Z5>C4O%&M7/CA+5+B^N]/T#PE#;)JOB.]B@NK2&
M;2\9?\%1_P!G#5O@W\4?&/P-\<VGBWQEI_[/7QO^-/P3C\0^&O%N@>#?B^_P
MD\&Z]KTL?@_Q!J>DV%IXGLDU#2H/M]OHUQ)J,FDR2:A96\UMMGI?VC?V1?B!
M\:OVU/#?Q*M)WTSX4ZO_`,$]OVMOV7?%'B:WOM+6^\+^-?C%X^^!VJ^%+FST
MB;45U747O-%\-^++MKJTTM]/T^30+>&_OXYM3L8'_.70_P!C+]OKXI?#O]D'
MX!?$_P"!O@GX,Z=_P3\^"?Q6\":1\8O!WQ<\">)]$_:7\1']GW4/@/\`#/3?
M!'AQ["^\6^`?"GB^UGM/%?Q'N?B1I.CS6>MVEK9P:%KFGHTZ@'VG\#O^"H?A
MZ_U7]K&[_:/N/"_PX\(?`CQ;^R+X,\%W.BP:SJNO>,_$7[27[*7P;^.4OA^Q
MT.VBO=3UG71XP^)&HZ%H6GZ19RSR:396\UTBO'<3#ZE^'O\`P4+_`&5?B;XZ
M\/?##P[X_N[7XB^(M3^*>B0>"O$GAK7_``SXCTW6O@UX:\,^,_'6E:WIFM6-
MI/IE[9^$/%VA^)].24&/6=#GGO\`3I+B&SN3%^17C#_@G)^UM%KGC?XV^#/`
MOA2[^(OPU_:,_8#_`&G?`/PMOO'WAW2="_:#U/\`9P_9-\"?!GXB^`=2\90?
M:(?"-_;:SI6H6'AC7_%.BV>F7]YX?T>X9;70[A-0ASOV@O\`@GG^W%^T)_PL
MW]KKP?X5\+_L]?M8?$']I'X<^(/AU\/+OQEX+\9:Q\(/@QXD_9JU3]B/XVZG
MXM\3V<NI?#GQ9XI7X;>/]?\`BXOAGPSK<<<][X$\/6NC>)[WQ"\'A^[`/TV\
M>_\`!43]F*R^!_P_^,?PM^(OAGQU8_&*3Q!'\*;JY77[7P[K:>#/$6AZ)XPO
MM;OM.TG4-1T'2]+36[9H-1N=.-M>7-WIL4;^7>I)6IXA_P""IG['_A;QSXK\
M`:SXP\5C4OA]\6M&^!OQ#\16/P[\8WO@+P1\3]?MM`GTCPYXA\;QZ5_8%E+?
MOXFTBWBD%W*()KN$7RVL<]M)/^7VK_\`!'KXH^%/B[^TUH/PET?P?8?LT+\%
M/!NC?LF^&)=2\,Z4OA?XC>+?$_PU7XT:?<6#Z-JVH:)HEOX5^$OAFZLKRUET
MFTUO6;N]<:?'=[-0C]E\;?\`!/?]HS6OV<_^"@/PST_2?#,OB?\`:!_X*7:%
M^U'\-(G\3Z=%::G\*K+2OV7X[F[O[N1ECTG68[CX8>+[;^R+_P`FX=[*WD0M
M!?6DLH!]^:Y_P4E_9:T#XEV?POO/$'C"?4M1^-OA3]G/3_%-CX"\27?P\O\`
MXU>,/%]KX&T[X?V?CF.S&A7.MV?B6Z_L_6$AN7@TZ2UO5EF:2UEC'U!\.?C+
MX%^*FL_$O0?!UYJ5W?\`PE\:2^`/&0O]%U/28+;Q+#IUGJLMOITVHV]NFJVJ
M6E_;'[?8^;:-(S1I*S(V/Y>/C'XA^+?@WXT_LU?L'Z>/V:_'W@_PG_P65^`G
MQDT+QIX!^.FH^(/CY>:'_P`+SU[XT^)?#OCW]G6/X?1#P1=^`-`M_$E]XT^(
M6H_$F70YD\/6]AH_AV\N?$=O>Z9_3?\`"[4/C5=^-/C9;?$_P+X#\)^"]/\`
M'5E!\%=;\(ZU/JFM^.O!#^'M/EO_`!!X\M)EC31?$4/B!K_3HM/@1HCIMM:W
M'G2M*VP`]LHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#S^Q^$W
MPKTOQK?_`!*TSX:?#_3OB+JJLNJ>/K'P;X<M/&NI*\#6S+?^*K?38]=O%:V=
M[=A<7\@,#M$08V*GT"BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`S]7;5$TK4WT2*SFUI-/O6TB'47ECT^75%MI3I\5])!^^2SDNQ
M"ER\/[U82[1_.!7XG^`?^"KGQ*\!>'?BGX__`&WO@#>_!'X=^`_V:M*^,6G:
M]X9TG7=2^W?$KPC\4]7^"OQG^#LSW^IWJW'B(^.;_P"&E[\*;."WM-0\1^'?
M&KRZA#'/IX>?]P*^&/\`@I-^R?JW[;7[%WQG_9T\-ZMI.A>,/%EEX7\1>`M7
MUZ.>30['XA?#;QIX=^)/@.?65MDDN!I0\6^$](%^\,4TD=J972&4J(V`/-?A
M-^V7^U`+J^\9_MA?L>^&?V1?V<X_AKK_`,36^-FL?M+>%/'8\%:;I"Z)=6FA
M?&+PM%X,\++X`\0ZEINKS7+1:=X@\7:5976DZAILVJO=)&K^X1?M_?L8R:)X
MN\13?M&?#+3](\!:9I^M^,;K5M<726\/Z)J^L1:!HVM:A;:C%;74>DZSJUS:
M6>E:@L+VU]+>6BV\CFXB#?FE^TOI?_!2']O_`/96^+W[*/C+]B'0?V<_$.J?
M#[P[KDOQ5^(/QY^%_C_X8?$;XL_"KX@_#SXB:!X+\,^&/AQJ>J^,[+X<_$W5
M?"6H:7J^O>-M*T#4-"\/WIM;CPW>W$S21?/_`.TY^RM^W;^WI\4(/C_XG_9'
M'[,[_"_X>_#[X5Z1\,/$'QH^%'CKQO\`&6YN/VB/A=\1O&&OW>J^"?$=[X%M
M/A]X'\,^"[Z\\+0^(M:TOQ9JVI7^H1OX7LI&MHY0#]?'_P""G/[":3WULW[1
MO@47&C^)&\,>(X3+J`E\)711Y;35?&"&Q#>%O#&J0?9KG1_$^NBQT/5K74-.
MN;"^N(+R%VL^(?\`@I7^Q#X4\?ZQ\,_$G[0'A#1O%GAWQ;?>`_$%O>KJ::;H
MGC&RTY=6C\.:IKB6+Z1::MJFGL+G0K&2]%QKB_)I<=U(RHWQ%\??V*OCGXZ_
MX?A_\(A\.M+BO?VS_@[\$?!/P)OSKWA"T/Q'UCP3^S;=^`-2_M*Z:]AU'PU'
MHWB:]/AV&W\5FRT];>T&KZ.S0:E?2'Q/3?\`@GC^U'9_#;Q7X?E\':*=6U#_
M`(*S?L5_M3V5LGB[P^PN/@M\&?&?P3U#Q[XD68WJP1WFFZ?X0\07MKH4\D6L
M:C%8B*SLY+NYM;>8`_5S3O\`@HA^Q[JOPPU#XMV/QFT2;PQI7B^;X?:CIIL=
M8C\;6OCR"TAU)O!DO@&33U\7CQ,^CW-KKL.D#1S=S:'=6VKQQM831SMGW_\`
MP4E_8LTWPGX'\97'QPT!M,^(]_\`$31/!UC:V.M7GB/5_%'PGTV/5?B)X-7P
MQ:Z=+KUMXR\)V4@DU;PO=6$.L6Y#J;0[2:_(G]I3_@FK^U+XA_:D^,_[4/A7
MP;'\0O#MO^VCX=^.?ASX1>&OBW9?##QG\5?AG-^R#X&^!_B)?#WCB9[?3_!7
MC/2/%>@WSZ;8>([RQTS6K"/9<:IID-RMW'[!^SS^PQ\8M`_:3_90^--K^S/I
MG[.7@WX<?M4?M>_%[XE^']7^/T'QK\>:[I_QB_9`T#X-^&?B)XIUQ+6*PD\8
M>*/&NFG3-5\,>'+S5[#0]#TO3=4N-9U&]O-0F(!^EVK_`/!0?]D#2?!/PW\?
MQ_&GP]KNA_%ZUU"]^&UKX4M]4\4^(O%]KHUY;Z=K\VD^&-"L;[7I(_#FHW4&
MG^(FDL(UT2^D6TU$V\YV5YOI'_!2?X"6\_Q'\2_$+QG\//!GP<T/Q[\,?AU\
M,OB+;>,-6US4/'OB7XB^$;GQ,FD>(/"3^#M)F\#:Q;7%O_9FEZ9_:WB236&9
MGEDTN[0:>_Y@?L^_L&_MJ?L=_&/X'?M3^&?A/X8^..K^%O!/[8OP7^(WP2L?
MBAX:\(^)-*\*_%_]H34/CQ\./B%\//$WB*T/A+4-1U9K>T\,>-?#^JZQX>>W
M@ET*[2ZOCIES%;>H>./V*/VN_BYKL/Q(U_X5?#[P/K'B_P#;R_98_:=\7?#^
MT^)UKXCM?#GA#X=_#]-'\76MCXFM-$\/)K.L^'M5:.*Y"Z=8IK]_!>7NGK)8
M7$2L`?I5%_P46_8\F^%U_P#%U/C%I8\*Z7\0D^$]_8/I.O)XTMOB5-IT.MVG
M@F3P&^FCQ>/$.H>';FU\3Z=8?V/YM]X:N8->MO,TR07->Q?`']ICX+_M/>'_
M`!)XG^"GC"+Q?I'A#Q7?^"/$L@T[4]*N=&\5:7!;7&H:+?6.K6EE>07EI%=P
M&:-X1L+[3R"*_%;]H7X'?&[]GG]L3X[?MMPZK^R_HFD:[^VO^S_\5OA#HG[2
M'QYT_P""GAGXG^'M%_X)RZC^RCX^T"U\8R^'_$Y\,^/=+US5_$6O>%+&[T/4
M5U*W\.&^>);-V9???^",6N>-/'GP]_;-^-WB.#X>W\?QG_;;^-GC7PUK/PF\
M:'QS\+O%-I;+H^AW%_X"\9W-AI=]K_ADZKI=U86/B"]T/2UU,P2WMI:-9M$[
M`'H7@K]N#X_^!OVP?VEO@)^UAX.^".@_#+X6?!O3OCW\-_&?P)OOBMXW\7ZG
MX#\2_%BY^'_AG3/'OAS7O"^G&'Q=_9S:;=ZS8^#K76=,@U*6Z2SU*YL85F/O
MMW_P4@_8]TK2M6U77_BJOAAM"^(?@WX6:SHWB;PSXHT+Q+IOC;XB:&WB+P+I
M5WX;U'2(-9C3Q;I,5Q<:#>?8S::BUI>0V\S2VTR)^6_Q@_9/_P""EO[45W^U
MS^T3;^#_``+^QW\7_B)^S5\//V?OA?\`"W0?CN/B-XF\0V?@SXIP_$?QG<:M
M\7=`\">&M(\`P>.]$^T>"]"GTK2=5U+39[FXO]2O+*T?!XOX8?\`!-?]IF3X
MI^`_BN_[.WPG_9QT33OVC?\`@GQ\4=7^'.A_M`^)?C5XFN-`_9TU+X_P?%#Q
M1XS\<>(]`TJUUWXB7,/Q$\-SVUIHEO:Z-/X6LM(TFVO=0UG1KZ>^`/V4\`?\
M%`/V5_B5:Q3^&?B),+P_%[P9\";_`$'6_#'B;PYXGT/XG_$.P;4O!'AWQ#X<
MUO2K'6-#_P"$GLO*GT?4-2M+?3KU;FU$-TQN(@VEX[_;C_9\\!6WQ+DN-9\7
M^+]0^$7CRV^&?CWPW\,_ASXX^)/BO1_&MWH&E>*(=$7PUX.T/5]7O9CH.LZ?
MJ;RVEK-;QV\Q9Y5,<@7\X?V@_P!BG]J74/VCOVKOVC_A9X-\%^-+R[_:%_X)
MZ_'[X.>!M?\`'D'@Z/XJ6W[,6@Z7HGQ,\%W_`(F72=>'P^U2ZM)]8D\-:UJF
MA:QI]WJ-C8V]U:P65_+?V?RIK_[!/_!1CQ9XA^)?QA\<?"GX9ZU_PL+]N:3X
M^?$']E3P3^TQXG\`>%?BI\,+WX)^&/AWX7TF]^-&G>%HM4BN?A]KFC0ZMKVF
MZGX.ALO%5U!?SZ;I]I;G38&`/V-UK_@II^QMH=G\)KRX^)UY>CXX^%_BEXK^
M&-IHG@SQAKNH^)K7X+^,='^'_P`3=)AT[2=%N[RU\4>$_&.MVV@:CX9O(8-9
M6_M=5B2T;^RKXP=[X5_;H_9J\<>'OV>/$OA+QO>^(++]J/Q_K7PR^$5GIOA?
MQ)<:WJ'C#POX=\6^)_%UAXDT--,_M3P7;>#M,\$Z\GBW4?%5KI5AX=U%+#2]
M4GMK_5-/M[C\X/V(/^"=WQ\^`OQ&_8A\7^-?#_P>\%:)\`/#'_!4"R\;>#?A
MIXL\2Z]X=\-3?M@?M?M\;_A'X8^'D_B/0K76=;T'0/`\XT_5KSQ!-8W^G7-F
MEJSZM*YNI*'[#_P@MS_P5/\`VZM1\(^((O$'[/O[-FLZI:?#32;?0W@TKP/^
MT7^UG8>"?B%^T]X9L=91_L%]?^&1X%\)76RW@2^TM/B?KFDWI(1);D`^]?\`
M@H5^U?\`%;]COX-:/\5/AI\"E^,EE<?$#X?>#?&FL7WC?P]X3T'X7:-X_P#B
M'X-^'MEXOUK3=0OH/$WC"(:GXO@CM?#_`(-L[O4)KB$-J-UI.GL]_']W6\C2
MP02L`&DACD8+D*&=%8@`DG&3QDDXZDU^>/\`P4Y^#?[2W[0_[-=_\%/V:_"/
MPB\1:UXP\6?#K6O$.J?%OXH>)OAKI_ARU^&7Q5^'OQ3TV32QX9^%OQ-G\12Z
M[-X-N]!O+2>/0!IJ7MOJ<5[>F&2Q=GPX_:+_`&D?%_[8W@W]F_7?A[\/O"VA
M?#G]EBQ^+O[4NI>%]<\1?$#1_#WQ0^(/BJ\\*_"/X=>"?'.H^&O`D<RZE8^#
M_'WB^[;5/#$>IW.BZ9"D]AI2_8;S60"#]NWXC_M]?"?2O%'Q._9HU7]B'PO\
M%?A;\)=3^(/CW6/VJ(/C!>Z]K_B+0IO$=_JWA?1[SX?>*O"'A_P%X>'AW3]#
MEC\<Z\_BZ:'5=2O(3X0NK:S663\_O&G_``5@_:^^(O@[5/%W[*OP)^$>EW_P
M,_8/\!_MS_M(^!/V@+?XCS^(M9MO&OAS7O%=M\$_A#J'@;5=*M-&\47&@>%]
M6U2P\7>,;#7$>"[T6/\`X0>XFNYQ![[_`,%-?V9_V^/VFOBQ\%]!^#GA[]G/
MXC?L=^"]-M?&?Q0^"?Q>^,/Q&^$MQ\7_`(O:?KFK/H6D?$"7P-\)_B#)XF^$
M/AO3(?#VN0>%(]7T6#Q#XG:]A\46>IZ18V,$GE/QI_8L_P""BOBW6_C#\2OA
M;:_LK>"O'G[:7[']I^RQ^T7X8N/B-\4$\(_`C6=)/B?PKX?^+7P3U73?AW!?
M_$>[T3X?>+;T6_A;Q#I/PY5M=TK2(H]=@T]9RX!D>*_^"K?[2_QALOCA\9_V
M)?!'P'U?]G']E']G_P#9S^/OQ=M_C=HOQ.N_BC\6H/V@/@[!^T/!X%^$.I^!
M/%&E^$/!.I^%_@]J_A34[[Q!XKL/'$,VO>);:Q;P_;Z;;?VI<^+:_P#\%O?C
MW?\`C+XH>*_!'AK]G33?!'PU_:`^`_P@\(?LB^,-*\=7_P"V#^TMX)^+VD?#
MV_F^+/PC^(&D?$S2_`.A17+?$K3KKP-X.U'X.^+IM<TSPOXIDUGQ)H4J6E>K
MZY_P2U_:@_9^T[]H[X,?L2ZK\([_`.!7[7G[.W[,WP*\<:[\9OB!XTT+QO\`
M!"^_9]^#FD?LSW?B_P``^%_#G@+Q/X>\=1>+?@;H6@))HFHZQX*:T\9>'XKR
M?4[S3=1DM;3RKQ#_`,$;_P!IO2O`?QI_9.\`Q_LNZG\#OC3^T)X9^.&E_M4^
M+K[QS#^TY\$;?3+CPC<R:+X-\%VWAC4M*UC7O"]MX+T[0/`GB2S^*W@ZST[1
M;R2"Z\/RPVK6UZ`?T[5^)Q_;`_X*)_M+_$7]J/4_V%_!?[(=C\`_V2_BWXY^
M`M[>?'NW^+?C/XD_M%_%SX5Z7I5[\2_#GP]_X5IXN\':-\)K#PWXAN[KX>VV
MK>*M'^([ZMXCC:_BT^"UT^^TZOM']C;XJ?'7XNZQ^TKK7Q.L;/3_`(8>$OCG
MK7PR_9Z=]!N-&\1^)/`7@/2=+TC7/&?B>>ZNIGU2[U_QDNM_8;RUM]/T][&T
M0VULP)D/Q++^QU^W]^S!\1/VI=(_8-\5?LX/\$/VPOBKXV^/.KW?QNOO'NE^
M/OV</C;\5H+:W^)GC3X>:7X3T35]!^)6B:WJ-K#XSM?"GB*_\)3V_BC[0I\0
M'3KMXHP#M?`'_!:/]FOQ?X#^'.KW'@CXYW_Q*\9?LS^%/VH=?^%'PS^$7C;X
ML:[X,\!:QXW\:_#7Q/-JU[X*TC4M.C'@;QO\/?%6F:\TT\+K;6MK=VT<XND0
M>NZK_P`%5?V87U'PQI_PWT_XS_'A=8\"^#?BCXHO?@7\&_'7Q)M?A7\-_'NE
M7&L>&?%_Q/\`["TJ:?PI:WMC:W4KZ5<PR:_;"UNFGTI%MIF3Q#]EW_@F+XC_
M`&6_BSJ6K>&?%N@:_P##ZS_X)I?#/]CW2]0U";4+7Q=XF^+VB?&?]H+XI^/?
M'6O:8EA/INC^'=:F^*.BW=F;+5-3O9-0O-:M7TZSMM*LY]5\$_9=_P""=W_!
M0#]AP7LO[//C_P#9R\3S_&?X.^`?!_Q>_P"%M3>.;MOA9\4_AWX5UGP[I/Q'
M^'D^@:%:-\2M#O8[C18[WP3XDC\%1I'IAEMM7C,TT,P!]]:%_P`%/OV8/&/Q
MA;X.:%?_`!*33KSXD^)?@7IGQY/PW\0VOP"U#XY^&;B;3]9^%7A_XM:EIC^#
M]8\<Z??P7=G%9V[7VFSZMI]WI0GGO;>:SKPO_@G+_P`%---^/WP*T4_'_4_[
M,^.>@_L[7W[2_C.]@\.0>'/"GB?X71_%#XF?#R;7_!JPW,MM=R^%]1\!6^E>
M+;-!`VG:AKN@.4\K6;<CQ_X<?\$R_P!I/PCJW@3]FC4_$WP0E_8-^$7[8'B#
M]KSP'K6GOXS3]H74YM1\>>*?BCH7PF\2:>UI%X6^P^'O&7C&_0>/HO$-UJNJ
M:#I6GV%]H;RSRSP_'WQ^_P""?/B3X8?#?_@DI^QOI_Q#G7]H37/B3\</@;X^
M\1?#O2=273?%?['/CRSUOXC_`+2UIKU]-`DUEH/AZWTSX<:CHHU"1]OC_P#L
M%+*"*&^OM1LP#Z%\2?\`!:OX@:GHW[>$?AKX`_$[P)H_P`\'ZEXT^%W[0>O?
ML_?$+QM\'/"GA.R_9YM/CBNL_'0:9XL\/SC6M9MS<V7@_1M"U#2;+5I]4\+V
M\]Y*MU=2M^B&G_\`!1KX<C7-`\)#P+\7OB'<Z7X5\!ZI\:OB7\*_A9K^L_"C
MX-:UXR\#V7CA++X@7XOM1U'PDZZ)>6NM7&E7+ZQ?:!I&J:3)K-WBY2YE^:_C
MQ^P'^T_XFO?^"A/PS^$7BCX`67[.W[>OP/\`%/@&_M/&>C^,4^(/PM\77G[*
MOBKX$^'I_#9T2X/AN_\`#UMXIB^'FLL+ZT%WIF@6'B*"TBN=4GTRYM.M^%'[
M'7[97[//C3XF:?\`!_X@_L_:A\-?CXGPHUWXD:S\2O#/C/Q#XW\)^-/!WP7\
M+_"#QA<>%M(L]3L?#GBG1O$5GX'\.7]A:>)Y8#:23:L+U+U;B.)`#Z3_`&1_
MV_OAE^V?J$DGPG^'/QRT_P`"WW@V7Q]X,^+/C?X:ZGX8^&_C_P`,KXD_X1VU
MF\.:]=2N\&KZFCVWB'3?#>O6FC^(+KPM>6VNKIHLF9UPO%G_``4>^$&B_'WQ
M+^SKX7\"?&GXF^,?`7C/P'X"^)NL?#SX?SZWX=^&VN_$);&[TRX\0S7%Y9:A
M>:-H^AZC:^)/$VM:!INL:9HFC^?+>W*36US!%\R?L2_\$X_BO^S_`/M3/^T-
MX@G^"'P8\,K\%+WX>>)_@Y^R[%X]TSX??&?XAZYXBM]7OOBIXZ\.>,=1GT+P
MW<^&[/2[6V\*Z3X3TR.[$VL:E_:6MW%E:6MI+SW[6_\`P3+^,'[3/[26C_$R
MQN?V;O`,>F_&'X->.=)_:6\*>%_B#X8_:S\&_#KX:>+=)\7^(?AG8W_AWQ18
M>"?&4_C"VT>Y\!0^(O%]K<V6E>$_%FNF\\.:U-!;6\@!Z1^RS_P4RTSQ)K_P
MT^"?QT\(_&K3/B#\2/C5^T1\&O!/QG\0_"&3P=\'?B+XP^$_Q3^)NDV7A/PU
MK]B4TN\U:S\'>$%LI+W3[271M2U/0M7-MJ]_*DES-Y_\<?\`@JY8ZY\%_P!I
M'PW\,/#/Q/\`V?/VB_!7P2^(GQ-^&W_"UM%^'GVJ[A^'NN^#]%UR\71EO_B/
M9Z9J^G3>+[!YO"OCKPQ:ZPMO'J4EQHL9TVZ:W]'\;?\`!.GXC^+OA[^R+X*?
MXI:/!J?P`_:._:`^,WB[Q7%9ZE;ZCK>F_&6?XZS69\/QQR,UKXATF3XL:==3
M2W-PENUSIETT$P#PD?!WPL_X(L?M(>%_!.D?#[Q?XU_9%:P\!?L^_'OX`^'_
M`!EX#^$'C#0?B'\6[SXJ+H5Q;_&3X_\`B;5?%6LZEXL\8ZYJUC>ZMXCTBTO8
MK6PU&>\O;35=2?562P`/TU_8`_:*^*_QJ^)G[;'@WXJ>+E\3)\'_`(P_#/1_
MA_:IX8TCP\OA_P`%^,?V?/A?XXET]KK2M"T9];DG\6:UXDOS?:E+JES&ETEM
M:WO]EQ6,,7GGC'_@L=\"_!.N_%==5^"G[3DGPS^`'Q@N_@W\?/CM;?#"(_"+
MX1:Q#=^'K&S\1>)/$$^N0WNH>%KVZ\2Z=Y^H>&=+UN?0K5FU'Q)::1I[PW,O
MO/['W[(7BK]FWXJ_M-^/M=\4^&-=TSXZWOP1U#2M.T'1]0TZ]TN^^&GP6\)?
M#7Q!=ZM<7=]<P7)UK5?#\VH64=M!&T5LZO<3/)-Y%O\`D5X%_8^_:S_:H\2_
M\%,?V:;WQ_X$^$/[*/Q2_;AO]0^*LVI_"'XA6_QR^(7P_N?#/PUU?7?"_@7Q
M'JOC"V\":;X6\:6.F#P[-XKL-$UV_CM$U*2W:T>_2VM0#]$/&/\`P5T^#7P_
M_:GF_96\9_"'XTZ%XAU?6+[PM\+_`!M-#\-[KPK\8?&4/A0>*=(\,>"](L/B
M%=?$"QN/%86;1?#&K>,?!OAGP]JNK1PK%JRV5]I]Y=?0?PI_;W^#/QD@_9/3
MP59^)[W6_P!K2P^(.L^'?##PZ*==^'&@?"KPKJ>L_$'6OB?;V^M3PZ-:>&/%
M<7AKX7:A%I4^M7@\>^-_#UE%;2:7'K.JZ5^:7AC_`((X_%S2?VC/"'Q$O?C+
M\#C\-OAI^W[XL_;5\/:H?@9=:O\`M'>.M(\7^)-8\3V_PE\=_&75?%[W-IHO
MP_CU:+PGX0FT73A:2^']*T]+_3A!;VUA;]__`,$S?V9;?2/VR_\`@H+^U$EC
MXKTOP!_PMSQC\!/V9_#7B;P_>Z)I?AOP+/XL_P"%K_'KQ%X">_L--FN?"_Q-
M^.VLW/E^5!<6"6GP^T46%[+""D8!Z=\>O^"BOQA^"O\`P4L^'O[)%E^S7\0?
MB!\$O$W[/L/Q-\4_$CPMIW@Q7\*WDWQ"@\.ZM\0+S6_$/Q/\.+:_##X>Z')/
M/X_A/A;4/$*3PK<:!;ZC&LD;>I_`W_@IGX!^,7Q$^#_@K7/@=\>/@KX?_:5T
M/Q/XE_9@^)_Q5T;P99^!_CUHOAQI[^UG\-KX8\:^)?$WA'4/%G@V%/B%X0T'
MXF>'_!6NZ[X-GAU*VT[S2]LE_P#:8_8N^)OQ8_:;\"?M'?"SXJ^!O!\MG\"_
M&/[-WQ-\&?$3X=:MXYTOQ1\,/'/BJP\0ZW=>&+S0O&G@VZ\/>+UM8]3TJTOM
M3/B#15COXIY]%FEMAO\`'?@K_P`$Y?C?X=\=_LBR_'K]I3P[\5OA-^PAIVLZ
M;^SMX5\+_#75/`GB_5YHO#>H?#SP'XD^,_B:7QQK^D>+_$_A'X9W-OX<N+KP
MYX:\):=KVI)>Z[>Z<MQ?RQ*`>A?M#?M=?';X<_MT>`OV8_A]\%_%OQ'\`^-O
MV,_C!\:]9\1>$Y_A5I.H>$_%?A+XN_"KP#9>*6USXD?%+P6LF@>"=(\:7-SX
MH\+:=X;\1ZYK]SXI\)WOAM)XM!\46=?$W[%__!8!/#OP%_9NM_VQ/`/[0FG6
M?CCPI\;D/[:'CCPY\-+#X3?$W5?@#HOC?Q[XVU>+3?!_BUO&&EQR>`O!FO:I
MIUY+\.-(T+4W\.ZI!IL\ACA\[]&_VCOV5_C+\0OVC?A7^T9\#OC#X*^'.M^%
M?@I\6?V>O'OA_P"('PXU#X@:5XF^'/Q7\;_"7QS?7WAJ72/&'@Z[\.>,=)U#
MX60V=EJ%_+KNCR6>L7'VC19)[>*6OEK7_P#@D-I'C7]F[]C3]F3QK\5DU7P/
M^S5/\>]-\>W&F>%I=$U#XF^#/CQ\)_C-\)]8T71);/7`/!FJ:=I7Q<ENH]98
M:T\\VDL_V>*XO//@`/4?V6/^"K?PE_:>^,'@OX.I\-/'_P`+=9^+G@'6?B?\
M$M2\8>(OA+X@M_B-X/T'3]'UC45N])^&_P`1/&GB+X=>+(M#UB'Q$W@WXD:1
MX8UV+0]LEQ;PZG'>Z79?)W[<O[0W[2%M_P`%)H_V;/`W[;?Q4_9*^$6D_L._
M#WXXK:?"?]ESX._M#:KXG^(_B/XZ_&KP3K%SJ]Q\0OA5\0=9T+3X_"?@K11!
M#:7EEIC3Z?))%;"[N+N2?ZB_8^_8$^,/[-7C_P`"ZAXC^)G[-_BCP!\,_"UW
MX/T*?P'^R5X+^&'QK\9::OA6U\+Z5??$SXJZ5K%X-4UA6M/[<UVY\,:!X8@U
M_5KFY^V6WV-DMD[SXR_L=?'C7?VT)/VQ/@)^T)X4^%>LZQ^S=X"_9K\4>%O%
MOPGC^(=K?^&O!GQ4^)OQ1DUK3;U_$^AG3M6O;WQ_;:?`'M[FWMX=+N))H[IK
MV);4`^/O&W_!6Z#]DG08O`_CKP!^T?\`M7P?!#X(>`_CI^TQ^U!>^"/A;\'[
MCPY\)_&?CS7O!UQ\0?$'PFLW\%WS:[HLVGK<GP1X(\"6]WJNAV-]J>FVTLML
MPO?3?$'_``5]LOA]%\:](^+O[)OQO^%OQ*^$MY\!=5TSX7:[KGPSU;Q'X^^'
M?[1WBV\\#?#CQ3I6H^&?%VL>&M"UQ_%&FW^DZ]X-\2ZSIE]HEP+<7=Z,:B--
M=\;?^"6?C3]HGPI^UQ;_`!5_:&M-0\?_`+6_['_A/]ESQ3XLT3X<6NBZ7HE[
MX/\`&/C+Q-I_C:P\.PZ[+$\,UIXEL=+N=#%W%EM-FNTOU>\\N'RK_@JG^PK\
M1?',?Q:^/_P5N?%?BKXH_%E_V(OA5I_@SP]X,D\4_P#"(V'P4_:&O_'4_P`1
M9;.S\R?4=/TRW\5W6I:Y;7B0:=:Z=HCO/<I'-(R@&%\:_P#@I1\0_%NJ_!WX
M?W/@WXA_LC?'WX0_\%'OV+OAC^T?\(=;\3>%_%+W_P`#OV@]0\37OAG58_%7
M@F^UCPIXL\#_`!,\*:'XBMY4M+E[G2/$GA77-.D1+K2+/4+GV[_A[_I=W<^&
MM6T;]F#XKWOPR^.&C?&RS_9#^)%YXF^'FF6?[1_Q2^"GA7Q7XFN?AK9>&)O$
M$GBSP')\0_\`A$[_`$_X:>(_$NDG3M?GCG%[%I,RVMO>V+;_`().'Q3X@O?B
MU\:_CKJ?Q(_:!\;?M6_LV?M'_%/X@6GA'3_#/A_7?#7[*PUZR^$_P5\+>#[6
M]N;?PMX.T?2O$_B4R7QO=1UB[UGQ+K>JW=U,UQ!#;ZWP9_X)7R?#7XE?LZ:E
MXK^/>M_$/X(?L=>-/BSX_P#V9O@[=^"?#FDR>$?$/Q2LO$&D))XL\662/J'C
M*W\$Z+XL\1V7A.":VLVMKF]MM4N7N-1T^UG0`=\2?^"Q7P`\!_#KX"?$O2?#
MOB#QQH/QP^`J_'XKH5[86L_@K0=2D\.^'?"_ASQ"VJBTAL_%'B#XF>)['X<'
M3]3DTG^Q=9M-:N=:>RM]%U$0><V/_!:OP1H6E?%G1_C!\$M4^'7QA\$S?!=/
MAS\.M*^*_P`,O'V@_&9OC[XAUOP7X`L?#GQ0T#54\&Z!K-AXR\,:]IOCO3O$
MUQIZ>$-(AL/$US=76DWYEM_(OV/O^"7V@_$/X5_M^3?%7P=XZ^$NF?M*_M(_
M$2+]GK2_$EK<V'C#X4?!;X>_%[6_B'\-?$NA^$O$.FV$OA/3_%GQHU+QA\6=
M/\':_H5M<7?AK5?#T&NVTT5R$7ZB\0_\$R?''Q2\*7VE_&O]HK1_$GB'PYJ_
MPR\9_!G4_!'P#^%_@#1?A_\`%#X6:P^OZ'\1=?T'3].NHOB#J&H7[-;:SH'B
M*X?PQ<:3+<64.E0-,TP`/J+]BC]LO2_VPO#/Q+NSX$O_`(;^-/@]\1;KX:>/
M_"TWB/0O&ND0ZRFD:;K^GZCX9\;>&9)-"\4:'JFCZM9W5O?V)C,4IFM;B&.:
M%A7SO'_P5'T31_VNO"O[*_COX5VFA2?$3XQ^(O@MX#\5>&OB]\/_`!YJ\WB#
M1]!U'Q%INJ^-?A_H5S_;W@71_$-CH^JI9)J4]SJ]G/;0G5-+L[:]M;B3[!_9
MA^"?Q'^"^A>,;?XG?%?2OBGKOBSQ1'KEM)X<^%_@WX3^&/"^FVVD6.DVVB:+
MX=\(6L7VD3&SDU+4-3UF]U'4+B_NYECF@LT@MHOSI\"_\$@]:\#_`+1OACXK
MV_[3FKW_`,*/!'[8?Q(_;+\,_"!_A;X%L-2?Q]\5X_%TOBO3/$OQ,T^VM_%G
MB?2K2^\8WZ^&8M3F==%TNULK%(YC#YQ`/VSHHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M*^41^W/^Q^?&6J_#]/VB?A=)XOT6'QE/J&CQ>)+>9D7X=Z7?:UX[BMKV(/IV
MH7?@_2=+U34?$=CIUY=7ND6FF:C->P0K8W1B^KJ_EY\(_LP?M\?`CQGJ?A7]
MAGX??%7PW\++#1OVQ_&4OP?_`&Q]`_9<\;_#CX3?'+X@^"/B5J/PN\4?LX_&
M+PGI>A_%O5=-\1?%+Q%9>'+OPSXF\:>+O#EA\-?%/C)-8GB>_L)=%`/U,_:(
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MA[]E+P9JWAR;PEJ>H:/%I^C_`!*\1_&*2T_MV]^(L.NWVMAM=B@31WMM#BA:
M[`/VE\/?\%`?V*_%?Q!TWX4>'?VEOA1J_P`2M6U2VT.U\$VGB6!O$<6MWVOW
M7A;3M&U+361)]&U;5?$%I)I6D:;K"V-[JUS+9C38+J/4;![GWCP3\7_AK\1_
M$OQ*\'^"/%EAXB\2?!_Q+:>#OB5I=E%?+)X3\3WVD6NO6NC7T]S:06L]V^DW
MUI>.+">[CA2=(YWCFW1#\*+[]C'4/A9_P2/_`&C]/^+%IX?^#_Q@\`_&']I/
M]K[P?\19AIXN_"OBCP9^TIXT_:`^!OBS7=9L;2]N[JPMK#3O"46K:6S2--H3
MW&@2^7`[(OZ-_P#!,CP+K&@_LE>"?B;XVT1=#^+/[35QJ'[2_P`7(/.:?;XR
M^+S1^(X;.%Y5-Q;V&D>&Y=!TNRTZ>:X;3TM9(/.=B[$`]#3]O[]CB3XG>-_@
MU'\??!<GQ,^'6F>*-5\6^%(UUJ2[LH_!4-]<>+M.TZ[326TSQ'XD\.0:;?2Z
MOX2\-7VK^*+*.VD:;1U&TM\E?\$I?^"E>I_\%*_#_P`2/B-8V/PPT'P5X:EL
MSI7A'PW_`,+1E^(WAJ#7/%WCW2/"Z^/[_P`7^$O#_@C4;C6_#O@EM;SX!U37
M(=/NKM]/U)K22&(W/PY\&_V`OVMM(T_]BCX!Z[\(=!\"2?LB_MP_&?\`:-\7
M?M/V7BKX?>(O#OQ'^''CGQU\5?&.E)X7T>X2\\<3^+_$FF_$6V\%:QHWBKPQ
MIZ:7IVB2ZA-JL:R:6B_JM_P2Z_9Y^(/[+?[$7P9^"_Q7T#2_#GQ'\)6WBR/Q
M/I^DZCI.LVZ/J7CGQ-K>FC^U]&FN+&^_XEFJ6T@,5Q*(&E>$E75U`!\^?LF?
MM^_M3_M?Z+<_$;P#^SG\*=$^$^B?M1_$'X!>)-4\2_&*:#Q7;^'?A)\3+_P;
M\0/&&CZ+::)<V>KZI'X>T?5M>T+P]%?*]Y<Q1VMS/;Q1W,L?DL/_``5=_:,O
M_@Y=?MXZ3^ROX6O?^"<,.I7>HV_C^3XAZA;?M!WGP?T[Q,WA>Y^.-O\`#5]$
M;1G\+7;QR^(M/\.G5D\1MX9B^V31K/)'$;G_``3Z_P""2'PD^'OPY^(6L_M8
M_LP?!?6OV@M3_:V_:,^,'A+XEZIX=\!>)_B!:>&/%_Q(UW7OA9KD'CGPU;+?
M:?J&D:+J%M>Z-:1WUOJ/AJ^M[*Y5+36;""YB\FT/]EC]O7P?_P`$MKK_`()4
MV?P!\.>(]>T_P1K/[-.B?M32>/\`X8V/P:U#X0ZEKE_!IGQ;U'X=:GXSU7XK
M6?B>P\#W<$>I^"(_#5X6\8V\D^DZTFE/;W5N`?36L_MS^`OCK\.O^"GD7Q(_
M9Q\'^.?#O_!/[Q-:OH/A'XF:%8^(]$^*6EW/P-\-_&3PAXONM*\3Z->V>DG5
MEUZ>'3I;:SN7CTE;/4[:XD^W+CP70_\`@I5^U%=2WF@_LX_LJ_L\_P#"L/@K
M^PS\%OVN/B+H-_X]U[P+>Z5H?Q-\+>.?$*^!/AEH^C>&)O#P32E\":C:64E^
MEC!BXMV>%`649>J?L/?M/?L_1?\`!0_X-_!#X$P_%_X>?MJ_"KX`^$_AC\1;
M;XC_``QT/2_AIXB^'7[+?AG]F[Q8OQB\._$77-'\2:CI\M_X.T[QQ9ZSX(T/
MQW>ZQ:ZYJEI>:39:IIEN-6\DO_\`@@S<?%36_'GA+XM:UXFTG3?"W[!O[*?P
M.^!'Q=\'?$_6M-TP?&OX42>.;_QJ?'7PEL-6C\)_%'X=MJDWA2ROO#GQ@\!^
M(]#UGPK?ZU9:%#H^L7EWJ-L`?NEXM_::M[/]A_Q/^V3X0\-SW=I:_LIZU^TU
MX7\(>)&GTNYN;>#X17/Q3T7PWK[PQ/<Z=/-$MMIFJM%"T]I(TY2(R1A#\#7W
M_!6>UN?A?_P2K\:^$=&^%/B/Q/\`\%`/BY\`/AU\2?!$'Q$4Z]\']-^,?PSU
M?QIJVIZ1HL*/KFI:EX8UNQM-$;3O$%AI16">>:_-O<P>0?L[XA^#/C;\;_V`
M/C!\+O%?P\\-?#_X\_$?]F'XM?"N3P)H/B/3=0\#VGC[Q#\-_$?@O2X_#?B&
M.;R+?P7JNK75I=Z')JHL]1TO0[NUAURTLKZUNX(_R:TG_@D9<^$?@_\`\$;-
M0\!?LR?`KP+^T'^RO\9OV5/&_P"U7XJ\(V/P^TCQ';:-\/OAMJ6B_$^6+QQ9
MVFG7OCUD\57@G,5C<W5SKK%K^&"8DF@#[@\)_P#!13Q7XC_X)[ZK^VE+\-?#
MUKXAT[XHQ_#]/`T>N:E)HTEJ_P"TGH_P*.HMJS6BWRW`TW4WU_R1;>7]NB6S
MW?9V,H^8_"__``67\:'XC_\`!0?X=?$;X*>$?"-U^S+X)_:?\9_LV:I:>,=1
MU&R^/0_9;\)+XA\<Z%XC?[`L7AC6H)=2\/2R66FW%_<?V1?W5U'")K.2,<[X
M4_8^_;0\&_LI^*/^">B?!G2=7\,:_P#M26OC[1?VH(OBAX/D^'^D_!J?]JGP
MW\=M2EU[P/JWB>/XKGQ_9^%M,U70M.T'0/"$WA:YUN339AJ.DZ:US#!B_&[_
M`();_'3Q[\$/VM?^$%\/^&?#_P`?-(_;0^,O[27[)=WKOB+2M3\,^-O"7QD^
M&OAWP+\1?`7BR6VO;6]\/>'_`(F:1-XGTC7+3Q%?W)LKVST:\@LK;2TD@N0#
MU'PC_P`%#?\`@H5\??BQ\2/`G[+_`.S/^S1XJTCX5_`7]D3XR^(F^(_Q=\<>
M$M?U.]_:B^&.M>/$\,:(+'POJ6EDZ'>^%M?TVUO[R6-)X)-*FNDCDDN52UH?
M_!1WX]?&.3X)VG[%7[.WP4@\2?%WX8?M2?%+XN>'/C=XE\3^!+SPA\2/V6_B
MQ\'?A'\6O"4FJ>#O#5]I_B'56\0_%BVFM_$5TS-?VVA3RRA4N[-VS?V=?@#^
MV_\`LA?&#X\_$?P+^S)X0^*-Q\;_`-G_`/8&^'EN)OC1X'\#:1H'BW]FOX(^
M-?!/CF?Q!-+_`&KK%_;1>(/$^BZ3I4NEZ5=_;M&T74+F&Y18=*@O_--/_P""
M%?A7XG^#_@K\-_VK+;P]X]L3\.O^"@WC'XO^,_`NH2^'-2\&?M-?M>_$W]F[
MQ;X3\1?#.06EA=ZQ!\/?#W@OXD:'X=UGQ-I5Y;I#I^B'6='F^V6\$8!OZW_P
M69^(6N?`?]@+XM^#_!?[/_PBU+]K_P`0?';PIXJG_:>^*EQX'^%/@S6O@I`T
M%S+H?Q%LDCM=7TCQ#JUE?P:#J5TEJE]"8U\I9D8-ZGK7[<G[;VK_`!._9F^#
MOP2M/V%_C-XH^/WPQ_:8^+-IXZ\(_$OQYK7P;U/1_@;\0_!OAC3M"\*^,?#]
MGJXN[Z^L_%-QIFM7\GGV^E:[H][:S(+F":WC\/\`&?[#_P"UY=>$O^">WAGQ
MI^S!\`_VA[3]A#Q?\9_!FI^&HM?^'7@/X>?&'X7:SX(TWPA\*OB'IO@W6]+N
M]$\&^)VT^QM9?&?A!]+:ST_Q)#J%[H-W/I=Y;>3[1X@^"_[7OAW]H7]C?]I'
MX0_L1?#7PEH_P1^#W[4OPG\2_L^^&_C7\./"NE^&&^+OB[X8^(?#VMZ!JVGZ
M/;>&[JWU:?PSXCU35K/3["*:WO[HRW3/<7;NP!^@?[&/[2'C[]H+PG\2-+^,
MGPQL_@_\<_@=\3]4^$?Q>\#:/KTOBCPQ:^([30]!\6Z/K?A'Q%<66G7.L>%_
M%/@_Q3X=\1:/=W5C;3_9=26.1&,?F/\`ES\%_P#@H7^TO\:?VB/'GA:;]J/_
M`()Q?"'P7X&_:]\0?`6+X(?$WQ3>Z;^TGXN\*^%/%VAZ/))X;T:7Q;8K<^)?
M'%EJ$]CX+5-'FAN]9>VC6*Y!,;?IS^QA\'OC9X`LOCC\4?VC;SP<GQH_:4^,
M$GQ7\5>$_A_/<ZCX0^'6CZ/X$\%_"OX?^`]-U^[LM,N/$]]H'P_^'OAJ'Q#X
MC;3+"+5O$#ZG<VT+V[132_G1^S1^R'\8_@7\8_BG-XW_`."?OP*^+L'C[]LO
MQU\:]"_:2U'QY\*?^$T\)^"O&OBO0]1T?5H-)UKP]>>+AJW@2VLI]6L=/L]2
MBNFNH(XM.>"=T<`'E7AW_@J#^VW\&I?V[9?VC_!_P-^*^H?LP_&[X0_LK_"S
MP/\``ZS\5>'M4^*/QU^.6D^!?$G@*ZOM:\17>I6>A^"QI?C-+#6_.A?5=/O+
M6>XDB58G@7Z?^)/QP_X*L?LW?!KX_?'+XW^'/V0?$_@7P-^SA\6/BUIO_"N[
MWX@Z?XD^'?CWP3X1U'Q#X8\(:QIFOQ-9^/-(UF]6/3]8UC3[S1VT]-,:>WAN
M!J&V#Y:\0?L$?MO_`!NU7_@H=J]Y\/\`P5^S_P")?CC^TC^SS^U_^S9XC\4?
M$W1_BCI-I\2/V=/!?PR\'Z/X&^(VD>'!>7]GHGBV;P3J>IW=[ILMY::%INIP
M:/IL0>SMIXL[XJ?\$WOVEOVCOCCXS_:%F_9N^$W[,/Q)\6_LE?M??!_XOZSH
M?QTU?QZ/C[\3?C?X$^''A7X8:M:Z=I8TN#PYH/@:]\-^+IQ/J%[H.I1V'B7"
MR/=Q%F`/7/$__!6+Q-\5-=_X)E_"+]DCXH_LM>-OC1^VIX`\<ZI\5;6+QAIG
MQ%L?@QXN\/?L]Z1\3].C\3^'/`_B6X\2>'](_P"$ON-5T"]AU*&/4"]F+!(Q
M<Q730\OX,_:0_P""QWCK]KC]H/\`9!T3Q?\`L(#QC\`/A9\-_B;J7B2\\"_&
M2UT'Q,OQ+EUV+2=`TR.34!<VMQ9OHH^V:E-Y]C_IBK&3+;7$:^J6_P#P3*\3
M^'?C)_P1L^*_@;X<?!CPSJW['OA[Q7I_[5FOV&G:/IGBG7]0UG]E?2OA)IU]
MHNIZ58P7'BW4K;QE82P->W]S*L6BW5W/&&-QE?KCX0?LM?$7P1_P4G_:W_:L
MU9M,'PS^-/P.^`GP_P#":KK4U]K3^(OA[?\`B^X\1&;296D71]+BM]4TT6R1
M-!!=74US<1VYFDNYG`/E[X(?\%0O'_[47BK]F?\`9\^$W@C0="_:IF\4^,YO
MV]O`FN)>:AIW[)_@?X*:C;^%OB2-7*3VT[>)/B/XYU;0-#^!]M,TL?B72[K6
M/$DH&E^'[^1?1_\`@J]^W5\=/V(=._9FU#X%_#GP]\3[[XE_$[QRGC[PSK#W
M46JW?PM^#WPE\6_'#XCV_@Q[>2.,>,KSP/X#\1VOAI+L/;3:U)802*5D->A_
MLY_L::Q\,/VZ?^"H'[0/B?PUX6C\!?MG-^RI!X2NM*O;0ZIJ^D?"KX):SX$\
M>Z;XBTVUL;6_TJ>3Q;J^L:FMU)J5TFM1ZY]LACM+RWO);OR^]_X)7_"3X0?&
M?]B/Q'^R/\+?!/PK^&/P6_:*^)GQA^-.@Q:QKUS-KUOXN_9H^)'P;TJ\TV#7
MK_6FOKU-2\2:+;7=FMQ:PC31/<;)&C<,`?/'[6O_``52^,/AK3_VFO%G[*TG
MPI\5>`_A+^R-^RC^U+\,_$/B/3M7U>'Q]IG[1/Q!U_PD;.0:;?VA@@738=$U
M&PVE9X9C>6MRHD($>[JG_!2OX^?!3_@H)\&OV6?CI!\,M7^$WC#X%?`'Q#\0
M/B)X7T;5M%O/!_Q7_:/\2?''P=\.IM0-YJ5[8Z3\/;KQM\*_"W@:\O-3D@OK
M?Q!\3/#T@633XY;EODCX@_\`!&/]J?PGI'_!2KX<_!34_AAXL^$O[3?@CX9_
M#;]ESPQXO\7:MX6'P>^'^@_%K5OC;KO@?79-/T._N3X8\.^,/%'BS2?!=OI5
MP;NS\+7VD:;#-:C2(\_H'XI_X)Z>//V@?C+\6/'_`,<=`\%>'?"7Q8_X)K?!
M;]E&7PYH7B>Z\0:OX6^,WPI^-OQJ^)MEXJTS66T:R?\`L[1T\:>#=3T'Q!`(
MM8MM5T^Y2.&"6TANI`#X;TW_`(+-_%J&\_9XT3XN_%K]F/\`9LL/BEX?_:TU
M3Q#\4?BII.M#PFVO?`GX]:?\,O"/@_1K2TU:-DU+7?#M_>:I<RR7$GG2:#>3
M1QQK+L3]C?V?_B5\6?VBOV0KKQG\+OVEOV>OB=\4O$5]K=OX1^-_PW\&:OJ_
MP5LYK#7[<#3SX8N]=BU;6'T[28[G3+^9M5M)'U&X6Z6-4@$3_DC\`?\`@G/^
MWK^RO=?LB?$/2/AO^S7^T?\`$?X0_!/]ICX7?%W0?'/QA\1?#SPUXB\5_';X
MT^%/BF?B/H.L3?"?XESB9AX9FBN=`ET.W6UEUB58=4*VI%U^^W[/]W\7;SX<
MV<WQM^%7PU^#7CG^TM16?P-\*/'UY\2?"-GIJO']AO8?$U]X`^&LLM]>YF>\
MLU\,1Q6Q2/;>W32,(@#\9_`_QW_X*C:[\;?VZ_!FJ_'C]F+_`(1G]@?4O`\?
MB:SM/@-XBCOOBQ:^./V9_"?[04,5AJ3^/&/A233#XE_X1]IC::C]H-N;K8@8
M)7G_`(=_X+J?"WQ_^SQ_P3S/PZ_:(_9]\6?M8_M%?M*?L0?"?XT_##27-Y?Z
M;X:^-?Q:\)^#/C,NC>&EU))]#U/1]#UF];3;N>^OTT6Z$5Q-!>K&8F_0?P/^
MQO\`$WPY^T#_`,%;?BE?7GA!M`_;FT_X(VGPF%MJ.K/K6GO\.?V3M,^"&M1^
M,[:6'^S--M3XLM)KS2'TJ.YO+C39[B?49I`MA:VOCNH?\$Y/'$O[%?\`P3P^
M`EC8?#.U^)7[+/[1'["OQ4^)>N111P6.J>'/V</BOX5\:_$.WT+5HM(6_P!0
MU#4]'T6[AT>"[BMH[^Z>**ZEMT9G4`Y&;X]_\%-?BUX"^,G[8/P&\:_LO:;^
MS]\/O%'QLB^&7P(U_P`&:]XF\7?%WP=^SWXS\8>"/$6J:A\7],\26NG>%M0^
M(6J^!O$,OAA-/\/:M9:99'1[JXN+E+Z;R?4/V,_^"A?C+]K7QU^U5J^EZ9I>
MC?"KP9^R+^PQ^TA\%])O-*:/Q3IES^T_\(?B]\1O$>G^,;^._EM]76SN/"'A
MRWL8+:WLA9*FH1F:Y^TH\7FUU^S#_P`%+_A-\-/C7^QY^S6O[(]I^SW\1/%7
MQ7NO@_\`'#Q9X@\8Z#XZ^`/@#XX^*/$'C#QIX6N_@CI/PT\0>%OB+K'A/7/&
MGBQO`%POC?P[HTNGG1]-UN&"WMB8:.F_L`_M1?L<>)/%,?["]C\&OB5X*^,7
M[('[-_[*OC&P^//Q#\5?#^^^%VL?LN^$?''P]\`_$[PU)X<^'GQ$G\<Z'JW@
M[QW<#7O!.J7NC:I!K^C1WL'B:_LM8-EH@!\=>%_^"KW[5/Q#\0?LC^!/&GQ\
M_9L_8TTWXW_L?7WQVF^/GQM^&5U=^`/B?\7M0\=^)_"6D?"SP)/J7C?P_P"$
M?#UKX9MM-T;5/%(UGQ1_PD-S9W-W/INGM#]FE?ZA_P""B?\`P4$_:^_9#^%/
M[-?AWX7I\(_BW^T3-X#\8_M%?M%7FC:!>WW@C7/V</@19Z9K'Q4\3^!M*CUZ
M.]T$^-=)OL>%]3DO=8M]$NF<&/4XXM]=_8?L@_MN_`K]G?X/_LD>!/`7[$'[
M8'P#\,?L^Z)\*?%%O\?+OQ]\*?'-K\2[N[UF7Q;XTE:Q\%?&;P7XM^&30W%G
M+I_A6#0/"/BR.\=T;4+J&!9#X9^RK_P0AT[PO)H^G?MA_%KQS\9?#?PO_9F\
M'?LQ?"*S^&GQX_:*^#VHP^%+UO$>O?&5/%FM_##Q]\.]?\0>&?$VL>)V\'^'
MO"WBC6?%=FO@/0-+&H165_-=P3`'=_%'_@J3\3O`G_!17X->#]+NOA]KW[`7
MCG]F3]F/XD>-?%=IH=^WC'PSX@_:J\>_&KP5\.OB7%XN;44L3\.5UGP5X"T7
M5-+FT,7<$?B>;61>K%!+"O%^!OVWOVZ/CWXJ_90^'?P]^(/PR^&=]\<OVA_^
M"F_PS\6>.M5^#S>.].TK2_V4M9D;X,Z3::))XRT!;6ZU33=-U>V\07YO[B:_
M2&:[M[6&2W$9Z/\`9,_X(Y_$#X::3\1_AA^T=\1_!WQ1^$>L_L,:!^PIX)O-
M)U7Q9J7C^U^'_P`,OVAOVA_'GP8UW77U;P]X?LK+6/`WPA^)7PO\+Q?V3JMV
MD?BSP)?SV1CT=[!W\_\`@-_P2X_;_P#V5_@W^Q3;?#;XE?LM?%W]H7]EGXS_
M`+:'CCQ!XO\`C/XA^+F@>#/&GA+]IZ75K+2E$7@/X<S:C/XPM=)O=/O?$DUS
MI&GV-KK.G21:5>:E::A=3L`?HI^P=^TW\>_'_P`0?VD/V6OVL[#P2/VAOV9_
M$/AJ6Z\8?#;3-3T;P/\`%'X8?$#3IM4\#>.]+T/5;B]NO#]].+6^TS5]&:_O
MHK>]LW>WN9(7!'YCZ-_P4.\7^*_VO?VJ_A1\2/\`@HI8_LZ7/PE_;5UKX#?#
M/X(:7^R)XA^*!\2?#[2])^&>MZ!J&I_$K3(;K3;'5?$^M>+]>\+W374ULVEZ
M?I=I?S00"=;J3];/V+_V1_''P2\2_&OX_P#[0'CS0?B5^U+^TOK>A:M\4=8\
M$Z9>:+\,?!?A[PCI[Z5X*^&'POT[5@?$,_A;PS92SRW&O^)ICK7B/5[NZU*6
MQT>%XM-AV?V0?V5M<_9]\1?ME:[XUO/!WB-OVCOVT_B1^TKX/DT:"\N;O0/"
M'C'X>_"3PCIF@Z_)JVE6)A\166H_#_5KRZBTN34-+2VOK%[?499WN8H`#\:M
M:_;3_;J^`/\`PU%\7?'OQST+XN?![]D3_@J'\"_V?_B[ILWPIT?PC<Z?^R3X
MJ\!>'[SXD^++2;1=3U2YF\4Z7XK^.?PZU".8@6UAX>^'6I$I/)XANFL/;OVN
M?V]?C_9_$G]MZ7X/_$72_AQ\!OV4-._8W^$^H?$VS\%V?Q*FL_C)^T/^T-\,
M="^)FL1^'+.2?5O$%Q\-_@UXR2_TKPYIUO,VL:IJ<,4<<UR;>%_8O@#^P'^T
MM>Z3_P`%0O`?[7U]^SWJ/P[_`&_?&7B/QAH<7P/\2_$S4-9\,MXJ^&6E_";4
MM+\06/Q`\$:7HUJ(?#_A/PMK-EJFCMJEX-:FUBVNH[FPM=':'E_@?_P3,_:,
M^$'_``3?UG]GK5?B;\(_B+^V-XH^.7P:^/GC3XP>)!XPC^'OCKQ?\&_CM\'?
MB/HEOXFOK?03XWN--;P5\(].\-0PQZ5NM+JY-K9M:6!^UQ@'T_\`\$^OBCJ?
MQ/G^(]U/^VGXC_:TL]'BT.W-OKO[*_B;]G%?!]S>O>21S6\_B/2],?Q,VI16
MTJ/%:K,MB(`\I0RH&\*T[_@IWHO@3XD?\%&?AO\`&'5O&HUSX"_'&;PI\%E\
M&_`/XP>/='M/!M[^SM\)/&6G1:[XE^'G@CQ3X?.H6'COQ#XGU#5XM9U+3=0L
M]#N=-GEM392VT\OWG^S5%^VM%<>(_P#AK+3/V5-.M&M=//A=?V<-3^*FH3M?
M>5`=37Q"?B-X=T*/[+',]U%I\FGAYI(HH)[B.%[F2WM>2^$/[+/B?X>ZS^W[
M=ZMXDT&\LOVNOC?JOQ/\(-IZ:@UUX8T?5OV<?@_\&Y+#Q)#<VMO$=2M_$'P^
MUC4D72[B^M9M'N]-=KB&]DNK.U`/SL_X)F_MU?M)_M'_`!U^%G@;XLZ_HNH^
M%O%?_!.OX+?M%7R6_AV+2KS4?B9XV\5Z[I?B+4;&[A)C.E16]C!;C3HQLLWV
M9DDD9B/CSP[_`,%4?VT_*_84^(EUJWAOQ#X'\1:'^VG\0OVG?#5AX,@&H^(?
MAO\``[]M;5?@)I>I^'[R*\\W09_!/@&2RUO4I(8KF/45TJ_NKE8@QV_>_P`*
M/^";'[17[+=K^S3X^_9L^(GP)N?CC\+_`-E?0_V3/BPWQ=T'QW??#?QEX5\+
MZ[)K_A;QWX;7PC/IGBFS\2Z)=7.H6]SH5_/#I6MZ;=P6G]I:1<V!U&][/]GK
M_@E%8_!-OV8=+U_XC6/Q+T#X/_L[?M1_!OXJS:QX?ETO4OB9K?[6'Q(E^*_Q
M$U#0].TZ\71?"WA>/Q=K'B*/2-+NX]:U2R\/OI.ER:E>7<%YJMR`?%FJ_M]_
MM9?$7XC?!KP+X*^+>B>"]&^*7_!7[]K+]C9_$.G>!-(UN\B^"/PY\)>*?$GP
M\>QCU&[6W;6=//AZW6YU&0'^TX;V4RI$T:9=^UY^WW^UE^QSHOQ2^!/Q/^.G
M@4>,_`?QZ_8FN-/_`&HW^'>E^'-+M/V7_P!IKXLS?#[QCJWC3PG=ZS?:%8^-
M/``T+Q9/<ZI;W*:-/IMG8:B\$;-<1#MO"W_!'C]IOX1_`GX&^%/A-^TG\(]9
M^./P"_X*`^.OVS?"WCWXN_#;Q7JG@;Q%H?BOX=^//A]:>$_&_A#X?>*/`FHZ
MYXJM[/Q9I][J7BU-:M=0U&]L-0O)[^6ZU?49+SUSXI?\$K?C=\=?`VK^-OC'
M\>_AGXB_;`\:?M"_LM?%_P`3_$3PQ\,=?\(?"3PSX!_9:^(EGX[\&?!?X?\`
M@FX\9>)_%*>'Q<QZK>W.N^)/%>HZ[JFOZ]J-]=W%O;"VMH0#XE\>?\%,?VDO
M#G[/7[?'Q&^$'[1NA_M'_!7X'_\`#.C_``D_:\\-?""WTFP;Q=XW\966D_%[
MX:6&FVD^H:%\0I_"WAVZTK5XM3T:`KI][K:Z-</)?;8T]*^*/[?GQ/@_95_:
M!^,'P7^/?[2=WX[\">$_A;:Z?%\</V1M7^#'A/2KWQQ\5/!^A7/B+P[>^,/#
M.DP>+=4BTVZU33SIMM=SP1V%\E])#&Z0S'ZK_:__`."6/CWXH:-^T=X+_9>^
M)?PY^#?PP_:JT[0O$WQ2^&7BGP?K.I>'-/\`C]X0\2^%]:T+XT^$6T#4+>32
MI?$.E^&K;P_\1_"%I!IVF>*EAL->@O=,\007>H7T7Q>_8X_X*;?M.?LX_%G]
MG3]H/X]_L.IH?B7P;X6M_ASK/PA^`_QT\+:IHOC_`,'>./!WB/1M2\:2>,/C
MIXXM=;\)2Z1H.KV.I:1HEAHFKSZC>Z==6VL6EM:W-O<`'JWAOXI_M1?LY_MW
M_!?]FCXT_%?0OCW\&_VJ?A[\9_$/PL\4OX$T[P1\1/A]X^^"J^$-:U_PUXA_
ML74;K1_$7A75/"_BR*?2]66TL-1AU2V>UF@>%EE'ZNU^:WP'_8T^.=U\?=#_
M`&M/VX/CQX1^./QL\`^%/$7@GX(^"?@Y\/=?^$7P$^!>A^-5L$^(&I^&O#'B
M#Q[X_P#%'C+QSX[CTG2;/6?&7C/7[B>PT73++0]#TW3[9+F>[_2F@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`*_#]?^"R^OVEY\:O&FJ_\$^?VIKG]F+]GCXR?$#X,
M?&']H[P;K'PA\61^"M5^'%[+I_B?Q3J/P-E\;:#\>6\':%((-0\1ZO;^`Y3H
MV@M=:JD&H-:"SG_<"OYQ_AUX@_:[^"6B?\%"O@9\+?V#_C%\1?&/Q_\`VU?V
MJO$_PW\>:U/\/O!OP"L/`_Q8U^YT7PUX[U_7M5\5/XDO=`M?LFH:G?Z/I7@Z
M34;JPMK=K0F+5+*Y<`_0OQM_P4%\8:U\0;CP%^Q[^R;\1OVS8-#^&G@CXI^+
MO'7@WXC_``E^%'P_TO1OB=HH\1_#CP]H7B7XM^)/#MKXI\:>+?#TEOXAAT:W
M6PT_1]"E6\U_6],N)K"RON7^#'_!6;X,_'+Q7^RYX*\,?#KXE^'?%7[1OBWX
M\_#?Q#X2\?1:!X8\9_`3XI_LXR3VGQ-^&_Q5\.C5M1-OXIT[4(!%;6.DWU[)
M<V-WIVHA%CO!#%\C?LM?#GXQ_P#!(N;5O@]8?LQ_&G]J+X;^/_AG\%)-!^(O
MP)T_P;JE];_&CP/\-+;P9XG\%>+=,\2>*/#%YI/AW7=4T=]4\.^,+II]+T73
M)TLM4(N#&)?EOPC^S!^VO\'/B]^R]^V;XO\`V6_'WC[Q5XW_`&R_VS?VJ?C3
M\#_A+JOPXUKQ+\#]'^.O@CP[X!^&W@V]UGQ'XH\,6'B;4]/\,^!/#MSXDO=&
MU1]/77-7U&WBMYX[*WNB`?OCXE^-OPV^)?[5'C7]@#QE\-[OQ/M_99\)?M(>
M)=7UK^Q[WP'J_A+QG\5_&OPLLO!5]H\]R-6NM4;4_`>HZM,QL+G19=-86]W/
M!<F""\\0_:+_`."F/P>_9=_;)_99_8O\2^$-=O+W]HBYT_0IOB!HS+'X-^#^
MJ>*/^$CTKX0Z)XOM8--N"DWQ2\2>$M5\*^%[>VNK9[6[CM[N[@326DO(?A;4
M?BE^USX=_P""B</[;MG_`,$UOVJ/$?A#XA_\$_?!?[/=QX+TO7_@5%XK\#^.
M/!?[57QV\8WMMXI6^^(\5HW]J^$=2\*>)-*?1=1O+0:?XBMX;YCJ,$L%C\M?
M&G_@F=^W!^WQH7[>'[4^L?$7XF_LA_$WXN77ANX^!/[.&M>`?A'XB\7Y_94@
ML_''[-4^J?$"WU_7SX+U'4_BKIJW$]YX<U4F*PU"]GGCCDO;N.0`_2C]HW_@
MK;J7[.7Q5_:>T;5_V5/%?C'X!_L<+\&;O]H7X[^'/BUX!L=1\%Z)\:K9KC1O
M$5G\*?%%MH>L>*-*T`0W3Z_!X<\1ZCKBV\22Z9HVHRRM;1=OX_\`^"CWQ8U/
M]H#XG?`G]D?]C'Q)^U,?@+X<^$GB#XW>+[KXW?#WX&VNBS_&?P8OQ)\(^%OA
MOHGCG3M1O_BCXH;P!=Z-K][%!-X:\/V=UK%MH5YXBM=5`AD_+?Q-_P`$Y/VH
M/VJ_BK^TO^V'XU^''CKX2_&G4?"_[#'Q6^'OP*\9_$F9/@3\7_&OP]^&6KZK
M\9/@A\7/`7A#Q-J'A7Q?:Z/XS:W\+Z3X@\165U;:3J366K:4UW8&Z%>O_MH^
M`OB+^T==Z_JEO_P2D^/_`(8^/VO_``^\&Z=\(/VH_@U\8?!/PF\6^!]=N?`_
MAN\MK/XK:MX2^)&@:O=6OPI^(<^LZ/8V&IVGC_1G\-:/!>Z/:0->26=`'[S?
M$#XW^#/A'\!O%?[1'Q9>[^'G@7P!\+]2^*_CV/Q!&B:KX2T+0_#4GB;7-/U&
MU@>42ZWIL$,^GMI]H\\MUJL:V5F)YI8E?\JOBI_P5TU/X&_LQ?`CXK?%+X'>
M)[']H#]HF'PW\2_!7[,/@SPMXZ^(/C3PW\`O%7Q(\*>'+#Q!X^O?#FDS6/AS
MQEI_A3QMX9?5M-U2?3+-?B+J\'@.TBGOD=V]3_X*'_`SX[?$W_@CA^T!\$&+
M_$_]H:3]DJTL]:@T_#3?$;X@^"-`T/Q#XHTS3XX84.H7/C*_\.ZIIME:01V<
MNL3ZE%:PRZ;+>)/;?`/_``5OU7X??M;_`++'P&_:B^%G[.GCOXU^'O%/AWX%
M^*_A-^TQ\$_C'8>!O$GP_MOB+\<OA--<^!-=@36M,%[I&L%X;/4K?4[+7X/#
MWCC3]/>_T.VU#1IS``?I-^U'_P`%1/AG^SK^R+X=_:GTGX7?%+Q]J/C?3+[4
M_!OP/UK0K[X1_%`VWAZQU36/'5WXYT?Q[IL&H>`=,^'FA:#K^J^*;[4=)OI)
M/[,CTWPW9^(=5UC0[+4O)OC[_P`%7/%?PSUWX_V/PM_9ETKXH:+^R9^S)X1_
M:A_:&U3Q?\?],^$^K67A;Q7X&U/XF+X8^#GA:'X9_$34_BIXFTWP/H]_J$\V
ML2?#;P]<ZND?AZTUJ746E$/Q7\?O^"3GQY^-/[!7CGXA_%#XH_M'>*_V_M=_
M9$/P8U#P?X1^*?@X>'/%.GZ+KGB76_"GP^U9M1\)PV=W>SV_B.*'Q]J^CZWX
M9LO'/B'2[/6M20/INCK8>2?&;_@G+\=K35?C#X+^(G[+_C_]M:#XA_LK_"?X
M+_LE_&F]^*6@Z!XV_9K\1>'/`'B&+4K/XE>,%UGPQXFL;&W^*5_:^(=>\0^&
MX-?C\2Z8MI8ZEHNH:?I\.F@`_0?Q7_P60O=)T7XY_'3PU^R]J6N?L6_LS?$_
MP)\+?C=\?/$GQ8C^'GC[1+[Q39^%I?%7B?PK\%/$7PU;3/%'A7X67_C;PWIG
MC>2^^+WAGQ"LLVI7NB^'=5TVPAN[[[)_X*$?MO1?L,_LJW/[36E?#FT^,`?Q
MO\'O!6C>$;KX@6GPSLM1F^,7CWPYX%TK5+CQ=<^&O&(L[32Y?$EOJD]O:>'=
M5OK^"![6Q@>XDCK\<_VM?^"<7Q*_:%.J_LO^'_V?OC-X:U3X[6/P&G_:Q_:Q
MTW]H&?P?^SUXQO\`PUI'A>T^*?CRV^$GAS7H-6\8?$[Q+9Z!J'AR?2]1\/Z5
MX<U!K[3];UA[Z6SB6+]$/$_Q[UOXW^&/VI/AAX9_8A\/?M<?"/\`9<_:*\`?
ML[#PAXPNO!=Q;?%:X\(_#/X?^-/B-XFT'0?B/I=]X1U#4OA-XY\36WA:TBNF
M2*YUOP_J<EIJ%KJ>G3PVX!N>.?VZ_P!ISX7^#-+3XD?LD?#71/BY\7/VA_AW
M^S)^R]X<\$_M2W'Q7^&WQ5\=^/-,\1^)=1\3^,_'NC_`7P]XG^%?@/P)X)\%
M>-?&?B"\U'X:ZWK5YI_AQ]/L]*@OM1M2OCTO_!5CXMZ]'X.^!_@G]F/PC#^W
M'XD_:*^)7[-'B'X2>-?C;<Z=\'?`?B'X8>`['XD:E\3+_P"*6C?#75?%FO?#
MCQ+X1UGP_J7A&SL_AGIGBV_GUD6&I:9I7]G7=ZWR?X9_8J_:=TWQ!J?[67@O
M]EW2/@MH_@G]O3X!?M)_#']A'PEXF\):88_AI\//@'\2/V>_B/J&DVV@?8?A
MGX2^(WB^+XP:U\16T;3!#IVIWOA6UTV_U03:D+B"3P]^PS^UCX?_`&F-&_X*
M5W7P2@N?BMJ7[7WQ6^(&O?LZZ1\0=(C\2Z=\"/&?PF\,?"30C_PDMPJ>&KWQ
M5'=>"[#Q?JNBF7[.MMJ/V*WO7FMQD`_;C]FC]IRT^.WP(UOXL^)O#VF>!/$W
MP[\;_'/X7?&/P+H7BQ/'UMX$^(W[/'Q*\:?#'XAZ+:>(UT3PO<ZUI\NH^"KG
MQ#X9OKWPUX?O=8\*ZUH&KMI5K'J4(;\W_AW_`,%=_%\%IX*^-'[1?P1\%_"3
M]D;]H;X<_'WXD?LS?$C0_BC?>*OB!/IG[.W@'Q#\7/$-I\;O"]YX.T/PGX)N
M/'/PG\(^,O&W@Y?#GC3Q/=:='X-UC3/$%C#),+RR]+^`_P`-/VK/!?PMT+X?
M^+?@9H+)^V;\9_VROBK^U=/)\08+NZ_9]TGX\^-?&^O_``RT#1Q8V]I;^++O
M0?A]J7@OP7XI_LZ1%;Q#I6KZG8730W4;+\`Z!_P32_:C^,7P"_9G_83^+?PY
MT+X5_"S]D#X!_MB_#>V^+FF^.;7Q'IOQ3UKXS?`/XB_LL?"5/#FFV]LOB#1[
M:U^'GQA\:^,/&,VK(38:MIFCZ99F^>1[B@#[`^$O_!1?]L#QMJ_@7X<_$K]G
M_P"`'PC^)_[67[.7BS]H?]A](?B]XM\;Z1KC:+HNE>)-)^%7QWTC5?!GPTN?
M#?CC4-%\0:+<7D_@KQ)KMA9C^V9?(8:1+#+^E'[,'[3O@;]IW]F3X<?M-Z`L
M_AWPYXS\&W&O>)=#UE9HM6^'7BGPS/J&A_$_P!XHAD@AEM_$GPP\;Z#XH\$^
M*(1!MBUOPYJ*P&:$122?E!\#/A5^U-JWQ*_8U^)O[7_PQT;]GWX1?\$T_P!F
M;Q_I/B?Q3<?$'2/%%E\1OB/;^!?#W@74_B-H*:-9F[TOP!9^!_!VK^([RVUW
MR]04ZG:Q+'YMG*7^E?\`@E#\+O$D_P"PCJ_B/XA^%]4^&^I_MA_&#]J[]J*7
MX<74`L[KX9^#?VJ_C/\`$'XA>!?"MO92103:9/:?#GQ)X8U6\TF]M+6\T?6M
M3U'2KVUAGLI$H`P_@A^VI^W=^TEJW@CXW_!K]C[X5:K^P]X\^(4&@Z!KGBSX
MZ:CX-_:@U7X5?V[+X9O/CKIWP\U'P--\+G\-'R)_'&A^$YOB=%XF\0>$H[?3
M[<6NMW\;P/\`A)_P5'_X6A_P4N^*?[#:?"ZWL/AAX4T7Q!I'@/X^+XFMY+;Q
MM\8OAQ9>&]6^*OPWCT)U$@N/#FD^,-"N[*YA*)>"/5!!+>&RNEM?'OV?H?\`
M@IK^R!\(O"'[&'@S]D_X??%G0?@]<?\`"*>!_P!IAOC'IOA;PCJWP4L]<>2P
MNKSX?S:5=^*O^%LZ?X3N7MX-*-S'X=U/Q)9Q&XU&UL)W9?`/@#_P2L_:C^`7
M@#]C?XWR?%SXA_$3]I#P9^TSHOQQ^,'P;UO6_`5O\)O#4_[0FK:UH_[4^J:-
M=:9X2T_Q#K>H6/AKQ8NJ:?'?>)KB%[KPA8V]M!<*EI'$`==\!O\`@N9K?Q-_
M9>_;`^*OC7X,>'_!WQF_9K6\\7^$/ATNN:O'HOQ5^#\7QCUSX##QSI]]=PRW
M,<VC?$WP/X]\+>*X-'N];T;3=6TS38=-US5[2]2_E^FOB?\`\%7[7X<?\%!/
MV?/V0&^'.D:M\,OB+HGP?T+XR_&R/Q4L#?!;XX?M*>'/C/XB_9U^&%_H+6S1
MWD_Q#B^"VHV_GW5U9&V_X2SPK)#)-<WUMI]]^</Q<_X(V_M%>+_^";OP=\%?
M#Z/P[X)_:Z^%/Q&_:;L]1T>'7+>W\-^.?V>OC_\`M@?$GXO:I\.];U2WM_LL
MLL?@[6_"?B?1+6:"2#1O%=@;6":$B6X?L]:_X(Q_'3XZ?LL_MCZK\3?BU\1_
M`'[3O[07QL\0?'3P1\.=!\>>$YOA3H_BGX0ZIHUM^RI!XBUZ+P#-XV:U\,Z)
MX!\&K*NB^+-,ATRVN;^QCMW-SJS:D`?7GCW_`(*`?M^V_P`:?VRM+^!W[(_P
M0^-WP9_8J\8>'-*\=:3:_&7Q?X2_:+\?>']6\%Z5X\U1_A?X2O?`.I_#S6_$
M^E^'KV]NK31M:\;^'GUR\T\:-I27&I7ME'<;?A+_`(*A>,_C'^U5^PO\,_@;
MX0^&NO\`P`_;L_9V\6_M*^`/'WBK5?$&B_$3P]X/^']AX4N_%OAWQ#X6MY9M
M-C\6Q7'BJ/3H+72;C6;*RU#2M2AU&Z6V6*^?P7PO\'?^"N_PY\2_MA:[\'?A
M1\`-#\;_`+8%U\)=>@^+_CCXO27$?P:\9:1\'-`\`^-/$"_#W2_"<S^,CH>N
M6]_K/ARU35K"VU.6""&\CBMRP;B_%'_!._\`;/\`V?OC%^Q)'^QU\.?AYXE^
M&G[%?[!/QR_95\.^.O'7QAM/#7BCQ-\1/BSX1\+0:+\0H_#O_")ZE)I5AH'C
M7PY/K&LV)U*2348-16#3FMHH-I`/KG]E#_@K&G[1O[77[4G[..K_``MD\%^$
M_`7A[XB^,?V4OB9)/>2:9^TIX4^`?Q*\0?![]H'4[::<BSL)O!GC]/!\.BV-
M@UQ=:SH.MZKJL\5G)H5_:6_SO\`/^"VOBSXS_LZ>!?B/J?PJ\$^$OC#JG[=W
M[-_[,WB_X;2:OJEY86OP=_:0^..G_#/P=\6/#\XU%-2GOKSPY>7.J0B[232[
M;Q!IMWI5S!(%:./CM!_X(K_%?]G3PU^P7\0O@'\:?B5\1OCO^S1XYU,?$/PM
M\3?B?I<?PEN/AQ\?O#6K:/\`M9:7\/K*3P2VJ:1/XOU:]TSQ!I-M?ZIJ2/=^
M']-4M#-%;WEKQ_B#_@C/^T-#\-?^"6VM^!=3\">'_C+^S7^T%\!9_P!K30EU
M[;X3^(GP%^&'[4B?M!6FJ:;JR:4DVL>/OAZ^G&V\*1S6D+ZA9^*M8T62[MK:
MSM9``?OI^TM^UG\`/V0/".@^.OVAO'4_@/PSXH\46?@KP_>6G@WQ[XYO-6\5
M:C:W=YI^B6>B?#SPOXLUR2\O8;&Y6T']FB.XN%CLXI'N[BW@E^??#_\`P59_
M8+\5_!:7X_>&_C=J&M_#Z#XL:A\")K'3O@Y\=[GXJQ?&72[$:M??#.3X!Q_#
M$_'9/&,.B-'X@&B-\-Q>3>&YK?Q'!'+H=Q!?R>+_`/!6'4_B+HU[^P-JGPD\
M+Z!XU^)-C^V_X#G\'^%/%'B"3PKX?UW5E\$>/!'8:IXAALM1DTFVDA,S&[6Q
MN2CHBF(AB1\!^,/^"4O[67Q+\<ZS^W!\0=`^&D_[2_BC]JO4?C5X@_9:\!?&
MCXB_"WX=3?#9?V=],_9A\/\`AJV^/OP\F\+>,K7X@V'AO39?'NL>)+2VM])\
M0:GJNH:#J%G);7%T;D`_577O^"M__!/?PWHWPQUS4_V@?,@^,WA;Q;XP^&6E
MZ/\`"GXW>)/%?BS3/`>M6OA_QGIMGX)\._#;5?&-KXS\-:I="+5_AWJ>A67C
M^TMK35=1D\,C3=%UB[L?JGX]_M&?#3]F[PYI'B;XDP_$F^M_$.L#P]X?TCX5
M_!7XQ_'3Q9K6N-9W%]#IUGX0^"O@7Q]XDC,T%K,5O[[3+/28F7%SJ$`^8?EU
M^Q_^P;\5/A#^U'\"/C?<_!7X7_`/P%X.^`_[6'@KQ=\/_!GQA\;_`!?U.W\=
M?&OXS_"?QWH.LWGB[Q\MYK_BS5=>TKP9K.H>+M8FU*.UM-7>WMK*WDBF+I[M
M_P`%-/V<OVD?V@]._9Q?X#P>'_&'AGX:?&"3QI\9/@IXG^*7C#X.Z+\7_#"Z
M!=6.@:;?>-?!"_VPD'A?Q%+;^(WT261--US[.+._2:$^60#IM=_X*O\`[%&A
M^!_A=X]A\:?$[Q-IWQGU[XL>#OAUX;\%_LY?M#>+?B=K'CWX'SWD'Q1\`:I\
M(-$^&%W\4_!WC#PBVF:P^JZ5XV\(>'%MHM)NY)KF-9+`WF-XD_X*]?L/Z-H?
MP<U7PYXQ^)WQ:U;]H'P'XQ^(GP<\!_!/X`_&WXK_`!(\;:+\/]0M-,\9V,'@
MCP=X$U+7-"\0^&;FXNCKVA>*K?0KW1+;1]9O-72QM;%I7^'OV*?^":7[3/P9
M^+W[-WQ'^)6E_"?PQ8_"[]LS_@HY^T#XJ\/>`_&&N^(M+T_P=^U7X)U'P[\-
M=)\+7.OV"ZSJ$MC>ZAMU6+6;IKVQLK823W=[<2$UZ5^Q#_P3B^.?[/7QR^"W
MQ+\=:GX+ET;X??`G]M?X7:U;:+JUS>WLNL?'_P#:9\`_%_P->V:R65NDME'X
M9\.:C!K&YDDL=1\B!!.DID0`_0;X6?M\?LP?&:Y,'@#QY>ZM&O[/6E?M0RW<
MGA;Q+:6\'P?U2^U#2VU:Y$VEBZM]=TG5-*U'3-<\'S6R>*-+U&RN;*XTH7,,
MD:_-'BW_`(+0_L0>")?A?)KVJ_&0Z#\4?V?_`(-_M21>,M%^!7Q*\4>#/A]\
M!/CIJ?BO1?!'Q*^+GB/PUH>K6/PU\/KJ_A&^TW79_$C6KZ5=7VDJR3+=2O;?
M&?AG_@GK^W/\!9=.UGX+6?P*\9ZY\0?V3_'_`.R?\1(O'?BW7]$L?A[#K'Q:
M^(7COPY\2=".EZ3=2>+X6TWQ9;1ZAX9?^S+F*Z3RTOFC21VU-*_X)._'>T_9
MM\9_""Z\8^`G\2>)?^"1G['/[!,-_#+J(TR/XI_L^^*?B]KGB[Q$^Z#SE\*:
ME!X_TQ-'<!KQGM[H3QJ`A8`_4K]E_P#;R^`O[7'BWXG^!/A?'\4M$\7_``HM
M_#.L:[H'Q8^$/Q"^$FH:WX*\;-K$7@OXD>"H?'FA:,?%OP]\6S^'M=AT#Q+I
M)EM[TZ7/-Y:6L]C<7?TC\4?B?X`^"OP[\:?%KXJ>*=+\$_#GX>>'=3\5^,O%
M>LO*FG:'H.D6[W-[>S+;Q3W=RX1/+M;&QMKK4-0NY(+'3[6ZO;B"WD_)?]HO
MX3?&']EWXM>.OVZ?AQ8:!XL\2V/[!/P:_8W\`^#_`+/KFJ7NM_M#^(/C]'X=
M\`ZIJ>G:=;74K>"4UKX@^%DU=[5(9(]/L]2N+J2S@CEOXONO]L3]F*Z_:\_9
M`^*7[,WB'Q@-`USXC^"M'TQ_&MA82I96OC+PWJVA^*])U:;2(;I)VT"Y\5>'
MK%M6TB"]CN)M#GO+""[29TF`!\\:-_P5T_9+OM/FO_$-G\</AK+IL_PBO_$N
MD_%3X*^,O`6M^$_A[\=Y]0TWX6_&;7M,URV@G_X5)X@\0Z3J?A34_%>D_P!J
MR>"?$MC+I?C[3?"[R6[S=EKW_!3O]F33=0\2:5X:B^*_Q5U'2/C1IW[/'A>R
M^#_PM\2?$>Y^*_QC?PEJ_CWQ;X0^%,/AZ.X?Q5;_``L\%>']=\3?%/QC*NF>
M`O!FGZ/J$5]XIDU&W:QKXHTS]A;]KC5?A7XV\!)\,?V0_@=XL^,/A+PA\%?B
MA\4O`>J^/_B%XKN/A4^I2WGQ#O=.7XAKJ%M&+BP-S;^$/#`8V^G:[K=QK=W,
MQT^V$E;X;?\`!-_]J/\`97TKX+>&/V=?$_PK\8>$?V,OCKXD\6_LTZ3\3#J.
MDWGBGX$_&OX8Z_X'^+'PT\?ZOH-O+<0^./!VO:ZOB+P=X]>*\.OZ=9?V9K=K
M]LN'O0`=G9?\%2T\._M/_'W6?B>OC?P9^R9\//V4_P!GCXH:)X4\5?!KQ-X.
M^,'A_P"('Q9^/FK_``1U)/%/AWQ)H^D^)HW/B"30[#^R_.N+*QL-^MINMKB"
MXN/K7XS_`/!3+]F?X'^*?BA\/_$1^)7B7XD?"_7O@EX2G^'?@+X?ZIXH\6>-
M?&/[0VC^*-<^%OA3P#:0S6UCK6K:S8>$-<DOYK_4='T?0OLZ2:QJMG;N9T^'
M/CU_P38_:I_:@B_:/\5?$GQ]\'_"GQ/^._[*'P*^&MO<>$K'Q%?^#/#WQ6^#
M'[0__"]=-@:RU-H]6O/!\EOIF@^%[O4&F34+J4:CJ<4$*O#",:;_`()\_MI>
M)]9_:W^+?Q>\,?L0?&3QO^TS:?LN7LOP<\9:)X_N?A?HR_`WPO\`%+P]=:#I
M?BQP_BW0O%6G2^+?#^HZ/\0])BM;EKJ'4EM8+%/)<@'NFM_\%7?AQX9^*<&N
M^,K/XX_#KX7Z'^SS\2_'7Q`^#WCS]FO5?#_Q(\(ZO\/OVA_V?_A'XD^)^M>,
M+SQJEJ?`_@C3OC;I&I:U8>%M`\5Z!JOA.?6?'&F>-Y)O"<OAO4_H_P"./_!2
M'X!_`OQUXR^'&I:)\4?B%XK\&?#[X>^.+BP^%7A;2?%1U[5/B[XDN?#'PI^&
MOA877B;1IM:^(/CZZL[K5-*BCAB\':/X<MY_$/C#QCX:TJ&6Y3X8_9/_`."3
M'Q$^''C*/6OC]X\\->//`OBC]F+]LWX&>)OA79:QX\\4Z!X'TW]JGXT?`3XA
MZ3\._`?B'Q]K&L>+-0^'O@/PW\)=9T9)=>U.349KW6[?[$L%E;^6*_PK_P""
M/'B_PU^R_-X$^*OQ,\"_&[]HC1/VB?AQ\:/"'CSXC>%9-8\":CX5^!-C)X`^
M#GPO\?:&UO)J&LZ#8?""ZUCP]KD\1FDD\0ZS+XBM8OM4"AP#]0_V3_VOOAQ^
MUYX8\:ZOX-\-_$?X<^+_`(7^,_\`A7WQ7^#_`,9?#=CX0^*WPR\72^'=#\7:
M=IOBK0=+USQ+HTEIKGA;Q+HFO^'_`!!X=\1:_P"&]<TZ]+Z9K%S-:7T-K\]Z
MG_P5/^!.D_%BS^'EW\,OVC6\#:U\8M6_9S\*?M)VOPRT^]_9V\8?M#Z5J%SH
M7_"F]!\66OBV7Q<NOZGXMLK[P1H_BW6O`>C_``HU#QE8W?AZ/XAB^A9*]E_8
MT^$/Q/\`A9X7\:7GQ7^'?[+OPL\1^-O$&FZT/!?[+'@5_"OA;38;#0K/2G?Q
M/KMS8:7?^-O$,\T#F/5;JPMX[#2TL]-M=\<3$?%'B+_@F]\=/%\'AWX`:[\4
MOA3!^QAX;_:Z/[4?_"/Z7X<\4?\`"ZM?T[3OB]+\<?#'PJU36KNXD\+V.BZ/
MXY:U2X\0:6D6M:CH^G6UO*8S->+,`9G_``2(_;._:*_;>G^.GQ.^,?A7]H[P
M#X7T_P`?^.=`\"^$OB/\)O@7X-^$&DZ5X?\`'VO^%[+P]X+\9^!_$/B/XH^*
MOB#X;M-#6#XCV_C.XCT*PU6Z\KP]=ZG;H+BN!_8[_P""O"VW@CPCX1_:]^'W
M[0<.OS_M&?M%_`'Q3^UY9_"#2K7]D8?$?PC^T?\`&'P=X%\`V/CS2M?@UF]+
M>#?#GAC1K#Q=H?P^O?A[>ZH#ILOC'^W;76[2P_2[]AO]F76OV2_@GJ7PJU[Q
M1I?B^_OOB]\:/B4NK:18W>GVD=G\4OB1X@\<V.F-;WLDLQNM*M=9CL+N<,(K
MB>!Y856-E4?FW=?\$J_VD/B!IME^S[\8OCM\(;_]C+2/VM?C?^U#;^$_!/@#
MQ!H_QD\1)\3/C?\`%#XR^&_!'BCQ5=7_`/PC@AT"]^)$]KJNLZ3IEM<:@MHM
MI:P6MG#;D`'T_P##_P#X*S?`WQSKO@"TU'X0?M)?#/P3\;-"^*/B+]G/XM_$
M_P`%^`/#OP__`&B-.^$NC:UXF\0+\-[>Q^*6M?$'1KW6?"V@W_BGP58?%GP'
M\,KKQAX>-KJNBQ7%M=0LWG'PX_X+:?LY?$#P7XU^(&H?`O\`:X^%_A;PY^R!
M\3_VX?!U]\4_ACX&\-R?&GX$?!W2Y=2\?W_PLM=/^*VN7,OB/1R+.RBT3Q_'
MX`34I=6TG4-.OKG0;U-87B_"_P#P3)_:4U^R_9M^&?QZ_:#^'7B_X'?L8Z1\
M3)?@7I_A/P=XATOQWX[\=:UX`\6?"/X2^,/C/JFJZA=6$<GPQ^'/C;Q%:W-C
MX0*0>*->O3J5Z(8EC@C2V_X)$Z_J/PV^#OPO\4_%S0Y-#\#?\$O?VC_^">'B
M^]T70M1AU#5K[X_:;X2T>3X@Z`+NX>&TL-#LM!OG_LN_$MU/<75J5E5(Y00#
MZC^/7_!4;]GO]GB/X;+XQ\,?%S6;_P"+?P+MOCUX$TGPIX>\(7E_J^AZCXE\
M!>$M'\'LVM^/-`T^S\=:SKOQ&\/6ME:W=]%X7AC74+G4O%>GV]JLDV=K_P#P
M4X\+^$-/\-:7XQ_91_:[\+?&;Q_\7+;X0_"W]G?4-!^`%]\1?BK>O\/XOB;J
MOCGP+XZ\/_M#ZU^S9>?#/PCX535Y/'_BS5_CUHR^`-6T"^T+QE8Z)J^H^&+/
M7_C>W_X)D_MN^(M6^'GC/XM?';]DOXB^)_A!^S1K_P"S-X)\)ZY^S_K.N?"G
MQ#X7O]0\"W=MJ/Q'\*^(]9U-=?DU*+P<%U?3XDCM;&XDMIM-,NR05A:3_P`$
M6/&6GQ7GQ67QK\"8_CGI/QX\7?&?X:_!_4OAYXA\;_L2>`M/\9_!R'X*^(O!
M.E_"?QCJ=_JMI:>(--CE\?:CJFEMIZV?CZX,^FZ5'IT%M%$`?6DG_!6_X;^(
M=9^'W@GX-_LW?M+?&WXK>+/!WB[XA>,?A)X7@^!/A#Q=\(_"7@#QQ<_#GQ>G
MC+6?BI\<O`GPWU[QA:>+K.]TS1O!OPT\>>.]0\1)9S:EIUP=(EL=0O/U*\-Z
MT/$?AW0?$*Z7K&B#7M%TO6AHOB*R_LSQ!I`U2Q@OAI>N:;YL_P#9^L:>)_LF
MIV7G3?9+V*>#S9/+WG\+OC+_`,$M?VAOBG\'/#_PKL[_`/X)]^&%O_"GBKPU
MXGN_#G[)0\&O\,[_`,9Z_JNI:MXR_9[UCP;JNC^)/!_BB&TN='F:[;4]-.MZ
MYH4&HZM(RW=Q'7W'^QEX=_:3\)_$'XT?#_XH:_X@U?X%_`SPS\"?@)\!=7\7
M6EL/%GQ/N?`?PKT*7XC?&?7M30R7&I77B[6]2LK&:=I?(?5M*UORDRC2.`?H
M11110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`5\+_LJ_M\_!?\`:7\.)=7'B3P;\.?'EY\4
M_C-\,]&^%WB+Q[X9;QMK4GP@^*GB#X73:QINB->6VIW4'B&]T1-1TZV@LI)O
M*O4@3SWAE8?=%?Q\ZU^R9XDU[]G_`.-_[-/@+]DOX_P?MR_$+_@I5XG^*OPS
M_:"US]GGQ;X)\(_#OP5H7[4$WQ`T7XZWW[4^M^&8/AO_`,(/I?PXTK5H8?"&
MB>*!XW\<76O0^&M#\$7VDZ[_`,)4H!_5MI_QM^#VK?$O5_@UIGQ0\!W_`,6=
M`TV'5]:^'%IXIT:?QIIFF7!Q'>7GAV.\;4X83PSEK;,2O&\H1)8RW(>`_P!J
MS]FCXH^*+7P1\./CU\)?''C"]\(67CVU\,^%_'GAS6=;F\':A`MS:^($TZQO
MYKG[`]LRW,CF,26]NRSW$<41#G^=[]F#]C+QMX?_`&@O`.K_`!RF_;0\/_'[
MX8?MJ_%/XG^'X_"'[+/PWU'X<>)O"?C+QGXRAM_%7BK]LK0/A38VVK?"?Q+\
M+-=L]/\`$/P^UKX[R>,--U"RT^TA\&79TS3](7S3P)_P3B_:'T?_`()U?\$O
MO"7P8^`\_P`'/VK/#_P;^/7ASXK^*'\+67A'QIX-\1>.?@#X^T'1[3XF:Z\5
MGJFG?VQXBN="T9&UJY,.G:A/923BV6U+1@']$'Q"_;]_9-\"?#3X_P#Q+MOC
M?\-O&-I^S5X;U[Q#\4]"\)>-/#VK:YH!T)'C?3;RS@OV:VN;S4A!H]M+-MM3
MJ5U;VK3B65%/YW>!/^"[GP+G^`WB_P#:'^,'@^P\`_#SP]IOP$U?3-7\)?%K
MX;_$N'6XOCYXWMO!6FZ%-;Z)K%MJ6B>*_`3R7VM>/M+U6P@MK#3-%UG^RK_5
M+G3YH1\!Z#^P_JGB/X$^"[*7P5^V[JGQW\)?LE?M%?"2\^"_BC]DCX"?#;X9
M>&]9\<?`J6QU30/B=\9?"GP1^&5O\<].O_&_ACP8OPZO?`7C[XJZI>?$&#PW
MK=]:VNCV_BO6]-J_%K_@GA\;M9^#WQT\,^&?V:;J&.;_`()^?\$K(M.\/6G@
MS3K>/Q)\3OV=_C=H/Q-^.O@[0M+M+)H]3^)T?A71M?L)]/$*7>MZMK$.E7=Z
ML>J3S``_H\L_VW_V0-0A\!7%C^TG\'+N#XHNL?P]FM_'6ARQ^+9'UR;PS$FC
MNET5G:X\0V\^BVJL4-UJ4,EI;B69&4>O_%#XO_##X*^'K?Q7\6?'7AOX?^&[
MO5K#0;76?$^I0Z98W6M:HSIIVE6\LQ'GW]\\;K:VL0:69E(121BOYVOVD/A/
MXW7]H;3_`-HK]AC]FKXRW'B+QO<_`/P-XC_9X^-_['&EZ%^SS\2/A]X0^).K
M:I=>.O#?BSQ5I^@^)OV8?%G@2"\UCQ#<S>,X?`^J:G>MHFHV7@CQ++.8Y_T@
M_P""J"?M'7WP:^!EK\#/`_B[7K;4OVB_AW;?'S4_A7\-O!OQD^,GPV^"]UHG
MBA?%7BWX.>%O'+)X?F\:6NOMX=\/KXF.E:O?>&O#^M:WXCTS1IKZP@\H`^NM
M7_;"_96T/P;X8^(&M?M`_";3?`_C>'7I?"?B>^\::+!HWB)?#,UE:^(H=+NY
M+H1WESH]SJ5A;:C91YN[>XO;>"2`2S(A\YT;XP?\$_OAG\!-"\7>'?&7[-'@
M?]G'X@^+]5U3PY?:%)X&T'X:>+_'5WXCN=>UO4=+L=.AMM)UCQ//XJL+K7-5
MNX+2?4FUBV?5KN3[2HN*_!W]D']AGXGWOQV_8I;XK_LS?%5?A-\(?VK/^"E?
MQ+DT[X_^"?"5U>>#=)^*^@_"^]^$GBGQ/)H&L>)/"5[>>+=3M=<O-'>QGF@T
MW48KBP\FVO;&2.#K]%_9D^)?P$_:_P#`/QB\9_L9?$WXO_LQ>$/C=^W+9Z'\
M._AIX'\.^,5^'NN?%[7O`6J_#OXJ:3\(;_4]-M[SPQKNFV'BG1D\0:/9[/#X
MOKB9D6&ZE4`'[>_L#?M=V'[</[,VA?M(:?H&E>%]'\1?$+X[>#]+M-(\1GQ3
MI5YH_P`'_C?\0_A'IOB6UUQ]+T830^*K#P/!XG,`LA%IIU5M/CNKZ.U6^N)?
M$W[?W[).A>'/C%K>E?'#X>>,M3^!_@;QCX^\:>%/"_BG1[[Q#'I/@FSDN-8B
MLK=[J*"YFCNA!I3RQSM:6FHW=O!?3VQ<D?(7_!-OX&_%WPG_`,$N?$7P?\2?
M#GQ/\"?B?XI\4_MV7/A[P#XMM=#T+Q#X1M_BM^T?\>O$_P`.A?0:1>:YX?TY
M+SP_XI\/:G;3:9?ZEIT5C>P7%I<31"-S^<?P0_99^-_Q%T/_`()K_!6S_9#\
M=_`;QA^R+\*_VHO"G[4_Q#^(_@_PYX?\$>(9/&?[.?CCX,^&=`\&>-+%?$.G
M_&Z+QW\5?$WAGXE1,(;G2K+1_"DVN^)!:Z]'IVC7H!^B5Y_P6>_9OA^+/[-.
MA_VYX+TSX'_'3X'>.OBOXK^,'B'QO%I\_P`+/$WA;2/!VMZ5\--1\,VNDW\6
MNZ_JMEXK9;R33-:(L9M-G%K!J,9:2/[#\5?MF?L,_`/P-X-^(/B+XX_!7X=^
M`_CG>:EXV\%^(+34]+M=,^)%[KDT-_KGBZQ71()9=8FO;F\@N->U^:%RMW.I
MU6[2X8BORI_9[^!'CWXD_M1_\$S?'7B?]DKX@?#3P9^S9^R%\5O@U\9K3XK^
M`O#&DZ3H?QBC\%_##1;:]TR"`ZM8>*+34-3T?7;+P]X\TK4);+6K>">YT])+
M2X%V?C/X6?L+_'KX7VWPLU;XT?"#]K;3O!B_#[]M+X216_[,F@_"_P`=>+/A
MU<^-_P#@H;\<?B=X2M]?\%^)[V^O+?P7\2_@]XT\&W^@ZYX.TW4+'2-/\.VM
MGXC.D62V#Q`']+K?MB_LKKXM\-^`S^T!\*CXR\8R>`(O"7AM?&&DOJOB=_BH
M-2/P['A^V2X9M87Q=_9&IC1WT\W"3M9RJS(P4-M_'G]I[]G[]E_0-.\4?M`?
M%KP;\*=#UB];3M(N_%>I"UDU6]1/,DM]-L8([C4+^2&,B2?[+:RK`A#S%%(-
M?D3_`,$X?V#(/@Y^T_XM^(&O?L_>+_#OPR\+_L>?LE?#7X":]\?+?X?>(OB?
MX:\1>!O%?QLU3QOI-W<>&M0UJQT;Q7I::GX*O;^_T9H+?RYM-BL;Z66UNDB]
MU_:Z^&7Q.T3_`(*$?LN?M4+^SOXI_:1^!/@[X%_%WX.^+-'\!67@?Q3XR^&?
MCWQMXA\/:UX<\=0>!?&_B_PK_:N@:KIVE7?AS6]8\,1ZYK>C;K-[G3HM*ENK
MR``^K]6_X*&?L0Z'XJ\#^"=5_:?^$-GXG^)'A_PCXJ\%:8_BFUD&M^'O'T$U
MUX)U1+Z%9-.L;?Q7:P2W.@KJ=W92ZG;(9[2.6(JYK>+O^"C'[#'@'XEZI\'?
M&O[4GP?\+?$W1=1UK1]6\':WXIM]/U73]6\/^#Y/'VJZ9="X1+:*_A\'Q2Z[
M;VC7'VC4+2-TTZ.[N%,-?A_XW_9__:&\2_!C_@I?\&H_^";GQ*A\3_M\^.O!
M?Q'_`&>/%\-]^SL_AWX7>'O&'[/WP(^&=AX&^*FHP?%S2=7^%>H_LW^*?!/B
M_5[^S\.PZUILL&H7A^'LVL33I'J-^?\`X)R_'Q)?$UIXC^#%GX[U6+_@L7_P
M3T^-0\7WUMX5OY?%/[/_`,&/!_P#\/\`Q5^(L4^K7LFH_P#",6=SX8\9R7^B
M7Q35KV+[>L>D79O2+@`_9#7_`/@H/_P3U\2_!N#X@^*?VC/@GKGP4\<:_K7P
MW74]>OX-0\,^(?$>EZ1-K6M>#;W2=0L99+C4(]&@EOI=(OM/#W5JH,44V]%;
MN#^W?^QM:?"'PE\;X?V@OAM)\)/&6H:EH/@WQ3IFIRW]KKFIZ!?76DZSI&DZ
M1IMI<:W+>:%>6%U:ZM9II0ETG[.[7T=O$%<_SR?M$_#/X@_LX_ML^$?&OB']
MF+QO\0_`WCS_`(*O7WQ-^$OPV^'ME\)=0UOXO^''_8DUW0=3E\#:+XW\?^!/
M"<4FB:YI-S=3Z=XSU+P>H;3+B;1;_7[V6U@JKX7_`&!_VT/!/Q4\._MMWOP2
M^-'@W0?'W[47[<_Q<U#]F?\`9H\<?!:#]HGX(?#?]IW1_@CI_P`.+W5K#QQX
MJT_X.ZMXK>3X+:GJ?Q*\'^!/'EY)HU[\4)#8:O?2V/B*RC`/WG\8_P#!4?\`
MX)]^`K/P]?>*/VJOA780>*O".C?$#0!#JEWJ,^I>`M<N-=MK3QK%;:=8W5PG
MA>VD\,>(SJ^M2Q1V6B+HFH_VO+9-`5/9^*O^"@?[&W@SQA\-O`?B#X_^!;?Q
M/\6M-\%:SX$L+2[N]4BU71_B3>6FG?#[5;J_TRTN[#1M.\:ZA?VECX:O-:N;
M"#5;J=8[9VPQ7\B_V*?V#_&OPT_:(^(WBU_V;/B=X)^$7B[_`()[>,/A_P"&
M(_VB]5^#OCCXJ67Q1\<_M4_M`_$GQ'X.\07_`,.?%OC7POH]UXFT#X@6'B&\
M\/>'=6NO#VG:1J>D^'[_`%&[OM'F5/EKX8_L;_MM_"#PI^R6OP2_9Y_:1^&O
M[5.G?!;]D7X<?%+QQ?\`C']F_P`7?L<>//"G@#Q`@\=:!^T/X0\9>,]4\?>'
M-:^$_A6;7H?#5]\/?!FLZWJNK7.AZAX6N[JXMY!;`']`-A_P4<_8SU#XP>)_
M@2GQKT:U^)'A/6_%/AC4=+U'2/$FG:?>^*O`QU8>,_"OA_7KS1X=%\2>)?#!
MT/5AJVB:)>WVH1&RF$,$^!GYX^"W_!5?X9?M'/\`LEI\'3X%N[S]H'5M6M_'
M?A[QIXO\0>$?$O@73='^'7C3XCZA_P`(7;W/@>YTKXE:[I&A>!=:U+7M,M]6
MT.TTK1TAOY=3>2XM[6;\G?`?[+/_``4+\>_M/?LU^,?VA/@G^UKKWCWX0?\`
M!1+Q3\7/B=\4?$_QR^!1_8^T3X+WOBGQY!\/;[X!?!WP3\59?$=X;OP%=^#K
M[Q3=ZO\`"[3?$>A:^^MIJU^EW='2;?V+2/V7OVJ/B]#_`,$[_@=K?[.?QL^"
MEA^QU_PUW\(_B=\9]=U_X,Q^&-6M_BO^QS\<OA=X'^)'PGNO"'Q0\:^*M2\.
MWGBO4M!L)+W7_!^@7FEWVOZ4DEC<0_:KBV`/UV\,?\%,/V)?&D'QENO"WQST
M#6;3X#_#OQG\6/B!>6]AK<-DOP[^'ECJ%_XV\6^&;N\TZVM_&.B^&H]+O8=5
MOO#,FIP6MW&EM)())H0_5?`+]OO]DK]I_P"(/B;X7_`_XP:+XW\9^&-"MO%,
MNFV]AK6F1Z[X6N);>VD\3>#[S6-.T^U\7:!8WUU;Z=J.JZ!+?VEE?RI;S2J6
M!/\`/OKG[%G[<?QO_9M^'OP)U7]DSQ'\%?%O[&W_``3B_;D_9P;Q-JOBKX'2
M^'?VG/B;\;/@1<?"KX9^&O@_)\/OBCKDMOX7UW4M/B\8:_K7Q/T_P,NCZQJ=
ME!J%C<:C/JE[I/WO\2/AM\9?V7?B+^R-^U;'\&$\3^%/V5?^";_Q`^$?C;P]
MI'BSPCH]Y>_&G7YO@KI_@KX86/V*;6M4N)O$_B#1M5TJV\2:'X=\0^&].N6^
MT7EXD5U`UP`?M1X_\=>%_AAX(\6?$7QMJ::-X0\#^']5\4^)M6DCDECTW0]$
MLY;_`%*]>.%7ED6VM8)92D:,[!<*I)`KX;^'_P#P58_85^*&C_$O6_!7QKMM
M6LOA3\-[?XN>)D/AGQ5:7M[\.[I$6W\4^$K"[T>&\\9:9+?2Q:,L_AJ'4D_M
MN2/2R1=.J'J?VV-1\1:[_P`$Z/VEM6\4^'(?"OBG5_V6/B+J&O>%+/5I?$$/
MA[6+WX?:A<7^AQ:S)I.A2ZM_9ES))9&^;1=,-RT+2BR@#",?@/9?`G_@I9^T
MQ\"?A?\`&W]G[]G#4_V6?%GP@_X)/^&/V?O@A=^(/C#\`9_'GQT\5_$37_@I
MXOUK4OAEK/@CQIXW\-_"U#\./`&N)X'\1?%Z#P]=:+X\\=:3JNJZ)90Z/JS`
M`_>OP5_P42_8N^+/BCP_X*L/B):1>.KCQWX7\*Z1X-\;^$M>\,>*M.\7>+-#
MOM=\$W#:/XFTFRO--C\2:99ZI_PCNM;8[:]N++4+"WN1=P30#I/B)^W_`/LS
M_#+Q#X^\+:_XG\2:EK?PS^)'A7X1^,;/PCX%\6>,?[+^(?C#X9W7Q?TOPR9?
M#FEZA%+?6OP^MDU[6Q&Y30TOM,M=3:VN]1M89/YTO$O[&/Q@^&W@7]O+]I_X
MK?!KXG?LIZ)X-^"GP'\9_L[^)OVA/VE?!'[3'Q?U7X^?L^_$WQ=XXT75_$FN
M_#SQW\0_L.H?$34O$]CX)TGPI;ZQKFCQC7C8P32>?]@A^@KG]C__`(*!Z7^R
MG^QYJVF^!?&7Q8UWXV_&+XL_M3?\%-?@S\'OC-X4_9P^,?C?XH_'3P@^J>!]
M-T#XO>*/&?AK1K3X;?!G5/[(\`^+?#]CKC>)/%7A'PWX173;2Y33-2LI@#[@
M\?\`_!9'X!?#S]I+X<>%]4\6:)JW[-OQ3_9.M/COX*\?>$_#/C3Q?XUU_P`9
M7'Q7\3>`[CP[9>'_``[9:A>+INEZ9X<N[G5XKC1(KW2]1M[N.\N(E58:]F\.
M_P#!33X%:OXE\9>.;GXE?#Z/]EO2_P!FCP'^T#X8^)T,VH_VIJMOXI\7:QX2
MO;"6T8L9[I-6LK70K'0;*P.N_P#"2&ZTF:!KI!"OX\_L@_LQ?\%%/V'_`!_\
M&/BC:?\`!/37_C>--_9U^,OPHU_P;X<_:0_9=TGQ)\-]7\8_M/\`COXH>%K5
M/%_Q"^)NEVWC#2SX,U>R_M.YTZ:W-O+<VI\F[U"\UFPT7(TC_@C9^V19?LV^
M*OAL]OX(T[QKK7@BW^-3Z!X=\=VFB^#(/C;%^UY?_M&)\`O`OC31+?0=>\#:
M98>$;B/PIH_CJV\#IX;T/Q7)/JNF7::6(/)`/Z0/@!^UM\#?VF+_`,=:)\*O
M$][>>)_AI)X;_P"$W\(>(_#^M^$?%N@V7C'2WUCPGK-UX?\`$5EI^HMH7B*S
M@OETC6(89;"[NM+U6R2876GW,2?,FK_\%,/@3\)M;\=:;\>?B)X)TM8_VD_B
M!^SW\,['X=:9\0O%WB#5/$O@/P-)XYOO"/BK26\)VSVWC\V-E>6\5CX<;7-#
MOKNYT>SL]6DN[YHHO)O^"<7[-WBSP%\7?BK\<?'?[)OQT_9S\8>+/AGX)^&.
MK^(OVC_VT-)_:K^(/CBS\-:QJ7BK3M(\-V/@SQW\3O"GAGP#X4UGQ-XM-CJV
MK^*],\6ZQ?:NQ'A#2=/,TLWSOX%_86_:=TG]NWX7_&;6/AC!'\-/#?\`P5#_
M`&R?VD-7U]_&/P_N?L?PA^*G['_C[X7_``Z\8KHT7BB;6YYM7^(6LZ1I*:%:
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ML+N*XD9+&[:#4K5%6.^M89L@_@E\,_\`@D+\9M'^$.B_LA>+OV:O#NH3>"1\
M=-)\,?MJZM^U)J6J>"[+3O&]O\3+7PA\0/"WP"BT^?Q-H7Q.U'2O%FGZ+XKT
M*XTB/PU8/J7B#4;'Q;J:RI:$`_5KP9_P6-_8B\?ZHNE:5K/Q6M;>]\"_%?XH
M^%]=\2?!/XA^'_#'COP'\#O#B>,?'WBSP#KNKZ+;:?XKTO2=&:SO;&ZTJ2;^
MT)+W3TL?,DNH<_1WQ#_;K_9Z^&.H^%=&\2ZSXJGUKQM\!_$?[1_A71?#_@CQ
M)XCUC7/ACX6CT5]4NM.TS2+&ZO;K7\^(-)BL_#<,+ZM>37(CAMR4?'X(_$3X
M9?MC?$WXZ?\`!.;]E?XY_L^?#WX!Z]HO[#G_``4J_9[\)>-/"WQ>M/B9X1\:
M>)+SX#?![X?P^*$T+1?"6E7?@KPC=6UGX?UZPCUO5[CQ-?3:MK6G76@:6="B
MO-7[;XJ?LD_\%;/C]!X;UW2?A+\%_P!E#Q[\,_V"/&_[,7A'QEX=_:.A^(GB
M[7?&U[<_#74);JWU'3/AKX<_X5_H7C73?#7BKPGI<MIJ?B:]\-76K67B/4;^
M,VP@`!]Z_&W_`(*I>'Q\,KO6_P!G_1-;TOXF>#/VC_V1?A1\3OAW^T'\+/''
M@/Q-X<\$?M.^,-.L=%\31^%M4O/#&JF/Q%X7;6[GPAKRW-UI@U71]0BO+&[;
M3[FS/WI^T=\:+[X,S_`)[74_"FF67Q._:%\(?"G7?^$GTSQ1J=S?Z-X@\)^/
M-:FT_P`)?\(S;W$=CXMFO/#5C+8ZAXE\CPS#IT&JQ7LZ7L^FH_\`/G\-O^"6
M'[4UCIOQ@GM?@'X(^",'Q3^+'_!-;XCV'@Q_VEK[X\ZO9?\`#+/Q9^*WB#XU
MZAXY^)OB70/#VIZWXJUNT\6:?X@\+1Z?IE_I=YH$^GZ5-J6G:Y97VD6W[I?M
ME?!#QW\;8OV9$\"V^F3GX6?M5_#_`.+GBS^T]1CTX0^#O#O@OXE:'J4UCYB/
M]MU!;_Q1I2PV*;7EB>>0.!"P(!X9\)/^"OW[%GQF\9>!_!WA?7_B=I,?Q)U+
MQOH7@;QMXV^#_CWP9\-O$OB'X=VOB#4/%WA[2_'>NZ1:^'[G6=*TSPMK^IO9
MQW1\VPTRYN(W94(KPS]HS_@M%\.OAU\"[7XL_"/X*?M!>,KO6X/A+XJ\'CQC
M\"?B=X1\)^-OAC\3?'?A+PI!XU\+>)IM%:RUBWFLO%NG7^A6]O+]HU62]TX1
MP^1<-(GG7@;_`()Z?M,>&OV>_P#@F+\/IM!^&U]XP_90^-/[1/CWXHZ7XA\3
M&[\(/I'Q&\-?M#:=X2MWFT^TDN]?TZ^O_B/X7M_$5EID(O;?3;C5#"LLMKM?
MYMF_X);_`+:/BGP-^T?X?\%^!?`'[+_@6?P7\'(?A!^RS<_M4^//CQ\&O%WQ
M9^#OQ/\`#'Q"@\4^&-7O_A]H7_#/G@&YT+P[?_#_`,-Z!I7A+6[IX/$"Z_K>
MC:-)9R::P!^JWQ;_`."I7PB^!]IX=\2?$OX(?M8^$OAS?:9_:GC?XCZ]\`O%
MVD>'/A'%=Z]JOAO08?B/#?)#JND7'B#4-*:ZLHK6ROC;Z%?:;K]_]ETN\2X'
MR1K_`/P50^,7A7]I;4OAUK6A?#2;X6:!^W3\7/V?M8U#3?#WB*?Q5)\(/AO^
MR#KW[0L6J:?>?\)F=,E\:W'B'2!:/J)TQM'N=$8V<.AP7CKJ:_,7[6_[!7_!
M1K]MO5/CCXS^*W[,G[+)U;XR?`7P]X7^%^A>//VI_&_CJ+]CSQ)X('B.PU?2
MOAUH_A[X/^$O"OQ$\:_%34]7TGXAZ!XYU:Z\+Z;\/-3'B+1=?O\`Q98:3X;L
M=<]G\:_\$J?VE?$7Q:\2>-K/Q)\*IM(UC]L7XU?&VWFU#Q%XAM-3D\$_$+]B
M7Q+^SOH=W>V-MX1OK>WUH^/-4M;_`%72K:^O$L_#SRWMM>7UY%_9S`'OF@?\
M%Q_V;?&$/P^;P9\#_P!K_P`4W/QL^&4GQ3_9[L-,_9\\6B[^//A[3+;3[OQ6
M?ARETL"WR^#K;48+G7+^_:PTXV:R7VGW5[9A9V]>\2_\%:/V>K?PE\.O$_PO
M\#_'+X^W'CWX2/\`'C4?#7P>^&NJ>)-=^&OPC@N]3TBY\7_$Z&5[.V\(_P#%
M0Z-J_A[3]$OKC^W-:U/1];72+"\@T74IK?D/@;^P1\8_AIJG_!(:]U[Q#\-[
MJ+]@;]D2X^`GQC72=9\2W$GB'QC-^SQX+^$RZA\-Q=^$+%=9\-CQ)X=OKQKS
MQ*WA#4QHLMK<C2#>R2Z=#\"_#[_@C1\8?@G=^$?&MQ\'_P!DW]KW7O$?P/\`
M#/P:^+'PV^,'QG^+/PG\->#M7\`^/_B;X@\&>//A;X^\.?!/XBWFNZ-K6@_%
M6_TWXC>"O$7P]T"42>&+#4?#VLZA=ZC<62@'W!\2/^"W_P"R/X`FU[4-.\,_
M''XD^`?!WPX^$_QE\>_%+X;_``SU3Q)X#\!?"'XN::FK:+\0/%NJQR0R:3I>
MEV;M_:UD]N^K)/#<6]K97$D+@<EH_P#P61T[PQ\</VZO`/QS_9\^+?@3X8_L
MG?%[2OAGX>^+&G^%9M1T'Q-=:SX"\':YX9T35Y!?R&W\5_$GQ'XD0?#FTLX?
MLNK>&]7\/7U^]A/-<A?/=9_X)6?'"_\`@S_P4.^'OABR_9D^%TG[6O[%'PS_
M`&=OA3X'\"WWC-_A?\-O&7A/X<^)?"VK65U#KOP]U#4-,\`VNJZW"OA_7M,T
M_7/$GV2)]:B\/Z%JL5G90>J_$']B?]J:W^*_[>J>#_AI^QS\</@5^VOXH^&W
MQ'U'2/V@_B1\5_#NK:3KO@;X2>#OA=J/@6]\&^"_@UXHT_\`LS51X(TS7=$^
M)5EX_.K>&-0NIG;P%K1M(/,`/TG_`&=_C]_PO_PSXLU^Z^%'Q8^#5_X-\9WG
M@S5?#/QA\,#POK-U+;Z#X?\`$MMX@T0QW5[8:WX6U/2_$EB]AKFG7<UI+<PW
M]FS)<V-Q&GQMIO\`P5J_9]UWQK:^%/#_`()^,VLZ)XK\;?$WX3_"/XGVG@6<
M?##XQ_&3X5Z+XBUC7OA9X*\6S7,5G_PD^HOX5UO2O#9U<:;IVOZM92V>G7LK
M*2.H_P""<7[)'Q;_`&7/@W\8_AY\9_$.BW6G?$3XU^+_`!Q\-_ACX2^)WQ$^
M+GAGX"?"?7?!G@KPOI/P=\-?$_XD^'?!7BSQ/I^EZEX=\0>)H]1;P=X3MK2Z
M\5W%C8:1%'9+=7/R-\,?^":7[37A[4_V;O@'XN\;?!A?V//V0?VH-=_:F^%'
MB_PUJGC&[_:!\=ZK%'X^_P"%?_#3QUX0UCP5!X*\.:/X9G^)GB%O$'CC3/B%
MXJUGQ9:Z;IENGA_0[JZGU&T`/=O^"2O[4O[0O[:WP6D_:=^,D>N>'/"OQ6TS
M1_%?PO\``5Q\+M#\&^%-!\+:Q?ZXND-X3\8VOBWQ3X@\=S#1--TQO%=UKS64
M=IXBOKI=(MTTJ2SAA_6>OC/_`()Y?L[>-_V2OV)OV;OV;?B3KGAWQ-X[^#OP
MVTWP;XH\0^$I]1N/#FLZK8W5[--J.DRZOI>BZDUM=+<)*5N],M)(Y6DC".B+
M*_V90`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`%>[N!:6EU=F&>X%K;S7!M[6,
M2W,XAC:3R;>(L@DGEV[(8RZAY&52RYR/QQ\0_P#!:GX4^&?BQHOP/U/]B_\`
MX*-#XG>)M#\6>*?"_A>W_9JTF:\\2^%O!&HZ9I7BCQ+HS?\`"S%BN=%TF^US
M1(;J[=H3$VLZ6LD:O?6ZO^RU?D!\:/"7BN;_`(+<?L-^-[#P;K]QX2L_V'_V
MQ?#GB#QUI\6LSZ%8WUSX\^!^H:3H'B*:WN;;1M-9WCDNM'6_6_FUB[NYO(TX
MR:)#J>E@'3:I_P`%C_V0?#?[*;?M?^-(/BSX"^'%I\>T_9LUSPSXS\%:=HGQ
M(\+?%--2FL-0TWQ-X:E\3R6.DZ9HMO:7^N:UJTNN-;:?X?TW4-4D!AM9%'J7
M[3__``4G^!7[*/C;4/A[XX\)_&/Q?XIT[P?X"\9267PS\%Z7XDAFM_B;\0[?
MX8>"-$AO-1\4:!:Q^(M>\4W!2UL+N6U@_LVUO]3>]6UL;IHORS^)?[%VL?'O
M_@IS\<?V8_'_`,/O%#_L?^.O`WQ5_:3\0^*9-+#^#M<^)OQW^!UA^SE>Z-8:
MA.S2V7B[PW8W_C[6[*\T2ZTN[LEU:WG1Q<[9X?B.#X:_M<>/OV'?CE^TO^T%
M\-_CSJOQXM_C'_P3T^`]_'9:-XEA^.GB#X=?L;>'O`-I\;_B7X/N_"%_HOC#
M^Q?B9\9?%/QG\;Z-J7A;Q#I,^K6::;J`TO3]4@<WH!^\?Q'_`."KOPS^"WP*
M^)W[1?QO_9B_;0^#WPT^%MQ\.K'4[CQQ\(O"*Z_XDU'XG>/=(^'>@:;X,\.>
M'?B?X@U37+VUUO6K.[UF&2&R%EI)>YA>[N&@LYN\\3_\%&_A[;>,O`'@7X5?
M"/XR_M#^(?BI^SIX;_:;\!V'P>L?`ES-JGPZ\3ZOJ6BV5W?R^.?'7@?3-,:U
MO+.RCU%?[2N[NV?5((UL)FM[ORORN_:%U3X4_M%?LM_$?P)^S)\,?V^M<\3:
MM\>?V$_&7B[0_P!JG5_VP?'^G-X8\%_M>?#VXU0^"M/_`&GOB)\0=)\,M8:&
MFO:YXTL?`5MH1UG0;73-3\5KJD&CZ,VG^A_L>_`?]H'X.?\`!83XJ>%/%/@G
M5F_9O^&'[+.N^&_V>_B7%92#P[+X0^(GQHO/B;;?#;[6J"WAU'P%>ZOJVEV]
MDK9CTE;-(52V@BC0`^@X?^"T?PT?P%XK^+U[^R=^U]X<^"_PS^,?B_X(_&+X
MN>)_!_PSM/!OPG\6^`O';?#[QE<>*4T7XJ>(/$D^A>%-<5XO$7B#1/#^IZ%I
MYAN?)U.]M[=[JONNT_:[^'_B+]I[PA^S!\/K*\^(GB#5O@S<?'?QSXQ\+W^F
M7?A+X6>`M4O;?2_AI-XLNA.TK:K\6=0&L'P9I-JIO;G2?#VK:[+$-+BCG?Y)
M_P"":OP5U9OV?OVR/AI\>OAN#X8^)'_!0'_@H+J*^#_&V@Q-IOC'X5?$7X^^
M,=1TF^NM-O);J+5-!\5:3J4UU9W,T-LEYI]Q"\5OY8BN9^;_`.")W[+EI^S?
M^RSXLNM<\$^(_#GQ4\<_'/XTZ9XJUWQ])?ZEX_UCX:_"#XI>,_A)^S?X>NM<
MUMI]:;P)X'^!?A7P;I/PY\/_`&G^P]$T:ZNKS1K.U?7-1DN@#7_:8_X*@?$O
M]F?XCZ'X'UW_`()Y?M/>*]#\>_&/2/@7\(O'^@^)_@?#X?\`BKX_\0Z3K>M^
M']-\/65_\1(M:TQ=8TWPUK]S;3^);'1[:)-+E6[GMY9K:.;Z,_9G_;7D^/OQ
M6\<?`[Q?\!_B9\`/BQ\//AGX'^*/BCP7\1]0\':I?6&A_$#Q#XNT#0;<WW@K
M7/$&CS7<I\(76H2"#49D2TO+57*3"6-?,?\`@I)X$\9>.-=_X)QS>$/#6L>(
MXO!'_!2_X$^.O%TFDV<MXOAWP=I'PP^.]AJ?B75C$"+/2+&]U?3+:YO)<113
M7ULC$&5<^&ZG^Q[9_&G_`(*O?M._$#XBP_M%>&?`DG[)_P"S3H'A/Q9\'_VD
M_P!IO]FW1]=U_2_%WQ8GU[2;W5/V>OBS\+AXMN])MK[3YGM/$$NK#3%NXI+9
M+<SDL`>MW'_!5#X?:M\(?A=X\^%OP7^*_P`8_B9\:_BM\>?A9\+OV??`[>%(
M_B1XE?\`9N^)7B_X;_%?QK-<^(=;T;P[HO@?PW=^$C?W>OZKJ=O:0R>(_"NC
M22+JVO6,$C=$_P""KOP@N=(TW3_&/PR^*WPN^,UG^T]^SA^RM\2/@%X]L-$L
M?B%\-/&G[4'C;2/!?PT\4:E-I6K:OX=\0_#_`%1]8AUBR\4^&M6U"RU+3[:]
MCMBMY:S0)^1_[)?P:^+G[$6B_L4_M8^(_A-^T%XX^'/P9\0?\%0_@%\5/ASI
M)\8?$WXF^!O"_P`=OVUO%7Q(^%GQITWPAK<^J^+_`!F-?T_PI:67C[Q)/K6J
M^*O$.CZKX"U>87\>DW=P^M\8_@?^T]^T_P"/_P!H;_@HGX'_`&:?'_A[2/#O
M[0?_``3-^)7PG^!WB[0X/"7QQ^./PU_83^-LOQ1\?ZY:^'[VY,^F^)/%&F^)
M-7M/`^@:^+.ZOK/P[;VL<IN[^SMB`?LW^TA_P4F^"/[+7CGXP^"_B9HOC-C\
M&?@%X?\`CYKNJ:!8V6IIK&F>+/'L'PW\,^$-!T][VVO;[Q5KGBF\LK*QMD4V
MY%QYLTL,44DB]?\`!/\`:_\`&'Q!7Q[<_%_]E3XW?LT:1X+^&UE\4[+Q%\1I
M_`^O>'?%'ALZ6-5\065AJW@CQ+KEOIOB7PM%+;0:GH>LFSENI?M\VE3WUAIT
MUZ_Y*Z]IFN?M??'#]K3]K3QE^P9\<?BC^RIK7[)/PI^!.A?!7X@^%K+P-\4/
MCGK]G\6AXM\4:KX1\$^(+W2_$^EK\/H,ZAHNM6NK^']9GUS2S+HLXE6RN*^<
M?BKX8_;4^+?A'XW?!O\`8X\*?MQZ/^RM^T=\-OA?\`CH7[96K?$WXB^+_A3\
M4?%GQBU&T^+7CSX>^(?C/XQ\2_%L_##X?_!?3_%^C^+['5/',FB76NIX,@\*
M7]G;2M<H`?J_\-/^"Q?P+^+7[$_QN_;5\%_#?XIWFB?`OQS;>`?$?PJO=.T_
M3/B)J>KZWXG\)Z#X,ETB*_NH-(EM/&FF^-_#/B?0KI[X6DND:G"S7(;+#U)/
M^"F_P7UCPC\&_&7@O0?$/BG3?CC^S%\:OVF?""/=Z3H4]AIWP+\.VVL>,O`7
MBB+4IQ/H/BRQU::Z\)ZD]Q`^FZ-K^EZG;7MP?LK;OQW^*'[!/[:/[.WBWXN_
M"WPO;#]ISX4?M4?"']FAM4UKX1_!'_A47A;X8?$K]D_X[_!JQT&WU;PI)\5_
MB#8_:O&7P.M[\:EK]M):RZS+\/++[9:"\CN[[4O1_''[`'[0GP;_`&]/B38?
M!;P?XQU[]DGXB_LS?MR>/_AS<Z+?V;:!\#_CK\=?`6B:)XA^%>A:1>0K<VJ_
M$7QK9R>/O#4C>(8=(LM4OM;T^#2=/MI$N%`/NK]G[_@KMX0^+-_^SQ/\4?V9
M_CW^S=\/OVMM*\+7_P"S?\8OB)'X+U_X7?$F^\;>&K3Q;X2T&;7O!/B36KWP
M9K'B?1KZW?P];^,M*T9=4O#)8QO'/$X'TY^VY^UI\0_V0OAYK_Q5\._LR>,_
MCUX#\#?#_P`;_$CXCZWX4\<>#O"?_"'>'_`NF/K.H(UGXE<W>LZA>:9!>75E
M;V$7ED6DD<LT<CQ*_P"+WP-\`?M=_M-?LA_\$XOV!];_`&0?C-^SSX>_9ETK
M]D;4?VDOCA\;X=)\)V5C=?LOZ+X0NH]&^$6C:=KT^L>.=2\9>+O"PTY[F.73
M;32-!FFU&\D9I(;:3]S/V]_!GBWXC?L/_M>_#_P%H-[XI\<>-OV:_C7X5\(>
M&M.@BNM0U_Q+K_P[\0Z7HFC65M.1#<76I:C<V]I;PRD1R2RJCD*30!^?WA#_
M`(*6:_\`$7Q5^QEJ_P`9_P#@G]JW@#PM^T_XX\$I^S#\3_%GQ.^%GC6[L;KQ
M]\+]?\=#Q?:Z=#HRZIX+U*V\$0FSE2UOH=4U)-;DTJ&?+2VT_H/[37_!6'1O
MV>?&?[77@&P^`OBCXC>)/V4=-_9BO+BUL/&VA^'8OB%=?M.ZO>Z)X=T[1Y]1
MTJ\31)O#][:QK?S:C]HAO5N`83;B-B?E7]H3]COXF_%?]FW_`((?_"OQ+\'?
M&_B32_@UKOP!LOVD/#NC7&K:1JOP]T;1_P!FD>#/$3^(M3\.:OI&MZ-#I/B=
MDTG4KK2=3CG@E651*8M^[Y%_:'_X)Q?%KPK\3?\`@IE\,/V>/@-\7].^"WQK
ML_\`@G7JWPXU[0O%'B?Q`VM:U\-O'EX_Q/N_#/BSQ?XGU[Q1'KW@S3-9N=6^
MT->^5HR02RV2HRI&P!^F7Q5_X*_:G\"?V5?VIOCO\9?V0_B!X#^+'[)WC#X,
M>&/'/[/%Y\3?`>HWVN6/QX\9^#/"G@#Q+X:^)>GPS>&[G3[ZW\8#5);*ZTRV
MU5)M)N](2T>ZN+.6;?\`B#_P4@_:N^#GP]U?Q]\8/^":_C+P3&_B[X5?#OP+
MI,7[2/PQ\03^.?'_`,7OB/X>^&OA?P['=:=X>6+08_[6\1V=S<ZIJ"2VB6Z2
M*0K?,/@C]N+]B3X[:#^S+_P46_9)\!?"CXU_M0R?M$:-\)?C?\,_V@O%'B0_
M$7XF^,I_"/Q4^$>B:I^SW\2_'&N#^WKO7/AW:6&H>(OA6CK'I4?PP748(=0T
MO6-!U34;F]^T7\!]%^)G[.WCWPM\"?\`@FO^UEX&U-OBK^ROXY\=^%?%7B/Q
M)#>?$WX>?"WX_>#_`!AXN\*>!O[7^+&JPZ3XI;PQ9ZY+!J&BS>'=1#/%*VL1
MO!;R0@'[1_LT?'O]J#XM^)_$.D?';]BO7/V8]!TO04U+1O%&J_&OP-\3HO$6
MKMJ%M:MH$>E^%=*T^[TZ1+*:?4?M]S));E;4VX3S948:'PD_:YT/XLW?[95I
M9>#=5T=OV.?C)XE^#NO/=:I9W0\;7_AOX2^`OBQ-K>D"&VC.E6EU9>/+;1X[
M6\-S-'=:?/<M(T,T<:>`?L'6G@+P]XU\<^'_`(?_`+#?[1?[+FGW'@_1[Z_\
M;?&?6=7U;1O%-QIFI_8;7PSI0U_XB>-=2CUNWAO9=4O+Q+:S74K:(O>WMW<6
MT*Q_,7@'_@F+\-OB/\1_^"H7Q"_:._9K\)^,/%_Q8_::\7^)/@/XH\5V@N[W
M6OA]=_LY_!_1-!N='G@O(UAL8_'NF^*;9([A$DBU"&\9QY94D`^M?V)_^"C?
MAS]L_P`3:1X7TGX6:]\/[S5?V7OA!^T\)M5\2:;KL$&B_%[7/%&C:9X6;[#I
M]BTFIZ2/#+W=Y?J%M9Q>I##"C0N[_*&D_P#!:OX=>+])_9<O]<_9R\00^#/V
MG/CQ\9_@U>ZCJOCWP/<VGPVL?@C\3+OX;S_$#Q#I6K6EA)XATS5O%NGV;VFD
MZ(LFHZ0EW975Q*Y0NOS_`/L?_"?]IW]@:S_9T^+4_P"R3\9/C7?^+_V"?A+^
MSC\2?`_P\O?!L'BSX8_%'X*>*/&>J65OK&F^(];TB$^'/%=GX@@MK;Q#%>S6
M=E<Q?:+P163^:OG?[//_``2(^,]IX2_8[^&?Q[\/6RZ!KWAO_@H=XI^/<OAJ
M]L9#\%?$?[6,MWXD\`^';#6+.:UF\1>*/!&HWFF2+XCM0L">)])=+2672K*Q
MN9P#[R^,W_!5I?"MYXR^'.F_LQ7/QC\37/\`P4AM_P#@FCX=\%3>/-`\,Z-X
MQ\1>(/V=;+X]6WB_6]0\0:!K>GVF@76EWTWA6]T6XT^Z:6ZQ=-*;5WAJMXJ_
MX*PI\'O@+^T:?$/[)OB7X2_M`?LE2_L_Z'?_`+,FL^)_#L/AC4O"'QY^+'@[
MX,_"GQ'X$^)'AO2SX<NO!#W'B"3S!9^'[670CH-SI#Z<'CCK\G_A]^QO_P`%
M,O@S\/?!OCOXD_!'6OCC\8?A/_P7.T7]J'7['X8^(?#]EJOQ;_9X\$_L5P_`
M1/B5HEQXMUC3;*"X\9:OI\,%WI^KW]K<"ZO;EY%2`AJ^HOVM/V)?VM?VZO!/
M[5/[1_C?X,:I\)_'/Q3\)_LC_`SX&_L\1>,=%@^*&@?"SX9_M>_"_P",?Q1\
M;^._'GP_U2UM=,\6:II^EZSJ6@6>D^([W6/">G:%!+I>NVU]>16UL`?3?QN_
MX*D_\(CX9_;(^$O[0W[(_A^T^//[+GPK^$WQ^C^"^L^.M!^*/PV^*/PX^)'Q
M3L_`G@SQ)I_C&3P?I]GIE_HOBM(X+RVU3PV;VQU:P_M*Q1K9()3W?QA_;I_;
MK_9T^`_Q;_:%^,W[(7P2\.>!/!_@?POJ'P[TWPI^T-J/C#7?$WC;Q5XN\&>&
MM(\/>((/^%=Z!::#H9LM?U;4I]9M9+V6U?3K.R%E-]J>:+XY_;$_X)Q_&?P3
MX!_;Z^%GP0^'?BK]ISP'^V!\'O!-_H'B;XJ?$[Q7\7/V@/"WBKX;>.O"EYJ7
MP$UCXO?&C7?$?CKQ1\'_`!)X<MM1UWP%I/BCQUJR>%_$LOB2!G6UUF`V_BOC
M_P#8XM/%G[*?[1WP_P#V6_\`@C%XF_8]^-^M?"3P?;67CAC\$]+G^)X\-?%C
MX8>)-4^'%A?>#O&VL7L=[JTFA#Q5`VKPV>ED^&B9[J.Z%M'(`?L3\"_V^/BA
M/^T/X7_9*_;,_9LN_P!FCXT_$C0O%OB#X*^(O#WCK3OBA\&_C;;^`;:SU'QO
MI?@WQ5::=HVL:5XC\-:3J%KJUUH?B/1;2>YTQ9[Z"8(D4<T/[5__``4GTK]D
M[]M7]D[]F'Q?\.[B_P#A_P#M(:+KLWB#XQ0ZQ:V]I\+M=;Q1HO@WP-!K6C2G
M[5>:/XJ\2ZQ:Z')J-G'*-.U&\TU+GRHKI9*\C\"?#']K']LK]KW]E+]IK]H+
MX"G]E7X3?L6VWQ6\1?#;PAXM\<>&?&WQB^*OQ,^+OPX'PKU+4O%&G^#GU'0_
M!'A?PMX<O?$<UM`?$NH7VO:CJMG/<:<J6<$UKZ!^U;^Q)?\`[4O[:G@_5O''
MA9-4_9ZO_P!BCXW_``7\:Z^M];V^H:-XT\9_$#P3KO@^ZT*+S$OH?$.ASZ$/
M%.AZO:!7T?5M'L;Y)8YX8C0!R/C?_@H[\>)9OC)%\&O@#X#\6GX._P#!1;1?
MV!=5_P"$Q^)%_P"%O[1U'QAX6_9ZU3P=XTM39Z#JN(;S7?CH=-U>U<`:;8:"
M+V(74EWY*6O@+_P5$U[XI_M=_M.?L?\`C?X,VOPW\8_";3_&K?!GQ3<^*X-2
M\+?&CQ%\+M,T.Z^*/A2&XCCCN=+UCP:_B_P9JK6I@^WZKX3U_P#X2"VT^&VT
M^\V?G9\`?V4?^"D7P1_9E^*?ASXH_!&Z^.?QH\7?\%<O"7[4<_B'P9\0?`/A
M^7Q3\'OV?]$_9?T/3_B#>P^(_%'AF2T\1?%O_A07B.72-"@O+>>"_P!4TR[O
MS8Z9J4$@^B?$'[`O[27CC0OV\OBGX6TJ;X=_M&R?M8Z)^U_^P=J?B7Q)IDY\
M/>+X/@?X+\-^-_AMJU]I$[6NC>`/C$B^/_@U\3],$[Z7K>A>*;[7;S^T)+33
M[M`#0^%O_!5_]J_]I'7O!.F?L\?LP_`ZZTS5?V7OV>OVC/&NM?&#X^WOPXMO
M#I^/4?B*2S\-:08O".MQZW)HZ^'YB99)K&2Z\P*HR"1ZKXM_;A_X*&^`OB]^
MS?\`!_Q5^RY^S.FJ_M.^)?''A_P'K>@_M"ZYK>B6\7@?P?K'CNZU34;E_!VF
MB2#4O#FD--86^GM=SRWMQ'9Q>=@3/^9GP8_X)E_M`?"37/AQK_QC_P""7/[-
MG[=$&F?L$_LF?`ZTM/B_XG_9VU4_#KXF_">V\5KXZTRTA^+.E:Y-;6$T>MV2
M+JOA^%HKZ:(QL'2,NGZ\?$3]F+XL^-/B;_P2;\?^#/@=\-_A)X1_9@UG7M4^
M*WPAT>X\"7'AGX(:'X@^!&J>!=.\&?#O3]-AT[P]?VO@K6KZVT#0;WP38P0Z
M396,&I:):Q6\,,:@'$WO_!3#Q-\(M4_:R\'?M?\`P7\&_#OX\?LV?#+PY\8O
M@IX6\(>([OQ5:?M`^$/B,VE?#_PS:?"[6M6TK3]3O?$VK_&[6]!^#&L:=IEB
M$T_Q)XO\'Z;>32-K=L\OWW\7?C'\0_@O^QG\5?V@?%OA7PV?BG\)_P!FKQ_\
M8]>\#V6H7\WA3_A-O`OPRUCQM>>%(M6P-1FT4:QI;:.^I(JW,MKONH55V11\
MX_M@_L<7/[0/[:'_``3'^/,?P]\%^*_#G[*GQA^-_C'XCZ[XA_L<:SH.A>)/
MV?/'6C_#J71K6^4WNM2Z=\<5^&_B6SM++S'T35]$L?$\:PRZ7]H7J/VM?V*-
M&^*GPI_:RU3P!K/QPU#XT_&3]GCXY?#WPOX9UK]K7]ID_!*?Q7X]^$GB#P-H
M-JGP)UKXPW'[//AVQFOKRP$DUI\-;*SL+J2ZUS;'J,UW>R@'P9JG_!0__@H2
M/V0?%'[7.C?"K]AVXTG3OV;]%_:&TOX;Q_&?QMK_`(VLM-N[/1?$^L:5XCCT
M.`VZ?V9X5UJWL1=6*BW/B>2U2286%W"&]O\`V3_^"BGQG\<?$WX<?#?]JGX9
M?#7X9K\8OV&8OVT/AUXM\!Z]K4VA75MX:\70Z+\4OA]J*^)[B25M;\(>'_%G
MPX\3JUG*P?3]7U>YD\R"T8VOBWB+_@F9I'PQ_P""7-U\/?V</V$?V7O#O[<_
MCC]D7PC\$?'FH^$?"_P0^%WBJY\5^(O`^AZ!\39M;^-7AKPEHL7B..UUF/4-
M3U"X6YCL/%5S;"XB1?M$17SKXN?L&?MI_'+_`()T?L6_#[2?A[X`^`7[8/P.
M34OV?O&D]GXWT+Q-9Z%^S%\7OAQXC^`GQYN?"WBC3+I+&2ZU;PW=^!OC%INA
MV=[#JJ^*_AMX;T^*\$\,UM=@&1X5_P""O_[87Q@UO]G[2_AE\,/V/_AY8?M"
M?"7XN_'WPEKO[17Q.\9^!],N?A1X6^,-[\/OAI<VLD4D#-X@\8>&8+7Q1J5C
M.L?V5KI4MX4AP!^S^D_&'XHZ!^QUXB^.GQ)L/A1JOQ0\)?"+XD?$75-/^$OB
M74O$OPEU>^\(:9XFUK1(?#7B6[SJ=]HVJZ;I6F?;;DEIK>[N;Z&!W6"-V_*S
M]L+_`()X^+-1_:V_94\=?#K]AK]G;]L3]F7X(?L:>(?V9C\*_CUK?P_DM/"%
MU8^*?#5[X'NM*TCXG:+XDTO5TM_#^AK97.H/I\UZDL,3?:(Y'D:3]/\`2_AO
MXJU_]B#Q-\'K7X(?#[]G_P`2ZM\$?B9\+_#'P,\$:CH#?#;P+#=:)XH\(^!_
M#VB7GA"QT/0-/\.7.DOHE[]ET6QTZVT2"_ET^-(I+%FH`_,O]GW_`(*F?M9Q
M?#/]D']I/]L?]G_X+^"?V6?VR-1^'/A70OB1\'_'/B.\U_X&^*OB]9,_PTN_
MC%X?\:*+*3P?XE\0-8^#;[6O#NKE_#6K:I8:A>Q7EA(Z)T#_`/!1_P#;2\4_
M`?XW?MS_``T_9Z^"E]^QC\'=2^)'B/2M,\4>+_&.G?'KXJ_!/X*7.OP_$WXD
M^&%AMT\%Z%/+;^%==O\`P;HFM6\\^J6ULB7SV=PPA;R7]GW_`()Z_MR>/?V9
M_P!C#]A+]JW2/@C\+/V2OV6M.^">J?%7_A6GCS6?%WQ-_:6U[X)-I?BCP+X*
MM((/#.D:'\+/A[IOQ+\/:-XC\67MIKFJ^*_$6G:=H^FZ)?:(YUBXEZA/V-?^
M"BO@3]E_XW_\$V_`VE?`+Q+^S=\5H_C%\-?A]^T9K/CG5]*\:?"/X`?'BX\3
MR>*M(\0_"Y/"<LGCCQ[X/L?&6OV/AJYL]?L].UV:2SGU;5],6W+L`?<'[%_[
M>6J?M:?M.?MU?!R#PEH&D?#W]F&?]E"^^&/B_3]0O+C7_'WAK]I/X!6/QF?4
M/%>ESR/;Z%?:/<7@TVQL8%BEEL/+NKJ/,T4DGU)^S;\9M4^.'A3XA^(=6T:P
MT.;P7^T+^T7\&;6WTZ>XN(KW2_@I\9_&?PPTK6;AKGYX[_6[#PQ;ZIJ$$?\`
MH\%Y=30VW[E$K\;_`(._L@_MY?L!?M.?M6>(?V/?@/\``GXR_`#XS^%/V0/!
M/P[M/BI\?KWX6^(/`WAK]E?]GO2?@MIFDQZ7X>^%GBBUN[6_CMY)]\K6#0S6
MLDD$'V2\@@M/5O#OAW_@K#\&](^.?PT^%W[-?[,/B3PI\1?C1^T;\3_"_P`2
M-:_:8\1:!XET=/CY\2/&'Q&C,O@Z'X57MK+=>$;OQ<]C;(?$ML-5738KJ233
MVN6AA`.W_9#_`."E?C#]I/\`;R_:3_9RU#P%X;TGX'>#X/$T/[./Q5T/5[C4
MKGXM7OPB\50>!_C:]_!+%'%8?\(QXJU'3M.MX(EPV)G$DPY7Y8_9(_X*M?M9
M>)_!W[!'Q!_:(\$?`3Q3X0_;H^$OQ-^(GA_1/@I+XRM/C-X/O_AYX'O/%\=M
M?>#-9O=1L/$'A[4QI%WIUUX@TF.UAT_6M2TC2S&[WD)KL/V?_P#@DA\3/V28
MOV`_B%\(_C5\4_&'Q4^"WC2Z3]I3PSXY^*NJ7OPM\3>"?C=X7U,_M%W?@_PK
M<`Z98ZM<?$F/PCXTMOL^+GQ#<^%;*6::(H+27@OV/O\`@CK\0?V#?@M^R-\1
MOV8=!^"O@K]M/X<_#>W^%'[3\-Q8V+?#;X^^'-?O))M;UK7O$<>B77BJW\4>
M#M2BTOQ%H>H^'[O2&\06]I>^'-7;R;RWNK0`^I/V"/VL/VT?VN/^%9_'JW\4
M_L7^._V<_B;;#5/&7PQ^&OB/Q*/C7^SSI>J6&NC0;'Q+JDE]J^F:WXQM-?TL
M:-XK\+:WHOA>[L;C3_$-I;-%?:;)''Z;_P`%6_VR_C7^R7\'?AQHW[*W@[PO
M\2?VKOCY\3&\`_!CX?\`BM-6FT_5+/PIX.\3_$_XE:Z]IHMM<W]ZGA_P3X/O
M84MK>*2>34-9TT10RG=L^5_AI^P9^TAXX_;+^`'[1WQ4_9A_8G_9/\1?`KQU
MXF\:_$3X]_LH^(M5@^+'[4UEJWPZ\3^`T^'WC/3;#X<^#9CX"U;4]4T/Q3K&
MG^/_`!5XRN["#0K?2=(E!NM1DN_KCX\?L,^+/VE_VYOA[\;_`(D^/_&?ASX(
M?`KX':WX>^#^C?"SXF^+_AGXUL?C'\1=?DB^(OBZYUOP3>Z+K4=G=^!M*\/^
M&_LLFK2Z?>6ZMNL5GA:9P#Y4^//_``6`NO"&I?\`!-3XL?#30M$O/V8_VOOA
MW>_&3XO:OKR3S>*?A[\-VT3PI,;FVEL&>RBU'PEKGBZSL?%AF#6=K%IVK3"=
M8[;><WXH_P#!1W]I[4]-^,/AKX+)\)-(\:Z?_P`%=/`7_!/?X7^)_&&B:QKW
MA2V\`>.OA#\$?'5KXR\1Z;I>HV5[JFIV^K?$O5,_8+JV2;3X+-$"N&<YO[.W
M_!([QM\*?BMX"^'_`(W7P?X]_8S^#&N_MH>#_ACX5\0^(KS6?$K_`+/O[5OA
MW2=9A^'6N64FC6L]W_PC'C_4O'-DNM7?B"YUR;2=0L;EYWN8$O1POPU_X))_
MM6_!;X-:_P"#?"GQ$^&7Q*\7>"_^"L7@+]MCX/7?Q/\`$?B/2F\4?`GX1_#3
MX,_"[X?^$_BCXN\/^#-:U1OB=<Z!\+(F\6>)X]!UN;6+^236;Z[U+5;ZZDD`
M/T-_92_:W^.^H?M*?$;]B#]L/P?X`T'X^^"OAOHOQH\">/?A/<ZM_P`*Y^-'
MPAU369_"]WXFTS1O$4LFN>&]>\/>)[=M)\0Z++->V<$EQ:/:WLBR$5^F]?G/
M^S!^RS\<M._:%^(?[9/[77C'X>>(?COXP^'.@?!CP/X)^#L7B.+X8?!_X1:'
MKNI^+)O#^GZIXG@T_7O&?BCQ)XGU:;5/$OB/5M,L+1'M+.UT'2]-MOM37GZ,
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!7YH'_@IYX!UCQA\7/!GPT_9D_;2^--W\
M%OBMXZ^"OC#7/A7\"HM;\(R?$+X<O:IXGT?2?%&K^+M!TBXA@DO((K34+RXL
M+&]N?.M()VN[:Y@B_2^OY`/@MH7[,WA?]J?_`(*!C]J#X_\`[??P1\=:_P#\
M%'_CQXB^'?@CX*^&_P!K"S^&6O\`@75->T)_#WB.6;X;_!/Q;X&U"+Q%K":J
MUQJ2^)&CN=,%NUV]O"-P`/W3TS_@JA^SS'K'[4]O\0_"'QL^"OA']C98(OCE
M\3_BMX'TG2/`.BZIJ%XD.A:#HMUX?\5>)O$?B+6O$VFW6E:_X=M-,\-RKJVE
MZUID%O-_;<L^D6_+>$O^"K/AK6K/6M=\;_L3?\%`_@AX)LO`OC_XA>'OB!\8
M_@1X5\.>$O&FA_#_`,,ZMXNN+?39]&^*7B35O"6L>)M#TB6X\)Z9\5M(^'DV
MHRW5I;7ATV<W"6WY.?M(?\)%\;=<_P""F=Q\!/AQXT^+7BWX;?MB?L.?M1VG
MPHF^'WC#PZWQV\$?LM:IX,U/XJ^$O!]WXE\):#H'B[4+B?PKJFF6VC)=:Q>:
M]=6<4.GIJHOM,,WIW[3_`.V%XY_:'\;7^G_LM_%7]I/QS\-/BQ^SM^T38?&+
M]FSQ-^Q[\6_`ND?"33[+]G'X@PZ)>ZEX^\7?"K0);;Q-K'Q%CT_P[/X9/B._
M>XU6:!=*BNK6>UN)P#]A/'/[?7PM\#?`;]FC]H!_`OQ8\2^'OVK?'7P6^'7P
MO\)>&M)\%R>.(_$OQX*KX)A\1VFM>/-$\.:?;PRR1P:U-8>)]5:UE=191ZBF
M7'QWIO\`P6:NM8^*?BCX*:;_`,$M_P#@J1=_%'P7X3\.>.?%'@^/X:?LK?VG
MH_A3Q;>ZIIWAW6KDM^U\MM]EU2]T75(+?RYWDWVDGF1H-I;\R+W_`()[R?"'
M]FC_`()#_%_1?&O[:OC;Q?I7[5O[`FL>-/AAXC^(?C#QQX6\%:6=9TZ[\3:A
M'\-)M%4>&HO"@0K!<WWDV_AV+<EP\:YK]F_A9X;\16W_``5Y_:W\57.@ZU;^
M&-4_8Y_9ATG3/$<^EWT6@ZCJFF^._BW-J.FV&L20+I]YJ%A#=6TM[9V]Q)<V
ML5Q!)/'&DT98`D\#_P#!6C]G+XA_![X+_%'PQX.^-%UXJ^-_Q]U3]FC1/V>I
MO#/@^W_:`\*?%KPOK]_HWC[1/'?A!O'Q\.Z+;_#C3M.G\8>,[VQ\8:O'9>$7
MMM3TY=4N;JWL)/I+]K3]J74_V5/!^F>-+3]F3]I;]I/3KDZY-KUG^S=X>^&7
MB'4_!&DZ!I9U:[U[Q9%\2_BM\*[6WTB:!)HK632;S6+M[B"59K.&,+*WQ%\/
M?V1/"/@__@KM^T'\:?#_`(<U;2[?Q[^S1X8\;:=>3Z1+=>!?#?QQU;7YO`_B
M_P"(/AJ"YA_L:'Q]XG\%:1X:T[Q-]GECN+_3M&BENHF>^N[B7Z8\,?`#XZ_"
MWX1?M.VGQ+_:A^(_[5-[X]^'?B"'P3H_BGP'X+\-7'@JXMO#'C:*YTKPU;>!
M=/M[K6Y?%$NM:1:O#?K<W$;Z#81V"^9>7(D`/DWP/_P6M\"^+O!'PF^*NM_L
M,?M\_"_X/_&[QO\`!/X??#CXL?$OP=^S5HW@K7O$/Q_^(7AOX<_#U8Y=)_:C
MU[6TL)]1\2)K6KWYT0P:7X=TK5+N0R7XTW3=2^A_VG/^"H'P%_91^*7Q$^$G
MQ#\'_%[6O$?PS_9C\2?M6Z[?>#-"\&:AHEW\/?"^K+H]_HNDW&N>/?#U]/XS
MFN6$EGI]YIUCHDD&6F\0V\G[JORG^(?P0\?^./\`@BG_`,$M/A%XM\)_%:UU
MJR_:._X)LZ7\5;#PGX4\<>%_B5X`\+V'[0/@[3?&NN2Z99:7_P`)CX&U+P;I
M4TT\^MS6-K=:!?6T.H[H9%A)^?/^"A?_``3[\7?#C]HS]J+6?@9X#_:3^*^C
M_$W_`()8_&_PG)K&J+\2_C''<?$)O&6FSZ-X+T#7)[76%C\0ZS;WUY=V7A#3
MI5OKN.!IK/3Y(HB4`/V-\*_\%?\`X67I\=V?Q6_9=_;)_9L\0^$_V>_%_P"T
MYX9\,?'3X>_"W2]3^+_PJ\`/IL?C:]^%^H^`_C1\0/"][K/AJ37O#0U#1O%W
MB#P?<21^(]+N;%KRU74I]/NV'_!5.9OA#\1_CSXJ_P""?W[>7PT^$7PX_9Q\
M<_M-W7Q"\?Z!^S#%X7U_P1X+^&.K?%:WT?0;CP9^U%XVU2?Q1XL\/Z0]GH%K
M=:1:Z9:ZQ>6-IXFU7P_'.)Q^6/C?]F;]HKX?^$?B7XZ^(MG^TM^U=!^TU_P3
M>\2?"[]GS6?&/A34=9^(O[(OQ`/PZD\5_$;X#ZY\/?!?AJWDTG2/C<-`\,WE
MEXPU/2QJ-MXU\!VWP^U>[CFU?PO:W'D_@7P-\`G_`&!_VG_AE\%?@3_P58L_
MVE/%7_!+#]I#X:WGASXV?";]LT_#36?%MY^S1JMIJW@WPKIGQ*TNX\'/XIU;
MQ98VNE^`=(\/6::YJ%XT&C>&H9%O&LYP#^CCX"?M2?%SXV>*=%LM>_88_:3^
M!7P^\1^#T\8Z/\5?BQXR_9/U'09+:[M+&\TG2;[P[\'OVD?BMXTT_6]7BO=U
MM9S:`\=FD$K:O/IS82N<_:`_;=U;X6_&>W_9V^#'[+OQR_:R^,UK\.=,^+GC
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M>)-(FDAGMH&D`-+4/^"H_P`0=8^*'@GX*_";_@GA^U3\0?BUXB^!I^._BWX<
M>(O%G[-OP<\5_"_P^GQ(\2_"Z71_%B_$[XTZ'X=U'5O^$A\,W,]O)X.\1^)=
M.O-+O+*^MKMX9'*=5X6_X*D^#)_VVO!W[!_Q2^!_Q0^"_P`7?&'PF\,_$1-6
M\4ZO\/?$/@G2?%?B>RUO5+3X07OB/P/XJ\0Z?=>.1I/A_4]1MY=*GO\`0-2@
MM;A=/U2>2"1!^0_[6NL_#SX\_M_?"O\`:._:'_9:_P""FGA?X/\`B3]@JQ\)
M^%X?@3\(_P!I2W\<:-XVL?VB_B1J0T7XD#X!P3W6@W5]X5GLO$%MX8\3:@MY
M9VVHV4]Q8P3RK7H\W[%NN?M%_%C]I^_^#'A/XV_#1M!_9<_8G^)/[&OQ0^.7
MA7XB:)XFTGXV_!G5OB1K^@Z1XFUCXA6]OK=[K4GV@^$OB)H^L7MSK%EX?\5W
M!U:U5Y+7(!]A?$3_`(+"?$+P-\);[]H?3O\`@G/^T5XR_9XC\7MX*T?XMZ1\
M8OV3]-M-?UI/B#/\*Y$M?!7B#XU:7\1+&%/B!9WOA\S:KX5LHR+5M65SHLL&
MH2^AW'_!33XXVWQ+L/V?6_X)H_M'R?M,WW@75OC%_P`*3@^-G[&TMS:?`S2]
M<TKP='\4+OQ^/V@?^%>I%JOCO4;KPIIG@V+Q!-XTFET75-8FT:#14M;VZ^&+
M3X7_`+0?CC_@@M\)/!?B#X)_$/1/COK/Q2TCQ3XJ^$!\):__`,)IX>O+_P#;
M4U[QIJ\=SX?FL(]7BL;#1[IM8%_-:1VTFB&'5EE-C-'.WU%_P5/M?@#/\1/`
M=_\`%?\`9W_;\U3QUH'PTU*Z^%W[37[!_@_XB^(_%&E7-YXFENM7^"_B.]^$
M]Q>:]9VE_>>']`\3BQ\;>';GP'?Q7C,NKZ;JMNZS@'ZG_"GXSGQ[\#]'^-?C
MWX<?$#]GSS=`U_7O&'P]^,]CHVC^-_AW'X6O=6L]=3Q/'X?UKQ%H3V<<>BW6
MLZ7JVDZUJ&GZOX<N=-UFVE6*]6&/\^_%7_!6_P"'7P]_8]^'W[7'Q"^$GC[P
MTOQ^LM?\3_LQ?`_3;7Q'\0/C'\5OA];0ZCXA\)^+O$>@_#?P3XMM?AN/%7PW
MM+#XDWMK<7?B;3/!VA:WIVF^(_$%OXB%WI-NWX">#?VQ?$W_``1[\5>"/VBK
MCQ)K?[57B_\`9C^/^@6</B>RT]O'[7?B3PWX[T[X5Z=XTMM%O)M-N_&YT6\\
M-)K<5A/$!J$IL90EY!<.?A']OK4?V>OV@/\`@FQ^RC\<_`_PI_:'U[2+;X#"
M_P#@O\5_V;]2LM9U?]GV:\^'FF^']=\%?%(6^IK<-ID8LM1\`>.=-N=&U"33
M/%7AZ]T'7;73=3@FMT`/TLO/^"@_C[QO\/?"?Q5_9=_8T^,W[0G@*]\,^)/$
MWC_6]<UC0?V:+KP'+X/U#7=)U_P;;>&?VC[?X>^+_%/CI]1\.Z@FBZ?%X?T?
MPO=6)L-7UOQAX<TK6="N]4\0?_@L_P"!/'?@'P'X_P#V8_V:_C7^TC8Z[^RU
M<_MD?$#2O#]_X$\&:M\,?@K97.K6$]E=P^*?$"0^*?BI?ZAX>\1VOAKP%HDP
ML_$;:'>?9/%,<DVGPWOYY^,OVAO^"BDO[(WP:_9A\>?`']LS5-)^,]AXWO?B
M7^T/\+/A#X-\:?&'PO\`LQ'QOJ'ASP%\-DT?P]\1O#OAOP_\=/B%\-[5KW4?
M%L>J/;^!M$NM+N3H]]XBU<OH_<ZS#XT^#OC+QS\5?@/^PE^U''\%/CS_`,$W
MK[]E3X3?""W^&^E:7\0?AK\2OA9>^+[+P3X+\?:/'XSUJW\*:#XUM/%5M=VG
MC;4]0GT>RM[2[FU"X:\VVTP!_0'X>^.ND?$;]G/PK^T?\%_#>N_%OP_\1?A3
MX5^+?PQ\,:%-H^B^(?'.A>./#FF^*/"EA9S^)=1TO0](U'5--U:R,CZYJEC8
MZ=(TGV^[@CADD7\R-7_X+(67PV'[4_ACX\?LJ?$[X>?%[]F71_V=M67X>^#O
M'/@'XO:/\3)_VI?'*?#/X4>'O#WQ%\+W-EX=\/\`BA?'5UIFC>,-(\5PZ8-&
ML]1&O:)<^*=%L=2O+/-_8[^-'B_]CCX,_"C_`()ZZ-\$/'?[0/Q6_8G_`.">
MWP.\>?'.Z^'_`(H\)R3VGCW5;&'P_IOP:\+6.K3:=::IXKU:?0_&.MZ#:ZIK
M&B"'P=H6F3N;VXU>Q,WQCX`_9DT+XVZO_P`%'O&6L?L4?M?_``*_8=^+/PB^
M!WC!_@SJ4>B:7^TO\4/VN?ACXZ\2>/\`5_B]\&O#\7CS5M=\.ZGX3MM'^'=C
MH-AKWC&/3-;\1:/:W^A65M8RW6F0@'WC\4?^"M7B+X*^&?B-I7Q0_9(\4>%_
MV@/AW\5?V<?AB_P>_P"%P>!]8\.^)T_:@\26_A7X=>+_``[\4]%TN_MW\/V^
MKSO9^(DU/P=INI:9<VMS"MI<!8Y9/T1_9Z^)GQQ^)FE^(M0^-/P&T+X'26%W
MI\'AJ'0?C;X<^-5MXGMYXKMM3N9-0\.>&_#L&AOI<T5I"+:X2[>]^UM(CPBV
M=7_`CX2?`/Q+%X<_:,_:6_:Z_96_;9_:[^$OQ.\1?`/P7X0^#OQNM/AKXR_:
M?NM!^%EEXDU9/C/KWPQT#Q;X4\/Z'I5GX[U&TTG2_`EAKU]K]K8S1>)[ZVEM
MH[I;?Z._8BC^/W[-%O\`M2_&'PO^R1\:]#_9^_:)_:M^"%K^SE^ROXDU^&'X
MG?"#P1KWA32O#7QI^-'BC1+KQ#X]L?!'AG4O&$DWBN?P%8:XSV5GI-Q=+;Z7
M+JGE``]8T_\`X*_:??>(?#6NG]F_Q5#^SUXM_;&D_8CTGXK+\3?!%U\0++XJ
M+XQN?A_#XA\2_`FUAEU_0/`-]XHTO77T^\G\43^+KCPSI0\3/X,AM=2TNWN_
M8;']OOXL:1^TS\(_V>?BS^Q]XA^%UI\?_$_Q6\*_"3QH_P`;?AKXVU":X^&'
MAC6O%R:U\1O`'A..\UWX?^&/%NBZ*TNCZQ%>>)S97>H:5IVLVECJ%_;VS_A]
MH_[(?[0D?Q4T;^W/V3OCM#_P4?M_V_D^/_BG]LOPL?#>G_L@^+OA%;?&F^AL
M?$NKPS?$`Z/J6J:3^S!?W?@+0=(NOAJGQ%TWQ!<RWR:G]IEFO9/N#2?"'Q&^
M/_\`P4]_9Z^/?P__`&(OCY^RIXQ^%'B7XI6?[8/QI^*E_P"&Y?!7Q0^%TO@'
MQ)X5^'G@'P#<:?XS\3Z9XUM]9\6?\(]XN.H^'-$\,R^'K:R/]JR7%W(D5`'Z
MT?LF_M0-^TAI'Q6TGQ1X&7X4?&7X"?%SQ3\&OC-\+AXG/C&V\/:_H_V;6/"W
MB3PYXHG\.^#M0\2>!/B3X"UCPWXZ\&:]J7@WPM?7.GZQ-IM]HMGJ6D7\2_.>
M@_M^_%SXT>+?V@++]DO]C[6?CK\-_P!G7XC:K\'=>^*?B+XW^`?A'I?Q-^*7
MA.;18_B%X5^">B:EI?BJ^\56O@)]9^QZOXL\97/PZ\):GK>DZYH/AO6-9U/2
M[B$<C_P3\N&^('[8/_!4GX]>%5@U'X-^.?C/\%OAAX"\96%TD^C^-_%GP'^&
M%YX<^+6I:$R(D5]IN@^*O$%MX)N-:MVN+6^UWPQK6GPW4IT9UC\)_9SU7]IW
M_@FU>_'C]F6[_8Z^-7[2_P`/?%O[0_QG^,_[+'Q7^`\GPVG\/7WA?XW>*M1^
M)%S\./C7+XS\<>$-3\!>*O!7B_5_$T%_XON+/6/#VL^'[W0!I#&^@N=+@`/H
M[XD?\%4_A_\`#+]NKX$?L/Z[\)O'#:K\6M-\!V7C?XI)JNA1^$?@;\3?BWX;
M^(7B7X1?"KQS:,[7&J:_\0X/AIXATW2+[PS>:E80ZK+I=O-NANWN;?&NO^"N
M7PJTGX^?MU?LZ^(OASXET'QQ^QO\//&WQ*\,S7FO:2^E_M!Z)\-OA!X=^+/C
MVS\'RQVWG^&=8\-P>+-!T>YL=8@OC/'>MK-N[VMO-;K^2WCG_@FA^WW^TU\#
M?VTOVMM=\5^+O@G^U/\`$'XZP_M1_!']E&]\.?"[QC)#X]_9'O-/UC]EGPYI
M_P`3[[7$N/#S>)[OP;:Z9:,==TW2],3Q7=RZD;*SN+LQ]_\`M._\$\/VI_VB
M_@Q^W/\`&_PQ\']3^'/[5'B7XP6WQB_9_P#!VK>(O"/]I>,/"_Q-_8T^%WP;
M^,GP?U76=%\5W.D65O>WC^*O"\[ZKK<6FKXA\*6VJVDEWITMEJ4X!^D_[0W_
M``5S^%7[.W@[]A'Q=XD^'NO:P_[:TND>(+O0=,UV`:M\&OA!_P`(?IWB3QO\
M8/$`&BW%KXA\.?#[5/$O@KPWK5G!<:'<WEUXLL[G3YI#;RVC^J>./VS?CG-^
MU%\9?V9?@!^S3X$^+NJ_!#X2?"/XN^)-9\7_`+1E[\)K[Q+IGQ>U#QCI^CZ'
MX&T>#X%_$70]0UC3F\$:M-=2>*/&O@_2IX[C3Q#J`::<6WXLZO\`\$FOVO?V
MR?$/CQ?C!XO^('[*'@?X,_\`!.SX"?L3?!3P_I5G\)/B'#\7Y?$'@N7XB?M'
MZO=075YK=WX(DL_B79_#_P"'%IKMEJFEZOK-AX-OKB$QZ4]I<77H/[,0_P""
MDO[.G[0R_'7XA?\`!/CXQ_&+Q'X\_8B_9I^`?B5_!WQ.^`WAC2]*^)/P3UCX
M@6&KW^NKK?Q3D9])U?3]6T35;?5+'3]7O+6"\OMEN;EKBTD`/O75/^"HGQ-U
MO3_V.M0^%7[+/AN]N?VG_CAXR_9L\;>$OC7^T%J?PH\<_`/XT?#YO$\OB[PY
MX@TKP)\!/CMX=\8:186/@[6KBSU[1_%NF_VI)=>'?LNG?V;J]QJVE^OWG_!2
MSP#9_P#!1^U_X)XGP-J4NHP^`/#.H>)?C*GB&VC\+>'?C3XX\+>-/B7X+^!#
M>'KC28=2U#7-=^$/P_\`$GQ#/B>+48-+M()O#F@FRGU?7#'8?F5XR_9M_;#^
M"VN_L):QX?\`V3_&OQN\4#]NWXQ_MR?M+77PP^(/PO@\(_"J\^+%IXL\*VOP
M_P!,NO'_`(I\%ZIXAF\-^'=>\-RW6IZ-HLMIJ4VAZ[>1PPW%]:V[^/ZA_P`$
MT_V_O%EA\2_^"AS^+O'6@_M3^)OVXI/VQ/#?[#]Y;_"B"QBTCX7:^?@Y\'?!
M>L?%*WUC6$36V_9GT#2H;FWTWQ5;Z'(^M3Z/J-RP^V*P!^AWPG_X++:1X]\6
M?MI^!/%WP"G^'_BC]F+P'\=/BG\)`OQ3M_$WA_\`:?\`A_\`L]^)/$G@?XC:
MIX;UH>`-#N/!&K^&O&NAZ?H_B+0KW2?$[:58>*O#NLVE]K$4]W:V?ZJ1_&SP
M3I'P)L/V@_B+J^C_``W\!)\,M)^*7BS5_$6KP1Z-X.T&^\.VOB*_DU/6IX;*
M%[;2K>Y:*2\:VMOM)B#I;1O*L(_G6^-G_!-C]J/XF?L?_M#>,O!G@*3P=^U]
M\-/VGOVO_BY^S+X=O=9\/Q7/Q0^$'[2&GZSX7^*/P?\`$^J6?B.]T.+3_BCX
M$\4:Y'X=6^U+1[?3/&^A>"]5U3^S(X+V\'ZM_M=_LM_$S]H3_@EYXG_9?\*6
MVB:=\6=5^!GPHTK3-$\67"_\([>>,/AO=>!?%<G@WQ'>6/VR$:/XAU#PA-X4
MU:ZMQ>6RV>I3S!;JW!60`Z"'_@JS^P,WPQ\=_&'4/V@M%\.>`?AGJ_@S1_'&
MJ>+_``WXV\(7V@/\1_$.K>%_AYJMQX?\2^&]+\0S>&?'>L:'JL7@_P`5VNES
M^'/$=I:-J6D:I=Z<\=T_M?[-?[9O[.G[7'_"?1_`CQU=>*+[X8ZSIVB>-M'U
MKPAXT\!Z_HTVM:<NK:!J?]@>//#_`(;UF^\-^(M-9KSPYXJT^RNO#FOPP73:
M3J=Y]EN1%^#WQB_8_P#VS/VO/B_\1?VI/%W[,FL_"3[3X`_81^`?A?\`9[\4
M?$;X?Z]?ZR_P&_:B\7?&7X@?&+4]4\-:K<^'H?#_`(:T[7H;?PGI<U]+JFO:
M=<WSWF@V=XD5F?V`^$7P,^)/A3_@I!^VC\?M:T2*W^%WQ>^`'['W@SP+KZ:A
M932:IXD^%>I?M`/XVTZ;3HYC?V1TJ+QGX;E2>Y@2VO$U$"UFE>"Y2$`^#_C?
M_P`%V?AGX';_`(*">`_`WPQ\92?&']BVPGN/#$/C?X?_`!BL/AQ\3YM)T6TU
MKQ`?$'C63X=>'?"OPQM;5I+G3=)N/$/C"6'Q%!Y'B30)M4TD^5)]U_#G_@J1
M^Q-\2O!7Q@\;Z3\8&TO3_@%::#=_%>S\6>`_B1X&UO1K?Q.+B/PUJ.@>&_&?
MA+0O$/CC0_%=Y9W=AX.USP7IFOZ7XKO8A::!=ZC<R)$WYJ_M=?LA?MB>+;7_
M`(*]_"GX=?`ZP\:>'_V]_!_A:;X9?$A/B1X<T32]`U+PO\+;?PL=$\0Z#J5L
M-7-]?ZS;&*.6W*V,%M(EP]U)\T2[7[>G_!-_]HW]I'X\?&CXA^`(],L-(E_9
MN_8CL?!;/XPN/#-WXU^('[-G[0/Q7^*/C#X=?VQI0DU+PG_;OA[Q)I-EI?BQ
MH+JRMM0O4>6VFBMIU`!^PO[.G[6WP1_:GM_&K?"/6/%CZI\.=:LM!\<>%/B'
M\,?B5\'O'?AF_P!3L%U/2I-5\"?%CPIX,\7VVFZM9&272=8;1CI6IFVO8K*\
MGELKM(?)-7_:[\<Z1^WU\-?V-]1^"LFC>$?B%\'?BW\5M,^+VH>--#OI-;_X
M5KJG@/2HM-T?P?H[7=_IEK<3>+KHW=YXBN;.[<V42VNFK&QGDXW]@OX.>(/A
M_P")/CAXV\2_L_\`CCX*ZKX\3X::;/JWQ-^/,7QQ\<>.CX2T?6V9[BXL[<6/
MASP_X8D\02:/HD*WUS>:M.=4OKBVL8!9Q/X=\7_#G[8.I?\`!5[]GKXT>%OV
M4U\0?L^_"WX4_$CX+:W\4V^,_A'2[FXMOB_KO@/6+SQI;^"KG1Y-8%IX-3PI
M=076B_:7O-9>YB>SNK94*L`>4?!S_@H9^U7^UMX[_:D^&/PQG_8M^'[?"G]J
M#]K#]E/PWX6\2_%GQ]IO[1WB'_A1'BOQ#X+T_P`>^%O#(\/W7A5M3UF&UL=8
MT];O48M,M-0BO4NV2RM/.?S;]B3QS^VG8>//"OBS4_'7Q;^(6AZQXR_9&^&/
MQMTKXF?#&_B-X]]\.OC%X4^+GB2ZU+5_#WA_Q'H&H>#/'FF^`K*+7[,6MC>S
MZ3;CQ,_BB+Q)!<Q=[\4?V;_VJ_VK/C%\'_"NO?L2_`;]E;0?@I^U9:?M"^(/
MVH_"WC_PMXG\0^.M/\->+M>U]8/A_H7AWP5X=\8Z5XL^*!U:.?Q]JOB?6ECF
MDU#Q)+<G4IKM/._?6@#YC_:8_:I\)?LNZ5X2U/Q-\-?V@?BA+XPU6\T^ST?]
MGWX'>/\`XV:SI%EI<=I+J_B+Q-:>"-)U"/P]H&FK?V2O=:G<07>H2W'D:+8Z
MI-;WD=O\O>,/^"O7[%_ABR\$ZEH>N_%'XL:?\0_@?I/[2/A6Z^"GP8^(WQ5-
MU\$=0NWMM1^(6IVGA'0=0O\`PWH?A*.*XN_&,GB6UTB;P_%:W-K=0G5(7T\8
M7_!1K]G3XU_'+QC\$+GPE\,;/]H7X.Z?I?Q$\,?$/X&:O\=/%7P%\.-XK\40
MZ$?!'Q/\5ZSX0@DU3QGX7\*0Z=KMAJW@])8KAWU2SNM/CEF::2V^./V'_P#@
MF3^TO^SGX2\#^'?'H^']U>>&_P#@DGJG[&M_-X;\47FI6;_&23Q]?>(H8[66
M\T/3)9?#$VG7D936G@BE$R2QR:>@",X!]=_MG?\`!6KX'_LW>$OBII_PYTWX
MB?&WXN?#_P"!B_&?5=.^&/P5^*/Q<\"_"G1?$WA35/$OPRUO]H'7?A_IC1_#
MCP_XT@TXWEG:ZIJFGZZVB-_;<UM8:-)'JE=G^T;^VM\1_@[_`,$UO!7[9_A[
MPSX)U'XB^)?#?['.LWGAO6;779?!4%Q^T5\5/@CX$\71VUK8Z]8ZZL.CZ7\3
M=:NO#@EUV62"_L=+?4Y-3MX[NWN_S:MO^"?O[?\`\&?!7[9GPO\`@UX$^`?C
M_3/VVOV<?@5X1O?%7C7XM>)/"B_"'XF?"O\`9\T+X"^*[&]TJT\%Z]<^,_#W
MB*UT^'7O#5SIMUH3Z?<IJ,-_$;2*RMI?T+_:9_8Y^+GQ;_X)>^!?V/\`PK/X
M13XL^'?#'[%&D:A/JNLWEGX2-W^S_P#%SX#^-O'9M]9BTFZO)(9-&^''B%=!
M=M*C;4+U].@N$L4N9)K<`]>U7_@H7\&=`_:$M/V>O$?@7]H;PY>:EXR/P[TC
MXP:]\"_'.E_L_P"L^.QHMQKO_",Z3\5[JQ31+^X^R6EY;G5((F\/)J5K/ILF
MLI>)Y1^1?C'_`,%M?@EX0_9X^+7Q^^$'P._:>^,7AWP3\.O$WQ!^'?BJ#X#_
M`!)\._"'XQ6/A+Q5<>$-?;PS\4KCP_=Z9I]AHNHV=YJ&J7.MV%A?'PW`OB31
MM,UG2KJRGNOEOQ'_`,$Z?VZ-;_:6\7?%?7O"?P7^)OB2R_;'U'XU_"W]HGX@
M_M!?%6XUSPU\!#=J_AGX*Z/\"[+P_%X'\*)H.A3/X6U&[L;^[7Q!;V?]KWC'
M4;^8IRI_X)1_M9^(K3XV>!_!_A[P#^R=\'_B?^R]^T'\-/%7PC\&_M'_`!&^
M,?P@\?\`Q>^(FJ>%[GX<>(O"7PZ\6>$M+M_@CX<\*_V=XEU'4X='U#6I;VY\
M0_9OLYCMO,D`/WS^"W[17ASXM_L^:#^T7KGA3QU\$_"NH^#KGQMKVB_&WPW?
M_#WQ)X.T33=-?5=7U'Q%INO16EQ8Z19V,-Q?PZM<PVT%WI4:ZD(X89`J_G?\
M-_\`@K'H/QP^./AFR^%GPB_:*D^`U[\`OB=\9--U[Q%^S?\`$?1_$WQQL?#-
M]HJ>$M=_9]L+FU.I?$'PWXFT[45N]'%CI-O>:HFH:=<,EM;"Z:#ZLM/@W\7O
MC]^P9\2OV:_VA]`\,_!SQK\4_@)\2?V>M47X:>-[OXA6&@Z#XN^'.I?#:R\5
MZ?XEO/#?A&:;5S::E+K/V,:/`EA<)#;+/<%&F;\H[W]A?_@J)\6/A+IWP_\`
M%]]^SI^SOXV^%?[$GBC]E3X6?%/X(?$#QK>7NJZTL/@W3]&\4#11X7\/CX=Z
M=XDT;PE/83VN@WM[>>#GUDRZ3<7::?`C`'Z%67_!63]F>+Q1JO@?QMX8^.OP
MI\:Z%JGP1MM8\*_$KX67FAZII_A_]H/QKK'PY^&_CR1['4]7TZ?P5>>.]!U7
MPIK.IV=]<WN@:Q:M!JFFVZ,DC?9/PP_:$^'?Q@\?_&WX=^!9M8U/5/@!XOTS
MP!\0-8DTQH/#4?C*_P!`L/$=UX=T75VF9=5U'0;'4K*'Q!''!&FFW\PLV>25
M'V_S]Z;^P'\:_@UX+_::^,GQ:^%/[/GP3\"2_P#!/2]^$\'@;X+^+?'?Q8\2
M/\6_AG\2)O'/@;QEKOB;QK8Z;JOBB\O;2,7-A<VDVEW.B:E?W-FR:C>W,^KO
M^OO_``30^"/B?X)?L@?#&'XE2PZA\:OBE:3_`!M^.FO+"T=UKOQ7^*KKXM\4
MW-Z\R)=/)92ZA#I,4-QDV4%A'9Q!88$4`'WQ1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!32B$
MY**3UR5&<^N<4ZOXW_B_I][<2?M#W6HR?'*]_P""V&G_`+?-K%\!--TO4-=M
M=5U/X97WQ#T:W^'D/PZTZ]NK+P+J/[)!_9C_`+0/Q-?68SX=LT;QK-*\/B4Z
M*Q`/Z@?@Y^U;\._CI\2OBM\//AUX>^(6I6WP@\3ZIX(\3?$J?PA/:?"V^\9Z
M#]C7Q#X5T#Q@]P8=7UK0YKV"'4;:&U5(I/,42L8V%?3H1!G"J,\'"@9'H>.:
M_$/_`((M?LR_#'X.Z-^V5\0?#/@"?PAXS\8?MK?M'>%]1OYY=<B_M/P7X?\`
M'`U+PO!;Z=J-T]BMC;3ZOJ+V5]9VJ//#*(?M$L$$21_F'XNT+Q=)^WC^T9+^
MT/\`M7^%/@+\>K#]NWPAXA_9\M]:_9(_:&^-'QHU']G:&Y\`+\+/#/[._P`3
M_#'[2_ASX6VGP^\::%JFLZ!\2='T[X(Z[=>&/$3>-=5\=&^M=*T\Z<`?UZB6
M!I7MQ)$T\,<,TD`=#+%%.TT<$SQ`[TCF>WN$AD90LC03*A)B<+\__M/?M)>`
MOV4O@SXI^.'Q`AU/4/#'A'7_`(:^'=6LO#T4-[K"7OQ2^)7@[X7>'2+5Y8P(
MDUWQMI5S=&1E*:<ES/&'**K?R.?##Q?XB\7?M1?LX?$CX5^'M*^#7[4=Q^W=
M\5?"WQA^"/PS^`_QF\-^(/A=\.O%'PS_`&D+'PWH_P`>/VBO&WB75])^*L'C
M+Q?H.@Z_:6C:'X4\*7[:M&/!>@VNB^%I[B_Z3XI^#_V:/B5_P37^(OP^L?!_
MQ2U+_@HEKR?L]>%_VNOLFA_&.#QA>>,M1_;N_9S7XAP>.O$MEIFG>&5UEM1E
M-]\,+A[B'5K+PG#<WG@:5-*L=2N(P#^S^*:&=3)!+%,@>6$R1.DBB2WE>">(
MNA(#PSQR0RIG='*CQN%=6`SI=?T*&Y6RFUK28KQM3CT5;274;..Y;69M.35X
M=)6!IA*=3ETF2/5([`(;I].D2]6(VSK*?RJ_9"^!WAC]F[_@H!^UM\+/@_X+
MN?AU\";C]GG]F#Q;H?A72EU6+P/+\0+K7_C'I/BW6],BNYI[$^(KW3-/\/+X
MAN+9_M=TPM;J_P!\UQYLGY>?M1_LC^'OBS^T+_P6!^*&K_#+Q3KGC7P3^T+^
MP.GP4\7:5+XMLM3\+IJ/P`_9ZO?BAJ/PYO-(N[;^S;V^BE>V\8ZMH6RZFL)9
M].U*X-LTL%`']3=MK&CWEA-J=IJFF76F6YNO/U"VOK6>P@-@[K>^==Q2O;Q&
MS>*1;K?(OV=XW$NPHV*,'B[PG<Z?INK6WB?P]<:5K,DL6CZG!K6FRZ?JLL`G
M,T>FWL=RUM?20BUN3*EK)*T8MY]X'E2;?Y/OVE?V>O$?P+^*'[3GP4^#?PF^
M(VG?L#Z/^V)_P3A\??M`?";X9V/BN\T+4_V?O$'AG41^T/-H&D:5;ZIK>M>&
M+;Q?%\/?%?Q2\)^#D>ZU?P[HVO6TMJR7]_'<85O^SQX'^/WQ<^&WA_X(_"_Q
MM/\`\$V/&/\`P4'^"6J?#SP3I6A^-?!7PVCT32OV?/&\WQDUOPUX<\O1[_0/
MAAXA\7-X)L=:D:"PT#Q'K]MKMK/!.)[\7(!_4_XO^/OP>\":C\+=-\4_$#PQ
MI3_&?Q)K'A/X<WL^L:>-*\1:WH7@_P`2^.M2M;?5?M(L%6#P[X2UNX$S3^5)
M<P0V*,;JY@B?@/V<?VLOA?\`M+^'];U[PC='1&TKXK_%3X266C>(K_2K76O$
M.L?"3Q!>^'_$6J:%I\=Y)<:AI,LUA<7MM+`CR)8H9[A(E5L?SA7/[(G[/_PS
M^('B33_CY^S;%XY_9;_9]_X+"?'Z]\)>$%^&?B/XD>'/AI^SG\;?^"=7@B70
MX/!O@ZUTW4=2B^&LO[2LMDL]EX8TVZTC3_'>AWQLHF?2Y6',6'[$'P\\/?L/
M?%3]J/X(_`SQ#X<_:F\#_P#!3#X;?$+X'^*-(TKQA'\1O"OPRU#]M+X-:'%8
M^'M(UFPT_6-"\!WWP2\0>(;SQ'X930],TV>P_M&\UVRFDMKR9P#^E7]K3]K3
MP?\`LD^&?AKK7B3PYKWC+5_BQ\8/!/P:\'>%O#4VFV^J7>M>+[BX:[UNYN-6
MN;2RM/#OA'1+'4O$GB6_FF"V6DV$\N"<5I?L=_M-:5^V+^SSX$_:.\.^!O%G
MP^\*?$H^(-0\'Z-XU_L]=>U+PGIGB35M#T#Q<\&FW%U!;:9XST[3(?$^@Q22
MFX;0]4T^>=5:;`J_!KXI?#S]KG1_'&NZC\&?&WAR'X._'#XI?!RSMOC;X'TO
M1]0U?6?`4O\`PC&M>/O`=L=1UIKKP%XLMM0N[?PSXBD;3;S6]*^UM+IUM;R*
M)OI/1=%TCPYI&F:!H&F6.BZ'HMA:Z7I&D:7:PV.FZ9IMC"EM9V%A9VZ1P6MI
M:V\<<-O;PHD442*B*JJ``#3HHHH`****`"O'?"G[/GP2\$:9\3-#\+_#'PAI
M7A[XR>-O$OQ(^*'AE=*BN_"_C7QYXSN([SQAXKUOPS??:M!FUGQ9?1IJ'B6[
MBTZ)M>U$'4-4%W>LTY]BHH`AMK:WL[>"TM((;6TM88K:VMK:)(+>VMX$6*&"
M"&)5CAAAC58XHHU5(T5410H`$U%%`&%IWA?PSH^KZ_XATGP[H6EZ_P"*Y=/F
M\4ZYIVD:?9:OXEFTBS&GZ5-K^I6UO%>ZQ+IE@!8Z?)J,]R]E9@6UL8H?DK=H
MHH`****`"H+JUM;ZUN;*]MH+RRO()K6[M+J&.XM;JUN(VAN+:YMYE>*>">)W
MBFAE1HY8V9'5E8@ST4`<?X`^'G@#X3^#]"^'GPM\#>#OAKX`\+VLECX:\#>`
M/#.B^#?!_AVREN9[R6ST+PSX=LM.T72+62\N;F[DM]/LK>)[FXGG9#++([=A
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`A`(((!!Z@C(/U!I>G2BB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@#R_XO?&3X>?`KP>GCKXFZ[_`&#X?N/$_@SP58216-]J
MNH:MXM^(7BK2?!7@WP[H^D:7;W>IZKJ^O>)=<TW3;*RL;6>9WG,K*L$,TB>(
M77[?O[&6G_&!/@!J?[1OPOTKXSMKNE^%'^'.J>(K?3_$MMXNUJRM=2TOPC=V
M=V(EM/%5[8WEK=0>'[B2/5'BF0BV).*\Y_:LGL=1_:V_X)K^$==O(/[$N_C5
M\<O&UCH=W&DUIKGCKP+^S/\`$H>$Y'AD1XY[KP[8>(_%'B;2UD4_8]5TFSUF
MV\O4-)LKB#\ZOVQ?VCOV1_VD?VCM$_9!T_XF_LS?"#P-\$/VA_A)\8_VEOCC
MX]^*_P`'_AOJ5]\8/ACXJT3Q9X+^#/P\\.^(-:TOQ+X[\;ZMK%MH=KXV\8QV
MKZ-X>M)(_"L&HW_B*[EL+$`_<GX6_&CX9?&BV\:7'PU\6:?XF;X<?$3Q=\)O
M'ME;>=!J?A#XB>![\:?XD\*>(=,NXX+[3-4LF>UO88KJ"-;[2=0TW5K%[C3M
M0M+F7U&ORF^$8LO#7_!8']K3P]X"NX6\+?$?]C7]FSXP_&'2-/D<Z99?&6W\
M?_$_X<>#/%$RP6TUB_B+QO\`"?PU;:=J9:]L+X:+\/\`PQ>266J0:G%>6'ZL
MT`%9.OZYIGAC0M;\2ZU.UKH_A[2-2US5KI89KAK;3-)LYK^_G6WMTEN)VAM;
M>600P1R32E=D2.[*IUJ*`/R?MO\`@MY_P3/O/$=SX3M?VBHKC7K)M.^WV,/P
M_P#B1(^GPZL\T>FW=^Z^$REE8WK6UR+:]NC%:S"UNC'*PMYMGZ#?`SXW_#C]
MH[X6>%?C/\)-9N/$/P]\9KK+>'M8N])U70KB\&@>(=6\+:H9-*UJTL=3M?(U
MK1-1ME^U6D7G)"MQ#OMYHI'_`#>^$2L/^"K_`/P5'8JP5OV0?V!PK8.UB/\`
MAKC(!Q@D9&0.1D9ZBOR?_8LT'XN?`;]E7]B7XH_L^^-/BGXM^,7QE\,?M\VV
MC?"OQ3XOO]6^&FN>)/"0^*_B#X6^#=.\*W<D6C>'M.C\=:3I4EO+#;M<RRZQ
MJ;7%UY4S"@#^MNOAG]I3_@I#^QW^R/\`$?2/A)\>?BN/"'Q$USP39_$;3O"]
MIX4\7^)]1E\%ZAKNM^&;/7Y4\,:'JZVUE<:YX=UG3HWN&B9I[*0!<%"WXM_\
M$N?B@_C?X^?LA>+[']O3X.?$#Q?\6O@%XJ\0_M`_`2'X\>)/B'\>/'7Q(U;P
M'9Z]XDU#Q[\&;^YO;?X,ZU\-O'&@:I'K@.D^#=*TZ_M]4\&:;IL+K;V4OI7[
M9'Q-T;X7?\%HKS5->_;V^$?[`]EJG_!+_P"%-A#XR^+MS\$+/3?']U#^U;\=
M[C_A&-&F^.-[9:,U]ID)?5;J+0S)J?D-&\X2U!+`'[]?"3XK^!OCE\./"7Q9
M^&FK2Z[X$\<::=7\-:O-INI:1+?6`NKBS,SZ;K%I8ZG9G[1:SIY5Y:02X0-L
MVLI/HU?RS?M)Z9K/QO\`!O[>_P`8M)_;4^(OQE'[,O\`P3ZT_P#:`^`7Q;^!
M'Q*TKPW\+_%'Q3\#^$/B7\0;'X@Z?I7PENV\`>(X-0UCP9I7AS6+"QEO=#OM
M-M-0LI;?[1<W+#Y?_:'U_P`;?LX67Q,.A?M`_'GPKX1^,_[!7[*O[5?QM\8Z
MQ\4/%FMW_A[XE>*?VF/AIIOQ%^)WA[4]1EO&\$-#X5\6^(HKFQT"&ST:WL([
M6+^S2EI$I`/ZT?VA/C[\-OV8?A'XL^-WQ;U.^TCP#X,CTU];OM-TF_UN]C;6
M-7L=#TZ.WTW3(;B[N'N-3U*T@)2/RX5D,TSQPQR2+[17\3/[4&I_#D>&?V]O
M"?[#'QU\;_M*_L0K^R;\"_$GQF\?W/Q1UCX[_#'3/VT=3_:=\"3>&M+\"_%7
M4-5UO3KWQMKGP/N=7UCXM^#?"E])I7A$V?@-]6MM-U[6+RPA]SU;Q3X8?X_>
M`+OPQ\??B9X@_P""E/C'_@IQI_P8^+?[.T/Q4\0W6KQ_L>:[X_FM_BRGB/X!
MSZO;Z;HOPET']G>VO/$VE?$[3]#M[>PU*WTZ[T;Q%/K$A@8`_KSHK^-SXMS?
M&R\_9Q_:L_96\7>//B_;^)?^"/\`\"OCUIMO\08/$?C#2=4^+X^(6CV!_95\
M?:OXJM=2L[KQ9K,'P9US5D\0$27UK9>/?"6I.SB[V&/NOC'^RII/@7XU:M\.
M=&^+?[3<_A'Q+_P2*^(O[:'BG3+KX^?$R6W\0_M.?"CXF_#+0?!7Q"O&76EE
MM;JSTWXC^*DN?#^ES6.A:FTME)?:9<?V9:^6`?UTT5_'[\9O&<7Q(\=Z[;_M
MM_M=>!OV:?#WB;_@G_\`LV^*/V9O&_QQU_XJ_#O19=<U[X,Z;K'Q<^(?P;U_
MP9\5?AQH'C7XQ:)\2;T2ZCX0FB\2>,;E[;2X-(\/3Z?=K%)N_$WX::GXY_9X
M_;H_:M\3?'_XX^,OC1^S7X,_93\?_"KXJ:-XG^+/PE\.:IX@L/@-\'O%OB+Q
MHWP6N)K>3P?:?$S4OM^J>)O#'BOP]/>^%8-:N[;7-/@O-+O0`#^JGP9\3O`O
MQ!UCXE:#X.\166NZK\(/'B_#+XBVMF9&;PSXY;P/X)^(_P#PCUZS(J->IX.^
M(G@_6)!"TD<<>LPPNXN(IXH_%/VB_P!M']G/]E'Q7\`/!7QU\>_\(9XA_:<^
M*.E_!SX.6IT/7M7@\0^.]8U'1=(L;'4+[1].OK/PUIC:KXCT'3IM?\0SZ;HE
MM>ZOI]O<7\<MU$K?DY_P3R\'?LU?#+_@HM^WCX<\0ZU-H/[3WC[XQ^!OCO\`
M"KPSXA\<^-;?4_B#\)/C7^QO\!]9\8^+O!?@W5]470/&_@_P[\3O"/Q7\+7W
MC?2=-U&W\-ZUH[^$[Z^TB:UT'2:^9?V_?@Q^TM_P4N_:W_;"\'_!+X?_``U\
M2?#G]EK]F/6?V9?`/BWXJ?$;QC\/K+P5^U+\0+[PA\;+SXG>#;7P[X"\:0Z_
MKW@36O!?PKMY[HWFDFRB\/'3S;7/]J74D(!_4U<7]C:36EO=7EI;3W\K06,%
MQ<0PS7LZ(97AM(Y'5[B58E:1HX5=U12Y`4$U:K^)?XX?M#_#S]H/P3^UI\??
MVX?#/[12^.?B!^QMX7\<?\$X;SX4>"?VG?%'@WPGK%E\`-6U#XM7NA:M\$_"
M5[X4^'7Q&\!?M`Z=XAT/XCZOXXUG3+33O">A0WC7L'AYKBXF^CO!_P`!/B7\
M1_@'^W+^T=\+O&7[07CC]J[X=?L]?LLW'P+T&U^(WC>;1O#GB;7_`/@GU^SX
M/%$/A#P+#XFL]#\0:YXECAE\17E[J<+W]WXLO+F2"(W\:W-X`?UF6FIZ;J'V
MK[!J-C>_8IVMKS[)=V]S]DN44.]O=>3(_P!GG1&5FBEV2*K!BH!!J&#7-%NK
M2'4+;5]+N+"XD:*"]@U"TFM)Y4221XH;F.9H99%2*5V1'9E2.1B`$8C^,CPQ
MH/PNNOAI\5Y_V/\`XZZ_JVM7/P&^#OA7]K/X,_!#X*?MF76K6GAZW_:N_9DN
MOVB/'GQAU+7O$.O>)],^/GA_]G_6?C)HMQX&\%7OAGXL>)_#6HZ_JF@6:?\`
M"-VE]:]-JOPU^!WCSPUX9\'?LM?&6Y^)OP"^(_[=?['V@>,_AQ^SKX-_:(\&
M?!SP%;QV'Q7T;QY%X>^(7CCQ!KUY<:AXMTN5D^(&@^&?%+VFC064,VLVNG3W
M*^:`?V(0Z[HES-96UOK&E3W&HV[W>GP0ZA:2S7]I&"7NK*))F>ZMT"L7F@62
M-0#EA@U,NJZ6]]<:8FI6#ZE:0K<W6GK>6[7UM;N%*7%Q:"0W$,+AU*RR1K&P
M92&(89_E5UK]DN'X,>%-/^.WPI\"_%"P^*7P!_X*U)\'OA+<1>(?B3>R^%OV
M4+SX]KI3>!=#T2>YOH[[X3_V1XU\07<DLT;V0LG6ZEU6:QT^&W7G?@)X7\9W
M7QV\%:C\9O%_C[P!^W+X/_:>_:%NOBIH'AK]G?\`:;UCQK\5O`7B?P5\1M`T
MW0?'7Q&%Y>_`2Y_9]NO`^H^`O$OA?XAZ':)X7T35?#7AJPT34HM?EU*SE`/Z
MFO%OQ4^'W@GPCXO\<^(/%>CP^'/`OA+6O''B:ZL[R'4[C3_#&@:9<ZOJ6IK8
M:>]S>W,<=C:3R01VT$LMVZK#;)+-(B-:\+?$7PEXZ\"Z?\1O`VJP>,?"VL>'
MK;Q+HUWX=9=1EU73[[28-:L(K2WB;S3?WEC=6KPV$HBN?,N88Y(T9P*_C[^'
M/[%$^@_LQ_\`!-#5O`_PD^)9^+G[2W[%7[6OPV_:92\N/B#?ZKX^N[W]GE[K
MP1X=^(^GZY?S6>E7W_"8K86WAU;VWTB>*]BBM;9PWF!OZ$O^"3ME^S?IO[&_
M@+3_`-FSPW=>%M,M;7PK_P`+:TR\\'_$;P7<?\+SO/A7\.-1\>S3Z=\2M(T?
M4;F\6WO-"M=3N=!@E\.V>K6M_H,<D&MZ+KFGV(!];?![]H+P/\8?AIX3^)UO
M!K?P^T[QC%?3:5X=^*-G!X*\7I'8:C<:9(UWH.HW9N(1+/;,\&&?S(9(GX+A
M:F^.'QW\*?`33_AWJ?BW3M<U"V^)/Q:\$_![26T2+39/[.U_QU)?QZ;JFKMJ
M>I:9'!H5E_9TSZE<6SW=[$C(;>QN?G"?QC^%]+/P^^&'A?Q=X]\$_$/XW_'C
MQ3\-+KP/X&_9-^-'[-'[5GB[3?'\FE?M,_%/4M*'P%^,_P`,1IWA;X=_$7Q1
M>^+M(TOQ#)X\OYX+&RTG1-;U'2G\.V4-[#_2_P#\%*OAK_POSX)?LO>"_&O@
M36[O2_%/[7?[-=[\0_!FF7NHW=SI&D&?6;SQ%IFJ:YX4EAF32].F8Z9JVL6-
MU:V4]N9"MS'!<J2`?I3;^*/#5WI=UKEKXBT*YT6Q>XCOM8M]7T^;2[.2T(6Z
M2ZU".X:TMWMF(%PLTR-"2!(%)J,>+?"A@L;H>)O#QMM4M+V_TRX&M::8-1L=
M-CCEU&]L9OM/EW=II\4T,E[<V[20VL<L;SO&KJ3_`"/?M5?LV_$SX=_%;]NS
MX9_`_P``_%S2/V0?#?[3_P"PA\;?B?X!^'/@[QI\1-'?X?\`B'X:?$"'XXZO
MX2^&FFW2ZS\1/#4/B'PSX,\3_$?P1X'FO[ZYEBU'4)=,N[BZDM9M+X/?LM^"
M?C+\9/\`@GYX!N+7X]?&G]DGQ9^T5^WYXDO+3Q+^S?\`'W]F3X?:#X.\3_LS
M_#[QAX;T:PTOQEI'A;Q59_`K4OB#I5\GA;4->N]%T3Q+XHU9?"6AZ9K%GIGF
M6(!_6DGBKPQ+J\'A^/Q'H,FO75@FJ6VB)K&GOJ]QID@RFHP::MP;R:P<$%+N
M.%K=AR)"*^:/V5?VS?A!^UA\!_AU\>O#-S/\/M*^)/AS7?%VF>"/B7K'@_2?
MB#H_AO0O$FM^'9=6\1Z)HOB;7K72[:<Z))J9#:C+)IUE=06^LIINJPWVG6G\
MY_@GX!ZMX%_;;'AGXIG]I+P+\=O"?[</@SQ5\%+_`.%G[)'Q?^)^F^+_`-EC
M2=8\*^&_".@:3^TOI>CZA\-O#'[/.C^!]3U'PS\8-'\9>(M!N_".VYU%=*OM
M733+F_\`!_V=_P!D/P[\4OAI^RG^S98?LG_M(^#/VQM/_:3_`&D9/VHOC#X^
M_9^^,_PC\-:!^RWXD^*OQOTR>35_B+\2_"7AWX=^-?!WC?X5ZYX*TGX?>"?A
MWK6LV0U*"RN+?1(ETZ:5@#^TJ36]&AN=)LYM7TR*[U_S_P"PK62_M$N=:^RV
MC:A<_P!DP-*)=2^SV"->S_8UF\FT5KF3;""XP->^(OP^\*ZG9Z+XG\=^#?#F
MLZB(FT_2=>\3Z)H^IWRSR^1";.PU"^M[JZ$T_P"YB,$3B27]VF7^6OP1_P""
M77@WXG_'CX\P>)OCSI,\VG_\$D-(^*?[`/P=\42:C)J>G_%7XS76L6FA_&?X
MYV5T;L&Y:+X/^$_A1X)M6GTV!])\0>+/BMX=\[[5IM];P?*G_!:GP9\:/BG\
M6?VO?!6B?LG_`!5U:9_V-DLOV>?B]\&OV&/$7[3_`(H^,_CBX\*^-=4G\$?\
M+JM=/\1Z/^SYJG@+QI:Z'<:5/8?\(;XWN0R:CX.G\3^([S1])G`/ZH[[QQX*
MTO4/[(U/QAX6T[5?-6#^S+[Q!I-IJ'GM;/>+#]BN+N.Y\UK-'NUC\K>;9'G`
M\I2XBL/'_@35="O?%&E^-?"6I>&M-FGM]1\16'B31[S0M/GMEC>Y@O=7M[V3
M3[6:W2:)YXY[B-XEEC:15#J3_);\8_V-/BO\4=8_:5^)GC+]F_XQ>+?B;=>+
M_P#@DA:>#/%5W\.?B-/XANM#;P[8:+^TO+X:FMM-22XBTO3I[_3/BYJ.F(\W
MAVUDN;7Q)=:=&9$KK?VD?V)?BG\._$O[<_@;]GS]FSXD>'OV6-._;F_X)Y?&
M&3X>_#;P'J?BCP]\1OA%X>^`_A.V^/MW\*_A1`FE6'Q1TK2_&6F:=-\0O!>B
M7^N:SXNUK3M?TZYL6NQIMI,`?U,GXG_#4:1:>(#\0_`PT"_%\UCK9\6Z`-(O
M5TN/S=3-IJ1U#[%<C3HOWE\89G%I'\]QY:\TRZ^*?PQLM"L/%-[\1O`=IX9U
M6:2VTSQ'=>+_``_;Z%J5Q"76:WL-7EU%-/O)HFCD$D5O<22(4<,H*MC^7SX2
M?L1Z)\3/C?\`LD73?!'X]>-_V<M1_;?_`&D/BAX]\)_&O]EKQS^S+\.OA]9Z
MQ^RKJ^EVCZ7\%?$/AO3=5T?X8>(_B58Z6;%?'VC>"M"UGQ5.\&EV&N036BS>
M(^"OV:]0_9X_:8M]0^.'[!G[1?QB_83\$_M/_MX>#/AE\&_AQ^SKX]^,>@>!
M+WXDQ_"'4?A[\1--^"]CHUU<3?"W6-/?XA:9H'Q&TZQNO#.EZI>ZK'8W<<AN
M)(`#^EW]E_\`;?\`A-^TA^S]X?\`VA;O4="^%?A;Q1\3/C+\,M#@\9^,O#D4
M6J:E\(/C+X]^#TUYINKM<V>GW\?B2[\"7.OZ9;VC2RPZ?J$$4K2/#)(?4/C[
M^TM\)OV=_AWXB\>>.?&?A"RGTWP7XL\8>&O#.I>+M!T/5O'7_"+>$]=\7MI7
MAE=3O(_MMSJ6G>'M0%I/!'/"3$S#?MVM_(+\/OV2_C5X-^"G[''BCXE?LI?M
M"6'[..@:#_P4I^&,_P`#K#]D2Z^/GQ$^`/C;XR_MR>.O%_P[\;ZC^S8?M^NV
M-KXV^"SOH7ASXF>&-%\267A;3)K'4(=4L?#WB:#6I_8I/V7_`!%\-+CXL:3\
M</V(_P!K[]L*;XP?\$Z/`/P`_8]\7^)_@EH?Q0\4?#+5;#PA\0M(\8>"/BK9
MC5$\!?L_^,=2\1-H'BW_`(2?4]>TJ"326TG1(]4L_$%A;:7J(!_1-X__`&[?
M"_@#_@GYX4_;^O?`FM7GA3Q3\(_@1\6H_`,>KZ?;ZW8Z=\<[CX?P:?I=QK$T
M1TUKCP]_PG]M)J%RL2P7*Z=<>0J>;&5^A?!O[2'P&\?(R^$OB_\`#?7[N'Q9
M!X`OK#1_&>@:G=6'CV>#[0O@VYBL[Z5T\0LJRK%IQ47%PT,P@1S$X7\B?VB/
M@S\5?$G_``;Z_#WX*:7\'_B'XM^+-E^QS^Q1X=U7X)Z9X5U`_$RYUKP:WP)N
M/&7@V3P?J*Z=J5IXCTFVT/6K;5M(U4:=-ID]A>Q:HUC]EN'A^4_'O[.%C\7/
M$WQ\_:1^#/[,/BW]B[P1^SU^R[\+M:\*^*/BW\*;#X#7OC7]IC]F[XR>*OBG
MI6L6'@HM_:>L:!X<\.V7B;PW>?$K5K"T'BFW\?6X\+:KKNA2IJQ`/Z:[#QCX
M4U3Q-K_@S3?$6CWWBSPK::1?>)?#MI?V\^L:#9Z_'<3:)<:M81R-<6,>JPVE
MS-8-<)']IBA>2+<@W'AF^/\`\#DUF\\//\7/ATFO:=IWB;5]0T=O%^A+J5CI
M7@R18?%FI7EF;T3VMCX<E81:Q=3I'!82'9<.C`@?"/\`P2J\&>+/$'PD\<?M
MG_%32[S0_C!^WGXLT_X_>(_#-].MU)\/O!,OAK2O#OPI^&UI+NF>.R\+>"=+
MT\O`;R]3^T+^^GCN7$Y"_F-K7_!-CXL:O^QE^V?=^`O@U)X:_:>\4?MY?$WX
MJ:??Z_8>')_B/\2_V?=-^-^@?$6Z\`>$_$?B6WO=(U+PW\1/#ECJ(\/^$_$4
MZ>"=?O+J/PWXK1=*>[$(!_0+:?M6?LT7W@U?B):?'GX3S>!&\0MX2_X2]?'7
MAX>'5\3K:+?'0)-5:^6SBU;[$Z7:V,DJSM;R),J%'5CP.M?MD_"ZXU7]E[_A
M5VO>#OBYX-_:.^/WB_X%W'CKPGXVTZZT;P-/X/\`V9/VC?VB[_796T^SU:#6
M[A3\`1X1N-#EO=!:TC\5_P#"1-J4JZ*NCZQ_,7\<_A:/`5S\-?B;XY_9U_:J
M^(_A?XD_M\?L,2ZS\&/B7^SW^S3\)I/BAJ_@3PA\5;37?#7PF^`7@?7?#7A?
M4M7@TG5/"VC>+O$_CF?0M(\;7^G:+IOA_4]3A\,7]R?LOX0?LY?M(WOQU7]J
M'X5?LD:O^SS\._B#^W-JOQ:^&/[-_P`1++PWX7U#P/IWA/\`X)3?MJ?L^3?$
MOXM^$?!=YK?A7X=V'Q>^-'BSP%I4VDZ5J6N7,`\1Z,=2D\ZZDCA`/WU^&O[3
M'[/?QDU"ZTKX5?&CX;?$#4[/2AKMS8>%/%NCZQ=Q:*93!_:Q@M+J21M-68&-
M[U%:W1_E>121GR35_P!MCX4ZU=^#-.^!'B;X:?'C4?$/Q/\`#?PZ\16?AWXQ
M^`-`F\(P>(+G6;3^WC%K6HK/XEE@N=!U."S\/>'H+W6=9EL[E=-AF%O,R?S)
M^!OV1?\`@H1\<M?L]7A^"7Q[^!7Q;\1_L)?MC_L[>-?%WQ%\%_L__!7X6?#[
MXT?$+P]X5F\/Z%\)M.^!^NZ]?3_"RXU>SU#P[X;\<WABN?*N)-<T:SNY+22Y
MD^^;;X=>/OC'>_\`!/9?A_\`\$UOB_\`LQ']E_\`:3_9TL?BKXK\=>'?@GX9
M:7PU\/=!U'1?$$/AQ?`_Q)\6^+_&?P[\*ZA/;76F^-=4LH--U*WNY+O3A)-_
M:IA`/VX\(_M;_LP>/OB'8_"7P1\??A-XK^)FIZ3JVN:?X%T#QQH.J>)KW2M!
MEDAUR\MM*M+V6YFCTB2*3^TD1&ELD1I;F..(;ZQO#'[;'[(WC3XES?!KPG^T
M;\(/$7Q5@\5:AX&?P!I'C?1;WQ0?&&DZ3=Z[JGAN+2X;IKBXU?3M'L+W4;VR
M@626UM;6>694$3X_`_X9?\$XOC;X-_9C_P"";S>`?@=9?"3]I3X:_MT?'GQ/
M\9_B)8Z9X&TSQGX%^#/Q@^#G[7WA+QIXL\3:]-<LOB#0?$-[XD^%%I?6<%QK
MFH7B/H,=G8M'9$6_D_[._@_XA_#[XO\`_!%?]G?Q[^R1X0^%/BSX#?&/XN1:
MK\9]!^,'P6^($_QR@T?]GOXJ:)XD^+/A2V\%W^N?$/4?"/B'7-8L+_Q#JGC[
M_A&M9L=9US3;*\T^YE+&(`_>S]HW]L[QM\-/CYX"_9=^`GP!F_:%^./B_P"'
M7B3XPZOH>H?%+PO\'_#'A3X:>&=8TSP]/JESXF\1Z?K<^KZ_J^N:M;6&BZ!I
M6B31N([J\UC5M&LH1/)[9\*OVBM)\66UOX8^*VEZ7\$/CWIGPT3XM?$+X!ZY
MXV\->*?%G@#P')XC\0>%8?%U_JGAR>72=5\(W>M^%]<LM/\`%.F/)H]_-IUT
MMM.YA?'PG_P47^#>C_%/X@^!=0\4?\$^OC;^TQ!X6\&:X?!WQY_9G^,OPV^%
M_P`9/AEK^HWD;W/@Z)?&'Q8^$&M'P]XDFLM&N;S5-'UK7;:T%O+)?:#/'#B3
MX*^$OP&_X*/?`?QQX;^+WC;]F_XE_M+^+OBW_P`$XKO]E;6K5/CC\%)O%GP=
M\9Z+^T)\8?B/X*TOXR^-_&GC#PO#XJLX/`/Q7T/1-2\5_#;2_'<W]K>$=;?[
M!>176F7%Z`?HC=?\%<_V7?#'[27BGX7_`!'^+GP8\#?!(_`;X0_&CX6?'76?
MB'9VFB_$E_B=K7B[3)=(TG[1$NEW%AIUGX9AU.#5K349%EAOBL\$*1+-+]D^
M)OVROV5/!OQ-T?X->*/C_P#"[0_BEX@N-#M-'\#W_BO3H]>O[KQ-;F[\.VT5
ML)659]<M1]ITF*21'OX,36JRQD,?YM/`/[%'[:OP7\-W'@O5/^"?/_#0UY\3
M/^"8/P;_`&/%U6^^)W[/6F^$?A5\4[*Y^(&A^+KWQ=>>*?&=QXF_X1/1]-\8
MVFLZQJGP]\.^)=3U"STL66C6&I7\L2VOH6F?L"_MT?`K7?!_PD_9X\'?$?\`
MMC5O"/[*?PL^.7QO\9^)/@)XW_9+^*FG?!S]F+P5\&O$/QVG\(^,/%\O[2'P
M^^+&A7F@7EMX4T3PCX4U2R:_TW1_$TWBEIM5U:&``_H(\`?MF?LI?%3QMXE^
M''PZ_:"^%7C'QSX0LM<U+Q)X9T/Q?I=YJ>EZ?X9OO[,\0WTL2S!);31+_-KJ
MEQ;23Q64H87#QA6(^2_C'_P6$_8@^&%I\,=2\/?&WX9_$_2_'/Q]\&?`[Q-J
M'A3Q]HA@^'47B[3?&-X?'6M!A,^HZ%I5UX/GTZ>#3!)-<S73RV\QBL+PI^/6
MA_\`!-?]K/XC>`?AS\!_&OP?^/7@/QQ\'O@5^U%\)?!/QMUKXS?L]3?LU^$+
M_P")?P4\2?#C3=;\%Z-\/=1/QS\76WQ"OM<7S=#\5^"/!'_"'2O+XCOM;US4
M+..VOOK[Q7\)OVJ_'7P+_9832O\`@G-%\*?&?[!_QK_90\>1^#=+^*GP#NM<
M^.OASX2Z;XW\$^-O#7P4U?3]<AT;2-`T+2_&]QXV\(R_%CQ/\/[O7+Q];T&[
MT70KJZ_MO4`#]$O`W_!0CX/:U/\`M`>+_'7C?X&^"O@#\*/%GPV\+^!/C)IW
MQQTOQ4?'DWCWP59>*Y8/%_@W_A&="OOA;X@L[C4+2VT/P]<:IXLF\5:+=6GB
M*TN[))9-/@]!U3_@H!^Q3HW@7P3\3-2_:=^#MMX%^).H>+=(\`>(SXQTU['Q
MCK/@..ZF\9:+X>$<CW&IZSX;CLKHZMI5O"]_:&%EDMP<`_E[J?[-W[3MW\8_
MB+^UM'^S3XIFFD_:G_9__:1L_P!GN[\7?!^7QUXKT;2_@4/AAXOTC1M8D^)D
MOPU@^(G@:^%I=S#7?$FA>'=4ELC:Z%XGO8HX-6EXG]GS]@C]I:#]L7X#_M3_
M`!%^#6G^"O!_BC]O/]LO]JOQ/\*+[Q=X'\37W[.OA/XN?L<^%/A)\,[?78=(
MOYO#.H>.M6^)G@:XU_Q(_P`,+KQ39:+K_BVPNH]7U.+3]4\3D`_5SQG_`,%(
M/V'?A_X2^&7CCQ3^TG\-++PS\8K,:I\.M1M]8;4V\1Z''JL&BZEXCAL],AN[
MZT\-Z#J<Z6OB37;ZVMM,\/NLW]K7-J(9=FG^U;^V5X._9M_9LTW]HC0=(3XN
MVGCG6/A;X4^#VBZ!X@L=(TGXB^*OC;KFC>'OAC&/%\]MJ-EHOA?6[W7M-OK[
MQ,NG:M]@T1IM0M=+U.9(;*?\*/BE^Q!^V1X+\5O\1O@E^SO\<=*^._VK]HKX
M?^`?C!\&_CW\`-$\->'_`(:?%+XO>+/%WA[PY\8/AM\4-2&E>*/AK'=WNC^.
M;V?P]!JOC%#=7FFKX;6^TZ".[_:?X\?!?Q#X_P#V`K;X6_%_X-6WQ^^)>D_"
MGX6'Q/\`"_X)^)]$^$4>N_%?P=!X6N=2O/@WXK\03>'=$\`KH/BG3[S7O`=S
M>S:+!IUKIVGV0:P9E$8!X?K/_!2CQI\-4_:?^&/QX^!OA3X=?M0?`3X>?"CX
ME>#OA_X/^+&N_$OX5_&7PQ\>=5U?P1\+;[P?\3=;^$GPH\3&Y7XJ^&_$GP^\
M:Z7=?#&W71]2TJ*;0]4\1P7QDL[G[?G_``4KN/\`@GC^SEIWC/QG\-[#X^?M
M(Q^!D\:Z_P#!OX9Z^W@CPWIN@:%)I4?Q$\=ZUXJ\00^+[WPA\.O#-QJ<>D:-
MJ=[I>NZYXO\`$=WHFBZ1HAGU*]DT;\T/'7[!?QG\,>&?V@_VX?C3_P`)SX;U
MJQU_]C@>'OAAX^^+$O[0/Q-T+X"_LB?'^]^,?B;7_'?Q(B73=$O_`!5XSNM>
MU.?1?"_ABVN-'\#^%M&TZ&YU7Q%K>HZM/%]:?\%+_P#@E_;?M>_`K]K;XG_L
MZ?$KXL7OQM_:=^$/A'1=#\.Z9\7CH7PB\<6&A+X9;PA8W]G<VD]C'X:BTFUO
M]7ALH[RWTR\U34I-1GB>[<3$`_0VP_:7\1Z#^VIJ/[*'Q*\/Z)ING>/OA?)\
M6?V=?&6AF_\`,\6:9X2NK?2?BGX.\66UU=WD=KXH\+7FH:1K>FW=DEEI^J>'
MM28&VCO+"1KGK/VBOVR/V=_V4I/#47QV\>CP6WBS3_$>LZ2QT+Q#K48T/P@-
M+/BC7=2ET+2]1CTC1-"76M+;4M5U-K6RMDNXV>8#<5^%-9TG_A-_^"C/[&/P
M?\'^(O%OBF]_8Q^!OQ,^)GQQ\?>)-9L]9\<0GXM:1I/@?X?^!?B%X@1)8=6U
M7Q;<Z=K/B:^TRPE)CBT6#45D^R>49,7_`(*E?LY?ME?'_P`9^`]'^">C:GX[
M^"&H?!GXO>#O%?@CP[\?IOV=YM*^+GB2[\+KX(\<^/=9M/#GB74OB/\`#NP\
M/VWB6PN?`&FII)?5YK6YOKB\M;G=IP!]6?%K_@J!^PA\#]?TWPQ\2/VC/!&C
M:YJV@>#_`!=8V%HVI:X\G@OQY9WM_P"&?&\DFB6.H0V_@N^M;">23Q1<21:+
M9DQ)>7D+31AO`O\`@HQ_P5O^`/[&'P<^/5WX/^(?@+Q=^T5\+/AI'XTT/X<Z
MC8^)O$?AV/5M5M6U#PGI/C[4?"+VT?AA/%=A;W4VBQZCKVCW5_&(KBT,T;*D
MOSS^S!_P3[^/_P`-/A]^TAX=\:^"?"4.N?$?_@FO^SC^S/X8U*'Q)INHR:C\
M1?A]X'^,FA>+O"]X5C*V6@V.J>+=!FM]5D)M-3_M"X<(5L,U\Q_$3]@S_@H7
MX8_9T_;O_9>^''P%^&'Q/MOVVOA)\/\`4)?C/KOQ\L_!E]X$\:^'?@7\/_AC
MK?@'5/"$_@37[_QC=1ZQX2N[O0]<7Q3HNBO;:E<SW-S:R0B"^`/V_P#VN/VJ
M]?\`V>_A/\+]7\%^#=(\;_&'X\?$7X<?!OX1>%?$&KWOAOP1-\0_B3+&EE>>
M-/$]K8ZI<Z%X2T2V2]U+4[BWM+O4KJ&U2PTRWN=0NH4/R/<_\%$/CMI/AG]I
MCX.>)_AK\)]`_;3^"_QP_9[_`&=?!%EIFN>)_%GP+\>^+/VKYO!__"G_`(@1
MVTC>%/'1\,>']#\5WWC/XC^"#JFFZ_9Z!X*\1+:>)[-)8M4M/KW]L3X/?\+2
M_95U3P)<?`B']HCQ#I=GX1U+P_\`#:/XFQ?![4I/%GAN>QN-.USP]\46T[5'
M\'ZYX?O(#J.FZQ;V<DHEA$:C$IK\@[']C[QE^R'X/\4_MX_&ZP3PKJ\G[6W[
M)OQV^+'PHTWXB^(OC!9_#/X(?!SPAJ/P"U#4O$'Q'UW3M/O_`(B>(/!_A[XB
M:S\:_%%]'H^D:3:7GA6V@T2!CH]I<W(!](_&#]NO]MJS_;6^(/['7P*MO^"?
M2:A\+/A7\#_%6K^)_P!ISXI_&#X/ZKX^\5_%:QUS[3:_#_PAX,\-?%!ETN/4
M-!N#8Z9>Z[J&I6D=Q%92ZGJ\\9NYOM'X+?M&_%YOVH_B/^RC^T;X>^'^E^,/
M^%;^'OCO\$?%OPPB\26_A7QG\,VC\.^$_B7X6U./Q/J>JWTWC3X6_%#4/(.O
M1MH%KXU\$^*_"^K6_@GPS?:1KT,_QK_P42_9V^/O[6EK\5O@QX%_8@_93\8Z
M/\9?A];^&O`7[<7BKXLZ?IOCOX0^?%;MIWC-_#NG?".]^(%_XC\$7K_\)1\/
M;3P9\1K/2[Z^L;"*^US1[>YN<]GX%T";XI?\%0/A_+X9\57'C;2?^">?[(NN
M_!/XU_$#4W%S?^(_C1^T%)\-];T7PM=R06ME8#Q98^"OAT_Q`\:'3Y+V+34\
M9>&K2[M--EU:U#`'["4444`%%%%`!1110`4444`%%%%`!1110`4444`?-_[3
MW[/,?[17@KPII.F>.-:^%OQ"^&7Q.\&?&/X2?%'P]:)J6J>!?'_@V:]LS=-I
M$U[I]OKN@>+/!FN^,/AOXV\.W5[:VWB+P)XV\3:'-/"FH&5*_P`5?`W[)_P\
M\*>)OB_\=_!'P!T30=#MH-6\>_$WQ[X$\"66GPR7-Q:Z>^KZ[K6KZ9.81>:C
M=6T"R7EY,WG7$,/G2,5)^)_^"J'QU^*G[*Y^`'Q[\`^*O$B:5<I^T/\``$_#
M#29-1N-)\?\`QE^+WP0USQ;^S7>ZKHUO%)IMYJ5A\6_@WI?P_P##>H:EAM.U
M#XM36T'^CZK?O'^(/Q5_:%_;2\._`/\`:9^`7C?]H3XAZQ\9/^"<'['7[2UK
M\=?B##XW22Z^*WCSQ+XR\):C^S_\3M=TRRTZU2ZNT\"ZJ)/#=YJ<IO(;K0]<
MEFL(YY;@H`?T4?!GP[^S5^R_>?M7?M$Z_P#'#PGXN\8?&+XY^'U^/GQ;O+C1
M;2/P]K&C^&O"GA'X+?`ZXL/#L]]:^'=-^&7@#7?"NC^&]#N0NKW#^*+KQ+K1
MEU+Q/=7,GZ#5_#UXY^!&A:?^S]_P5Q\;W'Q^_:$L_'-Y_P`%//#/ANV^&6J_
M'77M3\'?V5XR\,?L8>,[3XDK\*O$LFJ:9JGC.S;Q+<V/A?QUJVG:F\7A;P]X
M<T;-[IFA1(?Z3_V-_ASXH^!'[4'[5/P1N/VA?V@?CQX)L_!?P*^)^@_\-#_$
M[4?BOXG\(>(_'4GQ(TKQ59:+K^JQPS:1X?U0>$=)U&U\+Z9:Z9X>TF1Y3I6E
M6PN)Y)P#[FUCXU_";08/&EQJOQ`\,VZ_#C5O#6A>/8X]1BO+KPAJ_C*\T^P\
M+6'B&RLOM%YI=QKMUJNGIIZW4$8G2Y2<$6ZR2IZ>K!E5E(*L`RD="",@CV(.
M:_D6^/GP5\'V/Q._X+@ZX_Q8^-7A_P"(-S\0/V8+GP3X:/Q^^(0TC4H?%^F>
M!EGU6U^$6N>)+_P'XZ'AC4()9_!TWB7P7XIL_#$WFZ=8Q+I2+ID?:_M6_%3X
M]_L9^.?VBOV5?A=^T+^TKXZ\%>)O!'_!/[XK77C/XP_'Z:[\<_"S3/C7\;OB
MS\'?CE;>$/CWXDL+WQ)\)?"_BS1?`OA*_LYK"SO].^'GB&YUK5/"#>$--OVL
MX`#^J&+0]$@U/4M:@T?2H=9UFULK'5]6BT^TCU/5;+3/M7]G6>I7Z0BZOK73
M_MU[]BM[J66&T^V77D)']HEW^#^`OC3^SEXI^(NM_`WX<:IH&J>,_A//?_VQ
MH'AKP5K(\.^"-4_=RZIIR>*K3PY'X%TSQ%C5TFU#1++7EUP+?22W-CMEE8_*
MO_!-&S^+ECX._:&\.?%+Q\_B_1-)^.=U;_"S1K_]I/4?VI?''PY\`:I\-_`6
MK-X.\:?&?4]0U'Q+JVLQ^)M1\0ZWI4.MZK>ZMIOAW5]%B^V-$D!7\*OA9X,T
M;X<>'-5M[GX]?M&?!_X4?';_`(+,_'OX'_M%>-=-_:C^-^BV,/PPL-%UOQ-X
M;\/+K^M^.]2TGX97?Q`^(&G>%_!?B;XC>%X?#'Q$\0:+J:^%U\<6:75L\(!_
M47XZ^(7[.7[//B71M4\:WG@3X:>+?C3K&LZ7INK)X=BLM<^(&M>&?#6J^,]8
M@O\`5-&TF6\U.YTSPUHFJZS)+J]P0+>RE$,CSE(G[K13\+OC!X=\-_$'3-.\
M*^.O#_B31++5/#/B.\T.SU!;_0;]#>6,UG)JMC]KBM)EG:>.%TBPTKLT2NS9
M_D9^)?BWQ+_POJ/X):7\3?'GQF_9S_9]_;P^*_A/]F?XA_$'Q[<?%S5T\)>,
MO^":?B/XD^-?AU8_%[5;W5/%'Q"T'X8>/_%.M>&/#]]XMUCQ%X@T/1$T[PS?
M^)];GTB26'T+X=?$2;XE:[\5_AC^T#^T[\;?V6?`/[+G_!,O]EWXB_L?6WPU
M^/WB+X!V'C'QC\4/!?Q-NOBO\;HK#P1KGAC5/C-X@^'WB#PAX3^'.C>%O&%]
MXF\%Z/!J7B.SNO!&HS>*ENXP#^LK3?"?A;1M.N-(T?PUX?TK2;N![:ZTO3=&
MTZQTZYMI%F62WN+*UMHK::"1;B=7BDB:-EGF#*1(X;YT_:U^$_PE^/G@'3/@
M3\3_`!'J'A6;XG>)?#T7A;4-`MU'B.YU;P'KVE?$:.QTS4&TV_CT^/?X9BN+
MB6:2R"I'OM[A;I(@?YE-4^.O_!2;X[?#;P3^SGX%^)_Q0T']KWXE?!KX9_\`
M!0F%HM1U71+M/#_PE^`$^N6_P?CT#5)$M],\,_'7]I>+X::3KWA?1M8\-V4F
MA7OC)K6.QAD>PBLZ_P#M0_$SX^>'H_VZ?!/Q.\>Z%X"_:;^*/[67_"D]!T;Q
MUJ\WA_P[\+?@A_P3N\1Z'IEQHJ62Z396FLW/QGLOB'K6ORP6`OK;Q!I6GV5S
MJ>H'P[ILEH`?UZV.@:+IVDKH5II=A%I*Q21/IZV=LMI.)F9[E[BV2);>:2[E
M>2>Z=XB;B>2267<[L3I"VMQ<->"WA%VT*6S70BC%PUO'(\J6[3[?-,*2R22)
M$6,:R2.X4,S$_P`E6CZ?\5_V3-(_X)@_'?X$?%3]H/XD?'+]K+]D?]J'3_C1
M8_%?XO?$7XOZ'\8?$?P]_8IO/C7\+-4D^'OB#79?"OAKQ)X*\<^!-/@\.S?#
M;1O!J7.BZUK^DZU;:S]MLY[#+_8C\5_L[7_[4GP";P'^U5\6?'$OQ?\`^"6W
M[2?Q4_;1UBY_:"^*/CJ?0/BW?77P7D\8^+(O!OB_Q'XE\$?"_P`8^#FU;Q3;
M:1I?A'PEHEGH2V<=LNA_9XEMF`/Z:O@?^SAX,^!GB?X]>-=#U#6M?\7?M$_%
MJZ^+'CSQ!XBF@N=1%RGAW0O"GAWPGIT\,,3P^$_"&A:#!:>'M.E:9K1[W4YO
M,+7K@?0M?,_[&NF?#'1?V6/@3H_P7^-/BK]HKX4:3\.]#TWX?_&[QOXPT_X@
M>*_B/X7L8GM=*\0ZWXSTK2="TWQ#=RV\2VPO[+1].MVAMHHX[6-8^?IB@`HH
MHH`****`/@/]I+_@GC\.?VJ?']WXL^)WQN_:GM/!&M^'M%\+>,?V?_!/QHNO
M"'P&\=Z%I$][+<:?XJ\(:9H8UN>'Q''?-9^*AI7BK2?[>T^"WL;O-NLL<OWE
M965KIME::=8PK;V5A:V]E9VZ;BD%K:Q)!;PIN+-MBBC1%W,6PHR2>:M44`%%
M%%`!1110`4444`%%%%`!1110`4444`>+?`/]G_X:?LU^`7^&_P`*],O].\/7
M/BSQMX[U.?6-7OM?UO6O%_Q$\4ZIXR\7Z_K.M:G+-?ZC?ZMK^LWUTTD\A2WA
M:&RM4AL[:WAC]IHHH`****`"BBB@`HHHH`*X'XI?"_P)\:?AYXN^%/Q.\/Q>
M*OA_X\T:Y\/>+?#D][J>G0:SHUYM^U6$U[HU[IVJ6\4X15D>SOK:4KE/,VLP
M/?44`9VD:3IV@:3I>A:/:1:?I&BZ=9:3I=A!N$%EIVG6T5G8VD(=F816UM#%
M#'N9FV(,L3DG1HHH`X7QK\,O`'Q&N?!MYXY\)Z/XGN?A[XPTOQ_X)GU:W^T2
M>&O&>B"9=)\2:6=R^1JE@+B<6\_S;!*_RG-=U110`4444`,EBCFCDAFC26&5
M'BEBE19(Y8Y%*O'(C`JZ.I*NC`JRD@@@D5\I?`_]A/\`8W_9J\<^+?B;\!/V
M:O@_\*/B'XYDU!_%7C7P=X+TG2_$NJKJU\=3U.V;6$A:]M+"_P!0(N[O3;"6
MUT^>9(7DMF\F'9]844`%%%%`!1110`4444`%%%%`!1110!7O+.TU"TNK"_M;
M:^L+ZVGL[VRO((KFTO+2YB:&YM;JVF5X;BVN(7>*>"5'BEB=HY%9&(.5X8\+
M>&?!/A_2?"?@SPYH7A'PMH-G'I^A^&O#&D:?H'A_1;"(DQ6.DZ-I5O::=IUG
M$68QVUG;0PH6.U!DUNT4`86E>%O#.A:AK^KZ'X<T+1M5\57T&I^*-3TK2-/T
M[4/$FI6UI%86VH:_>VEO#<ZQ?6]C!#907>HRW%Q%:0Q6T<BPQH@W:**`"BBB
M@`JM>V5GJ-I=:?J%I;7]A>P2VMY97L$5U:7=K.C13VUU;3I)#<031LT<L,J/
M'(C,CJRD@V:*`*MC8V6F65GINFV=KI^G:?:V]C86%C;Q6EE8V5I$D%K9V=K`
MD<%M:VT$<<-O;PQI%#$B1QHJ*JBII>A:)H9U-M%T;2M';6M5NM=UDZ7IUIIY
MU;6[Y(8[W6=3-I#";_5;R.VMX[K4;KS;NX2"%99G6)`NK10`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`<IXN\"^#?'MOH=IXT\,:+XHMO#/BOPUXZ\/
M0ZW86^H)HOC+P=JD.M>%O$^FB='^QZUH&JV\-_I=_#LN+6X0/&XRP/%ZQ^S_
M`/!/Q!<_$F\UOX7>"M4NOC%I%EH/Q3N+W0K.>7Q]HNG0FWL=,\4N\9.K65I`
M3%!!<[TC0E5`%>OT4`?/OB+]E#]FOQ;XLU?QUXE^"/PYUOQAX@M]"M=<\1:A
MX:L)]4U>'PQ;:?9>'1J5PT>;R31;+2=+LM-FN!)-:6>GV=K%(MO;Q1K[#9>$
MO#.F^(]<\7V&A:9:>*/$UGI%AX@UZ"UCCU36++05NDT6UU"[4"6X@TQ;Z\6R
MCD)6`7,P0#><]#10!X;XR_9F_9^^(7CF+XF>-_@_X!\3_$&#3K32(_&.K^'K
M*Z\0KINGW"W=A9G4FC%PT-E<HLUFKNQMI!NA*<UT?B3X*?"+QCJ'BC5?%OPU
M\%^)M0\;>#=/^'GBZYU_P]INK/XD\#Z5>ZIJ6F>%=96^MYX[_1;#4-:U:]M+
M&X1XK>ZU"YGB"R2%J]/HH`\Q^%'P6^$OP+\.3^$?@[\.O"/PU\-7>IW6M7FC
M^#]$LM%M+[6+U8DNM4OUM(D>^U":*""!KN[>:<6]O;VZR"""*-,[5?V?_@CK
MO@?QE\,]:^%7@75OA]\0]:U/Q'XX\':CX=TZ\\/>*=?UFXM[O5-9UK3+B"2V
MO=2OKJTMKF>\E0SM/;Q2AP\:L/7Z*`/#]`_9H_9\\*^&/!'@OPU\&OASH/A+
MX;7NIZEX#\.Z3X5TFQT?PKJ.M:;>Z/J]_I%C;VT<%M>:II>HWUAJ%T$:>[M;
MN>*=Y%<BJ'C7]E/]FGXCS>`+CQ_\!_A1XSG^%C69^'4WB7P/H&L2^#H]/E\^
MRMM#>^L9FL[*UG_?0V"DV23%I!!O9F/O]%`')Q>`_!4'B\^/X/"F@0^-SX=@
M\(_\)7%I5FFO#PO:WDFH6^@+J:Q"Z72H;V:2Y2R600+*V[9\JXYVR^"GP?T[
MP_X3\)Z?\,/`5CX6\"1ZE%X-\.6?A31;;0O#,6LVE[8:S'HNDPV:6-BFL6>I
M:C;ZLL$"C4H[^]%Z)S=3F3TZB@#B=1^'7@O4(/#L:^&M!L;KP5:ZI;^`]1LM
M&TR&\\"-J^@7OAB\G\(N+7;H3RZ%J%UIDB6"0PRV,C6DT;V_[NOB7]F[_@G5
MX"^`OQ*USXN^)OB+XN^-_CW4O"GB'P'I6I>./#GPY\.Z9H'@SQ;JMKJ_BG28
MO#WP]\(^%M&UF_\`$UWI^F_\)'XBU^TU+7-<CT^UCU"\F5"#^B%%`&3H.@:%
MX6T?3O#OAC1-(\.>'](MDL])T/0=-L](T?3+2,DQVNG:9I\-O965LA8E(+:"
M*)23M49-:U%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7CG@W]H7X'_$/Q+;^#
M?!'Q4\$^)_%=UIWB;5K;P[I&NV=UJ\^G>"_$4?A+Q;<QV*R>>Z^&_$LL.C:T
M@3S=.OIH([I(Q-$S^QU^6_[1W[(OP,^`?@OX^_MB?"CPCJ'ASXY^`O#/[3OQ
MQ\.:IIOB#78M)'CKXI_!S3O"GCR.7P[;WB:=-H'B,>"?#7B:Y\.+`NEIX[TV
M/QG#;)K\DMXX!^B'AKXF?#[QC'XJG\+>,O#NOVO@?5[[0?%U[I>J6MU8>'M9
MTN$3ZIINIW\<AL[:[TR([M1B:?-B0R77E.CJ.:L/C]\%-5U?P%H6D_%+P3JN
MI?%)?%!^',>EZ_8ZC:^-SX*NI[+Q5'X9U*REGTW5Y]"N[6Z@O[>TNY)XY+:Y
M"QM]GF*?B1HGP&^/WB3]A/\`X)[?!OX(?"9?B;^S-XR^"/P^^+7[5%EH/Q9\
M+_##XF_$[QIK^C>$_B5'X<U#Q/XB$:W/A7QMXUU/6M9^)M]93#Q!X@M[:U\.
M3WBZ1J&L07?Q9^RAJ?B?P_\`\$%_@?XKU#X;'X6^(_@3^UWXAU;X/74NJ^'O
M$>HOJLO_``4%^)6CZM86-KX%@U&+P\^FKKWB+P#>VME%?6&IQ6$M_I-O>Z3=
MZ?&X!_7/7A7C;]I_]G7X;>+K7P%X_P#C;\,?!WC*\2*2+P[XB\8Z)I6I1I.6
M$#WD-W=QC3UFVEHC?M;"1,.N4(8^X02-+##*Z>6TD4<C1D2`HSH&*8FB@E&T
MDKB6&&08^>*-LH/YCOVS=%U+]BS4_P!OK]L;X8:K^PY^V/\`L_>(/&%QX]_:
MN_9H^/TEC:?&_P`-^(]-\.Z-X2\7_#'X4?%+1F\2Z?I^MZUILNBQ^'OA]X^\
M$7T]IJ-Y%INF+->:M:(X!_3M7!?#SXH_#SXM:/JFO_#7Q?H?C71=%\5>*?`^
MJZGH%XM[9V/B[P3K5WX<\6^'[B9`%74O#^NV%[I6I0#)M[RVFA))0U_-WXU_
M;H^+VC_LX?M77VN?&KQM\,_B[8_\%=OA)\-_A_X)\>:Y:^%/BUX.^"/Q.U;]
MG#6O#?PS/A2\NFU33=(UGPUXG\3B+28$NK:[@N]9-C=7=NKSUXCI5IX@^%?P
MH^*7Q@\(_M6_&GX=_&K1O^"O_P`<_@U\(/@C!\23/X)^(NG^-OVQ_%.F^,?A
MU8?"?PYKNH3^(=8\<:3X@\5:K?>,-3N;[Q!X;N=$DU^/48_!^@K+*`?UA>$_
M'G@WQTNM/X.\2Z1XD7PYK=YX<UUM)NX[L:5KVGD+>Z3>^63Y%[:EE$T+?,F1
MGK76U_'1XL^)W[4.D?&"Y_8U^'WQ(\:^(OA7XQ_X*+_M4_"GQ%JGQ`_:A\3_
M``"\2Z_X5\`?!SP'K'@KX6ZI^U#I_P`.?BEXNTL:_-XM\9^);G2[+0)_%OC.
M'P?)::;JD:Z=<V]Q]!^`[O\`:'^(7[3'P6_87_;0_:2\3_#GX9/X5^._Q>T:
M\^$G[5VN>+O$?Q)UZW\7>&M2\$_!CQ-^TM'X4^&/C;7]>^"OA3Q$]YJVGO8:
M7<Z[:W&BW;QW]A:1WMX`?T_6FOZ%?ZOJ^@6.MZ1>Z[X?BTV;7M$M-2L[G5]$
MAUJ*XFT>75]-AF>\TV+5H;2[ETV2]AA6^BM;B2U,JPR%7?VYHHUK_A'#K&EC
MQ#_9HUG^P?[0M/[:_L=KE[)=5_LOSOMW]FM>1R6@OO(^RFYC>`2^:K(/P/\`
MV#?@Y\,-#_X*N?MT^.?#WQ^^)GQ'G?X"_P#!/;4O">I:Q\;[OQ-H_P`7[75_
MA-^T5H3>+M?TRTUZ2P^(D5MH&E17_AJ\FT0:+X?NQJNK^';R>[OM873_`!S]
MO#P1:>%O^"JWQ:^,GA3Q7\38/C!X._X)8O\`'SX/>`]`^-&K^!-)^(OQT^$/
MQ1^(&B_"_P`!IHUSJ<'AW6=!\1ZS-HFAZMX*U&SO/#.O:IXG>XUW3+R;5&,@
M!_3/7@/QF_:H_9U_9YO_``[I/QL^,'@GX;ZKXM$K>'-+\1ZJMOJ.K0P3Q6TU
MS;6,,<]U]BBN)XH)+V6*.T25MC3AE8+^)W[#?B0_#C]K3]BSPC\(_P!H;XJ?
M&WPO^UK^Q7XG^/W[2^G^//B9K'QCTZ'X@V.D>!M3\/\`C^RN=4OM=MOA=<:Y
MXF\0^)=*;P]HFHZ=HUZ#+I]OI\O]FQ/%[Y^W=X=M_!W[4>O?M$_!O]KC]ECX
M4?M!>$?V5?#6B_$KX$_M;>&]*\6?#WQS\&=(\>_%3Q+\._$%E.WCCP'XF^&T
MVI>+I/B;X:UCQGH5[J]IJ5A;066K:4)=(TJY0`_8SP7XT\)_$7PKH?CCP)XA
MTGQ9X0\36$6J>'_$FA7D6H:1K&G3%EBO+"]@9HKBW<HP61&()5AU!KIZ_CKL
MOVD?VH/V\=7U"#PS:?#_`/9/N?#W[#7@/XE?!OP9K'[97C+]DCP!\-?$FK>(
M_&QU3]J/X96'@G]GSXPZ'\8_"6B>(M"\/K';^)M3\/VOAOPXEII6MZ9>:9XR
M@U?4?KG]F/QQX;_:;^.W[3&L?MP?M53>`/BS\&_BA^S-\/\`X:Z!X!_:,OO!
M?PBNM,\9?#?X>>(;/4_AAI;S>%]#^('AOXZ_$'7-=TW1-;;0I-1U_2]1T[0X
M+73]5MX[2$`_?VY^/OP9M=3^&6C2_$CPN=1^,U]J^F?"RW@OQ=#QS?Z#!/<Z
MS:Z!/:I-;W<NFP6MS+=#S4$:P2Y.8V`]>K^0+X=16_[/_P``O^"<?_#//C;7
M=;^+6H?M5_M*V/B7PQ?>-[CQQJOF^#O!_P"W!I_PS\.:EX>O=9UAM)M+O6?!
M_P#9DEBR:?+X@U'PY<#5+9-2L+RUM*=E\:?$&G_`#]F_XA_"+]HSXB?$WXK_
M`+2G[#O[>OB']MFVU3XE:[XD\1>#M0\!?`?7O%=A\2Y/AZM];:M\.O$OP[_:
M*TS1/A/INF^%]&T36+;_`(3&[T:&W-OI-PUL`?V$U\R_&7]LO]EK]GKQ+IW@
M[XT_'+P%\._%.JZ?#J]IH.OZHR:FND7%TUC!J]];6D%T^EZ3+=I)!'J>I_8[
M%I(I@+@^5(5_&G]B#3O$7PK_`&F_^";?]B?%#XV>)]/_`&NO^"=.O?&+XVV'
MQ4^*?BSXD0>(_B#IOACX/>)=-UR"'Q+=W%GH=_9WWC'6U9=#M=-MVMKA+7[,
MEM;P0QR_\%*]'G_9C^)?[:_Q_P##'QQ_9@B/[5O['N@?#/QI\#/C7!JNK?&*
M7Q!X(L/B!X1\`:C\#-"\-ZFOB+Q3%XVB\;:EH+>"HK"VM+GQ;IUEK$5S?S+<
M6L`!^VVI_M*?!?2_BAX4^#DGC:PO?'_C#X=>(/BYIVD:3'/JT-C\,O#8MA>>
M.-?U&PCGL-!\.WEQ=166B:AJEQ;Q:Y?+/:Z7]JDMYQ'\V>&_^"JO[`/CO1-=
MU[X;?M(^#OBC;>'?"6K>.[^U^'%GXA\8:C+X2T$1/K6N:=9:1H\\FIV>EPRB
MYNVL#.Z6Z2RJC"-@/A/_`()B^#;/X8>#OVJ;?]HV^G\'?$7X=_L\_LA?#CQ]
MJ/B%K(ZYX2^#&A_L?>#/$S7UY+:1WD%O;6?Q$\5?&07*0F2`:EHMVD]H9[1V
MD\._X)VW?@C]F3]K/]FO]C;]E#]M4?MT?LT>*_V8/B'XBUO3=6@^#>OZC\#]
M'\%:AX7M_`FLVGC_`.%WA+PW`FG>+?[;U#2+SP7XA:ZU_49H%UB-4M;*Z!`/
MZ//`WC?PC\2_!GA7XA^`?$.E>+?`_CCP]I'BOPCXHT.[COM'\0>'=>L8-3T?
M5]-O(2T=Q9W]C<P7,$BGE)`&"L"HQ_%_Q4\`^`O$?@#PGXM\16NC>(/BAJVM
M:'X&TZXBNGDUS4?#WAW4?%>LQ12002PVR:?H6EWE[//>26\`"QQ+(TLL:-^.
M7_!+#X]?"CX+_"#XC?";Q9\1--T[PEKW_!4;]O+X`?L>:/#%K6KQ^(O"6@_&
MOQGXDT7P%X)M=-AUF1=&\($^+M,TZ;%EHBZ/H(O[)H=,FM'D[/\`X*9:5'XF
M_:T_X)C>#-6EU0^#?%^O?M\:-XSTZRU/4-+L]3T>3]@GXR.D&ISV%[I^V.*Y
M5)[6:6Z@-K=I'<6]Q;SHDR`'Z-?`C]J#X,_M*P>)[[X-^);KQ;I/A/6+S0[_
M`%U-#UG3]"O[ZPO;O3;UM`U?4;*ULM?L[;4+&[LY;W2IKJU$\$B"4D5EW?[7
MO[/4&F_!77+'XBZ7XAT#]H3XFWOP?^%&O^&8KK7=%\2_$#3+SQ%INI:&-0T^
M&6"Q?3]5\)^(=*O;B]:&"WU+2[FSD<3+M/P9_P`$8/V=?@YX"_X)P_"__A!-
M%UK3=,^/'@[4->\<Q7GB_6];&HW-_<Z[X<DN=&N)=7U&WT.TNM(C5[9/#MVM
MJ3(M]'=WMT[:C/\`SU_LS?LL?LJWG[.W_!/#X6Z7J.J#XG>,/^"F'Q>\"_M#
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M_&XR17.L_$'3K+7M9>ZMM8TD)=#3[>SBB`/V\\?_`+1OP7^%_P`3_A'\&?'7
MCS1]`^)GQUOM:T[X6^$KN5O[4\5W/AZQ.H:M]BC565([6WP#+,R)),R01EI6
M"U[=7\</_!0G5/VP/CM^V1^U9^UM^SW^SBOQ=^%?_!.JZ^%G@SP7\2;GXNZ)
M\/;KP7XZ^!NH:5\>?VB[OP5X.U7PIK5W\1WUOPIK=O\`#[7H+/7O#CZ?/ILZ
M>7.CV[W7D_QO_:*_9Z^)G@__`(*@_$O]J[XEZK9?M?\`B[QO9:[_`,$]])TG
M7/C@]G:_LD:W\'/AAXW_`&<O%_PGL_#MDGA;[!<>([SXG7?Q(\66:26>E^((
M=7M_%E]8:3_89N`#^W:J_P!KM/*GG^TV_D6QE%S-YT?E6Y@!:<3R;MD1A`)E
M\QE\L`E]H%?Q_:S\%O'ES_P3S_:V_:S^&NL?%+Q?\>/#_P"U;XV\%:YKQ^+?
MQE\3:=X3_9@_X7M\.]%^/,O@WPGH][92?V3%\'8_%MQXL.F6N@:II?A&7Q?K
M6DZO8ZYIUFT_EWC&$^'/AK;ZU\&OVT?V//'G[(WB/]HGX`:1^U)9?L_^#?CO
MXT_9B^$'AZ^\&^,HQXC^/D@_:-\5^-K?0O%WB)M)L/'5CI7Q*\$6-E-IVB>(
M?'C:/!]HMV`/[2I-7TF&TAOY=3TZ*PN(C-;WLE[;):3PB![DRPW+2B&6(6T;
MW!D1V40(\N?+4L)4U"PDN(K1+ZS>[GM?MT-LES"UQ-9;E3[9%"',DEKO=$^T
M(IAW,J[\L`?Y'O`7PK^$'Q(\0?LW_`O0_P!IKX2?M?\`[-WB?_@IK'+J/@#]
MG#PO\4/"_P"SS\)-*\0?L$?%C5]:^%7@_P`;:[\6_BVOCKPCK>M:?IGQ'U30
M]#^)FLZ#X(\5^)M3T>2PT6YN%TN!W[)/PSO/AU'_`,$OOCMX1L_&5]\8?%_[
M8'[9G[/7BS4]>\;>(XY?$GPCTCX&?M4V_P`./`_B"^UV;5(X_"W@_6/`O@;4
MO#&F)8RR76JZ7816,%]JUS8JP!_6O_;6CYOE_M;3-VF#.I#[?:YT\8SF^'FY
MM!CG-QY?'-<#\4OC5\+O@Q\/_&GQ1^)/C/1/#7@;X>:>FJ>,]=NKR*6#P_8R
MRQPQS:A'`TL\/F22J(T:/S)!N**P4X_BC\):#>7O[*GB?QP?VOO@YI_[7&G?
ML)_M/V?[27[/?PW^#GQMLOVE_$_C6#P1JL'C/2_VE]3U;X[>//#G@OQA\/?B
M'!<W.B>)K[X:?#^ZU><K_P`(K''I5_;6P^ZOV]/V(/A/\)?@M\0OAS\)_AQX
MFUJR^(__``2K^,?Q!^(6F?;/&/C/4_B#\5?@+\9/V/;SX??$77;)[S4KC5/B
M%I%EX]^(5Y/J=M;"^U."]N_M,$\%DB1`']1&M?$GP=HOPZUSXJMJRZOX)\/^
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M;$Z=\+_`*'Q/^QYXY\$ZD]KKL:G4=1\:>,([[P=K>F:/<>'M;NO$FNP7DMI9
MN`?V'?$?XY?"CX1Z[\-/#/Q&\;Z)X3USXO\`BN;P1\.=/U:[2VF\3^)K?1M0
M\07&FV.\A=UOH^EWU]/+*R0Q10$-('=%;T1-<T66[M["/6-+DOKR+[1:6::A
M:/=W4'EO-YUO;K,9IXO)C>7S(D9/+1WW;5)'XK?\%==%^#FD^*?^"<7QO^/G
MAZS@^#_PB_:GEG^*'C'7+:\O="^'_@[Q7\'_`!UHD<_BR*QL[S41H=YXID\.
M6%Q=Q00Q66H?8;S4)X+.&;/Y+:%8Z/XM_:IU_3_$_P"U%X9^`WC?XB_MU>!/
MB?\`LLP:=^S1\?OB3\8OBS\!="\:?";6?@G%\"/&GAGQDW@_0?A1K?PWTWQ%
MX"\4VEWX2UC1_"VC>+_&VJ_%$:<WA[41I0!_82?%/AD!"?$6A`2R/%&3J^G@
M22QW,MG)&A-QAY$O()[5T7++<PRP,!+&ZBO;^,_!]Y)I,-IXK\-74VO"=M#B
MM]=TN>36EM9)(KIM)CBNF;41;2Q2QSFS$PADBD23:R,!_)@/V5_!WB/]A?3O
MB'_PK#Q-JWQ9^+7_``5ML/!_CW4;NX\77_BO4/@_=?\`!035D\2^$)%MI8HK
M3P/:>$5U9M2CT&2]T.'2SJES'K=Q:&=H>@/[-FE?#[PI^U;XT\%_#/Q%X4\=
M?#7_`(+F^!O"OPAU_1M'\0S7W@WX&7$WP!\33Z3X>CDO(6TSX3WFJ^//B#J>
MJR:2T.ER2>(=8GE>9"\:@']+'PW_`&F/A%\3M%\3Z_I6OS^'-.\(^,?%W@?5
MI/B#83^`I7UCP/J-EI/B*YTZ'Q/_`&>^HZ)9ZAJ6GVJZW:"33I9;VT1)]UQ"
MK^GZGX^\"Z):Z7>ZSXU\):19ZXBR:+=ZGXCT>PM=81U1D?2[BZO(HM01EDC9
M6M'F#+(A!(92?Y>/V=?@/>?&;]N_X6:)\;?@KXA\4?";2_VC?^"W=Y)IGC..
M6/PEI/\`;?Q$_9+;P3>ZQIL5GIMI?1ZFB^+[/POH>JPR2W6W4?$VC0MIVB&2
MU^3/',WQ9T_X#>&?V<_'_@CQQX#^&ATG]OGP]\.?'\7[)'Q`_:0^(6I7]A\>
M_&.@?"W]F[X>N?"OB_0?A;I.J^#[C3-3T;QAKVCVL&GZ->6FJ6WB/2-(TF6^
MMP#^N^R_:9^!U_\`'KQ-^S+#\0_#Z?&SPEX.\(^.]9\$7%]!;:BGA[QQ?:[I
M_AR2T,\B1W]_=S>'=1DETNT,M_:VAL[R>W2VOK627U'2_&W@S6SJBZ+XN\,:
MNVB;_P"VAI>OZ5?G2/+W>9_:@M+N4V'E['W_`&ORMNQMV-IQ_(/\./A]XWTG
M4/#_`(KU_P"'?B[3OVM/VE/^"&'[#OA[X(_$KQ;\*?'^LZQXG_;'TSX7>+_#
MOQ$@U+QUI_A#6[#PG\5=/T[6_#.G:]?^+=0T&;29+O3;S4;JR@LY[VT\YUWX
M%^+/$7[./Q2U']F_Q7\>?'7QG\%?L-^`_AW\7?V;_"/[(WQ?^`LD7PTTO]I;
MX%^*_C/H7B'XBW/A;6-!\<_M+7G@+P+\5_"7@'PMHFK>(OB#XLT;5/%.LZ':
M7.F&"_F`/ZS_``G^U1\,_''[17B']G'PE>0^(_$'ASX1>'_C!>^*M"USPUK7
MA9M'\0^*]>\)6^BI)I>L76IQZY;7N@7-W=13Z?%:+97%K)'=/)(T:GA/]JSX
M5>)_C3\:_@5<ZB?"OC#X(ZA\/-.U>;Q7>Z/HVF>*IOB1X=NO$>C#P;-<:B)]
M8>RM[.6UU:W%O%<V=U);`Q/%=02/^7W["_B?X"?%#_@H%XR^(W[*7P1^)OPO
M^!UG^Q/\.?"0\3>+OV;?B?\``+PQXT\46WQ9\<7;6/AV#XG^'O!6N:E<^%-+
M>WTO4[M_#4EI=W!/]F:E>6D'VVY^/OVOO^%<VO[5'_!2;X>>-/V??C-\0OCA
M^T-9?LM^$_V2=6\$_L^?%3Q/9ZUXKL?!]_%K,^C_`!PTWPSJ'PH\!)X.U;^Q
MM8\1W/BOQ7X/N;'3K>:X@EU,!EM`#^GJ/Q3X8FTM-;B\1Z#+HLEX-.CU>/5]
M/?2Y-0-__98L4OUN#:->'4_^)<+993,;_P#T39]H_=UO5_,I\)?@3\5-/_X*
M#>'_`/@G#J3ZC9?L[_!#XFZ'_P`%;$U)+VWO+!/#'C2PN_"GA7]G6%[35M19
M;=_VS(?BY\6Y-/U_3+>";PCX1BCTBZCMIM.C;^FN@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`KRGXH?%/X*>`[2U\/?&#XG_#7P!#XYSX:TO3O'_CGP
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M%?"OXFS_`!:U'X->&/#]G!H7C?Q</%&J>/;&34M4-U'?:9I\?C_6=2\8:K96
M44JZWJURS73QQ@AOYS/^">/C;]MSXN>,_AK^R%\'_P!MCQU\!_V?-*^%/[2/
MC?X0>.])^%WPM^,/B_Q?\+?`W[4FN^`O@YJFBZ]\=O#'C*6W\/0>!XCX:M$N
MK;5;&^T?1],N](BTTDW%Q[C^S+^VU^VM^W'-^S=\)=6_:TTG]B_69?\`@F]X
M*_:A\??&?PW\-/@KXPU3XP_%^^\=:Y\-_$C6VF?%G0-6\`Z9X$\+KX4D\9^-
M]*\':;I%\9/%5A::5K_AG1X89P`?U#U\/P?L<_\`!/OXV?%>/]J&W_9X_9V^
M(GQ;T3Q9=LWQ<B\">%M8UU?''A>Y;3KF_O\`4ULGAU+Q3H%]`(DU;4([O5=-
MO[*VE@NX;NQMI(/Q=^)G[;7[86E_"+]L3]JK2/VOO[+U[]D_]M!?V??`G[+.
MG?"SX'M\.OC!\//!/CKPAX.>[\<6NL^%=:^/5UXX^-6F:UJ'BC2M5^'7Q5\&
MZ+I44VFQ^&O"VHV=M-<ZA;^&?[8_C3]@[PMHWQV^(FO:[J'['OC/Q7^W3X9U
MWP?::)X:+>&OVB/!OBGQA\6/AI&;^/PPWC:?5?BUX9\/>*_A_HF@1>);NS;Q
MEIFE:?;:!)?ZO'+0!^V_Q1_9N_87O/'OB/X\_&+X2?LXI\1=&T;1/$7B[XJ>
M/=`\"V/B#2M#\(ZA:7V@^)?$GB?6H[>>RLM`O]-L6L?$&J742V7V&VMDO4AM
MXXER=$_8D_8ONO%TW[2/PA^!?[.^E_&7Q39ZGXC\+_M":#\-?!'BS6/[5\5Z
MS=>,/^$^TK65B>VU?4[S6=3FU6V\16E_'?S6<R:?::M%I`AM4_"L>"?VJO#7
MC'XU^//VJOVK_'=_^T#9_P#!)CQ!\6?B1\*;_P`"_LC7?PGU#QS>'Q_XGC^"
MFH>%=4_9XU.Y\3>"?ASJDUAHP>QUR/7O%=WX7%YK7B#4M'U.^TFX]=_95_:1
M_:$_:6\:^,?`.L_MK0_L;>&OV:OV1OV(O$/A+POX6\"_LT:;:?&SQC\=/A+=
M?$WQ;\5/&]E\4/A%XBBL/A-I5]:1_"O1/"GP4NOA\+/4_#_C&6;5=.GAT.WH
M`_5/X8?\$\?@GH'PV^-7P\^.6G:%^U!#^T/\6_%'QJ^+,GQ7\#^&+OP_J_C;
MQ-9+I)O="\(-;W^G>&#I.C(EAI-WIURVJV+F:\M=0M[F9F'H^L_L&_L5^(?A
M3X=^!NM?LK?`34/A%X2NH-0\-?#Z?X7^$AX:T7484MT.J:?8QZ6@@U2[6U@&
MIZFK_;]7\O.J7%X7<M^/7[%?[4_[0T'[7?PI^&_[7G[3_P`83\3/V@O&'[04
MG@CX3>%M&_9?^)G['_Q,\*_#O2+S5?#R_#'QO\,O`D7Q>^%4WA3P9'INO7O_
M``G/CRY?Q3JS7%GJ]B^KW)9>V_X*S_M1^//#'Q-N/A!\`OCK^TA\._C'\+?V
M<O%W[0E]X6^$OC7]DWX3?#5+"TU)[+P]XQ^*?C3]IOP!XSO/&>G65QI^H6:_
M#'P&"VKPEY-5M/-DLKJ$`_7[3?V?/V7M*^+7@SQUHOPC^#&E?&OX5_#A?"'@
M7Q!H_A/PGIOC_P`$?"K41<Z':Z%HDMA:0:QI/@IEL]3T;2;>)8])M$.MZ9I?
MD)>:M!/U_C;X%?!/XE^+O!'C_P"(OPB^&GCWQQ\-+Q-1^'?B[QGX'\->)_$7
M@74HM1L-7M]3\(ZOK6FWM]X>U.TU73-/U*RU'29K6]L;ZUBNK2>&<%S_`#M?
M\$_?'GCO]H7_`(*3_"+]J+Q_\?\`XA>%-9_:!_X(O?L'?&K6?AG!<?!9O`/B
M37O%_P`4?CQINL?#71VU7X32>)_^$4@UG3Y_B&(?!GB/1/%C>,?&>OR/XB_X
M0RY\/>$=#^A?^"N/Q[\?^'_BMX/^#WP/^+W[1WP]^,/AOX`^,_CY'8?#/XU_
MLX?L_?!VS\+0>(Y/!T/C+XJ^*?CYX4UY_B)=Z/K]M;SZ1\-_#EY9V\EMI]W_
M`&Z%LO$&9P#]F/AS^S]\!O@]JWB'7OA'\$OA%\+=<\7.9/%>M?#GX;>#?!&K
M>)Y&N9+UI/$.H^&=%TR\UIS>2RW9?4IKEC<R23D^:[.<WXG?LR_LW?&S6M,\
M2?&;]GSX(?%SQ%HEBNF:-K_Q.^%'@/Q[K6D::EU+?+I^F:IXJT#5KZPL5O9Y
MKQ;2TGBMQ=32W`C$LCN?YM;'XP_MD_M1?"_]JWXY0?MR_'_X*O\`!'_@G-^R
MK^V#X#\)?"#0OA#I>@W'Q;\4_LO>)?B_KMOXLD\4?"WQA;:EX&UOQ#I*/J_@
M&VN+":_%R6NM4N]'MK;3HO5M-_:H_;"\3#1OV6=.^+GB.+XY?MR:_P#LD?M#
M?`+Q?81::VJ?"S]GCXH_#+2==_:Z@T2^GT^]73_"7PO\:?"GXHWGABVN8-1U
MWPI:?%SP+X>MM0ET^;P^;4`_?7XG?!?]F_QU:^#8_C-\)_@CXQL_#&IZ3I'P
M]3XG>!/`?B&U\/:S=S6]CH>F>#5\5:5=Q:3J=U<):V>DV6B"WNIIDM[>SB9U
MC0<_'\/_`-DWXO\`Q,O/$Y^'?P&^(_Q>^`NK:=X4G\4W?@7P-XG\?_";6HM/
MMM;TK0+7Q'>:/=Z[X1OK?3;^TU*ST^QOK*2VMKR"XCCC69&;X/\`^"OGPKE^
M('PE_9&TS_A=7Q@^"FGZ+^W;^RW9ZO\`$?X7^+=`\,:]H]AKOBF;PM%XAU77
M/%7ACQ1H%M?:7JFI:;>Z'JFIZ6;:W\42:>)8[J.[?3[O\N4^)GQUU/\`:3U/
M]G7X;_M9_%OPMX6\:_\`!2_PY^S_`*C\9O!%W\,K[XF>*?AK:?L(:3XDN-6O
M/$MQX#U/PAKOBGQ!K>G'Q%/XHN/"UU%;Z]=MJ>D6=E':V%K;`'],FE_L]?`+
M0_%FJ>/=$^!WP?T?QSKGBQ?'NM>,]+^&G@O3_%FK^.DM=8L4\::IXBM-$AUC
M4/%B67B+Q!9KXCN[R;6%M==UBW%X(M3O4G9I?[.O[/NAZI\0=;T3X%?!S1]9
M^+5G=:=\5=7TOX8^"=/U3XFZ???:/MMC\0;^TT2&[\9V=Y]KNOM5MXCEU*&X
M^TW'G(_G2;OYW]*\5?M>?!>7]DWXZQ_MK_M*_&N76?\`@I+^T-^PE??!7XBS
M?"RX^'OC;X*_![]IC]I3]GWPK?>*(/#/PT\.Z]KGQQU^S^%ND>(M<^*#ZQ;V
MTVLZB;/3O"&G:;ING00Z7_!//]KS]J[X_?M"?LM^-_$GCOQ1867Q3\<_M)>"
MOVH?A=\2_CI^SQ>^%=.D\/?#_P"(WB;P?X8^!?[//AO78_C=X&\6?#3QQX`\
M/:==7?B/1#<7WPZU+QMJ?C*.]OI-'U730#^DBW\#>"K2]\,ZC:>#_"UKJ'@O
M1[CP[X.O[?P_I,%[X3\/W=O96MUH7AFZBM%GT'1[FUT[3[:XTS2Y+6RFM["R
MAD@:.U@6/R#X@V/[*Y\=ZCX^^).B?`_5OBS\$OAW=^/KSQ!X@\/^#/$?Q;^&
MGPO9M9N)_$MH\MAJ/CWP]X3OI]"UY;>[TZ."PU6_TK4K:S^U7MK/$GYC?MY?
M%GQ/J?[='PA_9G\>?M4>./V,/V=-8_9A^*?Q>3XE>!?'7A7X7ZMX[^+/AOQ)
MI6DZ?I-QX\UM+NX_LCP1I%TGB"Z\#VW]D3>*)IU6]GU/1OM%BWXY?"OQ1X@^
M-/C+QY\??VK_`(Z_%+X0_'+XZ_\`!#KX9^.KG19_B7IWPKT/XK>+O"FH?'3P
MGKNA:?X#N]%TNVDTC5(F\._$'6/`FCR>7%XA^)6IWNGV%A9WB0T`?T^^$_@O
M\*?BY\;?"'[=OPI^(.KW6C?%?X#Z1\._&6A6=G;W7PZ^._PMBG\0>)_A=JFO
M:-KVG0:IIVM>#-1\9^([K1M3C6"6ZT?Q!J>AZKISPS1R0>OZM\!O!^F_#_XC
M>#O@MIGA?]G_`%OXBZ5JEG=^./ACX%\*Z+K.GZKJMG_9\GBA;6PL=.M-3\0V
M=L<Z??ZG]H>VN8K:=A*MNL3?R>_#3XG_`+77[''P/\&:1\"?CM\=_C+K'CG_
M`((3_$?]IO1_!7C_`%WP[XDT#X?_`!D\`_%G]G#X?>'O&_PH\*?\(>VC^%--
M\%>!/B7XENY/!<%AJ&A:\=#L)K^U?5KC4]3OX]2^(?[57@[P]H^E_!C_`(*!
M_$!?#'QH\8?L<:)#K>K?MEZ1^V'\:?"GCCX@_M4_#WP-K_Q+\*6FK:&-+\$^
M#=:\,^*+NP\1?"/Q/IM[\.]0NX8M)M_"%CI'VRQF`/Z1/A[^P1^S#\`-,_9A
MU/2;+^PO"7[#_P`./'>C_#1-?U:VB\.:)<^+[%9_'_Q8\6W>I%;>X\8:BG_"
M2:YK7BF^N(!%?^)?$6LRR123M(GNEQ\=_P!G36?BQ\)?A:?&W@GQ-\5/B/X!
M\8?%OX/:;IUM_P`)1/K/P[T!-(T/Q=XX\.>)=,L=2T/3]":+Q7I.DOJ+:S8I
MKL6K"RT\ZC&;B-/(/$?[..H^`/V(?C%\"I?CS^T=\5]6O?AK\6W/QB^)/Q`T
M_5?CG?WWB&PUW6D@A\7>&O#W@W3-/@T^6X71-!LM&T31X-+T*.#3;=XC']JK
M^=3]G/\`9N\&_$WXT_\`!*SX1?#_`/;)_:;F\+:_^QK^W%J/Q+\5^$/VO_%?
MB7XV>$_$L<7[#E]JWP>\+_$UKK5/%?PB\-Z1?-X*\60^&_!<G@[5%6/5](NM
M3N_#=[J6@7(!_8#9V5GIUK#8Z?:6MA96R>7;VEG;Q6MK`F2VR&W@1(HDW,6V
MHBC))QDFN6A^'7P^M]9N/$=OX$\&P>(;O48M7NM>A\,:)%K-SJT*ND.J7&J)
M8K?3:C$DDB17LD[7,:R.JR@,P/\`'%X^_:P^*WB']FWP9X"UCXU_'-/BO\(?
M!'[5Z:5\:/$'_!07XM?LJVNI^$_@W\??&GP]\$^(_%%M\-(-6\2?M1?'K9X6
MTK3+[0-7\.:OH.HZ/?O/JFEV%[JL.I)Z-?\`Q=_:1^/?P_\`$_QK\0_M9?M/
M>"M>^&'_``0]_8$_;7TKPS\)?C!K_P`-O`NO_M"^*O"7Q$\4>+/%GB[P]X=6
MW?6],\67EK'9^*?"XOK3P]XBTY+6/6-.O+K2]&N]-`/ZYH_!WA&&[COXO"OA
MR*^AU+5M8AO8]#TQ+N+5]?MWM-=U6.Y6U$R:EK5K));:M?*XNM2MY'AO)9HW
M93)X>\)^%O"-K/8^%/#6@>&+*ZNI;ZZL_#VC:=HMK<WLYS/>3V^FVUM%-=3'
MF6XD1II#R[DU^9W_``4:^*7C;PS_`,$F?CC\7?#_`,1?%GPO\?6_[-FE>+[+
MXC^`M8N/#GBGPSX@O=%T6_EUG1=9AN8KC2YH[FYE;[2LERT4+/OMKY=UM-^&
MWB?]H#QQ\*W_`&B_$W[.G[:O[2?[1?[*W@B/_@G3\8/B1\:/%WQ_^)_Q/A^&
M_P`09_VN?AUI/[0?@.W\<6\^D/X>\`^-?@_?ZSKOQ+\$>!-2TGP3X3\-6EYI
MKZ!HNFZM+:V0!_7W9^%?#&G6.KZ9I_AS0;'3?$-YJ>H:_I]GH^GVUCKE_K8(
MUF^U>T@MT@U*\U<$C4[F]CGFOP2+MY037PQ\;_V`=-^/.NZKIWBK]H?X[:%\
M`]9D\&1:A^R_X(U#P5X5^$$FA^#=.T^T'A.%-.\'KXHMO"WB.]T^/5?$FD0:
M^D-]/++9P-:Z8YLS^(O[0/[4^M_M7?\`!1V3X?\`[,'[=/QC\.?!36M6_8D\
M"MK/[.7Q,OO[#M-0\::O^T+%\24\,:9J=CKW@&;5M7T:P\/V^MZPWA_4?+>R
MTZ[28ZUX>T^33N7^*GC76_V4/VN_B-X'\<_M2?M9_M->`='^)O[-?P=^!>C?
M"S]O7XVZ+^T7\!-6U;0YGN](^*?[-.L>+=-T7]JQ?&_C;5'\3^./B=X@T7XK
M^9X!\^PLXO"5AX4LO#5@`?ULV.F:;ID<T.FZ?8Z?#<W,UY<16-I;VD<]W<8-
MQ=3);QQK+<SE5,T[AI9=HWLV!63IG@[PAHNDZCH.C^%?#>DZ%J\NH3ZMHNF:
M'IEAI.J3ZM'Y6J3:CIUK:Q6=[+J47[O4)+F&5[R/Y+@R+Q7\RG@+]NB;Q-\/
M/^"3?PHM/VD/'_BC]H[3?VT?%GAC]I_P#I_Q)^((^(6J^'_!_P`/OVG->U7P
M-\8H[!I;_7I/M6@^#[GP_P"#?&>I_8O$-]I6E6L.G:C803W&F?F+_P`-W_%3
MQ=X<^,?Q._9^^)_QL^&FA?%7]@S]K7XA7O@*X_;I_:G^/WQ:^&_Q)\$:[H%_
MX=\8?$+1/B;=#PG\`?BAHE@M[H%GX7^#&IP_V7I6Q+QX[*RM-P!_<)XR\3_#
M'X*^`+OQCXQO/#?@#X<?#C2EN[G5KBS@T[P]X-T2T@&GB>-+.V\C1]-M+2;[
M(6MX8;>VM':)O+MRPKMK;5-/N],@UJVNX9]*NK"+5+>_C?-O-I\UNMW%=H_>
M&2V99E?'*$&OY!?^"D/P*U[X+^%&^%_@[XO_`+67Q:\/_M@?\$T?VKOB/\</
M#_Q5_:1^-_Q-AU[XM_`:^_9?\0>"_B[X>TR?Q=!8^"?&,^G^+KGP-K]AX0LM
M&\":EX$TK0O#5OX,LEM9Y[W^@C]EKPK^SU\0OV#K;P5\%_'GBSXG_"7QM\,O
M%/A?6_$T7[07QG^)7B^YUG7_``U/H_CO3--^,_B;XB:_\6-!U;3-1N;[3],.
M@>.-,OO`]S%!#X2DT%]/LA;`'VIX"\>>#OBAX,\,?$3X>^(M,\7>!_&>C6/B
M+PKXGT6?[5I.NZ'J<*W%AJ>G7`"B:TNX'66&3:-R,#BM[5-4T[1-,U'6M8O;
M;3-)TBPO-4U34KV9+>ST_3M/MY+N^O;NXD*QP6UI;0RSSS2,J111N[$*I-?Q
MA?L9:-^SI9?#[_@G9\!/BM\2?BSX4_9;\1_LM>+-1_:?T,?'[]J'PY:7'[:7
MA?3/"OAC3?AYX\\:Z+\3=.\3>`#X-\+VNMSZ!\)=&U3P[X&L=1M!<VOAV*[T
MZQ,/[.?L':EJGQ0_X)3_`!%TK]L'7/BE\0OA%_:_[5'@3P[\1?&;>,YOC%\3
M_P!DC2_B5XXT;X3>.-=DO(C\0+OQ'>?#(:;:Z7JFLI>>+=?TO2M(\0:_<:OJ
M^JW][>@'U/\`!+_@J%^R%\?_`(J>&/A#\/\`Q1\0H_$/Q$NM>M?@]K_BWX+_
M`!8\%_#OXX?\(MX=U[Q?XBN/@_\`$;Q+X0T[P=XWMM)\*>&M7\1RS6&KH+O1
MK8W^FB^@W.OZ$U_(AHG[5_[37P6T#PW^RS^PM^T_X+_X**_#+5_V7?VKKSX=
M-#\$M1^'G[3?[)[?#C]G[Q9K?P#O-?\`'NB2O\/?%^AW?C72O#GPN=]>\!:#
MX[U?Q)XGAE@2^&GG2[WQLZ[\:O#7P+^,OC3]ASXX:=I,.J_LC:99_$3P?\#_
M`-J+]L;]H;XYZH;7XA^"[?6?CS#8?&WX)^$K'X<_'O0?!%W\18=7U;PM+HGB
M/4M2&8-#GFT33+>W`/[!_'?QC^&GPR\1?##PGXZ\5V?AWQ%\9_&,W@#X8Z9=
M6NI3S>+?&%OH&K>*)M#LI+&RNK>UN(]`T+5M2,VIS65H8K*2,7!G>**1_P`/
M/BIX7^)UQX]M?#</B"&;X<>/M=^''B-=>\/:IH`?Q#X>,'VZ;1FU.W@&M:',
MMS%)I^NZ?YVFZA$QDM9Y$!-?RS?M.?#'_@F3<ZC_`,$\_B1\-_$_B_Q7^SSX
M!_:GTW2/CIXLU/XU?M.>,O"/@FS\;?LP>)YX-3UC6O$OC35-5T'Q/XK.F?#B
M3Q!XAL;N#6YM3_LU[V]MM8U[76U;6\+>+M,'Q+U&R_:%\7^.-/\`^"=DG_!0
M_P#;EM/&VNWOB?XJV.C3ZQ:?#GP-I?['_A;7?%7AS6[/Q?;_``RU&QUSXJ:Q
MHMM>74WAJ^^(V@?#N[O63Q'9^'IP`?UF5G:QK&E>'M(U77]<U"TTG1-#TV^U
MC6-5U">.UL-,TK3+66]U#4+VYE98K>TLK2":YN9Y&6.&&-Y'8*I-?R1_LI?"
M+Q;^TQ^T%^QG\*_VC[[XW_$']F_1M(_X*'W?P4B\7^,OC/X6NO'G[/FB_$+P
M+IWP%A^)NIWGC(^-/'FDV/AO7-8T?P^WQ(US4KWQ!HNA>']4O()396)B_<+]
MA+PGKWQ?_P""8/PO^&GQ*USQ>VI>,O@EX]^$>M:YXEN]2U;QI9:))?>,OAWI
MTVHZAXEEN=7U75])\-PV$27VO7-WJ-_):17.IW5W<33W$H!Z1\`_^"BG[+?[
M1_BX>"?AYXK\26>M:A\/-9^+W@^3QOX&\5>!](^)'PI\.ZY:>'=>^(OPYUOQ
M%IMEI?B[PMI&J:CI*7]WIUT;F&RUC2=5^R'2K^"];C+7_@IU^S_J?PT\"_%C
MP_X-_:!\7^$_BEXN\?>%_A>_@7X,^(O'M_\`$#3?AO.T'B+X@^'[7P9)KJ1?
M#B4(9M"\3ZY<:.OB")H%TFSNI[NTAG_G+\6^#OCY\1_#,'A?X'_%;P#^T7\/
M/^">7_!,O_@H=\&],^+WPT^%_B[P-=0>,OB;X,^%O@KX<>!_%0\67^K:'XC^
M)5Y;_#.^U+4='\*:<NBZ3%H6HZA/,YUBPT^S_<C4OVB_V7_A?^P!^S3X!LOC
M=\1OV;?!OQ;_`&8_`FE?!_XQ_!#P5+XGUWP?IFF^"/#9V>'M6UGX?_$WP]I?
MB74(PFB1'Q%H5SKE[>ZA.^CW]CXK^PZU8@'TG\/O^"CO[,'Q13]E'5O!'B/6
M]9\"_MHZ3KES\!_B@NDV]K\/]=\3>'8+Z;4OAKJVJW>I0ZCHWQ(672-=L8?#
M,^D2&;4]`UC35NQ>6GDR?=]?RX:II?B/PW_P1$_8+\#>(_AU:?"WXM)^T5\`
M]"^$7@K3=`\1>'?$&KRZ)^U#J<O@KQ]!X>\3ZWXG\56/C'XH?":SA^+GC)-<
MUO5-3.K^,/$%UJ=QYLDJI_1Y\+OC)X'^,1^(3>!;K4M0MOAG\3?%OPC\27]W
MI-]IVGR^-O`EU%IOBVRT2[O(HXM:L]"UIKK0+[4K`R6D>N:9JNG"0SV$P`!Z
MG17\DNN>&_$]E\?;J_/@SXEW7_!3.]_X*T?#W6-!\=7'AGQA'JZ_L._\)[H=
MKXGT71OB#I^DR>&+#]GR;X$1>)X?%O@^WNY/#QU0G6'\/3>,XK"_3](O^"'O
M[+/@KX9?LOZ1\>M:\(>--/\`V@_B3XP_:=\,^+]>^(/B7X@ZGJ^G>!=/_:^^
M-5]X8\(>&?"WC#6;K1_`?@V6&VL/%=MHWA30]#T_5=3U>\\3S+>7>M3WDX!Z
MYXL_:!^"/[,?C+XR?&[P9^S]^T5X^_:-_:@_:+TW]G"/X>6_AJVL?'GQK\7?
M`#P%XJGT&Z^&W_"5ZQI6@VOP2\-?#[2/&7BK2_%SZE8^&FBN-:U>98]8UN\:
M[^XO''[1/@7X5Z'\"M2^*L.L>!-5_:`^(?@3X1>#_#5]:)J6J67Q1\?>&]<\
M2Z;X/UF729KJPMKBRMO#6NVM_J,-S/IJ75@1#<2QS0R-_.'\/_V/_AQ\;?VK
MOAI?_'O]G71_B1:Q_P#!:7_@J"\]U\1_A;:^(;%OA9<_`OXY^*O"4U]JNO:;
M-*G@:;XA:3X/UCPQ"YD\+ZGXDCTZ\MG.IP:>)_N[_@L_\!/@MXE\%?L#>._B
M5\#O#GQ*^&_P%_;D^"\GQ%?5/ANOQ,LO!_P!U'P;\0_#_BR#6_#YTG7;F^\#
M7.O?\(!:ZW92Z=?VKW,6DSW4)$)E4`_3_P"#O[2/A'XT?$_]I;X5^'M*UBPU
MK]F#XD>&_AGXRO-16`6.K:QXF^'/A;XE6=WHIB=I&LHM'\5V-K,;A4D%Y#.%
M4QA6/HW@GXC67C2S\87\GASQ=X+MO!OCKQ7X%NI/'ND0^'5UI_">H?V?+XL\
M.LU]=1ZCX*UUO]*\-Z[(]J=3LB)VL[8G97\KMU^S?\.=3\5_MW?M,_"/X(ZG
MIWB'PY^VG_P3PO/V5?%.C^!/$.E2>`_@Q>_"?]E;2+M?A#X5N[>STWP!X>7P
M9/>>&O%,O@_0M,NK?1K&3PWKV;32/L5GPGQ1^%UH+CXE?$'XLPZ)J]AX+_X*
M6_\`!5G5/#G[/7[2?[/?Q7^,_P"S;\<]-\??$GX;Z?X8UOQ)IOA-+NTT/Q?X
M=CA63X*>+=5\)^+=/CL_$GC;4=!@@>QFO$`/[(**^=OV2&NV_9G^"37_`,,%
M^"]VWP]T$R_"J/4-4U2W\"9M_D\/65[K21:K)IUG'L_LV*^A@GM;![>T:WMQ
M`(8_HF@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`*^1?CM^Q?\`L7_M">-M"\5?'_X$
M?"#XA_$)](NO#FA:WXPT;3G\4:CH<$EO>WFBPW(EM=0UG3K9X[6>:QE-Y!;*
ML):../:*^NJ_B^_X*S_M/ZCKW_!0#XE_&WP/X1_:#\4^)?\`@E=I_P`!-)^`
M.K?##X"_%SX@_"__`(6GXE^(GA+XO_ME:?\`$GQOX:T&[\)^%5F^`^F>!?`$
M[ZMJ5C&-*U34[JZBETF:&]NP#^NO0/@7\'/"GBGPYXV\,_#3P;X?\5^$/A^G
MPJ\+:[H^AV6G7V@?#B/41JZ>"]*>TBB2R\/+J@^W_P!G0HL)NLS$%R2?$/%/
M_!/G]B7QKX$^&GPR\4_LQ?"#6?`/P<TFYT#X7>%KKPG9KI?@;0;Q72\T3P_'
M#Y4EGH]VDCK=:8)&LK@,?.@>OQ4_;-_:Y_:@\=?`#_@HI^V%^SG^U'XD^#_A
M']D?X>^!M=^#'P^T'P7X*UK1/'6G^)OAYX9^(T?BSQO=:TNJ:JTWB&R\2VUO
M8VUG/9Q:;:V[R0QS23&2MG]H/]KO]MCP/\0?^"HOQ7\(?&EO^%<_L=_%'X)?
M"OX8?!>W\!>%[O3[F]^-GP,^!FJ7/BOQ=XNU6YL[F+2O!_B7Q[K'B2SM9;[3
M-/FO98H-9U6VTM"R`'[6:G^PU^Q_K7Q5T7XX:K^SE\)[_P"+/AY]!ET?QS<>
M$]/?6[*?PM9C3_#EV'V"WFO=$L@MMIE[<V\UW9Q)&L,R^5'M\W_:&_82\%?&
MVP_9Y\$Z%>^'_AM\(_A#^U/X6_:H\>?#_2?!-EJ2_%/Q3X'N]8\6>&M+_M&?
M4K:V\-1R_$R[TCQAXEU!M)UV77;;2IM&$%BVH-J5O^'WQ0_:X_X*?_LD?"WX
MMZ]XBT;XU:UX'^(GAOX">&?A#X\_:$G_`&=X_''@SXT_$_\`:8\._"[QJ=$N
MO`'C*\\,GPA=?#CXD:%K_@>X\6J-"\->*M$M-"UO6[R#6+&2XW=,^,'_``5`
MTOXQ_LS?LI?$+XG?$[X+:/\`&W]JCQ/X4\/?%#XC#X(>-/CCJ7PB3]F'XD_$
M7Q#H&NZ;X&GOO#\&H:3XI\-3IX*\67-G8S6\ITR[DL-0_L>2.\`/Z%OBO^RG
M^SC\<_%/A_QO\7O@SX#^(7B[PKHNO>'/#_B'Q+HD-]JFFZ!XHL;C3?$&C0W)
M*/)INJV-W=6UW9S^;`\<\H5%+L3R/C3]A7]CKXBW/PVO/'/[-WPD\47?P?TC
M2-`^&=SJ_A'3KF;P;H6@,C:+HND2&,.FDZ4T:M8Z=.9[.V;<8H5+N6_`GX8_
MM-?MO_"3Q[\,O&/Q#_:?\<?&7PQX3_X*)?M$?L)ZI\,M9\#^%]%A^(WPG^''
MAOQ)XL\*^./$MS9Z<FJW7QCN5MM/L%\2:6UEH.I6L%O=V^@JE^RKYS\/_P!H
MS_@JOXS^`?A']N/P_P"/OB3?^`OBIX*^('C/XI6&O:Y\#A\&?AWX+U7P%XXF
M\+3?!OP]I,:^.-&\:^!?',/@S3+BR\0ZAJM[?"V\00ZII2:F4L4`/Z2?AC^Q
M7^R3\$?B/XA^,GPI_9]^%?P\^)GB2/4QKWCGPWX7L-,URZAU:X%[JX-XB[;*
M/4+A1/?"S6V6X*YFW*,5T?Q._9<_9M^.OBCPE\0/BS\%_AI\3/%G@VSO;;P?
MXH\5>&=+UW4=(TW6(@+ZUL;VYAE\S3[Z-@TEM(9K63(D6/)W5_.?\0]>_;,^
M'OP[_9^T'QS^V[\6OBC8?M^_\$XOVFO%OC!M0T3P7X>N/A3\0?A5^S_X$^*^
MD>+OA9-HFAPR:;<ZQ;^*=2\,^(+;5)-1BO(;A]3M?L5W%`$_7W_@D)X`\9>#
MO^">W[)>M^-/C3\1_C)>_$?]F7]F_P`=VDGQ$N-)NI/!-KKGP2\$7?\`PB7A
MVXT[3[*ZGT2Q>8^5<:S/J.K7$@::[OII78D`^FO"W[.?[*.LWOP:^)'@SX5_
M"?4KSX'^'&\&?`[Q?X<TG2+E?A_X6TY;K1_^$<\&:GIQ>"QTC3L7EE%86SM;
MV4PN%B2*;>:Z?XJ_L^?L]?%C6_"_C/XR_"KX;>.=<\%300>%=?\`'7A[1]5N
M-$>\OXA;V5G=:K"Z+#>:G-`(]/D,EO=7TD`$$D[1BOY3?A;\<OVO?!O['O[%
M7QHF^)?Q?\%_L9>"OV:_'/B/XV>(?V3=-^#[?%+P#\5[W]I/Q#;Z-X\^+?PY
M\7)I-EK7P(NOAUX:UW0M+M_!=M:ZM_PE$/BF^GCO%LMUO^NO_!;G2+SQS_P2
M_DU;0_B/XV\.?9/CC^P/XDA\1>$[FRT+5_$D.K_M=?`/0K*74C-87HL_LMYX
MEL?'.GI9+!+8^+?#?A^X\R6SM+FRNP#]8-'^"OPD\/Z'XA\-:'\.?!^E>'_%
MOA;2?!'B;1K'0[&WT[7?"&@^'Y?">B^&M3M(XA%=Z+I?AJ>;0K'3Y5:VM],E
MDM(XUA=E/CND?LF^#]*_:MTS]IU+JS4^"OV;=(_9Q^%/@.RT&RLM,^'NCS^-
MM5\6>/-;T_4DE>:9_%EE9?#KP[9:9!::?;Z%I_@Z^/G:E_PD/EZ7^"7Q<^)_
M_!1/Q?\`$3]L[X,?L]?$']H'7O&W[%>H_#CP5\-?%<GQ4^"/@3PMXFAE\!:'
M\2M1^(_[0>D^*_#7]K^*M)\3W6HWWAR[U/1E\.Z+;Z5HFHC3[H7D5XT//?%G
MXT_MMR_"S_@II^T/I_[9_P`5_"-[^S[^W?I/[,OPJ^&?AW2O`,W@CPGHFO\`
M@?\`9,U;5M5>[NO#UWJGB`VE]\3]>.A6-W>?9+$R7MQY]T-3*6H!_4EXY\!^
M#/B9X6U3P1\0?#&B^,O".M&Q.J^'/$-A!J>D7[:9J5GK&FO<V5RCPR26&K:?
M8ZE9R%?,MKZSMKJ%DFAC=?(/`OPP_9;37]3TGX=>#_A$WB;X4^+M'U+6=.\+
M6/AZ76/`/C=?!MOH.AW>J6M@'NM`\0GP*;;3;![M+>]?P^8HXMUJRY_G1_:?
M\8_MI_LY>-?^"C5IX?\`V^?C_P")[#]B/]F'X$_M2^`K+Q+IOPWDA\7>/?B?
MKGCFTUGPOXS-GX1MY+KX86D'PVBCLO"-B]I<@>(=5,FN$I:F/?\`&WQ2^.^K
M?MM?%#X-_#;XS:Y\#;7XL_\`!5S2/@QXL\8_#+PI\/M-\8W_`,.K']BVP\<K
MH]_JUQX6FGUR\BU>T=M-UOQ"^JZMI0FC2UNOL=K#94`?TM2_"GX:SVVBV<W@
M7PO):^'/'.J_$W0;=]'LVBTCXAZ[XAUCQ;K/C33T,6VU\1ZGXG\0:YKU]JL0
M6[N-5U:_O))&FN96;EM*^`_P`\/?%:\^+&C?"KX8:/\`&;7+2\FN_'-CX6\/
M6?CK4+0P6VEZE>#58K1-5<2VT]KIVI7T3B2>"XBM+R=X[@1O_.KXT^/?Q->Y
MT']@V3XS_M*_$[XXC]MG]L+X7_"*[\-?&/PM\$-6\8_"KX2^%?"/Q9LKCXY_
M'VY\$>*K9_\`A7&C_%;1-/M;'P_X9L?$'B:#3K33);'S=(U.>3S[]AK7_BY^
MU%XQ_8Z^-/QM^/WQ)M?B=\.?V;/^"LWP_P!9\0_#7XG>';[1/%6B?LT_M<?L
M>Z#H%AKGBZ/P>L/BO3_$%GK*6GC76K*VT:7Q&OAOP[<VPTB:SNS?`']/_P`5
MO@9\&?CII>G:)\9?A;X#^*&DZ1J$6JZ58>.?#&D>)+?3M1A!$=Y9)JEK<?99
M@&(9H2@D&!(&``'G?Q,\%?LF^.?BI\*_`'Q9\)_!WQ1\7K3PYXK\5?!_PSXR
MT3P[J7BR#POX9;1=*\8:GX-LM1MI+H:5I!U[0[75UL%\BW2_M/.C",K#^9;X
M)_&__@IM/^S=X)_X*'Q?$:)V\6_!W]IKXE_$CPKX^_:<\+^*_"'BS6/#GP=^
M*?C#P1\+OA)^SCIWPCT/5O#7C;P!X]\,:-I5SX;B\=ZKXB31-,UZ/7%N;V"4
M1_8GP+^&^B>`?^"I'[`NIV?[47Q,_:A\0_$3]A3]H_Q]XI\3_$3X@:+XP@CO
M/$K_`+/NKVWB;P?H>CZ7I:>"O#7C_P"WW6MZ?I2K+I\UE;62:4P@L9#(`?N]
MHUQ\#KOXBZK\.]!B^'\WQ-^%_P`-]`M=6\+Z=9:.?$?@OX5_$O4M2C\/:==6
M<,'VC2O"7B_5/AGJ+66FL([#4;CPDTHMW-DCB+PU^SI\`O!J:DGA/X+?"WPV
M-8UVT\3ZJ=$\"^&M,DU#Q!I^K6VO6&L7<MIIL4DU]8:W96FK64[N6M-0MXKN
MW\N90]?AA^TUX%\->*_^"A__``4-\0^*/VL/B3^RU8_#/]@W]D/QU;:I\.OB
M%X=^'K:MJMEXH_:QL-(\0>)[G6M/OI]<T+PCJ=_::8FB0^1IU]JGC?3[;4'D
MO9]%B?X^\#?M1?MZ^)?`'P6^"OBKXH>-=%^,'_!57X"_LK^*O@CXW^R06-[\
M*_$^G:S9V_[4NK^''O;2QL='O1\"]$OOB?HFF+;W,5WK6L6UQ;)&EW;+*`?U
MN:]KN@>'K#[=XEU;2M&TR:YM=-^UZS>6MC92W>I3+:6=D9KR2.%Y[ZXE2VM[
M<L7N)9%BC5V8*?&/A9;_`+-3^,OB-X;^$&@_"RR\<?"'Q;+HGQ'L?!WAC0-*
MUOP=XO\`'OACPWXUNK?4Y=/TVUGM[[Q/X9U3PUJE]-#*ZZA;BS@NI'ET\P6W
MYM_\%SO`>F^(?V$M'AO_`!)XIT&V\+?M`_LS3_:M"\13:-]L@?XO>#](N!KE
MRRRF\M8;:XDO4,\BM!?0PWIE\R')_,#XN_#GQ/X$\:_\%S/C'\*_VJ/VC]!O
M_P!D[X6_LR?$+X4W'A?XGZ9-H_C'Q?X:_8C\)ZO:^+/B;=?\(_>M\0Y=571=
M$L;Y'NK*QN;"P95C\RZDE4`_JDO?A/\`"S4FTY]1^&G@"_?2+N\O]):]\&^'
M;IM+OM1N&NM0O=.:?39#97=_=.]S>7-L8IKJX=IIW>1BQ\_^+_CG]F']F_P#
M>^/OCGXB^"WP6^&8L?#_`,.;_P`5_$6Z\'>"/!YTN5I;#PMX'NM4UO[!I;::
M6EGM-#\.22FT4R2P6-F-[J?YRI_VD/V\?CO\5/CIXI\/_$'P?\*=5^`?[1?[
M,ND>$?$/Q$_:0T/X$?"JV^&^M>'_`(>>,?%&@>)OA!X@^'>JO\0[/XOZ!K7C
MS3=#URV\9V,E[K"Z9'HDL#:+.K_I-_P6YT_4M6_9<^"^G:3XM\'>!-4O/VTO
MV8(;/QC\0-$TOQ+X)\.W#^+KS;J?B30M;N;/2=5TJ`@F>TO[J"VD!7?(,"@#
MZ>\3:]^RA_P4V_9F^./P1^"G[1'P^^(W@/Q1X9G^&OB_Q7\!_&G@_P`;R>!I
MM<L?.T^%_P"RY]8T>SO1:P?:+/3=4MGM;FVB9)+66VWH?J_PU\+/`/A;P=)X
M%T[PAX57P[?6(L_$&FQ>%O#MCIOBB26U2UU&]U_1]-TRST;4+G5PK2:EYE@(
M;AY9%,0B(C'\_P#\7M-^+/AKPW^PG\([?]L3X<^)KSXY_P#!3;PCX`^*'CW]
MBSPKX"^"GV[X/WG[,/QR\2?\*R\0P>";WQ+;?:[[Q)X,;5WUR66#5/LLUG#9
MB'^S4F?A/!>N?&/X0/\`L>?%^R_:/^/?C*^U[_@JOXR_8\\1>$O'?CE-?\&>
M(/@CK^@_&FRTK1=7TDZ5`]UJOA*\\,:/K&BZZUP-3>_MA]NGN8"8:`/Z(-5\
M,?!#X0>%=<\=7O@[X=^!?"OP\\/ZCXNUC7+'PAH6EVWAK0/"%GJOB"^U93IF
MF)+;0:):R:QJ2&U3S(&N+Z6W7S;F7S)O"VF_!KXHQ^$/CIX:\.^!?%=SXCT#
M2-?\'?$Q?#.DW&O7?A_4K%;O1KW3/$%WIRZW;VLUA=B2V03PF.*9E\M-S+7\
MB?@'XN^+M7_X)Z?LL_$>S_:\^(W[0'QQ_:+_`&//VJ[?]I3P/X@^+.G>.].'
M@Z']F[XBWUSXBE^'^FZ9;7G@^P\,ZUIVES:9K.HV.G7$4VJO:ZC>R2745NGJ
M7P=^++^(K3XT^$_VD/VAOB+^S-X)_9@_X)M_L$?$']C2UT/XE?\`"K-$\>W7
MB'X.?$_Q%\3OBKI<"L?^%F:I9?%"#0?AAJ6C3PW]MI<7A6QM7TJ9M62<`']7
MEI\-_AW8:M=:]8^`O!=GKE[JT.O7FLVGA;0[?5KO7+>VO+.#6;K48;%+RXU:
M"TU'4+6'499GO([:^O($F6*YG5XH/A?\-+9M1>V^'?@6W?6!J(U9X/"6@1-J
M@U>,1:L-1:/3U-\-4B58M1%R9?ML:A+GS5`%?S.R_'/]J1/&'AK_`()[>(/B
M-\0=(^*7_!037?V3_C?\-/B+!<ZG)XE^''[/GBCP8OC_`/;2LO#=_#OC\+3^
M"KCX5>+_``#HPU2ZM)-/U+XM^%9M-$LTEM%%YQX'^.'[7'BOXV?&'XX)^TK\
M.O!OQ.^%W[<_[2GP:L?@Y\1_CAJGA_4/'?P]\,ZWXM\,?!OX0V7[.%WIT=JE
MYXJT&+P9XK\&^*+.(WGB6>]DUL:E<Z9J0BB`/ZR;KPYX>OIK:XO="T:\N+/3
M;[1K2>ZTNQN)K71]3^R?VEI5M++`[P:;J']GV'VZQB9;6[^PVGVB*3[-#L^8
M_BY^TS^R?^QA'X-\$^.O$/AWX97GCI]<U#P/\.?`W@?6]<\1>(4T^ZL/^$EU
MK1?A]\,O#>M:Y<V&GW>L6$FO:W#HOV&TEO8I=0NXS(6K\'O^":OC/XV_$#Q-
M^PE\</$?[7?P[OM8^))\3?\`"^/!7B#]H_4O&'Q`^-'BK7_AMXDM=>\#7/P.
MNH8]+^'?BWX<>/='N=>;0/#UKIZ>%I/#^N:5>/=VT>5^B_VVO@[+XN_X*Y?"
M3Q;X8F\>W_Q%\-?\$S/VJ?B'X#\-^'?'FO\`AK3=?\?_``Z^+_P)E\$>'+ZU
MTW4M.MY_#^OZM?QVGB/1YKBWL-<S:MJ#C[+%)&`?O&W@?P4]O=6C^$/"[VM]
MJ,VKWMLWA_26M[S5KDDW&J74)M#'<:C.23->RJ]S*22\K$FNBCM[>*!+6*"&
M.VCB$$=M'$B0)`J[%A2%5$:Q*@""-5"!1M`QQ7\>D_[3/C./X!_`37_@7^T-
M\4/'_P`</B9_P34_:Y^)O[<OAJ[\8W^JZA\-O'W@[X':[K;?$#Q5I!U.9O@S
MXX\&_'VWU;P9X=\/6T'AFYDM],:R&B2RZ;=)!^_'[%'PQ\0>'OV%/"7B#1?B
M+\4O'OQ4^,O[/OA+QK?^+?B=XUO?&FL-\0-=^%=G]BNM,-^;*QTFT34[B"1;
M"QBLK61XUFN':=I;A@"MXP_X*6_\$R_@;\7=1^#GB3]HOX&^"/BC#K=EX5\2
M:7IZ1)%HFN:A>PVT6C^,?$^AZ3-X>\.W4-W<1-J,'B36+`:6L@N=2^RQ9E'Z
M%:7X>T#1'N9=%T/1](DO7\R\DTO3+*P>[DR6WW+VD$33ON9FW2EVR2<Y)K^1
MCX9?MF^#OV:/^"4ND_#?P3\9_P!C#X:_M5_`O1_BI'^V3^RY^U1H6DVWQC^/
M/QDT:;4+_4?"VA?"W4/$6DZ_XG\5?%#73!%I/B:?1O%VF:S'J>DFU^T06TZK
M8\;_`+2MR?AG^TAK.K?M#^/-&_X*E^#/^"DE]X*^"WP!;XFW%E\1;_X7VOQY
M\)Z9X'\(^'_V=K+Q/]G\8?!KQ/\``FXU'Q/J7BB3P7=R26MQJ-_=:Q816)N8
M@#^M5?"'A-=,GT5?"_AU=&N;G[;<Z2NBZ:-,N+S]W_I<]@+86LMS^YA_?R1-
M+^ZC^?Y%QQGC/Q5\*?!&I_#3P%XOBTBPN_CO\0[[X=>`=!;PU/J%AXL\>Z-\
M-/B%\:KO3KQ;'2[O3-.DM?A]\'O''B1-6\0O8:<\WAV#3(+Y]<U#1=/OOY2]
M"_:8^*5G??`:]TOXY>*[S_@J/XC_`."C?[2'P[_:$_9JG^)&I3ZU8_!7P]\0
M/CE+X0\/ZG\`K?4-8L/#7PBTGX'V/PY\2>"?'NG>%K*QUJ+4]+U*S\5>(9-0
MLGN/2?V&OBY^SK\7?&/_``1^\7R_M"7?Q0_;O\4_M1_'+4?VF_`_B#XS^*?$
M_C?PCK6C_L%?M_Z=XPL_$WP9U'64T7X9VOA?Q'=:'X?\-SP^"O#+7NGW,T6E
M76LVGVZXC`/Z#?VH/VR?V3?V+[;P%KW[37Q0\+?">/QQ>ZQX<^']YK.E:K?7
MFKW6CV5IJ&M:9HZ:%I&J7L:6EC-9W%U&L<,!B,1.[8`OL_P=^*_PK^./PT\)
M_%CX)>,O#'Q`^%WC:QGU3PGXO\'7MMJ'A[6+:/4+RPU!K2XM,1K<V6L6FHZ=
MJMI(L5YI^KV=_87\,%];7,*?D3_P5,\/_&CQ/^V)_P`$L-'_`&?_`(B>&/A;
M\4+CQI^U<=`\9>,?!H\>>'].9?@UH0=;[PU]OTPWJ2.T392\B91&P!^?C\H8
M/BA9_#_X+_L.?LV7GQC\'_!CPS\./BU^T]X*_P""@<?QT\8?$SX9>`O`W[:?
MC#Q!XD^)]UX=^*/C#X2^)?ASJW@#X9?$;Q[XO\=>-?@+X@B\3:/\//%WARZ\
M'II^IZE"]P5`/["H-!T.TL+O2[31],M--OQ=?;;"TL;6UM+O[:K)>&XMX(HX
MI6NE=A<,ZEI0QWELUX7^SE^S'\.OV7?!.L?#3X93^)/^%=W?C#6O%WASP;XC
MUJX\0:-X`77+_P#M:?PQX(COQ)-HOA*QU5IK_1M#6:6VT>29HM/^SV\<,4?\
MGGC+]H7P[H7A#P=\(?$7[<'[/WC#P9)X?_:,\<?#']I^X\>_M:R^$]6TRP^,
M.B^&4_9;_9[NO#'Q&TJ_^/7C_P`#7&JR12>.M4UOX@W>GZ7;>&=/M(Y5&MW,
MVQ\&_P!I3Q5#J'[$OQT^(G[2'@OX_P#C/XE?"C]@3PMK7[)&M_%_XK_#3]I+
M2O$.H>,]#T`?%'X+^$=)\7>'O!OQG'B275T\7?$B/7=&U;0_^$;\*>((_$>M
M65O<2M;@']6WC_\`9K^&GQ.^,OP?^-_C2WUG6?%'P-DU^]^'ND7.L7<GA#2M
M?\06#:9+XJ;PRSG39?%&GV$MQ;:3K1B%Y817,ZPR#<".]^&'PM\$_!WPJ/!G
M@#26T?03KGB7Q)+;R7EWJ%Q=:[XOU[4/$WB35;R^OII[NZO-6US5+_4+J>>9
MW>:X<YQ@#^3KX$_'/5K_`.%7[)?AF[^-GQ(UK_@KO<_\%!M8TC]J3X.0_$?Q
MW=^*M#T:W^-?C*+XB67BWX/ZEJT7AKP_\"K#X)R^$KOP!XH?POI'A/6=`DT'
M6M*U*?6;V]0?0?['<&J>"?#?_!'?]H&V\=?%/4?&_P`=_P!H;]H/X:_'+4/%
MWQB^)'B#PSXZ\$WG[.7[3_B^V@U_P]XI\1ZGX1CO/"FL?"GPEK7A4:=::9JB
MW&C3P6<6HF]O]H!_4)7R38_MO_LZ:Y9_LL:QX3\9S>-/#?[96KZGH_P$\5>%
M]+N[_P`/^)Y-)\,ZGXMN;V[O)Q:3:5ISZ1I%Z;>YN;8F6Y18/+4N&KNO@Q\:
M/A=^UO\`""Y\>?#Z37]4^&7BZZ\:^#;75+^SU;PI-XALM%U34_"&MZIX?NH+
MBTU0:/>7EGJ$6C>(--N;2>98OMMA-!(D<B_R2_L&:5^S[\2_@?\`\$1?@)HF
MIZMK'Q/^$WQ;\7>!_P!K/X<V_B_XFZ5XP^%GQ"T7X)?%6+_A'_$=@VLZ=JG@
M"YC?3+^00>&WT?3;^VA6Z!N;26WED`/[4+BYMK2(SW5Q!;0AD4S7$L<,0:1P
MD:F21E0,[LJ("<L[!5!)`J:OXFV\6_$W5/#_`.R-)^TK\=[[X>?L@:3)_P`%
M(?!<'C[XW1_%[QA\,H_BK\/?VU1H'PET#XC^(?"FNZ=JL6LZ;\`M&UA?@[K?
MQ#UV[TNZNM`U.2R:^U];:YC_`*@O^"<L5S!^R'\+H9_CGJO[2%M&/$8TCXO:
MOX7\8>$[CQ-HC>(]3DTF.WL?'EI9^)[_`$[2;-XM*T[7;\70UJSLX;^"_O89
M4N'`/N*BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"ODKPC\(OV0O@)I/QA
M^'>C#P+X1M?CCXU\9?$KXT:'XN^).H:SK/CGQG\3;."+Q;X@\27/CSQ9JWB`
MS>(-.2UA6"*ZMK"UL([:'2K6TMHX47ZUK^4CXC?`KQ7\9/\`@JY_P4O^S_\`
M!-W]GW_@H#I?A_7/V1;7_A)_CU^T/I'P:O\`X46VK?LT>#;Z3P[X3T*[^"/Q
M.37=.OT+:C<W45]HLIN;:.*[6\N)GO``?5W[7'_!#_X/?M*Z)8_##X;_``A_
M9"\!?!NY^%7@;X0Z5\6M8\(^-_B-^T3X1^&F@1Q+''X+UW6M8N]`UC7M)TF2
M^L?A[XQ\5ZQK.I^'(=6>ZBDGCA-K>?L`_P"R9^SK=1?M!VVJ_"GPYXALOVK+
MW2=1_:%TKQ0=2\4:%\3[S1/!&A?#G2Y=8\/^(;_4]#L([3P?X:T/2DM=!T_2
M;1I-.AU22!]8:74)/Q#^,'[6_P"WO\&O$WC>#X2>+_V>_`OPR^%7[7G[)G[%
M7P[^`7BSX&:AXIT?2M/_`&@8O"/@BPU;6OB1X3^+GA36M7\/_#/5?%6F7&BZ
M7H7A_P`&ZAK6E^')]/O[JV&JP7.G^EI^UG^W/H7CSXZ?LG:O\9_A)K7QB^'7
M[6'[&?PN\.?M`)\!'L="E^&W[4?A+Q-KNKV^J?".'XEBUN/$7AJ]\#ZW::7>
MV_C"WA>/4]/OKS[8()M,4`^\?!W_``3L_P""?/P-T;QGX,L_A#X2M]%_:&M?
M^%9>(O#WQ9^(OCSXG6_CO3;F*76X?AMX=LOC+XY\8-9Z3''HEUK>F^!O!BZ=
MIUBVG7VKZ=I-O)#=W([?X3?\$\/V-O@=?>$M5^&?P4T[1-8\"^/[_P"*'A+7
M-3\6_$'Q?KVB^.-1\$:O\-KC6+;7?&GBWQ#J\D,?@/7=4\*V&BW-Y/H.E:-<
M1VNEZ79K:61M_P`*?B[^T?\`'^^_:7^`?P`_:1\6>"/C/XM_8G_X*\_!2RTG
MXQ_#WP1/\-_^%D>$?B7_`,$ZOVD_C'IVC^)/`5GK'B[3-*\;>#9=3O?#6J7W
MAN^2QU>,:>4\-6%_:75QJ_>:_P#MB_\`!2'4_"?[//CKX8?'WX=Z]K7_``4:
M\"?M'P?L\_"/6?@)H.D77[/?Q3^%_P`.?%OQ7^%D$6J2WTGB'QIX1\36'@>\
M\`?$6Z\?:5J.LZ%XA\0Z/K&BZ-&&FT&R`/W>L_V1OV;["ZTR^L_A-X=M[O1O
MCIK_`.TOI=PDVK^99?'3Q3'<1>(?B-$QU(_\3G5HKNXCN[=]VE,DI5=/4!0/
M&4_X)?\`[`L?Q&U?XJ0_LQ_#^#Q7KDNO7FH6MO)XCM_`W]L^*;/7-/\`$GBJ
MQ^%D&N1_##2/&VNV/B36[35O'6D^#['QA?V]\8;G7)$@M1!^2WQN_P""Q?Q=
M\6?##0?BW^R[8"'1]8^%O[+?@SQ-I,G@_1O'>I?#7]I3]J[QF]E<:'K7AR74
MM)O;SQG\"M!\(^-=)UKX=S>+;'3[_P`2:EHC:S>QVB0&^X?QI^WU_P`%+_@9
MX3OOA!XZ@^*6MZ]\6/VF/V;_`(+_``)_:?\`'7[,'PN\*?&"VTGXP>!/C7XQ
M^*L4/[./A7QLGPW\3:K\/;KX,Z?HGPXU?6+_`$/3_$%Y\4-+M=>T_69?#%S<
MZR`?T8P?L]_!>WO?@_J2?#S0I-1^`/AW7?"7P;O[M;R^O/A]X:\3:)I/AO7M
M%T"YO;JXFCL-3T#0M'TBXAN7N!]@TZTMXRB1`5QOPA_9_P#V7_V)_`'BZ'X1
M^!_`_P`!/AFLDGBKQ5'8WLVC>$-'@TVR$`N0-7U&73/#>AZ78Q^5::7IG]FZ
M)IT.Y;.R@\Q@W@?_``3E^*G[5OQ$^'?Q-T7]K3PWXBM_%WPW^)VH^%?!?Q#\
M5_#WP]\)M?\`BU\/Y=*T_5M$\6^(/ASX9\2>)=(\)>([:2\N=&UZQTZ6STN2
M]L3=:9:BUF7'X3?MB_M+_M1^-?A-_P`%`_A+^U%\;?&/PJU+Q=\-OVPM+^"O
M[-FL?LO:+-\"OBW\+/`<FL77@'QA\#/VK?"-A=ZOXK\4V7@32K'Q#XWT7Q/X
M@FU3^U-2O[>3P+X;L=.E%D`?OYJ?_!-+_@GWXOM?AW<:E^RI\&-9M/AYX3B\
M(^!+D^'4=;;P%)XLN/B)8^$;NXAN%;Q1X+M?&FHZAXPTGPSXE?6=`TW7M7U?
M5M,L+:[UC4IKKZ`^/WA/]G_QG\)=6^%G[1VB?#S7?@Y\3;SPM\+-1\%_$.VT
MR7PIXIU7QCXBTGP_X)\*6VGWP6*76[_Q7<:'%X333A'JEAKT6F:CHTMG?V%M
M=V_X.^-?VHOVL/V([?POX=_:5_;7TC7_`(>?'W]@OXC_`!5^'GCCX;_LO^"?
M[=_9Q^+7P;UG]G_PW8VGPV\'27NK/\6-`\96?QOMK#1M!^)^J>)-2?Q#H^ER
M7&JVFG2ZE'?_`!MXR_:Q_:3^.'C?2?@+\=)?CC<Z/\&O^"A'_!%GXP>`[W]I
M?X>?LZ?#OXU0Z5\5OVO;+PSJFB^(O#O[*VIZ_P"`[?3EU3PLFM:%>^)X_"/B
M&+3]2_LG5=)^WP64^K`'[_W7_!.__@F/^TEX>^'GBV^_9@_9Z^+V@>"-+N_!
M/@CQ-=^&;'Q&AT'PGXGU*RU#P?J6LS22W7BW0-)\5:?J]I?>'?%5SK>DC48M
M1@N;-S+<K)[?X)^"/['_`,5/A3XT?P)\/_A7XW^#_P"T-XX/Q>\9'1["SU7P
ME\1/'MI:^&/#:>-Y=K26TFLV-M\.O"NFVM]8?9FL3X7T\6HADM=Q^>O^"0'_
M`"8%\+/^RE_M6_\`K77QVK\!_P!A/]I_]J/]BG]C[_@F1XPL/CWIGQU^%WQ]
MU;XR?#`_L@Z?\'?!FGZGX$TK3-&^,_Q!T'X@V'Q"T"XN_B1/#X/U'P=;1?$"
M^\2WDV@7FDZ\]SINE:/>6MCIM^`?U:^,?V9?@#\0;WXM:CXW^$_@[Q1>_'?P
M'H7PP^,$^LZ8+UOB!X!\,'7&\.^&/$"RR&.?3]$D\2ZY-IAB2&XL[C49KF"=
M)TADC5_V9OV?I/&7_"PV^#_@(>.O^%D6_P`8/^$L3P_9QZ[_`,+0M?"DW@6+
MQU_:,:+<?\)&W@^=_#<^H;_,NM)6&TNO.CM[<1?A5_P3X_;6_;P^-OQK_9)\
M6^,X?CAXO^"_[3NA?$6X^,EM\1OA3^SOX#^"/PLU&/X8>(?B/\.-8_9L\9_#
MCQ'J'Q5\3V-EJW@Y?AQKWASXE-KU]K,'BB7QG-<Z->Z'=64GK/\`P4%_:L_:
MDT_]KF\_9J^"^O\`[0'@/PQX-_9UTSXS1:U^R_\`#_\`9E^('Q-\4>.?$?C*
MY\)Z/#XCT?\`:A\5^'-%U;X;^$3;)J_B'PU\.XV\5:[%)-;7VM:):FTED`/T
M^^*7["/[&'QOL-5TSXQ?LN_`WXGV.N?$Z7XSZO#XY^''AGQ,=1^*=QH6A>%K
MSQS=2ZM874TNO:CX6\,>'O"^J732;=4\,Z/8>']1CN='MTLAQ?C+]CO_`()W
M:7X*\%Z!XR^`G[+WA;X=?LZ?$:+XM^"=&O/"O@'P9X,^$/Q"\2:I#?CQ%8:?
M;Q:1HGA9_%.LW5C=7FFS16VC^)M0_LJ2]T_4)[;3C%^%GAO]JG_@IU\5_A=_
MP4%^-GC?]IK4OV>O%'[#_P`*/V5?&NB_`7PE\%_@9JFAW?Q3\6_L._!#X[_%
MC1OB!XCU:S\?ZKK_`,.O$7COQ;XLDTGPWHWB33O$.A6FJV@7QDJ:;;Z)9?._
MQ\\4?%>/3O\`@M+\?)?C_P",Y[V7X,?L)?%6U^#VN:)\)-7\`WFH?%#X+_#3
M6;:`V.H?#QO%<^A?#B36;S3_``G;6>OV]K</:6>H^+1XCURP@U&(`_I9F_9.
M_P""<_P?^(WBC]J9OV=_V4O`/Q/M-433O%GQEM?AE\.-(\3:?XC\<ZI'HLLV
MIZ]::/'<:;XK\9:CXIBTG5-88V_B#Q&NMI8ZI>WMM=")O2O@[^Q3^QO^S[K_
M`/PF'P%_92_9P^#?BQX=8@'BWX7?!/X;^!?$_P!B\17$5WK-@GB+PSX;TW6$
MTS49(+19M-2]6P^S65A9QVR6=A9P0?S(_%WX4^+-(U+_`(+!>)]7_:N^/&M6
M'AS]MG]EZ.X^#OB1/@SJW@WQ=!XP^*G[.&J:1>77AH_#/1?&5C8^#(9;?1/"
MNK:%XJL+5+#3WU6Y&N:U;ZE/>^I^&OVP_P#@H7\4?'/Q,_:9^&UO^U-<:=\*
M/VO?B;\(XOV=M1\3_P#!.CP7^S+IGP+^$7Q5U3X<ZCX-^)/A'QI\<='_`&M;
M#XY^(/#&EW'C&;79=%M[Y=>\1:%:>#-'\0^#H/#VJ:V`?O7\>_V</^"?WQ1^
M*WPVO/VFOV<_V3_BA\:/B/+?^"_A=J_QH^"/PJ^(/Q!\2MX(\/ZY\0;[PYX:
MUSQCX4UK6Y+;PSX?TC7O%!L(+V.TTZ"UO+R)(Y7)>U\0?V?/"7BK]K/]FWXT
M>)_'VAZ;;?!'P#\4O#WP=^#9T[1M.GO?&7C6'P_8>)_&^E:@;Z#5+V/P[X+T
MC3]!M_#VFZ;+I^FP:A<:A=.IN+=8_P"?7]GSXA_%?]H;]LC_`((Q_M6?%[]J
M6_\`B?XI^.GQM_;>U*;]G71?^%<6GPQ_9YL="_8\_:2TG1O#?A[1-'\(:?\`
M$72/&&C:9;Q>&OB$_BSQCXBAU+Q+9WDT@-U!;R1?HA_P4?\`A1JWCO\`;_\`
M^"8>KVO[17Q8^`NFV'_#3OVS5/`&K>!=*T]%T+PQX!UZYBO+CQMX0\364/\`
MPE5GYFA:ZY,4TNAV2KILEA=Q2WI`/V5\:^!_!7Q*\*ZYX$^(O@_POX^\$>)[
M"72_$O@WQKX?TGQ5X5\0Z9,5,VG:YX>UVTO](U:PE*J9;._L[BWD*J7C.!7F
M>@?LO_LT>%/"7B[P#X7_`&=_@7X;\"?$#PWHO@WQYX*T#X2>`-'\)>-O"'AO
MPY%X.\.^%/%WAS3O#]MH_B3PWH'A&"#PMHNAZS9WNEZ7X<ABT.QM8-,C2U'\
MXOPB_;5_:SU;]G_]F3]OOQ%^T%\11\4?CS^WIK_P-^(W[`VHZ!X!;PUX0^'E
MQ^T'XU^!\'PPT?P>VC)\0/"_C/X:>$?!>E^/->\1S:W=Z_>WUYKMSK)EL;F"
M6+](/^"JOQ)_:-^'GB?]FK5/A-KGQ:F^"6C)\9/$/[3W@7]F+QE\&O#7[4.H
MZ0NA^%='^%OCKP5I?QDO-'T_Q5\-_`6N:CXLNOB5HOAW7;+7'U'4O`M\]EJ>
MBZ?K!L0#]"O&?[(_[*7Q&\7>#_B!\0OV8_V>_'?CSX>6FFV'@#QMXS^"_P`-
M_%'B[P-8Z-()='LO!_B36_#5]K/AFTTF51)IMMHM[90V,@#VJ1,`:[CXM?!7
MX-_'WP=<?#KX[?"7X9_&KX?75_8:K=>!?BUX#\+?$?P=<ZGI4QN-+U&X\,>,
M=*UG1)K_`$V<F>PO)+%KBSF)DMY(W.ZOY=/&'[=/[7OQYT3XFZY^QE\3/VE/
M&VG?#']FGX,^+/V:_B7J=[^Q5\%O"/C;Q3KNDWVOZUX]_:I\+?M(?%KX3^(?
M$.B:M?6!\$:Y>_#OX=7/A[3(K75-1TV(^(#!&?I7Q7^VG^U)\._B)X[_`&(+
MN^\=7_[1VI_M.^%OBS\.-2U62SN-9TW]CSQM\/M0^.&N>';K4M&FU&S\26'P
MH\2^#O'_`,`;CQ/IERT&M6=IX8NQ<7NM:G=&<`_:KX=?L6?L<_!^'3;?X2_L
MF?LS_"ZWT;QK8?$G2(/AU\"/A;X)ATKXBZ5H>L>%]+\?:;%X:\*Z8ECXUTWP
MUXAU_P`.V'BJU6+7;/0]<UC2;>_CL-3O;>?U6Y^$?PKNH]*CG^&GP_E&@^-K
MCXF:`9/!GAR3^POB5=6&J:9<?$/1P^FG^S/',VG:YK5A-XLLO(U^6RU?4[5]
M0,%_=QR_R_?LS_M=_M^^/O"O[.'Q_P!/\1_&/4K3XGP_%F7]I)_C+\8/V([7
MX,:5I&K^#/&.KV%E\$/@SX%^*&H?'WP_XQ^'7Q!L?!6B^`;/5=`T/Q*-`M?&
M]C\4/`@O;C2C*WPY\9/C?K'[+O["MEX]_:T_;.^+O[2O[6_PWU_]HE=.\%_&
MCX+_`+)7PU\*>%O"GA+PL=5M_$OQ<OO`8NK/POINN1:;;Z9X6LIO&'BCQ!J?
MB_Q)JNMV4V@V5G#:`'[??L.?\$V?V;?V(OV?_`?P:\._#?X2^,/%V@?"BQ^$
M?Q$^-+?!?P'X5\=?&GPY:Q75M<6_Q#NK&TU/4]=TV^M;N6TN-$US7]=L6MF>
M%_,C=DKZ,\7_`+*?[+OQ!G^'5SX]_9N^`?C>X^#Z6<?PEN/%_P`'OAYXEG^%
MT>G-"VGQ_#J76?#M[)X)2Q:WMVLT\--IBVS00F`(8DV_S;_L_P#[0G[6O[8?
MPB_9&L?&?[5_QK^&^I:K^Q'^W)\2_&OB#X1:UX(\/^(O''CO]G3]I;5/A9\-
MM?\`$OB&P\(7%E?7=IX<\.69UVY\-VNB:7XMO;C4KG4+.:PU*2S/J/[+W[1O
MQI_;M^(7PWT_]H#]LCQW^RGH/@;_`()[_L5?M%>&='^%?B/PK\*9_C[\3_CM
M<^/M1^*_Q)UG5=>L+EO%/@_X>W7@/PIX'O/`=E%>^%X+CQG-/JB6][J,$,P!
M^XL?[*^E7/[:$W[9.O>+[_6M:TCX`V_P!^'7@9M.:TT?P#HVI>,9O&?C[7K6
M^CU66+5=5\=7]IX5M;QIM%LY]/L?"EA;QWUU#)Y4'KK?`[X*O\23\96^#_PN
M;XOMIZ:0WQ5;X?\`A,_$DZ5$P:+3#XY.D'Q.=/C8!DLCJGV9&`*Q`C-?S#_L
MT_&K]OSXU_&#X>?'V+XV^(M*N8_VXM/^$?CKP-X[_:E^%OA_X&7'[/%E\7A\
M-_$_A#2?V6&\-P^+;CXIZ[X%=?$/@/Q!+K!\2ZAXWGTF>VO7T>[?3;G]0_\`
M@IYXK\91_&__`()Y?"'1_P!HSXD?LW^!OCI\7?C!X.^)OB7X9^-=.\!:UK>B
M:7\([W7M*TH>(]3M+R+39X=7M(KNPU"R6VU:TF1S87D!EFW@'Z2:#^SQ^S_X
M5^(NM_%_PQ\#/@[X<^+7B64S>(_BCH/PR\%:/\1=?F*:E&9M;\;:?HEOXEU6
M4QZSJ\9DOM3G?9JNI)G;?70E]+D\/:!-KMKXHFT/1Y?$UCIEWHEEXBDTRR?7
M;/1M0N;6\O\`2+75V@.H6^F7MY8V5U=V$-PEK<W-G:SS1/+;PLG\>'B/]L/X
MJ2_"R/\`9SM_VB/VF_BOXG\&?MD?MP_#G]FS]H.S_:GMOV4O#7Q;_9V^`GPS
M^%OC-OB9^T#^T>/`OC>\^(LOPQ\2_%V]^'7A>U\&^'M0@^+6N>"+K49]*G73
MK^WM/9/AG_P4"_:F^!GP(_9V_:4\?>*_&'QKE_;X_8A3P'\%O#-UXJ_M+PQ#
M_P`%"_`/B+4O"WPN\(>%]0UA=$T'0(_VA-#\5:/?WU]_9TVK>*-1^''B37['
M0FNHKC3)P#^H/3_A/\+-(F\67.D_#7P!IEQX\BO(?',^G^#?#ME-XSAU!9DO
MX?%DMMIT3^(HKY+BX2\CUAKQ+E9YEF#B5PW:6%A8Z58V>F:796FFZ;I]M!96
M&GV%M#9V-C9VT:PVUI9VEND<%M;6\*)%!!#&D44:JD:*J@#^//QMIW[:GPR^
M"W_!0+XC7/\`P43_`&LY/BM^P;\;/V8_A5X3-M\0;37?AYXCF\4?#3]G?PS\
M2]1\0^%?$_ARYM_%:>(O$/CGQ+XLTY?%-O?6FF:K-!>0:1!-)<J^_P#&'X[?
MM5?LQ_&[XX_L>^&?CU^T?\6OA'=?&7]@<>(OBC\1?C];>&OBO\.?"_[0WP?_
M`&A?%?CO2=+_`&A?$VD7%G\,/#?BWQC\(?`GA?1[F.'3)=%N/$>I0^'-1T_6
M=8AN%`/ZN]9^%7PO\1>*M'\=^(/AOX"UWQOX>18]`\9:SX/\/:GXJT.-9)YE
M31_$-[IT^KZ8BRW-S*JV5Y`HDN)W`#2R%N5\3K\!-(^+'@*Y\7:7\-+3XT^*
MH-7T[X<:QK6@Z"?'^K6^D6@N];T_PQK]S8-K)CLK*47%]9V5\@2V?S)(O+)-
M?S7>#=7_`&L/&'QS_8__`&=?%_[5GQ:\)?"GXR_MU_M)^%K(?"C]KF'XP_%R
MS^"OA']@SQK\8-.^&?Q&^-^@K<:A=ZC%\1?#MW>6$UQ</XIT/0KW3]2T;6=.
MUN'3=6L_'O-N?'OQG_8CTW]I_P#:0^-,7AWX`?M]?\%$?V;M)^,VH?'WXB_#
M+Q0_P\\*^#/#OB;P%+XN^(>C^+M'NKSQK!_PD<WA-O&5QJ$&MZ]H.E6>D7,T
MMO%)`0#^NRU\`>`['Q?J7Q!LO!/A&S\>ZS80:5K'C>U\-Z-;^+]5TNU$`MM-
MU+Q+%9)K-]86XM;406=U>RV\0MH!'&ODQ[7:;X#\#Z-K.I^(M'\&^%-*\0:U
M?1ZGK.NZ;X=TBQUG5M2BLY].BU#4]3M;.*]O[Z/3[JYL([NZGEG2SN)[59!!
M-(C?D#_P5[^*/QM\)Z5^RQ\,?AI#:V?PF^+?Q(\0Z7\;O&VN?M%^+/V8-#NO
M#7AWP#K&L^%OAYJG[0?@OX8?%7Q9\.)?B)XCBL88/$=AIE@-6DTY_#5UK6FI
MKQU"W_-SP%JOQ5O?%'[./[)/[7G[5.A:9^Q]XV^)?[6WBBR\6_`K]M?QI\0K
MF"W^'W@7X'>*/V?OV>/B#^UW>^"?@9\4M5UWPAJ?CSXI>+8-!>PTQ_&=AX*\
M(7DNK^(M-\/ZGIL8!_6%+8V4]S:WL]G:S7EB)ULKN6WBDN;-;I42Z6UG=#+;
MBY6*-9Q$Z"98T63<$4".YTS3;V&YM[S3[&[M[U2MY!<VEO/#=J4,96YBEC=)
MU,9,9$JN"A*GY217\KG_``3W_:JU_P`.?&;]F'5OC!^TYXTUSX+:G:_\%(?!
M&F^-?BG\0KO6_#GB^+X:?M!Z?:_#6Y\2^-?$NKO!KFO6G@H22>';@))JE]:O
MJ-S)=RVY6)?C_P"+O[0OB?XO?`KX&Z3%XBU<?%?P1^P;XO\`COI7Q]^,'[=7
MQI_9T^'PL-3^*?Q4T?PA;_"OX??"/PWKNK?'?XQVUI\/M.>W'B77O#.@Z#IK
M^"8)9]3L]5N5M`#^Q?PU\1/AGXD^(GC[X.:%]D;QC\'M.\%ZCXIT/^R%MK;1
MM-^(%AJ&H>%KBPE,*VLL&H0:-J*'[)CR)K&6*5595SJ>%O'WPQ\:^)_''A7P
MGKWAS7?%?PIU;3?#_CO2-/$4NI>#=7U33(]9TK3=40PJUG/=Z5/%?6R(Q5K>
M0.I'(K\D?^"57C+QO\2?BI\8/B/\1+V_U?QEXV_9$_X)XZ[XFUS4+46UQK&O
MWGPZ^)L^K7EPJ0PQ&\FN93+>!$5O.E+R*'<D_FCX^^&7PV^#_P"T'_P5P\>6
MGQ(^*WPO^*>I?M&_LH6>EZOH_P`7/B%8^(++X'_&#5?A1X2_:(\>^&?#C:U<
MV-_%X0^&.M_$+5=-\3)HNI)X`729-1TQK%='58P#^MD6=HL[72VMLMRWWK@0
M1"=N,?-*%\P\`#ECP,=*\L;Q1\+OBO=_%_X+Z/XKTW4/$?@&*Q\'?%'0-"G@
M77_`ES\0O!5KXCT6&[CN+2>&PO=9\&^(K/6=,G$%Q$]I>J_+K+$OY0_L+:UI
M_@__`(*%?M&_`O\`9W^)'C/XK_L=VO[,WP>^)ES?ZSXRUWXI>%/AW^T-?^(K
M_P`-W'AOP[\1?$&MZ_>'5?'/PRM-'\7^(_"4=U;+82V%CXDN([J;Q0LL'P/\
M:_@;H&H_M:?\%PKOP/XR\7^!/VI38?L]_$K]F-=,^('B_2==\4>*=&_9(L?'
MFI'P[X>LKB]F\5:.-7\)>(]/O(=(T?4+G1=-T[5;#1'TN>PB>U`/Z9?@Q\'_
M`(??L_\`PH^'WP4^%.@6_ACX=?#'PMI/@_PAH5N=R6.CZ/;+;P"64@-<7ERP
MDN[^[<>9>7UQ<74O[R9C7HB6=I$YEBM;:.1G,C2)!$CF0@J7+JH8N5)4L3N(
M)&<$U_(7X?\`CG^U]^U#\3?@1\0X/$7Q5\-?![_@JA\<?@Q8^!O#>A6UQI5K
M\./A=^RGXSL?BS\4'6YU3Q)HOB+P#IGQ3^&_A74?#=_JFE7C7T^IRII]A%J]
MU<7UK><O\-M9_:>\;W?ASXR:]\;?@?\`"GX^6WCG]I.Y_:-\/>,/VO\`XWO^
MT[K\-E:?%_0['X&I^S)=_`'P]\+M'DT*SL]%C\!6>B^(-%TW3_#6@:-KV@ZY
MXC_M'^WM2`/Z^/&WB;P;X!\'>(_&GCG4=*\/^"O"&CZCXD\2ZUJJ*NEZ-H^E
M6\M]J>J7FV*39!:6T<UQ.ZQN^U6(#$\W_"OB+P]XP\,>'/%OA+4;/6/"OBG0
MM)\2>&M7TXDV&K:!KMA;ZIH^IV1*1EK2_P!/NK>[MV*(6BF0E5)('\DGQ;^!
M_B/PC\./V9O`O@76OCGXUD_;3_X):_M\>)/VB--\0_$#XA^/;SXF_$WX;^#?
MV7O%OPTUR:TU;5-0CT7Q=8ZOXG\5VMA)X=M])N]0T:^OO#[1SZ0C62:VA_'B
M?]B;X$?L]>.OV0/$VO\`Q>T[]L7]C/P7^RE\/O!^D^._$7Q$T'P+_P`%)$\/
M^$]+^$UKJEA?W=Y;>#;/6I_''B"Y\<);ZSI+Z/HWPDU6.:Q@,$$L(!_6)XK\
M4:%X(\+>)?&GBC4(=(\,^$-`UGQ1XBU6Y)%OIFA:!IUSJVKZA.0"1#9:?:7%
MS*0"0D3$"O#_`-FC]I_P)^U9X-O?B#\-O#7Q/T?P?'=646BZY\1O`&L^!+7Q
MEI^HZ?#JECXA\&#60DNO^';JRN;>6'5K>-('\^-0-Q(7\R/VC_V:?VL?AY^Q
M)\;_`-GK5/'WP(^)'['G@']@[XB^%-5U'Q!X=^,J?M<^/_'WA#X,:Q?7OCC6
M?&]G\1W^'XG\5^/=-?Q/J5A%X6EE9+^XTT7$L3?-^=?A/X*?L]Z?JG[)WPE_
M:PUSQC\)OV/+S_@FAX:^.WPOM-3^*GQ'\+>%/$W[8&O>(_#7AGXN"Z\0S>*(
M;V_\6_"_X8^'O@W=?#/P#J.LVEI8IX^\=ZSHNDZI>/JMYH8!_6U17\H?P+_:
M`\:?"6T_:9UC]HSXH^)?`E[\1?\`@E=\*(?@?JGQ+U_5-)OO'GB_3-5_:*\+
MZ)J?A.75M0NVU7QY>Z???#&/5I-.N[S5SJFK:'%=2M/<6H/NW_!,SX,M\4_C
MG\$/'7Q5O_BK>WGP<_X)E_\`!+OQGX,TF^\;>.M'\)Q?$V^^#'C;2O$VO:_X
M:AU.TT;Q/XF6VO9[74AXAM=1FAEF6:YA6[6*50#^D:BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`K\X_C3_P2O_9/^.WQF\=?'OQ9#\8O#_Q*^)<7A6+QQJOPS^.GQ0^&
M-EXB_P"$+\-V'A+PW-J6D^"?$>C6%U<Z;H&F6EA#<3PR3"-&PXWL#^CE?C3\
M&?!=C^V!^WW^WU\6/B9JFLWOA_\`93U/0_V+/V:(]/UC5/#VK?!*_P#$_P`%
M/"/CW]I/XE^`[FROO+\-_$[XB77Q'T/PI#\5=(BL/&-AX!\.IX1T[4K31=1U
M^VU8`^WKG]AW]G*]\/6OAJ_\'7NHV5O\3_@S\9);K4?$&L7^KZC\1O@%-X>N
M/AEXEU;5KRZFO=2O=&G\+Z/-=/=2R-JLL$DNH-/)/*[>-_M1?\$[OA?\>]2U
M/6M.L)=%UGXI?'/]GCXB?'?5K7Q/XG\/ZKXI\*_`2R\4Z9H5CX?U?PW?Z?JO
MAW7+&Q\3W2Z??:7>V3-*2]Q*RKM;\QOAC>O^RE\3/VW_`(\_L%:;\9_CC^S1
M\'/A3HOPVU3X97OQE^+WQ^_X77^VGJ/C6VM-5\6^$[WXI^*/&VIP6_@6UU^T
MB^+NK^%-9@M[U;76!%87-_I:01^`?LC:+;_M2?MQ_MH_LL_M3>+/CG\9-8^/
M7[''P1\2>-/$OBSX>^+?AMX$\)_%JU\2?$:]F\6?!GPHUQ8R?"7PQX&CTWPI
MHOPPU8WD7BK7M=\'76K:OK-YKM_J<K`']`'P^_X)Z_LE?##PU\-?#/A+X66M
MO%\+/C%'^T#X>U[5-8UO7O&&J?&<>&?$?@Z?XB^,?%NM7]]K_C+Q)>^&?%OB
M#1[J\\17U^K6.H-;PQPPPVZ17/A9^P+^RQ\&?C'JWQY\`_#A['XD:A!KMMI>
MH:KXH\5>(M'\$VWBF[2_\4VWP[\-:[K&H:!X"M_$E]$ESK4?A?3]-%ZX9&VQ
M.\;>2?\`!-;X\?$3XP_L`^`OB#\2=4B\0?%#P39?%+X:>+?$#P!8/$GBKX&>
M,_%OPUO=?D\AD@O$UJZ\'C4);VR<6NH?:'NK63RID>OS?^$W[5?_``4[^-GQ
M+_9Y^$6G?'7]FKPHW[5O[/'QC_:"TSQBG[/?B6]U/X.:?\(_'5AX+B\+:?I,
M_P`6)=.\?WOBF?Q3X9GN-8U63PW#H,%AK4L&G:Q+-9VX`/T*_9-_X)R?#GX;
M?LN_%'X+_M`^"OAU\0->_:2^-_Q;_:(_:#L=#TR:Q\):M\0/BA\1-0\9V=GX
M>GA_L_6K/3_`VFCP_H?AJ_AN++4K1]';48)8+N[GD?TSP;_P38_8^\%_#?XA
M?"VW^&NI^)?#_P`4V\/R>.=4\>^/_'_CKQGJTO@Z_P!=U'P+/:^-/$WB34?$
MF@W/@.Z\2:M)X-NO#NHZ3<Z`]R9K.5;D&<_E+\"O^"B'[:7[;?PC^$>M?"/Q
MM\+?@+\1]$_X)X^#?VS/BL^O_!?6_B%X)^)'C;Q'JNNZ';>#O#EW/X]\.7'A
M#PI<S^#->U#5ULY?%6NZ&FKZ/9BXN1$+J\X[P7_P42_X*`?M1:?^T#\4O@]X
MX^"7P8\!?`?]@O\`8T_;"F\":_\`"W5/B/K_`(I\;?'GP3\6_%^O?#N#Q0_C
M3PG:Z1X,N(?A9J4,NNR:9>Z]IT]QIBV5I<13WDEH`?T'?`S]GGX2_LX^$+CP
M1\(_#5QH&BZAJ,NLZS-J?B'Q)XLUS7];N+>&VNM9U[Q'XMU;6]=U74;F*WB6
M66ZOW10NR".&,!!X!H__``33_8AT._\`%U]9?`?1)D\:Z'XU\-ZQI.K>(_&^
MN>'K31?B1/J5QX_L/#/AW6?$U_HO@V+QA+JU^VN'PG8Z,]RL[1HT41*'^?[X
MR?$#]JSXX^%O^"V7CG4?VF+]?@0?^"7+_%^U_9^U;P-=ZIINF:5\:_\`@GM\
M2/$NF>$O"6MS_$.72O`<GA[7]4LM9\1Z_HO@^ZO_`!U=Z<$U$67G&=/?;#]I
MW_@IE^SCX%\,?!OP_JOPK_:4^)?Q(_X)U>'?V@/V>O"?@GX1:EX=N?A]XD\`
M:C\,_"VN^#6M+WQ_-/\`$ZS/@OQ-/J^GW=[?>%[_`%3Q!I$F^VTRSNX[%`#]
MW/B?^R#^S1\:=.T#2?BM\'O"?CW3O"_PX\6_"/P_;>(H[^^72OAUXZ?P?+XK
M\,VKF^65;?6)O`'@V>6]9VU2WN/#VGW%E?6TR222>6>!_P#@FM^PU\-YYKOP
M7^SMX/T6_N?$OPB\87NI_P!H^*]1U74O$WP$\83^/_@[K&JZKJOB&^U'5KKX
M?>,+F77?#XU*YNHH+H11S1SVUO;P1>/_`/!,O]J/7?VA]#^,GAWQS\<Y_BK\
M2/A3KG@.T\8^#O%?[/&K?LU_%7X52^,?";:M;:?XX\"ZCXG\3VU[I7B6]T_6
M;_P5KVFW<<%UINGW]K(]Y)9B[E^%=`_;_P#VE/AW\8?B#X>_;*^,:?LQZMI.
MG?M5:_IWPV\6?LN:I<?"K4_AG\)_AMX_^(OAOQ[\*_V@-,\<7\/CC7_!_@SP
MKIGQ'\6^';W1+=]4\/+XDTR*RT^_MK:6,`_=_P`%^"OA3^SW\/+?PMX1T[PY
M\,OAKX>O]<U.&SDOUTW0-+O_`!KXLU+Q-KES)?:O>,D,FN^+_$NI7\GGW063
M4=5:&W51)#"/G;X(?\$Y_P!A[]G7QOIOQ-^"7[./P^\"^.-*\/ZIX:T/Q-IT
M>KZE>Z+H&O&5];L-!_MO5=4MM'AUQ;B5-6ETJ&UGU2W?R+V:X@"QC^=7]I#]
MM#]I;XP_L\_ML_`?XTV?BR?P7#^S;^R[^T!\.M>^)?PHT3X0_$:YA\1?M8?#
M3PC.]WX=\-^,?%FGGP_KMM!!XATJ*]-AK&FQW<=E="ZYE7[2\1?\%$?CEHW[
M6'PG\(_"#QIXC^)WP(U/]O'P+^QW\2]3UWX&:-X8^%_A+5]3TJ70/'/PL\'_
M`!%'C-O%?C'QY\-/$5BMWJGBU/#T/AXZC?GPT]A*^G7%VX!^N_@3]@[]D3X9
M?%>S^-W@/X'>%?#/Q,TO4-;U;1=?T^Z\0&T\/:IXDTG5]!U_4?#/AJXUF?PI
MX:O=8T;7];TS4+K0=#TZ:YLM6OX)79+J4-UGQ_\`V1_V;_VI8/#L/Q\^$WAS
MXC/X3NS>^'+[49-5TS5])D9UDDAM=;\/:CI&L#3YY$26YTN2^?3+F1$DN+21
MU5A^,/P'_:Z_;SU#]G'PQ^WE\8OC7\+=4^"VD?M/VOPY^('P=\*?!X:'<Z/\
M![O]H^;X):Y\2-9^(U_XMU&[N-=\#:/K6G^-M7L-,\,Z=IHT3PWJ:?:YY7>X
M;],/V&_VA/'/QZ\"_$7XW_$KQ!X<TOX?_$?X^_$;P[^S)HHCL]):Z^$/@36)
M?`F@:RE_=RV][XBU#Q]KOA[Q'XJL=UM&Z:)>:4+..:W=9Y`#VOP_^R#^S/X4
M\(?$;P#X;^#/@S1/!GQ<\.>$/"'Q(\-Z;9W%KI7B[PSX!\`:+\+/!NBZG;1W
M0'V+P]\._#NA^$=/CMC;E-&TNSMW9S$'KD?&7[`O[''Q!\53>-?&7[/O@+7O
M$]U\-++X.WVJ75MJ,;:G\,],MK:TTKPAJ]K:ZA;V.L:;I-M:6\.D/J=K=WFE
M)$!I]S;%F+?7U?R6^,_V?_!'[$/[1&@?M._M.?LS_#7]JG1_BS_P4`\.ZG\%
M_P#@H7\+OB=KUS^TIX(^(/Q4\;2VGPC\,>/O"NGW&GSZG\._"-PMO\-]4\(^
M"]:UGPCJ^BVES8ZQX2O#J;FZ`/Z+?'/[$_[*?Q)^)=S\8O&_P0\&:[\2[ZUT
MFSU+Q9+#J%I?:O!H6I:7J^C?VU!IU_9Z?K,^F:AHNESV5UJEG=W4`LXX(YA;
MM)$^/XY_8[_8ON_BG%^T=\0?@S\*(/B9;ZEI5S-\0_$,%OIBWVMP_P!F:=H=
M_K<-Q>VOA[7-=@.G:38Z/J.MV%_JD!MK2VL;A"$0_D]J'_!1/]H+P[_P3I_8
M?_:>U3Q7I-W\3?B7^UKK/PZ^*>FKH&EQP^*O!VE>+OVA[*Y\&P:1#:RW.BZB
M=/\``/A33(-0L%COK"X"7E_]H6>X67YT_:M;]K#XO_\`!)GX6_M,?%/]KWP_
MXOOOVBM$_9"^(*?#GPY\)O!\'PX\%^,/B'XZ^&GB32[GP-K-EJUIXKUO2_",
MM^1J&G:YJNH/KS6UUF[T6-@(0#^@3PA^Q%^R+X`^+*?';P3^SI\)O"OQABU3
M6]:M_B)H7A#3-.\3VFI^)=/U_2_$-S8ZA;1(U@=;L/%/B&WU2&S6""^&K7<E
MQ%)*ZNOI'QD^`GP9_:%\-6_@_P"-OPV\*?$WPS:7DM_:Z/XLTR+4;6WNI[*Z
MTVYD@W%)8A=Z=>W5C>1)(L-Y:3R6]S'+$=M?*7[(/C;XX6_QY_:[_9^^,_Q8
M3XTCX-:G\&-<\(^-Y_!.A>!-4CT_XI_#M?$&K>';C2?#LTVGS:?I.M:?>3Z/
M=2O+J266H+97UU>R6BW<WP?\4/VR/VL?@%^UI\6-0^.[_%#1OV?+?QSXJM/V
M8CX`^'WP^\5?`SXMZ9I'P@U;6-#^%GQ$\:V3:I\2O!GQ4\2^/[#4(M+O8C;V
M#'2[+2#I#MJGGH`?K7IG[('[+^C?%:;XXZ5\"?AK8?%F?7K[Q7)XYMO#-C'K
M/_"5:GID6CZEXIC8)]EA\2ZAIL$=K?>((;9-7NU#O<7DDLDDC[7QF_9C_9]_
M:'ET"?XW?"'P/\3+GPM#JUMX=O/%6BP7][I%GKT=M%KEA9WH\N[CT[6$L[1=
M3TXS&QOOLUN;FWE,,97^?WX&?M!?\%:_CG\&OV</BOX#U_Q->W?[17[/]]XV
M\6:UXN\"_!C1OA#X9\7^,_A2OQ`^'.K?`PZ3=W_C+5=+L_%[:?X3&A^,Y?$%
M[KWAF_NM3O9M`U:();9_Q._X*M?M2>)/!'CGXU?"`_V7\*O"UE^P?^RK?:A;
M>&/#>I1:/^U5^TOX\T#6?C]XWFF\07%DB/\`!_X;^(_`'@CPOH]_=P>&X/B/
MX^EB\0VVK+I\L6F`'[V^/?V,/V3OBB?!_P#PL/\`9W^$?C"/P#I.E>'_``C;
M:YX)T6\L]&\.Z'>6>H:1X=BL7M19W7A[3[VPL[JUT&^@NM)CF@1Q9Y+;O7[C
MX8?#N[^(>E_%JX\&>'9?B9HOAR_\(:5XY;3+8>)K+POJES!>7^@Q:JJ"Y_LN
MXNK:&X:T=VB65"\:H7?=_.YXT_:`_P""G.F_M$?L^?L]V7Q(\5_!GPG^T#^T
M4/!'A7XC?''X;?!WQA\2H/"6G?L[?$#X@>-=+O/"W@.X\.Z%=?9/$/A!+GPE
MK,MIH4D=Q>01ZBFM6%E<6]YVGQ3_`&S_`-H+PE\8?B?X,^$7Q-^,WQ*TW]E?
MXO?LV_";XZ?$GQQ9_LX^"_@C)XA\8V/PXMO%GA&#PS)H%A\4O&7C#Q9:>+CX
MC1_`VKV%MH6JW5QI>GZ?>6.D2F4`_8VU_8K_`&1['XHZY\:[/]F_X-6WQ7\2
M+J8UKQ[#X!\/)XBO)]:MK.SUG4!>BQS:ZOJ]KI]I!JFM6:6^K:A'&RWE[,)I
M_,N^.OV/OV6_B=\//`GPF^(GP#^%OC;X:_#"XL+KX>^"O$WA'2M8T#P?-ID!
MMK/^P;*]@F2QBCMR()+>(BWN8DCCN8IEBC"_A?X>_:R_;5TS]E/0OVYM?_:2
MOO$FG6'_``46M/@3K'P,A^&OPZTGPKJGP3C_`&W?$O[,FH^'F\0II$WB:3Q;
M>Z5?^'=7T_Q3#JFD6^EQ:'-8W&DZI<7\NJ+V?BS]L;]JCP[_`,$X?VF_^"A]
MC\='G^)_P[OOVE;?PU\`=1\)_#^[^#^BCX?^-M;^'?A>RN+:PT>T^);S>"(+
M6Q\=>,=4NO'U_'>VMIJ)ETS3-+FC:W`/W,\+?L^_`_P1+H\OA#X4^!?#?_"/
MZ)XR\-:'#HWAW3["STGP[\0O$UQXQ\;:%I]C;PI96NC^)O$]W<ZUJNFPVZ6=
MQ>3.QA"'8.'\:?L8_LF_$?0?AAX8\>_L[?"'QAH/P56QC^$VF>(O`VA:K!\/
MK?3HHH;.Q\+F[M))=+TV*."VW:9!(-/F>UM))[:22TMGB^+OV+?&?[<D_P"T
M+J?A7XZ6'Q`D^"M_\%9-<L;_`.,NN?L^:CXZE^(VE>+--LQXD\(?\**M=$@;
MX?\`BC0]5GSH^MZ)>W?AZZM-,0^)M2>ZE\SS_P`-_&'X_P#QX_:#_P""E#7/
M[3^K_L_>%/V'OB/X<^'OP[^$?AGPO\,9HM3TB^_9]\"?%&#XG_&C4OB!X5UW
M5=:\,?$'Q#XDUV#P19^$O$_P_:'3]`O(+V]G>WCN+L`_2*Y_9&_9:O?BWIWQ
MYN_V=_@Q<?&?28X$TWXF2_#CPH_C&REM+NVO;._M]:.EF[35[&YL[5[#6@_]
MKV*P1Q6E[#"OEUYG^U1^Q'\,_P!KGXC?LS>+?BQ9:#XF\)_L\>+_`!YXOE^'
MGBGPKHGBWPWXXN?&?@F?P;%9ZO8Z];7EG##I:W,FH131VS7(N%C\F2)EWU^4
M/@7]J[]I[PWX<_X)E?M`7W[3][\8+C]N7X_ZK\'_`(G?L_W?A;X=VW@CP_X;
MU3P5\6O$4OB?X1/X<\!:+\2=%U'X,WW@C11XUE\8^*O&FF:C:W%S#<VVBQS)
MJ<7A_P"P_P#&W]O3]IFW_8<\'^+_`-NWXI:;J'[7G[!/BK]I/Q7XIT/X9_L]
MV6M^#_B'X'\2:#X3T:U\%?:OA+J>BVGA[73K!U/QI:^(-!\2W5_=0E?#D_A:
MW<0(`?T?ZY^SM^S_`.*/"'A7X?>)O@9\'O$?@/P+Y'_"$^"M?^&G@O6?"?@\
MVMN]G;-X7\.ZEHMSI&@-!:2/;0MI5G:M'`[PJ1&[*?%_BG^QEX%^)?Q3_8X\
M6)/9>$_AC^QUXR\<_$[PE\%/#7A[1M+\#:W\2M7\%W/@;X=^([G3;.U@L]-C
M^%VG^)/'>L>';73;:`)XCUVQU-62335$GX5_!7]N3]J/]INR_9XB\8_M;:Q^
MS9IVL?\`!)WXM_M,>/O%_A'0?@Q'!KOQP^#G[0OA[X61^,]0G^)'P\\46&G:
M'XBTEM2U#7_"VDVMI;QVMS+9Z1/8W4$.J+Q?P?\`V]_^"E7[84'C'P]X3N/%
M7@+QIX*_8K^!_P`4/#E]\//%'[.'PJ\.ZAXT^(OAO6]?U'XQ?$2R_:3\%^*=
M5\1?#S^U]&TW3KO3O`!\-6&A:(_B&VOM5CUG4=)N=$`/ZG+WX9?#?4K7Q58Z
MC\/O!%_8^.M1LM8\;6=[X3T&ZM?&.K::+!=.U3Q5;SV$D/B'4;!=+TQ;*^U=
M+RYM1IU@()8Q9V_EQZK\+?AEKH\5C6_AUX$U@>/-.T?2/'`U7PCX?U`>,])\
M/17D&@:7XK%WI\W_``D6G:'!J%_#H]EJ_P!LMM,BOKR.RB@2YF#_`,R-]^U=
M^W9+\!OVZOVDO$G[5OB'1/'7[*/Q5_9"T+PY\+?ACI'P'\0_L_:K)\1_`/[,
MNH?%'0KS7;SX7^(O&7C?P1J_B+XA>,;KPUKWASXB:#?/IE_:7-AK<UK]C,7K
M?BC]O;XX_LY_'+XGZS^U3\5/BO>?"/Q)\1?VG(O@3XK^`4O[/'C'X$2^%_`'
MP_\`%.MZ/\%_$?A:?P7<_&_PA^T!\-H/#FOR>*-0\2>+;_PC_P`)IH6G76H6
M3>&];CT(@'[U:'\&?V??A+I.FW_AKX4_!OX9Z%\/[O7O%^CWNA^!?!/@S2?!
M-_J6B7FD>)_%&FW-AI>FV?AN[O\`PW<W^F:]K=J]E-=:)<7EEJ%S)82S1-S?
MBGPK^R;XYUZZ_9_\:^'/V=_&'B>]\_XK7OP3\4Z/\-?$&O7?VJX-G<_$FZ^&
M^K6]WJ$_VF[)M9_&,NC/YUP3!)J+2_+7\L?Q1_:[_:C^,OPU_:?^#7C7XO>*
MIOA-\7O^")O[6O[3&E:-K'Q#_9K^)WQ*T[6/`FJ_#O2_#U_K-_\`!WX2^%=$
M\)_\)MX4\>:_X=\:^'+N#7=UJP_X1G4/#6MZ;)J;?3_[8W[7_P`9/V</B'^V
MAK/P4^.R_%Z'X;_L7?`KQAX,^+FO>$_@;XXUKX?W_P`2?VD-+\!>./&,GB?X
M?^`?":ZKHOA7P1?7>J6>BZG)J.@:?>16VKZGIE[;1W`<`_IE\1>$O"OB_P`/
MWOA/Q9X9\/\`BCPMJ5J+'4?#7B+1M-UOP_?V0`46=[HVI6USIUU:A551;SVT
MD0``V8`KA6^`7P*?P9IGPX?X*_"5_AYHNIV6M:-X#;X<>#F\&:3K.F[SIVK:
M9X7.C'0[#4]/,DALK^UL8KJUWOY$L>YL_P`X'[3'[5G[2OPI^(OQ&_9]^"'[
M7WQ'\<^"OMG_``3I\86/QZO8/A-XU\:>!O%W[2'[3?Q!\#_&'X<V?B#2?AY:
M_#^[TO7_``AH^D>(='\,ZWX:O[GPC!J<EEH<=KX8@TG2-,_4#]CCQ1\7/!G[
M=7[</[)OC#XV_$/XV_#+X3?#+]E/XL_##4_BQ_PB>H>.O"]W\:;?XO:?XV\.
M7/B?PMX8\*_\)!HKZM\-[;6]'.K6$E[I0U:ZTF"=M/M+15`/I3]G?]B;X0_`
M+X8W'PNN-,TKXIZ,/C1\5/C=HUS\0?"?AC5)?#7B7XI>/-6\>W4&@VSZ=+:Z
M:F@7NJFPT>^M8X;];2UMWDF\Y=U>S^$-)^!OQ5\%_#'XB>#O#OPY\9^!]1\)
MZ9XL^$GB:Q\-:%?:5'X/\;:-;:IINK>#9Y=.SIFE^(M$O[6Z!T];1;RSN4$R
M,K%:_"V3]HOXN?##]O?3+?XW_'[XE^/?AM\5OVJ&^"_P0U']G;XS?`^\^'GA
M>.]T.ZU*V^#WQK_9MU?P-J?Q$LKO2;[1+ZW\0_$33-3N]9'VBWN8/$'A[3S-
M;3?.7P)^,_CW]BKX(_\`!)WQC=_M`?M!>)_@_P#%W_@EYXC\;?%+X;32_#W7
MK'P]:?";]CCPE\0?`Z?![1E^'MC%X<UCPI?LNFZ/>:M-KHU2PAMCXYD\32Q7
M%]*`?TO_`!-^(GP<_9N^'OB/XL_$?4_#WPU^'WA>ST6#Q+XI_L>9+/3-.;4+
M;0]#ANXM"TVZOFLK>]U2WLK1$M9(+!+IGQ;VXFD6EX-\9?`KXP>+?B(WA%_"
M'C#QK\'_`!5?_"?XAW;>'5.O>$O$B:58ZI?^%+O4-5TJWNY8)=)UBRN'_L^X
MNM)NX+LHD\Q69$_CN^+G[1WQO^)?[*/[;_A/QC\46\8?"GQ[^Q/\$/V@?!W@
M[7_VCO#'[27C_P`)ZKK/[0?@K28=5\7:OX7\(^%]-^'VI^)-!UB%;WP1ILNI
M:"9=)@U/1HM*ADEAN?Z&_P#@F_\`\E]_X*K_`/9]^I_^JC^'%`'WU\#O''P0
M\=>&_%-Q\!;GPK-X9\(_%#XE?"_Q7!X1T#_A&['2?BE\*_%FH_#_`.)&@7VF
MG2]()U;0/$_AZ\T>ZODM9;34HK.WOM,OM0TJ>QO)O2;KPKX7O==L_%%[X;T&
M[\2Z?9RZ=8>(KK1]/N-=L=/G6Z2>QL]7EMWU"VLYDO;U);:&X2"1;NZ5T(N)
M0_\`(7X'^,6H_"/PE\>_$OP3_:T\8V?[3TO_``7%_:O\"^%OV5?#WC#P%J^C
M^)O!?B_]NKQE9>-;/7_@KINB0>+M8LM0\*WVNZ_<^,_$%_>:EHRV<$NG:O::
M18VVG1_6'[)_Q_\`VOOBK\:OV;_'WC'X[>"/AMXB\0?M"?$_P+\??@IXP_:'
M\-:Q<^+?"5B?%=A/\+O"W[-5WH<6N>`?'_@K5[/P!J^B:SH^H6FIVOAY-57Q
M+=>((/%<=RX!_2?'HFC0_P!G>5I&F1?V.)AI/EV%JG]EBX3RYQIVV(?8A/'\
MDWV;RO,3Y7W+Q5%O"/A1M8O/$+>&/#S:_J%D=-O]<;1=-.L7VG%/+-A>:F;8
MWMS9&/\`=FUFG>`I\ICV\5^67[:7Q%\/:'^V'\#?`7Q:_:L\1?LT?!'Q'^S]
M\8O$^K'1_BQH?P?M?$WC#PMXD\(P:<T_B76+83O=Z9IFKW-U:6&BZG9W]V\7
MESPWE@MQ:S?@E-^WM^T-XL_9H^%ND:C\=/&G@GXZ>$?V+_CK^T+8?&?XY?M$
M>(/V??#'Q)\%>"/CG\7/"G[/^K^%O`7A?PA%+\>?BYXK^'WA+P3K.NV.K6MC
MH6OZ5KVDZSK-@4\0&XC`/Z^O`/Q4^"?Q'\6>/O!'P[\4>#_$WC#X`:[:>"O'
M^@Z(D$FI?#'7M:TB+4K7P_?1"WC_`+(N-0T40W"VUHPCFLUC#Y554>!7OP?_
M`&>/CY\>_A]XS\/ZW&VO?L2?$WQKJ5[\/O#NAKH7AFR^,7Q%\`OHDWB/Q1%)
MI%C#KOB'3/!_B347T;4;">]M[67Q!J,\EP]\X,'X2?&']K[]H@?'/XM^#?$W
M[0OQ`^&/P`OOVU_^"97PS^+_`,1?#U_8Z'-\&?@I\9?V![?XE>.9M%\87%J]
MM\,-,^(?QU/A#3?$/C)D,FF?\);>"SN=.GNH+RU_4+_@EE<?#JZ\7?MXM\*?
MB5J/Q<\"Q_M+:;;:+X_U/Q]=_$Z\UU+;X9^%8)Y6\=7MYJ$_B$0SQO"M\;Z[
M#E#B>0@L0#]2-"\7>`OB';>*+/PSXG\(>.;/P]KVK>`_&EIH6M:-XFMM#\3Z
M?:VKZ[X,\40:?<WL6F:]966IV3ZMX=U9(-0MK74+5KRS2*[B,F]>Z/I.I6D6
MGZCI>G7]A!+:3P6-[8VUU:0SZ?+'<6$T5M/%)#'+93PPS6DB('MI8HY(2CHK
M#^3+X4ZSX'^`MO\`MK:%>?M0_%'X57OB#_@L;XQ\)?&NQ3X\7VG>,_!W[/7Q
M$TGX<ZE??$S^S-:U"ZUCP79ZSK-]HFC0_%:.QM4T[PW=06.D:K86EM:36OZT
M?\$R/B-XKU_XN?M^?"70/BYXF_:`_93^`_Q>^#?A;]E_XQ>,/B`OQ?UW5X?%
MOP%\'^/OC%X,/Q?<W6I?$C3/`'Q"U^33M.US7M;\2:]IXO[CPYJ6O7SZ*GE@
M'Z">+/VB?@-X0T;0O&&N?$;PM<Z+J_QA\(_L[Z5K_AYYO&EM;?&/XC>.=&^&
MWASX=:A=^#[77CX>UG4_'NJZ'X9U)-:;3;'1M5N;./Q%=::BB1/<J_C;\3Z!
M\,_`OP`_:3T33OV@_B'H_P"T1X(_X*V_"?4-;^%%Q\9VU[6O`O@R_P#^"G'[
M,&O:;\5-#^$_C>^U?P;I'B6RN=<\+W6A?$O7O#=]81V^IC0+^[FT;5[_`$V;
MU+]KGQ;\=/V6_C_\4/V4?AU^T?\`&:V_9OUOQW^RIXB\<?$'X]?M+?&-M3^%
ML'QFTWXP:7K.FR?M+VP\6_%KX4_#GQ/XE\'>%8!+I5PUKH&J2+;Z;J/AZPU.
MYR`?UI45^3W_``2JU7Q7_8/[2/A+6/VIOAA^TQX7\)_&#0T\#6?P]^-?Q+_:
M5O?@IIVI_#3PB=;^&OB3X_?%.RMO$_Q$%]XAL=0^(&B?VG>:YJOARU\97.A7
M>MW=A:Z1#:_K#0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`5^;%S^QUXTT;]L;]I7X@>'M42
MX_9R_;L^!NA>&OC[I5EX@U#P_P#$#X9?'+X6:"_@#PE\0/AO<02G3I-"^)OP
MHU8^&_&4$=DFOZ#XO^'G@_Q'9W][8:YK-K8?I/7\HOQS^&_B;XT_\%1/^"D%
MCJ'[+W[7'[5FA_#N^_9$T[PO:?`_]KFP^!'AKX>P^*/V<O!^I:UIB>&?$'Q8
M\!6-W<ZE?-)XCU&\T^T=64S-YESJ$S0,`?M/^Q[_`,$WO`/[%>L:;<_#?]H7
M]K[QIX3T;PK?>$M&^%?Q=^/WB+Q]\*M)M+V;3I5U.P\$7MM;Z7;Z[8KIRP6&
MK*OVFW@N[Z,%OM3FNZ^-7[/?BC0O$OQ[_:5_9GTS3;[]K?XK_`WPE\"O#]UX
M\\7W6@_#?1M/\):WXKU7PKXDU".RT+7KR"3PQJ/CC6M<O4LM.O[K719V6E+%
M;JQN4_,3XR_\%`_VR_V<[3X@:G\/O@S\&=3^`?[,/Q8_9A_9JUCP'XJU'XK>
M)/C3JA^,MGX&\)V>L:E\0?#TWB#0;)_`WB+Q1HFE7VI7?AO6QXK:6YF2[.KW
M6F65_P!A:_MY_MQZ#XE^.?[.GB/0/V=?$?[1OPZ_:;_90^%GA[QGI=EXX\/_
M``EN?!O[6_A_Q9XBLQ>^';C5=6\4)JOPL/A/5-/6Z.MS+XQ@CT^:=-'N+FY>
M(`_4#]F+]G7P=^RS^S'\+OV;;75HKJP\->$T\)ZEK5S<I:77BWQ7KL=W?>+-
M9B,YC>34O$>NWVL:L(HXQ,6N&98%V%5S?A[^Q1\"OAAXT^"GC[PEI6O6OB3X
M!_";X@?!7P%<77B+4+VW7P+\2O$?AWQ7XDM-7M+AGAU"_.M^&K&YL=1*Q7%J
MDUU;[GMWBCA_`KXZ_M=?'?Q3\7/!W[+7[4LOA#4OC1^PW_P5A_X)K:UK7Q*^
M#FC^)/!GA/XF?"G]I/3/''BOP!=Z7X=UK4]0>PU/3AHGB;PEXOTQ]9UC3;ZV
ML)K</#>S?;:^D/&?[>W_``4%MM)^%?C+P+IWP$\4:9^W/HO[0F@?LB^`H?"O
MBFP\4_"WXF?"#X<?$'XH^`;7XDZU/KVJV/Q!TWXFZ1\.]3\/:RFD:9H$OA/7
M-5TJYL8]:M(;J&8`^X=5_P""1G['M[\.O@K\+-%L_C!X#\(?`_X63?`W1H/A
MO\<_BCX"U3QG\&[R07.I?#/XF:[X9\2:=K'C?PIJ=^HU"ZLM5O6E6X,D=K<6
MUI--;2>]>$_V$/V8/`K?&*'P?\.D\-Z/\=?@K\(_V?/B!X<T;6M;T[P_/\*_
M@?HOQ`\.?#OP]H.FVE_%'X7_`+)T/XE^)].FO-`-A=7L<EE-<RO=6<<Y_)KX
MQ_\`!;*>Z^$O@+XL?LZZ+IVO6'CGX#?!+6+_`$_5/!?CWQEJ7@+X[_M)^.(O
M!G@CP9X@\(?#G1_$WCS5K[P,?#GQ.F\1^#M`T6YUW5M6\*6]AIK7-E>&^7A?
M$_\`P5T_::^$=GXR^''CKP9XQUGQ)XR^*O[-?PU_9M_:$\1?L$?ML_"CPSXL
MU/XRS^/I/BKX:7X'>*_AAIGQ-^)/COX*^'_A[<^*;#0_AKI.I-XNTWQ)IBO!
M`=*U5J`/U&\=?\$KOV0/'VIW]]?>'_B3X?L/$GP(C_9J^(?AKP1\:/BGX,\+
M_%CX-V7PM\0?!K1/"WQ0T3P]XJL+7QI<>'/`'B?6-(T#Q%JPE\2::\\-W%JQ
MN;2UDA]4^)7[!?[,WQ8/A>7QAX/\0M>^"_@R_P``O"NJ>'_B-\0O">L:%\,G
MU?PMKR:7IVK>&?$VE:A;ZM;ZMX+\.7MIXH2X'B6UET_$&JQK<7*S>:_\$\?V
MDOCG^T+X5^,-I\=/`7BG0=3^%7Q1F\%>$/B1K_[/_P`;OV:M/^-G@ZZT/3M?
MTOQOH?PQ^/GASPUXUTS[$=1D\.ZW)%9/H\FM:9=-8.D9,*?F3\1/^"N7QI^"
M7Q4_::7XT:W\.?AKJ7P+;]HK7_"O['WC_P"$OQ.\'>/OC!\(OAI;S1?"SXH?
M"CX^ZI'#\,/B%_PGJ6\7B?6-$\*ZCJ]]H6E7E[I-WIEEJN@WZT`?M+^SG^QY
M\#/V6=2^*/B'X4Z/XMD\8?&O6?#NO?%;Q_\`$7XD?$#XM_$/QWJ'A'1G\/>%
M!XA\=?$SQ)XI\47UGX;T62;3=#TZ35/L.EVL\\=G;Q":3=X%!_P2@_8E?7KW
M7/$/P_\`&OQ`BN-,^,&CZ?X6^*/QJ^,?Q,\`^%].^/GASQ/X/^+L'@KP#XX\
M<:[X0\&?\)OX4\9^*?#>JR>&='TR3^P]=U'3+=X+2=HJ\N^"O[3W[57A#]JW
M]F?X`_M.ZQ\(/&.G_M@_LT_$SXR^#)_AIH&J^&+OX9>/?@O<?#?4O&?A!Y]5
MU2]_X3+PGK/AWXLZ0-$U&6VM-;M;[PQ?7%V&M;UDB\9_X*6?M_?&O]G/QK\7
MM%_9U\?V'C'QE\!_V<M1^/\`XK^!/A?]F/X@?%NYTW3M'TOQ/K&GS?&KXMZ5
MK-AX5^%_A[XBKI+67A*.V9?%,-KH&O>(AI6J:79S;@#Z:\)?\$?/V#/!FA_$
M'0-.^&GC;5+?XI^!/"/PS\=:CXM^-_QI\:>(=<\$>`_'6E?$CPCH+^)/%/CS
M5M<M;70O%NBZ??6+V5_;S1VT<NEF0Z9<W%I)TEK_`,$I?V'++XY7?[15M\*=
M8C^)MU\9M#_:&CG_`.%G?$YO"6F?&K0ETY(OB-H?P^;Q<?`VA^)M733($\47
M^E>'[1_%2S:@/$/]H_VE??:/SY\*_P#!1;]J'Q!^VE+\*_B[XGT7]D?P+K?Q
M5^'GAGX#>$OB;^S?\4-<^'_[2_@;Q1X'T'Q-J-QX+_:H@TRS^&VF^/;B_O-6
ML-(T"YUFW\F[M$T22QU#4\NWOG[>DG[04_\`P4D_X)8^'O@[\9(OAQHOB9OV
MN+?Q!H5_H5SKV@:_>:+\$KC6X;S7]+BU;3K?5TL]-M;ZTT:VO4FBTS5;V/6H
M?])M(A0!](_'G]AG2+K_`()Z_M$_L0_LN:=X7\#6_P`9_AM\6?A_HK_$+Q%X
MRU+P_P"'[CXYSZM;^._$]UJXA\5^)Y+_`$VW\4^(?$/AVRAAFM3K]OI.G%],
MTMI+FT]<?]B3]G>Y\!_LQ_#G4?"-[?>&_P!D.^\(:O\`!.WC\0:UHHT;6_!/
MAW_A&=%U;6;;PY>Z/IWB2<V)DN;RSUFRN]*N=3E;4#IZW*QO'^4?P2_;D_;4
M^+/AWP/^VI%XZ^$@_9<U;]N+PQ^QYK?[.\?@>P;QB?"_CK]J;0_V0]$^*$7Q
M*TOQ)K-Y:>.=,^('C'PSXKU'P9=Q6>G6WAF'6=/O[*'5HH`WW5^WY\;?VA/A
MSXV_8\^%'[/'C/P%X`\0_M+_`!E\5?"S6?%?C[P==>,K70["S^&7B7Q99ZKH
MFG1WFGV4^O6-]HR366FZE=QVNJ`2+)'<06UQ!(`?I+7YZ>'O^"6/[$7ACXUZ
M7\?-,^$^I2>-]#\<R_%#0])U3XC?$C6OAIHOQ->>YNH/B-I/PDU7Q5>?#33_
M`!SIUU>75UI'BFT\+Q:SI-S/)<:==VTS%Z_.?X0_MC_MX>`_B+^RIXN_:0^-
M/P:\:_!WXR?M/?M1_L5>./!GA_X40>"K[0?$O[)FN_'GX=>(OCV?'*ZO<R;?
M&GBO]G;Q-XMN/"$6F66A:%X>\5Z9I%J#<Z)=7^H>0_!_]O?]N?XQ_&/4/A#\
M,/C?KWBSPG^T3\&_CSXR_97_`&F_B5^QOX:^$WP+L_&?PAU3P;XL\/#P?JEQ
MXSEU_P"*W@+Q!X+N_%_AGQ3J^O\`AK03;-%X>\4^%M3NX+FYF(!^K=G_`,$J
M/^">_A#XCK\9C\$]%T_Q;#\8!\:]'OM8\:>,)?#GAKXK:K>:C-?>(/"'AG5/
M$LGA7PK<^)]5UN\O-=TS0-+L+#Q)JL\5UJ5G>7<<#IK:%_P2G_8-\-6[Z;H?
MP(TVQ\.)JC:OI/@V/Q/XR?P+X8N&\067BI+?P;X+E\0/X9\(Z7!K]A;ZG::3
MX=TS3M-M9_-^SVT:3S(_XO3_`/!0;XY_M\_"!OC/?>$/AKX*^!GPM_:M_8O_
M`&?O$/P:G;PM\2=5\5?&_4?VF_AUX?\`B/\`%-/$=KK27NG?"BPM[^5?@AJ^
MG>8OC"&2V\7)_:EG!NCT_`/[:O\`P5*\9^$OV0OBC;_'7X*_\(A^V+^V#^TC
M^R!IWAV+X&Z4FH?"#3OA]\8_VA/`'@SXKW=Z=;FO/&_B'3S\*],T^YT"UL-/
M\,3Z7)::AK<<%S'K&JW0!_2GI'@OX9>$OB3XN\7:9::)I/Q,^+EIH<OB>X-^
MD>N>+K/P!I@T?2)ET^:Y\RYM_#VFWBVKS6=L$@CN(_M+;I$)\8_X8<_9</QM
M/[0\OPJTNY^*O_"2W/C--<N]2UR[TV'QA=Z%)X9N/%5OX7N-2D\,6_B*30II
MM,.L0Z0E\+::95F!E<M^(/P\^/'QS^)_[87[*?@/XK^+?A<?V@_`%M_P6/\`
MV>M7_:ILOA;HEE?Z;)^S_?\`P`L?"OCWPOX3U"]NM"\-6%U:^)/[1\8^&;@W
M^EZ[<:5;+/)!:1+",OPO^W!_P4#G\'7GQ,T_XTZ]\3_@'\?_`-J'P9^SS^R=
M\3_#'[+G@;6OB7K/@SPYH7Q#\:_%/XW>'_`WATZ9X?\`%&C^-+?P%=>#_A?;
M:I%<V-UIZ:CX_#7%E;0:?,`?M3\,_P#@G/\`L:_!WXA>'OB;\,_@IHO@_P`2
M>$-1US5O"%KI.J^(HO"GA+4/$<#6^KW7A?P2VKOX2T%[F)W51IFC6RVY=FME
MB8DUZ#IG[&O[+ND_"?XC?`RV^"/@&3X2?%SQ+XG\8_$KP'>Z);ZAH'C+Q-XP
MU)=6U[6=<M+T3B[OKF_BMIK>9F#:?]BL$L#;1V5JL7S]_P`$Z?B_^U5\4?#O
MQNTW]I_P;XWTN/P+\5%TSX-_$/XC?"W3_@OXV^*7PPU[PSI'B6UO?%?PYT;4
M]5T+1?$?@C6M1U3P#JU[H4\6D:_+H$>NV=K;QW^ROS)N?^"AG[3^@?M5_`/5
M_!VM_&WXD_LM?M`?M6?%/]F?4O$WQ1^#WP(^'/P@L]6\-?#;XO:]X5A^".H:
M!XPOOCQXDGL->^'6HSW?B?Q;X,TGP?XGTKPWJ)BU.>XU32MX!^OWPU_X)Y_L
M@?"37_!GBOP-\'M,T_Q1\/O%C>-O"/B34-:\2Z_KND>)#X*U/X=I?1:KKNL:
MC>S);^#-9U+0;6TN)I;.VL[N3R($DPXJ>//^";_[$7Q.^-&J_M">//V=O`/B
M3XNZW/X9OM7\77]G=--J&L>#9[&?PQXCN]/CNH]*G\3Z+_9>FP67B22Q;6HK
M.PL[,7IMK>*)?QC^"G[77_!2+Q_X2_9/UUOVA?!6O^//V^/A7^VW8_"_P\?@
MUX-T;PE\'OB)\"'EO?A#KDVQVO?%B:G<QG1?&EMJUY!9W>GW$=QIZZ?<VWFM
M]P?L-_M^_$/]O3XN_!JX\!2Z=X=^%W@/]DOP]\1?VJ]&CM+#4]0T_P#:;^(&
MMZSX!7X(7-[F*Z\.7WPR\3?#KXJ7NK1I#YFJII>CS>5;Z??6SW(!^@O_``Q_
M^SE_PJ3_`(45_P`*PT3_`(53_P`++_X7!_PA_F7_`/9W_"Q_^%I?\+I_X2C?
M]K^T_;O^%G?\59L\[[/]O^7R?L_[FN2T/]@+]CGPY\6_&WQRTK]G_P"'T7Q-
M^(EKJUGXMU^?2C>PZE#X@M)['Q(4T6\EGT.RF\36=S+;^)+BRTZWGUV(JNJ2
M701-OYU_&S]I;]K;2?VR_P!OK3O!GQBT#PG^S]^PW\#/V0_VBM<^'EQ\.M.\
M2^)_B':^-]`_:0UCQGX#TKQ1=WUJ?#&E^*O^%4:4NIZBMK>:I:R16PTF>RAF
MU-+SX#M?^"@/_!5'X-?LR^._VM?&'ACQCXG^&WQ,_9O\!^-]!\=_'#0_V8_"
M'PH^$GQ_^-OQ?^#_`,+_`(<VGPRT_P"#GQH^(WC[Q!\(]'T#XKWGBW4HOB/I
M6F7[R^!)DUF?2KK79;&W`/WY_9W_`&0OV(_V6?B?XMM/V?OAI\.OAY\6?$WA
MZ76_$%CI%[+=>+H?`]]K4>V"PL]1U"]O=#\"KKD<$5EI.EQV7A^UNX;>"VM8
MVAB1=_XM_L%_L?\`QU^*6C?&OXK_``!^'WC/XHZ*-(CC\8ZEI.W5=6MO#XN!
MX?L/$[6LMO#XKT[0C=W+Z-8>(HM3M--DFD>TBB8YK^<;]H+5OVF_V)/V\O&V
MOW7[5/B[XX_$?7?V?OV4=$E\?>+_``;X%\/W.D>%_B)^VYX#\*>+O">EZ;X5
MTNQT\:'<Z;?7Z6#7J7%_8QW;*MTY`:OM?]K;]O3]I3X8_M8?M?\`P'^'?C?P
M_P"'--N/%7_!*CX.?"OQGXKTW3KSPO\``:__`&NO$?[16B?%+XF:M'=(EKJ<
MCV?@7P]#I-KK=W#IEOKL>EM+YL+S6ER`?JM\/?V%?V*OA#\9-0^,?P[^`7PG
M\&?&/7K;7[E?$>DZ+8VNMVUOK82#Q=>^';)G,.AC7WN8QXIO="M+(ZO-<(VK
M2SR3`MV_PF^`O[+GAO2?A_>_!SX<_"JUTOX4>!M;^"GP[U;P=INBW*>#?`:Z
MDD7B/X?:'JEAYS6&D2:QIB'6M(BN`LNI6GF7D;7"%J_"OXI?LO\`[4]U_P`%
M0/V7?A=<?\%$OC3:ZW:_L2?M1:_:?%/2?`GPKM_$][H]C\:?@MYGAS7M(N-"
MG\*7LMXFLV4%QJ\&EVNHK:^']-2*2,S7S3\9^P?\3/CW\=FT3]F3X8_&.U_9
M-T/P;\*_VKOCCXM\4_#_`,`>!'_MWXF6O[;7Q:^%.@VNN+JD^J:=;:9X4\.^
M'M+O/%FG0&&;5S/#<W>J7`N%NP`?I]XJ_P""2?[+_C7]J/X7_%GQ+\)?@MJ_
MP%^#_P"RQXH^`/@/]G;4/AKIMUX:\/>*O$OQET#XIGQ]HL+R+HFEQ6%KI6J:
M-_9L6CS3WL_B.]NWO+:.%H+WZI^/_P"RM^QK\3]`A\5_M(?!+X*^*_#?PN\'
M:U%'K_Q$\+:!-I?@OP'960OM>@DU"^AC@TSPO::?IWVK4+>:1--@MK1I98U1
M&-?SR?"G]L?]OK]MJ&SU/P7^T[+\!K[P?_P28^&'[6VK67A#P%X/U?1_'OQP
MTG]H3]JOX<>(KR_&OZ?J+Z'X0\;:1\(]#GU+2]%V75LB6UO87L4(N#/^K_QN
M_:(\0?%O_@A]\=OVGI]*TNT\5^+_`/@FO\9OBI=:3J-E9ZOH?_"2-^SQXJUF
MZAN],G@6QOM(N=5@E>32YX&MI;&4V4RR1[BP!]O:)^RY^RT_P\\2>"?#_P`$
MOA*WPP^*,?@K5_%7AO3?".A'PGXVB\':3X9L/`-_JMA!;?8-7C\/:+X4\)VO
MAV:9)5L;'0M'CM"D5G;A?/\`Q!^S/^PA\*_'>J?&3Q1\'/V??!'Q!^*NKZEX
M6U7Q[K?AGPKI.M>-]>^(5K_9.KZ--J-[!&VJZOXPM$-A?P+OO-9B#0S^>"P/
MX&ZA^U)^VW'\(_VW?VDM#_:BUGPUH/[(GQ1_8[\-_#GX+:3\/_`G_"$ZQH/Q
M`^'_`.SC=>.=&\47L^E/K4NFZM<?$?6Y=/M],N;`:,RQ&S(`"K^Q7_!0#Q[X
M@\/Q_L$#3[/PK?6/Q$_;C_9U\'>+K/Q+H7AW7HY=`\4W-\E^NC6GB"WN9+35
M4F\E[74]&B&K:<BR744L$4<TJ@'O?PR_8$_8F^#$^J7/PH_96^!7P]N-;\'^
M*_A]K$WA3X<>&M'DU/P+XZN='O/&7A"]>UL$-QX;\377A_1+C6='D+6-]-I5
MD\\#-`A&]\-?V+/V2?@WHNL>'/A7^SC\'?`.@^(?"M[X&UW2/#'@/0-+T_6/
M!NHW;W]]X7U*UM[-8KS0[J]=[J;39U>U>=C(8]QS7\^7@KX^_MH>#?@Q^RM^
MW'JO[7_C_P")G_"Q/^"B/@W]E37O@9K>A>&+?X2W_P`%OBC^T'XF^#11K;3=
M"TK7[WX@^&X;O2M;T?QE=W2SK/I":;)8R6,M:NF_M"?M5^%?^"7&N?\`!5>X
M_;4\9Z[\6?BK\)]0\5Z=\#M3TOP?J_P(^&ESXM^(T'A"5?#?@JTTUO%#7/P#
MT&^NM:\52)J\VH75SX0ULZ\EC:_:XK8`_?[P/^QK^RC\,_`<OPN^'_[/'PA\
M'_#N?QGI?Q%G\&:!X&T+3O#\WCO1+BRN]&\6RZ=!9K!)KVE76FV%QIVHNK7%
ME-:PR6[QLF:]GTWX?^!]&\9^*/B+I7A/0-.\>>-M,\.Z+XO\7V>F6L'B'Q+I
M/A$:F/"^FZUJL<:W>H67A\:UJW]DV]Q*\5C_`&E>^0J?:)-W\M_[5/Q^_;!_
M9%\1?&W]FOPO^U[\7/BLEW^SO^RM^TEX;^-GBNV\.77COX7^+_B'^U/;_!SQ
M3X2:\T[PU:^'Y?!GQ`\.W$NJ^$O#5_YMQ:_\(CXMAC$UDV^"K\>OB3^VY^SK
MK_[>USIW[=_QE\5>&/\`@G5\4OV.O''A*S\7:#X+U"Z^)GAW]HC5/A5XF^+7
MA#XN7=AI.D#Q!X1T/POK7B'1OA_I_P!L\.V'ALWIU#7=;6QLVN[4`_I/L?V6
MOV;],^+%[\=M.^!OPMLOC+J+F6]^)MMX+T*+QI<S-&86N)=>2S%\;EXF:-[D
M2B=T)5Y&!Q6MJ7@/X#^%[;X9>'M7\*?#?1+3P[II^%_PDTC4=+T.T@TG2M0\
M/CP^W@;P7:7,2I;6E[X9LAI!T/3$6.?2;;[)]G:WCV#^>VZ^,'_!1OXT_%/]
MH;XL?!KQ!X^TZ?X(_MBCX6:#X4N_B]\,O!O[-5A\+_`7BSP5;>*M!^)7P^\8
M:=!XZN]9\6>"]3US4$\2VFJQEM5OM%D\.7(MXY8Q]9?\%BOA?JOQ.\7_`/!,
MJUMOBI\2/A@)_P!N_P"&FBW%W\-M<M-$O(;C6]!\0"+7;:_N+&^:#6-#>W<Z
M/=J#'#]IN#)%+O7:`?IYX8_9'_9=\%Z1XDT#PE^S[\(/#>B>,5>/Q7I>C>`?
M#>GV/B**2]L=1:'6+>WT](]0@%_IFG7:07(DACN+*VEC16B0CV;0_"/A;PS>
M>(=0\/>'M'T2^\6ZNVO^)[S3-/MK*Y\0:X]M!9MJVKS01H]_J#6EM;VQN[DR
M3&""*,OLC4#^7CXF?M2?'GP[^U)\-E^"OQ@_:(UWX5^"?^"H_P"SC^P5\6?'
M/Q9^.O@A/#7C+4/%ER/`_P`4?AOX/_9YT7P1?ZAJC6&G3KXJ7XK:_P"-/"WB
M`ZXB:]I/AW4M)261/6?V4/VJ?CW\1_\`@I#-^QYXI_:@U35/@#^SIXN^+NH?
M#;XL0V\@O_VS_$VGA8=>^`6N^-[S15\.^+-4_9CA\01S>-?^$3OTU#5KU=%2
M5WDT+7+>$`_=C0/V7/V;_"OQ'O\`XP>&_@5\*=#^*FJ:KK6N:C\1-+\"^';/
MQE>ZSXDN+B[U_5;GQ##8)J<NHZQ=7=S<:C>/<&>[FN)I)I'>1B=V'X!_!"W^
M),OQB@^$OP[B^*T[S2S?$2/PCH:^,9)KBSM-/N)VU\67]H_:+BQL+*TGN!.)
MYH+6WBDD98D`_,']M*Q\?_%#_@HE^RQ^SE%^T5\:?@K\&_'7[,W[1GQ%\?:5
M\)O&MMX'EUSQ#\-?%GPJ3PKJ5WK;Z?=7=@FEIK^I&X-M/!'=6[F"Z#0;@?Q(
M^(_[4_Q[^//P1\2ZK\.OBU\8_%?Q[_8P_9.UKXI:]\<KO]J6T_9T^#6F6`^+
M7Q7TCX-?$NY\":3X,\7W_P"T)\2OBKX<\"G5/$5C?VWA[P+86?A#P]IMQK%K
MJ'B]+&\`/ZJ?C+^R)\)/C_\`%7P#\1?B[X=\/?$#1?`/@KQIX0L_A[XO\,:7
MXC\,ZC/XSU3PSJ4NNWD6J_:8!?Z4?#%O#IP2Q+QB\NV^TJ'\L]_\2/@O\!O%
ML&D^)_B=\*?AWXL7X;:1J4WAZ_\`$?@O1-=G\*:1%ILD>HP:$MSI]S-8VS:;
M$\#6=@B))"HA2(_*M?SJ^*/VA/VO?$5U\+?V4;KQ]XYU?7?^"G_@/]BCXI?#
M/XD^'M1LM(\1_!CPAX@\*Z7XB_;<F\'-`L<.A6'AWPKX,U34?#E[-\VE>)/B
M=X?MK;[1</86MS\^ZQ^TO\5=;_:S\`_&CX$>/?BC!\!_C?\`MR?M'_LL_$"?
MXL?M1W?BO6?B#:>![/QY#JVA^&/V4?\`A![+2OA!X&\+ZEI-OH_A>35/%"^/
M4\-Z1H&L:YHNG2:ZZ3@']0OA^]_9J^)OP.U?XO:'H/@?Q7\%?BYX(T_XC:_J
MX\)VU[I?CSP?I7A"PM=)U?6-*GTUKK65L/!^A:9IVFV]Y9S75MI^FV5C:PH(
M8HAT7[/6I?!'Q7\)_!/Q(_9\T?PWIOPO^)/A7PWXK\)W7AKPPOA&UU7P[=:1
M;)X?NI=%;3]+N[-XM*6WMDMK^R@N[2.,6\T4;1E!_*U\$K_6/V;_`(&?\$KM
M9^$O[0'Q1^('BO\`;)^`GQ'^'_QN_9P\1^+M0\>>"[;X*>&OV9/%>N7_`,2_
M!W@^QMWA^&%G\"?&N@^"?#EWK,#6UM>'QG+8:_)=,MR8LKX0V_[5?Q4_9@TC
M0?@Y\4M)\#:O^SE^PY^SCJ'PI^)?BC]M2?\`9P\(_"'7/%WP?3Q7:_$WQ_\`
M#VU^$GQ*T/XF>";3QB6L-=UC7/&.FZ7<:7HVI>#U.EWUG<30`']6'C?X2_LW
MQ:]K/Q`^(7P\^$J^(_'^GV7PXU_Q9XH\->&O[4\7Z;JK&ST_P?JNJ:A:&?6;
M>]8_9[72[J6<2D+'%&=BA5^$/B7X$Z7X@^(7[//P:LO#7AK4/V?E\#V'C7P%
MX3\.+X<T?P:/'WAH>)?!]O%#:6%EI,[:GX<ACO1_9[W#P0B&.\,4K(A^"/\`
M@I9X%MOC=^Q-\'[/X@^/)?#S:K\7/V7M7\1>-?A5X_\`^$6T-M4UGQ1H%G>:
MKX9\96[VTLVAWU_JTA\+7ME-#<7C7>DSVX<R"%_R@^(G[,4OA'QY_P`%;?%O
MPQ_:M_:/T8?LO_`C]EWXD_!C5/"GQ=FU&[UGQ3H7P3^(?V/Q%\6?%?V>YO?B
MM=66O>$]<T:+P[XAFGTK3--ENE;SKG4GATX`_J6F^&GPYN-;U'Q+<>`?!D_B
M+5[>VM=5UV;PQHLNKZG;65_!JMG!J&HR637=Y':ZG:VNH6ZW$L@BO;6VNDVS
M6\+IL:GX5\+ZVFH1ZSX;T#5TU>"VM=534]'TZ_34[6R=Y+.VU!;JWE%[!:22
M226T-R)8X'=VB5&9B?Y!M"^,7[=/[47A;]ISXXZ/\7_AM\._B3\$O%GP;UWP
M;\1/BK^VKJ'[/GPS^!7A6Q\(?#GQM;77Q)^!LWP:\0^']<^''Q.GU'Q''J'B
M#7O&UG:>*+'67BTZ\L9+"%4[OXM_$[]H[PY\(OVQ?CSX>^-/Q=U'4_\`AZ]>
M_L@-H5W\3=2\$?#;X:?L_:[K7P_/B34(_$=GX7\5Q_#>;4+G5K3P[<?$V_TC
M4H?"FG:GY5G!;279E(!_5YX=\)^%?"%K-8^$_#7A_P`+V5S<&ZN+/P[HVG:+
M:W%T8TA-S-;Z;;6T4MP8HHXC-(C2&.-$W;44#H*_DTUWQK^TI\'/'EE\)_B-
M^TGX.^'W[*/QM_;-_9$\,^*=`^'?[71_:-^)_P"S_P##SQY\./C:?&-AX]^,
MM[\//A]KWPJ^'7[0/Q2^'GPRT3P1?ZM9"V#7/Q"LM)UZS5II(9OA!XJ^(GQR
M^/7P0_9FO?VB?CEK/[/WA_\`X*%?MR_L_>"OB1X$^)]W/J?Q:^"GA']F+7/B
M3H6@:M\2O#J7%UK%EX&\>Z,NE1>([V>*:/4=`?1+35;A-1`NP#^L6BOSO_X)
MI7OB*'X+?%#P-K_B[Q7XXM_A'^T]\>?A?X5\0>.-9N/$/BJ7P=X?\5I>Z!8Z
MQKEY_I>JS:7!K$FG07=R6G>SMK=9&9D)/Z(4`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5^=OQ#_X
M)M?#+QQ\;?B]\?\`0OCG^U7\'?'WQRNO!EW\1A\&/C##X)T'69?A_P"`]!^'
M?A0_V._A;58T.F:#H$4BR2RSSRZAJ.IS2S-;26EI9_HE7X0?\%!/^"M'C;]B
MKXD_$6WT"W_9_P#BQX0^%6H?"6#Q7\*M"'QPU3XTVFG_`!*N]`L9;KQAXV\,
M>#-:^$_PFU:!Y?$^H:#HGB>+5[;5=$M/#>HZKKOAZ37S:6@!]V^+?^"=7P!\
M>_"[XD_"?QO?_$KQ3HOQ;\;_``8^(?C_`%W5O%\+>+/$'BOX&ZEX(U3PMJ5U
MJUKH]M`6UBZ\!Z6?%B_8#_:WV[5Y+5M-N+BUGLO+/VK_`/@G=X>^+OB'4/&7
MPXU'QKX1\9_&#]H?]E?QY\;_`!9X7^(-UX.\0Z9X._9UM_&.G:5J_P`/]5MK
M9[G1/$EEI_BF:)XK9YUU8;$DB5%G2?S3X,?\%&/C!\4/VVO%?[-?B/PM\`?A
M?IOA[XL^,O`%M\*OB!XN^(?A7]IS7O`7A7PM?:W8_''P1INK^%8_A]\1_"WB
M741I5JGAGPU?0WVA:/>7.LWFOWTME/ID?L7[7'[5'[2OP[_:J_9D_94_9S\#
M_!K5=<_:-\`?'/Q,OCWXU7_CNV\,>#M7^$6EZ'K=I:36'@6"74-:CUNRU"^B
M>P6?2YD>%+M-22."2VN`#JO!/_!,W]F'P=X9T;1;ZT\?_$3Q)9?M!^`?VHO$
M?Q5^)WCG4?&'Q6^(WQF^%[0)X$\0_$'Q=<PVYUO2_#.G6MIHFC>$[2QTSPMI
M6BVZV&F:19QS737&M\+?^"='[.?PC^+6A?&#P\OQ*UG5?`UUXUO_`(4>#/&/
MQ+\3>)_AA\&K[XB/._C.\^%7@+4+AM%\)W>N)>7]HUU%'=7&G:=J.HZ5I$FG
MZ9>W%I)^3VE?\%O?C%\3Y/A9\//A]\(/A;\,_C1<?"KXJ_$3XX0?$Y?B]\3_
M``AX:U?X8_M">._V:K+PG\/K;X,^'9M0URU\>>.?A5\1=8T[Q5XDUK0HO#/A
MK2M).J:'J.J:Q%:1>K?#'_@IK^V_\:?&GQJM/"G[._[/G@7P1^S[^SI\-/CI
M\3)?B5X[^*L/CZ+4_%/@?Q;XD\0^#/"?AC3O!%O:ZXB7GA@W&B:[XBU'P.(]
M)O+2&YTW4+FYDN[$`]\_9!_X)E>`?#_[,7[1'P[_`&E/A9X-T_Q7^U_^T%\7
M?CS\6/!_@;5)$TSP!<>(_B+K.M?"S0?A]XST1M/U33;OX?:,FE>*M*UW1I=,
MGTOX@Z]XKU32HK*&]^S#W:U_X)H?L[S>!_&G@7QGXC_:#^*MKXQU?X9>(K;Q
M'\5/VAOBKXS\9_#WQ)\'3?2_#KQ)\(_$M]XBCOOA;XBT&\U*\U&YUSP7_9.J
M>([Z8S>*;K6U"H/@'X=_M^?\%-?B?X"^#_B[0_A/^Q!IUY\;?V%;?]O'1+*Y
M\5?''4;;PAX(CT#P5JEOX!U>9M/T67Q+XO\`%USXVTQ([^Q3P]H?@(_;;2XG
M\?QZ?#JVJ_'7QV_;9^-GQ?UK6/C9^SWJ.J?!7QS\8_\`@F3_`,$\_P!HY4\1
M?$#XD^(=!\+)\5_VN/B9X-U[PEH7ASP_XLT+0_#]S%I>C1IJ'B+0+6WN/$]O
M/>V&K6Y^V'480#^E+X#_`+//@_\`9\TSQ78^&/$_Q5\9ZAXW\1GQ3XF\2_%W
MXH^,_BAXAOM26QMM,M8+&Z\5ZI>V?AW1[#3[.WMK/0O#%AHND1E7N9+.6]GG
MN9?`4_X)K_LKW7Q1U'XI^+-"\?\`Q)N+F]^)VI:-X`^*7Q8^(?Q#^$7@W4/C
M.UVWQ3N_"'PR\4^(-2\+:2?&0U+5H;RUELKRPTNRU?4M-\.VFC:;<?8U_-.?
M]IC]N;X#?MN_MS>+OC9\5_@GXK^"?[+W[#_PK_:-^*?P\\->$_C)I?AZS\'>
M'K'X[^*O&%W\'M#U'XG>++;0_B-JMCX+AM=5UO5M/U6U\06L.FP?V592Z8BW
MO'V7_!;7X]>&?A?I_P`7?&WP`\+>.-%\5_LS7GQF30?AKX<^+'A6Q^#GQ,U+
M4_"5AX'^%/COXI?$2(>$_B/I.MGQKI5O?^//!^D>$1'?Z;K7]B^&]:TQ=/U*
M]`/UN_9Q_P"">7[./[+OCF/XB?#NW^).N>)=(\!GX6>`9/B?\5?''Q-T[X1_
M#2;4;35+[P+\)=*\7:OJ-AX$\/ZK<Z7H$>JQ:1`EY?V7AK0-/GO6LM.2!\?]
MHG_@FA^RI^U!\1?$/Q-^*&B?$:#7/'7P[NOA5\4M+^'_`,8?B9\,?"GQC\"R
M:-KNAZ;H?Q>\,^`_$N@Z7\0[?PY9^(]3_P"$>'B.&\73S)'`RSV*-9O\0?`?
M6?VJ;_\`X+'>!O\`AIK5_@O)J&L_\$H?'?B/1="^!5G\1--\,:;)=?M/?`MM
M3AUN/Q[K^L2:SJVG:A=WFGZ7K]E;:0+S2`)9M+T^6YDLXO.?%OQ._:U^%_[>
M_P#P6"^)7P%N/@=JGAOX,?`3]G+XEWOA'XRI\0KVY\5:OX6^!DOB2?PGX<OO
M#/B+P_HOP]LM6T/3M7>;QAJ%MXM)UZ338+GPQ%IXO-50`_1#_AUU^RE+\6/"
MGQ8U*#XTZ^?!/B+1_&_ACX6>)?VB?C9XC^`VD?$+P^L@T7X@V7P5UGQO>^`+
M7Q5IDDLEU836NC0:597SM?6NE0WC-.?=/VE/V1?@]^U3;^`)/B2OCK0_$_PK
M\3S>+?AQ\1/A3\1O&7PF^)7@[4[_`$VYT37;71_&_@/5]%UQ-#\4Z#>7>A^*
M/#UU<W.BZYITX2]L9)[>SN+?\M-)_P""L_Q=U[POXG\!V?PO^'MC^U/XH^-_
M[-_A3]GOP+*?$^I^'/%_P:_:<\/Z/\2?#7Q$U_38M9T[6;FZ^'WPYMOB!;^.
MWTG7M.TN7Q-X/6ZL5L[#4[/3I_?_`/@I!XW_`&C?"GQG_P""9&@?!+XOZ/\`
M#!/B7^UYJ'@7Q[:ZAX3\7>)]`\7V[_`?XJ^(=/T_Q1H_AOXK?#9_$'@FSOM!
MFO;OPA>WZS:AK*^'=7@U_3#X?GLM:`/;-!_X)E_LC>&_C/X?^-VD^$?'$.M>
M&?%LOQ+TOP%/\8/BK>_`^/XQRM<L/C6_P.O/%T_PN/Q6@-]?SVOBN/PQ%):Z
MK>3>)(+9/%"6^M0?4WQ!^"7PT^*?BKX3>-/'?AU==\0?`_QA>>/OAE=O?ZE9
MIX<\87N@:CX8DUM8+"[M8M0F30]7U.QBMM26[L%6]DE:T>=()8OY\/@Y\;_V
MG?V:/B+_`,%1_BOI&M?!3Q-\-OAC_P`%#O@QI'Q8\(:S\.OBW9>+/B!)\7=+
M_9Z\&>/;[X5:Q??'/4_#OP<M]$L_'0\8>&[:_P##7Q6TOQ5J]E<Z!J">'(M0
M;QA%ZCX!_P""I_[9?Q7^)6JZG\-?V;+KQC\+-$_;2\0?LP7_`,.O#O[,7[3&
MN:S'\./!GQ3OOA/XT^.EW^V';:U;_`C3;CP[>V4WC.]^'9^%%];0>&[:ZTZY
M^($.JJ)0`?L)J/[(7[..KVO@FQU/X7Z7?6?PZ^+OQ9^._@VUN=6\2R6^C_%?
MXZ:]\1?$WQ8\6^4=:V:C+XRUSXM?$.^O=(U5;[0+,^);FWTG2M/M+/3(++YD
ML?\`@D)_P3]TY;V"U^#'B./3[CP_XG\(:;I"_'C]H:/1_"?@SQM;Z=;>,O!7
M@33(?BK%:>!O!WBF#3+>WUSPQX5CTG1;^RDN]+DL_P"R;RYL9/&/^"U/@71=
M=^`_P0\62W?BC2?$6D?M:?LU^"[35?"OC/Q9X0NI/"GQ-^+GA;POXXT#4&\+
MZSI*ZIIFO:)(;6XM=16ZC@=8KJT$%W%'.OAGQ+_X*(?M>?">^_:N\7^&M%_9
MJNOV>_V+?VV?V;?V2KKP!JO@KXL3?%[XD^"/C=XE_9[\$)J]C\3U^,)\*^"?
M$O@AOC=9:BNIZA\,_'EEXQBTRYM)]%\+S6Z7^K`'Z?\`B7_@G]^Q]XL\2Z+X
MLU3X*Z1::MH.D_#70K.#PQXC\;^"O#UWI'P=\4:3XS^%UAK_`(0\&^)]!\)>
M*8/`WB30]+U#P\/$VB:NUBEK]@5CIL]S9S=/H/[&'[,OACPE\)_`N@_"K3M-
M\*_`WXL^)/CE\*=)BUWQ:Z^#_BIXO\7^+O'OB3Q;9W<_B"6_OI]6\6>//%NK
M7&F:O=:AH:G6IK*'3(M.@L[.V_.;P-^WI^UA\4/@K^V#^V3X8C_9[\/_```_
M90\=_M7^%S\"];^&'Q)UWXU>.M'_`&4]+\2QZ[J;?&K3_CEHG@KPOK'B[7/#
MLEWHFB'X%^(+6UT6XMK6\UK[9.U];\#^TA_P45_;3_8WD\)6/Q8TO]F;XN3?
M&/\`9$^.GQW\`:Q\-/`'CWX>:9\-_B9\#?!.C^/K_P`'^-K#6_VA/BE??%#P
M-XGTK5I]/TOQ;X3N/A[-8ZAI<;W<$D>N64%H`?I%XS_X)V_L9_$&?Q'=>+_@
MEINKW/BV#]I"V\0S_P#"6?$"PFU"']KJUT"R_:*7S-+\6V36C?$NU\+Z#%>R
M61MI="_LZ-_"CZ#)-<O-P/A#_@E'^PAX&\#>(/AMX=^$'BB/P5XCLO#-A/HF
ML?'[]H[Q0FA1>#/M2^%I_`=]XH^+>LZG\--2T2"]N[*RUCX=WOA?5DTVXDTQ
MKU].;[+7YQ^*_P#@H#_P4>\'^#?VLO$E_P")OV)+R?\`9._8J^$'[<.II9_L
MV_'=(OB'X>^,/A'XH>(=/^"]A;S?MB;_``=K/ARZ^#OB.&\^+MQ>>+;'6+?Q
M+HH@^$6E2:)?2:RGQ`_X*U?M>:WKWQ[;]FS]GFZ^*+_`:Z^"NDP_"#PG^RG^
MTY\9?$WQ1USQ;HO@OQM\2]-B^._A/Q-X&^$_PJNM.\&>*+X>!(=;\.>-[?4=
M7TJ&?6=1AM+][6R`/V^^!7[.'PB_9NT77]"^$FA^(-+M?%6NS>)O$NH>+/B+
M\2OBGXFU[79U*2ZCJWC'XK>+O&OBV_E*E@J7.MR0Q[F\J)"S9\#T_P#X)F?L
M-Z7\1=-^*]C\!=+@\=:'\3+_`.,'A[53XR^)$MEX8^(FKZ5XBT76M>\*>')_
M&4GACPM%KMCXKUUM?T/P_HVF^'==U"ZM]7U;2;S5],TJ^LO5OVD?V2/V>_VQ
M_"/ACPE^T=\-[?X@>'_#.LCQ5HFD7VK^(-%_LO79M,N-,DNO.\.ZMI-S+(ME
M>W-JT,\TL`WEA'YBJX_!W]G/X:_LP?\`!/S_`()\?L_?MD_">"U^$O[1WQG\
M+_#WX*Q>.(/A[\5_VF?%GQ1\3_%3Q7:0P?#3PW\)-*^,7@*TU?QGXLUG0-,;
M0]2U35)?#_AG5-)AUS7=&U+3=/N;8@'[Q>#_`-CO]FWP"OP(3PC\+]/T9?V9
M4\?I\#1%KGBRY_X0%/BBQ?QZ+,WVO71U;_A(6),Y\1'6#9YQIILQ7EW[`G[)
M>M?LG_#3XH0>/M5\%>)?C/\`'O\`:)^-O[1WQE\5>`-%N-#\+ZMXK^*7C;4-
M1T:PT:ROH8=0CT_PSX'M_"WA[_3$,]UJ=AJNK7$MW?ZI>ZC>_CZW_!8?]KKX
M4_#O]HCXL_&/X3^#[_PQ^QS^T7\/?@G\4_AKJOPXUCX6_M"_&3P?\5/"OAR7
MPEXJ^%7A/2_C/\5_#>F?$C0_$NOQ:IXD\+3WVNZ7XO\`!,6IZAHNF?#V_P!&
M-GJ/[4?LE_&CQ_XZ_9$\"_M*_M$>)/A1;7OC_P"'D?QTU,?"F#58_AW\._AY
MKWAZ'Q?I7AB/7]:UO7-0\87W@[PRRQ>*_&Y_L6R\0:]%JU[I/AGP]I(L=+MP
M#WG3O@]\,=)\?_$CXI6'@O18/'WQ?\->!_!WQ-\1M#)/<^-?#'PW7Q>G@C1M
M<MKB673[FS\/Q>/O%\-J%M(Y)X-<N;>]>YACM4@^>O"O_!._]BCP7+X[_P"$
M?_9V\!Q:?\2/"^N^!_%/AK5$UCQ%X);P1XG6T7Q%X*\.^`_$>JZKX,\$>#];
M:PLIM4\+^"=!\/:%>W5K;W<]@]U$DP_F9_81_;/USX>?MJ>#_P!L+Q1K7CO6
M=,_X*F+^T[I'Q<\!ZWIOCS1_`GPO\0?"2ZU_XD?L&0>!]2\0VEOX8\0:AXL^
M#ND^-?AI):Z';632W^JV>K-J6MR2W5Y<?6/QY^//[:W[3_\`P2+N_P!LQ?VE
M/AQ\(?#7QO'P,\?^'/`/@;X1W:>-/A%$_P"U3\)]'T/PY9?%2Q^,UW!XEM7T
M];B'XD?VKX<AEN+FZDT6";2=)_M.TN@#]JM"_P""</[#?A[2O%NBV/[-7PYN
MK#QWX9MO!?BX>(+34_%=YKGA*PUBUU_2?#MWJ?BC4M8U-='T'6+&ROO#=C!>
M0P>&Y;6W704TZ*)(UJ^"_P!BK_@G_H7A/XRZ;X1^"7P*N_"7Q.N_#EI\=YI(
M=+\4VGBO5_AE<ZMK7A2;XA:QK%_J\]QXB\!W'BC4-0T34M6O4USPY]MM9;.Z
MM([73?L_+?M??$#X]?LS_P#!/3]H?Q]??$O0O'?QQ\)?#GQ7_P`(W\2-'^'5
MQX$TK3];\5ZHF@^%]9D\'V'BOQ6]G'X(?Q!:7+:A#K%R/L>BQ:EJ%G>S17HO
MOR^^(?[/7PR\'_'S_@C[_P`$W?&Q\S]D'QK\%OVG/B5XL\*7OC6^M=/_`&F/
MV@?A[X7^&NIZ;HOQ/M@EK>>+["*7X@>*_B6NAWVMW-MXZU^8/J.D-I_@^2SU
M0`_7R;_@GY^Q+KWA70="D^`/@#4M!TS5/$OBG0M0ADU:75CJ'Q`TRQTWQ7J:
M>,;?6/\`A)-1A\6Z+8:9I^KI<ZW=66JZ78Z?:3Q2VEK;1Q[/B;]@S]C[QEIN
MCZ5XH^`7@;7+70-4\=:QI<E_!J4FH0W?Q/UVY\4?$6*?5QJ*ZM?Z7XX\1WEW
MKOBK0]0O;K1=<U:YGO\`4-/GN97D/YQ?'G4_"?["&K^#OV5O^">@\<^&?B1\
M2KGXE?%Z\_9U^!GPA\(_'/4;;3-,A\&Z#=Z_:/\`%SXN_#OX;_`WP#X?UWQ/
MHVL:]I&H:E`GB.#4$L/"Q\-RXN+KY\_9U_X*"_MV_MD>"?#FI>'?B1\*?V>]
M<M?V*_BQ^T!XP,'P1M/B8^H^.?A%^T5\0/@W_9^E0WWQ5&D>'[#Q%I?@N"_U
MJ)-4\<65I?7ES'X?U`VL=O>R@'[WZ3^SC\"-`U2ZUC0/A-X&T&_O/@[H7[/D
MS:'H-GH]LGP2\,7OB#4?#OPOM=/TU+;3['P=HM[XJ\13Z;H]E:V]O:'5[M80
ML;*BU_%/PY_9]\%_L]>(/A'XUT3P!X2_9IL_AOJ?PX\3^&/%%Y8:#\-[#X8:
MMI$WAG5/#>LW>JWEI86/AV\T>_FTBX%W>PQM!=&'S0SK7\\/Q<_X+`_M&7_P
M3^%WQ-^"MU<ZS\5[#_@G_P#`7]K[XZ?#'PC\(OAYJ/P6^%U[\5DU[5H]6^+_
M`,6?B9\8O"WBC3/#'BRRT>XTWPQX"^&FBZIX^TF'3UUVXO=>'BK1-.L,C]J_
M]J7]I7]M[]C+_@LY>P?$OP?\"?A%^R?\,?B?\';GX5:9\/-&\3>(_BVL?[/&
MG?$3Q#XAUKXA>)_'&E7_`(3C\77/BL^%?"FG:!HL,]E965M>PKXPU6_73+D`
M_HITW]F/]G2#PKX\\+Z;\)O`K^#_`(NW/AS6/'^D1Z;%=:/XWNO#.D:!H_A?
M4=5B>2:&]?2='\,^'+72[A"!#!I&GO$V^%)*Z*/3_@C\>?#_`(5UJQD^'WQ9
M\,>#/&VG>)/!VMZ+J6C>+M'\/^/OAYJ[Q66HZ/J^D75[:VGB#PIK-G-:3+#<
MBYL+R"XL;R-76:&OY\]?_P""C_[47AWQ7\.?&7P5D^*/Q/\`V?M&_:J^`G[+
MOQ'O?B1X3_9Q\(_"ZP?QO!X7\.>-_#7A_P`;ZE\25_:+^(?Q(\#ZOX@LKJZ\
M3Z=X1F\,ZK>)>V$XGD5;ZY_1+X+:5X8_9G_X*-?MA?#[PWJ6B>$/@E\;O@E\
M%OVNO$'AF:]L-(\,>`OC]JOC#QY\%OB)XGLX'&F:5X8M_C=X;\%?#K5KJU7[
M<_B;QQX&\<>))IM/O[Z\&K@'WO;_`+/WP0MO"FA>!8OA3X$/@[POX]TKXI^&
MO#<WAO3;G2/#_P`2-"\4IXVT7QQHEG<P2Q:5XGTKQ;&NOZ?K%B(+RTU(O/!*
MADD#?.S?`G_@F[X3\>>+?%$_PQ_8[T'Q_K\&NZ/XQN;[0?A'9:K=IXC2>+Q;
M:ZIIMY$D=O<^*H[J>+Q@YLX+OQ1')Y?B%]154"_<L<D<T:2Q.DL4J+)')&RO
M')&ZAD='4E71U(964E64@@D&OYM_^"OO[&/[*>E_%G]@[QQI_P"S=\(+77OC
M;^W[\/?#7QN\1Z?X'T^QU[XF:+XDT+Q(M]H_C;5+33I+/Q'I6JSJ'U:P\3QW
MB7\<9BM#%,TDR`'[(?"7]GS]A:S\/^-_!/P6^$O[,=YX8UW6=!\2_$'POX'\
M+?#?7='OM4L]3U/5O!=WXETG3K6_M5@T'4$U:7P#9WL*:?X86VNK;PE;:;;6
M;0P^T>(_@9\$_&,7CV'Q=\'OA9XJA^*G_"/?\+/B\1_#[PEKD7Q'_P"$1CLX
MO"?_``GL>IZ1=)XP_P"$8BT^PB\/?\)"-1_L6.QLTTW[,MM"$_GQ^,&A?$3]
MF'XO_P#!4#Q5^QE\7-#_`&8_"?[)7P'_`&6OBT/@UX%^!/PSU?P?X^^T>%?C
MCXE7P+XGOO%VDZM#H?A74=2T[Q)JMXWPUL_"'C=-1\67E]?>+9K==(LX,Z]_
M;Y_X*8?'GXB?&+Q1^S?X2N--T[]G36O@WHL/PTBNOV2-!_9^\>P>-_AQ\+/B
M=XHU7X^>,OCU\2_#'[26A0W.G^/]9TKPCJ/P-AT3P]8"Q\+RW=_XNU6/Q)I=
MR`?OKXI_91_9;\<^,9OB)XU_9K^`/C#X@7%[IFHW'CGQ3\'/AWX@\8SZAHK(
M^CW\WB;5O#EWK4M[I+QQOIET]\T]@T:-:R1%5(]`^(OPJ^%_Q@\-/X,^+7PW
M\!?%'P?)=6M[)X4^(O@_P]XV\-/>V+^997;Z%XET[4]+:ZLY/GM;AK4RV[_-
M$Z-S7R1_P43\7?M5^$/@9H%U^Q_`]W\2-0^*O@JP\6V>AW?PFA^*$_P@"ZM?
M?$;_`(4?9_'&5OA;K/QB33[.T_X0W1_&&E^(-+OI6NXI-#O',;P?BIX"_P""
MCO[5_P"T=XW\%_L[_`+XB?M1^)KOPI\#_B)XY\9?%31/A?\`\$^?AQ^T%XB^
M+7A/]H;XA_"GQ/\`#KXB>%_VB_$WAKX#/IWP(C\-:-X:^(8^`_@\3>-;[5-(
M\5:1XJ\%Z5J2Q7`!_0?;_L;_`+(5GXGM?&UI^RK^S?:^,[*/P[%9^+K?X&_#
M&#Q/:1>$+ZPU3PG':Z_%X775;>/POJ>EZ9J/AU(KM%T2^TZPN]-%M<6=O)'W
MFE?`KX(Z%H_@?P[HGP<^%>C>'_AEK<_B7X;:%I7P]\(Z?H_P^\1W2:A'=:_X
M'TRTTB&R\)ZW<QZMJL<^JZ#!87TR:GJ"R3LM[<B7\!]<_;E_X*(?"GP3J/PJ
M^*%YX2_X:\_:G^%_[/UG^R)X>BC^%&J^%_!OQC\8?&2Y_9\^,UQ;:_X!LO$G
MA#QCH/PZT74OAY^TMK6F:KJGC*#0K3Q-XD\(7.MS^'=%TR^ND^%O[6/_``4?
M^*OQU\5VOAO5?B)J.E?!/]M+PK^SWXM\+W4O[`W@GX#ZY\&='UWPGX<\>^-/
MB+8^--7L?VOW^*WB'PWK.M?$'PJGPNA\*>#;SQ#;:'X;\.^%==T>>\$P!^LW
MQ\_8"^!_[37[2OP:_:"^-OACP1\4=(^#OPO^*'PWL?A'\2_AIX1^(G@K6I?B
M5K7@O6CXHN8O%MMJ=M9:KX>E\&PQ:>(=)F:07\LGVFW:%`_M7BO]E']EOQY<
M^"KWQQ^S9\`O&=Y\-M$F\,_#J[\5_!WX=^(KGP#X;N8_)N/#_@J?5_#EY+X6
MT2XA_=3:5H3V%A+'\DENR\5^`?@K]K3]K/4/V(?`O[1GQ%_:_P#C5=^//VEO
MVB_BK^S9\&OA9\$OA?\`LG^"GT;Q!X0_:W^,OP^TS4[SXI?&WX6_$?0-&O-4
M\$^!7T_7O$7B.P/A?1M#@L;;P?X%MO%=N=;U2K\,OVF_VYOBSXP_8H_9@U3]
MJ7QA\+]9\9?MH?MK?`3XI?%;PA9_LZ_%GXH^(?`/P*_9O\2?%3PQIM[XSN/@
M?IWP:U3Q?I^IQMI(\9^&?@UH>DO):Z?JE]X;UN_L))[X`_>9/V9M%B_:)^'?
MQPMM;M]/\-?"+X+:M\'?AA\(=+\,:;IOA3P1!K^IZ/<:SX@T&>UN4BTR6ZT3
MPYX<\+P:5IFCV%I::+HUI;),\$<<$7:VO[-W[.]EXQO_`(AV?P$^"]I\0-5U
M>XU_5/'-K\+?`]OXQU+7;M2EWK=_XFBT)-:O-7N49DN-2N+V2\F5BLDS`D5^
M!OPE_:"_:4^.7B+P'^QU\1_VS_BY\+/#2_%3]M'P'<?M;^#M%^"?P_\`CA\4
M(_V:O%7PRTWP!X`FU+Q7\%/%/PPT;Q2-$\3:MKOC?7_#OA;PYK_C&TL;>;3K
M*ST^77/M'&^*?CI_P45^)7[1WQR\$_"+]J*_ET7]C^3X+Z#X"\:2?$']DOX8
M?#O]HG3=;\#^&_%7CCXN?&WP+XC^"?B74_&FC^)M>D\9^`B_P3\1_#3PIH-]
MX:N3X7@T[7+>Y-`']%O@G]GOX!?#/4=?U?X<?`_X0?#_`%;Q99S:?XIU/P3\
M-/!?A34?$MA<&$SV.OWN@Z+87.LV<YMK<S6VHRW,,A@AWHWE)MJ>)?V;/V=?
M&=MH-EXP^`?P5\5V?A;3H]'\,6GB7X6>!M=MO#FDQ',6EZ#!JFA746D:=&>8
M[+3TM[9#RL0-?"'_``4_^,?Q=^''P>_9.3X;_&>X^`.L?&?]L_\`99^$7COX
MF>&;3P;JK:%X*^(?B;R/%ITN3X@Z-X@\-+:.D2F.YU73[BVFM$\F]2>RN+JW
MG_,?XQ_M5_$[X6ZYJ_[%OAC]K[]IG]H/QYKG[5&E^$/@)\5--^)7[,OP>USQ
M79^'O@%;?&CXG_#;X[_M(GX":G\._!?@GP_K>I6FA2:AX,^'5G\3+\75MX=\
M.Q7=]%*B`']-GB3P7X.\9>&[SP;XO\)^&O%?A#4+:*RO_"OB30M+USPW?6<#
M1M!:7FAZI:W6EW-M"T431036KQ1M%&412BXYO0/@U\(/"NE:MH7A?X4_#;PW
MHFOZ+I_AO7=&T#P-X8T?2M:\.Z0NI)I.@:MI^G:7;VFI:+IB:SK"Z?I=Y#-8
MV2ZKJ2VT$0OKH2_S,?"C]O?]KWX(?!#2OVHOC)\59/CUX6^`7QO_`&JOV*/B
M=X.T/Q+H7CNT^)OBS08M/U7]F#QK9^.O"7P_^#^B^,?&-SJD^E_#O5]<TWX5
M^!Y_&]KK0\0WFAZ?X@=K..Q\4O%W[?/@?Q-\3?AYXB_;K^.OASQ;^S[_`,$E
MOA+^W/X@;PWX?^#*6WC;]H?6_P!H']JQ]8\/^+K;Q-\-/%5S:?"V#1=(T'P-
M=^#_``=J'A75-0\/>$?#$%SXG%QIDTUZ`?TCZ_\`L\?`#Q7J^A^(/%'P,^#O
MB37_``Q::78>&]<U_P"&7@K6-7\/6.AF,Z)9Z'J6HZ)<WNDVFCF&(Z7;V$]O
M#IYBC-HD)1<=S!X'\%6VF^(-&MO!_A:WTCQ9?ZAJOBK2H/#^DQ:;XFU/5HH8
M-5U'Q!8QVBVNLW^IPV]O#J%YJ,5S<7L4$,=S)*D2!?Y<_B!^V+^V?^S3\+/V
MC;G0_P!I;XE_&'X@_%#]BS]B3]K'X?:G\5?!WPGN-.^`&N?M&?'O2/A+\<M1
M^'W_``B_@*QT]OAS\,/!/B)/&?AC3O'GA3QA8>&)O#5SJ'BX^+;&/57U;7^(
MGC;]O'P#;>%_!5E^U5XZ\)>'_BU^T1^R]\//#VNW/[0_P)_:$^-?A+2/B`_C
M#P_\3-0TW6?#WPPT7PE:Z#XFT1-,U;PX?&7A+Q)'I'B^TM]1\/I':LNGL`?T
M2K\*OV8OAAX:N?`Z?#?X#_#SP?\`$[7K#0;SP>O@_P"'WA+PU\0_$^I(;;3-
M&N?#XT[3]+\6:]?I&;>PTZ6TU#4+I$,5O#(%*CT?2OAW\/\`0;;PO9Z'X%\'
M:-:>"/M9\%VNE>&=$TZV\(&_LIM.OCX7@L[&&+0/MNGW$]A=_P!DK:?:;*>:
MUFWP2/&W\G?[34/Q.U3XU^(_V=OB;^U%\>O$OPS_`&/?^"PG[!UCX0^,_B[Q
M?X2TKXD>$O`_[0W[.WPL^).KVOB[QOHO@[P]X;N=-\`^._%.IK\-=;U/P[%K
M&C0ZZ]CK^L>)2EA):_UP:%#!;Z'HUO:ZI<ZY;0:5IT-OK=Y>1:A=ZQ!%:0I#
MJEU?P*D%]<ZA&JW<]Y"B17,LS31JJ.``!=*T/1-"CO(M#T?2]&BU'4;O5]0C
MTK3[33H[[5K]E>^U2\2SAA6YU&]=$:[O9P]S<,JM-*Y4$:E%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%?D-\<?^"0'PU^-'Q%_:"\5VO[0/Q]^&?@/]J'5O"OC/XU?!KP)J_AJ
MW\#^,/B=X-M]%L=%\>W5QJF@:AK\4IT_PYH=IJ7AJ'4D\-:FVG17-UI[7#2.
MWZ\U^)_[>_\`P5>UW]AGXL:AHVO>&/@3XJ^'OARY\%S:UX8L_C).?VC-2\.>
M+F\'VLGB'3?AOI^@7^F^';?3;_5O%"VD?C35=(C\16FB:;<:1<R/J\4*@'U3
M:?\`!/W0K[]I;P/^T;\0_CE\8?BF_P`(_%OBSQU\%?AOXPO/#K>$OA9XG\:>
M'=9\*:Y=Z'?Z?HMIXEU&Q?0?$.L6-EI&M:O?:?9+>"2&$200LGD'[<7['WQN
M_:0_;%_8L\>?#?QYX]^#O@?X3^&?VAK7X@?%_P"&FM^$M.\7^&I_&_A#3M'\
M.Z-IUCXBCU"ZO8_$=U'/:W5UIVC7?]G1Q+<R7-HXB9N<^#7_``4H^)?QI_;E
M\;_LRZ/\//@EX;\%_#OXF>*?AOXJTCQC\:(?#W[3T%IX<\,7FM6WQ,T?X+ZA
MID(\2_#[Q%?KIMCI=YH6HWMS%97KZI>F**%HZ]G_`&S?VM_V@_@Y\;_V=_V=
MOV:_@U\/?BO\2OVA?#_Q?UC29?B3X]U+P'X;T!_A7H%CK\KZA>Z;H^L7-Q:W
MT%S)`T=O!]I67RFB!7S,`'+:1_P2B^#OPZ\,?!NS_9]^*/QE_9^^(GP=\'^+
MOA['\9/`OB.QO_'OQ&\$_$#Q;-\0_&F@_%*7Q-IVK:7XR76/B/<77C^UO]0L
M?M^A^*;_`%:_T>XM1J^HQ7/N'@7]A;X<>"]2^/6O77C'XB>,O$W[1_PF\*_"
M+XF^)O%^NQ:GK.J:-X3\)ZUX0M-7CN5M81'K5WI^NWDMU<;#$9UA\J)(XE2O
MS6^'7_!7K]I?X\>+_@E\-_@1^Q_X0\0_$#Q_\`/V@?B?\2]*\:_&2'P7I'PM
M\6_LT_M,^&/V<OB3:G7'T348?$?@X:MJ.L7.BW=E#%K=_.^A,UK#9OJ+P]<?
M^"H?[4":/\,/B2G[-7POU3X+_M3>*?B5\&OV5_%6C_%'5)]9O/CSH6A?$:;X
M5:'\6]-FT2*#1_!?Q7\3?#;5]&M-<\,3:G=Z':S6]_?V^UPM`'Z)?#S]B;X4
M?#3PU\+?"V@WOB673_A)^QW9?L3>&FO;^.6>;X46%AX.TZ&]U!UA03^)3!X)
MTDO?J$C+O<GR1Y@"^`6/_!)G]F:P\*-X2>_\>R:='^QG\)/V);*\_P"$A%KJ
M>E?#CX)^//&'Q'\!^*=-O[>"*2T\=Z7XJ\97U^-97,1:SL!]FQ$P?X>_:@_X
M*?WOQ:_8F\&>._AQX(UFWTGXG?LJ6OQ]^,$GA+XK:Y\-OB-\&->T;XP_#CX7
M:C\.])\4^'],O-1LM:T[XL:AXF\%ZS>&&W:]L/"VN1VT4MO-<M#F?M)_MD_M
M=?M'?#G]H'3?V=_A!X>TG]E_X`?&KPM\!?B3\9-6^)OB/2_C3K?C'X;>(_!5
MS\7]1\&>%=%TXV5YX"T.\U,>%-2U'7M9LKW7/[,\5W!L3IXLS=@'Z$R?\$RO
M`>I>-K/Q_P"*/C?\=_%VOZY\/]/^$_QP.O>)M+NK#]I#X8:5J_B/4['P)\8;
M`:.MMK7AY;7Q9X@T"ZM;&/3VOO#VI7&EW3R1-D<]HO\`P2@^#5KX%U'X+>,_
MC3^TG\2OV>Y?AAJGP?\`"WP(\:_%C4+KP-X/\'WZ6<6GPZ.]K;VFMWNK^%+3
M3;"W\&ZOJNIWM]X<6QM)K"19[>.4?&MU_P`%N=9G^(5WK?ASP#\*?$/P`T_]
MJ;0/V;[O3M,\5^.K_P#:*DT6]^)&C?"GQ+\8K7PA9^$)/"+^%_"GB;4KW4[[
M0#K9UU_"^BWVI@HVV,<9X_\`VQ_VBOVGOB_^PW\9=(^&?@CX??L8WG_!0R]^
M'OPR^)TWQ&\1V_Q!\:1>"/\`A:WPNU6_\<^%;:TL_#.E>%_%_B[POKD'A>PO
M=1O[RX:WT@3VD5Y.0@!^FW[,G_!.+P+^S9\:K/X_R?&S]H#XV?$K3?@?K7[.
M^E:U\;?'G_"8MI'PLU7QQX3\>VOA[34^PV:VT>D:QX1LQ9S#?/,E]J,E[+<3
M3J\?)?M`_P#!*OX3_M"?%SXL_%75OC1^T3X#MOV@M-\'>%_C]\.OAO\`$63P
MSX`^+_@/P;X9L?"%IX)\5:5%82W2:7J6@0ZEIVJW6F7MEJ-U;:U>Q?:51+<1
M^X?M@?';XY?";5_V;O`?[/?@3X;^.?B'^T)\7_$?PUMU^*?B;7O"_A7P[IOA
MGX'_`!8^,=_KDUWX<TS5=1N[@1_#0:9%8I;J)5U&2191)$BM\4?L\?\`!4WX
MC?%/XY_`;]G+XA_!#0/`GQ/\5?$C]L_X1_'"WT[Q-J.J:1X-\8?LIZ#\/O$&
MF7O@2[FLHW\0:#XZT_QW;W,C:LMA>Z2D21&.:8R;0#U:P_8=.M?\%/M%_:PU
M7P!H/A3X8_`?]F'1/@[\&WTN[TXR^*?%FHZK<?;M2U70K2>1[&R^''A6"'P]
MX*N;V%+N%-;UE+7[/;$K<_5_[5_[)_@G]K3P=X2\.^)O%/COX>^)?ASXZTGX
ME_#+XF_#'7?^$<\??#[QOH]K?Z=!KOAS56@NH8IKC2=5U32+V&YM9[>ZT[4+
MJWEC*R<?E_X/_P""G/[6OQQ\=_LU_#GX"?L^_![4/$'QT^'_`.T?XY\2WOCC
MXBZ]HND>`M)^`?[3OB+X$27]E]ET2ZO/$=SK&B:)%KR:4([,1ZM<-:-<_8D$
MQ\3\/?\`!83]IK5/A9^U+\6-7\)?LZ>&M7^"_@OXK>+)OV9_$>J?$?PI^TK\
M)S\-O%%OX1T`^/?#'B?1-.TKQQH'C[?;>(I_$_@6YNM$\.Q:WI^F17VH2Q2L
M`#]6M)_X)W?!;3_AS\>?AUJ.O_$7Q/%^TA\1?A[\5?BEXH\2>)Y-1\4ZUXW^
M&L?P[70-7&H^1&L332_#'PW<:G$D(BO9?MN]0MRP&5%_P39^#.F_%;5_B+X6
M^(7Q^\$>%O$OQ)3XR>*O@;X,^+GB+P]\%?$7Q436].\0R^+[_P`'V#1F-M2U
MG3(-3US1K.]M]%UV_DN;O5+&YDNKCS/(_P!HW]OCQ_\`"WQ9XS\*6#_!KX<:
M#9?L)>#?VH-.^+'Q:U/Q1-X5\(^,?$OQ</PZU/3/$6B>&-/O-=U[1=.TJ^T[
M4-`TK089O$GBOQ,UIX7TZT:YU2`C\_O!7_!8[]JS4O#'B?P6WPT^%GBOXX>&
M?VNOV>?V?M$UC5?"7QI^"WP_\>>%/CYH?CZXM?%C>&OB7X<TSXA>'8=&UCPE
M$EO=C2KRVUK3?.FM"LSM%"`?MY^UA^QY\,?VR/"_A/P=\5O$?Q5T;0/!WC'0
MO'VEV?PS^(FL_#\W'BSPMJ5IK/A?5M5ET<>9J,WAW6+*VU32%F/EVM[&)=KY
M*UQFN?\`!/7]FWQ)X*^-G@/7M)\8:IHO[0OQH^$WQ_\`BG/=^--9?5]>^)_P
M7U?X5:[X(UR+4Q(L]A#'JGP9\#W6KV%KLM=7:UU$7:%=3N@WXL_M`?M9_P#!
M1KQWXC_9O^&VA>.O@/\`![XR?"G_`(*@ZC^R-\3]:T>Y^(Q^&7Q;\1O^S]X"
M^.?PW+Z(((-9F^'6M>%?BI'H_B_P[J$O]IOXGT6PO-(N9+%VD'W)_P`%5/'G
M[:?PT^`7[$+?!;XE_#GP5\:?&'[>'[&WPL^(^MFQ\4)X'\1R_$'XB6/AV;0U
MLK20ZT?A[K.OW%K%XNTRX?\`M*^\)F\L[.1+YXV`!],7'_!,;]EYO'OC7QGI
M\7Q1\/Z%\2O&6J?$/XC_``>\.?%3Q;HWP.\>>-]<T+5?#VN>)?%/PRM+Q-#U
M._UNQUBZFUE&V66JW\=K>W]K<36T9')>%_\`@DA^Q_X<T'Q/X>O['XJ^.[37
MO@=??LVZ+=?$CXL^+?&VI_#;X):HTAU'P#\++_6+J6;P/I5^AM8;Z;2S]OO+
M;3-*MKF[E@T^WC3XZUS]O+]OG2K']K^?3-)_9E\0O_P3:\%:9XB_:@D>P^)>
MAI\6]:C\%:M\7?%>E_"-+^#_`(I_3M'^&=E#'I>IZL^IIJ_BD36A,-L&>/Z"
M_P""S7C;XU>&_P!A!/%_P(\=O\-/%MQ\7OV=DN]?M[_Q#IFHQZ'XA^*7A*RO
MM.LM0\-7^FZA&MV+Y+;4;=[@6NHZ6UY87*-'<$4`?5NO_L'_`+./BK1OCMX<
MU30]?GT_]H;]G/X??LI_%.&#Q9JD4U]\(/AIHWC[1_"6D:?)%+YFBZS;Z9\3
M_%0N=<M/+U"^-Y9SS.QL[<CS7QS_`,$O?V5?'WC.7QKCXL>#=6O_``UX1\'>
M.+'X9?&3QSX`T;XDZ'X(L+#3?#=I\2-*\,ZK91>)+FQTS3K.Q^WSFWU&6S0P
M/<F)V4_F7X[^+'_!1?\`98'_``4Z_:(\,W'[+'C&U^!GCGP/\5_CIIVH:=\1
M=+O?'L/A3]D#]F:]U72_A_&=UGX<73/AMHUW>)<:A<ZF^J>);N*R1;:&WD8L
MO/VU?'_P?UC]IWXF?"[X=V'P]\.?$']M#P?:?%3XX^)-#^,?Q@T;P-\-=8^`
M'AGQ=X7\;>)/AUH5UK-WIZZQ/Y7@^63P%I^G^%]!;?JVLPSZA-&9@#^DQ$6-
M$C0$+&BHH))(50%4$G))P!R22>IYKXH^(O[`O[+WQ:_9K\'_`+)WB/PSJ8^%
MGPVU/PSX@^'S^'/%FK:#XX\!>*_!U_<:CX:\8^%O&FD7,&O:+XLTF[NKQ[;7
M+>X6\`N[E&=A,^=+X+_$+QA^TQ^Q)I?CKP1\7OA;XN^(/Q1^$GC2U\)?&CX-
MR:A<?"VY\:7%OXB\.Z'XN\*Q:O'+JUM8:1KMM;3WFDZO`=4TG4K"_P!*U*V6
M]M)X!_/%\+/BK\%/^"9VH7WC;XV_LQ_M;?`K]M3P7^S!^T;XRTVX\2_'3QW\
M3/@9^W7KWPF\*67B3XE7UI]J\=>,O#XUZPBM;+QSX6TZ7PSX0N]#L/$'B"=+
M=X=+=(`#]S_A/_P2P_8[^#OCG1_B-X<\&^*M<\5Z1XME^(/V[Q_X]\3^/8M6
M^(4W@R/X?MX]UVV\3WNH0ZOXL3PJDFFVVJW2L]F+F[ELT@DN'8^Z>$/V//@;
MX"^`GCW]F3PAH6KZ#\%/B"?'\&H>"K'Q%JJ67A_1_B6;I_%/AGP7*TS3^%?"
M\LE_J+Z=H6EO%8:3_:-Y'I\4$,JQ)^'FG_\`!7+]K[PSX1U2+Q+\*K7Q1XK^
M+'B+]FWX:_`CQ9KOP0^+?P6^''@GXQ?M(?$[3OAC#X2\?7?BZ*XO/%F@^!FU
M6U\4IKOA\VTWB*S5]/:WL)3&\GH'[2S?\%._!'[2G_!-'P?XT_:5^#5S-XO_
M`&A_B!HNI:C\//`OCOP3X=\=6D/PG\1:Z;#Q[X,A\:W5IJ6FZ19V-W!I^FW5
MWJ5G)K$^F:\HM[BQDMR`?L-X\_8__9X^*'PB^&'P3\3^!;.]^'?P8U_X>^)_
MA9IUA?WEE=>"?$7PJDA_X0K5]"U6TG6]M;_2(X7LVE$S-<6ES>6MP'CN95/@
MNG?\$J?V+M-A^+^EP_#_`,13>$OC3X:\:>$?$OP^NOB#XSG^'F@Z#\0M1L=;
M\76?@+P:VKC1/!1U?7]-LM?:;1;:":UU>$75F]NK/&WY1_L??M2_M-^.M`^!
M?[%O['MC\&?@SXYUR\_X*$?&GQ]\1OB)8?$7XG^%?#/PW^`?[9M[\$=(TOPW
MX;\1>.=0\3:YXG^(?C+QE:7^LRZEXQCTWPOIT%T^AV*V?V32[7MOAA^W7_P4
M6_:E^,/A[]GKX2>+OV;?A%X[L?V?OB)XQ^('BCQ9\.?$OC_P_'\3?A)\??%G
MP>U4>&+#3O%FDRS^%?&-AIFF:P(;ZZ2^\.RB:VB?4)))!$`?L>G[&OP>3]F'
MXA?LFW;^,_$/PN^)?ASQQX=\3W/C;QEKGC7Q9=0^/;:ZAU6]?Q-XBNKS47NK
M.2Y6YTI7D^S6$MM;+%"(XRA^?_"'["F@?&C]E?X3_`']N73O!OQJ\4?`'6+>
M#P%\4_"&LZUHGB6(^$[=M)\'>/K#6=,71M<\#>/9/#DB:7XFMM(U.[L[J\MI
M]0CNO)OHK#3_`"/4?C7^T3^W]_P1/F^./P%T5_!'[2'[1W[*,7B;PKX>\+:O
M<17.G>+=:M8X=>T?PEKDEQIMS9ZAJ-I;ZS9^&-2GNK22PO;W3[BXE0P.U?BK
M??&_2OV2_BQX\B_8U^"O[07[/OA?QC_P2^_:.^(?[1'PR^,.B:_X:T"]^-7P
MI\0_"^P\*_'/2[+Q!XI\4:M-\0+J_P#B+XA\'^-/&EJECIWB@:CH#SW>OZQ8
MR3Z0`?O8G_!)O_@GEXHT30+G3_`%UJ%QX7\0>)-5/Q%T+XM>.1XXU>_U:72X
MO%&E^+/B+I/BE?$.OZ7._A[2;74-!U759;"V72+2W%K`+5%3W7X,_L7_`+(?
MP09O!/PE\(>'_#]S8?![Q'\+&\-V/B&2[U"R^$WQ`\=Z]\0=7T]M-DO9KR#2
MM6\8Z]K-];:B\0!>9[:WG*1!%_(']O34O%/PN_9:\._L.?"SP/\`%/X??LO6
M_P"Q9XU\5?&WXL_"SP'K6M:QXPN;KP#K*6GPDTC6]/M[RW\.M\0-9-[XD^,?
MC:[D?4[?PS>WFF:3<6VJ:X=7TOF/AGXEB\#?L[_\$)OVZ/!6G:]IGB=?AU^R
M[^Q9\95US3KW1M;^)'PX^+GP8\-Z9"MQ'?RHFL66@_$'0;+Q=X<\07:73SV4
MUW+ITJ1ZC)Y@!^J/C'_@D7^P%X\_X5W_`,)'\"[*;_A67P;\-_`#0UT_Q'XG
MT:+5_A'X-6;_`(0[P;XS@TG5K*W\9Z=X4ENKVXT#_A(HK^33Y[VX:-RIC2-?
MB[_P3-_X)]?M#?$'Q7+\1/AKH'B/QGJ/PYT;PC\0/"6F>.=;TF+6/"[Z7<>'
M_"7B#QSX&T+7;.RU35[&QTYK;PIXK\0:3/=PS:+!+873W&EH\.7_`,%*_P!I
M#]HG]G'1/@UK/P?TN^T;X;^(?%GBFR^.OQHTGX.ZY^T!JGP<\/:7X,U35_"N
MJM\)O#NM:#JVLZ)XA\46UIHFOZY:WDS^&=/D;4?L%TNX)^/G@WXR?M5>.?VE
M/VO_`-IS]G3]HC]GN^U;1?\`@F5^R_\`&3QC\1(OA'XI\3>!_BPWAH?M':WH
M%KX'\+ZMXF\-ZIX/TK5I=,U--:FU>\OM2TR<6]K:VMPJSRJ`?M9J?_!*?]A3
M6?B3J'Q5U7X)VM_XHU'QSX+^)S6]UXF\5S^&;3XC>`;K1[WPYXZL/"DNLOH%
MIXLAGT#1VO=>CL/[2U+[!#]NN)SO+>6?#+]D_P"%_P`8_%G[6WB/]L;Q=\$/
MCI\0?VH_B+HWPRN_ACX4\1)J/ACX;_"_]FZVN=6^'?P)TV*YU1->U+QEX4N]
M=\3?%KXELUEI5VGB7QQ?32:)8Z/86,LWYH?%C_@K?^T6O@3PY^T?\%_%&K^,
M=`\+^`/V-/&OQN^#N@?LVV>L?"OX;G]I'2/A?K_B+PIXW_:%U?XEZ%JUGXNM
M=)\>1WFAQ^&?!6O0Z;%?Z.-5AD^U,T6=^RW=_;_^"H5U?!/+^V?\%A_^"@UW
MY><[/M'_``2P_9\FV9[[=^,]\4`?U*V-OIFD6VG:)8+;65M964%GING1NJ>3
M86$*6\$-O"S&0PVT$<<8(#!%4!C7GOQ-^"GPN^,DO@*;XF>#M*\72?#'QWI'
MQ,\"G5%E;_A'O'&@P7EOI'B"R$4D?^F6,=_<^3YF^,,X9D8J*_(S_@H[\5M2
M^#O[8_P;\8>%-$\!GQ]H?_!/3_@H_P"//!GC#5O#)UGQCX:\5?#+0/A'K?AU
MK#4R1'IWAV?^U=:34;*7%MJ[236L["<6.?DCXJ_\%!/VY_V(]/\`&VN?%7XH
M_#G]HZ;XE_L+Z5^U1\/;&Y^'-M\+M"^#GC_Q#\3?`OPTLM%GOM.UW5)O$'PV
MT,?$.R\0:W<ZW+:ZFMEX?OI6OH([AO)`/W[\:?!C]GC4]8^)'_"?>'/!LVI_
MM0^'_#7PM^(&F^(]2CMC\6='\%Z;XL;0/"O]G75]`=6GTW1O$OB@FUTJ+[;)
MITL\DX>&T5XO.?'O_!/K]C#XG^(=*\5>//V>?`7B'7M'T/PGX9M[VX@U.U6\
M\/>!5L(_!^BZ]9Z=J5G8^)M-\.1Z7IT6DVGB.VU6&UALK>)$\N-5'Y'_`+5/
MA;]I[X3_`!`_X)O:S\=OVB-"_:`UJY_:Q\1^-/!VNZ?\+=,^&\_A/51^R?\`
MM!:EK6A&UTK7=:L=>\-VUR-#;PU=7'V;5(X8=0BU)KKSH)5T];_X*8?'CX7_
M`+#W["?[4OB.?2_&.L^/?V9OVM_C9\7]$^P6>DVWCC5/@A^S5X[^*OAO3[>X
MC4KH$$OB'P[9_:)+5<&`NC@H2*`/V?\`CO\`#;]FWX[GPG\%/CWI_@/Q=J>I
MWUUX_P#`?@+Q#XABTKQ?=WW@J)+?4?%O@RRL-7TOQ6Y\-0Z_%!JNK:"WEZ;#
MJ\$5_-$E[$LGG/B+_@GI^Q5XJ\$^`/AWK7[.?P\D\)?"VQU'3?A_86%IJ&B7
MOAFQUEVEUNWL=>T34-.\0R)KMP[W6NF[U6Y?6[R22\U5KNZD>9OYZOBU\9/V
MH_V4_C]\$_VW?V@?C/HW[2?BRW_X)<?M=_M!^%_A[X;^&6F>!?"/@C7Y="^$
M7B.T\':+J^C:UK.K>(O!O]K7UC'=ZQJD8U&/2[:ZU&-R&$2_JQ_P3[^*W[<O
MC#XUZSHGQOTCXK^)?V?=8_9[\,^.]*^*GQ:^$_P_^%-U!\;Y-<T2QU;PCX'M
M?`OC_P`8_P!O>!=>\.:AJ'BG2;K588+K38[**S_M"^\W>P!^@.F?LF?LW:-?
M_`#5-,^#?@FTU']E>T\4V/[/%\FFL]U\);7QMX<3PEXMC\)32S.]H?$'AV./
M2]3DG:YEN(8HI6?[1&DR\YXP_8>_9+\>_&32/V@O%OP'\!ZQ\9=#U70M=L/'
MKV-U::NVM^&)UN?#NL:C%87EKIVLZKHEPD<VEZAK%E?W=E)%"T$R&&+9^0O_
M``5'_;H^/_[/WC7X]:W^S-\0_B%K][^S)X:^`GBGXI^"8_AQX!O_`(+>`W\>
M^*M+>UT#QUXLU;5K7QMJVK?$/P?=S:DUAX;MXG\-:=/IM^MS+)>I"NG=?M&?
MMEWGQ@_;!^)L'[0MIIWPL_9N_P""BW[,_P"S7X5^"$'PT\.7&G^)/AK\8/B1
M\!/AOXL@\1^,9[E==BU6U/Q?O];T2_T^)#;S:/;6ES'<174LD0!^O_B']C[]
MF'Q7\$6_9N\1?!+P'JWP-.I:MK*?#6ZTHGP];ZQKOBC5/&NKZO9(DR7ECJE]
MXLUK5M?FU&SNX+S^TM0NITF4RL*D^'7[(?[,GPD_X0K_`(5I\$O`/@L_#GQ1
MXF\:^!FT+1DM7\,>+?&?A.?P+XL\0Z2^]GM]4\1>$;JXT+6+K<SW]E-(+@O*
MQEKPS_@H]\8[WX3?`W0-/\,?$GXG?#GXE_%+XG^"_AM\,C\&O!_A7QI\2_%_
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M^1?"=A9OX:\+Z)*L^D>';-K!+4SZ'IMPOVJSTJ^^U64%T\UU'`+B>:23\*_V
M>_VROVW/"6B_L^?'+XK_`![N/C=I7C[XK?MD_LO7?PAB^'OA?PMHNMWO[-/@
M7XR^,O`OQ+O-2T:VGU]?'GBU_@S<6/BM-+N$T$OX@CCT;P[#Y1D6M8?M=_MI
M?"+]G+]E#]ICQ+^TW?\`QCO/V_\`]D7XE?%FZ^'EUX+\#Z=H?[/7C6T_9'UC
MX^>%]5^%]SH6E0ZK<Z/X4UZWM]`\1V_C6;Q"E]>1%FDL2YM:`/VO_;?_`&+/
M"O[:O@;X*_#KQ5=Z-:^#_A;^TA\%?CAKOAK6_#Z^(-"\;^'?A9XA&I:K\/[Z
MP^VV*VUMXDTJ2YTV*^+3QZ?,T,\EE=PH]O)UWB3]D/\`8SM_AA:?#3Q;\"/@
MC:_"JV\7:9K5GX>U_P`+^'+7P_%XZUS5K/2-(U.&>_BC/_"4ZUK5_I^DZ?="
MY.J:GJ-Y9:;`\\\]O`WY`?MU?MI?M*_"_P`5>-=)^&_Q<N_#$FE_\$,_CG^U
M=9V4&C^%M1&G_'KP]\7?@-X;\)_$V6UU#2;BYDGL=,\3>+-.MM+EG3P[>I=W
MHETZ6YM8I[7XC_X*#:S^TUK?[,/[4W[/'Q+_`&K_`(B?$&VM_#7_``2^_:BT
M7QK)X2^''A[6=#U3XU?M>>"?`FL?#BUT_3/#,FGS^`O#NM66D_$#PXEWYWB&
M+Q%HNFV>HZYJ&BB^L+X`_HW^(W[#_P`(_%/@OX9_"WP1X<\)?##X4^#?CMX+
M^.'BCP!X8\)Z;;:'XRU'P,(;G2=,-K!]GM]&)U73/#M_)?64/FC^PK2%4"ER
M?HSQ!\(/A?XJUOQ-XD\2>`_#.M:]XR\`VWPL\5:OJ.EV]S?:_P##FSU+6=9M
M?!>J7$BE[OP]!JOB+7+^+3I"8%NM5O90NZ=R?B?]JCXB?%O]@[_@F[\7/B)9
M_$'Q1^T)\7/@S\/KZ]L_B1\0=(\,V_B3Q+JFN^,H+&VU_P`0:1X5T[PWX66+
MPCIWB*.3RK:QTO3Y-+\.Q2:G-'NO;T_C]\2OVG/^"E?[+G@#Q]XFU7QK\0G^
M'7Q.^$7P*\.^#_BG^U)-\#[[7OA?\>/'_P"T%\-/A1K_`([\$:/\*])\-6=_
M\,$\"?%BY\7WMCXKMM3MO#NN>%/#EG-K\]OKLR2`']*<'P7^$UM>/J$7PZ\(
M+=R_#NT^$D\K:'8RBZ^&-BMPEIX#O(I8GAO/"]O'=W44>D74<UHL-Q/#Y?ER
MNC>??#_]D']EWX5Q6T/PZ^`OPN\'K::UH?B*V?1/"6EVMQ#K7ABTGL?#E^ET
M(&NA)H-I=7%OI$?G>3IT<KBTBBSFOY^_%7[1O[87[.?Q[^)'P0N?VR/B%\;?
M#7P]_;N_X)`?#B?Q[XS\,_">SU*/X7_M+?$KP=I/QO\`#NKR^$_!FEZ-9Z3X
MKT_6)],N]2>*'4-+@O8?[+U'3[KRISZ_^UG^V?\`%#PI^UM\;/V:=&^-7QGD
M\6>*_C'^S%X4_9S^%/[/^J?!.P\7ZK>^(?A3\3O%OQ*\%W7CGXC^"_$OAWP!
M;W%KX=T_Q;J\7B?3]>\1QVEE9-H\$-GK"X`/V4^)7@7]DK4O$VH?"?XK>%OA
M+J'BK]KB_FN=0\$>+M+TB[U/XWZI\)_!=D7NY--OHI'\0:AX$\#>'[!X[I%-
MSHVD:5;2PR1+;HR^[Z9=^#?#=QH/PYTN^\/:/?V?AH3>'/!5O?6%KJ4?A+P[
M]@T8W6EZ%YRWSZ%H[7.F:;+=P6S6=E)<V5K+*DD\*/\`S'_LL_&CXP_&[]LC
M]A.#XV^*H_%7C7]G;]N[_@IY^SI-?ZGXM\!>,?%ZZ%I/[*C>//".D>*_$7PW
MTGP]X0\2^)/"7AWQ?:^%_$FN:)X;\/V\E[IUI]HTJWN+DO-]D_M(?#37O%/_
M``6L_9VU72/C)\7_``!)IW_!.S]H[Q/'8>`;[P);6MW'X5^//[//G>%YD\3>
M`/%,S>'?%TEY#+XGACGBU6>;3M..C:OHL:W4=V`?N?17\V'[)'[5/[56K7/_
M``2_^-?B7X_^*_B]_P`-\^-_C;H7QQ^!6M67@&W\)?!K3]'L?&.OZ9)\.]/\
M->#=+\7Z4/A/J>@6/@/Q5+XH\4^(8[NYN?-GDCN98R?Z3Z`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`*_'7]HC_@CG\/OCSXT_:2US3OVDOCQ\*?`O[6,_A_Q1\;?A-X2TGX)>(?#
M7BCXF^#X/"UEX6\7VWB_X@_"GQ7\6?"VA0V?A6Q?7O`?@GXA>&-&UN_2&6*Z
MTK3!J&CZI^Q5?@)^T;^UO^VFGQ2_X*T?!KPYIG@G3?AO^S[^S;X%\?\`@SQM
MH_Q8UC0/BA\([#Q]\(OBCJ.C>+/!GA;1OV=Y;[QYK7BGQ/X"N[V\M-4^)EO8
M^#+RTFL?#_B#6Y+:_P!-L@#[D;_@G-X6UK]KKP-^UK\0_CU\:_B;J/PA\1>+
M_%WP5^&/B>P^"FG^%/AKXB\=^&;_`,(^(9(_&GA'X1>&OC/XTT&'0=4U*T\.
M>%/'WQ,\2:!H3W\]T+*^N[?2Y]-\T_;:_9.^.?[07[9W[%/COX6?$WXF?`KP
MK\*_"O[15KXZ^-/PGB^$E[XO\+2>-?".F:1H>BVFE_&3X?\`Q/\`"]W#XGG2
MXL+BXA\'W.IZ:JK?6.HZ;-")F\$TW_@L"G[/OPIM=2_:P^"G_""6>E?L8?";
M]J'P-XI\)_&/2_B9'\0/"7C?Q)X2^%6A6OCR[O\`P7X$TWX:^)]6\=^*?#W]
MHW%OJ_C[PGI6D:E>Z[?>+!:Z;.)/IS]CK_@IEX*_:Q^/WC?]G;2[7X+:WXD\
M'?!SP_\`&1_'G[-?[27A[]IWX22V&I^(HO">L>$-5\7:;X)^'.I>'_&NC:Q<
MVMS;Z5=^&KBVU?0+A=52^LITETU`#O?V;?\`@FQ^S_\`LL_$'X:?$SX;ZU\4
M=0\3?#7X"?%7X`QR^-?%.D^(XO&NG?&SXS^%?CY\3/B-X[F/AFSU35/B=XF^
M)/A2+5+G5-*U+0_"L-MK.MVEMX/B$NG2:9S_`(2_X)E_#+PY\0/`'B'6?C3\
M?_'?PL^#'Q=U[XZ_`C]FOQ7KGPX3X+_"/XG^(D\2-=>(])D\-_#'P_\`%3Q@
M-'O/&/BN^\'Z3\2OB;XRT/PA<:]>2:+ID$R6LT'*_$W_`(*<Z7\*G_;;\+>(
M?@IK]S\7_P!DKQ[\#_"'@_X9:9XG:>7X_P"E?M1?V5I?[.7BKPOX@G\)6\.B
MVGC[QM/XC\#:YI]CIGC*X\':]X,\00/-K<T45L_)Q_\`!5_PCI_[5_PR_94\
M0Z-\&-9UOXB_%C6?@IJFM?!3X\>+_C!=?#/Q]:?#O7_'^CZ/\0[,?L\^#?!V
MAW^JIX9U31+O0S\1Y?$^BWT^DW-QH5Q8SZI-HH!WEU_P24_9;DT;]LKP_I^I
M?%70M'_;<\2Z%XH^(MAI7BCP]]D\`76D^+5^(.J:?\'+74O!VHVOA+2/&?Q#
MFUCQUXPL]9A\4OJ7B3Q%K%S93Z;:'3K/3L'Q'_P2)^"NJ:[\6Y/"WQ\_:U^%
MGPW^.OC=/BE\5_@/\.OB9X*L?A#XO^*TTVAW.N_$:YL/$GPO\4>-=-UCQ?<>
M'=*G\7:!HOCC3?`&N20SFX\'!;R\6?Y\_P""1G[;'B7Q1^Q!^S=X5^(-AX@\
M=>.O#?\`P3Z\-_M,^*/B/KOBDW>J>,[J36_$6E3:)>QW.F3W,>H3?V4)GUV:
M_NP1(L9TX^7O;@->_P""_/@>+2_!-]HWPH\+Z3J-_P#LO?`W]ISQGX9\>_%'
MQ/8^()E^.^G^*]9\,?"7X2V7@WX-^,IO'WBJQT/P=J=_KGBO6X?!/AC2[O4/
M"^C&*ZO?$$CZ2`??FG?\$T_!/A'Q?J^K_"7]I#]J3X*?#WQ'\2KKXL>)/@3\
M./$/P8_X5AJ_B_5=5EUKQ*T&K>-O@=XT^,OA?1/%FISS7?B#PYX'^+7A?1;B
M6:1[2RLG8M7):)_P24^"7ASQ!X/ET;XX?M66/PM^&_QZ/[1GPT_9UC^*7AIO
M@7X`^(%UXB\2>+=8MM!\.R?#QO%-WX4UGQ-XMU_6W\.>)?&>OVN@7U_*W@U_
M#,3-$WO_`.TG^V?X:_9X_8MU7]LIO`GBGQII?_"(?"S7/"/PU@N+#PUXI\3>
M)?C9XE\%>"?AIX-OK_62=-\+W.I^,/B#X:TC7-5U,2VGAR"6_P!1NH;B.Q>&
M3\H?^"A'_!07]J#POX.^*?[)6H?";PS\*OCSK*_LYW<?C[X9_'?7]2\.2_"'
MX^?M`Z;\)-8_X1/Q9)\*O#_BOPS\0-#ANK;PYJ=_?>%6T\P:W/XLT$RRV_\`
MPCMF`?IK^VU^S-\1_P!I+Q?^R"G@'XD_$GX-V'PM^.?CGQSXX^*GP@USX?Z-
M\1_!GA_5?V9/CO\`#K3+GPTOQ)\'?$#PWJ3ZKXO\;^&]!U*RE\&ZY,NDZG?7
M@BM8K66]MO+[G_@DI^S[:Z5\)[CP-\3/VBOA;\5OA-X[^)OQ)M_VA_!'Q`\,
MS_&WQWXN^-=AI6E_&'4/B1K7C;P%XR\(^(X_B)I^AZ1::I:VW@K2H-!ATVQ3
MP.GA1;.U$/K$$EW^PY^P[KNH7^O>!O"^H_"[P_XO\1+JWQ_^.GCKQCX$TB^U
MSQ3J^OV]OXQ^,^N>%O\`A.-7TBVEUA+*VE@\(PW:1):Z+HND6]K#90)^,'CS
M_@JMXX_:9TCX=_#S1[?_`(07QQ\+_P#@I-_P2^T+Q'XZ^%]A\>/#'@#XH?"S
MXX?M)Z+H&KZ7HI^-GPE^%.OWVD7,6D:[X6\1+8?\)%H6N6X%Y9WXT^^MT8`_
M9K]GK_@G1\"/V:O%'P@\7^!-;^*.L:S\$_A=\5?A/X2E\;>+-/\`$!O="^,G
MQ:U#XS^--8\374?A[3]2UOQ//XNU.[BL]3DOH;>+2G$-S87>H;]2?S6X_P""
M37[._BG7?'>M_&?XA_M'_M$GQ=\,O'GP:T"S^-?Q:.O2?"_X9_$RZT&^\;>&
MO`_B7PUX>\)>.=4GUJ\\+>&YW\4_%'Q7\2/&EH=%M(;'Q';6\M]#=]I_P2N\
M8^*O'W[$'PV\4^--?U7Q/XCO?B%^TS9W>M:U=RWVHW-KH?[4GQHT'1[>:YF9
MI'BTW1M,T_3+-"2(;*SMX$PD:@?CU^PQ_P`%*/C#^R;^PI^PEXR_:B\$Z)XM
M_9\^+?A#XG>#?#?Q9T'XB>*/&'QGMO&G@#2/BI\0],D\>^&=:\*VEK-H.M>'
M?A_J_A^W;1=<US4M&GBTV[NKG48F>U(!^EVO_P#!'?\`9T\=Z+XML?BQ\6OV
MI?C#XC\4_"#PQ\$K;Q_\0?BYIUQXK\&^#?`GQ6\+_&KP#-X&M/#7@SPUX)\/
MZ_X,^(G@GPAKFF:NO@^Y?4Y?#]I_PE4/B&2[U:74>TM_^"5G[/DWCR/XH>+O
M'G[07Q*^(DGQ"^"7Q/U7Q?\`$;XHIXFU;6?%GP"C\6Q^!&G\SP];6>CZ$?\`
MA,M3DU3PKX3M/#OAEYH;672=)TAY-1.H?FAKG_!>GQYX5^%-S\4]1^!'@;Q-
M;^+/@5\1_BWX%T'P5JGQFN9_A[X@\"^$QX_TCP/\;O$>M?"72_!D%EXT\)1:
MJEAXT\+>(?[+T_Q1H8\.+8ZM<^(]%D/TK^T/_P`%7/B_^Q1K'Q3\)_M6_`;X
M:Q^+K?X.6?QA^!=K\'/BKKWB30_&9U+XHZ!\)[?X?^*;[Q1X$\/>(H/$%GKW
MBO1]0DU+POX1U:75]&L]8FTSPPMY%!9N`?:WQ/\`^"<O[/'Q6;Q5J&M3?$C0
MO%7B7]J30?VQ[3QSX/\`'%UH/B_P=\=O#?PR\`?!_2O$7@S44L[BUTG3XO`/
MPW\.Z-)H]S8:C:R%M2NR1=7IEB]5^.'[)GPS_:'^"OA[X)?$_6/B-J>G>$/%
M'PY\>^$_B%I?CC5-`^+GAKXC?"?Q)IOB[P)\1=%\>Z0MK?V7C'1=?TJVO1J4
M<!@NT>ZL[RSGL;N>V?\`GP_;(_X**?M"_M(_`?QI\%?`=MX=\!:O9_'/]CSP
M;XQ^*/@7_AH'PEX.^(GPX_:!^(0\.>(?"7@KQ7XH\">!-:TCQ!X8U&SMO#/Q
M%LK2_O9[WP[XJL=9\-:I:7UMJVDZ;6^"WQ0^/7P'^/GP?_9K^"NM:5X,_P"$
M<_X*:_$W]GKQ[X<\=?%OXN?$KP!XT4?\$UO%OQ3\->'M,@ULW7BZU^'VG^*H
M]/U>TL9K\OI?C;1?#.L7=P]KJ6LO&`?L9XH_X)7?LZ^,)/%T^N>,_P!H>6Z^
M*^BZ7X;_`&@9[3XT>(-.C_:1\/Z1=7CVND_&O3;&WM]&\002Z1?W7A*^NM"T
MWPSJ5_X/D3PY=WTVGP6\<7UU\??V>/AA^TI\']?^!WQ0TS4;OP+K\6D!ET+6
M+[P_KFCWWA[4++5O#VL^']=T^2.^TG6="U33K*_TR_@<O!<VT;,LB;D;\M_A
M;_P4^^(FO?ML3_LK?&B/X"_`#4[?XB3_``VT7X;_`!+TOX[>$_BC\68]+\*R
M:O<?$?X*^/=<\+6WP5\?:)XFU0QKX:\#Z-K.H>([#1+34[K7=8CU*&'39>I_
M:_\`C-^UOX!_X*/?LP^#_@_XC\)6OP=U?]E7]IWQ[XP\)>+(_%=SH7B#7_A[
MKGPRNKB_U:QT*\TZ&[U_2?#VHSQ^!$&H6BBYO_$!U)GMS`4`/L*/]A?X.W'P
M6_:*^!WB;7?BEX\T#]JO1[[1OC;XJ\;^.[K7/B#XJ@O_`(7>'O@Y+<KXF-G;
M_P!GWL7@3PMHNG6\UI8HL=Q:F],33RR%N'O?^":W[/Z1>))O!_BCX^?"OQ#X
MI\1:?XEU;Q?\+/CAXW\&^(9KRP\%^'_`)L9197LFAWVBWGASPOHL-QH^K:+J
M-C#>VK:EIT5C>W%Q-+\>?`S_`(*:_M)^*]7_`&,?BG\7O@9\-=`_9=_X*"_%
M*_\`@W\#AX'\3W^H_&7X6^*I_!?C[Q]X`UKXK?VEK$OAKQ=H'Q"\/_#3Q/+=
MVOA'1_#E_P##QUMHM9GUR\>WL;_Z"_;N_;R^('['/Q#\,^&+7X?>%_$^@_%C
MX*?$!_@O?7]YJPU3Q#^U+H_C'P/X-\`?"[5-/T>>ZU.7PQXPU'XF>$$:?1M#
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MO&/PP_:3^'/[7'A_X":W\#]$D2\?7K#0KCXB>`OC'ITJ>(O"6KZIXC\+Z%97
MVBV>MJ]U9W?L?[2'[;'Q[E\+?&WX0_'SP=\.;7Q[^R[^T!_P3%\?Z7X@^"?C
M/XO^#/#GB7X6_M@_&C_A!/#&GZK9CQ!H?BNX\:^`M4\.^)9O$6F7.M)X(\86
M8T6XN_#]C&;_`$1`#]3;C_@G#^S7<?#[Q=\/_B9X@^//Q5^'6J-X3U#3=*^+
MW[2WQF\20?"N'X;:O!XH\&7_`,+_`!#+XTT_Q!\/-7\':Q8P:KH_CO2]<B\>
M:8+:.!/%JZ=!':QWM0_X)T_`OQ!I/P]B\8^,_P!I#QSXR^&'CZW^)7@[XM^*
MOVDOB_>?%32/$T&G:GH;+8>*+/Q180Z/H=WX<UB_\/ZCX<T#3=(T/4K&9[N]
ML9];EGU:7\V_C[^TQ^U5^UC_`,$^?^"E?Q?T?3?@3X*_9CT#]GW]O_X=>'-"
M>V^(US^T##J?P7^'OQ#\-1^,[OQ?8^*;+P/;R:CXC\.ZC<V/A^R\+)-I=K)I
M=])XBOIH;G3IOH?]C3]JK]IG3OC#^S9^S+^T%X8^"\_A?XW?L>VOQQ^#?B+X
M67WQ!N/%7AC2/`.F_#O3-2\,_%/4/'6IZC;^+]:O;7QAI\T/B?0;3P\MU>6E
M[+=Z2GVA-H!]+'_@FA^R'I5G\/I?"7A3QW\,=;^$NJ_&36_`WC[X<?&[XQ>"
M_B%H8^/_`(ME\>_&?3+KQ[I?CF+Q)K?AGQUXJE?7-2\-^)-1U;0=,OXK.^T"
MPT>\TO2[FR]'^"_[%G[+?P5\2>%_B+\(?`2Z3XC\/_#36/A9H?B@>.?'/BF>
M\\"^)?&^I?$G7(M4N_$'BG6HO%.L:WXUUC4M?U#QEKQU7Q;?3W313:[):+'`
MGY?_`!L\:?MEK_P5<_:G^&_@[XF_#2R_9_M_^":/PD^)^H?#[Q/H7Q!UF]7P
MU/\`$C]H+PIXCUCPS-IOCW1-"\.?%R[UO1O$-K:^(I-$U7P[)X2/A>UOM`GU
M?3=0OM0^-_V5O^"G7QY_8G_8R^"X^/\`X'^&_C_X9:9_P2^\7?M6_"=OAU-X
MR/Q-ED^#EWX(\,/X6^)VM^*];ET/6)/%6J^/-'N'UCP[HFCOH-A:ZE(UKKDZ
M6\<P!_2C\)/V>/A/\"/@-X4_9I^$>@ZKX&^#W@;P3)\//"&@:/XR\:C6_#OA
M=[:YM4M]*\>7/B&X\?6FJ6L=W-)8>(X_$P\1:?=>5>V.JV]Y;V\\7@=Q_P`$
M[/V9#X4^.FAKX;\8^(_$7[07PNN?A#X\^(GQ9^+WQB^./Q%NO`H.K7>D^%;/
MQ[\8?'WC;QEI'A/1];U>ZUZU\+:)KNFZ%_:A6[:Q,Z1R)\\_L0_MG?M1?&KX
M[>)/A=\9/A!XKD\!S_#@>/=#^,=O^QC^V-^R5X0\*>*;76H-&OOA/J*_M7>'
M].E^(%U?V+_\)+X=\6>&;G3)[BP6XBUKPMHUQ)'96/YT_M#?`_7_`-H[_@K/
M^V_X>O/V<_B)^T[X=^''P(_86N-'TO0/VN=7_9RT;X77'CBQ_:&.M7<.D17L
M=KXEN/&O_"+V$EW-:0+-IW_"*1"<R-J4.T`_>[X-_#'XC7O[,^E_!3]J8^!_
M%OB*3P'JGPI\<ZA\.]9\5_V#XZ\(-I5QX2BUF:ZU33?#7B'0?$/BCPNR7/B2
MRTZ66+2-=NK[^P]<N+=+2XC^>=6_85-[\8OV+M+T>^T#PO\`L?\`["G@F&7X
M0_"J#6?&GB'QSJWQ1T+PU!\.?AU-XCUSQ#=7*3>"/AK\/1>Q:2-5UOQ1K^N:
M_=07.H-9I8BXN?SJ^*G_``4-_;0^".G_`+5>O?#[P/\`LZ0_!#]AKXY?LE?L
MZ/\`#3QDGQ(UGXG^-8/C9<?!GX>M9?\`"T;#Q8FA:,WA'5?BSI6IR>)KGP9X
MHN=?71;J-M.M%D+WGIWC[]MW]O;X4?&7PM^RUKDO[*_C#XR^*_V@O@MX'@\>
MV?@SXA>$_AWI_@3XW?#WXL>*[*,>"+GXGZWXNU36?"&I_"S48;B2S\3;=8TZ
MYLEGGT66XEO;0`_6;XX?L_?"?XZGPQ!\2;OQWIMYI#:WIWA^\^'OQK^+7P3U
MN[@\16,<>O:%<:M\(_'?@75_$.EZI9:=%)>Z!J=UJ.G2K9+<M9;H/,7S_P``
M_L&_LH?"[2O'&A^`/A)8^&-*^(_P7\/?L]^,;+3_`!)XR$6J_"+PM;^++;1/
M"B>=XAE?33:IXY\52S:[I367B._N]8GOM0U>ZO([>>'\-?B)^W%\=H/VB+7X
M,_M%+X/\9_%7_@G%^VKX)U+Q/XX^#_A3Q'X(\(_'/P3\9_\`@GW\;OC%X%TO
M2/"NO>(/$K:'XTTBZEN-#\4:7;^*-9M3'%I-U';6YOH9KSTO1?V^/^"A<OA[
M]D+QGKWBK]FJY@_X*:>#_B9HO[-W@SPU\)OB%93_`+/?QATKX)^+_BW\(QXZ
M\62>,O'%Q\3/`_B+4?#]EX1^(]XG@SPY)H4.H'Q+I]UH^EV%^Z@'Z)3_`/!(
MG]@2;1;WPO'\'_%%AX/U;1_A5HNO>"-'^/'[06B>!?$Z?!'0?#7ACX6ZSXL\
M$Z1\4K+PMXJ\7>$?#_@_PWI-EXW\0Z3J7B^YL]*@CU#6[S=,9/H7PA^Q9^S1
MX$^(O_"V?"WPSM],^(/_``MWQ[\=QXC/B3Q?>W`^*GQ.^&&A?!GQQXI%IJ&O
MW6GAM;^&OAG0_#+:0+3^P[&'3X[_`$W3+/57FOI/QA\=?\%C_CC>>#;GXM_#
M3X2K#X>\"?";X%^`OBMX*U'1)]9O]#_;3_:*\?V_P^M_`>D36ES%>>)-+^"N
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M([?7%O\`4M/D^"VN&U;5?`5UIES>2:?>:5>-96C//=VTVHJT"-'>H02?$/V#
M?C#^U/\`%WX=?%F#]I/X;ZYX#\8^!OB7K?A3X=^+/%?P^D^%MQ\4_!$N@Z3K
M7ASQO=?#AO$7BB?PU):W>J7'A[5;0:Q+%>WNBW-]9Q6]O<Q1+^6?A'_@L#\?
M]&UOX$:?\6O!_ABQ\-?";QKXI^&?_!1;QM#X8UWPUIO@[7;SXP>*?@E\,/&G
MP[?62=/;PCKVNZ/X>\4ZCIMU=V_B"'PWXJM+ZVMKF"&.*Y`/U\\(?\$^/V2?
M!&K^"]>TCX7WFH:S\.;SPI>>!=1\7_$/XF^/;KPJG@7PEXP\"^#M*T63QOXR
M\0&Q\.^&O"?C_P`8Z+H_AB';X>LK77[YH=,69HY8\+PC_P`$S_V'O!&M:=KV
MA_`70Y+K1=)\?>']!LO$'B'QIXM\/>'O#?Q2TC4]!^(?A?P[X6\4^)-8\-:!
MX6\7Z3K%_::WX:TC2K/0[P212O8>?:VLL/Y(?L_?\%!/^"@_[47PL^-WQ#\-
M>*_@C\(KW]GG]E[X9_M2W6B^*/AW_P`)5;_%32OVD--^)OQQ^$6@?;[/Q=I=
MYX3T#PE\`_"O@WPEXBU.'1YM0U_XH:SXON;34+6S\.II2=7>_P#!6?X_^)_V
M</\`@H3\=/!GACP9HEY^SI\"OV0/C!\+M"U>T2XAL!\;OA%X.^(GQ`A\17-U
M>VPUFUTRXU;6_P"QU5XKC[/;P6L:W5WA)`#],?A1_P`$Y_V`_AYXEN-9^''P
M7\%W>N^%?`WB_P"!]S:ZEXK\3_$&U\,_#CQ[!93>+/A/)X?\5^*/$>E:)X0U
MBTBLVD\%'3K72K>S<"STZWM[AQ)ZC^S_`/LI_LP?`_7]6\4_`SP\EIK6G:&W
MPEN+K_A9'C;Q_!X0\.Z%?6-Z_P`-]$L?%7B[Q+I_@;2M(O++2S)X4T&UT6WL
M19:=;O8Q0VMK''^#6D?M2?%KX6_M5_M0_`3]GNYTOPW\0OVW/^"HFI_"OP_\
M>-<\,1^.O!'P=T?PW^RAX,^)&J>);G0&OK#3-<\0^(M+T9M'\"VFJ7<FBSZE
M--=WUIJ%O:_99/O_`/X(U:7XHT#1?^"CWASQQXGTOQMXST'_`(*G?M(VOBGQ
MEHOA^S\*:9XIUS4/AS\!]?O=;@\-V-Q>6VCSW;:P#J=K%>7$+ZNE_<VPM+6>
M#3[,`^P?C?\`\$[?V,/VCO&GB'X@_&CX$>&/&_BKQ=HFA:!XNOKK4/$FF6OB
MVR\*R"7PG<^*='T/6M,T;Q%K?A)T@/A3Q'K.GWOB#PU]DL1HFIV*V-H(>^O_
M`(`?LS>'[CQ9I&J^$_"FF7?[07QG\)_%CQ%IVIZQ>PW'Q#^-'P]U#PYXZ\*^
M(+.UN]4\RXUOP]??#;P]XA@L-'2&T5?#:SW-E)`+H2_A%;_\%"/VW?%/@+X6
M_M32?%;X5:+\&/VH_P!M7Q!^PCX:_9QM_A]HDGCCX/-XE\8_$;X6^!_BA;?$
M)=:O=3\2_$GPOKGA/3?%_COX>>(=-CT=?#TVNV,-OI5[HZ7-S\3_``$\$?MG
M^(?@A_P1AO\`4?VQ8/$/C;X@?M4_'ZV^$_B3Q?\`!_PSKES\')].^&G[3.E:
M_?WZ)J5G??$>^OH;/4+G1X_%M]+8Z+>3Z?;26E_I&GG3+@`_K;_:`_9M^!_[
M4W@/_A6GQ\^'FC?$;P:FL:7XBLM.U5[^RN](\0Z)<+=Z1X@T#6]'O--UWP_K
MNF7"B6RU?1-2L-1MB6$5RJNX;@_AK^P_^RE\'[OX?ZA\-_@IX2\*ZA\+?&OC
M?XC^`K^Q&I2WOAWQU\2O!ES\/O'_`(IM;J\O[F>?6/&'A*\N]*\07=Z]R^IF
MXFOKGS-1<W=?A%I7_!1_]OCQ%J7P^_9.T./Q9X_^.=A^U#^W%\$_'_QO^"WP
MR_9ILO$OC3PI^REXJTZT\-7/A7PK^T?\:?@Y\$M'\<^*O#WBW0-6\1:9;S:U
M)9Z;H7B.71O#EPMJVL2>Q_#GXR_\%8_C=^T9HO[+NH_%[PA^ROXLT/\`8PTS
MXU^/X?'?P5^#GQ)^)EUXCC_:C^,OPP\+>*+23X:?$GXA?!?PS)\3_`W@[PY<
M^)?#MCXE^(=EX02VO[?3M.TG7=06_M`#]K=!_9?_`&?O#$'@BVT#X3^#M*M_
MAM\0?%_Q5\"0VFF*D?A?XB>/K/Q)I_C+Q=I2EV$&L>(K+Q?XFMM3N/F\^'6K
MY"H$O'COPW_80_82^'OBK7[CX;?`7X/Z3XCT_P`,>(_!>J:-I=E:7T/A#PC\
M4&U"]\3^&M,\*S7=WIO@70_',=SJ']I:9HNEZ+::Y8^9;217%E`L4?XE2?\`
M!;#XX?"_38?&7Q>\*VC>!?V>?A?^T!\/_P!J?Q`8?`5EI-_^UKX:T3XN>-OA
M!H^E^7KVD:KIVC>(O"WP1DTO3M*6#PM<>*?%GQ>\&Z+#:VET;(RP^!_C#_P4
M<T77_P!J3P_X.TKPYXE_:C\-Z=_P3?U']H[6?AKX*^`GAOXW:]'XG^!OCCQ'
M\=_^%<^'?BE+X3^%_CWQ/X:UBRETOP3X;\6ZI9/IF@0SP:6E[JMT\5P`?MQX
M5_X)M_L*^"8?%D'A;]F'X5Z.GCKX8ZU\%_&#VVAEI_$7PH\03^&+C5?A_JES
M//+<W/A>=_!GA58M*:7[-:0:#IMM9I;V]LD==M\8_@1^R-!X'^*GB7XX>`/A
M=!\/_$GPFT+X8_%K6?'-I8Q>'KSX1^#;N[N_#GASQ'=Z@ZVT.A>&]1U2YOM(
MD9HI=,U"=+RUGBNHX94_`SPM_P`%'?VV/VD_$.@?"K]E37OC_P#$J?P+^S;!
M\4?$GQ$\-?!/]AWX8_$[XB_$3Q/\:OCC\)I-)\=_#3]JGX]_#;1O"_A#X/ZS
M\%9_!_B^3X1^']8U&^\<7>O0ZW?>%-*D\"W7B7[4_P""IFM_%CQ)_P`$$OVI
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M_:3U_P")4M]^SO\`![XE_#/Q+\//@=\"8OB;IWQC\=?'+2_A1<_#GP/X3UZ]
M\.^`E\(^)Y=:MXM!U;XQ:G?2^&;:WEU/5?%FM+87YFX/P[^VG^W?\(]3^.FK
M?&CQ+X@\2_#[]A[]I3]FGQ#\8K7Q#I7P:U/Q_K7[*'[0OP0ET/QQ;>--=^!5
MK#\/TUWX(?$&6\^-DK:38)JC>!(]-M=9N[^:]TR:Q`/T>^$W_!)K]E;X5>)/
MVJ=-L_A_\/\`5OV?/VHO#OP@\.ZI^SA-\/[*W\%>&H_A1H8TY+]]0FUC4)?$
M.IZSJ\5KXF@U*33-(U/0=7LK2YM+^YO+:WO8O4IO^"87_!/RX^']]\+9?V2?
M@JW@+4K_`,-ZO>^'E\(6<=O/K/A"+6(/#FM&YCVWZ:UI<&OZS!#J\=TFHO!J
M-S#/<RQOMK\C_'/[6W[=_P`:/'GP;^$GP[\:^)_!F@?M73?M-?'GP7XN^&2?
M!KPUX^T#X)?!GQIX)\#?#;X:>#M>^,=J?`\FH:P=7N/'OB_6I+;6?%>M>'KB
MUM]*M[727U+4W_;#]BOQ5\>O%?P#T.;]IC_A%IOC'HGB7QQX9\2:EX2U_P`(
M:]::UI^B>+-5M_"FKZRG@0?\(IH/BZ[\)G11XP\-Z*\NGZ5XDCU(61BLYK>W
M@`-CX=?L:_LK?"+4/"VJ_"_X!?"[P#J/@CQAXQ\?^$KOPIX3TS19O#_C+X@^
M$+7P#XW\0:6]C#";;4/%/@ZQL/#VM2)A;_3K"QAG1C9VS1;OQH_9<_9X_:)U
M'P)K'QN^#W@/XEZW\,-7?7?AWKOBG0;2_P!=\%:I+>:3J%U<>&M:*)JFD+?7
MF@Z+/J5O9W45MJ3Z58?;H;A;6$)[U10!\S?#W]C']D[X3?%3Q'\</AI^SM\(
M/`WQ>\62ZK/X@^(OAGP+H&D^+-0FU^X:[U^0ZQ:V4=U;/K]X[7FO&T>#^V;O
M%UJ7VJ=5D'TS110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!7YK?'7_@GQK'Q2^-'QM^+/@3]H?Q%
M\)K#]I3X->$/@U\=/!,/P]\+>,['Q?I/P_T_XBZ9X.U+2]<U2\TW5_#4EA:_
M$C5UO["![ZUU%H(Y(VL9+BY=_P!*:_`+QO\`\%`OVG_@3^V5_P`%.]-T?X$?
M$?\`::^"7[.DO[.'C*]ATOQW\.O!GA_X'?#B\_9D\.^./B(WAVT\5:CI^M^,
M/%7B+6[J]\1VOA;1K6^>\%OJ#RZAI\C:?:7H!]=_%S_@EA\'OCA=Z4GQ`\8>
M*;CP_IO[&F@_L>C1=%MK+2)X;#PKXQT3Q[X6^)VD:OYMW<Z3XO\`#?BKPYHN
ML:-;>5>6-M>Z=:S2/.$9'^B?V>?@5^T+\,/$5_K?QJ_:]\3?M$6!\'67A31/
M#-W\+/!/PTT73KRVU/\`M"X\8ZB/#ESJ=_K7BJ\@5-*:?[;I^E0Z?O":2;EQ
M<+^?'Q:_X+>_!KX?:;JGQ.\->#-/\<_L^^!O#GPH\5_%+Q\/B_\`"[PKX\T#
M0/BMX?TSQ-#J?A/X/^)-?LO%WCJ+P1I.O:+=>-[+2UAU:S\S4H-(L-7N],FM
MV[B^_P""O'@'_A?5]\/M`\":3KWP@T']HX_LI>(_BE#\7_AU;^-;/XPV&J7?
MAGQ.FF_`J35#\2-5\'>%?&T,?@W5/$L=A$LFJ1:G=V5G<Z1ILFH.`?1GQT_X
M)[_##X\?MD_LT_MC^(/$.M:9XC_9ZTV^L=0\$V6GZ7<^'OBK-HNH:AXA^#5Y
MXLO;Q)-0L6^"?C'Q+XW\8>$H=*V+>:YXJEN;]@^E:<\?SQH__!)N33_BGX"\
M4:A^U5\2M7^$'PM_:TU']KWP)\`&\$>!;#PI8^/M6TSQK;75MK?B>S@3Q5K_
M`-EU3QK>ZOI.IRW=F]FT3V5W9:C#<*]OQ'P3_P""OGC+XEW'[-7CCQE^QQXZ
M^&W[-G[47QEM_P!GGP!\=+CXD_#[Q']G^+6L:OXN\/\`A>RUOX>:3?GQCI7A
M3Q'XA\)3:!8^*+ZR@@74]3TG?:BSOH+IOL3]L']NOPO^RUXR^%/PKM=(\->)
MOB?\6]*\=>*]*T[QC\3/"/PF\(>'?`WPXM]*?Q-XI\3^,?&%S%:P1R7^N:3H
M^B:3IEIJ>K:M?SW+Q6B66G7]U``?)GAS_@CN?AS\(?@/\)_@W^UU\5_A,?A7
M^S5>?LI^/_%WAOP?X.OM<^,?PKN-1FU6UCOX-;:_L/!FO:9>W-V;'6=`AGG2
MWO;J!U<O%+!U7A+_`()/3?!CP[\+--_9C_:U^,?P"\1>%/@1\'OV=OBIXJT?
M0O"GBZ7XU>`_@=I>L:5X!U75-%\41W.D^$/'NF6GB'6[<^*]`AD,UG>16UQI
MTYM4F?SKPQ_P6$\6_&;P!X(\0_LT?LEZU\7O%^J_"WXX_$+XC>';KXP_#KPI
MX>^&&H?LZ?$S3_AA\2M`N_&D]SJ.F>+8+O6+F>[\$:WX2AU2R\1V#:9=3#3;
M>^>:V\-L?^"D_P"U'\<OVC?%LOPK\"ZO!^RQXR_X)/?`O]KOPWX>'C7X?>$/
MB'X#OOB9XU^,]KXD^)]AK_\`P@?B_7)O&%M:^%X/`]KX/FO]?\+VK^"[/Q98
MZ.9_$%[YX!^S_P"T!^RUX#_:9_9@\7?LK_%?5O%>L^$?&?@K0_"NJ>+;;5AI
MWCR'6?"]SH^L^&?B!8:W90P)9^-="\7>']%\9Z?J=O;110>(=/@N4MUC7RA\
M0K_P2@L/%UIXU\0?'G]IOXJ_'#XT>,-6^"(C^+^L:#X3\)WFB>"?@/\`%'2/
MBMX8\!67A3PQ!;:)-IFL^(-+9_%-]._VK59YH+Q8[?[!!;'\_/@)^W;^V9\6
M->^+W@K0!KFL?`JW_P""<7P`^+VF>-O&WQ3^'<?Q,^$\OQ.T+XI+XN^-]]XS
M\(_#SP?K/CGQG:6NBQZ@^B6EQH>GVM]X3@GT.RT&YU6=PWP7_P`%H/'7P4_9
ML_9A\)0>`_#OQ^\=_#W_`()__LJ?'C]I#Q[\6/CW:_#7QCXIO/B)\$]*\6G3
M_A]9:]I/C;7/BY\6=8M-+U/5];?6]3\.VFL:U?6S-K1U#6!:P@'[M_MC_LJ^
M"/VTOV?/&W[/7C_5]>\.Z'XNE\/ZG:>(_#,EM'KGAWQ'X2\0:;XI\+Z]8)>1
M3V=S+I.OZ1I]\;.[B>VNUA:WG'ER-7Q/9?\`!([PCJ7Q-USXR_%']I/XZ_%W
MXE^*/B-^QS\2?$&O>*9O"FG6<^H?L6?%"_\`BM\-]!T[1/#FBZ5I^F^&=5\0
MWQ_MW3F6\FD$,5S'=FZ59%^!?VY_^"I'QL^.?[/?QTUC]B_X<>*?#GP4^$'C
M#]GGP5\2_P!JG_A;-[\+/&V@_$CXA'X1_$O4O`GPW\&:/I4VO^)(?#W@?XD>
M%=*^(-]J'B'PH(+OQ*=.L++6K5+J5?VN_;B_:RMOV.O@G9?$.R\%S_$WXA^/
M/BA\+O@1\$OA;;:S:^&Y/B7\;/C1XPT[P3\//!TGB2^@NK+P[97^J7[W>J:W
M=VUQ#IFEV-[=M!,8UC8`]-_9K^`7A?\`9B^#OA_X+^#=1U75O#WAW7?B'K]I
M?:TT+ZC+=?$?XD>+?B9J\<S0(D1BM=8\87]K9A5!%E!;ART@9C^<?P#_`.",
M'P;^$:?#C0?B%\;/C7^T/\,/@EI/Q&TKX(?!WXFW_ARU^'/PT/Q2TW4]$\5:
MG8Z3X8T72;GQ!K*:'K>MZ7H.K>);W4[_`,/P:WK!TV>)K^3'RI\#OV\_VCOA
M#^T=^UPW[1_PY%MK7BW]L/\`89_9_LOA!HGQJU+QYX$^$/\`PNOX7^-'U?Q1
MX$UF\\,Z99W<=Y>^'M-OM7TNV\.^&7U:4)->W*W%G")?I/\`:,_X*J?%7X4_
M'CQ?^SW\)?V5+7XU>.M+_;0^%O[('A.S;XO6'@5/$%W\3?V*M`_:U3QSJEYK
M/A6XTS0+#0+S6V\&:AIS7]\TNEV4GB6WO'O9(_#A`.TU/_@DQIFN?!S7_P!F
MO7OVNOVE]>_9NNOASXN^&?A3X/ZOJG@^XT_PKH/B.W;3-'6[\2P>&[7Q-XN7
MP-H=S?Z3X5M?$&HS6T2RV.H:DFH:GI&GW<7T?^TE_P`$_P#X+_M4_$6Y^('Q
M1O\`Q;YMW\"M>^`TFF^'-5317M-&UGQSH7Q$LO%6D:K'!->:9XO\->*O#>CZ
MKX?U*-98K*\LH)V@E,>T_F3X:_X*!_M&_#;Q3\8M'L/@5J7Q,_:%^(/_``42
M\#_LA6GPD\:_M8W6I_"#P%XG\1?L;>(_C\T_PT\37?P<TG_A$/AYINJ>")-.
MU31I/#^M:K?2:QK'B6SU2XD@TGP>W>V/_!7SXOZ]!X,^"7AW]E7PA<_MX^(?
MVBOB?^S]K_[/NI_'ZRTWX=^%)/A7X0TOQ[JOCR[^+"^!;K5[GPOKWAC7]%?P
MP(_AVE_?ZE+>6T]M:6]JMW,`?75Y_P`$ZCXS^'__``@_QM_:B^/?QSDM?B7\
M"?B+H>L^-[CP?9+X;;X!ZUI7B+0-*TC1?"_AS1--\WQ7KFFMJ?C?6[];[4-4
MN)TCT[^R+.W6TDS/B7_P2^^&OCS4/B%XLT#XJ_%#X9_$WQ=^UYX;_;3\+?$G
MP;/H/]O?#KXL^'_A)'\#Y[;1+76-+U+3-2\,:[\.+C7=%U?1]6MIHKF36Y;I
MF+V=LE?0W[*/QU^*GQ__`&<Y?B3XY^&'A'X;_&C2O''[1'PQ\1_"[1?B-<>-
M_!^E>.?@1\;_`(G?!>.TB^(8\)Z%>W6D>);GX?V>OMJ!\'P7.F66NB)-/OS:
M)+=_SJ_`;]J3_@I'\1/#/_!*?QUXET'X;_$KX@^,/VPOVL_#'A737_:!\7Z.
MGQ)BTC]F;]LBUUC2_C3<R_!S1]'\/^$/ABNCZ-XB\-/H$/Q&U3Q`GAE98=#T
MW7X=+M[H`_:#3_\`@F3HVI?%#X5>/OB]^U)^TO\`'KPY\'/%>B?$[P5\+?B=
MXA\&W7@^R^,6CZ5=Z<?B++>:'X.T;Q1+))<:A?ZK9^&/[<'A_2[VZ,5K:G3X
MH;*/W3]IW]C3P]^T?XS^$'Q1T_XH?$KX)_%KX*W7B&W\)_$/X7W'AM=4N_!_
MC>&PL_'W@'Q#IWBKP_XATC6/"_BVQTVR2ZMI[19+.^L['5+1UO+.!E_+37O^
M"U?B[PQX.3P%XZ^&GP7^$O[5=O\`M"_&+X#>(M,\=?%#QQ=_`;PAI_P9T7P]
MKVH?%36?%>@_"VY^(\GAOQG8^)]%7PEI%M\.S>?:M12+4[^UBMWGE_23]C_]
MLO4?VK_V&="_:U3X>'X?>)]1\,_%>;4_AYJ>IWVH:=I_BOX4>*/&G@V]6PUV
MXT;1M1U3P=XEU'P?_P`)#X5UR;0-,U#4?!^N:1J-SI%C>S36$(!P'P0_X):?
M`CX&?%SP'\3M'\:?%OQ;H?P8U?XE^(_@#\(?&NO^'=2^&'P1\3_&*WEM?B+X
MD\%Z7I_A72]8DU;5;6[U2QT>76M:U*#PQINLZM9Z-;P"[62+ZE^//[+'P=_:
M1UOX(^(OBEHE[JFK_L^?%72OC#\-[NPU&33S9^+-(M;BWMX=31$DCU/0Y9Y+
M+4[G3)502:KHFBWJ31O8A9/QS\!?\%E_C3X6\(>`/BW^U)^S;X*\(?";XX?L
M6?M'_M=?!J?X4_$G5?%GCVX'[*^F>!];\?\`@GQSX<\1>%?#FE:%=>*?#_CB
MQUWPGJ%CKVI068C71]6+7SSR6OS+^W__`,%+/^"B7PH_9>^+_A;QQX7^`7P6
M^*7Q<_8Y\4?M5_LW?$[X)_%'XA:EJ_@'1?!.M>"[WQ-X#\6P:_X,TD77Q/TK
MP_XIL+K3-7\/S7W@?7KBVU73[R!=-+-,`?L]?_\`!+O]E*^/[:I31_&5A_PW
MMK7A37OCL++Q6X$-[X3N9=4AC\`"[L+O_A#['6O$E[K'B[Q%86_VNUU3Q1K^
MM:MY<#W@CBO?%'_@F?\`LR_%_P`3?$GQ;XRM?',VL_%)OV1Y/$4MAXJ6RAMI
MOV*?%_B+QK\%Y]&A&ERBRE_M7Q5K-OXN\XW::]IMPEM$FG2Q+<5^:'Q._;T^
M.W[(?QY\7^)_VI/!7ASQ;\4_#'["FC>,],\!?L^_%_XLR_"#QUXX\4?M!^$/
MAA\/](;POXWTC0M#LM?U/4O%%P]]XXU?PI?:EX9TV\N=*T^[U&W\R6[]-^.G
M_!1_]LC]EB#X#?"C]H7X??LD^$?V@?VH/$7Q$U3X9^+-.^(?Q?U'X#>"_A/\
M+/"/A'7_`!WK'Q#$?PU?XCW?CO1-?\>^#_"&F^&/#FAR:;XEEU:YUV+7-*L-
M(O;>@#ZNN_\`@E#^SK,OQST/3_'7[0OAWX6_M!Z?\<+?QS\"O#?Q6;1_@Y:Z
MM^T/X-U7P1\3?$V@>%;?0?M=IK.IZ;KFKZE96^I:QJWAVP\27TOB"/07U)89
MH_IS1?V2?A+H/Q1^!OQ>L%\3?\)?^SW\$-:_9^^'QFUF.33!X`UY?"2WXUNR
M%BK:GK>/!>B^3J23VJ1G[7FU;SQY?EW_``3M_:U\3_MD_L]M\3/'/@FQ\"^-
M_#OQ`\;_``U\3V6A-X@E\&^(K[P7JGV&'QOX`NO%6CZ#XAN_`_BVSD@U/0)M
M8TFRU$0M+#<PAXMS?D#X,_X+2_M9^"?V=_V1OVV/VG/@'\"++]ES]J_PMK3:
M7IWP;\:_$#6OC+X,\6:9X#\6^+]+N?$FE^)O#&G^#1X>\47GA&YTBQMM,\1:
MG?Z6-2TZZU&YR+VWM`#]F?C-^PK\*/C3\=]%_:,O_%WQ<\!_$>S^&%G\%?%4
MGPT\:V_AW0_B=\)]+\:WGQ!TCP'\0])OM#UI=3T72O%.JZ]>VKZ//H.I2V_B
M+6]-O[^\TV\%K%R.C_\`!,W]E33='^%OAK4_#7B#Q?X5^$_[+7Q`_8ZT;PMX
MNUU=4T/7O@C\3I?#DGB_2/%MO#864VJZQ?)X8TV"#6;6YTZ:SB:Y:WB2XDBG
MA_*>^_X+7_'/PSX2^)7B2X^'?P,^+:K^QM\:OVFO`EU\&K[XM'0_ACXU^$%I
MH^N6OPE^.VL>.O"?ARPE_P"$^\/^*]+'A?Q/X2N8!)KOA;QE8G1YM/BM=4C;
M\3/^"BGQK_9V^(U_^T3^T9\"O#Z_%:W_`."=6E_$_P`'_"#X4?&;QGK_`(1U
M+6/BC^TMI/PO^"7PZUM]3T&P\-0^)-?\9>,?#5MXQ^(>G^&=3E\-:7?W4.FG
M7+'2ECN@#]BOV:_V(_!O[,>MSZQX;^-/[3?Q(MH]`B\+>'O#GQI^,^K?$+PS
MX0\.V\SRVNF:!I=Q8:>9GM8S%:0ZQXBN-?\`$`M+:"&35Y`)&D\I^-G_``3$
M^%/QF^/WCO\`:2L_CM^UE\%/B/\`$WPG\._!OCO_`(4+\9H/A[X?\3:/\*XO
M$L/@@ZGI3^$]9>>\T9/%_B,17!N\9U2Y(C7>:^+/VA?^"F7[9G[(7C/2/V?/
MC5\&_P!GSQE\?_C1HOPS'[./B#X:>+?B'IGP@U7Q=XS^(&B?#KQ5HWQ";Q5X
M?/B?2M(\$7^L)KZ:OI,=S<^(-&6.VATK3]5E%J/0O^"?D_[0)_X*??\`!5:S
M_:-N_A?<>-;3X.?\$W'L8_@]-XP;P7'H5SI7[79M)5M?&L<>IVFM3R13+JBP
M^=:2K!9O'.[;DB`/L35?^"<G[.NO_#SXW_#;7_\`A/\`6])_:'^('P9^*'Q2
MU?4_%QG\2ZWXW^!&H_#?5O`FMQZJ--1;:8:G\*_"E]K2_99$U6X34&D$2WK+
M'X/^W5_P3LN_VE?C%\"OB)X'U77?#+GX[_"_Q=\>_$F@^.[GP7XMT[P'\)/`
MWQ2T3PC=_#75+'3Y]0TSQ);:O\0[A;Y+6ZA34[&5H[LO;1/;S?K710!\(_#/
M_@G%^R[\,?#>EZ);^&_$7CC6;?XL77QO\3?$/XG>)[WQS\1_B1\3KWPC?^`)
MO$?Q&\3ZK&7\2K'X&U&?PEI^C&UM-!T;0UCM-%TS3MK.]#X+?\$U/V6_@#\1
MO"/Q/\":%XUU'6/A;I_B[3O@GX;\:?$+Q+XN\"_`^T\<6IL?%%M\(?"FLW5Q
MI?@C^V-,:;0Y+FQCDN[/P_>7N@Z?/:Z/=3V+_?M%`'YJ_L\?\$^OAUHW[,?Q
M?^#'QX^'WA/4;O\`:0^-OQ?^./QAT;POJ&I6]D/$GCSXI:KXS\+2:)XHTV72
MM=LM5\*:;!X8N[36-+N-.FL_%-OJ6JZ?Y,EY,\VVW_!,']F"^T+5])\37'QK
M\;ZI?7/A*]T+QOXS^/'Q0U[QY\/=0\"QW\?A;5/AKXGG\1)=^"-6TT:IJ)FU
M714AU#5_MMQ'KESJ4,C15^A]%`'@_P`!?V=/`/[.ND>*],\$ZCX_UV[\<^*9
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M?Q`^&VK0+K'PVT[X4>)/"_@WQQXN\#^`?%WA'P]97MCX)B\8^`O#&K:=X3\5
M:C\.TOY;CX?ZCKNDWUQX4O8;&[TPQS:?8M;_`*&T4`?!WQ*_X)I_L<_%CPWX
M]\->+_A=(\/Q!^*.@?&N^UO1?%'B?P]XN\.?%CPMH&F^&=`\>^!O%VC:I9^(
M?!WB#3-&TC3K6"YT74+:-C:QRS0R2@/7M/[-O[*GP,_9(\*^+O!?P$\&MX,T
M'Q[\0M8^+'C**;7-?\1W_B7XD>)-%\.:'XE\9:QK'B74]6U:^UWQ);^%M*O-
M<O;B]DDU'5A>:G/F[O;F23Z(HH`^+]$_X)Y_L=>'/CG-^T9H_P`%=)M/BI+X
MUU;XFI??\)#XSG\)6?Q.U_0;WPMKOQ+T[X97/B.;X::?\0M7\.ZA<:/>^,K/
MPE#X@:T8^5?Q3/++(G@K_@GG^Q[\//'WA_XF^$/A`-+\7>$?'6O?$KP?/+X^
M^)^JZ%X/\;>*;+Q+I_B+7/"/@W6?&NH>#/"SZS:^,?$J7]AH.@:?I<\FKW%P
MUE]I2"6+[1HH`^./%'_!/W]D#QCH'B+PUK_P8TV?3_$_QP\4_M):C=:?XI\>
M:%XAL_CEXVAM[?Q7\1_#7BW0O%.F^*O!NNZW;VL4%XOA#6=#T\Q-/''91I=W
M0F]`^$?[*/P`^!6L6/B+X7?#^+P[XAT_P+-\-H=?NO$?B_Q-KD_@RX\9ZO\`
M$.ZTK4]7\6>(-=U'6)[OQKK^L>(KS6-7N;W7+N_OYS<ZE+#LB7Z'HH`^/_$'
M[`?[''BKP_\`&KPKXB_9_P#`VK^'OVB?B=X;^,WQHTN\CU5[?QW\4/"-SH=W
MX=\9:@5U-9;'5--E\-Z.J+HLFFVD]M;36=W;3VE_J$%U)\3_`-@S]DSXR:MX
M_P#$'Q$^$%CK7B'XGZMX(U[QMXAL?%/COPQK^JZS\-](U70?!.I6NM^%/%&A
MZIH5WH6C:WJVG0R^'KO2C=6M]/'J'VO*E?KRB@#X8\3_`/!-+]AKQ9X&^%WP
MYU#]GGPMIGA;X+Z3J&@?#1/!FM>,_A[X@\,Z!K#RSZYH*^,_`7B;PUXSU;1/
M$-[/+JOB/2-=U_5-/\0ZXW]NZU;7^L*M\/<?%7[,OP(\;?L_ZG^RQXG^'&C:
MI^S_`*QX-C^'VI?#(W&K6>BW/@Z(0A-#:ZL-1M=9CMQY$1,T.IQWCLI=[AF9
MRWNU%`'S9\8/V/OV:?C[?>+=3^+_`,)/#GCC4O'/P]M?A5XIU#49]9M;W5/`
M5CXGLO&>GZ%]JTK4[">Q.G>*-.L]:T[5=.>SUO3[V`-9ZE`CR(_-_#3]@_\`
M9!^#_@;XE_#?X<_`7P1X=\%_&;P]HWA;XM:*(]4U;_A9.BZ!HM]X>TN#QMJ.
MN:EJ>J^)+N'1M3O[*?5M5OKK5[];J6;4+ZZN6$P^MZ*`/EKXG_L3_LJ_&7X8
M>`_@W\2?@KX3\1_#SX6VL-G\-='W:OH^H>`+:#1G\.B/P;XIT#4]+\6^&C/H
M;MI5[)H^NVDFH606&^>X5$V^O?"CX0?#'X&>"[+X=_"+P1H'P_\`!6GWNJZE
M;>'_``Y9+9V7]IZYJ-QJVLZG<L6DN+[4M4U*ZN+R_P!0O9[B\NII"TTSA5"^
MCT4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!7Y;_%W_@GM\1?B)\7?VL/&/A;]IJ[^
M'/PY_;*\*?#_`,%_%WP)IWPI\'Z]KUOH_@OP-8_#N\N_"OC77IKLZ=K.L^&8
M]3LDNM1T/5;/3CJ:S1V$UQ86DJ?J110!^/>@_P#!(_P1\)I]:TG]GCQ?X&^'
MO@?Q/I?@>PU32?'7[//PC^-/B30+_P`'>'M'\(S>(/`_B?Q_HM\+#5->\/:+
M:-J-MXHTSQ;H?]NA]632=LL]I+Z)X$_X)LZ3\)?C+XV\?_"WQUX1T/P9\1_C
MQXJ_:+\4^'?$GP'^%?CCQ[:>/OB%K5SXE^(=EX3^*WB'2+C7M!\->)_$EQ-K
ML5F]I?ZGX?OK_5$T#5K"TN;>WM/U`HH`_+OPK_P3*\,^%_V;_P!DK]G6+XHZ
M[=Z=^RG^T]\/?VE]*\22:)I\=[XMU/P!\2-:^(MOX8U"S6<P6%CJ-SK+Z;-?
M6TDEQ#!`LR1M(Q4>L?M8?L->%?VE?'OPP^,UAX@T[PA\8OA!H7BSPKX3USQ'
M\/\`P;\5O!>I>%?'-]X?O?$N@>*_`/CC3KW3-2A>3P]:7.DZGIESHVMZ3?YE
MM]2-I+=V5U]V44`?`_PV_8:M/!NMKXB\0_$NX\2:I??L_?$?X$ZU'H7P^^'W
MPVT1;;XF^(_"7B36-8\-^&?`NAZ/X?T*'3+GPPT.DZ?)IVHW,B7\EQK.J:M>
M*]Q-\^^%_P#@E0/AM%\#7^%7[1'B[P7J'P\_8Q\._L)?%&\?P=X5US_A;_P/
M\*:SJ7B'P]*8]2B<^#/&>C:OXB\72Z?KVC231);>*-1MY["?R[1X/UZHH`_)
M'P3_`,$IM&^$LOA.+X1_'WQUX7T>7]FGX=_LG?&K1M;\)>`?%]M\7_A+\.%\
M5QZ7F75]",_@OQ/>6OC+7-,OM3\/.EA+IT\9.DG488K]:7PX_P""3NE?`^S\
M"Q_!;X\ZYX9O=$^"?P+^!GC>Y\7_``D^"_Q-A\9Z%\`_#%SX3\(>*[&T\9>#
M-03PGXT;1[J6VO+K2G?0KQ5BEO\`0;RYB2X'Z]T4`?D1X[_X)&^#/%^F_'+P
M;I/[1?QG\$_"K]I+QY\.OBY\8_AOH&C_``GN-)U_XM?#W1?`'AQ_'&BW^M?#
M_4M2\(S>-M'^&OA&'QGI/AZ>RTNYGT/3I]&M]&'VZ.^^VOVLOV5_!/[7/PW\
M/>`O%^N^)?!^J>`_BM\,?CG\,?'W@Y]*'B?X>_%SX.^*;/QA\/\`QIHT&OZ9
MK6@7]SHVL68,NF:[I&IZ1J5G/<V6H65Q;S/&?IVB@#\EM3_X).>%?$5S\6O$
M_BW]I;XZ>)?BE\5_CK\`_P!H:?XG7>E?!VQU3PIX^_9VT35?#_@<>'?"VD_#
M2Q\"MHEQINLWJZSI6K^&]2@NIW%S%Y$VYCU/AK_@E]X(T_XQ:=\>O&?QT^,7
MQ)^)\'[47@S]K'5]=\0VWPVTBW\0?$#P3^S'9_LKZ;H]WI'A+P-H.F:?X5F\
M#6-MJ\VGZ-:Z?<PZ_&OV.\MM)4::/U`HH`_/0_\`!./X4M\8+KXS'QM\0O[?
MNOVV-`_;E?3//\-_V.OQ&\/?L[^*OV;[7PFJ?\(_]M_X0J;PGXMOM<N(C=G7
M3XBMK62/68]-$VGR_)W[4'_!/Z+X>?$+4_VG/@#\+_VCOC-\=O%_[26I_&Y9
M_@M\0?V9?A]XI^%UUXA^%&C?"_Q%%H;?M`ZOX$\%:_X0UG2?#>FO?:)J>LZG
MKJ:O<3:E:3I&BQ#]O**`/A#_`()M_!WXJ_!+]E'P_P"'?CAI6K>'OBMXR^*?
M[17QK\9^%]>\9:%\0=?\*7OQY_:"^)GQBL/#/B7QIX60>%O$GB[1M$\:Z9:>
M-M4\*27'A.Y\9)K[^%+B;PW_`&4U>7_!7_@E]X(^"7CCX&^(-(^.?QA\1>"/
MV;?C+\5OC7\%OA5XBMOAO)X=\'Z_\9_AM\:/AKXYT>7Q)IW@:P\?>(=!N[#X
MUZOJVG6_B#Q3J-UI.I>']!BL;J'33JECJ/Z?T4`?F!X@_P""5WP=O?B/XZ^-
M/A'XB?$WX>_&;Q=\;_$GQSTCXB:`?!NI7?@[6?&'@?PUX"\4>%+#P]XG\*ZW
MX5\1>"=:TKPKIEW=Z'XTT;Q$@U0->12QLD`B^W?!7PFN?#7P?NOA1XD^(/BS
MXB7&I67CJSUCQYXEM_#=AXEU`>.]9\0ZO=>78>&-#T/PMI=IH<?B!M&\.:7I
M.@V6F:5HFF:5I\5HT=L2_L5%`'YH:M_P2N_9S\3^"/V=?AUXRO\`QKXK\'_L
MY_LX?M#_`++^B:/J&HZ9:0^,/AY^TOX=\!^%_'\OBU]+TNRE;6(=)\`:=%HU
MQHSZ5;VLE_J$LUM<.;8V_`>)?^"/OP3^)WA'4O"'QU^+GQN^-MK%^S/XF_9/
M\"W_`(MUGPMI-]\-_A3XJCTJ/4/[`_X1#POX?MM5\5E/#^@(WBOQ3!KFL7<.
MDQ6][<7$%S>)<?K=10!^9'CG_@EO\(?C%=>-]6^.WQ'^*?Q>\1^//@&_[.^J
M>(]<N_"OA_4;#P9;>/="^(GA[5=$C\&^&O#]GI?BOPSKWAS2Y-,UVVMEN97C
MGO-0%WJ%U/=/OZE_P3OT_7/$'PS^(6O_`+2W[0NL?&#X)>(8=7^#/Q2N-8\&
MPZO\/-$N?"&F>"/%_@:Q\.VGA"#P9K7@[XCZ+H^G2_$+2_$?A_56\4:Q8Z?K
M5],=2TZRN(/T8HH`\Q^$OP^UGX:^%9O#^O\`Q-\=?%K5+G7=9URY\7?$*XTB
M;6V.KW/VD:5:PZ#I6C:1I^B:6/\`1])TVQTZ""SM_P!V@(YK\3OV'?\`@B_I
MOAW]E+]E'X;_`+<'C7XB?%37O@?\)=4\*Q_`>^\=:?JWP1^'7BSQ/X=UCP?X
MBU7P@N@:5I5YJUY'X>UG4K?1]2U74=1_LB;4[F?31;S1P/%^_P#10!^<&I_\
M$Y]+\3?!WQ)^S]XW_:9_:.\:_!S7?A#XS^"MMX)UKQ'X6CM=-\(^,;3^SS-=
M:AIWA2SU7Q1K/AK3A'8>%M2\6WFM2Z/:QJD09BS'9^-O_!-+]F_]H:]U:7XJ
MVOBG7],UO]EC3_V2=0T6'7'TNV/@#1_&%KX\T3Q!97NG0V^JZ9XYT3Q38:=K
M&C^(+"^MY-.O].LKJVACN($D'Z#44`?DQXN_X)`?`WXHOKOB#XT_%[]HGXP?
M%.XT[P;IG@;XP^,OB+CQW\)8?`'BB+QIX6N_AY)H^FZ9HVE:M:>)H(-3U#5[
MK2KW4-<:&*WUF>]MD6(=OX;_`."9/@;P^G[2&JR_M!?M+ZY\1/VIO#/P)\,_
M$[XKZQ\1HY?'D=M^S[J?CZ_\'2^%=1MM)MK7PPEY;_$/6-+U?3=+LX=*ELH8
M&M;*UN9KV>Z_3"B@"K8VB6%E9V,<DTR6=K;VB2W$C37$J6\20K)/,WS2S.$#
M2R-\SN68\FK5%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
E%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>onco_p2.jpg
<TEXT>
begin 644 onco_p2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`V@"
MJ`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`**BGD\I-_'![^F"3U91G`P,L`,Y)P#7P_P"`O^"B/[,?Q(^(^A_#;PSX
MH\2-<^,?$_B'P5\.?&NJ_#WQWHGPJ^*/B[P@=07Q9X;^'/Q/U7P_:>#_`!7K
M.@2Z7?V]S:V&IE+^>UF_L.?5H8Y)D`/N6BD'(!]0*6@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`*Q_$5WK-CH.LWOAW28=>UZTTN^N-&T2XU"/28-6U2&V
MDDL=.FU26&XBTZ*\N5CMWO9()DMED,S1.$*G8I#G/!&.X()/YY&/R-`'F'A#
M7O'6J>&+[4_B=X0TCP#?PW5Z)-'MO$]KXHLO['BBC,5Y<:O#::=;HTX>X$UN
MT/[D1+ND82$K^$7P_P#VC/V5?VN/VG/V?-#\,_%'X/\`P=_9W_9I^*^H7O[/
M_P`#]%>ST;Q[\9OCK%_;'A7P_P")[7PWI-JMAX4^'6G/KVJ77A71DQJ_BO5+
MD:Q>Q6=B\,$G]%,L,4\;131K+&XPR.`RL/0@_P">U<M:^`O`]E-;W-GX0\-6
MMU:2)-;75OHFFPW4$T;!DFBN8[99TE5U5Q(L@?>`V=W-`'#_`!=U[XVZ)8Z-
M)\%O`7A#QS>W`U(:S!XN\6S>%(=/\J&U;26MI8-/U`W8NIWNH[H;4-ND4;J7
M,F!ZS8M>-;1&_2-+DQQF5(CN19-H\P*>X#9P?3I5L```#@```>PZ4M`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`445YC\9OB=I'P9^%?Q"^*6N0W%UIO@+PAKOBJ>SM`K7>H'2+"6Y
M@TVT#';]KU&Y6&RMMWR^=.A;@&@#TZBOQ@^*7[<?[27P3\(_L46GC]/@)X2\
M??M8>(?B#%XE\0_$[Q!J'A/X6?"'3M"^&6K_`!.\.Z;K.M131R7%Y/#IUIX0
M>_NI[.#4/$VJV5O;*'N+>"7V'Q-^TS\?/A)=?LT_$7XF:Y\&?&GP6^+OCJW^
M%'CG5_@[_:6J:/H7B'QO<_9?A5XQ\-^(]2O'?5/#^IZQ"_AO78&C:**YOK&[
MM+EPS)0!^GU%1HVZ)6!R2@(;&,DKUP??GFORU\%?MU^+[K]O;XC_`++7CS0=
M(T;X?#4&\)?"/QK:O*MUK'Q&\/\`@S1OB#XD\&Z[YJM;1WNJ>$-;.M>&Q$R2
M7EMH/B`*C/9@$`_4ZBORC^#W_!4;X42?L^?`KQ[\:9]9/Q+^(?P+\._''Q_X
M=^&'@SQ%XSL/A[X2U<R6DGBGQ&-)M[J;0/#$U[:WIL)[]GN[F*TOG@@FCL;E
MXW7G_!5#X3>'?C3\9_#GBG3?$*_!/X:_#'X._$?2OBUX=\-ZUKNDW>E?$BR\
M;:AJFN:_/;Q"RTGPG96?AS2Y=%UM)94U.6YU>W9$FTXH:4925U%M=TO3_-`?
MJU17R;XS_;;_`&=?`6L_&OP]XB\:M!K?[/WP]TKXG_$S3K73Y[NXTOPEK1G3
M3;FR,),>I7ES-`+=;"VD-R+BXM(F0-<Q;OAJR_X*:ZCH?CGX1>&M7T:7XE:%
M\5?V@_VK_AO<Z[\./!7BIM1\+:%\"9O%MOI'AZVT-UN9=?\`&UAJGAQ=+\7F
M&2.P%BE]KFGDV]NT2KEE=*SN[-*VMFKI_=J!^R]%?D1^S)_P4W\&^*=>\3^!
M?CCJ>L:5XHU+]I_QS\%_`&LV?P[\0Z;X+M(3J;1?#/PAXI\4>5/HVG>.M>LT
M^SBQN+I)IM2FMK*>.TO)TMSZIXF_X*:?!"7PQ\3M6^&>C?$WQX_@?2_BI'HW
MBC3OAMXHD^&GB;Q9\*8M<MM>T*Q\916S6TMO:Z_H&I:-<:BL26;SV%^EE<7$
MEL5+49-V2=[7MUM_30'Z1T5\"6'_``4$^'T?P_\`!7C'6?A9^T&]UXHT&YU>
MZTS0?@UXIU9M/32=.TB\UB]>4+'$-(,FJ@:-<R2K=:Q!:W4UI:R"VFVUO%?_
M``4T_9<\,:3I^N6NH?$/QIINH?#?2_BZ;GP!\-_$WBN/3OAUJEO<W(\3ZS)8
MVPBTBTL$LKQ-2@OY(+VVEM;F,6LC0R;1QE&UTU?:X'Z"45^9/[2/_!2OX._#
MWP?XITSX5ZAXF^('Q+_X4MI?Q=T6?P7X%U;QKX9\'^'_`!IIUY=_#[Q'\0[V
MQ>"VT#2O$8LKBYT^"[E%U=65O->"%;)3<5S7A#_@HAX;\#VGB[6OCSXQM-1T
MW3_'7P6^&FDZ-\/_`(?^)+_Q)IOCCXL?"*V^(NF:!J-I;27SZ_<ZQY5\VFR>
M'K:58Y)[+2VCDN&+E)-W:3:6K`_5NBO@>[_X*0_LX:?\.T\?:DOQ+TZ^N/B;
M/\'K#X877P[UH?%W5/B+#HFF^*%\.:9X$B,M]>3W'A;6-,\36UQ%.;.31+R*
M^-PJK(J>W?L]?M._#G]IC1/&^L_#RR\9:>WP\\7W7@/Q;H_C;PQ=>%=>TCQ5
M9Z/I6MW6EW&F7<LLJS6]IK%FDN2-MQYL6"$#L@/HJBOQ4^!?[87[3W[1GQ!\
M47/A#XF_LV^#8/!_QZ\1?#?5OV:/%]OJ$'QGA\$^#/&9T#5O$%[=SZI:WUOJ
M^N^'H)_%&@QV^@3Z3-!<6<(O761I4^RM+_X*"_`'4?B39_#ZYB^(.A:;K?B7
MQOX-\)?%?Q#X-GTSX/>-O%GP[MM3N?%V@>%O&SWLBWM[IRZ%X@CMY+O3K&RU
M:30=4_L>[OXX8I)G9VO9V[_U^'<#[AHK\?\`XS?\%8O!ND?#?0/''P=^%?QI
M\2:9XC^*?P>\+^&_&NN_#'4M.^'WCGPAXP^-/@OX<>*]4\$ZZ-1:2^U.33?$
M<T?@FUU2STD>)=<N]'2Q$VGRW5Y;=OH__!0_PGH'BWXZ^(OBC?>*?"_@'P%X
M2^"NH^'OA?K/PNU#1OBY:>(?BOK_`([\-Z#HDD"ZS?0>)-<\9ZGX,N6\/:%9
MI9R65E)8S7ERWVX_9Q1<MDWZ`?J317YW7W_!3C]G32?"\>NZWHOQ@T;Q$OQM
MTG]GK4_A9>_#FYE^*VA_%+Q%X$UOXC^&-%U3P?I^I7TGV7Q-X6T*>\T/5=/O
M;^PO'NK*,S1*US):_0_P`_::^'G[26A>,=4\#6GB[P_JG@#Q5=>"O&OA+X@>
M')?"WB[PMXBMK*TU)+75M&DN;L)%>:=?6E]93P74\-U;3*RN&W*$!]%45^#.
MA?\`!0?]HU_"?@7]K/6]:^&0_9R\<?MA>(OV:-2^"T.@31?$CP+X>M/C-K7P
M,T7Q1J'B_P#M1S>>,H=>T2+Q/XA\*2Z+;VEGH>K[([HM9^?)]&?!K]LKQ*WP
MC^+W[7_QGUF[MOA7XI^(FK^#/V<?A!H&DVMWXJUVR\/ZWJ'@_P`+:;H,4.=1
M\5>/?BQXCT^[?3M,C*6UA:F"60V]A::A?1`'ZM45^$7AS]K;]MGQI\"/VJ?B
M_J0\,>&/'_['O[2&H)XC^$N@Z9;W]CX@^$?A_P"''P]^(OBCX9:EKDSSS:CX
MKT70/&6IQ'Q7IR64%[KVBYM[,:=-'N_:CX<>-](^)7@/PA\0=`F:?0_&GAS1
M?%&DRN`&;3]<TZVU&V!P,%ECN`KXR`ZL,T`=K17XY?MN_MQ?%+X`ZO\`M.Z+
M\.]2/B/6O`?@;]G]?"_AJR^'<>H3>`]9^,GCP>#YO&NKZ]=^(K&W\3VC02D:
M1X=2TLQ#KJ:;:7=X;349KBU[;XD_M'_&_P#9C_X)YZU\=-;MOB'\2?BEH2W.
MH*GQ-\">&O"/BJSM]7\;FRL1XR\+^$_$.H:-INF:1I%W"D5SINJWUS<Z<ME>
M30&ZFFA0`_5>BOQ)U[_@I5XX^'W[17C^'QQ\'/CT/AIH7[+_`(4^+DGPTT[P
M)H%[XX\'QZ;XM^(4'C_X@>)!9^(I[*VT!?#?AVPGTO3HM8O=4U)P(;#3FG^U
M&W^H/B/_`,%'OA=X3F2_\$>!OBC\9/".C_#+P=\9_B%XQ^&_A^RO=`^'7PP\
M=:5+KWAGQ'KLVJ:EIUQ>W>I^'HKCQ$/#^E07.JV^A6DNHW,42-!'.TF]DV!^
MBU%?F]-_P4U^`<.K>.H1IOQ0G\*?#33M8UGQO\3+/P3=W'PWT'1],\"P>/;&
MYN?$QE2&YO\`Q-97UAI'AS0]-BO=6OM9N[:UDMX!<0O)ZI\`/VP]$^,_Q`U/
MX5^(/AK\4O@S\1;?PE;_`!"T7PE\5=#TW2;_`,3>`KR]&GQ>(M)ETO5=5@+6
MMXT5OJFDW,D&HZ5-/''<Q')8%FTVD[+=_P!>JOVN!]FT5^8'Q`_;QL?@G\9?
MVD?"/CG4-6\:IX7^(O[-?PL^#_PR\'^#+6T\37GCOXV^!;O7[+P[%XDO];AT
M_P`0OXAN;>34UOM071+;PW;6L]BWV]VC=ONWX2_$2Z^)?@.R\6ZCX.\6_#_4
MIC>6^I^$?&EG:V/B+1;VRD>&>"Y2SN+NSFC9D\VUN[:XEM[J!XYHR`VT(#U*
MBOACX-?MK6'Q.^+FF?"#Q-\)OB7\(O$OBCPUJOB[P3;^/XO#*3>(M"T9HVO&
MN;#1->U34O#VII930ZB-,UFVAD:V9U\Y;F&:W3HOCI^USH_PF^)WAWX'>%OA
M]X^^,GQC\2^"M6^)K>!?A];:8MUX=^&^BZI!H%QXNU_5M:O+'3=.M-0U^YCT
M3P_:!Y[[7-1MM42VA6'3+R:(`^Q:*_$?X8_\%*O%'A#Q7^T%+\8?AU\7]>^&
M_AG]IW2?`:^/K?P[H5IX=^#'ACQYX?\`A9:>"_#/BB$WMKJ]U?VOB?QBT>NO
M96FI'2'O6:ZNGB2-:^KM;_;TT;P;\=-"^"_Q#^%WCWP3;^-?&.J^!?A_XVU&
M\\*W6F>+M7L-.U34],U&WT.QU>?Q+IOAWQ+'HVHV^BZW?:8+6:XCMXI_LXN4
M>FDW>R;LKOT`_0JBORT^&G_!3OP/\0-5^$]S>?"KXM>#OAK\:/''B#X<^!/B
MYXCT[0X?!6H>./#NF^*=8GT28P:G+JMK8WMAX+\1'3M9N;&&TNKJQ-JH'FI(
M&>"?^"H'@GQOJ/P?U*/X0_%KPW\(_P!H'7-1T_X._&?Q1;:%I7A;QCHECHVH
M^([7Q?#IC7\GB#3O#NN>'M,GU[1+C4;""2_TF2&Z*0B>-&:C*5[)NV]@/U.H
MKX`^"W[?O@KXN?$GP'X#E^'GQ%\%:9\9]#\=>(/@/XU\5V6E0Z)\5]/^'GV*
M[U]=+MK*_N-1T6_G\/WH\4Z-I^M6]O<:GX?M-2O$$3V,L)Z7]HG]LW1O@MX[
MTGX6^&/AO\0_C'\2+GP-KOQ/UGPE\.K729+WP[\/]`E^RW7B'5+C6+ZQMS)=
MWN;+1])MVDOM5ND:.)8T'F!--.ST?8#[:HK\-X/VO/C+^U+^V=\*O!?P(U_X
MB^'/V<;CX`_!7X\1^(/!MCX'>?QGI_Q:\7^(K.#7?%\GB6.\O=.\$:79^$]1
M\*7FC:/#%XC/B*VUFZ>2*SALFE^\?CA^UVWPM^*>B?`[P/\`"OQS\;?BUJ/@
M:\^)6K>%/!-SHFGQ>&/!,6HS:)I^K:UK&N7%KI\-QKFM6UWI^B::'^UWTEE=
MS`)!"79`?:]%?EWJ/_!3#PKIVO\`B-9OA)\4!\//AQXD\`>!/C+\39ET*UT/
MX6?$'Q[I'AO5QX0U73VNY+[5[_PJGB[P[:>+[K23-::+>ZB+=I)GA?%"X_X*
M;:-#J?B.]?X'_%9?A5X._:`B_9N\8_&-)/#K>%=`\>ZC\4++X2Z+=0:>;L:U
MK.BW?BG6?#T=[?6MHL6F1ZLP;[0+&XDIM-;IJ_?Y/]4!^J=%?C3X-_X*5?$+
MPKX(\7>+/C)\#/'>J:=:_M(Z]\#_``AJW@Y/#\DFN:E<>*=:T/PQX;LM%34)
M+JXUB"'2H!?7UU+96L\^H0L6MXDE=>U\2?\`!3^V\(R>,I-?_9S^,%G8_!3P
MSX*\4?M,RB[\+377P$M/'[:C?^']/\06EO?2OXGUN+P?9V?CG7+#PY++_8_A
MW6]'FFDFN+Q8`.+CHTUZ@?K!N4G;D9YX[\=:6O@?]C+XP>*/BOXZ_;`DUCQA
M=>+/"WA'X_OH?P[\V.S2UTCP9>>"/#.NZ99::]M;6\D]C,=0EO8IKIYYV^T8
M,NS:J^4K_P`%,M$?4K/7U^"_Q&A^`NM_&'7?@1X7^/5WJ/AZ#P[K_P`0]&\6
M:OX`CCCT"25=8L/#6K>/=`U7PKI/B6[/V:YN88[LVZVLZ2!`?J=17Y)?\$U_
MC!^T#\?]=^,GQ8^+UY\3(/#E_P"-/'OAOP=X=U6_\"GX7:#;>'/B5XD\-0^'
MO#&DZ-I*>+E\2^&--\,06_B'6]=UNYLM6N-7G>QL($CC=?UMH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"OF#]L_P/XA^(?[+GQM\+^$M..K^*+OP'JUYH.D1[!-K&
MI:)Y.NVVC0>9\AFU>33!IT2D@/)<JA8!B1]/UY'\=?BYH?P)^$_CKXL^)+.]
MU+1O`_A^[UN[TS3!&VJ:G)&T=O8:9IPF983>:IJ-Q:Z?;>:RQK-<HTC!`Q`!
M\'7WQ(\=_'7X1?L]_$_X#_L[_!S]HOP?K/@S6++Q3HGQ!\8VO@3Q5\/O$+Z;
MH.F"QT9]:\(>)=+E6"\@\1^'?&NCWHTS4+:X@T@0&>/[4B?&WC/X#>-O`'[.
M?[,7["FICPS=?&3XS_M8Z5\<O$/ASP!)?WO@CX._#3PC\6F^-7B>V\.ZE>Z;
MIL]MX;\*V]AH?@O1+V;2]/&HZMJMR+*QAM]@7[4O?VN_B1^SUH/PW\<?&?\`
M9B\+_#3X)_%?XD^`O!U_K_P_\=6VLZQ\+O$WQB\0V?A[PSK'Q(T*3PAX;T^]
MTS5/%FMZ1I'B'Q#H]^KZ/JFJ6[O;:Q!<3W-GZQX9_;[_`&,O&?Q>TOX:Z!\0
M]/N_B=JOB;Q'\,](NKKX=^/],T^^\8^%I]2_X2/P!8?$/5O!=CX3F\0Z>^C:
ME<S>&XO$ANYH;1KRWMY[=X9I`#[D@P((0,X$48`SDX"`#G`R<#G@<U^47C;]
MA+QE\1[W]M+6;C4=&\*^,OB!\9/AU\=_V6_'MG=RW&J>`/BA\+?AQH>D^$?$
M.K6\<<4L%FWB;29]'\2Z.DSP:]X'U?6M)N2\.I21CWM/^"CO[(Y\3>*/#+?$
MRZ6#P=JGC/0->\=_\*_^)?\`PIZT\0?#RQU'4O&GAV'XU?\`"'GX37VO>'+'
M2[TZCI%CXSN+Q;NUN-.@CGU&">SA\*^-_P#P5%^$6G?LX_'WXJ?`FZN?%'Q*
M^#?PUT3XF6'PZ^*7@'XH?"RZU[PQX@UZQT;1?%EEI/C?PYX.UG7_``;J+W<Q
MM/$'ALWEA++%'$UVOFQB0`^4/A'^PQ^V'^S/X0BL_A9X8^"7Q"USXM?L;_"K
M]F_XF6GC/Q[K/A^P^&/COX::?XPTNW\8Z-?VO@K6[CQQX)N].\:WDFI^&X(]
M$U6[U72;:>UD5-1NI;7TKX>?\$__`(H?"S6M<^$D>E^!OBI\!OC?^QU\*_V9
M?BQXMUGQ5J?AKQ;X*N_A)X2^-EL^M:1X2?P]JUKXRT_QSK'Q#T/3;.%=?T.]
M\-VUIJ=]=F<16"WGZ4ZO^UC\"O#/P]UGXDZQXU1?"WA[XE:I\'M4NK;0?$^H
M:FOQ+T?Q1<>#KSPG:^';#1;OQ+J6JR>(+9[:QBT[2;P:G%-;7VFO>6%U;74O
MR7\%O^"G?@7X[7WP3T[1/"&O^`=3^*/Q<\:_#*^TKXE^"?B[H%C+_P`(CX+^
M,/C-SX%\>ZA\-=)\`^+=>;1_A!JNL:SH\.M1CPSIAN+36Y[76X[/3[S2/M%%
MN/PI^\].EFM^UKZ?,#Y$T_\`X)9_''5?A[^S^?'/C3P;J?QAO/&.FP?MB:X-
M2UZ\TKXE_"W2-6\&ZCIWASP_)+;+<7'DO\,O"LO]GZA';VIF\0>*0\K+-A_0
M[7]BG]ICX1ZI\+OB;\.=%^&7CSQ=\*?VZ?VV_P!H*T^'6L^-=2\'Z-X@^%_[
M4^J_%&S\/0P>+T\)Z]'I'BOPOHGCO3M0NM-FT:ZTZ2:WNK*/4C*L7G?8-O\`
M\%./V/;B#Q/JP\=>)8?"7A33_$&IR_$>?X2_%J/X8^(XO"VKVWA_7X/`7Q%_
MX08^$_'E]9Z[>VNCVUEX3U35KC6=0N([;0DU1R0/I/X$?M`_#O\`:*\/^(/$
M?P]3Q?;0>%?$K>#O$FD^//AYXX^&?B71O$2Z%H7B86-YX<\?Z!X=U>2"X\/^
M)=`U6RU2RM;O1M0L]1@DL=1N62=()YI.7,W=^B[6VV^[UW`_,N']A;XX7OP6
MMO">KI\/]/\`&$G_``4G\!_MC7\-GXAU&XTNT\`Z'\7_``]\0]:TFRU:;P]%
M+<>)(],TZ]L]/@DTJVL[R[$'GR6D4LGE\)HO[$/[4DWBK4_#ND^&OA5^S+\-
M[ZQ^.B^.[;X,?'?XN>+_`(9_&_4_BOX<\2Z993P_L[^)O">F>$/A?*?$FN0>
M,?$^LV.JZAKEE?1W-KI-_P"(C?7-[)^N_P`;?CEX,^`WA_2_$/C"P\8ZLNMZ
MW;>'M$T;P!X!\8?$CQ/JNL7-GJ&HI;6GASP3HNM:HL*6&E7]S<:G=PVNEV<=
MN3>7L`9-WSI)_P`%'OV85\$^'O&%KK7CC5KOQ-XX\0?#2R^'&B_"?XDZG\7[
M;Q]X1TV/6?%_A75_A3;>&'\;Z1J?A?1I8-5UD:CHUO;6^FSVEY'<2PWMHTQS
MRNY7U:M>RVT6UK;*VP'PSX\_9?\`VY?BA?\`PGO?&?@?X*:OX.\'?![6?@Q<
M?`76/VA_BKI/PYTOQA:7.F/X=_:2N;OPM\+HF\7W]QX?LM5\/7?P^U'1Y+_1
MHI],30?%FF_VEXEGKT_]F/\`8/\`BS\'?A/XV\#^*-;\`WNI^(?V0D^`>G-H
MM[K4FDIXM2;QTQU&<ZAHL4J:`\7B;3E$Y6[OMT=RDEJYC5I?T[T_XP_#N^^%
M%K\;I/$$&C?#2?PE)XYF\2^*++4?"::9X7M].FU:\U+6M/\`$=IIFJZ&+"PM
MYY[^VU6RM+NR6"47$"-&RC\Z?!/_``4^^%?COXT>*+.V_M7PK^SSX/\`V=KS
MXY:K\4?B/X"^(/P_DU"S/BZ#1=*UCPK#XHT;3H_%W@S7M/N([C1M2T"TU*XU
M'4)[.QM4:ZO+6VF)3E))/9;:)?U_P0/FSP]^P%^V%\(?#7Q.\(_#&\_9^\6:
M5^TE^S7^SK\,/BO>?$'Q;XZT'5/AM\2/@K\)(/A!KFN>"VT7X?>(!XZ\':YX
M=T_2M0TS0]5F\)W5IKZZK<7%W':7T5NO>I_P3O\`C"/&%GK;:]\/GLXOVO?V
M2?C\T,>HZ[)<2^$?@)\%%^'/BO3EC?PY&G]OZEK/^E:';%ET^33QNO=1L;K%
ML?6_BY_P59^$GA[X2?$7Q!\/O"?Q.O/BIX5@\%'3_A?\0/@O\6/"OB-M,^)U
M]>Z7X"^(M]X9F\.6VOWGPSU:_P!-U*U&O:6!C5].F\-7DFE>()[>S.=\*/\`
M@I=X?T/PAXJUO]IB;2/#$WACXE>`?A3;CPI\,?B[X>\02>+_`(C^#KSQEX;T
M75OAKXUL]0\;Z-K&I65E);V>C1'5-2FO)[*S6U-W>16X%)I-)Z--/Y[@>._M
MD?!#5OA+\24_:M/Q@^"'PO\`$FA?M4P?$SX2#XR/XP'PJUK3=>_9]\'_``?\
M1>&_B#?^&M+?4?"FL2-X>U+6/#^N:9;:Q;Q'['#.ZM<RP1>Y?\$J9/''B;PE
M^U1\6/%^H^'-;;XR?M1>./&WAGQ;X-T3Q%H'@;Q5HT/ACPAX5;7_``7I7BN^
MU+76\+3:SX=U*#1]2O;YSK=G;1:LD=NM\((O9+G]O?\`9G\2?"N;QGXBTGQH
M8)OB&/A.OP?\6?"/Q4/C#??$<Z9IGB&V\)Q?!S4M%?Q1<:C<^'=9TCQ-!(^F
MK91Z!?0ZS/=0V0EFBCN/^"CO[+FC_#_P7XHTR]\97][XQ\;^)?A5X8^#WACX
M8^,-3^-0\>^!;6YO?''A*?X0Z;H[^*=+N?`FE:?=ZGXIDN+"'3=)TU+:X-VZ
M7VFB]D#Y#^+/[%7[5/[0WB?P_:_%'PI^QGX>GT'XP^&_'%M^U/\`#M?'UC^T
M!#X+\&^-+?Q)HWA[0?#-YX&M;'2?%>K:38VGAO7]?D^*%UH*6MUJ-Q;:#?F2
M*T3"\%?\$S/&OAV]@^%E_P##[]FWQ%\(="\6^/+WP]\<-=\;?&+4_CQIGA3Q
M5_PD$FAI:?#`>&=.^&NE_$?PS;>)+C1QX]M_B/?Z;J=O8RZD_@VVN]7GAM_T
M-_89_:(U_P#:C^`UW\5O$6E6&DW<OQ-^+WA+3[.RT_5-,9="\#?$'Q#X7\/2
M:GI.MQPZKI>O2:3IMG)KNE7]M:7>G:HUS97-K;7$$L,?SG^Q_P#\%._AU\;/
M#7PDT+XGV7B/P)\3/B1I'C*ZT_6M2\`>+O#OPB\4:UX!L=0U[QAH/@;Q[K-D
M-$UK4O"WAVQN;C5HX[[[.;G1_$%I8W5Y<:+J,5K3G)Q4;^ZG>VGY[O?2[TZ`
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M=/X?\/?&WQ5?^(]<U;2_`WA_P]\$?B#+XD^)&EZ#8P:AK7CCP!HU_HVGW/B/
MX=6,,\*#QY#Y7AO4)Y((M*OK]KJS%P1DXNZ_%76C3V>G0#YATS]@?XZ^)_B[
MH'[1OQ0\0_"&P^*&O?MG?!7]H;X@>$OA_J7BV^\#Z#\+O@;\#?'WPA\->#/"
M&NZ]X3T/6O%OC#4+[Q7;>(=4UG7_``]X3TZ=9[NP#00Z99+>?<'[/?P"\4_"
MCXH?M;?$#6]6T"]T_P"/7Q:T7QYX8L=*DOY;_1]+TKP-H?AB6RU\7-A:6T=]
M)?:9-<*FFW.HV_V9DW7`EW1+\^3?\%&OA9I/BKXA^,-:U_3_`/A1'@[]GSX*
M?&T:I9^%_%Y\=6=G\6OB9XL^'-C-J^G7#K:&T@UCPY<VEUI=IID.O:3/;737
MXE#1P+]0_`3]KSX7?M#>*?&W@;PQI'Q$\(>-?`EGH^L:WX0^*G@#7OAWXEG\
M-^(C<+H/BBPT;Q!!!>7.A:H]K/%#<21Q7,%Q&]M?6EG<`Q5('Y_^+O\`@FYJ
M?QK_`&GD^)/C[X>?LF_#;X4^'?BO+\5(-7^#WA/Q'+\?/C)J.DW<=]X3M/BE
MXAUO2M'\.>%K675+32M?\;CPROB:\\4W6DV>EMJEO8--)'TG[(/PE^'OQ1^$
M.I_L=_M)?#^QU[QG^R/\4_$D>FZ7JEMJUC9WNC:CJOB/4_AS\2?#NIVS6R7,
M>M>$?%5U8R7ME<3>1<'4+5A#<(P7]2?B5X[L?ACX(\0>.=0T+Q5XDM/#UF;V
M;0_`_AK4O%WBO4QO2,6VB^'='AGU'5+V0LH2"WC)P"SE45F7XKU/_@IA^SIH
M'@_4O%GB33_BIX8O]&^*OACX+:WX"UGX8^(4^)NF^/\`QOH5_P"(_!>D'P/8
M1W^LZH?%>G6#'P__`&$FK2:I<W5I:V\7VB5TC`/B[QG\"[O]A?X)?MLZ#X-L
M=*\3^./VUOC'>^$/V=/!WAB+Q#K-U8V'CCX8^%OAKX>\/^)#J%NQ@7PQ<VWB
M_P`8:QJ'G7=A::-+&;G5)"%M(/KO]DJT^./@WXM:Q\![F-=*_9L_9K^`7P-^
M%F@37.AD:C\0OC=>Z-_PDOC?Q-IWB:=EDF\*^&/"L_AKPW%IUM;BTN->O]7:
M6X^U:6L1T+C_`(*9?L^6/@O4O$NLZ!\6M#\5:?\`$ZQ^#D'P5U3X<:G'\;]8
M^(^KZ%:>*=)\/Z#X!@EN)]4;4_#=]'K]MJ$-\NG)ID=U<7EW:FVN%CW/V(?V
MH/%'[3Q_:AOM=\,ZMX4T_P"%7[0.H_#7P;HGB?PQ<^$_&-CX>M_ASX`\4I;^
M+M&O)9IK?7H-4\2ZA#<D2M&8XX?*9D"L0#QO]IO]A3Q]\;?B1^TAXIT;Q=X4
MTG3/C1X1_9>\/:'!J2:P]QI%W\"_BYIOQ%\1SZDMMI\EN8]8TVP-AI2VMQ-(
M;QU-XL$(W-]=?M;_``%O?VD?V8?B?\#-'URP\-ZSX[\)'1M(\0:C92WVFZ=K
M%K);WNG7-_90/%<W%@;ZSB6[CMY8KG[.\C0L)0@K\O?'W_!2/XUZSJOPL^&/
MPB\)";QU\1_B/^T-H%UXO\.?"CQ7XYT?2-!^!_B^Y\(C3]-\+W/B2TNM6UV7
M4/(G\2ZDVIV^E:?ID;ZC;VT8NHK>'[I_:1_;*U']FCQC^RWX%U+X5^//B1<?
M'?Q)XF\-ZM?>"/"]YJE]I<OA;X=ZWXOGCTK2DN(1<:]J=UIBO::++.-F@VVO
MZ@]PK:/Y5R`>8>&?V2OV@O&'B_XZ?$OXS>)/@Y9>,?B[^R'%^S7_`&/\-X_&
M5UX=TG5++4/B++9:[//XGM8+^?3I;+QC9-=11QQW`NK>Z1(6A$,LWR9>?\$B
MO$WAM/"ESX?T+]C?XU:C=_L\?`OX0^-K+]J+X.>(/&UEX9\8_!KX<67PY'C?
MX:ZCI%];W[:!XETRS@_M;P)K<%K;ROIUI=PZO:O<7EO7T%\`_P#@I7::_P"+
MO'GA'XI?#_XHVZQ?M-ZS\#]!\;Z)\+M6A^&O@Q-7U_1O#GPS\/?$CQ=/<BST
MWQ9X@US7]+T">+3TUB*SUK4K+3]3DL99-J]/X)_X*7>%DT/0=+\1>!O'GQ,^
M*WBWXA?M)^']!^'WP*\"MJ&K?\(C^SK\8_$OPG\1>)-1M?%GC&PLK:VT_4M&
MM;.6X_M\W.N7EY;W&CZ)&EU]DMZC.44TG9/?1:_>@)'_`."=\?B/]F;]K3]G
M'QAXF\,:5IG[1WB"WUG2-1\!>%QI&B>"7L/!/@#PWHT=CX2O;F>Q6PTOQ!X*
M@U"'P[]K>QN-*DBT>>XD1IY6U_V-OV-?%'P'^)-[XW\5?"[]B'P!<Q^"V\)Q
M:G^S-\'O$'@SQ?XHNGO(;B\U#6M;U_4)?[$T"?R!<Q^$-/35A'>R"237)HX$
M63[@G^+'AV'X,WWQHUFWU?PCX7L/!5]XZU2#Q=ILWAW6M#TC3=.EU:\37M,O
M?W^E7EK;V\BW=O,6:!U;#L`K'\R?V5_^"GT/BWX6_&OXD?M2>&].^"[?"_PG
MX+^->G:;8QZOJ5YK'P$^,%H=1^$VL)IKR7VH7GBS4D:ST*_TW3U(E\17]I9V
MELHF44*<DG%/1WTTZVOKOJDDP.U^.G["OQ"^(OCW]IGQQH4O[/OC33/CIXP_
M9_UT?#SXZ>!/$7B;PT=-^#GP^U/P??V\NH^']3TW6/#/B=M8N].\2>%O%>A"
M]FTZ32ULY[1DNWF@^IOV;_V??&WP?_9M'P8\5_$[4M<\4W.F^++6/Q;HDNJ"
M+P7_`,)-]O\`[.TSP+)XBO=6U>+2/!27<,/AH:Q?7ES&+.)IF"$0I\ZS?\%6
M_@1I&F>.[[QU\,?VB_AC<_#OX6VWQEU[1_B-\+8O#FLWGP\O/&%AX'T_7=#T
MQO$EW/JBZAKE^OV2U0I<FVMKH2Q17\8L6Z+5_P#@I;\,;"U9M'^"O[3?C#6+
M#PQ?^/O$_A3PS\)&'BSP7\/+.[N[:U\9^*-!\0:_H-U867B*.PO;_P`+Z#!]
MK\;:WIMN][!X55"JM('S]^Q-_P`$VOBC^S7\1_@UXO\`&GB/]GK48_A!X-\4
M>#M6\2_#7X;>+-"^*7QMUCQ!H1TFY^*'Q?\`&_B;Q9KDFK^+-8N5_M34M)AL
MGMK?4KO4;F+7;R&2TL[3ZE^-'[,7QGN/VHM%_:S_`&<_'_PV\/\`C>[^"I^`
M'Q%\&_%WPKXD\0>$?$G@O3?%NI>//!OB/0]0\(^(-#UG0/%WA/Q)K>O130S1
MZEH_B71-;EL[I-,O=-T_4%QO%G_!3+]GCPVVBW^BZ=\1_B/X*O/`_P`./B;X
MK^)OPX\&MK_P^^&?@+XMQPW'P]\3>/=:NM1TJZL[;Q#8SQZHECH>FZ_K>G:.
MPU?5]*T_32+D\GXK_P""K7P&\'ZWXML]0^'_`,?+[PGX%^*D?P:\5?%'0OA?
M<ZY\.-)\>ZCJ5GHGA?1&UG3-6N=3U&?QIK>JZ%I/A9=$T359;S4?$.@V%_#I
M=WJ4,8`,G5_^"?GC[Q!\"OVI?AAKGQ,\(7WBO]H[X[?#[XS2>)[?PQJ6GZ1I
M,_A6_P#@]J.N6DFCB^NYXY=8N?AKJ+V207L\5BFKV<4L]Q]DEDD\"T3_`().
M_%'2?CVGQ(O/BK\&M>\-:?\`M4:K^TI9>*]3^%WB&?\`:+U^VUU]6,/PT\8?
M$Z]\6ZCI5QX.^']GJTFB^"-/T/PYI"RZ;9:.EVVG0:;/8ZG]BZ?_`,%(?A+J
MO@TZUI_PY^-DWQ"?XJW/P4MO@'/X-TC3_C3<_$>UTFV\13:-_8%_XIM_#EI8
MQ^'+NWU^7Q!J'BVTT*WTMQ-<ZA%,R6[9%I_P4T^%^JVVB:?H'P;_`&B/$/Q*
MU7QA\2_AYJ'P8T?P+X?N?B1X2\=?":W\(ZEXQ\.>+XI/&L'A'2##X>\=>%_%
M.E:Y%XMO/#.L^']7L;RPUJ2>]L+2[J,I1O9VNK/1;?U_6P''VW_!/#5H_P!G
M+]DWX&:QX\T2]D_9Z^/W_"W/%>JP:9J44'C3P]=6'Q@TS4?#>GIYXO=/OKFT
M^)UL@OKB9H8O[+G?"[XBOY=_!SX7^._B9XQ_8G_9=T3XL>,_CG^S]^S=)K?A
M^6'7?V4?%GP&\0_#;X2^&_AEKGP[T2U^)?Q*\1>)=2T[QEXN31+_`$OP?H:^
M%/"W@PZ@\%QK>I6EU.P=/T?G_P""G\GBKXI_LPZ-\)/V?/BO\0/!/QU\-_&2
M^UB&'2O!^E_$;P]XE^%.L>&-#U;PW;:+XA^)7A_1XKGPI?:I>R>/8]0O6*VD
MVC2>$I]=DDU*.T^IOVI?CMJ_P=\2_LX:;;:QIOARP^*7QJL?`GB(ZAX6G\0O
M?:'+X<UO5KBVL;R+6-*7P_.3I0F?5Y+;5_)@1H/[-=YED0C.4;\K2OW2=O2Z
M=@/EG]DS_@FUK_[-/Q/\":P8_P!DG5O!GPJL?$]AX3^(/A[]FN3PY^U#XJT[
M6_#UYX<T>T\7_$T^-+S0='OM)TW4KNW\2>(/"WAQ+SQW!%:6\UGX;M9=5MM3
M]J^/_P"R3\8_$OQWT_\`:-_9Q^+?@;X:_$?4?A/JWP/\<0_$CP)K/CS0-3\(
M:AJ;ZUH_BC0K;0O%OA&[TSQEX-U:::]TZUN)[G0M=B<6.JQVRHMT.X_9G_;2
M\,_M-7-LW@GX2_&S1O`6K^'-<\2^!?C%XN\-^&;3X;?$32/#VN:;X=O)/#^H
MZ'XQU[6]*O[J\U-+S2-(\8^'_#&I:OH]EJFHV%O-'IMZL/C/C3]OG4_AE^U9
M\6/@]XQ^#GC)?A)\*/@MHGQ=\3_%K1QX6N8/#.BS/K$^N^*?$]KJ7CK3]2D\
M%V%CI+VEFOASP[K7C"[UE7A'AU[-X+F12DY-R>K>[V\@.F_9._8%L?V4/B/X
M6\0^&?'+Z]X,\'_L=?"+]EK3M(U+3GCU_4M3^&GQ"^)7CJ_\>ZIJ$5S]@5O$
M,WQ`D1=(M;-8]-N(;I;:86<T%O!N_&S]E;XQZE^T+#^TU^S5\7O`?PT^(6N_
M#.P^#WQ$T7XJ_#+6?B?X&\2^$])U[4-?\-^(;73/#GQ`^'&NV/BWPA>ZQJ_V
M*!/$*Z-K]G??8=32R>W@U!.$O?\`@J'\+?#.B^*=<^)OP9_:"^#UOH_P<\1?
M'GPI:_$7PEX3M-2^*/PU\)7FB6?B;4/`^G^'_'7B&XCU[0CXF\.W6I^$/%H\
M+^);>SUFSD&G22"YBM\[6_\`@J1X+T^X?3M'_9J_:H\2:XGPMUKXWR^&X/A[
MX<\/Z[;_``C\/ZUKFCZAXXNK'Q=XVT!K:SNAH%U?:!I-P8?$&OPW=A#8Z5]I
M-_%8(#BM9_X)H_$O43\4/`R_M'Z!<_`O]HGXA>"/C#^T-X3U'X/7"^/?$/Q1
M\/Z-X)TSQMJ?PY\;:7\2-/T/P)X;^*U[X`\/ZUK_`(=U;P1XSG\/77]HVOAS
M6(+6]B6R]$U7_@G=/>_L]?&/X$V/Q8BT\_%3]JF']I2U\0_\(;)<0^'H;?\`
M:"\)_'.+P:VDOXG634W"^&/^$<&O+J=@%DO3JQTEU@.FS^6?%#_@J/X;U+X2
M^-=;\#>%/B5\*]1U?X)7OQS^`GQ(^(?@;1M8\)_%7P!8:SX9T^7QAX6\/:9X
MR76Y;"6T\4:5JNGZ=XMA\):IJ.B7\.JPVB(/*/>>*/\`@I]X4\#0?%AKGX'?
M'/QSX>_9O@\,M^T%\4?"7A_PG#X(\#:?K/P_\+^/[CQ%Y&L^,]-\0:U%:Z%X
MD35K_1?#FDZQJ.E:9:SWE\((I=-_M%N3:2;T6BT7DNF^B6X$5[_P3[^*&HZK
M=^'KSX\>"A\&[#]J;0_VI_!WAZ#X0ZZGQ%TKQ#:ZW<ZWK7A/7/'+_%IO#VMZ
M)>3W=Q'I=Y!X!TN]L$F;[8FI[(]MGX]_\$[_`!E\4OB!^T/J?@#X_6/PS^%_
M[86B?#[1?VEO!-]\+U\:>*-4D\`Z#%X,.N?"KQJWC?P[8^!-8\6_#^RT;P9X
MB'B/PC\0+"*VT.QUK1K33]4ENC+W_P`0_P#@H#X:^%_Q%\.>#/'?PH\>:!X.
M\:>/?#/PW\(_%236OAR^B>)-:\8QZ<OA_5])\*OXRC\>77A*^U'5+716UZ'P
M[*;747S<6<-J!<UX5\$O^"EWCSQ3X4\3:CXZ_97^)T.M/^T%\8O@A\.;+P??
M^!=33QOXF\!_%[Q1X$L?!:PW'CJ2\TSQ1X?\-^&M3UWXA:[J,=EX*L%\.^(+
MO1-5U.T%BMRY2<K7MHK*R2_):OS8'V=^S1^RU8?LV:C\9GT?Q.-;T+XI?$&S
M\9:/HK:,VFOX.TS3/"FA>$].\.M?G5=0/B`Q6>AQ2R:K);:9)(93&;3Y1(?D
M6Q_X)I^.%MO#OPAU?]HC1=2_9&\'?M`:Q^T#X:^$L'P=FL?BK'?:E\1=:^+-
MC\.-6^-3?$V\T>^\`:!X[UZ_O=/>T^$NF^+KK2$L='U'Q+/]EEO;OT&?_@I=
MX$^SZ-X7T[X._%O5_P!H#6_BQXE^#=M^SE:6_A*+X@0>*?!WAY?%_B;4KS5K
MGQ/%X)M_!^F>%9K'6/\`A)I/$@MKI=6TFTMH)+R]$">C?L`?&_X@_M!?`'6?
MB'\2H9M.\4Q?'/\`:;\%C3;RRTZRU#P_HGP\_:!^)/@?PMX=U>WTBZO]+DUO
MPWX<T#2]&UR:PU"_M+C5;&\FM[^^@FCNY9`]._95_9[_`.&:OAE??#R3Q5'X
MTFO?B)\3O'K:TNB#0O+_`.%C>/->\;_V5]B_M/5RXTAM;-A]L-VIOC;_`&K[
M-:>8+>/Z6K\2OV7_`/@ISXDN/A)\*+[XZ?"7XGWNO_%*Z^)WAOP-\3+#1O".
MF^"?BK\2_A_HOCGQPGPY\*V-GXCFUVSU35/!O@?Q"NA:QJV@Z?HNLZIH5U9V
MMS(US9S7/WKX._;.^&OQ!U7]F72?!=EJ_B&?]I_P%J/Q,\+FT%LC>&/!>DZ'
MIVJZAJWBR&659[`VVH:I;>''M5C>;^W([JT(4VTAH`^P****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"OG+]K/X2Z]\<?V>_BC\,?"MW9V'BCQ)X;_`.*7NM2#_P!FQ>)=
M&U*PU_01?F(-(MG-JNE6D%TRJVRWED?:VT"OHVO,?C-\5/#GP2^%OCSXK>+!
M?/H'@+PSJ7B34;?3(!=:G>16$68K#3;8N@GU#4+EH;&RB9D62ZN(D9U!)H`_
M)SXN:-^V+^VSX&^%G[,WC7]F?6/@=X<3XE_!SQI^TC\4_$_BWPQJ&AR>'O@W
M\0O#7Q&NM`^$=OH.H7M_XAU'QWXC\%:7IMI>7MOIUOHF@:C<7UVINHQ`$?\`
M9$^-]S\)O@CH2^$$M/$O@[_@H_XK^/>NK%J=A%+8_#'4O&?Q1U*V\003;RDL
M\NF^(])G6S13=%I]CQ"02`>N6O\`P4#^,W@*7X.^+?VFOV0M8^"7P-^-7C'P
MCX#T?XG:=\9/#?Q)UCX=^(_B3JMEH7PRC^,_@33?"F@GP=I?C#7M1L-$DUGP
M]XE\:Z=X=U;5M+L-9FMC,LU?5>B?MQ?LC^)/BI;?!#0/V@OACK'Q9N[[5-+A
M\"Z=XFL;S7/[7T:XN[74]&DB@DD@BUFUFT^_#Z3).NH,EE>2);-':SM&`?D=
MX4_9:_:XTG]A#Q'_`,$TI_@*))-'T'XF:'H?[1+^-_"$'PR\5:)-XP\4^-/`
MFL7NAB[7Q@?$GBZYN-+TGQ;HUWI*OIMY>:EJT]RUB\<D^'^TW^RK^UW^V'I?
MQ0\87/[/I^#VO:!^Q3J?[.'A7P=K'C/PC=R?$+Q[XK^(_@KQCKMS:W/AZ]N;
M&R\%^&+;P@/[!O\`5+J">\FU*\$-HFZ3?^PQ_;J_9%7XC:S\)V^/GP]C\=>'
MIO$=IK>ESZRMM8Z;J/@_2UUOQ9H]SXBN4A\-KKWAK2"=2U[P^NKMK>D64<UQ
MJ&GV\4$K)\\?&S_@IE\#+#]F7]H+XX_LV^/_``-\;?$_P+\$VGC"\\$V^HWU
MD=0T_5-4M-.TS49H98K#5)?#.JK+=-IOBG2(KO2;M[>0V5Y=>6Z@`^9-%^"U
MYXJ_X*H_$'P1I>IOJWP,\&7/P]_;6\8>&3.\]CHW[0VM>$=5^$>BZ4\:J]O:
MS:M8>%O#_P`119,3,VH:'?:E,BR:F)KCFO`_[*7[4\[?LV_!;Q)\*;GP_P"&
MOV>_VM?VAOB)JOQ@M_%_A>[T?Q'\._C%\!?VO/!>@:UX<TVWOCXEBU73=8^*
M?@JPU6SN]/MY(;G4Y&BDE@L[J5/UBOOCW^SMX,\'>)_B_?>+?"VBZ!;^-+SX
M>>*_%L%E(MU-X_\`#/B&Y\"S^%M2CL;"37-2UW3M>M;K1;2T:RN)G50;,-:2
MQS/\>_!C_@J/\.?CYJ7P7T+X?P^%K7Q1\0OC5XF^%_C7PCXJ\5ZKI&O^%-#T
M7PK\:O$>D^(?#"3>$(++QKK6NV_P=U35?^$6CNM*FT[PTNKZI=:CYVEVUI?N
M[2:3=GNOZ]0/`?`'P:_:<TS]BS1/V&?BA^Q)IGQ&\-?##X=:?X&U#Q)I_P`;
M/"WA#0?B9:>#?$.DR>$-=\!W^GZA!XL\.^,;JVLU\817.L#17T#Q-IENLFI/
M+.LIZ;]GCQS^V1^S1>?#WX/?$;PIXI^(%]^T;^U/K>G?"/P_\7OB/I/C?XD?
M`S]E?PS\,-,U[Q9K/Q%^)/A#2KZP\9:CHGBO3=;D\-Z?JM]<:KY/C+1-"OO$
M5Q<6R11_<5O_`,%#?V*I]3\9:.G[1WPW6Y^'UEXAU'Q=>76K-8Z'I=GX3NK>
MQ\32)XEOK>U\.:G)H%_=VVG:K:Z3JE_>6>H31V,\"W<B1-Z[\&_CE\#?VD]'
MO_'/P?\`%VB>/]/\(:[?^$-3U>RL;ZTO_#>OG3=)UF^T.\MM8L-/U?2[RXT7
M5-!U<V\UM"+W2=3TG48O.L[RTF=`?+/_``4-^%W[1'Q-TCX'1_!/_A/-9\$^
M'OBK'K/Q^^'?PM^+5W\#/B)\2/AS'X;UR#3M`\/?$W3=6\.ZKHUM:>+IM%U3
M7M+T[Q/X>E\0Z7;2:=-J(MC+#)^8W@_]@CXX^%?`/CDZU^RCXQ_X2O5?VH_B
M#\:OA'J?PI_:PBT7XQ?!"U\5?!?X8^#])OK?XI>)_$:W/C.34]7T#6]+\?6_
MB#7]=:_*S3BTU;3)+65_V=7]N/\`97NO'VM?">U^,WAM/B1I$_B?3G\+W=KK
MMA>WVK>#M+N=9\3:1X?FOM*MK'Q/K6B:5:7>HWFC>'+S4]36SM;FX6V,-O-)
M'Q?[#_[>'PL_;9^']MXC\)+-H/B^&7Q9)KO@>X76[^71M(T'Q]XD\&:/JK^(
MKOP[H>D7W_"0VFB6>N"PLGGO='&K1Z5J2_;;.Y:@#A/B?^S;\?/CA_P3/\3?
MLP_$[Q?IVH_M`^._V>M0\`>)O%X\I-*O?'MYX>N8//U2;3HH+:;3KN]%O8:Y
M/;60M;Z":]=;-H9_*/Y_?%7]CK]M#]K6?4[[QW\'-!^!%SH7[*_@'X:^'[*R
M^+EE>VGB#XB?#CXP>%OB6^D6VJ>`+O3M8\*>%_$<7AEM)TKQ!8/8ZUHJ7-MJ
MD*:=?6%KM_7=OVX/V5T^*@^"<OQ@T&W^)K^-KKX:VWAR]L=>TV*_^(=HDTDO
M@C3/$&I:3:>&=3\5.+:X6WT.PUFYU"ZF@FM[:"6XC:(<Y;_\%#OV,+SQ5J/@
M>S^/W@Z[\6:2?&<>H:';IK,EY;W?P\_M4^,],_Y!8AGUG0(M$U:YNM$MI9M7
MFL[&:\L[*YM3',X!^:\/[&GQ,\7:=XJU?3?V3?B5\-/B--H/PT\,MX]^-W[;
M/Q#_`&F/$FN:9X:^,'A;Q[K'A3PT/B)\7/BA::#X%L/[(O-=LYI[G0]1NM26
M."TTW9>W;UW_`,1?V*OC_P")OCYXY\?V/AS2)/#6O_\`!0;]E3]H+3[A_$&E
MI</\,_A5\,Y?"?C+5'LVF::WU&TU60+::4P%]>0L;BUP(]]?J7;?M'?!2]M_
M@W=V?C_1KRU_:#EMHO@S-:&YN?\`A/S>>&+WQI:R:)#!!)<M;R^%=-O]=:YN
MH;:WM["UDDNY8&:-)/G;XI_M\_#'X3?M9>'_`-EGQ=!<Z=>>(?AK;>-(O&,<
M7B74H[?Q#JWBBR\-^'O!O_"/:-X0U1IWU<7J7[>(O[;M]+TY=MC>QQ7$GFQ@
M'Q7^TS^PQ\;O'?Q>\3_&;P]X6USQ;9^'OVE-.^)NA>`_!_QW\8_`7Q;XY\#:
MO^SQX1^$GB-]`^)GP[\7>!]?\'>)]&U72[ZXL;2\\2Z9IVJV5NUI/*MI?%7X
M?PK^QQ^T'\*/C%\%_P!JCX+_`+*L&@^(?`^L_M+:'XX^#OQ)_:G\1?%CQ[XQ
MTCX\>&_A#:67Q3OOBU\1?%/C^&W\8V&I_"/3M(U[1+3Q1>0WOABZB>WN);Y9
MK8?:7P__`."G?[-NE_#+X=ZO^T#\:_A+X8^(_B[PQ-XLN]*^&[?$KQAX2F\/
MR^+?$?AO3M>T+4M3\`:'XBN-"C707CUS6=8\.Z/8Z3J$-_)<21:4EM?S^Y^"
M_P!OG]COXAWOQ!L?!_Q^\!:O)\+?"%Y\0?'-T;ZYT_2M'\!Z?>W&FZCXTM];
MU.TLM&UWPKINI6TNGZGK_AV_U;2]-OO*MKZZMY;B!90#C_\`@GI\&/BG\"?V
M>M6\&?&#1=*T+QOJWQC^.?Q"N=*T+68=?TRWLOB1\3/$OC/38[/4X%B$\8M=
M8C51+%!<H,)<P0S!T7XLB_8/^-FI?`G]@'X3WVD:5I5Y\$O&?Q?7XLW4.LZ=
M=1>'O#/C_P"#'QU\!V-_H[^;G6WAUGQ[X</V:Q9I4C>65E$=K.P_2GX(?MA_
MLX?M&ZAK^D?!SXEV7BS6O#%AIFK:YH5QH?BCPIKUEHVLB3^R=<&A^,]$\/:M
M=:!J)BD2RUVSL[C2+J13%#>O)\M6/%?[7?[.'@;0?&WB;Q9\5=!T/1?AS\4]
M%^"?C:\O+;60?#WQ2\16GA&_T3P?>VT6F271OM2L/'GA"^M[J"&;3#9:[:73
MWR0+/)"`?A)KO_!-GX[WW[+_`,1O@(W[,U_J7Q'T3]E_XW_!SX>_&7Q!^VO\
M7/&_@?4_$'B/X7ZSX#\*7W@7X->-_B/K_AOP(WBI9]/CUBSG\+:!H_AN#S[>
MPE:V$2)]Z?MA_LA_%3QY\5/@1\</`_@:[^*/_"O/A9XK^%'C3X5:)\=/&W[/
MFMWVG>*[SPMK%KKOAKX@^!O$?A02W&@ZKX6@MI]%UG4H=-O]-G\U`+J"'/LW
M[1'[?GP_^#>M:]IV@^(_!GB&X^&D7CAOBQX6U`>/[;Q9:ZIHGPLG^(WACPUX
M,FT#P+XE\.:GK&IPFPEUV34]1MK'0M&O!?-+=7D8TV3YCTO_`(+`?"_5]8_9
M(\07VH0>#/AO\9?AQK'B;XM0:CX.^(VOZYX,\<?\*UT7QOH_@/P9?6OAW2[S
MXAW$.I:I<Z/-J'@WPGXEAU=;1)K6/3C*BL`>2>,/^">/QYUW0/C+%X-^&O@W
MX:V?Q!_9:_95^%7AKP)%\1[_`,91:)XM^&'[3WQ#^+?CBTU+Q;XAGN-:U867
MA?Q5920:[?WURNL:LUW#"Y9=TGT/^TQ#\=_V>_VG_%_[1OPM\(:%XSU+XV>#
M_P!G[]FSX:Z-J5S?SQ1^+;KXD:EJ?BW6_$5AI[+=VGA_P_X+;5M:>]62-)+F
MS6`MO<+)[7J/_!0/X36_C3P_XFM/B1X`F_9SN_V3?BO^U!K'B4:3\5KCXDQ^
M&?A?XO\`!>AZWXAL/"UGX"N-,_X1C0K#Q0Z>(=%U'4K'XDPZY)I=KIGA"^L_
M[5FM/7O@A^VA^RK^T[XRUCP9\'OB+;>-/%OA72K3Q1-IUWX2\:>&VFT"[GDL
M+3Q1X9N_&'AO0K'Q/HDEPTEHNN>%;G5K%)':%[E2Q!`*'[;OPR^./QG_`&4O
MB!\/O@;XID\(_%G7K30A9W^F^(-3\'R:C:6.NZ=>>)_#-GXJTJ9-6\,'Q1HM
MMJ.@QZ[8W$=YIBW_`-JBEC>/</RN^&7_``3C^/.C^)Y/$1^%GPZ^$FAW'[:/
M[+'[0<'@KPW\1]5\<'2/!?PF^'VN>%_&$%UXBUU/[3U;Q-)?7\,\B+-)#?2S
MS365ZP5I3^L7QF_;A_9B_9Z\:?\`"N/B;X^U73O&%MX;L_&>M:-X6^''Q0^)
M)\&^#M3U&;2].\8?$:^^&W@SQ;IGPR\)ZAJ5O>6MEXF^(=YX8T.ZDL;]H+]X
M[*Y>+SWQW_P4]_8<^&GB'6O#'C/XWQ:9J?AJ_P!#L/$\MIX`^*&O:+X87Q-I
MNG:MH&K>)/$OAWP5JWAW0?"^JZ?JMG<6?C#5=5M/"DF;B+^V1-9W<<`!\H_&
MO]C+]HNZ_:DO/VKOA?I'A#Q+K7@OX[^"?B+X1\!>)?$?]B6GB_PJGP1NOA5X
MOLWU%;2\M-"U[3[F]>_T6ZO('BN(X9$$UNDZE/K+]B+X._&OX9S_`+4?C/XW
M:-X0\.^*OCW^T'?_`!>TSP[X-UVX\1:9HND7WPW^'_AA--N-5N++3Y+F_@U#
MPS?+<RK:10R$K)!OA9';O/'O[='[+_PR^)UM\(/&GQ#U#2_&DVH^&-&O9+7X
M>_$S7?!/AS7/&IQX0T#QG\4_#_@_5/A=X'U_Q,"DFAZ%XO\`&.B:MJ4$UM<6
MMG)!<V\DNA^U]\?;W]GWX*:IXR\,V5OK/C_Q+XE\"?"CX2Z!=J[VFO\`Q<^+
M?C#1OA[\.],OHX72X_LL^)?$>GW^MO;E)X?#]CJUU"PD@3(!\0?L\?L4?&CX
M<_&OX&_$#Q'%H$>B_#KXE_MN^)M=$&J12W+:+^T)XSB\1>!C8V\8?SKA+=&&
MK1L\9LI/D(<G-?2_[9_PB^,OC;Q5^RO\5_@CH7AWQ?XI_9V^-VJ?$*^\%>)/
M$)\*6OB?0/$7PG^(7PRO[>UU]K2^@LK[3Y/&T6KQI<V_E7<5C);B2.216KDO
MC;^U3\9/@5\;_P!C/X):AX`TWQ3H_P`?O'%O\.?&'QFGU?2M+L/^$AL?`7B+
MQ)JT7AOP#I^J3Z[9WMS>Z"MP)]2670-/L[IK1+C4;@(Z^I>'?V@?%>B_MF>-
M/V8OB39:;%I?BWX4Z9\;_P!GGQ%I4,T3:QX>\/W^E^"_C#X#\0FXN'2X\4>"
M/$NH>&?%]E?6,:0ZEX4^(=O:O!!/X9G:Y`/F7P+^R7\<++X._%CPQX@LO#VG
M^*_B%^W1\-/VF[2QL]:&H:=8^$?#W[17P@^+FOZ9+J+QQ%]2@T+P5KUG8Q1P
M1I<WIL1F)9G*_-/B/_@G[\<7^'5GX6G^!_PM^(/BNT^*/[97CKP9\4=.^,OC
MKX,_%GX1:A\>OCWXX^)G@?5?"WCGP'_9^L/I*Z'XIM6\5:"NJ"-]6TVV1K"^
M2/=7["ZK^TK\%]#\=?$'X;ZUXQ32/&'PM^&]O\7O'6GZKH^NZ;9:+\-KAM83
M_A+8]>OM-M_#VL:;:/H.K)JJZ%JNIW>C/:%=7MK$RP>9\]ZE_P`%-OV.M+L_
M#>J2^._'5YHWB+P;X$^(-UKVB_`?X\Z_H'@3P;\3K6.^\`Z[\7M<T3X;7^E_
M!FW\464T5YI]O\5+OPA?):.;N\M;6VCFEC`.!^//[-'[2WQ*_P""?>A_LEQ?
M$&S\3_$_QEH?PK^%_P`:?BQK=Y)%=:CX`EU[0(OC?K]NUU;W#:QKFN^"H/$.
MB:?;WL`-]=ZHMW?,4\X'X'_:O_X):ZIX-ANO&WPN^-_B_0?``^%,7A3XC:S^
MT!X[\1?$JQ\-_P#"L/&7@[XB_!*33[=[2YU1O!>C>)O#LVBZOH5FKPVFD:BU
M[96;S0JI_6^^_;K_`&=-*^)OA_X5:OJ_Q'T;6?%OC&P^'?A/Q9K'P)^.&E_"
M#Q1X_P!5AGN-+\&^'_CA??#V#X0:OKVJ16UPNE6UEXUEAU:YB-AIEQ=Z@\5H
M]CX2?MI?LN_M*>,O$/PK^%GC>Z\>>(_#MSXLT[Q3IJ_#[XAV>B:1?>"?$=[X
M3\2:3K'B/6_"5AX4@U.SUS3[NWBT>;5_[0U"WC34;&TN=-F@NY`#\/=:\%?M
M!_M_?&7]HVSM9/A%J&K0?L4_"SX46^N_#+5/&&I_#*RUF;X]KX[L])OO&/BO
MPSX:FNO%ESI7AW7]:U#2M+T>6V\/Z;J&@03W=S-=K/7W'^TM^PCXN\1_M,^+
MOV@_#GP;\`_M":5\3/AOX4\)ZUX(\;_$_P`8?"Z_\%^(_`MC>6&EZMI>I^'I
M)-.UW1=>L;J*WU2UNXH]0TZXM7GLTNTNBL6(?VZY]#_:_P#V@_!=SXJTWX!?
MLT?LJ:MI>D^.WU/]EGXUZC9^/;L>`HO&_BW6-?\`C+::)IO@'X5?97U32-&^
M&^@:A;7FO_%NVC3Q)X(A\6Z%XB\/W3>N?%?_`(*,>#/$?A/X=:G^S?XDU*3Q
M/)^UG^S#\%?B;X/^)?PN^(?PU\9^'_"/QL\=:7HEW>WG@3XH^&/!_B[3XM:\
M/:B-1\+^)#H\FDW2;;BRNKG9,B`'R)J/_!+WQIX9\8:EKFE?LX_L[_%/0?B9
M\,/@CX=UOP-K/Q)^)O@SP9\%/&/PQ\&V'@G4]/\`"MG8B>3QM\+9]&LM/71=
M,U"SM]8@ETK9<VZ+?3O%[GK'["?QEO/@9\>OAK9KX2L]3^(O[>/P0_:1\.6]
MO>W;:18_#_X=?&_X'_$?5K!99X//@U"/0_AMK-KIE@T;J;B73[=YD5Y'3UWX
M1?\`!0;0M+\`^,=9^/;^)M5\7_\`#57[5'P;\`^$?@[\)OB!\4_&.N^$_@E\
M4?%'AVPO;;P-\+O#WB_Q/-;Z-X5T>VO/$/B&XTR#3XFS-=W$$\\=N?<-"_X*
M$_LE>)=$\4>)M'^*<5SX=\(?`F']I+6M:D\.>*+6PA^$+:KXIT.^\0Q/=Z/!
M+)?Z#K/@W7=*\2^&3$GB;P[J,$%EK&DV=S=V\;@'P7\:_P#@G!\2O'WCWXF_
M%5-(^&OCZ_E_:@O/C;X1^&7CF^UJP\*>./!>O_";PS\//$?ACQ+J^E6UQ=>'
M==6YT*/4M#O8[/4[.*>VCCNT6*Y>6W]C_9B_8X\=_#/XI?#[XCWOP@^"/P,T
M30M6^.&J:EX`^$6N^(_$3SCXA^#O@UX7T#5/%GB#7-.TY?$GC)C\.=2BU6\L
MH8].T[P]%X4T>UN-0ET^YN9/4/C+^WEX$TC4/A?X7^%OC'1(_%'CG5O@1X@G
ME\8>!?'6K:'=?#'XVZQ-I^@K87&@2::^D^,M?@C,NA+K$KVFE,K7.NZ9);90
M;?@#_@I5^RK\2?B!X>^'7AK7OB"+[Q/XL\=?#O1O%FL_"'XE:#\,[WXE_#J]
M\1V_B7X;P?$O5O#5KX*N?',-EX2U_7K?0+36;BXFT.SCO',4E]I]O=`'R3X6
M_8C_`&F?@]K?P#^*/P]@^&/C#QK\'?BC^UEJ%_X-\0>(]:\/:/JW@;]I7Q%H
M6JV.H6&NVV@ZDT.M>%O^$?M9K[3;BT6"[AN+B&VNS,D9;[2_:O\`V?\`Q_\`
M''Q#^S'XA\(7OAW3KGX*_&ZP^*&M1>(EO7L[O3K/PSKNDK:6]O9I(]Y,+[4K
M9Y;226VCN+59T^T1G:6YCPQ_P4R_9@\8_$;PI\//#[_%Z\MO'_Q#?X4?#[XH
MS?`_XGV'P1\>_$&VM?$-WJ/AKPC\6]0\-VO@S6;S3(O"VM"XD@U(6UVUC<G2
M9]2CM+Y[6K^U_P#MPO\`LK_%O]G;P')\-_B/X\TSXS:_XOT[7)/`'PT\?_$'
M6M/T_P`,>%9];AB\):=X,T353K_BR]OO(#>&(O,U+^P8=4UM+?[)IUQ,@!XU
M^Q[^QK\8_@[^T?XD^+.O^$OA+\#?`US\/?%?A#Q)\,_@+XT\?:Q\.?C/X^\2
M>-/#GB32OB_=_#_Q%8Z1X:^'6I>$M)TKQ!HEE;Z+I[:I?'QOKD6H7<UC96%Q
M<7/VH_V-OC3\5?C;\5O$/@N;P9<_#G]I?]FA_P!G#XF7FM:IJ6F>*/ALMC>:
MUJ6C>./#&FV^FWMAXM(GU*!+O0;R]T@,\!4WA@E9ER?@1_P4\\):C\4/B1\-
MOC7;?$72II_VL_$?P(^'7BNW^"_CBP^'7A,:QK%CHOPG\`_$[QVNC+X>\,_$
M3Q;J%PFFV>E:Q>+J/V^^TQ-7338]7T>6_P#J+3?^"@/[/6K_`!4LOA;I\GQ)
MGCU/X@:A\)=,^*?_``JOQO'\$-2^*NE1W;ZA\/+#XK2Z0GA>Z\16TEA?V+/%
M<MHTFK6-YHL.K2:O;36*`'YS?\.X?BWXH^%?Q4^&TW[-W[#/P7\2:O\`!;Q9
M\,-(^,?PPT_6I/&GB[Q%XE@T:)M=M9#X&TB^\#>%=3M=.?\`X2O2YM1UC5+_
M`%);:(17EO:Q:@_W+XB_94\=ZK\==?\`B?!J^B)H^K?L01?LOQV9DU!=27Q4
M/$'BK5CKAD2V\J+1%AUV!!.LKWXEBDQ8@",M]!_'_P#:C^%W[.`\$V/C9/&/
MB#Q?\3-9N_#_`,./AQ\-O!NM^/\`XA^.-4TVPEU;6(]`\,:#;SW,EGH>DP3:
MGK>KWTECH^DV:*]]?P//;1S_`)SVG_!67P7X4^,W[1J_$CPS\<1\(?AOX.^&
M?CJPLM%_9X^(=YXI^%/@[4/!8UGXC>,/C19V^B)?^"]"T+4(;VZEEU[9.VG6
M%_<Z);:I:6EQ,@!A_$W_`()F_&+QW\#?V9?AI:>.?`-GK7P6_85'[*_B._O/
M^$@>RU7Q?_PCOPKT@^(=*6#2I)_^$?\`M/@&_E+7B0:AY5]:E;1F64#U_4OV
M$/B?>?!G_@HK\,XO%?@I;_\`;+T3^S/!=W.NMR6/A:X;]FGP-\$'E\4M'8"X
M:`:QX2N-7`TJWOI/[.NH$&;KS8D^B_'W[=/PF^''C?2O#/B3PK\8U\*:LW@Z
M.'XT6/PUUJ\^"<3^.VMX_#!/CN-A;WEO>S7VFP75]IMI>V&F3:C8QZC<VS38
M7@M3_P""G/[-^E^+?$/AN[TWXT1Z)X)^,MM\`_'_`,3T^#WB^?X2^!OB=J7C
M>W^'FB:%XD\>06DNCPIK/BR\T[3H+RRDO8=,75](N=?;1[?5+.24`^"K[_@E
M7\<Y_'.J:PT_[,6K+J/[0OP@^-)^,/B;PGXGUO\`:!C\,?#F_P#`MW-\)M-\
M2S:.R^'/"U@WAG4F\.-I>LRV;QWD=M?Z);M<75Y#W/C;_@F]\</$VD^,O`&I
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M``C6KZRL$+3@'Q9H?[`?QN\#:]\)/C#\%_AI^PU^SY\4?A!X[^(-_IGPJ^#O
M@;7/!/P5\4>`OB;X2\/^'_$NG^+?$'A;P-X=UF\\;PWGA70K[2?%<7@%5M;.
MW?2)K6Z@"LWW9^Q/\"OB%^SS\%=3\`?$S7?#'B7QEK'Q;^/7Q3U/5_"-IJ=I
MX?DG^-'QD\<?%86=I!JR)?P_V=_PEXL9;>3SQ`\#0Q7M\B"[FWOCK^UK\-_@
M1XB\$^!=4T/XC>/_`(E_$.UU[5/"'PR^$_@C4_'/C75?#_A6.S;Q+XEDL+*2
MVL]+T#19M2TNTN-1U;4+)+F^U*SL=.CO;B1UB_/#QM^W=\2?C9^TW\#?A=^S
M'XA^(.A?"/Q=\'=/^.&J_$+PK\#]*^(=YXLL-4\;Z%X:MO#^I6GBV[2;P'X<
MT'[1JVC^/M5GTBT\2^'O%*Q:(8(I[:Y\L`T?@K^P#^T#H)_9:\"?&WQ7\(+_
M`."G[(GQ3\7_`!S\&VWP_3Q?-XS\;?$#4_"WQ!\&>%+/Q.^NZ7IVEZ3X<\-Z
M/\5/&>HWZZ9+?W6OZI#H=K)!9627IGU?^":7P%?P]\2OVF/BZ;36[?P)8?%K
MQ_\`"3]G73O$>EW&F77AKX6V?BR]\9>.(-(M+P1S0^']:^+.N^(Y]#GABB@G
MTBPMT@B%JMN:^]?C[^TYX-^`FH^!/#.J^%_B7\1?'/Q*B\3W'A/X>_"3P3>^
M.?%U_HW@JTTZ[\8^*+K3[>:RM=*\->'SK?A_3K[5M5U"T@;5_$F@:39I<ZAJ
M<,->`ZM_P4E^!7AZ^NK-/!WQ]U6'PQX7\/\`C/XN3:3\&?$4L/P$T/Q/YSV<
MGQD2Z^P7_A6_M;6UO=6U?3+>UUF_TG1;.YUB\A33A%/(`?HK17YS>)/^"FOP
M`\-^+O&GAVY\._'"]T'X:_$S2OA3\2_B;I7PE\07WPG^'_B?7]/\':KX??Q#
MXZ@?^SVLM4LO'7A^Y?\`LHZG?:-8W"WWB/3=%L[O2;C4O*?#/_!430M$U?\`
M:!D^./PZ^)'@KPA\*?VB-.^".A^*=(^&^MWVFR#Q%XH\.^#_``Q!K9M=9UF\
MU#Q3>ZKXA@O;C3]`TXO-H[V\EAITU_/;VMP`?K?17YF^(O\`@J=^S[X1LFO_
M`!1X/_:$\-IH?@Z?XC?%*R\2?!?Q'X;UCX%?#M_$^L>$]$\7_&70M>_LW6_"
M5EXHU+0[V;PWI%KI^L^+M1TT)J3>'8;%GN(_1/V;/CYXL^+O[27[7/A6;Q':
M:Y\,_AY+^SW??"V.VL+"V6UT+XF?!CP_XXU.8WEO;1W^HOJ.K:C-=J=4FEEL
MHI!:0^6BE``?=U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`5\[_`+5_PFUKXW_L]?%;X8^'+ZTT[Q%X
MH\*7$'ARZOF=;%?$.G7=IK6B1W[H&*6-SJ>FVMM>2!&,5O-+(%)4"OHBJ&J:
MIINBZ?>ZKJ]]::;ING6EQ?W]]?3QVUI9V=I$\]S=7-Q*RQPP00H\LLLC!(T5
MF8@`T`?BA\9-&_:Y_;.^&/PX_9;\5_LSZA\#M)U+QU\%M=^/OQ9\1>+_``[K
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M.W@^.)H0!K6EB$7.H^5>7`M]_E2Q18$C`'YS^'/V8_VIM,_83\8_\$Y[KX!P
MW6NB;XTV=E^TA-XK\/+\/_%\7B?Q5XR^(6@>,=1M2K^*XM?\8OJ]GX;\3V<E
MH+JQU/4=0E>\FT^$(<K]IO\`9@_:K_:N\-_%'Q#8?L^?\*?U/1/V#=8_9BT'
MPC/XPT&[U'XB^.O$GC3P=XAA.GS:4Z6=GX1\$Q>&;E?#^H:K-Y\K:W>>7;P1
M^8)/W"^(/[5O[.7PITGP7K7Q$^,WPT\':=\1+:.^\$W6O^+M)L(/%%A+##<+
M?Z)*\K+J%D8KFW87D7^B8GC+7"AP2^7]J+X`1^-]/^&4WQ8^'D7Q`UJ_TC2-
M*\'-XJTEO$6H:CX@T:/Q!HUK::6DQN+A]1T.>#5;+R@PN+&59HR=R*X!^4Z?
M!74/%/\`P4N\7_!:RU+^U_V?_#^O>`_V]?'OAN.1BNB?&O4=&OOAQHGA>_X>
MV;3O%%]X3TCXE1Z=,5FDO]$UJY,8_M#S7YSP=^S3^TTEU^S+\&]3^%FHZ%H'
MP$_;7^/?Q2U3XMIXHT2ZT'7/AU\5O@E^UYX-\/:KH.FK,NKQ7FE:O\4/!-M?
MZ=<QK+!]O9X"\=I*R_H5X]_:V_93_9__`&H;7X*^*]2\,>#/B_\`%;P-;^/M
M9U^:/1M)36K;1]7M?"'A'1?$6K^=!J-]KFIRW]W#X5M9K:]B:TT[54AEM3"D
M,SOV5_\`@H-\#/VF_"GA>Y@\1^$?!OQ.USPQK/C#4_@]<>--*UKQ?X>T31+Z
M2TO-2N88K?3IY[**$VEU/<BQ@-K%>P^=&$W2T[-[)OY`?GAX,^!7Q^@_8<T;
M]A3XJ_L?2>,]*^&7@:;PKJWC_P`+?%/PSX73Q]+X:\::/JVA^*_`.H3VESJ>
ME>+_`!##;MXQOVURU6W@\1Z=]EOVO([H./T*_8%\/?M)Z!X$^*#?M$S:FT>H
M?$J63X06_B^7PMJ'Q/M?A?8>$/#&E6:_$S6?!EEIWA[6/$,OB6Q\1S6$MM9I
M/;>''T>TO)'GB9(O1/!O[<W[(_Q"M?%%YX(_:`^%'BBV\$^%M2\;^,)](\8Z
M5<0^'O".D12SZEXCU&0N@AT:RA@EDNM18"T@1&:24`$CN?A%^T]\`/CMJOB+
M0OA%\7?AW\0M9\*0V5SX@TCPAXITW7-1T>UU&:YM[*YU&ULW9H+>YN;6Y@@N
M$,UM++#(B3,5Y0'XKP_LY?MS^-_VL?@]XX^*>B^.=?TWX5?MEW_Q(E\92?$W
MPY!\)K7X,2^"OB?H7AC3_`?PNTG3+/4[36+.VUW2['Q3J^O7][J$]U=R6T#3
M6MW,(OO[_@GCX3^,7P4^&>H?LX?%#X4WV@P_#7QO\:]5T/XKP^)M&U;PQ\0=
M+\??&_QI\1/#<^C6%N1K.GW+^'_&D:ZK#J,,;6E]I=Q#ON%N()1]/_%W]JO]
MGCX"ZDFD?%[XO_#SX=ZG)I4>N+8^+O$^GZ)='1Y9KV"/5#!=,)?[/:;3;]/M
MFSR!)9W"M(&CP>GMOCO\(KV^U33=/\?^$;Z^T/P!IGQ6UBVM==TZ>33?AKK"
M7DFE^.;CR99$7PS?)IUZUIJP8VDZVLQBD94)H`_"+XE?LT?MX_$KXS:%<_$+
M0_'7BZ'P#^WI\%_C9I?C%?BEX9TOX+1_`CP/^T#X:\86.A^%OA1IVC6NKW/B
MK2O!-O<W6N:EXAU&[NHKFPU)[:ZGN;JQ6/VGP7^Q[\7--\*_LXVEWX#TJ#4_
M`W_!1GXW_'GQS%%=Z8SI\,_'.J_%DZ?K%P\:HE]=:EIWB;0XKRQS)=>1(8)]
MRVY4?IQJ/[8W[,&DZ_9^%=4^./POL/$>HS^'+6PT.Z\8Z-%JEW<^+]&C\0^%
MXH[)IQ,!KNASQ:IITSJL-Q92I.DACD0OD>$?VW_V4?'ENMSX.^.WPL\16TGB
M;0?!L<^E>+=.NHI?%/BI[B+PWHL+`1I<WNO2VMS'I4=N\BWS0R"%VP<`'YK?
M\$\_@EJ,O[3/Q;CN]4/B;X&?\$_?&GQ-_9F_97OV9G4ZE\4;W2/B3\3H[D\+
M/??!+PYJ_A/]GC2[V/<L2Z)XUM),3M<`?6?Q[\#_`!G\(?MP_"#]I3X>_"^X
M^+'@^3X*Z[\!_%^DZ1XATG0-8\)WFO?$+0/$ECXUN1K&(=0T"QT[^U/[1BM6
M-]&]I"D$4AG!7Z!U+X[_`+,/P"MOB1IVJ^.?AE\.[?P)X@T35OB;9"\TW0_^
M$=\2_%ZZFU;P_>^)K2TMHVBU?Q]=SS7ME<SQ27>LW3W$[22,21#>?MO?LHV7
M@?P]\2KCX\?#&/P+XMNM<T_PWXF;Q58#3==U'PS#YWB'3-,E!9KK4='CVM?6
M`1;J$,I>($J&`/R8_9D_8'^._P`.?A_\0=$\4^%/#\.M^(/^">'B_P#9WT>5
M=9L[F4?$35/B9\6/$>G:9)=K!O@T]]*\4:%=W%XC&V6=V1D>2VWUK_%[_@GK
M\<OB+X5^#7@_0K'PQX<;PU_P3-^(_P"SIK-_+J<$%E;_`!<N?BM^R_X]\*>%
MKK[-:M<3^%M>M_A=XML-5U&"*2WM[:20M;322HA^[/$7_!4+]D#P[XX^#_A`
M_$G1-7TOXSZ7XRU3P[X]T;5M'N_!FDKX)G^P:A8^(;M[Z'4K34;S68[K0["U
MLM+U!AJMI-:WS63#->Q?M'_MD?!?]EO3?A7K/Q3U8Z?H_P`6O'FE^!M#U2.:
MPCL]*74-)U'5Y_%6M/?75H\7AC28K*V@U&YL$O[^.YU;3EBT^6-YI(0#Y$_8
MY^!GQ&TCX]:W\7_BA\'?B+X(\3#X8Q>`YO%OQ+_:"T;XK7^HLVN#5;K1/#.A
M^'-!T6TMO#5I<AKNUU?45%VYD6$6R9=CYS\?/^">/C/XQ?M>?%_4[V6T3]FC
MXP^"_#WQ8\06\>K"/5&_:E\(?"WQ3\!-"?\`L4PO%_8D?@.[\`^+DU4NL_\`
MPD_@.QCVOL1T^\;O]O+]D73O&?AWP#J'QU^'MGXL\4P^%Y]%TR;6HD,P\:P6
M]UX2@N;J2..VT^]\1V]U;RZ/8WTMO=WRRH8(6R*O?M;?M7>'OV5/`7AOQ7>>
M$]6^('B'Q[X_\(_"SX>^$=%U/1-#'B'QOXWOGL-!L]2\3^([NQ\/^&='$D<T
M^H:WJET(+2WAD,<-S.T-O*`?F=\+OV#OV@G\*?#R]^)X\,-\5?%GC+]HG6_C
M3XGM-:74[:WM_''P3O?A!X'N[5EMEDU61+:'3KN\MEVO:K-/`C.@(/5?LR_L
M[?M0V'BS_@GD?B_\)_#O@S3/V+_@GX@^"7B75;+Q]I?BN/Q;/:_!?2/AWI?B
MS0K2WT^WN++3]6U/18IX[6[D-Y:I/(TN0J$_:GAK]L'6/"WA'Q3XP_:S^$UK
M^RYHV@ZIH6FZ'KFH?$[PE\2?"_CF3Q&NW38/"6L>%(8;R\UA[M7LVT*?1K;4
M990LEFEW`XEKK[K]N3]E>U^'?ASXJ'XS>"+GP3XNUR]\+>&=2L]5%W=:UXIT
MQ9&U+PS8:1!"^JSZ_I?DS?VGI*69O=/$;M<Q1A30!^4OB+_@GS^T'?\`ASQ[
MID&A>$'F\0_L*_M]_L_Z>6\31*A\??M#_&GP!XW^&]LZ?8BL.D7'A_P_J#ZW
MJB$G39HX;6:&?*E?T6\'_`GQIH_[3_P/^*4FEZ/:>%O`W[)Q^#6OSP:A&;Y?
M%K:WHVH16MM9K"KW6F0VVG7&V\9D1&,:I$"U>6:S_P`%9OV;T\0?&SP=X4G_
M`.$B\3_"OP%:^-/"YO\`5K+PYX3^*4]W\/\`7?B"^B:%XKO(;FV\/OI>FZ%+
M!K>J^)[33M,L#<1W*37,,<_E^_#]O+]F[11\/M(^(OQ*\&>`?'GCGPIX!\32
M^#KWQ)9ZLWAY_B'96DWA^RU37]-B?1XXM2O[HZ9HNISSVMGKTT:R:89EFB4@
M'RO\9_V>OVE_"/[1G[7OQ&^"?@/P+\6?#/[9OP<^%/@C59?&/CA/!U[\)?%?
MPO\`#GBWP+%*UI<:=?IXH\%ZKH/BYO$*Z=I\EMJ=IXCAU0#=#J9D3RE_V!/C
M7I_[)_\`P4B^`]G;>&=:\0_M%?!?2OAS\'-5N-:A@M=6U'1_V9=`^$T%UXAE
MEMGD\/P2^+-*ENU:0731VK1W.=P`'WYKO_!03]D?PWX]N/AEKGQI\&:;XTLO
M&+>`=3TB\OY(CI/B\R:7%:Z'J]U]E:TTR^OI-8TZ*R6]G@CNIKA88))7XKIO
MVK_VFXOV9O!O@+4]-\#7OQ+\>_%SXJ>%/@O\*_`5CKFG^%XO$?CWQ=;ZOJ%E
M#JOBC58+C3_#VAZ=I&@ZSJVK:I+:7MQ';6#6^G:;J6HW%I93@'Y7_$#_`()\
M?&:^^+/Q@)\&:C\5?AM\=OBM\._BSJ#2?M":A\-_#O@^^TWP[\//#GB31O$_
M@BST>^N/&9T:7P!;ZKX;U'2[NTEGMI[32KA+:+3X7'W#_P`%$_#6JZ?\%?AC
M\2M(MCJ=K^S/^T1\`?VAO$^FGS;B6[^'GPO\9VO_``L6>!2))9[_`$7P+J.N
M>)=.5E>6;4-"MDB#S/FO.-=_X*/>)M'\!>-]!U_X!2>&OVK_``]\6O!GP.\.
M?`4>/[/Q1H/B_P`<_$G1K;7O!6M:/\1-(T&S-QX%N-';5-1U?5;GPWIFJZ0O
MAW6;:\TJWGCMFFZ+X^_M@?M#?L]0R3^-OV4_#OC'X9:58>%K7QKX_L_C=X9\
M.:CXCO\`7+30;?Q':?"/X1ZYHNM^(_'B:'J>M2:1!I>JZYX=U'7;NW2'3X)S
M>P,P!Y_^VAX&_:9^-OQ?_9"^)W[.7PV^'OQ+^'OP,^(<?QNMO$E[\6-.\.?\
M)>-9\">)/"R:/I4?]F:E`]J\>NVVI6>K+<R6UQ$&39C:]=Q/+J'QF_X*:_#$
M:9IX@L?V/OV=O'^H_%C6X)OMNGV?Q%_:4F\"6/@KX9IJ$:I%-J]GX0\!Z]XX
MUFW`\RTTF_\`!-W<QQ1Z[:%_</A1\?M?C_:3^(?[+/Q-\*^'_">M:-X?M/B+
M\$=9\.WMY)I?Q(^$C2)I6H3O87T"?V1XF\&:Z1I.NZ5:2S6<EI=:=J5HT233
M0Q>Z?&?XD>&?@#\+OB5\9-7T@W&G>$O#NK>+=<M]+MTBU#63HNEO*D4DL<,K
MS7<L%I#8P3S*XAC\I2!#&`H!^7W_``4]^#^C?$3XJ?LF^&M$U^32?'7[1?BC
MQE^R;X_T73W,5]XL_9;\<>'KOQO\<B\L>)[1_#FD>"TL]*U5B(;&]\:W%NNZ
M;48T?@?CC_P3T^*UM\8/VB-8\"_#[1/BW\*OVDI/">H3>&IOCOX]^"VE^`+K
M0?AOX;^&%[X>U7PMX4E31_%/A&71O"6CW6E1VMO'?Z>)=1LMAA:!A[!!_P`%
M1_@UK7CW]FR>\TS3=(\"?%SX3?$/QOJ7B#Q#8ZQ/XJ\&>-M`M/A==Z?X"T*T
MATAAK5YK%AX^O5N[K25DWKHCR(LEJ64?86M_MV_LMZ%X5^'_`(TN?BQX:O\`
MP[\4_#E]XP^']WH4USK\_B?PKI*JVL>(-/L-*M;J^.DZ.SK%JE]);I;6$Y^S
MW<D-P'B4`_)[Q1^P'^U;XK^.'@C6=<TK0=:\)?#_`/:Z_9[^-/A_QOJ_[0'Q
M*GT[2/@W\,?B5X/\0-\+?"/P,$\7@'3M0\+>%]&ET^'Q%K&F7VN>(KG3UO$U
M2WO=1B2+]2_V$_@CXO\`@#\'_$'@GQTNE#7M5^-WQ]^(%NVCW@OK5M!^(WQ<
M\6>,_#YEG6*("\_L?6+(7MNR'[-="2W#OY6X^I>._P!H3PIX?_9G\:_M-^"6
MTKXC^$O#?PJ\2?%7P]_9&M"WTKQ=IFA:!>:]:P6>O0Z?J7V2'4TM%@%^NF7I
MM3(9&M)O+,9^'/@U_P`%%_B9XJ\*^'_BY\;O@A\#O@C\!]6^'VE_$;5/'UC^
MU[X=^(WB3PYHGB#3M'OM%&J_#ZR^%WAW48))9=;LK/5#-JD']D3OBX5SE5`.
M4^./[!OQ1^+O_#R"T@UCP]H,?[2/Q4_9N^)WP;OI[B6[MY[SX&?![X4>'I=/
M\96L<8EM].U3QIX"N;*Y1'G:?1IQ=("[;#YEK?[#_P"T_P#&GXIZG^T=\2=(
M^'/@KQWKOQN_8;U9_ASX9\57>O:-I?PY_9=^*B>.?$OB*YU^:PM$O/%&K6VH
M:O'H^EPVT:Q6L-G9W%RTY9A]SS_\%,OV+K<:AY_QJ\-PRZ4EO<W]I-#JZ7UK
MI%U9K?6WB::Q_LMKF/PA<6I:6'Q68_["D2*79?,Z;#K>-/\`@HK^Q]X"U;7M
M#\4?&;PSI=UX8ATBX\570%_=:7X5TWQ!866I:3K7B+5;.QGT[1]%O;+4K.Y@
MU>_NH-->*7>;M421E`/BGPE^R'^TY\%/&L/QP^'OA[P#XZ\<Z;\>/VT];3P'
MK_BZ3PYHMW\+_P!I+XL77C_PUK<6O1Z?=_9/$^DK;:2-2TZ6V:,VT]];Q7'F
MA6/F&C?\$J?B99>%_P!G'3KCQ?X;:>YO?C3X:_:SM=/DN;;3-9^$7QK^-_@S
M]HSQ#X)\';HC+>VNG>*_`<O@"Q>X^SJ_A/QYXCN]H;=!-]TZ!^W?X)T3XH_M
M0^&OBW?^'?"'A;X)?%;X:?"_P1JUB=1U'5OB#J/Q!^%/AOX@QPQZ;;PWUU?:
MM'<:S/9V5MH\<XFL;<W,Y<$-'[Y\.OVQ_P!G/XJZ_P"$/"_@?XE:#K&N>.S\
M0H?#.FHUS;W6H:A\*7TE/B+H;0W5K`UKX@\(KKFF3ZQH5WY&IV]I<->&V-M#
M-*@!^9_A_P#X)Q_%S2[#69=5\4>&M<\00?M1_`WQ7X2O[BZG06?[/'P/\3>(
MM4\+^'G>2'=%KEGI7B632C9QC[/<+I-I*K`OA>RT_P#8*^)R_`W]G?X7ZKJO
MAJ/4?AC^VU\?/C]XSU.ROG9Y?A_\4_BE^T)XQTPZ(Y@$LOB:RT7XLZ*D\+HB
MK=VUZL<S(%9OL_7?V_OV5?#]K9WMW\3;"\@OF\8M;QZ+I6OZ]?\`V#X?Z_?>
M&/%^NSZ?H^CWUS;>'-#UW3;[3;O7[A8]+%Q:7"1W+^4QJ3Q-^WY^R9X2N-#B
MU?XN^'7M]>\)^$O'<6K:3%J6MZ'I/@WQZ\L7@KQ1XFUS2M/N]*\,:%XK>WG.
M@ZEKEW8V^IQ02RVS/'&Y4`_"[X0ZWXFO?B#^P!^QAX(^(OP9^,7AC]F/]K:W
M\1PWWPUM/'3?$6P\%^`/A_\`'#3]4\2_%W2]7T>ST'P4=,G\36?A]C<W<MQX
MA\07UO)I8:(^8/V@_;3^!?Q>^(GBW]FKXL_!*S\&ZWXQ_9Z^*.M>.F\*>-M3
MO-"TSQ+I_B/P-K/@F\MXM;L[:\>QN+%-434(]]NZ3?9S%E6<,/HSXC?%+X,_
M`?PCJ7Q6\=7OA;P9X;^TZ/9W'B6.TMEN-6U'Q)J=II.@:99?V?:/J&LZKKVK
M7]G8:1IUHEU>:E>W5O#;122R@#XF^('_``4Q^%_A/XO?`C1["YMG^%GQ(U/X
MO>&/&NO:OX=\7V7C/P[XN^'O@[3?$FE>'=-\*RZ;!J\NI:K+JM@MQ:'2+N22
MSN+>:W*!FD`!Y7>?L.?&#Q#\&?C/X/U6Y\'Z;XP^)W_!0GX7?M::<]KJ%S<Z
M=H_A'PG\?OA#\4]<T@7C6RSKK)TKP/K%G8LJ*KWLUD\C(C2,G#?"#_@G3XZ^
M$WQ3\.Z7>^!/"?Q(\`^'_CGX@^*^@_$WQ#^T%^T!;ZAI%GXC\8Z]XZB\_P"!
M\7B]OA;/XLT'4_$%WIMCJ5KH<5A<VVS4+F);N6X#_H;#^WI^S-?>$?#'CC1/
M&6I^)_#OBR+QQ+IUQX3\%^,_$][:#X:ZA:Z7X\77=+T7P_>ZAX>E\+ZA>06>
MJPZW;V,MO<L\3Q@QR%?F3Q__`,%#+VU^(][I_P`*K+P-XX^&-U\$_@7\7_"/
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MC)IECH'Q`^(7AWPEK>J@:7=65VU[I6FZU<WE@@D>*2\A@6>"6)FB=NE?MZ?L
MQ:EX<UGQ!!X^S_8?C30/AW=^'9]`\1VWCFY\;>++(ZEX6\,Z;X&N=)C\4ZIK
M'B735;4="M-/TRZ;5+!)+VU+VL4DJ@'Y1?%7_@F'^TAXX\7J=0UWX=^-_#+^
M'?V9+7P;XA\5^,/B+:ZA\%H/@EH_@NS\5>%/`O@/2KE/`]Y%XQ\0>'=4\1GQ
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M[.VBFN8FBH`_%WQA/XJ?XC_#W]D#X<?$;P3\3-$T/]NJS^)7_"'Z)\._B79?
M$WP?ITGCWQ)\3_&<_CSQ->:/;^!;;PYH$^N7L-OK=OJ$S:FMUI6FVYDE5POV
M/^R[_P`$_?&G[/\`\3?AQH>I^&_AKXR^'GPGU[Q/JO@GXKZC\1/C#=>/(]'O
M[374\/V8^%U]KUS\-]*\7Z=!K;:'J?B.QL8M.N-)MIIK&VMKV^:&/Z;L/^"@
M?[,6JQ7.H>#+C5-;UW5?#'CKQ#X/\KP#XPTBW^)+_#ZSEN_$^D^$/$5WX52W
M\1W^F"(+J-KI9U"\LU\R66T9('KP<_\`!30W'P<^%?Q_L_AO'I6F>-?V?O''
MQBU_X9>(X?B;:^+]1U3PYX!\*>,M.TOX8>(U^'`\/>+?!]FVO75GXG\?C3+?
M3Q916&HZ/97JR7D,`![7^T?^SQ\86_:&^%_[6G[/\_@;6?'W@7X8^,_@QK_@
M+XCW>K:5H.O^$/&.OZ+XGMM5TO7='@N[K3-:T37='0SPR6TD&JZ3=36P:.YA
MMR?+OV0OV$/%/[-7Q=^'GC._\4Z+XFTCPU^S5X[^&7B62U@N;2>_^)?Q+^/B
M_'7Q1J>C6<Q<0>%8M6U/6K#28IV%Y':I8"4%Q,YT?"?_``4'7Q#\6/@K'JWA
MVS^'/P:\>?LH?%3]HGXDZ]\0]#\6>'-5\'7?@%?A7J0.C>(O$<7AC2M6\"66
MC^-M;FOO$2^%YX=6&G66H65_IMN)[:;W:/\`;^_9CBT?QIK'B'QG?>!H?`?A
M;1/&VO6/Q`\*>*O`^MMX3\3ZB-)\-^(='T/Q/HNEZIKVDZ]J;Q:=I5YH]K>Q
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M9+*2XT'^R?A_X?O/#\MKX=L1(=0U"9KW4%DA2UK:!_P4%\#M\4?VE_`GCSP-
MXK\`^&/V<=3T*UU+XF7>C>+M1\)ZE8:IX7D\176HZYJ"^#++2O!S1RH-.T2T
MO-8U)_$[2Q3:7(9)4M2`>0^)?V!O&E_^S_\`MJ?!VR\7^'EOOVC_`(^V'Q5\
M(:O=0:@L.@Z)IOPY^`7@J/3];,2_:)-3EN?A/K%^9K,FV\O4[8$[Q/7-^,?V
M&?C=K7CCXDV.B^*/AS#\*?'G[8_P`_:\BO[R/78O&UCJ7PN^*?PY\9^*/`\U
MFD!TJXLM0TWP9?PZ1J4<P<W&H6T-Y"(8YB?T(^$O[3'PJ^-'B?Q-X'\*7VNZ
M=XX\(:+H'B;7O!/C;PEXH\!^+[3POXJEU.W\->*H_#?C#1]%U:Z\+Z[<Z-K%
MII6OV]K)IMY>:7J-G%.;FSN(H_H#`]!^0H`_(G]J#]@;XN_$KQW^T5=_"OQW
MX'TKP?\`MB?"_P``_#'XN#QK8:U?Z[X%N/AM=>(W\/\`B_P''8G[!JGVNP\1
MW5CJF@:Q+;0^='#>6UV"'CKZ'_9-_9%U+]F3XA?&G7#XJL]>\-_$70?V?M"\
M.V:1WB:EIB_"#X5:9\/=2GU22X+0.=:O=-^W64=JS"&WD6.8^8&-?>%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%?+'[:_@;Q=\2?V6_C5X)\"Z9-K?BC7_``3?6^EZ'!-';S:\
MUO<6M_=Z!'/+)##&^N:?:W>E)Y\L<#M>".9A&[D?4]4[Z^LM/MIKK4+J"SLX
M(99[FZNIDM[:WMXD+S33W$C)'##&@+222.J(H)9@.:`/YI?CE^S[\0/VJ+WX
MY>*?@E^S)XV^%'A[3?\`@EK\:/V>M1T+QQX$T[X=S_$[XW>,]?\`"VN_#7PC
MHNA&?RM7?X<1>%?$C0^-)HQ;6UWXOM+32;PJ]\\?U#\`?@YHWQ3_`&BO%WQ3
MUC]F_7?#G@NZ_8F\*?#[2K+XI?"BR\-/;>.M/UB]B\3:59Z/J5I+]FU.\@G5
MKN^MEB?485W"62$(3^O]C\5_A7JFB:IK^F?$'P3J/AK1T5]9U_3_`!3H=YH>
MEJW`_M+5K:_DL;'[JY^U7$0`9,\.N;F@_$7X=^)I[*U\->-/"FOW&H64^HZ?
M#HOB'2M4EOM.M9_LMUJ%FEC>3O=6-K<D6US>0"2""X(ADD60[:`/Y>/AW^RU
M\;O`_A3X":G\9_AO^TE'X*\2_P#!.;X,?L\2Z7\'?`OA3XB^+?!/C+P%K'Q*
ME\;?#;QAH'B>0WWAS2?&V@^+O"USI^MZ8183:GH+Z?XBNK>/2M(N3^F_[`_[
M*EI\/OCG\<_%OBKX0:_I%G9>"/V9=`^$?BSXJ:-H.I^-[32?"WP=TG1]5TZV
M\06[:BEIJFB:C!_9VMIH]X(1?P%1<7,:(U?J#JWQ>^%.AVMQ>:Y\1?!&D6-E
MKMUX7NKW5O%6AZ?9VWB:Q*)>>'I[N\U"&"+7;5I42XTF20:A$S8DMU:KES\4
M?AS975M87OC?PM97MW-H]O:6=WK^E6]U<3^(9OL_A^""WFNTFEFUR?\`<Z/$
MB-)J4@V6:S-Q0!^<7[3?AG7/"O[?W[/GQPN/@YXX^)'@";X!?%3X/:GK7@+P
M=:>+KGPUXV\5>./A]K/A:Y\06[SP7&G:1]@TC67_`+<*O;Z:4E\R2%IE67XW
M^$O[,7QK^'/P._X)T:EX(^!RZ-\8_AKXE_:NU/QH;[P[8Z?-IFH^+?V;_P!H
MC2?"+>/;B)$GGTCQ-X\U#P/83&[FE2>_O=-GF`,2E?W2TKXT_!_Q!'K-QH7Q
M/\`:W%X:4MXAFT?QCX>U*+04#%"^M266I31Z8@ES%NOV@439CSOXK1T?XJ_#
M7Q"VLIH7COPCK+^'8_-\0+I?B+1]0;08SYQ#ZR+2\F_LM2+>9@U]Y"[8I6R!
M'(5N,W!623N];W[6Z-=&^^X'\N^F_!']J[XD:/=:QXI^%/[5>I?$"Y_X)[_M
M8?#/QQ)\3/#W@WP[X-TCXO\`C+X7V<.F_#/X1^%O!]W+;Q>'3XI^V67A[49F
M_L_5D6U%I+-(99A^M/P;_9_UWX>?MM_`_P`9Z-\-KGPSX)LO^"<VM?#;Q3KV
MG:+9Z9HL/CZP^+?P>UC0/"^K?8EA0ZW!I$7BZ\LXWC=DMUU1EE`8JWZ#6GQX
M^"M_X=U7Q=8_%CX<WGA70I4@UOQ):^-?#5QH6C7$AQ%;ZKJ\6IMIVGSRGB.&
MZN8I'R-JD<UWN@^)-`\4Z1::_P"'-7T[7-#U"V6\L-7TF\M]0TR_M)-_EW-E
M?V<LUK=V\@1FCFMYI(W7#*Q!%*4N9WLEY(#\D_VD_B'I7P__`&T_B#/<_LV?
M$+]I+4_$7['/@G0=&\->`/!7A[Q8PO;WXC_%:&/0_$=]XAU33;7PSH?BAY([
M.ZU:<3Z;%;VUU+J(40VT5Q\/?!G]GS]IO]B7P%X;\"^,?@A\3?CCKGC7_@FE
MX3_9CBO/A%:Z-XETSPY\4?"NH>.;V3PUXFU/6?$&BMI7AW3]*\8V6G:1KK1W
M%M<V^A2V\:M<26L,O[]:!XL^`.N_$6[USPSXH^'&K?%'4?#MKX?O)M&\2:%?
M>+;[POH.I:C>VNG2VEGJ$M]/I>D:KJFJ3*K0-%:7=Y=\H[R"M+1_C[\$/$-Q
MJMIH/Q=^&NM7>AP2W>M6NE>.?#&HW&D6D$BQ3W6IPV>J3R6%M#,RQ33W2Q1Q
M2LL<C*[`&0/R`^#'[*6K+XA_;3\1_%;]G76/%+>+_P!F[]FKP5X4L3::'9>*
M?$CZ+^SY-X>\>^#?`_BK5&C31=4;68+70;N^CNK"&WU(64US-Y5HDD/S9'\)
M?VF6^&>B6?@OX3?'CQG\&?V<_BE^ROXV^'OAWXP>`?!?A;]H`^'?AGJ6I0>+
M_`'AD:1J,?\`PEVB>#_#USIS:2^J:A$=0U"VN8M,NKWS?M!_HWU[XD^`/"Z0
M/XC\9>&="6YTV;6;;^U]=TO33<:/;7%A:76K0+>W<#3:;:W6J:9;W-]$'M8)
M]1L8I)5DNX%DYN+X]_!.X>PCM_BQ\.IY=4U1M#TZ&#QIX;EFOM;2:.WDT>TB
M34V>XU2.>6.&2PB#W22L(S$&(!`/P8^(5G^V9XJ^(W[5OQV^'?P$^.WPU\&_
M&+XJ?L1-J%K;:)X)F^.S?!CX?>$?'.C_`!%\3?#K0-0UK4=)TCQQI]]<:)):
M6EQ?G7=,L;^.X"VVIQW%G9R?LN?LJ_&ZS^,/P&\2>+/@Y\2=+\(^'?VX/VH_
MBM?O\79]!\1>*])\*>,O@U)IO@WQAXJO+"[N=,FUK5?$KQJMUIGVLV^I'$;K
M+%YZ_OQK7Q?^%GAOQ/I7@KQ%\0_!F@^,-=CAFT3PMK'B71M-\1:O'<2O!;MI
MNBWE[#J-[]HFC>.#[/;2><ZLL>YE8#+/QU^#DWB"T\'6GQ3^'\WC#49[BTTW
MPU%XN\/R:[?7EG/]GNK2UTD:@;VXNK><-!/;1PM-'*KQLJLC;0#\8Q\)OB_\
M"_VC?!7Q[C^`?Q)\;^"?#O[47[8%QJFC?#G2-%U3Q1!X?^-GAKPY!X2\7Z?H
M%[KFC03>']0\0QZDFHWMO/YUJ6FU&Z@,;2.WWW^W%H?C+4/`7[/GQ$\(?#CQ
ME\0I/A!^TA\)OB]XN\#>$;33+[QW)X,TBP\2:3X@;0M(O=4TVQU;6M'/B:VO
M9M*CU1);N"RNQ9-/<)$K^Q_L]?M2_";]H_\`X30?#KQ=I.KWW@KQKXW\&ZOH
MD6M:)?:K$?!/B:Z\+S^(HK+3;B6X_P"$9UJ\MO/T'5I%-MJ=G/;SV\KHX+>D
MZQ\:OA)X?\;:1\-==^(_@O2/B%KYC&B>"=1\1Z3:>*-4\[<(/L6ASW::C/\`
M:"DBVVRW/VEXY$M_,92*`/Y\?%WP,_:-U'X.?MC_`+,UO^S!\4]9\4_MG_'3
M3?C/\-?C3JB>"D\.>"_#7C4_#W6=WQ6U1?&!UOPKXR^"0T/4-+BT;2]/UK[;
M<6UK%X>U"ZB>>9/UY_:P\+-=_!'P_P"$_$O[,E]^UMX2DOO#6F>/OA]I>H>'
MK36[?2--@GF/BW0;;Q)J&CVVJZKHNJVUE=PVEKK&E:F8Y9)M/NA=11))]`W_
M`.T+\#-*\8/\/M4^+?P\T[QRDUG;-X1O?%VAVWB'[5J,R6]A:#2I;Y;PW=Y-
M+%';V@B^T2M+'MC(=2>D?XJ?#N.RT;49?&&@Q6/B+Q'+X0T"[DU&U6WUGQ1!
M>7NG3:!ILOF;+O5H;_3M0LY;*)FGCN;*YA9!)"Z@`_G/L/V7OVB(O$>J?$_X
M??"O]K+P%^RYX+^,7@+QKX!^`?\`PL3PZO[0^DVR?#;XA>#_`!YXW^&T'B/Q
M1K^E^'+6QU+Q-H)T[P3J7BQ;Z\T:WUZ33U@OIK2UN.[^'_[._P`2OA)\9?@K
M^U=X!_9=_:=\4>"-)^)?[06M_$KX?_%+Q=\,O$GQ_P!9U_XP^!/AYI5K\>;/
M1I_&%CX8L&DF\)G0W\+#Q+:>(H0VHZM>0V\U_);U^NGCW]M;X$:+X"^.'B'P
M%\1_!/Q'\7_!'X:_$7XBZWX!\-^*-*G\07<'PZT'4]8U33HX%DFDB<W&G?V=
M/=K;W$5C<S*+A=PV'J-2_:7\)^&?V5=*_:I\7QOHWA.;X+Z)\8]5L%N+>2ZM
M[#5O!MGXL_LBTFG^SV]U?L+M-/LU8VZW5TT2KL\P+0!^4GQ&\`?M):MXE_;D
M^Q?LH_$\Z7^VU^REX(T3P6NE:I\+YM.^''C?PU\*/B-X6UGP9\1&E\<6#V.K
MR7EWX>CT^X\/6/B#1KZXU78]_:QVUS.OA_CK]D3]K#2OAG^U1\!M%_9]\0>,
M9OVR_AO^S5IOAGXI6_B+P(-!^"FM^#O`WA;PCXQTWXA+JGB*S\16Z^!+K1Y_
M$WAN;P=I?BB/4]2V6\!M')G'[7^'_P!M_P#9?U;X9^$?BQ?_`!I\`:#X2\:B
M.'1[K6?$NDVKC58[#^T-2T61%N7+:EHL)VZU#$94TV56%S)&K(3W_P`:_P!H
M/X?_``1^`GQ`_:(U_4$U+P'X"\"ZKX\EN=(N;2X.NZ?8:>]]96>AW+3"QN[O
M77\BQT<_:!!=7=Y;(LH$@:JE)RWMIII?LEU;Z(#\??&'['WQYNOV4_\`@HIX
M$L?A;>W_`(_^+?[8D?Q!^&]E%?>%XKKQSX1T[PI^SWIFG^,;"_GU46]HBWO@
MWQ//:P:W>:;J-I<V=PZV4)FMS/\`IE^VI\+_``_\5/@,-,\3?"/QW\8KWPYX
MK\&^+O#GAKX7^(-+\*_$?1/%.E:M!;6/C+P3XDUG6=!LM(U[PM:ZA?7XG;5(
M)9M/&HV<(F>Y$,GBMI_P4\^`%[\4?A3X>C\8^#+3X6_$'X,?$SXFZU\3]6\7
M:;8V'@[Q)\/M<^"NDCX>:G;F(V\FO7<'QDTV[NHX]0$ML;:!8K>XCN]\?T!>
M?M9>`](^).H^&-:O=&T_X>67PDT/XN+\6)_%/AX^')-%\0^(7\.Z:C645W_:
MD%K<7:HL&L2V_P#9=Q)*EO%<&96%2!^)=I\!_B+^SMXA^$_[77QI\+>*?!7A
MW4/VX_!/B'Q'X;\?>-K?XC^._A[\+9OAGJ/PA\&>)_B9XOL);C2+C7'\7^(;
M_7M;CT>[N=%\-Z7JNEZ=#?3"QGE;[6_;NT3XO_M#+X@^%WA_]BSQ!XO\5:!>
MZ8G[-_[45IX[\`Q>#_AOKWB!=$O9?BQ*LWB/3?&^@WW@'6K#2]3;2=+\.:\_
MB$:/`D,Z6SS(ON/CW]O7]BOQ#\1O$'[./Q#\;?#;Q9X=U'X?:YKWBR]UZZ\.
M>)/AO=V.G^(=,\/ZAX)UVVF:_M;_`%6;^T?M<VF3VMQ:M:V%V\Y5HQ'7V)HW
MCWX/Z)IWPS\+Z!KOA32=)\?P#1OA1HNE26MGI_B2UTWP_<:Y_9WA&SM1'#<6
M^G^&=-N]3\BQC$5KI5E+/B.&+-`'Y:_M#?&+0/!/[<UW\8[>(:YI/[$O[$GQ
M?\8_%VZLI%B5M8\=36%[X(\!B6,3I_;OB)/"]S=6=@3YD1N[:01[9HR?O:^/
MCW]HK]CBXDUKPC'X$^(OQC^!-Y)>>"+F^%['X4\2>-?!<Y'A^\U)HXEG;2[R
M_2QN;GRD!DC=U0`8J'XAZY^QE\`6\0P_$@?!'X9O\6-6D\2>*[;7-,\,Z1)\
M1-:TZ*U$FO\`B.T:U67Q->6$-O9I_:^JPW9LXX((Q<Q")%7=\"?M%>"M?\?>
M*_`%YK/A716LO&47A+X7PP^)])U*[^).F0_"+X9_%6]UG2+.TE,EBVGV7C^2
MT_L2X,FHS:5IEMXFB0Z1J]C(6DWLF_0#\T_V;OA=^T?JGQ;_`&"]5^(7[-WB
MWX8:+^S+^SA\6_@UX[UKQ5X@\`:W:R>);K0_@E8Z'K7AU?#7B76M0N]*U]O"
MOB"UT^8V=I?>1;72ZG9V*36RW'R;\+?V(OVH_@_I?P)\<:Y\'_C-XGATWX6_
M&?X4>+/A]\%OBUX'\!?$#P3<:U^TK\0OB9X6UHW.KZU'X8UWPGXH\*:UIL6I
MZ;8Z]!?Z<_\`9;2VT[6TUG;_`-('@_XA>"OB#::M>^"/$ND^)K/0]8U'P_JE
MYI%U'>VMEKFDRF#4],EN(B83=Z?<`P7<22-Y$RM$Y5U8#X!\!?MJ?&[XO_#G
MQC\6_@O^SFWQ,\#7WQ8U3X>_`JXL_'>E:!>?$;PMX7U:^\,^*/BSXDD\0:98
M:9X0\#/XHTG5[7PH]K?Z]J.OZ-:6VLBV@AU&U1D!O6'P(US2?^":GBGX!>!_
MACKG@CQ'>_L]^//!_ACX6Z[XPL?%VOZ1K6O>']9AT[0-0\8))::9J>H/?7L:
M2WZS0V`FD/[X0)YE?E?J/[*?Q%U#]C63X)>&O^"84O@7XYR_L]^`_AKJOQ<M
M]?\`@8KZYKVA0^`[?Q:+A],\217\L7B2?0[^^DEO)'$ZPG[3<-/(@?\`1FZ_
MX*0G2_A+::SK7P<\1Q?'W5OCSXD_9JT'X%:-X@\.ZA)KWQ3\)6>JZYXCETWQ
MY<RVGA>/P)X?\(:%K7B[Q!XROYK:RT;3-,G@NX_[1,=G)Z?JO[4WQ<^'_A'X
M&^/_`(R?"KPQ\/\`PO\`$/XBZ=\.OB&]I\1=,\7R>`+OQ=<-I?P]UVRU'0-.
MFT/Q#H7B'Q`]CHEY+_:.GW&F7>J:>%BNA(Y1M-;IKKJK:=P/FKXJ_LQ_%[7?
MCG^V!XJT/X=S7GA[XE?\$SO@W\"_!.I?:_#XCUKXI>&?'7[2NJ:WX2MH9[V*
MZM);+3O&W@ZYGN[Z&UTB>.\LX8;R1[">.#\[/`?@C]IG5?AK_P`%!_V0/AS^
MS7-\0O%7QG\!_#'X`^*_'FK^,O"&C>#OA!XH\0_LC^"/AUKVI>.;34+N;6M;
MM/#;7MWXAMO^$1M-;>^O+&.VC\AI!/7]-WC?XB>"/AGX<;Q7\0/%&D>$O#D=
MQ86<VN:_>0Z=I\-SJ=U!8V$4]U,8X8GNKRY@MXMQ4-+*BC&<CYN\%?M+_L/V
M/BA/^$`^)_P.L/&/QO\`$]N+B?PW?>';'7_B/XNM`GAFQEUR[LDAOM;UQ$LH
M-!TR?6I9;R6."VTS3WD1(80@/R_T/]D']I7X&_%_Q3\6?#/PNOOC!IGPS^-W
MP.U[PQHG_"2^&](\2_%7PCX7_9(\,_`_Q1XGTBYUR^_L^V\0Z5XAM+B_2V\0
M7&E_:IH+C[-=E#%<'S3XU?!CXM_!SX$?%K]L[Q=X8@^&WQYN_P#@H+X)_:0^
M"_PF76].UG6;.#XE6/@S]EO5O@S=ZQH@GT^Y\1?&/P'KWB&/4;'1YKG3K;Q3
MK6EWS7=PNDO=#]X;K]I7X"V/Q+C^#EY\5_!-O\49?($?@>77+1-?,UU`;JWM
M#9F3Y;^>UQ<PZ>[+>R6[),D!1U8^0^)/VFOV)_B)XE\/^`-=^(WP;\?^,M(\
M4P^(O"'A75Y=$\1:AIOCSP9+?3:?J6@0ZC!<Q:3XTT*YM;]]'NK-[;7K"YAE
MN-/9#&T@`/S5\;_L(_$[X6?$7P#XM\+_``R\>?&OP5<?LT>`OA!XFT+X5?%Z
MQ^$?B71O'?A2ZN]3\0^(M0&K2VNF>(O#WCK5-8U/4]32.^ANK;59)+HVEVDY
M`\JL?^">WQ"\":QXQ@;]EGQIXY^%?QI^$O[/VC:=\*/!_P"T5;^&-,^$&I_#
M/X6Z5\*_$/PM^(MWJJP)XZ\*6]IH>E:YHWB?2K2_N)KG4?%=L=(A,EE//]J1
M?\%:?@OK6B?L\>+/#.I>';/P?\4_B+XG\'?$2[\4:_;Z3?\`PHT/0-.\5W.G
M:[J$=O;:C8ZE_;DOAN`:=8I>V\\UKJEJX;[2?LY^RKG]N7]DFS^'GA[XKW'Q
MY\!?\*\\5:WJ7AKP]XIBU*6YLM5\0:,\L>KZ-;06UO-?_P!HZ48)&U*VDM(W
ML(P)+KRD=&8`\W_:K^#^J>//V8M-^&L?P.D^+26=Y\-9;CP+H_Q!'@?Q)HA\
M)ZEI6I67B+P)XXNH%6U\7>!=3TO3];\.W5T+-+V?3RLUQ;S2@5\1_LS_`+,G
M[90^/G[./Q.^/EEJVI^%OAGX^_:DG\/'QEXNT'Q1\1_A_P#"GQO\/=!\.?#'
MPYXU\1:1;V5EXJ\0G6K+63)<Z5%=K:Z1=:7%=ZE<RP3$?LUI_P`3/`.J_#\_
M%73O%FB7?PY7P]=>+&\917T0T!?#5C:37U[K;Z@[+"FG6EG;SW-Q<.RI#%#(
MS[=AQX)8?MV?LBZIX1\0>.[#X\^!;KPIX5OM$TSQ#J\=Y=^7I>H>)9)HO#]E
M<6S6BWQN-:DMKA-,2*VD^V-!,("_EM@`_'?7_P!C7]K_`$/QOXABE^&?BWXA
M_!;Q3\:OVU?&\OPT^'OQNMO@^][XC^*WQ3\.>(?A%XV\::O8LMS?^%H_!L?B
M6PFT2PD:\TN\O?M4]A=3>7$[_@M^P'^T_P"%/!GA#1_$/@72+'4]&_9S^$OP
M[O(;;Q1:WMLGB3PC^VSIWQGU2RBNIF:>:TL_`-JU[;WLO[R[F5;-T2Z)0?I_
MJ/[>'P[USXJ?LI^%/A#K/A7XE^`OVA_%WQN\*ZYXXTO69D/@N[^#WPDUKXF7
M%NVFM8&674;F32#87VGZB^FW%G:R?;$$N`C>A>&?V\/V0_&%MXHNO#GQZ\"Z
MI!X*T*Z\3^*98[R[METKP[8R"&]UY_MMI;&ZTBVF(CFU"Q%U:HY4-*-RY`//
M?^"AOPH^*/Q@_9VC\*?"?PG!XS\8Z9\4O@AXWM?#EYK%KX?@U6R\`?$[PMXM
MUJR.KWD<]O8ROIFB3^1--;RQF78FQB_'YN_%;]A[]J#XX_$CQ/\`M?ZS\-XO
M!WC:+XS?"SQ?I/[..E?%9='U[Q!\/?AY\'O&GPKU=9/BEH>FG2M$\>ZC-XSN
M->\/W4=G+:+::3'HM_=6ZZG+-!^R'PV_:W_9N^,/BG6_!7PO^+_@_P`<>*/#
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M^#'Q*^-'B*TU&_T/X9^#]<\8ZI8Z3;_:M1O+30[&6]DM;.`C:T]QY0A1G94C
M+^9(P1&-?%WP4_:X_:6\5V&A?$_XS?`KX:_#;]G37_!&L?$";XJ>&?C=I_CN
M?P=H5CX>D\3Z?)XTT2'PQI<=M'>Z=`]M=7.AZEK4&FZGFVFD99(G`!XWI7['
MWQJ;P/\`\$_?#=_HNFV=Q\$8OC?:_%*=;^VF.C6GQ!\)^(=&TB73452=1D:?
M4K8W,,+J8_F+%BIKQKP?^R7^U=XV^#O[/OP4\>_"OP_\.F_9]_9A^-W[,USX
MJB\;V?B;1O&=_P"(OA1X8\$>%O&NDV5GIMIJ>G>']9U#P\LS6=_$VJV27$HN
M842%/-_8R]_:2^!>FO8)J'Q-\+6`U/X83?&BREO-02VMYOA7;K`TWCK[1,$@
M3P^BW,&;R21`3*@"EF`KY'\6_P#!3#]G"SUSX3ZKX1^*_A#6?AGKGQ`U/PC\
M3O$=S;:_9S>%;&X^#WQ6\?\`@_4+"SNM)M[[4G\3Z_\`#^VTC2GL[:ZMK^!]
M2%J\ES"B``^'/%W[&7[5W[3_`((\&?#OXA_#S2O@2GAG_@G_`/&[]DJ_\2IX
MWTWQK:W?C7Q+IWP>L?"/B2UL]+L]/NW\)ZC=>"=5FU2QF":@^D[[258YKH*F
M/XW_`&%OCE\6_"&N:QHO[,>@_![XN>%+3X9:WH^O^//V@-9^*J_$?7_AU\3/
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M:07UIX:\2^%WT:[O]1TWQ+K>BZ/9G4M+NW6'3+V_DN+?=;I%+^T=%`'YK_LU
M_"+X]>(?VK_&W[6/QQ\!Z#\(0?V<_`O[-G@OX=Z1XPA\;ZIJ%KX;\<>(O'WB
M;QOXDUNRT?1M/A@N]5U>TTOPAH\$-S<VNE0W^HZA<0W>J/I]G^E%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!7S!^V9X7M/&G[,OQE\*WQ\:BUUSP1J=A<'X<^&+OQKXV
MBADDMV:?0?!]@&OO%$T)4276@6227NKZ>MW86<,]S/'!)]/U%+)#$C23O%''
M&K2-)*R(B*BEG=G<A55%!9F)`5022`,T`?R=ZK\._CCX[^&MNGA/]GZ:+X&?
M#3]IGX-ZA\1O'WP]_8Y^+'PP\4?M!?#73OA!\1-+.N:K^Q_\2I[/X@^/[#X+
M?%7Q!X$U/Q'I^AZ:(/&<%G?:KX9\/:L?"$EIJ/N_A3X5^./@IX4TS]LW]G3P
M/\8_C%K_`,*/BAXYM[KX5VO[,GC3]GWQ-\0?AM\2O">FZ)X@T'X9_!_Q58:;
MXR31=-\;Z5X7UPSWGAO2H"\7BK5+*W>*">X?^C&U\4>%+VQN]7LO$7AZ[TVQ
M\Q;[5+75]-GL;3ROWDRW=[%</;V_E@[Y!-*FS[S8ZU-8^(/#FI&V&F:YHE^;
MN"2YLQ8ZE8W1N;:%Q%+<6PMYY#-!%)B*26+='&^$9@W%`'\Q?Q#_`&./BO\`
M!F\_9WE^)>C^,/'_`("UKX$?%V]^+_BOP-^S/XH_:PETW]K+XV_$H_$GXG^)
M==^$?A"SU3QG;-XTMM6G\->#?'^E>'-:3PK:^%SH>L76C66I6]XGN7['G[)<
ML?QCU[QM\0?@SX[^(DGPP_95^`=S\!O$'[0'@34?`FJ2?$7P?KGCK5]+LY[:
MXO-5T/PUXOT>YM/"D,\"WUYKGA:U&F&_AM+F*:W3]^[KQ1X2T^"6XOO$7ARQ
MMK?4&TB:>ZU?3+:"#54`WZ9++-<)'%J"JPW63LMRH89B`(J>?7_#EI*L-SK6
MB6T\DEE`D4^HV$,LDVI.8].A5))E=Y+^13'91@%KIP5@61AB@#^/W2_A3^T;
MXST'Q!KD7[._QH\&Z_XN_86^+_@;X@?#KP_^R9J/P.\">!_B/<3^"M9T7X-^
M#_L6E/XJ^*UYX=OH]4L=$\:ZW<^(X/%(TY[WPAKMXD^KVUM]J_M5?L;>+M)\
M":KHO[,/P/US0+_Q;^Q)\/;;XK:'X,T2^\.7GQ)G\`?M%_!#QEXX^'5SK(-C
MIDGQ0\7_``JC^+GA_0])U35K76]2&K:A;HIMGN7C_H@LO&'@K5(;V?3O%/A;
M48-*0_VC-9:WI-W#IJ+U^VR074B6:*1SYYC`Q[5:T_Q)X8U1[Y-*U[0=1DTP
MXU)-/U33[M]/9U9L7RVT\C6A9$9L3B,E48\A20`?SQ?M(>&])^)T/P8^('[,
M'[*?QH^&'PH^'/Q#T[4_CMH>K?L6^)],U_7OMG@633O!6O6'[//BW3?#7BOX
MO6/PNU":XT[Q$-!\*:]'!<ZDE[X=;Q,EI++%^DO_``3;\"W'P]_9O\0Z7)+\
M3ET_6?BE\6O&FAZ;\5OA-=_`W6-%T?QCXKU7Q`NE^'?A7J4\FK^#?`::E>ZG
M=>#](UNUTC5[32;J.&XT32[>.TM4^ZH?'/@6YTZ]UBW\8>$[C2=.8#4=4A\0
M:/+IU@S`E1>WT=VUM:L1D@3RQDC)%;MI=Z=J^GQWFG7=GJ.FW]N)+>\L+F&Z
ML[NVG3Y)H+JUD>*:&1&RDL4C*RG<K=#0!_*'^R=\.=0^(Z?L:M\`/V<?B+HO
MQ7^$'[5?QJ^+7Q>_:*UCP'=^"_AIKGPO34_B]I&J>`+?XH:@]O;>/;WX@ZQK
M/A?1K30M$75O^$>73;K5]:M=-2PMQ<Z7P,^"?QT^,?Q)_9H7XD?`OXN?"V\U
MS0OC=X$^.?A6S_9$T/X'_!CX)CQY\+/$^EIX/TWQU8:0?&'Q;TK2_$*6T>D^
M/]7\1Z]X,UJXMM.U6RU*RUK4;#3X_P"D[X1^$_@W\'=$;X2_#6Z\*Z)8^'[C
M6=:?PC8Z_!>:CI+:UJ=SKFKWEW:7FHWFJV\5QJ-_<7DLMR5B0S#;LC"*.Z_X
M2;P7XATC5)M/\5>&=0TVV5[+5+_3]?TZ:UL?._=/#=7]E>$6$QW@(6FAE20H
M4*OM(`/Y@M?^'OQ;_:[_`&0/VHOC9XD\!:OXS\;^!_AE\/OV(/@IX;\'V&I>
M,+W6]-^%GQH\'ZI\?_&GA:PT&SOK_4+?QMXZT*ST^ZGA@EG'AWX7Z=J#M'8S
M7#K]6?M5_L6>$%\._M\WOPN_9U2/7HOAW^SX/@)/X0\!:E+?6_B?2+B[O=;O
M/ANNF:=-)<:W8:A8Z7=ZY/H`FU0R6]JVH.-R%OV0^%&@_`GX,^!/#7@+X8W_
M`('\->!M+N;O1?#FFV'B2RN;:35+B[EO;ZS@O;W5+RZU#5Y[RZFN+Q);NYOY
M9YWDFW/)FO3[GQ9X1L-0@TN\\3>'+/5;N5;:VTZYUG3+?4+F=@&6""TEN4N9
MI6#J5BCC9R&!"_,,@'\V_P`1?@'\68?CS^T9I?QE\*?'_49OC/\`%7X>^./A
M7\0_A)^R[IWQOCO_``'IG@;X6^&O#7AC_A<UW9W%]\`-=^&WB#0?$Z:GI_BJ
M^\%Z`\$D_C#1]:U>\UZ]LK7L8_V1M=M?V>KGQ=8_`#58?CQ;_P#!5'X;_$J#
MQ#%X,O;7X@V_PSL?VNO`UQK/BZSO9K6'5CX,3X97/B&?4+JQ:31Y_#4NHW)$
M]L)'7^A2^\8^#=-UNP\-:EXJ\,V'B/55WZ9H%]KFE6NMZDF7&ZPTJXNH[^\7
M*N-UO!(,AQG(-58?'7@"ZU2UT&#QCX/N-:O_`+2;+1H?$.BS:I>_8VD^UFUT
MY+QKNY^RM%+]I\F%_(:.3S=I1L`'YX?\$_\`PG:_";QM^TM\)=7^!?B_X?\`
MB^W^/7QR^(-C\19OA5+H7PY\9?#7XA_$J\\5^`-,\'_%&VLTT3Q.]CHFKVJ3
M>%;"]DN/#3Z=>6UW96/V:))/SK^*?[.GQ4MOVG/V@M/^(7AS]J"_G^+O[1'A
MKXG?"OQO\#O@1\)?B5X<U+PGI&K>$M5\#6NI?&_Q1HEWXP^"UW\.-0T*VT_7
MM(O_`!'X4TU='TZXU30I=4.L20-_0^OQ%^';7VLZ<GCKP6VI>'XI)O$%BOB?
M0S?:)#$%:676;87WVC38HE9#))>I"B!E+$`BO/\`QG^TC\$/!'@Q/B#JGQ%\
M(ZAX2_X3#P;X'?6M`U_1==L[?Q+X[\3Z5X1\/V<]QI]]-#`\FJZW:/>,\@-E
MIRWFH3A;6UGD4`_FQ\6>#M3^$WPY\,?"WXP_LR_$>#X^G_@I5X#^(7B7]I'4
MO`^CW/@'QAH/BG]H*#5?"&LZ)\6+W5%GOI=1\*W>CZ!!X.TE+O5=&ETF:#4=
M-LK);:ZN/I[7/#WQQOX_V=/@-9?LQ_&YM:^`7_!0SQS\8_%GQ+U3PWI%I\&[
MOP-K?QG^+?C?PAX@T'Q8?$"W_B*PU71/'7A_4+XZ7H,L/A^.'5]/U^XTS6+:
MRTS4?U7USQS^SY^T?XG\4_"_QCH,7B'P[\&[_P"''Q:?Q9J>I06?P]EUFRU*
M;7/"6O:+XGT?788;V?P]J>D/<7?VQH]/22`Q3BYC$L0^E(OB-\-+K1K+Q-!X
M[\#7'A[4KF6UT[Q!%XHT"71M0NX89YYK:RU5+YK&ZN88(+J:6&"XDECAAGD=
M0D<A4`_F!A^"7[5?Q,O9?$'BOX(?'#2/B##\(OVS_`_C'P];?!WX0?#OX+>&
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MF30!^&G@#P;XA\'?%+X3_&?QK^PS\;O%GPPB_8BA_9HM?`5E\)O"%[XF\`?'
M70O&%SK7CKQ%>?#RY\10C^POC!I4NDV5G\2+".6.7_A#67Q%<:9I-]8WUS]D
M?#?]F#XMV'_!(7Q=^S#XI\/V4OQ>UO\`9T^-WA70_!=]JMCJD/A[5_'$/CC4
M?AUX&GUV1Y=*DN_!]IKOAWPV=2@N9=+L[S2A-87\NGP6U\_Z`_"GX^?#'XL^
M`=-\>:'XI\,6UO-X3TKQ=X@TF;Q+H4VH>#;'4]-746C\5)!>'^QFLX7E2ZEO
MUMHD\J4E@JOCS'XQ?ME?"?X6^#/#GC70-6T'XJ:?K_Q9^&WPEDC^'WBSPYK9
MTG5_B5XFMO#6GZAJ,UC>W<,-MI]U<BYNH'9+B:)'6$>9B@#\T?A5\%;_`.*_
MQK_92\6Z]^R3XQ\!>"/A)^R#^T=\)?&6G_%3X;^%]#AF^,6KI^RPVE:M#I5K
MJ6LV.J0Z[;:'XFT_0?$TJI<:G/X/U>6U=M/M["\NOCSX@?L?_M*ZK^S_`/$G
MPE;_``6\;3^(=9_X)S>'_@SI&E+:VSW-SX\TO]J;QKXG3PA"ZWI5=0@\&:AI
M6JQ1F6.WATZ6$),K(8T_H;^`G[1.B?'OP?\`$7Q=HWAN_P!#@^'/QI^.7P4U
M*PU"XM+BXN]7^!OQ&\2?#G5M6MY+7,2V&NWGAV?5--A?]_!9W4<5R#,CYR/V
M;OVL?A?^T?X*\+>)='U3P[X;\1^*HM<N8/ASJ7BWPW>^-;6#0M?U;0I;B?2+
M.\^W2Q3MH\MY'+'9[([=EWME&-`'Q+\0_@;X8^#7[8OP]\3>'/V3-5\;_`CQ
M=^S;XL^!]S:_";P)X*U73O"/C#5OB-X*U6UO_&&EZEK&A76F:3/X9LM8:3Q3
M#'?-$MM/;R2BYN+>*X^=/V*?@-X_^(WQ;\=^`-?\;:CI7@7_`()[Z'\:?V3_
M`(%?$CPM<PRZV_CSXM:]::SJ?CW1Y=4@U&TM?%WPI^#-G\.?AY;W%Y!JD%OX
M@USX@:=(<+<6@_=71_B-\//$>OZQX/T3QOX-UCQ5H19-<\,:5XFT/4]?T@J0
MC#5-%L[V;4+`H2BNMW;0E&*JP!P*X32+?X#_`+.&F:EHUOJGP^^%MAXCUSQ%
MX^U*+6/$.E>'CJ^M>(];BG\2>);N;7-2CN+V>_U[5K9;V]:61!>ZA:6X,9F@
MBH`_&_\`;1_9X^+_`(!\=>%/'/PLTS]JCX\_&[0?A/XN\'>%_B'J7PY^!WQS
M^&_C<Z[K,.I6_P`,_B?X=\7ZQX3G\$Q2:C%:/#XZL[/1M/L]&FU!9=9GGA6V
M.1\2/V;/VBOB3X0\9?#2P^"2_#SXR_$7]ICX6?$KP7\<]#N(['X:?LX0^`_V
M&?V3?!/B[QGX>UK3=1@US4[.X\9^%/&WPK\*>%]/A"^)IK#48M7>VT2TFN&_
M<;Q'\;/@]X2DTE?%7Q/^'/AU]>MH[O0!K_C?PQI+ZW9SE1#=:2-0U.`W]K,7
M18[BT\V"1G14D8L!6+!\</"D.O\`Q/T_Q"MEX0T'X7KX1-YXV\1Z_P"&].\,
MZM#XLT*/7()[.^DU,'3K>P66.RG?64T\7%SN>Q%S;;)WJ,G%W6_FK[-/\T!\
M^?L6>!_$'A;]E&U^$=Y\*=2^`_C/P9HWB/P!JEI=SKJFGZ[XJAAN[>Y^*7AW
M7X+FYN/$FB>,]2N6\5VVI7[1:YYMY+9ZI;P7MNZGXQ_8X^)TGA3_`()=?L\>
M`+3]GOXJ?%_4/AAX`B_9:_:)^%WPINO"$'Q)\`^//A5;7WPT^)IN-&\3^+O!
M?]KW-QXGT6ZU&V@T375UR]TC7=-\1V$<]K<),?T?^`7[4/@O]HKQ-\=?#W@:
M".XTWX*^,M'\%R^+]-UK1_$'AWQA-K/A/3?%,>J^'K[1Y[JWDLK:+4ULI%DF
MD8W4$I!V$5Y1\`/CM^QSXF\2?'SQ7\+O$_@'PSXGL?B5X@\/_&.2Y\0:#X?D
MU[Q-\.;/2M$U+QM<V,FM&WO=(BL)--TN+QF+>"._M["*WN;ES:!45W>_6]_F
M!^2\'[&_Q-?PI^SM\3/$W[-'Q`\=_`#X._M,_'_Q=:?LB:]JOAV_^/&C_`'X
MS?#6]\(Z#?ZI:WOC5/#WBGQ9X,\>/_PFU[X&N?'E[X@F\+W\VEZ9=ZIKNEC1
M[OJ?$OPA^)GA#]A7XZ_"[4_!GB#X=V_[2'[6/P_B_9#^`_BO6-*U?QM\*?#6
MI?$/X=Z_90:L^EZ]XBL=&?3U\(>+/B*/#.FZUJ,GA72H3I\I@U!9["#^@?PE
MXW\$^/-$3Q)X*\4>%_%^A/+/!'K'A77-)\0Z4\L#^7<0IJ.DW-W:-+$5VS1+
M,71AM=01BOS<^,G[;_[(=MXF\4^*+RRT7X@_$[]F'XP^#OA9:Z-/K.@V.O:-
MXA^*>N>$?!>J>*O!5M?ZG)'J6D>';7Q?;?\`"2:Y:V)>RCM=0THRV\X<.Y3E
M-IR=VE;:W5O[VVV!Z-_P44^$/C3XQ?LM:/\`#OPEX4N/'6NM\5OV?-3U+1+5
M;:4W.A>&/BKX,UCQ7>2I?2VT,MK9Z)I^H7]Y'(P,MI!,H1V(C;\^_BC^QOXY
ME\`_MNCP/\`[>/QEXP_;P_9F^)_P>N]%T?PW9ZM?>`?!_P`:/@/K_B'7O#5X
MEQ"VD:=I.@Z)XMOIH'FTMA!:Z@WV?=,3)^V_AWXV_"7Q1H.M>(_#?Q*^'6O>
M'?"X=?$VM:%XW\-:OHWAHQ0M*T>O:I8ZE/8:5)&D<KRK?7%OY<4;2-M521U7
M@_QWX*^(.B+XC\">*O"_C30VDEABUCPEK^D>(]*DN(N)H(]2T>ZO+(S(<)+&
M)R\9.UP#Q4@?SX:[^RM^T!=ZK\4_@3'\`/$.I^/_`(@?\%$+G]K'PU^UW;77
M@1_AYIGP@NO'.B>,K.UU+7F\3CXA:/XV\&^%M/'PVMO`Z^%GM-7M[>SO]$U"
M;1+JYEM.^T7]B[XI6'[+'P8T2#X*VUI\7?#_`/P4P\$?&[Q,QC\)0^(K'X4V
MO[6-WXG\0^+;K6AJ9$^E1?"K4YY[BQCU*?4Y-#EETV#39I9#9U]X:#^W?J7C
M7X@_%'P3\./V8OBW\0-,^#_Q>O\`X+>-O&F@W?A*WT*Q\4Z79^'M6U%HX-4U
M.SU":SM-'\4Z3J<K)`Q,<TD<>^:-EKZ<_P"&C_@-%J3Z'=?&'X2V?B"WMM9O
M+O0+GXB^#;?6+*W\/_;#KL]SITFL"[A@T4:7J+:Q</"(=-73+Y[UX5M92@!^
M,?PG_9O^+.KC]B_X7>,/V2_$OAW3_P!F/]I;XI>*?B=XQ\4R?!F[\`^,?"NN
MR_%6;PCXH\+2:+\0-<UOQ!810Z]X?'V76_#NDZMI5U.EL^F1O97#6W)?$']D
M_P"-'@OQ?\=?&_@_X%_'Z'Q0W[;'QS^*7P&\0_`2[_9DU2PL?!_Q$^`W[.7A
MA&\5?#KXW_$#POX9U#P#XV\:^&O&4.K1QQ1>(]%U#0K[4WTR"RUNSU.]_=6\
M_:"^!^G^&='\9W_Q:^%EGX2\0B[.@^)KOQ]X3MO#VMQZ>Z)J$ND:U/JT>G:E
M'8LZ"[:RN)UM]Z>:4##/*VW[3'@#5?B)\.O!WAG4O#WBSPW\1/AI\5OB58?$
M3PWXHT/6/"-K8_"SQ#\.-`U.T.I:?<W-E=FZN/B"C27EK=O;6$NDW<-VZ2'"
M@'C6G?#WXJ>-_P#@GAKOPP_:"^&^G:[\5/&W[/OBSP?\2OA7\*M9\)^$4U?5
M?%/AS5=*U/PMX.UN>_TWP-X>UO4;2_%M87;ZQ:^%;'7IMYU>+24^VK^5Z^"?
M^"D5Q\/O&=CX>^&?Q63X61_$'X-QV5YXW\)_LCZ%^V]JOP\T--=/Q'_X1Z/P
MAXQU/X.ZG=Z3>S:*GA'Q!XI\0Z/XF>RN-:N-(C,8@O)_W<TW]H?X&:W;:C=:
M%\7_`(4:U::/+I,6L3Z5\1/!]_;Z5/KFI6VDZ1%J4]IJ\T%A+J>JW=MI^F)=
MR1/J&H30V=H);F:.,]-K7Q3^'?AJ_OM.\1^-/!OA^_TO06\5:G9ZWXFT32;S
M3?#0N5LFU[48+^\@EL='^WNMH=4NEBL3<N(//\X[*`/YUOV?OV-OVO?!_P`<
M_#7Q-LOA)XXT*PT7]IW]J7XHZ'>_'#X@?##Q5XFM]%^)'[!WASX8>"-9\>OX
M)\6ZM87AU;XMP7^A:EI7AMM2N=*99;N2271`-2O?-KS]C#]N?XE:7#J_CCX*
M?&B;X@7'[)7QX^%/CF\^)/Q5_9T7P=/\3_&NE^&3INC_``C\(_#GXAW^F>'O
MAM=:G9ZJFA7NO6^@ZO':16[:WI=DY:YD_I2M?CY\$KKPK?\`C>V^*_PKF\&Z
M=J2:'?>*K;X@^$)_#%GK,Q@6'1KS7XM6;2;;5)VN;?RM.FNUNW\Z("$F1,]O
MX1\:^$?'FB)XD\&^(?#GBS09&F6WUOPQK6F>(-'FEMF:.>.'5-*N+NQEE@D1
MHYUBG<PN"D@5@10!^,G[?WPXU?X,Z1^R=\3?V?=.\-^"OC+;WMY^R?I7@C3+
M:RTA/&^A?M*Z#8>%]7TVW@TN$6MS<>`/$GA_PS\5GOG\ZV@L/!&IR&=8IFN*
M_0O]GGPKXK^!"?#K]F70/A5JDGP8^'/P<T6*T^.TGB_PO)8Z[XVM[LVVK^')
M_`RWK^,8=3OY&N?$UYXDN;0:)/-?26<$IN%(KK+GXB_LQ?$;Q3I%S<>-?@=X
MS\6_#&?6?%N@E_%O@77]<\%76F6=QH?B'Q+8+'J-U?Z#)IUEJ=SI&K:I&EO]
MB@O9K.[GB6>2-O3?`7Q6^&GQ0BO+GX<>.O!?CFWTR1+?4+GP=XHT+Q+%I\TL
M?FQ0WDFBWUZMJTT6)(1*R"9"'CW+@T`'Q8CU67X>^*X]%\%:;\1M3DT>]BMO
M`FL:G:Z-IWBTS0M%+H-UJM]9:C8V,>HP/+;F>]LI[0%PMP$B9I%_!J']B;XY
M>+?'=^GP,_9P\6_L/_#37_@[^T/X-^,O@OQW\:O`'C;X>?%>_P#B)\,=3\+_
M``KT3P/\/?ACXX\>6OAN+P?\0+S3?&6H^*M2MO!<T>DV,VC0Z-J-UJ^-._<[
MQ%\=/A#X4\76W@3Q)\3/A]H7C&\:R2T\,:QXOT+3M?D?5))H=,4Z3=7T5['_
M`&E+!-%I^^)3?R(T=H)75E%!/V@O@O+XW3X;I\3_`(=-X_:^?23X/'C#06\1
M#65C=SHHTO[:+O\`MA84EGDTH1G44M@TK6RQDN0#\)_B-^R!^V-^T1X4\+^$
MM9^!%E\&)O`_[$_A7X$K/XG^*W@#Q+H_C#QIX!^(?P[\6W6@7/\`P@>JZ_?:
M=X/\=Z=X+U+2+#5)K>^N(K+5P_B'3-*ECETR?]!],\.?%OXT?$G]F/7_`!C^
MR9?_``;T'X,?$FXU#Q(/&GC3X*>*[^^TL?L[_''PE8:MI>G_``]\5>*5?PYX
M?\8^*O"VF^'OM5Y%XADN=?O-3/A3P]8Z5?WMS],?$G]KCX1?"KX\_#O]G[QI
MK>GZ)XH^(_A'Q#XOTG4M5U72]-T>TMO#^H:;IL>G7DE[<PNNI:Q=:E#'H]JB
MF2[:*;RE?8<>A>&_CQ\&_%WC:]^'7AGXE>`==\:Z7+?1WWAG2?%&C7VMV]QI
MZRC5(!IUO=R7#7>ELCQ:M;(AN=-<2)?10$8(!\_?L3?"#QC\&H/VC-)\7>'H
M?#MIXP_:B^,'Q"\$6]K?:5>VUWX*\5:G8WFE:E#%I-W=)I@OW$\KZ=>+::A$
MX9KFSB+H7^XZ\P^('QF^%GPJ.G#XC>/_``AX).KI>OI*^)_$&F:+)J<>G/81
M7[:='?W$#WQM)=3TV.>*T6:5'O;8%,R*#A^'?VB_@=XOU6ZT+PM\6OAOXAUF
MRT:3Q!=Z9HWC;PYJ-Y!HL-O'=7&IO%::C+ML;:WFBGNKHDQ6L,L4MPT4<L;N
M`>UT5\^:9^U7^SKK-OKEWIOQG^&]Q:^&EL9-=N3XNT6.VTV#4]132-/O+BYE
MNT@&G7>J21:=;:DLC:?/>RQ6D5R]Q+'&U#XJ_M*>%?AQ?Z+H&FC0?&'B[4?%
MW@3P]JGA&V\<>&-!UOP_I/CS49=/L/$U];:Q=HSVR^1-)9Z:BK?ZTT<EOIBS
M2H00#Z2HKYJ/[87[,8O;K3S\=OA1]KLM,GU>ZB'COP\XCL;2Z-C=L)8[YHI;
MBWN@$ELHG>]6.2*5K8(ZEJLG[5/P[D\4^%+;3=;\(:I\-_$_P]\5_$`?%FV\
M>>&/^$;L+/PQK>AZ');/9F\-[=P2W.L@7>K6Y.GZ3/#'9:@\5S<Q)0!]/T5X
M##^U'^S[>Z1XBUS2_C#\.]8TSPDEB?$ESI'BG2M5&CR:G))'IL%Y'IUS=3)<
MZ@T,PL;98VN+OR93;Q2!&(]'^'_Q&\$?%'PY;^*_`/BG0?%V@7,UQ:QZKX>U
M.UU2R-W:.8KNT>6UDD\B\M)E:&ZLYQ'=6LJM%<0Q2*5`!V]%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`5\P?MF:1H'B+]F/XT^'_%'BG6O!&@:SX#U:QU;Q=X>T*[\4:MX?LIS"DNI0
M>'+`&ZUR"`E6U#2XV@%[IOVR&2YMXV>9/I^H)X(I0#+T3Y@<@`8YSG&1CU!%
M`'\B^KZYX[\9>"WL/"7@7X"-\#/A1^U)^SV?C'^TG\&?V?OBMJ?P:^,'PVM_
MA+\7H-)U+XE?L_+\0/#/B+Q9:_!KXL7'PKNOB1!X7^*4NC,-3T/7;R^_LGPI
MJ6A3>_V4-Y^SYX!TO]NSX+>.M+_:'L/A+\8?&%KX^\-_!SX%>+_@GX'U;P#\
M4/!NFZ%KGASP!X(\0>.?BI=ZG;VOC?1_!NL->:?XFN[6/4]1UEXQ"PG%?TN,
M=/S@D$.ZL",;"RAVRK$`98;LG.2!(<A4G*OW6?RCS2I)+C#8`VCGY@,$8(.,
MDXP>F*`/Y:/'G[//C[X*:G^S9_PT)XK\+:+X&\:?L[_&'Q9\0OB;\3/@5XJ_
M:+^'MM^V!\=_BG8?$7XMQZAX7\.?$'X>2^'/$>J>&M6'AWX6>+]:U/4;>P\,
M>%-6\,Z?9074\<+^[?LA?L_^#M1^.OB+5_%7A_7?VD;3X(?LF?L^>)O@;K7Q
M&\&ZQX/FU3QIH6M?$'4]'U+0O"GBBYU7_A$_%D,NC>';#1;RZO+_`%G0K6'3
MKB.[B$\AE_HDC>UN`8$+MY2*VUE=2%P5#J&5=P)S\R@KN&1VS73^SBK%%/3Y
MV"MN.,J')QDG<`H*YRX"\D$4`?QM>']3\<?$'PSJ'BGP[H*^'_$'C']@+XXZ
M;\4_A;\*?V<_$?P2\&?!WQVW_"&ZE;_!B/5Y!J%]\0=?\"ZFEYHZ:K>ZA>ZG
M;W6E/?6JVL&MI:C[2_;%_9PUGP+\,9]*_9J^&&MZ*_BK]@WP)-\3O#_PSTJ]
MT_6/&_ASP;^TA^SSK/Q*T&-=(BAN]3\::E\(]7^+6G6L`<ZYJ4.LZA:1F5I?
M+/\`2NL=A@,IRN#MVLQ3;L''=0"A!`<C*D$9'->,>$/C7X%\=_&#XQ_!K2;?
M6D\4?`W_`(0-/&$M[806NCS/\0_"\?BK0DT*^BO9I]1`TR4KJ33VEBMO=(]O
M']IC'FD`_!?]H;5/V>?B/;_!+Q=^ROX:B\'?`OP+\4H?^&B_$EE^S7XP\1>#
M=+N%\"W]G\+=8\5?#ISX1?QCI?@W5&U*RU:=I[V'PI>:C93ZK$Q58H_T]_X)
MU^$K+PU^RSXOTSX>_$[7?B5I.N_$7XS>*/!7B;7/AEJWPBT;2I?&'B/5]:?0
MO`W@G6K[5+S3_AQH7BB^U./PE*EY<6,FEL(].>2QA@=_T.3^SXF#AFA;)&&.
MUOFPHW+@G;G`4D8#8&>`!YG<?&OX7:9X_P#$7PE37IKKXD>&_AM:_%S6/!NG
MZ/K5_J\?@'4=:UK0+#6X7MM/DL;J;4==T+6;"VTF"\DUF6XMGF;3UMIH9Y0#
M^91/#&DZA^P)\8_@CX7^%?CV/_@I+I_A#XHW'Q5O;/X<>+X/B-X@TFX^*^CZ
MI\8X-'^(#:99Q7\'Q6^&,%UHO@V"VU<+KKW5KIVF+%+:^9%U?QZT[X??&O7_
M`(A>(OV)?A_X@T/X(V?[(^I^`/C?_P`(_P##[Q-X$\/Z[XFU3XJ_#.3X;^#_
M`.R=2TG2YK_Q;X8TF'Q;->"Q62]T;3)[J*]D=+L5_2K\//&_AOXD^"O#7CS1
M],\5Z)IOB?3H]3L=+\9^&M:\'^*K."5GB\O7/#.N6MIK.CWB%?WMKJ%M#/$K
MK(RJC[CW!:PB7!#QJI(`((*;MH(YY4=%P3G:0<%"&(!_-C\:OV3/`-GIG_!7
M1O#OP<MXKWPA^R?\--3^!#:9X=N-^B_$"]^`VJ:IJ^J_#F"UA6.R\6WWBOPQ
MX2GU6^\.QP:I>:GI.D+?23/:VRIYA^T@WPY\8:-^VE\-7\$Z_P"-/VU/B%:?
M`W1OV?\`4=*\#^(-3\8:)XYN_!'A:33-7M?&UMHTUCX1L/#OB!V\0>(M3FU&
MSM[&U@N[F[1L[&_IN^(OC;0?AMX%\0?$+5])\5ZYI/AW36U*YTSP/X9UKQEX
MLOH(@%\G0_"V@6MYK>M7Q#EDL]/M)[E@&<1[48KSW@'X>^`/#6M^-_B'X<M=
M9M]7^,=YH?B?Q,FK-=B0W=CHEOIE@B:7=0QR:/+%8*D5W92`2+<)()5#*10!
M_.DWPCUZW^-GQX\+_M+_`!.\6>"_B9XF_:6T?Q?X&FTS]EG5_BIXF\;?#RUT
M[P3/\(]2^'/QIL)YKO0+3PW::3+X0O-&MY8!X;U_0M?U#5K65=06XNNI\+?L
MZR:#^SW\!?B3I?PJU'2_C3_P]4\)ZAKGBFUT*\'C1/A_J/[0>M:7K&H7NI[5
MU3_A$9O!&I7,5XMS.FD?V/-NF@,<<17^B+XA>-M!^&>@Q^(-8T?Q9J]K-JVA
MZ&+3P;X8U?Q9JZS^(-7M=(M+F32M$MKF[CTVUN+Q+G5M2>$6NFZ=!<W]]*EO
M:R.O9[K%@22=OR[BV551A3DDX7'W<E2<';T(&`#^3[0]2\<?!KPK\5/!G[.'
MP5TS]J'P=8_#?XR>-CXH^.'[*GCK1?CU\#==\8_%&#6-1^'7Q<U.ZU6WL/CT
MI/B7Q#J,&GZ?IVA^(-2A\,0-<2:AI`BN6T/#?@?4-:UG]K/QEJ=I\1/C=\/8
M/!G_``3:^(MWK=_^S9:?"CPOK,WPN_:O\;ZQ\5XOAO\`#;0/"VE/JVG^$OAK
M8S6NH7[VWB7Q!K5@M]IESKNHZ98:;9I_5BPTTA%)CX+.@#`$-@@G.000<C<3
MRQ.YBV:@>32T9E=B=Z$ON.U0@,(W')4E5S&OF1[E4$JS`G%`'\Q7QR\)ZIX_
M^(GQP^(7PB^&/CB__9R@\<?L%^-O$OA7PU\/?$&CP^*_@SX!\1_$)OB5I^E^
M"7TZPU75;70M4;3?$NN:#:Z?+<:KI=B)[>VNX;F..XV#\)+_`.,G[1MWX\\+
M_"[Q*?V1_B3_`,%(/V<O%/@;PQKW@[6]"T+4X/"7[+VJ>#_C1\1;;P7JEG:2
MZ+X)UWQG#H?A^6^U#3;#3]7U[PUK5]'!/'>K=R_TR*;`MM3)9A@A0P^[QD@X
MY'&"1G&`#U%/6.TW)A7+$^8C'=N'R@<`$.00Q!&TX(<-A0*`/S:_8;^'UY\.
M?B]^WIX?L/"USX3\'7/[1FGZMX$TY-+?2]"N--O/AOX6.I:AX>M%ABL393:N
M+D7<FG0B"6[2;>CW!D+?D]=^'/$7@/QK\2_AO\#/!_C7XU>%?'VO?MB>,/'_
M`(,^./[+_BGPG\8/V;]<\;>'O'^M7_C'P_\`M"22V6G>,]$UCQ;?V>A>!]!O
MM$U;5->\+:MI=KH_B.X%MYJ_TG^._B7X$^%J>%[GQEJQTE/&OC?P[\._#KFW
MN[PW_BWQ7/-:Z%I2K:QS-`+R>*5/M$RQVL!YFEC##/8L^FS/EI,G)P-QV;BP
M9FX^489]K,2$W%D)+@@`'\V7BCX8?$'X&CX0>.OV>_V>[;6/&:_\$?/VD=)U
MSP8O@F>YT'Q?\3;/QE^S)>>$?"OCC0((M/?Q7K/V23QS>:?X1OKJWU/7(DUW
M3[66-KAYH?F&3PQ\3/'WQIL/%>A:G^T%\7O#^I?\,43:EXN\=_L\:+\"-#E\
M0^$OVC;2_P#%%KX/\$^$_AK\/<^&_"FC&:274_$47BK5+2U1XCXOU&VMY?*_
MKL`T\D,KD,S)$N)`6WN&C4*H).26V@@'``(/E[R6W$6F0-B;`<@,%#*7VCY0
M0F<@#/&!@=/:@#\\/^"?/A7Q'X6^#W[2UEXAT/5=$NM:_;<_;G\1Z1;ZK93V
M4^I:#XC_`&B_B'J>A:S9QSQQM<:=K&G7=M>Z=>1AH;NUGBGA=XW5C^2'P:\%
MS>.?!/[$_P`!_A-\#_B/X/\`VD?A'^U^/C-\8/B+JGP:\3>#=`\'_#C1_%_Q
M+N_%FJ:Q\1=8T?3M&\3P?$+0]7T[P_IFF:-J^JOKQO=\ULD=A+)'_3^;C33&
MTGG9B=P&</E"S\CD$@ALJV!E6,B\%FP&Q7FGV[O^]=,$EB[*8P""6(*DJ%0*
M2W=>AYXH`_F\_P""=GP@U7PQXU_9,\'?%_5?VE-+_:-_9\TOQKI/C?P2/V>-
M)\/_``\T_P`0ZCIFHZ1\0?%'B_X_67@JT;XC>!/B5K$L_B[P=K-YXSUG4O$-
MYJUA=W0DU6VOH[3Z>_;T\8?#3P+_`,%"_P!F_P`1_%CP5XC^('ABV_8E_:TM
MM,\/^%_AUK_Q0O[?Q;J?Q:_9ATC1=8NO#7AS2M;OH;(V^HZCX9CUV>P@L-,O
M?%,%G<ZE:+K&3^T4M_I`N4C-S']LDC:6&+.)I%3!+K&5\Q@"R[V48`(WG&*^
M._@WXL^#/[2_B^;]IJT\,:AI?Q)^#UW^T-^S+HU[J-]^_DT#1_B3X>M?B"MI
M:6SK!=Z;K/BGX7^&K^VN)5$]LEG'$^QY74@'X"/X3_:I^'?P:\%?L[?%#PO\
M</AUX:O/V3?B"?!&C?!S]G[PC\9_'OQ!\9>.O%WCW6M/^!7Q"^)7C#P!\4+'
MX8Z1\/?"&L^'=+U.RTQ?#-Y)$VHR:?XMT]]-B!]!D^%_QBM=#^#/C[Q]\(_B
MCXM^&OPY^*'[`7C_`..7A&#PEKOB#6?$7A#PG^R-J_A;7;^3PI!'+J?C"/X<
M?$^\\/:]XAT:UM=1NX;O1BTUK-<0[*_H-_9[^/?@W]H+X.^'_C-H]E?^'O#W
MB#6?&&CVEIKL\$=W%-X,\;^(/`5T]PT3+$%N]4\.74UJ@9F\B:$L=Y;'I_C[
MQMX3^&W@;Q1\1O%=Q-:>%O"FAZGXCUNZ@A>::#2M(M)[V]FB@!CD=T@AED$6
MY79_[K$T`?G5_P`$YK:\U/XC_MS_`!$@^&/CGX9^!OB?\;?!GB7X>V7COP+J
MGP]O?$'AV'X3>&-,EURR\-ZS;V5Y:6=S?6LZ&.[LK*[C=3'=VD#@+7YL_$/X
M?^,]-T[]I7X-0_`SXJZ_XITC_@H__P`-5:MH&A_"SQ%<:?\`%+]F235OA]K=
M\WA7QA;Z,GAWQ/,39WQD\%6VLC5M0O\`1KS3DTR>01PO^X%K^UEX!N/B=\'?
MAUIT%XUK\:?@GXA^.WAWQ3J$EII^D67@S0;SP-;+#JD<TAN+;4+]?'VESPK(
MJPQQQ3K++Y@4-]-7^JZ!IL27>I:G:V-O<-$D5Q>726MO,T^%@C2:9XXB\QQY
M2;P\C8*A@5-`'YI?L&>']>UOX[_ML_'+2?`?C7X:?`GXT>.?A-/\)?"_C;PA
MJGP_U+4=1\#_``JTCPO\0O'5KX(URRTW5_#]AXE\16T-G;/?Z787&JMH#:NL
M+07T4TOY]_M#_##76\;_`+;_`,$KSX'?$?Q%KOQO_:G_`&9?BOX#U+2_A/XD
M\1^$?%'PIT7Q?\&X/B#*WCBRT*X\,VT>FPZ5K<GB'0[_`%.&[>U6YGDM9X#*
MR?T=1ZMI4<CVHO+=)HC!OA:6,2(UV^RW#)N++]HD98X"P`FD=(XB[NJF"UU?
M0[VZO+>SU"VNKNRF,>H06\ZS2V-QY:L(+I$9C;3%"KK$^UF4B0`H=Q`/Y[_V
MW/V8/B_K?Q\_::N/@M\._'NF?#B\^!__``3U\7:X/A;X4T&ZF\<3_"/]HC]H
M/5_B?X?\%:-XGT#7?`OB[XAZ+\/YO#%ROA;6M`UJWU6QDT+2]4TO4+2\MK9_
MO3_@G7X&\/:&/C[XQ\.:Q^U5K[?$3Q]X>UO6]?\`VF?A'X'^":ZWJ^G^$=+T
MN:Z\!>!/!/PE^#-K:Z5;PVL>G:]J$W@FU&H:W;W<T%Q=)BY;]&(/$GAV>VGO
M[;5]/GL[:62SN[V*\MY+6UN(&`EMKF=9#%%<0.ZK-`[":%I469$+@5/I6M:)
MJUM)=:-J5GJ=LMQ-:R3Z?=0WD4=W;,8[BV>2!WCCGMY`8[B)F#P2`I*$88H`
M_GT^'7PF^&GA7]HW]KK6OV@/V7?VJ?%?BOQ/^VGJ_CSX4>*_`OPL^.^L>`;_
M`,'77A/X5V?AW7VU7P?':^!KFUM_$^D:U<7M_J,CM#!:.;V3[)%%$(/#W[*'
MC>]^$'P,.L_`3Q%=>*HO^"P^N_%7QDE]X&N7UR'X/ZG\9/BQ"_C37I+FR^W#
MP&_@O5]*=KR^+Z4=%N;$LS0"!A_0'<^,?",&MVGAJZ\1:-;^(M0MY+JQT&;4
M[.'6+RVB;;-<VVG/,MW-#$2#)-'$T:`JS-@YJ2/Q?X5.MR>%X_$&COXC@LTU
M&;P^FI64FMQ:?*6$6H3:8D[7L=C*R,J7LD*VS."OF[E8``_FSU/0[SX#?&O]
MG"[^(OP1\>:IH4?[<O[>'B7PQ\/]!^&VK^)M?OO"&O>!/!4FC>)/"7@>TL);
MS5-!GN9+^^CN=)MIX66:]N[>)P)67*LOV1/VHO'7@/\`:7G\*?";QU\,X?VD
M-+_X*(>.?@[X+\26+^&=4^'WA_XK:O\`LGVG@?P/XNBL;B.P^'_B+XFWGPZ^
M('CFU\*FZM;K3&U^_ANRMS9WZ0?T+?$30O@C>>+/`WQ(^)%SX;L/$OPE3Q%K
M/@[7O$&M6VD#PS#XIM+70-=U%)+J[M[007]O%:V#3W!>-9-D:%9GP>_UCQ_X
M)\/KH1U[Q5H&BIXFO+?3?#SZKK&GZ<NMWUW&9+:TTIKNYA_M"YN$5FAAL_.E
ME5'>-&1&8`'X"S_`37/VP/B5\.M%\-_`/XJ?L[?#;PA^PQ\7/@A\8_$GQ*^&
M.L_"N#_A8'C?3_"%I\/O#GARWUJRM!XTU#X7^)?"USXVT_QUH,&IZ-I5W!IE
MSI6M7-Y>LL7B6F_#3]HG]M;]E&3]OJ?P[XPC^(OQ@^*/[.^NWO@CX8Z;X*\4
M^-+?]GS]G^%-,\0VGPRT?QMH?C#P;XGGUGXLW7Q'^(VAZ)K'AS6=&\6Z"WA<
M1:1?,+"1_P"ECQ+K_P`/]0TOQ)X7\1^(=%AL[NRGT'Q%97&NVEA<6T&N:=,O
MV2YD^V0W&GSWVG22S6;%X9WBQ<6[?ZMSS7@B_P#@I\)/`6E?#_P;K/@WPIX!
M^$.B^'/`EGI%MK6F0Z7X)TG3=*M+/PUH5^S79_LHC24LA81:BT,]U`T,J>:9
M=[`'\\GC#]GOXA:IXV\!?M!?#N?_`(*.Z_H?AGXWVNL?&G7/%/[,_P"S]X.^
M*\L>H?`3QE\-?"/C[X3_`+/FK_LN>%O"?B^'P'>:SI?A_P`:W.I_!3Q#X@ET
MK5[C5O"-_<WOAZ6:/]8OV#?AQI?@KX1_&J73=*_:EO[?Q]\1O&/BV^_X:8\(
M>"/A=XU\6:CJ&A:;IEYJ'A'X?>!_`GPHTKP3X>UR/3H(K"RO/`OAG4&OUN;Z
MZ@4S^?)[/\;_`-L/X9?L^KXQU+XE+K6D>%/!WA;X?^*I_%T-OI=QHNKI\1_&
M&N>"M%T'0]VK0WM]KUM?:'+J=];-:P6XT6X2_M+JZ%O>PVU[1/VQ?@-K_P`;
M;WX":7\1/#=]XWM/".C>,X9+;6]`N-#U.PUO5;K2+32]%U2WU:4ZKX@%Q:2R
MSZ3:VK3P6I28L0P``/Y]9OV<?VF]>^&OC+]F;]FKX;_M$?\`"AQ\!/B*LGA+
M]JWX*>'/AKXU^%GC*QU_0;_P=\*/AO\`'G2M#\-:C\7M/\=0+XL\.ZU-?R^/
M=*TSPVFDW%YXTN);B)[O]1_V/_"OC/QE^UQXX_:&L/@3X_\`V<OA6?V:_A?\
M&Y_"7Q#\)OX&UGQ?\1/#?B'Q)KFJ:A;^&)EAE31O!6FZI:^&-,\2HEQ9^(H]
M[:;/-86T4\OZ=:)\0_`_B6?6K7P]XL\/:]<>'+HV/B&#1M9TW59M!O5$A:SU
MF*PN;B33+M?*D!M;U(9\QR8C(CD*^$^"?VI_!_Q!_:7\;?L\>%$LM>7P3\*_
M"OQ,OO'&B^(-+U?1)Y?$_BGQ7X5/A98-.6<V^JZ3<^$[J>^::^W#[0ML;6*2
MVE9@#\<O^"@?P]_:V^*7QT^.GA1_AO\`M&>*/`YE_9_U#]FR#X+>%/"$7PBU
M&PTKQ1HFK_%#6_C5XR&GOXRU#Q-I&J6,L6F>&6U:*UC\.)#>:-I5Y<W&HR0=
M9\/_`(=?&_X9_M?>%;/]G/X2_M*>&O!?CK]IKQ)XU_:=\&?';X;^`-;_`&?=
M.\)ZMI>N7'B;XI_!7XX?V8OCK0O$>KZ]_96K>%_".C>,-=M;J]U"6PU+0?#N
MGVMQ$OZP6'[5?@I?VB_BM\`/$\NF^$9_AMX4^$?B*T\4>(/$6DZ=8^*[_P"+
M=UX^MM.\-Z197OV2=M5T[_A`[B0Q13WDNHK?I]G@C^R3,_O2^/\`P4VE:QKI
M\4Z!'HGA^XOK37=9EUC38]*T:ZTMVCU*WU74&NA::=-I\BF.^BO)H'M'^2X6
M-@0`#\Z_VM/"_BWPU^V'^S-\>;'X.^.OBMX'TCP!\4OA;XE?X;^#4\;:]X8U
MWQE>>&[KPMK>LZ29H'A\.036-VT^L+YT>D31^=<B"!Q*?C;]DOX*?&_1-/\`
MV(_V=?$7P#^(_P`/?&?[)WQ>\>>-/B_\=-3\/V=M\._'N@1Z=\6M-M];\*>.
M8-2>Z\6WWQCG\6Z)>:EH1@.HZ*FI:H?$MK;/IT0N/U\^.O[4?PI_9ZB^&%Y\
M1=>BTW3OBQ\0-$^'/A>_BN='^R'6->LM1U"WU34;G4-4T^&V\-VEMIKOJ6K0
MR7*VOVFRS$PN%(Y;X0?M@?#?XJ?$'XQ^`3K'AGP_=?#/XOZ?\)_"]S?>,O#T
MS_%:74/@=\'/C>NO>"+2.YBFU2QBTGXPZ7IQBTTZIYC6#WR7!M[NW%`'F7QU
M^$WBSQI^VQ^Q;XX7P/+XE\`_#WP-^T]:>+]>N-/@OM(\-:UXJL/A)!X4-['=
M1NB7>JMH^M1::P()CM[[$@V;#\!^$_V:/VB?`?@K_@GGJ7PW^$5QI?Q&^%?[
M-O[1&C^+%UC2[.&PT+XE:_\`!C4K'P5IWCM)6CCN8M7\:?8K<IJ$KQRRLJ3K
M&@V1?N)-\5/AK;^+(/`5QX\\(6_CBZMWN[7P=<>(]'@\4W-HD,EP;N#P]+>I
MJ\MMY$,LHG2S,6R)W+!5)KYT_;*_:TG_`&1?"'@_QM/\*?$_Q*T3Q3XST+P)
M++X;UGP_I3Z/K_BN^ATKPM!=1ZW<0O.FLZO<0V"26RNEJS^==&*%6D4`_&+X
M8^`/VBI;/5/'?Q`_9?\`VK?C9XSU3]C[XR_"7X@^#_CQIW@K0?"?C7XR>/OB
M%^SQ;Z;X/\$:#X?-GHOA+X:6<VE>*O$%[XI?2K73X_"EK?7^B7.LW.CWELO8
M>`_V0_VB?@W\/-(^`GB_X7ZE\3O&^B?M(?LO?%^]_:-\-6^LZY9>/O".@W&B
MZ5K6@ZK>^(-0U3Q!IMQ\(!I4VGZ?:W][);WOA%[#5T$6I3:OYG[LZ5\:/`I;
MP]H_BKQ3X0\)^-]?FATR+P-J'B_P[)XBB\2G3['4KOPO%8PW_GW^MV-KJ=A+
M/:6<,LIBNK>X1#;W-O))NZC\5_AEI'B>R\$:I\0/!FG>--22.33O"%[XHT.V
M\4ZA'*':.2Q\/S7Z:O>1NL4C*]O9R(PCDP3L?:`?C'\!_P!DOX@:%X*_X)DV
MGB;X,3V>H?#'X[_M"^(/B[#?:!I?VGPQX9\3>!_VC8O#-YXF,N)3:ZEK>O\`
M@P0LWVQGU&?29]S21VL\?`?"WX,_M%_L\^*-3^)FG?LW^+OB(?!GA_\`;G'A
M?X?6MG:6$'B"]^(?QB^'>L_"W04D\V]M[+2?$%O9WFJRW$-E=/:Z)8:E=P:9
M/<QQ6DO[G:3\:/A'KS>(UT+XE^!-:?P<&/BY-)\6:#J3>%@DTUNY\0BSU";^
MQBDUO-&RZA]G<-&1M.5W9\WQ_P#@;;VUU>3_`!@^&,-I8ZI::)>7,OCWPK'#
M:ZQ?PBYLM)G=]67RM3O+8FYM-/?;>75NIFMX)4VD@'X*VG[-'Q2UGX._#K7_
M`/A5G[26C?&+PY^T'HW[1'[5_B;1?`OA[P+XQ^+'B+7M%U/1=1C^"]E=WGB"
M&ZT'X6))IVD?#_PG<VT4UIX5TC3_`#"NJ7%]-/\`J+^P3\,-/^'OAGXKZEIO
M@/\`:!\&?\+"^+FH>-]3F_:-O?#,GC3Q-J]UX8\+Z3>^)K'1?#*QVWAK1KPZ
M,MFNFW=II^H7-_;7FLRVJQZ@CU]EZW\2OA[X:US0_#'B3QOX5\/>)/%$SV_A
MCP_KFOZ7I6M^)+B)0TL&@:3>W4%_K,T0(,D6G6]Q(@92R@,I/90S1SQK+$P9
M&Z$$']5)'ZT`2T444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!7SG^UIXHC\&?LY?&7Q-/X3U/QU;:1\/?
M$5U<>#]'UG5_#NH:_"MF4EL8M=\/D:YHR-&[O<:GI)-_96R37%LCRQHI^C*X
M#XG?$KX?_"3P7K?CWXI>)=#\'>!=!M3/K_B3Q)<QV>BZ;:2NEONOIY%=5CF>
M58MNQ]Y;;M8$B@#^1#4_&/BVU^&/[;>C_"KQ?'I_@7Q)^QO\&/'5EIG[/GC'
MX[:SX.\-?%"U_:$;PUJT_AK7OBC=WFK1?$&U\.36MAXEU;PJFE:=JL=AIT]_
MIKWUG-<C[U^+GP`\:?"[XF?M4>$_V<]>^*L2?!GX<_`/]K'P!H&N_$OX@>,K
M7Q/\1_`OB;Q'?>/M)FUWQUK^MW4\_P`3?!4.K:)KUF]Z^G7&HW6FWQL[4V5E
M);_I[X-_;[_X)[>-_$/AWX>>"/CM\$M>\0^,M2L/"?ACPSI#VSOKVHZGJ8BT
MW0[.`:5';O)=ZK.#!:OMB-U*)N&<O7U1\6/ACI'Q?^&GC_X=7FHZCX7M_B)X
M4U?P5JWB+PV\%CXDM=%UBTGTR^&FZCY3/;SFRN;F.UFP_P!F:;SH0'`(`/AG
M_@GMK^O?'S6_C]^VEK%YK\/A+X^>(?#WA?X`>%M2OM1.FZ!\`/A)HX\-Z-XC
MTW1KB;[+IE[\5/B-<_$?Q_<7D%N+S5O#6H^"FN[F2.RL[>U_-7XE_"?XGZG\
M-?\`@I-^T!X&U'XZZK\;/A_^T]XY\&?"VWTSXF_%'3K'P/\`!O6/%'@+2?BY
MJOP]\"Z#KD>@7'B"/X6ZAXZU+1?$D?AK6O$^F:C:VTWA=HKVWMXG_HO^'/@'
MPQ\+/`7@SX;>#-.M])\*^`_"^A^$/#FG6R*D5EHGA_3K?3-.MD5>BQ6UM$ON
M02>3FN3\:?&?X/\`PL\:_#CX=>+O%WACPMXX^->M:MIGPX\-7DT=GJOCC6](
MLDU+68M-BC@,=Q=6=BT=S/+=2PM*I$<+S3@1$`_F$U)]3T3P_P"*(/A[\9K:
M']E#Q?\`%#]G'3?VB/!G[/GQ$_:+\<1?#+P#!J/B$>-?&">-OB#HNC>+M!G^
M(.ES>'=.^(UEX7NFO7@TQ]6U5K6ZGNKB35T;6/A)\*?VH)?C!\"[WQ9X?_9-
M\&_MT?LBZ]XF\76-Q\2M0\*VWP[O/V)?VF?!%_K%]?Z[<:AJ^K>`X_B9XJ\*
M6UT+M[[0]+U.ZTZ]6"U6VMWM_P"J]-&T.PLKRVMM'TJWLKMIY[VTM["S@MKN
M2Y)^TRW,$<*Q3O<;CY[RH[39/F%LFN9\&:Y\-_B'X7.J^"+[P9XL\)74]_HK
M7?AJYT/7O#]Q/H5[/I.H:8T^E/=:=*^EWUG/875DS%[&YMY;6:&&6)XU`/YG
M?&GQ&D^)_P`9O&WB[Q)X@^)5U^PIXI_;BCN?BUK-M-\0=!T._P#`EI\!]#3P
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M6UWJ_@M+^PMXO$&E:>EG=K-J_A)M3LK>VC\TSK;2([`'X3^#Y/AQJOPD\,P_
MMOZ_\2-)T>']A[P//^SGJ-KXA^*'AO7U^(TMQXPMO%FN>"Y?!EUIVI3?&*V\
M0W6@1Z?)=(^OI#%H:V:?9EK>^&GP8^*'QLM?BCXA_:]L?B==_&7X;?\`!+3]
ME;QR+:3QCX^T"QT[]HRQ\)?&N[U[QC<:)X=U;3=!U3XEIK-AILNK74UM>WEC
MJKW4<,*?:%>3^G2?1=%NA9"ZTG2[E=-F2XTX3V%I,+">/(CFLA)$PM9D!(22
M#RW7)VL*MFTM&:5VMK9FN(U@F8PQ%IH5W[896*YDC7>^V-RRC>^!\QR`?FK^
MVY<>*]2_X)2_&J\TY]?F\;7G[).H75M/I7V__A)G\0S_``\262:S-D%U(:K+
M=/+M-N!=&:1L8<FOS@_:!^"$>K>&/VU?VA_L/Q%F^,OPI^+/[--Y\%_$UEXD
M\>)<^%XFU'X1IXCF\*^'[/4QHTUIJEI<ZE'XB=-)N6O85N(+YA!$RC^DUX8'
MB\AXH7@V>687C1HO+"E=GED%-@4%=NW;MR,8XKS;P7\2OAY\1-:^(_ACPO?V
MVJ:K\,?%47@WQ[8MI6H6B:7XD.E:?K<-A)+J6FV=KJ;+IFHV%RMWIDNH62><
ML(NA<12Q1@'R_P#MX1:WJ'[-VDG2AJTVJM\1_@7>3+I*WG]H2P1?$KPE<:F`
MMEMN1&;59WN\$*(!*),1[Z_&S1O@*VF_#+PC^TQ;Z3\4+/\`:#T7_@JUX'\-
M6/B^3Q1\29=3T;X,>)?VM/"_@[QEX;TOPRVK-H6E?#O6?A_K&L1Z[;6>B0:3
M?64USJ-_-(IN+EOZ(?'7QN^%OP_\??##X8>.-=_L7Q7\8=1U32?AO;W_`(?\
M12:'XAUW0].FUFZT%/%D&BW'A#2O$<NF6UU?:+H.LZ[INL:_%97YT*SU![&Y
M6/U2X6V@@:1H("@=&PRQJADDE10Y++M#;V#;L%BW(RV*`/Y<;;2K&Z^"'[2>
MK26/Q%3_`(*T7_B7]JD7MY87GQ*'C2U\+R?$[Q7#X7T[PW/#=IX4G\"Z;^SZ
M/#*_#*V`GTZRO%@N=%AC\0,\B>4_%KPG\-9[3Q+I_P"PMH7CVR^%>L_L6:K:
M_M56&@6OQ'M-.N?C5:?&/X%/\*]<NX=:VW]U\>Q:#XL0:MKNF1S:XOAY97U:
MX9(=/`_?3Q/_`,%+_P!A+P/XCU_PWXE^/'@_1O%7AS6-?\+Z]IDNB>+OMMGK
M'A34KC3-?TQY8_"Q6Y_L?4+>YBO9+:2>V@:-Y1(T;+(WO/P%_:1^!_[25GXM
MU/X*>*+3QCIG@W6]*T;Q)J-IH>NZ3:P:SK_A'PWX\TI(9-=T72!J8O\`PGXL
M\/ZJM]I_VNW7[8;.>=+VUN;>*E)<KC;7H_FK]-K+OO\`@'\^O[0_[$'PP\*^
M)_\`@HUX;\%>`_'VF^%OA5^RMX;^-/P$TK1?&OQ:NM-\._M#GP_XSOKWXB>$
M('\37TEY\2KO5-%T26ZU99;_`%.:["2R1R7%Q++<>:_%#P;K?CGXO?&#6/C9
MXM\,^`OC;JWB[X2ZM^S]\2_'?@KXV^)?C#X4\":=\-/AE/X;O?V>]:\*,/#.
MB>'IO&*>+W\7>'4CLY==\:2^+G\;6][I\^F"+^M+R82S,8HBS@!VV(68+T#'
M&2!V!SCM0T4#%2T<1*'*ED0E3C;E21E3M)&1C@XZ5('Y:?\`!2KP!X$\;?L_
M_`K7/B_X/LO''@[P9^T9\"_$?Q+FNO#6H:K#I_@N[U"70_&FK:AI%E#=ZE%H
M[V^J)'JX2*4V.GS/)*4A@DD7\/?VGK/X::UXV^*5W^SY\`_A+\)Q\(V_9S;]
MG'QII'[._P`3_%7[0GCSP)I^C?#V^T7Q'\)OBK#JV@V/P2\`:#I-U>^%;C2+
M>RULW[:'JT^NZ'OU5IC_`&'LL;*494*,"&5@I5@P((*G@@@D'(P1D&F^5`"?
MW<62`#\B9(484'CHHX`/0<"@#^:CX:>#KC_AK/P#>^+M"^+%Q_P3SM?VC/$G
MBOX2:%JFC73>$K;]LC5;#PE]AUCQ)H2H?$/_``HC2_&MU\3=7^$2:EIMOX5T
M/XO746K2S2:=;^!ELOO+_@H[8?`*^^,'[)2?M+>'5\5_"98/C]+K/A^[T37O
M$FCZGJ,/A/PBVD1ZQH'A_?-JUI#,9)8[:]M;RP2[6UN)(1-#;NOZS".$8(CC
M&TY!"+P1CD$#@\#D>@]JX+7_`(;>&?$GCSP'\1M4BGD\2?#>W\5VOA>9+J>*
MVMH/&EC8:?KZW%HDBV]VUS;:99K"]PCM;%&:':7;(!_)S?>#=;L_AM\$/@]\
M3_V?O`+_``ON=8_;A\4_LY_$_P#:G^`/CG]I'5?AO\&]:^-4$OP1^$/A/X>Q
M:]H\VA?$#7?!/]B>(/"GB/Q;K6GW7A'POH.E:?I:>8KZ?'[?XC\.?''X8^&/
MA]X%^&_]O6/B_P#X*?\`[,_@7X!S:A):7.F:O\//BMX)%CX+\>_$N]L)&:[L
M+[2/V;]?USQ-]MO!)>-K?P_L[22[^VW<#/\`U*;(LYVQ[L$9VKG:3DC.,X).
M2.A)S7BNO_`+X?>)OC-X'^.VMVU_?^/?AQX9\4>$_!LL^JWSZ-HFF>-+C3)_
M$EU::#YXTQ-:U)-(L+-]:^S_`-H)I\)L(YUM99HI`#^:K]H_X=P:)^T7J?AS
MX5_L^_#[X2>(?@!\;?V6O"/PKU[1/V?/%OBS]H+QY\*O".C>`-!'C;1OVC;7
MQ/8:;\/?AGINC?:_",O@W3M$UFVU0Z+J]UK<5G=ZE/+)';?"OX7W6E>--/\`
M"/PF\;']OR7_`(*)ZSXU^&7CJU\&^-+?Q%X:^&^E?M<-K&NZK9^-I8UT;P_\
M+M6^$,OC1_%VD6%]9:'XILM7U`:MIVI7MU!+7]87EQ'`*QL0-HRJ9P,9`&.G
M`.!QP/2EV1#'R1CL/E7H,C`X[9(QVR1WH`_D.T7X8^+;CP9^S5_POKP'X&O_
M`-GS1?!_[3-EHUA^T/\`!/QI\;/AEI/Q7UW]I_XFW\UYJ_P_T;4M.31O%FH>
M"I[1_"/B[4[&:2UT^XE_L6>WGF,[_L7X3^#.I:U_P2;O_@KJ=[=?'F\A^!'C
MWP]X6N/$WA+5K.]\10Z;+X@7P!;+X<\:&\UOS]%L(-&T[0KK5VFU.8:=8ZD+
M@W$B3']9MD.W;MCVCG&U=H([XQCBG`)V"XQV`Z?X=:`/YG_V??V>/V5OC?\`
M&G]B+PY8_LT>#W^%^B_LF?%I/C?X6NO@W'X+\&:C\?K"?X!6VH3_`!&T!_#V
MD:5XO\5S7D>MW0U#7[?4I;O5-,76(Y[C4-*L[FW^8O"WPB\>ZS\/?V7(/VF=
M*\.7'P;\-?LFZK\+O`-Q^T=^S;XR_:7T+PO\0--^*_C3P]JR)X9MO&?A:Z\%
M_$*3X>Z9X/M/"_C?5X-0U-=%LKJ'1[JQ5Y&G_K[*1;MQ6/<.-Q5=PR1QG&1E
ML<=SCO0!$Q(`C)'4`*2/J!TY]:`/Y@O@#^QSK_B5OVM/$@T_Q1\4?C/\*/V>
M?V?9_P!DCXI^-M'\:>!I'^*NG?L\7.G:)XSTCP5K6OSZ/:>)]-US3]"T]M2U
M<ZOX@T?[!;6$VI)&#&WS4_[,?BRX^%,EY\$+JS\.?&;2O@''X4^+OPX^"_[)
MOCWX&_%GXA>']5\2_#^Z^,FG?&KXMS?$7Q"GQ-^(::/9>-#9Z_>V`U_Q'JVJ
MZS-I=S&VH"(?V)`1#)`C&#@D!>"3T)'<D]/4^IKC/&WQ`\'?#K3M+U3Q;K.G
MZ)9ZUXATCPII4UY(T:7WB#7IGM])TJ!HXI<W5],C)"K!4)!+N@&:`/Y??CS\
M'/`WBBY^/DO[%OP-U;P)^S=XB_8_\">#?BYX3^'WPMO?A=X0\4?';2OV@/"M
MQX0GT[P=IVE:!#J7COP_\.+CXBQ>*/$VGV!U'^S[S2;;4M1FE@LEC_6/]DCX
M+:5\!OVROVRO!WPS^'<7PU^"-_X1^`FM>$]$T'1VT;P5J'C%_"U]9>*]<TR&
MW6&QN_$-Z]I92>)=24MJ=_?JMYJES/=R&4_JBAC>-7V*%90V&4`C(W8(/0\Y
M(^M+F(#?F,*.=_R@`<`G=T';G/I0!_+M_P`%`M"^)'Q#_:<^+%QH7P3\*^#O
M%OPX^(_[+E_\./'VB?L]:GXY^.?Q@\/VNO>'-2\2>*-"_:"@U>SM?A;X*\&?
MVCK7AS4=#T;2K^\O)+74[B\N8(;P*?2OA-\/;;X:_MM>#T\)_"+PM^T3_P`)
MS^U/\3/'/B#XG>.O@7XG\$_M2?L]CQ1X9\;7^H^*]8^,NHI<:=XX^'OA^:SM
M/AYHFGR7^F7%YX<U;PU9Z?;2-I=NR?T?A(MJE5CV@94A5VX.>5P,8.3R/4^M
M(IAW84Q;L!P%*;MO*AL#G'4!NG4`]:`/P[_;2TO]G:Z_X*'?!F3]I;X9:5\5
M_AS:_LD^/;N#PMKWP\E^*>BMX@?XCZ=!;ZA/X*;3=9L;K45MI+BWTN^N]-EF
MLI[F06,UO-.[M^:'A/\`9@^-5KX&^&OA']I+3-#\)_"BZ_99\3>!?A+IOQI_
M9;\3_M7ZO\/3K?[3/[1/B&+PSX;T^P^+'@B;X3_$33_@;J?[.-M!J-Q%K.I7
M=OX0M-'M9=+B\*7-G<?U-W?P:\"7/Q<TSXYSV?\`Q</1/!=_\/[#6FO+DPV_
MA+4]7AUV]T\V37'V/?+J$$<RW7EB:-5\I6\LE3ZR3$>\;$KN`RI)3D`^ZGD`
M].30!_-KX!_8TTC7=4_;=\5_$KX?>(?C%XK\&?LJ_"S0O@+\2/BAX-U"QUC5
M/$>D_LQ7&@S>)_#OA74]2U:WTGQ_<:G!::=J6J@W'BB"18]+GUB>%1"W1:;^
MP/\``JX^/?P<TR]_9=\&7OP^\0?\$^/%&J_$*QU/X?6-UX5\0_'2SE\#+H/B
M;Q_875A+IWBGXMVT>M^+;C3/%7B6+4?%EK=W-Y>VNH17<;2C]V;#XM>!=3^)
M^N_!ZRFU"3QOX;\-Z/XKUBTD\,^)+?1(=$URXNK6PEM?%MQHL7@_4[PSV4ZW
M.C:;K]UK-A&J3WVGVL,UM)-CZ%\>?A_XB^.'CC]GO3)=1?Q[\/?`?@WXC>(%
MDL-FA_\`"->/-2\2Z5H,NGZJ)'AO;LWOA364OK541[-$MY'++<*5`/YR=>^`
M?Q-\<_L.>+=$\3?"3Q7XQ\6:+_P3Z_88&FZ5XH\-3^(?$<?C+X6?M%_M':WX
MJM=*CUJ&[OI/%^@^`M4*.ELPU5M+UN*PC9H=0\F3T;XO_"7X<W?Q;_:!\4?L
M]?LZ:9X2LOBW^Q3J7A#]F+6O"?P-LO"$&A?M`V&J^*K:ZGT%M,T+2G^'?CB>
MTU"U73O%@.BWVV6&XBU-5@#+_2F);5D,RR6YB0<RAXRBA#WD!VJ$/J1M/H:\
M>^&/QQ\"?%?Q?\8?!GA--0;5O@EXOT_P1XUEO;%+:R?7=2T"P\20#2;E)91J
M-HNF:C:-)<@1A)V:'8=FX@'\SFO?LP_$/7?AAXDU#X$:DOAOXKZ%^RMX]^#F
MK_"WX'_L4>)OV7M5\4>%M9U+PC<:MX2^*'Q%U'XP>/$\1>,]"E\-ZG_P@)-M
M;:E+KNM^)+RQOHWUJ[>7]'/V#?`WPYT+]LWXD^)?@E\!=5^"_P`(KC]D/X#>
M#=/%Q\+F^&EGJ7BSPSXR^(_]M64T1T[36UG6M*M+BP@U74ITEN+B5EDDED#*
MQ_:<26;,L8>V9V+,B!HBS,CL'*J"22CJP8@$JX8'!!IX:V4JP:`%F,:L#&"S
MG)**0>6.TDJ"3P3C@T`?SS?MM_![PIXL_:._;FN/&O[,_B+XO^*_B9^RY\%/
MA]^S?XKL?A>?%\ND_$R-OC:ES!X4\8RV5RG@+6-*U75?#&LWFN6]UIDUG!MF
M^UKAP?/1\#?BWHWQF\-?\$^O$#7.J>"_VM[/]GO]J3X]26M\LJ>'?#?P;L+?
M2_VJ=$U&<,)X;'XS_$#P1\&?#DTUN436KOXM>.YU^6RU*27^E<W-BH:0SVJ@
M@.SF6$`KN*AV;=@C<"H8G&X$`YKRG3?@Y\/K'XK>)?C9:6%K-\2_%G@SP_X$
MU+Q)-.]W<KX*\.:GK&KZ7H=A'),T5CIW]J:YJ%]<K:)&M]>&"XNVGEM8"@!\
M4_\`!2[X76'C+P5^SGX@G^&,7Q$T#X5?M2?##QQXWTVV\)V_B^\T[X=6FF>*
M=+\17,>AM:7<]YI<<VHZ0=2L+>"2.2WABED@=+5=GYW>/OV8]!\3^'OVY/C7
MX%_9V^S>.M1_;,_9,\6?L^^)(/AO;Z-\0-$^%GA7]GS]BYXH?`4CV5IKGA3P
MQH>M6/C6RU/1-'FTVPM;ZQURQOK-C:S1+_1ZUW9*R*]S:AI0/+5IH@T@)(&P
M%LN"<@;<Y.0*>TUL'"/-`)"VP(TD8<N%5]@4G<6".K;<9VNK8PP)`/YH_"_[
M,OC*;XNSZ3\8SJ?ASXIQ?MM:+\;=(\7^&OV3+CQE\0/%.EZ+\6-*\0^&M6T[
M]I*V\86TFE>"KOP9`?!WC(2Z48=$\#WOB+1)[&6TE<-^AW_!673_`!%XC^`7
MPS\*^$/!GC/QMK[?M"?`WQB;#PCX;U#7YH?#_@+QWI/B/Q)=W@LHY$M_L^DV
ML\\$4S!KJ5/)@#RE0?T#\`_&'X;?%#6/'^@^!O$$&NZE\+_&.H>`O'%LNGZK
M8MHGB[2H+6XO]*W:IIUE#J7D07MLQU#2)-0TQ_,\N.]>19$2+PA\:_AKX[\?
M_$KX8>&_$,5_XY^$$_AB#Q_H36&JVKZ#+XQTZ]U;PVHU"]T^WTG4WU'3K"ZN
MBFB:AJ3V"HL.J+8W,B0,`?@M\??V:M1\?>$_^"G7QDLO@/?:U\7=;_:'_9X\
M6?L^>,=0\#0/\3+;PUX4\'_LY:H\GP^UBYM6\0Z':Z5K^F^*DOX='NK,I>6V
MJ17BR!)UKT'P[\)K31F_;-\%?&#]G;7O&'[4GQ6^-?Q9\4?`[XR7GPK3QBLF
MB:MX8M;+X*Z[X:^)TME>2>#].^'$V+3$.IZ:_ARX2YNX4C^W.S_OO%):3;S!
M);R[6_>&)HY-K<_?V$X;K][GK7@GCK]IGX1^`M7^*?AC5-8N;_Q9\'?A1>_&
MGQGX4TS2;]M2A\$6=EJMY#<Z=?:A;:?X9U#4]0_L:]MK'2X=?%XLZQ-?)8VL
M@N0`?@1XS_9\O_%/A;X#Z;^SK^S3XO\`A?K?PM_8^_:!^'/[24:?#4^!)O$D
M_B'X.:?X>\(?#;6K^.&Q/Q'\0S?$ZST_Q+I<QGUD6IT:\\0QS12ZCY\OT-JO
M[!_PRN/`/Q#TY/V4?`Y5O^"6>@^%_#]O!\,_#"RQ?&[4='^)5OX@MM)1=+5X
M?B5=%O#D>H:S!LUZXD33?,O6>.+;^SGB3XLZ!X=^%6H?%IM$\3^(-)TSPO%X
MKD\->$=!N/%GC>YLI[-+R.PTOPSH(O[W5-9>&1433M/^T-/*&2WDF4!V[W1M
M;L=8TS2=11);!M8TVRU*'3-4B^P:M;1WUM'=);WVG3E;FUO(5D$=U:RHLMO,
MDD4JJZ,H`/YG?$G[+_Q;\3Z_XP;XVO\`%SP]??%#]GG]E_PAX$\9^$?@/9?%
MSXAZ2WASX76</CGPAH'Q(GU"+7?A7XRT[Q\^MZQJ<4(MWUF35A>M=W1M$2V_
MI-\`6#:7X+\+Z8\]_<MIV@:-8F;5$,>IR_8]-M;?S=0B9Y&AOIO+\V[C:21D
MG>16=F!)ZWRT.,HAQT^4<?3CBG``=`!]!B@!:***`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IDF!&^>1L
M;CUX/'XT^LW6-6TK0],U#5];O[72])TRRN=0U+4;Z=+6SL;&TB:>ZN[JYE98
MH(((4>2661U5$4L2`*`/Q1_9@\?6/PI\!_\`!8[XEZQ;:WJNC_#[]K[]I+QA
M>:=X8E:+Q+<Z?X<^%7@S5[ZST&>-6:#5YX[>1=-D569+IHG"D`Y^&OA'\?KS
MQ%_PN0>._P!HB7X3_#+5/V(_"7QITFY^''Q^\;_''Q/\+?',GC".W\%:EJFN
M>)YKO[;\1M6:XTS3==^'6BR7&A>(KB<Z/)I$4EVN?WP^#OQY_8U^*OB'Q9X(
M^!WQ2^#7C7Q-X@.H>-?&?AGP)KGA[4M5UP7#V6CZMXGUO3M,+3ZFL[S:?I^H
M:I<1SAPUM;SS;"B'OK#]F[]GO2[=;?2OA!\.M-M8KB*X$%AX/T.VB:ZM]4BU
MRVF9([!1+-;:S%%JD#/O:._1;E?WBA@`?G=_P2X^+7Q7^,?B#XY^(?VFO$7B
M;1/VEM'M/AOH^M?`;4_M&@>&/AS\,+GP=I.K>!_&?A7PM]HDAU5_BM?7.O>(
MO$OC*<W-S8^((;SX>P/:0^#Y!>_G3^VPWQY_:4^._P"US\3/@A\(/%/Q+U']
ME#3_`(9^#OV?OB/HNNZ%8:+\*_C'\%O%>G?'#XB:BVE:A<)?>)&\0W%GI_@W
M6H]-65[W11/I!+9:*OZ4;Y/A9X3\8Z+XBU-/"^B>.?%\`^'N@ZU=V^GV&O\`
MB*W@%YXE7PGI]Z(8;K4H;=;#4-:33(WE2!+:\O%C14F<9'PGUOX)ZUI_BZ7X
M/7_@W4]+C\9>(-/\9MX/73I+./QQ;W/D^)K;6_[.B5'UR.Z.S53=^9=&3B=C
M@4`?BK^S/^T7\(OVMOB=^T;\0_C3^T!XN^'-G_;'[/.N?L[^!D^+FK_#"#3?
M@[\2/@Y\/O%^B:EH?A_3=6TFU\<7_B[QYX@\4>'?$%S?Z;X@:SU+2QH=NMA>
M68V?37_!(VQ^&ND?`[Q%I^@^(Q<?$S3_`(G?&73/''@ZX^(>O:]J7AZUTWXP
M^/+;2I;SP-J_B/4H?#$UT!+NU"#1=+NM;9&FO+B^9%=/T'/P"^!27/AB_?X7
M^!S=>"42W\(7+^%M),WAF*.4R11:)-]A$FFPQ2KYL,5JT4,,A\V%$=V8]3H7
MPY^&7@W7_%'C_P`/^$/"_AOQ)XLCCD\8>*-/TBPTW4]>2P\R2&;7-0@@BGO?
MLNZ9TDNI'V&25LY<F@#\!/'6B>)O&W["G_!5?7=!L]9U_P"+>N_M3>-[#XGZ
M;I$=Y-XLUCX8_#OQ/\.1=^"K6&T8:@=/N/@S#K<&F6-LNRXM=5OXX8I#?2B3
MZT_:/_;1_8F\'?LOV7BOP;XB\`_$/Q/X?^"FO:Q\)_!OPO\`$.B6GQ'\.:#:
M^$[/3]:70=:T6*YUCX365CHC)9:[JSMHLEA:6LEHZR20_94]A_9_U[]EOQ=^
MU/\`&_QU^SW^TIX+\97_`,2=%TVY^+GP5\,ZOHNOZ7<^+?"C/H$7Q+LI8+A=
M0T[4I-/A_P"$;\0-:K?:5JALK,S"WN[0&3I+3XP_\$ZO`/A3Q#\39M>^!7PZ
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M60L`?R]>"?VC/B7=:KX1^&_Q%_:#73/V9[W_`(*=:W\*_BC\5/AS\6/%^I>$
M]!\`?\,B0_%CX>_"_2?C?XJU"3QO9>`/&_QFNK;2;WQ=?>(K6]F1X]'TS7[>
MQU2V637F^,WPZ\)?$SXF?"_X:^(M)UGPC\5OVJO&LOA'XM>/_P!I_P")_P`.
M/@_I&E^$O@YX$GU67Q/\7?"/BB#QIXUN3=&2#PY83>*+B*[>&Z8W-PD,:K_0
MUJ-E^S58>*=+_9PU+PYX(36OB;X2\5^/;'X;S>%;-]+\2^&/AK/X)\*>)M9N
M+-=,.DR_\(ZWC+P5I+&Z=;Q8+VS2V5XK>4Q=O>_!+X,7^C6N@:A\-_`M[X?@
MOK'5;+1KKPSHL^DV^H:?#'#I]];V#V1M8KBU@BBC@F6,.J1HNXA%``/PL^'O
MC._^)G_!*=O&GQ%\;CQ[XW^&_P"T_P#%;3_A1XZ&HZKK%W'XC^%W[8'BOPW\
M(QX?\0:X?^$COEMM)TO1-`TN_P!5D;6K[3B+357N;B2Z5_W0^'GQK^&WQ-\1
M?$+PCX#\5Z7XDU[X3>*5\&?$;3=/6Z6?PCXF?2[;65T;5/M%M!"+Y["]M+D+
M:R7,7E3!O-#94?%7[0VG_LTZC\6_AYX*\;?%8>!_"_[-5WX._::\7?`WP_X7
M:ST+Q?K7Q!\=>(?#/P@\:^,]8L+%FO-'L?B1X8\4ZI:^&[`!-4\3V=OJWB(R
MVMK9*WVWXC\6?"+X/K!XA\3:GX9\")X]\;>'/"\>JWL=MI)\4>//%MW!H'AK
M2Y;E8HWU'6]9N_L^FV"3O)-*ZQP(0J*H`/SZ_:;(/_!43_@G#\V`OA']JP/Z
M?-\-[+"G/!R,G`R>*^$_'N@W>@ZC_P`%;?CYX=\:?$#P[X\^$W[6OPHU#P(?
M#GCCQ+X=\/6MY8_"K]G&YNKK6/#.BZE8:'XO?7+"[?PWJ<7B^PUVR718+:WT
MVVL;JWDNG_HEETKPUJ^I:?KMQIUA=ZOI:74>E:I/90OJ&GQWD*PWL=E=21&X
MMH[F(*ERL3HLJG9)N4[:\X^*WBCX,_"7X=_$'XC_`!.&BZ#X!TRU/B3XA:M=
M:*]U;R0V@L;0:GJ]M9V-Q=:C-"D-C$DK0W%PL,,84^5"-@!_/!>^./CAXQ^,
M'QNN_%?[3_PN^!7Q.\%?M=V.A>'+#XC?'3XP^&/'%E\/+3QCX6_X1#POX.^`
M>CSV_P`-O'GAKXB^%YI]*MM4O=$UW4;S4=8OI9-4LY=.B$/Z0_\`!2V^URVT
M3X`W%E\=_`WPI-C\1-3UO6?`7Q#^*GBOX&>$OCOI^G^"-96Y\&WGQ8\(ZCH6
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M2WAT>_MM0U!I?I+Q+XH_:*\)>(]"_9;L_C%XK\=:G^WUX(_9J\<^`/C+I.L^
M*;'_`(1^_P!'T#PSH'[4^O>!9M0G37/`N@>)-!L-"^(/AG1K/^S#H5UXFUN2
MTL;&Z>14_H9O_`7P\U2TL=*U/PGX<U+3])"-IFGWVAZ?>6FF[1\@L8+BTECL
MSL(`6`1@IU!&:W)O#_AYY=.NY-+M&N-.@>WTNX%JAN;"WEC5)(K.98_.M8GB
M1(W2)T3RT5,!5Q0!_,KX"\3_`!2U;Q_H.F:W^U5\.?AE\4?!W[9%GX?UGPQX
MO^/'QZO_`(Y>(O#&G_$3^Q!\*C\!;BZE^'E_X:\?^`Y$TS1/%=MX?N;*SM9M
M.\:7/B..\M[_`%!;NE>*X_!'[&'[./Q3\2?$?Q=JOCSX^?%_Q_X*U_XO?&O]
MHCX\:%\,?AAIGA3XC?$\:;/J</P^\7Z*HLXK/1(M+T6QE\AM2N6BMM6U26QM
M;.U@_I'N?!_@634U\077AS0FUU522/7I=$T\ZV&B3R8W34C9F]>6-257,KNJ
M.5QY;;:MS>$O"%YHZ:1<Z%I%SH<4GGQ:7/IMF^G0S2/([21V36_D)*\LTKNW
ME[_,DD;(9B:`/YDOV4_%?B_XX_$C]E7X4^-?C1\1?%OP\N?VI?\`@I/X'NKG
MPI\4/BKX;C\8>"?`'A;3O%'@+3Y_$4GB2R^(NH>'=#N;Y;KPJ_B'6YM?TW36
ML;1[\1J4?1^`GQB&J?$CX!>&?VK/C?\`$#PY^SEI?P]_:7T;P_XJ\1?%?QMX
M`TC7?BQX)^.VJZ!I6B>.?BCH_B'P_K>KZUH?PR%A'X9T_P`1^*9!J:O>7HM]
M1U*T6XC_`*6+3P[X.TUK>>RTC2K*2&6ZDM6MM/M8)8+B[A$=_+;^5`KV\U[;
MK''>20^6]S'%$DI81@".7PAX'U"U2PN/#NAW=A]HFNET^YTBQFLS=3.S37@M
M)[5X?M#/([R7003,S,SR-UH`_F:^)'CKQ1K_`,1_B]HOAC]JCP-\(_`%M8?`
MK4/V4/B!\4_C5^T/IWC_`%+X2R>!?"FH:7XL\`^$]$NO[#^,,OB#QDWB[2-?
MN_&-MXB\0ZNL=B-;#V4MK-/^JW_!1_Q9>>%?V-?#/B*_\?:WX,LYOCW^Q%I'
MC#QQX7U_6O!FHIX-\3?M3_!/1/']R-9T2XT[6-+L-=\+:IK%KJT4$T+OI%_=
M6<Z-%++$WZ&7/A#P'=R6,U]X>T"[ET^**'39;O2+":2PAM\>3#8M);%K2*(J
M%CBM_+C1EPB@@5YC^T-\"/"7[1G@+3OASXLOM9TW0-,^)/P>^*`FT4Z:D]YK
M'P9^*O@[XL:#I%RNJ:=J-M+HVKZOX,L;#7(5M5GGTBYO(;.[L[AHYXP#^=OQ
MG^T9#X0\1?'*P^%OB[Q'XS_9*\;?M&?!CX?_``Q^,/Q'^,?QQA^%/PK\;#P'
MXCU#XF:P?B9H'BI?'FM^`%OK?2]/&C_\)++X8O/&&H+;RS1"%@NYX-^.WQ/^
M!/PPL_VL]%^*_B+XN?#[X5_M.?M`?L\>+=+TSQ3\1==\#ZYX$^+VA>"M4^%V
MMZ-H_CW5M9UN^'@WXTS>&K#0-:U::]U:Q\)>)?$.FV-^=!N+>"/^E<^%_!::
M-%X>E\/Z(NC>9YL>DKHMB-.$N6;S%LELQ:B0.6(E$(;<05;=@U\Z?$'X._`_
M]JC1O#GA_3/%1O?"7PE^/.F>*?%?A?P)>>'1X;\1_$'X-:P2_@/XD6\^B:HU
MW8>'O%5MI<^MZ%97&C:H-2T.PL[F_6TAO+.X`/P^^*7@'XI^$[;XJ^'?B-\7
M_C?<^-_AY_P2+^(_[1=T=+^,?Q+T6VTW]H.Z\0?%_P`3)XAC@TCQ'I_VF[\%
MWT&GZ3H&GW/FZ5;6NCV$+Z=<6]M:10]!\6;WXP?"?1$O/@!XU^+5]X\^*?\`
MP3$G^+OB:&\\9^,_&=WJ?Q(MO'GP7EUKQUINF:QJ6JII'B4>'O%?C:2*#PC:
MZ7%!;SFVTO388[73X(/Z.KG0?#<\D\M_IEE<3WNERZ1>2W%E'-]JTJ8R-<:9
M+))%)OL97N)M]J7:-S*X(;<Q,RZ-X>@D@FCL;.*XBL?[+M95M8OM$.G'R@VG
MV[F(R16;&&(O;QE8B8XSC*)@`_ELUCQ/K-U\*O'VJ>!OVMXO$FE>+_B#_P`$
MY/"NJ^!_@W\2?CQJVJ>#;[7/VROA[X;\9>)K[QK\1=1O-9\->(O'G@[Q)<^%
M?%WA#2-2MK66UT0WEWI4,UW=33^P?M(^%/#7PU^/'QH\$ZOXH^(-C^SY\.O'
M/[$?Q"GBU[XI?%37-/\``9U[4O&&A^-/$5OXHU;Q=?Z_H=I<Q1Z6^JW-MJT<
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M\`Z1\;OV8_%GAGQ!-XC^/,/P&\6W%]\/-?U3Q5\);CQAJ^O:A\1=%\#>*I[*
M6[U#5],UZRT.^U[1K"-D,6HW%I<?T]:;\1?A#+\&]'^*$>K:1I7P;U#P+9>,
M;/6=5L3H?A^S\#W>D6^K6U]J%GJ%I:#2;%-*FBFDM[^VMGM8V>.6*)D*)N:7
MH?PP\1>'M,N])TKPOJWAG7-,TO4],DL]-TZ?2M4TJ[MTN=(O;=8;;[/<6LEK
M=I+92H"GDSAXSA@:`/@?_@GU\6X_BQ^R1\4/$EEX2U/P1%X;^(OQ;\(V5VGQ
M$\;_`!+\)^+1X7TC2HH?'7PK\8^.[NX\27/P\UQY`-"C\R"RMM1LM7_LR&*T
M:,G\@?@M\2=.\1_#[_@FZ?@5\4_B;XP_:WU7XF6-Q^TA:1_$#XG^*(+3X"VG
MP^^*EU\6'^)NDZYKFH^%-+T"TO)?"LW@U_LEF\7C`Z9+X=<74^H//_3MXQN?
M`G@CX:>)[KQ#J6C^!?`&B>'=4DUW6KE[#0=&\-:%%8R_VAJ<\\L,>G:=:V-I
MYDSSRP_9X0FZ12BD5\K_`+.MI^S3^SM;_`+]D;P-XAN_$/B#4_@=XI\<?#77
M=4TN+4M5\8?"[X>ZOX*TO7/$&J>-=!T+2_#TDJWGQ+\(BUM&^Q3:I:WXN;&S
MGAL;N6$`_*RZ\,:)\-]%_P""</C#XQ>.OB]:_L^?%SX7C6/VD/$WB#XM?%Z^
MT76/BG-\*/#MW\/X/'-P/$\L?AGPHTLNOI%IFEPZ'H>HZFEK_;D&HWJQS/Y]
MX7^-OQM^!G@+7_VD?!H^)GC[X0:C^T7^V+^SS\"+/5[GQAXCU.[^"/C>ST'6
M?V=?%:Q>))+S6M3\/Z)\=/"FO>%?!'B/6#<WD7P^\91#[;<:<8F'],=[HWA_
M4--ATV^T^RN]*58HH].GM();()"H2!!:O"T2I$H40@(JH`"F,`B4:7H9@ALO
ML-I]DMO+^SVIM8OLL(B8/"(8C%Y<8B=5>,1JJQLN]<'<2`?S"_%;PK\>_P!G
M^S^-?@+2O&GQ5U2[\*?LI_L)ZC\6_$^E:UXMU/Q(=$\2_M0Z_<?M5^(_"=W;
M7-S>VFL_\*_U#Q6EQ?Z&(=9TWPW;1/ILUM-8Z?)!Y]\8[_2K'XE_M3ZM^Q#J
M?B6Q^$L'P_\`V,M&\8^+/#:?$_4+&T\$VOQ@^+,GQ>'AK56N?^$NN?#UGI6H
M:?+KD'@K4,1+)K#V4R7AU!V_J^FT_1KEKF::VMFFNK?['=3M"@FN+50X%O*Y
M3=+;KYDF(FS&-\GR_.V?&?B)\3/A)\%KWX=:3XFMTTN3XN>/=&^$WA"#3=!F
MNH-2\3:_!?7FGZ=??8;.2*RT^18+V62ZNT%C'([^:Z.^"`?SIZO<Z;X=U3X3
M3R_'N/QI^Q]XH_:G^'EC^TWH7P.D^,VE^"/!/AQ_@C\;D\+P>(-9U/5+WQ!I
M/@SQM\5-/^&4/Q)TWPYJ=II4<^G:>_B&)!K^HF[_`$O_`."8"^`I?&/[=\WP
ML@OX_A;=?'G01X'OKT>)O)U#0[?X8>'+!KC3;SQ:3K=YI<=W;74-C<RR26I@
MB46#FS6&OU,M/#'@^VLC:6VC:3#87K,\UI%86R65RS;"?/MEA%NYW1(06CW9
M3J,L&U[+3])T^.:'2[:ULS+$J-'9P109VH8X04BC5!Y:X2,%=J*`H`48H`_E
M+\+:[X2\1_"#0+7X6^*?B#J?[>__``\*^-?AWP@=(\3_`!+OM3T7P/I/[<WQ
M+EU*#4K.2\D\&:?\.H/A)!=VGB*!K./2+D2W"WHDU=BX^F;/XM27?B+]CGX$
M)JGCI_BGX-_X*0^+]8^(^@"P\6@:)X";P;^T-_9S^+=:N+3^RI]%U*ZU#0+O
M0[":_N(+]889;6$)8JR_M;\!OV=_AO\`LZ^$;WPAX0M[^>"^^('Q4^(TFIZ_
M)9ZEKBZO\8/B3XJ^*/B:WCU&ULK5H],A\1>+]5@TZV"!K>PBMX99;AXVN)>%
M^(_[2GPE^'7QK\&_!:#PIXV\:_%+QDOA[6[RS^'7PP\0>-3X*\.:_K\OA+1_
M'7Q$US1-+ET[PAX7_M9KNS_M?5[I#:VMOJ>H&`:9I^H7<`!^&_P[^$/A+2_^
M"=/['7Q%\7_$36OA[\3_`!/,+GQ=J_QA3XP^-O`7CP:!JOB^YM_`WQ2T[3=2
MN]0\+>'9%MTO]+CTNTTVVN-?MK5KFWOIKMUF[']GG]HVT^'GQ+\!_%#XM^!O
M&GP&\"?%/]@J7P;\/_"]K8_%#Q?X7O?B/X2^/OQ"N)M.\)1ZC8ZCK=OK'B?P
MQK_A[Q%X4TW78++5W\-7`L4CCM=,,%O_`$9W6G^'GL8[._LK%['.U+2:TMY;
M;*N615A:!HB"PW(`F&(W`%LD_'OQ;_;$^!?PI\2?%'PMXTM]:FO_`(&:3^SY
MK_BB"Q\-17T-E8_M)_$?5_A5\-)]'F>9$G?_`(271KQ-=6W6WETRP$5T@D)5
M:`/YI_BOX]\::S\`[GPKK$5Y\)_''P__`&)-(\4_"_Q9JWPT^*WC_P",_P`7
M/&K:5XMU:.P\`Z]I7B#2]'\`:CX)U33+2/4]8<W^JPO*+C4(YH8XTE^SOBWX
M.\0:MH7_``4+^,C/\0I/B7X`^,_[&FJ?"77K'7O&\%QH,=W^S'^R?/XNF\,:
M':W\.C"35]7BU2+Q3<V>E3OJ$JW=IJ4SJDMO'^^/QC^)?PW^"L?PYG\9:9<B
MR^('Q%\/?"+PZ^F:3;WZ6WB#QC;:I-IUM=1@QOI^E31Z3>+=7:9BA4K')#(L
MWR^N"Q\.B&=GBM3!/Y4MP\RIY4JP)&L+R,ZB-E@1(8E+9""..(_<"@`_(;]A
M[0?@M\.OVN?VQ/!^H>'HO#7QMU;XW^/_`!-X&L[C2_$=O=ZI\)-8TKPGJ<^K
MZ5>R1OH5YH]SJ%S"6F:[-S]IS;QJICE1?B_]I[PSIW@+XX_\%.+3P;I&L^'_
M`-HKXC>"_@IXM_9IO]#TSQ6OB'Q#>?\`"-^)[/XH'X>ZII40L)-=AMK.]AN5
M%W'=V5S=V#Q^1-<6KO\`TG);>'X[I=15+`7C0M$+XQ6WV@P/L)3[5Y0D\K<(
M_D$@3(0$$!0(9['P]'+'?W$-LUQ$7$-Y-!#)<1B0Y,<,\D1D0.P`"1L&=AN.
MYLL0#\?OV)K_`.$^L?M.Z`W[,:^+8_A=;_LE2+\>8KU/'UOX<E^,6J>./A_)
M\.UU.#QD/(E^)=CX=L_BQ_PE,]D6U5++4--AU^61HM,6'Q?]L#PA\*/"/[8/
M[5>M_$3PK);ZC\2/V'[VV^#NMOH/B"^A\0_%"QTCQS87]CI5_IMI=V3Z_%82
MV4<EE>RQ%K219!&RX8?J!\8_VMO@[^SWXVLO`U]X8^(_B/6Y_"R?$?QC9?"C
MX7>)O'DW@7P"=7NM#M_'GC2T\+:;>7UGH^H:S9:EI^GBSLM2U749='UN6UT]
M[;2-1O++UOPI\7_@W\6?$6H^&]!U>#5O%'AKPSX,\6ZMHNI:+J.FZOHF@_$3
M39]2\*W%[9ZQI]K<V,^K6,%R7L9%COK5HYK>]@@E5HP`?A!^U7\*5^#2:=8_
M!C2?&F@Q_%7_`()I_M1ZQ\2HM*U?QGK$GBCQYX3\2?LU3^!M7U^[N]0OYIO&
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M\@BIZ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`*^?OVIO`_A[XF?`#XL_#[Q5XNM?`7A_QEX&UOP_
MJ/C&^N;2TL/#L>HPB"+4K^>^FM[-;**X:);I+F>**>"22!G'FYKZ!K,UG1])
M\0:9?:-K>FZ=J^E:E:S65_INJV5MJ.GWMI<(8Y[:[LKR.6VNK>6,E)8)HWBD
M4E75E)%`'\U_Q9_:A^+?[(?A_4O`MWX"_9K^)WQ<\/?LE_&SQ/\``;]H']GC
M3H[C6?#.D_"W3O`T&M77Q(\&V\&IR^&O#.K6VNZ1K=A+8:M+X>U35/"LFGS6
MS7IMY(N<\:_&W]L#X)^`?%+Z=\>)7^&WQ.N?V=_"Q^)/B+X\^`OC/X\^'2?$
M7XCVWACQ]\:-`GT3PMH%CX4\$W/AN[B73[G4K6]T/1->OK22.=4@*G^A;X?_
M`+.OP&^#S:]/\*?@W\)_AF_BB-$\3#X?_#OP?X,?Q($+$?VX_AO1M,.JJJM(
M56^6X6-9K@H%,TCMSOPY^#G[->DIX^TKX7_"WX+Z#%JVJWN@?$NS\$?#[P?H
MUKJ^L"VMKR_TSQE::7I4,&LWS6^I6UQ<PZJLTDB7<<LZL)0&`/R"_:,^"?@J
MP^)?[$6BV_[7_P`9?&OAUOVJ;Z._U[4_C'X:U+6?AQ)XC_9O^*E['=V_B>UT
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MEMIAO-3:TF:UU2:S>9S"X25@,@`_&'X4:W\9/VCOC=\'O@'K'[2/Q@TWX=:7
MI/[<?AN7QCX,\3:=IGB7XP>%_@Q\??#/A+X;>*=0\5VNF2I>7FF:%>-X:U#7
M])BA_MZYTJ_N6:)KR55^\?V1=0^(O[2__!-LZ'XX^(6H3^/O%?@_XO\`PLF^
M)E[Y,>KB?3=6\6>!M*\4W[0BWBDU.WMK6TOKJ6,0B6XB>4"/=Q]\Z=\.OAQX
M0&B:KIGA?P1X;'@SP_/X;\.ZA9>'M!T5/"_A:X>UDN=#T>YM[:W30M#GDLK%
MY]-T][33GDM+=WMF\F)8VZ"?AOX<NH?A5X67PIH-W_8MSXP@\(:):Z=8PG0M
M1U>6WNM;31[&*WMVL;_6;B6.>Y5-ES>RR&5Y9&8N`?S%^(M1^.WPVU+]ECP3
MX<\,?!W3_B'^QO\`L8?M-17'BSX#?$-/'P\2^$_!OP+72_#6L>(=*L/#^FCP
M':^+?&VB:7K.F:+K%_K%YJ6OR:@UG<OY$TK?HOXW_9N\">//V9_^"=FG^%_C
M3\./@;J'P1N/`?Q8^']]XR@\.ZI9>,+O3O@WKWAF\MX-%UO4K"WUXSQ^.YM:
MUB<"XEF<M>WI,DYEK]3_``5\$?A+\-;#6=+\`?#3X=^"-.\1RW%QXAM/"/@G
MPSX5MM;EN1(+B35[?0=+L(-2>832B62\21W61U8L'8U\Z>!/V5?AI\*_@I!\
M*OCEJ'@'XT?"_P"'NI^()?AK=_%OP!X1>S^&_P`+EG5O"O@C5[WQ-<ZWH^JS
M^!]%9/#5KXU:WT"ZU;P_I^D0:G8K>V$VH:@`?DW\7?C-K_Q:_P""=/B;XTZU
MIW@BV^+?[+7[:/PNT_X0_$3X8:1'HWA?XA^+?"O[27P_^'MOX@\%VEH\NZP^
M(?A[Q/KG@_7-.TZ\NK;4H=2U"R$LMJK;/U$_X*#M\79/V;+O3/@O\0M&^'7B
M_5/&W@FRENM;\::5\/+_`,1^&)-?2;Q+X)\*>--7AGL=!\7>*M$CN--T#4);
M>5X[R12L:.2T<_BSX.?`[]H3XB_`"P\.?%CX>W_PM_9X\0CXFZ?^S]\.)?!M
MUH?B#QYH$9M?`/B3Q')H6K3S6WAWX<7EU<ZUHGAFQT>STV7Q7)I&M:A=7$VB
M:9:Q_9GB[P)X,\?^';GPIX[\*^&/&WAR]:)[S0?%VAZ9XCT2[:)]\+W&E:S;
M7MC</$P#HTL#`2`R*%8\`'\V7PA_L?\`:P_:5_9,\%>'?BK^T?X,M=`^#'_!
M1CP1XRUK7O'.B7WQ8M7\&?&C]DJUUCX=:=\5/#]M?:9K_AS3=3-@MGXGT66Y
MO+_0]+6PNKJWFO973CIOVAOB1\1?`VC_``FN_B1X^O\`XI?"'0OVE88_B'XA
M_:,LO@7X3L_!_P`-_C?XO^'7@SQ)X@N%\/:GJ'Q,^(UK8:'IUI_9R?8M._<1
MOJ4OG7Z^9_3AX>^&'PY\)2:!/X;\!^"/#K^%=%U+P]X:ET'PMH>C'P]H>LW&
MGW>KZ/H?V"Q@_LG2M4N=*TVXU"PL7@M+V?3[*6X@D>VA:/SZR^&_[.GC76+Z
M"R\`_"/Q!K/PY\2:G]J0^#O"FH7OA+Q7KC+KFJR[WTMWTO6-4:]75=0E39=7
MLET+NX>223S2`?S>:9\3/$_QA@3XL^/=3_MGQC\1?^"4O_!*KQKXDU1FCC-]
MKWB3]I7]H+5=6OV2%4C87E_>-.I$:(\?ENJ`&OVI_P""B6O:SX=^'W[.,V@7
M<UB^I_MO_L<^']5,)@Q<Z)XB^-WAK2]8T^9)XIE>"^M+I[>=$".$<LDB,HK[
M6MOA7\-+."&WM?`7@B"WM]"T3PI!#%X6T2."'PSX:O;N_P##GAV.);,(FBZ#
M>WMW=Z-I2XLM,O;JYN;*"":>5GZC6O#V@>(K>UMM=T;1]:M[#4]-UG3X=6T^
MSU"&RUK1KN+4-(U2TCO(9TM]2TR^@AO-/O856YL[J*.XMY(Y45@`?SCZ-XM^
M,7@K6/AW^TGI7Q@^+OB;7?%G_!3/]IO]G6Z^&FJ>+&O?AY<_"K2_V@?CEX6T
M#PAI_A-K406]S91^'[!+#55N&OH(DM[)'6UMXXJ\B\;:]IGQ3_X)K?$G]H_X
MA?M2>,-=^/?Q$^'WQ4/CGX/W_P`1=(MO#DFK)<WUOK7POM/A).\=]I3?"NTT
MM-3@33[:/5X$T*YO=1EN+.ZNM_\`4'!X%\#P6UI:Q^$?"J6]CX@O?%MG`F@Z
M2L%IXJU*_N]5U'Q+:QK:+'!KU]JE_?:A>:Q$L>H7-[>75U-.T]Q*[<S<?!'X
M,W>M:YXCOOA1\,[O7O$]C-IGB+6[KP/X9FU;7].N&BDN+#6-0FTU[G4[.X:"
M![BWO)9HIV@A:5&,,94`_#CX[?M+:GX/^'G_``5OT;4OC.?#/C7PI\5/!=A\
M'M)U+Q=I^D>)=+T?6_"GP]E2W\"Z9>7D&HR6MY<R:U,K:=;2QR2?;F1V*3!?
MGG]I#5]#^(GPA^/OQ-^)G[0GB*;XOZ!^VAX<^&/A7X(R_$RRT?1/#GP]\!?%
M7PIX4\'Z3'\,/M*7.LGQ9X4@7XKRZ[<VTEQJ-UXIM=1@NETRRB(_I=UGX3_"
MGQ'JTFO>(/AM\/M>UR2P.E2ZSK'@_P`.ZGJKZ6S*YTZ34+W3Y[MK!G"L;1I3
M;E@K&,G!I=0^$_PJU;5[GQ#JOPU^'^IZ]>V]G9W>N:AX/\.WFK75KI[1/I]K
M<:E<:=)>3V]D\$#V<,DS1VSPPM"J&-"H!_/Q\(OB7^TM\2OVB8OB%<>,?#7A
MOQ!X<_;)NO`OBW0O'G[45AX56R^%EMX@O_!Y^&NG_LW7'@B*>\UG6_#%W#K_
M`(-N6\1OJGB/Q#:Z=?VEVUKO1/NW_@IC\4]&\+VO[.WPS>?Q#;>*/B?\0-9T
M_P`.:I_PN"?X%?#RSDT'PAJ.JZE<_$;X@VUO<2?V?%9122Z9X>MS#>:KJ0B$
M3JD,A'WO\0=*^"/@./7OC[\1/#_PZT>7X=>&M9\1:Q\4=>\/:&FK^%/"^BZ;
M=7^N:A+XHFLI-3L=.LM+@NY[ITN4CCMEF#?(6!N?$R]^#UQ\.KWQA\5[+P3K
M/PVT72T\;ZAJ7C'2M*UKPWIVFZ=:#5(_$<B:K:7=K%'96H%W%?>4LD,8$B,I
MQ0!^`/[-FL?$O]I?XD_LK_"7QU\<_B-%X3;]EK]L;Q5XED^'?Q!NHX_&VK_!
MK]IKX'^!?`LEUXQM8Q>:QING:9XGOMVJ6S076M6XCAFN5M[F_CG_`$/_`&1/
MC+KD'_!,R_\`BE\5->\7>.;[X9^$?VC++Q#K]E,UUX\\0Z%\'O'/Q+\.V4MI
M<0HS3^*Y/#7A:QM[6Z56>;54CN9`SN^?T,\)Z#\.)K70?%7@_P`.^$88)]`E
M7P[K6BZ)I-JP\.>*)+'7[JWTR[M;2*6+2M<GM=-U:]MH&2WO[FUM+NYCDFMH
MI$L7%QX*\`:39Z8+?PWX6T.\U!K&RT^--*T/2KC5-;N;F[DM+:T`M;2:_P!6
MO9KF=X(HVN+^[GFE9)99)6(!_*7X4^.WQ-TN]U?_`(0;XGMX?\,?&3]@GX_?
M%.V\*Z/^T;=_'KQ5X2UGPKJGP<U+X>^)_&&I/&B>"O'::-XRUN"&UTD6UKJC
M'7BL-S'H\-Q'[;XT^'7CG1X_VX?#EE^T5^T3;Z;\%?V"_#?[4G@#_BY^J?VA
MI_QIUGX;>/M6NO$5UJ4L?VF\TFVU/P9IMY:>%Y2NB13W5_YEM,EP%3]^/!5M
M^S;J_BGQ]\./`_AKX4-XJ^&]S;V'Q(\*Z'X6\.07WA:Z^)N@Z7XLBMM=M+73
M(D@;QKX?AT?6;E9-PU>SM["6[\XV\(C]AE\)^$YSJGG^&O#TQUK2$\/ZUYNC
MZ;(=6T&.&>VCT74]]N3?:0D%S<6Z:==>;9K#/-$L(25U8`_FM^+_`,8?&'B_
MP#^TK\8?B#\>O%GPP^,7PE_9\_9F\=?LR^&-`\<#PK;>+M8\7_"FQ\7ZAK&G
M^!DEC3Q]+XT^)EQJ?@RZTV*UU#8FD6NGP10RRX?T!OVI/$VB_"+_`(*3:/\`
M$KXP?\(1\8SXV^%>I_#/P?KOB>WT'Q9867B;]F_X!ZW<V/@'P]=W4.M/9:AX
MKN/%OEQ:18RQ->KK!W`VNH-!_0%=_#WX?7^H:%JU]X(\'WFJ^%;<6OAK4KKP
MYHMQ?^'+5$CA6VT.\ELWN-)@2.**(0V$EO&J1QH%"HH$&O>#/AU<7=QXN\0^
M#_!U[JFGZ)?V$OB#5?#VC7>I6^@.IN-0T\ZG<V<EVFE3"(RW5F)OLLNS?)$Q
M6@#^=#Q6WQ!MO`WQM_:?MOC-\6H/&OPT_P""F'A_X4^#M&B\>:E'X'TKX=ZM
M\7_A7X0UCPJ_A%F.F7]IJVC^+-4CE6]$K6[M`;5(#&,_>'_!,7P+X%\%^+/V
ML[2V\9:O<?$:T_:F_:7TO4_`>M>.I-6OK'PB/BC%J^@^*Y_"-Q=M<VEQKMAJ
MFCW\OB6>S1M4M]6LW%S*MVN?TN\'S_"OXD>"M-\2^$+;P5XI\#>,)[?Q?I^H
M:58Z1J.@:_>B[BNK;Q'$T=N]I?7HOK*"YAU-E>Y6YM89EF$T*%>HL_"?A/3M
M?U/Q9I_AKP]8^*-<M;6RUGQ+9Z/IUMKVKV=BJ+9VFIZQ#;IJ%_;6BQHMM!=7
M$L4"H@B5`J@`'\Y'Q,\8?&SQ]^U=^T+J>K_&+P?\+_%/P;_:%\#Z+\*--^('
MQ^U'X76=C\--(UCPCJ-DUI\(S91Z=\2-*^)^FRZ[HL]Y+_:$VKWVI-IVFM'>
MVR1KY#<?$6V\0^#(_CEXS_:,\;Z1^U]J7_!0[6OACXE^#$?Q;O=#C\'?#GPW
M^TMK7@O0?`VG?"*+4;4OX<_X5II/AO7?[:_LIVUNVUQM7:\GL[@;?Z6OB!K?
MP:\.^+?AA'\08_!$'C;Q?XFO_#7PHF\0Z=I<VNZAXHA\/:IXAU'3O"U[=6LU
MW!J*^&M$U?4KE;.:%VT_3[EF8JFT^>_M`_LK_#OX^Z3I5AJB6WA34=/\?_#W
MQ]<>)/#VCZ1#X@U2\^'&OPZ_I.F7^I/`+BXL)IX?L\HDD=X('D\C:3B@#\A/
M$7[3$EMX*_8[\%#XQ._Q7C_X*=:CH'Q"\"6GC&.3XB3_``\TR_\`CY;7FB>(
M/#D=\^N1>'5G7PO:I%JEI%I;73:'%&7EDL8W^%8OB_J'C&WU3XC^!?%+^'_"
M_P`<O@I^VW9:]\,=>_:+\1?%7XGS:99?#;QP]FWQ/^'NJS0Z'\/+S3M4TZ>3
M3;&RL+6YTH2#1I)YVA<#^MVW\(^$+6^N=3A\-^'(]5OKJWO[W4H]'TQ-0O;Z
MSB-M9WMU=K;"XN+NU@/V>WN)9&E@B)BB=$.VEM?!W@ZRDOKBR\*^&K2;5+BX
MNM2FMM#TN"34;J[A^S75Q?216JM=SW-O^XGEG:22:']U(S)\M`'Y:_$?PS_P
MEW_!'2#1E_M<%OV+_#E[!'HES=6NH37-A\,=)OK>!'M`UP\,GDL+F!!^_@\R
M!LB3:?SN^$R_!7Q5X^\!_"CXF_M,>(O`_P"S;X7_`&,_AA\1/ACKFG?M&3^%
M]'\0?%GQ$^J6_P`8[M?'D7B*V2_UOX8_9M"L[?P5<:@\'A2TN+:6YTA(V4U_
M1Y\0_B#\//A%X8MM>\>ZSH7A+PJ=5T+PQ;WFJ/!9:8FI^(=1M=!\/:3"I3RE
MEU+4[VSTRR@50KS3Q0J!N`K8/@;P-)966GOX.\*FPL+PZE86#^'](-I8ZB\A
MG>^M+8VGDVUZ9F,KW,*).96,A?><T`?C1X>U7XK?M%?\$*M4U[XSCQ1J7Q.\
M2_LM^/\`4+R_^S7NC^)_%MOX=B\1P^"O%>IV-M%#<_;?&OA72?#_`(JU6T:W
M1+I]7N$FM_+D:.OECX;_``/^#'Q2^//[$?@SP3\8_&NN>%->_8+_`&HO%/B[
M4_!'QIO=1UT^)+3Q%^P[]O\`!4_BC3=2O=4\/:%:R7>EZY<^%M-N=.:VFTG3
MPR0VMU<PW7],@M[98/LP@@6V*E/LXBC$&SH4\H*(]OJNW'J*QM+\+>%=#=WT
M7PYH&CR2/?2R-I>D:=I[N^I2V\VI2.;2WB9FOY[6TEOF.3=2V]N\Y=XHRH!_
M+"OQ%^+GQ;C^#?@;XK_%G1/#W@31_P!GGQ*O@37?B=\>O$_P+T_Q-XM\-?%?
MQIX$O/%">-=$GT__`(3/Q[X7\.>'M"#:7J%_.L*/+K-UI]XMU)*/UZ_X5Q\6
M_C/_`,$TO#O@\?&&+Q;\<(?@;X4UC2?C1\.M>U6&P\6_$'PMIEKK>@>*M'U>
MQ^Q7.KZ/XJO]+M9[E03;ZS;:A,L\<EK<[9/TLDT#0)H(;:;1='EMK=M\%O)I
MUD\$+[VD+0Q-"8XVWNS[D53O9FSDDG2C2"!!'$D,,:C:L<:I&BA>`H50J@`8
M&``!TH`_F)\:?M/:]\<?AK\6/VM_%^G>,IO`-KI_[.7[('AKP39_$3Q1\+O!
MNB?%'Q/\1_"X^-OCGQWXGT&ZMI/#7A/PG\0;ZW\->*?%B1QWNG>$?#VH6*WE
MBFJ32IY=\'?$^O77Q!\*>`]3^(GACQOX1^'7_!47]FU_`EUX%\:^*/B'\/\`
M0[+QC\%%UW6=%\"^-/&6M^(O$>O^'8=6N)VAO+C7=3M4U0ZJFG3Q0*+6W_JM
MUJ[\-Z!H>L:MK;Z/IN@Z7I][JNMWFH?8[;3+/3K.*2[OK[49I@MO%:P0QRW%
MS/<$1HB/)(P`)'GFJ?%GX/>&_%-_X-UOQ/X,T+Q1HWA4>/=1TC4;S3K&]T[P
ME#>_V4GB>Y681^1I$-[*++^T&(CBGD\L,H;D`_GC\"?M#:Y_PK3_`()Z_#C2
MOBKJ6K_'W0_V_P#X^:=\0_`,_C*_N?'$>CZ3\%OVQWT70OB-HQU"75X=%EU^
M/P==Z-IOB6`VU^UCIUYI=M<Q:>T]II?\$^]5^(OBGXD?LK?$W5OCK\-].^)7
MBJ+Q%_PT3\/[_P#:!\4^*?BKXYU[6-'N+CQ%X;U_X&ZW>26G@/6?`/BFW\JW
ML]-T?2XM#TR$VTLMS#/!--_1-IWC7X=ZEXWF\"V5[H=QXR3PCI?Q"?3H(8)+
MF7PGK.J:CHVE^($G6+;):7FI:;J5K!*)"[/;RL!L8$]N-/TRW<W,6GV,<Z!W
M66.UMTFW8^;;(L8<$@!20<]`:`/QH_;)OO`WB/\`;S\+?#W]J/XF:S\,/V9=
M._8]USQO\.IW^).M_"+PAXJ^/<_Q.OM#\6I?>+M&USPVVK^+/!OP\C\.:KX6
M\+2ZK)OAUG6=633;P6;F+Y'_`."9'PXA^*/[5<GCKXP'QQXA\<>&OV6_A'XH
M\&^)M>\5>,]+U;6M,L/C'\</#GA#Q#XDL(-7L+;61JO@?2_#DXLM:L;W3KX%
M=4^QFYO+BYF_H,\/_$[X<>//&WQ$^'>D:EI>M^,?A'J/AG2O'VAF%)[OPO?^
M,?#%IXP\/P7@FB,8;4O#>HVFJ0F!W'V>?#E7!6I_BE\3OA_\$?!MU\0O'^IV
M7ASPS::QX.\,SZK)!\B:KXZ\7Z'X$\(Z>WD1M+C5/%?B71M)@PI2.:_1WV1A
MW4`_%_\`X*O>,]!?XC>#/A+>OX4\%ZW/\"OB[XZ\/?%+XF_$SXG^!?"UEJ.B
MRZ1:V?ASX?Z/\._$OA;_`(3;XP3WT]KJ6AZ??W=\^GV-M<31:5?0R7"5\(>+
MO$6O^-?AA^T%XE\3W]]X@\3^(?V8_P#@B/J^J:Y<6]T;G5;N/]KGQP=0NKJ1
MX@\ET[)YUQ&Y:;,R/.BR2;F_K,,%E?)'+=6=M*RE]@N8(I60AV1BAD0E=Q!Y
M&"0W/6N$^(OC_P"''PHT&TUWQ_JN@^&/#^HZ[X;\)P7VJ+##93Z[XCUBTT7P
MOHZJL3E[G4=8OK:TT^'85$\@"E"0:`/SV_X*S:?X9U/X1?L_6?C37Y?"O@V3
M]KWX,OXL\1Q:^?"@T7P\NG>-X]3O[CQ,L]J=`M(K>0K<ZM]JMOL43M+]HA8*
MX_*[4;ZR/Q"^+'@+X;_%"QU7]@"?]J;X8VND^.OB+\4?B%+\%(=?_P"&7?$^
MN>.O"UO\9=*\5V6K3?#3_A:FG>`@MW:^-O\`A&E\?:E?^&9;_+7EF?ZG)K>U
MNE"W$%O<(&#!9HXYE#KD!@'5@&`+`'&1DCN:A&GZ9Y1MA96/D[O,-N+:W\K>
M`%WF+9LW`*%W%<X4#.!P`?S7_"/X1V_CWXU_LJ?!'QE\<_\`A<GP9U.7]M;6
M["#X.?%;XAW'@HZ-I.K?`Z[\*_#C4O'$'B>76/&&E>"I-4U46EZVO7LRM(EB
MFH,D5U"WD^C:UXS^(C_L\^"OCM\2?#F@_![0?V>?B/I/@37_`([_`!/^(7PX
M\'>*/'O@KXZ^,_AG/?ZI\0/#7B;PF-9^(OA[X?\`ASPS/HEMXEU^>\NH+G4M
M:CT^]N8+BYB_I]U#Q9X(\/\`B#P_X1N[[1=/\3>)DUB3POH4C6MK?ZTNC)9S
M:TVE6Y"/<BPCO+.:_,`;R(I8I)L*0:S/AM\0?A]\9/!MCXV\#W6G^(/"5[J'
MB+3M/U`6BK;R7GACQ)JWA77(TAN8E9&L]?T35;*1M@5Y+9W4LK`D`_F5;X3B
MTLOVFO'>L?$'4/BS\3_`'_!('PKXG\*_&SP=XN^(-C::WXTB\1?M8>#;'Q5H
M<XUZ!=7?_A&=$\/6]I/=1WNGOJ%J?$MA$NL7]SJ4_;0_#SX2CXR_M,7OC;XG
MQ_!3XL_$']CK]F37_A!\0O$_Q"\8:3?7/C#6OA+KVD>-/$FE:$OB:UD\7PZ6
MFP>)DLM,U;_A$[26ZUR"'298IM03^G46=B`0+6T`>(6Y`@A`:$!@(3A?FB`D
M<"/E`';"_,<L;3M-9E9[&Q9T01(S6MN66,YQ&I*95#DX0$+UXH`_(S_@E?X@
M\*ZC+^T5X'\-^#](TRW\`>*/A]IVH>-OAQ\7?%'QD^!/Q#NM9\"0ZI_:'PS\
M2^)M1U233]8TA9/L/Q&T73=0N+>Q\036IGD6[EEC3\SO$7AWX?\`PWUCXZ>&
M++6]9\"IJW_!4O2]+_:/AT?XB>,M,\2Z!^R'KVH7NLIXEUK38?$2ZEX9^&WB
M+QX/"FF>(OB786EBJZ#J.H&[\21Z9:W4EK_55!;VMJI6V@M[96)8K!%'"K,3
MRQ$:J"2QY)&<GDY->:>+/B9\,/"5OXVO_%FM^'M,A\!>%;CQKX[EOS`\N@>#
MK.WO;R;7]5A2*:X735M]-O9HY#&_F"UE\M6*T`?G]_P3ZGTRU^.7[:?A?X/^
M(;WQ/^REX?\`$'P9F^$&J1>)]3\;>#[3QQJW@[7)OB[H7@'Q=J>HZT=9T.QG
MMO"%YJD5EK-_8:5XBU+4K*%XKC[7;P_JI7/^&=8T/7M"TK7?#CVLNA:YIEAK
M6D7=K&L-O?:7JELEY87L4>R)A%=6LD4\1=%8QNI(%;X93G#`X.#@@X/H?0T`
M+1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%>`?M2>(O&_@W]GWXP>-OAQ+Y/C3P5\/O$GB[0C]CMM0$
MUQX8L7UVXM!9WB26TSWMEI]S9H)%)5YU9,.JD>_U4U"PL]5L+W3-0MX[NPU&
MTN+&]M9EW17-I=PO!<P2K_%'-#(\;CNK$4`?S>^-/^"FG[1?V;X@^/\`P8VE
MWOPW^/'@+Q1\,?V+'_X1_3[EH_VJ?`&J?"WP!>:5J,\EOYOB5/'OC'XE>,=9
MT32KI)[1M&^$.I6]F%2[8S^G>*/%_P`>?V>_#'QX^,_A3XS7X?2/^"@OPP^&
M_B3P/>^#O!A\,>,K#QX_[/GP^\9:UJ-R=(?Q'8ZIJ<>OS:A8_P!F:I9VVDW,
M$$=M:+&9U?\`6VR_9"_9PT_P?\)?`-I\*O#T?A+X%>.=*^)GPFTAFU":/P5X
M_P!$DU272_%>FW,UY)>3:K:2ZUJ<P?4+B\@EFNVFN()9HH'BZ;Q)^SK\&_%^
MA^*/#?B3P38:MH?C+X@:/\4_$FG7$]ZD.I^/M!O/#^H:1XEE,%S%(M[97GA7
MP_<1+&Z6Y?3(-\+`RB0`_$7X4_M$?%6X^/%G^SQX.\0:#\)=%^-O_!1'_@H1
MX?\`&'Q(\,>$/"T.LQZ7\#='L?$_AKP[;?VEIUSH4WB[QK]I3^U_$>K6-[K=
M_8Z->K%<?;@WD=SJ?A7XOVG[4W[;.K>$?VD=?TSQ/\/_`-DGX5>(8_&.F^$_
MAU=W?C?Q!HNE_$G4-"_X2*UE\/W6@6^F6-S9PVU[IF@6VF'4D,T=^S+)&B?I
MEXG_`&1OV1/'&F^(OA3XD^''@[4QXD^(.O\`[06K^'1JVH67B9?B#XEOS;^(
M/B=IEY8:M:^*-"OM4O99-/NM7T.\TZU<7,^G!A'<30/V?@+]E#]GSX76?B"Q
M\!_#71O#=IXH\%6'P[\016=QJ<AU3P7ID6J166A7<UU?3SR00IK6K9NO-_M"
M9[^XDGNY9"K*`?#7[0?Q`\7_`!O_`.".^H_&V\UV70/%WQ+_`&.?A[\6-:N?
M"\%M'9KJ7C#X?^%_%^N6NG1W,5V;739KG5+J..6*3[3:V:J8KE'0R5XWIO@?
MXC7W[1'@2TT3]HWQII6KV'_!.>W\9-XTTO0/AS+JES%:_$:RFTOPO-&?#<FE
MQ:-8W317$[16<.JZDMK%;W6HR0RWJ3?K)H'@WX'?\(#<?LR:'8^%KWP/X(\`
M>&?ASJ/PLCO8M07P]\/IO#Q\/^%O#VKZ<]S-J-KIEUX>T9['36U!O-O+6PF,
M<TKPR,O+?"G]C_\`9U^""RK\+OAS;>%_.\,:CX,=QKGB;6IO^$6U745U:]T-
M;CQ%K.KSKI[W\<4T4(E`M4ABM;7R;2-8``?B7\//VR_VW_VFK3PQH_@*/7K'
MQ59_LH?!KXL22?#O4O@WX2M=7^(WQ$TS65N_%&O6OQ8F4ZCX+L]9TB*&;P]X
M;"62+=7-M<OYILEK[R_X*-ZAXLUW_@DW^T;/XZM=,MO'=Y^S%?W?B^QT:ZMK
M_2X/$$VB6CZU%IUU;RO:7FGQZA]H$,]M,T$L*!4D4.,?37B7]@G]D3Q=H7@3
MPWKGP2\-R:5\,_#Z>$_`R:;>^(-`O=`\*I+YP\,PZMX?UC2]6O/#S2C?+HNI
M7MYIL[<S6TAR:]M\1_!;X7^+?AC?_!CQ#X.TG4OA;J?A=?!5]X(EB9-#N/"B
M6D5BFA-;PM&PL$M(8H$C60%44!6%`'X8>)_!?Q;_`&,?V.?'7[0'@EOV4_"'
MC8>"/V?-+\'>)?@U\"]6\(^,K./QK\5_AEX=UM?&E]XD^('C;3/$\$^@:_-%
M=6\&D:3&U\TM\TT2+&(?1OB-\0OVG?`WQ4_:Y^&VG_M.^,=1T?\`9T^`7PK_
M`&A?#.J7W@OX=?VOXA\0>.]4^(%AJWA?7)+?PS#:_P#"&1CP''/:6&EP65[!
M-JNH0BY%O;6L9_0_2/\`@GU^Q]H6G:YI&E_!31(-+\2V>DV&NZ=/K/BK4;+4
MK/0?$&D>*M&@EM=3UV]@B33/$6@Z/JUH;9(&CN;"`;C"&B;VS5/@+\)=;\0^
M.O%6K>#--O\`7_B;X.TGX?\`CW4KAKAI_%'@[0;C6;K1M`U/;,J/8Z=/XAUF
M2V6)8I$.H3Y=@1@`_%WQA^T?^T7K7PR_X*)_&J#]H:Z^'0_9#O+/6/AEX0@\
M-^!)?"FLW4/[,?PQ^+3:-XO?6-'N=>U;2]:\2^*-1TA+&#4;0LE_";,+J,=O
M,///AW\>/BYJ/[0FC_#?1?$$WP4A_:U^/G]K_$_Q-;:?IUSXA\/W6D?LM_#K
MQI+X"\.7.NVMY8:1J^HZK>W-M+?2PS:E%:Z5<QV!2<R./T(\%?\`!,OX(S?&
M[X^_%7XS^!/!?Q,@\>_%[PG\0OA;IFHQZY-:>#=%\(_#CX<^$M,T37]%FOT\
M-^));#Q'X(N/$FEMJVF:K%9/>6[1F*:'`^L?'/[)7[.?Q+TSQ%I'COX4>&?$
MMEXJ\66/CO6OM\=VMY+XRTW3X=)L?$MEJ5M=0:EHVKVVF6\5A'>:-=Z?)]E#
MPL2DD@<`_%Z+]N/]H;X*>+_B1XO\<>,KGXK_``+_`&=/VP/B1^QUXOUV+2-$
MCG\1Z3XP^#OPS\=_!/Q;K5QH]M:V8\8^!?B]XJ'P<\6WE@+2UU*Q\017VHVY
MU2RGN4;H/QK_`&^/%'CG0O@;J-QXWOO&4'[/'@KX_P"O1>$O%?PJ^'>NP>)/
MBKXA\3W<%@U]\1K"\36/"_PZM+33/"W_``CVCPK`-2MKR7Q3/=QW%K''^GGQ
M:_8D\':S\$O!7[.GP8T/P7\,/A/;_%CP;XS\?:)'I$UTVM>'-(\8V_C3Q;!:
M2L9Y;OQ;XOU"R@AO/$FN3W5X6GN+^>ZENTC8^V?%_P#91_9[^/<VAW?Q<^&&
M@>,]2\-07EIH6M78O-/U_3+#46C;4-,M?$&BW6FZU'I5^8D-[I@OOL%V5#3V
M\C@,`#\2].^/?_!2GXC6OC;2=-2Q'QE^"?@'X/0Z[9>`_B1\%?#OPJ3XB:SX
M`T[Q/XL\0^*;#Q-;WNJ^*_"/B37)=8TFVET?4X]$TJ'1KZ/25@U&":4?J]^U
M;\3_`!E\*?V9O#/QJN=7'A[4/A]XH^!OC7XI)I<EK=Z3=_#\>.O!]K\;--DG
ME=X9-,C\`ZGXNOK*]BG'DW&GV-\)'AB=7W_$_P"P/^QWXP3PS%KW[/WP\N+;
MPAX4TGP+H%G::0-)LK?P9H,GFZ-X5O;32)+&#6?#^F2%WLM(UJ/4;&W:>Y,<
M"FZN?-^A?%WPV\">//`>L?"_Q?X7TC7OA[K_`(=NO"6M>#[VTC.AZCX9O;!M
M+N=$GLHQ&@TZ73G:S-O%Y:K`VQ-N%(`/P`\)_MF?M6>)?&/A'X97VN7NGZI^
MTI\6?!?QM^"EY!8V5G-8?LR6NK>.KOQ%X9M+HQNEU%JVB>$/`;1ZB/,>"/XA
MW#LZQ?9IC)X=_:P_:+L/A5^Q#\>4^,&I^+/%_P"V=+\1=*^)OP9NK+1FT;P$
MMK\)?B5XW&K>!-/M+)=9\.S?!SQ%X/TGP]K4MU//:ZG#=3+KK3:G<PS#]UU^
M`_PC37_`?BF'P)H%OXB^%_AFX\%_#W6+>RBBO?"'A.ZMK.RG\/Z)*BC['IDE
MG86=K]G086"WC1&7&3Q_A+]D;]FGP)\0M;^*OA#X,>!-!^(7B%=?74_%%EHM
MN=0/_"67#7?BK^SUG$UKHO\`PD]T\ESXC&BV^GKKL\DLNJK=O+*S@'X/_M>?
MM,?$;QS_`,$W/AG;ZQ\18=5U3XZ_\$V_V[O$WQ:M83IJW?B?4O#?[,EW?:7?
MW=HB^?9K9:U=ZBP:!(8GN%DC;.TH-+XQ?$CQ]\9?@_\`\%%O"_B/XT:M\.O!
M_P"S!^S=\,_#G@?X<>'I]`TVQ\9:7X]_9OTGQQJOBKQA+JUI=:CK5IJNM:C<
M^%=)M[>Y@L+7^PKSR(OM\CRU^R>F?\$^?V+=%?Q2^D_LX?#'3F\:Z1XM\/>*
M/LF@11#5_#OCS2KS1/&/AV;#?N?#_B'2]0OK34=$M3!IDBW=Q)':QS322-O_
M`!$_8A_9+^+7B#3/%7Q*^`/PT\:>(M'\.0>$=.U?7O#5C?7L'ANS@EM[#2))
M9(\W=KIL4TW]EB]^TOICRR26+V\CLQ`/E?\`:;^,_C;X!?\`!-GP7\1OAUJ]
MMX:\11>&_P!E/P?<>,+JUM;^#P'X6^)WCGX3_#;QGX]-I>*]I*W@SPGXGUGQ
M#$]VCVEM/IT5U>I):0S(?S2_;-UOXAVO[0?A_P#9?N_CMXU^(/P[\-?$?]D+
MXH6WBS4]1TB;Q;X%\4>-?B-KWA22TNO$%EI\$+17>G6\.N:%'>AY;*Y$KVX-
MM,$K^DG5/AUX(USP7/\`#G6_#.C:SX$N]!_X1:]\(ZMI]KJ?A^^\-FT6P;0[
M[2KZ*XLKS39+%%M)+:XAD1[?,9X9L^&Z'^Q)^RAX=^'GB?X4:3\"/AY!\/\`
MQK=65[XL\.RZ%;74/B"[TOR/['N=3O+D2ZC<W&ABUMAH4S7GFZ*((CI;VC("
M`#\>+KPM\0_!/Q=_X*P>./`G[07Q%T36O@M8?LO^(=)U6UN/#MY+XYUG2/V6
M_!TOVKQW<R:4\NM0E+.:":PBEMK$F\FG>'S_`"W7'M?VC/V\?C1)\</B)\*]
M4M=#UOX/?$ZT\.Z1I/B+XP?#WP!\+M`\.Z1;>&=<N8?B+X+\0^%KC4-;TSQI
MHE]J$B^*7\3V\MG;W\%_H1M3IR02?M[X/_9/_9Y\`>&_%OA#P;\+?#/A[PUX
M\TC0]!\9:/I]JR6OB32/#6B#PYH-CK!=Y)KZ+2]#']F6IGE>06S,KN[L7K!\
M8?L1_LF?$#Q9I'CGQO\``'X9>*O%>AVFAV-EK.M>%=+O9YK/PQC_`(1NVU>)
M[?[-XAA\/E4;1(]?@U--*>..2P%NZ*P`/RAU#XR?M&:;\+_VB?VI8_CIXLO=
M&^`'[<_CCP!J7P_:'0[7P1#\"O"7Q;T;1=>-^18IJNH2V/AC6I'2YGU.X33;
M2Q::")'6YE?SW3OVQOVHO$_B;P?\,]0\636%[^V%\6OA5\;O@?>&/2VN/#O[
M+]@WQB\<_&7P#;0I"894T/P%\`;"QUB]N/MK6O\`PNW2(Y+L75_I\=?O7%\"
M/A#%X4\=>!?^$`\.2>#OB=K'B7Q!\0/#<VGPS:1XNUKQC(LOBC4M;LY%:*\N
M];D1'OYG&Z9T5R0XW4Z;X%_"*?5_`VOR>`/#3:U\,]!UWPO\/M3&FVXN_!_A
MSQ-IFGZ-K^BZ#($'V#3M6TO2M/L;RVB`CEM[6-"`-V0#^<CP]\>/VE/#'[-/
MP5^.VO>./$UY^SCX4_9>\(^)_B/;?LY>/OA9X)^+'PJ\17&KZM)K_CCQ5\-?
M$]K9P>-?#UYI,<,F@:!HUW;3$:=?PVFB:C+)7T7X&^-7[:GQ:\?>*_B=X'\3
M:#X7\(^!_P!K+6OA/+I7Q"^,6B^$_"S_``H\'^.+#P];:3JWP?G^'%S?2>-/
MB%\/)[7QYX7\0+X\M]2U*_\`%6C74$5EHWV#3Q^INK?L%?L::[=^#+[5_P!F
MSX1:A=?#[3=,T;PE-=>#=(E;2]'T6Z:^T?2)2UO_`,332M)OF:]TS3M8^WV=
MA>$W5I##<$R5T_B#]C_]F/Q3\5M-^.'B'X(?#G5_BQI#:3+8>.+[PQI=QK$5
MSH%L]EH&H2F6W:UNM5T&S9;/0]7N[:?5-'M(;6UTV[M;>UMXX@#XY_X*,>&;
MOQA\6O\`@FQX>L_%6O>"[K6?VL/%VFIXL\,W%M::_I27?[+/QY^U2:5=W4-U
M!:7U[:1SV,-Z(GN;(W)O=/DAO[>UN(O@B7]I'XV:VB?LPZ;X_P#B5XJ^+6F?
MMB?M.?";P)XYOOC)I?P/TZ\^&'P;T'0/$L%S\5OB7'X,\7:EK.HZ3IOB>..T
MTSP]X:GU?79+.&:_FMX+:YN7_H?\1^`O!OB^_P#".J^)O#FDZYJ?@+6Y?$O@
MS4-2LK>[N_#/B";1M2\/2ZSHT\T;O8:C)HFLZKI;75N4E-GJ%U!NV3,#Y'XO
M_9&_9E^(&FW>C^./@9\,?%NF7WC;4/B1>6/B#P=H6JV]SX]U:.VAU;Q;,EW8
MR[]<U2&TM8-2OF)DOH((H;GS(D"4`?A?X._;H_:+^!?PP\#?&KXF^+[CXIZ!
M\:/@)\<OAAX*LK2[AU_23^V#\#_$VMW7PKT70M7M].TI]2F^/'@\Z[I_GQZ?
M"=6UOX=6MPMA9RZE+&:?BCX@?\%#%\9?$[X0:1\8?#]C\1/V8O@_\)_$E[XH
M^)'QZT[X/>&=4\3>)O#MWXD\:_$7QQX=G^$7C6Q^(_PY'B6#4?#ICF\4^%M*
M\-:':I;P,M\J:@G]`J_L^_!-?#?A;P;_`,*N\#-X2\$>*-/\;>#O#)\,:-_8
M7A?QAI-W=7VF>)M"TQ;);33-;T^[OKR>TU&UBCN8'NKC9(!-(&P_BM^RO^SA
M\=-5\/Z[\9?@C\,?BAK/A;<N@ZGXY\%>'O$E[I]N[K*]BD^J:?<O+ICS)'.^
ME3F73I+B.*XDM7FC1U`/BC_@JL]]>_L0:--?ZQ:Z3JT_Q>_9>GN-<TF:UN;.
MRU";XQ^`1/J.FS7T#6ES:QS3//:R7-N898Q$\D6T[:_//XK?M3?M.?#;XT_$
MK]F7X6_&'4/BKX$D_:0^`_PO@^,GB[QGHGAO5/"5_P#$GX3>-O'&O_"N[^+V
MG^$/%^F>%-0USQ3X?\.>']'U5_!^KZCH3^)[;08$M-0U32KJV_HB\?\`PJ^&
M_P`5/",O@'XD>!O"WCGP/<-8-<^$/%6AZ;KOAJY.E7$%WIHN-$U*VN=-G6QN
MK6VGM4EMF2*2&,JH"XKSO2_V4/V;-$^%VJ?!/2O@?\+['X1:W)=3:Q\-X/!'
MAM?!NJSWEQ'=SW.HZ"=-.GWMX;J&"YCO;F"6\@FMK62&>-K:`Q@'XR:GXU_;
MT\*W_AOX`^)?'7@YCXZ^*\T/A2&S_:UB/Q%T/PW;?"_6?$O_``BOC3XZ0?`(
MZEI]]KGBC1GU'PS:S?#TZCK&EO>Z-;ZVZVR[-GP+K/[6'C#XW_L^?L\?%O\`
M:3ET1=<^#W[=&M>)]8^`GQ/T_P`<WMU%\*OBM^S=:?#31_%?C[_A!?"L9\>^
M&=!\:ZAI7B+4;7P[H>I27$E]:2@?VGJ"2_JOI7["_P"QYHGPWU3X0Z;^S=\(
M(/AOKFH6VL:UX5?P1H=S9:OK5DC16&N:G/=6D^H7VNZ="S6^FZW<WDFJZ;;D
M6]C>6\*I&OHW@;]G/X$?#*/PQ%\._A%\._!">"M&\2^'O"(\+>#_``_HC^'-
M&\9WVEZGXOL-'EL-/@EL8?%.HZ'HVH>(O)D5M:OM+L;S4FNKFWCE`!\J_LZ_
M&CXI>(?V`HOBW<2S?$/XL^'/A[\:'TWS+<37_C/Q#\,?$?C_`,-^%5O;>S`-
MQJ6OGPII4-^;=5-Y?W=PZKNEP/R#TCXR?MF1_LM^(_VEI_CKX,MM)^)O[*_Q
M%\9"Z@_:NU3XE^,]1\?6V@67B71]<^%WP@NO@9\/-"^%5]X$U`7VE^*O#GA_
MQ1KUKI6G3SV^I+=WNFB8?TS>&_!?A7P=I5MH7A+0=)\,Z%9/>26>BZ!IUEI&
MDVLFH7]QJM_);Z?806]K%)>ZG=W6H74B1![B]N9[F5GFE=SXS8?L?_LK:7X@
M\:>*M-_9U^"=AXC^(]EJ.F_$#6[3X7>!X-4\:V.L7+7>LVOBB^CT);G7(=9N
MF^T:S'J,MPNKSA9M2%U*BN`#\+OVI$^*'AOP-\:_A)?_`+0/QB\>^&?CE_P2
M?_:#_:`UVQ\5>*8KZ?2_''PZT+1]3CL?"LEI:6TFD>&_$]GK%[H7BGP];!K/
M6-%N)+&1%6:5FK_MN:%)IWB/]ISX7Z-\:_B%\0O"=O\`\$[/B!\3GUK5O&MO
MXH\0MK,'QC\`2QZ;-XEMXI+UM`M]`O9/+T9I_L8TR_>9HS%.LA_HDO?A+\,]
M1O+;4;_P%X0O-0LO">H>`K*^NO#6B7-W9>!]62"/5?!UI<3V$DEOX6U..UMD
MU#P_&RZ3>);PK<6<@C0#A_`W[+7[./PQLYM/^'/P.^%'@2PN-'U3P[/9^$OA
M[X0\/V\WA[7+J&^UO09DTS1K;S]&UF[MK6YU33)C)97TUK;27$+O#&R@'X'_
M`!<\>^,OV8_#'Q%^(7P"^(VO_$;Q1IW[!W[--S_PF7C3QN?%5UX$T/QO^TQ<
M:)XWUIM>_LCQ3_86B_#GP/XAUKQ):2OX>UV/PUI^GK?OHNHV\9MY.EU?Q]^U
M_P#!NU?P_P"+_CQX*T'X5_%CQ=\`_"]SJ>D?M<:I^TG\6OACX>\<>)=1TWQ/
M\3[#QYXJ^"_PJN?"?A#Q+%#H^@:'>SV>JZ;:ZWJKRZ;>V;M`H_=CP)^S5^S[
M\+K#4]*^&_P3^%'@/2]:TZ]T?6=.\(?#KP9X;LM7TG4;F>[OM+U2VT?1+.+4
M-.NKBZNI;BQNUFM9WN9WFAD:1B<3PO\`LB_LM^"-%\4^&_!?[.WP1\)>'?',
M$5MXST'PW\*?`>B:-XKMH)1/!;>(M+T[P_;V6LV\,P$D$&HP7$,+@-$B,`0`
M?`/_``3KB\+Z=^U/_P`%*]*\*?%#4?B_I&F?$W]G"QMO'VM^,+/QYJFK36O[
M-GA*WU"TO_%5I-*FJW^AZG'>:)="29[JR:Q%C=A)[>11\5_ML>,=&^('@?\`
M:.UCXA?M+Z[I'Q!\%?MP?`/X;>"_V=&^).F:%X8G\'>&_P!IWX%RZ)>GX7&>
M"[\2W^HZ#)=^-%UNYM;N6-],_M2VDCL[)R/Z$/`?P:^%'PL2^A^&/PX\#?#J
MVU.#2K;4+3P+X2\.^$K6]AT*S_L[1H[N#0=-L$N4TK3P+#3DF#I960%K:K%`
M!&,;Q#^SO\!O%GB>X\;>*/@Q\*O$?C&[BT^"\\5Z[\//!^L>)+R#2;ZSU32H
M+K7-2T6ZU2>#3-3T[3]2L(9+IH[/4+&SO;=8[FU@DC`/R"T[]JG6;32/B]X'
MU[X^I8_%O2_^"GVH?#;0_!^I>,;"S\<P_"B7Q)X7O]'\,Z5X>N;B'5YO"<_A
M;5EN[5K:SELI=,N!,DLD)\RO%[W7_BW>?L;V7[2FO_M!?%77_%M[^VC\&O@U
M!X>U/Q!I\_@O2_!MU_P46^&7@B[\C1EL!'<:Y/X06]\-/KE]+/J4>A:I>Z;'
M-';.BI^]E]\`/@=JGC.7XCZG\'_ACJ/Q#G.GF;QY?>`O"EWXTF_LI8TTP2>*
M;C2)-<<:>D4:66;_`/T5458#&J(%UI/A!\+I/#<7@X_#[P8/"<'B"V\60^&5
M\+:"-!B\466OQ>*[3Q''I!TXV$>O6OBB"#Q';ZPENNHPZ[#%J\=RNH1I<``_
M#^^\6?&'PCX?^&7[1=C\<OC'K_BS5_V]O$GP(F^'^I^-9Y?AMJGPXN_''Q%\
M/VGAF3P>\0TN.XACTW3)++777^T;22WA7[4+6%8Q@?L5_'FX^(OC#]@_QMXD
M_:N\8^*OVBOCKXZ^,5M^TC^SO?\`Q*2'3O!,GA?X3?&W4]3\'S?`N*Y#^"--
M^&GC_0-`T:RU"YTRR>\N$L;F>[O)-6MO,_>>X^%OPYN-/M-+G\">$;K3].\1
M?\)AIVGW/AS1IK*Q\6_:I[W_`(2BSM'LC;V_B(7=W=78UJ&--2^U7$UP;KSI
M7D;X]^&O[&'B[P]\=M%^,_Q'^,UGX_3PGXA\9^*?"NA:3\(?!?P\U"37O%>A
M>(/"MIJOCCQ7X>N[C4O&USX:\*^+?$NAZ/\`;K:S`_M-M1G+W2@4`?.G[>O@
M+P7K?[9O["6M^-_BCXY^%N@7.B_M*:+<>)O#?Q1U/X96FF7-EX8\$:Y:):Z[
M:7MA;Z9J.LPIJ,6JN+F&;6]&TF.TNC+::8`GQ=\&F^(GP>^"W[&GQF\"?%CX
MGW.J_$O]LSXH_"/7OA=>>+)9?A1<>#M9^.GQSTZ32++P4$32M.OYM0TNVU%M
M?3&IOJ,\CS7;1;(U_H:^(?PD^%WQ=T5/#7Q6^'7@?XF>'([E;U/#_P`0/"F@
M^,M#6\2.2%;H:3XBT_4K`3B&::'S?L^YH998F+1R,I='\*/AI%IF@Z+%X"\&
MQ:/X6UV7Q1X;TF/POH*:9H'B6XO[S5;CQ#HNGKIXM-*UR?5-0U#4IM6L(;?4
M);^_O;Q[@W%U-(X!^&'["7Q%_:`^(GQ/_9^^*_BW]H'P6ES\2/%OQ.\+_&;X
M6>*OVA=9U+Q'K5]I7A+QQJZ?#OP/^S=J/@G2-)^'7C3X:>)-`TG5=1BTC7+F
M]L_!6E^*Q>/J*7_VL?:G[5&G^*_B#^VA^S;\$[;XN?%'X=^`?&_PA^-NO>+-
M+^&?BZZ\'W^KW_A27PN^CSOJFGJ+^VD@%_<KYMO+%(\)>#=Y4DBM]T6/P,^"
M^E_$"[^+.E_";X;:;\4M01H]0^(]AX%\+6?CN_C>(021WGBVWTJ/7[E);<"W
ME674&$D&(F!15`[.]\*>'-0U[3/%%[HNEW'B/1K2]L-(UZ;3[*76=+LM2\K^
MT;/3]4D@:_LK6_\`)A^VVUM<107?E1?:(Y#&FT`_FQ^"O[0'C/XY/\&/#W[2
M_P"T]\0/A%X-L?V`+7XM^$/&&B?$H_"B_P#BM\9?#/Q;^)/@+XF:SK/B&VN+
M%O%>H^!/"WA;X9:S=>&!NM6F\=:AK%U8W".HAX+P?XO\3>*?A=\?OC]\4_C)
M\1/"/QVUO_@FYK_Q$\$:9??$F_\`!]A\0=;TOP9\?M&T#6$^'T]Q:6/B:!M+
MT?3/%D&F0V%Q:6NMSOK<=I#)(#7])&O?L[_`;Q3H'ASPKXF^#/PJ\0^&?!]Y
M-J'A3P]KGPZ\&ZMH?AJ^N)6FN+S0-)U#1+C3]&NYYG>6:ZTRVM;B65S+)*TF
M&&GXG^"7PA\:W^B:IXQ^&7@+Q5J?AK3-1T;P[J/B/P?X<UN_T+2-8T^XTC5=
M,T>]U/3+JZTS3]1TN[NM-OK&RE@M;RQN)[2YBE@EDC8`_&+X"_%;4OB;\;_B
M#9_%WXY^*?!7B;X.?"O]E_7?V>_A='\1#\.O#OQ&T/Q]\([#Q!XC\?7WAXWE
MDGQ.:[\:2:YX<N4N%U.ST)M&2T,5M/=[6\B_9+^(G[0'Q+\5?`SXU:[^U'\/
M?#GC+6OCA%X:^+?P]\9_M":]-KGB/3;G5=:T#Q1\$;3]FFZ\/VF@>%?&6G1Q
MPZCX2CTV[&IV%YHJ:A+=7EAJ%^T_]`6H?!WX4ZOJ_A/Q!J_PX\#:OK_@)43P
M-KFJ>$O#U_J_@Q(HC!$OA34+K39;KPZL5OB")=(DLQ'"!&H"E@8!\$O@\/',
M?Q/'PN^'O_"RHE*)\0_^$+\-?\)R(V7:\7_"6_V7_;WE.``T?V_9\JX`P*`/
M2X23&I/7OGN>OJ3CT/<<@E2"9::JA!@>N><?0#@#H``.^`,DGFG4`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!7S_\`M5?$'Q)\*?V</C=\2?!]S;V?BGP-\-?%/B?0+F[MHKRVAU72=-FN
MK.2>UGCF@N(Q+&NZ*:*2-P<.I4D5]`5XI^TC\.=4^+WP"^,/PNT2ZL['6/'_
M`,//%/A33+S4%D:RM;W6M*N+*WGNA"#*8(Y95>3RQOV@[><4`?BK\;/V[/VN
M/V*9?!NO_%GXA>#/VC])^-?[&?[0OQ[\-^'="^%EK\-+CX8?$OX'>'_AAXCT
MRRE.C>(M9U'7/AEXLM_B+<:3J<^KW$_B#3-3TJ"XL-2$<KVM<MXC_;`_X*-_
M#3X=^.-:UO4?$&JV]]_PH'_A#?BC\4/V>?#_`,*=#T?Q]X_^-/A/P+XI\"Z3
MX=TGQ#XA'B7X>WVB:ZUWI>KZE(WC'3=.\P'7KK57@U)/UB^&/[#/P%\*:':3
M:SX#T_Q/XKO_`(36_P`(O$^L>+=1UWQDUQX-U#3;&+Q3X0TH>*=0U(:3X6UZ
M_MA<ZEI>G):+J!M[1+XS1V\4<>W9?L*_LW6FD3:!/X(O-8T22;PO+%I7B#QE
MXXU^QT\>"O$&F>*?"T&EV^L>([V*PM]%U[1]/O[1+=%D)MHX)II;=1"`#\F_
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M:"Y@6+4+>\B22&[3:H'`#]A;]F";0O&WAO4_A5HNO:9\1;+PYIOC*7Q)J7B7
MQ)K.L6/A"];4O"UN?$.N:U?Z[8IX<U(1ZCH@TO4;$Z=J"M?6QCNY'F8`^-?V
M%M*\:>`?VR?^"@&D_&3XLCXL^+[#PU^R`=1^(U_X5\.?#[^T(+K0?C(]G:7/
MAWPW*/#]E=6;RR6J/I\=L+N#[*TL#W*33R_L''(DJ!T.Y6^ZPP01Z@C.0>QK
MY'LOV%_V9++3?&NE)\-XI[;XCW?@F^\=37WB;QEJ.H^)[GX=7-_=^#)-5U>_
M\0W&JS?V!-J=[]B1;Q(O*G:"5)(%2-?K&RM(K&U@LX%"06T:PPH"Q"11@+&@
M+EF(1`%!+$X')-`%JBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBCIUH`**C\V/*K
MO&6.%ZX)Y.,XQG@X!.3VJ2@`HIK,J#+'`SC//4_2HVN(%94:5`[@LBE@&95Q
MN91U(7(WD9"`@L0*`)J***`"BBB@`HHHH`****`"BBB@`HJL]Y9QRB"2ZMXY
MV&5A>:-96'JL;,'8<CH#U'K2->VB*SO<P(B`L[O(JHBJ`S,[,0J!596)8@`,
MI/#`D`M457%U;%#()XC&%#&0.#'M*A@^\$IL*D,&SM(YSBI8Y8YD$D3K)&V=
MKH0RM@D'!'!&0>1P>W%`#Z*@DNK>')EFCB"D!FD8(H+,%4%FPHR2`,GG([4L
M5S!/S#-'*,$YC8,I`8J<,,@X88."<9&>HR`344A(`))``&22<`#U)/`%0FZM
MUY:9%&0-Q.%R6V@;C\NXM\H7.2>`,T`3T4BLKJ&4AE(R".01[4M`!14,]S!;
M+ON)HX4Y^>1@BC'JS8`]!DC)P!DD"H)=2T^&W-W->6T5L"@-Q)*B0_.VU#YC
M$+ACG!SC:"Q.T$T`7:*IG4;!6*->6P<$`J9HPP)QM&TMG+9!7CD$$9!!I;2_
MLK]&DL;NWO(TEF@>2VF2>-9H)#%/$7C9D\R*56CD7.4D5D8!E(`!;HJI=W]E
M8+"U[=6]JMQ<16EN;B5(A-<SMLAMXMY&^:5OE2-<LQX`--T_4M/U6UBOM+OK
M34;*=0\%Y8W$5U:S(<@-%<0.\4BY!Y1R*`+M%4X-0L+JXN[2VO+6>ZL)(XKZ
MVAGBDGLY9H([F&.ZA1C)`\MO+'/&LJJ7AD21048$W*`"BBB@`HHHH`**R=3U
M_0]%6%]8UC3-*2XFCMH'U*^MK))KB5MD4$3W,D2R32/A8XU)=V(503Q6L""`
M0001D$<@@]"#W!H`****`"BHUFB=WC22-I(SB1%=2\9(!`=0<J2"#A@."#T(
MS(3@$GH.30`45SEUXP\)V$FL17WB70;*7P]I]MJVOQW>K6-M)H>EWGVHV>I:
MPDTZ-IEA=BRO6M;R]$%O<+:7+0R.L$I6QHOB7P]XCBEF\/ZYI.MPP2B&>32M
M0M;]()C$DZQ3-:RRB*1H98IE23:S12QRJ"DB,P!MT444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!7S;^V/J^KZ!^R;^TEKF@:O?:!KFC_``1^
M)FIZ/KFF7MUIVH:1J5CX1U6YLM2L[^QE@O+.YLKB..XBN+6:.>)XPT3JX!KZ
M2K@OBG\/-$^+GPU\>_"WQ)/J%MX?^(?A'Q!X,UNXTJ:*WU.'2O$>F7.E7TMA
M//!<PPW:6UU(UO)+;SQI*%9XI%!4@'\\_P`+/B\O[)_P"T_]JSQ'\(?VW->U
M_P`*_!?1-4L_$GQ>_:*\:^-?A1X[\<?$'_A"O!?AO2X?#^O>.->T^U_X2GQ/
MXMTY],OY]!:;1;1]4O`Z30$O])_%/_@H7^T_^S[>_$'X6_%;X>_"S7_C1HMO
M\`O%O@V3P+KNM6O@C7O#'QJ^+&D_"RZ\.W-[KUA%?6'B#PWK>H"VBU::`Z;?
M6\T6HR00)%+#7Z5^-/V4?A5\0_V9+K]D_P`96^K:Y\,+OP'HW@"22>^%KXB7
M3O#T6GC0]5@U;3H;-K77M+O-*T_5;+4;2*!K?4[2&YAC38J#Y_UG_@FW\,/&
M5YX@\0?$OXC?%CXF>.?$-S\'%N/'GBG6/#-OKUIH?P-\<:=\0_!7ABQM?#/A
M'P]X>ATF7Q1IL.H>()WT276]==Y#J.L7$I29`#O?&VL_M00_L=_%WQ'XTB^'
M/@WX\6OP^^)6JZ%;>$M8US5?"6@&+2-1N?#32ZV]G8:M<ZII]C&AO+RRMH86
MU-?.M<0;0/QQ^'GBK]NCQ/XC_P""6>KGQG\*O%'Q*^(7P&^/&H>"=<U^^\;0
M:.?#-QX`^`%U?>(OBVGE75YXD\7VEXU]<01:/$8;F?4-C7=O"]W(?Z1?$?AG
M3_%GA;6/".MQM<:3X@T6_P!!U:%)9(VGT_4[&;3[V-)T*RHTEO/(JRJ5=6(8
M$$5\9_"C]@SP3\*?$OP/\1VWQ+^*'C(_LZ:!XV\(?"/2O%VI>&9-.\*>#O'6
MB^%=#U#PV@T/PIHUUJEG86O@_2&TV[UFXOM6$OVI[W4;PS((@#X1\2_\%0/B
MS:V_PS^&1L/AIX*^,MSI?QTN/BIXHU;P[\5/&_P^LM1^`WQT\5?`*\L_"6B_
M#[POKWB:>+QSXI\*76J:==:O'90Z'H\O^E/<W?E6\OV]X8_:U\:>*/\`@GUX
M@_:UN?`MQX.\>:'\'O'WCR\\$^([+6--M[+Q#X*TK6YWMI+;6M/TG6_[$O+W
M2EFLY+NPL[V;39XI6B60E3>/[`W@/2_$V@^/O`'Q%^)OPQ^(V@ZK\:;Q/''A
M'4/#%WJ>IZ3\>/BMK_QE\<^%M;TGQAX4\5>$-9\/1^./$%Q?>'X-2\,W.H:%
M':V:6>I^:DLTO>_&CX)^)M4_8[^,/P,\-Z]X@^(?B[Q5\(/B-X-TG6O'VMVM
MSK7B/7?%/AS6;"T.MZOY&EZ=;+<WM_'#YD%MIVFZ;"4,-M!:6PA`!^9/C/\`
MX**_M>?!?P1H/CGXO>`O@]=Z?\:/V2?BK^T'\'+?P-?^)+F;PQXH^&?PML/B
M6/"OQ`.JVEM]OL]5T[4(9+B^T55CL7CFM%>9MDM>N_M/?\%!OBS\$]4\:V7A
MSPKX4U=/#/\`P3]N_P!JZRCU"6]CEOO'-O\`$WPCX)C\/22Q?NXM#GL?$$LP
MGP;F.Z0,RF/@>D_"O_@F[X)O_A]X#?\`:"\1_$;XG>-+/]F!_P!GN\T+Q9XW
MCU#PW\/_``YXU\#V'AKXDZ%X)A\/:;H]LMQ?HDVD)XGO'U?6_P"SK.SCMM8,
M"+OTKK_@EY\(M=7QI+XW^*7QQ\=ZAXW^`,G[-5WJ'BGQGI=[+I'PN/B/PUXH
MMM.T"UM_#=GI>F:A9ZIX9M7&IQZ?)=7PN;N75FU"ZDCGA`/-K7XY_P#!1SQ7
M\0K;X5Z+X=_9F\(^+=;^$.G_`!ICNM:U7QKKVB>&=`U;Q+X@T'1?#ET^GZ=;
MW.L:_J+:7#]NO8([?3--6.[FC-RSV\1\5^#?_!3']HG]K/1/!L?P$\$?#7P?
MXKT7]G+7_CS\:+;XC7FM:IIMEK'AWXD^.OA&?AYX.DT2&&6Z75/&'PQ\93+X
MCNP(;/28]/E-M--<;%^WOB3^RCXX\>_M"VWBG2?B?\1/A;X%M_V<-$^$_P#P
MDWPP\3:)H_BV_P!5L_&?BO4;NQO8M5T75F@AATC5+&[M-;TN*RU&UOWF%A=6
MQ659<+3O^"7_`,!/!^E^"--^$.O_`!+^"?\`PA?P4O/V?'O/AWXHA6\\6?"S
M4=1N=;O=$\8R^)]*\0IK6J2^(+_5/$,?BL0VOBJVUK5]5O[35[>>^G=@#XVA
M_P""GWQ@\;?$+PG;Z*_PD^!W@/Q/X"^"OB[P1=_'>T\9V5A\;=2^)%O;W'B?
M0_`WCO2=,D\*>'7\*WOG^%HAK]V;VXUV2SFFMH[*[A9Y=`_X*I?%;Q3\9K&W
M\(^"](\8?#74?CEX]^!__"OM!\#_`!4N?B7IUMX)O/$OAW_A9EYXU'A;_A6"
MZ+?^,?"]YI,^DG71-86=[I]W)<F=I;=/M/QO_P`$VOA3X[\#Q_"#5?B%\68?
M@3Y/P^M;GX*6^NZ#+X,>S^&YT)M'LM,U._\`#-[XZ\+66J3^'=/OO$MKX2\7
MZ'#KVH/>7=\));VY:3L-(_88\,>%KWQ)!X'^,/QO\">!O%?C'Q-X_P!7^&/A
M+QC9Z3X0/BWQD;J?Q+J%C=IHLGC+3+35M4O+C6Y]"L/%=OH`UN5M433!=%F8
M`^<?V#_VV/B]^TGXPL],^)WB#X/>%];OO`^I>)_%?[/T.C^.?"OQR^$>M+K5
MA%8:-K-EXML;.S\7:1:6%T]AK'B#14%H-1>QN[1I+&_B==CXQ_M8_M,:U\;?
MVF/AQ^S3HGPJ72/V2?AMX;\:>-+CXG3:\+KXB^*?$'AC4/&L7@C09-&B:/PY
M9PZ!I\5K-XBOENPFIZG&R6<D%G)O^B/AS^Q+X,\$_&;PO\>_$WQ$^)WQ<^)/
M@7X?:]\,/`^M_$C5/#]W+X:\)^*=0T/4/$,?F>'/#7AN;Q'JVJ-X:T"WG\0>
M,9/$6OBVTR.--44S3M)5^,'["GPW^*_CGXF>/[/QQ\4_A=KGQJ^']C\,?C$/
MACXJM]!M?B+X1TVUN].LK;68KO2=3FTS5;;1[^_T>'Q+X7N=`\1IIEQ]F&JA
M8+<P@'YV?L=V>I_MJ?MC:W^VAJEEX0U#P7%\*/V8/'_PST;Q0WBV7QO\-]!^
M*OP<O?'>E6/A;[%K$?A&QU1M4UR^3Q7>OIDIU:*"PC61UM(ZH?M@:M^T%<?M
M,?M_>%=)\>Z-_P`*CT/_`()O>#_%FJ>!-6?Q+>6::)K&J_M,:1J%[X>TH:C_
M`,(]IOC[4-2\/W"ZAX@%ALO_``];^'-/O6DDTW)_73X'?LR?#3]GO4_$=W\-
M;2]T;3?$/A7X5^"XO#?VTSZ#H'AGX.>%)?!?@C2O#]H\2S6<-GH,BVUU)/<W
M<MVUO`Y>,*5KS;XW_L/_``\^-WQ#\3?$Z]\8_$;P9XC\>?!L_`3XAP^"O$%M
M8:-XZ^&$.L>(==T_0]>TK4=+U6#SM+U+Q9XBFM-2TXV&H-#J=S87-Q<6,\D!
M`/R6M?VB_P!HOX1_LS>#?A?\9=!^$WB;X>?$S_@FE\5/B=\.=+\%W'C+2M;T
M*V^"_P`!M%UNST'Q?K,-YIEW>MXDTB^M/MEYX;N-,NM.NWG@L;D[$N3WWPB_
M;I^-UK\1_`WPBO;KX1_L]?#_`$VZ^`/@WX8^$_BEH'Q'OKSXV>$/%?PH^'OB
M75=9\`_%JXENO"_]JP:MK^N^#]&T+5]2O=8?4O"Q?6+@3ZI#O_1[QU^P1\&_
MB%X>^'OAK7M0\7OIWPV_9Y^(7[,WA_[-K%K!-+\.?B5X#TSX=^(Y=0;^S9%N
M=?&@Z5:G3]01(H;2],D[6EQ&P@'':A_P3<^$^OMX&TOQ7\1?C3XL^'OP^\3^
M`_&7AWX3Z_X[>_\`A_:^(_AQ'H[^&+]++^SHM7AMHM4T2RUV]T6QUBR\/7NK
M&XN9](9KF<R`'-_\%"?A[\3/']A\%-7\/^`/$7QN^%'@CX@ZOXA^-?P(\&>*
MYO!_B3XDZ.WA+4;3P;+;7\6K:$FKV/A3Q6T6LW?ABZU:WM-7G:RN9%G;2TB;
M\\_"_P"V[X-^$'AWP7\!OV*]&\=_#S7O%?Q+^+,OQ%\._';1/B=\7]9^`.L?
M#S1/!)\6?#_3O"$>JZMXENK.YN]<\/7^D16^NRZ#9VVMZCK-K=-;W"VR?MS\
M:?V>K/XR3>$=0C^)/Q1^%VO>"I=6;1M?^%/BZ?PO?2P:Y!9P:K8ZK:-;WNC:
MS8SKI]J\-OJ^EW_V*>,W-B]M.2Y^<+3_`()F?`C1[+1[[PQXC^+/AKXH:1\0
M/&GQ.D^.ND?$76$^+VM^,/B'8V&E^,;WQ#XENTO8-;T[6](TK1](E\/ZGI]W
MH%KIVC:5;V&FVJV=OY0!\R?"C]M+]L#]IGX@>'/@A\.-`^'/PJ\<^"O@/H7Q
M>^.7B'XG>&?$\MM?ZEXL\>^+_`O@_P`.>#O!AN-,US2+#Q%#X!\0>*+C5M9>
M273M/N]+LUM+FYG)'R)XL\??M#6M[^V#/\7]=\)?$+PCX6_;4_9/\$ZGX*GU
MGXEQVGAWQ%XT\0_"#34E^']]8>*])FT/PQHD.NWMZ=`_<Z?J^L[;W4K"XMY9
MK23]<[__`()[_#>X\4>'OB)IGQ2^//AKXL:/X$N_AKK7Q8T'XG:I;^//'G@>
M\\27/BXZ!X[U"\AO=.UZUL?$=[J.I:+.^E0WF@OJ5[!HMQ86T[PMBZQ_P39^
M"6M:YXCU"3QC\6/L7B[5_A)XK\7^%7^(%_=Z!XF\9_!F_P##%_X*\<:Y:7<-
MQ>W?B<MX1TF'6-3-[&=:B6Y>]26YG>X`!\<:_P#M_?M-:?X`^(W[6N@6GPL7
M]EKX6_M1^(/V>9_AA=Z7K<OQ3USPIX%^+4?P1\4?$"+Q<MX=*T[4Y/%-OJVL
M:5X7ET>9#HUI9I/J`GNF$<_PQ_;B_;'U&T_9U^,GC@?!:Z^"_P`;/VLM0_9@
MG\':#HOB*U\=Z;!?Z_\`$3P]X;\<'6[J^DTH3P:EX.L$U308[2:*2QO+BYAO
MA<*+=?LS5/\`@FQ\`=5\1^)M0EO_`(BV_@;QE\78?CUXK^"UKX]UV+X.^(OB
MXFIZ;KMUXMU+P6LRV^=2\0Z/8>(M7T6UN8/#^K:ZD^JWVDR7EU=2S]_I7[#O
MP6T?X?\`PR^&MG%XC;PW\(_C?;?M">#4G\1WLUW;?$2TUWQ#XB@FN[EU,EUI
M`U'Q/JQ;3)"8&ADB@*[(5H`^9?\`@I!X<UK7/B%^RE?^./`OC_XE_LJ:/XF\
M>S_'KP1\.H]?O=1OM5N?"$\'PUU#Q)HWAG4-/U77?"6E^(V:6^TY)+BV^UM:
M7%Q:RQQ97\S?V>?$U_\`'+6O@)^QM?2>-X_V<=4_X*"?M3Z[!X=\>7-_<^)=
M4^!7[*'AZQ^(?@CX+^)9]6O=2O;_`,/6_P`6?%'@ZVUC2;_4+MY/#O@F[\.7
MS26TES;O_1M\7_A,WQ<T.PT,_$/XE?#M;6XEFEU3X7^+KSP=K-Y'/;/;26EQ
M?V<<KRVA60R(@2.:&=8KBVN()XD<?%/Q%_86M_`/@W]FVZ_92@TKPY\1/V4?
MBI=_$?P/9^+=9UBYL/B'HOQ!MM4\+_'KPEX]\57R:]K=WJ/Q*\*>(];U>/Q?
M>Q:G?Z=\0M.\+:U>1W-K!?K*`?`WQC^$3?`#]HSXW_M%_M3?LZV/Q6^!GQ,_
M:@^%D/@3XE:9\7==M_$WPOT?Q%:>!?!'AJ[/@33=7TN-]%M?'Z)/J%I$\DT,
M4@O&@GB9T/Z#_L[W^G_"W]NO]K/X`>&+"UT[X;^,?A1\"/VO/#FEZ;#';6&A
M>-/B=K?Q/^$_Q/MK2RC"K;Q^)K[X-^&?&MRL2(MUXDU[Q1JLBO>ZG>2R=MXK
M_8(^%_Q`\3P>)?'OCOXV^,]`M/B5I?Q:LOA5XB^*OB74/A38^-]"O8=3T*^@
M\(R3M`;#1M7ABU>PT5KB70H-31;O^S3("P\*^('[&OQK^+FH?M-^--8\7>'_
M`(9^-OV@?%7PA^%%OJ/AGQ#KMY?>"OV.O@MXDO;^'0]&U6UT73I8OB9X_N?%
M?Q4\77DEN]II.@W'C70_#8U'41X1GUO60#[S_:)^"MC\??AK)X%N-170=2M/
M%'@;QWX3\4#3H-5N?"GC7X<^,M"\<^$M>MM/N9K:.[6TUK0;6/4+,W5L-1TJ
M>_TR6407LH/YE0:5\5/V1/B)\$O^"=?[)_C#PAX7T_XB/^T=\?-#\7?$/P5)
MXBT7X4_"R#QW!XF?X7>%O"NEZ_HQUU['Q7\0I[+0KZ_UFP73?#9$,EM(;"`2
M?LSI-A;:5I>FZ79AUL]-L+/3[199I+B1;:SMX[:!9+B8M-/((XU#S2L996R\
MA+L37SK\=?V5?AQ\>?%'P]^(&MZGXT\&_$KX5G7(O`OQ$^'7BO4_!_BO1=.\
M3VT=EXDT5K_3)HUU'1-;@AMUO])U**ZLI9;>WG$(GAC=0#\/I_'G[<WP/^)7
M_!4GXS>#_%_P"N?$?P-L_@Q\2_C';:QX2\57&G?$S5?"'[)7PYUG4]"\'6T>
MK0-X*TV^T?2ITM-2O+K6KJ'4M01)+1[2S,EQ[)\:O^"E?Q7\'_%GPY-X`\:^
M'?%?@K_A*/V;=!\<?"_1/@OXCUN3P+!\<]5\):7<Q>.?CK_PDEEX<\.>);:#
MQAI^K:1H5MX;U-KB!(HKJ6W^UHZ_H]X=_8+^"?A[P+^T#X`-UXY\0:5^TUX5
MTWPA\6]3\5>,]:\1>)-?T_2_AM9?"N*Z;Q#JMQ=:G%JD_A;3[:.ZOC.\DM[Y
ME[@2OQYEK7_!+7]F[6=?O]934OBMHMAK?B/X4>,_$GA+P_\`$WQ-I'@[Q1XU
M^#"^&H_`?BS7O#MM<C3]0UBP@\)Z+;W#2PFUO8[5'GMGE57`!\>WW[:/[;FD
M6?Q$^.M]KOP6?X$_#/\`;X\8_LK77P^7P;KB_$'Q)X,T[]HU_@YIFO1^*4UR
M32=)UC3--O[265/[,NX=9N=,ENV33%O1;0]$_P"UW^V?'<?L_P#QCG\4_!>#
MX'_'W]L30O@'IGPZM_!.M7/CW0/!.H:WXYTC^U+SQA+K\.GW&OWDG@>=I((]
M"$-BFH1!/M!C=A]^7W[$/P<O_AOXO^%5S'K<GA'QK\?-5_:3UN'^VKX:A-\3
MM9^)D?Q;O+R._$PGCTS_`(3*%+J+3(V2V6R)L0BVX15_.K3?^"=_Q2U_]J3X
M=^)K[P?X-^%?P;^%/[2%U^T);ZAH'[37QG^)D7C'5!9^()-)T;PA\`?$WAC2
M/AY\)+K6-=UI-;\>ZW9:QJ<DT5B^FZ!!Y-]=W*@%W]CG_@H5^T/^TI\0/@YX
MX.BR7_P5^-^N>+8X_!FF_!CQ7IC?#3P:BZH/`WB?4/C->ZN^A^*;RY&FVC>)
MM/MO#^GVEC=ZI-9V-Y<FP+R_6G[2GQ^^.K?M5?!G]D/X`ZWX,\`^(_'7P;^+
MGQ^\6_$CQUX3N?&UE8^#_AGXB\`>"K#PKX;\-0Z]X9AO_$&O^)_B'I\^H7MU
MK,,6C:%IUW<I;7=S-!#7J'PN_8>^%?P;\4V.K_#_`,2_%30/!FC^*M>\::#\
M'+;XF>*_^%0^'M?\27=[J6J2:+X)>_.F6.D2:OJ>HZS;>&8U'AVPU.^FN;'3
M;=\%NU^.W[*OPT^/?B+X>^-]?NO%WA/XC?"MO$L/@3XB_#KQ=JW@CQCHFD>,
M[*TT_P`8^&SJNCR1MJ7AOQ/:Z=IW]L:%J<=WIT]SI6F7ZP)>V%M<1`'X;_#[
M5_'O[?W[9/[-?B;XD/\`"6\B\#_!KXI3:MX*\<?!RP^)/@^W\9?"']H:]^&'
MC[7_``;:^(/$<5GI.N>+I_#$.H^%O&2V5YJ'@^UD%A##J3QO<G]=OVB_B!\>
M=0^./P8_9U_9]\:^!_A=J7C+X:_%WXL^+O'?C+P/+\0/L7ASX9ZQ\+_".F^'
MO#WA:/Q'X6AEOM9U[XHZ?=W6HSZGY6FZ3HMVJVLTMW#L[GX5_L9?!3X+^*/`
M/BSX?:1J.CZG\./AIK'PG\.K+K>IZA`_ACQ#XI?QIKMSJOVZXFFUCQ%K'B:6
MYU?4M>U*6ZU*\O+R\FFG,MQ+(V]\=/V7?`7QWUOP)XNUG7/B!X(\<?#:'Q+9
M>$_''PO\=>(O`'B>PT?QC%I</BG0)]1T"]MEU'0==71=(EOM,U*&[MA=Z9I]
M_;K!?65M<Q`'YC:[^U3^V_<V?[8>NZ!X\^"^DVG[`_A,2^.M(U#X=:GJ`^.G
MB_PO\-3\5O&!L-2;Q98S?#+PWJ>@*ND:+<&R\2SVFJ3F[N?,M8`LG,>/_P!M
M7]M"\L/VX?C/\._%GPIT+X0_LC_$7X=6>B>!/$GP[U/4/&/CKPMXL^$_P5^(
M6KZ5JOB&'Q+:6V@W]F?B#J\=EJ$.EW<CS&VM[BRBCLFFN?N7Q)_P3-_9U\2R
M:YYE[\5]+L/'7A+1?`WQ:TG1OC!\0;/3OC5X8T2$VMOIWQ8C&NN_C.6[T^2Y
MTC6-2U*1]4UW1KJXTG5+RXTZ5K6O5]8_8M^"FO>'/VC?"VHZ?K+:/^U1XDT[
MQ3\7K:V\0:E:KJ6J:5X5\(>"[)]':WEB?0X(]"\#>'X?LEB\=N)H9Y0A>>1G
M`/QT;XW?M4_!Q?\`@IQ^T%X*^*7A'74\)_'/X)6^E>`O%'P_N9K1-4^)7PY_
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M32EP#\F/V;]/TO\`X*2_$W]JS5?&*WO@KP]^T7^Q7_P2J\>^-=#TH07,LVDZ
MS>_M1^)/$O@K[5<@%M)U^%)M$N[DQF0:=<;XX]^]6_8;X?\`P?TS]F+X)?$.
MT\&W`N]7$GQ&^)5UJ5W;00)<^(-1MK[580;*V*VL5GIT-M8:;;01@!;"R2%"
M@*JO1_"[]F/X1?!KQKXC\<_#;PVOA;4O$_P[^#_PJO[+3KZ]31(/`WP*3QK%
M\-]&TW16F;3=.BT>'Q]XA@>2SMX9KJ&6VCNI;A;.W$?MVN:/9>(='U30]11I
M=/U>PO-,OX5EFA,UE?VTEI=P^;!)%,GFV\TB;HY$<;LJRG!`!_//\.?VD_\`
M@HIXY\#?LEZS=_'OX6:?>?M=_L:W/[1\=U:_!A)7^&.I^&/ASX2^(%KI=C!)
MXM*>)V\76VM36?B">\&GII%U/NT>">&U03S+_P`%!/VKOCG<?#;PE\-H?&/A
M?6+?]DWX2?'GQOJ7P=^">G_&#4]?^(?Q9O\`QWI6@Z)<6'B#Q;X;MO"/P\L'
M\"SW=_<Q_P!J:MK5UJ9TRVN=)32I;NY_730_V1?@3X#TOX%Z7I.BWUG8?L^?
M"6;X"?">*X\4ZVYTCX>7OA32_!1T*8W5_(VN7TOA_1K"TCOM2:[U`SPF[CF6
MX=F/GFK?\$[_`-G"XL?AO;Z&OQ$^&VL?#;P+!\*O"GBWX7?&+XF_##QQ=?#I
M+R74AX&U_P`6>"O%6AZYXKT&*ZFNKZRTS7KK48M.OKF[OM/6UN)I)2`?EO\`
M%C_@H'^UCH^DR^/_``YJWBNT\;?![PC\$KW]HCX)67P7T2]^%_PS\4^*)M&7
MQKX<\??$_4/%D.KV^MZQ9ZI)>>']-\/VEU+X?5M.;4/MXFD6O5=<_:W_`&O+
M#Q)\6?BROQ(\&Q_"/X/_`+?WP_\`V6U^%,?@"*;6/%7@[XB1_!&VU#5M2\:M
MJPETS4/#3?%4W.A16.DSK>RVDSZG,D;1P+]:^*O^"7G[&\XUBZUS1O'5II?B
M33O!^F>,-,_X7?\`%G2_"_C.Z\&BSL?"6O>.-(B\9)IOBWQ?8F&TAMO%'B*.
M_P!9FF\LW%Y/,WF-[[<?L8_`76/"_C7PM>>&=3?1?B'\<O#_`.T7XIMO^$H\
M31/J'Q6\,2>!Y]$UU9[?6%GMK&V/P\\(B30K*YAT2\CTZ6*[LI5O+Q90#X$_
M9R_:B_:3U?\`:BM?AU^TE\0[WX6>)?%GCKXI:%X7^!6O?!I;3P3XK\(>%H+^
M]\)ZC\+?C39ZO<IKWB0Z#%9^)/$-MJ-HJR6C:A;PV-D]CN?=_;T_:?\`B]X)
M^(]WX!_9]^*7CG_A8O@KX*ZW\5-<^&7@/X*Z!X_L+.RAO[^'1_%?Q.\6>(O$
M.B6_ASPE=SZ+?Z5!IVEA]5OFBO[J"9/LJH?L#P+^P7\"?A_\4/#OQ:L&^)7B
M#Q+X+N_%FH>`=/\`'/QC^*'CGP?\/+_QRDD/BJ]\">"_%WBG6_#7A>YU6VFG
MLWFTK3K>2VL;B>RLGMK:5XVM?&W]A+]GSX_>.I_B1X[T?Q9;>+=1\$'X:^(;
M_P`&?$GQ_P"`(/&7@+[;<ZA%X3\;6'@OQ%H5GXKT2VOKR\NK6SUJ*\6WFNIV
MA:-970@'Y6ZU^V5^VI\4-`^,_P`2/AS\3O`OPQT?X#_L,_`?]K*Y\)7GP\M_
M%<7C3QKXVT+XO:UK'@N]U:YUNPN-(\):@?AV;>[N[..?5;02V9LI/DN3)ZKK
M/[>OQT\-)\2_`&I_8[CXG_%^Q_9I\7_LE+;:/";?_A'OVA;;1]+\06$P8(NM
MM\+[^T\4Z_=SSQ*\UA!%;S@XW5^@7AW]A;]GGPQX:^('A+1_"^HVFA_$_P""
M'@_]GCQA;KXL\5RO?_"KP'8^,=-\+Z#;S3ZQ)-87>GV?COQ-'+KNGRVNLWOV
MU#=WDSVUL\/FVJ_L@Z/J7[7/[.GQ*O[SPC;_``]_9H^#M_X.^%'A%9]1N_'%
MWXEGBMM(BU?6[N_7_2M!\*^&K;[/HZ_VAJ-T=5U*\OKU8Y91)(`?H#I8N1IM
M@+V0S78M+<74Q"KYMP(E$LNU`JJ)'#.%``4'&!BKU)P..!@=.G`]O05%-<6]
MLBR7$\,"/(D2O-*D2-+*P2*-6=E!DD8A40$L[$*H).*`)J*0$'H0?H?H?Y$'
M\12T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`5Q/Q(\71^`O`'C3QI)/H<'_"*^%]<\0+)XEUB+P_
MH"MI.G7%ZK:QK4R2QZ7IH:%?ME\T4OV:`O((W90I[:O+/C9\)_#_`,<OA1\0
M/A+XIN=3L]!^(/A75O"VI7FCSQV^IV=OJ=N8OMEA)/#<0"[M)/+N(%GMYH)'
MC$<T4D3LI`/QYTK_`(+(W4?A']H;5=:^&/AO7-7^#?[.@_:-\.7_`()U7QM%
MX+\:Z!;>*[?P;JV@6FK^./!WA:YO;BRU>\L7M_$GA^'5_#-_;792&]6ZL[J!
M.[\>?\%)_P!HGP`GQ\&O?LO>%+:?]FCP+HGQG^*D"?%.2Y$?PG\36M_JFD0>
M'YE\.Q)J/CE-*TG59]0LYUM=(BGMXHH;J43AEU-4_P""4\WC'3?B7;_%3]J#
MXM_$_5/B3^S9<_LMMJ6J>$/ACX9LO"'P^_X2[1_%FE7/A70/!OAK0K!-3M)=
M)%IJ$VLOJ,VJS7U[J4]Y!''9Z?;?2GQ0_8>\*_%&3]JQ]6\5>);&3]K+X)>&
M/@CXJ?3[2PV>&-&\,:'KVB6NL:%'-'(UQJ5S'X@N)IH[]A;*T$05$!<4`?,'
M[1W_``5)?X#_`!330(_#'@CQ3X4L=`^%_B;Q!HVBZMX\UOXIZ+H?Q"ALI9=1
M\3:?X:\%:SX*^'T-E%J4%QHR^//$NC#7[*/[9;RI#<VK'S;X7?M?_$#X=_$K
MXV?!GPGH\WQ2^,GQI_;N^/?@OX3:7XU\5WNF>#/"?A'X>^'_``EXA\5ZCJNI
MW'VZ[T_1-`TW5K2'2/#FB6PDU#4]1BAA2UB^T3I[A\3O^"6&B>/_`!!\8;G1
MOC_\6_`'@C]H:#X4WOQJ^'OAW1OAY?Z9XQ\5?![P1X7^'WA;6+?7]?\`"NI>
M+?#>FW_AGP;X;@\3>'M`UBTL]9O---Q]MM(K_4+6XX[]HO\`8HT#P&D'Q0\*
MZ'^U'XQ^)5Y^U%XT^.OAWQ?^S?J'P_TWXD?"K5OB+X/N-!\410V7CK3-:\,^
M(_A]J]AIUAH^O:+K&@:Y<7LTVGW7D1+8FXC`&>+/^"EGQ+\*^!M.O=9\%?"+
MP_\`$F+XT?%+X.:MX*N_%'Q!\47VKZE\-(-.%S??#_P]X!\$^)O&GBR"\O+X
M+=7,>A0VNE6SP3W4@:3!9HG_``4Z^*WQ2\`>`_%'P:^`GA[5=0U;X`>._CWX
MWL?&GC#4=`M_#-A\+_&-UX,\4^'M-(T1KW5-3O=5MTCT9KNSTWR5E>74D@>#
M[-)R7P!_X)R_$#7O!/P]^,&H?&+X[_`/X_:5\3OCSXPL/$FI1_"?Q[\3Q\._
MC1KEBMYX=^)8U_PKXC\!R^/M<T3PWH'B/4]:T#1H$\*Z_?W&FZ5:1VMC'9Q?
M6'P=_P"">'@OX/>&(_#>G>.O''B!#\$/BA\"Y+_6H=&;4)]&^*?CZ3X@:SXB
MO9K>QMO.UVSU"::"W94ALKJ,EY+:*1TC(!Y;X#_X*.>/=8N=*O\`QS\)O!GP
M]\)?%3]EGQ)^U+\#O$&L?$0G3G\+:'HVGZS;V7Q8U4Z3%9>$#?V>L:9?7%W9
M)?Q:7;27,<@N9X/G^+/C'_P5!^.?Q&^`W[0VE?#S0=/\!?$GX:^&O@-\4/#O
MQ+\,-X^T30-=^'GQ0^(WB'PE/<^'[;XF^!O#VKW<MGJ'A&2R.MPZ5>>%_$&D
MZ[]IT?4GN-.O(T_17Q5_P30^%/COX=_#+X6^,?$GC+4O"GPZ_9*U?]D8K8RZ
M?I=]K7A+5M"T#03XIDNX[2Z:P\36*^'+'4[-8H9])%Z66ZM+NT!B?C+?_@EG
MH>MZ9\88?BO^T/\`&WXL>(_C!\"O`?P(U/QEK5M\./#FI>&M!^&/B[Q-XS\#
M7_@S1_!_@O1?#6CKX?U/Q-(UMIMWHVJ)J%[%J.KZU<ZA>ZS>-0!P/Q!_;$\>
M?L[_`!)\<-\0/`LVO?&CQG;_`+-GPP\!?#KP[\0KZ?X:ZE\1?C/X\\5^$O!L
M%M/J>F1KX9M42RN-6\8Z^EO=3W=G8B""W,J0$V_B#_P4G^+7P;UCX@?!WXD_
M!+PG)\>_"TGP8UGPUI7A;QK?7'@7QEX+^,_C2[\`:=J2:S?:?'J6B:IH'B:P
MGM=4L9X+R.6SDM[^TDD1VB7UC7?^"<&F?$CP[XI@^.7QO^*/Q0^(.NZ?\*IM
M,^+D.C_#OP%XS\%^,O@OXTO_`!Q\-?'W@RW\,>%T\*:=KWAG6KR+$&H:%JFG
M:M8P7&G:]9:A8:IJ,$[?^';/A3Q7+XH\7_%[XW_$[XO_`!F\7>)O@]J6M_%3
M5M+\#>%+^U\-_`_Q'/XK\$^`/#?A+PAX8TSPOH/ADZQ?:AJ&NNFGWFLZS?7T
MUS<ZHB0:=!8@'M7[)O[27CGXP>*_V@/A7\6O`VB>`?BC^SUXW\.>%_$EGX8U
MVZ\1>&=7TWQMX$\-_$;PQK.E:E?6UG=J\NC>)8+._L[F!7AO+*5XV:&10N]^
MVC^T9KO[,?PIT'QYX9\&VOCS7/$7Q3^&OPQTGP_>:NVB6USJ/Q&\26WANQDD
MU);>Z^RI%=74+/.UO,L49>4Q2>7Y;_.?[0'['7Q-U7Q=XNUGX$>.OB'X,OOV
MJOVEOV=O%G[1WC#PQXU7P)KOP]^#?P-\%Z?9ZYI_@/6M!O-'\4BX^(\7PV\*
M>`-5MM,U"ZOS:^.M9NIU70(;^V7[!_:(^`?AO]H?P?X/\(>*M5UK1K+PI\3O
MAO\`%6SGT,6BW4^M?#3Q'9^)]*L+G[;;W4?]GWMY:1V]\D4:W)@9A!/%(5<`
M'YT3?M]_M0Z#XA^.NB^*?@'\-(#^R=XK\!VOQ\U33?B/K$]K<>%_B9X4\)>-
M/#$GP]M)]$BDU'5['0/$5^=<_M:2"R^VZ;;Q6:L+N1X.:\3_`/!5OQHGQ9\3
M6G@3X"ZYXZ^$W@;XR67P;\0S>'/!/QN\2_$#7IX_$^D>$O%?C'PU<^&/AMJG
MPTAT?PC<:G<ZK?Z5K/BZ'4Y='TB^>:2QNGM[:7[J\5?L6>!O%-]^U?J5QXB\
M6VUQ^U[)\-9?'@MWTPQ^'I?AGX)TSP)I)\+++IZO$E[I.D6=U?KJ;7Y-^UR]
MO)%#)%!'Q4_[!DNE^.?&&N?"O]IG]HGX&?#SXD^.&^(OQ%^#WPUNOA4OA77O
M%EQ=6E[KE]H?B3Q9\+_$_P`1?A_;>,KBS!\96G@KQ=I,FIB>XDTBZ\/W-S-/
M*`?,>K_\%'?CKIMMX@UU/@3X*O\`0O$7[2/Q"_9,^!*KX^OK76/&OQ9\'_&O
MQ7\-8K[Q7:MI#V_ACP?;^'O"M]K>HWD=U>:C)J<,]C;6B(\+5E>,O^"EWQ>^
M$L_Q@^''Q6^%7@NW^,W@KXC?`7X5^"K'P)/\2?'?AG7_`!%\:_`?BWXGS:EJ
M-AX6\,:WXXN-/\,>"_!'B#4[C3_#F@:AJ-]<6'V"/R/M27,/OOQ__8V\#:'^
MR[XQ\"Z+X*^-7Q8N_P#A??C7]HOP_'\,?%OASPI\:?"?Q&^(OQ9\0_%?4/$7
MPT\2:I'IFAV=SX2UWQ5J4>AV.JI=PW>B11Z9J4>J,9?.^8_V7?V`O'7C^W_:
M,\>_&G4_VD_AEKWQ)^)'P4\;?!/QI\3?'_@/QM^T[X$U[X'>#FT33_B7J>HP
MZ/XE^&FCZKKNHZSXDT-?`Z>&+CPO)\/[B?0M1T2.VUBZM4`-/1?^"EW[0'B7
M_A6G@K0OV;HV^*OCSXN^./A9ID'BNT^*?PG\#^(K30?!5MXQT3QMX7G^)G@K
M0?%\VB7$$EW::W:76@7%Q:7EA+:V\SF>.<?;O[1O[3GCO]G7X$?#G6M5\$:+
MXA^/'Q4\9_"_X1>$_!%AK-W:^$9OBS\2+ZRT=8KC7;B!+ZV\(Z1JDM[>37KP
M)>3Z9;!(HUNI0JGA;]B=;?QC\)_B-\4/C_\`'/XV?$#X0^.-?\=Z#X@\=7'P
MVTS2Y;[Q'X3/@ZZT2V\)>`/AUX/\.Z#X:L].)NK:QT2QL]0FU-GN]2U34%V1
MI[;^TA^SAX!_:>^&]U\./'UQXCTNV&N>'/%?A[Q/X/U*VTCQAX+\8^#]6MM<
M\+>+?">J7MAJEG8:WH>JVD-W;-=Z=?V%R/,M=1L;VSFEMV`/SAU/]OS]I/PK
M\2M3_9OU[X,_#/Q!^T9IWQ`^'&@:=9^'?&&O:5\-_$?A7XK?#3XL>+_#VO0:
MUJ5C?ZMHNHZ)K7PRN[+7K&\M+_SK#SY;%1/<V_E_9GQJ_:%\8_LU?LGWWQO^
M+?A;1;SXBZ!X<T1=4\&>"]1O9/#MYX]\0WUEH6F:#I.L:K&ET-)?6=2M('U*
M^B$R6BS3LA?8M<E\._\`@GU\/?!OC2R^+7BSXG_&+XP_&>/XG>&/B9JWQ4^(
MU]X#C\1Z[-X+\">-OAUX3\(3Z1X%\`>#/!VD>"=#\/\`C[79K?2/#/AS0[BX
MUEH]6O\`4;JXDO%N_J3XV?!KP!^T/\+?&/P;^)=E<ZGX,\:Z6VDZ[:Z??2Z;
MJ,2B2*YM;S3M2MQ]HT[4]-OH+;4-.O;<B6VO+:"4;E!1P#\,/VM/VX_VO/"_
M@7XI_!?7=#^'/PU^/WA6W_9.^-&F^)/`'B/Q/J'AW6?@Q\6?VA],^%U[IEO-
MJ,1U+2?%-CXXTR+POXGMIS/8ZKX.U?5[[25M[L0&"/X@_M+?M?\`P`_:#_:^
M^*%WX4^&/C63X._LV_!_XE_&#PK#XS\9V'A72_#FC7?C:\O8OAC8S)<N?$>K
M:%:"6:?4Q#927END$HEB977[ZC_X)<_!O5_!_P`8M"^)/Q4^/OQ:\8?&3PQ\
M.O!NK?%_QWXJ\%0_$KPIX6^#^N+XK^%6D>!+GP=\//"GA+08_`_BV,>*K6]G
M\):IJOB'7F>]\:7_`(FC=;=>NF_X)^?#76?#WQ\TGX@_&+XY?$?5?VD?@Y:?
M`_XE^,_%6K_#.S\1W/ANR_X2!;;5]#B\(?"SPMX9TKQ+%!XAN;1)X_#DVB+;
M6=@%T%9$NI;MJUU?:ZOZ?+4#XL^)_P#P50^(L'Q0^)?AGX-_"";QGX>^"FN>
M"?"^OZ2GPT_:%\9^+?B)XIUOPEX,\=>*M*\%^*/ACX!\0?#'PNWAK0_'>B64
M,/CC7H;G5-3BOIY;;3-'ETV^O?K3]D3]I;]H3]ISQ)XNU_4/AMX"\)?`_P`)
M^._B=\/AKJ>(=?E^(&LZ[X+UVTTW2R/#LUJFGZ9:F![R/5_M=W+.M["GV:.)
M"R+U>I_L`^#O^$R\2^-OA?\`'[]I/X$?\+#A\&-\5O#WP@\6?#BQ\.?%+6O`
M?AO1/!.B^+]=7QI\*O&^M^%?&4_@[PSH/A;6_$GPGUSX=:AKVD:/IJ:I)<W-
MC:W4/T/\!O@%X*_9S\+^)?"O@K4O$^I:;XI^(7C/XEZE<^+=3L]5U%-?\=:G
M_:VLP6]W9Z9I>=-CNL_8H[J.ZOE0G[7?WDI,IJ?)S>XFHV6_?KN!\V^+OC_^
MT1XT^//Q(^$W[._A;X27FB?`VP^'9^)>K?$[4/%5IJFNZS\0#>ZFFA>"D\/,
MEKIYTKPQIEQ?RZOK$=]:S:E=6NGQVRF"ZD7Y+T__`(*._&FZ\#^#_P!I^X^&
M7PX_X97\=?M$:=^SYI]O%JWB:3XS:0GB+XDR?![P?\0M1B)_X1.YTV[\?R:<
M=7\-V5O%JEEH%Y+?K?37-J]M)]Q_$K]C3P;X^^+=_P#%[P[\;?C_`/!7Q)XK
MTSPMHGQ'T?X,>-/"_AKP_P#%32_!.I7>H^'+?Q?;Z[X%\4ZQ8W6G#4M4T[^W
M/`NM>#/$5SH^IW>EW.KS6OV=+?S*R_X)>_`FQ\0Z0\?C_P".DWPF\._%V7X]
M>'?V;;KQGX9N/@;HGQ?-_=:[9>,[33W\#?\`"P[C^QO%]Y/XYT;PMJ?Q&O\`
MP-I_C'[/K4?A<R65C';0!\DZ+_P4!_;*\0?"?]G[XI0_`_X&Z=9_M*_$CP]\
M,OAM87'C;QC//_:FIVOCB?4-?\1/#IR1:5IL0\+Q36MA$;V]GC,ZS7"R30M#
MW2?MW_M&R?$^R_9'_P"$`^$\'[5U]\</&/P\N-8GU'Q9<_!G3_`/A3X%>!/V
M@1X]VQ/%XHFU*]\+?$/1?#R^%H[N*YBUR"[NGNOL"1F3N?C_`/L):VOP6_8V
M_9Y^!6M?$2T\)?!#X]>'?$&J^/[7Q7H&E?$[PMX-AT/X@C4/%FG:]_8=KHUS
MK]CJ_B6V2"VA\,RVMQ:RFVNM,N[4W,<OI4?_``30^$(\,:)'%\5OVB+;XN:+
M\6M;^.%K^TM)XZ\,7_Q^E^(7B3P5IGPTUN\U/7M6\!ZCX)U31;_X:Z'H'@"7
MPG?^`;CPM'X9T#1K:WTB&ZT^"\4`^4;'_@HE^TSXF\7^"_@!X)^$/PGOOV@[
MKXF_M$_![QS#K?B[Q+9_#K2_$?P6TGP-X@T[Q/H>IVMM=ZU<Z'KFB>,#<SZ3
M>PKJ<%XD-K%>`12RM&__``4=^+R?';1?"^B6?PE\>_"OQ5^T/J/[-D&O>%?"
M/Q>%GX4\7BYU?3=+FU'XD:NEMX%\57ND:O9067B[2/#@:"UN8KNTLM4-W"]?
M<WPO_P""?/P-^$WB;X6>-M!UCXEZOXQ^%VO_`!?\7R>*O%?BJRUS7/B+XQ^.
M%CH=AX]\5?$B]DT&!]5U.XA\/Z>=)M=`7PSH>C!7MK+2$L1!:0^6Z!_P2S^`
M'AWQSIOBK2OBC^T<GAWP_P#':]_:*\(_!Q_BM`WP<\'?$K6?$NI>+M=NM!\'
M)X8CE.EZUK^L:M?R:=K&K:L=(GU&YD\,SZ%+Y4D0!\,_"S]MS]J/X2?`?X':
M9XNE\`_$;Q_^T!\2?B-X<^&NO1>&_B[XQN/#>@?#F7QGXF^)'B3Q]H/A)=>\
M3^*A8Z;8:/IG@S0O!]A:W$GV])=5NDLM/O;A/U+_`&-OV@OB1\?_`(:>)M4^
M*7P]OO`7B[P?XWUKPHMZWA+QSX-\-^.]*L+>SO=*\:>%=%^(FF:1XMLM(U2"
M]:WEM-5M?.M+^SNHEFN(A'*_FUU_P3)^#TL=VEA\6OVC]`ET?XAR?%'X+7?A
M_P"(NA:7??LT>+[]?&=MXCN/@;=Q>"6FTW2?&6D^//$'A[Q?X=\?M\0M`UWP
M\]EH]SIPM+&!!]9_!?X*P_!O0-4T>;XG?%WXM:GK>LW6NZMXO^,?BZT\4^)+
MF[NEC06MI%I&B>&_#.@:/:1QJECH?AGPWHND6H+M%9"221V`/QTT;_@IA^U'
M=_`'X-_'#Q!\'/ACHME^TOKGA_X??!2UTFZ^(?C34QXONI/$%YXF\0^+_#?A
MS2+G68]`TKPYX2\0:GIOA[0H[_7M0NK:PLY+JW-S,UOVW@C]OG]J#XF^*/AM
M^SQX:^$_AGP7\>/&6H_&#6+WQW\3/"OQ.\'_``RN_AG\)I?"UM'XX\+^#_$%
MMH_CN_NO%>I>,M(L;;0[Z:U73$M=1NKBXN(5B#?;4?\`P3Y^!<'[-?PQ_9AM
M-4^)>G^%_@QJEAXB^%7Q`TKQA'I/Q<\!^+=)U;4M8TGQ;X>\9:9I-I;VFMZ?
M<:M?VJJVBR:3?:7<3Z3J^EZCI]S=6\_-:M_P3G\`ZWIW@N_U+X^?M3W7Q@^'
MFO>(M>\&_M'2_$[P_+\:-#'BZPM=,\3>';>>;P')\-Y/!6LV5A8)=>"KCX<3
M>%TNK&TU2UTNWU:WCOUOW>3;WKO7OJOT_7N!\I>!_P#@H#^TW\6-?\+_``F\
M`?"3X4?\+ET7XG?'_P"$?Q?/B?Q5XFMO`NG>(O@+J?AJ34]>\'7%G!)J>I:1
MXC\,^)]-UG3['43'=6%W=?V==2N+2:1N?T[_`(*#?M0Z_P""OAM^TE9>$O@O
MIW[/_P`3/VK_`(8_LV:/X9U63Q9+\2;?0O&OQRT;X,ZA\0KG4H+J#0+>X%W/
MJNI1:!-92?9;!+19;PW9FC?]"OA#^PW\$/@+?^`]>\"?\)I-KO@23XHZC)K7
MB7Q0WB'6?'?BSXS:G!K'Q#\<_$/5K^Q?4?$GB_7M3@6Y.HQW.GV]HFRQL[&'
M3;:RLK;\J]?_`.">'Q)\9_'_`,.Z+X6^`WC'X._!#P_^UWX5_:`O]8U#]K?4
M?%GP9_LKX?\`Q+L/BE>:I\-_V8],OGLM"\:_%C6M&AL;^/7=-MM.\$VGB#Q%
M>Z)>V=U*D5W`'9Z;_P`%+/C'8?$&&"]@\"?$#X;_`!`L?VB8_`/B+PY\/OBA
MX,T:PUOX-^'_`!!K6D6UIXN\8R6^G>.])ODT&XL-<O\`0K"%$O4DN-)N+BR,
M4CU_%O[7W[1NN_L_77B+XW^'?AS%X,_:&_8H^)_QS^'NB?#/6_''A[Q-X2O?
M!?A_P!JKZ/XB\7+J%M?O/XGT;QQ<7B:EH']E2Z!<Z99VUNTTD\UR?LO0O^"5
M_P"SMHVH:!>3>,OV@==TWP=_PL>'P!X0\0_%[5-2\$?#O2OBKIFLZ5XMT+P?
MX4-A%I%A8O;:]?C3;R\@U'7M._T>"#6C9PK;'V#7/V&O@1XG^'?@#X7ZA_PE
M\OACX8?!3Q/^S_X<\OQ(&U+_`(0#Q?H'ACP[JT>IWLUA.;[6FTOPII'V75&B
M0PW'VFX\AWF^2Y\EH\B:>O-?Y6Z]-=K`?$3?M+_M8Z!XN_9;^$WPA7X*^//^
M%M>#/A;XNN?`][8?$"\\;_#+X)-HFA_\)A\1?B!XUEUNYTHK:/+/I7A:.YM3
MJWB[766%5=+;5+ZV\E\)?\%&?CAXT\:?#^UT'5/A[X]^%W[0OB#XH>"_AKXY
M\.?#7XE>%O"^DZEH.@>)-2\)ZWHOC+Q%=P0?$G2F/AZ:SUNYTG3K2UNYHYKO
M1;O[,D?F_?7A_P#X)P?"3P=\1KWXI>#OBM^T=X1\1ZEI_@/1M7CT#XI0V>EZ
MMX>^&^FV.D>&/#6I6[^&YKBY\-VVFV`M)M#:\&G/'=W[100R74CUS_PM_P""
M6O[-'PFUOX7WOAGQ-\<]1\/_``0\1ZMX@^"_PU\4?%_7/$?PT^%L6L6VJ6M[
MX?\`"'@Z_A:RMM!6WU>[M[./4'U'4]/LBFF6.JV^EF6QE@#\O_@'^T1\:O`W
M@3_@GA\7?C_XIL_B%HMS\*OVK_B!I]_HFK>-]+\3)IGP^^"&I^*=5MO'5E=Z
MO)H'C?5M4>RA@TJ:]L'CT6/S+S3UAN]TH]B\??\`!1/]JKX&?!OX>?'/XJ>&
M_A-J?AK]HGX`_$SXL?"WP_X1C\01ZI\.M=\*_"F3XM^%]`\5:G?WDMAXKT[5
M/#K10:MJ-E'9R6>L)+':J]K(A'WU\.O^";/[.?PTU[P%J6E:W\6==T7X5W?Q
M,/PX\`>,?B!+XD\!>"])^+'AG5/"'CGPKHF@WNEB5?"]_INLW30Z7=WUV+*[
M2PD@G6'3;""WYS3_`/@E'^RU#H%[X1U?4OC1XS\&VWPW\;_"3X?>$/&_Q9U_
MQ1X=^#'@/X@Z1)H/B'1OA38ZC&[:!(="DCT73-3U6;7M4TK1[:UTFQO(=.B^
MRL`<_P#`S]HO]IF']J/X9?!3]HF'X63Z3\?/@!XV^/'PZE^&]MK]I>>"[KX?
M>)?AGI.K^!=?FUBYG3Q##<:1\3M,O8]?BBLF^WZ;-&EE#!?1A.=_:F_;5^-7
MP<^+?QL^!?@KPUX;UGXG^(O"GP3O?V1=/U*.XBLO%WB+XCZWK?A?Q9#XFN$<
M)]C\$2>%_%/BS4"IB/\`PC^ELN2\@9?OK_AG/X<'XL?"KXT-'K;^./@W\,_&
M?PF\&7#:F!IL7A'Q[<^!KSQ'%J&FI;+!=ZA<3_#OPR\%ZAMVM_(NE2/%W(*K
M>._V:/A)\0_C5\*?V@O%6DWMU\1_@QI_BC3O`VHQZE+!IUG#XKTZYTO49K_3
M0K07]S:V-[J<6ESRE3IXU34C&#]J>@#\=/'/[8/Q4_:PO/AIJWP-/AO0_!&G
M>/\`]B?5O".L>,;#6$GM_C%\7-+\0>-?$7A[Q79V,T%R;'P'X7F\/0:OH@>W
MF.LZF+::15C?&GK?[4/Q0U;QY\!_!OQLTOPAK_C?X0_\%-=2^!&L>*_!%UXC
M\/Z1K&E6'[&GQ>^/NE>*-.T"/5MIU.73[6PT&_T'66U/21ON;Z*W-Q#;21?I
MKX`_8>_9U^&UCJ6F^"/#^J:19ZO^T=JG[5%[#!KUU*I^+>I7D=U/=6YD5_L?
MAVT:**TL/"]IY&E:?8Q1V-O#';((Q%=?L2?L_P!SX_\`^%CW-MXED\31?M&1
M?M3MO\2W#::?BR/@WJOP&-Z^FM`;<Z'/\.M8U"PFT3`@?4I1J_F+>HL@`/RD
M_:(^+_[3WQX_X)W^)OVAM2U#X9K\+_B];_"'QG\/_`FGZ9K.F>,?#-I?_M$_
M"^;P#!K?B(7<T6HR7VE^4/$T<5G`^G7-Q-#9+*D3*_Z)_LL?&KX[S?M!_%S]
MF/\`:"N/A]K6O^#/@O\``OX[^#?$WP[TO5]&T^Y\-?%C7/BYX,UGP[JMCK-W
M>3-?>'_$WPFN[BPO8YO],TG6;82Q)+;2$K)_P3-_9NO-'U_PM+K?QMNOA_J]
MRMQI/PRN/C-XQN_AMX'4^.='^(\UMX'\'7-U-H^BVDWBO0[&]BAEAOAIEK]H
MTK16TS3)GM*^K]&^!W@30OC-XA^/-A#JH^(7BCX7>!_@_JUU-J<LNER>"OAY
MXC\<>*O#5M#I6Q;>'4(=9^(?B::[U,$W-Y!/9VLK?9]/M(XZERW]Q.WGOZ;O
M;U`_+KXR_MO_`+1/PY\9_MO>.++3?AK-\"OV'FN=:\2:5>V^M3_$+X@+>?!E
M?%VB>%]'N+:=-*\/VT?BG5=&N-5\27L%X+?26NXQ;1+:O,W)7'[7?_!0'1-#
M^)NDVGP3F^)NM:=X1\%>)O"7C2S^%GBOP7IND7FH^++/PYX_T4>%-4U)[[QE
M<>%M)O&\6:!#I=Y'J&N65E>6\T7VAHA)^IEM^RY\&X]0_:#O-0\.2>(+/]J&
M6-OC+H'B*Z.J^'O$]LO@ZV\!S:;_`&7-&([73+SPS;)8WEFCM'.SS3'$DK&O
M"K#_`()T?!ZTT;4='N_BK^UGKCR:9X>T;PQK6L_M3_&6?7_AYIGA75+?5]"M
M_`NIVOB>SDTR>UN[.S2\U34DU?6-<LK6+3M?U#5;`RVTC7+R._QWTWVT\[=^
M@'A7[+_[9WC_`.*?Q5^'7PSUSQUX'\9IJ^L?M!Z+XMGTOP!XO^&7BOPMK/PJ
M\+_!37-'\*>+/!GC6*UU/0?$RM\1=6N[U($FL]1T8Z)>V,SQ33FOSX^,/Q]^
M(_QO\3ZG\0SJEAX2\=^"?@E_P59\`^&M:T2&XM_[-TCX4266E:7J5K-#<1W%
MOK\FD:8TMM?Q3QR6NJR1W\1`A"G]:3_P3(_9R30X+.PU_P"/FC>,U^(OB+XJ
M:C\9M"^/7Q'T?XV:]XP\8>&;3P5XLN-=^(]AK,&L7^E:_P"#]-T?PY<Z!^ZT
M2RT_0]"DT:QTR_T?3[VWZ3P5_P`$Y_V8O`-CI.DZ%H/BR31='TGXTZ%#I6K^
M-M=UB&[TC]H$1+\3[/5+Z_GFUK4FUQ(R$OKO5)=2MY9[F[%Y)?3R71@#XE^,
M/[1G[:7P"M/`%IXJU_PM8_"\?":]\>>(?VC[;X-^,/'GAFQUM=5TG3])\!>*
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MKQ9<7/PHL_A'HG[;_P`1/V6;GPJ-'UA_%^I^%_"_Q'\1>$+7Q@->^WC3K?5H
M]/L--$.G06<D$WE3RW#B658XOV#KY\\&?LP_"/P%I^HZ5X<TC4[:QU/XX^(O
MVB;J";6K^<'XI>*?$%UXGUC5XW:0.MA-K%Y<3QZ06:PBC9;=8O)CC1?H.@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"N9\9:W?>'/"GB37=*TN+6]4T?0M5U33M&GU6TT*#5;VQLI
MKFVT^?6K]7LM)ANYHT@EU*Z1[>QC=KF9&CB8'IJ\>^/_`,)+?X[_``7^)WP?
MNM:NO#L'Q'\%:]X0DURRB\^YTL:U8RVJWB6YEA%RD3.IGM6FB6Z@\VW:1%E+
M``_)ZU_X+(:)8:5^TM%KO@/X3^*?&W[._P``KC]H*ZT#]G[]J;P7\?/#FKZ%
MIOB1/"^M>"O$OC#0?!>@+\//B'HVJ75A)=Z%JFAZI'+I-]!J-E>7D44R5Z%J
M_P#P4]\:>!+WQAIOQ:_9?USX?7W@:'X,>,_$44GQ0T'Q#%I/P5^,7C,^"%^)
M6IW&C^&GAM;_`,$ZI<:=)XL\(1R74=K8W%Q<V_B>>.S>23@=6_X).?$3QMH7
MQ`T7QW\=_`EM:>*OV/=?_9#\-:/\,O@[!\/_``]X/\.ZGXU\+^,K7Q0NG0>(
M-3;5]9>[\/S_`-J!Y;"VF>^C:U@MY+62XN_J7XY_LF:7=:G^TI\8=<TS4_BI
MI_Q)_9`NO@+JOP>T#3('UOQ2ND)K>HI_8E[=W"1?VSK4M^MCI@N-J:;>_9KU
M9E\@``'NWPS_`&CXOB?^T1\<?@GX;\,2W_AGX$^&/AI<>)_BG#JZ2:/=_$?X
MD6&H^*4^&-AI":>?,U7PQ\/CX/\`&6O:@FLNMM;>/_#EBVFQ/+]HD\)\/?MF
M_%CXI?%WQWX5^"/[.<'Q`^#WPJ^,&F?!;XE?%+6OBSIO@O68-?\`M>GV_C75
MO`_P_NO".IP^+M"^'UOJ/VW7I-1\;>%;Z_CT_4+;1K"[N4@2?H_^";O[.7BS
M]FW]EOP=X?\`B9?S:O\`&3QY->_%+XU:Q=OOO[[XC^,DMI+NPO9ERMQ_PAOA
MNQ\-?#[3KA3A])\)6)5(Q\M97@G]C_XM_"#XJ?$77/@W\<]$\+?"3XM_&33_
M`(T>,O`NM_#H>)/$.F:Q<ZAIMYX^T/PCXD;Q%86EEI7CZ#3!:33ZAI-W=^'&
MU"^N]-%Q.+?R@#XN_8._;L^-=O\`!K]C[P5\:/@]JTT?QR^&7BA?AQ\;M7^*
M6D:QJ?Q'\:_#[PE=^)]2@\8>'!H,=QX4B\30Z9J*Z!K5SK^L2RV-M%?:OIFE
MM/\`9(=^\_X*^KX8T?X\W/BCP-\#/%'B'X-?`OQQ\=E\,?L_?M<>$_CK=1:=
MX!\4^#_"/B#P3\2;G1_ASH9^&7C&.\\=>'KO38;NV\16&IP_VTL5U')H\@N/
M:+O_`()FVNJ?!#]E#X+:C\5-1CL_V:O"?Q'\)S:_IVFM;ZEXEMOB%\,O$_PW
MGO;,F[#Z3=Z=#XD?5(6:>Y\R:W$+L0_F#QQ/^"3GQ`U7X0ZQ\(/%?[0/A-_#
MEI^RM\4?V5/A[IO@OX/V?@S3_#/A[XBZ[\(M=G\::P+?Q#J$FO\`BR:?X4VR
M:M)&FF6DIOUN+6..Z@EGN0#TCQ3_`,%-?$GP>E^*6G_M&_L[ZO\`"_7?"?PC
MT/XP_#O0/#'Q%T+XD:G\2]+\4^.[+X<>'/!Y:WT/0+/PWX]O?%>K:+876E^=
MKFBV*:B]POB*\ALIY3SOBK_@J-XU^#UY\6O#/[1'[/6D_#3QS\./AW\!/'_A
MW2]%^.&C^*/#WCAOVC_B#XZ^&GP_\/ZEXJU?P/X*TSP%<6?B+P'J7_"5ZMJ7
M]JZ9H=L9;N"74K&W$]UWG[<7[#&F?&X^-/B7J^H>,M;EM?V;V^%>D>#/AUI^
MG2>-9_$_A[XA:/\`$[PKXO\`#%UK-U#I3Z_H^O:%9-8Z9?)':7BK-!+/&DQ(
M^,_@W^P]\>_VKO%W[1WQ&_:+\1?$3P?=ZSX+_9B\'?!;QK\1/`'@[POXVT_Q
M=^SU\2_BS\5-%\6K\,M#UG7=+C\(Z1J'CK2-,BM-=U^;4?%<\OB>=Y-/L)=.
MBM0#]'OV0_VTY/VG->^*_P`/]<T7X::+XU^%\GAJ2]O/@[\:=+^/GP[UW1O%
MVF2:AIU_I?C?1_#7A,07UI-!=:;JNDWNC0SVMS;&1)9H)XL_*M_^VWXR^$WQ
M9^/7@_P=\/\`Q_\`&SQ9J'[;/A?]GWPQX8\7_%?2-'T#2=2\5_`SP9\1;:?P
MM=7GAB5?"?@^R_MPP7NB3-K4ZW,-[J=M>RO/#IP_0_X!_";XQ>`)?$-Y\5_B
M+\.O&4NI+IUOI&G?#KX36_PSTK2X;%9?M-U>$>(/$%YJM]J<LHD=7FMK6P1%
MB@CG;?._SO/_`,$];:;XV:U\8A\2KE)-7_:\\)_M5?V&NB((H)_#'P<\,?"8
M^#S=&]:26*]3PX-9.J%0\+W36JVK*@D8`]H_92_:.\2?M'>#?'-_K_@./X;_
M`!#^%?Q1\>_!WXA>!_\`A)X?%.FZ;XN\#ZC]CFN-*\4VVC:0-8T?4K22RO[&
M[.C6DHBO"DL'FP,S_C/XR_:V_;5U+P3XHUS5-#TB]_X0_P#X*>:'\'_!Z>%?
MB]+:>(M<MH;VW@/P?NK6^^&>@:39^$'M+JWN9/%MWK>H7=P]_>PR^&A'I5O<
M7O[@_L[_`+/"?`34_CS?Q>)7\1)\;?COXY^-KPR6"V/_``C\WC4Z<TF@1%9Y
MA>163V+NMXWDO*9C^Y0#GY#U+_@G1XJO/%_BF.V^-=E;?";7/VLO#/[86F^$
M6\$,_B?2?B'I9M%UO16\4)X@CM[KP[JT5A;"V!TF*ZLI)+AG-RI10`</XN_X
M*DZM\*-&^,_ACXW?"GP9\,?CE\*/BC\&_A;9Z#J'QHTU?@[KDWQW\)R>+_`O
MC+5OC)X@\*^&8O"GA'3=,T_Q,?&MYJ7A66?1O^$7OVM$U)KRQ4?3'[$G[:6C
M_M?^$OB#?6J>!8?$OPJ\=W/@'Q5=?"_XDZ5\7?AEKEZNDV6NV&M^!/B%HUGI
MMMK^BZEI.HVMP@FTVQO+24RVTZ.\/FG@OBU_P3OA^)7Q0^,WQCL/BA)X8\>>
M//&7[.'Q)^'=Z/"MGK-A\.O''[._A_Q+X=LI[_3[J^AC\7Z!XPTWQ+>6.N:1
M<-IDD-C+>16MZLMT)H/J;X'_``T^+/@32O$LGQ;^)OAOXCZ_X@UJ#4+-?"7P
M]L_AQX<\,Z;%86]@-'T[3X-6UN]U,RRPM>7&IZMJ#W$DD[111001QI0!\#ZE
M_P`%'?BOH/B2?Q9XE^`&C:;^S58_M6^)OV2=4^(]C\3VU#Q]:>,-*^(VH?#G
M2_&/_"`MX-MM/3P7>ZI:64-RW_"5RZS'>7UPJV,=E8I?7W&/_P`%6?'EI\+;
MSXS^*/@3X0^&GPKU3QG=?"'X>_$?XI_'_P`'^"_!OBCXMGXB2>$(K?Q!?7.C
MS3>!/`&C>'-(\7>,O$7BS6B=0C@\+7>E:;X9NKW4+"61/A'^P=\8/B9JOC*P
M^-?Q$DT#X#:3^W3\:_VBM%^"L?@2QM]?\97:_%K7O%GP]U+5_B`/$%V9_!EU
M-<V'B6VTVW\/6E_+-$D$]\;9A''],Z5_P3_CT+]FKPC\#]'^*-Q:>,OAK\8+
MSXX?#3XI7'AB'46\->-G\;Z[XMLUO?"T^K)!K6A/IGB/6O!VLZ3-JUL-3T+5
MM0,-S87CP36X!\3Q_P#!9V/4M`T[0-#T[]GK4OB-<?&F3X-7OQ.M_P!HG2-1
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MPV\'^`/BO'X@^#&B>,O#/C+4O!%SXB?P_P"._"_ABU\7>%H?A_KFFZ;XGOO#
MUII%G?:SX>3P]IOAS3&LF31('D`/*[__`(*O?$G4M#^)7Q>\`?`;0_$?[/'P
M7UKX&-\3/%VJ_$.YT+QM'X7^-FE>!+Z";PGX4B\*:I8ZMKO@X>-X-1UV#4-;
MTNQO-/T^>SL'GO9E:/W3]D#XL?M=^/OVE/VR?"_C?3_ASJ'PA^'/[3'B'P79
M:DGC/7)_&'@W1E^#WPM\3^#-`\/^'Y/"-OIFHV>JVWB&T\0^(KJ_UZVETO7-
M<UG3+&'4+/3;2\O-CQ)_P3@;Q;\,/VM/AWK_`,<M>U&__:RU;X8Z_P")/&,O
MA#28M2T'7/ASI7@G3WU"VTVSU&TL+W^WKCP7%?36Z'3H=/:_DAMQ*D"-)[7\
M-?V6?&OPI_:&^,_Q=\*?&J0?#SX[>+K7XB^-_A'J'@:QN9_^$^L_AYX:^',6
ML:7X^76X[RSTN32_".A7EQHLGA^X+W=M((]0BAE:,@'Q-^U9_P`%:=#^`/Q5
M^,GPYT#4OV:_,_9ZT+0]1\<:!\:_VDO"?PA^)_Q3UO5M"T_Q?=>"_@-X(U&V
MNK[Q+JNG^%M2M(DUR\B?2]2\:ZG9>$;.U\_3]3NX?SP^+_QJ_;`^)GB7]I?X
ML>"O%>CZ9X*O?B[^S!\'?`]Q:?%'X@>'=3\'^!_C/?\`@"]TZRT#PU:Z(FC0
MZIXQTOQ$D/B_Q&9O[9T475\FB-=B.$U^WOC+]CKXF6_QA^)_Q=_9^_:/G^!U
MQ\;[/P[)\5_#=_\`"[1?B=H^L>+/"^A67A/2OB!X:74O$7AI_#'BW_A$],TG
M0KV:<:_I%]'I.G7D^D?:;;,G)^(_^"=MKXETOXL6FH?&'7KC4OBO\;OV>/C=
MJ.LW7AO39;FQUKX`WOA.^@L1!;WMI;7*^,)_"P?5+J**Q33SJ$RV=G(D*(X!
M\):Q_P`%-KS]DV[\7?L_:OJ/[+&D^)OV88/#-G\5O"'Q-_:TATSXG_$GQ;X^
ML;'XEWOA?]GW1/&UC#XP\;Q>&O"'C/P_MUK7+*WL]3\3WL_@G1K)$T&YNU^P
M/A9^V!^TS^U''XI\?_LZ?!WX7:C\`]%\:>(?AYI'B?Q_\2]?\.^._$VK>'+:
M2SU'Q98Z!I7@_5M)L/"NG>*);.SELY]6N-9U#1[?4M0LRE]#:Z;=^I^*OV-?
MB?I_QB^*WQ;_`&?OVEK[X(?\+XO/"FN?%WPI>?#'0_B1INJ^+_"7A30?`=GX
MT\'WFJZ_H<G@_P`07_@OPOX>T+5_/M?$6E7PT73;W^S(KN"9[G-^&/[#_P`1
M?@IXUU>7X5?M.:_X;^#'BCXJ3_%[Q9\(KSX=^'-9N]1\1ZS)'>^,=+TGQ[/J
M$%WH7ACQCK"'5]4TQ/#]]>6LTUQ;:3JEA;3!8@#\O/V:OVK_`-JZ\^#'["'Q
M-\>:=%\5OB#XW_9<^*OQ/\"26'Q!\2:=<_%.+PU\+8_%U\?BIX:CTV+2)O%>
MHS0FVT(6,VIP6-VPEC<,X`^T_B7_`,%4=!\*:+X&\:^%]!T;6_`][^RC<?M-
M_$36M=\1VWAS3_!;^,O&7A7X5_`CP5?ZS(LNG:5<?$KXE:MXML;C5M>DMK31
M="^'_B'46BN)X&M:[S]G;_@FWJ'P%\0?L\SW'QZU'QUX-_9;\/>/O!'P<\(W
MOP_TW1;G1?`?C;1]1T.#P]K'B"U\0WCZ]<Z#IUU86MOJ\NEV;WD&E0+):033
MW$[V_`'_``2\^%W@/P%^TYX$M_&GB2\M_P!HCQ!:ZEI.K+;6EGJ/PBT'PS=K
MKOPS\*>#2'N+>?3?AIXRDU'Q?X>:]@$<FJZI=)<6HMVV$`N?L1_MWC]J#X@_
M%[X3WFN_`KQIXC^%^E>$_$B>.?V<OBK8?%KX7:WI/BQ+F+^S#K5G$LNB^)]`
MU&RFM=5T6^DDN6M;BTOT2W$K0(GQ)_;E\6?#^S^)OA>3P7HM[\9/"O[5W@K]
MG+P;X*&IW*6GBS2?B3H'@SXA^$_'#W*0M/;6$'PR\4ZCK.O2(K6MEJG@SQ98
MPR2+I[$?3OP)^$GQM^'M_KFI?&']HF?XWS:C9Z=8Z58V_P`-/#WPVT30([%6
M\^[@L=*U+7M0O]3U-R)+VXN]8%HI&VST^U0[:\^\3?L3>#/%/[9'A[]KS4?$
MFHM=Z'X!M_"\_P`-FTZTD\-ZOXMTFR\=^'_#?Q'O+YY?M:Z]HG@KXH>/?"$4
M"P-%/INK63^?"=,CBE`/D+0O^"@_[0WB[2/AU\6-&^#/PYM_V?\`XX_&/5_@
M-\+]8U/QMKT?Q!LO$=_<>*/#OP[\=>,-"@T`Z7_PA/BSQEX;72[^QTB^?7-$
MTW5[34UFOOL]S;)\M_LQ?M*_M%ZO\"/^";OCGXZW<'BZ;XG^*==@\+>,=!^(
M'B^Q\6^*9](\%_$75=0U/XO:2+>UT/759M%MK6ST5'O-/64K>,5EM86;[S\#
M_P#!-F;P3XE\`Z-'\?\`Q3JO[.7PJ^,^H?'?X>_`*[\)Z)"-'\:3SZQJ6C:?
MJ'Q#BO&U?5_"'A3Q#KVH^(O#^@MH]I/#J2V`N]4N[>P@AK%^&_\`P3%O/`-E
M\'O"5U^T1XC\3?#']GGQYXB\6?!'P1=^!=`T^Y\&:-XCT_QMIESX6O\`Q-9W
M[7?B:"SL_&(M['4;ZPMKE(M'M//CN)KBXG(!Y%\./^"H/Q;@T7X(?$[X]_"/
MP3X0^"O[0/P8^/'Q6\"ZUX)\6:OKWC#2&^!'@L?$75++QEI>IZ1I^F6L/B/P
M=9:W>:?%I-]>2:7?VMO9W=W=Q&6Z/K?P0_;2_:=\8?$#]EC3OB[\'_A9X(\`
M_M=^"?%WC_X?CPSXW\0^(_'GA31])\+:)XRT/3_&45UHFFZ`^IWNA>(-/>_;
M2)Y;>SO3-9QB80?:9>M_X=R^#[+X<?LK^`]9\6ZIXR\-_LK>`OC)X$309M&L
M[3_A:6A_&#X7:S\+]6T_5IC?R+H36^GZQ)=P26QO?-F18I)(HB[-\<?L;?LP
M_M,)^T%^SEK7CRP^-WAGX/?LM_#?QOX3\(:+\<_$'PQU.ZTZSU_1-'\,^&/"
MGA9?A_IZ:EKTFA:/I%O!JGC'Q)J#R7=C!96T-E]J^TW#@'WA\;/VG_C;;?M-
MV7[*'[-O@+X?^+/B%H_P1@_:`^(/B'XI^*]5\.^%?#_A#7O&&N^`_!&@Z=!X
M=TW4M6U+Q'XLU_PMXIE,TRP:9HFF:%-<SB\EN;>&OEG7?^"E7Q^\)^`_'_[1
MWB'X*?#FW_9F^"?QCT+X+_%^[3QUJI^)$5ZGBKPSX`\?>.O!=K+H\'A[4?#W
MA#Q=XC!L]'U&YMM2U[0K"[O4O;.X,5JWV)\=?V-O$?Q$^-^C_M'?"#X[^(O@
M!\7X/A;-\%/$NMZ3X4T7QQHOB_X;1^)+CQAH>FZGX>U^ZL[:#6_"OB74=;U+
MP]K]O<>9:C6]0M;FSO+:14'@&J?\$L8]<M?$OP^UG]H[Q]JG[/'Q'^)7AGXO
M_%SX*W7AGPTB_$'QYH>N^'O%FL-)XULA9ZGH'A;QKXK\,Z?KGBCPYIVFO]H>
M2[L['4K&TN#&H!QQ_P""A7[03>)=<U:]^#_PZM/@CX?_`&T_$/[%]UXA7Q?X
M@N/'^I>)HO$Q\.>'/&5KX>_LF+1K/P^EQ<::NM1RZO->W,LM\^GV]C%:0K>>
M(_!#]L?]L[X;_L[P?$CQ?X>\`_&B?Q5^VK?_`+-W@V#4?%OB*Q\4WOB'Q[^U
M'J'PLL]+O]4O;1M,T;PIX;M6-CX=OQ!J5W!96^EOJ.GW`2ZCK]`Y?^"?GA*3
MPAX@\(?\)[KZVVO_`+9<W[93W*:?:"6T\42^(]/\2+X1B26><2:.MSIZ1M?N
MPNG$LL@@3*HO!V'_``3=O-/O9=%C_:#\62_"&P_:?\'?M6^#_A9-X2\/%?"O
MQ!\,_&W2OCA?V,?C".2/5]3T+6M=L]3TE;6[M%ETS3-;N&2:[N+2V8`'B7BW
M]O\`_;$T;3_VB=>TSX(?!.[TK]BK1;.^_:4L1XV\7R:AXEU>'PU)X_\`%.C?
M!2^N=(TNWEC\-^!C!>IJOB_3$CUC5FDLX[:PMP;E/?/^">'Q.N?BIXS_`."@
M?B=-?U;6_#K?M=^&I_`\.I7<MQ'H/@_Q!^QM^RAXRT_1M-MIG8:=9+?^)M4U
M,V<4<4)N]2N;@*9+B1B[XU?\$X++XJ>+_C5JOAOX\_$+X4^!OVFK+2=/_:+^
M&_A72O#EYIOQ&ATS3ET&YN;#7-2M#K'A#4=?\,J/#NOW>FO=&\T[#01VMTB7
M"_3G[/?[,?A+]G35/CM?>#]2OI[+XX?$_1OB7<Z/<Q0QV/A2;0_@[\+O@U8Z
M%H_E?--IZZ)\+-*U!I;D?:#>7]W$288H``#\ZM2_X**?M$7F@:W^T=X>^%'P
MRN/V0O#?[1FG_L]ZH;CQ#XG3XUW,.I?%C0O@C+\38;:*RE\+0:'I/C?Q#::A
M<>&G@?4[GPY:7<JZC%=/'&-#_@E!9_&[Q]:?%7X\_&F;P?K>J>)/C/\`M+^&
M$\1Z=XD\;:IXEAU'P=\?_&G@F7PI;:9JMT/"^F_#WPK8^%DT?P7#8V*:LVE6
MEE<:DT5[-?++ZO=?\$Q/#,NL:GX?M?C9\1+#]G;7?CQH7[16M_LY6^G^&SX5
MO?'^@^,=,^(T-C%XFDL&\1VG@R^^(.B:3XJU3PU'*R7=S:-9+>P65Q+&?L+]
MFS]GS1/V:_A_J7P]\/ZYJ>OZ?J7Q,^+OQ-DO=6C@CN8M3^,'Q+\4?$[6=.C2
MW`C%CIFK>*KVSL&8M,]K#$\S&0D*`?F[\+O!_B3]M/XI_MW^(/B)\5OBCX/L
MOA1^T'XO_9[^$.B>!/'6K>"M.^'^A_#KPYI4$WBU;;2IH?M_B#Q/KVJ7WB.>
MXU9+B"2SM]'$*"UC1;CYV^!'_!0W]M3Q)X!\&?"[P9X:^%/Q1^)WA#X-_'SQ
M;XT^)OQ0UOQ!H-AXO/[/7QF\4_#`ZGI]GX7M9Q?W?CC2M!LYQ,9M.MK'5WNK
M^6YNK>3[$GZ0?$3]@N]UGXB_%KQ[\&?V@_B1^SI'\>VMKOXRZ!X`TWPSJECX
MM\0V^E6_A^3QKI,WB33KZ;P9XRU'P[;0:)J^LZ)N348K/3M1EM%U.R%S+J_#
M[_@GO\(_A3J_@^[^'^H:WHFC>"/V<_$G[-^BZ!/.-31O#OBG7Y_$NL>)M3U2
M[S?ZGXHO]8NKN_U"]N"%OKR]NKF90[@*`?-OPY_;S_:(_:J\5Z-X2_92\#?"
M?29_#7[-'[/?[0GQ<U7XU7GBN_L;?4_VDM'\4:[X!^%WA*W\'W.CS1W\>C>$
M-4U/5_&6HSW]A;1WFFV\'AW4)%NG2MK_`.WQ^T1X:CM/C5K?@7X03?LO6'[3
M/@S]F/QE8:=>^+'^+FCZGXL\=>'OA)+\2++6Y;]/"5_X8TOXC>);*.70+CPU
M8ZG+X;2?4$U7[4B6E>G>&_\`@F=9_#&7P%J_P,_:"^)7P>\6^'OV>?AA^S3X
MZ\1Z%IGA;6#\4?`7P>COHO`&K:[IFN:9=6FF>-O#T.L:_:V'B/3-ACL-9FL9
MK.XAM++R=J[_`.";?AO5?$ND)KGQJ^*&L_!_2OC%X;_:"F^"5Z?#A\-ZS\8/
M"M]I^NZ5XBUK78=%A\0W6CGQ;I=GXQN_#,-S:V-UK\2R/,+(?8B`?$?[,'[;
M_BS]GWX?:6OQD%IJ/PE\3>)_^"E.MZ+\0;N?6KKQ`/B9\%OVLOC5J-C\/;J\
MN+F?35T[6/`FG7=CX7TN&T6^AOM&MM.M)IH'CA'`:/\`'?\`;H\<_$;]KK6/
M&6H_"_1M"TG]@[]GCXO^-?A"+/XF6J^';#QUI7[1MU=:9\.M6TOQ]9W?A7Q[
MJ,GAP6WB;Q-<K?BZM=/\.MINF:3=Z7=&]^XOBU^P%I&I_"WX3?L]:/87/BWP
M,G[7'BG]H#QQXHUG4[/2]1\.Z+XR^*_C#XV^+-'TJV@CWZC:ZEK_`(ED\*0V
M,07S]%;_`(F1F'GD^U?&']A/3?B;\4O%7Q0\+_%OQK\*IOB?\*/#WP8^+_AS
MPQI_AO4M&^(?@/PEJ7BG4_#&GS_VYI=W=>'[K3QXW\4Z9/>Z+-#-<:1JK6T'
MV.YM[>]C`/D?]E3]JG]J?X_Z/I.@_L]^'?@MX<^'GP1^'W[-FD?$.Y^+4OQ'
M\6^+_%_BGQW\-?!_COQ5H_A36-+\3VIT*#PQX3U=8;7Q#XMA\97^N>()(3JL
M5O;FYN6]`_8A_;M^*O[27Q3U+PI\2-6^!/@'5],M?B#+XH_9DGT7XD>%/VGO
MA>/#GBR70O#>H:[#XQU0:/\`$70M2L($OM<\1>#?"ND:+I4VLZ#%:7FHP7D<
M\_H7@W_@FYIGPKU?2]1^#7[0/Q>^%=C>^%?A)X7^)VA^&SX4N=/^);?!O0-(
M\+^&]?NY-;\/:G>>&M?U+0-&M](\0WVA3Q)J-@[1I!;W"17*>9_%O_@GK\8)
M/"^N:_X0_:?^*7C[XM:/\./%OP>^"/B?QW>^'M!U7X0^&?BMKOA]/'GBR'Q9
MX0T#1M?\3^-+'P[HEA:Z-J>HS0D/IPG>!]3O[C4*`/OG]JSX^:/^R]^S;\:O
MVBM<L+C5](^#GPW\6?$&YT>UD6WN=:;PWHUYJ-KHT-S*KQVDFK7L-OIPNY4>
M.U^T^>\<@C\MOR_^,_\`P4$_:P_9<A\=>$OC;X0^!GB3XD2?L]1_'KX47OP\
MMO&VB^%+V[TGQ]X-\#^-_AWXOTSQ#XEU_47N-"G\:Z;/I?B[3-7L+?5(XYY9
M]`LV"P/^JFO_``+\&^/OV>]3_9T^(D>H>-O`GBGX7W7PI\9?\)#J-[?ZQXH\
M.:IX<D\,:W<:GK%S//J$NL:K93W%S+JKW,EY%J$WVQ9FF16KXAO?^"7/A+Q7
MHWCY/BK\</BM\6O&7C'X8^'?@OH_CKQ:?#4&I>"/AGX=\1Z#XK71]#TW1-%T
MW3KC6-=UOP]877B;Q%J*SZAJ_DPHIM(XMC`'TEX9\7_M8VW[-GQ%\<_$'PU\
M&8_CA:^$?%7B;X<^%_!=_P"+M5\#R36_AR74O">D^)]1U:32=8OYYM11(-8N
MM*31HI('/V**U<>8?SL@_P""M'B'5]0\'ZGHO@KPU)X"\0?LE3_%;4->FEU9
MI;']H:Z^&-S\2="^#:2I?1VOD7L.F:OHLD4B?VN=3LT@CNXGFC$G[=VVEQ6V
MC6^B@^;!;Z9%IF91GS88K5;7,H!&?,1?G`(ZG!K\TK+_`()7?!/3_@W?_!JT
M\1>+8-,O/VCC^T9#K\-W#'KNGZF/$$NK1^![*Y\EO+\%1:5=7_A9=+/!T2^N
M('+LQ)`/SRU_XQ^.O%WQET)-1=_"NJ>'/^"EWCSX<Z\OA?Q%XPDTOQ5C_@EO
M!\5KJYFM-9UZ_CTS3H_$/C5#9Z%IZQ:/!)H]A?BWEU3[3J,WZP_\$S]5U/6O
MV'/V<]3UG4;[5M4N_`9EO=1U*[N+Z^NI?[?UI1+<WEU)+<7$A147?+([[5`)
MP`*S+K_@GO\`#:X\=:WXZ'BGQ/'>:U^TYK'[4KV2_8/LMMXSUO\`9CT?]EN[
MT2'_`$;?_8(\&Z):ZT@)^V#7))LS&S*PCZ9_9\^"VB_L\_"#P-\&_#FI7^KZ
M%X#T<Z-IFHZJ(1J5U;F^O+[S+L6T<4'F![QT'E(J[$7C.35RDFHI12LDF]+M
MI:O3N![/1114`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`5Y_\5_B-HWP@^&7C[XJ>(K34K_0/AUX1
MU_QGK-EHT=G+JUUIGAW3;C5+V#38]0O-.L9+V2WMI%MDN[^SMVE*B:YA0M(O
MH%>0_M`?#6[^,GP-^+WPFL-2M]&O?B3\.?&'@BTU:Z@DNK;3;CQ-H5[I$-]/
M;1/')/#:R72S211NCR*A56!(-`'PX_\`P5-^'+Z-X+N[/]GO]II_%'Q2O+UO
MA%\.]=\*_#[X?>,?B;X4T;P]H7B'Q)\1]&;XF_$OP7X6\-_#WPXOB31M'OO$
M7Q#\3>#%OM>U'3]*T"VUBYU&P6YYBU_X*[_"7Q'<:+H?PX^`?[0WQ1\=77AG
MQ+XJ\5_#CPM%\$M(\7^`+/PIXDN?">K:7K(^(/QI\%>'?%?B4ZS:O'8>'_A7
MX@^(5_J5K);7MBD]O=VKS:OQ^_X)^ZA\7+/]EWQ1I9^$&O\`Q0_9H\`ZK\,%
MTSXV_#6U^(_P>\>>#_%6D>#+3Q/8ZSX7U$37VG:E::WX!\.^(?"^NZ6RW^ES
MP75E)+-:ZI=!?!OC+_P3)^-?QB^&"?"W5-0_8ZT31M0T75-+,OA7]G5_#%Y\
M*K_5KE_,\0_!+5-!O].U#0]7L[8Q7%O+J$T:2:M:6U]<*_E",@'VEK?_``4+
M^%F@^#OVI/&>H^!?BA!8?LE^(_`/A7XC:=/I7AZVUK4]6^(?PQ^&_P`5],A\
M-:?=>)87D.E^'OBAX?LM<BUU]!N;;6K;5+6U@O;6W@O;G\^M0_;U_:.^'?QN
M3P=HG@/QA\;]#\7?\%`OBY\&8]"\/1?#*+Q#;^`?"OP2\1^/M$^''@^X\<_$
M?X?:59>*Y=3TR/6K74_$.I6GA]]"TK7+*Y\16^ISZ99WG=_%#_@F1\>]6LOC
MOX#^&/[07AC3OA;^TC#\'=4^)D'Q!\%:GXF\=R^-/A'\+/AS\)6U+3O$-IJE
MM;#3_&/AWX9>'+C64O+>>ZM=1-]+92_OCCT7Q%_P3S^*D7B*_P#B/\//B9X1
MT;XD:3^VEJO[6G@*?Q'X:U/4O"UO'KWPRU[X6ZQX.\4:?9ZA;7UV+C1/$-_<
MPZGI\\+V]['9D1-'YV0#Z7_:M^-VO>`/A)\)/'T&J?$#X17_`(R^*WP3\-ZG
MI-AX-\`>.?%FEGQUK]E:7_@?Q+IVK^*!X8L5E:X?1?$6O>'=<UBYT@PW%[X9
MEUIE@:;R_P`$?\%//AIXI^(/@KP:WP4_:`\/^"_'OQX\6?LT^'/CAX@\.^#(
MOA5=?&SPQ-XV5O!WVRP\<W_BPP:Q_P`()K-OI'B%?"CZ`-6EL?#VJ:CINNR3
MZ?;>U_M$?L^>//VA/@_\)_!>O>*M`T[QMX,^)'P9^)7BW7;#2KU="UG5OAQK
M%AK?B&#1=.:<W6GVFLW\%T--CN;B=[*WEB29IBA8^":7^P'K]AX!^"_A*X^(
M.FO-\)_^"@7B+]M*\NUT>Z6+6-*UGQG\4?%<7@>!&N"]M?6Z?$*"U;4V,D#O
MIKLL`6=0H!]>?M&?M!G]GWP?I'BJ/X6^-?BI-K&L1:1%HO@[Q#\)O"CZ<TL+
MS+?:UXB^,_Q'^%W@_3++Y1"GF^('O9[EU@M[.9C4W[-_[2/@3]IGX):'\=_!
MMIJF@^%M8;Q39WVF^)3I*ZUX<UOP'XCUSP=XVT+6Y=!U+7-`EO/#7BCPWKFD
MW-[H6N:WH=\+'[?I&JW^GW%O<2?/?[;_`.R#XG_:=N_@/XJ\(^)?"6F>(_@7
MX_U+QQI?ASXB^$?^$Z^''BB36M"GT&:/Q)X9>>V2[NM)CG^WZ%=R%S8Z@/.$
M?)KT?]CO]FG4/V<_V=9/@=XJ\0:;XQFN_&GQU\7:IJVC:&GA?3+N/XU_&#XB
M_%&\T^PT*&6:'2+?3$\<OI,5I;.;:(6F^V"PNBJ`?GI^US_P4?\`&'BS]C?]
MI/XE?L_?!_\`:$\"^&-'^''C+5/A/^U=<Z?\.%^'>N:GX+\3Z+HVHWFD:3;>
M/-5^(UA::C+<7R>%]0\1?#_3-/\`$MM8:H]A<>=#;0W7UEX6_P""A%I>>(_&
MW@'Q1^S+^T'\-O'?AKX4:A\:?!O@[QVOPKT[7/BE\/=-UVU\.3WWAU[?XGZE
MI?AG6+2]O]+?4_#OQ(U;P=K.BV5]#-JUK:31SV\7S??_`/!-S]H6X_9E^+'[
M%\/[1'A)_P!G;Q+X(\<>$/AS::A\/KJ7QUX:A\4>)+3Q%H$'B#7(-22SU+3O
M!ACOK2P2PM+:ZU"*YB>_F+VZ[_>_VPOV#=2_:E\8ZWXK3Q^OA)=6_9V\5?!-
M+*/2I[TG4->^(G@;Q]::KJ!%Q%'=Z$9_!@TK6=%<!M0L+^9#*JEE(!Q5M_P5
MT^$T'@WX@^(/$?P3^-6C>+/AG\3_`($_"WQ'\,]'NOA#\1_%-[JG[1?B&R\-
M?#76O"NJ?#'XI>,/!GB71K[4[N2VO;6R\3)XGMKVQO--C\.7&H+#;S]IJ/\`
MP4O\-^&M"UBT\<_L\?'/P9\:;;XB>$OACX9_9XO_`/A6VM_$CQOXE\?Z/?\`
MB'P=_8.H^$_'NO\`@2+3;O0M+U+4M>U34_%=EI_AF'2]2-_<R);QR7'SOH7_
M``2W^(LNJ^-O$OBOXJ?#^WUOQA\4OV&?B2VD_#_X9)X+\)Z.G[''Q/\`^$^E
MT33=)L[MD8>,+5(M.74)6%Q!<M)>70G4*J]7^W9^SNFDZIXA_:@A\2_$72O'
MVE?$WX)^+?A=J/PN^%>L_%O6/!_B/P3X5\9>#;QO$'@C15DU+Q'X3\0Z3XGN
M[;6WLH5ETX+;3)N/0`[G4/\`@JKX,\-:;\2],\?_`+/WQD^'GQ>^''Q.^&GP
M7'P7\3:U\'+CQ!XO^)7Q3^'T'Q.\/Z?X:\8^&OB9K_PU3PW:^#)9==UKQ7X@
M\7Z'8Z-IME?W.IV]H;5XC]5_LL_M8^$_VJ/`^O>+-!\+>(O!.J^#?&&M^`_'
M'@SQ3>^&=2U?PWXGT)X#<6ZZMX.UOQ+X6UW3;ZUN(;_2-8T/7+ZQU"TE1U>.
M3?$GX[_`']C/XK?M5)^T'\=OB#JVN:)X\U']J'X/_%KX'>,/C#\&H/"]EXKU
M'X5?L[>&_A/XBU/Q'\#]6=KS3/AUXC.K^,/!6EZ9J[6^NW6EZ0FON()KF$-^
MR'[-OPD^('PM\*:MIOQ*U7X=:MK6J:^^IPVOPK^'ME\.?!VDV?EP0PV%GHMJ
M\LUV_P"Z,\^H:A*]Q-)(58I&B*`#Y:A_X*=>%-5\0Z>-'^!/Q7O?A!XS^)_C
M7X&_"3X^VVK?#)?`?Q+^,?@?4]?\-ZAX4L=+NO'%EXJ\/:-K?C#PUK/A#PKX
MV\0Z38>'-6UO3YWN;K2M*>TU6ZXS_@E5\4/VA/COX"\9_'SXVP_&82^.HKF^
M\,Z5XJ\6?!V^^$\JKXG\4POI'PD\-^!]5O/%7AE/#=MIVG:#JES\11I\NJ2R
MPW=E)?(+N_:?PI_P3:\1^'-<\`^"I_BQ;W7[,GPD_:$\9?M&?#OX66_A98?$
M5MXJ\5^+_$_Q#M?#.M>+)+M_M?A3PQXV\8Z]JFDQV]C%>SVKV5E<S,EON;[5
M_9!_9_F_9@^`O@CX)R^(/^$I;P=;ZRG]NBS^P"].L>(-3UPXMMSB,0G43`/G
M)81;V`W`4`?BQJ'_``43_:S\3?!.W\>Z]\&?BAX*B\/?MTZ7\,H_$_A'7?@_
M?7/BW0=-^*E]X8E^!-IX5\/^-M4U>]\3/96Z:7J_B34[72/!NH3K]M@\5_V>
M)+Y/N^Y_X*I>#=!\&>*3XZ^!OQ'\"?';PO\`'[3_`-FR7]GK7?%'PO/B"[^(
MNO\`PW\/_&7PY=IX^MO&$GPXM_!ES\*/%&F>,=:\3RZ^8=#2UUS34M-3NM/M
M3J?,+_P3N^(UNVJ>!5^,NB1_!W_AJ_2OVK_#&@2>#)I?%VE>(QXY3QOK^@W>
MNQ7QM;W2[N_DO;:RE%G%-;170,AE\I2=OXN_\$U/^%A?$OXQ_&?2?B#8Z;\0
MO&'[1OPY_:/^',FM^#-,\5>'?"NM>!_V;_!?[.&I^%_$7A_59&L_$NA>*?#/
MAG4;J])^SW-K-K$;VSB;3XG(!]4?LH_M=>'OVI?"GC#5;/P?J_@'Q9\.?&>I
M>`O'G@W5=<\.^*$TK7]/MX+Z*XT;Q7X0O=4\/^)?#^JZ;=6VHZ5J]E/#)-!,
M([JPL[I6MQ\B>$O^"L%KKEM\-_'/B7]EGXN>`_V?OB5\5-=^">E_'W7?%GPQ
MN_"UE\1M(\>>*?A];PW_`(<TKQ+=>+K3PC?Z[X7GL5\7:AI5A;IJ=R+"UL+^
M&WEOV^T?V;_A!\0_A9X<\2P?$7Q/X'\1ZSKVMMJ=K;?#OX<:3\-/"^AV*V4%
MK%I]II.FM)-?3N\#3W.HZC*]Q(\OEQK'$BK7Y2_L?_L(?''XG?!#X-^%/VB/
M'%SX9^"OPX_:'^.7Q6C_`&?)_`L&C^*-5UG3_P!I'XMZ_P""AXF\6O=R2WOA
M6]&I6OC6TMX;&">[@U2RB>X>WC1F`/I'0_\`@K1X&U/Q9HVCW_P<\5:3X7\?
M:%\6]8^$?B^+QW\/-=E\8S_"'PAXA\>ZGI'B;PAH.KW_`(I^&E[XI\(^$_$6
MM^#I/$]B;2_BTQ]-U2?1M?N+31YZL7_!4SQ1?>%?ACXFM?V.?B1X?3XU:-9^
M)?A,GQ/^+/P7^&FG^-/#G_"'Z;XIU/5(-6UGQ-=1Z,?M.K66B>&=/\06VF:C
MXJ>4:Q;VUCHN;P7O"O\`P3X^(_ABWD\!V?Q5\!1_"+2=!^(6@>'[>S^"GA6Q
M^*%YIGC/PKXE\,Z/I/B7XB1$7US9>'!XB74+B^T^&#4=?&DV5CJ+K;37ZS]K
M\6OV'?'_`(Z_9S^$O[.WA_XC>"(_#?@;X*:#\%?$]M\1?A1X?^(VAZ_::)X+
MTSP?!XTTFPUF02Z'XMLHK"6]TNX@D,$4\T?F;6@1R`9WBG_@I3J.G:I\1(/!
MG[*WQ7\?:-\`_"_PV\1?M*:M9>+OAEHL_P`)=1^)7A'3OB%;>"-.TW4_$G_%
MP_&GA/P%J^D^+/&-EX=O8='L=/U;3+?2=<UO4[V.QKD/$G_!5^RT>V^*WCG1
M_P!F/XG^*/@+\"OB#X;\%_%OXVV/B_X>:?I7A_2_%%QX62S\6:)X-U;6+3QG
MXKL=,L/%NG:SX@M-/TN$Z?IBS/:7>I7<<MI%S=I_P2Y\8_#[2/&?@;X*?M#Z
MWX-^&WQF^&?P=^'?QQT[Q#X5L?%GBGQ+>?"#X>>'OA'!X[\,^(+J\ADT/Q3X
MJ^&WA;1-`UQKM+^T^TZ9:ZK!&ETUP9O1-=_X)UV+_L[_`+6_[/\`I?CJYTW1
M_P!I_P`3V.O:?J;:2ES<^"+?3;#PC96.F^2\R1ZHD=OX0B$ES*\+.]T5VA@I
M(!]>_M1?M,:)^S%X$T+Q3?>$?$'Q`\2^-?&?AGX<?#SP!X6N-,M-:\9>.O%U
MZMCHNBVU_K-S9Z7IEMD37>HZMJ$T=IIUA;3W,H<JL;?%WB;_`(*G'P(GB[PA
MXW_9>^)NF_'OP1\9/@;\'M7^!^A>,/`7BC5-8N/VB[?69OA5XK\&^+[+4+;P
MWKF@:]/H.IZ3)_:4GA^[T_6=/U&VOXK>RLVU&3Z]_:T_9K@_:<^'GA_P];>*
M=1\`^-_`WC;PO\3OAOX[TFSM]1N/"OCKPC>"]TF^FTV\9+?4],GW3V6J:?,R
M"[L+B:-71RK#Y'TW_@G1XJU_QF/C!\6/C"OB[XTZU^TA^S-\:O%GB'1?"-OX
M=\./X4_9?NM4D\"?#C1-"2[N6L;*0:[X@O-1U6>[N+N74-9N9`IA2&)`#ZY^
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MC7S++_P31UWXJ6_CCQ_\??C'?>*_CUXF\.?![PY\.OB%X?\`!VE>'+/X/:#\
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MBG4/AW\;O`7Q=T'3_!/PL\/^`=`5?`NB>,-&&FSPZ?<7%[=7NO\`_"6R7FI:
MC<W,GV9[*&"QB6,G/.?'#_@GMXF_:"^+FG>(_B+\9[?6OA9HWQ-\-?%#0_",
MOPF\'6_C_P`.W?AC[#/9^#/#GQ:@">);/P1>ZA:W5_J-K)&U_+'J%SIIF>UD
M90`0^"/^"H%CXEU[X37WB/\`9^\9^"O@O^T7JGCOPY^SS\:+WQGX0U;3?'OB
MCP7X4\5^.;'1/$7A#3F_X2/P*?'?A3P1XIU;P1?SIKEEJ!TE[+4I-)O;JR@N
M?/\`PU_P5OOY?AWX!^,OQ#_8]^*_P^^%7Q:^"WC;XQ_"W7K?QKX#\;^)/%D'
M@3P79^-=1\.3>"?#4\FL:#?:QIUS+'X=N=2E7[5]EDGU:ST2)XP>J\$?\$T=
M5T#Q)\)=&\3_`!JU3Q-\!_V:M8\>^*/V<_A5_P`(KI6G77A7Q5XV\'^,/`=G
MJOB_Q/!-)=>*X/`/A?Q[XETSP59FWLU0ZD]SJ+SR6L(;O(_V`+O2/@Y^R5\,
MO!GQD\1^%-:_9*\`:IX-\(^.[+0=)O-5U&[O_!UEX1MM;N=.OXVTY7M5L%N9
M;$H]O=QS36K&,,LJ@'K'[('[6?BC]J*W\3:AK/P>TOX=:-I>C^%];\/Z[H'Q
MM^'?QBTS78O$BZG+-HNJ+X-:UU+PIXHT&VL].NM4T[4=.N-)GAUJV72-?U.>
MRU.&S\1\6_\`!4GX;^")?#UCXA^'?B:UUB[_`&F=?_9Y\::2FL:<UQ\.=(\/
M>*O#/@R^^,7B622UAAC\!Q:YX\\`I<2,UO);6/BF+4'N'MK"[8>B?LH_L87_
M`,!?B[\6_CSXU\>:1XR^(_Q:\&>`OA_J,7A'X<^'?A3X1M/#GP[U/Q9JVDWT
M_AOPTTEOK/BS5+KQ=>C5_$NI227:V5GI^F6PBLK<*W/:_P#\$X?A?XK^+W[5
M?Q2\0ZIJ&J67[4WPJ/PSUCP?<6MO_9/A*;4M&?2?$_BS09HVCN1K?B)K70+^
M[G\R(QWGA[3)H'CFB650#YN\6?MR?&;QM^T_X-;]G_X,>,/B)HOAKQ1^U'\'
M?^$"?XIZ)X#\(_$[4O@W/X/TS6?B)?ZQK=A)IFFZ?X>\43>*/"VDP1Z7XCUB
M?5-&O_(6""Y)C])\/_\`!4;4?BK;_"SP_P#L_?LU:_\`$OXM>.O@MK_QX\8>
M`O$GQ/\`"_PZT;X6^"O#?C1OAW=VVN^-YM'\3Q:QXAUCQI9:]H_A73=(\/M;
M:O'X>U34+W4-'LXA(?>?@9^Q7I?P2'[/<T/C36?$FJ?`WP=\4=#U+4]0T^RM
MYO'_`(G^,6O2^*_'?C;5UMV(L]1UCQ7>ZMKDMM:[H?M&IS+]Q5KP+0/^"9FH
M_"RX^'/BSX'_`!U\0?#[XG^$?`GQ#^$?B'Q?J'@OP[XMT_QK\+O'_P`0+SXE
M_P!@:QH%]-!!:7_A#Q-?7MYX2UFQG$]N]]?6U[%-:WD@4`^Q-!_:_P#A;JW[
M*;_M?7RZKH7PST_X::_\2_$-I?103:]H%KX2M-1?Q3X?N;:UFEM;K7-&U31]
M4T)H[2ZDM+S4K0_9+F2WF@FD^(/%O_!4KXB_"OPSI'B_XR_L@:CX'T7QKX&L
M_BW\.XM+^-.E^+M9U/X6V'BSP)HOC^[\::9:_#S38_!7C_P+X:^(&D^.9_!M
MC>^+M`U?1[+6+:W\?6MWIEUY?W/X;_91^%FE?LN']DR\AN];^&U[\,];^&NO
M?;&C34M:L/%>G:A:^*M5NI(D$4>K:U?ZQJ>L2RQ(([>_N]]NBI'&!\R>#?\`
M@GI=PV@T?XU_'/Q)\<-%\.?`[QI^S]\*;'6_"7A_P_/X+\%>/(?#=MX@U+5K
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M^,4SZUH_BV.'Q]@"W$=IXT\->&?%EG+8J98-2T2-8R@NIB?18?\`@G]X5@^"
M$GP53QYXI.E-^UCXC_:N&M/I6F-J?]O^)OC?KWQMN?"QML_9UT:#5]?N-(AO
M`S7[:;%#/(HNC(*`/7OVI?VI;S]G]_@OX/\`!GPWD^+WQH_:'^(=]\./A+\.
MSXNM?`>B7NH:'X+\2_$/Q7XD\7^.;S1/$7_",>$/"?A'PIJFI:O?V7AGQ'K4
M\S6.G:/X?U2_O(H*^/+W_@J/XVAO],^&>G_LF:OK?[2:_&[7?@-XH^#&G_&/
MP]%I6D>*;3P-_P`+`\.>(M'^)NH^$+'1];\"^)=`>.Z.MZKHWA74M)BCO(YM
M"NM1@@TR[^S/VHOV9+#]H.V^$OB"P\<:S\*OBM\#OB"WQ&^%'Q,\/6&EZO?>
M'=<OO#&O^#?$.F7NAZT!IVO>'_%/A+Q)K.BZUH]TT2W$4T,R3136T35\^?#/
M_@G?X>\'>-_!?Q7U7XK^*_&_Q0TGXYZ[\=_'/C34=$T;3Y?B!XBUCP2_P^L=
M'N-,LO\`0_#OA_P_X>,%OI=EI;R.K0%Y9)#,[4`?0'[27[4\?[,GP.L_BEXO
M^']_KGC/6-5\!^"O#_PK\.^(+.:\USXG_$77=.\+>'O!MGXHN]/MK%+%O$&H
MI!=>)9=-6&+38+G58]-ECB,!^?M7_;7_`&E-+^(/P^_9^'[)'@"7]I7Q[H?C
M#Q\/"C_M2R+\'O#_`,*?!TFCV-SXUU7XM6GP"O\`Q@]_JFO:Y:>&M+\*VOP3
MEO)=8@OYKB^M]!MX];N/JG]J3]F[PI^U'\*-4^&?B?5M:\.2G6/"OBSPSXK\
M.O`NN>$?&?@77[;Q/X2\2Z0+J.6V:[TK6K.VN6AF0PW<*-:SYBD85\LZM^P;
M\1-8U_P5\69OVK_B-;_M#^!K+Q7X<L/BQ;^!/`T<=Y\/?%RZ7)J?@2^\"!/^
M$>GT\:EHFFZW:WK7?VV#5EN;A'5+J6*@#QK2O^"I_P`1OB1<?#CPO\%_V2+?
MQ7\2O$OA;]HN^^(O@WQS\>=*\`6?PF\=_LP?$6R^&WQ*\":EXAL/AKXW3Q)'
M/K4]W)X8\2:1I<46K0#2Y+K2=,M=3GN]-\^^%W[<W[2WQJ_:K^&NK?##X>^"
M+GX,?$3]A?P?\>KWX<^.?C=K?AF;P[97WQ5O]!\7^+X'T'X`^-H=7^(VC/!?
M>%-'\'?VKIWA7Q%HNFVGB&Z\:^'KV^DT&R^OO@Q_P3P^'OP5\6_#KQ;X>\6>
M+;_5?!OP]^.GA;Q!>:S%8W-]\0_%O[0OC:Q^('Q)^(OB>^B2)D\0ZCXGLYKN
MWL[.)=/MK2ZCL(B(+&V!X[PS_P`$VH/AZ?@3>_#'XX^//!&O_!SX-/\``/6]
M:M]`\-ZL?B;\)Y?&4'C67PMKMCJ*M;:-=C5HKI+;6]((NK:SU&ZB4,7!`!YW
MX7_X*9_'CQSX=^!DFB?L::%H7C#]J._DA^`FC>,?VE+6UT+6-#T/0)?$'C?Q
MAX\U_P`*_!SQ9J7@G0="MT@@T6VL_#7BGQ#XDDOK43Z+H#K=Q6NC\(/VK/$_
M[0O[4_P&T_5_#-]\+/%?PW\5?MD_`SXY_#+3O&+^+_"<'Q'^&7AWX4:S8ZAH
MOB<:+X6?QIX8U+PYXMT'Q3X0U?5/"OAS5(M/\1M%J?A[2-4M[JW3V[6OV!_#
M]S\&_P!G'P!X7^(WC+P-XY_95=I?A-\6-)L=)O?$-@;W3KG1M;M-5T:^C?1]
M6TS6]*N!:7VGRJD9:UMIXV22)6.O\#/V$_"/P4\9^!_'T?C7Q;XM\;Z%XL^.
MGQ$\:^*_$,6FI>_$CQ_\?+7PU8>*-?UB*QBBM].BTK3/".@Z+X?TO3XUM=/T
MC3;"Q!D6W5R`<'^UE^WIXW^!'QFL?@IX`^$?PO\`$FL'X;M\2O\`A)/CS^T%
M=_LY^$/%<IU:]T:S^'GPTU]/A!\4M,\2^.II[5)=0CU^[\(:%H=O?:;)?ZHT
M=Y)):,U'_@HI):_`GXL_&D?!W;)\+OVN-:_97_X1F3Q]N;7%TCXGZ/\`#<^.
MSK,/@QX]-%R-6_MH>&X].U2.)819)XDF28:@G=?M;?L8:E^U>GB?P?K'QY^(
M'@[X4?$?P;=>!/B-\,=&T/PEK>CZ_H-W%/;7]UI%[K]A/J/A/7;RSNYK1]<T
MQY)X$$<MND5PJ2UXCXM_X)7>'O$>H>-M%T_X]_%WPW\(/&WQ@TCX\7_P<TN+
MP\WAJW^)5AJOAO5[S4$UJZL9=<N=)U?4?#%K?WNC27"0+?SW=RCCSMM`'Y7_
M`!/\9?MF>._&/Q1\47-IHL$GQ&_X*&:%^Q3<7]C^VC\<?"::=X%_X6+HQE^"
MGA;PAHO[.UUH/@7PIXIA\)0Z?XB^/WAO4[GXG6-EKGB2/3?`%Y%J<L"_:'P<
M_:I\2?LZWWQ`^`'A3X=^+?'WQNU']H_PU\!?AO\`"[QW^U!XM\??#32=?F^%
M6G_$7Q3>:=\6O'/PNC\;^%_A;X1T^ZOKB=G\#>(O$.LSQVJV.AV<ETEC9?>$
MG["'@V99ED\4>)VW_MN:9^V^,Q:>`OCK2-8?6[?PPNT-CPU+<N0\A'VXC(R"
M<US7CS_@G1X%\9^(_B!X]L/'?C;PA\3/$_QSTG]H#P7X]\/KI?\`:WPU\<:7
MX*M/`4B:/:WT$]CJ>D:IH%O/9ZO8:G')'=QW3J&0Q1LH!\Z>-/VV_&OP"^+7
MQ?\`%?QW^&NM^&?'OA7]EGX':L/A!X:_:*'C'X(WGC7XD_M(_&[X6>$8O#DN
ML?#OP;:Z+?>)CX6T+6]7^*.K:/8:L?"^NV/AS4_!<=]X.8W,LO\`P4_^+^G_
M`-B^$A^SG\)_'?Q3\3?&CX<_"3PS!\*/VFM0\3_"/6C\3/`OQ&\6:9J;_$[7
M?@?X5U32+[PSJ/P_FT?Q;HT_@6\GM]/NVUO1I]8=;/1]0]_U/_@G+X4\:CQ7
M??%;XK_$GXA^+?%_P;\(_"?5/'6H-I&D^)(+KP+\7_'WQF\*>-M);2[-;+3-
M<\.^)O'#VVB116\MI8Z7H^EVJ1R"*1I-^R_8H\2:S?\`PRU3XL?M%_$_XO7W
MPG^,G@_XQ^%#KVC>%]$MK35/!GA7QYX5L]+EM=%LH([B+4K;Q[?7.HW[$W,T
MMC9QHEO$A4@'Q1\6_P!MO]L'6/%/PP\#>%OA=\*/`GQ<\`?ML>%?@3\5/"3_
M`!X\62_#?Q];>)?AKIGQ"\*IH7CFT_9]U/Q&GA+Q+I/B2WC\17^H^`+37O#.
MHZ0T=CH^O0W)GB_<O0I]5N=(T^;7+.PT_67M8#JMCI>HSZOIMIJ!B0W=O8:I
M=:;H]WJ%G#,7CM[RZTG3+BXB599K"T=C!'\'?$K]@;PCX]U[XE>,],\?^-O!
MOCSQQ\<?A[^T!H?BK1$TV>Z\#>.OAQX%T;P!I9TJQU""6ROM.OM'T=&U&TU!
M9$FGN)&4J$4U]U^&].N])T73M/O]2N]8OK2SMK>[U6^CABN]1N(8(XY;VXCM
MP($FN75I9$A'EJ[$(`H``!N4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7F/QC^)NF?!KX:^,OBEKMC
MJ>HZ!X%T&]\2ZY;:+:I>:H=(TT+-J-Q:VTDT"2?8[,37DH,B_N+>0KE@%/IU
M8OB/0-*\5:!KGAG7+*#4=&\0Z/J>A:M87"[H+W2]7LYK"_M)E[Q7-I<2PN/[
MKF@#X>^,?_!13X"?!6]2'Q/?:_=::O[/ES^TAJ&O:#I*:MIFD>"+CQ9X9\#^
M"]/O%AF^US^*/B?XN\2#P[\/]"LH)[C7-1TK5XE>+[*&/RC\=O\`@JQX@\(_
M#[6I/`WP/^(7@_XV>$?B=\!M&\5?"OXP^$K<:K%\./C!X^TOPU;>*=.A\/\`
MBVTL[S^WK::^T;PW<0Z[*VF>*I;"WU[2C$)87X?0_P#@DM\1)_V;/VF?AAXN
M^)V@7WQ2\?7'P8\/?`_QLR:EJFG>#?AO^RSXC\/^-_@%X<\1VUS!:W5S!+XV
MT?4_$'C>RLW>*YG\3ZJMG<N4A>M?XB?\$_?VK?C]-\8_C%\4/$'P7\%_'3Q+
M8?L]:3\/?"/@W4O%?B#X;06G[/\`\4]-^*D<WBGQ!J.BZ+X@+^-]7L6MIHK#
M2G;PW;.@M[C4I`[L`>R0_P#!0NY\)>/OCC>_$O0_B9I.C?#_`,`?LV:W#\#9
MOA/HUO\`$'PQJGQW^(WQ/^'6C7!\2Z5X[UJ3QA>ZWJ'P_:_?PY'X?TE=#TJ\
MTN>VU/6;K4+JVTWHQ_P5'^%VD>#?B-JWQ!^&7QC^&_Q&^'OCSX?_``VB^!OB
M;PSI;?%+QIXR^+,,-U\,=&\':=HVK:QI&J2^,K:22:T)U.%=/@L]2FUB33H]
M/N9(_.[S]B[]IKXF?$WXD_&3XGS_``<\,>*OB5X8_8ATF\T#P9KGBG7='TJ_
M_9C^.WQL^(?BMHM2UK0-/N[Z'7/"?C[PQ;:5/+:PRRZS;ZG#<16=G:V<T_EO
M[>G[*OB'0O%WQ8_:ZNO'>C^$V\(_%S]D[XT_":>#P'X[^)L5CXK^"FE:QX&U
M+3OB%X2\!:+J7BFX\'^)-.\9ZUIU]J/AV"[N=`M+I-=D:$V.V@#](/V:OVK]
M*_:/U#XK^'X/A[\0OAAXM^#/B'P[X9\<^$_B1I^D6&M:=J?B;PQ8>+]/C3^Q
M]3U>SGC&BZE9S-/%<-'(9T,3,N6'S#XT_P""BR^*K']HS0?@Q\-/BC>1?!^Q
M^-WA-OCH-!\,WGPTT'XI?";P9XEUR]L-6T^YUR;Q/!IT>K:%+I.FZUJ?A9/#
MNL:XEOI<%W+)<JC<Q_P2_3XI^.=?_:^_:&^(FGVD6G?M`_%[P5K7@O6M,\&^
M-?A_H'BC2O!OPG\+>#[S5O#'A3XD6MCX^@\+P:CI[:-8:SXFT^RG\17.E:EJ
MUA:QZ5+99\^^(?\`P3R_:"^(/QO\5?$*QC^`7PLLM2T[X^VNN>*_AM>^/-+\
M2?'BR^)GPP\:?#WP3H'Q?\*31/X3A'AC4O$NB^-M3\1V0U34[O7O"]L+""RB
MOKHD`]>_9C_X*.R_$/P]\(_!WQ"^$/QKTOXG^,OV8[/XT>']:U;P7HVCZ3\<
M;WPQX+T+5?')^'.G6FIF\BN;[5M1#:'8:GIFBP7L.HV,MCOLI8G,5_\`\%:/
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M1CH<&Z,,WP]_P5(^''Q,\::-X5^`_P`*_BU\<].N_A]\(?B?X@\4>![+PG;6
M?A?PA\;M+BUWP/>W&C>)O$NA^)M:F;1)6U/6[?PUHNLOHEM!,M]Y<ZB,S?M0
M_L8^-O'GQV@^.'PZ\$?`;XFR:S\.--^'WB3PC\=)?%UC:Z)/X?UC5=4T;Q-X
M2U;PLEVZO<PZQ-8Z[HU[8^5>1V&GSVE]93"X,WSM\2/^"<OQZ\<3>`-.TK0_
MV4OA]J'A;2?A!IVG?&KX7Z3\1?`'Q%^'6G^"ET>\\5^$O"&BZ7JDVF>(/"MW
MJ%EJUIX6M?$VK.=-T;6WM-1BOS:@RP!^@G[5/QNU[X/7O[*8TSQ+<>&K?XP?
MM3>"/A'K%O#X(TKQF_B'2M>\`_$OQ;/X;N9]2\4^%W\%P7P\&;G\8Z9;^*=4
MTR[M[6RB\,7MIJ5Y?:;\^?"'_@IS\/OC3X]^&/@N#X1?&;P=H/Q?\4_$+P%\
M/_B/XR\/:/8^"O$GCCX8ZKKNG>)/#.GZCIWB"[O);MXO#VH:AIVH+IW]D7<$
M<UJ+D7]M<6:_0G[5/[.WBKXXK^RN?#&LZ/I\GP'_`&G_``)\;]?;6S<AM8\/
M^&?A[\3_``9J&GZ:]M;S[=9GN?'=G>P-.L=N8[2Y5I8W:,GY;^&7[`GQ+\%^
M$_V)-!U/Q7X0N[O]F7X^_&GXK^+)[,ZFL6N:+\2-=^)NJZ3I^A^9:AUOK.+Q
MO8+??;=D8>TN!#/)E'<`]@_;`^.WQC\(_&#]EC]E[]GZ_P##7ACXB_M-:]X_
MN=0^(GB_P_+XMT[X>?#3X1^&K?Q'X\U[3/#[ZGI=IK7BR\_M70M(\-6.IW0T
MM+N]FO=1ANK>V-NWS1XW_;M^+G[$7Q/^+WPV_:PU6#XX>%/#/P>\`?''X<^/
MOAQX!TSPEXZU/P[XF^+>A?!CQ/X:\3^$+;7Y?#MYJ?AOQ)XBTK6K/4=#FTV3
M5-#GG@BT9]2@CAN/KS]KW]F3Q_\`%SQ=\`OCE\$/%GA[P?\`'C]FOQ1XFUOP
M5<>,;._O_!WBKPUX[\/MX7\>^`?%$.ES0ZC;:;XDTG[-)!JUBSW6DZEIUE>)
M;W(0Q'XY^+?_``3P_:&_:4TKX]_$?XW?$#X9P?'7XE>#/A/\+?AKH7@ZU\0C
MX:?"_P"'/P\^-'ACXN:Q9G4=2#>(=?UWQ?J&BW$FIZC-!;0)*FG6L%K';PNS
M`'M4_P#P4[\#Z#H?Q5D^(7P=^,_PW^('PRUSX7>'[7X0^)M$\-2^/_'E_P#&
MBYUG3_ABOA.#1?$NK:-)_P`)5J/A_6+3RM3U33I]%FT^Y&M1V$:&5=#7O^"A
M7B+PY?>!_`&K?LE?'ZR^/OQ)UWQQ8^"O@9)=?"1_$NL>%OAMX7T'Q3XR^)`\
M5P_$67X<P^"-(A\3Z'HLM[)XM6_D\3ZA;Z%:6-S?.8$X/]IC_@GM\1OC5\:?
MB5\:O"7C_P`+>%?$<UM^RYXB^$RZQI^IZO8:?X\_9V\5?%'Q!.GB^QMIK%KK
MP]XDL?'L&E'[!=K>6QCNKM`KK"E.\9_LO_ML^,/B9\(?VH'\4_L[Z9\?O@V/
MBYX#T+PA;:=XY?X8:M\&?B]X?\&VVLZ3K&KR79\2OXMTWQIX&T7QEINIVL%O
M8+:_:O#<UG)'*NHI=H\K=WS:Z?-6T]+]?\@/'_$O_!4A)/B!X!^+OABR\;ZM
M\`K']FKXM?$+XI_".+0/"5KX]\+^-OAC\5])\"^+Y]:.J"#4[2]^&L)UR3Q!
MIVF^)O[/NM-TZYOK6QU.0VI?T+]LO_@I-XG^&<L_A7]G#P!J_P`2/$OA7Q/^
MR--XZ\5VX\%W/@BPT;]I7X@7VE:3X!M[C7?&'A^Z?QYKWA31A=V%Q#!/I6@0
M^,_!^O:O<+I=S=26M?X%_P#!-O6?@GXQ\->/_B%XNT'XCZ8/@]^T=I7QRL+#
MP_K&[QCXO^/GCJ;X@>+QX7\,6PU2=O#D5K+=^'],T427FKW5NELB"YN9VC;Q
M_P#9N_X)_P#C7Q-_P3;TSPA8ZCJG@KXX^./BG\//C]I^I_&'P[JMEXA@_P"%
M)^)/!>G?`CPG\2_#[FR\0:'=6OP;^$_PU\-^*]&F%OJ>@ZV^O^99PWK7%L(`
M^@]/_;_\5^&?B+\6O#'BSX=_%O7?B#'XZ^"WP[\`_LUQ:1\'(/$FF>-/B5\/
M=5\>3:#IWC[0?'=WX9UFRL/#FA:SXJ\4>(/$WB.QTG0+#2[V*TO;I5A630\0
M_P#!2?Q7X?\`&^D_"1?V1/C$WQNG\&:]\0_$GPMU/QG\$-#U/1O"NB:];>'H
M[W1/$&K?$RW\+>/+K7[^Y0:#I7@C5]:OY(MS:C;Z9)^Z/$7O[#/[4^M?$GQ9
M^TE-XT^"WA[X]W'Q.^#WQ<\*:/9V'B_6/AL-5\!_!WQ;\&_&'A'7&N;FQU]M
M'\5^&O&&II8:S:R_;]'ODL]0^RW(MVM)JG[1G[$/[77[37AN.P^)=Y^QSK>O
MZ[H>MZ*GB,_#KXBZ=XF^!T^L7DOE:Y\+/%NG>,8-<UR]L;#[+++!KTUA!>Z]
M:0ZE']CM%_LX`'TW^WY^TW\5OV=OV3D^-GPJ\$W%]XQN/&GP+T:[T36$\///
MX:TOXA_$WP?X7UR#5+'6-=T>RN=2FBUU?!UB+'4;C^SO$6MV&L7:_P!A:7JE
M];^7?$#_`(*9W?PZO/&MIK7[,'QDGE^"7@C1?B'^TO'H^N_";6O^%%>$]?N;
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M/%OA[[/K*:0MA?SZ?)IGBC0M5TR[M[6[M01-+]^_M"_L?^'?CC^R3/\`LM6^
MK_\`".:?I^B^"[3PIK4]E'J\.E:K\.]2TG6/"EYJ.FS-%%JME%?Z+9'4K!VB
M2\MC/`&C#@K\CZ-^P1\:=>B^'MYXX7]E+X>WW@+]H[X*_&)-.^`'PFUGP;9Z
M[HGPGN?%$M_#K6HWNMW=]>:YXB'B!9;%"BZ5H)6XB6&^:4SL`:6D?\%;?A'=
M>/;72]5\+:IHGP@U[Q1\2/`_@SXU3^+?A[?6/B3Q%\*(_$)\3W;_``^TO7[G
MXBZ#X7OI_"NO6WA?Q%K'AN"Q\0&P6>U\FUOM.N;KDOB%_P`%%OVBM3_9UU[X
MZ?"[]D[QWX?\)ZUH?AKQ3\)O'WC#Q'\+KC2O$/A[4OB'X.\--)KWAD^+K;7/
M#>I>(]!\12ZUX6L=4@4W-C'<O<26]]I\MHT7PY_X)B>-?`%KK'P;BU+]F^^_
M9ZN=1^)HTSQ5>?!1KK]IFT\#_$V[\27D_P`/1\19M;&D1GPV?$MW9:3XU313
MKDFC6VGV$L*3V\M[/U.@_L1_M>+^SWJ_[+OC#X\?!W6_AGX9^$K>`OA5KMA\
M,_$MCX[N_$WAW6_"FL?#3Q/\1;N?QE=:-=6'AFW\-3:/KNC^&-+T6;Q(FIMJ
M`U#3Y;5()`#]%;+XA>-T^"][\1O$_P`+M8\*^.+'PSKVNW'PIN?$G@[5M;@O
M]*CU":PT!O$VBZS?>"Y+O5XK2V:.]AUJ73;,WZ+=W2&WGV?-?[(O[<%I^TKX
M_P#BG\(?$'@FT\`?%#X3>&_`OC+7=&T?X@>"OB?X?N_#'Q$N_$^G:'<6GBSP
M+J>I:7'K.G:GX.UO3O$.@W7D7NFR?V==)]ILM2MISWOQ1^!WQ5_:"_8\\?\`
MP'^*7CKPYX1^*?Q/^'OB7PAK_CGX7:9K=IX;T+4-9>\BLKW0=+UK6;K6WL[:
MQ:SMKZ"YUD37V+W9-;1W")%X#^Q3^P_\0?V<?C)X^^+GC;7_`(*+%XN^!'P>
M^"6E^!_@?\,M0^'/AG1K;X2>*/B3K<&OW,>H>(M>GU75O$,'CP2:M>W#+<O>
MV[QB4Z?;Z?:VH!G?'K_@I#>_!3XI_%WP+;?`'QUXW\*?`&'X8:]\9OB+HFM>
M%K?3O"'@KXFQVBVNM:?H.H7UMKWBK5=+GO4EE\/:':SWL]A:7ESNA8VD=SH>
M'OV]_B/J5E\>?#?B;]FG7?A]\;/@EH'@+QHWPT\7_$SX;6FE:_X#^)EUK=KX
M8\277Q%M]5G\)>'I+27PUKD'B33[Z[D;2[JS6.VFU%)E(O\`QD_83\3_`!1U
MK]M+5+/X@Z%HO_#4_@WX0>&-&,_AZ\OI/!]S\,8K..>^U)%U."/68M2:T62"
MVA%EY!;$K3<YX/\`:O\`^"<'BG]HOQQ\;_&FE?%#P_X;/Q0\#?LW^'=)T/6_
M"M[K^CIJ?[/_`,0/'/C@P>-;6'6=.'B?PEXM7Q@NDZEHD+:=*(;(S/=S>;Y8
M`/)/%O\`P4U\:^-?@F?B+X!\'7?AJ'X=_M5_"OX"_'G7_"/C3X4^/])\(3^-
M_'7P@TCPS'H=Y?VFH:=XV\._$"V^*^A6%]JOAV"+6/"T;WTK_8[JT$X^A?!W
M_!1.X\:>+M'O=,^"OB:W_9V\0_'#6OV>/#OQ_O?$WA1;76?B1HM[JND2RP>!
MX[V7Q';^"[OQ)HFJ>&+'Q+<K$\NIVJ_\2T6D]O=2_"7Q0_90^+_PZ\"?$O\`
M9W32KCXJ?%/]JC]KS]D;]HJ*Y^"OP$\1?#SX`_#3P7\&OB=^S>?&NE:_XPEO
MM3\#^%K?2?"GP3\0:W8:3J?B(>*]=%_IUMI^EZM?SFY?Z[\"?\$\_BCX/U'P
MY\.4^+O@G4?V6/"7[1NN?M(^'?`TW@76K?XJ6NN:GKVN^+[;P3<^.%\72^')
M/".G^,/$%]JT31>#HM8:".UL7U!HT=W`/,K#_@I%\4?C/X3_`&>/B!X2^#/Q
M/^$?P^^*/QL^$O@31?%>M7'PTO;;XG:QXP\1ZEH.H^"K'3=7BU/5;'PH)K55
MN_'"6&ASR26UT/#]W*J)<R>@?LZ?M]_'76/^&=]+_:/^!L/@G1OVA?&GCSX;
M^#_BWH_C/PQJVCW/COPY)XNU/1?#^I>&M*22;0VUS2_"NL:3I%S>W*'4M7T<
MJD).H0%NX\)?\$_O%'AK]G?]D'X&R?$G0KB\_9A^.7P\^,-_XDC\.:@EOXL@
M\$^-=8\6W.@V&F/K+RZ-/J,>K&PAU">^U&&T>)I_L4JR"%/!/VB_V7?VE_`O
M[)7C_P"%_AK5-(^+_B/0/B;X#\7_`+&MCX"\`:II?C#P!\58?C9#X^\-^*_B
M3XDU#Q'JFBMX6\+WMXT?C#6H--T'35\#0:]:3Q7%[K$-M.`?H3\$_P!J&R^,
MGA?XY?$6/P]=>&_AK\(/BC\2_AUIOBZ]OK6[M_&]G\(7;2O'OBW2+6"W66WT
M73?%>G^(_#ULTKSO?3^'KZXB98FB5_C73_\`@IQXLUK0OA/XGO/V<?%'A+P!
M^U#+XOT']EWX@ZQXR\)SV?C+QOI?@SQ?X]\!Z!XZT6SEEU+X>_\`"S?#W@C7
M+SPM<WL&KVZ3VJV&L_8;J>*%_NWX+?LW^#_A-^RWX+_9AM&EU/PKX?\`A=%\
M.=;U&=V_M#Q1-J6BRV?C+Q-J=QEGFUOQ=J^H:SX@U>[<F2XU75+JXD)D=J^"
M?`G_``37^+VF6G[-'PX^(GQ]\)^+_@/^Q_XGUWQE\%O"ND?#J_T'QMK'B./P
M#XX^&WPWNOB?XKF\5:GIFMVGP[\-_$#7)+6T\.^'O#CZOJR6%]J%PWV;RV`/
M>/V!?$?[1?B[]G/3_BQ\8)?%_B/QI\1/"'ASQWX=TWQ3XO\`AIJ6CZA_;_AF
M'7[:/PPG@CP3X4_X0_0KV\OX[*WTCQ+<:]JNFVL=NU[J=S<1W,T_YK_#;]NG
M]NGQWIO["GBS6/AQ)XEU'XE?'?\`:1\'/I'@_P`;>"?#]C\8[;P;X7_:(LK'
M0O$E@]KIMAX,TKX<:MX+\,W=[JLUW</K,>CSZK;QWL[/;7?[N_`/X:W?P:^"
M?PF^$U[J\.O7/PU^'7@_P+/K5O:O8P:M+X6T*QT9]2ALI9[J2S2]-F;@6TEU
M<-"'$9FE*[V_.SX,_P#!/'XN_"GQ_P#`:2\^-G@OQ#\'OV;OC9\>/BS\-?"T
M/P]U32_'$EA\=-&^,MEJGAOQ'XK_`.$LN]*OGT._^*T4VG:E9^'+(RV&CW%M
M>6T]SJ"7=F`4;O\`X*IV=EX?T#0]1^$_]@_'W6/B[\3_`(.W_P`+?$_Q'\':
M#X5\.ZO\((;"]\:>)=8^*.I&UT&/PPEEK&A_V5/;P7.J:A>ZU86,>D>;]I:V
M^S_V7OVK/"O[2_P%_P"%U6>FW'A!M%UOX@^$O'GA[4+_`$S6/^$1\6?"_P`2
MZSX8\7V`U[1)[K0]?TJ"ZT6;4-)\0Z1<RZ;K6B7-EJ=J42Y$4?Q'XP_X)=:W
MK/C#Q!\5-%^(W@!_B4O[1?Q=^-/A"#Q]\++;Q]\.#X7^,FF>&M.\4?#SQQX-
MU/5XFUY`_A;2+^Q\0Z3J.A:C87EHKV@B66=9/O+X)?!/Q+X&^#K_``U^(VJ^
M!/$>H:S'XAB\2R?#KP%8?##P8+;Q!YL$VF:!X1TN:[2RM(;*7[.+J[OKS5+E
MMT][>W,SL[`'Y9:I^WK\;?CE\7OV%?$_@?P5XP^$G[-?QH^+?[1%AH'C!_%7
M@VYU7XU>$?!/[)?[1/B_09=2\$SZ9JUUX=TU_%O@WP[XZ\*3:FFHP7L.CQ'5
M[6%9H;"\[#X0_P#!2_Q1>^%OA%IMK\+_`(@?$Q;[]EWPA^TU\3OBAXJ\3_"_
M1;WPA\.=2N]0/BCQ+XYC\/\`AOP)X5EO=#TS3[F^M]*\#>&-/.MRPM:V&DVK
M(\TFI\-O^"8GQJ\!>)/V7](U#]IS1O%/P1_9&\6_%+4OA'X%N/A?;:=XH@\+
M?$;X'_%[X.VNB:]XQMM;9]2OO"T'Q)LIM-O8=/L[:YTZQU*VOK*>^N=/OM.]
M/_9^_P"":\'PFT^'P]XQ\>V/CCPS>?L5>'/V/?$NG6N@W&C3:QIVFW6L#6?$
M45P^IWOV2WU;3-9GLXM+*S2VDB";[=*"$4`\E\+_`/!8;PS'>:'JOQ3^&UEX
M(^'OCCX?_$;XB^!]=T'XF>$/'OBB#3_A[X2N/B!)HGQ&\%^'O-O/`FN:[X/M
M;JZTJ&:]U.U35;2XT2^O;>^:V,U+XQ_MR?MQ6/@;]G?QQX8_9OTCX:V'Q@^/
MWP/\/:%#KWQ)\&:_>>,_!'Q,AU^[M_!>LP-H5R/!/B'6;6SL)-1U&W-U_P`(
M[&Z/::I>3&XMT[3P=_P3.\?VG@U_@I\0/BQ\*?$GP.A^'OB7X9K_`,(S\`_#
M7@_XR^(_#6L>#M0\'Z3'XR^)-O?7<=]>:)#=VVIR7ND:)I%SJ]]81I?R/;3S
MQMOZA^P9^TOXD^$7A/X<>,OVK]'U[5_@OXP^#/C/X`^(D^$NEV,/A_5_@KJ%
MT^CWGC_3XM69_%]SX@T2Z_L37OL5UHL&V)+ZQBMKEYMX!B>+/^"EWQ,\):I\
M6=0N?V<8+[X;?LOZG\/?"O[4_C*R^)NFRW_@?QMXWTCP[K>IZ+\.]#7PV4^)
M%GX(TSQ7H=UXEU674?"RXO5@TRTOKB&=%S/&?_!4CQ]X;\(_M*?%+2OV8M;U
MSX.?LV>,?&G@/Q!\0QX\T"V7Q!XDTK5--T?PK'HWAO[`^N)I5Y/K6EWWC36[
MNW32?!VDS7E^+[6#I=[:+IZ__P`$T?B9XGOOBU9ZI^T3:6O@?]J74/AUXK_:
MH\(Z3\/K"U3QAXZ\$:7H6B:KK'P^U&74)[CP1I_C;2O#&@V6NZ;(-6*+IXGM
M;A+F>:9_H3PI^QIXH^'7PU_:(\%_#CXI6WAS6OC1\:O%/QAT+6[_`,(:7XDT
MKPJ/$.J^'KYO!^J>&];-U8>(]"N=-T6[\/:NLWV9[O2]7NV@%M<I%*H!ZU^R
MQ\;O'/QQ^']WXN\<>%/`?ABZ-]''H\_PV^*FD_%WP=KFF3VD5S%J&G>)M.T?
MP_<1.CR&"XL-5T6PNXY5)19(625OB:P_X*4>//%46D>._#WP*TY/V>OB7\7/
M'OP(^"GQ3U#XB6Z^(?%WQ%\(:SXM\&Z-J&O>`D\-;?#G@7QIX\\$:SX?T'64
M\37^N*)],U"_\.V-E?+/!]/_`+&?[(,O[+.G?%:YU7Q=IGBKQ-\8?B+)\1/$
M</ACPM9^!?`>A78TFQTB'3/!O@K3YKFST2Q>*R^V7^R=WO=0GEN9".%KP7PC
M_P`$VM6\*ZOX8\'_`/"YY]2_9L^&WQL\9_'_`.%OP?N/"FGPZOX7\;^+-<\6
M>,++1;GQM;S)>:CX+\)^,_&6JZ]H.EO9I?IY.GV%QJ,UG:B%@#)_X)0>*/VB
M?BY\+;KX^?'R?Q3<7'Q0M;F_T2XU+XLVGBWPU<_9/%7B.SO$\.?#;3/"OA_2
M_AK;:4+:#18H;>]U6?6+2P@O+QTN6=Y/UMKYY_96^!"?LT?`?X?_``3BUYO$
M\7@6RUBSCUQ[-+"2^&K>(]7\0%FM4>18O*?56MQB1MRQ!SRY`^AJ`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`*\Q^,_Q.T?X,_"GXB_%7Q!%/<:-\//!?B+QC
MJ-O;?\?5W;Z!IEQJ!L[;D#[3>/"EK`20!-,A)`!(].KR?X[?"O3?CA\&OB?\
M(M6O;K3;#XC^!O$G@^?4[)4>\TTZYI=Q90ZC;(_RR3Z?/+%=Q1,0LKPB-CM8
MT`?E#XB_;)_;D^#/P=\+?MB_&?X8?!F7]GZYN/".N_$OX9^#=8\52_%_X6?#
M+QOK&C:?;^+KC6-0MD\,^+-2\'6.KVFL>*-#LDMD:Q2^>PO)9+?]Y]C77_!1
MS]F2S^)MO\*Y_$'B;^VYOB#:?"R;7T\%^(V\"V/CW4;6VO-)\-7WC3[`-"M]
M2UB*[MUTN(W3"ZEFCBW1NZ!_B3QK^SI_P4:^/_P#T3]AWXJ^'OV?/!GPEDM_
M!W@WXR?M+>&?B)XOUKQ5\3?A#X>OM.FU31OAW\&KSX>:>G@OQYXMTO2+70]?
MU'Q1XYU#1-%MK_5[S0UU.[%@L7KGQ(_8K^+?B7X2^+/`GAY/!EMJ.I?M[_#C
M]I#28[O5M2M;"+X:>$?$WP[U.ZM7N;?1+F=/$2Z7X6U&&WT[R9;:68P0/J44
M4Q9`#Z/G_P""@_[.$/CKQ;X&BUWQ%J">`=>UWPKXX\>:9X1U^]^%WA3Q/X7M
MQ<^)-!UKQ]%9G0;74-"!^SZJGVAX;&]#V<\Z7,<L2?.'Q@_X*B?"C5?V>/VG
M_%?P/O\`6+/XL?#+]DOXW_M$_"S3OB7X&U_P[HOQ!TOX<>!-<\1V'B+PU'JG
M]F#Q=X6_M2RTF+4SIUY;3BTU*U9C$EY!(?(_#G[%?[6?A'X,?M`?L,V&@?"3
M6_V=_C3XW_:$\5>'OVB;OXE^*].^)?A3P;\>O&'B#X@W/AKQ/\)Q\,;J'Q!\
M0_#7BGQ/JVF6>OVWQ"B\.ZQX8@TR_O?[+U*.30'XKXE?L+?MJ?M'_#]/"OQ;
M\.?`+X?:C\&_V%?VG/V7_A1<^!OB3XP\36WQ7^)/QT^$EC\+[/QEXI>^^$OA
M5OAOX`T^ST'3KMO#ZP>,M5AU34KJZC=[?3(%O@#]'/"7[;/P=;X&>*?BEXC\
M2M`/A?J_ACP)\3+>+2KM+_3/B+KN@^"M1M]&TW1Y'FO+N/6!XTT*ZT1H7F6]
MM=00Q2R>3+)7R!X'_P""G5]\3+C2=-T_08_AIJ!_;:3]G>:[\<>&/'%_H7B'
MP;)X[UGP3IUGI.KVUC!;Z)\4M=EL+:X_LK52^E>'UCU#^TI\1!V\H?\`9IFU
MO_@HI\)_AE;WL%UX+T7X!_"3X\_M3>#M/BO?^$>O_BQ\&1+X$^!FI2W!\FRU
M*\\075WK+WUI=:>+N_T7P!I-P_DBQB5>XNOV(OVI;OQ7+X%?1_A(_P`(-/\`
M^"C6G?MNZ7\0_P#A8'B>T\9W_A35_'>J>+/$'@:]\`CX=7-C:^)=!BU_58[*
M_3Q?/I.L>3I0#V#MJ"6X!]=W'_!2_P#9@TZ^\817.L^,Y?"?@$>,(O$_Q7MO
M`?B6X^$UI?>`H[E_%FFP>.X[.32[N^TF:TN;!H8"Z3ZC"UC;RRW.(S]!_`#]
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MTVT\)>%+RW\+VEK/K=[J>IV!`/UT^/G[0/PW_9L\!R_$;XHZI<:=H!UC0_#6
MFVVFV-SJ^O\`B+Q5XGU*+2?#GA;PSH=DDE]K?B#6KZ80Z?IEG&TTVR63Y(H9
M9$^8Y_\`@IM^R[IO@?Q'XV\1:KXR\)/X,^(/A'X9>,_!GB?P3K6E?$#PIXJ\
M>K*_@V/5_"+12ZF--\1I!,^D:I9)>VE_Y4B6SR21NB]'^W=^SE\0/VA/!?P@
MOOA-J/A>T^*7P!_:!^&O[0W@33?'EQJECX"\6:MX!;6K"_\`!_B_5=%TG7]7
MT33M>\/^)-8@L?$&EZ#KE[H.NQZ3JBZ/J-O;W-NWP[XD_8'_`&F_C3\4O$O[
M1/Q4A^#'@GX@^,?C1^R=KJ_#+P?XS\6>,/"7A3X1?LVZWXGU^Z6]\<:G\-/!
M][XP^)/B'4?%FI211IX+T#0K&SM;#38-2NE\V[`!^GOBC]I_X9^#/@)HG[1_
MB<^(]`^&VLKX&F>?6O#FI:9KFC6OC_Q)HWA;1KKQ!H-W'%J.C0VNI:]82:R;
MV*-M)L?M%W=*L=O(!R?C/]M?X#>!T^+4>L^(K^>]^"_BOX<>!/'>F:+IEQJ6
MJ6?BWXKWVE:9X-T73;6+#ZE>7MYK6GI.MN"+(7"-<%<$5Z)^TA\(=/\`C]\`
MOBK\$]6BB:Q^*/@+Q+X+E>82)%9S:UHUY:V=^\D<,L]L=/OFMKQ+F"(W-O+"
MDMJIN5B4_D3\.O\`@F1\>-'\6_LM^//B#XW\"Z]KEAXJ?Q[^V?;Z=>>*KJ#X
ME^+_``[JNI:]\.+[P>+SP]8#5QH>I2:#97=SXC30[E-,\.V,EO&\C/"@!#XA
M_P""@GQWM[/X;WGA[Q'\/=8M_%F@?\%';G4KO3O!_B/3[5-:_9/\9V'@[P79
MFW\1ZA!J"W.FZA#K5GXIF,<EAXAFCBNM+:SM3&[_`*P>(?C[X<^$/[*MS^TK
M\6;F[B\,^"_@U8_%;X@76AZ=-J%U#86OA:TU_7Y]+TJ.5IKAHP]Q);6,<I=E
M"Q(Q."?R>B_X)H_M$#P_X`TB37/A5]J\,R?\%//MLJ:[XN>W<_MI_&#5/B)\
M,#$[>"$D:/0]*OX[;QL[QQMI=\C1:/'X@B)N%_0G]I7]FWQ]\9O^"=_Q;_90
M\-ZEX6T_XD>//V9-8^"VD:QKMYJT'@ZW\4ZCX&7PO%J.HW^GZ-J.M)H*ZAFX
MDNK?0;B_^R?O!IOFYA`!R]]_P4Q^`$5I83:%X;^-GC34-3_X2F^L/#GA/X1^
M*+_Q-<^$?!\6G/K7Q%71;R'3[N+P`LNIV]I8>(9UB35;M9H-.M[EXFJW%_P4
MJ_9UU?7_``[X?\#V_P`2?B?)K?@SP#\0-4U;X;>`=8\5Z)X%\)_$W4+O3O!V
MK>/;RRVR^'H]4FL+^3[.;:ZN[:UL;JZN((X(BQ\B_:*_8N^)OB?X_>&OVB?A
MK\/OV>/C)J$OP:M?@QXV^%?[07B7QO\`#_P[!;:/K/\`;N@>+/!/C;P;\+_B
MQ?V-S97,^I6&JZ'J/@QK/7M/N;:;[9IEW9P*/$O$?[!7[2VH2>!=-\#_``J_
M8M^!=[I%A\'K:/XW?`OQ?\8/`7Q#^$EMX.UZSU[QIX4\)^!X_AAJVB?&/P?=
M,VN67A*U\9^,_AM;P)KTZZUX>N+>"87`!^@__#<7P-E^'0^)ANO$W_")3?'D
M_LUB=?#MX;[_`(6:WCAOAV;4V2OYJZ,/$8,?]LAO(^R`W6U4!`^"?AG_`,%'
M/B/I/QG^"?PA\7?#GQQ\1K/XCZ)^USXAU76/A_X&N-5U*V7X2?M077PG\"0:
M3:V=];VEQH^@^&MZ_$/4)0+C3KBY\)WK),=7F1.8U;]@S]MRWM+KX0>'==_9
MJF^`L'[;>G_M9Z?XDU?4?B?;_%R^T>Y^*5G\1M;\%7NB6/@R[\(:9?V$LFJP
M:5JD&MZG'JX33[6\BT2-[C4%]2T/]C7]JSX4_$7]G3XQ?"EO@/XL\4_"D?MH
M>$O&?A/XB^+OB'X0T&]\$_M2_'C3/C%H6O\`A?Q+X:^&OC'5+KQ/X2M]!TG3
MM5\,ZMX8TO2[^ZO-52S\40Q6=E>7X!]J_M#_`!SF^#GB?X07^I>(+/1/!NNZ
MC\2;CQ=I,WAC4]<UW7]*\$_"SQ/X^DMM!U&SO;>W\.WVGP^';K4I);^WO4U&
M*`Z7;);W<\-RGGGP*_X*/_`/X_>,OAOX(\(Z5\4]%N_B_P""+CQ]\*];\<_#
MO6?"/AOXA>'M/T73M=U6;PQJNHGR[NZTW3]1BGN+9XXB\45Q-:/<01><VW^U
MS^SSX[_:!_X5FOAB[\.:8?"#?&#^VSKMUK%FLZ?$3X%_$#X8:4-*%AH>K^>]
MIKOBO3KS4?MS6"0Z1!>7%LU[>QPZ;/Y/X`_8Z^*/A:\_X)HWVHZIX)DD_8R^
M!I^&?Q-CL;W7I$U_7I?@1HWPN:Y\!F?PY;-JFD)X@L+B^,NO_P#",7/]C&&X
M^RF_9].C`/IWX_?M0:;\`[S3[.Z^$OQH^)"W&@:AXIU74?ACX*/B+1_#6@Z7
M/Y%W=:]JDU_86UI=;LRV^G1F>\N($DE2((H)UM<_:A^%.B?LS7_[6HU6ZU7X
M-6?PR@^+L6M:59375Y>^"KG2(=;BO;;3B$N&N383JSVC!98Y0\3@.C`?$/[8
M_P"QG^T-\:_VA?"OQ;^'&I_`OQ=X'B^"FI?"35/AQ^T&/B'=^'_`7B*\\4:G
MK[_&/P'X<\%V[:?XF\8W^E7\/A35-*U[5/"T4FE:=8/9^);/;=6]]@?'/X*>
M*O@-_P`$4OBE\!O%ES8Z_P"+/AC^QUK'@;5+KP;%JNH:?J^J:)X6-I))H,=_
MIFDZI>075PF+6.33;6Y=65!;1DI&`#WKP[_P4L^`FH:KXDTGQCHOQ-^$EQH_
MPNU3XUZ"WQ2\$WWA1?'_`,+=$O\`3])U;Q7X*6>69]42SU/5=*@;3)1;:KY.
MK:7<O9QQWB8P[W_@J-\!O#WA[Q/K/C[PC\8?ACJ7A'Q#\)-'UCPCX\\`7^E^
M+/[*^-WBBU\)_#WQ7IVBVDM_<ZKH.J:I<M%.]@)KVTFM;FSDLS>HL#?)GC#_
M`()_?M#?MKP0>,OVH/%_P:\*6/AS]F;Q;\&/@+H_P.'CW5HH[CXF:AX'UW6O
MB'\2[GQG9:!.]TUK\//"VCIX!TEM:TBUCN-:F'B6_EEMW&VW[`G[0WCS1=,C
M\9^!OV,_A-K>B?&K]D7X@'5?@E:_%"_UCQ;X?_9\^/6A?%;Q6OB76_%7A;0G
MM)-;TW2I8?"/@ZPTR^L-(UF[O)-3\62V5VL]F`?4NC_\%)_A]XDUW3]"\-?`
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MX.']D?PI^TEHG[0MGKW]B>,3^T!JVG>%_C!'\=-`^%NI6+Q)X$L8D\=V6D6>
MI?$.PUJ74[WPQ9WEI'X4M]1OOMJ`'U3\(_\`@IA\'/C!XS^&GAK2/`OQ?\.^
M'OC'=Z]HGPQ^)/BWP5/HW@7QAXM\,#4I-=\*Z9J4ER]Q_:%E!I-_(EQ-:QV5
MVUM/':SR-&U>^_M#?M+#X`V&B7B_"+XJ_%1]735[VZB^&VAV>HP>'M'T*.SE
MU'5/$&I:GJ&FV&G(%OH4L;9YVN=1F6>.VB/V>5E^2OAY^PK\0?!WPU_8+\%W
M_BOPE<W_`.R7\5/%'COQ?=VD&O/:^)[#Q#:?$"W2T\-![-)$NXI/%]D[MJT=
MM;JMK=@2M^X+ZO[9G[(_QH^//QE^"?Q2^'6L?"C5]$^'GA+XD>$/$GPJ^.VE
M^-=5^'%W>>/)?#,FF_$S2]'\)7=HVI>,_",6B7VGVFG:T\-M?Z;K-];1:EI$
M^VYF`.CO/^"F?P3OM&^%%_\`#7PC\5?C-K?Q;\!:A\5=)\%?#3PB^L^+=!^&
MVBZI/H>L^*O$VGS7=K#IL=IKEK<Z)::;]IDU#5M6MYK/3XYC&SCF?'?_``52
M^$7@[6O&-OI7PK^-WCGP=\--9\,>%?B?\3/#'@Y7\#_#_P`:^+(/#MUI_@[7
M]0O[VTN!KEA;^*M&'B&"SMKE-`NKH6.I/%=J\2?._P`&_P#@GE^UA^S`_P`*
MO'GP-^)'P!UOXJ>'O@EXC^!/Q#TCXC>%OB#I_P`,M6T6X^(WB?XB^#O%_A+_
M`(1>YD\2:/?>&KWQ/?V5UX1NHKFPU6PFBLQK]E-9+J<WAW[4G[*/[7OP(^`/
M[5^D^%_'7PE\9?!/XR_&30/V@_%5A<^`/&EQ\:;?QSXP\6?#?_A8WA7PE#I/
MB"?PG%X3UKQ-H5SXETK6KQ+_`%+PSI=[/I$?AS4A!#J3`'ZY>)OVS?AKH'PH
MU+XL7NE^(/[$TO\`:(T#]FR2V2S@DOSXY\0?'#1O@/:W<4;2>7_8P\5:W;7$
MUT6$BZ4)I?+W@(?E7P;_`,%%['P396ND?$'2/&_Q>\9>-?C7^T1X`^'>D_";
MX=7$=_):?"#7;>VB\.7&CMK%\TEU96-Y%#-XCDN;;3;D0O=30V19(VX[QS^Q
M#^UGX\TC6/AIHOQ*^!FC?L_ZS^U+\.OVKK1=3\)>.KOXMW=_HWQ[\#_'K6/`
M5[>P:C;^%M*TJUUW1-9GL]<MM/O]5UF,Z/H4\'A^!M2U0^K_``3_`&%/'GPT
M^,WPU^)&L>,O"^H:9X$^)_[6_CRXTRPL-9%[>V/[1&HZ+?:%803W,*VJW?A]
M=-F35GD*P3M-']A:8*]`'(^!/^"C\?ASPQX5M?%WACQ_\;_B5\4OC!^UUX&^
M'WAGX5?#[[!K$D7[-?Q8UWP1JGAN^TR\UNXMX;C2H;*.)O$=U?6UIJ]O;2ZD
M\-J1]F'K&I_\%*/AO/I?PKM_`?PI^+_Q5^)'Q3\+:UXVM?A#X*\-VMWXW\)>
M%_#.LW'ACQ)JWC&.]O[33=&73/$EO/H,4#WKSZGJ$<T5@LJQ2,O&?!7]A+X@
M_##XL?!GX@:AXM\*:GI?PQ^,'[?OQ#U"SM8-:74;[2OVO_BIK/Q'\,:=9-=V
ML<;7GA(:K_9^MM,4M[AH?,TZ66.12/C'XP?#Z^_80^)OPQ^+&G_M&^`_A3\3
M?$7@OXD_#?6QX[_9X^+WQN\`^+_`^K_%#6/B)H]SX=M_AUJ_A74],^(_A>^\
M2W-O8:'?:[%9^+#/';_97@M5>0`_73X;?M@_"WXB?LKW'[7L<6M>'?A59Z-X
M_P#$6HG6;$Q:W8:1\.O$GB/PUK]Q=:;"TCK<"\\,ZA)':AFD*F-"=Q)KPBQ_
MX*2^%#\/5^)WB;X%?&_P1X0U+5?@59>$=:\2Z!IL6F>,K+]H'XF>'_A;X+OM
M&O[+4KNWCFM-=\3Z->ZYIEXT-Y8:1="[*OC97-?\$_\`X/\`Q2T;_@F)\.OA
MEXATZV\)_$SQ/X6^*6N1V/Q+\'M?P:<WQ1^)/CKQ[X=_X3WX?K=:;+$UWH7B
MK2W\3>#FNM-N])DNKW1I187=D\$/S-<_\$NOCQXL\._%YM0^('P1^#NK>)_#
M?P'_`.%>_#?X*^#?'@^!VG?%#X"?'31_CSI/Q5\9^'_%'B9;ZYU?Q3K?AO1_
M".IZ=X6MM*_LWPC#+&NKZU>O:3Q`'J7[=_[>_CCP?:>)OA%\`?#7C"/XFZ!\
M=?@M\(/$_BS2M%T'73HMM\5-(U'Q/:S>&=-UJ]MK'4=?U'3-&NM,TJ/4!]A@
MO9'FNDDCB6*3XH\-?MA?M<K\2OBY;>/?B9\8_A]X(_9]^)O[.WP.NX_$?PA^
M%FLWGBCQ'\4]#^#OB.[F^*7]F7MC-H_C;Q'>?%2--#@\(^5H.E^#+33=3N8;
MS5;N>*+[)L/V`_VCO$WB_P`>?$7XJ?$OX4ZGXV\>_M,?LU?'C4(?!?A'Q7H'
MA;1](^!NA>)=#OO"&C0ZQJ.L:O=2WMOK-N^G:QJ=]))-<I=R7L5A;RVUK#WG
MQ*_8(\?>/=0_:WU"S\9>'-,/[1G[5_[+_P"T-H\-YIVK2'PUHWP#\`_`+PCJ
MN@:C)`"+[5-=N/@WJ%UIT]BAM+>'6[!+ITDM;I*`.S\5?\%`M,UZW^+^E_"W
MX8?&#7?"G@*_\=?#[5_V@_#WA?3=6\!>$_'GAKPYJ=WJ5\+.]U*UOM<TKPOJ
MEM%9:E?PVYTW^TMMG+,(A--'C6G_``49\,>"_A]X.CD\&?%7XYZ[X7_9\^%?
MQE^-GBWP3X6TNR@\)Z!XZ\)1:]:^(=>TV74X[>WU?7+.RUSQ"/"NBRW]Q96%
ME<A'>-(6DY;PC^Q5^U1\*M'^+WP3^%WQ8^#$?[.7Q8\:?%?QL_\`PE_P_P#&
M&I?%OP]:?%NVU>Z\1^`['4[#Q;8>$[G3KCQ!JAG@\6WFD2ZKI6CO=V,&A75[
M]EU"'S34O^"9'Q1\*ZWIOBWX<WW[-GC35_$7P*^"7PE^)NA_M`?#CQKXOT"S
M\3_!CP./`^G_`!!^'UQX4\5^'[QK#4].FN(=7\#Z_:?9]72UTZ:/7-%=;E+D
M`]O\<?\`!5OX2^$+_P`=WMA\+_BSXR^&WPJL_AGKGQ/^+/A?1K*\\'>"O"GQ
M5\)>$O&?ASQ%?M)>PW]W!#HOBVVN]6M+"VFN],M[&\N9T\KRB^Y^S)^V#\6_
MBI^TC^U!\(?%/PCUT>#OA7\4H_"GA/QGIEI8VNFZ'HG_``B6EZW!;^+)Y=:N
M[C4-3U^XNY+_`$BXL+&VBBTV>WANHQ<)(U><^+O^">?CKQ)\%?VY_A5!XY\%
M:?>?M8>"_AEX;\/ZCH_@;4?#OAWP;>>!/@KX(^%M[-)X;M-1O/(TF\O?"4^I
MZ=I6EW%PUE87UK8O<S36\\Q]_P#@_P#L_?'/X/?M,_&'X@:%XH^&.I_`_P".
M^JZ!XP\9>&]8\,^+8?BAX;\8:!X5LO"<4'AGQ!9Z^_A;4-`U.&PM[^[;4]%B
MN[)T-M`DJR?:%`.N\1?MN?"_P?=?M5:?XLLM9T'4/V2])\+>)O&EG?1PQ2^)
M/"?C;P@?%/A7Q)X1+.!J.GZO=VFO>%(F.TQ^)O#NJZ=)AHE)\0U/_@IGX-TM
M]/UG6/@S\6-(^%,?C3P%\-O&WQENK/1V\&_#GX@?$"]\/:/I_A[Q-`M^=7-O
MH_B/Q1HWAOQ%K=E9S:;I.KW7E32^5%)*O2?M4_L(6W[1GQ[^#GQ8M_%Z>%O#
M^@VFE^%?COX/71VO8?C;\._#'CW0OBGX*\,:E=Q75HMB_AGQMX>GCBN;B.\B
MF\,>-/&VD-`3JJY\H^*?_!/[XP?$C4/B+\(1\7_`>F_LA?&+XX>'OCQ\0?"9
M^'>OM\:(;_1O&'A?Q[J_PX\,^-X?%\?A2T\(>+?%7A+2KK4==O/"LOB/2=*E
MU#1M*MY&NH=9L0#A/A)^W1\<_BNGB[2_&/@?Q/\`#*UT+]MC5?@IHWCC2?#_
M`(>U+2?^$?TKQE::-IWPU\0V5_XCEO!XFN;":4Z_XGTX&VBC9)]-MFDS'7KG
M@S_@J/X0\5:YX`-Q\"?B]X<^&/Q!^-MY^SOI?QEUJ+0(O!</Q5CUKQ#X<TO1
M9((]2DUF>PUK7?#MQHMKK-O9-8QZI/%;2L`#(8_#W[$/QO\`#GQ$\>:?9_%K
MX>7'P$\3_M46_P"UKH^C7GP]\1_\+6TOQE?:EINI^)O!M]XHB\<1^%K_`,*R
M76GSW6A:A%X;M-6@_M'[!>1R0V*RRW+;]@+5X?@7\&/@U+\0]-D/PL_;(T#]
MJC4M93PA=R0:_I>B?%[6_B>_@6"S77C+IE[?1:N-%_X2!IKQ+9XI+]-)GCD\
ME`#6\*_\%(=,\5_%+X:>#;?X`?%C3_AU\8OBMKOPD^&?QMU&3PY%X)\7:WX<
MM?%$VIZG86::D^N1:/\`:/"&L6=C<7%DCZ@8X[JW4VSAS[)^TI^V%8_`#QY\
M,_A3HOPM\8_%_P")WQ5T3QUXH\,^#?!^H>'M*O)O#/PX'AM/%>I+>>)=0TZR
MN;JVNO%OA^SL-&M99=3U*:^=K:'R;6XD3\?_`(4^!?B%J_[5W[-WP7^'?Q+^
M*_Q$^#_[,/[1WQ$\=7W@OQ3^RGXE^%.A_!KP['I_Q!LX-)\0_'#Q*!IWQ,N+
MG5?&*6G@`^$C"+_085O-1COA&+E?TX_;J_9+^+/[4<.B:5X#\<_!GPUH</A?
MQ9X:U>V^*GP.OOB;K>C7WBDZ1#!X]^&?BO1/B'\.M7\)>+=`T^QU&SBT^^NM
M<\-ZLVHVEY?:<MSI,)8`^.[;_@I'X]^#GQ:_;/\`$WQ.^%WQI\<?!KX4Z_\`
M#'Q/K3:7IGA6WL/V<?AOKGPF\+>(O%#^)W>:SO\`6-0TC4[O5-6U?1[*?5]1
MMK2&:>V<VS00CZW^)?\`P46T+X/?&+3_`(9_$?X/^*_#7AK5_B'X<^&^C_$:
M\\8?#]8-7U7Q5Y$6CZMIO@3^WCX[N?#<U[<1V;ZNFC^5$^9G18`7'E*_\$S=
M6A_9V_;7^`C?&W4]6D_:\^%FA?#>+QQKWA&?4M<\)W.B_!/3/A$WB'6E_P"$
MCB'BBYO9=-;Q#<PQMH@_?&PCG#".5O+_`!)_P2F^*&N>/?'^JV_Q\\`KX+\8
M?M*VO[2EO=Z[\`I?$GQHM+O_`(231/$=Q\,I?B???$VWM(OA[ITNESV/AN#2
M_"&GZQI.EW=MISWEQ:Z:]K=`'NTO_!5+P!!HWCGQ'/\`!7XMP^'O"7Q*U_X)
M:+K\T/AZWT3X@_&G3/B6?AMI7PW\(:E=:K!!<ZGJTT5_XEO-2NOL^D>'?#^D
MZO-J]W'-I\\8R&_X*R_#VWM)/#NH?"3QA9_&QOB9X=^%=A\'U\6>`[IM3U[Q
M7H&I>)]!O[;XB6^M/X%&A7NCZ1?N=1?4P8[V`Z>86N653<U__@FXWB']G?4/
M@Y/\2;6+Q;HW[5_C']K?X8^.;KX>PZOH?AGQIK_Q.\3^/=+T#Q1X`O\`Q2UK
MXW\-1Z7XMUCP;XEM/[>\/S:]HM_>W-D=!U`64T&5=_L+_M&ZEX:U&RU#XC_L
M8G5M2U[3K^X\+VO[#VJCX1WNEV&FW-@D6JZ/>?M"77Q)N?$$-S<#5+#6['XI
M:1:V$BR6"Z1<6D[A0#[;\5_%7Q%=_LN>*OBW>^&O%_PB\3P?#'Q/XIN/#FJ6
M>B:QXQ\$ZEI.D:C<M&UI]M?P_J5_92V@GM0]]_9UXC0L\RQ2G'P7=_\`!4./
MX7?#*UUO5_@M\:?C)I/PT_9_^%_QP^-WQ3T*R\&:5%X=\#^,?`,'CC4O%VJZ
M"NL(CZCIFD0ZGJ&I^'=!:Z?%HPT\R0S0$_77PJ_91N_AG^Q;8?LH7/Q#UCQ;
MJ,'PL\2_#N\^(>NV#3W5S=^)+;6(YM4CT/\`MFXD@TNPFU7R=&T+_A()FL-'
MM++36U25H7NG\!F_X)[:\_P!_:2^"Y^*5@TOQ^_9!\-_LLVVO#P%<`^%9O#_
M`,$]2^$(\:SZ8?&;#7$O)=0_MW^P4U'2'M(XOL!U:Y9OM@`/T_TW4+75;"SU
M*QFCN++4+6WO;.XB.Z*>UNHEFMYHVXRDL3JZG`RK`]ZO5S'@W19O#?A?P]X>
MFG6Z?0M!T;1FNEA:W2Y?2]/@L6N$A:68PK-]G$HB\V4Q;]AE<@FNGH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`KS[XK_`!'T+X0_#7Q[\4/$QF&@?#_PAX@\8:L+=5>XDL?#^FW&
MI3P6R,0'N;A;?R+=#PTTD:D@'->@UXO^T7\*A\</@3\7?A&M^NDW'Q%^'GBO
MPA::LT;2KIM[K6CW5I8WLD<>))8+6\D@GFBC(>2)'5#O(H`_/3Q=^WG^TO\`
M"GX"^%OVM?BQ^SIX7TGX"7\OAO7O'>C:!XSO-1^*WPT^&/BV_P!-L]/\>:M8
M7%A#H6N-H5OJ=OJWBG0=+E@N[/3H[M[6YF:W8GZBO/\`@H)^RCI?Q+C^$FI_
M$YH/&)\9V'PZN)AX/\;OX1L?'FKV=I?Z'X1U'QVGAUO!FGZ]KMG?6LVCV-WK
MD3Z@)0+<N2`?S9^)6E?MS?M)_LQVO[`_B']E_4?AMKWBO0_!OPG^-G[0VJ>-
M?`VJ_!O1_A5ILUAI_BWQ=\,QIFMOXV\5>+?$'AW3?*\.>&+CPQIC^']2U1+O
M6;^--.G6^]=^*'[)?Q0U+X+?$'PAX4\#QW6KW7_!0#X._&'PW;/JMB;VX^&'
M@[Q3\&I;_7Y+][A/WMIHOA;7B;61UO)H[=X/*D,X,@!]HW/[?/[+UM\3_$OP
MH_X3O5+G6_!>JZCX;\9>);#P/XVU#X9^$O%VDV4.HZIX-\2?%"RT"?P)HWBC
M3;&XAGU/2K[787TR21;'49+74B+(^+>-?^"G?P&O_@Y^T-XU^"^MW7B;QS\(
M?V=_BW\>_!WAGQQX-\=>`M*^)_AWX<>#M7U^#Q%X-U/Q)H6CCQ9X*GU6QM--
MU+7/#<EY]D@O([DJD4]K+-\;^'/V>?VG/#'P'_:?_8'NO@AKVI67QA^)W[4'
MB/P9^U-IWBOP)'X&OO!'QV\>>+?B#H>N>.K>X\06WCRQ^('AB3Q.GA#4M`L_
M#ET=2@TVUN["\FT9I+^'S;XI?LT_M5_M-^`/#WAJ;]G35O@9J_[-_P"PI^U3
M\"+5KWQ?X!O8?BY\6?C!\#+'X7^&-`^'EYX=\1:FTG@2*\T6/73KGBI]%EBN
MM2TZV>U6>#4I$`/UI\"?M>_`/5_@QXD_:!\0:_HWAP>"G\*>&OBU/_9-\E[X
M7\9ZIH?A36[+PM<(-/;5M76,>/='?1)X(KN*[M-8BN+1B))V7YC\#?\`!5#P
MO\3-130_#_AF^\,ZQ'^UU:_LWNWCKPA\1M%T76-#N_'%UX)L=8T+Q#<>%[71
M8_'.LW*6MW8^"M3O8KW3XC>#68K3['+M^5+K]F_7;[]N?X._`>SEA?X<>/\`
MX/\`P'_:(_:Q\$VUQ!+%H/Q"_9GTNW\$^`IK_P`B!MD?Q)U"YT[2;L0ZC&NH
MVWPTLIT$L=I(ZW[[]F+]I&3QCJ7PAM_@YK:>'-(_X*F>&_VS+'XN)XD\&#PA
MJOPEUKXG7_B2_AMK$ZXWB:W\7:!8:M?2ZI8SZ#$YCTC?;WEU/?Z>LP!^ETO_
M``47_90L_$OC'P[J'C_5+?3_`(?GQ3;>,/B./`OC>7X0Z1K/@>RN-0\8>'G^
M)T&@S>$9==\/6MK<'4-.@U.5Q=0R:;`\^I(;,>M_`C]I/X5_M,Z5KNJ_#H^-
M;8^%+C35U;3/'/P^\9?#O6(8-<M9K[0M5M;#QCHFD2ZEI&M6=K<36&HZ8UU;
M.(9[>X:"YCD@7\I/A3\)OV@_AA^S1X^_8:\>_L47/Q[\*)>_&JUE^(4WQ:^'
M/A'X??%WP!\0?%WBCQ58K=WJZ_9>/-%^(NJ0>(_[%N2OAS28],U6RCUB/Q'8
M0^5>'ZL_X)S?#W]I;P&OQTMOC##\5?#_`,'KO4OAO:?LZ^`/CWX]\"?%+XQ^
M#M*TCPC=VGQ!37?'_@34-9AU3PAJ.OR:7'X%TOQ%K^M^)M)L]-U.74+X1ZG;
M6\`!-X*_X*A_`K4?&G[37AKXBP>*OAGHG[.'B:_TC4_&FO>!_'D?AG5M,T^/
MPW:^>VJ-X:6SM_$6KZ_XFL-%\+^#H9;GQ'XJEDAFT#3M0CGB9OIWX$?M9?!O
M]HB^\2Z%X$U#Q-I?C#P?%I5WXF\!?$#P9XE^'WCC1]+U^*2?0=;N/#?BG3].
MOI-%UF.&<6.IVRSVS7%O<V,SPW]K<6L7Y'?M`?LG?M.>)O$G[4WA+P3\*I]<
MM?$W[3_P'_;1^%?C6[\;>!+#P!XYO/@?XC^&7B"]^!'BNPN]8A\5Z#JGC-/#
M&MZ?97]]X>N?"\4L.G7FH:Q:V[N$^P?V<?AC\:/&O[;7Q'_:]^)WPAU7X!:%
M=_L^>%?@)X4^'WB?Q3X'\4>+]>NK#QI=^-M<\5ZU)\.]>\4:#9Z9ITIM=%\-
MQW6O7.ISK<:I=FWM+26.-@#WWXG?M[?LS?"'X@ZI\./&GC+6(-4\+SZ':_$#
M7M&\%^+?$?@CX777B;[/_P`([;?$SQGH6D7_`(?\&3:LMY93(FKWL1T^RO+7
M4]9_LS3)TO#Y5X=_X*%>"-&;XQQ_%FUN[+5/"/[2?C'X%?#/P?\`#OP[XB\<
M^.?B%;^%O"?A#Q1+J.G>%]%M;[4+B2UM?$DD^KWJI;Z3IULENUS<P//$DGPE
M\7_V)/&5I\7OVK[#Q?\`LY_M!?M0?#G]I7XDZEX]\,_\*Q_;9^(?P#^%RZ?X
MJ\-:38>(?`/QT^&FD_'_`.%>@WNG:7J.CSV]OXAMO!/CXZMX3FTRP>!=7LX[
M"ZY'Q1^P;\<-'^+NM_&E_AE\4?&/A;2_CM\9-1B^%7P4_:<\5?`/XEZCX`^(
M7P^^%>DZ'XS\*_$7P3\4_A/?ZI+I.L>#=0TO5?"GB;QGI4VM6!AO)K2YN%CB
M8`_5+6O^"B_[*^E^!OAWXYL?&/B+Q1'\5;OQ98>"_"?@_P``^,?$GQ#O+OX?
MWDNG?$6'4O`>GZ/)XDT)_AUJ$$UAXV36[&P?0+]%L;I3>3VUO/Q/P%_X**>"
M?CC^T5\2_@'IG@?XAVQ\)^(?#^D>%O&2>`?&7_"-:W8ZQ\.H/'TFI^)-6NM&
MMK#P9F.22PTVUUN:VFU*80I`IFF$0^&/AU^S#\;/V=?B[\+/VH?@S^R+XO;3
M'\#_`+2?P[\??LZ>*?VE]+^*/Q9TS5/C'\5_#'Q2M?C3>?$[XM?$;Q/HNL:]
MXTUWPU>2?$#0(_B9K3Z1;:Q;3:1)?7EOJ$$GUS^SOX._:)^&W[6WQC\4>)O@
M.8O`7[2MU\-/&NI^,M%^('@K4=*^$^I>&/A(OAOQ!X0US2[C5+#Q-KE['XBT
M?3;'2=2\,:)?Z/<V^I7-U(]E;VH:8`^E?CI^VC\'OV=_$<WA[XC:=\4%AT_P
M[;^+/$'BCPS\+O&'BKP9X5\.W-U<6G]J>(O$NBZ=<Z?8Q6S6ES<7T,;7%U96
M437MS!%:XE/J_P`3/CK\,_A)\&]>^/GC/Q`+;X6^&_"T7C34_$EC;3ZC&/#<
M\-O<0ZE;V]NAGN(Y8+J"6-$7S&5QA"WRU^/_`/P4+_99_:?^.?QC^,B:9\-/
M&'QO^$GC/]G.R\$?!S0M._:4NO@S\-_AE\5'7Q@GBOQ+\1?`%IXIT5O']WJL
M.H^%FT/4[S1/%EC:II\^F2Z;ID$EUJ3?77[1/P!^*/Q"_P""9FM_L[:#H\%_
M\6]2^`GA/P/!HDVM:/I]O+XETO3]"@OK5]=FNDT2"%)+&X7[6;O['(%4)*R.
M"0!-2_X*O?L?:1'XF.I:S\4K*Z\&*FH^+-+N_@M\2[75O#G@R5'EB^)6MZ?=
M>'8;C2OAU-;Q2W,/B>^6WMYHHIA%"\L4D2>D>._V_P#X"?#;Q3)H?BZ#XFZ;
MX<@O_!FFW?Q4'PP\67'PDM+CQ]I>A:MX:ED\?063Z3)87-OXET:&[U.#SM.T
MV^O/L5]<P3V]RL/SG\>_V6/B=XX\>_\`!0'7_"WAG2;W3OCY^PQ-\$/AJT^J
MZ+9'5/B*?#OCW38-*OA=W<+:5:_:]>TM3JNI&UL`)"YN<1.R_FE\<?V"_P!L
MKQQH7Q5\,>*?@_=_$ZZNM-^"A^"'Q"UC]J27PQ\-?@=\/_`WPR^$VG>+/AW8
M_!2SUZ/PY?>*U\>>&/B%KMSXRN]`N;7Q0=?L1>>)+'2[,1S`'Z^Q?\%"_A[H
MOC+XX:-XS75[:#X:^/O`OPY\,>#-%\`^+YOBAXE\3>.-&N=5TG3K/09O-B\1
MMJUI8:EKFE7N@*E@GARPO-2OYHH[>1QMW_\`P4N_94TOP5HGC;4?%'BNR35O
MB'X@^$D_A*3P!XKE^(6C?$[PUHC>(=0\#:QX$M=.N?$EKX@GTGR+W2;6&QN8
M]8MKZQN=.GN+:X6<?G')X0\;_%/]MGX_?M#_`+/F@:9\7U^"OQB_9N\3V/AF
M#Q'I_AW2?B)%#^S/XU^%GCW0?#_BK6'M_"J>*/"Y\>PZSI\EW?V5D\^FWFDS
M:K92Z@LZ=SX!_8R_:*U/]HOPK^U#\0_`/ASPAJ7Q!_;*G^-GCOX8:?XNT+6_
M^%5_#SPW^SS%\&/"QOM7L)$TSQ;XRUR^TQ=9UY?#+:G;63:C;Q0WUY%:23Q@
M'JNH?\%5+31_&/PDTC_A`]>\7Z'\4?VF_B[\$)1X3\!>-H/%7A32?AQ\+_$_
MCRUM=4\/:N%N;WQ_)?:):V>KZ/:K!;0:1_;NJ0Q+_8<\4GV7IG[;/P+\1^#?
M"WBW3=2\0-;>,?C(GP`L="G\/W,/BBT^*7F7?VKPWJNB[Y);&33K:PN=1U&=
MW>"VTU#=LYC9<_G;K_[)O[2?@WQCIOQC\%_#/P_\1-;^'G_!3+XR_M0Z+\/Y
MO'6@^&+KQA\(_BC\$/BI\'8;BQ\0ZG*-%TG7M-NOB#8^(I-&URXMWN+/1Y[?
M8EX]J&W_`(*?#'4M2_X*7>.YGT)--\#Z1X*\*?M'>-_"4DZZQIO@3]I7XB>$
M(_`6HZ/:ZM!$VD:AJ2^'](?4Q?Z5/Y>89YH4^S7R.0#])/CO^TY\+_V;K'P;
M!XT?Q)JOB+X@:[<^'?`?@?P1X<U'QAXU\7:K9:;=Z]JZ:)H&F@W-Q;:1HMG>
M:MJEY(\-II]A`9)I4+P))^=GQ=_X*?W/BKQU\`_A[^RO:W^N6WQD\(?$GQC?
M^.[WX8>*/%=QX=?X?ZSH/A:;PM+X.M9]+O;?5++Q)KCVOC*;4)(D\,QV=ND@
M9M2AE'T;^V#\%?C)??'+]E_]J?X(>"]"^*/B7]GN7XN>'-<^%NL^)]'\&3^)
M/!OQE\(Z9H&IZKX;\1Z[:2Z38^)?#>K:!HEW!!J-YIUGJ6BS:UI\ERDTED4^
M7OV2?V'/CA\'/CY\"OBUXZMO#L2#P_\`MB>)?B?IVAZ[;W^G^$/%_P"T5\3/
MAAXR\/>#]')BM9=8M=,T_P`+:A;ZAJME;1V$E_$TD<826.60`^P?VG?VV8_V
M;OC'^SO\++KX<^,O&T?QK_X3S^T-0\&^'=0\0:AI1\&^'CJJQ:58VLD27]U<
M76/M=O(Z-;:8EQ?`E8&%>`_`S_@J-X1US5M9\*_&71/&FBZA_P`-2^./V?-,
M\;Z-\-?$D?PPT&[/Q1N/`/PJT;QGXQN533=+\2^+)+KP_ITPMC>V%GKFLV5A
M?W-E<W!BC]I_;*^%_P`9=3^*?[*WQS^"7@'1_B?JWP,\7>/KKQ%X"U+QCIO@
M6\U?0/'G@'4O"'VS2=<UI#I9NM&O+RWOY;"\D3[3`DH@#7&T'YHN_P!C;XW:
MY^R=\1OA3?:)HNF^-/&?_!07PC^T59V5MXDL;N"U^&]M^VO\//CMJDW]H)LB
MAU*P\%:+JYBTV(+)<7MO#:1J9)XU`!]<>%O^"A7P!\7?%;2/AAI@^(,-MXI\
M8:Y\/_!/Q+U/P!K6G?";QSXW\-+J`UOPOX2\<S@6>JZE:3Z1J]M%*UM;Z=?W
M&EZA'IM]>&V<UWW[17[7_P`+?V;]0\!>'/$UEXY\7^._B9<ZXO@GX=?#'P=?
M>.?&^O:;X7MK.[\4:[#HMC-;^1H'A^#4M-.IZK=7,,$4NH64$/G3W,<3?F9^
MS;^PIXX^#/CWX6^`_%W[*?@_QUI7PI^(^N^*=%_:6N_VD/%GV)],GU;Q5J'A
MWQ19_!>?49TMOB%8:5KT.@W]H=%AT-KEM1U*UUKRKH05]7?M,?!;X^:'^UK\
M$OVNO@+X&\(_%B?PM\'OBI\!/'7PY\5>.(/`<\&C_$#Q+X"\8Z'XV\+Z_?:3
MJUE#=Z1J_@J73/$=K+%)>WF@ZE$-+C:ZLV28`^?_`(.?\%56U#P9%\0_C);:
M9X?\+V/PW_:?^+_B'2]/\)ZW!XOM?`WP$^(NF^%EG@2^U6RTFSOH=,U:S75-
M)U-%NY]1,K17=K#;R!_I&_\`^"DGP<,.E#1_A]\?O&/B+Q!K'B>T\)>"/#GP
M?UU?&/BOPMX.MM(N=>^)FBZ%XBN/#TS_``W1]:T^TT[Q)J,NG2:Q>2);Z787
M4DL*R_F5J7_!,O\`:HUWX-^,/"NJ:1\/+7QEXN_9?_;J^%\T6G>+1?:/9^-?
MVA_B/X3\7^!;&WU&^T^RN[[0X;33;];W5+RQMIHWBC-Q9PM.(D^Z?VT/V-/%
MOQ!^/_PR_:&\(_#/P_\`&ZQ\._"WQ3\)O%GPJU7XI>)?@Y>P6^L^(M%\4:)X
MR\)>)?#DMM:W%U8ZAH\FGZQH6LS0PW=G=Q7UG<)=V`AN`#T^;_@IO^S]=GPI
M;?#[1/B[\7[_`%_P#HOQ1UG2?A/\--3\6:G\/?`WB+4+W2M%U/XA6376GR^'
M[S4]1TS6+6RT&!=3\0W#:-J4D>EM;P&9O)O!7_!6;P+J&J?'>W\>_"3XQ^%=
M(^$WQ9UGX::!K=K\/-1O;/Q==P#PG:>&-#@#Z@LX\?\`C+5_$GDZ#X96"-9=
M,6VU*[N;&-[CR/(O@G^S#^UA^R#\3?'_`,3O@=^SM\&-1\+_`+0GPU^$VD^(
M/@W9_&6]TT?`[Q_\+;?Q)HEF+7QEKGAJ:;QKX,UG0-;L[[5)[4KJECXJL=3O
M+6QN;;4XY5;XF_9._;$LM>^,VE>$_`7POU;3_$7[4'A3]LCP5XOO_B7)IFFZ
MCXGT+0/!FEZM\*-?\/R^&[W5[%M072=?ATOQ3:ROIUN\FD7-W"BFY1`#ZUO_
M`/@I[^SYH'A/Q%K_`(PTSXI^"=?\%?$[P!\)O''PU\3?#Z[B^)_A+Q+\4XH[
MKX>7VH^$M'U#66U#P[XLL'>\T;5O#=[KBWJVU]:PP-?Z=?VEO)X+_P""C7PK
M^)?CG2_!/A?X5_M&ZM*WBCPGX)\8:];?".]/A[X8>*_&,MD-*\.?$EGUA-8\
M.ZA;)J.GWNN3Q:%J>G>'K.ZAGUV^LHDN/)^0]0_8G_:9^+OQM\3_`+3WQ&\,
M>`O`GB?QO^T1^PIKL'PMTWQ@/$Z^&?@]^RAKOBC7_$&M:YXE_LZUL=5\8>*-
M6\>^(7T[1=+BFL],T;2-+C%TVH:CJ")T_P`6_P!CK]H7Q-^UMHGQ6^#GPU\.
M?`+73\>?AGXQ\;?M'_#;]H+QIHMM\3_@GX5U>QO/&7@GXH_L^06T'A'QOXK\
M8>&[6Z\'_;M9TJ^&GM/9:U9^(;5K'RJ`/TM^//[0OA']GS3/#!U?0?'/C3Q+
MXZUU_#O@GP%\-O#T'B;QIXGU6VTZYU:_32]-N]2T73DM]-TFQN=1U"[U#5+"
MTMK:%G:8L5C;\T?C5_P5(UO6M3_9R\+_`+,O@7XB:M=?&7Q7\5-&\7ZI=?"U
M/$'BOP)??!W0=:N?%_P[E\"7GBK0]GQ#TS7+.R&OV5]?BQTKP\)M2L;S4I)X
M43[8_:F^&/Q@U?QS\`_C7\&?#?AWQUXI^"WB3Q6]_P"`O$OBA?"%MK_AKQ[X
M/O\`PGK$VF:])IFJVMOK>C-=6^H64-_;I:7T<<]O)/"70M\??`?]AGX[^$?C
MC\#/CMX\3P-!J=S^T1^V)^T%\8O#'AW7I=3TGP1+\??A\GA/P5X6\+WUYI6F
MW'BBYTE[2RCU_5EM-/BEN9-2N((?LC0(P!]8?M*?M)?$CX;^)?V</@E\)]$\
M->(/C/\`M#ZIKNG6VK>,/MMKX5\&Z%X,\-0:UXO\9:OIFDR/J%VT$ES;6FF:
M1!<QQRW]P(;BY\F)RWC/BO\`;=^(O[)OBKQ'X3_;$LO#.MZ!8_!N;XR>%/B1
M\(-#U;[9X@T[0_B-X/\`ASXW\/:GX'U.^>>'4_#FK?$[X=7-G/I5Z\>HZ9K,
MC&W-Y;R1OZ_^V)^SQ\5?'WB'X#?'7]GJ?P:OQM_9S\3>(-5T?PYX[N]0TCPO
M\0_!OC'1H]%\:>![[Q!I=GJ5WX>U'4+:VM+OP_KCZ5J5E8:M;QO?VCVLDK)\
M6_'K]D#]M#]KBP^)WC[XHZ+\*OACXF/PU\/?!_X)_"7PUX[NO&0TC1+WXP>`
MOB9\4_&OC7QY<>&-`TP:WXK7X:>!=-T30M&TNZL],LO#]PUS?O=ZD=@!]7Z3
M_P`%+?@2VC_&C4/&6C?%7X7:A\$/#WA/Q7XC\-?$CP%)H'B;7-!^(>K3>&_A
MU<^#=)M=3U)M?N?'/BF)/#'A[3/.M-4EUZYM].OK*QFD/ES:I_P45\":%%H6
MEZ]\%?VD-#^)OBOQ;)X1\'_!/4OASHL?Q.\8W$&@+XEO-:\.6\7C*;PA>^&-
M,T@R76K:Y)XOM[;2I87L=06WOO+@D\(_:]_8"^*?Q\^+WQ=^(?@O4O"&BOJ/
MPL_9:NOAA+KEU+%87GQ;_9K_`&A=2^.5KHOC6VL-/NKZ+PAXE%MI&@W>J6L>
MI36"W]SJ%OIMU-9"":UX^^#G[</CKXN?!7]J^'X7?!_1/'WP*U;QSX<TSX'W
MGQ9NM03Q?\.?B-X5ATCQ'J4OCVU\$0:'H/B_3]9@M;K0K0:=>V$^E6UQ%JE^
ML]W;V]B`9>O?\%4?"Z_$GP=XFT&P\5?\*.T']F_]L3XC?'7P5?\`@=(OC/X'
M^(7[-GQ-_9J\)WNC:AH;ZN%LI_#&C?%#QA>Z]I-K>7L>H6JV6IV-Y/':VZ77
MOG[3_P#P4(\'?`W3-"LO`7A/Q-\8_&OB/PS\./B!I>F>$-/LK[1!\/\`QY\2
M_"'@*UUN^UBXUS2+:TN-8/B8Q>$+<S-%JVL&QAN9K73WN;V'Y5_9^_X)]_%C
MP9^T#<_'[XYIX!:V^+?A7]N35OC?X4\-:O=:QH7A;7?VD_&'[,FH>$/!_AQK
M_3K&Y\1Z=I/@OX+:O9>)M<:TTJ.[U5@\-G)'>K,_DW[''[)'Q*\;_L@_&;7K
M*Z@UOQWKGBOP?X&_9XN?'[ZWX?M=0^`/[)/Q@L]5^">AZO<W$>J:SH\7BNU\
M*/9W>J1V3130_P!E:TUI+$RT`?:__#Q/PMX1\3_M`7OQ8T_QKX$T3X1_#[]G
MSQ2?A?K?@"U3XH:;K/QV\3?$WPAX0\-[M!\5>(='\3>)?&FN_#V:VT?1--O(
MX=/^UZ=Y^I2M?R"TVK__`(*.Z3::WX6^']O^S3^TK=?&GQ3INO\`B>V^"\WA
M+P?IWC:U\"^&+G2+75_&MS<WGCJ/PLVB^?KNFVEA'9^(+K4;S49)K%K*W^S7
M-Q%\J?$?]A+]J/\`:`\;_M`_&?Q-IGPS^$_Q"\;Z+^PWXN^%_AA_&=]XX\,V
M7Q)_9&^)_P`<_&$VA>,M7T_P]I]W)H?B;1O&?A*VDU"STW4(["YOM2^RVUV=
M'@FN>F_:3_9M_:V_:<T#1M0^)'[)G[)VO^*;+2_$6C^#K^W_`&DOBQX%^)WP
M>UC7(A9'Q1IGQ=\"_#;3=5U7PW=0I;WFK^%=%&D75RUA:VURVK17$D=D`?HO
M\3/'OQ:\3?LS3_$#]GCPQ-;_`!7\:^"/#FM_#OP_\1M*&E7/AV_\71:9<V[^
M.-`N+E'L[WPQI^H2W6O:$UT9H[VPN--$K/\`.<W]EU_VF;C3OB/>?M*:AX<F
MNSX^U#3OAQIV@:+:Z3);^!-$MK;2;76M9>UO;U)]0\8:E::AXGBM=Z#2--U*
MQTMM\MK+(W.?LX^!?VM/AK=>!/AS\8?'GPZ^*GPJ\"_LV_"_PG>_$=[;Q-#\
M:O'G[0?A^"'2_'WB_P`22WE_/X?E\(Z_8VL>IV.+2/Q&^M75W/J=Y<[\U]CJ
MBH,(H4=>!CDG)/XDDGW)/4F@"(6T08.%PX.=W\1[X)QG&<'`(&><5/110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`,$:`Y"(#TR%`./3.,]S^=
M.P/0?D*6B@!NQ,YV+G.<[1G.,9Z=<<9ZXXI/+C_N)P<CY5X/KTZ\"GT4`9,.
M@:%;ZO>>(+?1=)@U[4;.TT_4-;ATVSBU>^L-/>>2PL;S4DA6\NK.RDNKJ2TM
MIYGAMGN9WA1&FD+:GEIG=L3=Z[1G\\9[FG44`,,<9ZQH<=,JO^%.``Z`#@#@
M`<#H..PR<>F:6B@!NQ,D[%R2"3M&21T)..2.WI2[5R6VC<>K8&3CID]>*6B@
M!I1&^\JGZJ#_`#%&Q#U13V^Z.GITIU%`#=B9)V+DC!.T9('0'CD#)XI0J@Y"
M@'U``/YTM%`"%5/)4$^I`/M_+BC:I&TJ-N,8P,8],=,>U+10`SRX^?W:<]?D
M7GOSQSSSS39((94>.6&*6.1&CD22-'1XV&UD=6!5D9>&5@5(X((J6B@#)TC0
M-"T"T%AH.B:1HEB)'E%EI&FV>FV@ED),D@MK.&&$22$DN^S<Q)+$UJ[5SG:N
M?7`SSG//XG\S2T4`-V)M*[%VGDKM&TG.<D8QUY^M5+?3=.M+BZN[6PLK:ZOF
MB>]N;>U@AN+QX8_*A>ZFCC62X:*+]W$TK.8X_D0A>*NT4`!`/!&1Z&F[$Z[5
MR.AVCCK[>Y_,TZB@!"JMC*@XZ9`./IGI1M7^Z/3H.GI2T4`)M7K@9'0X'%!`
M888`C.<$`C(Z'GN*6B@!NU?[J^O0=?7I2X!Z@'\*6B@!-J_W1Z=!T]*-JCHJ
MC\!2T4`)M7^Z/R%+@9S@9]>_YT44`%```P``/0<"BB@`HHHH`****`$(#=0#
M]0#V([^Q(^A([TBHB`!$5````JA0`.@``'`[#H*=10`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`"'@'Z&OB#2/VTAXK\0^,M-^'G[/7[0/Q,\+_#_XEO\`"CQ5
M\1_!NF_!Q_"MGXHL;C2[?Q#);:+XD^-GAGXF:KH_A8ZO:MKNI:1\/KX!(KV3
M2H-4BLIV7[?;[K?0_P`J_GK_`&@-(_LSXC^--7_9!\`?M=_"/]JW7/C+X5:Y
MT[1=$UU?V=?B!=?\)5H5IXJ\<>.&OI-0\`?\(]K'@>&\FU35=/ET_7GDBM[>
M.S;4DR0#]Q[?XS_"B;QRWPO_`.%C^"?^%EI`;J3P`/$ND'Q?%;_9EO?,?P^+
MLZF`+)X[M_\`1SL@D28_NG1CXG\8_P!N7]F'X+^#/BWXO\0?%WP5K$_P2\(>
M(_&WCWP7X6\3^&]8\?VVD^&+8RZA8Z=X7;5[6YN]?N+F2TTS2M(DDMIM1UB^
ML-+B=+B\BK\./A_^S5XPC\;CX?\`Q8@^.>G_`+16D?M:_%3XP:#XP\(?!+1K
M[PAXBO\`Q3X_\5ZKX/\`B-J'[0T>V_@\!77@GQ/H.@^)/#5_J,6J^'M)T^;P
MA8:-+I6DV0KI?#WP\T_Q3_P3J^+_`.QVG['_`(YLOVQ+3]D_]IKPAJ_C'6O@
M]96NE:G\3]4\'^*H;/7]+^,=_%]D\0ZC\2/$UYHU_H%S8:I=:C->M;SW\=B^
MG1L@!^X?A3]J7X:^-/$>K:;X>UG1]2\(Z)X!B^(%]\3K3QM\+;[P6MD=7N=&
MO=+DM=-\?WOCZQO-'N;2X;4M3U7P+IWA+Y/LEGXJNM4CN-/AZC2OVF?V>=<\
M,2^--'^-OPOU3PC!KVF^%KCQ+8^-=`N=$@\2ZQ-!;Z5H,^I0WSVD.KZE<7-O
M!8Z?)*MU<S3PQ0QN\B!OP-^/?PZ\:?'1_B-XA^"OP,^(>C>"9OV8_@5%J7@7
M4/A_=?#F^\71^`OC_#K_`,3?`=OH%U#IMI-JVN:%:7URFF,476X'SB2"[;?L
M?&;X40?M#>.=1\3_``J_9H\6>%O@9KWQ[_X)9>'O$_@WQ#\*&\$V_C!OAG^T
MSXT\5?&KQ)J'@A[.`W7A?PQ\,_&?A30/$NMZCIXLM1T_0KZR#7-EI@E8`_H$
M^''Q@^%?Q@TJYUSX5_$+P?\`$31[*_DTN\U/P;K^G>(K&TU*$!I;&ZN=+N+F
M&WND4AC#,Z28YV\&OF/XT_MK)\!;_4M3^(7[/WQTTGX4:5\1/#/PXN_C/'%\
M(-1\(-J'BW5-&T'1_$5KX7L_B]_PMF7P:==UB/2[O6I/A]%=PRV]S?PZ3=:'
M&NJOY_\`LR_"F7X:_MI?MIZAHGP_B\$?#'Q9HW[/NH^%'T?08]!\+ZSK^E^%
MO$VG^)[S2K>S@MM-:ZM=UA;:@]O$C[C"LP)VFOF;]H'XF>(/C)^U1)X(^,/P
M?^.MO^S7^S[\1-!UKPQX8\*_#+6O%=I^T%\3-#BTG5O#_C+Q#JUI)'I>G?#/
MP'KTLUSHV@O))=>(?$.G1:MJ[0Z39VUI(`?MQ"[/$CL`&9<D+TS[9)./J<^N
M.E+(Q5'8#)52P'/)`SC@,>>G"D^@)KP#XQ?"OQ%\8M+\*#PW\;OBS\$#I2W]
MU=R?#.[\,:=?:XNJ6=I';6NNCQ'X>\1(!I#PO-:Q6B6[)<7%RLSS)L"5_@E\
M'O%OPC3Q,GBCX^_%?XWKKC:<;%OBA=>%)Y/#JV"W@F71V\-^'=``&IM=1&\^
MV"Y(-G;F(Q_O`X!XE\.?VZ)OB_IGB;Q#\,OV7OVAO%7A3PQ\1/'7PTO?%S:O
M^S'X;T-]>^''BO4/!OBNXAM/%W[1WA_Q7_9-EK&DW_E7<WAJ*YNK0)/;64S%
M8C\U>,/^"Q?P7\.:AKT6D:;X5\2:9!\3D^$/@^^/QJ^&.AW/BGQ7%)<+JNNZ
MIINHZC]H\%?#;2%LK])_'&M/*MW/;+!8Z+/-<VJ3?)/[,OP^^#/PZ_X6!'^T
M!^S?^U=JWQ8?]J+XV^+M+U7P;IOQH_X0Z^T+5?B[KFN>`]22P\.>-M&\#7MG
M<:-+IES=R3:,Z7BF4ZLUT6F=^YF_9BO9=+^!P?X$VGFV7_!3KQKXT\2&3P+I
M6Z/X3W5IX[%AK&IN;$M+X1GEO-.:W\]I+%FE@;9N"D`'ZQ>!?VN_@GXAG^'/
MACQ5\4_A)X4^*WQ)\.:-X@T/X76_Q2\*>(]:U"'7K.&^TQO#=S936A\5V%]:
MRK/I^IZ39-;7\+A[;>`33OB-^VK^RS\+KGQKI'BOXZ?#.T\6^`/#&O\`BSQ%
MX%3QEX=_X3.#3/#FE2ZOJ"+H%QJ=M=B\%K$##;S^1O>6(.\:/O'X<ZI^SMKO
MA[XX_M'_``_^*&G?'K3$^('[7:_%_P"%%Y\)/A3X)U[P9K_@>6;PI<_"EE^)
MLR)JW@:;X56&CCP9J6AW%QIEOH.D>'8I/#ZW%IJ;>9Z9\`_!=EX=^#'Q/_9/
M^(O[,'B35_VD/%7C/]J&WM_BU?\`P[TG6/!.HW_Q!T/XD:EX5^*5U\5KDW"V
M]KJVB:C8>$T#2C6[*[U"WTE;6.TWN`#])?!7_!1O]FOQU8_#/Q/I7CCPY9^`
M?B/\/H_'LWC37/'WPFT>Q\"3S0^#)8/!'C;0KGXBGQM9>-?,\>^'+._L-)\+
M:SH^B:A>PV.M:]975YI<.H?4OB_XY_!SX?RW</CGXF^"?"$NG^$+WX@:@GB3
MQ%INC-8>"-.U&QTB]\5WO]H7$'V70+;5=3T[39-3GV6GVZ]MK42F:9$/\_'P
M2^!,?QVT7]E'X:>(/@]XO^%7A_1O^"<?Q&_9L^,-QXM\$Q^$&T/XZQ^'O@#8
M2ZE-)N":Q?#Q'X>O;G2O$6^5M=NO#%S-%-/%#'/)YKXH^`?[4OQI^#EQ\>OB
M?X;\36_CWX>?%W]D_P"'NL_#[3;7P]J_BKQ7^S[^S"=<E\;Z]X1\)Z]/_P`(
M_P")-4U_XP^+[WXKZ;HVIY@\3:?X'\,V:JTR6E`']+?PM^,WPF^-_AT>+O@]
M\1_!GQ-\+FYFLCK_`('\0Z9XETE;RW(\^U>^TJXN;=+B+<I>%Y%D"LK;=K`G
MXF3_`(*,Z;<6/QV\3:1^S/\`M(^+?A]^SG\8?B9\&?B=X[\&V'P5UBSTS7?A
M3<VD?BO6]-\(W/QKTWXF^(?#MI97UMJBR:#X%O\`6IK.5E@T66XM+B%N-_X)
M_P#AWP9X:\8_M`^/K'4?C']K^(6J>")M=UKXT>#?#7PNM?$&J:'H%Q8Q7OAC
MPMIDEM(K6]G*EGK&JWNGV4M]<1V\:&>.!6'QM\(/C+\1/@?8_P#!03X/:-^S
MO\8?B#\3?C1^VU^U/X\^%D]MH>E:1\*]2\(_$9M$TOPWXDUGXBZQJ]GIMAH@
M&DW^K7GDVM]=O:)'':6\]Q<1Q``_6F#]NK]D,V?PYN-1_:+^$>A77Q>\/>'_
M`!3\-M'\1^-]!\/ZYXLT7Q.T,.B76D:-J]U9:E<?;KN=+&-#;[Q?[[1E6>-X
MUY[PM_P4#_98\2_&;XK?`L_%?PKH'CKX1ZU;^']:L_$WB/PKI,.OZB-!E\0:
MY_PB*_V]-J.K0^$+>WN;/Q8UUIVG/H^HV]Q;R1R)"TH_G4_:A_9]_:*^'_[+
M'Q3_`&/5MOB7XSA\-?L:Z+X3^$MG\$/"W@35?"OQ-^(=YX;\2>(O&L?Q.\=:
MRDFOV6F>$O%\TECX4T33IM,U*ZMH]*?1G%_=^;#]7?M"^!_%-QXU_P""B'PW
M\/>#O$"^)/VH]._9\\7_``;\<:1I.@W_`(=U2/P+X*@L/B9HE_XIN=22UT+Q
M%?R:/-I\EG?(D.L2:E91RM-:W,Y0`_?7X2?M`_`[X]V>K:C\$_BW\/?BOI^@
MW:V&M7WP_P#%>C>*[32KY@66SU"XT:[NXK2Y906$$S)(5^8*5YKU^OQS_P""
M>/A/07^/?Q6^)UG+\=[GQ)KWP6^&?@KQ)?\`Q5\#>"_AQX=GB\'Z[XBN](TC
MP]H7AJY6\UK5_"Z>(+ZPU/7[FP%G%IMWH^G6E_<11PQQ?L90`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7S]JO[)W[,.N:CJ&KZS^
MSW\&=5U35;NXO]3U'4/AOX3N[W4+V[F>XNKN\N9]*>:YN;F>22:>:5WDEE=W
M=F9B3]`T4`?."_L=_LGJ"%_9M^!P!&"!\,/!P!`);!_XE'3<S'ZDGO1_PQY^
MRAM*?\,V_`_8>J_\*P\'8/4\C^R.>I_,U]'T4`?-Y_8Z_9.((/[-GP.PS%F'
M_"K_``=@L>"3_P`2CDGN30/V._V3QM`_9L^!PV<K_P`6O\'?+P1Q_P`2CCAF
M''J?6OI"B@#YO/['7[)QSG]FSX''/7/PP\'?_*CWI%_8Z_9.0EE_9L^!RLWW
MB/A?X.!/U/\`9'/XU](T4`?-Y_8Z_9./7]FSX''Z_##P=_\`*BD_X8Y_9._Z
M-L^!W_AL/!W_`,J*^D:*`/F\?L=_LG@%1^S9\#@I.2!\,/!P&2<Y_P"01Z\_
M7GK2_P##'G[*'(_X9M^!^"VX_P#%L/!W+=<G_B4=:^CZ*`/F\?L=_LGCI^S9
M\#@<YS_PJ_P;G.<YS_8^<Y[T\_L??LI%F8_LW_!#<YR[?\*P\'98YSEC_9&3
MR`>?05]&T4`?.)_8]_91+;S^S=\#RQW`L?AAX.W'=DMD_P!D9.XDY]<G/4U8
M3]D?]EJ-52/]G7X*HB'**OPT\(*J'=NRH&D@*=WS9&#NYZU]#44`?/J_LF_L
MOJZ.O[//P85XU"QN/AMX2#(JDE51AI.5"DG`!`&>,4UOV2_V768LW[/'P7+-
M(92Q^&OA$DRMG=(3_9.2YR<O]XY.3R:^A**`/`$_91_9CCV^7^SY\&DVG*[/
MAQX37:<$<8TH8X)'T)%30?LL_LU6T2P6_P``O@]!"@E"Q1?#OPHD:B=G>8*B
MZ6%`E:1VD`'SL[%LDFO>:*`/-?!WP:^$GP\U2?6_`7PS\">#-8NM/.DW.J>&
M/"NBZ'J$^EF:WN#ITUWIUG;SR61N+2UF-L[F$RV\$A3=$A'I5%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`'2OG5/VE_AW=_%7Q[
M\)M,O-0U#5OA7X5M?%?Q)UZUTJXG\*>#8;Z&6\LM&UG7$;[/%XAN=,@FU8:/
M&LEW#IJ"ZF1(WC+?1+=#]#_+VK\S?V+M5\#^%H?V\]:\7WNF:1J6@?M8_%/6
M?BAJVMRQVJZ=X<LO`G@>^TG4M6N;QE:/0;?PI"UQ;SS$VR01W[(=HEP`>WP_
MML_!W6_@O\1/CSX$N=>^(?P_^%OCO7_`/C.^\(>'M0U*^TW4?!VIV>F^,[Z'
M2F6&^O\`3/#2W;7^H7%K$SBRM[B2*)S$5/U)X4\4Z!XV\-:#XO\`"VJV6N^&
M_$VDV.NZ%K.G3)<6.J:3J5O'=6-]:S(2LD-S;RQR(0<X;#!6!`_&W_@E[\6_
M@?XM^&W[=.BZ/XW\$^(=/'[;?[9'Q*O-'T34["Y*_";QO\0]3O/"7C%[.%_^
M18\4:+:W%[HNK;38:I:1R2VTTR1R%?J3_@E;;ZK;?L-?!07K2G2YH/&=UX02
M9F9X?`]UX^\3W'@^/+8)A_X1^2Q-IMWH+0P>6YC*4`?H=1110!YC\5/BCI/P
MG\.?\)+K.C>*];LSJ%GIWV3P;X<OO%6KK)>+,RW!TK3LW)LX1"1<3@;8MZ$Y
M#"OBB;_@J'^SQ+X#USXE:1IWQ5U7P9X?O]?TG4O$:?#'Q%::)!J_A?7KSPMX
M@TI]5O$@M$U'2_$NG7^A7-L[JRZK9SV>?,0U^CEQ#$Z,SQAV"D#*EB,C&`.>
MO3@9K^;S^P+V]_X(N?M)Z!<:7J/VW4_VD?VPH%LEBFM[V6QU+]O+XI2H;8G9
M)"EU97`N;:X3`6.>.8,OF)N`/WF\9_'+P/X-TGP]K,NH'7;77_'OACX;K_PB
MJ1^(Y-.\4>+-4@TG3[;5(].FD-A#;W4V=3EG(.GPJ\TZ!4(/H4'C+PE=:U<^
M'+7Q/H%QXALU#7>A0:O82ZQ:H51P]QIL<[7D*%)(V#20JI5U.<,,_P`]7Q[^
M&/AGX+_'0>`?A#X/?PCX"E_:J_X)E>(I]#\.PWD6DG5[CXNBU\1Z[*L;L)+F
M]T_3[9]<O,N;PJ);LR!W:L+]B&^^'W@?]LGPCX'^'>I_"C]J)/$?C;]HGQKK
M'Q9T_P`(>//!'[57[/\`=>*=6U_Q#K&A_M%0>(=0O-'U/1$N=3M_`7A:XU+3
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MX@?"#XD:QX+T3Q5IEQ=VVF1W]Y>>#[30-4T75+NSMM4$5Z+IK>UNI7C4`_J0
ML_%7AG4-1O='L/$.BWVK:=##<:AI=IJ=G<ZC8V]PH>WGN[&&9[FWAG0JT,LT
M2)*K*R,P92:-OX^\#7D&I7-IXQ\,75MH[M%J]Q;:[ID\&E2HVQH]2FBN7CL9
M%;Y62Z:)@W!&:_E5O_A)XZ\)?`C]@'QE^SQH^O:3^T5\>O\`@GI^T%-\1?$%
MC_;7_"4?$KQ_JOP+^'7C&UN/%LTE]#=:CK\&OP7E[H\5[+;7=O=2M;:?)9O-
M&K>/?$KPWX(U#]GO]H?Q!\&_V@OAEKWB>S_8?U[PKXN^!/P&_9P^+_PO\807
M4/C;X?7FFZS\9O$?BKXQ_$2TLOB7X4U#^W=/BM=4TK0?$FL#5M;U"&+^S=/N
MGC`/[&;#Q7X8U2/4I=-\0Z+J$6C3SVVL266IV5RFE7-L&-S;ZDT,SK8SVX5S
M/#<F*2+8WF*NUL?)NK_MS?![3OC+J_P:TY]:\5ZOHX^!:7.K^"]/3Q3H@G^/
M_B7XB>%/!PDO]+N98H+6SU;X;:X/$5ZY,.CP/:/*':9EC_#K]M#X867P1^*G
M[37P]^"7A+Q-X1^".J?!+]D#QO\`&7PY\-K3Q#=2:GX#L?CEXMTKXI:U%9Z-
MY^H7^J7/@B-8O%-QIWGZMJ.CPR?:$D*BN%&I_L_:]^V'JFO?LEZ!_9OP;U?X
MW_\`!':V34/#7@GQ7X6\/:Y>Z1^T/^TG<>*KZR&J:3IO]JV5K:"RL]9UBT%S
MI45[%/97MV+JTO4A`/ZI;7QUX,N]0M](M_%?AR;6+I;EK?28=;TV74IA9RO!
M>&&RCN6N91:S1R0W!2-A#+&\<A5T90P>/_`IU>;0%\9>%VUZWN$LY]$37=,?
M5X;J4;H[:735N3>QSR+\R1-"'90652`2/YN=`^#_`(7\/_"+X6?''2?!MS8?
M&F^_X*Q>*K*;Q^(;]_%;>"M3^.'Q-T6[TIKT3-,OA6?1"(I+#]WI[PND@C.Y
M7/$?#.Y^#6F>*_\`@FYX9B\#>,M!_;"L/VQ$C_:H\4>(?AU\0M$U'5?&=YX?
M^+4WC^/6?B/K>B6?A;7M,\3^-+&/6O!VD6'B'4SJ/AJRM]0TB";2='O+JV`/
MZ3/CO\</`/[.OPN\4?%SXE:C<Z?X5\*Q:9]J&GV-QJNK:C?ZYK6F^'-!T71=
M)M`;O5=:UW7]7TS1]*TVU5KF\O[V"&)2S4?#/XZ?#/XK?!_P3\=O#'BG3!\-
M?B!X7TGQAH'B'5+JWTNV71M:MH[BV74FO)8TTV_MF=K/4K*Z>.?3]1AN;"X5
M;B!U'YQ_\%)=/^+/QD^-7[&?[-WP>TCPEJM_:?$'4/VJ?&P^(-YKVF^`FTC]
MG^?2G\"Z+XGO?#VEZMJ36^J_$/Q-I>O65I:VKO<:AX*MDFV6QEFC_*33M/\`
M&/PJ\0^&?V4?VF_!&L:Y\`?V9?VV?%WQ/^)VB_"CPQ\0O&OPZC^#/[17ACQ;
M\5?A3;KHNG:%-XE\1_#GX>?&'6O$OAB\M3HEW+ISVFA+>VUO;I`S@']4T'Q"
M\!W=G#J-KXT\+76GW'V\07UMKVESVD_]E6[7>I^3<Q73PR_V=:JUQ?%'86D*
MF2X\M!FGQ^/O`\VHV&CP^,/#,NK:K91ZEIFEQZWIKZCJ&GRQ>=%?V5DMR;FZ
MLY(?WL=U#&\#Q_.KE>:_EV_9^^'/PR^._P`6/V;O!!\!:O=_L]:I^WQ_P4XW
M?#S6?#_BCPII-KX*TWP!J=_X-\-^)O"6HV^F:GHVFP:G;:;"/"_B"SLR'C33
MKJQ\W=;&TOPOT;0_VD/$O@'XJ_%/PI\$/B7X9_:^\$:Q\#O#5A^SM\0_&7Q8
MU7X1>'KWP7IWPVTCX8_$;0O'?]B6?PKO/#$.H>#?$%O;^"KC1O"EN^M3:ZRJ
M5FD`/Z@7\=^"(]:N/#<GB_PRGB*TMGO+K06US3!K5M9QQ>?)=3Z6;G[=#;I`
M#.TTD"QK"#*6"`M60_Q;^%<=OJ=W)\2?`D=KHMI#J&L7,GBW04@TFPN"BV][
MJ<K7XCL+2=I$$-S=-%#*701NVY<_RG>`/`=C<1^$O#WQE^-EOX&_;`\(?&3Q
MWXE\;?#_`$[]FSQ]J/Q\\8^+7\3>-[:\GU;XL:?XGO['5_A!\2-$O!]F\7Q:
M,O@6R\&7NCZ>D>FW=@\=?1'[._[)?PLN]=_X)-V?B#X-V=W:>.OV>?CYK'QJ
MLM8T'4)+7Q3XGT#3_AG>>$;CXB07B;;^^T^\UK7)=(36T;R;B:8PHK1)M`/Z
M.-6^(_P^T'3-+UO7/'/A#1M&ULP#1M6U;Q'I&G:9JQNE#VPTV^O+R&UOC<(R
MO"+:64RHRLFX$$PZQ\3OAQX>=8M>\>^#M$E>?3;6--7\2:/IK/=:TMPVC6Z"
M\O(=TVK+:71TR-<M?BVN#:B40R;?Y(_`'@#4=)TSX6V_[1^O6_PR^`%I\*?V
MAOA3\*-:^*?P(\5?&SP=X>U[P_\`MA?''0Y_#,%G9ZG;2>#/$5Y\,K?P+)X,
MU3485.I^'M*2ST6=EB5)?=?#_P"S#X.\9^%_VP)/$.F>+_CK;^`?^"7'[.MK
M\%?B%\0/A_XH\->(KWQ*;/\`:?NGU_0/">IVTVLZ-XU2+1_!;26D/F>)],CB
MTE7MXGOH?M`!_1!HO[2_P=UWXN>+?@;9^/?#P^)O@I?#IUSPS=7UG:W8F\3V
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M6IZCJ>D^*'M+O61"EAX6NM=T>WL1!=R`'[`_"[]K7X3_`!.\<?$;X?6VO:?X
M?\2_#SXEZI\+QIOB'5-(TZ\\7ZWI6F6.JW%SX/LI+\WFMV)M;^*19;2"0[4E
M9E54)KU^V^+_`,)[SQ5/X%L_B;X`N_&]M--;W/@ZV\8>'Y_%5O/;QK+<0S>'
MHM0?5XI8(F66:-[-7CC97<*I!/\`-OJGP'M[SX>?M1?&IO@=J/A7XZ:=_P`%
M"_V2=5\!ZTOAW4;CQ=X(\+GXS?LY6WBFP\,ZFL+7!T#1/#EYXKT[6;NQ/]G3
M:7#JS7DI@6XV^>^*-1\>?$']ICP[XHO/#5]\-OBIX3_X*,30W'P;^'O[+.IZ
M%+X=^&>G?$G5?#MG\6OB3^TA?:#>W7B)?B7X3ALO$UM)H_B+3_#^NG7DTRVT
MVZL;*1H@#^@3X-_MG^!?C3\1?!_PV\/:!XEL-6\:?`>?]H#3;W4[6VCL(/"T
M7Q"E^'!TRY>*YDD_MA-7@DO'C1#"+$JWF;B%/9ZY^U9\*O"GQYU7X"^,==TW
MP9K6F?#[0OB`OB+Q9K.C:!X<U.V\0:]<Z!9:+IE[J=]:FZUK[3;/(UFBLQB9
M"FYCBOS!_84\*^*]%_:M^"M_K'A[7=/TNQ_X)QW'ANYO;S2;^VLK7Q(W[3NK
MZC/H\]U(&@@U)]-,5_\`8))$N1:8N/+\IE8\'_P4"L/@W;_M9?'BY^.7PB\2
M_%"#QC^P\G@GX,:;H?PC\;?$B\U7XKW^O^(8+#0_#5YX;T'4[#1?$]U-=Z7]
MDO+W4-)%F`+U[ZWAMI9X@#]T?$OQ:^%G@S4=$T?Q?\2/`GA75O$IQX<TOQ'X
MLT'1-1\0'>D1&B66I7]M<ZL1++'$?L$5QB21(S\[*I[#4M7TK1M-N]9U?4K'
M2](L+66^OM4U&Z@LM.LK*WB:>>\O+VY>*VM;6"%'EFN)Y(XHHU9Y'5037\F%
MK\%/B#X0USQ3X#_;8\:ZWX,UWQ7^R]^R%X7\#^);W]F?6_VBI?$5AX&^"'A?
MPW\2O!_@;Q]H5KK/_"%_$/0?CO:>.O$&I>'T@TO5-87Q;X<\2:?-J-L+IK/]
MA?\`@I#X`^)WBS]@?PQX:^'D/B[Q+!H7BO\`9TUSXK:=;^$KOQ/XT\1_!CPA
MXR\)ZE\3OM/PVMW35/&FJ1Z!9RZWX@^&UF6U+Q9:6&K>$[>&[N]0CLKH`^@?
MC[^WU^SO\#?AQHOQ&B\>^$_B1:^*/&.G^`?">E?#_P`9^#M8G\1>*M0`D_LZ
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MUE`/Z$;7XS_!^]\'W'Q"L_BI\.KOP#:2-%=^-[;QKX<G\(6LBLB-'<^)(]2;
M1H'5I(U99;U"&D0$`NN?G^__`&\?V9H/B1/\+M-^+'@C7/$TGPUC^)NBG2O%
M/AJXT7Q+I4^MZSX?M-(\->(3K*:3KGBFZU/0KZ$>'+&YDU&*+[/=21BWF#K^
M#%U\/?!]EXU\%?&6VU/XD_'O]F73/VK_``;XN_:7T?1/V6O'_P`+OAGH\D/P
MJUKP_P"&/&&A_"RW\.23_$/0M#\2W&E7'Q`U#0?#]UI&B:F^F75ZH-G<M;_0
MFJZG^S);?M4:O\4O"WP.UW0_A#\7OV//&?P]^#.M?\,V>/[#3-9^.VA_'?Q]
M<^))]+TK_A`S>>&=1UV7Q#9>(=%\1:I9Z+;>(M#E_P"$@TR[GT=8[H@'[=_"
M'X^^!OBW\/=/^(5IJ-GX<MY?#MGXDU_0->U;0DUOP597MM+?1_\`"7)I^J7]
MIH^+")KTRW%R+8V8-TLQA#,N]/\`'7X)VNL^'/#MU\7?AG;>(/&%E8ZEX2T2
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M9M'599IQ`0#^@'1OCW\#?$>@ZOXI\/?&/X7Z]X9\/W$5KKWB#1O'GA?5-%T2
MYN)&AM[?5M4L=4GLM.FN)5:.".\FA:9AB(.:KV_[0_P#NY]$M;7XV?"BYN/$
MNJ3Z'X=AM_B#X4FDUW6;:Z2QN-)TA8]58ZCJ4%[)':2V-IYMREU)';M$)75#
M_-E^TEX+T3X\Z_\`'+XB_LP_!;QWH_[/Q_9%^#?P?^(5K%\&?&?PRTSX@?&5
MOV@_!GBW1-)TSP9KWAGPSK'B'6?AI\-5\2V7C#Q'I^A7NG:)_P`)5:>'KO54
MU&UOK*W[[]H+]EKPYHWP[_X*U:EX+^!,%MXDT?XC?`+4O@3/X>\$2+JNFOI>
MD?"O6I+SX:-:V8>WFL_$:7>HWD_AY@[:E%=2SO),DE`'](OB[QYX)\`:%=>)
M_'7BWP[X.\.630I=Z]XGUBPT+2+>2X;9!'-J.ISVUHDD[_)#&TH>5R%C5F(%
M<C:_'OX'WOA:U\<6GQ?^&=SX,OM3DT6T\60^-_#<GARXUF*WN[N728]:743I
MQU**UL+ZYEL?M`NH[>SNIGB6.WE9/CG_`(*8^)?B%X4_9OM=5^'W@\>)`_Q(
M^'%IXWUN/X6K\:[_`.&W@*?6D'B?XDZ1\,6TO7H?%6K^%K+;=64$NB:Q!:R,
M;N;3;Q(VA;\:_A_\$M8\=^([.PN?!'QE^)'PB\0?\%=?V;_B)#J'Q:^!?_"K
M9_$WP\A_8^U*#Q'XXU#X9:3X#\`:1X7\&W7BAHK:X>Y\%^';97GLK+Q#:VFN
MW4]I*`?TNW/QW^"EGX'_`.%F7/Q:^',7PZ,GDKXY/C+0#X3DGW^5]GBU];]M
M,EN#)^[%O'<M,7^4(3Q7`?LU?M/>"OVG[#XO:QX$A8Z%\)_C5XJ^#)UZ+5-(
MUC1_&%QX7T3PQKC>+?#6H:-=WMK<>'=5MO%%JNG/+*ETQMIWEB5&B9_PIUOX
M8WGPF^/J^-_&OP,\?:Q^R5\-?V^/CCXBUSPEX7^%/B[QCI&@6_C'X'_#NS\#
M?$2T^&_AK0-7U+Q7X0MO&$?B*SCO?#7A_6K/2M8U-[ADA=V<?I%_P3)TJZT[
MP+^V'X@L?AEXL^&.C>.?VTOC/X]^'_A#QQX(U/X;ZK+X.UKPE\.4\,ZA_P`(
MIJMCIUWI-CJ9L9FBB>R@EMBLUI>0PW]G=VT(!]L6O[3'[/NHZWKWAC2_C3\,
M-0\3^&K+6;_6]`M?&WA^74]-M?#T4DVNSWEHM^988=$BBDDUB0KC2XD>2]\A
M5)K\^O@A_P`%B_V<?BS?>#SXB>T^%?A[XFWFHQ?#+Q%XM\<>`+G^WM,T[3-3
MUE]:\7:+I'B*[U?X66UQI>GQW%E;>/+;2KVZGO;:P2`7;-$/S0\!Z-\8/BA^
MT;^RQKOCCP#\>K#XB^"_VM/B@/BW\*M(_91T_P"&WP`^$7PZUOX9?'31M.>;
MXG0?#32]4^*$7C:VN=%NYM8O/B-XPTF_-^QUBQT6[O-#LKKOOAS\(['X#?LO
M_P#!&KXE?%C]GKQ0NG?"KX?6>E?M)V>D?`GQ'XZ\<^'KO7O@5J&@:<_Q!\#^
M%O"FM>-;ME\5/9VEW+J&BW<MCJ;Q->+%(&90#^@RU^/7P5N_&-K\.8?BQ\.Y
MOB!>:>FJ6W@R'Q=H<GB2XLI+)=26X@T=+YKZ56TUEU((D+2_V:PO]GV0B:M;
MPO\`%[X6^.M3N]#\$_$3P7XKURRT\:I=Z3X?\1:5J^HVFGM>SZ;'?7=C8W4U
MS!:-J-M<62SRQI&US!+"K;T8#^;3X;_`2Y7XHQ:!\9+O]L?3_BA:_MGS?'OP
M-H'P]_92\.7GPV\6Z%J/C@Z]X-^(5]^T5+\"9=<\._#<?#[5HO"GQ.\)>(?C
M/HGB/PYIR:QX,A\*QW;Z3I)_5_\`X)9_`+PW\(OV6/`FMZC\)HOA[\6_$:^.
MIO']YJWA>3P_X[U-9/BAXSO](3Q*;^VM]78MIDMA<VEO>!%$$D4L<85PQ`/:
MO$7[86B>"OVG?"'[-/C;P!XP\+W7Q"TGQQK?@;XC:FNEQ^!_$>E_#?P=I?C'
MQK>P727SWMI#HEMJ:Z?<M>VT"B\C=@3`/,KU+0/VG_V=O%.A:]XF\.?&OX:Z
MUX?\+MI@\1ZOIWBW2+JRT-=;O8-.T>759H[DBRM]5OKF"UTZYN-EO>32*MO+
M(<X_)7]I/QS\3/VC_P!JGX,?$W]FKX(?%?6I_P!EWX!_MF-XHE^,/PA\=_"[
MPG<?$3XC>"_#?A+X=_#W3[GX@Z'H-GX\U/Q'?Z?>7\EMX2?7-(_L-+>[N]5A
MAU&S$WYM:E\%OCI\2?"/[0]^/@[^U9XJU'XA?L?_`+/'AKQ59?$']FN?X2Z9
MJ/Q/T/\`:1T?6O%/@+X;^`?"'@[P^+G0/`6AS7PMVN-(N+N71K*ZURWU?6=&
M9=3H`_J7\-?M*_L_>,K/5]0\)_&7X<>)+'0=5TW1-9N]$\6:/J=OIVJ:Q<-:
M:19W,MI=2HDFJ7*-#IS9,5[(K"V>7!K9\4_'+X/>!X_%DOB_XD^#_#<?@2/P
MO+XQ;6-:M+'_`(1J/QO?'3/![:N)I%-G_P`)-J(-CH@E`.HW>+>V$DI"G\2O
MVO?@3XOT/]HOXC>+O@]\!_%FJ^!M*_9Y^`VK7&G?#'P!>&S\3:W\-_VB+;6]
M3T/P]::5I\&GZ]XYTCPA+?ZAI^@VSRZS/I@D^S0O')&'\L^,'BS]I+QE\1OV
MR?C3\(?V</VC?#7A3XHZK^P!X6EU7Q-^SVVK?%:+X2^%/%/Q)M/B]\0/A=\'
M_'6G7\7B7QKX,AGT^]T_P[JVB3>(M#MKRR\2_P#"+"]CTI+D`_?+_AI'X`CP
MW9>,7^,GPXB\*:A>ZGIMIXAG\6:/!I$NHZ+`UUJ^GF^FNH[>*^TVV4S7EI,\
M=Q;QE6DC4.F[3TSX[_!K6?!T'Q!TKXF>#=0\$76NVGABW\46NN64NC3>(K_4
M+;2K+0X[U9#$VJ7>HWEI9VUB#]HFGNK=(XV\Z/=_.G\`?V;?&WB/XF_#2W\4
M?!?X]>(?AC)_P4%\9?$6YNOCU\*K[1]7O?!%Y\`-.L-+\<>-M%AT2TT/2M-O
M_%-BL4=Q=:=I-M]M6QT[4+*UUB&XLX_L*Z^"[:?_`,%);S]FVPTJVN/@9XWU
M7P!_P44O=#L5@@TCPKX[^'V@:W\&-:T*;2XP\%E8^(?'WAWX%_$?0H8H;2TU
M#5M-^(NR*>6WEN8@#]3OVC?CUX8_9L^#GC3XS^+=.\0ZOX?\%Z'K.N7MCX8T
MB?6=5N(='T35-<F5+>$JEM`;;2YQ-?W<D-E9*1-=31Q`FO4?!_B2U\9>$O"W
MB^QAEMK+Q5X<T3Q)9V\Y1IX+77-,M=3MX9FB9HS+%%=(DAC9D+JQ1BN"?E+_
M`(*#ZK=67[%O[2'AS3?!_P`1?'7B+XD?!7XL?"_PIX;^&/P\\9_$OQ%?>+/'
M7PU\7:-X>BGT7P-HNN:GIVCRZE-!:W_B*_MK;0]+-Q`=2OK9;B+?YU\-_P!K
MK0/"WAW]B;X0_P#"LOB\GCKXT:(W@W_A&/$W@G4OAWXC\!Z;\*?"*V_C7QIX
MT\-^/8]!UZP\-65YI<=MIDT6FRW&MC4],NM-BFM;I9:`/H[]H7XS^,_@WH^@
M7W@;X(?$'X[:QK>I3V3>&_A\=$M[O3;:WM9+B34]4U'Q#J6F:99660D,9>=Y
M9[AD@CC)DW+\FZ=_P4S\%>)O`GP\U?P%\*_B-XU^*_Q*\??$#X:Z/\!K6#1M
M&\=Z3XJ^%#,OQ*M_$-]J^I0^'=/T_P`)DVZW.J?VB]I=R7MG#9O+),,=;_P4
M2^.GQP^#OPT\+Z1\!/A;\4/'/BWXHZ]=^#=2\<?#3X8>)_BW=?!'PV^E75WJ
MGQ)N/!'A;3-2O?$FM6^R#2O!?A_4)-$T._\`$M]:WFMZ[:Z5I=[:WGYX^!M`
MT7X0:]^QG\<?A+^SG^U]+\,?@++\=_AO\7-'\=?`+X@_\-`:QK?QATW2==OO
MC==_#RUT_4?&?CQ/$7BW3[HZ]J_A_1[O[-=ZB"EM;:?;;80#[]\0?\%+/@YH
MWP*^$7QYM?#_`(ZU?0/B]XITGP1IVE67A^07WA;Q;=_$&T^%^NZ!XTN9I8['
M0-1\)^-9KS0M5MKJ?S;C4-+U&UL%N)+?YO;_`(V_M8>$O@=\0?@-\./$.@>*
M-2UC]H#XA6?PY\+ZAI6EF70]*U>]T3Q)K<<VMZI-+%:0`VWAB^,=E%)+?3K^
M]CB,4;N/Q2^(_@CXL?#C_@G)\&_A5KWP#^/OB7XI_$[]K'5?VG-5\)?#/X/>
M,_B1-\,_#>L?MK7G[2%]X:\?3^$=/U5-`\0:)X'\76^GII<Z-)JOB#1==M+!
M7>U8#[%_X*`?$V[\0ZG^P)XN\'_`[]IWQC8^!?VF?!_[0/C*P\%?L[_%3Q+K
MGAKX?:;\./BQX1N[;Q#I6E>';BXT;Q:-9\4:*@\&ZD+7Q%+9SRW<=BT,3F@#
M]EJ*^=/"/QQUCQ-\<-8^$<GPE^*6BZ#IOPJ\*?$JS^*^O>'WTWP#JE_XEU:^
MT^;X>VU]<0P3KXYT*UMK?5==T>;_`$G3[2^MUE@BD8+7T70`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`!&01ZC%>+:)\"/`_ASX
MM>+?C/H<5_I?BWQ_HFC:)XXM[2]9=!\3+X?\]-'U74M'>-X6URQM;B;3TU.)
MX9);!A;7"3!(V3VFB@#S#XM?"?PW\8OA[XE^&?B2XUC3_#GBZT&G:^?#FI/H
MNIWVE22Q-J&EG4H(WN8;35;>-K#4#`8[B6RFEBCGA9A(O9>&/#6A^#?#FA>$
MO#.F6FC>'O#6DZ?H6AZ381"&STW2M+M8[.PLK:)>$AMK:&.)%Y.%R2223NT4
M`%%%%`"$!@00"#P0>0:KK9VJHT:P1JC;BRA0%8N0S$@=69ADL>22QSEFS9HH
M`KFTM6^];PMGKF-26'HQ(RP]FR,@<<"E%K;`@B"($9P=@X!.2!QP,]`.!VQ4
M]%`$!M;<DDPQY.,D+AC@``%A@D`*``3C``QQ2&TMBNTP1%<$;2@*X;J,$8VG
MH1C&.,8.*L44`0?9K?(/DQY`"CY!\JC&%7CY5&!\JX7@<4KV\,@P\:L..".#
M@Y&?7!Z9Z?@*FHH`A:W@;.Z)&)QDLH8G;TR6R>.>_<GJ33#9VI8L8(BS!025
M&<*691[!6=BH&-I8D8)JS10!`;6W9=K0QLHR,,H(Y;<>N>K?,?4DGJ37R5HW
M[&/PRL/B?X2^*NN:[\1?'>N?#[7?$7B?X>Z;XZ\:W^O^'/`_B'Q/9WVFZCJW
MA_16@MXUO+?2]5U;2])GU*?4I-'L-1N8=/,!DW#Z\HH`C:*-V5G1692"I89P
M5S@@'@$;FP>O)YKR;XK?"'3_`(KZ78Z5>>*_'/A!;#4H-3AU'P#XFN?"^K&2
M".2/R)KNWAN$NK.42$S6MQ!)'(0')W*#7KM%`'C/P3^`_P`._@!X,A\"?#O3
M+FTT5=7U_P`17MSJFHWNM:UK7B3Q3JEQK7B/Q!KFL:C+/>:GJ^LZI=W-Y>W=
MPY+RS,J+'$J1K["((E!41J`Q)(QU))))]R23]3GK4M%`$!M;<G)A0DDDDKEB
M26/+'D\LV`3@`X````46T"E2(E!12JG'(4X)&<YP<#KZ5-10!";>`A@8HR&.
M6!488]>?49&<'@DGCDY%MX%R%B103DA1M&2""0!@`D$Y(`)/))(!J:B@"`6M
MN,_N8^2&(V@@D$,"0>#A@&''!`(P0,/:&)FWM&A?`&\J-V%)(&[K@%B<9QDU
M)10!%Y$.21&H).XD#!9N.6(QN/`P3G&!BD:V@=2K0QL"=Q#*#EN/F)/)88&&
M/(P,$8%344`1+!"I!6-05``..0!P.?8<#/;CIQ1)!#+_`*V-'P0?F`(RIR"1
MWP1QGZ=*EHH`K?8[7##R(R&SNRN=V<?>SG/3(ST))&"S9E,4901E%*+T4C(X
M[$=QZ@Y![YJ2B@"NMI;(`J0QJ`<@*,8/KD<Y]?6E6V@0,$B10Q)8`8!SG.1T
MQR<#H.,`8&)Z*`(!:VP9G$,89B2Y"@;R1M)?LYV_+\V<+P..*0VEJ008(R""
M#\HR0Q+$9Z]2<<_+N8+@,<V**`(A!"#D1HO(;Y1@%@<Y(&`3D`Y())`)Y%!M
MX&(9HHV88PS*&;CIRP)X//7KD]234M%`$9BC)R4!/OSU[<]LG..@.#C(!#&M
M;9SN:&-B0`=RA@0.0"#D'DYY!YYZ\U/10!#]GAY_=J<C!R,Y'''T)`)'0M\Q
MRW-!MX2`#$A`.0",J#Q@A3D9&!CCCMBIJ*`(_*CQMV+@8`&.!C&-HZ+C`QMQ
MCMBD$,(.1$F<`9VCH,D#IT!)('J2>I)J6B@"N]I;2'+P1N>>&4$'(`Y4_*>!
M@9'`Z5*D4<8*HBJ",$`8R`,`?0#@>@X'`I]%`$7D0YSY29`(!"@$`D$C(P<$
M@''M1Y,.U4\M-J_=7:,+U^[_`'0,X`&`!P,`"I:*`(A!"!@1)CIC:"!\I7@'
MIE6*G&,J2#D&E2&*-2B1JJ$$%0!@@]00>QR>.G)XYJ2B@"$V\!4J8U*L2Q4C
MY23C)QTXP,<?+_#BD^S6^2WDQY)SG:,Y((S]<$X/49;!R3F>B@"`6MN,XB0%
ML;C@Y.W&,G.2!@8!.``!C@4[R(<;?+3;DG&T$9)R3CIDGDGJ22>YS+10!'Y,
M60WEKD?=X!V]_E!X7GG@#FO/=+^%'@31OBAXM^,>G^'[:'XB^.?#/A+P=XF\
M4//>7%_?^&?`UQXBO/#&AQ)<3RVVGZ;IM[XK\07QMM.AM4N[W4I;N]%Q.D4B
M>C44`(5#8!&<'/?J.GUQ[]\'J!7#W'PX\%WOC;2?B-?>'M,N_&^A:%JGAC1O
M$<UOYFH:9H&M7=A>ZKIEE([%;>"_NM,L9[KRT621[=,OMRI[FB@!I56Z@'`P
M,\G''?KVIAAB9MS1J6'0D<C_`'3_``Y[XQD@$Y(&):*`(?L\`S^ZCY.[[H^]
M\W/3KEF)/=F9OO$FG"&(``1J`,[1@87/7:.@S[8ZGU-244`1)!#&[2)&BN^-
MS*`"<#`Y]`#@`<>U2T44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!7S]XQ_:A^!?@+QGXF\">+OB1H'AW7/`_@)?BAXYDU5-1M
MM#\&>!)+M[*WU[Q5XK>R_P"$4\/1WUS&\6F6.KZU:ZKJA1VTVPND1G'T`<8.
M>F#GZ5^3O[./C;X1_"KPI_P4(^.WQ@OM,L(=`_:A^(-S\2M>UV+^T)].\,^#
M/"?@.W\%Z'+%+'+(;:RLKJ)]`TZ*(1"]U8_94$\[N0#Z9T[]O[]D/Q#X!\:?
M$WPK\=/"?B;P9\.+_0K+X@ZKX=M-?U^Y\#KXC:V_L;4?%>@:5I%UXCT+0+Z*
MYCND\2:AI-OH$-CY^I7.IP:=9WEU!]?V%[;:C8VFH6=Q!>6=];0W=I=VL\-S
M:W5K<1K+;W-M<6[R03V\\+I+#-"[QRQNKHS*P)_'K]E&7P?^T[\2_P!I+]J/
MXA>(/AK:?\+F^#'AKX0^#_@IHOBGPEXE\3^#?V;_`(?ZEXUUB'Q5\6[+1M0U
M+9XQ\;:Y\1=0U&^T>X62R\&:'#X?\/FZDU.;4A7T+_P2TU75M3_8@^"::C?7
MNJ6.E6?B_0/#&J7\\EU<ZAX-\/>.O$>C>$+A[B;,SP#P]::?!9;F(6SA@1"8
MU6@#]!T\S)W[<?PXZ_CS_GUJ2BB@#A?B3\2_`OP?\%:]\1OB5XCLO"7@GPQ;
M17FO^(=02ZDL],M9KF&TBFN$LK>ZN2C7-Q#%F."0J9`6`7+"M\,OBQ\._C)X
M)T7XC?#+Q38>+O!/B-+Z30_$-A'>06>I1Z;J-YI-[);)?VUG=%(-1L+NU9V@
M56:'?&7C>-W\V_:^U?1=!_96_:.U37]3T[1],A^"'Q0AFU#5KVWT^PBFO/!F
MLV-C#-=7<L-LK7=]<VUG;Q2/_I-U<0V\:O+*B-^,^B>&_#_[1?Q:^"?@P_&'
MXE'X3^&O^"6%AX]LO"OP;^./C7P+X:U?XA>'OB%:^$4UW5;CX8^*-(EU35/"
M,WVS3I+>2]$;:C!!8:S#>PZ9)8L`?T1%U`#$X!&03D<<<^O<9ST[UPWC[XA>
M&/ASX>G\5>*M6CT?0+.ZT^RN]2DM+Z^C@NM4U&UTK3X7@T^WN;H_:;^]MK8/
M'"ZQO*&E,<:R2)^8?@CX^:KX<_X)!R_'CXH7/Q'^(EWX1_9=\>^(_%5SX3\0
M7^F?%#Q);>&]+\1V+R:3XML;B/6;#Q;)8:?%)#XFMKJ+4+#4D&M>>L\`K\N/
M`/C77K?QC\;?A[;^./"=_P""=9_9Y^"?Q0F^'W@7]ISXR?M4>#_"WBR/X_\`
MPYTRWNY?&/QEU#4[S2_%]YH_B">W\26GA:9=)OS;V-[=>;=,D[`'].WPS^*W
M@;XM:1KVM>!->BU_3O#/C/Q;\/M;N8[+4K`6/B[P+K=UX<\5:1)%J=E92R2:
M5K5C=V<EU;I-8W!B,MI<SP,LA]#:>)1EG`'8D-@\9X..>""<=`>:_./_`()M
M+(OPQ_:/.!]G/[<'[8+VH0;,PGXW>*3)&6#DG]]YT;/A,#.%(`9OR?'CO6;[
M4/A?X_M?C+\5)?VQO'7_``4'\<_!;XE_!^T^-/Q'73Y/V?9/&'C+PYJ/AR?X
M,6?BR/PMX6\/>&/A99>&_%>@^.=#\*:+J]CK%T-9M?$!O=0>0@']#5[^T%\'
M(=)\$Z[8_$3PUKFB?$7QROPW\%ZYX7O/^$LT77O&G]H:EI$V@VFK>&TU33DN
M;35]'U32=0EN;J"TT_5-.O=-O;BWO;:6!/8%NK=@I$\+$[1A9%.6;H``223S
M@#)/I7\I?[._P9^"FL_LU_LV^`+3QQ\0M,^).L_MZ>,/!'Q7\+Z1^T5\7CXE
M\':%H/[27QJL+*VTOPE=_$6\3X4:Q?Z<-(74O%?@W1_"WBKQ!+J+:YJ.N:CJ
MNIW&I7&O\3/$GQ2^'OBBY_9V\,?%'Q/8?L[Z7^W=XX\`ZWJ?Q6_:0^-/A&UT
MS01\)],\2_#_`.%GBG]HK1+[Q'\7O"W@S6O&-_J<MG"NNQKJ5WING^'+[5HM
M/O9K>Y`/ZGA<0'!\U,%0PRP'RD9!YQPP.5_O#IFC[1`0&\Z+:<X;>H4XQG!)
MP<9'0]P*_FW^&WP]^(WQ)^/O[,_P'\4_M1>+KWX>WFD_M=ZI)!^S7^TS\4-;
ML8O#VA^(OA[J?A?X=ZQ\8-6%MXV\9S^";S5-6TF+7;R\_MNUT&>ST-=<D\BY
M+??/_!170-<EB_8&^&7ACXA_$_X=6/CO]MOP;\._%.O?#GQMJOAOQGJO@JZ_
M9O\`VD9M5TE_$$3333K>2:=87=Q<WT=S/%J-G:Z]:O#KVF:;J5J`?J?]IMR`
M1-&020I#`AB.2$(R&(P>%ST(Z@TOG18)#@@=2N6P0`2/E!^8`@E?O`$$C!!K
M^53XP>%OB5:_%+]J7X7-^T1H?PJU+X"'P1I_[.'CG]H']M7]H?X>^)/"GA.#
MPW9^(++XD:=X/\/077ASXX3:WXH?5].\7S^,9_$6H:[8VQ\,W$5K:2PQB73/
M'LWPR^+6I_\`":_%'4?CYX]^+WC[]J$^!OC7\$_VL/B?J&IZ'`OA#XE^)=$^
M'_Q8_9GO?$$'ASPKX$^%=EI?_"(6-SIOAF/1-*U[3-&UR*2VU?5+R2Y`/ZH6
MO;1&1'N84>3[B-(JN>0`=I(8`DA0Q`!9E`.64%S7=LCB-YD61LD(2=Y`)&0N
M-Q7((W8VY!YX-?R"Z%\2_B3X"^#GP,\>?L1_&7XF_&?X^^,O^">7[1WCO]H+
M2M5^+?C7XV?V5XR\,?##PO>?"GQ;=>#]>\2Z]H?A'QOH_CB36;#POHNCZ7HK
M:O%%>V5QIUZ)))F[676OBI\-?AYXC^*'P)_:>^&T\6O_`+-FLMXD\$_#W]KC
MX_\`[1_Q2\=6U_?^&+O4?C7J>@?$[1X(?A_\1O!NC7.OWFJ:QH@T2XB2ZELK
M6R@AT[3[2R`/ZH?$'CSP3X4N?#]EXH\7>&_#EWXM\1VG@_PI:Z[K6GZ3<>)_
M%M_8:IJMEX7\/0W]Q!)K?B&[TO1-9U.VT73%NM2FT[2M1OH[9K6RN)8^H\Z+
MCYUY`(^A&0?H1R/4<C@BOYH_VB_AS^Q&4_8CN_`'QJ\6>)O!&F_ML?!RR^,V
MHG]K7XSZ[X>^'VD?$/\`9\^.UG%X@O?%LWQ3GG^&NO\`C'6[#PS:W.OZ7K^A
MZK;7US+865QI"^,/$<&O[?PXU_P;\+_VY?!&EQ?$/4OCYHOQ&^-D_A+X-^*?
MAM^UC\4=;\1?"?PMI?PQA?2OAU\4?@IJ/C"^T3Q5\-+"SL7U:?Q[>V^M7&L:
MMK.EZQ?:E<7KBYD`/Z%]9\>^"]`\1>&O!VL>*_#VE>+_`!HNLMX-\,:CJUG:
M:[XJ_P"$>T]M6UW_`(1_2IIDOM8&C::IOM5.GP7'V"U*SW7E1LK'E_@_\:?A
MY\=/!D/CWX;:^GB'PS<:SXCT&/4%L-2TXG4_"NM7GA_7+8VNJ6EG>?Z%JMA=
M6IF-NL$YC\RW>2-E9ORN_P""A?@+X-7W[<G_``3M\5_&;4-2\.^$=1/[0W@[
M5O$C?$WQW\/-"AU&W^&\_B7P9HYU3PWXL\.6FEZGJVO0WJQ_9Y;6]\50QKH&
MJ/JNEQQ::OP7\`OAUIWP^^#O[)7[1_A/QU\5=+^)'B3_`(*27'POUB8?%SQ[
M+X+U3X<^,_BQ\4_#.O?#X_#9-?3X;-HM[#+::B[-X6DU5M;L+75)]3>^A$Z`
M']2QGB`)+@`8!)!`!/0,2`%]><<$'H1F-KRV3`>94)!(#!E.%`)8@@%5!9%+
M$!0\D<>=\D:M_,?^PQK/QM\9?%#X`_%#XD_'CX5>#_C/?_%?XPZ=^T'\-M4_
M:(^-'B'XO>.+B]U[Q1I]W\+]:_9TUS1(OAWX&TGP"]KI+_#Z^T98;#3?#^F:
M?J%CJER^N:E=7OV1_P`%!=5^%+?MF?LD>%?V@?BCXE^''P)U[]FW]L;6O%]K
MI7Q5\;_"O1?$GB+PMXG_`&8[CPG;Z_JG@CQ#X=U"\?38]1UG4M,L1J$)O+RW
M^QNUU;7-WIFH@'[5&YMQC,T0ST^=>>G3GGJ"2.@Y/'-5-1UC3-)TZ]U;4[V&
MRTW3K6ZOKZ]N&,=O:V=E"]Q=W$TA&$BMX(Y)97/"HC,>%./Y!4^,^M>+_A7\
M&OAC\3-7;0M5T_X*_''Q7\,_CY^T5\9?CYX)U/Q1\'8?BSXIT/X30>&/#_P_
MUW1=0\<_&"[\*P>';ZU\1Z_,-<TNP?2)HVN9+N3=[M^Q)X*NOVO[#XL^-?CE
MX^^,_P`1=0\)?L$?L"^.?#OA6+XM_$G0O#.J?$GQ[^SCX[U/Q%XKUO0/#/B7
M1?\`A*]9U#4]*M[@V7B`W^B7%Q?7=W?:5>:C>)<VX!_0_9?M'_!W6-5^$FE:
M'XXL-8F^.NFZ_JWPGN-*L-7U/2_&6G>&=.M=5UJ\L]9L=.GTJQAL["]M+E?[
M8O=--ZDZI8?:7#!?;$O;9E7=/$KG"LI8*1(`"T>">'7()3)8`@XP<U_);X0\
M4IX!_99_9E7]B[Q1?S?M#V?[)W[95]XG\*>&_&/B+Q/?VOQW\*?`_19?!>G:
MGX*UC6=3TG3?$.D:V@FT7PTFDV=A_:SAVTUS=SM--X>LKS6O`U]>^!OVWO@O
M\$=*\4?LT>)_#GBO5/!O[1_[3?Q:\>:WJMV^AWVD_$;XL:3XYTO2[GX>^--(
MU**ZT_QCXETF?3O%`77M:M[6X\F*&SB`/ZTUEC<,4D1]A(?8P<J1U5@I)##!
M^4C.>,9IOGPYV[P6/&T`ELX)Q@`G)`)`QEAR,@@U^3'_``2=^(&B^+?`?Q_T
M#1O"O]CS?#KXMVGA36-?\-?%[QO\:/A'X[U:V^'7A">7Q-\*?%'CNZN+^QTF
M\@DMU\1:#9I#:67BH:M-,)+Z[NY&_.B;Q@TWP0_;H\97/Q)\?Q?\%*]%^(7[
M5.F?#KPHWQ#\>6OC#3/"FCPZM#\-]+\%?#.'6%\,R^'+7X8K:^(?#DMGH)MK
MOQ.?[16\EU;:&`/Z??M5O_SU3\_IU],Y&#WYQG!QP?Q0^*G@/X-_#[Q=\4_B
M1XET[PIX#\!Z!J?BGQ;XCU-IQ9Z/H.CVLMY?WTR6\,]S+Y<43+%!;P37%S.T
M=M;0S7$L<3?S"_%CQ5X`T=-)L?V*OBU\1_$'A36/^">WQTU;]I^]T_XL_$CQ
ME!H_B'3HOAFGP@\8^)=3\0^(M2?PM\:)_$M_XTLWO;%]+\57NGG4H=2B^R:5
M9K#0_;L^&'A_X8?#W]KGX8>%M0\<2^!-;_X)O_!WXSWV@^)/B5\1?&EM-\3K
M/XQ:OHUWXS$GBOQ/K4\.JZCI$C1:W%#*FGZK'%;->64GV:V$8!_1C\!OVJOA
M[^T(^OVOA31OBAX4UGPQ!I%[K/AGXL?"7XA_"GQ';:9KZW#Z)JL%AXX\/:*N
MI:?J8L[Q(I-,EO)K26UE@U.*QNE^SGZ3-W;AE0RA7<956#*Q`R2VTJ#M`4L6
MQ@*"Q(7FOYXOVRO"4'@;Q/\`%7X2_#GQ!X\\#^"W\;?\$[-+T^#POX^\9P:S
MHUMXZ^+7Q_MO&+:1KESK-_K>G76O6<=O%J%U'=-,\5M9G<OV.T,7.?&O]GOP
M/X7^,?\`P4"\':)K/Q<TWPW^SU_P3Y^$'C_X/VO_``OCXU7,WA3XB:]K?[4F
MJ7WC[[?>>/+C4=?\5VVH>&M,ETW6/$=YK#Z+$UW;Z;%:6NHW<<H!_2&LT3L4
M1U9AC(4Y(R,@G'0'L3@$@C.0:\7\>?M"_"GX?6'Q9NM9\4VL][\#_">F>-_B
M;H6EQRW^N^&O#>MV6M:AHE_<:=&JM(=8M?#NLR:=#'(7N?L$RC:Q3=^>G[(?
M@]?A+^W!\3OAIX;UKQM/X+U?]DSX-?$/4M+\4^./&?C:WO/B)?>(]6T[7/%J
MW/C#6];DMM:UNV.=6>PEMH[LK&);94A@6+X\_;(TSX)Z+^TM_P`%/8O'D\6D
M_%7QQ^R+\`]>^"UI>Z[XET^Z\6W]OX,_:"\-^*KCPSI=MJ$>D>()M*31-%MM
M0L9+.^32W$%T+6"749IKH`_H4\)>+M$\:^&/#GBW0[EI=(\4>']%\2Z6UQ&;
M:Y.EZ]IUMJ>GO<VSG?;3-;7<)F@D^>&0F)\,M9WCOXE>`_ACX>G\6?$#Q3I7
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M;2!7G\/Q_P#AQ<?%CPW\';?6&NO%GB_X<WGQ5\/_`&6W,FE7G@JRU"UTR34V
MU$LJH\EU=Q>3!Y>6B+2EU"D#XH_:\\-?"KXB_P#!*3]I?1/@?!'XU\!:A^S9
M\3M0^'\/AO6M?UE=2UG1]!U+6]"ET[4I-0N-9U*2V\3:?:7*6TMY<17CP?8;
MB&XM)9;:3\\-`^$/[*_Q]^./P1TCX>2ZAXK^&=K^PE\2]1O/^$1^(OQ(LK1?
MB$NI>&!??VAJNG^);/6)=7T>X>.XM-)N=0%OI.H!;BUL8;I%>,`_I,%U;G&)
MD;=@C!R"&Y#9&1M/0-]TD@`Y(!\N^-'QJ^'?[/\`\-?%OQB^*_B2W\)_#3P#
MIJ:OXR\3S:?K&KQZ)IC7EM8F[?3?#]AJFL78%Q>6R&*PT^[GQ(7\K8C$?RNZ
M!XG\<_$S0?@#'^TE\7?#_@OP[KO_``3=_9AUKX3^+_CEXS^-F@Z3J/Q`U"+X
MA0?&CQ9H>H>`=;TFSN/C3:7<?PWEU#4=?\_Q&-#N=+.D$6M]K'VK]0OV^;;7
M)?\`@B/\:-,G\47?Q6\06G[./A2P'C"*WU-[OQU-9:EX6B@UM8KV%-5GEU?R
MH[IY;N'[9,TK7%SEW=B`?H!\&/VW_P!G;]H+Q?=^"?A3XI\6:YKVG:?<:GJ%
MOK?P;^-?@*TM+2TF6WG+:O\`$+X>>%='>Z$TB(EA'J#WTBAY(;62.-W7ZO%Y
M:E@GGQAFWE5+`%O+($F`<9\O<OF8_P!6'0OM#H3_`#D_M/\`B#P#JGP1\6Z3
M\-O^"@7[0'[1'B75/%_P@TG4?"6H^(O`6DSZ/I.J_&#PE;ZUKGAZ_P#A'\(?
MAAKVESQZ?-<:4UU'KEPMO:7L[P^3,L<\?$?'[]G?P5X83_@KC;>$;?XF:?;?
MLX?!7X<_$_\`9MM+;XG?%R:T^'7Q2OO@EJ/BW6/&?@>&;Q9,?^$HU3Q3X=T7
M4=0O5:^EN+N&>%HE-_?)=`']-RW5NV=LR':2K<]&'4'T/MW[=:\D^%/QR\#?
M&&\^*MCX2N-0:X^#OQ8\1?!GQB-3L38+'XT\,:/X=U[5(=-8S2_;M-33O%.D
M-#?$0-+*]Q&;>/R<M_,9\7]:^&GB+3O^"@`/C+QE=_MLV_[4G@NU_9;TW0O'
M7Q+/BO1/$]UX+^"FH:1!X5\.:=J[^&-*T6ZOI=3;QBKZ5%8W.BRZD-=,D(3;
MZ;X?D\,V'Q[\4+^TPVKZ?^SG??\`!1K]K>Y^(<6JC7K7P!JOQ'_X9H^`#_#?
M_A/XM+5;74_#SWD7C.72$UGS=!E\3V^FD(^H0V?E@']00NK<C*S1L,;LJVY<
M9`.&7()!(R`21D$@`TAN[92`TR(3GASL(P`3N#8*@!ER6P/F4=6&?Y4?!'C;
MXN?LW^"M._;&\"2^--?^%TGQ:_:8_9C^%WA[Q/J7B#5;CQ!\.?B"U_J'[(][
M8P:]++J$FEV/QUTRT\`^$KV\,DD&@?$2TBC8:?;1F/T+QY^R3X?\$>(/VF?A
M9KES\0_&;_LY?\$P?@G>^!/%P\:^/[&>]^-.AWWQPU+6?BK)%IFN6MOJ'Q!U
MOQ/"OB.YU2]CU&^M[K5KB)`L4[)(`?TV_:K;Y?W\7S@%#O!#@AF&P@X?Y4=O
ME)PJ.Q^5&(:+VU896>-@25X8'#*VUE('(96RK`X*L&#`%6`_F)^*W@CXB?"G
MX%?%,?LZ_P#"Q;+QA\3?^"??[-7Q(^)5U!XI^(_B'Q'XAU=?CL;'XR^,X]1G
MUJ_\3Q^/)?A%J_BU);OPY=V'B"X,%BL!^TVFG-!G:5X+\*:W<>*XO`_Q>^'G
MB#P)XVO?V8M*\3?"/]FJP^,G@WPM9P/\8-)M+KQIJ^JZCJ]L^F^)->T&ZGT/
MQ`=)EL]8U2Q\Z[UR>>5C.0#^DCXA?%?P'\+;;P]J/CKQ-IWAS3?%'B[PKX#T
M6ZO4NY8[_P`6>--7@T+PUHT9LK>X,%QJVJ7EK9V\UT(K-9946>>`,&/H3R?N
MB\9#$@[".03@D8P&SG'7!'.<'H?Y?_VB?A#\//`/BO\`:S\#_P#")7S_``!^
M#?[:W_!.+XGZ7X;U2#Q+XK\,_#[PUXKT/P3!\;M7T&'4Y=7FL/#NM:=8-=^,
MH=/=M.9[C49[R!)9[MW_`%+_`&P_C%X>^'/_``3P\3W/[*,,'VWXJ:)HOP'_
M`&<(_`=E=V%G8>-?C9XB@^&7A77=$CMH(6TRR\'ZCX@NO&$]PRVD%O:^'[F3
MSH05DH`^I_V;?VL/@I^U?X9\4^,_@IXOB\5^&O!_C?6OA]K&H_9)].5->T6W
MTZ\E>*"]$5S)IUY8ZI87NE:F(DL]4L[E;JS:2#:Y^C3=6XQF:/D;@0P((W*G
M##(.794`!R695`R0*_D2^(?P_P#VE_V0X_&?P2/PI?X;>!_CU^S'\'/!6D:)
M^SYXT\1^,K^\3]D^]\-^'_%^IQZKI^@^&M4T;Q?XT^!U_J5A/#I:B^U8>'5V
M7<]X(VK8^/.J?!CQ%KO[8VD_LD:'XN\$>`I/V'?V4C_96@Z#XU\`7Y\7#]L/
MQ+I.O^)M#L;R&PUA-<F\/6EE8:QXGT^&*ZO+S3;B>ZN;R=+JY<`_K4%W;$,1
M,A"L$8@Y`<X^4_[0SDKU49+``'`;JV`R9X@-S+]\?>3`=<9SN0L`XQE2<,`<
MU_,A^U=\&?#/PN_:5^(/PP\17WPY^&WP(U+X":);_`V_^.'A_P"+/Q3T73M>
MO;C74^*FM_#WQ/%XBU/4?#?QFCOKC2-5B\43W,WC"Z:.VFT[4E=)0_BNLZ'X
MNN?&GC71OC)\?]$T'Q/+X5_9#O\`]G7XX>/OA7\6M0^+6N^`-'^"GPCMKCQ!
M\![K3+]AX+U?6/C9;_%&Z^)?A.XLX=<U*^\0P+XP?4M`.E16X!_6REW;R$JD
MJL02#C)Y!VE0<8+`\%02<]J07EJ4,GGQ^6,Y<L`JX&<L3C:"N&#-@%2K`E64
MG^8RT^!GAKQ/X1M_&OBKPSXLO_B!XM_X*Y3?#W7/$MMJWC;1?$%Q\'-7\7ZO
MHNO^$4GL-3M+S3?AAXCT.6XM_$6A6+6OAW7K:[E?6(KYY'D;BO$FE>-_#/\`
M9/A?59=(T?\`97\`?\%`OVQ?#-WIGQ4\+>,_'7PA\(6%U::?JGPGTCQGX/T;
M4;-[[X8:=KFMZ^OA;3KX7GA'0=5N].B6SBMK.-80#^JC[9;8!$\;!B`-A\S.
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M:1X?MM-M/!5]J,XFM+"W1M/O43>S`']/QDC"[RZ[>>000=N=V,9SC!SCI@YZ
M&HC=6X4.9DV,,A\_)C(`)?[H!+*%)(W,P`R2`?`O@W^T'\/OVB/@O:?&?X/Q
M:QKG@O5)?%4'AE]6T:[T*YUUO"6O:MX;N+G3+6_`F?2M2U31[M="U)1]FU*Q
M:"]MB;:9"?YA?`WC<_$GXK6^O+J&F_L_S>,O@M^W[X8^-OA']FOX)>/_``Q\
M6?@]8?\`"*P2:1K'Q%\?MK5W<_&#XIZ7):W7BKP-:0Z+INI:9K*NGAN]DAU4
MJ0#^OGSX0-WF+MZ9Y(&!DY.,#`Z^G?%-%U;MG$JG:XC8\X$A`.PG&-W(&,Y!
MRI^8$#\-_P#@EQKFBV7Q+^(OPK\.>#?@UXET7P'\&OAF3^TU\!_"?C+X=^'/
MB+>-<3V'_"-?$#PUXCL[2VO/B@D=HWBO6]=ANM:U*X_M.>/4[Z*64Q/\*_MN
M_$+6/%GQ=_:E>V\-_#7X3_%[X5_'7X46/PRLM'_9Z\6^*OVG_BCX8\.^(?AK
MJ`^+&D?'VPUO3HO`7@"Z21K*/3](TS6=/N=*TS5-&U#9)J-Y#"`?U8B\M22!
M/&<,5.&[@X./4`Y&1D9!&<J0%^UVVW?YT>W)&<XY`R1@\YQSC&2`2.`:_F/U
M[X)Z7XC\2:UXSUCP;XGO/%6M?\%@YOA_J^M-/XPM[R_^"&H^`[>XU7PDPMKZ
M&.+X8ZW>6T!UW1X8H_#.NR1K%K,-\<AJ7Q!\#Z_X)U;XA>$%LK3P9^Q]X`_X
M*C_%2S\4^'_$/PR\0_$;X1>$/A_KO[(GPJU_P"E]\*]%U?P[#JOP8LOCOXKU
M[5)=&M+AO!FC>*]174+C3&M]+N[=`#^GQKVU52[3QJ@Q^\)Q'SG'[P_)C((S
MNQG`ZD`Y^M:W::-I&JZO,Q>'2K"[OYDB`>5X[*&6>6.)&:-9)ML+JL1D4^8`
MC%"<C^>S]GCX%_#7QW^T+^SYX;\0:C9_M'?`;3_A5^UAJMC'K'PFUOP=\&]/
MNKSXG_#3_A'?#&C_``Y\17VNZ%-X7\-PW&K1^![;59+VR$"G4=%M8FL[6XA^
M?_A0FA^'-/\`@1;?M=>$]>\6_L\>'_A!^VIX(^$OA7QWX$\2?$/0=)^+WAC]
MK_Q]H'P\MKCPWJ.E:X4\16/P:TW3M'^&NJZC9K/8Z1:%M(U",2K,X!_29\"O
MC5X2^/\`\(/`'QI\&C4H/"GQ&\/6OB;08]:M;:RU1=-O#)Y/VVTL[[4[:&4+
M&S2+#?W2(H),WRMM3XZ?&WP?\`/A-X[^,?C(:C=^&/A[X=O?$VMVFA06U[K,
M^G6(0S+IUE<WEC%<W!WKY<;W4"N3@R`X!_EM^%W@J>V\&_L]6'[0FM^&/AK\
M)M1_80^$FA_!E_C7^SAXO^-_A/0/&<'B/XAM\3].\.Z!IOB[PG#\,_C#]BU/
MP!<6^N:AI\WB?4=(@LM/T&_L$TW4+>\U?B=H7P9T3]G?]J[P3\:]-\?_`![_
M`&@+SX&_#70OV9/B;\2/@_XSUWQEXE\`6/P^L++3=7\`KJ=EXG?P'K4NI6VJ
MWGC@6>LV6MW$]Q#-K=U>R29(!_6?I6HPZOI>G:K;!UM]3L+34(%D`618;RWC
MN8A(JLRJX210X#,`V0">M7Z^=/@[\>?A]XX\:^-?@1X<FUFX\>?`CP;\);OX
MDQRZ+>6^AZ)/\2?"SZ[X6T9-<E`L[O79=$LAJU_I,+&ZT[3[W3+FZ5$U"V+_
M`$70`4444`%%%%`!1110`4444`%%%%`!1110`'H?I7Q[=_LX^!/`?Q+^-7QO
MU3Q!##\./B=X3L-4^-'PT\0Z78:MX"U/6O`]L9HOB*\$]L]Q8ZK%H=FEGK8(
MO+/4K73[*>2U2YLXY#]@G@$^@/M7\Y'Q2^-/Q3T'XR?&+PS\;OBY\8[;3/B1
MK/Q^\+_!BS^'_B#X5^*_V>/%?A?1OA)X@O[+X>>)/#MAI+?$;P;XPT1+#4+[
M6=9OM4N(CJ=LMM*+>WN(HV`/UIU?]GGX/?%KX+:Z/V>Y?"_P;L_C5X-M;(?%
M3X6>#/#NF^(=0\`>*(K"_O%TFZ;3K<P#7M&,+6EY/#(]DTUO>+;FX@C"^L&;
MX.?L??`*V;4+[2_AY\%_@EX)LK.YU2^:8:?X=\*Z#;16HO;^2&*>XD"`":\N
M!%+-+-++.X9W;/XE_!;QWX]_9>^`/[,/COQQ^T9\5=>^&OQ$_8,\=^//$_AN
MWT?PF+;X92^`?`GPMU[PM>?"K38-%6\M;_0],U?6-+8>)-2UV#57N8KZ^2%H
M`J_%GQH_:"^,/B?X"?MM?"[Q+\0/'?BOX=>,_P#@F]XH^-&CZ/\`$[XN?"?X
MQ>-M!UZ'Q"ME;ZO-=?"OPOX:A\)#7]#O;2[G\)ZK_:DMI-`LMG>M%(00#^L/
MP1\2O!?Q%F\8V_@_7K+7)O`'C'4?`'C".S>1CH?C'2;#2M4U'0;OS(X\7MII
MVMZ1>2B/?&(=0MB)"S.J=W7YU?L`,9/$'[?1#84_M[_%$Q$+MV*_PG^!S$^A
MRY+#)Z[N.M?F7X_^.7[5_A7X8?'WXUV?[0_CB;2;W]N_Q7^R1HGA^/3?`^C^
M'/@W\,K_`/:1@\,WOQ+3Q3JVDR6MCXBT;0;&7P9X>\1>*I&\+>&8O$5E>ZU9
M:@]BUS*`?T7>(O#GA[Q=HU]X=\5:+I7B+0-3C2+4=%UNQMM2TN_BCECN$CN[
M&\CEMKA$GABF598V598XY``R*1SOASX6_#7P@D,?A3P'X0\.);Z;>Z1;IH>@
M:7IBP:3J6J2ZYJ&F0K9VT(BT^]UB>;5+JS3;;SW\TEW)&TTC.?Y[?%'Q!_:Y
M\(G1/A<_[0/C#PYX;\?_`+5G[.GA'PIXJU7XI?"KXL?'#PWX4^('AGQ\_CW0
MM8NO"WA73-"@T;5Y=,TK5/"-WJ>AFZAF,DL;W=K;I#)=^'_CW]H[P=)I?Q%U
MC]J?XK>-+?X:?\%1+[]B9/">OIX3_L#QC\&H_C/_`,(&UYXU@T_PY;7^L^/(
MM.UV$P^(]/O-'ACBT+38!I32?;+J[`/Z"]6M/`G@OP5JD&IZ?X<T+P!HF@ZO
M<ZW;75O86'AG2_#5K:7-WK<M_;RHFGP:1%8_:Y]0,R+:);^=)<E8?-D7@/A=
M\/?V=KKPEHWB+X2>"/A8?!'BS0--UGP]K?@G1/#+^'_$OAC7VL_$^DZIIFHZ
M/"UGJFD:FYL=9LKF*::VN&6UNX'<+"X_GKT7]LCQ_P"+?V@V?X=?%/XDZQ\+
MOB]X;_;1\*ZGH'Q8^)7PQ\47D^J_"3P/K^H:1K7AKX0:%X9M/$7PST?0];T2
MZTJRG\3:EJ2Z_I\[K>68N8R[WO#?Q%_:(\:?#O4/$VF?M(?$'P!8_`__`()3
M_L0_M'Z1X7\&6GA#3=$U_P"*OB/P/X^U+Q#?>(()?#MQG0M;'AZTM]3\/Z8N
MFVC1B$6K6L<"1,`?T=^(=;^&7P6\&^)/&'B74O"'PU\":1-?^)?%7B'5KK2O
M"_ANPGU.^$VI:UK>IWDEEIMK)?:A<^;>7][/'YUU.7FE+N2:FD_#'X2R^*C\
M6-(\">"#XTUK3X%/CVQT+2&U[4=-EB5[=AKT5O\`:Y[>:!T*2"<B6$I\SQ[#
M7Q/^W)\0/$ME_P`$NOCQ\4-+OK:T\7I^S)=^-K/4/[/TW4[:V\0/X6LM8CNH
M]-UBUU'3+@1W["6&&[M+B(.$.TNJN/A#XZ^-OC]H?@?]J?\`:)T']I3XE^'1
M^SG\;O@OX>\"?#/2U\+0?#N_\.>(;_X.:=XJTGQ+9OX=N-4U6VU>U\7:K';O
M#J=B=*DF$T#,0NT`_9#QYHW[-GP-T[QK\>/'/A[X9^`+2RV>*?''Q'U'1=&T
MJ19M+W2PZSJ^M?9DFDO(78^1<22/=2W,B)$9)Y$5E\`ZC^S_`/M(_#:]\4>%
M-!\)^//AQ\0+JXN]1DU#PHBZ?XGO85^Q3W6J:9KNF6EQ/>Q!!`L^H6BW"JL;
M0R;`CU\J_P#!3K05\9_L;_8Y?$&M>'$O?B#\$)9;S0+JQMKIQ>?$#PS$T9?4
M;#4K=TC-Q]IB1[=P+F"!Y%DC1XG^.OBK^T'XI_9W\(?\%7OA]K/[2FN+XB^!
MG[,]IK/P`U?XH>*?"-GX^?Q#J'[.NNZSI6O:))_9&A0^(-?U3XBI;16KV6CW
M*W6MQ6^GV]D9V\A@#]-_#OQ4_9"\&>+-*^'WABZ^'/AKQ9X1^(D/P(TC0-"T
M"&PNM`^('BGPQI?CE/!-DUEI<,5K>:UX6O-)\0W(BD6WN;26VEN9FG`0=]\?
M_C#\!?@EH'AGQG\>_$'A?PYI:>,-/L/!=WK]H^I:E/XVN]-U:.TA\*:596>H
M:W?Z^NAMKTK+H5A<WMOHL>L7<XATV"]GC_G?^%VJZCK7[2OAS5=7NWO=6U;_
M`(*;_LRZKJM].$$U]JNH_P#!/KX*WVI74A544RW-U+)*Q48W,=JJH"C].OV_
M/AY/\0?VJO\`@G#IMMX_^(7@26;XI_M#007WP[U;2-+UBTO+7]E[XC:W%JMG
M-K&@^(+:+5#;Z1<^'EN6LI(UT'Q#KUMY/VF[M[RS`/T$E^'_`,%/C!8^#_B!
MJG@#P+XWBN-)T[7_``AK_B'PEI6IWL.EZQ9Q:C87%G)J]A)>VB3VMS%.+>01
M/"S_`+R*.56"YWB+]GGX1ZS8>.AI?@3P?X6\1^/_``OXB\+ZQXT\/^%]"L?$
MXM_$FF7FF7ERNJ0V*7,MQMOI9V\V1EN)L&X$H)K\`_!G[0GQD_X1/X6_M%R_
MM/\`C75_CEXG_;HF_9\\0_LMSZSX9G\/:=\,5^*NN>`)_#$GPYATB+Q';>)O
M#_@_3K7X@W_B[[8SRAY[R3_B5SQ1+KZAXY_:(T'X"_LD_$CQE^V)\1]-\.?M
MB_&[P-\(?B'XLGA\':!H/P(^'\J^-]3FU/PQX@FTJ6'3/$WC'4/#6@>"F\6^
M)9KF&/4-=:>SM;.:>WAA`/W'_9L_9C^&O[,OPQ\(?#GP9HNBRW'AGPCX>\):
MCXP7P]HFE>)/%L7A_38--AU#Q%=:796QO+RXCA$LP=FC\QV957=BO0M"^#/P
MB\+WVJZIX;^&'@#0=1UQ)XM8O](\(Z#I]WJD-T&6YAOKBUL8I;F"Y5F$\$K-
M%,&/F(V:_!WXU^)_&WA_XI^"_P!GOX8?M6_%'XM?#G3O`7B'QM;>)[+]IGX-
M?#3QE=>+3XNFTAO"FI_%+6_"&KZ=XNB^'5CIVFW<WAVUL+?68X_$UO<>();F
MW>U#?I3\"/B?\2]-_P""=NB?$_\`:,\5Z7XB^)'AKX.^,;_XB>-_A)J^D>);
M76KGPA_PD.G_`/"4>%=6T>'^P+[6-1TW2+35;B2PA.C1>(9KR.!/L$2H`#ZP
MMO@;\%[+P_J?A2T^$_PYMO#.LW*7NK^'X?!OA^/1]3NXY&FBN]0TY=/%K=W,
M,I+P3W$4DL#<Q.F!C1TGX2_"O0-8C\1Z%\./`VCZ_!8PZ=#K6E>%M$L-6BL+
M:".V@LHM0M;*&Z2VBMH8;>.%9EC6&*.+'EQJH_EHN/VJ?V@O!NE?M?Z/X0^,
M?C&PT*Y_X)J_$O\`:7\$Z?XA^/?@CX]>-_`GQ`\+^+O!NAZ'XFGUKPMX=TN#
MP7J6MZ%XQDGO?!5Z]_:PW5E8WEHL"/,9/I7]H?XN_M!?LDGXR>"?"G[1'Q"\
M71^.?AG^SSXTU[XD?$FXT37I_@DWQ8^,NE?#;XB?$/P[%::3IVE:#X8\.^'-
M1EU"STJ^2YT[1KFWMKRXNIT2X:8`_=GQ!XG^"OCKXC3_``-\46WA3Q=\0?#O
MA30/BI/X)UW1K;6;G1O"FL:]K'AK0?&"KJ%E/86R7.OZ#K6F64MO/_:`GT^Y
M;RHX2LC^AQ>"/!D%E9Z;#X5\.PZ=I^K+KUA81Z/I\=G9:XLTMPFL6EJMN(;;
M4UN)IIUOH42Y$TLDHEWNS'\6OV._#O@GPA_P4U^+7AGP'^T'XH_:)TS3_P!@
MKX3-J/BKQ?X_\/?$C6-(UF[_`&@?BK?2>'_[>\/V=FD$0M;R/7(=)OQ-?VD&
MO1,LHTV73HHOG+]K/XQ?M.^._P!I']K?P5X7^(]_\(]3^!VC:$GP&DU#]H_X
M=?`+PEX?N;CP;%XDM/BIXW\*^./#FIWGQ5\(:EXB7[)K$\.H6VBV>AZ?JNC1
M);:KYEXH!^P'CG]HG]A[X2_%7QI;>,]=^%WA;XJ>#]!C\1>/_$4_A-4U+P]I
M,NFB]M6\3>.;309;*PU&^TYXY+#1M0UN/6M0MI[0VMC-'=6WF,TSX<_`?]K?
MXD?!G]K#1]6;QQHOP[^'OQF^''AK1M6\-Q#PIK=G\3O%'PRO]:U/5=#\7Z!#
MK4.K:!J7PATZWT69(K2`)>ZI*PNXYK62OPG^/WP*NO$OPB_:R^*?B#XO_&2S
M\1ZO^VW^SS:^(?"OASXB6LW@"[O_`(@?#;]E3Q%JT^GVTV@^;>6F@:AXIO=.
M\%7JW,45GH&D:!"UO<O9R27/5?&;Q?\`M(>$_CE^T=\(_!'QI\7>&;C]F;1_
MA]!\`=?^,7[4W@+X7Z;<VVJ>%]"\;ZG\5?B9H'BKPF=4^-_AW7_$]WJ7@W5;
MC3KFUTO1M+T6X\/VD%IKKS7E`']+6K>`?`&JII\FN>#/">J+H,0&D/JF@:1>
MG1X8=K*NFO=VLG]GQQ^4A46IA1?+0C&Q<9OP[/PQU[PSIGBWX9V_@R]\*^)=
M(TTZ1KW@V+1IM(UOP_8P/:Z*;/4M&4VE_I-K:EX=+6&::TM[9C':A(V9:_$_
MX&^*G_:/^)/[0?B7X[_M=^./@O\`%+PM^T/K7P8\%?`[PQ\2M"\':3I/@9-!
MTJV\-VMMX,U>R?4?%-Y\1EU;4M9TSQ+&CWI,-I<:/)"+&5&]"_X)+>)_@I\&
M?V,/V;(-9^.=Q+XK^+&G^`?!:?#_`,9^/K775\*_$Z73M=M+/X:>%-!5!>^$
M;Z[&A:Y*OA?4/]*>?2;[;M>TD10#]@-*^'7P_P!"O#J&B>!_".CWYN)[MK[2
M_#FD:?>M=W21QW5TUU:6<4[7%RD427$S2&29(T65F5%`JVWPL^&-E)J4UG\.
MO`UI-K*31ZQ+;>$]!@EU6.X<R7":E)%8*]^D[DO,MT95D<[G#-S7<12"5`XQ
M@Y'!ST_KZCL>*DH`Q-!\,^'/"UA_97AG0-%\.Z7O>7^S="TNRTFP$DAS)(+.
MP@M[<22$YD<1AG/+$FJ<G@KP=+KA\3R>%/#C^)&A^SMXA;1--.N-;[2GD-JW
MV;[>T.PE?+-P4V_+C'%=/10!QFG?#GX?:1#JEOI/@;PCIEOKA=M;@T_PYI%E
M#K#2,S2'5(K:SB34"[,S,;M9BQ9B<DG-S4/!/@[5EN%U7PKX>U);O2X]#NA?
M:/I]V+G18I3/%I%QY]N_G:9',S31V,FZU25C(L0<EJZ>B@#"O/"_AK4)WN;_
M`$#1KVYDET^:2XN]-L[B>2;27FETN5YI87D>339+BXDL'9BUF\\SVYC:60L7
M'A?PW=S:C<W6@:/<W&L6$6E:M//IUI--JFF0&Y,&G:C+)$SWMA";R\,5G<M)
M;QF[N=L8\^7?NT4`9L.C:1;7TFJ6^EZ?!J4MM%9R:A%9V\=[)9P,S0VCW2QB
M=K:%F9HH"YBC9B50$DUE:MX)\&Z_J,&KZYX4\.:SJMK;O:VNIZIHFFW^H6UK
M*'$EM;WEU;2W$,$@D<2112+&X=PRD,V>GHH`P[GPSX<O!&+O0='NA#8S:7%]
MHTVSF\K3+E8TN-.B\R%O+L9TAA6:T3;;RK%$)(V$:8HV7@7P3IEI+I^F^$/#
M.GV$UFFG36-CH6F6EG+I\9<I8R6UO;1PO9J99&%JR&`-([;,NQ/544`9ECHF
MC:7IL>BZ9I.FZ=H\430Q:58V-K::;%"Y)>*.QMXH[9(F+'=&L05LG(.369I/
M@KP=H+!]#\*>'-&8)<1AM*T73M/(CNY%END!M+:'"W,BK)<+TF=5:3<P!KIJ
M*`.4OO`G@C5++3]-U/P?X7U+3M(6-=*L-0T'2[VRTU8E5(EL+6YM98+,1HB(
M@MXXPJHBK@*H&Q/HNCW5@VEW.EZ?<:8\2P/IT]G;S6+PKMVPM:21M;M$NU=L
M9C*+M7"C:,:=%`')0>`?`MKG[-X,\*VQ/EY-OX?TJ$GR9%FBR8[12?+E1)4S
M]V15<8901L3:%HEP;YKC2--G.J0I;ZF9;*VD.HP1QF)(;[?&?M<21$Q)'<>8
MJQDQJ`A(.K10!\Y?"C]F/X=_"7QO\9O'VE0-K&O?&GXFW/Q1UBYUJSTJXDT'
M6;KPSX?\+2Z?X<GBL(;JRTLZ?X<LY#'+<7$[7$LY:?RC'%'[?=^%O#-_;75E
M?>'M$O+.^NS?WMI=:797%M>7Q6-3>74$L#Q7%T5BB7[1*CRXBC&_"+C>HH`^
M??C%^S?X$^-EQ\'H_%<VJVOA[X-?%#P[\6]&\(:++:V'AO7_`!/X/M;\>$8O
M$EBMHYO-+\.:O>P^)--LK>2U1-=TO2[N7S%M$CKW!]&TB26ZGDTRPDFOK<6E
M[+):0/)=VBL[+:W+M&6GMU:20K!*6B4R.0@W-G2HH`S8]'TF&3SH=-L8I?LB
MV`DCM84<6*,&2S#*@(M58!EMQ^Z#<A`>:I67A3POIL;1:?X<T.PB>6.=X[/2
MK&V1YH6#0S.L,"*\L3`-'(P+HP#*00#6_10!EW&AZ+=K>K=:3IMPNI11P:BL
MUE;2KJ$,4;1117H>,BZCBB9HXTG\Q40E%`7BF?V!H7V.TT[^Q],%A820S6-D
M+&V6TLYK=M]O+:VXC$5O)`_S1/"B-&W*$'FM>B@#SGXE?#>P^(_@_6O"O]LZ
M]X/O-5T^6QLO&/@Z]32/&/AMI=N;[PWK7DSRZ7?JJ^6)XT(:)GC=61B*\-^`
M_P"QYX&^"?B3X@>.]2\5^/?C%\1OB5I?A3P[XE\>_%W7AXKUY_"?@B75KKPM
MX3L$:VMM-TO0M*U#7=9U5;.PL;=;G5=3N]0NO-N7$@^N**`,O4-$T;5EB75=
M)TW4E@D66%=0LK:\6&5#E)8EN(Y!'(I`*R(`X(R#FFW6@Z)>S6EQ>:1IMW<6
M&?L,]S96T\UENV[C:2RQM);D[5RT+(3M&3P*UJ*`,QM%T=@`VEZ>0+C[6`;2
M#`NP21=#Y.+G))\__6Y)._)J.3P_H4UO<6DVCZ9+:WDDDUW;2V-M);W<TI!E
MENH'C,5Q)(54R/,KLY`+$X%:]%`&7;:'HUDMNMGI6GVBVD$MK:I:V<%NEM:S
MM"\UO`L2(L,$S6\#2Q1A8Y&AB+J3&I&-KG@CPSKV@W?AV[T>P&G7,%W#''#;
MQ6[V3WJRK/=Z?-"BRZ??@S230WUH8KJ&X83QRK*`U=;10!P'PN^&7@WX._#K
MP9\*_`&C6^A>"?`'AW3/"OA?1X&DDCT_1-&MEM-/MC-,\D]Q(D"+YUQ/))/<
M3-)//))+([MTL'AOP_;3S75MHFE6]S<3M<SW,%A:Q3S7#J$DGEFCB622:1%5
M'D9B[HJJQ*@`;5%`&=9:/I.FQ/!IVF6%A#++)/)%96D%K')/*<RS2)`B*\LA
M`+R,"[D`L3BFR:+I$UR]Y-I>GRW<D*6TEU)9V[W$EO&[21V\D[1F1X$D9I$A
M9C&LC%U4,2:TZ*`*/]EZ;Q_H%GQ<?:QFWB/^E;2OVGE/^/C:2OG?ZS;QNQ22
M:5ILJ7,4EA:21WA<W<;V\31W1D7:YN$*E9BZ@*QD#;E`4Y``J_10!3ATZPMD
M2.WLK6"..-8HXXH(XXXXEQMCC15"I&-JX10%&U>/E&&-I>FO''$]C:/'$XEB
M1H(V6.0$GS$!4A7RS$N,,2S$G+$F_10!0?2M,DC2*2PLY(HY$ECBDMXGCCEC
M;?'(B,I57C<!HW4!D8!E((!ITVG6%PP>>SMIF5)(U:2%'(CEQYB#(.%?`W+T
M..15VB@#ROX=?!WP/\+]=^*?B7PIICVFM_&7QX?B1\0-2N+Z]U"[UOQ0OA;P
MSX*M9VFO9IFMK'3/"_@_P_H^EZ9;&.QL+2Q6.U@A#R;_`%2BB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`(R"#W&/SKP"']E;]G"W\<:[\38/@C\,(OB+XG
ML-1TOQ%XYC\$>&T\5:WI^K6QL]3L]4UQ--6_OH-0LS]DO8[F:5;JVQ#.)(_E
MKW^B@#S/_A3?PN_L_P`/:2?`?A0Z7X2\/7WA+POIW_"/Z/\`8O#_`(6U*SMM
M.O\`P[I-O]B\JRT6\L+.TL[G3856TGMK:&"6)XHU0>:Z1^QQ^ROX?T77?#F@
M_L__``BT70?$_A_4O"GB'2-+^'WA2RTW6O#.L7*WFJ^']1L8=)6UNM&U&[5;
MF[TV6%K2:=1,\)E&^OI:B@#E_#?@OPOX0?Q!)X:T/3-$D\5:[<^)_$;Z;86E
MDVM>(KNSL=/N=;U,VL$/V[5)[#3-.LYK^Z\Z[FMK"SAEF>.VB5,8_"CX;-X;
M\4>#V\$>%G\+>-M0U_5?%WAY]!TIM&\2ZEXJNI[[Q)?:WIC6ALM4NM=OKF>\
MU6:]@G>_N99);DR,[9]!HH`^>/!/[)?[-'PUT^VTGX??`WX6^"M)M/$MIXSM
MM,\,^!?#.CV$/BZPCN(K'Q.EK9:7#$NO6<5W=Q6NJA1>6T=S.D,L:R,#W[?"
M#X8M;36?_"">%1:3^.5^)LUL-!TH6\GQ#35(]<7QL\/V3RF\4#688M4.N%3J
M+WT:7+W#2J&KTBB@#P?3/V7_`-GG1?$>J>+M)^#'PSTWQ/K=UJM[J^O67@CP
MQ;:MJ-WKFG3:3K5S>:A#I275S/JVFW$UEJ,LTKO>6LC03EXCLK=M?@/\';*Q
MU#2[7X;^"X--U;P+H/PQU6PB\,:%#9:E\//"]K=V7AWP3?6L6GQP7/A?1+2^
MO+;2="DC.F:=!=7$5E;0)+(K>MT4`<9KOP[\#^)_!&I_#;Q%X5T'7/`.LZ*?
M#FJ>#]6TJQU#PY?>'VMDLVT2YT:[MY=.FTLVD:VWV&2V:W$`$8C"@`8NI_!K
MX7ZSH?B7PUJO@3PIJ'A_QE?Z?JOBO1KSP[HEUIGB+5-*?39--U#6K&?3Y+75
M+RPET?2I+2XOHIY+=].LC$5^SQ!?3:*`.=U_PEX:\4Z.F@>(]#TS7-%CFL;A
M=,U6QMK^R$^F3Q7.GS?9;J*6#S;.X@AGMG\O=!-%')$4=%(\O\=_LT?`/XG^
M);?QC\1/A#\._&_BJUT+4O#%OXA\5>#?#>OZS#X>UBWN+/5=&34M5TN[O%TW
M4+.[N;.ZLQ-Y$MM/+"R%9'!]RHH`\KL_@?\`"*PO[75+/X<^"[;4+'Q'IGBZ
MSO(/#.B0W-MXHT;0;+PMI6OPSQ6"3)J^G^&M-T_0;/4`_P!JM=)LK6PMY8[:
M%(QV.J>$?#>MZQH'B#5=&TV_UOPK=7E[X9U6[L+.YU#P_>:CIMUHVHW>C7D]
MO)<:=<7^CWUYI5Y-:R1/<:?=7%I(QAFD1NCHH`\7M_V=?@9:?$5_B[;?"?X?
M0?%*12K_`!#B\(>'D\9,IC\DJ?$:Z<-6.8_D9C=;W0E'9D9E/0ZG\(/A?K7@
M;_A66K^`?"6J?#S[(M@/!-_X?TF\\+BS20RI;#0[BTDTT0)*3(L?V;8LI,H'
MFDN?1Z*`/G2]_9%_9AU'P?I7P^O?@)\([GP/H5[/J.C>$YOAYX2E\/Z7?77E
M_:KNQTI]':RM;BZ$4:W,T,*2W"HHF=\"O8M)\%>%-!\*6O@;1=`TK2_"%EIS
M:1:>'+&PM+;1[?2F1XVTZ+3HH5M$LFBD>)K=81$T;,A4ACGJ:*`/!=)_9<_9
MTT&RU/3=%^"?PQTK3]:T'6/"^L66G^"?#EG:ZIX;\0W=G?ZYH.H06^G1QW6D
MZO>Z?97>HV$RM;7=S:P33QN\4;+WFI_"[X>ZS-JMQJW@_P`-ZE/KGAT>$=9E
MOM#TF[DU7PJLC2KX;U%[BSD:]T))7>5=*N3+9"1B_D[L$=]10!Y+\/O@1\'?
MA1*9_AG\-?!/@.8Z>-):7PGX7T+0)6TL7\^J?V<TFEZ?:NUG_:5U=7_V<L8Q
M>7-Q=`">:21H_B!\`?@G\5]6T_7/B9\*_`7CW5M)B\C3+_Q;X5T77KJPA)9C
M%:W&I65Q-!$S,6:*.18V8DE22<^O44`>>WWPH^'&IV6IZ=J/@OPS?V.M:QIW
MB#5[2\T/2KFVU+7='MM-L]*UB^MYK1X;K4]-L]'TFUL;Z9'NK6#3;&.&5%M8
M=F9XQ^!OP@^(>I:-K7CWX;>"?&>M>'7230-8\3^%]#UO4]'DBFCGC?3KS4+"
MXEM6CEB1T,;#:R[ARS$^JT4`>2ZC\"/@_J_C*P^(FJ?#CP7J/CW2V@;3_&=]
MX7T&Z\3V?V972W%OK<^G2:A#Y*2.D)CN%:%&*1%$)!BM/@!\%+#43JVG_"SP
M#8:DWB^'X@&^L_"/A^"Z/CFWBNH(?&'VB/3A+_PDL4-[>PQZSO\`M\4=W=+'
M.GGR[_7Z*`(XHUB01KG:N<9QGDD\X`SR:DHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`*.IZGIVC6-SJ>K7MIING6B"2ZOKZY@L[2W1G6
M,//<W#QP0H7=%W2.HW,!G)`/.67C_P`&:E-IT&F^*/#VI3:PMV^D1Z?K>F7K
MZHFGO)%?OIZ6UU(UZMC+%+'>-;"46SQNLQ0@BO-OVIM#TOQ'^S7\>](UFSM[
M[3[CX1?$&>2VNHQ)"9]/\+ZGJ-C*4)'SVU]:6UU"P(9)H8W4AE!'\Y_C+X<>
M+=(\9_L)>*_@+:C3_'_P._X)J>(?VG?"7AK23);6WC#Q-H'QE_9SOO'WAZ[A
M21A<W'Q&\+>)_'&A7TLNXR3Z_+<R[I0K@`_J:L=4L-2:Z2RN[:Z>QG:UO%MK
MB&=K6Z0`R6MRL+N8+B,,I>"4)*@8;E&165%XP\-3V>G:C!KFDSZ;K$D4.D:G
M#J5E+IVJ33LR6\.G7T<S6U[+<,K+!';22/*58("017YX_P#!-#XFZ%\8O#W[
M2GQ+\+W$MSX9\<?M)>,/%.@-<,PN[?3=:T;P]>)87ENY+6=WI\\DUE=VAPUO
M=V\\+HCHPK\=;*Y\5:#X>A_8\L[_`%1&_8+_`&F_VIOBHXFO;RVOS\&?"_B3
MPQ\5/@O>7LZ3>;=0Z?X>^.VB6%NLX%K<1:*8ECC6+8@!_47JOQ!\%Z%=26>M
M>*/#VD7$)MEFBU37-*T^2)[M));5)$O+N%T>ZAAGEM490UPD$S1!A$Y7/;XM
M?"Y1\WQ&\"(>/E?Q?X>5L,`RG!U$'#*0RG&&4A@>17\T7[3^EZ-\9?V*/^"@
M7[8&I6<6ICXD?MA?!O2OA)JUS+(3IOPX^%/Q;^#?P(L+CP_(-CVD'B."R\;7
M37%NRIJ5MXIO)6#13+G[<_:\_9A^`>E?M8_\$\M#TKX3>"K+2O'GQ6^*NF^-
M-/M=(@M[+Q+IND_"A[C3K76+:/$5[;V-S;P3VL4H*03(CQ!2`"`?LUH_C;PC
MX@NGLM#\3^']7NDL/[5:WTO6M-U"?^S//-K_`&AY-I<RR?83<J]L+S;]F-PC
MPB7S%91GWGQ,^'VG06MUJ'C7PI8VM]'++8W-YXCT:V@OHX)FMYGLY9KU([D0
MSHT,IA9Q'*K1N58$#^=KXK>&-+_9M_;X_:1^.WPYA/@[X=_LJ_#?]B[1?&?A
M#PM#/'HK?`?X[C]IC1_BUOT6"46JC0-=LO"?Q-BF2-)DU#PDZ^8([J8'P?X*
M>%_%/Q(\9_\`!/OPGX:^&GPC^.=S??L?_M1:U_PAWQU^(&O^$_`,T&G?M*:;
M&/$T>O\`ACP+\3;F[UFQCO[:VTID\.3V]Q8ZC>S+JEM'`OV@`_J8N?BG\.K+
M3;'6;WQQX1LM'U222'3-6O/$NBVNF:C-#(T4T-C?SWR6MW-#*DD4L4$LCQRQ
MR1NH=&`EU3XF>`-#M=)OM;\9>%]'L=>)&B7NJ>(-(T^TU@B$3D:7<7=Y##J#
M")E8K:O*P#ID8=2?PV^)W['_`,;/#WQ&^&WQ>F_9,_9]_:%\%>%_@5KOPYUO
M]D?P?\78O#6@?"GQ->_$?5O%]YX^^$VL?$GPQX>\/^*V\6Z/+%:Z];^)-,\'
MZG;ZHDEM975S;M<72^3Z=\/_``_\2[#P-^UA\'?V5=+_`&FOV4+G]G"#X66O
M[+WC?QWH?@?XF_LV:WX'\;^-]8\<:QX,TCQC+J7@OQ9)X@DOV\,:O:6OBK2-
M3,GA;P\^AZMJ.D?N[(`_I`N_$6B6.D1Z]>:KIUKHLD4$ZZK<W]I!IQANBBVL
MHOI9EM#%=-+$MO()ML[2Q+$6:1`6/XET1-2CT4ZGI_\`;4M@VJQZ/]NM?[4D
MTQ9DMVU&+3_-^UR6*S.L37:0F!93Y9D#D*?SQU3PS\+_`-LG_@E_>^#_`(#6
M>MZ#\/\`XL_LTWEG\(--U5;K3_$7ARYM_#TY\$V-[')=7%S;:KX=\3:9IUO,
MBWUP%N+$K%<RPF.5OR;\%?M`>(-8^.7PU_X**ZC>SGX=?#W3_@'^QQXAAN);
MZUL;FW\<?LLZS\:O$FLL)`;9Y%^-?QV^%/A>]F-L[+?^"[W2R\<FG32S`']-
M=AXP\,:K>3Z=I>O:-J6H6OG"ZL;#5+&[O+9K>9K:X6XM8)WGB,%RC6TV]`(I
MU:)]LBE1F7_Q)\!:5#<7.J^,O"NF6MIJDNB75UJ'B+1[.VMM9AB2>;2)Y[B\
MCCAU2&"2*:73Y&2[CBECD>$)(C'^=3]EO1?VG?!7Q(^!OB'X%>'OA/XM^)?Q
M;_9,UGXV_$"U^.GC;QWX)TB.V^*OQ\\9^,;>[TB?PAX%\>:A>:A'IVI65H+:
M_P!-M+>WM8HW%T6(MT^69+7XK^.-)U30M6\+_"G7OBIK/_!<GXG66L^`?%?B
M3Q?<?!'4-;N/@GX$DO?"]WXH_P"$2_X2VY\%V\B/Y6H3^"K.ZEN(MS:5;1NK
MFW"T5*ZUMIUU`_K`?XP_"E+)-2?XD^`4TR2]ETV/4G\9>'%L'U"&V%Y)8+>'
M4OLYO4LV%TUKYGGK;_OFC$>&.A<?$KP#9Z3::_>>,_"MGH>H3?9[#6;KQ'HU
MOI-_-R1%9:E+>K973D*2$@GD8@$XP#C^<[]J;X8^-/AWJ?\`P3RT3QM^R=\!
M-8UO6/VTOB)+=?L^_LS>,1=^#OBI9G]DKXN+`=4U[XPZ)\+='L]=@ELH]8D@
MU:7^SDLO#-@EMJ-QJ$D5M+\]7_A;5O$/PE^!5YX-\!?#72G^*'_!3KQ=<>%_
MV6/'OB/Q-'X*^#KV/P\\1^'M2^%OQ-U&V\.S:MHD\VI^'K[Q7JEEH7AC5](M
MWU+2)M%&I65T+YH`_JRL/B?\/-5L-8U32_&WA+4=,\/PI<:[J-CXDT6ZL-&@
MDCEFCFU2\@OI+:PA>&&65)+J6%&CCD<$JCD-TOXI?#K6_#^I>+=%\<^$-8\+
M:-;W-YJ_B32O$VB:CH.E6EG`US>W6HZQ9WTVG65O9VR/<74US<QQV\"-+*R1
MJ6'X"_&7X5>-_#^J?L@?!+XX?"']FGX)?"[]H#]M3PWX>^*&E_LT^+_%^K^#
M?B/X4\*_"GQUXP\%>$/B1J/BOP9X#O8!XE\?:7;:8=(6WNK#5;*P&GM<K)K1
ML7\Y_P""BWP]^'_[-WCG]IKP%^SSI6G>"O"7Q<_X))?MU>(_C)\/_!H>R\,V
M-UX"\%/;?#SQY_8FGD66E:[/<:[KOAV&XMUAFU6!%\Q)O[/WJ`?TA^%_B?\`
M#OQM?3:9X1\<>$?$VH6]HM_/8Z!XDT76+N&R=HT2\EMM.O;F:.U=Y8U2X9!"
MQDC`<EUS)XG^(W@KP9I&OZ_XJ\2:1H.B^%85N?$FI:E?V]O:Z';R;/*GU-F?
M=9QS"6-H6F5?-21'C#(=U?GA_P`$]/A#X_\`!&F>&?%/BG]G;]EGX5Z-KOP=
M\'II/C?X)>-?&'B7Q[XD>?3-"NH[;QG8>(_A/X$LK&VOK=9=4N6T[7-9$6JI
M';*MQ"PO%_,+]L7P-\5I?$G_``60UA/CMXAC\.^'-%^"=[-X!N/"W@%_#_BF
MU\2?"?1I?#&F:KJ,_AZ3Q-I=KX"NKJSDL[GPQJ^BW/B&+2HT\52:Q//=W,@!
M_4'17\_O[07[67[7W['?C#XV?#3Q#\5=.^/6J7?P<^%?C+X<>(+GX7>$_#=Y
MX$\7_$GXU6'PBO(K;0/#DFF6GB71-)AUJ#5]!TOQ)JK75S?V-GIVJZ_+!>W-
MV/L/]@?XE_M0>*?&'QP\'_'BQ^+6K>!?#=O\,=<^$GQ*^-7PZ^&_PO\`'_B*
MZ\2V/B>T^)'A;4?#?PRU";P_=:-X:UCP]HNJ>%=?&GV%W>:3XN_LF[:]N-#6
M^G`/T_HK^>?]IW]JW]KKX>V'_!0GX\>$/CGINF^%/V)OBEX'M_"WP/?X=^";
MNT^)WAFZT_P)JOB;P=K?BB]T^X\5)?:]8>(-1TOPM=:#/I^IV7B"XM)I[K4;
M<0V,%?XO_MH?'71OCKKGBOX(^//VAOB)\*O`W[5_A+X`?$'^W_`7[-_AC]F7
MPXUWK6C>&/&_P\T36-4U?3OVF/''C3PSJ]W,M]XR\->'-9\,:=KCS:1=ZM':
MV4D``/Z#=4UC3M&A2XU*[M[*&2>VM8I;JXAMTENKR406MM&TSH)+BYG9(8(4
M+22RR)'&K.RJ<O2_&7AG6=7U30-+US2=0UK0S;+K>E66I6-UJ.C->1F:S35;
M&">2ZT]KJ(&6W%U#%YT8+Q[E!-?SI?'R3]JWXR_LX?#;XQ^._P!J6_T?PSJ7
M[=O[+O@KPKX$\"_"SX=Z3_PCLR?MF>"O!.D>,]9\5>(--\3:EKNKZ$DMKKUK
MIHBTOPE?7UC;6>O:!JVDR7=C<ZWC?XT_'CX5?M`?'#X*>!/%7B3Q5XU\3?%#
M]G_P'?\`Q@\%?#OX#6OQLU?0]3^%_C?Q=XDN;(>((_AY\)M1\8W[:39Z?H<G
MB7R=*TC3K:_;2]-FU#RHG`/Z/JYWQ;XL\.>!/#6O>,O&&LV'AWPKX7TC4=?\
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MQXH_8Q\.?%WPSXF\*_"WP!<>*OAMX\F\?>`OA]I?@SX3^%(M-@L-7@U>V\9Z
M?HOARU\=ZIK<UOJEI#J>LZ_.)[R9?,/AW^U!^VKX1UO]H_P]XJUOXRV.A_LM
MS_LA?M(/I'[0?_"AO$?Q?\2_L\>/O&'Q,\/?M!^$_%.J?`2]\2>#+*TB\$^#
MK[QWX.0ZG?\`C#2-8TA-'OY[>%XK90#^E*BOYT_'O[7_`.UG\0/&UAH/P^O?
MBPO@;]H3XZ?&?0_A:OP7LO@/9?$G3/A/^SSH]AX<U:/P7K_Q]\7?#WX=P7_Q
M`^(#^(;RXU36?$=SK5CH6AV\GA^QDBN9W7]+?V8?'W[1V@_LI>*_$O[2'AWQ
M0/B=\/+OXT2Z)_PFUQ\,9O'/BWP)X2U;6[WX8:MXXM_@MXJ\:?#RT\7:MX1B
MTBS\10>&_$=U%/J5G>:B8;.2\^R1`'W_`$5_-S\"?BO_`,%%_CU8?#'X@:;K
MW[0'@3P3^T)X$\=ZA\1OB9\29_V(E^#/P*DNO!6J^)_A=X]^#'A;P+\8_$_Q
M@O+#PSXKT[3?#'B;PU\0/":7/B/1=2N[W7H=/FM9[F'D-'_X*1?M1?%3X#_%
M;]H+2-=T?0=7\&W7P<_9V\/_``M^&T'AK77U7QW\1=2TN/Q)^U%I$WQ.O/!F
MDW7P[\8QWC/^SR?$VO:/X8U#1Q=:QXDOY'\M(0#^G6BOYRIOCO\`MZ^#[SX>
M_L^>.-1^+?P=\/\`[1_[6/P[^$WPV_:%^.=]^S%XB^-7ASX?WWP4^(GQ*^)V
MG"S^!7Q#^+/PUM/%&H^*?AQ)X7^%VJ>(C'?#3O%GVA=.O+S1894^SO"GB;XO
M_!O]L'X7_`+Q5^T9XD^+W@C6?@+\8_'8U;QIIWA#3]8GO]$\3^'+30+'7-2\
M.Z;I5GJVI^'[2\OTBOS:V=U=V5W"-0CN)85N'`/U2_MO2_[1&D&^LQJIL_[0
M&F?:H/[0^P^=]G^V"S,@N#:_:"(#<",PB7]V7W_+6J#D9'0\BOY7OV9_&/QM
M^+_QC^"/[17B?]H?XG6'B_6/^"5,?QM\16&@VO@1=,\5W7@WXQ6L.H^!_L6J
M>$]0DM],\87EG%J.M7^G3P^(8Y[EH-,U*QM76(;-O^VK^WY\*O@-XT_;$D\`
M_'/Q5\-K[]E7XG_%[Q!'\;==_9(?X:^%?B:VG:1JOPHE^%6B_!;XT>,_C)_P
MA%D=3U+3O&FE>+O"NCW=MI.EVVI:C_9>I3WA@`/Z8;KQGX7L?%ND^!+O7-/M
M_%^NZ1J>O:/X?DN$74]1T?1IK2WU74;6USYDEK83WUG%<R@;8WN8E)RXS8O?
M$^A:?<:C:76J6$5WI&F+K6IVC7EL+NQTB1KA(]3NK3S?M,-A+)9WD<=W)$L#
MR6LZ([/$ZK^//P<^%GQ%^&G[??[/"?$G]I7Q?^TAX@\0?LN?&76M2U?Q-IW@
M?3])T76[CQ#\-)M</@BV\(:#I%Q8>$]6OYGFTC2=6O=9&FZ?;6D%G=9-U-<8
M'Q*^&_B/Q#_P5._:#O+;XW_$GPCIVF_L2?`3X@R^%M)N_#,?ASQ)IUA\3OCS
MHLWPXU*TU#0;J[G\)ZA+I-SJEVEG>V^M-J?B75MNIBU;3K6S`/V3;X@>#%\$
M6WQ*;Q'I">`;KPW;>+X?%TU];V^A?\(O>:=%J]MKKZA.\<$>F3:9-'>K=.RQ
MBW82$@&M_2=6T_7+"VU72KJ"^TV^@@N["_M9H[BTOK2YA2XMKNUGB9HYK:XA
MD26"9&9)8W5T)5@3_,C)K?QT^`_[-7P]\.ZC\>O$GQ0\$?&/_@D_\9?B9#X*
M\:>&/!1\/_#OQ+\)OV>?#6N^$+?P;;:;H=I,='@M-3CT^_LM=FUAM3DM1>WD
M\TLTD9]JT?XS?'#X>_&WX2:A\9/B3\7OA=^SGXBLOV3/#/[/OB3X1>&_AQXK
M^"FIZMXE\&>'K7QWX!_:-TI%O/B)X/\`$_C#Q_JPT_PKK":-;^%+?PE<^'IM
M'U32K^#5!<`']`NL:OIGA_2=4UW6K^TTO1M%T^]U;5M3OYX[6QT[3=.MY+N^
MOKRYF9(;:TM+6&6XN)Y72*&&-Y)&5%)$.@:]H_BC0](\2>']1L]8T'7]-LM8
MT75M.N8KS3]4TK4;>.[L-0L;N!G@NK.]M98KFVN(7>*:"1)(V9&!/Y@?\%<_
MC!/X&_9RT#X1Z+I?BKQ+XH_:A^*/@CX(_P#"*>`/#FJ>,_'FJ_#+4-1/B?X\
M7GACP=H<%SK/B.YL?@QX<\;6;:?8Q*SW&JV2R2HDN&_,;]GG]J;XHZ'^S_\`
M";]BSP;XB\>_L_:WX?\`VU];_9?'BWXD>"[GPA\8/AQ^S7K5KK_Q:^"%]J/A
M#Q]IC'PUXOUKX<W&F_#O1Y-<TXQP-H)N[:WD=X)I`#^H^BOYP)/B7^U6O[3F
M@_LG^%?VN?B#/I>J_MR:W\%K;XJ^)-&\#^+/%4'PY'_!-_5_V@[K3H;>'1--
M\+ZEJ&G>-[.>[T;4=1T:[%GJGV&\U2VUB&TGL;S=TGXM_MM^)?C-\5?"W@3_
M`(:=^($O[./QH\`?"#0KZR\4?L>^&OA=X@\-Z+!X(O\`QUXH^.=GX]^*W@+X
MIZSK_C'P_KNMZA;W/@WX>76G6DEKIR^&[6ZO/M-F`#^B*BOYQOA-^T'^W=\;
M-<\,_&[P5X4_:!GMM1_:<\6>'?$?AC5_&'[(6A_LRZ/\%/"_Q9U[X8>)?"%I
MX=OOC-'\?U\;>$/#&@SZB==NO`,'B/6O'=O>-96,F@76GQM6^#/BG]JCXI>*
M/V2;#6/VP/BOIND?M67'[5<7C&PTS3O""7'A?0_@9XOTT^#[/X?:G+HLUSX>
MU&\M+X:7K^NRM?:CJ.G1-'&UK=2M<J`?TA45_,IX&_:D_:_^-OAO]FSX,V7B
MOXLW^MW'@3]K>_\`$?CWX4:[\&?A[X^^).M?`']I;Q5\`?!5S?:W\4]?\)>&
MMECH.B67BKQMI6A9U'7=6<SBWCTAKQAZQX`U+]M'XV_$+XG_``X^+?[1OQ`^
M"WBGX)_L0?L]?%/7M$^$VI>`+ZWU7XP>*]3_`&A]-U'6]1\0:?9Z_IT^FO'\
M/](N=5T7PY>V^C:Q>*J74]W:V-M0!^^MMXGT"\UB_P##]IJ^FW.MZ3#9W&JZ
M3;WUK-J6F0ZB)&L);^QCF:[M([U8I6M7GAC6=8Y&B+!&(WJ_G?\`^";J>+_C
M-^U;XC^//C/XL^/+/Q3XQ_9;_8F^*?B7PYI^JZ=IWAKQGK/C/X6:Z^JZ7J&E
MBQ+S>'K#4C<ZKINFV<T36EW=3&6:9%14]K_X*;_';Q_X5^(5[X$^!_C#X[Z5
M\4/A]^S9XF^/6OV/@7Q]\-_AU\*?#W@ZW\276AZ+XN\<W?CBRO\`5?&FNW&M
M:+JFEZ9X+\-V%W'<Z1;:I<ZI+I[_`-GRS`'[:T5_.9?_`+0O[1]EXV^%'QI^
M/OQ&^-_A?]G_`,>1_L?CP/XV_9WU+X2ZU\._#GBOXBCP+:^)?"/[0/PVU.^7
MXGPV7CGQMK8T&?Q%X>T;Q'I6D:!KL$HGT2>V6XK[]_;8^(OQ*E^/7[('[.7A
M'XD^)?@MX.^-VM?$R\\=?$OPG-IMEXCEA^'_`()GU_1?!.CZWJUC?V6CWGB*
M_P!LLUS$HO9[6RF@MF^=B`#[2^,O[0/P=_9]TG1=;^,7CO1_`VF^(]8&@:#+
MJ@O)I]8UDV5WJ)T_3;'3K6]O[R:*PL;R]N3;VSQVEK;R7%R\40#'NF\:^%X[
M?1+JXUO3;*'Q*]K%X>:_O;:P;6[F^M7OK2TTN*\DAEO;V>SCDNH[.!'N3#')
M)Y6V.0K_`#U_"NS^(G[0G[5?PU^&7C_XY?$;6(_V>_C)^VK\(O!_Q,TF\T&#
M6O&/AOP9H7P5URPU35YX]$DTJ\\3VD'C+4/A]XGUG3X5:^30;Q2T5S=7E?9O
M_!37P'<>(M;_`&&+>W\=^*O`MO%^USX1T/\`M7PKJ-AI%SIIUCX?_$1(=7MK
MJ^MKBWM=1L3:?9K&:3,02_N8C$[RQ!0#]-/`GQ/\!_$U?%+^!/$VF^)4\$^-
M/$OPZ\5MILIE&B>-_!]XEAXF\-WNY4V:EHUY(MO>1KN1'9=KL#FN]K^9?PG!
M\8/A'X1_:H_:*^'WQ\^).E#P-_P5(\?>!HOA=:Q>')?`'BS1=6^-/@OPSXRO
M_&-O_90UCQ!J?BK3]:NIVU"75HDTB6VLKC2;>T=;O[5Z]^SA\7?VV_C!\6O!
MGQMAU3QO_P`(1>_M)_$'X?\`Q*\'Z_\`$3X-V7P?TSX/Z+>>+_"=IHWACX=Q
MZR?BC9_$G1==TSPIJUM?7%A+JVLQWNKP7$)L[B%8P#^@::00Q/*5+!%+%5QN
M/L,D#/U(KB?AU\2_`WQ9\.'Q;\//$FG>*O#RZOKF@/JFERM+:IK/AK5;K1->
MTUG9$/VG2]6LKNPNTQA+BWD0%@,GX"_;,\<?$S6_VF?V4/V8_"GQ3\0?`_P3
M\6],^+7C+QW\0_"CZ98^)M37X;Z+I]UHW@/1-;U>WN[72)M8NM2;4[^:"`WT
M^G:5/!;R1AW:OR0^!WCGQ=9_!SX-_LY_"CQC^T-KWQ7N_$?[</Q/DA^''Q;\
M`?!SPM=>"_"?[0B^%I_B#\3?B+X@T_4[O5=1L/$6K:?IWAWPIX2TC5WU(ZWX
M@U'6=/CM+&UNX@#^J:BOYO/"'[:_[07@;X`^`?&_C#QSJWB_XD_M+_L]>(_A
MS\&[&26WN](N/VF_"GQ9UKX1Z-J&FW%G965G*UYINJ:'XN\1WMO9:?%J,&AW
MVJBRLK<2(GZK_M$^-C^S-^PGJ^M_$SQ_\3KW5O!/PK\.>&-<\?\`@J[TL_%;
M7/%MUI^G>'$U?1=3UUAH]OXGUG7[E)5U7572PM;BX>[NY8X8WD`!]V4UV"(S
MGHHR?H.I_`<U_,1IOQR_:[TA?&?P3U?XJ_$7X<:G;_MB?L3^!=#U35?BKX;^
M.?Q'\(^"/CHMM:^+=&U3Q_!X?M/#^J7=TKSZ@NB75GK]AHUY)'`E_J=G!`*]
M;OO%OQZ\)_&WXB_L0?\`#5'Q<M?!5Q\?/@5I6G_'#Q1KNDWOQ>T+PE\0?A9X
MO\8>(/!.D^-[O3C#`VMZ[X,MK#1=0N+'^TK*/4[RVL9B?*,8!^\/A'XF>"?'
M>K>-=#\*:]9ZSJ?PZ\3MX,\:6EHS-+X?\3+I&G:\=(O@Z)MN?[)U;3;T!"ZF
M&\A;=EB!WM?E-_P3+\-#P?XM_;[\+CQQXC^(_P#8?[8/V%?&/B[5[37O$>L>
M7\`_@SNDU75K.*".^NXF<PRS/$MPQ3-SF<N3^K-`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`44'H<>GU_3C/YBORLU']O#XBKXUU+X&Z7X0\+M\>+3
M]J6T^$4>BW=MK#:)_P`*9ET*+X@7?Q;>VAU)+_,'@:.^TVWC-^MB?%J6QDCE
ML6DM*`/U3HK\.O@Q_P`%,OCG\3/^%6?$74OAQ9Z5\$_BM:^.];U;5;GX%_&[
MP]I'P)\"Z;X6\5^(O`WQ`\<?M`>(-7C^%OQ"L;Z71=!TOQIH/A3POX:?1+SQ
M(W]B:]KT.F-+=<;'_P`%5_C+9V_Q.EMM)\'?$'2--_8@_:0_:J^&GCZ?]G#X
MZ?L]^$M9\0_`?0-(U>UT?3(OB=\2?%5Q\6OA_P"(3X@TZ=_&'@^\\*.EE`_V
M:%VU.TN+8`_?>H6N(%=(VE0/(<(N<EL^F,\>YP.1ZC/@'P<U3]H/Q'\+FUWX
MM/\`";2/'7B&U_MCP[!\.K'Q5JOA70-(U?0["\TBSU:3Q+JVEZKXHU'2M1GN
MUU.^MD\(VVL6"6XM=.T6X:1A_.M^R5KFO_"._P#V6/C_`*[IO@KQW\6OCY\,
MOV\OBQJ_Q`'_``M[PQXFU'Q#\']&TG5X+#X@PCXU>)/!GQ&M=5N-<N++3)]7
M\&VP\$:/!#:>$K?3+UI=2(!_3K\2_ASX3^+G@3Q-\-?'5G?:CX0\8:<VD^(+
M#3M;USPY=WNFO-#--:)K/AO4=)UJSBN#"L-R++4+<W-J\UI<&6UN)X9/'OA1
M^R-\`_@MJ_@[6/A_X4O++5_A]\/_`!9\*_!]]K/BSQ;XLOM$^'OC3Q9H_C77
M_"D-WXJUS6;J?29/$7A_1;BP@N99O[(LM,M=)TPVNFQ"U'YJS?MT?MRZ1\"_
MV;?CCXT\#_!+P[X&^/OA'PKX[\2^/?`/PH^-_P`=-%^!GASQ#\/=+\6:?-XW
M\*:'XY\">(]7C\1ZGJ#6D.J6%]IVD^#8(S;ZK<^(FC&HW'5?LH?%S]HOXQ?M
ML?&?4(?CS\+/%/PN;]ES]A;XF1:)X;\#^/-:\`:K8_$A_P!HP>(]1^$,VH_&
M.Q@\)7GB+5/"9N[[Q9J_A_Q3+J6@)X.TBZ\/0ZAX:O\`5O$H!^G?P@^`WPH^
M`MAXGTKX2^#]/\%Z5XP\6:SXXU[3=,DO&L[GQ/XAN3=ZQJ,4%U=7$=F+VZ9I
MWM;-;>TCD=S#!&&(KE!^R[\!)O'WQ4^)B^!='?QS\;/!%O\`#[XH:XLUY]M\
M5>$H;$Z>FEW\7VOR8%DT\16DUS:P6U[/!:V23W,@L;41?&W[</[:OQ*^`?B;
M4?"7P>UOPKXC\>:+\(-:^)\_PIB_9G^,/QY\37EOIUSJ\5IK/BCQ5\.OBO\`
M#CPW\(/`=Y)IHTO_`(2;Q7:Z[MNUU&^AMKB+3A87GPYX'_:>^.\GQ$_;`_:Z
M^%%M\+]$T*;]B?\`8>_:2\7>`_B)IWC+QC=ZG#K_`,/OBKXWNO!?@_4M`\6^
M"[#PK-+I,]Y:'Q?J=AXD8ZC9::C^#[BVFE:V`/UJ\3_L`?LJ>,/@7X-_9IUS
MX;W#_`_P'<V-WX<^'^E^-?'GA[2XYM-E-S8G5;CP]XGTK4?$*6E_Y>JVT>OW
MFIQVVL6]IJ\"QZE:6US%ZU+^SE\);F[^#^H7WA^]U74O@-/J%S\+=4USQ%XC
MUW5_#MSJFCG0=0NKC6-8U:]U37[NZTIFM9KOQ#>:K<R$F9Y6F_>5^5MU_P`%
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MCB9/`[S_`()P_L?W6C?#70(/A??:'IOP@\)ZGX%^'`\)?$3XG>#;_P`+^#]9
MU/\`MC5O#UKK'A7QEH^L7>FW^HK'<W%OJ5_>HSP0<`0QA?BG]F#_`(*,_M+?
MM!:Q\`O%D?P=OI/AK\;]?>35_#6G_LQ?M&:&WPO^'.LQZPWA7QK-^T[X@U>;
MX._$6:`6NAR>)K+1_`?A?2U.KWT&@ZWJ4>D6U[K/TC^V3^VUXR_9#\?:.NM>
M%-#U_P"&GBG]GCXW^-?"1M[75'\8:Y\<_A4-`OO#OPV@N+74WTUK;X@V'B6Q
MT_1K<:0EZ=8M;HQZE-&ZVJ`'H^O?\$[/V6_$%OH<-QX8\<V,^@:+<^&;?5M'
M^-/QGTOQ#J7AN[U?5=<GT+Q+XCL_'\>M^*K!M2US5I(D\17^I2V<%[+96$EK
M9A8`OB;_`()Y_L@^(X-!TR3X:2>&[?P_X7L?!MK8>!?&WC[X?VFH^#=,>5[7
MPUX@L?!?B?0K;Q+I$4MU+))'KD6H3RRW$GGW#_:9EF_/+QU_P4W_`&I/#7A7
M7_[&\`?!/4/'/PA^'5E'\:(;^U\;IX4?XTZA^TO=_L]:?HWAFXA\16VL:-X)
MU8>$O'/BS3[G4[77M:73AHDS)=1B6"]\I_;\^)7[47@A_CA<ZMXR^'O@+XQZ
M7^RA\!_%%[X\^%!^-EG8VOAGQ)^V!KWA>/P5X=T>Y^,FGZ+9:I%&NE?VI\1#
MX=M_$'B"SFUG0KBQM]%O=,L="`/Z'?"WAGPMX/\`#6B>"_"&D:7H'ACPSI5E
MHFA:!HUI#8Z7I&D:?`EM9:?8V=NJ06UM;01I%%$B@*J\@DDGY[?]B7]F%_@Q
MKG[/3?"?0A\'?$GB>\\9:UX(BN=:@L+_`,37OB"+Q/)K,MY#JD>KK?1ZS;VU
MU`\.HQ1P+;PV\,4=M&D*_G5KOQ4_:S^#W[7?[0VM^*OC/\/?&'A'X0?L<67Q
MJ\3^#=+^"WQ`TCP[KVC^%M;\5:KJ6F>"?#^H?M,Z]:>%/'FL:?I7]GMXWO[O
MQ+9-&;>*;PA(L19N!N?^"G/[76D_#?Q3\3?^%+KXE\,C]FKQO\7K#Q/J_P"R
MO^T7\#?`?PV^)&@6^@ZMX6\#>)/%_P`2?&>H6'Q@\+>,-)U75+:Q\5>"#X&U
M!]2\/I>Q:'_9^OVMM8`'[4:=\%?AUH_BO2O'.D^';73_`!;H?@*P^&&DZU;R
M78FL/`FEWLNHV'AZWMC<FR6TM;V>6>&0VQN58JAG:)1'7AOB7]@+]D[Q=IVO
MZ3K_`,*H;NQ\3_&#6/C]K0MO%?CG1[VY^,>O:99:+JWCR'5M"\3Z7JNGZK=Z
M3IUE8-!IM[9Z<D-NA2R60N[<9\`_CC^T%J?QC7X8_'2_^#VM6WB7X$>#/CEX
M9O\`X6^!/&7@EO#B^(=?UK1-7\&ZX_BKXG?$8^+7T]-.M+RP\4V-GX*2Y^T7
M,%SX;A\J*9OO>.6.90\3K(AZ,IRI^AZ$>XR*`/DSPC^PS^S+X(U#P1JF@^`+
M]K_X;_$2]^+'@:\U[Q[\1O%]WX:\?ZCX*O?AU?:]IUUXO\6Z[.HN/!FH7NB-
MIDLDND".ZGO%L1J,KW9=\4?V&?V7?C+JNI:Y\0_A?;ZOJVK^(-&\6ZA?Z;XF
M\:>%+FX\4^']/N])TCQ(9/"'B30?*UVUTN_NM.DU6W$-]>64BVU]/<Q10K']
M:T4`?(&F?L&_LKZ7X*\8?#R/X92:GX/\=SZ!>^)-(\4^-OB'XT\[4?"[7;^'
MM4TJ_P#&'BS7=3\,ZII#WMQ+9:EX8O='OHKAHKG[0;BVMI87>'_V#_V5/#7A
M#XG^!].^$^G3Z#\:/">J^!/BG+KFN>+/$WB3QKX,UK2[K1M2\+:OXU\1Z_JO
MC,Z%<:;?7MLFF6NOV]K:_:99;..WF=Y&^O:*`,C0-"TKPOH>C^&]"LX].T30
M-+L-&TBPA,C166F:9:Q6=C:1-*\DICM[:&.)#)([[4&YF.2?F;XJ_L0_LR_&
MOQGJ7C_XD_#:/7?%.MZ-'X?U^\MO%'C7P_9>)M)M]+U/1;&U\5Z'X:\2:/H/
MBIM+TS5[^UT>Z\1:9J=YHZS^9I=Q:2P6LEO]844`>'>,OV;O@I\0O$7B+Q7X
MW^'VA>*-=\6^`_\`A6/B.ZUJ&6_AU?P(NK'78O#UWIT\S::\$&KD:C;78LQJ
M%M=I%-;W<;11%*GP7_9F^#7[/A\0GX4^%[OP^?$YTD:Q+?\`BCQAXMOKFWT&
M&Z@T:Q74_&?B#Q#J4&G:7'?7BZ?I=K=6^FV8NI_L]G&TTK/[Y10!^;W@W_@G
M?\,I/V@_CC\<_B_H?A_XC:CX^^+VA_%#X>6=U_;Z6'A+^PO#&AZ39PZ]X>?4
MD\*^*-3L=9TE=<TF^U?2-3.E7?V:XTYK2[M8Y4]@U3]@C]DG6?'.N_$?4/@S
MH$WB[Q+XFL_&NMWRZAXBAL+WQG8W=G?0>+AX>M]9B\.6OB=[RPM+B]U^STFW
MU75)(LZI=W@9@?L&B@#P36OV8O@9XC^$FH?`O7?A[H^I_"S5+L:C>>$YI-1C
MMCJB>((_%=OJ]M?6]]#JUAK%EXEA@UVPU>PO[;4K#4X(;NRNH)8HRO!P_L*_
MLKP^%_$'@]OA+I%WHGB<^')=8.I:IXDU76KB]\(P:A;>&M4B\4:GK=WXGLM9
MT:#5=1BLM:L=8MM7C2\G4WS!R*^MZ*`/B^X_X)[_`+(]WX9TSPE=?"A)](TG
M5M7UVVG?QE\01XAFU7Q!8Z#I>N7.I>,%\6+XMUA-7TSPOX;L-1M-5UN\M+RU
MT+2H+B"2*QMT3Z#UGX.?#3Q!\*]6^".K>#]%N?A1KG@W4/A[JG@:.T6TT*[\
M&:KI,VAZCX?>VLS`4L;O2KB:TF$3I(RR-)YGF$L?3:*`/!?''[,/P(^)*SKX
MX^&OAOQ(MSX!/PNG74[1YP_@,ZIIFM#PZN90T5M%JNBZ3J-M/"R7MK>:?:W%
MM<Q21`USW@+]CG]F[X8VOC.T\$?"S0-%C^(WA/3/`WQ`E9]3U2[\:>%-&'B$
M:7HOB6_UF_U&_P!7M[)?%>OI#+?7,]WY5^T#W#V\-O%%]-T4`?/6O?LJ?L_^
M)_AOX5^$>N?#+P]>?#[P-%:1^"]`C6]T]O"9L8)+:VG\.:OIEY9:YHMV()9(
MIK[3=2M;VZ5Y/M-Q*9)"W<_#KX/_``[^$WA9/!7P_P##=IX>\+I+>W#:7'->
MW_VFYU*5IK^ZU"^U6[OM1U.[O'<_:;O4;NZN9@=KRE`$'IE%`'QW-^P'^R+/
MJ&N:A)\%?#8_X2*UUFRU73([G6X?#LEKXC@FM/$$-GX7AU5/#NDIK=G=7MEJ
MG]D:78->V5_J-I<-);:A>Q3^E:]^S!\!/$U_<:EKGPK\%W]S>>!+7X87Z2:'
M9I9:A\/;&1)M.\(7^FPQQ:==Z)I4L:2Z-9W%I(FC3+YNE_9'YKWJB@#Y0A_8
M?_99B\(:YX#;X.^%[OPKXBU;1==U2PU(:CJMW)K/AL2#P[JUOKFI7]UKVGZG
MH!FF_L*_T[4K2ZT82RIIDMJDUPLT=S^PU^RI>Z3X?T.]^#'A&_TOPOJ^HZ[H
MD&H0WU_<6^IZNMG'J\]UJ5Y?3:GJT6K16%E#JECJ]Y?:?J4-I;1WMI.D$2K]
M9T4`?,0_8U_9H2'X9PP?"/PK9#X/:3+H/PW;38+O2SX6T&XNK2^N=!LFTV[M
M7N-`N+VPLKR30=2>^T<W=K!<_8O.C#T[0/V-?V8_#.M:SKVD?!SP?%?:_I7B
M#0M4@NK*74M&ET7Q6@B\3:3:^'=3GO/#^EZ=K\0:'5[/2],LK?487>&[CEB=
ME/TW10!\Y?"S]DG]G;X*Z]9^*/AC\+/#GA/Q#I^E7NA6.LV*7L^I6FA7[6C3
M:%;7NH7EY<0:%%]@LQ8:-#)'INF+`$T^UMD>17V_B#^S;\$_BEXW\,?$CQSX
M`T?6_'/@^.VM]`\3N;RSU:VLK/4AK%IIEW<Z==6C:MI%KJ^=5MM(U87VFP:B
M3>0VJ3/*TGN!=0=I.#C/MW[^O!./3FJ4VIV5NDDD\ZQ1Q`M(\F51`H+'+'"C
M"@DC/0$]*$TWRIW>UNO]=Q.44FVTDM7)M*,4MW)O1;]6CR+5_P!G3X+:]IF@
M:-K/P[\,ZEI?A;X?:Q\*/#]E=Z>LL&E?#CQ!HEMX;USP;:J7!30]5T.SM=,O
M;0DB:U@CC+<9KGH_V2/V<(O'&F_$@?"'P8WC/2!X=?3M8?2U?[/>^$M+M]$\
M-:N=/D=M,GUW0='L[+2]'UVYLIM9TVQL;*UM+Z.&SMDB[O6_C;\(_#DUO;ZY
M\1O"&F7%TVR""YUVP2:1^ZB(3L^X=&!4$$$'D&N(;]K;]FI+C[*WQJ\`"XR1
MY)UZT#Y#!2""W56(!]#UKU<-D6=XV$IX/)LUQ<(1YISPV78S$1A%WM*<J5&:
MC%V=I2:3M*ST=O)Q'$&0X24(8K.\HPTZC<:<,1F6#HRJ232<81JUHN<DY134
M4VFU=:H]'\0_"OP#XK\<^!OB1XA\,Z9JOC7X:C7!X%\07D!EU#PPWB6R73M>
M?29"^RU?5;!([.\D6,R2VZ"(N%R*^=/VC_V5=)^)^G^+=:\`>%/@I:_$SQU/
MX*@\8:]\6OAI;_$7PYXHT#P7=W,^DZ?K>@RW$$5SJ>EI>7J>'M<97OM#>ZF:
MV8J^P^Z:1\=O@WKZR-HOQ+\&ZH84\R2.RU[3YY@AZ$0+/YK9R,!4)/I7HJ:S
M82AS%*\PC`+&*":0'<B2#:40[R4=6`7)P17GUJ%?#?[Q1K4-&_WU.=)65KN\
MXQT5U<]"EB</7_@5Z-;1/]U5A4T?7W)/3SV/@;]E#]@KP=\"VUCQCXVL_`?B
M?XIZU\7=2^,UCJO@OP+8^!?!_@'Q#??#.T^#D-C\/?#5D[)H]M'\-[67P_?W
M<C/=ZL-6UJYNMKW[!/I#Q9^R[\`O'7C*V^(?BWX5^#];\;6LVFW'_"276DQ)
MJ-[-HLZW6C2:P]NT,>NR:1<HEQI;:U%?C3ID22R6!E4CW>*XCF^X6SM#89'0
MX)QG#J#UXJ:LN_D[/U-DTU=--=T?.M[^R5^S?J'CP_$ZZ^#G@63QTVJPZ_)K
MXT2WCEN/$=N"+?Q-=V$032KWQ-`=KP^([NPFUN%T1X[]&2,IUF@_`;X1^&'\
M$3:#X$\/Z5/\.%\3KX'FL[)87\-'QI<)=^*VTLJW[AO$%U%%/JA!/VF2-&;&
M.?7J*!GSKJ_[)G[.>N^$M*\"ZK\(?!-[X4T+6O$?B+0])FT6W"Z+K?B_7=2\
M3>*=2TB]A$6HZ;=>(M=UG5M1UF6SNX6U*?4KP79FBF:.NU\+?`_X2^"7U)_"
M/P\\'^&CJ_A+0O`6HKH?A_3=+CNO!7AAM;;P]X7EBLK>&-M&T=_$OB!["QV^
M1;OK.HM&BFYDSZK10!X-9?LP_`+3?$O@#QCIOPI\%Z;XF^%NC67ASP!K.G:+
M;:?>^&/#^FV3Z=INBZ?)9B'.FZ;8R2VFFVMR+B+3X995M%A,CEK/Q/\`V;/@
M/\:-=TCQ+\5?A/X#\?:[H6DZCH.EZGXK\,Z3K=U;:)JQ#ZAI!DO[:8SZ;<3*
MET+&Y$UI#>HE]!#%>(LZ^X44`?.J?LD?LTKXGT+QE_PI'X:GQ-X:AT.+0]6/
MA+1A-8-X8CMXO#-XL2VHM9]4\.16EK'H.L74$^JZ-';Q)IMY:K&@7T#XF_!_
MX:?&708/#/Q/\%^'?&VBVEU%J%C9>(=*M-273M2@4K!J>F37$;7&F:E`K,L5
M_836UY&KNJ3J&;/I5%`'E7A'X'_"7P'%X4A\&_#SP=X9B\$)KJ>$X]"\/:9I
M2Z!_PD[6K^)'TP65O#]EF\02V5M+K=PA\_5984EOY+B4,[:'Q-^$WP\^,?AN
M;P?\3?">A^-/#%Q<6]W)HNOZ=:ZC9B\M"QMKVW%Q&\EG?VV]_LNH6;P7MJ78
MV\\99B?1:*`/)8O@3\(8?#%]X,B^'?A&/PMJOB./Q?J^@IH.GIIFK>*8[NTU
M`>(M2M$A6.[UIM0L;._?4Y0;R6\MH)Y9I)(@3D_\,U_`8?$!/BI'\(_AY%\1
M4O'U-?&,7A'0TUT:N\,UL=<6]^QETU\VMQ/:-KR!=8>UE>U>^-LS0GW"B@#S
MKXB?"/X8?%NSTW3OB?\`#_P9\0-/T>]&I:59>,_#.C>)K;3=1"-$+ZPAUFSO
M([2[\IWB-Q`J2M$[1EBC$'SZ[_9,_9GU#2/#OA^^^`_PBN]$\(7.KW7A72Y_
MAWX2DL_#TGB"Y^V:\ND0-I)BL(-=O,W6M6MJD5MJMP(YKZ*>2&)D^AJ*`/C#
MQ9^QWX+\0_%+]FSQ!IMKH'AGX9_LUW7COQ'X3^&FA>&]/TS2%\:^++`Z?8:Y
M:QVD4=G91:.M[K5U';06R>=?:I-<NQE&ZOJWQ-X2\,^-/#VH^$_%^@:-XH\,
MZQ:/8:OX?\0:99:QHNJV4J;)K34=+U&&YLKVVE7[\-Q#(A(!(R!7144`>%^'
M_P!F;]G_`,*VL5GX<^#7PPT*V@U[0/%$,.C^`_"^EQIXC\*.9/"^NLMEID/F
M:OX=D8OHVI2;KW3VRUK/$22=;Q3\`O@OXWC\01>+_A=X!\3+XLN-#O/%/]O>
M#_#VK-XAO/#,4L'AZ\UA[[3IWO[O0HIYTT>YN6EGTM9Y18R6XD?/KU%`'G?@
M'X3?#?X66EUI_P`./!'A/P+IU_?MJFH:?X0\.:-X:LK_`%)K&UTS[?>6NBV5
MC!=7O]GV-C9F[GCDN&M[.UB,GEPHH]$HHH`**:H8##-N.3\V`N022.`3T!"^
M^,]Z=0`4444`%%%%`!1110`4444`%%%%`!1110`AZ'Z&OSF\)_LTZUJW_!03
MXH_M1>)_#.G:5H>E?"+PE\*_AE?1WT4]WXBU"\>_OO&7BC4-/MV9;&>RLFLO
M#.G27:_:I;(SX`A"`_HU3=J_W5Z@]!U!R#TZ@\CWYH`_/'1/^"<?PJT"?5-"
ML/'/Q?7X+:DGC7R?V=&\>7'_``I[2)/B!%JT/B./3M#6R%XFDLVNZI>Z3H+Z
M@^EZ-J$Z75C#&T$"1\GI/_!*_P""-IINKZ;KWCGXV>.(]0_9Y^*?[+FG2^,_
MB/>:S_PC?P:^+6BZ/H.O^&O#L'V*WBT][#3="L(=)U!A/>P%7>664D!?T\HH
M`R])TFWT?1-,T.UWBTTO2[/2;;>Y>06]C:1V<.^0@%W$42[G(!9LMCFOBC2_
M^"?7P)T?0_@YX>M+;Q*=/^!G@SXW>!?`P;Q%<JZ:)^T!8V6F?$%=381'[=<S
M6FG6O]F3OM;3Y`TD0+&ONNB@#XB\6_L/>#=<^&_P<^&?A;XE?&CX8:1\$_`V
MG?#7PM>_#GXB7OA[4;_P78>'M-\++I/B9FM+RTUW.CZ9`D=S<V@N;>Y>6XMY
M8G=LT/!_[`GPG^&7Q#^&7Q`^%.M^/_AJ_P`-?A=\.?@N?#7A7Q9/:^%_&_PU
M^%&H^)-4\!^'/'>E3VUP-<70KSQ;XB>.^$UO>W$>J303S-$`*^[**`/B3XZ_
ML*_"[X^>.K[X@>(?$'Q)\)ZUXA^')^$WCF'X=>.+_P`(6/Q`^'\=YJNI6GAS
MQ7'9P2R7EM:7NLZC)!-;R6UR([N:!I6@9HSY%>?\$K_@/--90Z=XJ^,'A[PX
M_P`)_@[\$/%W@W0OB)?V?A?XC?#+X&:5<Z-X#\.>-=.>UE;4?)L;N:+5+Z&>
MVN=326>.<F*>1#^G%%`'YP^.O^"9/P(\<^)_'.I'5OB1X2\$?%R?P[<?&KX1
M>#/'%]H7PP^+C^&-'TO0M,7Q=X;AMV.VXTK2--TK7_[.N[(>(]*L+>PU7SH=
MP/O^E?LD?!W2/VC+_P#:=LM`EA^)5_\`#S3/AHTBW\W]@VWA_2=R6LECX?V"
MPLM3^QM_9DNH6ZI--IL<-E(&AB51]/T4`?"7PT_8,\`?![QEIVK_``[^(/QH
MT#X>Z!XDUCQ=X9^!MO\`$B^'P>\/ZUK=_>:C=Q:;X6:Q:XBT&.YO[B;3_#;:
MF^C:;)L-M:A41$]B^/\`^S%\,/VDIOA%/\2]+NM1D^#'Q4\+_%_P?]DU">P6
M/Q5X3N1>Z;#J2P@C5-$FNXK6>_TBY_T6]>RM3,&$0!^BZ*`/A#6?^">_P$UP
M_'Y[S2]>63]H_P`=>`_B#\1'A\37\32ZY\-Y;&[\-QZ*0C#1--.J6MSJ^H:=
M:*;>[U/5=4O9`9[R5CVOQE_8O^#WQ\O/B)>?$FRUO4Y?B;\&-*^!GB+['KUW
MI_D^#="\7:GX\T672/LZJ=-\0Z7XKU675K/783]IBGM;+"$6Z@_75%`'Y^M_
MP3T^',_B7PIXTU/XD_&[7/%>B>&[CP3XKUK6OB+/J$_Q8\#7.JRZP_@[XG1R
MZ<MMXET*.[FDB@M6@MC%9R2VID>*60/GV'_!-WX3Q>&?%/@/6?B)\>?%'PYU
MOP/K?PVT+X?>(OBOJ^H>%/!/@O7H;&.ZTGPQIPM8C!):)9BSTF]U";4;K3--
M"VMK(K;I#^B5%`'ROX\_9*^''Q`M=?AU.Z\7:5=>(O@;_P`,]W6J^&O%NJ>'
MM8LO`'GW]P)-'U736AO=*\212ZC<R6^OV<L=Y"Q3R]NW->^^!?".G^`/!GA7
MP-I,^HW6E>#_``]H_AG3+K5[^XU35[G3]"T^WTRSN-5U.Z9[K4M2FM[6.2^O
M[EWN+RY:6YG=I9')ZNB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`**"0.2<#U-8^N:]I/AW3IM5UF_M-.L(/\`6W5Y<1V\*95F
M`WR$!G;:0L:Y=^0H)XHW#[WTLDV]=-E=FJ\@3&<\YZ8[#)ZD?IFO)OB+\<?A
MG\+8[2/QIXEATS4-6,D.B:);0SZKXDUVX6-G,&A^'-)COM<U65$5I)38Z?.E
MO&K2W#Q1*SCY$^*W[9FOZQ\2;7]GK]G/P/<^-/BYJ-H+S4==UB.6W\'?#G0[
MB6XMT\5>+-F+F.U_<BXTJSE-I-KN5CL&8$M7L/PS_9+\$^%=1NO''C:YG^*'
MQ6UV%'\3>.O%:&Z:[F=0TEAI.D%VL=(\/V[_`"V&CPJ\%K&J,O\`I!>9OH:>
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M%`PJ@#M5P`#H`/H*B'$-;#<BRC"87)N6S]KA:7/C)3C)255X_%RQ&-I59.SF
ML/7HT;KW*4$DEQ1X:PF(?M<XKXW.:TKODQV(Y,'2NTW3AEV!6$P%2FK>ZL70
MQ4[.TZDWJ?+WA_\`92^%F@RBZM_"'A:WN62/SC::#I>'=0@.VXO;2\O!A0\?
MF&X\YXW(D=F^:O2+7X+?#N!S))X,\,7,I0QF2ZTBRG9XV14:-E:#RBI1$7!C
M(P#P"6+>M45YN(S',,54]KB,=C*U2]^>KBJ]25WNTZE23BW;64;-NS;;2MZM
M+*LLP\?9X?+\%AZ>B5/#X6A0@K=.6E""DO*?,DKJ*2;3\&\3?LS_``*\7QC^
MW?A1X&GG3=Y5W:Z'9Z7?Q%EVDQ:CI45E?1G&,%9P0>1@@&O';S]E7Q=X-87?
MP)^-'C3P$;8!K;PSXGOYO'_@N;RQ^[MI],UUY-1@@`+QE[+4XIA&5*G,:BOM
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M9[N^^`^I:G>>7:"TN9Y7EF^&UY?7$<,-D0R>&&E1(V73QB+NIX?`\0<T<!AZ
M>2YURQE#+:,IULJS6:24Z65>VJ/$9;C;IU8X+$5,3AL;SRHX%X.K3I4,3R^W
MS+(IQ>.Q$LSR5RM/,:\84<TRZZM"68>QINAF.&;:C/&TJ6%KT6E/$QK4XU:Z
M_0U6#@D`C!QR,'H#_6G52T^[AOK=;F!UDAE$<D4B'*/'+#%,CHP)#*RR`AAP
M<\<5=KYB$G*$9/[45)>:>J?S5G\SZ=6:34E--*2DMI*2337=----:-6:W"BB
MBK&%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%,:2-<;I$7.`-SJ,D\`#)YR>!Z]J<>`?H:_G3
MM?'/[<?[>_[4W[9/@SX1_M5ZE^RQ\._V7->T_P"'O@G0_!WA#PGKNH>,?%UY
MH\U_!J?C.Z\3:=J-Q;Z1<7MM*LCZ8%:"U\I8[:XD=J`/Z*O,CQG>F!U.Y<#\
M<^X_.FB:$YQ+&=N=V'4XP`3GGC`89],C/6OXU=4_X*3?MZ_'O]FG]EJ?X6?$
M2Y\$_'I?VB_BS^SYXUNO#NC>'3I?Q@U;P7X*^''CKPE<RV6KZ)JL=L^HZ9XY
MM-'U%=#%E]HUJ"]>U=89;>"#W'X<_P#!7SXP>-/CE\5_BKI^JZY=?#KX7?\`
M!//QU\5?$'[/VJ0:59Z1I7[0'P^F\'Z9K-KJ-^FF'Q#9JOB"ZOX;S=JTD%EI
M=]<-]D^T6RLE1@YMI6T5W=VTNE^H']7'VB#+#SHLI]X>8F5SQSSQR,<]^*4S
MP`!C-$%)4`F1,$LP51G.,LS*H'<D`<D5_/C^SA\/OV_+WX-_!S]M_P`<?MRZ
MWXRL/%'@G3?C[\1O@//X%\*P^!KCX5ZWX5G\=P^$/#%_8:<-8M-?LM(O;*UB
M+!&AN_,M;G4+TPQSO\76?[0?_!1+XG?L4_%?_@J3X=_:UN/!VG>!/'7C'4_"
M?[-D/@SPI/\`#NY\`>!/&3>%=8T/6K^?36\2'5;E;*[O+:W-^+K4'BMH%OK(
MWTT`G8#^N'S8LA?,CW$`@;UR0>A`SD@X.,>E)YL62/,3*G:PWKD$@$`C/!((
MX]Q7\YG[+O[;WQS_`&@O^"H7P2T"^\<:[HWP6^)G["WA_P",=_\`!N&VT@^&
MM.\>WFF1G4]5M;U]+.O2HNH_:?L#/J_V>:T\F1[4NY-+_P`%"OVE_P!KG_@G
MO^T9XI^(]EXMU_XO?LY?M'^!O$/@[X/>#-6BT,+\&_VCTT*.Z\/Z1IMW9:39
MZG=Z1KD^G7VKV<>L7NHHMAJ.MVKJJZ#IQNP#^C)9HFSMEC;'!VNIP>F#@\<\
M4>=%Q^]CY&1\Z\C.,CGD9X^M?R6?MY:?_P`%+OV'_P!@_P`&?M/>)_\`@H%\
M6+_XJ3ZCX>TWQI\,K7P?\+3X8L-7U_P_XI\07$-CX@D\)2ZD#I)T6VL&MC9^
M0\C7!,H55D;W+]NGP7^W#^RAX&_9X;0?^"COQS\3:K\5_C_8?#/5-4O?A]\(
M])GBTGQ]_85M9W8BM=`NK5I/"0T?4)=+MX$M8[UM=O3=,K1PXJ,7.2BK7>U]
MNX'],0EC()$B$+]XAU(7OR0<#@@\TGG1<GS8\#DG>O`]3S7\U$/C?]L+]L3]
MO'XQ?L8>`_VK_%/P)^&W[(O@#PS!XO\`&N@^&_#UQ\1/BUXSN([6RC\4ZE!=
M0K9Q13Z]'J5W=6&FW-AIEKIMO9PRQ:@^J30VWF7[:OC;_@H3^S3XB^"GPY^+
M'QR^-WB#]GVSTKQ?>_$3]HKX#?#C3-0\?>([^*]=M`T_Q<EAI*VGAH:7I8C:
M[N+0Z;97$N\QW\A+PLXPE*7*K)VOJ_\`*]WY(#^J8.C$A75B!D@,"0,D9(!Z
M9!&?4$=J;YL6[;YB;@-VW>N<>N,YQQUK\M?^"5GQD3XR_LQ^*O%=C^T9XA_:
M9M].^(GC+2=&\>>,_">F^#/'WAW2K;1/#>IZ7X#\<:+I5O'IQU_0(]4&H0W]
MF]_!J&AZUHT\E_=W/GK%_,7<?\%"OV_="\'?$+XJZ-^U!\<6N?!7[56J>![V
M;7?`7@[5_P!GS0/`4OB'4+*PMO&'B:T\*_V[;7%KJO\`9-G<Z/8O!?7FC3SQ
M6E^FH/;)(1IRGS6M[N]WYVT`_N_$D;`E9$(4X)#*0#@'!(.`<$'\14;75LHR
MUQ`!D#)E0#+$A1G=U)!`]2#7\T7C/XD_M(W?_!6SPQ\%/#/[9/Q2N/V>_'GP
M47]J;3O#FB:5X*N=%_X1^&Q\5ZS!X+TF:709=2O?#6K6'A*VEBU!]16_FCU>
M9E9-L:U\ZZ/\;OV]OVF?V8/VK/\`@HYX;_:UU?X50?L_>*?B1??#;X%Z#H?A
MVY\#_P#"$_"^,7WB32/$LVJ64]Q<ZGKVG6;QV-Y?B_<74$=U:S:;%=R)%*5V
MDMVTE?;5VU`_K;U+6M'T:T>_U;5=.TRQB>*.2\O[VWM+6-YY4@@1YYY(XE::
M:6.&)68%Y9$10690;ZS1.NY98V7`.Y74C!S@Y!Q@X/Y'T-?Q??M=?M'_`+5_
MC?\`9J^"?[9/AS]I'XA^'O#WQI\6?"SP[K?P73PWX2A\#^"/&CW=_I.HZQX:
MDO;&^U>_M#K/ABY\2:=9:G<"&&2[MHF!>%91ZA^V5X^_;9_9E_:9_93_`&:]
M&_;9_:3\;V'Q)^%?B/QQXM\2>#/A_P##[5OB'K=]>^)O$<FF:=I'@LZ3/IE_
M)X?L-/@TV+9>V?F:7!/=S[Y8`*TE2E!-NVFZOK]G3;^\OD!_7B9H0`3+&`<`
M'>O.>!CGOVH:6)06:2-0,Y)=0!MX;))['@^AZU_*7J_QE_;%\1:K^QG^Q9X-
M_:-^.O@WQ-^TYXV^+&L^./C;\9_A]X=\(?&#3/"/AB#7]4B\,Z+X?T^.33+"
MS33?"VKMI=S!';WU_)=Z<4N+.&.Y:;OOV]_#?[9W[!7[.6K^(K+]L[XD_%?P
MEJWQJ^!^F>#)M6LM/L?B'X;MKWQ#>P^,?#L^JVD,\FNZ5XAL9+&WM5O+B>\$
MJ!?W*2J:R`_IU$\!(431%B"P`D0DA<;B`#D@9&3VS3O-B.<21\#)^=>!ZGG@
M5_-'\/OVX_C%\7O^"O7[(_PTTV;XP?"_X0^)O@'K$WB[X3>/](C\/)XI\1:)
M\//VA-;B\7MITUN;J?3KR^T7P_\`9+Z*X2.YO?#LL1119_OO2/\`@MIXL^./
MP;U?]F'Q]\(/C[\2OAK:_$7XGZ!\&/$?A3PO>6MOH+6?B77M)2?Q05GBE=];
MM;?4);>`']R46-<KG@`_H2$\!QB:(Y&1B1.0#@D<],\9]>*//AY/G18&,GS$
MXW<KGG^(<CU[5_)%^TW\?/VM_P!F3_@H%H7A+P3\9?B-\2_AG^RU^RS\!OC%
M\7O"VLWD<B_$OP-8:WI?P_\`BIXMUG3(XVM)=>O['Q4OBS4[BWY2ZTZZNK<&
M>VM8Z\3L?^"E7[3N@?LD?'?6?A]\7M8U/QM\8OVZH?@_\)OB-XMN(]3M/A9\
M/_$7A_\`MBUN]'&I6]S96$D#7&DB"*[MKNWL+!]6O?(EDLTC-*#E&4E:T=[_
M`*?UZ`?VE++$YVI)&S8SM5U8X]<`DX]ZDK\S_P!D/]DW]H7]G/XCMK7CK]L3
MQU\??AWK'P[73=;\'>/[*T,UC\1UO=-D_P"$LT#4@;N\@TN6TBO[`:5+?0PP
MK,C1V[L"4_2]6#*&4Y4C(([BI`6BBB@`HHHH`****`"BBB@`HHHH`****`"F
M/(B`Y=%."V&8#@=3C(.!Z]/4UD>(/$&C^%M(O=<U[4(-,TNPB\VZO;@MY42E
MEC0817=Y))72***-'EFE=(HD>1U4^(H_C7XQ1VD[0:EX$^'5T':6"=Y++QEX
MGL_-V1HZ021S>&M.O8]TK9E;5'B,8(@$A`I1;3>B2W;_`"MNV^@'0^(/B+K>
MJZI+X3^&.C0^(=5AF2WUKQ3?2_9_!GA/*W+2"ZO(V:X\0:Q&UMY(T#1(YIK:
M:6)M7NM-A)8^#?'NUU[PIX+LK;3]8'CSXU>./$,'ACX=KXHCMO\`A&/#^O:M
MYQN/$Q\+Q-'9'2_!^D17>KR(\=Q/<R0V]G-.AOPXJ_M>_M@_!C_@G]\,?"6M
M^+M,UK4&\3^)[#P)\.?A_P"$;)M2\1^+/$=_%/=?8K"&1BQCB@A=[S4)C,ZW
M%Q9P-YUS?01R?G1HW_!1WPGXG_;#UFR^./P;^*'P.\7_``6_9F^(7Q2\'?#3
MQW%H\^J^)(K33)_$FOZA8W^D7U]I$&IW7AK1#;:3;74JW/F">.58#%(A]/*O
MJZQGML5"'U/!X7$8V2G!MXC$T/91PN&G)7BH8C$UJ%.<'%)PE.\MV>-GCS+Z
MI"GE?,L5BL3AL(ZB2:PN&JU8K%XRSE!N6'H.4E9R:EROE?7]?/V?_@!X-^!>
M@ZA:Z(9M8\6^*[I?$'Q'\=ZMBY\4>/?%L\4<=]K^O:E(IFF+>4D&GV".+'2;
M"*&QT^WM[:)4KZ$`QP#QV'IBOPY\"?\`!<W]G/QM^SU\8?COIG@KQO9S?!76
M_AWIOB/X>:A-I,?BJ_T7XF:U:Z!X;\4:7(95LIM)_M26YM+YI&66REL@MQM:
M_L?.]3\0_P#!6?PC>_%@_!'X&?`;XO?M$_$K2?`_AOQQXWT'X=P:%!!X(M/$
MNDV6K6VF:OJ^MZA9Z8^J6<5]'#?6Z7",MS%-!;K<212;/-K5\1C*]3%XVJZ^
M+K2<JM9N5FW;2E"4I>QHQLHTJ$+4Z-.,*5-*$(I>G0HT\/2A1I0C"$%:,4E>
MW]^6]2;=W.H]9R;E9-L_72BOR*U7_@K/X2CT_P"#&C^%?@!\;?&GQL^-,'CF
MZT?X`6.B6.C?$'1-/^'?B75?"GB35O$7_"07.G6&F:<NJZ1<MIUS<21PZE8@
M7]M(;8J[8MO_`,%EO@Q_PI7]HGXH:O\`#7XD>'/&G[+/BSX;>%/C#\%->M],
ML/'.AW7Q0^(FF_#30KJ"Y-Q)I-Y96WB&^NUOYX966-=(O$3=YEK)/!L?L?17
MP[^T[^VSI/[-'[,_AG]J;4?AEXS\<>`-4TWPCKGB2T\+2:>^M>$-!\7Z=97U
MGK&H6UPRK=VMI+?6]C=_96W+<S0@?))N7PB\_P""I?A;Q3\3-:^&/[./P6^(
MG[46K>&_A)\.?B]K]U\+[[PU;6>GZ3\4#HUYX:T9+GQ!J%C:7.LCPWXCT3Q7
M=P+=1JNCWCF$RW-G>00@'ZLT5^+?P6_X*[^(/C_XG\<>$_A?^P[^T#XDU7X:
M:_=^%?B$EOKGP\C3P;XBMK*YNTTK6OM&N0?O[E[<VT;V)O(!*RL\HCW,(_A1
M_P`%H_A9\1_A3\;_`(Y:[\(/B/\`#CX2?`F.]TSQ/XSUZX\/:C#?^.[:[TNU
MA^'NDZ;I]Z+Z?Q#=#5%GMY'C2P9+>827$;`"@#]J*Y;Q?X8T/QEH6I^%_$FF
MVVKZ'KNGW>F:GIEX@DM+VRO(C!<6\R'@J\;L`<@J<,"&4$?E'X&_X*R-K.D:
M-X\^(W[)?Q_^$7P7\1^"?'_C[P_\8O$MAHNK>&]2T#X>?#WQ-\3-1N+K3]#N
M[C5="_M7PSX5U,Z,-9@LQJ&H&SL+8R3W2"MS]GW_`(*9^*?VB)OA5XF\,_LA
M_&>V^"_Q:\62^%?#_P`8%U;PAJ^BZ<8WU.(ZOXFT'2;ZXUW0].6ZTJXL9)9X
M'6"Z,?GO'#+#)(TY1:E"3IU(M2IU(MJ5.I%J5.I%JS4H32G%IIII--$5*<:L
M)4YQA.G47)5IU(*<*E*6E2G.+T<:D+QDG=6>SV/=O@KXJ\1?`?XG77[+7C[4
MI]3\.:E9R^)?V<O&6M7$D][J_A&UC\G6/AGJ][(YFN_$G@`VHN+&\N29M7\,
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MIHK_``C^!GQ`?]G;XFMX\_:?\2#2OV?O@KI^L>%M3\5_$'PZVBZ-J\?C?^V(
M+E-'T706;59-/<:BR3P7EBZ3!1<0FM/P7_P54OO&/CGXM_`N+]E+XN:9^U'\
M)[+PSXBNOV?M3UOP=;:[XD\$ZYX@\-Z+J?BW0/%;WZ^&+FR\,6WBO0]<U2W,
M_P!HDTK4K22T$TQN8K;PCWS]>J*_$_X=_P#!7SQ+\2/#OQO\8:7^Q=\6;+P?
M^SLWQ.M/BYXFG\=_#^XL_"FK_"[PYXBUW5])EMXKE+F[N+VY\/R:1:2VJ30+
M=7<4LC")'-=U^S__`,%3[OXV>`='^-FL_LR^/_AA^SWJ7@WQMXZO/C+X@\:^
M!-5T72-$\$66LRWBSZ#IEZOB">YOM1T:;2K-8K3:+B:WFE*VTHDJE"3BY):1
MW=TOSW?DM0/UVHK\=/A-_P`%7/$WQJTCP5\0_`O[%/Q_O_@5X[^)/A7X?:1\
M84N/#%Q8PVWBOQ;IWA&'QC>^$K:ZD\3)X7TB]U*.ZUR^AM95T^RAN9Y#Y-O/
M-';T'_@KIX#US]B+XP_ML)\*/%=MX>^#_P`0M8^'FH>`9M=T`^(M:O='A\+R
MR:C9:@A_LZ"TF/BB%5293(AM)@20P-2!^P%%?*]A^T1K_B/]E_0_VD?`WPMU
MOQI/XC\"^'O'VE?#*QUC1].\0S:?K2V5Q>6)UG4'31Q<Z-IMS<ZC/*2(KI+)
MX8`))8Z_,S0_^"W>B:]^REK?[85O^R]\3+?X667Q`T#X;:$LWBWP?)J?BCQ%
MK*-+=)8Q0ES:QZ3$;5IEN8]]T]Y'':[F1A0!^[=%?DGX(_X*Z?!3XB>._P!D
M?PGX6\-:]=Z-^U?\+?BG\3+/Q?<7^E06/PW/P<TG5[SQUX7\6Z=O>]EUC2-2
M\/ZIHL[V1^SB[6.5&EMG25N/^'G_``5OU/XQ6-UXZ^#_`.R!\=OB-\#+/X@V
M/P_F^,>BMX<6P>:ZURUT6Z\1VGA-KF3Q)?>'M*DNX[C4[FR@N)+6RW73)MCD
MV`'[.4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%``>AQZ5^/?Q@_X)7>(]:^.'Q6^.?[-?[5WQ!_9?USX^65M8?&O0]"\*Z?X
MST7Q7Y=F-.N=3T,W/B/PU>^$-<NK2.%3J]G/?S6<D;3:;#9M<7<=Q^PE%`'Y
M%?#W_@D3\(?A9H'[(/A_P)XV\5Z1;?LI?%+6?B_/>:C;:9K&L_%WQOKS:4^L
MZKXPU",:9;Z9]M;1[2VBBT?3O(M='@LM+M+6QMK*WBAL^%_^"1GP.\,_M0?'
MS]H*/5=0O?"O[1/PW^(OPX\=_!:;3;2V\)RV/Q5CT*+QO<6FKV=Y'JEI%J@T
M5Y(;*U@@^R3ZE=SPW22>3Y7ZV44TVMFUZ`?B[\&_^"4WQ5^$EYX#\&/^WA\9
MO%G[-?PTU_\`M?PI\"+_`,.V-@]QI4,ERUIX,\8>.8?%-V/$O@V..Y6%_#]K
MX0T'25$1-IIUJK1I%P.H?\$/]%;2/&_P:\-_M6_&;P?^R#\0OB%#\2?%'[-^
MEV&AW44NL_VI::W<Z7H_CVZF%QI?AV;5+.WN/L%QX7U.:1XH[G4)]2U>TM=:
MK]X**0'XW_$S_@D?;:S\>O#/Q\^!/[2?Q!_9HUWP9\&?"7P+\+Z3X$\/Z?JU
MOI/@;PC8_P!G6EA#JNHZU:ZC(M]91VL%\\PDN9&MA.+@W$LDS>O_`+2'_!.S
M_AJ#X#_LZ?![XE?'#QCJ?B#X"^,_!OCK4?BA<Z'I%WXB^)OB#PEX:U3PU<7W
MB6S-Y!;6-QXCBU::^U"XLIYFAN88PL4J!<?IC10!\'_\%"_V&]"_X*"?LZ/^
MSWXH\=:M\.K";Q/I?B>3Q)X?TJUU>^BFT[1]>T9[2*SO[VUM]EQ;>(+IO-DD
MD,<D4;A&Y5O-OVY_^">/B#]M;5OA;>R?M(^.OA'H_P`*KQ==T;POX:\-Z1K>
MEW'C2SNH9](\;"2\U33)H-9TI(G@LDD%U:HL[N\)8LI_3FBA-K5.S[H#\;OB
M?_P2>US5_C1H_P"TS\"OVM/B7\!/VC+GP-I_@7XE_$*T\-Z;XQT3XIVUE::)
M8W&O>)?!HUWPHO\`;FJV^A:<VHQ2:Y?Z%)>:7HVJ1:5%J6FS7&J0C_@F'^T-
MX=>SU7X=_P#!1[X\:)XOU'1KK2?B%K?C7PEX;^)WA_QM+>7\]W-J47@WQ!K-
MK8Z!?0P3M8Z9<_;-:O-*M%C2POK8PP>7^R]%.[6S>N^NX'PO^Q%^Q%\.?V!_
M@9KGPJ\&>)-?\3R^)_$FN?$/X@^//$WV2/4O$7C#5=!T30;K5!I]@L-II&EZ
M=X?\+Z)IFEZ7;R7+P6NG>=>ZAJ&IW-[J5Y^3OPU_X(DVWQ&^&OBWPKXG_:J^
M-&C?`7XH?%_Q)\5-:^$_AS2?#V@'Q;%<^);O4]&OM6UGS;]8)9,I/`EQH^JM
M:Q16-W:36VIQ07MM^^_QHNIK7X=:_P"3+-`UU';:>\\"AI88-0O+>SN)%!9!
MA(9I"QW#"Y->@Z;IUKI5A;6-HBQ6EE:06MM$O"106\2Q1(N>@1%50?09-7&3
MC34T]9R:LTG;D49-Z]^=+2VS[@?CY<_\$F+^#]K#P[^U7X8_:F^(7A'4/!NE
M:'X*\'>"-/\`"FCW%AX6^$6A6K:?:_"?3=8N-;?=X8&GW%_8@W&DS7!M[^7S
MGDE'FM\O?'3_`()&>$/#$GQ>\)?##]I?XV>`/V??C7XHMO&OQ8_9C\(?8+O2
M=;U;6KN.RTKP]X=OQ=+)90>+==M=-TJWL=7T'7(H='L;]]7GU*RTJTM)/V)^
M-7QX\1>$]=_X5Y\*O`5[\3/B1/H\VKW>G1:K:Z/I7AS31#=&TO-6O;H,SRW\
MT!M[*SM8I9))7C,QCB96/SWX5\6V?QR7P?;^$+K6M*?4/!>M>)];\6WT-O\`
MVQH/BK4[2SA\1ZE,5G:%-:\):7J$OAK2HHO-BTS5?%SW<<971IU'10I2474T
MLM;M)NUM'=[:VM;?7L.VE_T].OS_``\SE?C;_P`$O/AY\=OV5O@G^S-;>)-0
M^%'A[X4>)O"?C.VE\.Z5;ZW,]]X;MI$32I1JVI&22,M.R27\MW=7$TZ/=R^8
M\KAH?VLO^"8MU^TK\>OA'^T5X7_:,\>?`SXA_!OX?-X`\+:EX-T33]1N4AEO
MM7N[K6TN[C5-.GL=0NK?7+[3I88))8&M1&^4E+&OK?X>^);;X8_`[5OB#XJO
M]3?P_`^M>)-'&H7]YK&IR^')GCM_#-K#/*\]U>7FNV\5I<6EO&'EEN-46**,
MNRJ?H'P?>ZOJ/AO1]0URUBL=5O=&TR[U&QA,OEV>H7%HLUY`AF9Y/+CE?8A<
M[\+\PS7/4<N:2<F]==TF]+Z7?7\A'XI?M#?\$S]!/P6\'>-?CO\`MH?'BY^+
M_P"S]XLU_P`?^`OVFH5:\\>Z(FNW=HMOX,M?"]K=:AJFN6*70MH]!L/#^MZ5
MKIU&9K2VNY+#4M1TO4-OQ%_P2$USXL>!/$FA_&K]M7X]_%WQ'XF\<_#7Q6?$
MOB:UT=M+T2R^%NJW6JZ3HGASPCJ%UJCZ,FIW=U,=9O1XAN#<^7:,EC'+;M+-
M]]?$*X3XD_%WX8>"VAAO-#L?$=[XIU&.243V]W9^`;,77GO:,@\J2+QKJGAP
M6\Q)W'199(\YR/KZ-!&@4`#`Z*,*#WP.PHG:,*<=&Y1<[V2LK\J5[7W3OKTV
MUNP_._7?^"?/AO7?VX?@I^V\_P`0M>L_$WP3^$O_``JC3/`T6E6$VB:Y9G0O
MB9H/]L7NK/=)>P7/V?XH:K+)916?V=IM/L2LJJUPLG%_MU_\$UYOVZ/$WP[U
MCQ%^T/X\^&^A_#&YM]:\-^$?#>A:5JNDQ>,;+4;;4+#QD'O;^T>/6+%K6&&W
MW0S0A(U8H&7G]1Z*S`_+OP?_`,$SO#VE_'B_^/?C[XL^+?BOXC\1_LA:#^R-
MXYM?%.CZ+;MXUT73%TV35?'FL:G9RR7"^(]?OM,%[=64$*Z=;SW<LD`RH4>$
M>"?^"&W[.WAO]F'XJ?LM>(?&/CWQAX0^(OQ)M?BCHGB"6?1=(\4_#GQ%I>@_
M\(UI,OAZ\&EZIIVIO;Z*T^GWPUS2KNRUFVO;U+^R4S*R?MW13NTFDVD]U?1^
MJ`_%FT_X)(>,-5\$^-O"OQ*_;K_:7^(>H^)?AQ;_``L\.:UJ&JVUI9>!/#=O
MJVEZP^IZ1I-U?:W?W7B^[;2;;3KKQ`_B&UW6#W$;V=Q)(LJ_KA\-O!B?#KX?
M^#/`4>KZAKZ>#_#6C^'$UO52K:GJJZ390V8O[]D+*;NZ$7FSE209&8@FNVHI
M`%%%%`!1110`4444`%%075Q':02W$K(D4*EY'D=8T1%Y9V=OE55&6)/85QO@
MGXD>#?B(->;P?K5MK2>&M:N/#VM-;K,HLM7M4CDFM6\Z*(R#RIHI8YX?,MYH
MI%>*5P:`.YHHHH`*Y;Q=XQ\.^"-&N]>\2ZC'ING687=(V6EFFD.V"TM8$#3W
M5U<R%8K>WMXY)99&5$4L0*N>)?$FD>$=$O\`Q#KMW'8Z5IL/G75Q(6.`2$CC
MBC17EGN)Y62&WMH$DGN)I$BACDD=4/D7A+PI?>-_$+_$WQWISVUPKW5OX$\'
MZCLN+?PMHJ/;Q1:S>VV7MI?%6LO;#4I+K;YNC6EW%H\)6:"[N)P#.\.^%]>^
M*FK6?CSXBVMWIOAVSDL[_P`#?#6\VQC39;:9KBW\2^+(8Y7%UXCDD6&XT^SD
MD-OH4<=NPA754GDKZ)"*,8&,8QC.!CIQ[4*H55&!D*`2`!G`]!T'MVIU`'X<
M?\%FOV?OC1XVN?V/OVGO@EX!OOC!K?['OQSL/B'XE^$NC1RW>O\`BKPG+KW@
M'Q5>7>@Z9%;SOJFIV6H?#K3M)-G#'/=16/B*ZU9(I+?2;J&3\L/BFOQ#_;-_
M;EU;X^^$?@)\=?AAX(/[*GQM\#>'E^*OA%O#VH_$#XF)\)O%EC8>"?"MKI5_
MJUCJEY=W/B/[';6YNS>3W%G*OV)(VM]W]BA1&!#*K`XR"H(..F<CG';/3M7D
MWQE^%>B_%CP1J'AB^FGT>_,MMJ.@^)=*9+76O#6O:>YGTO6]+NPN^*XL[@`M
M'GR[F!IK:=7AFD4^AEV)I4*\H8FI.G@\51J83%U(:RI4JLJ=2G7C%IQD\/BJ
M&&K337OT(5J2<?:\RX<Q5=X7VN&HPQ.*P;J8C#8>I)PC6FXQ56ESQUC.K3IJ
M%.2^&;3U1_%[\4?^":?[3MG^PU^RE\7OA]\(/B;9?%ZX\,>*?@9^TY\%X/".
MI?\`"<:UX*L?CKXM\:_"GQ7?>%OL3ZJY\/26NBQWEQ)$ETVAWOA&^DDM['0;
MO'W?\"K?XV?\$QOVM/CG\3OB1^S3\9OBK\(?VHO`_P`*M6\/^,?A3X5MO$FO
M>#/%6E>';?[5X)\3VFKZCI=G82KJ%]<Z8+*YU6RU"+4=/6Z@T^]L;JZFM/W@
M^$?QMUC0_$<'P0^/3V.A_%6`-;^%M>C)MO"_Q<TFUCB>'6?"]Q*%MX]?2)U&
MN^%_->]LKM9I[,7-E*KQ_8\05U.47L",`]N1R.GM6>/P.*R_$>PQ*C/VE/V]
M#%T%?!X[#2ERT\7@ZJC&%2C4:TY4N27-3E&,H2BL<JS?"YOA_K&&3I-5'1KX
M.M[F,P&(C'GG@\91;<Z5:E'1\\FYJTTVI)O^9_QSXO\`C_X4_:I_9[_X*D>)
M?V0?CA'X-\4_"#QW\'?B5\#=!TW3=9^,OPG72/&?C>S\`^*]6\/:DOARRAA\
M8:#JL/B#7(_M4,&E/+;V":GJ#317]S\@_$C]E[]J/]H3X:?\%0OVM9_V</B;
MX+O/VG=:_9JT'X+?!5M"O[_XH:[X8\"?M$?#_P`5^)/$>I^#-%2\U"-[3PUX
M?T[5()DBN8);R/Q+=Q/?Z)]CNKS^R$0P@@B*($`@$1J"`>2`<9`)`)^E*(HE
M^['&.2>$4<DY)X'4GD^_-<9ZA^67[)WQCO/VH_A=/^S-\8/V+?VG_@]X6\-?
M`KPWX.\4ZQ^T+\.]-\)^!_B"IT2U\'ZYX>\+30^*-8U&^N#%;2Z@OVVQL+B*
MPEANE%I=IL3Y6_X($?LP>*?@)^SM\=]1^+OPA\8?"_XG^*?CS-I[+X^\/:IX
M>\4:O\-O!?PX\!0>"52WU*&"XN=`T[7]6\=P:9+$)+.29KN-&8P83]]PB#HB
MCOPHZ^O2@1HH(5$4'J`H`/U`'/XT`?SY_P#!,CX>?&']G7QE_P`%/OB;\0_@
MC\5H-/U3XN>(_B%\/M!C\(WMKXB^*NF:-H>JZE%8?#:#6&TRU\1:GKTEM%I>
MB>5?PV=WJMW:12WD"2-,OY3?`C]CC]I[XL_L(?ME?LAZG^S5\?/A?X_\;_$V
MT_:;\#Z_\2O`=SX/\#^+!I&H:+:1_#2'6_$-SIEX?'FH!;[4)-/&FG24@AD%
MOJT9*QR?VR>7'_SS3L?N+U'0].W;TH,<9ZQH><\JIY]>1U]Z`/Y\/`?[8O[2
MWC_X):9^S_K'_!+KXZZKJ&A?`CXB^'OBQI_Q+T@>!OA9XE?PA\'/%%MH/@?P
M-JYM+_4];G^*_B&QTCPA%_;&CZ+_`&7I^OW%W;6>N$!K7X'_`&;/V;/''AC]
MLO\`9K\3?L7?LZ_M_P#[,?@Z#Q8UW^T-X;_:&2VT[X2Z+X-@BD;^Q=%ULRC7
M?$J7<DL\(L?$]_JUS=*^E7T5M;74$XB_L',41QF.,XSC**<;OO8X[X&?7'-`
MC0``(@`Q@!0`,'(P,<8/(QT-`'\[O_!<'X$_$/XN?&+]@OQ)X>^`?Q;^/WPZ
M^&_BWQ]JWQ;\,_"'P_J^J:^_A>ZU?X874VEQZKIE]I":'J&NZ=H^L6^CW=QK
M>D8N[<O'?0M'O'YS^'O#/Q]\'_LW_P#!0W]F+P)^RU^TIIOA#XY>(?#'_"AO
MV=9K74?'GCSX0:-XWAN];U/QGXL:]U2^UVR\/7MWX92SU39>>(9[;6K^VN(S
M=VY5V_L[9$;[R*W;YE!X].17PGKD\FC?\%`_"EK#Y8MO&G[.7B2:X5$`D^V>
M$?&>DI%)(XP2!;:]Y:`\+@`5[N3X:EF#QN'JQE*IALHS#'X6*E*TZV!I_6I1
MFKI<KH0K]'9VTZGD9MBY8..!G'EBL1F.$P-2;2;A#&5/8IK2]W5E35DU?Y'X
M0^'_`(/?M3>%_A1_P34_:/TW]E+XR:AXQ_8!TV]^!_Q/^!^IZ5_9GQ!\<>';
MC0?!=]J/Q,^&FA^;>3ZQIDFL12Z=IMM?6^FWVZWU$SPV]K;17(^Q/V,_@[^T
M'^T/_P`%+_B]_P`%#OBI\$/&W[.'PVMO@J_P=^&7@+XHVD>C?$7Q!J%Y=>#H
MI=8\0:!"T\EOI]C9>$]:N+F&:\>R-WKVAVVES:S#I=Y>C^@"&.,QQLRH[;?O
M%5)Y.3R03SWYYQ4P55SM55SUP`,X&!G`YP./IQ7@1FJD8U$TU.*FFE9-22::
M71:Z(]9)I)/1I)--W::T>O7U/Y[_`-F;]FGXY^$?V8?^"N?A;Q'\+_%&E^)O
MC?X[_:?U7X3:/?64\-[XWL_&&B>.[?PO<:*B-YMRNK3:E8):,G$K7,2MD,RC
M\[_V1_\`@GSXAU3X,:C^S[XT_8;^.OPA^.GQ"^`?QG\`:O\`M3^(?B+\0)OA
MK;:MKND>(Y]/2X^&MYJA\':/'K=O_9?A^U6+38IK;4Y_M401?.>;^R#8@Z(H
MSC/RCG'3MV[4;$_N+_WR/\/<U=VDTFTGNKZ/U0S^<W]AW]HK]L_]GSX0?`K]
MC+Q9_P`$\OCC-XU\">,/"/PUU;XN6EE:6'P'TSX:7_CBU@\4_$"Y\;1RSQW>
MN>'O#.IZMK5IHME"=,UZ>RLX8_$-A=S/%%^>&@_\$F?%FK?\$\?VBO&7B+]F
M_P")O_#8S?%?Q1;_``OTI_$7CK3]1N_!-S;>"#97=M\.;#7H/!>H13RMXC"7
MNH:#=W<J0*TEP&MHDC_L_:&%U*-%&RD@E6C4J2#D$@@C(/(.,@\U#,D:@8B3
MH0!M4#`[=.G/3IS4MJ*<I.T8IMO?1*[TZOLNXF[>K:2]6TEWLKM7?3<_/KP-
M>_$3X)_\$[?`-HGPB\=>.?B'X5^"7@[PG>?";PG!;)XVN=4O[#3/#FHV]E;7
M\]K"D^@?;Y]5OXW<R/8Z;=QV\4D[1*?Y[?@S^S#^UIH7_!,NP_9"U[]EOXPZ
M9X[\$_M/_#7XLPZA=Z,L6GZ[X?EO]/BU-])LY&&I2R:`FD/=:J;B`1Q17EN8
M[B;;(%_I;^(?[<G[+_PK\87WP^\7_$RPC\9Z2`^J^'-%T7Q#XHU#2<@$)J"^
M'-)U2*SN%$D6;6:5+H"6,"'YESRUO_P47_8UN;E+6[^,&GZ-=N5V0^(_"_CC
MP\S!D++Y,FK>&K2"5R.3&DID"Y9@%Q7T6&X0XOQE&CB,+PGQ)7P^(I1KT*]+
M)L=6IUJ,TG"M3]A1K2G2FG>-11<&M7):7^=K<7\+8:K4H8CB+):->C.5*M2G
MF6$ING4A+EG3E*M5I14XRT<6U).ZM=,_"/1/^"7?QF^$O_!37PQ9>`?!^OR?
MLAZSX?\`V@_%?@OQ5:6J_P!A?".__:*^`WB/P?XN\$7KVZB6PM]'\>Z#ICZ)
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M%'@OX7W[ZA>7O_"S/`6D:[KMCHOCQ(KRTM39QZWI-EI&I"*W#VN_4)$@8Q1*
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M>:,O8.+3/MZBBBO@S]`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`,7Q%H-AXGT34M!U19&L-5
MM)K.Z\F1H9EBG0HSPS+\T4J9#QR+RKJIYQBOG3XAW_Q#^&?A;3+/P]XQT37=
M7O+JU\,>#M,\1^&I]0UGQ%K-VLG]G6$]U:>(])MB\-I;W,^H:DUM&D=E;W%W
M,@*[9?J*1TC1F=@J@<LV,#ZYX_/BOFSP=%+\3_B=J_Q)EV7?@[P9]H\)?#X;
MQ/;W>JK(\?BSQ3!$UO&(9S<?\2*TF$LI>RMIY$9!*5.E-I<S;25KM.VODF]O
M^#=[`5-)T6R_9W^%NN>(==UF]\=?$"_@EU/Q5XSUSRH=7\;>++N2:>.U@6)1
M!I6BVUU<RVOAWP[I\<6FZ)I8AM;>(OYTTOS'^R/\-;FT^#=A+/\`:?\`A*/C
M/XB\6S:I?INF?PU\/D\4>(?$%Q:QM*SQM/.^LW*&Y=&1_$'B-+P0O;V5O!#Z
MC\;O$A\?>--;T.S=IO"/P0TB7Q5XRNH)%$%YXQN;"9_#7A7S`Q5;MM]O>3V\
MB_+'/"20Y0-Z!\(;>W\!_#B'QGX@O!8:/HWA'3M)TZ2\411Q:?8;KB^OI!&7
M,MUKFKW#2Q".V62:UAL8%C>906Z'#DPM-K^)4JTY-=N9)TXVW;<7SVMJI1T:
M:N=/O_3_`(`>-(&^(_Q6\)_".R@BC\"^`++2_'WC6&WC18;C4;*Z5?`?A<J$
MVPV<=U;MKMU##LD*Z=8Q$I$7CE^@_$][=VME!9Z:\::IJ3M9:>7'R),8B[S%
M1@$6\"RS[?2/.,+7DG[/OA[4X=!UGXA>)+=X?%/Q5UJX\8ZA%*PE>PTB>&&V
M\+Z1#(KR[+:TT6&"YBMF;?#-?W*R*LN]5WO%GB2R\.V/C#XAZ]<FVT'PCI5U
M'I*RH8V^V6B7J:E>*K3,+B34KQX-+L`L,+B.U<`L+K(P_P"7EEJT[=[R2V?J
M]-KVZ7`\QAU_PMX5U3XL_$W5,0Z'\,-"C\(0:B8HI+N[.G+-K6L+:M&5>6_U
M;7-4CT]8XWAEN;Q;6#(*Q@>G?!6#7_#OP;\(7'CNZOW\3RZ$GB'Q7)K%X]Y=
M6NLZX'UW5[26X<A5BTZ[OI[1(HECMK:*W$-M%%;QQHORK)X*UW6-$^`?P8U&
MVD:]\<>+9/C5\:6=`CQZ+X?U!/%=OINH(BM%YNL^,I_#&F&W\W$UOH^J,A9+
M>1:]U_:?\:7WA_P!#X1\/S%/&'Q-UG3O`GAF&'8;E9=8D"ZI>QQR12HZ6&D+
M>3R*4QLR5(=1BY>]*$%9N4DI.]^5)6;;:TZMWLGIK9@='\$?B#XH^)47BGQ%
MJ^DZ;I'A_P#MRYL?"4=E-)=W-YIUGY<=Q?7MX3]FF>:YW1JMFJPQ-#+$9+DH
MMP_J'BWQ3I_A+1KK6-08F*$"*&WB!>ZO+R;*6ME:1=9;FZF*QPH!@DEF(521
M#X*\,Z;X*\*:#X>T^-;>TT?2[6Q1%RPW11KYTA(4,[2RAY9'89)+,<<U\[_&
MKQ?*/#'C3Q9HKQW-[X<1/!WP]@NFD;3K_P")7B2YCT'3[I8XDE:233+_`%&W
MA61XG51'=R(56.5ES4%*4DG[JO9VW5[+:^_E?YVU#O\`]G#XE^(_BY\*M-\?
M>*]"LO#6HZQK_C>*QTRQF:YMF\+:5XV\0Z3X,U9+AG<S?V_X3LM'UTN-B9U'
M$<4:!4'I*>-_#TGC*7P'%?++XDM]&@U^ZL(XW?[-IEU<3VUM-<3`>7"\\UO+
MY43D/(B%U&W!.9X(\.Z?\.?AYH'AN+R[2P\*>&=.TX%E"Q0V^D:?';LS%%&]
M8U@+,VT,4VD_,U?,W[(UQ??$VY^)O[1VJ,I3XH>,;[2?!$2QRHME\-O`D]SX
M=\/IND"[GU6\@U'69RBA?-N@N6*<)1]R4V[):7Z<SV5_/7[@/MDL%&6(`]Z`
M0>A!^AS7RI^V#\5;_P"&_P`)+O3_``I=;?B-\0]7TCX>>`K6%G-Y_;GBG4+?
M39-1C2+]^(M&L)[K4II8]IB$",77@U]'^&].N-(T+1=+NKJ>_N=/TFPLKF^N
M&D>>\N+:VAAGNI7E)D:2XE1Y6+DL2WS$G)I.+44WI=NRZV5M?1WT[ZV`VV8*
MI8G``)_(9/IFN$\$>/\`3O'J^([C1K.]73O#WB_7?!W]I7$2I::M?^&YHK#6
M;G2G5V,]E9ZR-0T=YV";KW2;]%4I&COY[^T-\3K_`.'_`(&NK3PC]FO/B7XP
M*^%?AQI5QO*7'B?6'6QMM0NDC5I!IVAK,VKW[D!&@M/)W!I0:['X-?#Z+X5_
M##P9X`2[GU&;PWHMM::AJUV0;O6M9F!O-<UR\()W7NLZQ<7VI7CY)>YNI7))
M8FAQM!2>G,WRKNEHWZ)V7K<#TTL%ZD#ZUY5I7Q1M=:^*FN_#32]-N+W_`(1C
MPS:Z]X@UZ)XSI^FWVIZE-9Z/H+D,6?4+ZUL]0U%E4?Z/!:J)0IGBS>^*/C:V
M\$^&+G4-T3:K=&2RT.VF=8HYM3-M/=++/(^$2RTZVM;G4K]^2+2TE2,-/)#&
M_/?`WP!/X&\*23:J[W7BCQ9>-XF\4ZA/%Y=S<ZG>P0+#!,2S-C3K&.WL50G:
MDD,S*`9&)%%^S51Z-S<>5[V23YK;V\[6?39@>TTR1MB,W'RC//`Z^O\`D>N!
M3B0H))``&23P`!U)-<I?ZA_:NH_V#83DK"T4FMSP@YM(&!DALS(<#SK\H5(3
M<4MTE#;2ZFI`YW78T\4B]%T63PE9H);AXGEC?Q#);1S23VFY0NS28C'$K303
M;K^5Y+;*P1RB;)^"W@&P\#>']4N((PNI>-O$.K^.M=F4N4GU+Q%.LZ^6)&9H
MX;>RCM;>*W4B*!8RD2(O!T_%UQ.T^@^`-!"02:R\K7KQ*I.E>&-)2UEU*Y5`
MN$>>2YL]*MF92BW&H0.Y`S7IL*+%%'&B"-(T5$0<!%4`*H'8```#MTJE)J+C
MT;3^ZW^0$E8WB'7M,\,:+J>OZQ<I::;I-C<7]Y/)G"06T9=\``LSL<)'&H+R
M2,J(K,P!MZCJ-CI-E=ZAJ-W!8V5E;37=U=W4BPV]M;6\;2S3SRN0D<42*SR.
MY"JH))`%?.VFQ:U\</$-EX@U*UDLO@]H-[8:CX3TRX@FM;_QYK5E,\T/BS5X
MIEAF@\-6,A@F\-:3);_\35HVUC4#&ALK6*;/>VG<#0\/>&=1^*6LZ)\0_'FG
MWFF:5ITAU/P3X%NWEB6Q<J18^(_%%FC(D_B%H7=[*QG,]OI$$H;']H-)Y/T*
MJ[0%SG&>ON2>IR3Z9))/4DG)H50BA5&`.@]/:G4`%%%%`!1110!YI\4_A9X'
M^+WAM_"?C_P[9>(=%FE^T(EPA2]TV^B4_9-6T;4H/+U#1M8L9#YUCJFF7-K?
M6LRJT4PY4_/46D_'CX%VT=KH44WQY\`V*`B'4IH-.^+6G6$)98;;^T75-)\9
MO;((HQ<7HTS6)HQ(\\]]<`M)]H4$9!'J,5Z.%S*M0HO!XBE0S'+9U)5)Y=CX
M2K8:,ZE.-.I5PS]I&K@L1.,5&=?!5*#K02IXF->G>+\7&Y'A<5BEF%*I6P.9
M1IJE',,$X4<1*E%WCA\4U#DQV%4FYQH8R-94JC=3#3H5.6<?!?`/[0WPT\9W
M*:,NMCP[XG9U6;PGXO@E\,^)()&2/=$=,U..V>=UD8QAK5ITD*L4=A@U[JL\
M+DJLJ,5Z@,#C(SSZ<5YG\0/A+X$^),#6GC#PKI6N1;$-O=3VZ)J5E.F\)-9:
MC$J7EI)$K9C>"=&5CD<XKPM?V</&G@K,_P`'OC#XQ\,1P0O#:>&?%WD^/_"J
M(8W(`MM79-85VN"KO)%K44AC`0.,*E=*H9#B8J.'Q>)R:KK;#X^B\=@N7FT4
M,?@:<*M%).*A3J9?.22E>5TD^+ZWQ)@&XULOP^=8:/NK$8"K]1Q[Y%[\I9=C
M*E2E6N[<LJ6.ASWNHI79]A>9&02'4@<$@Y`_$4I=1U8<]*^1+7Q7^U=X8=8/
M$WP<\'?$&S,BI_:GPW\;6^AWT<"2+')<W'A[QM]A@:6:,M<+:VGB27RV'D;R
M2LE=1:?M!643*GBSX=?&'P1,K1J4U;X9Z[XCMU+;BY;4OAT/&VEVT<(`+W&H
M7MC;,LBK%+(ZN@E\/YJX7HPP6/ES)<N49EA,SDXR<>24:%.=''/G3;:>#BX-
M-2VUUI\3Y8V_K<<=E7_8WR[%X"E=64KXQTZN"5F[/FKQ6J493NVOI6BOGB/]
MJ[]GA)(X-1^+/A;0YI%E(_X2:6\\*QY@_P!>CR>([33(HI8<@2PRR+*G5D`K
MKK/X\_!'46MDT_XO?#6_>\V&T2R\;>'+IKD.Q5#`L&HR-*&8%04##<",YK*I
MDN<T8N5;*<SI16\JF`Q4(KKJY4DEIJ=D,^R.HU&GG.4U)-I)0S'!R;;V24:S
M;;Z6/6:*Q(_$OA^95>'6=-F1E#!XKR&5-A&0Y9'90A'(8D*<C!Y&;<6JZ=.A
M>&]MYD7J\3B11SCDID=:\V:=/XTX;KWTXZK=:VVZ]CT(8C#U'%4Z]&HYJ\%"
MK";DKVO%1D^97TNKJ^AH5\*>.2'_`&_?@LBF/,'[/?Q>DD&X>:$G\6^`$CR,
MYV%XWVY`&Y6QG!%?57@7XK?#SXF?\))_P@?BG3_$P\(^()_"WB%M.6Z*:=KE
MM;6]W+9F2>WA2Z3[/=0R17MDUS83YD2"ZD>"=8_E2Q2+Q7^WUXNU&&))X_A=
M\`_#/AZ2Y`YM-2\;^)=1UVXLV+!?GET_3=-N&4%L+Y9X)Q7T61TY86MG<L6G
MAG0X9SI5*=9.E5OC\&L!AXQIU.64I5*N.H.$4KRC+G2<=3P>(H?6*>3T*;4I
MRXBR:I%)I_[IC(XNK=*^D:5"HY/3EM=V2/N>'_5)]/ZFI:KP2(45<X95PPP>
M"/?&/RJQ7S47HDW&\4E))II-:-7\FGVV/HXI1C%*]E&-FU9N-E9V\UJ%%5WN
MH(\%Y`H/0E6`_/;^8[=Z:+ZT(RLZ,,X^7+'/IA03GU':I=6DN:]2FN3XKSBN
M71/WKO31IZVT:?4?6W7:W6_:VY:JO<`%,%=W#<?ACWQUZX/':G+/"YPL@)(W
M8&<XXYQC/<4DES#$I9Y`@VEMS!L`+U8G'"KU)/`')XIOV=1<C<9J5O=NGS)-
M=$]5=I:=6NZ!^[;FTV>NEU?SZ.UK^I^7/[%GAVY^$7[1/[:/PG\46<?]I>(/
MB/I/QS\,ZW=VX\W7_!7CS3QI*-!<RAI;@:/JWAVZL[Q!(R6MW<&,*@=2WUW\
M9_B;\/\`P-:1Z;K.EV?BKQ#XA9-.\.^`K/3K35-;\2WDN8X[>&S>&3R+-G;;
M=7]YY=A;0AVF?:&4_$G[8'Q@FT[QIH?Q4_9S;_A+_&?P:TSQ=X8^,^O:7I5W
MK/@SPM\-_%4=LM['XFU.SDB@U/6_!_B^QT+Q;;^&-%FO]4LM.TOQ*VJ0:;9S
M7$[?9WP&^#OAKP_I=OX_OO$$_P`3/'GBFPL[[4/B7JAAN)=4M[JVBN81H$2%
M[;1]"99MUG9:<4B$+(9&ED!>OT_B6A+%?V;QIGLYTJ>:X3!8"KE&$J8C#YI7
MSO*,!AL/7JXJJE&648/%X".5YI&LJJQ6-IYM"&748X>AB*T/RW)L3R5LRX1X
M<5"K/`8FOCIYQB(*OEU#+LTQ=:M5IX>G&I&GF6,IXZIC</5I1]MA<-.E#ZTE
M7M3?A'A[]C+PU\1M;T;QY\=/`W@/3FL':^T/X1>"?#&CZ=X/T6:3RWAD\5ZK
M::?;ZGXVU>V56CECGGMO#419TBTBZ8?:W^V?"_P[\$>$HI(O#/A#PUX>B<+O
MAT70=,TJ)L*%_P!58VMNF[:`H8AF"@*IV@5W,0VQJ!G@8YZ]3UJ2OC,SX@S?
M-H4J6+QM=83#TYTL+EU&M6CEN%I5)N<Z>'PM2I4LJDM:M2K.I7Q$U[7$5:E5
MN1]GEG#.2Y2_:X/!TIXJ<Y5:V8XFG"KCZ]67_+QUW"#I)1TC1I0A2IQ]VG3A
M%**:J(@PB*@/4*H4'\``*=12$@#)X`KQMW?=_B>_I\E^G^0M%,$B,=H.3C/0
MX_/&/UI]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!10
M>A[5^`WQ4_;O_:Y\`>(_VV/B+H'CWX!:C\.?V4_V@/"_PRTCX"^,/AYKMO\`
M$'XF>'=8T3X>7MW:^%/BAH_Q4TM=.\9W5[XMO8O#UG?_``O\56=_<I;6,S1J
M6FC`/WYHKX#A_P""BGP23X@V7@*[T7XF+87'Q'LO@O=_%./P1JDOP@T_XSWB
M10GX97/CDI%:G7[369H/"^H74=H=#LO%TW_",3:HNL136D?+:1_P5"^!GB3X
M<?$SXK>%_AY^T+XE\$?"G3KNZ\2:YI'P<\3S:;J&J:?XR_X0G4/"WA'4Y(HM
M+\7>)[#4RMY?:;H5[=K:Z5YEU-<+)#-;H`?I+144$HGAAG5659HHY55QM=1(
M@<*Z_P`+`'##L<BI:`"BBB@`HHHH`****`/*/C)JM]9^";VPT601:]XDO;#P
MGHLA?9Y.H>([J/24N,JZOBTCNI+N0H=\<<+2_+MR*FM:WX2_9Y^#VN:_J\DM
MMX0^%G@'5-?U&=3)+-)IOA?2)]1OY`7>266\N4MY&4$N\L\HY9FK@I[Z3QW^
MTS/X;5EET'X,>!]-\0ZBBSR*H\<_$"ZU*VT>"[M_*D@G^P^%M&NM1MV#I/;3
M:E!(!A\'YD_X*2^/!#X#\+_#G_2W\-7_`(J\"^-/C.+01E(_@CHGQ&\(Z/XR
M6\+LLDEK-%K#:A-:VP-Q?6NB75L";=[E'Z*='GK4J?62C*:[1ERN/3[47=:V
M=U;N5&$I.R5_2W:_=?/L=CX9\-:S<_"WX;^$+S35L_'7Q]\5)\4OBY%<*GGV
M.GZ[/_PE.LZ?>L2SC^Q--&C^#[&,/L1--BBCVJ&%>W_%C3V\7ZOX%^#>F"%=
M-U.]_M?Q7:[0B0>#/#OV:XNU3"X/]ISRVF@21G"B/6A*W"8/#?"/XCZ9\2G\
M;?'"UM;EO!VD7^J^"_`ETOV>:/Q);Z/<P6FHWWAUK9I4N].?6(KK0K&[MI+B
MVU.ZMKZYLV-KY;2:/[/&JZGXU\>?&/XAZQ#Y<.F^)C\+]`)D+1"R\)()_%-]
M&"2D=Q>^,K[4;&[16!2WT.PBECCDMRJZ\TJ4I23;E2YM'=Q4Y;6>B;I1:49)
MM)1C'6Q)].ZU?_V3IL45O&K74\L.GV,"*"GVB8>4IV*0PAMTW32[`-L49`P2
MN/G[XVVCZS=?![X16=R\DGBOQEINJ>(4W@3MX(\`PIX@UV:Z7:SM;:A=0:1H
M4LF/^/C6($W`$[?9]&D7Q!X@O=9Q%-I>E22Z9I+&,R![X;3J-]!/O*/%RMJC
M^6IW)*%=MIKY.NO'%M'^TU\8-=F5K_4_!?A_X4_`GP#HK-*%N_%WCY-5^)7B
M3[,$>?"76EWO@234;TVT!L[#0;V24R01!UY*;7M'KK'WI7OI=)1;^;BM.^H'
MI7P9U>7Q_P#%7XU_$*.3SM`T/7;/X3^&GX,;Q>#4DN/$-S"W!8/XCU.^C9B3
MN$:C<0N!QFIZY9^/_P!M71_#:O'=:3\#_A3=^+;Z-'\P0^,O'^J#0M&62W.4
M6>TT'3=:G:5?W\'VB!7V>8H;S#X/Z9^TO\,-!U7]GRP^',RZI=_$+Q=JUK^T
M%<:EX<N?`5GX-\6:S?Z['XHFT2XU>'Q/KGC?3I+O^RH_"?\`9-M;S74-O=WF
MJVNF?OC[/K?[)F/&EIX^^''Q;\<?"GQ->>'CX5\<:GH-AX1\0WGCW1SJ]WKZ
MW&K3^,_#VO"P\0PZS?W]W::YI<<$EK%?7-B+:6V%LMOI%PYY:VCR\J>ODO6]
MKZ]]2X*+;YW96_&Z]?,],\9>-KK7?$'_``JWP+>*?$I@CO/%6K(OF6_@GP],
M0HN+F0?NV\0ZM&Q30=*D(F,9?5;A5M8(_M'EOQJMM(7XF?LI_#+R&&F7GC;Q
M!XI2T:5Q%<-\//"[W%H;DG)N9(KO68;PF1BSW"+,VY^1]%>`?AWX?^'6E'2=
M"AF99IY;W4M2U&ZEU+6M;U2Y*O=:MK6J7(-U?ZA</O:2::1@H81PI#"D<*>5
M?'SX#ZW\5M3^&GC+P-X^A^&?Q,^$NOZIK/@_Q3?>%E\;Z(UGX@TT:1XCT+7?
M"K:[X9?4[#5K%+?;-;:]IMW875K#<0RR+YD,D0:4M79:V>N_1NVOX/T(>[MM
MT-?XW^(+J;2!X&\/222>(?%.GZL)A;*\LNE>'[&QEN=4U6Y6$F:!)O*BTS3W
M('VG4+R&*+S,/M\U_8A\5:/<_LC_``DUB:[L[6VL?#>J1:K.=EG:6-SI6N:Q
M!JIN/-\H6:V\]O,UP+CRVAPQG((9CZY\*/A%-\/[+5-2\4>++[XC_$CQ0;63
MQE\0]8T^QTNYUF2QA:WL+'2=#TY1IWACPUID3RC2?#6FO):V;3W5U<7%_J=[
M?ZC><"?V/O@R?[5T]=*\00>#M?UJ]\0:[\.+?QQXP@^&VL:MJ4[W>HW.H>`X
MM73PS<0:A>.U[?Z8VG?V3>7A-W<V,UT%F&G-3=.5)R?(YQG=;MI6\E9WLEJ]
M+Z%Q4'&3E)J2^%6T?K^7W^I\U_$+Q*?B/\?_`-F3Q?;ZNI\%^*OB=K$/P[MY
M;?R4UK0_!W@;5=?OO$=L\J[V&OZJ@&DGY1<Z/IL%U&#'J"A?T4\3>*]%\&>'
M-0\2^(;LV>E:7:^?=3M&SR,Q*QPV\,"!I)KNZG>.VM+:-6EN;F6*")7ED16\
MJ^,WP$T7XL^&/#6EV&J3^`O%'@#6K#Q+\-?&GA^RLYK_`,#Z[IL+6D$UCIUU
M&+"^TRXT^2;2=3T6Y6.TU#2YY;4O`3'+'F>%O@GXTGU:SUWXS?%FY^*]UH]S
M97OAS0;'PG8^`_`FBZC83F>VUF3PQ9:GKEWKVN0R"&6WOO$6O:I:Z=<0I<Z)
MIVDW.Z9E*4)\K;<>6*CRI7;C':VEKZN[;\_(@\1\+6OB?XA_M#^%]:\8Z>=/
MN=!\,W/CFWT269C=>%M'U&Z?1_".BW]N5:)=5OHI+W6M;V,OD3FWL`9/LC,W
MWG>7EO8VUQ=W4J6]O:PR3W$\K*D4,,2EY)9'8A4CC0%G<D!5!/:OB?X->+X;
M;]IG]K;2_%MQ;:?K%EJ'PRN_#T-]<6<!F\"CPM<K;W^G^9,KFU.KG48[UWV)
M'=)$&&6%=LWB*]_:&\1WFA^&I)+;X(>'KMK'Q-XKAE!'Q2UZWE>&\\'^&)H6
M<-X/T>:)X?%?B.(M'JFI0S^&M)?RK76;V*92YW!2E[M.'+'=V3?.ULKN[:O9
M+2VVH',&XN/BWXM\)>+K^*2/0]9UZ;2?`VA7!!AF\(^'KE=<U[QC<P$&.<^)
M=0TK0M.LQ*KK#I4\0C*K>W7F_:$:A8XU'1451]`H`_E7S7X1FL]3^/\`XTTB
MW2WATWX4>"/"WAC3+.#$<%C=^)X3K][Y<"(D,2MID>CP(JKA(X%VB,/M/L'B
M_P`7VWAFSB2"!M1UN]D-EHNB6S[;G4K]EQ#$-@>2"T0E9+R\,$L=K;J\A5G4
M(SJMKEB]+14DO*235]M;6;TW;VV`D\4Z]<V<4.FZ+B7Q!JGF6^G0N@>&U4*S
M2ZI?("'%A:E!&S+\TT\L-M$-\VY-/1='BT/3S$\OFSEGNKV^D"))=7;*/M%W
M/L"Q_,%``QMCA147`6L[PMX:?2XGU+6)1J7B74HE?5-1EV2-$'8RC2[%A%%Y
M.EV+/Y5I"B(&5/.E5IWDD?9U@3RQ1VD)VK=R+%,V3D6^2UP%'(+/$#&=P("N
MQZA:R`SM$MFN;V]\0S1CS=1\FWM'9566+2+-91:0G`W;9KB:ZOBNXKF[4')B
M4CIG=8P6;@`$D^@'7-0`PV=NBJ%2&,*JJN%5%)'3)&%4'/`SCHN2!7A>IRZK
M\7]5ET70]4O='^'>DSW5GXFUC3[F>SO_`!;?1LD<OA_1[^`+-;:-;_.NLZG9
M7$,]S*K:7;2"-[B9*C%O5Z13]Y]E^=^R`Q9TG^.OB2>SBN3-\(_".I-;ZAL^
M6'Q_XGL+IEFT]9E*K<^%]!N82MW)"7@U34HS9!I(+2X+_24$$=O&L42)'&@5
M42,;41%4*JJHP%55`554````#`JCHNC:9X>TNQT71K"STS2M,M(+*PL+"".U
MM+2UMHQ'#!!!$JI''&@`55&![DDG4H<NBORK:^GWV\_ZM8`HHHJ0"BBB@`HK
MYB_:9_:]^"?[(VB^#=?^-6K>)--LOB!XWMOAUX0M_"O@?QEX_P!7UKQA=^&_
M$?BV'2;?0_!6AZ[JH)\/^$]>OVN6M/LR+8M&\JS21QMK_`+]J7X*?M,^'=7\
M3_"'Q?%K^G>'=5DT'Q-:W]AJGAS7O"^MQPQW!TGQ-X:\1V6E:_X?U!K>:*XC
MM=6TZTED@D25%96X`/H:BF&2,8S(@RI899>5&W+#GE1N7)Z#<O/(IP(/0@XZ
MX(./RH`6BBB@`K+%@A96>(;D)9#O.%/(R`#@$@G=@#<,;B<"M2FNP168]%!)
M_"I:NT^U].6,K_)QE*ZMHHV;>Z>@+R<M=/=G.-_)J$HJ7ES)VZ6N[Y%WI-M?
M026UW:6MW;R`A[>XACF@<'[RM%*'B(89#`H0P)SG)KRS5?@-\']2AVZI\)OA
MOJ*9VA;OP5X:N=N]F)*^;IV5^9V;*LOS,3R37JNIZYINC:==:KJMW;6&GV4#
M7-Y>7=Q%;V]M;IS)-/-*R)'&B_,[,0`/4X!_,GQ5_P`%!9_B-\5O"WP/_9>\
M'S>,=5\8ZAK%A%\7?%`U#3?AEI2:!9?:=4U#1H;>S;4?&2:<6B:0V,NFZ=.9
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M,H6X_P"$2\*0H=$\,VKEI%#VL$FIRH56XU&943;])PPBU5N(U3:,!`$4;?8G
M``'0#..1TQ7NT>,LRRBBHX#B#/,YQ[BZ*S#,LQQN(RG!1<6_:95E.,K8BABJ
MBERU*>.S6A:E._L<%&4*==>3'@_*\=6CB*^29/E.'A4IU5ALOR_`T<RK3@XU
M(PQF-PN'ISHQ4M*N'P=3WY^XZLX.<7\;^&/V;/%WPCT#3_#GPM^./BW0/#>@
MZ=!::-H7B?P]X4\5:/I-A9Q"**SB%G8>%[IK>U@A41&:[EFSN>::9F+-X/\`
MLYZU\88[CXQ?&LQ>`?&VC>.OB#?6TVO2W\O@W4[W1/`=L/"=E?VHNC>:#9Z<
MXT^6:+SK\)N>3>Q!W'T/_@H#^T1_PI_X<V_A#PYJ4EI\0_BD/^$=T)[`B;4-
M`T*>5K?Q)XO,'S*(]+LY5M=-\Q&%[K]WI>GQ+))<87)^!/[)<WB?X8^$(?CA
M-J,_AFSTJQB\,_`F'4)+7P/X9TJ%2]JWC"UTU;3_`(3GQAJ8E:_\276O->Z7
M;ZA<W-GI6GVT://+Z."^N0X9QF>\1XC"*AQ%F,,%A*M7*Z-3,\=@<ME1KYA5
MPRPZP#Q"KYE'"M8FKBJ&'YZ&.C*7-2POUGR,50P\>)J&4\-T<9/$Y/A98_$4
MXYG6IY5@\7C5.AA?K$J\\=]7G0P\L3*>&HX-XBJZU%QC&DJDUL0?\%!OA#8Z
MU<^&M3L?%FN^(+-6\ZS^%^BS?%6P\S"L8QK?A))[$%7?R5,CHFY<,R#D][:?
MMN?#B=\WWPY_:!T*RVJSZIJ_P<\3+8PB1HU4R?V>-0O,9D!/EVDA`5R1\O/T
M?X;\">$O!>FV^E>%_#7A_0+.TC^SVUOH^EV>FP0PCI%%':P1[4'`"9;@#))!
M8],8XR&&P/\`)\V&CPW0,OW3TQW/;KFOF:N8\)ZQPG#>.O&"ISJ5\_4)14?=
MC*.'P^6SI4$]9J-6K6:CRQ<Y6<W]+A\!Q;"-J_$.#J6BI)1R1U9V2CS)XBKC
MZ;Q$DFE+V=&FU*[Y4Y<J_*[]IG6=?^)OQG^!_A/5OBIX\^%W[/?Q.\.:@NC>
M)/A[=W7A/6M=^(BO%)IN@Z[K]Q!!JGAZ.?3_`#IM/MGAMI;B\C:">/SE2.N]
MTC_@GEX(T0K>Z/\`'K]J]-0:<LUY>?'_`,3ZC%/(0"&FL+R-["9.051H<<\G
M=T^T/BE\+O`/Q2\'ZCX/\?>'M-UKPU.BSM:7(-LUI<09>&_LKV"2*XTV^M6)
MEMK^SEM[JVDS)',K8-?E!J'Q)_:T\`>+/%?PI_9-\1)^U/X.T&T,ESK/C:VB
MDUGX0W@*0#PS;?$A]:T'P_\`$K4X+>*:YL=!U6-M=MREO'JFHR1,3=?=\+YK
MG>>Y9A\GX4SK"<,/*,-4IYC3S"KA,OR'%4)8NKRYAFN>8K#O"8;'U?;PP]2&
M:RHT,=4ITJ.#G[:I'"GQ_$.6Y7E&9U<SXARJMQ$\SJ4EA*N6T<57SK#5Z5*,
M8X6AEN%Q$,14P?-'_9JV!M4H.2A5E*2=4]\^(%]\=?V5=)MO$EI\>](^*F@&
M9K.R\!?%;3;:U\9:ZVU8[71?"'B+PY"+O4-6=UQ"+_2;LSRLB7%Q$A,@S/!?
MQ%\?_MBZYK?@KQ9J.H_`?0=`6%]<^$HEETOXL^)-*NHEVZA?ZL3;BP\,WDC/
M!YGAXW4C[)8+FZMV;97$?"GXT?L]>`_$6GZ_^T;9?%_0/CL(?L]]XO\`VBO!
MFHVQMGD9$N(/"FH:6-5^'WA30_M,F+6ST:\L#-;&*:=KH@W#>^^/_%/[-/QP
MBL-?\"_&;X=Z7\3_``_97$G@?XB^&?%^E)KNA7C()([>YDAO$.HZ#=O&D6KZ
M'J"W%E>6YD5X&D",L8B-?!.%/%</8JOFTXSITN/<!P]AJ>"P]=U$H5LNP6%P
M]7!8[+^9-RS;%1>;Q<E7P]"3HPA+BPKGC*=2=//</0P,)R4N"L5GLZF*K81*
M#JTL=B\8OK>&S"W-_P`)]*3P+48TYXRDG4FOK/0?A?X,\*>"CX`\/>%]+TSP
MBVFW.FRZ+9P16]G-;WD#QWAN40$W,MX7=[RXG+S7,DLDT[R2NS'YG_8XU&[\
M$R?%']FS4YKB67X)>+6M_")NI3-/)\-O%4;ZSX1B#MAGATE&N]'5LD)%:PQ#
M`0"CX<?MH_#23X>MJWQ9\9^#O!_B[P[?:GX6\7:9/X@L6237]!<07MUH"1$3
M:QIVL(UKJ&BM8VTINH+V"./]X71?//@=XZM]2^(7QW_:]\;P-\/?A9KVE^'O
M"OA"]\7QR>'KK4?"WA`7<[^*;RROXXI[>._NKN=;'S0)9[41HD8D#Q)X&#R;
M-\'EG&>#SJCCN2M/`U,%7QDL35J9KQ51S2C2P]/*98B'/F=6MEN89SB(+!.K
M/ZO5F^2-*E2A3^AGG&2XO,N#,3DF*P;]G/&+&T<-4HQ^H9!/*YU*BS:,:B67
MJCCZ.`ITXXJW/6J3]FYN7,OTMCSL7=C=CG'3.33Z^4_@5^UGX0^/_B+6M'\'
M>!?BAIF@:;IIU71_B#XJ\(W&@>"?&5L+];"1/"VHWLJWE[<0O)'-)#<V%FWV
M9C+&9`CX7]I+]INQ^!FGZ%HNA^$M9^)/Q:\=7<NF?#;X8^')ECU/Q)J,(!GN
M]2OC#/#H/AS3E99-5UJ]B-O;1DXRRLR?-1X>SJ.9T\CJ8&I3S:7+&>%JU*-*
M5*7)SSEB:E2I&CA848J4L3/$U*4,*HS^L2I<DK?9+B#*9Y?6S98R+P5*4HSJ
MQHXAR=12Y?94<.J3Q.(J3G[M&E0I5:E?_ES&H?4IN(P`3NY&>G/Y9SGVKY)^
M/O[7O@/X*:_IGP_MM(\5_$;XJ^(;%=2T7X;^`]'?6=;;3_.,`U'5I$(MM"TN
M:56ACU#472%Y@$`QEJ\%^&GQ7_:VT/\`:&\`?#+XTZA\)_$EO\1_!_B;Q9K/
MA#X<Z5K$%S\)++2)(O[,NKCQ)?WD[Z_9WTMS#I<KWMK";B\#RV+^7$?,YS]F
MJXF\)?MH_M<^#OB,(9_'GC#7]$\?>`-:U-T,NK?#![:6ST_1]$N95\TVWA=/
MLR75E;YCAN+R=2C&V=T^IH<(TLLJ9CB\VEAL^PF7<.QXAP^!R7'56LXH3S2.
M45(PQ4<-#$4L/@:WM\1B:E*ASXBAAIRPM2-":Q</D\5QC]>HX/"8!XC)\5F&
M?5.'9XS-,%"#R_%QP*QR]IAY5ZE'V]:BU'#QJ590IXF<*&*A&JG2?TS\#OVH
MX_B7XRD^'?C?X5>/?@K\1#H<_B'3O#'CN+3I3KFC6TR07=YHVJ:1/<Z?>&S>
M2,75ND@GA65&=`I%?8`.0".XS^=?$O@^72_BU^U=K7C32XEN/#_P'\*:C\/[
M74T3_1KOQSXMFM;WQ':VUSM\JX_L32K2SM+SRY)!#=W!C8+(K"OMD=!P!QP!
MCI[8[=*^<X@I9;2Q."^H83^S9U\KP>+Q^61QF)QU/`8S$^TJ1I4,1C&\7*C4
MP<L'B>6O[]&I7JT9-NFV?2\.U<95PV-6+KK%PP^9XK"83&?5Z>%GB\-AHT:4
MJU6E2C3I\_UN.*I>TA3A"I"G"<$X.,Y+1117A'OA1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`!Z'O7YF?!G_@G[X)T7]H#]ISX]?%WP5X`\;^(O
MB9\>['XJ?"K4+_3'U74?".FV'@3POX<MEN8-0C^PPZS;:KHUS=VUW;PRO;J\
M4D-Q'*"1^F=%`'XG>#_^"<?B;P!\3?%4DOP_^$GQ6\':W^TIXM^/7ACQQXZ\
M8_%2T\0^";'QW\0]1^*>JZ&_P\TS63X+U[Q#X3\7ZUJ<W@OQ,8+1EMCI\FJ6
MMS?6LEQ)].?";X"_M"_L]?L57OPG^%FJ^`KOX[Z5J?C/6?">K>)(-2N?!$=U
MXH^(^J>)]NJ10Q#4)HXM`U2XMG$*;S>K&$RH&?T5HH`@M!,+6V%QY?V@6\(G
M\H,(O.$:^;Y8;+"/?NV!B6"XSS4]%%`!1110`5Y]XG^+7PJ\$WZZ5XS^)OP^
M\(ZF\"72:=XG\9^'-!OWM96=([E;/5=2M+AH)'CD1)A&8W9'56)5@/0:_,/]
ML3]H_7OA-\?/@E\#/!7P'^$_Q:\1_&/P-\2?%CZW\5O'NC_#[3M$L/AS<Z'Y
MFFQZCJ7A'7K>^EU`>(9I8(9KJU<2Q/L6:2>1JJ,7)V6^O5+97>_EJ!]K_P##
M1O[/>%/_``O?X-88X4_\+0\$88CJ%/\`;F"1[4H_:+_9\8@+\=O@VQ/0#XG^
M"23]`-<S7RU\/_CY^S#IUGX7\%?&@?LW?#?XWWTG@V#5_A;X6U+P]XTM](U?
MXBO>1^#;;3-8L_#FGKJ5IKPLKE;/5H]/L[)I(I1-+$-K/WG@[]HC]A[QWX@\
M4>&_"/CGX):GK'@W3-3USQ!%;V&C645EHFB2/#K&L)J5[IMKI]_I.F2H\=_J
M&FW=W9V[+^]F48-)IIV>Z`\0\'?M8_LS?"[]HS]J>/QU\<_A1H0\:WOPT^(/
MAC6KSQ[X:?2M>\,V/PXTGP1=V6FW\&I2PS:GHGB'PIK$=YHT3O?!-1M+R*!T
MO"5\L\'?M!_`+X]?M4?$?7?$WQ4^&^D_#[PY\-OAM:>%](\3>-/"FG)XPMKK
M4_%.JR7-]9ZAJ@MWTF2^N(;O^QKDF\FEL-.GU*VAC2.WD[[PE^V;\"?BS^UW
M\(?@%\#[?X6?$3P-XX^$/QP^(OBOQ+IGA]DO=!U3X>:U\)K/PI;:;]MTFTL[
MS3?$EEX[UR[DN($GA(TR%H+@.TJ2>'?M=>)?#7B_]J2S_9V^&?[,G@OXC_%'
MPC\*M-\;^)_$'B7X_P#B3]E_2+KPCXOUW4=+L?!EEJ7@0+?_`!)MKJ[TRXO-
M>\/:M97WA^TC>V2Y1I9A`=U5BFI^\I^SC#FT;]V,8K1V[73N[>J*C.4-8NS^
M7]>O<^W="^-W[/GB?7[6QTWXI_!KPS\-OACJD^FZ-I\/CWP/I%CK.O:5'#;Q
MR:7IMMJT-M#X7T)FN+6U98HX;S4(7^SH+6W1YO&OA]XWT[P:GCCX:0_'']GB
MP\`^(?BUXY\<)\2K;XW>$;CQ`_@WQMXFG\5:AX>B\-FX@73]=674KS1(-8;5
M[FUM+&*.[BM6NRBQ<K\&?VU?@#8_&J3]E'XG?"KX?_`;X@^`OAG\,=2F\-"T
MTS5]$T?Q)XH3Q)]M^'^EZOIN@PZ4EEX2T;0-/U8:[)<P:7=Z9K=FT+I)#<11
M_16D?MI_L,:])K5MI_Q4^%<B:+J7AC2K_P`[2VLK-IO&GBJQ\#>&I+6XOM(M
M[75-.UCQAJFF>'8-2L&N=-75=0L()[B-KRU,F//+E4;W27+JEM>^KM=N_5Z[
M:Z(D]QTCX\_LU:)I>FZ/IOQS^"]M8:79VUC8P#XI^"G,=M:Q+%$I>77FED.U
M`7DD9I)&R[LS,2?(87_8ULOB]J?QRA^,OPHC\<:Q%;+?7$GQ@\*MI#ZA#H]G
MX<AUJ/2&\0?8(]=/AW3[70UU+RVN%TV)K6$QK/<&3MM9_:!_9?\`#_\`PM:'
M5O'/PXL#\%KOPUIGQ7MBMB9/!5_XQEL8/#&GZW;):YCN];FU/3X=/MU26262
M[MXPH:117+^%/VP?V/\`QAX[N_A;H'Q)\%3>-[1]=@30KG1+S2!?S^%K6YO=
M>@TFYU/2+.QUBXT6TLKNXNX=-N;J2.WMKF=8VBBD=(2LY-:.22EYI6M]UD!Z
MZ?VE/V<=VT_'WX);\CY3\5/`F[.<KP==SG=R..O(YJ.7]IO]FV!Q'-^T)\#X
M78X5)?BQX"C<G&<!7U\$G'/`Z5\,_$O_`(*=_L:^!/&'P-\.^'_%O@'QQI/Q
M=\9WWAWQ#K_AV":ZM/`FBVW@KQ7XGM_%&HII^C71U&&XU/PW;^'%TZS6744O
M=6@N)(H[6WN)(_TE\+3>$/%GAS0O%'AV#3[_`$'Q%I5AKFC7\=@;9;W3-4M8
MKVQO%M[BW@N(/M-M-%-LFABF4.%D16!4,#ST_M/_`+-*JS-^T/\``Q5499C\
M6O`(51D#+$^(,`9(&3QDBHF_:G_9B0[7_:-^`Z-M#X;XO?#Y3L/1L'Q"#M/9
MNA]:]E_L;2@01I]J,?\`3&,@^Q!4@CO@C&0#VIXTK3N]G;-_O00G'L!Y>`.^
MT<#L`.*`/#V_:R_974D-^TO^S^I`#$-\9?AR"%+;03GQ&,`M\H)X+<=:JS?M
M?_LEV\L,%Q^U%^SK!/<D"WAF^-GPTBEN"9%B`AC?Q,KRDRND8"!LR.J?>8`^
M]'2=-)R;"S)XZVMN>AS_`,\_T.1W'/-(=)TXMN^QVP^[@"W@"C:<\`1_Q'&[
M.<@8X'%`'SS<?MI?L<VDLD%U^UE^S1;3PLJ2PW'QW^%L,L3LJNJR1R>*E=&9
M&5U5@"596`P03#>?ML_L96,?F7W[7'[,5E&Q51)=_'OX56Z%G8(BAYO%:*2S
MLJJ,Y9B%&20*^B#H>D%MPTVQ5L``BSM3M```V[H6Q\H"\=@!2OHNDN%#:=9$
M)G:/LEL<9QNQF(\-@97[IP,KCB@#\]OB7\9_^"6OQ.U:SUGXE_M)?L;ZYKNE
M6WV.WU.__:*^%VFZBFGI*+C^S[NXL/'EA/=Z:)1YC6%\UQ9DY)APS9].T3]N
M+_@GQX5TO3_#.B_MC?L<Z)I>CV45IIVC:?\`M#_!:PM-/L+6-5BAM;*+QA&D
M%O#'MVA(U100>,Y/UP-`T;G.F6!)Z%K*T.W_`'08,#UQC'M3/^$>T<G+Z?:.
M>^ZVML'ZA854^^1@]\X%`'Y<:W^U/^R[X:^,?C/XL_"_]M_]BF^L?B7X;T'3
M/%6A>*?VC_A?%:66M>%K2XL=(\3:1<Z=XP83)+I3Q6>IV$NP2BSBFBN4W$5[
M7X$_:Y_8DTW&N^(/VV_V3?$OC*_@ACU/5XOV@?A'':6K@&233M$LO^$SG&FV
M$1E*^4))+BXPDUW+)(<C[@70M&7@:988P1@V5KW&#\PA#8P<8W8]J/["T?)/
M]FV&22>+*U7!..05A4DX`&6))`&23S3E)R:<G=J*BGY)))>=DDKO70#YH7]O
M#]AV3(B_;+_92D8,4VI^T/\`")SY@X*87Q@3O!X*_>SQC-4+7]N3]C74?$+V
M<'[6G[,SM96D>U%^/?PI9IIKIGSY42^+6D9HEB*/\G#@J#D,!]3C0])4$#3K
M#!))_P!!LN2>I)^SYR>YSG.3UKR?Q)\%-&\1>()[^?6]>L-`U467]O>%M(;3
M]/L-7EL`1;B?5+>P77[*QE7<FHV&FZI9V^I(QAO/,MI);>5QY;2YD[V]UWT3
M\T!\[^*/VT/V9/'=_J?@OPO^U7^SUHVC6O\`9R^(/'4/QQ^%YC:"^C$LVB^&
M6'B:47.I&)5BOM1(2ST\W$5K`]U?BZALO5-$_:K_`&.-%L+/1M)_:=_9MM[3
M3K98+>TM_C9\,@(H8DWEBB^)RV2H,LLC`LY9I78DEC]`Z?X4\.:5:6]AINBZ
M78V5I&D5O:6NGV=O;111*%AC2WB@2%4A4`1J$`7`QR,U>_L?2\D_8+($XR19
MVJDXXP2(02,#!&<$<$$4KNUNE[_/^OZU8'-^`OB5\.?BIHK^)/AAX_\`!/Q'
M\.Q7DNG2:_X"\5:%XPT6/4((H)YK!]5\/7^HV*7D,%S;32VK3B>.*X@D=`DL
M9;MJJVEC:6*-':016\;MO9(46-"^`NXJ@52Q4!2V,[55<[44"U2`****`"BB
MB@#\B/\`@JM8>.=0\5?\$VX_AK<Z%8^-8?\`@H%X:?1-4\3:5JFL^&M'NKK]
MFC]IK3X-0\16&BW5EJ,NF"YNH+5O(O+5FGNK>%9=\J1O\'_M-?L[_%']G.YT
MGX@?&GXF>$?$WAC]I?XW:GXR_:E\:7NF?$+X>?!?1;_PI\.;7PU\']!U=/AU
MKEGXWT?PL'M]4,^IWFO1VEYK)M'UF<1+;1U_2[/9V]PR/-&KE&#KN5&VNH94
M=2RDJRAG"E2"-Q]L$UE;W%M]DN(UG@(PZ3*D@?KG>'4JQ)))XY/L2"`?S&_L
MV?"ZX^.7QC_9,^$GBGX^_$CXE?!J+X)_MT>)]"\2_#/Q9\6O`VA:WHN@?M+_
M``1F^'?@O4=<\27<7BSQEI?@73;ZY\.:'XDU&[GG\0:3HL,UMJ=Y8SWINOVQ
M_9`/P@CE^/UA\)=?^)FNG2OC9KVF^.U^(^L>(M872O&MKINFQZCIG@]_$,LK
MVGA:"`6YM+33@FGI.T[Q`N[L?KN'2[.W\DQ1*A@1HX]B1Q@(Y0L"L:(C;O+4
M$LI(P"""`18@M;>V,I@BCC,S^9*41$WO@#<VQ5W-@`;FR?>@"Q1110`W<H."
MRY],C/Y9KX1^)_[=7@G0O&$GPA^$7AG6OCY\8=TEMJ'A3X?/!/I'A)T<P27'
MC/Q;)YFB:'%;S?N[B%YY)[>8?9;L6D[*IP/$?Q9_L?XC>*_`5U^WC\'/#GB2
MRUBY27P7XA^'/A[^U/"T5ZYO].TB^NKKX@Z9;O<P:?<6L:3WL$,UZOESB!7G
M"UJ>$OV9?BCX/L]1E^'_`.T+X"\*0>(]0N/$FJWWA7]F[P18MKNJ:D4FN=<O
M[B#Q0Z:I>WLN;B34;G[1-,TIS*84@CB]?*,1DV%J5Z^;Y=B,VY*7^Q8"&+>!
MP=;$RNE+,L31A/&?5*<?>E0P3HUZ\^6*Q-"*<GY&;X?-L53I4<KQU'+HRE+Z
MWBW16)Q<**<+4\!0J<N%6(J^\OK&)FZ=",6XT:TIKDX6']F7XW_M$:Y;:[^U
M7XXLM.\!6ES!=6GP&^'=Q=0^&KX1MO2#QGKSO'?^(8PK;)[/;%:.[$`N(H'7
MJ/@KX9T?5/VR_CG=BUTS3;#X(>"?AY\./A_X=L;"ULK+2-*\9:;>>*_$.K6-
MI!'%!#_:MU#86+/;HJLNG2(226KM7^"?[4<D0C'[:4Z$'<TT7P"\`*[*`YVL
MHU8P;<RJX*Q*^^.,ALAM_AWB+]C3]IVU\=WWQA\!?MN7&B_$Z^T&P\-W[W_P
M0\'2>%/%&DZ9-//I]EXGT6WU4K)+9/=7`L=8LA!JMC'/+'#,T4LD+>W2XGQ.
M/CF&!Q];"99@*V1U\ORG"Y=AY87*<HQ-?,,JJ8A1PE&G4G-9CE^&Q>"QV.K+
M$8RI2J)5:M5V/'Q'#\<*LMKX6G7Q];#9G0Q>83Q=7V^-Q5&C1KJ,J=2348U*
M.(="M3P^']A1G*,DXVE)/]/Y'6`ERR="IR0,8YY/;OU->!?&;]H/PC\*O[%T
M*3/B?XA^+[E=/\$_#C0[B&;Q+XCOG8(TWV;<S:?HECGSM6UN[5+*RMT<EI9C
M'`_YW^&OAW_P4)^(/BKQO\/-;_X**?"W2M0\#W>F:?XXL_A;\`_#>H>-/#"^
M)M$L=?T&VNAXKE^PZ/J.JZ%>PZE877V>_6.VGBN1#*Q`3TGX9?L$?%+X8ZEJ
M?B70?VR/%.L>+];N&GUGQSXP^#_PV\7^--10N7^PMXAU[[;=V.GH6(CT_2UL
MK&/"E;;*BO-AE^3Y;4E4QV9X;-%2I0E2RO*5B4J\Y04H*OCL1A\/'"T%>,:M
M*G2G7G'F]E.FI*K'MKXO.L:H4<LR^KE<9RE&KF6:4X1G1TTEA\#&4Y8ARBO=
MJSG&,:C4IJ<4XRXWXJ?`#QYI&GP?M+?%V%?B'\1+'XI>`/%OC7P[X<M[F\L?
M!WP5\(ZTFKCP%X+L95\W4X-+NE3Q)KTC)'-X@U.U>8Q1+':VZ_J7X'\:>&/&
M_A?1O%7A'5]/UWP]KEI%?:7JFF7$=Q;7=O,H*NKHQQ(#E9HV"R12J\<JHZ,H
M^0]8^#O[16BZ1J^O^(?VZM;TSP[I5K=7^KWEQ\$?@_:Z?8Z9:0&:\GN[B>QF
M6*&*%7>:9PJ"(`F,`$M\8?"_]G?P5\1?%&MGX#_\%,?B!8ZWJ!;Q/KWAGX-1
M?"[0=&O6O9`9O$<'@A=&N=)MC>%UCOM4TG2H;>YEDADN6>:57?IQ&;4<^PM*
MAG.*>"Q&`=9Y;6PV%E/`4L)75*+R_P"I4I)T'0C0I>SQ%&ZJVFJT9RE&<.'!
M9'B.'<56KY/AX8^AF%.'U^CB<0J.-J8ZE.4GCZF.G"H\0\1[2HITJB?LO<5)
MTXQ<'^CW[6GC;XA^`O@/X^\7_"YM(3Q;H5DEXEUJ]Q8Q0Z5I:S)_:VJPKJ5Q
M9Z?/J-C8>;<:?9WMW;V]U<K%"\PW`'\VOV1_VJ_!/@V^^,_C?XN_M':[!X1_
ML7PW<Z'X5^-U[;:3X[U;4+2TNKGQ!XOT#P^L%O"UCXBGO[*RT/0?"LNLQW%K
MI<=ZC$S2%?4/B;^QO9>%M%LO&'QR_;Q_:#U_PKI&M:+#'8?$EOAGJ7P]DU[5
M-5M--T5=1\'VO@6UT36[B?5[JTAT^+6[;4H$O)8I`I8*1Z%J?[-'@C]JGPQX
MS\':E^T=XC^)GAOPEXJU?X;>+]/3X?\`P-4^'_&/@R^6VUK0H[ZS^&5GJ.CZ
MGHU[''!(VG7L4\#)Y8N74D5Z^4YKPEEV3RR#,\+BLTHYKCX5<RSO*\)A,-F>
M!R^I6P4<1AZ%+,X3AC:T:.%JU,.U7P-.D\1.'/.4G*'F9GD?%.99MAL[P6*P
MF65,KPSC@<IQ^,QU?+\5B%2QLE/$5<M4)48SQ%7#*HWAL4YTZ,5RQ2DI[L-M
M\7OVQ8-+U6\NM8^"?[/NKQI<1Z+;2367Q1^(^B3H);6?5KR,JG@_0=4MW63[
M!:-)JTT#IYUS`'"'[=\%?#WPA\._#6G^$?!FD:=X?\/Z6@CLM/TZ&.")>\DT
MI4;Y[F=\RW%S,TL\\I:261G)->!^'OV>/B1X5T+1?#?A_P#:;^*^GZ3H&EZ?
MHNEVS>$_@I>"VTS2[6.SLH#-<_#62ZG>*VACC-Q<W$LTNT-*[N6<WA\%_CAF
M1C^UG\3BF]#&H^'OP1$BH!\Z$GX?$2,QZ/B,)G[C]#\QFN<5,?%8+#TH8#)\
M+B*E3`X##WA'7W(8G&33=3%X^5.RJUZTZBB[QPZI4E&G'Z7*,DA@N;&8R;QV
M;XJC%8[&UW[3WY^]6P^#@TJ>$P,9MJC1HP@W!)UI5*O--_1NJ:%I&LV\EGJM
MG8:E92J%EM+^VM[RUEQT\RWN$EA<^[(2,G%>)>(/V5OV>/$@;^T_@]\,96D.
MZ5T\&Z%;-*QR-TK6=K;/*0"Q4RL^&)/4DG%;X,_&G<=O[5WQ3"]A_P`(%\#V
M('NW_"N5R?7Y1]*MQ_!OXO8_>?M2_%@\#E?"'P+3)[G#?"]L9].=O<FN#!X[
M'Y?4]K@<?CL)4NGS8;&8F@TUIS+V56*4FM')6;6[/1Q678#'0=/%X+"XF,HN
M#5;#TJEX-6Y;SA+1+9;1>L;/4^=7_9K^`OP/_:+\+^(M#^''@RSTSQ_\.?$N
MFPV@T"SN;32_%OPYN8/$UE?:9:3QW,5GJ.L>'-6\0"YN+=8YY8/#-F@)\K!\
M^^'GAFT_;EOK3X[?%C4UMOV??#NMZG'\,_A`;EK72M6G\-WLMHWC#XC!VAAO
MI3<6SOI^@NIL;")%-SYLA8#N_C[\(/B=8^+?V;-7G_:3^)UY-#\<X=(BFO/#
M/P:MY+*W\3_#'XF>'KJ2U^P_#:"&XGD%_&JV^IP7]@X_>&S-U#;7$''WO_!*
MWP#JFKZUJ,G[0?[2&FZ-XDU2?6_$7@'PWXB\#^'?AIKVLW+B6[U/5O`NE?#Z
MWT"XN;V4*]XL5I!#<LI$\<B2SK+^@87B"E/"8?'9UF^9QSO$Y3A<%EN>R]KG
M&+R_#97F.<4,UC0IXS$Q=+,<QPF)R##8?,E7C6P]++<;&3?UZ%2E^?XCAZNL
M=F.$R;`Y7++:&8SQ>-R=O^S,-C)XW+<FGEWUFIA</)8C!87%4<ZKU,OG"5*=
M3$T9:>SC%?'7B/QK\5O%_P"VE_PM_P`+2_&+QA^RI\+_`!OH^E^&=:^"^CZO
MK/@^2P\.>&1_;7ABP\*Z9+:S>*X;OQ1(;74_$-A::MI<$22VECT5H?=_$WQ5
M^.*?&/QU^T9\'_V;?BGXWT6_^&.D^"+>U^)7AZ/PEJOA"_T[5+NXN-4\*>&+
MC49?$6N:9?P7:WFN:;:V^F7MY<6UI#%.5618_P!`M!_9[\6>%]'TSP_X?_:%
M^*>C:+HMC'IVDZ9I?A+X#V-E86D`6.WM[:WA^#0BCMXH45!"J`9`8$&KK_!/
MXG.4S^U#\7"OS%@?"OP,#\X(VRCX19C[Y^5L^@Q6^,\1<%6K8.5/A#*ZE'+L
MBH<-4J=;&8G#QS'*:=6A6Q-7-(X"CAJL\WQE;#TZ]3%4,3"CS*5.K3K4YUE6
MPI^'&,]G57^M..P=3$YM+/E/"X'#UYY;FSI5J%*6`GC:U>D\OPL,155'#5,-
MSJ'(X.E7A"4/B+X`_&SX-^![_P`7>.==\1?$OXO?M$>/!!'XIMK'X->/=.UV
MUL]-=_L7@KPOHMQHRZ9X?\/Z.9F=+*\UM9I9BUQ>S/<L0.T^+WPU^)G[6>H>
M!]9T3P'?_`*?PCK%OJ>F?%CQ'<PQ_%&TTV0'^T-+T;P]HTUQ;65GK%M*UK>1
M:YJ]T(A)(ZZ:LBR,WU1_PHSQR&0C]I'XPJ$8M\GA[X&[]O'[I6/P=7:H(R`X
MD7DC:<@C2_X4UX]5'2/]I7XSJ&*E,Z%\!6"*`,HZ_P#"F`)"3T(VA1P58\UX
MU?B^G0SC^W<HRKZMF;5J>(Q^;_VE1P=)8>="&%P>68/(>'\L6"I4YRHPPF(P
MV)P_(_>HS7NKLH<"XC&95_8>?YO3Q66.<ZE7#Y?E$LJK8FO/$K%U,9B,TQ6?
M<19I];KUUS5,3AZ]"NHV5.=-IM_(&EZ/^U_^S3\)XO`?PL^%7P]^*MYI%Z)M
M+\0V.MW&BWVNK-=+=:S?^*],U2>VEN?$.K[II)=5AUJ4->N9986C"Q5^A'PU
M\0>)/$W@KPUK7C#PK/X(\2ZAI%K<ZWX4N[ZTU*YT+4GCC^U:=)?V4DMK=^1+
MO5;B"0QR1[#@-N"^=6_P;\=J1YW[2GQH<<DE-#^`D//\)`_X4K*,CZ<]>*E/
MP>\;ACM_:2^-BCG!72/@("<G)W,/@EELGN0`<9QTKQ,WSUYU34L1E&487,)X
MNMC,5FF7PQ='$XZ=?E<X8BE/$SP5.G&4>:G2P>&PU.#E)1BHNR^IR;(GDBIX
M;#YKF6*RZAAEA\/@L=5P^)IX:-*-.G15+$_5*..JM0@U*>+KUYS;<YSG-MKW
M:681#.5P!GE@/7/\O2O&OAY\=_!?Q(\9?$GP!I$TEGXL^%GB"WT+Q+HFI&&"
M_>"^TO3]4T[7]/MTFE:YT+4$OGM+>\.QEO["]MI(E*1O)1D^#/C&4`']I;XY
MK@8)73?V?FS[XF^!$N.>PX['->!G]@O0X/C9#\?]*_:#_:!T7XER:%<>'=7U
MG2E^`]K;>(-+F54ACUS2A\"SI.H366Q3:W5Q827"D*6E9HXG3DR^.5NEF:S*
M>)A6>7REE$\-%2A#,J=>C-0QL)6Y\-B<-[:C"5*49X>ORU9\\+TY>AC'F,:N
M!E@8X:=#ZUR9A3KN4:GU6<4G6P\XW3J49>^J<E^\LXW5TS[TWKG&Y<^F1G\N
MM+D>H_,5\]+\$/&X&/\`AJ;]H$G<6W'3/V<,\H4V[1^ST(]O.[&S.X`YQQ31
M\#O'(`'_``U5^T$?<Z3^S5D_7'[.P'Z5YIW*]E?>VOJ?0^0>A!_&@D`$D@``
MDDG``')))X``Y)/2OG63X%^.9,?\96?M")CGY=(_9G.?KO\`V<W_`$Q4#_`7
MQTZLI_:Q_:(&Y64,-'_9B++N&,KN_9N9<CJ-RL,]01Q0,^D@0>001SR.>AP?
MR/!]Z*P_#>D76@:%IFCWOB'6?%=WI]I%;7'B/Q#'H<6MZQ+&H5[_`%.+PSHO
MAS0([NX(WS)I.AZ78JQ(@LX4P@W*`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"OS5_:6_9:O_C?^W%^RA\0O$_PXTGQU\%/A]\+_`(\:
M'XWNM8N]%DM-(\1^*D\*OX15M$NM0@UF^:ZFTV[V7>F6%Y;V3QAKV6V5XV;]
M*J^!?VIOVJ_B7\(_C5\%_@;\(_@Q9?%[QI\5O"7Q&\:Q6M_XXL?!$5CI/PW_
M`+%DU2&VNM0MKB"[U"[@U;-G`P0-+$%+H&W!IM.Z;3[K1@>1^&?V-+K2_P!I
MO]M/58/`6C^#/A?\4/V=?V>_A=\$?%6GGP]*^D:QX5T;XPZ9XN@T.R@N+S6O
M#IT*\\3^%KF.:^L;&WO[B2&73Y+TVLIA_,#2O^":WQY\8_L]WO[/FO\`P0^)
M'A7XR>"/V:/%_P`&O"O[07C7]I[2?%WP/U75T@\/16D'PX^%6F^(]:\5:+X=
M^)P\-V[>)+?Q1X9\)GPN+V[MX+?5%9Y!^LWP\_;^T[XFGX:Q:3X"E\&^*]2_
M:'U?]GCXT_#[XG^)=+\,^-OA?XJT+P!XD\>7%IIUG!%>6OCB\N]'T2'6-+M]
M)N(X=2\,W4NNPSF&R=#[A'^W9^R%/I.OZ]'\>/AI/I'A7^SD\0WD7B:PN!I5
MSK%U=V>EZ?+`CO<OJ>H76G7L-II=O%)?SO:2&.V94#4@/BCX)>`_VH/B!^V#
M^S-\9?B7^RM:_L[^`_@I^S?\>/A%JSM\4OAQXSO=5\4>-M9^"=QI,FGZ1X*E
M:2S\+36G@"^DT.[FFGO/-;5(-8TGPT8M,;7O0?VTO"?Q!\8>,1I&H_\`!.G0
M_P!KOP,/#\7_``B_C;0_B[\-/`'C?PUJMS%<1ZMI^K#Q[J/A:[L].M95AO;"
M_P##6OZM=MYO&CFYB+GZTE_;#_9>C^%VF?&EOC'X#?X9ZOKMQX5TSQ4FKQRV
M]YXGM;F:RO/#5M:)&^JOXDM9K:9;W1!8C5;98))+JVCBC:0>/>"/^"D?[-/Q
M!^/FN?`C0?%.GW5]9^$O`OB7PSXOCU"&X\.>-Y_'4VN);Z%H;QPF6*]TM-$:
M74)[XP6N+J)(Y"\<H4`_,'P3^Q-^V)X!T:\^&WBCP-??$2X_:$_8:^'_`.S1
MXT^+^D?$[PI?)\#?''A;7/BIJR3>+9/&&M:%XQ\=^&=%TGQ]I'AJ/7/!6EZ_
MKVL+HES<2:5#Y\3UJ^&_V&OB3\2/A-\2_A7XV_9F^)'PS\?V/[(?Q!^#/A'X
MO>+_`-ISPO\`$[X>OX[O_$'PVUWP[:?";P?I?B74=>\/:)<^)_AQX<\<0>(O
M%VA>"KWPZ_AK3M%@TZYDU*6=/V$\+?MG?LL>-[/QG?>%/C3X!UZU^'FF3:YX
MOEL==@F72-`AN39OX@9CQJ&@M=9MX]:TTWVES2D)%=OYD>_O?AI\>?@K\8=&
M\1>(/A7X]\)>/="\*ZU<^'O$FJ^%-3M=7T_2=:L=-L=6N=.NKJS+P_:[?3M2
MT^Z:.)Y"BWD.&#N10!^)>E?\$_/VD-;\2?LM^//%^A:5_;GQ<\<V_CW]O'3V
M\1Z7/#I5SX7\7W'Q5\"6]D;:ZN+3Q7>Z'K&F^$/!$AT^:[MEL=&EO+??;L&'
M`^'OV-/VPO$?Q>^#/B;XA?!7Q//XJ^&7[0'Q4\6?$3XZ>)OVB_"?BSP]X[\,
M^*?!7Q8\/>%YOAA\+K;56E\&>&5M_$7AC39+"[@T'7M'$,&FVVAZMIKZGJ=O
M^U7@_P#;<_9/\>WVOZ7X/^-7@C6;[PIX;U[Q=KEI#?7%M)9>%O#$4L_B'7HX
M[VUMOMVEZ-'#*^H7>GBZCM$3>[!60MI_#K]K[]EWXK7WB/3?AO\`&/X?^++[
MP=H4GBOQ%#IFM6Y.E>&H[I[2X\2O-=""*XT2&]62WN=9M);BRBN<Q2W*S2!6
M`/R^T[]DK]H'X5?LN_\`!.S5/!_P9TSQE\8/V3/C!<_$'XG_``JTGQAX&\,:
M[XLTG7?`_P`7_`NH)HGC+5K^V\'7FNZ6?'NCZS%'K&MV5E>V]M<6[:C#*!C]
MM_!&J:YK?@_PQK/B;PW/X-\2:KH&CZEX@\(W6IZ;K5UX6UN_TZVN]4\.76KZ
M-+/I&IW.AWLTVESZAI<\^G7LEHUU8S2VLL4C?'/PL_;A^%'QZ_:)3X._!KQ)
MX2^(?A&#X3R^/]6\8:%J=[--;:PGBR;08=*@@FLHK2^TZYM$6\M]9L[J:.63
M?'`[JH<4?CY^USXU\)?'?0?V7?V>?A7#\7/C3=>"/^%I>++76/$MMX-\%^`?
MAX^HRZ-IVK>(-<GM+R:6_P#$.LP7%AHNE6%O)<7#VUU<RF."WD8@'W[17Y+Z
M=_P4N_X5W\:=-^%_[6_@G0/V;8)O@)/\3=0N->\7_P#"2:B_BV'XP>(_AU#H
MGA^UT'3[C^W?#VJZ!X=D\9:=J-K;MJ,&FW`_M*TM8H9Y4^I?&/[?'[(_@%/"
M$OBWXX>#M'M?'WAJS\8>$=3,NI:AI.I^&-0P+37Y=5TS3KS3M,TJ1CM:\U:Y
ML8(F203/&8I-H!]AT5\17/[8O@?PC\1/CEIOQ2\4_#KP1\-?A2_P'BTWQO-X
MXBO;O4;KXW6&HG2(?$VC)9I%X2CN=4M(+#PW-+>W4>O03S7SFU2'Y_J+X9_$
MWP)\8_`^@?$CX9^)M,\8^!_%%M)>^'_$NC3-<:9JUI'<36K7-G,R1F2+SH)4
M#;`"5)&1@D`[NBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`_"WX,S?LV:3\>_P#@KOX@_:6'PTM/AWI_QL\#KXAU7XEPZ*NF
M6VB2?!#1#J<"7&L)YR"5580Q61\^:Z,:V8>Z,8KXD_98O_BWXT^%/@[X4?%7
MXU?&SX"^$_@U^P!=_M"_!NXT[Q]J?P\\3ZU;>+?CY\>--\%:WXYG5X[GQ+!\
M//@YX%^"]J?#6N"ZMK0^.;E]6MC<:C;S2?M=\9/A=_P3;\*?%)?B-\?_``5^
MRMH_Q6\27T.J0^(OB]'\/(?$&LW\/V>SAU6&'QE,3<W%K]CMHH]02V+6K6\)
M2>-HU(]%\3_#+]C3]K36!I_C+P%\'?C?K/P7NM%U.*+6='T7Q7+X//CK0['Q
M%HK+.\5Q`VE^*="@TO5H+,376D:M8V^FW<EO,EO:-&`?CY^SQ^V'\8/%OPL_
M:L\:?%_XE7_A?Q-9_P#!-OX:_%OPUINI:O#H*Z-XNU3X>?$:*X\>>'+&Z>VC
MLKG7]8TO2=2-U:H$&HRVT*JLQCC;QWXC?'7Q+XWLOVVM>^+7[6OC_P""WB;]
MFS]GCX*7_P"SIX3T/XOQ_#)/%FH>*/V=-)\>:M\5)[&TO;.Z^)VH>)/B)?:G
MX9C,@U334?0FM88F>]5V_>[Q+\`_V-/VA_$MK=^+_A%\"/BUXI^#ES_PB-N^
ML>&/!_BW5/A]<QVD=Q!X<FCDM[N716LK>:"^T_2KI(O[,F>WU&P@MKH0W`^.
M?V\OV9?@GK\4FL?&+XL_`?X._#+6_"FC_"?0Y/$O[/G@#Q%\3M%M&MKZVU'1
MOAI\5M3U1/$^@RZEHKFWM;+2]#OET6.VGOX58/($!-*2:DDT]&FDTUV:>C/S
MEUKXJ7<'C3QQX.OHOB9XI^(W[3?Q8_8<\#^&CX6^--S\!K+Q#XJF_89M/'.N
M#XG?&/3M-UG5=!\)S:-X>UC6+RPT'0-<U[Q)K&G:=I^EZ3>,+@+S'A3QC^U%
MXV^$^K>#H_BQ-X[T?X`_M1?&;2/'GPA\`_M<2>&OB;XV^%7ACP'X6U72]+^'
M'[0/BG3/#6L>.=.^%/B6_P!2>_76[/PP^H7`33;Z\LULT5OW4^(?PS_81T+X
M+Z):_';0/@(WPK\;6WP^TE=<^,,7@VSTGQIJ7@WP<^G^!+BZU;Q3]DBU'Q%I
MO@[2KU-(F25=1MM$M]2BMC'8BZC/$6'P[_X)8?&;2O#WPYT3P3^Q;\4-%NO$
M\M]X:\(Z#IOPC\56*>*;/1[*UO)-&TK2TO4AU%/#^F6%GJ$-C%'YVBVD-G>)
M)8H(2[OEY/LJ7.H]%*UN:W>VE][:"48J7,HI2Y5"Z6O(G=1O_*FDTMC!?Q]X
M?^*?_!)W6_B-X0UGQYX@\-^,?V0-3US0]:^)\D+_`!%U/3KKX:,(+OQI/:O)
M:W'B>=4+ZQ>6<UQ:7>H-/=VES<031S/^$_AKXJVW[+]K\!?C'\3?B'X:^+NG
M)_P3#^+:#1OV>]`T[P+\9_V?_"^F^!?`NOR^(M7U/1=7UA=5G\47K:%X=TGQ
M?XPM=)D\/Z[I+ZI9N4DU""3^NW_A#O"7_"+'P,/#.@+X+.CKX>_X1)=(L%\-
MC0$M%L$T1=$6`::NDI8HEDFG+;"S2T5;=81"H0>8>"?V8/V:_AK9>)=-^'/[
M/OP3\`:?XSTZ?1_&%EX*^%O@CPK:^*])NH9;:ZTSQ)!H6AV$6N:?<V\TT%Q9
MZFMU;S0RR121LCLI11_+QJ_C#XK^&_&'Q'^"7BK7-"T_P9X@^$?[/?QCB^%&
MC_M*^+/VG;CP;XF3]HWX4Z1::KXD\=>)O#OAU=/\4:WH^N7YU+3?#^G_`-@Z
MJUM_:EC>ZG$OVQOW9_X)RMNB_;4X5?\`C/W]J,A0"K!?^$YF4>8K*K!FVEU.
M"KHRNA96!/TSX6_9$_93\#V+:9X,_9K^!'A/3GC6&2R\.?"?P+HMK+&FK6&O
MHDT.G:';QS*FN:5I>L*)5?;J>FV%\,7-G;R1]3;Z[\&_A?XPTGX=:6G@KP9X
MX^+E_P",?'&F>%-(LM*T/6/'NJ:6=/O?'GBV2ULH+=M:U*V;5M.NO$.LW9FO
MIVNX)+F>9V!`!Z_17"_$;XE>"OA-X2U;QW\0M=M/#/A'0CIPU;7;\3&TL?[6
MU2ST73_-%O%/,?M.J:A8V<>R)CYMRF<*&87]?\9^'/"_A6_\9^)=8T[P[X9T
MJS.IZGKFM7]KIFE:?IJHLKW][J%[)#:VMJL+"1YIY8T13\Q!&*4GRINTG97M
M%.4GY1BM6^R6KV!;KH=0'4N4!RP&3R./US[=.O6GU^=7AW]K?X4>(/%FO>._
M@K\7?"'QI^&Z.K?$[0?!6O6NO^(_ANS6Y2W\:P:/!)_:D_A:X%MY>L+%;.D4
MF-0TYYXQ/`G92?\`!17]C0^&K#Q>OQ]\%R>&;_6[GP[9ZI#)JT@O]6LK>"YN
MTTVVCTLWFJ65M;W-O/<ZO8P3Z3!',C27R[@*Z*V&K4H4*L82KT<0U&-2A%U/
M9U=>>E6BES4IPM>TE:491E!N,DS"E7C4J5*4HSA5IR5Z37/-TYM*G52A?W*C
M;MU5G?8[;]H^$:MXZ_98\/(ZB>;X\KXD*'.[[+X0^%WQ+UB5P!V%TEE%EOE#
MS1C.YE!^IX#F,'KDMCZ9X_2OB'P+\5?!O[0W[0FD^)/A]KFE^,?A_P#"[X3+
MJMIXHTB9;[2-2\3?%S4+&:P^P7(^0W&F>$O";R2;2'6S\6J6`#C/VY;%3'\O
M`W'C.=IX..<D8ST_IBN[-(5*%'),)4ISI5*&40KUZ<[NI3K9ICLPS&"J*[]G
MSY?B,NDHNS=DTG'E9XN25J>,Q6>9A0J1JT,3F4,)0JPDO9U(97@Z.'K."^WR
M8N6(I3E'12I\LK-)*Q1117E'T(4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5^67[6^D?$CPI^
MV]^R/^T%X;^#WQ3^+O@GX<_#'X_>%?$^G_"_0],UK4;'6/'=OX7MO#WVE=5U
MO0[2V2Y:QND:::Z$,<2R.[*%K]3:^0_VD/VM]&^`WBGX9_#+0/`7BWXQ_&?X
MNR:W+X%^%?@9])M]9O=$\,007/B;Q3J^J:[>V&E:#X9T.*ZM(KW4[R5MUY>6
M=E;PR7$ZK0!^4<?[+'[2'B?XO_"[]ICQI\)-3\(>*/B[_P`%)(_CSXE^&EC?
M:1XAO/@_\%_!G["WQ[^`W@N[\>ZIHEQ>:!_PDVN:K=^%7\0/HNH:C866N>)]
M'TPW=S]BN[EN,L/V+OC+X;_91_8+U+3OAE\0?#/B#X.?%/XM^)_CIX7^%7AS
MX<2?&6./QCKOC6U\-^-K#0?B)H.N^&?%M_X>6YL[C^SKO3-1UG^Q]9^TZ3'+
M/"\;_M!X`_:Q\%ZC\/;KQQ\<=,N/V5;C3/%UWX(U/1/C[KWA7P9"=>MQ&]J-
M!\376M+X<\3:=J\,HGT:_P!)OW&H)'<)'`)+2X6/U+Q'\>_@;X.L[34/%WQE
M^%?A6QU"PTS5+"\\1_$'PGH=M?:9K4PMM'U"SFU/5K6.ZLM6N"(-,NH&D@OY
MB([5Y7(6@#\'?"7[,'B_X:?&WX*?M(^&_A)^U9\4/AEX8_:8_:*\>?&'PI\7
MO#'PTM?B1K/BOXO_`+//PO\`A]X=^.'@7X0^`M-\%:+:^#]-U3PC<^'KG1[K
MPMIGC1=9U#Q/XKBTM]/O8KZ\].\??"KXI^,_B1^U-J7AC]GGXF?#2/\`;*_8
MJTSX+_"#6[7PIH,__"G?BBNE_%GP_P#VC\1YO#NHWMIX"N-(N?$^@>)VU".:
M6&2R8QVUQ<:M;RV2?LY%\;_@O<:AXOTBW^+GPSGU7X>Z?!JWCW3(/'?A>;4/
M!&E74:RVVI^+K*/5&N?#>GW$3+)#>ZQ%9VTD9WI*5YJQX,^,OPA^(VH:[I/P
M]^*?PZ\=:IX8>"/Q+IO@[QKX;\37_AZ2Z3S;:/7+/1=2O;C27N(_WD"W\=NT
MR$-&&!!(!_./\0_V8_C[\8?AG\'M%\&?LJ>-_A!??`C_`()]>.?@1\0=#U:P
M\.:2OBKXD:_X:\$>%=.^&G@B71=8*>/-"TC4/#&H:_;^+;<?\(W/;+IL]M<F
M^OI;.V_?_P``>!YOAU^SUH?ACX?>#]`\.^)M(^'&GV^F^'H]/M-)T[_A+++P
MO;6D%MJD=A#%&V[4+>&UOY]KL8D?#.J(IZ+1OVA?@'XBT35?$WA_XV_"77?#
M>@ZTOAS7/$&C_$7PCJ>AZ-XA>8VRZ%JNK66KS6&G:PUP#`NF7EQ#>M,#&(2X
M(J"U_:/_`&>KWP;KOQ%L_CM\';OX?>%KUM-\3^.[;XE^#)_!GAO44>*-['7_
M`!1%K3Z'HUXDL\$36VHWUM,LL\,;('EC5G9WM9W[===@/YN_#W[-_P"V1\1[
M[P%XQ^(?PO\`VF+WXJ6W[,_[7GA'XOO\0H?A;I'POLOB9\1/A9=:-H/@SX,>
M'O`D\)A\,WNNNMKHFKW4,^GWFG?8UGU>[U4W*1_1W[3O[$OQQ\:^%_A'X;^$
M_P`,TT;5!_P3%_:`^!GBN\L#IGARUC^(&K:Y^S3K/A7X>ZU?P&W3[5KB>%O'
M-M8R3R-96I7595>$3S-)^T>I_M4?LPZ)H'A_Q7K/[1OP)TGPOXLFN+;PKXDU
M/XN>`+#0?$UQ:2"*[@\/ZO=>((M/UF:UD(CN(]-N+EX'.V4*W%>.>)?V^?V?
MM!^+OQ'^!<?C?PI<_$OX??#+P-\24T:[\;>!M%M?%$GQ%E\7+X7\$>'M1U?Q
M+9QW'C*XM/"D.L7>E7,-M]CT'Q3X4UN29M.UFUFD+/L_N`^;_P!E+0_&VM?M
M&_#_`,:-^S!\1/@!X%\$?LG:+\)I$\;Z-X4T2W?Q98>)XKV]TC2;;0-=U:ZN
M;'2K6,06NK7EM9Q:DACEM8S$QEK:^)WA'XN?`+]O[6_VK/#'P9\:_'/X3?&/
M]GOPG\(/&]A\,CX?O/'GPZ\7_#?Q9X@\1>&-;7P[KVM:++XA\+>)M/\`%6J:
M=J0TBXEO-(U&QT^ZEM9;>5V3ZZ\+_M6?!Z;P-\)O%/Q-^(7PT^$&M_&/1M-U
M7P?X/\:?%+X>P:GK$^IK`8M+\-WUMXADTKQG.DEU;0)=>%+K5;.[DGA^R33+
M+&S]UXG_`&@_@+X)U@>'?&?QK^$WA'Q`U_I.E#0O$_Q$\(Z!K']J:]'<2Z%I
MITS5=7M+T:AK4=I=2:39&`7.HI;7#6<4PAE*H#\[_!O@/XH?&?\`;?G_`&D/
MB'^SGKWPT\)ZA^Q'KWPIT72?B#+X0U_7=/\`$4?Q^US7=/L]1;0KW6M,TC6_
M$/@DZ?X@GT:UOKTZ;!=+I=]J$]S;.J_F+J_[,/[8[?LS_P#"@?$7PK_:4_L2
M']F3XI>%/A]X+^"FJ_"WP[HUQ\0O%/C/XHSC3?C%XDUR_L=831(]'U3PW+9Z
M+::@VE76B375IIUOJ&K306;?TL?&/XP>!/@3\*/''QH^(NM1:+X`^'GAG4O%
MOB35]AN#'I.F6KW,BV<$9\R]O;LK';:=90;I[^]GM[2W5IIT!^7?@U^V%\3?
MB/X@\/Q>/?V2/BU\#O`?C'PUJ?BWPO\`$;QQK?@V]TB'1].LK?58U\>:;I.I
MOJ/P^U&_TFY2\AM-7^TI;-%<VE[<V]U;RQJ`?E_-^QW\?-8G^)L&M_"+4KO3
M_%WB/_@CK,;>_?2[Z#6+#]GJ_P#-^-;SV[W31R6_@B%]^L&=E>Z4DVL=PZ^6
M_P"PW@;X_:5JG[2?CS]EWP9\.KE=#^$/@7PQXD\8?$.PN;'3?">B^(_&C37N
M@_#[3M"ALS)=:L^A1/KVHSV]Y%#IUO/9QS6S27BLOH/A3]I3]G3Q]H/BCQ/X
M'^/7P8\9^&/!,IM_&GB+PK\3_!/B+0/",VUF\GQ/K&D:W>:;H,F%8A=5N;0G
M:V`<''':7^T1^Q_IDK^)M)^/W[.EHWC7Q:?#4FM:?\4OAI`/%?CJTCM-._X1
M]M2MM<7^V_%-G%+8V1TDSW.JVZRVD#0(KPH0#Z=HKR+7/V@?@/X8\4P>!O$O
MQJ^$WAWQK=7DNG6W@_7?B)X1T?Q3<ZA!I]GJT]A;^']0U>VU:>]@TK4=/U.:
MUBM'GBT^_L[R2-;>Z@DD\\\2?M6?"X^$-!\;_"OQM\+_`(N^&[_XI^#/AGKV
MN>%OBYX!&A>&9?%&NV&CZA?W6NG5KG2KO5=`BU"&\7PA!<KK^N3O;:9IL)N[
MJ($`^H**_)O3_P#@LA^QA>^"/`?C&3XO?#&RNO&GQ=G^&%WX0N_BQ\-8O%/A
M#2XO$?B;05^)?BW3/^$E:YT;X>W$7AV/6+7Q)=0PZ=/I6MZ+=I=-%?12-]QP
M?M9_LL7/B'PAX2M_VD_@)/XJ^(.DZ-KW@+PU%\7OA_)K_C?1/$2,_A[6/".C
MIX@.H>)-,UY$=]&O]'M[RUU14=K&6<(Q#L[7L[=^GW@?0-%>/0_M#?`2Y^)\
MGP2M_C5\*9_C)#:RWLOPHB^('A63XC1VL%LU[-._@I-5/B-4ALE-[+G3LQV>
M+IPMN1(?8`00"#D$`@CH0>0?QI`+1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`?BK^REX5^"?Q#_`&DO^"AVH?M':=X'U[XS6'QU?PF^E?$V+2-1
MFT/X!Q>#?#\WP]M/#</B(R0V_A+6?/US4;M].7[++JINOM!6XA&WX/\`%\'B
M;X7>+_\`@I1\>/V2OCQ??"SX;_LV>%OV,/&?PR^'_P`.]&\$Z]\,_B7X<T_]
MF_PM;Z1IOB^\UO1]7U'4/`P\*VW]FZ#IOA'6-!@@FOYM5OKS6WMM/M[7^@/X
ML_L=?LS?'/Q#!XK^+'P<\%^-?$=M8MIB:UJFFB/4Y=-9VD.FWM]8R6EUJ.G;
MW<BPOY;FS7<P$(#,&Z.W_9G^`UGX?\8^$[#X5^#+#PQ\0-"\,^&/&F@66BVM
MII/B'P]X-T&W\+^%-&O["W6.V_L[0/#UI::1I=K#%%#:V-M#"BA4%`'X%^.O
MVGOC?X9\<_$_P+X!C\7:;'\;OVZ--\!:]XG^#UM\%O#?Q(\/^%[?]GRS^()\
M,>#O$GQCUCP1\+]-\5^,-7L(]'M?%_C_`,23ZK::1'JL.@P7WB.71A#RMOX#
M_:5^._[0G[%/@C]H;XK?&SX>ZMH?QB_:D\*>!=67Q3^S'XG^)T_P]T'X6Z5X
MO\$^*/B(WPQMOB[\(H_BI'::MJG@?7Y;*YN&OO#=G;^(1IVDZYK37\?]#VO?
MLS?`7Q3X?\7^%?$7PK\':SX>\>ZSIWB+Q=I5]I$,UOK>OZ1!:6NE:W=,V9DU
M;3;>PLXK'4+>2&[M!;Q&":-ER8O`O[,'P"^&7_")_P#"`_"OPEX6;P-J7B'6
MO"DNEZ<$N-'UKQ98+I7B75XKJ1Y+F?4]:TQ(]/U"^NY9[FXM(HH'E,<4:H`?
MF]_P5B\,:W/IG_!,CPUX4@\&ZYXEC_X*,?"S1]`M_BA9W=SX,U?4E_9K_:?M
MX1XLM/#]M'/)9W9B,MS'IMHC&9A]GMA%NC'S-^V'K7[1/[.T?PSU7Q!HW[.O
MPU\;0?";]N;Q?X?U#]G7PUJMM8VVH^`?V<[CQ!X6UBZN_&VD1:C:Z[IGB"%+
MR!M/!LYK<10W@G56C/[]^+_AOX)\?7?@F^\8>'-,\0W?PY\7VGC[P3/JEN+E
M_#GC*PTO5M%LO$FF%B!;ZM::5KNL6-O=@%X[;4KN-<"9LY?Q!^#OPT^*IT[_
M`(6'X.T/Q;_9>E^)]$LUUJQCO%ATCQKH[:!XLTZ-9.$M?$&C.VFZG&O_`!\6
MC&%CM-`'X82_&?XS?LQZ_P#!3Q1\7_VL_C)\1_`'[1O[%O[0/QD^)@U/PQ\.
M9KOX7>+_`(5^%_A7XITGQ!\#M&T/PGI;Z=%%;^-]<T>/P]XKU'Q3]O$6EZAK
M>N7^HP7U_>_+G_#7G[5NB^!OVF?#F@_%3XQ^%VTOPA^P/X[^%?B+XQ>,/@G\
M5OB9X=3X\?M5>$?AEXCU'69?A1;'PS::;XE\(RRW%S\/;[7-7DTU-3U&T74=
M.6>VBLOZ8]5^!'PCUQO#+:QX!\-:I_PAGA/7_`WA47^F070T/PCXIL=.TSQ#
MX>LEF#HFDZQI^DZ;9W]FR-'<06-LC@^4IKS+P]^Q/^RUX2TK4M$\,_!+P!H6
ME:Q'X;BU:QTS0+2U@U)/!_BN#QQX6^WK&H-V?#_BRV@UW2&N#(UA?Q1RP,H1
M5`!^17Q2^)'[07[-WQ=^+/[+D7[6GQ0\4>&?$&D?LI:O;_&_XH6_P\O?'7PE
MB^,/Q*\9^`OB)JNEWVA^"_#WAB#3;JRT+3;K1DU/P_<67AO5KZ66UCDAEBB@
M[WXL^-S^S+\?_@Q::W^U%\1/C#\,M#^`W_!03XE>+O$^JKX&\8?$7P+9_#OP
M/^S5K-C8:;JV@Z#;W&MZUX>BU[Q)KN@6>HVXEGB\3?V?JBW]C9:8(OU_\6?`
M'X-^.[SQ3?\`C3X<^$O%-UXV\,:?X+\5S:[HMGJ+Z]X5TF]N-2TO0=0^TQNL
MVG:?J-U<7UG"5!M[N5KB)DEPXYGP?^R?^SGX`M],M?!WP?\``^@PZ/:^,[+3
MUL]$M6,5K\1(M'M_&]O*\ZRR7D7B>W\/:%;ZRMZ]P;VWTC3;>5C!:0QJ`?S8
M>(OV@/B_XX^%W[0_P[\2>+?BIKOPU\2?LV_L[_&GPEIOQP^*?PG^+/Q'L+K6
MOVB_A_I5CK.JZG\)=.LM&\(7/B+09[6_U'P3+J&LQ:==M(;2XA1)(1^NW_!3
M2/PK+\$_V?%^)4ZP_`A_VE?V>F^.EW<-,N@1>`X?$EM<B+Q9/!GR?"-QXFC\
M.P^(9)P+(:>TXOI(;<NQ^P_#7[&/[+?@W3-4T;PK\"_AKX>TO6[./3M7LM&\
M+:;IL6I6$6NVWB>"ROC:11/=VUMK]E9ZG:QW#2?99[6`0%(HDC7WC7?!_AGQ
M/X;U'P?XCT/2]=\,:O:2:?J>@ZQ86NIZ1?V$R[);*\TZ]BFM;FTD3Y'@FB>-
ME)!&,8`/P7_;NTOX5:K^T+^SEI_P`U#1M#^(]U\%/VK+/XHZI\'KC1;/5;/]
MGI?@EK-_IU]XBDT""YM;?2H?BG9>!X_#$^JPLLMY=:E!IZ3>?=8^4/A?^Q'H
M?A+X]?LD67@+XV?&[PBWBG]@3QC\>;VZT_7/".H6\/B*!?@S+JFBV&E:MX,O
MM$MO#>N_VB\.MQ)IQU.\6UL]^J"2%GE_HT^&O[)O[.'P<LO$>G_"WX->`/`U
MMXOL)M*\3_\`"/\`AVPLI]<TJ>"2VDTK4+M8C>3:7Y$TT4>F^>+&%)9!#!&6
M)KOH/@]\-+6^T#5+;P;H5OJ7A;P5=?#GPY?0V,4=SHO@6]%@+KPM82*`8-&F
M&E:;OLU_=DV4#8R@KIHXS%8>G5I4:TJ=*MR>UI))TJW))2A[:#3Y_9R7-3LX
M\DDGKL\*V'I5W"4XQ<Z7-[*I;][2YURS]C--.GSQO">CYH2E'2]U_.M^Q'?>
M)OB+8_#KX:ZK^T)XZ_9K\.W'[''@?]IW6/'/@S5_!_A7Q-\8_C!\4/B'\0?#
MGBSQ-JVL^)=!UK2=1\(_"G0_`WAJQA\'VNG66CQW?C:&34K(V5MI$4/1:/\`
MM%_M?_$GQ_X^\8^$];^,LNM_#?\`:@\/_#&RTT_$C]DGP/\`L\1_"S1O%'AK
M0-83QMX(\6_$#1?B[K&O_$3PGJ6J>,M-UO2/"<\]QJU_X:L/"`6RAN4/[?\`
MB3]D#]F?QAH'@OPMXF^"OP_UOP_\.89;7P-I>H^'K.YMO#-A<"(76EZ:K)N3
M2+LP0M>:3(TFFW;0P-<VLK00E+'B']DG]FOQ7XVTKXC^(O@K\.M7\<:)_93:
M;XDO/"^E2:A!+H3I)H5PY^S""ZNM$>-&T>YO(;B?2RD?V"2W**1G7KUL35G7
MQ%2=6M4LYU)N\I<L5"-WII&$8QBMHQBHK1!AL-1PE&%"A3A2I0YG&%./+%.<
MG.;4;NSG-N4N\FWU/CO_`():+\9OB1\"?!?[1GQC_:'^('Q2U7XA:)XKTBP\
M`:G8>$=+\`>#[#0/B'KVE:?J6EQ:1H</B;6/%E[::7C6_$'B#Q+J=G<0W266
MC:/HFG65E;I^IU<IX)\#>$OASX;TWP?X'T#3/#'AC1UN4TO0]'M8[/3K%+R[
MGOKE;>WC`2,37ES/<2;<!I97;'-=761N%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%?E-^U-I
MOCWX&_MG?!C]L'3OAWXP^*OPLA^#/C[X&?%33/`.BOXJ\:>`8=<\0>&_%VA>
M.M&\,6KC4M0T9[[09=*\3KH\%WJ,=O<6<BVLD$4N/U9J-XHY""Z*Y`*@L`2`
MW4#TSW]:`/P#^*GBN]^(_P"U/\&/VN?C;^R)\:O%G[+FF?!#XV?!?PS\/?%G
MPD/CWQ3X&^+&I^.?!WB30_C'=_"01ZKJFD:?\3_!OA[5/!6E>(GT_P#MG1XK
M6WLKV&PL_$]S(OSQ^SK^PUXCU75/B5>?&K]F9'\+WG[&7[0<'P6\&>.?".G:
M[%\+Y_B%\8OB!X@\%?#71[._@OK7PSXJM/"&IZ.%T;37@FT>"XBTN&1!;>4G
M]0#6T#C:T2$8QC&!C(/&,8Z#D<\4_P`F+&/+4CK@C(_'U_'KUZT`?RE?'/\`
M9>U+X6?LQ_LQ>+](^!W_``A5_IO_``3&_::T+]IC7-)\*6>AZCJ'CKQ)\._@
MYK%MI?Q5U*TAMKC7?$6L^-[/Q5J0/B*XO;B?Q')K-_)+]MO+R>:QXX_9I^(W
M[3?A$#]C']G#Q;^RY<^'O^"??Q)^%GC#Q7J7@&V^!8^-7C7XAVG@.[T#X<Z-
M+##9V^LQ^1H/BVYC\<3VU_I6EWWBZ&Y6:XM[R[!_IZ^(/P\\)?$_P3XE^'?C
M31K77/"'B_2;S0O$>BW.Y;;4])OXFAN[.;R\,8YHVVL`1ZC!YJQ*GA?X?^$`
MDALM"\*>$?#J0M-/,L%EI&@:%IPC1I9I6_=VME8VHRY)(6,<%B,M*3:48RG)
MM*,(QE*4I-I1C&,4Y2;;222;;8;G\Q>K_LEZ/XL\!^+O^%;_``H_;,\0:GXI
MN/V;/"OCKP9\</@/\!OA!\/H?#O@SXN:'?W7ANS\'_!/X&?!K1O&.J>!=#.M
M:=>^(I[3Q)I%GX6^V:;9:F;.[BB?U7]J']CKPOI?[17QQNM)^!OQI\#_``K;
MQ)^QA\2OAIXH_99^#?A3QGI'A_XP?#SP/^T]I&J>,M>^$=_X>UKPM\0]%T[3
M=7\.^%/%&DW/A?5&34O$?@S5IT@ETB'4;;]D?AM^TK+XO\:^#/#GB7X>ZOX)
MTKXI^']0\5?"C6-2NUFDUO2--?>;/Q!8_9;<^&O$-[I<EKKEEHYNK]Y+"Z,,
MDR7MI<PK]<^3%DML7)ZG')X`R3W.`!GK@`=!7;C<)C<#5I1QE&-&<Z4*]/EG
M"K&47*4)+F@Y1YZ-:G4H5:;?/3JTIPJ1C).*J<)0=I*S:NO-'\K<7P[_`&J-
M;@^%FB?&3X#^-_"'PDUC3?CBBZA^S3^RI\#_``Y\6/B!KNL>,[.S\$6GQ4TC
MQ1X&\<1?!&+Q[X8BGU3Q?_PCMOH,E_<6\=YK6MZ6D?V9O0?AU\"/$WPR\7>&
MM4^)7[+?C;Q)K?Q4_P""7?[+_P`&_#7BS3?A7#XON?`W[1WP\@^-%IXOMO'V
MLP6-S/X(\20Z+XM\"VZ^)+N:-+FUTI-/CO0=*AA'],$EK;R@B2&-P>NY0?3_
M``'-(+6W"A!"FU1M"D9`&<X&<]ZY95923344GV376^BO;\/2Q)_,!HWP-\=?
M#CX,>+?"/QB_91^(_P`>->^.?[`?PF^#7PF\-VOPWC\9VW@'QSX=^'&K>'M9
M^&WBK4;NVGL_AA`WCNXL/&=SK=]<:=I]K*[ZPMXM_I:^7[7\._V'/%VG^$_V
MN+'XY_!^U^+WQ:LOV+?V/_AEX0^)?B#PG8^*=6\<?$_X;?!;Q7HGCN]\$^(-
M1@FO9=1?QW;Z5J-Y<V-Q;32ZE+87<C&9$9?Z%?LUOA1Y,>%QM&T?+@Y&/3IV
MZ]ZD,49ZHOTQQTQTZ=*S`_.W]L_]GGQY^T;_`,$[/%7P/\*0V</Q.U+X:_#G
M5/#FG>(R8K*[\=?#J^\*^.=+\/:W(9D-O;:SKOA:+0=4E=I%BM[ZY:5)(PX/
MR-^U/\6_VCOVR_V6_B9^S_X,_9%_:(^&OQ!\3_#(WGBB?Q[I%EX2\(G4_#.O
M^&=7UWX7:-XG_M40>+$^)&B6.O\`A>TU#2&FTN33K]EU*:&.\>$?N68T8!2H
M(4Y48Z'!7(]#@D?B:C^S6X&/*3`.>G?.<_F<^]`'\VWQ0^!_CG]H7QMXQ\:_
M"C]D[X@_!?X>Z-^PQ>?`SQ_X0\4_#R/X?W_QG\;^(?'W@75/"G@>V\%M'$GB
MCP]\*O#_`(<\3D>)F@FTU5\4'1M)O+BSGO5EZW]H[]A#1KZ7_@K=_P`(%^RI
MX;E7QU^QUHFA?LWQZ!\,]!MH=5^)UE\&_$\$5A\-ULM/A%AXAMO&4?A]99-)
M^QW*ZK#I\K2F6"%T_H>,$+*5,:%3G((ZYR?YDD>F3BE$,8``10!C``QT.1^M
M`'\_G[0/['FJ_$[P!^TKKVJ?`,>+/B1XR_:(_92UO1-4O/!ME?\`BK6O!?A'
MP)\#+7Q<]EJ5Q;MJ$VA:5?6OC*UU2V^T"VC>WU>-X6!D#=CKW[,WBW1OVDOV
ME)_`OP8O-%^&/B;]J;_@F7XW\+Q>'_"UMIGA34=*^&NJ>$H?BGXJT>PLH8+&
M.+PI9:=`GBG4K:WAFBM;(K.\L<;+7[I>5&?X%].@[`#^0`^@I1&@&T(H`X`P
M*`/YG]/^$?Q<\+?`?PE\+G_99^*%WXJ_9M_;QU3XX:Y>Z?\`#FSO-,\>_"+5
M_C)\2M7LD^&.HC<OC6>T\-^-=)U>?1;1X[F""SNH'1;F")'SM=^`/B[QGXM^
M.EI\0_A%^WQI_AO]H#XQ>$OC9X+\-_"'X>?L[V?AJ_\`#MQHWP[D\&:/\1?%
MWC#X.:_\1OA-XY^$;>'I/"MSI5Y\1M(AT72/"]A_PB$EB+Y//_IM:UMVQNA1
ML8QE<XV].OI3_)BPR^6H#?>`&-W3J1R>GX#@<57.^7EZ+U[W[V_#JP/YT?V>
M/V8_B;X#^,'A'P5\6M#_`&R=2\2^%_VI_%7QET?Q%X.T/X$P_LYZJFLZMXHN
M[#QWXG^(]O\`"B'XH2&3PGK5QX;\0^%]6^)CZSJ!NCIZQRV#"./^B^,$1H#@
MD(H.WA<X&=H.2!GIDGBFB"(8Q&HP0>,CD8P>#R>!R?2I0`!@#`'``Z`>E2`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44'H<=>U<!J_Q%T#1/'G@
MSX=7L\H\2>.=.\3:KHMK%9W,T+V'A)=*;6;BYNT!@LUA.LZ?'")R#<33B./Y
M@:NG3J5ING1ISJS5.O6<*<7*2I8:C.O7J-+:%*E3G.<MHQ3;T&DW>RVW^>QW
M]%%%0(****`"BBB@`/`-?&G[1DO_``M7Q7X!_9OLY)?[/\574/CGXGM;EQ_Q
M;7P?J5M<OX>NW1XFCB\;:]'9Z'<('!FT>/6$P5;-?9+LJJS,0J@$DG&``"23
MGC@<\U\D_L]V;>+_`!E\9?C3=`2CQ3XQF\'>$YFY,/@OP*&TF!+<G<!!?ZQ_
M:>H,8R%DDE+$<8KT\MDL*L9F;;53+\,W@K6;>8XJI#"X2:B]&\)[2IF%W>'^
MR6G&2E8TANWII:UUHW?OT[=]=GJ:7QW\.I_;'P&U.S@@6Z\/?&'PS]EF15B-
MI8W=M?6-S;0@8V0RP$1-&!L9!&I&5!KZCC&%`)S@D9ZY^8U\P?'O5)(O'G[.
M/AZ.-94U[XM6LUTOR[U@T31-6U02-G+;4EC4X`QZFOJ$#:,=>O7'<Y[`#]*U
MQBG')\@C.7,G3S.K37-S-0J9C6YG+JI3K1JU)7^*4G-ZR;"<I2Y7)W?+Y=6W
M\^^HM%%%>.9A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!14,\JPQL[.J8!(+]/J1E>`,D\C@=
M:^6?'_[:?[-7PT\1/X5\6?&3P-8>((6B%WHT.IQZEJ&GK,!LFU.'39KJ73;8
M$DO<WT,$,:Y+N-K&NK!X#'9A6=#`8+&8RJH.;CA,+7Q+C%-)N:H4ZCA%73E.
M:C!)ZR1RXO'8+`4_;8[%4,)2NHJI7J*$7)[16[;?I;I>^A]645Q_@GQSX8^(
M6A67B7PAX@T7Q-H=_#YMKJV@7]OJ>G38;:ZQW=M++&Q1LJRY#*0=P!XKKR0,
M9(&3@9[FN><*E.<Z=6E5HU:<Y4ZM&O3G1JTJD&XSA4I5(QG"46FFI13^1T0G
M"K"%6E.%2E5A&I3J4Y*4)PFE*,HR5TTT[IBT445)04444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`=*^8TB3Q'^U8MZ"LD/PU^#;Z>59<M#JGQ)\6VUV7]$8
M:9X"B3/#,MT`!M8U]-M]UL=<'^5?(WP$N'\2_&#]I3QB$D%H/&/ACP1:.W"3
M1>#]#$K31G)#IYVKD`K@`EQR<FO6RNE-4<YQJ44L+E,J$9MV:J9EC,)@)QAI
MK.>%K8EQU3O%V>Y<=I;[)6W3N_5:K=>9]=444A_J/U(KQY248N3UMV\W8@R]
M3UG3-(:P34M0L[!]4O4TW3DN[FWMFO\`4)8Y)8K&S%Q)']IO)8X9GBMH2TTB
MQ.40A3C1=P@)YP%W9'/'T],=_P!*^<OC!:)K'Q&^"&GR[7CLO%FI:BD,PRKZ
MDFB7ESITD9.%62&TT[6LM@[`X4C]Z#7K/Q!\0OX4\%>)]?@C$MUI>B7MS8PL
M`5FU`6[)IT!#'!$]\]O%CD_-757P<HPR[V5652OF<'*%)*"5"7UN6#I1NO>D
MYSBJLE/W53DK7V5I+W;WUO\`/5+OM^.C^6OI7BGP_K=UJ5EI&M:7JMUHUZVG
M:O!IU]:WDNE7Z11S-9:C';2R/9W2QS0N;>X6.8+*A*88&N@!R,^^*^$?V;OA
MI'\(?B5J.BOJ6H7FK_$CX7^%?'GBVWO;F:>)O&6CZE?:3KNKVA=V"RZC%JNF
M)J.XF026MH5)211']W``=*VS+!T<%BW1PV)GB\,Z-*=/$5(J$ZD[..(;A&4H
M1A&O&<*7*VG"/-:+E8)I)VZV7I:WWW>]M=]WN>:_%_Q+)X2^&OC/Q!"P6ZT_
M0=1>RW,%!O9+>:&T7/7)N'B`QSGT&34?PC\'CP)\.?"7AB1=EQI>B6@O<8^?
M4[B/[9JDKXZO+?W%RQ)))SZ]<#XY*E[X<\.^'G42CQ1X_P#!NB2PL`PFL;C7
M;>74UVY&Y8].CN)6!R`L9)&!7M6Q0F"H'R8QSCITQZ5C*=19/'#KD;Q&,Q%?
MFE)ZSPN'I82AHDWR*=;&N36K56R3=[/2*6_O6:MV5K_>T]/,^-?BO+<:Q^UG
M^S!X?#A+73M*^*'C.8!=V^33-&L]+MD8<[03JDC)(<;77&23BOLZOC/4XFU/
M]N/P>@*M'X5^`WB6^*^8%:%]?\5:98*0F[+B9;0@\#:(\Y(R*^S*]#,I4_[.
MX8IPA*,EP_&M6<FWSUL9FV;8M35VVDL/5P]);)JDK)QY6RI=2MI:R:MLDTG;
MY;/S"BBBO',PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"JUW<Q6L$L\TJ0QQ122O+(P6.-(U+N[LW"
MHB@LQ/"J"QP`35FOS_\`BUK^J_M,>,;S]GKX?>(;[3O`&@.J?M!^-=(9C,MO
M=)"UM\*_#^K)Y<</B#6X'EEU^\M3/)HFDJ8I4^U:C`B^EE>7?VA7E&K7C@\#
MAJ;Q.99C5C.5#`8*#2J5JG)9RJ2NJ.$H*4:F,QE2AA*+]M6@>9FF91RZC3<:
M4L3B\346'P."IM>UQ6)E;E@E>\:,%>IB*[_=T*:O-IR@I)<?$/QU^U;X@UWP
M=\+=7NO!?P-TB]N_#_B_XL6$>W7O'=S"[6^J:)\,;LEH;+3K=A]EO?%Z+-(L
M_F1Z6`Z&<>QZ!\'/V>_V8OA[KMYX<\)^&O`WA;1M.OM9\4ZQ);6\][J$$,+W
M6H7NOZS?B?4-4ENBK23_`&VZF-Q<.VV,N^#[+X?\,^%?AYX4TS0-!L+'P]X7
M\+:5#:Z?8VP2TL-,TS3H,#'*QQI%#&SRS/@D!WD8G<U?GVZZG^W?X\LKJ.2[
MLOV0O`^KQWUEN)MS\?\`Q?HET?)FDB=5N'^'&@WUM(1Q'%XEO8TDC:6PCR_O
MX::SIXG"8>K6R+@C)W2KXW%TZC6,Q*YHJ@\4Z52@\WSW,*L5#"X2E45*A#VM
M:-/#9=@<9BH?/UZ/]G*%>NJ&<<5X^%2&#HU6W"DHJ,IT\/2Y92P^78%U%/$5
MHTE.K&3J3BZT^4X?]E30?VD8K?XB>+O@YX/^'?PM^%'QD^(^M_$[PK:^/5UF
M\U;3]%UBTTJUM_[-\':.NFVNA0ZU]@DUUH)[E@EQJDA^SQ`%#]I)X-_:2O42
M74/CIH6E7@9F2TT7X8Z/<6/0E$DEU.]EN73)`;#@D#(.1@_1>FZ7:64$$$-M
M!`D,*QI%`-D4:QA8XTB1=JI&D:JB(JJ%50`.]:GDQYSL&3WY_P`?\CCI7%F?
M%>+S+,*^.HY;D^$IUW&-.-3+J&98BGAZ-.-'#^WK9U3S*IB<1.C3I_6*U\-/
MVCG*$D[7Z\MX9IX7+L/A<3F6;UJL8<U5X;'U\LI1K59.M65"C@9TXTJ4*DYQ
MI45>,:<80O9'Q7X0^./Q/\&?&S3/@-\<T\-7FH>.-$U/Q!\)O'OABSN-,T_Q
M=_8&9/$?AC5-)NI)ET_Q%I5E)#JB&TN)+:\T_P`V1$1TVG[2@=GC5G^]T8@8
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MK=9+FT6=;H6TK<F`7")&DWEYVF14"L0=I(&XZ=3LVG:\79V::OILUI):Z-:/
MH:1DI1C)72E%25TXNS5U>+LT]=4TFGH]0HHHH*"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`Y3QGKL7
MA[PKXAUR>00)I>C:C?&?&?+-M:RRHP7C<=ZJ`N[YF.WC.:^9OV)=,EMOA-JV
MLW(G:Y\3^/?%>KRSW+;GNTBOSIEK=IP`(;BUL(98MH`*L#R26/2_M0:C*_@:
MQ\+V?FB;Q=K]E8W<D+%#!HNDF37];G+*,[$L-+DC9=PW"0CN<])^S/I[:;\#
M_AW#)$L,UQH4.H3HN`?/U*=[V5FP%RS-,2>._P!:^@IR6&X,QE1PASYEG>'C
MSW2E'#X"AC7""O%3<98J&)A*WN7H0FM9<JU:2BEJG*VCVMIKOW6BWU>NEE[T
MQP"?\]:Y#_A--!3QM:^`&N'_`.$FO/#E_P"*X;-(+AXET33M1T_2I[J:Z5&M
MH'>_U&&&WMYI4FN!%<R0HT=N[5ULGW3]5_1A7R_H)M+O]JWQ5>"5I;S3OA8N
MD?=RMO92:WH-[L#X&5EOFN04&2DENY8_.@'E83!PQ;QLZDJL8X/+<3BTJ<N5
M3JQJX:C1C4?+*\%.LY<NG-RN*:;NIBKQD^NWY?UUV[79-\2();WXT_`]EDV1
M67B+Q3,\(D9&D>#P5J44+."%&TMJKX&&`/.>>.O^.,DTGAK1=&@0._BCQCX3
M\/R*<D+;7.K6]U<.5!&<1V9`)XYP3BL7Q5:I=_&WX7GR]B6EC\1-7DD^0%I8
M-*\+Z9`^`2QV+J+@;@"-IXQUZ#Q[$NH_$7X2Z8;@HMMJ^O>()[8`GSTTS1YX
M[5VP1A(;ZXA8$\!RHZD"O1FE3JY%6;C)4<NK8V$5)[T,=F%2*;6L6JF"=K75
MFG96:*3^&WV8-ZJRU=_3YV]=;LX;7IWB_:S^&6GQRB&+_A0_Q>N)8$1@;HQ>
M./@[%`9&5#&%M`\IC5I%?=,Y1&7=CZ=BYC7/O_,U\IZW:M<_MH>";I'&--_9
MP^("-$&;).K?$GX>E7:/H0JZ0P5B,AFQG!Q7U;']Q1Z#!^M<F;4X0GD?(T_^
M,<PLYV6GM:N:9S*47J_>C'D;;UM):)6"2]R+]-/*VC^?0\1^($1U/XG_``<T
ML$/#9:OXI\57L)`8?9]&\-W>D6\I!.%,6K^(-.97P<.RC'0CV\D!"Q^Z%)..
M>`,G'KQTKPBR%U?_`+1FLR&,FQ\,_"6PMHY>@%]XT\6WT]U$4'4_9?!.FN'.
M3M95!QFO=^B<_P!W^E8XM6IY?3=E*.74IS2:=GBJM;$Q;VL_9U(7OU3(E]G_
M``K\EI\G?[SXL\%RKJW[;GQ7NW"L_AWX+_#_`$.-P>8GU'7M9U:XC(]9%2WD
MQV'7D5]JU\7_``'B6X_:._:VU4KEXO%'PNT!9`N3Y>G_``^M[J2$.?X8[B_9
ML=MYQ7VA7H9]S0Q>#H2E&2P^0<,QC*+37+B.'\MS!QM'2,J4L;*C-7;]I2DV
MU)N$7/?KHDM=_/\`'\->H4445XA`4444`%%%%`!113=R^M2Y1BTI2BFVDDVD
MVV[))-ZMO16W8#J*;O4=3C\Z-Z^OZ'_"J`=13/,3.W<,@9P>./7G%1O=6\:-
M))/%&B!B[NX1%"C+$LQ```Y)SC'.<4KIOE33EVOK]VX$]%>?:A\2O!-JWEV_
MB/2M3O&E\E;'2+A=7O/-QRK6VF_:I(V!QS,L<><AG!S6EIGB"_U5F:/0-2LK
M7"DSZG&MD[$J&5H[8O+-(C`Y)`7:2%P3TU]CB.55)494Z?,TY5FJ;=MG"+NY
MI_+RN]"G&WW+?3733>^E]SKZ*0=!G@X&?R]^:6LR0HHHH`****`"BBB@`HHH
MH`****`"BBB@`HI"P!P3@FOF#]HOXWI\+-+TK0O#6D2^+?BSX_OYO#WPU\$6
M;A+K6=7\HO=:K>2<_8O#_ANR\S5]<U&4!(+:$11;[F:%&Z<%@L7F6,P^`P-%
M5\5B92C3IN:@E&$)5*M:I*7NT\/AZ4)UL36DU"A0A.K/W8M'%C\PPN6X6IB\
M75C3HTY4X7WE.M6G&G0P].*O*=?$591HT*<4W.K.,5O<XS]HCXM^);SQ+I'[
M/_P<ND/Q5\86LUWKVMPR&6V^%W@1F:"_\8:R8BRV]]<<VGAJRFV37M^3,B_9
M[:1QZQ^S]X*\">`_AW:>&?`,HO-)TK4]9T[4=8N`SZCKWB;2]4N]*\4:MJES
M*BSW6HSZ]8ZA%<W$V?-D@+1'[,8,_&4]AJ_PUN+?X(?"N_7Q!^TW\6H+?Q#\
M:/B_<1)J,O@_39%5+_Q/JC,&\A;8--I/P^\+LT<$")'-Y0CBFDD_07X;?#S1
M/AEX.T3P?H`G.GZ1:"(37+O/>WUY///?:GJE_<.3)<:AJVI7=WJ>H7#L6N+Z
MZN)V^:1L?3YS2PN6Y%@<LP6)5/#8RK3QRCRJ.-S^>'<Z-?/\?37+]7RZ&*4\
M)D&%J<U:K"AC<;4CAY5E3?R>2JKC\[QN98JE[7%8>E4PZ<I*=/)J.*]A6P^3
MX6:45]>J4%2Q6;UH*5.C4GAL)&55TZDX^`_MW3^);7]DSXX7/A9[F.ZM_!-S
M-JLM@S+>Q>$TO++_`(3>2V=&5XI8_!AUV7S(W26-5:2,AT6OHGX?:1X:T3P;
MX4TOPC8Z98^&;#0-+M?#]MI,4<>G0Z/#9I'IPL0B@?939B(PMR7C*L2Q8DZ/
MC73-/UKP=XJT;5DCETK5_#VL:7J4<H!B>PU#3[BSO%D!X,9MYI`X/!7.:^5O
M^"?FKZIKO['_`.SYJ6MSR7.H_P#"N[#3A/,29+BQT>\O]+TJ<D_,PETNTM'#
M/EV4AF9F+&N)1E5X+7(U%93Q31A5Z3Q+X@RG&2H3J-/WI8)<.8F,/=VQU5Q<
M5S*7J5*T:'&&'IR2<\QX;Q4Z4E9.D\HS7`PK6T;_`-H6?4N:2<;?5HP:G[1<
MGVA@#H,56N251B"0=K!2.F[!P2/8XJP2!C)QGI7AW[17CVX^'/PB\:^*=+@%
MYXAM=$N;+PK8Y`DO_%>LLFC^&K.,,"&:?6KZR0C:W[O>Q!537@X?"U<?B*&!
MPRC+$8O$4,)1BY<J]MB*L*5)2EKR1<YQYI.T8Q;E)J*;/<QN*H8+!XK&XE\N
M'P>'K8JL[I?NZ%.565K]7RV5M;O34^9_A/=#XS?MB?&/XK,#=>$_@;H5G^SM
MX-G.][*X\6W<UGXQ^*6HV4CP[)KFRED\+^'9Y;>1X_\`B7W4)D$T-Q&GZ"6^
MWR@$QL!(7`QP.GX_7D=#TKP+]EWX8)\'O@IX.\$32BYUNULQJWBW4F4+-K/C
M/7XXM9\5:S<L0'EGU'6KR[N'DE+2;65"V$4#WU[B",$O*B!02=QQ@#^OH.I[
M"O8XDQ>%Q.9NCE\^;*\KPV#R?+':,?:X/+L/&@L4XK2$\PK^WS*I33E[.KC*
MD.:I;VDO$X7PV(PV4T*^/DEC\RGB,SQJG;FI5LQK?6889-\K2P=&5/"-2CS-
MTM5!KD)JI7U_;:=;RW=Y-#;6MO%+-<7-Q-%!!;QPIYCR32S,D<<:H&=Y9'2.
M-$9F8<9^;?&W[06FV_B&X\#?"^Q/Q.^(<<D\$^C:-,IT/P_*CM`\WBOQ%$DM
MEI$=I*CBXM/,EU(E&C2U\P@#)T#X'Z]XN:76OC[K@\=W5TAFB^'UE%+8_"[1
MPC!K>"30"!+XKN8R=TEYXF>]M6D59;;2[5@&KF66/#TXXC-ZKRS#U(PJ4*;I
MRKYAC*$[?O\`"X-2IVP\6]<1C*V#H)>\JDDXJ6E;/'4J2P^4899IB(3G2K5(
M5XTLOP=:/*G1Q>-4*S^L/F3CAL)0Q5>:NHP4H34;H^*/BGXM2RZ=\&K3[#X9
M$TUC?_%C7K66/26,8,4LO@'2+V.!_%[))E(M=8KX7$T3K;2ZR8YX8_6_`GPX
MT;P4;BY2XN]=\0:HQDUKQ-K<GV[6]5F525$]V_\`J+2($K;:?:I#8VT:HD$*
MA`3Z+:6EO8VT-I:0Q6UK;11P6UM!&D,%O!"@CBAAAC"QQ11HJI'&BJB(JJJA
M5`JQ6%?%Q<?88.BL)@W=3I2G]8Q%=*[@\3BN6C[6<7RMM484Y<J:IQDW([,/
MELH588K%XEXO%PMR35/V.'H7LIQPV&]I5=&$XW24JU646[\[M8``.`,#T%%%
M%<1Z@4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!116=JNIVND:?=ZC?3);6EE!-<W-Q*RI'#!;Q---*
MS.0H58T8Y)`XR2`,T=4E=MM122;;E)V226K;;LD@/EKXQRQZLGQ)UQW:.T^'
M'P\\3V-I.7=H!XE\3:)<1S_N%55DELM*:W8L'+`ZG'&A#$D^V?"/3%TCX:>!
M-,5F=;+PKH,)=@X)9=.MB25D)D#,V2P8EE)(;N*\'^*-A>:;^S;\2-3E@6WU
M7Q7I]]XCU!90[&&[\1ZA9K;Q2K(6(?3M--C8RHK%2]H610'VCZ>\)6[VOAG0
M;>1P[Q:1IB,ZC"N4M(59@.P8J6`[9KW<?*,\DPU"$G.CA\VJX6-[?OHX7+\.
MYUK)6Y*E?,,5537)>=1NVZ6DG[JM;?2U[I)+6]WK?S^5CH)3B-B#CISUZD#I
MW^@Y]*^7/AJ#?_'_`.)^IG88[+P1X:MU,:H8S)K'CSXE7`=)E=C(T^G:+I1D
M!!3]W&ZL,[1],ZG.MKIU[<NP1+>VFG9ST58D,C$DX``"DDDC'7-?,?[/EK*W
MBOXQ7D]P;F2PU?P!X*CDVJ$*^&_AAX7URX>,KGB34O&6I&3+,1/YH)X%<N#F
MJ6`SB=_>>&PM%;VM6Q^'A)-+1MTW5DDW9^S>CM9D%=2[-)/;HT^OR^_[KTUS
M)??M$Z1"S2M#I7@;QC+\N1"K:CKNA6L:'$:8=AI14LWF912OF$$8[6[47WQJ
MTIS(I.C?#[5W,0`W++JNNZ2D<A[A3#9W"J"!N!)4\&N5\.V?V_X_^*;XR12Q
MZ?\`#S2X(,</!/?>+?$$DN%(!4E+:W!8C#!1@G!KH_#(EO?C+\1KJ1E=-)\)
M>`]/B&S:\;7]QXHO[E=VW;(&2WLBV"=N.0N06Z:_[NI44598;A>G2<9)VA]<
MK3IR4+J\6GFUVW=)SAIOS-[:IJT;?-J/2_GJGHSB;>*YNOVQ]5G5O]#TC]G3
M0[>13&2!=:Y\0]:E1EFQ\I$.A,)(@?G4I(P(C4CZB7N?5B1]*^8_"Y:?]JOX
MN79D;R[3X3?"#2Q'P55Y-<^)E_Y@8,0-RSJC+M&5RVXA0M>]:UXL\-^&81-X
MAUW2="@RW[_5]1L].@8+RV)KN:*/"@@DE@`,G.`37+F5*<<3@<+&U:K#)LKD
MX44ZD[XK"PQL8J$>:3DUB96BDW9)6NF3)-M67V4M'>[24?ZM]_;SKP%')>_$
M;XSZZ[R,5\1>'O"5O&6!BCL?#OA+1=6WJ#&AWR:CXKU,-L>50(PI9'#1CV<Y
MV''78<9YYQWY'?W'UKXN^''[2_P&T?3O%5]J_P`6_`]Q?:M\0/'5R8](UJTU
MVZ:WC\27NEZ;YMOH+ZE,Q_LS3M/VR"+88WA*NRNC-UUS^V5^SY&9;>R\6:WK
M=U&A)MM"^'WQ"U1G(4_*D]OX7-FQ.,?\?(`/WB!S79B>'L_Q%?$.ADN;5_94
M,-1FZ.6XR<(1H86G1CS<M!\B?(V^:VK;=M4B5]-[:6;\TOZ^]+8Q?V9H6F\9
M?M.>(I7).J?':\TH*8GC*GPUX1\,Z86+/D.I9W4%.,QLP`#`5]>[U]?YU^6'
MP._:DM-+TKXDS>'/@Y\<O&<_B#XT?$K7+2;2O`L]IIQAGUE+&U@GO]2N+;R+
MU8=/4W5M-!OM)&:*0AD*K[[_`,+X_:'UQC!X6_9=U[3@T0GAU/QOXU\-Z7:G
M.W,,MA8M=7Z/DL#G`4*&SG"UZ>?<.9RLSQ3EAL-@\-26#P].KC\SRS`+V6%R
M_!T4O9XO%T:\Y6A:].E-N2:Y7)-%22;;;=^KZ+;I:^SOV]#[2+J.Y_`$_P!*
M4$$9!_Q_+K^E?'D/_#:OB#89(O@MX#MV#LKI-KWBN\4%LQ^<DD>G6^]5.&6,
MA"1P2.:E@^"O[1>I,9O$G[3&J6DDC/(UMX.\(Z)I-K$2`$BA:^2^F\I>3AR6
M)_B`Z^0LFA"36*SS(\.E:WLJV+S"3[ZX'"5J:2[JH[]KHGEC9>]KWNK>6FC_
M`*UMU^NVEC0@,P4D;L$'IZGCCIWJ-KNV09>9%XR=QP0,9R01D8')SC'.<8KY
M(7]E_P`4WX8^)?VC/C3K;$L`(M:TK1HU0DMM5=,TJ%A@G()=B!@<XJ]:?LA?
M#T_O-:\0?%#Q%<-M$KZK\3?%?ER[1C<8+"_LH07'#J%"D94@@TI8+)H/EGGS
MJM;K"9/C:BOH])XRI@(2CTNI<U]HVNTK1ZR_"SZ>O];7/I>;Q)X?MT,EQK>E
M0HH+,TM_:QA0N22VZ48QCOCTKS[7?CU\%_#)9==^)_@G39%`;R+CQ!IXN&#=
M-D"S--(3U`1&)':N7MOV6?@-!%'%+\.-%U'8%);6)=1U<R,`1OF74;VZCD8Y
M.XLI!RW'S&NYT3X1?#3PV(E\/?#WP3H@MV#P-IGAG1K.2-QTD62"Q202<9+[
MMQ.26S7,YY'1>O\`;>,=VE3CAL'@(SML_K#KYBJ:MK[U!W=TGLRE&#O[UMMW
MZ7TLK]=$_F><2?M7_!69FAT;7/$/BBX91Y,?A'P#X[\5"X+`[3!)H/AV^BE0
MD8,BR>6I(#NM5X_V@-=OW\GP_P#`#XYZZTA/D33>'/#?A&V<8^5FF\;^+?#Z
MQ(?O`3K',%SF$MA3]'K:Q(I5(HD4\$*H4?H!^!ZCM2K;1*?]6F#G.!R<@CGC
MD^YYI3Q64^[*AD>(J3^&<<RSFI.@X2WDJ&7X+!.4XWNHSKINW+SQ3;$FELWM
M??JK.UETUMKY['BUKXH^.FJ`-;_"/POH$3*?F\5?%*(7J,5R-UIX4\'^*;)R
MC'9(JZJHW*QCD==I:E<V'[3>HH%MM?\`@MX2+L0TA\->,O'<T41P2$W>)?A_
M#),1E4F9%BC8;WM;@?NQ[^```!T`P/H**A8FA3DY8?+,MPS?\M"KB;/NEF%?
M&7VVE>/D+G=K:6[6O^=^W0^=!\)/B9K/D'Q?\=O&,BQE3<6'@S0/!W@W3;DD
M894G&FZWXEMHTSD*GB0N2/FD?K6O_P`,\?#2YDBG\0:=K'C2ZA*/%<>-_$NO
M^*I$D3!$D2ZSJ5U%"V1P(4C5!\B*B`+7NE%$\QQTH\D,3+#1UO'!TZ&"33W3
M6%I459[V26NH<[^6EENE;M?^MWN<YI'A;0="@B@TC1M/TV.&/RHUL[2WM_+C
M'1%:)58K]6))Y//-="HVJJ_W5`Y.3P,<GO\`7O3J*XG=RYYSJ5)VY7.I4G4D
MUYN4G=Z:O=]6Q-M[^?X]/1=`HHHIB"BBB@`HHHH`****`"BBB@`HHHH`*0L%
MZY]>`3_(&EKSKXH?$OP9\)/!NO>//'VNVOAWPQX>T][[4=2NW``52PBMK6$'
MSK[4+N4);6.GVJRW5[<R1P6\4DKJITHT:N(JTZ%"E4KUZTX4J-&E&4ZM:K4G
M&G3ITX14I2G.<E&,8Q;;:23;L9U:D*-.=6I.-.E3C*=6K-VA2IQ3<ZD[M>Y!
M)REJM%NCGOC9\:/"OP2\'7/BWQ$+V]G>XM=*\.^'-*A^T:[XM\1ZE(T&D^'=
M#M'*>?J.H7.(TW$10Q[[B9EBC9A\%PZYKGPV\8Q?$WQYI,7C_P#;%^/JOX<^
M&'PKL+II=,^$W@F+%Q_9T]^R7O\`8/A#PU&]IJ_Q-\;162'5M4>*&TL[J1],
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M8>M'EKYDY.K0RK#57*G@:$'FN(IXB6(PU*CZG\`?@1:_"'0;Z\U&\E\3_$7Q
MK>OXD^)'C>\"?;O$WB*\!DE6`/+*]CH&F"0Z?X>TE79+#388$DW7!FF?Z0Z#
M)XP/KC\N35/3?M/]G6'VU8EO/L5K]K6'=Y*W/D1^>L6[YO*$N\1[OFV8SSFL
M3Q7XO\.^#-!U7Q'XGU6TT31-(LY[W4M3O[B"UM+.U@0O+---/+$B*J@XRP+,
M0B!G95/YWB:V+S'&5L36<L7C\542DZ<4G5GI"E0H4:25*E2CI"AA\-3A1IQT
MITTC]`P]'"9;@X4:?)AL+AZ<I+GDW&E!+FJ3JU)/FF[WG.K5G*<FW>=N5+PS
M]K#XJ1_#/X-^*'L'CG\8>-H4^&_PXTDDK-J_Q!\;A]"\-6T8X=H;:\NUU+4&
MCR\6G6-S(BLX`KT7X+?#O2OA-\+?AU\--(E:XL?`?@[0?"EM=.@22[71=.AL
MGO)$4`++=R1/<RCC$DK`@'('R!\)=&\2?M1?%RQ_:-\9:;>:7\(_`QN[+]G[
MPGJL,UG=ZM<7(DM=3^*FK:?.BO#/JEHYLO#23+YMOICR78V/=5^A\<*1!5C0
M(H'`!Z9Z]NI)))SR<D\FO;SF,<JR[`9`JBGC(8F>:9[[-^UHPQ]3#K#8#`1<
M92C[3*\/5Q7MZEFX8C'XRA-M48N'AY7">:YIBN()TN7"K"TLNR1U(N-26#=>
M.*Q^+Y7K&.85Z6$<-;2I8'"R27ON<=U(8Q&W;<0W!8XQV`YZXY'XU\$?$75;
MWX\?M.>$/A+I$TJ>!O@+-IOQ/^*%W$"]MJGBJ[CF3P+X19?+57>U/G^(;Q"^
M^,0V/[M]X-?=^J&[%N[621R7`CF\I96*H9?+)BW$!CM,@"L,'Y6)P<`'\A?@
MI\&/VZX[[XG:9J2?#KX6)\1OB%K'BCQA\2+?4;CQ-XQOK.^DC@LK/P[8O;KI
M]K#I>EQ)9:3<7<A-L%)>S`;%>APC@J56EGN9?VIDV5XW+\!3PN7U<YQ:H0I8
MC-95\/5S'#86G1KXO'5,MPE.O)PPM'$UJ6(Q&!E##59>Y/SN,\=6C+*,JAE>
M9YIA\PQCGC*.787G53#8"#Q;PN(Q-2M2P]&&-K_5:2=62C*A3QD/>DX\GWO\
M3OVD?AO\(;NS\,7EY?>*?'FKQ'_A'OAUX/TZ?7O&NMS`'F+3+7Y;&U`54?4M
M6DT_3+<\37FYD2O-;[X<_'GX_P#V:[^)&N3_``;^&MV8VN/A=X%U6.7QOX@L
M7&Z6U\<>/X!&-)BNH]MO=:'X-50D3RPR^(+D,RKZA\%OV:?`/P8M-1GTFQEU
MGQAK4S3>(?B#XBG_`+9\9>(IG,;RRZAK=TK74<#R+E-/@>.SA141(_D4U]%Q
M1B-%0<`=!Z>U>;_:>6916:X=H/%8BGS<O$6;X'#RKRG+=Y9E&*IUJ&6QHM/V
M&)QE/%8]+V6(P]3+\1&<%U+*LVSZ$ZG$U:6#PU=J<<@RG$5,/"FE)33S/-,+
M6]MCZE63;J8?!U,'@^7GHXFCBX3TX/P'\-O!WPWT6UT'P;X:TSP]IUK%Y0M]
M/AC3S2OR^=<S?ZZZN)0`TT\[R2R.6:1W8EJ]`'0445X-:M7Q-6=?$XBOB:]1
MWJ5L35G7K5)MMN=2K5<JDYROJY2=[=[W^HPN$PV"H0PV$P]##8>FDJ='#T:5
M"C!))6A2HPITXJR6D8):))6204445F=`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!29`ZD#\:4]#G@
M=^WZ]J^:-9\!?$J[O-5U>P_:OU_0M%?49S!80^!_@U>6&C)-<".#2UU'4O"U
MQ=R_9VDCM8VOKF2[E?8)7>9R6`/I;(]1^8KSSXF>![#XC^%;OP9JVY]"UN[L
M4UU(KM[2:73;.Y34I+1&16$T=]/:6]C=P2X@ELKBZ6=98PT$OCTWPT^+=ML%
MQ^U_XG@,D9FC\[X=?`^+?$'B0RIO\'+NC#SP(77*AYHE)S(@,#?#WXI*"S_M
MC^(%4`DEO`'P+`"A=Q))\(``!<L2>`O)XJJ<Y4JM*O3E*%6C-5*4XNTH333C
M.+_FBU=/H]=[#3:O;JK?(W_VGE1?@IXDLMTD0O;CPWIR&WV[P;CQ)H\>U%8-
MP5R.<C&<YKZ#LT6&TM800!%;01C.`<)&J\@8`/'(QUS7YY?&OX??$[4?"6FZ
M?%^U?XE\2)J7C'PM8/9:?X%^"AF3&MV<DEQOT_P?++LLF2*2X4H4V%5EVK(#
M7L$O@OXBP.89?VTM6AF6YN+$PR^"/@-'(M]:(CW5DR/X3#BZM4EB:XMR!-"L
MB-*BAU)[9U%_8^7T4V[8O'XAN2<9/VE'`4XMQ:322HZ-O5W>KNQO9?._7737
M=^6FFMSZ*\<WD-GX2UV27!6>R.G*N\(6FU66/3(%#%7`)GNXP"489[5XI^SP
M%FL_B=K`B$8U7XS_`!%CA"K%%D>&[RQ\$L2D7RD1OX9,0RJ,`AXP,GQ+XA>'
M?B!'<:#IE_\`ME7YT*34&U77M2O?!WP/LM/TFTT!8K^*XN]03PFEC`/MS6?[
MF^GACD4$_,0*X7X&^'?%VE?!.#Q[?_MF7WAKPOKGB_XD>(!KFJ^%/@59:),_
MB?XD>*K^.Z&LZKX:2UV:E-.9K58[EHW6>&*U5HUA`UY5#)J\4ZD*V,QF!C+2
M#A]6MC)TG*Z<E+ZQA9KE2NXN$DU%MNEI#5;MV[:I;K?6R=]-MSZU^'J2-\7_
M`!U=2E-Q\&^$[<@/D\:QXBG+L&`<;O,SS\OI6?=^,[3P'>?M!>.+NR-_'X;M
M/#6+2T.V]U&:RT&6:QL,L"HFN[K5(K>%V!$8G!8;5KPOX=?#+XL:K\1O&ESI
M?[3_`(R57\,>#YAJL'P]^#5Y;:A!=+J%S`ML/^$+:'RHQ*9!-"Q64S9&%"DX
M^M_`CXU^*=`^.]E8_M*^*+^].LPP1VR_#?X3@:KJ&B^%/#&J6$5Y);^$1+&[
MW+1VP6S\H&)4;;O=W?KJ0IRQ=18J=Z6(P&1X>NDU%*A5KY6ZL9.STG"C!RDK
MR@E>+4MVFT[6VC%?.T5WMT_K6_EGPX\!?'_XZ?'OXU7GCWXL:W\$8+GPG\))
M];\&_"%+.#7$L-0TKQ!>:!IS?$C4;:?4M/OK"S>ZEU)=$L8K6XO+[*%6@#/]
M@>&?V./@+X1DFUN_\+7'C_Q$\#&^\5?%+7=8^(NNZE+&"T=S>R^)KJ\L&N%8
M$^9;Z=`Q)+?>9RWR[\`_A_\`&+Q1\8/C=J8_:/\`%VF:D=&^#7]H7T'P]^$M
MRU\X\#"YBMI(9O",EO$-,FO;NWCF@B0S+M^T,[Q*1]3:_P#"KXVZ?HVJZC)^
MU;XY9+33[ZX=/^%7_!K9L@M)IG+;/!8<#:AR00<XP<XKU^)\]S>>8T\%A,1_
M9-"EE^148X+*HK!4YJEE.71I4ZM7#QA7Q--.$%%8FM5=HPNWRJQS6?+;W4[*
M]G9MW36B2V^REUON>A_`KPQI=A\,/!\G]D:1;2WFBQ:A(EOIMI;H#J<\VHX6
M.*%(T0+<(51%"(#A0!7L']FVH#;(+5/E*Y6&-<`CID+TQU&>E?(_P^^"OQNM
M?`_A"*#]JSQK:QQ^&M%CCMT^%_P:DC@1=/MP(D>Y\&/.ZJ`%#3.\N%^9B<FN
MINOA!\<XX)IG_:V\<I'%#)))CX5_!+[B(S-DGP1Q\H//'UKY',XK%YABZDI3
MJRGC*\H.<G.3YJSY?XG-9M**:5K]=25.6U[W[Z]MK[;)>A>_9BBC?X<:EJ46
M&BU_XI_&C6[8GDBWO?BOXPCAW$?>#);B2,<!(W1`!CCZ.6(`@D+WXVC'/O7Y
MS_LM?"CXOZO\!?AQKFF?M.>.=#L=>TJ]\06NFCX=_"&[,"Z_K6J:P6DFN_!\
ML[37$EZ]U.DC'RIII(4"1QJJ_07_``IOXY?]':>._P#PV'P6_P#F*K;.:=)9
M]G52FH\LLSQT86BD_94\55I8?G3BFZD<-"A%R=I)JS]Y2'.5[+LK/JF]+V[;
M??KO=OZ;``X`P/045\R?\*:^.)Z_M9^.SCGGX8?!;_YBJ7_A3GQS.,_M9^.>
M.F/A=\%5_/'@KG\:X3,^FLCU%&1ZCKC\?3ZU\S#X._'++EOVLO&[!@0J_P#"
MK/@J/+/8J1X*R=IYP20>AR*<?@_\<6!!_:O\;$[E93_PJSX*Y4!0"HQX*P0Q
M^8D_,"<`XH`^E\CIGGTI,CU'YBOF7_A3GQU&[_C+;QSST_XM9\$^/F4_]"1R
M<*5R<\,>^#4I^$'QQ/7]J_QMTZ#X6_!8?GCP5SCWY]Z`/I;(]117S*/@Y\<1
M(K+^UEXX"!44Q'X6_!0JS*BIO+'P3O!(4'`(`R0!BE;X/?',[?\`C+/QP"'W
M$CX6_!4;ESG81_PA.`,?*&`#XYW9YH`^F<CU%%?-)^#WQN,81OVK?&Y?S=YE
M'PP^#"L8]V1#A?!84*%^4N`)#]XL6))0_!WXV;&1?VJ_&ZEG8E_^%9?!ICY9
M(*Q`-X,(VH`1G&Y@3N8T`?2]&1G&1G&<=\>N/3@U\UR?"'XX.6*_M7>-XPV1
MM7X8?!@A5*;=H+>"R>#EP<YW=\5ZC\/_``CXI\*Z?=VWBWXC:Q\2+^;46N[7
M5M7T'PMX>GL;(VEM`NE1VOA32M)LIH$N(;B\%Q<027;2WDL33&%(40`]#HHH
MH`****`"BBB@`HHHH`****`"BBB@!,C.,C/7&><>N*6OF7X\:WIWA74="UC7
M_P!K#0OV<]+U&&73;#3_`!*WP@LK+Q#J5NS3W$UA??$JQENY[N.WGMTGL]-N
M3%'&D,SPJ\C._DU[XKTS3?#&F>-=1_X*.>$M/\&ZU?2Z9HWBV]'[,UKX8U;4
MK=6>?3],UZ?2(]*O[Z%59I;2UNY;B-58O&H!(`/O.OEO]IO]EO0OVG+3P%9Z
M[XU\8>#5\`>*D\6:=<>$;JR@N)]06SN;!)F74+.^MH;ZR@NYY-)U-(#=:9=R
M&YM_WJHRY&C^'?&WB'PU'XST#]MN[USP?-93:E%XKT?PE\!-3\-2Z=;B4W%_
M'KMEX8GTM[*`03F:Z6Z,$0AE+R*(WV\UJ>HS:+X.T3XAZQ_P4&T72?`'B6XM
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MX<\7:&VL66D1`W&IMX4U[7]%\3RV=NLER8=(>YAAEDME%%CJ$^I^#M4^(FF_
M\%!=&U#X?Z&DTFM>.K'3OV<;OP=HZ6QC%P^J>)[?0I-$T](#-")FN[Z$1&6,
M.5,BYT_&.B^)O`GA&3Q]X\_;G/@GP(C:3YOC;Q;X:_9]\.>$D.OWMGIFA!_$
M>L^&K/1E_MO4-0L-/TD->#^TKR^M+2S\Z>ZA1[PV9XFAFD<XQ#J9GBY5.?%2
MQE><ZN-4H2I3]OB9<U=U%2J3=*HI*4*O+*Z5V95<LPW]F5<LP=.C@:+H2I4(
MT*480HW<&U"$4DE)P3FMIV]Z]W?G[G]OWX27=FMM\//"_P`4OBGXF*11P>%?
M"/P_\1)J4MPT8)AGNM9L=,TRP*#/FO>WL*(5*@L^%K&T7X0?%+]IC7]*\9_M
M,:1IOA#X<^'-1CUCP9^S_IVH?VFU_JT0B?3?$GQ4UVV1+35Y]-`>33_"6G?\
M2:&>7S-8-Y/%+#-0\,^,?!OBW6=,\.>#?^"E_@#Q+XA\0ZC)I>C:%X8N?V6-
M9UK6]6CLY=1ET[3-,TK2KF_U+44T^&:_DM+2&:Z6SBENFC$*.X]/M?!WCFX\
M47?P]M?VW]4N?'&F:#9^*]1\&V_A+X"2>+K'POJ&I7VC6'B2]\/1>%FUFVT&
M^U;3-2TJSUF>S33[G4=.O;&"Y>YM+B*/TZ6?87+Z=6GD.3?V97G3A2CG&-S.
M6:9O1IR3C7C@G#`8#!Y?4G%J"Q5*E6QL8\RI8JC>7M/,CDV.Q<XO/,SCF&&Y
MHIY;AL''!X":W<L<I5ZU;&TTXPDL-*4<.YKFG0FU!P^MK*R6RACMX5ABMX0D
M<$,,8BCBAC4*D:(H"(%``"HJ(```H%7Z^`_B5XCTGX*7.FP?&3_@I)X=^$\^
MM9&CVGQ-NOV:O`<NJE7$3'3(O%&D:3)?D2LL9^S";#E4P&(!YKQC\5?AKX'U
M#2]%\>?\%3/ASX)U76M$T[Q1I&E^*?%7[+'AG4]9\-:T]Q%HWB#3;35[.RN[
M[0M4EL;V/3-6M(I;"_DMKI+6XE:WE"?-I6O=RDY2<FYR<I-RU;<I-M_?IT/H
MTHK2,5%)1BE%*,4HJR22LDDELDD?H[(F_'3@GKGO]"*$0)G`4%O08)QGOU/:
MOSH\0>/?`OA7PIX6\<>*?^"H?@OPWX)\=$OX'\9:]XD_9AT7PMXOC@5C*OA3
MQ#J%A;:1XA155FF;2;N\*!225`-;?C?Q%X8^&GACP_XS^)/_``4AT'X?^#_&
M$H3PEXM\;:[^SIX2\->)I6MTN1%X<UW7-.T_2M:9K;%R$TVZN6,#^:`8RK4.
M,6XMI7BVT]G=JVMM_G<.M[OTOHO1'W_N7U'KU'3UHR.F1GTS7Q&GAJ]U3P6_
MQ0M/V[]4N/ARUC)JR_$&Q_X4?)X(CTBV9S/?IXK@T)M!_LZ$AQ-?-?F"+:0\
MHV\>>Z;\4O@QX@\)^)O&VB?\%/?`6K^"?`Z:<WC;QEH_Q,_9ROO#/A/^UK^V
MTG2Y?%'B.S\[2O#W]J:K>V>FZ>=4O+-;S4+NVL[;S+B>&-F,_1[(]1^8I<CU
M%?G/\-?$/PI^.^NWWAGX-?\`!2C2?B[XCTG2SK>K^'OA-\4/@5XVUW3]'>>*
MS76+_3/!RZKJ-AI@NKB"V6_F@BM#=30Q>:9945O.M?\`BK^RYX;UO5O#/B7_
M`(*W^#O#OB/2+FYT?6O#^M?M)_L^:1KFD:IITS0W]GJ.E7^H07^G:E:3?N+V
MUN8(I[>1!'-$C@B@#]7,CU'3/7MZ_2C(]1TSU'3U^E?G?\._!?@SXQ6NIW7P
ME_X*'>-OBC::.+&36;KX<?%GX9>-K?2DU>">ZTHZE/X9M]3CL(]1MK>YN-/^
MTO$MY!;S2V_FQPNR\QXIN_@UX)^'>@?%KQ=_P4VO/#'PL\5316WA;XEZ]\;/
MA!I?@7Q+,WVG;!X?\87@BT+6G86=VS1Z=J%SA+2[=MJ6\S1@'Z;Y'J/SI<CU
M%?G#_8WPW;0/`_BX_P#!1WQ$OA;XJ:[I?A3X9>(O^%R?"H>'OB#XJUJ5H='\
M.>!-8*?V?XN\0:O,K1:9HV@W.H:A?2(8[6VE8$5IZUX,\(^'?&%Q\/=?_P""
MA7C70?']AX2O?'=[X'UKXJ_#+3O%UKX&TQ;M]2\:7?A>_MH=8M_"E@NGW[WW
MB.6Q32+5;.[:>\C%M,4`/T+R/6C(Z9Y]*_,SX=W'P<^+XUN3X3_\%.)OBB/"
MFD?VWXG;X=?&_P"#'C0>']&E$_E:WKY\,MJ8TC3?]'G\O4+_`.S6;&WEQ*?*
MDVU?AOJ/P0^+VJZQX>^$W_!427XIZ_HEG<ZEKNC?#OX^?!CQKK&B:?:-MN[[
M4],\-2ZG>:99VK?)<W=W!##"V5ED4\4`?IYD>H].O?TI:_,SX:ZE\&_C)J^L
M>$?A)_P4SG^*.O\`A^*YO-;T3X>?&_X/^-?$6E6MJ\4=U=ZI8>'O[1U"RL;6
M6:&*6YFA2VBEE1'E5W4'8L;3X;Z[X2;QSH?_``4;U[6/`]MXLM?AY-XST3XO
M?"K4O#$7CW4O$%GX1T[P7<^)-/2;2E\87GBN_L/#5EX;FO!K-SK][;Z-!9/J
M,\5LX!^C>1ZT5\BK^S!XR5V;_AJG]H,[T*LIUS0,`\8>/_B1YB=<=4(SDYS3
MT_9C\8+NW?M2_M!2AD*8EU[0V()((8-_8F01C`[<T`?6V1C.1CUR,?G0"#T(
M/T.:^16_9=\6,1G]J7]H7:!]T>(]&"D_WCC1<_09P.U._P"&7O%(``_:C_:'
M&/[OB?2E_0:/B@#ZYHKY(_X9@\5'K^U'^T.<#`QXHTI<>YQH_P`Q^M-_X9>\
M5?\`1TO[1/\`X5.E?_*>@#ZYR,XR,^G?_/(HKRWX8?#?4/AWI]_9:E\1?'7Q
M&FO;_P"VIJ/CK4;;4;^R3[-%;&RM);:UM52TS%Y_ELC'SG=MV#BO4J`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@!#C!STP<_2OYF/CW\/M3\8?$O]JG
M_@FC'?7=E9?M._M!Z1\;O#D1,L<-E\+_`!+\*=0U?QEJ5M<V\D<YAT3XJ>#_
M``G>S*AC$%UJ1<DY*O\`TT=:\EO_`(%_"G4_B_H?QZO?!NES?%OPWX0U7P)H
MOC4K*NJV7A36[J"]U/2499!$\-S<6T+,\D;S(J;(Y%0E2`?SN>,?%>B?MK?`
M/]IWQG\0O!NC>*-*_9Y_X)I>#O`.K:;XJT'3=?L]`_:3\>76N_$;XLZ.EMJ5
MK-;#Q%X`;X/_``3U2&]6);_2]1OK*YMIK:>-7;H_VMOV/?V2M$_X)/\`P:^)
M.B_LT?`+1OB)=:3_`,$^K6X\::9\'?AY;>)7M_%'QL_9^TKQ9;OK4'AX:@8O
M$.D:OK&G:Y$+K;JECJ-]:7PGM[NYCE_:R[_8C_9FN_`'Q;^&`^&EE9>"_CI\
M2=9^+?Q4TG2]4UK2V\7>/?$%QI=QK&M7U[8:A;WT:WSZ+IT<MA;7$.G_`&>W
M^S+;"!Y(VZ!OV3/@++\$M/\`V=KOP/'J/P@TO4O"NK6'A'4]6UG48;:]\$^*
M-&\9^%7COKR_FU$1Z'XC\/:-J%C!]J\F(V$,(3R`8R`?@5^VU\#_``M\%OVX
M?A3>_LH_"/P+X`\2?!CX%R?&/P/\._AAX2T/P'H/B2_@^.'@'3/'^B?V'X4L
M]&TF>]\7^!HK[2G,UI*]W=0:=&P9HX=GS-')IW[2'QD^!&O^!/@[\(OVA-)^
M)7_!07_@H%XPTCX6_'6WTYOAMXAMKW]FR'7A_P`)A!J>@^(;0W/AV-)M2M3>
MZ)>RV^O:;:Q1&WE$,\7]+'Q9^%_@BZ_:0^`WQ%'AVW?Q[,/$WA&Y\1K(PO$\
M&V5C)XJ.E%'D\HVI\0V&GWK,(O-$T,>),9!^6/VLOV'OV2M/^%=IX7T;X,Z2
MOB[Q7\6=?U/X5:?I6IZ_I(M/C-\:X4\/^)_%43Z7JUC)!;C1+>ZU?6[83PV)
MTS2KJ)8XQ*5?UX8>GBZ.2X&$:DJV/IXE.I6:5.$)XNM14I2C=PHTH4_>G;W%
M&3VBVK:^'72U]NUM;7=W:UUUL?GE<?LP>(/BK;?"'XE>%?V4?V(_#^C?";XD
M_$Z?4?V+/#1\,:!\%/C%8V^DP:-=?%"WM9/!>C:#XA\6^%M5@N5L;C7?"VH:
M9!&AEBO(IVBG7C/A5\*O#OQR^&O[-7Q'^!/[/WP=^)?@_P#9\LOVHO`7Q/\`
MV)OC-JNE6OAJR^+?B/QMH4_C7XP?#W2M8B\1>"M7;0=;MM:TG2=VDKH&DVGC
M*[LM!72;Y[J(?J]K'_!,_P#8Y\#_`+-]_P"$;GX5P:M_P@GAK7?$]CXAN]>\
M2KXF3Q1;^&#!J&M66O1:L-3TQM9>QBGOK&PN8K"1W*FW90";7CG]@/\`95N_
MV<_AQH=S\&=!M]0^%_@Y-+\$7/AN[U3PQJ]C<>)KFVOM?M!J^@WNFZC?Q>)-
M<F;5M8AOYYQJNJE-0O$ENU$@UQ=2.(C6I86,H4:^<T<#EW-*4^:G0PN.5.<D
MY\R49XB-5)-RA&6EG[B?*V]&K)][K9>7^?IWRO\`@EUXJ^$7BWP1X^O_`(*?
M"V7X,^%=#U]/!^K?#C,)L/"_C?09[J#QE8:3]@O+O1FTM]9>:YL7T1HM*$,P
MCL[>W1#$OWE\*#<R'XHW-P"1/\3_`!!]F;*L'M['1]`TV/A>5"/9R1LA)8&,
M\X(K@?V>?A;\/_@Y>^/OA[\,_#&F>#O"/AF7P;8:5X>T:V%M86<+^&+.[DDX
MRT]U=7$\MS=W,S2W,\\CR32N[$GT/X0JYT7Q?/)Y6ZZ^(7CV5C%YH0FWU^ZT
M]6*R_,KM'8HTP4F,S&0QDK7/CZBKSQM:'-[+^SN'8+F>J=7!TZC>[^)T7)N[
MU2UT3&U:,K_%>.VFEE^&J>ENG30\-^!VDIHG[3W[6-I:SR-9W-S\)M2CMGCP
MEI+J/@IYKF&!LX$)F0RH@`\L2$```5]0>/97A\"^+Y8HS+)'X:UYHXP,EG&E
M76U<9&<G`QD9S7S]\+5(_:>_:;9ILAK#X,A+<(5V!?!E\3*9"`KM,6VE02RK
M`@.`P%>\_$BX>T^'GC:ZCB>9K?PMX@F$*`%I/+TB[;8,D#G'7((Z@@UTYS.<
M\\P$IR<I2R[AIR;>LO\`A'RO5O?;=]=]=P:M+Y1?_DR_KYON=)H$*V^A:/`@
M(6'2[&)0>H"6T2@'@<C'/`^E87Q"U<Z'X&\8ZOC(TSPIXAU)L`[MMCI%Y<M@
M@Y!Q&,8YSWKH=$;=HVE-@C=IUDV#U&;:,X/N.]>._M'ZL=%^"'Q1O5?8_P#P
MA>NV22,0%3^TK5M-+-D'A?M8;IV.,'!K@P<)5LXR^BO>EB,TPM&S=E*5?%4Z
M4>9[J//43EV5WND0E[]NS]=AG[,NEC1OV?/@KIP1XVA^&W@^21'<R$276B6=
MY*-QYQYMP_N`.?6O>*X3X:Z>FE>`?!&F1AA'IOA+P[81;P58QV>BV5NF4/W"
M!$`5[$'UKNZRQU15\QS+$+18C,,;6Y?LQ=3%59/E72[=W_2"6EE>_6]K/7_A
MO(****YB0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`/Q!_X*JVFHW_[4_\`P2VLM'M?A/?ZG<?&']IP6EI\<V=OA.\B_LG_
M`!">4^,8TM[UC:):QS2:2OV.=)/$:Z3&Z*9!(OYB_#FQU^Q\:ZUX&\/?";X,
M_%CXF:5_P49NM:\1>"?!U_HNF?LQ>+[SQ1\!+ZXL])^'GVVQO](TF#1=)T\W
M/B6QO+*::3Q(YN)X89KM5C_J*^,G[-GP#_:%C\/0_''X1^!/BK%X3O;S4O#,
M?C?P_8Z\F@W^H68T^^O-*%[')]BN+RQ'V.YEAVM-;,T+DQLREWAS]F[X">#]
M.\(Z3X4^$7@+PYIO@+7)O$W@NRT7PYIVG6_AGQ#<V4^G7&M:.EK#']CU.>PN
MKBTFO8\3R02O&SE3B@#^<C1?'-_\-O\`@GE\>?ACX4LO^$6_:&_:U_;8\??#
M^^_9E^'>CF#4/V>/%/Q8NM#F\3?"3PCX6*Z=#%_PCWPT\,ZS\2K6_P!+MK#P
M[XHU+Q!JVOZ()+;6/.DX_6?&6A6/P'^`/[*WC30=6\,6O[,G_!63]E+PY8^$
M_BMI%II&JQ?L_>,M9UW7_`M_XET?4;B^MX-/E\.ZAJ.EWS7EQ)9O]DN(9"8U
M=:_I?O?V9/V?=2^*]G\=+[X/^`;KXQ:?-8W-G\29?#NGMXOM[G3-*U70M/ND
MUGROM7VJST;7-6TRWN6<SQ6-_<6R2+$^P8?Q%_8^_9<^+NJZUKOQ0^`OPO\`
M'NL^)&\,OX@U3Q1X3TO5K[67\&)J<?A-]2N;J%Y+M_#J:SJJZ.\S,UB+^Y\@
MIYK9`/Y\_P#@I3X<_9[\,^(/VC;7]E6/P;IW]N_L0?$R^_:9T7X2?V5'X(>&
MV\3^$E^%NM^+]*\,HOA6U\:RZFNI6FEW,MM'KUYI#7RS;[2-2OU[_P`%//&G
M@[Q=_P`$JM+T'PEXQ\!:]KMMXN_8*+:==:MI6MZ;;21_M._L_6J/XFTRQN99
M_P"PX;V6WCU=#&@^SLT7655?]6]!_9-_9G\+_#WQ1\)_#OP*^&&B_#?QM:M8
M^+_!>F^$-(M=`\36;[-UMKEC%;*FIP?NTQ'=^:B[1M`KS*T_X)S_`+"=AI/B
M/0K+]E#X'6VB^+M-TS1O$VE1>`M%6PUS2M%\2:!XPTFPU&V^SF*YMM.\4^%O
M#>OV<;J1;ZKHFFWD>V6UB90#X"\2?LN^*?BY^SE\6[3Q+KW['GA_XL_#B\TC
MXS?`SXA?LF^''T*X\"_$+X=1WFMZ)JGBIDB@N;FSU&:&;0-2LED:VU#PWJNJ
MVEQ'*LNT_0G_``2S\-:AXU^!US^VA\1+U-:^.'[:MOX;^+7C'4H@_P!D\*>`
M;?39K'X0?"#PVSJI@\+?#_PG,T[0Q1PIJ'C'Q'XP\131FYUEWK[.^%_[+/[.
MGP5A\20?";X,_#_X>P^,+$:;XIC\+>'K+24U^Q"RJ+755MHU%Y$%GF7;*&&)
M&'>O3_`W@/P;\,_">@>`_A_X:TCP?X,\*Z18:!X;\,:!91:=HNAZ+I=NMKI^
MF:986ZI!:65I;JL4$$**B(H`'%`'X#_#'4?!.F?$W_@HKXM^('PS^#_Q>_:^
MT_\`:"ETJR\#?'CQ#X0\-W<O[/L-CI4/@2+PCK'CZTO;:S\&P>%KK6-4M[31
M8'LM4U8WUM=`WMPS#Y@^"&M6?QT_:7\*_$?X)^#OV2_@]X0\:_\`!.#]FCQ5
MX7^'/[17ANVUSP;X.T;6OB)\5+NS\.^#88Q;P:9-IHO?+:"R@B@CL=EI;10V
MT<<:?TA?%3]E']FSXX:M8:]\7_@A\-OB/KFF110Z?J_B[PKI>L:E:PPN9(H8
MKVZ@:X$2.25C:0H,D``'%9/BG]C+]E'QOJ6FZOXM_9\^%'B#4M&\.:3X/TB\
MU/P;H]Q-IGA;0GN)-'\/V#-;C[+I&FR7=R]G8PA((&GE,:*7;(!^;GP4T;X-
MR_M@?&?3/VI(/V<;C7-)_9M_9YT_X*3II_A:T^&4WPWFA\7R_%6;X-V/BD36
M-CH=S\4S>0>)X=+"7CP6WA2/5@T,6G$_E[]A@B^(OPNT3X#>`O"/Q/\`@-9_
M\%,_C,/V8OA[KD]C9?"_Q7I5Q\![JZ\<Z%X?N+JQO]"M_`UIXY77Y-#6ULI=
M#2Z26/381"J,O],GB?\`8R_91\:^%/"/@;Q;^SY\*?$?A'P#;2V7@KP_J_@_
M2;W3?"]G.=TUIHL,UNWV"VF/,L$#+%(>70D`UZ3;_!3X1VEOX"M;3X<^#[2U
M^%MXVH_#FVM=!T^VM_!.H26$^ER7OAJ&&!(])NI-.N;BSDGM%CD>WFDC9B';
M(!_+WH&A^!M)^"W[,?ASXJ/H^B_!/7/^"G_Q4\??MN_!FWL9M#\`?L_>-/'5
MEXN\5?#WX(>+O#,B00V'PJT;XAW7@RZ^VZC:6OA;Q+=:E9^)+:V_L;6(%BZG
M_@H)\6OASXH\`_MM?"#0?V?O@AX'\0^&?A_^R_XH\/?%_P"'7B'P?KT'C+X;
MZC^V!\.=,T/2O%+>$[*UCTRUMM1TB;4)=`U*[GECL+F1H!BX&_\`I8U'X'_!
M[5[WQWJ.I_#3P5?WWQ/L](L/B+<W?A[39Y/&UIH%K)8Z)#XG\R!EU@:79RO:
MV+7JRR6\&V*-U1$"\'HO['_[+7AWPCXE\!:%\`?A3I7@WQDUBWBSPW9>#-%A
MTGQ%_9FHPZQIRZQ:K:[+Z.PU6VM]1LXY]\=O>P17$2K*BL`#P']D#P_K&D>.
M/%4NLZ_^Q?K+2Z`?LT7[-7A33]`\66\AU*#SG\07%O=7$]QH)(=44A`NHO")
M`NV,-X9^VW\,/AC;?MF_\$J(D\`>!XE\2_M._'\:]"GA/0U&OJ/V-?C_`*AL
MU98]/":FB:D(-2*WZW'^GPP7O,\1DK]&?AQ^SK\"O@_JUYKWPN^$W@3P%K6H
M:<=)OM4\+>'M/TB]N]-,T%RUE//:0QO+;M<6MO,T;$J9(8W(W+FO0-;\%^$_
M$NK^%=?U_P`.Z1K&M^!M1O\`5_!VJZA8P7-_X9U35-'OO#^HZAHMS*C2Z?=W
MNAZGJ&DW,]LT<DUA>W-J[&*9U(!^%OP1\,_'RU_;@_X*1:7^S1K?P@\`^&](
M\9_`E=<T;QIX,U;4XI7?X5W4MLGAFU\,:CH]GI-F(I;GSEE@<RW4IF4#G=\K
M?\$NM4\!Z=X\_8@UOX]7WAO2_"*?\$S$TW]GC5_&<UC;>%3\2)?CYXV'[04&
MCW.O.=.@\:/X0L/A.K[1'J<OAMM7CM97LI=2B/\`3KI7@+P7H6L>)_$.C>&-
M%TS7/&DUE<>+=7LK""WU#Q'/IMLUGI\NL742+-?O8VC-;6K7#.8(&,495#MK
MSO6_V9_V??$O@W0?AWK_`,'/AYK'@7PM(\OAOPEJ'A?2KG0="ED+F232=.DM
MS!8/(9)#(ULL1?S'#Y#L#<9149)QNWL]-/G^GZV`_F$\7_"GP5\=?CCKGP>^
M$&H6>@?LV?%C_@H?XWT?X0^+/",=O#X<\-_%`?L,?&K4_$/C/X81VRII<7_"
M%?&/3=*\8:7?:'Y=FOB[2OMMF3/%N;T;6_!GQ=TG]HRV^+G[1VDVOAGX\_M`
M_L5_MXZWXN\,PW-M=0^"_#G@/X;>&/!OP_\`!MC<VC,DUE;Z?;ZSXVN((Y7%
MKKGCO68PJ%$5/Z6]-^#7PHT:Q\&:9I'P[\(:7IWPZU"35O`=EI^A:?:6WA#5
M9M-O]'FU+P]#!!''I=_+I>IZCI\MW:+'/):7MS"SE)G!T?$/PQ^'OBS5;?7/
M$O@[P]KNLVFC:WX=M=4U33+6\OK?0?$D2P:_H\-S/&\L>G:S`B0ZE:*PAO(U
M5)U=0!4`?S*_#3]E_P`2?'O]CSX6^+_C=H_PM_8]^#>D?L,>+/@R?C=X>U_3
M-6\8_$Q/CEI?PQT31=0^(J:?IFEK8>!-`G\-#5=3T;Q#J<[7NI:E:*TUE:P7
MURVK^T'\6O&FD_#OQK^S3XC^'W[,?COQRW[-6H:CX6^/7[*5U83W.F?`[PQX
MK\#V/Q?\,Z[X7L['^V_`>E:]\,)=>.FVNF:O>:7JDT-S:V,9>WB:OZ6/^%:^
M`3X+'PY;PAH$G@(:/_PCP\'2Z9:R^'/[#$/V<:2=(>-K(Z>(!Y*VIB,2Q_*J
M@8KBO`'[-OP"^%4^IW/PV^#_`,/O`]QK5J+#5YO#/A?2M*DU*Q4%197C6MNA
MN+0*S+]ED+08)'E\G(!^0G[5VH_LXZKXJ_X)QK^S+J/P[U+XQZ5\<?AXO@)?
MA-+X=N-6TK]GR'P]JUO\9+/4)?"^'TWX;?\`""W5W_;%E?20:9-JJZ0I@DU*
MWM&3\SM$LY?@[^S9\&BFGWW_``@'[7O[2G[+>M+>1.%TK3/CI\'?V_\`P/-K
MUC.T8"6UWXS^%>GG6X7F*QW\_@[Q#).7E$2O_57X%_9K_9_^&&K:AKWP[^#?
MPY\%:WJL,]MJ&K>&O"FD:1J%S;W4SW-S`]U9VL4RPW$\CRS1(ZQR.<NIP*WY
M_@M\);KPYH/@^Y^'7@^?PKX6U^S\5>'?#TVA6$FCZ+XETZ_EU6PU[3;!H3;V
MFJV>I3S7UM?0QK/#<S2RHX:1B0#TZBBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#Y^\2J+[X]_#N!E1AHWA'QO
MKD?F2*2CSW.DZ&3Y1&2'&HLJD'Y2/6N^\0_#GPWXK\6>"_&&M6K7NI^`9=3O
M/#4$SLUE9:GJMJMC-JZVP^1]2M]/-Y8VD[[A;V^I7H10TH9>(\16=Y8_'#P)
MKS6__$KOO"?BWPH]WEL1:A/?:1K=FD@(*A9TTJ>*-CD&1E`8,0#[R1P1[$<?
M3MT_#I797JSI_4*M*M.FZ>7RI7IRNE3JU<0JT)+5ISC4G=7BW&;NK2UTD[<M
MG9V5^MM(O1/9]=+:]=#P/]HW6#I?PPU?3(1YE[XMU#0O!MM`&(>=?$VM6.E7
MJH.^S3KB\DD`Y6-&(QC-7/&"_:;SX9>#@T>Z^\0VFH7,)<B273O"5A)K,\GE
M*<F`:A:65I-D%$-U"I.)%!XCXT:MH"_%3X,:-XDU"TTK2;"_\2>.);O4IHK6
MQDN/#>D_9[2![B=XX2V[4Y+A8V;<7MT9$=E%>C>$K>/Q5XID^)[F-]+E\/C0
MO!N4<2#3+J\CO-9U9_-4&+^W+BTTQ;6%,?Z#IL-P[;KIHX^SD6!R[*L1*/)&
MG3S3'.;CSNKC,8HX+`48RDG%QHRPLZ[48RDO:SBN7EBQK2RU[I^>EM.UDDVO
M2ZU*?P[4-\0_C1.&W!M=\+0\-E4:U\*:;$4"]`5X.1Z^N:T_@_<?:O!E[=@A
MA=>,?B9,C!=N8V^(GBE(6(_VH$B8>H-<?\"K]M7G^,'B"22,Q7GQ7\3:?"ZC
M:OV;0%MM*C.[<RL`(L;NY[GBNI^!*8^$O@JZ960ZKH$/B!U=2KH_B62;Q"ZL
M.<E6U,C(/)!("@@#+,8N"Q\$DG3Q&3X6<4X^[*AEN+4HZ:M0E3:LERQ=KM7B
MFY;3OO=+\(_Y+U/)?A=<._[4_P"TY`8B(X=)^"4BRMD!Y)O">KQM&I)P?*6#
MS>!G,F#U%?0?Q&4O\//'"@X+>$_$8!]"VC7@!_#-?/'PP1E_:K_::+9_>^'_
M`(&RH".?*70_$L/`R>#)$S[B`0<KCY<U]&?$!7;P%XS2-_*>3PMXB5)=N_RF
M;1[Q5EV9&[RV(;;E0<8R,YKJSF/+G>`2^SE7"\KZ6?M,FRR7=I6L^NR=TK,E
MO6+[V7I:2;_R-WP^"NA:*I.2NE:>"?4BTB!/X]:^?_VN'B;X`?$2RDW[]7T^
MSTBV,:%V^UZEK&G6ML`HY^::1!D=.M?0NC*4TC2T9M[+IUFK/MV[RMO&"VW)
MV[B,[<G&<9->&?M#VIU#PIX6T[<"+_XG_#:S>WR%^U6]QXMTZ"]@<D,PC:TD
MF<F(+(IC'S;2<8Y/*'^L>42FWR1S:A7E)65HT*\<0WJK+^'NU9;NR3$D^9VW
M3;U]>O4]WL8A!;Q1!=HB"Q*O951550,<85`JX]N]7J**\=*SD^LI2FWW<FV_
MZZ[D-WW"BBBF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110!!/;0W&SS41S&P="RJQ1QT9<@[6'9A@CM4QZ
M'OQ^)_\`UTM%)ZIV=G;1]O/733S`YC7_``EX=\4^2OB'0M+UI+1Q);QZKI]K
M?QQ/E3OC2YBE"O\`*N2N,X'7`J_?M;Z;I%Q)\L%M96DS_="I%%!`[_*!PB1H
MG`&%55Q@**V*XSXBB4^!/%_D!S,/#>MM"(R0YE72[MHPF.=VX#&.0>1R!50C
M*<J-)U*LJ:K4E"G*I.=*G>I3YY4J4I.%-RLY2<4G=MM[%)N\5M9K[]/UU\KG
MR7\-=0OO#7[)/B;Q3ILO_$XUS2OB3XDTJ1]H-SK7B'4]8CT)A("0S3WTFGI'
M_&Y9%4%F%?8WA;1X_#_AS0]!BY@T71M,TF(E0N8]/LX[-#CH/W<*_+_","OD
MGPMJ6A:_\*/V;O`FG7:&3Q#;^$M;OK.U02*VD^"X;3Q#JLLX575(3XDL])L9
MBV%EFN)8L.0R5]I1Y.[(Z_U+<<>V*]/.'*.*JPE#DGBLPS/&RCRM*-&E4I82
M@DW9ZU'B$D[_``-IZLN:T=][W^6B5OE9OS]3Y4\"?N/VL/CZA`5;GX??!.16
M(&Z5T'C^%B.YVB)`<]^]?0GC-+B3PEK\-HI>YGTC4+>!%**6DN+>2!0#)\F<
MR<;N"0`?2OGG18'M/VR?B($*K%JWP/\`AY?2("2TDNF>*O%EE',=Q('E1W<T
M>$"Y$F7#%4*_0_BYV&BO`CA);J\TZU4MG&)=2M1*./6`2]#GTKKSUQJ9GELJ
M;<E/(^&4W;:5')\'AJBTWM4I25[]+/712T[15K]='T=G\M[=+:G0V*E+*T5@
M59;:!2#C((B4$''&<]<=Z\.^,L;7FK?"#34C,K7'Q0T>]*+DL%T?3]4U0R8'
M!6/[-O.[Y0P0\-MKW>)2L4:G`*HJX';"@?TKQ?QRAN/BC\'8!O/E7'C'4"JD
MA,6VCVUL&?&!PU\-N[/(XQSGS<O<8YC3JRM:EA\RJ*][<T,#7E"]FG\2CKLM
MW=#INS?I_P`#]3VRBBBN(S"BBB@`HHHH`****`"BBB@`HHHZ]:`$5E<;E8,I
MZ%2"#]".#^%+35144*BA5'15&`/H!P/PIU`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%1RQ1SQO%*BR1R*R.CJ&5E8$,&4\$$$@@]
M02*DHH?^336Z:=TUYIZKS`\L\%?!OP%X`U?4=9\,Z)'8W>HQ-;\W-W<0V%I)
M=37TMCI-M<32P:5937L\MU+:V"00R3L9'1F`(]2`Q^0!_#_/>EHJZE2K6G[2
MO6JUZEE'VE:<JD^5))14I-OE5EIWU>HVV]SY9OX9=,_;'T6\966U\4_L]ZY8
M1N3A9;_PIX^T.Z,2DG`=++Q-),%ZR(LA7`@DKT[QS?7%WXB\"^'+/S/,O=<E
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M'I7DQDXRYXZ/DJ0\N6K!TYKYPDUY7,D[7\U8****0@HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BD`QG'<Y_'N?QI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@!CH'!!)&1CC'OZ@BFK$J*%7.!SVZ_E_G\:
MEHK/V<&V[/WFFUS2LVFFGRWY;II.]KCN]OZUT_(!P`/2BBBM!!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
-10`4444`%%%%`'__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
